Last updated: 2022-08-20
Checks: 6 1
Knit directory: genie/
This reproducible R Markdown analysis was created with workflowr (version 1.7.0). The Checks tab describes the reproducibility checks that were applied when the results were created. The Past versions tab lists the development history.
Great! Since the R Markdown file has been committed to the Git repository, you know the exact version of the code that produced these results.
The global environment had objects present when the code in the R
Markdown file was run. These objects can affect the analysis in your R
Markdown file in unknown ways. For reproduciblity it’s best to always
run the code in an empty environment. Use wflow_publish or
wflow_build to ensure that the code is always run in an
empty environment.
The following objects were defined in the global environment when these results were created:
| Name | Class | Size |
|---|---|---|
| rv | list | 2.9 Kb |
The command set.seed(20220803) was run prior to running
the code in the R Markdown file. Setting a seed ensures that any results
that rely on randomness, e.g. subsampling or permutations, are
reproducible.
Great job! Recording the operating system, R version, and package versions is critical for reproducibility.
Nice! There were no cached chunks for this analysis, so you can be confident that you successfully produced the results during this run.
Great job! Using relative paths to the files within your workflowr project makes it easier to run your code on other machines.
Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.
The results in this page were generated with repository version 540aa2c. See the Past versions tab to see a history of the changes made to the R Markdown and HTML files.
Note that you need to be careful to ensure that all relevant files for
the analysis have been committed to Git prior to generating the results
(you can use wflow_publish or
wflow_git_commit). workflowr only checks the R Markdown
file, but you know if there are other scripts or data files that it
depends on. Below is the status of the Git repository when the results
were generated:
Ignored files:
Ignored: .Rhistory
Ignored: todo.org
Unstaged changes:
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_(gene_pathways)_mutation_signature.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_agecat.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_mutation_signature.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_race.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_sample_type.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/any_mutation_tmb.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/cosmic_driver_mutation_(gene_pathways).csv
Modified: public/table/co_mutation_nscc_allele.Rmd/cosmic_driver_mutation_(gene_pathways)_sample_type.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/cosmic_driver_mutation_(gene_pathways)_sex.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/cosmic_driver_mutation_tmb.csv
Modified: public/table/co_mutation_nscc_allele.Rmd/inactivating_mutation_race.csv
Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.
These are the previous versions of the repository in which changes were
made to the R Markdown (analysis/table_s20.Rmd) and HTML
(docs/table_s20.html) files. If you’ve configured a remote
Git repository (see ?wflow_git_remote), click on the
hyperlinks in the table below to view the files as they were in that
past version.
| File | Version | Author | Date | Message |
|---|---|---|---|---|
| Rmd | b427d90 | abalan2 | 2022-08-19 | added table S20 |
| html | b427d90 | abalan2 | 2022-08-19 | added table S20 |
| Cancer type | RAS | Non-RAS | Non-RAS alteration type | RAS(n) | non-RAS(n) | Group | Mean | 2.5% | 97.5% | n_eff | Rhat | 00 | 10 | 01 | 11 | Driver | -log10(p) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| colorectal cancer | RAS_12-61 | SPEN | Any mutation | 375 | 11 | TMB quintile 4 | -0.65 | -1.89 | 0.52 | 1567.85 | 1.00 | 409 | 371 | 7 | 4 | FALSE | 0.53 |
| colorectal cancer | RAS_12-61 | SPEN | Any mutation | 340 | 31 | TMB quintile 5 | -0.42 | -1.15 | 0.30 | 1577.73 | 1.00 | 273 | 326 | 17 | 14 | FALSE | 0.62 |
| colorectal cancer | RAS_12-61 | SPEN | Any mutation | 39 | 107 | TMB quintile 6 | -0.83 | -1.53 | -0.12 | 1256.67 | 1.00 | 50 | 22 | 90 | 17 | FALSE | 1.73 |
| melanoma | RAS_12-61 | SPEN | Any mutation | 163 | 55 | TMB quintile 5 | 0.13 | -0.44 | 0.72 | 1551.42 | 1.00 | 210 | 139 | 31 | 24 | FALSE | 0.18 |
| melanoma | RAS_12-61 | SPEN | Any mutation | 10 | 56 | TMB quintile 6 | -0.06 | -1.31 | 1.22 | 1612.58 | 1.00 | 34 | 4 | 50 | 6 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | SPEN | Any mutation | 267 | 15 | TMB quintile 4 | -1.27 | -2.66 | -0.16 | 1478.70 | 1.00 | 482 | 265 | 13 | 2 | FALSE | 1.37 |
| non-small cell lung cancer | RAS_12-61 | SPEN | Any mutation | 476 | 87 | TMB quintile 5 | -0.79 | -1.32 | -0.28 | 1489.92 | 1.00 | 710 | 456 | 67 | 20 | FALSE | 2.49 |
| uterine cancer | RAS_12-61 | SPEN | Any mutation | 71 | 37 | TMB quintile 5 | 0.51 | -0.21 | 1.24 | 1484.69 | 1.00 | 170 | 57 | 23 | 14 | FALSE | 0.77 |
| uterine cancer | RAS_12-61 | SPEN | Any mutation | 15 | 77 | TMB quintile 6 | -0.56 | -1.64 | 0.56 | 1330.89 | 1.00 | 23 | 6 | 68 | 9 | FALSE | 0.49 |
| colorectal cancer | RAS_12-61 | SPEN | Any mutation | 754 | 149 | TMB overall | -0.60 | -2.58 | 1.49 | 1423.08 | 1.00 | 732 | 719 | 114 | 35 | FALSE | 0.25 |
| melanoma | RAS_12-61 | SPEN | Any mutation | 173 | 111 | TMB overall | 0.03 | -2.46 | 2.44 | 1518.03 | 1.00 | 244 | 143 | 81 | 30 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | SPEN | Any mutation | 743 | 102 | TMB overall | -1.00 | -2.63 | 0.65 | 1421.98 | 1.00 | 1192 | 721 | 80 | 22 | FALSE | 0.66 |
| uterine cancer | RAS_12-61 | SPEN | Any mutation | 86 | 114 | TMB overall | -0.02 | -2.80 | 2.64 | 1611.37 | 1.00 | 193 | 63 | 91 | 23 | FALSE | 0.00 |
| colorectal cancer | RAS_12-61 | KMT2C | Any mutation | 367 | 12 | TMB quintile 4 | -0.42 | -1.55 | 0.63 | 1578.07 | 1.00 | 399 | 362 | 7 | 5 | FALSE | 0.34 |
| colorectal cancer | RAS_12-61 | KMT2C | Any mutation | 320 | 61 | TMB quintile 5 | -0.58 | -1.12 | -0.04 | 1432.68 | 1.00 | 240 | 295 | 36 | 25 | FALSE | 1.43 |
| colorectal cancer | RAS_12-61 | KMT2C | Any mutation | 47 | 116 | TMB quintile 6 | -0.34 | -1.01 | 0.33 | 1315.00 | 1.00 | 51 | 21 | 90 | 26 | FALSE | 0.52 |
| melanoma | RAS_12-61 | KMT2C | Any mutation | 157 | 85 | TMB quintile 5 | -0.30 | -0.81 | 0.22 | 1247.58 | 1.00 | 176 | 127 | 55 | 30 | FALSE | 0.60 |
| melanoma | RAS_12-61 | KMT2C | Any mutation | 10 | 54 | TMB quintile 6 | -0.38 | -1.61 | 0.85 | 1553.59 | 1.00 | 24 | 4 | 48 | 6 | FALSE | 0.26 |
| non-small cell lung cancer | RAS_12-61 | KMT2C | Any mutation | 159 | 13 | TMB quintile 3 | -1.04 | -2.46 | 0.10 | 1460.96 | 1.00 | 451 | 158 | 12 | 1 | FALSE | 0.92 |
| non-small cell lung cancer | RAS_12-61 | KMT2C | Any mutation | 267 | 36 | TMB quintile 4 | -0.31 | -1.04 | 0.40 | 1466.55 | 1.00 | 469 | 256 | 25 | 11 | FALSE | 0.41 |
| non-small cell lung cancer | RAS_12-61 | KMT2C | Any mutation | 476 | 155 | TMB quintile 5 | -0.35 | -0.70 | 0.01 | 1547.17 | 1.00 | 648 | 427 | 106 | 49 | FALSE | 1.23 |
| uterine cancer | RAS_12-61 | KMT2C | Any mutation | 68 | 42 | TMB quintile 5 | -0.66 | -1.58 | 0.10 | 1397.71 | 1.00 | 147 | 60 | 34 | 8 | FALSE | 0.91 |
| uterine cancer | RAS_12-61 | KMT2C | Any mutation | 13 | 91 | TMB quintile 6 | -1.77 | -3.01 | -0.58 | 1448.30 | 1.00 | 15 | 7 | 85 | 6 | FALSE | 2.36 |
| colorectal cancer | RAS_12-61 | KMT2C | Any mutation | 734 | 189 | TMB overall | -0.45 | -2.28 | 1.48 | 1355.53 | 1.00 | 690 | 678 | 133 | 56 | FALSE | 0.20 |
| melanoma | RAS_12-61 | KMT2C | Any mutation | 167 | 139 | TMB overall | -0.30 | -2.32 | 2.04 | 1504.93 | 1.00 | 200 | 131 | 103 | 36 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | KMT2C | Any mutation | 902 | 204 | TMB overall | -0.58 | -1.73 | 0.53 | 1443.05 | 1.00 | 1568 | 841 | 143 | 61 | FALSE | 0.51 |
| uterine cancer | RAS_12-61 | KMT2C | Any mutation | 81 | 133 | TMB overall | -1.08 | -3.61 | 1.77 | 1426.94 | 1.00 | 162 | 67 | 119 | 14 | FALSE | 0.38 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 30 | 39 | TMB quintile 2 | -0.04 | -0.81 | 0.76 | 1262.86 | 1.00 | 60 | 18 | 27 | 12 | TRUE | 0.03 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 40 | 74 | TMB quintile 3 | -0.32 | -0.94 | 0.35 | 1412.72 | 1.00 | 50 | 21 | 55 | 19 | TRUE | 0.49 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 40 | 87 | TMB quintile 4 | -0.83 | -1.50 | -0.17 | 1443.10 | 1.00 | 37 | 23 | 70 | 17 | TRUE | 1.87 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 49 | 153 | TMB quintile 5 | -0.84 | -1.45 | -0.22 | 1331.44 | 1.00 | 35 | 21 | 125 | 28 | TRUE | 2.11 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 28 | 104 | TMB quintile 2 | -1.31 | -2.06 | -0.53 | 1517.90 | 1.00 | 21 | 13 | 89 | 15 | TRUE | 3.11 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 193 | 411 | TMB quintile 3 | -1.50 | -2.02 | -1.03 | 1540.23 | 1.00 | 24 | 61 | 279 | 132 | TRUE | 9.10 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 387 | 655 | TMB quintile 4 | -1.22 | -1.57 | -0.87 | 1395.91 | 1.00 | 51 | 124 | 392 | 263 | TRUE | 11.22 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 363 | 423 | TMB quintile 5 | -0.53 | -0.86 | -0.24 | 1449.90 | 1.00 | 95 | 154 | 214 | 209 | TRUE | 3.13 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 45 | 78 | TMB quintile 6 | -0.47 | -1.08 | 0.20 | 1412.72 | 1.00 | 66 | 26 | 59 | 19 | TRUE | 0.81 |
| melanoma | RAS_12-61 | TP53 | Any mutation | 17 | 14 | TMB quintile 3 | -1.35 | -3.77 | 0.26 | 1496.19 | 1.00 | 81 | 17 | 14 | 0 | TRUE | 0.73 |
| melanoma | RAS_12-61 | TP53 | Any mutation | 22 | 16 | TMB quintile 4 | 0.31 | -0.87 | 1.40 | 1330.98 | 1.00 | 72 | 17 | 11 | 5 | TRUE | 0.23 |
| melanoma | RAS_12-61 | TP53 | Any mutation | 165 | 119 | TMB quintile 5 | -0.28 | -0.72 | 0.15 | 1586.89 | 1.00 | 167 | 123 | 77 | 42 | TRUE | 0.68 |
| melanoma | RAS_12-61 | TP53 | Any mutation | 11 | 52 | TMB quintile 6 | 0.15 | -0.94 | 1.28 | 1388.73 | 1.00 | 26 | 3 | 44 | 8 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 83 | 180 | TMB quintile 2 | -1.13 | -1.68 | -0.58 | 1537.65 | 1.00 | 199 | 64 | 161 | 19 | TRUE | 4.10 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 159 | 324 | TMB quintile 3 | -1.56 | -1.95 | -1.19 | 1329.64 | 1.00 | 194 | 121 | 286 | 38 | TRUE | 14.52 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 270 | 450 | TMB quintile 4 | -1.41 | -1.72 | -1.11 | 1475.00 | 1.00 | 162 | 176 | 356 | 94 | TRUE | 18.70 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 491 | 996 | TMB quintile 5 | -1.74 | -2.01 | -1.47 | 1536.96 | 1.00 | 105 | 227 | 732 | 264 | TRUE | 34.74 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 277 | 216 | TMB quintile 2 | 2.65 | 2.07 | 3.41 | 1382.04 | 1.00 | 62 | 68 | 7 | 209 | TRUE | 14.81 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 459 | 392 | TMB quintile 3 | 2.51 | 2.03 | 3.02 | 1245.46 | 1.00 | 49 | 85 | 18 | 374 | TRUE | 34.74 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 243 | 206 | TMB quintile 4 | 2.15 | 1.52 | 2.71 | 1369.65 | 1.00 | 25 | 53 | 16 | 190 | TRUE | 11.44 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 38 | 34 | TMB quintile 5 | 1.98 | 1.16 | 2.71 | 1328.23 | 1.00 | 11 | 11 | 7 | 27 | TRUE | 6.17 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 14 | 77 | TMB quintile 2 | -1.18 | -2.03 | -0.38 | 1407.15 | 1.00 | 59 | 10 | 73 | 4 | TRUE | 2.25 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 27 | 167 | TMB quintile 3 | -1.16 | -1.86 | -0.46 | 1590.27 | 1.00 | 68 | 16 | 156 | 11 | TRUE | 2.98 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 48 | 132 | TMB quintile 4 | -1.37 | -2.02 | -0.79 | 1485.36 | 1.00 | 76 | 36 | 120 | 12 | TRUE | 4.83 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 73 | 68 | TMB quintile 5 | -0.68 | -1.31 | -0.08 | 1656.66 | 1.00 | 144 | 59 | 54 | 14 | TRUE | 1.52 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 11 | 39 | TMB quintile 6 | -0.96 | -1.86 | -0.05 | 1699.54 | 1.00 | 31 | 7 | 35 | 4 | TRUE | 1.42 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 163 | 378 | TMB overall | -0.61 | -1.43 | 0.16 | 1452.88 | 1.00 | 183 | 85 | 300 | 78 | TRUE | 0.89 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 1016 | 1671 | TMB overall | -1.00 | -1.83 | -0.14 | 1392.35 | 1.00 | 257 | 378 | 1033 | 638 | TRUE | 1.71 |
| melanoma | RAS_12-61 | TP53 | Any mutation | 215 | 201 | TMB overall | -0.28 | -1.67 | 0.91 | 1423.09 | 1.00 | 346 | 160 | 146 | 55 | TRUE | 0.17 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 1003 | 1950 | TMB overall | -1.45 | -2.36 | -0.58 | 1485.47 | 1.00 | 660 | 588 | 1535 | 415 | TRUE | 3.01 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 1017 | 848 | TMB overall | 2.32 | 1.70 | 2.92 | 1134.10 | 1.00 | 147 | 217 | 48 | 800 | TRUE | 13.28 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 173 | 483 | TMB overall | -1.05 | -1.72 | -0.37 | 1420.44 | 1.00 | 378 | 128 | 438 | 45 | TRUE | 2.75 |
| colorectal cancer | RAS_12-61 | ATRX | Any mutation | 375 | 19 | TMB quintile 4 | -0.56 | -1.44 | 0.29 | 1368.82 | 1.00 | 404 | 368 | 12 | 7 | TRUE | 0.68 |
| colorectal cancer | RAS_12-61 | ATRX | Any mutation | 338 | 35 | TMB quintile 5 | -0.60 | -1.23 | 0.07 | 1664.89 | 1.00 | 269 | 324 | 21 | 14 | TRUE | 1.13 |
| colorectal cancer | RAS_12-61 | ATRX | Any mutation | 42 | 59 | TMB quintile 6 | -0.24 | -0.91 | 0.50 | 1415.35 | 1.00 | 73 | 28 | 45 | 14 | TRUE | 0.28 |
| melanoma | RAS_12-61 | ATRX | Any mutation | 162 | 58 | TMB quintile 5 | -0.30 | -0.89 | 0.28 | 1323.07 | 1.00 | 209 | 142 | 38 | 20 | TRUE | 0.52 |
| melanoma | RAS_12-61 | ATRX | Any mutation | 8 | 30 | TMB quintile 6 | -3.02 | -8.22 | -0.40 | 1433.25 | 1.00 | 46 | 8 | 30 | 0 | TRUE | 0.86 |
| non-small cell lung cancer | RAS_12-61 | ATRX | Any mutation | 267 | 32 | TMB quintile 4 | 0.04 | -0.65 | 0.69 | 1480.76 | 1.00 | 476 | 255 | 20 | 12 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12-61 | ATRX | Any mutation | 481 | 160 | TMB quintile 5 | 0.12 | -0.22 | 0.45 | 1591.41 | 1.00 | 673 | 416 | 95 | 65 | TRUE | 0.31 |
| uterine cancer | RAS_12-61 | ATRX | Any mutation | 14 | 11 | TMB quintile 2 | -2.30 | -6.24 | 0.14 | 1374.48 | 1.00 | 120 | 14 | 11 | 0 | TRUE | 0.83 |
| uterine cancer | RAS_12-61 | ATRX | Any mutation | 26 | 14 | TMB quintile 3 | -2.44 | -5.76 | -0.11 | 1437.18 | 1.00 | 201 | 26 | 14 | 0 | TRUE | 0.96 |
| uterine cancer | RAS_12-61 | ATRX | Any mutation | 70 | 19 | TMB quintile 5 | -0.60 | -1.88 | 0.49 | 1482.72 | 1.00 | 179 | 66 | 15 | 4 | TRUE | 0.50 |
| uterine cancer | RAS_12-61 | ATRX | Any mutation | 12 | 112 | TMB quintile 6 | -1.18 | -2.33 | -0.03 | 1470.37 | 1.00 | 23 | 5 | 105 | 7 | TRUE | 1.33 |
| colorectal cancer | RAS_12-61 | ATRX | Any mutation | 755 | 113 | TMB overall | -0.45 | -1.85 | 1.04 | 1403.82 | 1.00 | 746 | 720 | 78 | 35 | TRUE | 0.26 |
| melanoma | RAS_12-61 | ATRX | Any mutation | 170 | 88 | TMB overall | -1.42 | -4.96 | 1.34 | 1547.82 | 1.00 | 255 | 150 | 68 | 20 | TRUE | 0.45 |
| non-small cell lung cancer | RAS_12-61 | ATRX | Any mutation | 748 | 192 | TMB overall | 0.09 | -1.20 | 1.38 | 1551.49 | 1.00 | 1149 | 671 | 115 | 77 | TRUE | 0.05 |
| uterine cancer | RAS_12-61 | ATRX | Any mutation | 122 | 156 | TMB overall | -1.57 | -3.75 | 0.30 | 1442.51 | 1.00 | 523 | 111 | 145 | 11 | TRUE | 0.87 |
| colorectal cancer | RAS_12-61 | ATR | Any mutation | 339 | 35 | TMB quintile 5 | -0.54 | -1.22 | 0.15 | 1466.63 | 1.00 | 268 | 324 | 20 | 15 | FALSE | 0.94 |
| colorectal cancer | RAS_12-61 | ATR | Any mutation | 42 | 65 | TMB quintile 6 | -0.87 | -1.70 | -0.11 | 1456.84 | 1.00 | 74 | 32 | 55 | 10 | FALSE | 1.49 |
| non-small cell lung cancer | RAS_12-61 | ATR | Any mutation | 159 | 12 | TMB quintile 3 | -0.50 | -1.67 | 0.56 | 1438.94 | 1.00 | 457 | 157 | 10 | 2 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12-61 | ATR | Any mutation | 268 | 15 | TMB quintile 4 | -0.07 | -0.94 | 0.82 | 1341.06 | 1.00 | 487 | 262 | 9 | 6 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | ATR | Any mutation | 475 | 93 | TMB quintile 5 | -0.22 | -0.68 | 0.20 | 1297.41 | 1.00 | 688 | 444 | 62 | 31 | FALSE | 0.51 |
| colorectal cancer | RAS_12-61 | ATR | Any mutation | 381 | 100 | TMB overall | -0.69 | -3.01 | 1.77 | 1405.21 | 1.00 | 342 | 356 | 75 | 25 | FALSE | 0.25 |
| non-small cell lung cancer | RAS_12-61 | ATR | Any mutation | 902 | 120 | TMB overall | -0.25 | -1.26 | 0.76 | 1618.20 | 1.00 | 1632 | 863 | 81 | 39 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12-61 | PDGFRA | Any mutation | 267 | 16 | TMB quintile 4 | -0.07 | -0.99 | 0.85 | 1474.49 | 1.00 | 485 | 261 | 10 | 6 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | PDGFRA | Any mutation | 476 | 115 | TMB quintile 5 | -0.29 | -0.70 | 0.13 | 1351.43 | 1.00 | 676 | 439 | 78 | 37 | TRUE | 0.75 |
| non-small cell lung cancer | RAS_12-61 | PDGFRA | Any mutation | 743 | 131 | TMB overall | -0.21 | -1.96 | 1.58 | 1582.11 | 1.00 | 1161 | 700 | 88 | 43 | TRUE | 0.09 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 192 | 22 | TMB quintile 3 | -0.50 | -1.35 | 0.29 | 1433.67 | 1.00 | 280 | 186 | 16 | 6 | TRUE | 0.64 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 381 | 85 | TMB quintile 4 | 0.22 | -0.21 | 0.65 | 1268.58 | 1.00 | 381 | 336 | 40 | 45 | TRUE | 0.49 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 357 | 160 | TMB quintile 5 | 0.39 | 0.04 | 0.74 | 1357.62 | 1.00 | 232 | 258 | 61 | 99 | TRUE | 1.54 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 38 | 65 | TMB quintile 6 | 0.42 | -0.23 | 1.09 | 1445.67 | 1.00 | 66 | 18 | 45 | 20 | TRUE | 0.64 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 26 | 30 | TMB quintile 3 | -0.36 | -1.56 | 0.71 | 1494.89 | 1.00 | 188 | 24 | 28 | 2 | TRUE | 0.27 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 48 | 29 | TMB quintile 4 | 0.17 | -0.71 | 0.96 | 1537.09 | 1.00 | 159 | 41 | 22 | 7 | TRUE | 0.16 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 70 | 30 | TMB quintile 5 | 0.41 | -0.35 | 1.16 | 1207.62 | 1.00 | 173 | 59 | 19 | 11 | TRUE | 0.54 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 14 | 47 | TMB quintile 6 | 0.48 | -0.52 | 1.51 | 1416.17 | 1.00 | 25 | 4 | 37 | 10 | TRUE | 0.45 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 968 | 332 | TMB overall | 0.15 | -0.86 | 1.08 | 1434.16 | 1.00 | 959 | 798 | 162 | 170 | TRUE | 0.12 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 158 | 136 | TMB overall | 0.17 | -0.92 | 1.28 | 961.07 | 1.00 | 545 | 128 | 106 | 30 | TRUE | 0.12 |
| uterine cancer | RAS_12-61 | NSD1 | Any mutation | 73 | 46 | TMB quintile 5 | -0.20 | -0.93 | 0.49 | 1252.32 | 1.00 | 165 | 62 | 35 | 11 | FALSE | 0.24 |
| uterine cancer | RAS_12-61 | NSD1 | Any mutation | 17 | 69 | TMB quintile 6 | 0.50 | -0.68 | 1.89 | 1432.73 | 1.00 | 21 | 3 | 55 | 14 | FALSE | 0.37 |
| uterine cancer | RAS_12-61 | NSD1 | Any mutation | 90 | 115 | TMB overall | 0.17 | -2.24 | 2.79 | 1333.56 | 1.00 | 186 | 65 | 90 | 25 | FALSE | 0.05 |
| colorectal cancer | RAS_12-61 | FLT4 | Any mutation | 375 | 20 | TMB quintile 4 | -0.02 | -0.85 | 0.83 | 1527.40 | 1.00 | 406 | 365 | 10 | 10 | TRUE | 0.02 |
| colorectal cancer | RAS_12-61 | FLT4 | Any mutation | 339 | 40 | TMB quintile 5 | -0.50 | -1.10 | 0.13 | 1569.68 | 1.00 | 268 | 322 | 23 | 17 | TRUE | 0.92 |
| colorectal cancer | RAS_12-61 | FLT4 | Any mutation | 40 | 72 | TMB quintile 6 | -0.33 | -1.08 | 0.43 | 1514.89 | 1.00 | 59 | 24 | 56 | 16 | TRUE | 0.41 |
| non-small cell lung cancer | RAS_12-61 | FLT4 | Any mutation | 267 | 14 | TMB quintile 4 | 0.32 | -0.61 | 1.38 | 1310.97 | 1.00 | 488 | 260 | 7 | 7 | TRUE | 0.28 |
| non-small cell lung cancer | RAS_12-61 | FLT4 | Any mutation | 476 | 74 | TMB quintile 5 | -0.19 | -0.68 | 0.32 | 1414.87 | 1.00 | 702 | 451 | 49 | 25 | TRUE | 0.33 |
| colorectal cancer | RAS_12-61 | FLT4 | Any mutation | 754 | 132 | TMB overall | -0.27 | -1.86 | 1.49 | 1401.88 | 1.00 | 733 | 711 | 89 | 43 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | FLT4 | Any mutation | 743 | 88 | TMB overall | 0.09 | -1.47 | 1.86 | 1426.44 | 1.00 | 1190 | 711 | 56 | 32 | TRUE | 0.04 |
| colorectal cancer | RAS_12-61 | PTPRD | Any mutation | 338 | 29 | TMB quintile 5 | -0.87 | -1.65 | -0.14 | 1551.42 | 1.00 | 271 | 328 | 19 | 10 | FALSE | 1.57 |
| colorectal cancer | RAS_12-61 | PTPRD | Any mutation | 38 | 61 | TMB quintile 6 | -0.56 | -1.34 | 0.21 | 1367.07 | 1.00 | 72 | 27 | 50 | 11 | FALSE | 0.81 |
| melanoma | RAS_12-61 | PTPRD | Any mutation | 169 | 147 | TMB quintile 5 | -0.32 | -0.74 | 0.12 | 1442.35 | 1.00 | 164 | 118 | 96 | 51 | FALSE | 0.86 |
| melanoma | RAS_12-61 | PTPRD | Any mutation | 13 | 115 | TMB quintile 6 | -0.15 | -1.40 | 1.43 | 1617.08 | 1.00 | 19 | 2 | 104 | 11 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 159 | 16 | TMB quintile 3 | 0.15 | -0.94 | 1.17 | 1223.60 | 1.00 | 457 | 154 | 11 | 5 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 268 | 53 | TMB quintile 4 | 0.58 | 0.02 | 1.15 | 1490.80 | 1.00 | 468 | 242 | 27 | 26 | FALSE | 1.40 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 495 | 298 | TMB quintile 5 | -0.01 | -0.28 | 0.24 | 1489.22 | 1.00 | 596 | 380 | 183 | 115 | FALSE | 0.02 |
| colorectal cancer | RAS_12-61 | PTPRD | Any mutation | 376 | 90 | TMB overall | -0.67 | -3.00 | 1.65 | 1538.76 | 1.00 | 343 | 355 | 69 | 21 | FALSE | 0.25 |
| melanoma | RAS_12-61 | PTPRD | Any mutation | 182 | 262 | TMB overall | -0.20 | -2.57 | 2.61 | 1462.12 | 1.00 | 183 | 120 | 200 | 62 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 923 | 384 | TMB overall | 0.18 | -1.49 | 1.84 | 1346.14 | 1.00 | 1528 | 776 | 237 | 147 | FALSE | 0.08 |
| melanoma | RAS_12-61 | PIK3C2G | Any mutation | 159 | 99 | TMB quintile 5 | -0.03 | -0.50 | 0.42 | 1532.12 | 1.00 | 174 | 119 | 59 | 40 | FALSE | 0.05 |
| melanoma | RAS_12-61 | PIK3C2G | Any mutation | 14 | 85 | TMB quintile 6 | -0.19 | -1.38 | 1.15 | 1447.50 | 1.00 | 17 | 3 | 74 | 11 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | PIK3C2G | Any mutation | 267 | 12 | TMB quintile 4 | -0.28 | -1.42 | 0.78 | 1245.60 | 1.00 | 484 | 263 | 8 | 4 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12-61 | PIK3C2G | Any mutation | 474 | 103 | TMB quintile 5 | -0.40 | -0.85 | 0.01 | 1291.06 | 1.00 | 679 | 443 | 72 | 31 | FALSE | 1.16 |
| melanoma | RAS_12-61 | PIK3C2G | Any mutation | 173 | 184 | TMB overall | -0.07 | -2.60 | 2.39 | 1615.92 | 1.00 | 191 | 122 | 133 | 51 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12-61 | PIK3C2G | Any mutation | 741 | 115 | TMB overall | -0.30 | -2.04 | 1.63 | 1342.25 | 1.00 | 1163 | 706 | 80 | 35 | FALSE | 0.13 |
| colorectal cancer | RAS_12-61 | CREBBP | Any mutation | 375 | 17 | TMB quintile 4 | -0.88 | -2.01 | 0.08 | 1370.09 | 1.00 | 404 | 370 | 12 | 5 | TRUE | 0.97 |
| colorectal cancer | RAS_12-61 | CREBBP | Any mutation | 341 | 49 | TMB quintile 5 | -0.24 | -0.80 | 0.34 | 1593.53 | 1.00 | 267 | 317 | 25 | 24 | TRUE | 0.38 |
| colorectal cancer | RAS_12-61 | CREBBP | Any mutation | 48 | 116 | TMB quintile 6 | -0.57 | -1.18 | 0.09 | 1514.97 | 1.00 | 42 | 22 | 90 | 26 | TRUE | 1.10 |
| non-small cell lung cancer | RAS_12-61 | CREBBP | Any mutation | 159 | 11 | TMB quintile 3 | -0.18 | -1.30 | 0.93 | 1414.85 | 1.00 | 459 | 156 | 8 | 3 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | CREBBP | Any mutation | 267 | 12 | TMB quintile 4 | -0.26 | -1.28 | 0.79 | 1262.95 | 1.00 | 487 | 263 | 8 | 4 | TRUE | 0.20 |
| non-small cell lung cancer | RAS_12-61 | CREBBP | Any mutation | 474 | 106 | TMB quintile 5 | -0.32 | -0.75 | 0.09 | 1556.61 | 1.00 | 685 | 441 | 73 | 33 | TRUE | 0.88 |
| colorectal cancer | RAS_12-61 | CREBBP | Any mutation | 764 | 182 | TMB overall | -0.50 | -2.33 | 1.33 | 1388.26 | 1.00 | 713 | 709 | 127 | 55 | TRUE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | CREBBP | Any mutation | 900 | 129 | TMB overall | -0.24 | -1.38 | 0.92 | 1265.32 | 1.00 | 1631 | 860 | 89 | 40 | TRUE | 0.17 |
| colorectal cancer | RAS_12-61 | AXIN2 | Any mutation | 375 | 20 | TMB quintile 4 | 0.52 | -0.33 | 1.46 | 1016.30 | 1.00 | 409 | 362 | 7 | 13 | TRUE | 0.61 |
| colorectal cancer | RAS_12-61 | AXIN2 | Any mutation | 338 | 27 | TMB quintile 5 | -0.70 | -1.51 | 0.08 | 1452.14 | 1.00 | 272 | 328 | 17 | 10 | TRUE | 1.08 |
| colorectal cancer | RAS_12-61 | AXIN2 | Any mutation | 38 | 63 | TMB quintile 6 | -0.45 | -1.25 | 0.31 | 1493.35 | 1.00 | 69 | 26 | 51 | 12 | TRUE | 0.59 |
| colorectal cancer | RAS_12-61 | AXIN2 | Any mutation | 751 | 110 | TMB overall | -0.22 | -1.96 | 1.50 | 1374.20 | 1.00 | 750 | 716 | 75 | 35 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | DOT1L | Any mutation | 267 | 24 | TMB quintile 4 | -0.47 | -1.27 | 0.23 | 1491.91 | 1.00 | 479 | 261 | 18 | 6 | FALSE | 0.67 |
| non-small cell lung cancer | RAS_12-61 | DOT1L | Any mutation | 475 | 75 | TMB quintile 5 | -0.27 | -0.72 | 0.20 | 1521.93 | 1.00 | 699 | 450 | 50 | 25 | FALSE | 0.57 |
| non-small cell lung cancer | RAS_12-61 | DOT1L | Any mutation | 742 | 99 | TMB overall | -0.36 | -1.34 | 0.66 | 1460.50 | 1.00 | 1178 | 711 | 68 | 31 | FALSE | 0.33 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 188 | 17 | TMB quintile 3 | -0.78 | -1.92 | 0.24 | 1461.57 | 1.00 | 281 | 184 | 13 | 4 | FALSE | 0.82 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 367 | 34 | TMB quintile 4 | 0.01 | -0.67 | 0.70 | 1440.87 | 1.00 | 389 | 350 | 17 | 17 | FALSE | 0.01 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 324 | 74 | TMB quintile 5 | -0.31 | -0.78 | 0.16 | 1540.22 | 1.00 | 237 | 289 | 39 | 35 | FALSE | 0.66 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 44 | 128 | TMB quintile 6 | -0.25 | -0.91 | 0.47 | 1408.75 | 1.00 | 35 | 14 | 98 | 30 | FALSE | 0.32 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 923 | 253 | TMB overall | -0.35 | -1.81 | 1.08 | 1567.64 | 1.00 | 942 | 837 | 167 | 86 | FALSE | 0.20 |
| colorectal cancer | RAS_12-61 | SMARCA4 | Any mutation | 375 | 16 | TMB quintile 4 | -0.79 | -1.86 | 0.24 | 1450.08 | 1.00 | 405 | 370 | 11 | 5 | FALSE | 0.86 |
| colorectal cancer | RAS_12-61 | SMARCA4 | Any mutation | 339 | 47 | TMB quintile 5 | -0.60 | -1.19 | 0.00 | 1400.64 | 1.00 | 263 | 320 | 28 | 19 | FALSE | 1.31 |
| colorectal cancer | RAS_12-61 | SMARCA4 | Any mutation | 43 | 100 | TMB quintile 6 | -0.22 | -0.88 | 0.46 | 1453.00 | 1.00 | 55 | 20 | 77 | 23 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 160 | 35 | TMB quintile 3 | 0.56 | -0.09 | 1.22 | 1404.06 | 1.00 | 450 | 145 | 20 | 15 | FALSE | 1.02 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 268 | 67 | TMB quintile 4 | 0.05 | -0.41 | 0.52 | 1441.75 | 1.00 | 455 | 244 | 43 | 24 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 479 | 194 | TMB quintile 5 | -0.12 | -0.43 | 0.18 | 1478.57 | 1.00 | 630 | 410 | 125 | 69 | FALSE | 0.33 |
| uterine cancer | RAS_12-61 | SMARCA4 | Any mutation | 72 | 39 | TMB quintile 5 | -0.59 | -1.50 | 0.18 | 1528.81 | 1.00 | 168 | 65 | 32 | 7 | FALSE | 0.76 |
| uterine cancer | RAS_12-61 | SMARCA4 | Any mutation | 15 | 52 | TMB quintile 6 | 0.13 | -0.86 | 1.14 | 1521.79 | 1.00 | 26 | 5 | 42 | 10 | FALSE | 0.09 |
| colorectal cancer | RAS_12-61 | SMARCA4 | Any mutation | 757 | 163 | TMB overall | -0.49 | -2.22 | 1.29 | 1419.88 | 1.00 | 723 | 710 | 116 | 47 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 907 | 296 | TMB overall | 0.16 | -0.70 | 0.98 | 1460.15 | 1.00 | 1535 | 799 | 188 | 108 | FALSE | 0.15 |
| uterine cancer | RAS_12-61 | SMARCA4 | Any mutation | 87 | 91 | TMB overall | -0.26 | -2.42 | 1.94 | 1743.70 | 1.00 | 194 | 70 | 74 | 17 | FALSE | 0.09 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 192 | 18 | TMB quintile 3 | 0.59 | -0.27 | 1.51 | 1397.74 | 1.00 | 288 | 181 | 7 | 11 | FALSE | 0.71 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 375 | 39 | TMB quintile 4 | -0.94 | -1.65 | -0.23 | 1620.29 | 1.00 | 387 | 365 | 29 | 10 | FALSE | 2.11 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 340 | 59 | TMB quintile 5 | -0.41 | -0.93 | 0.12 | 1482.37 | 1.00 | 256 | 314 | 33 | 26 | FALSE | 0.90 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 43 | 66 | TMB quintile 6 | 0.48 | -0.20 | 1.20 | 1545.16 | 1.00 | 72 | 21 | 44 | 22 | FALSE | 0.78 |
| melanoma | RAS_12-61 | PTPRT | Any mutation | 176 | 200 | TMB quintile 5 | 0.10 | -0.28 | 0.50 | 1581.91 | 1.00 | 153 | 95 | 119 | 81 | FALSE | 0.22 |
| melanoma | RAS_12-61 | PTPRT | Any mutation | 22 | 153 | TMB quintile 6 | 1.82 | -0.48 | 5.76 | 1413.67 | 1.00 | 13 | 0 | 131 | 22 | FALSE | 0.50 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 159 | 17 | TMB quintile 3 | -0.24 | -1.48 | 0.77 | 1376.22 | 1.00 | 454 | 155 | 13 | 4 | FALSE | 0.18 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 268 | 38 | TMB quintile 4 | 0.02 | -0.65 | 0.68 | 1473.24 | 1.00 | 471 | 254 | 24 | 14 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 483 | 272 | TMB quintile 5 | -0.48 | -0.75 | -0.20 | 1381.19 | 1.00 | 600 | 403 | 192 | 80 | FALSE | 3.00 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 950 | 182 | TMB overall | -0.08 | -1.20 | 1.08 | 1506.57 | 1.00 | 1003 | 881 | 113 | 69 | FALSE | 0.05 |
| melanoma | RAS_12-61 | PTPRT | Any mutation | 198 | 353 | TMB overall | 0.88 | -2.38 | 4.72 | 1475.90 | 1.00 | 166 | 95 | 250 | 103 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 911 | 348 | TMB overall | -0.29 | -2.08 | 1.61 | 1272.75 | 1.00 | 1530 | 812 | 249 | 99 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | HGF | Any mutation | 267 | 27 | TMB quintile 4 | -0.32 | -1.22 | 0.54 | 1588.66 | 1.00 | 477 | 259 | 19 | 8 | FALSE | 0.33 |
| non-small cell lung cancer | RAS_12-61 | HGF | Any mutation | 476 | 138 | TMB quintile 5 | 0.11 | -0.27 | 0.45 | 1496.85 | 1.00 | 673 | 419 | 81 | 57 | FALSE | 0.25 |
| non-small cell lung cancer | RAS_12-61 | HGF | Any mutation | 744 | 180 | TMB overall | -0.09 | -2.34 | 2.18 | 1563.69 | 1.00 | 1157 | 678 | 114 | 66 | FALSE | 0.03 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 194 | 51 | TMB quintile 3 | 0.92 | 0.37 | 1.50 | 1461.15 | 1.00 | 277 | 162 | 19 | 32 | TRUE | 2.80 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 378 | 146 | TMB quintile 4 | 0.46 | 0.09 | 0.84 | 1625.24 | 1.00 | 356 | 295 | 63 | 83 | TRUE | 1.91 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 352 | 209 | TMB quintile 5 | 0.41 | 0.09 | 0.75 | 1507.04 | 1.00 | 214 | 225 | 82 | 127 | TRUE | 1.76 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 44 | 95 | TMB quintile 6 | 0.40 | -0.22 | 1.04 | 1497.03 | 1.00 | 56 | 16 | 67 | 28 | TRUE | 0.66 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 83 | 18 | TMB quintile 2 | -0.77 | -1.78 | 0.04 | 1504.36 | 1.00 | 341 | 82 | 17 | 1 | TRUE | 0.97 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 159 | 34 | TMB quintile 3 | -0.23 | -0.91 | 0.44 | 1542.72 | 1.00 | 442 | 150 | 25 | 9 | TRUE | 0.31 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 268 | 56 | TMB quintile 4 | -0.66 | -1.26 | -0.12 | 1516.03 | 1.00 | 451 | 256 | 44 | 12 | TRUE | 1.64 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 475 | 123 | TMB quintile 5 | -0.41 | -0.81 | -0.04 | 1477.57 | 1.00 | 671 | 438 | 86 | 37 | TRUE | 1.46 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 14 | 33 | TMB quintile 2 | -0.04 | -1.20 | 0.99 | 1187.21 | 1.00 | 102 | 11 | 30 | 3 | TRUE | 0.02 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 26 | 103 | TMB quintile 3 | 0.18 | -0.55 | 0.92 | 1520.70 | 1.00 | 134 | 14 | 91 | 12 | TRUE | 0.19 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 54 | 121 | TMB quintile 4 | 0.66 | 0.09 | 1.24 | 1583.07 | 1.00 | 105 | 20 | 87 | 34 | TRUE | 1.63 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 86 | 196 | TMB quintile 5 | 0.15 | -0.34 | 0.61 | 1636.64 | 1.00 | 89 | 32 | 142 | 54 | TRUE | 0.26 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 18 | 95 | TMB quintile 6 | 0.33 | -0.72 | 1.40 | 1470.03 | 1.00 | 13 | 2 | 79 | 16 | TRUE | 0.28 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 968 | 501 | TMB overall | 0.54 | -0.36 | 1.46 | 1267.79 | 1.00 | 903 | 698 | 231 | 270 | TRUE | 0.62 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 985 | 231 | TMB overall | -0.52 | -1.17 | 0.08 | 1406.39 | 1.00 | 1905 | 926 | 172 | 59 | TRUE | 0.95 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 198 | 548 | TMB overall | 0.26 | -0.54 | 1.06 | 1593.32 | 1.00 | 443 | 79 | 429 | 119 | TRUE | 0.28 |
| colorectal cancer | RAS_12-61 | ALK | Any mutation | 375 | 20 | TMB quintile 4 | 0.30 | -0.54 | 1.16 | 1449.81 | 1.00 | 408 | 363 | 8 | 12 | TRUE | 0.31 |
| colorectal cancer | RAS_12-61 | ALK | Any mutation | 338 | 42 | TMB quintile 5 | -0.28 | -0.84 | 0.34 | 1602.33 | 1.00 | 268 | 318 | 22 | 20 | TRUE | 0.45 |
| colorectal cancer | RAS_12-61 | ALK | Any mutation | 40 | 45 | TMB quintile 6 | -0.57 | -1.43 | 0.24 | 1646.99 | 1.00 | 78 | 32 | 37 | 8 | TRUE | 0.76 |
| melanoma | RAS_12-61 | ALK | Any mutation | 162 | 76 | TMB quintile 5 | 0.10 | -0.41 | 0.59 | 1492.46 | 1.00 | 199 | 130 | 44 | 32 | TRUE | 0.17 |
| melanoma | RAS_12-61 | ALK | Any mutation | 9 | 51 | TMB quintile 6 | 0.69 | -0.66 | 2.27 | 1374.16 | 1.00 | 33 | 2 | 44 | 7 | TRUE | 0.44 |
| non-small cell lung cancer | RAS_12-61 | ALK | Any mutation | 159 | 13 | TMB quintile 3 | -0.76 | -2.26 | 0.48 | 1378.69 | 1.00 | 457 | 157 | 11 | 2 | TRUE | 0.56 |
| non-small cell lung cancer | RAS_12-61 | ALK | Any mutation | 267 | 22 | TMB quintile 4 | 0.12 | -0.75 | 0.95 | 1171.92 | 1.00 | 483 | 258 | 13 | 9 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | ALK | Any mutation | 474 | 118 | TMB quintile 5 | -0.07 | -0.48 | 0.30 | 1736.86 | 1.00 | 681 | 430 | 74 | 44 | TRUE | 0.15 |
| colorectal cancer | RAS_12-61 | ALK | Any mutation | 753 | 107 | TMB overall | -0.16 | -1.60 | 1.31 | 1395.06 | 1.00 | 754 | 713 | 67 | 40 | TRUE | 0.08 |
| melanoma | RAS_12-61 | ALK | Any mutation | 171 | 127 | TMB overall | 0.37 | -2.05 | 3.14 | 1483.54 | 1.00 | 232 | 132 | 88 | 39 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | ALK | Any mutation | 901 | 164 | TMB overall | -0.50 | -2.32 | 1.11 | 1568.68 | 1.00 | 1629 | 846 | 109 | 55 | TRUE | 0.25 |
| colorectal cancer | RAS_12-61 | RNF43 | Any mutation | 192 | 12 | TMB quintile 3 | -1.31 | -2.95 | -0.10 | 1394.90 | 1.00 | 285 | 190 | 10 | 2 | TRUE | 1.16 |
| colorectal cancer | RAS_12-61 | RNF43 | Any mutation | 375 | 30 | TMB quintile 4 | -0.69 | -1.45 | 0.04 | 1481.60 | 1.00 | 397 | 365 | 20 | 10 | TRUE | 1.13 |
| colorectal cancer | RAS_12-61 | RNF43 | Any mutation | 343 | 76 | TMB quintile 5 | -1.17 | -1.72 | -0.68 | 1528.82 | 1.00 | 243 | 321 | 54 | 22 | TRUE | 4.96 |
| colorectal cancer | RAS_12-61 | RNF43 | Any mutation | 48 | 146 | TMB quintile 6 | -0.41 | -1.09 | 0.30 | 1364.71 | 1.00 | 34 | 15 | 113 | 33 | TRUE | 0.61 |
| colorectal cancer | RAS_12-61 | RNF43 | Any mutation | 958 | 264 | TMB overall | -0.91 | -2.37 | 0.55 | 1499.23 | 1.00 | 959 | 891 | 197 | 67 | TRUE | 0.67 |
| colorectal cancer | RAS_12-61 | PTEN | Any mutation | 375 | 29 | TMB quintile 4 | 0.47 | -0.27 | 1.22 | 1285.80 | 1.00 | 406 | 357 | 11 | 18 | TRUE | 0.65 |
| colorectal cancer | RAS_12-61 | PTEN | Any mutation | 341 | 69 | TMB quintile 5 | -0.54 | -1.02 | -0.05 | 1277.28 | 1.00 | 260 | 313 | 41 | 28 | TRUE | 1.49 |
| colorectal cancer | RAS_12-61 | PTEN | Any mutation | 46 | 80 | TMB quintile 6 | 0.14 | -0.53 | 0.76 | 1424.26 | 1.00 | 67 | 23 | 57 | 23 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12-61 | PTEN | Any mutation | 159 | 17 | TMB quintile 3 | -1.66 | -2.90 | -0.58 | 1422.69 | 1.00 | 451 | 158 | 16 | 1 | TRUE | 2.32 |
| non-small cell lung cancer | RAS_12-61 | PTEN | Any mutation | 267 | 27 | TMB quintile 4 | -1.95 | -3.45 | -0.96 | 1300.06 | 1.00 | 470 | 266 | 26 | 1 | TRUE | 2.76 |
| non-small cell lung cancer | RAS_12-61 | PTEN | Any mutation | 474 | 75 | TMB quintile 5 | -1.20 | -1.84 | -0.65 | 1234.05 | 1.00 | 694 | 460 | 61 | 14 | TRUE | 4.08 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 14 | 16 | TMB quintile 2 | -0.24 | -1.85 | 1.16 | 1383.54 | 1.00 | 117 | 13 | 15 | 1 | TRUE | 0.12 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 29 | 63 | TMB quintile 3 | 0.67 | -0.11 | 1.42 | 1462.31 | 1.00 | 177 | 18 | 52 | 11 | TRUE | 1.07 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 58 | 120 | TMB quintile 4 | 0.31 | -0.26 | 0.87 | 1526.91 | 1.00 | 119 | 29 | 91 | 29 | TRUE | 0.56 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 112 | 315 | TMB quintile 5 | 0.65 | 0.07 | 1.31 | 1420.92 | 1.00 | 55 | 14 | 217 | 98 | TRUE | 1.44 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 21 | 103 | TMB quintile 6 | 1.36 | -0.01 | 3.10 | 1457.39 | 1.00 | 13 | 0 | 82 | 21 | TRUE | 1.04 |
| colorectal cancer | RAS_12-61 | PTEN | Any mutation | 762 | 178 | TMB overall | 0.03 | -1.55 | 1.60 | 1357.26 | 1.00 | 733 | 693 | 109 | 69 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | PTEN | Any mutation | 900 | 119 | TMB overall | -1.61 | -2.68 | -0.74 | 1238.98 | 1.00 | 1615 | 884 | 103 | 16 | TRUE | 2.85 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 234 | 617 | TMB overall | 0.54 | -0.74 | 1.74 | 1404.67 | 1.00 | 481 | 74 | 457 | 160 | TRUE | 0.41 |
| colorectal cancer | RAS_12-61 | BCOR | Any mutation | 375 | 11 | TMB quintile 4 | 0.38 | -0.74 | 1.58 | 1353.59 | 1.00 | 412 | 368 | 4 | 7 | FALSE | 0.30 |
| colorectal cancer | RAS_12-61 | BCOR | Any mutation | 338 | 39 | TMB quintile 5 | -0.20 | -0.83 | 0.42 | 1424.36 | 1.00 | 271 | 319 | 20 | 19 | FALSE | 0.27 |
| colorectal cancer | RAS_12-61 | BCOR | Any mutation | 43 | 57 | TMB quintile 6 | 0.06 | -0.66 | 0.76 | 1655.67 | 1.00 | 72 | 27 | 41 | 16 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | BCOR | Any mutation | 267 | 22 | TMB quintile 4 | -0.13 | -0.91 | 0.60 | 1407.33 | 1.00 | 481 | 260 | 15 | 7 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12-61 | BCOR | Any mutation | 480 | 92 | TMB quintile 5 | 0.24 | -0.17 | 0.67 | 1348.61 | 1.00 | 700 | 439 | 51 | 41 | FALSE | 0.60 |
| uterine cancer | RAS_12-61 | BCOR | Any mutation | 48 | 19 | TMB quintile 4 | 0.37 | -0.69 | 1.30 | 1507.87 | 1.00 | 168 | 42 | 13 | 6 | FALSE | 0.33 |
| uterine cancer | RAS_12-61 | BCOR | Any mutation | 72 | 69 | TMB quintile 5 | 0.30 | -0.28 | 0.87 | 1492.73 | 1.00 | 149 | 50 | 47 | 22 | FALSE | 0.51 |
| uterine cancer | RAS_12-61 | BCOR | Any mutation | 10 | 46 | TMB quintile 6 | -0.88 | -2.14 | 0.35 | 1566.06 | 1.00 | 29 | 7 | 43 | 3 | FALSE | 0.78 |
| colorectal cancer | RAS_12-61 | BCOR | Any mutation | 756 | 107 | TMB overall | 0.09 | -1.58 | 1.87 | 1388.39 | 1.00 | 755 | 714 | 65 | 42 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12-61 | BCOR | Any mutation | 747 | 114 | TMB overall | 0.05 | -1.24 | 1.21 | 1581.56 | 1.00 | 1181 | 699 | 66 | 48 | FALSE | 0.03 |
| uterine cancer | RAS_12-61 | BCOR | Any mutation | 130 | 134 | TMB overall | -0.07 | -1.71 | 1.39 | 1493.84 | 1.00 | 346 | 99 | 103 | 31 | FALSE | 0.03 |
| colorectal cancer | RAS_12-61 | CTNNB1 | Any mutation | 192 | 38 | TMB quintile 3 | 0.74 | 0.15 | 1.36 | 1440.79 | 1.00 | 281 | 170 | 16 | 22 | TRUE | 1.75 |
| colorectal cancer | RAS_12-61 | CTNNB1 | Any mutation | 376 | 35 | TMB quintile 4 | 0.74 | 0.14 | 1.39 | 1440.72 | 1.00 | 405 | 352 | 11 | 24 | TRUE | 1.62 |
| colorectal cancer | RAS_12-61 | CTNNB1 | Any mutation | 340 | 48 | TMB quintile 5 | 0.31 | -0.22 | 0.88 | 1332.99 | 1.00 | 269 | 311 | 19 | 29 | TRUE | 0.56 |
| colorectal cancer | RAS_12-61 | CTNNB1 | Any mutation | 38 | 35 | TMB quintile 6 | 0.43 | -0.30 | 1.20 | 1534.22 | 1.00 | 81 | 27 | 24 | 11 | TRUE | 0.61 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 83 | 12 | TMB quintile 2 | -0.92 | -2.07 | 0.04 | 1714.52 | 1.00 | 347 | 82 | 11 | 1 | TRUE | 1.06 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 159 | 22 | TMB quintile 3 | -1.32 | -2.74 | -0.36 | 1436.01 | 1.00 | 445 | 159 | 22 | 0 | TRUE | 1.50 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 269 | 33 | TMB quintile 4 | -0.40 | -1.03 | 0.24 | 1276.11 | 1.00 | 474 | 258 | 22 | 11 | TRUE | 0.61 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 474 | 47 | TMB quintile 5 | -0.79 | -1.44 | -0.24 | 1505.23 | 1.00 | 713 | 463 | 36 | 11 | TRUE | 2.05 |
| uterine cancer | RAS_12-61 | CTNNB1 | Any mutation | 26 | 28 | TMB quintile 3 | -1.98 | -3.50 | -0.76 | 1374.40 | 1.00 | 187 | 26 | 28 | 0 | TRUE | 2.36 |
| uterine cancer | RAS_12-61 | CTNNB1 | Any mutation | 48 | 33 | TMB quintile 4 | -1.52 | -2.65 | -0.48 | 1549.11 | 1.00 | 151 | 45 | 30 | 3 | TRUE | 2.25 |
| uterine cancer | RAS_12-61 | CTNNB1 | Any mutation | 70 | 61 | TMB quintile 5 | -1.80 | -2.78 | -0.96 | 1566.92 | 1.00 | 138 | 66 | 57 | 4 | TRUE | 4.03 |
| uterine cancer | RAS_12-61 | CTNNB1 | Any mutation | 10 | 15 | TMB quintile 6 | -1.67 | -3.08 | -0.35 | 1520.12 | 1.00 | 39 | 9 | 14 | 1 | TRUE | 1.88 |
| colorectal cancer | RAS_12-61 | CTNNB1 | Any mutation | 946 | 156 | TMB overall | 0.55 | -0.24 | 1.39 | 1361.30 | 1.00 | 1036 | 860 | 70 | 86 | TRUE | 0.71 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 985 | 114 | TMB overall | -0.85 | -1.69 | -0.15 | 1310.85 | 1.00 | 1979 | 962 | 91 | 23 | TRUE | 1.52 |
| uterine cancer | RAS_12-61 | CTNNB1 | Any mutation | 154 | 137 | TMB overall | -1.73 | -2.81 | -0.76 | 1443.68 | 1.00 | 515 | 146 | 129 | 8 | TRUE | 3.09 |
| cancer of unknown primary | RAS_12-61 | ARID1A | Any mutation | 39 | 15 | TMB quintile 4 | 0.08 | -0.99 | 1.09 | 1419.68 | 1.00 | 93 | 34 | 10 | 5 | TRUE | 0.05 |
| cancer of unknown primary | RAS_12-61 | ARID1A | Any mutation | 48 | 62 | TMB quintile 5 | -0.42 | -1.15 | 0.30 | 1571.21 | 1.00 | 104 | 37 | 51 | 11 | TRUE | 0.62 |
| cancer of unknown primary | RAS_12-61 | ARID1A | Any mutation | 7 | 16 | TMB quintile 6 | 0.38 | -0.96 | 1.81 | 1567.51 | 1.00 | 8 | 2 | 11 | 5 | TRUE | 0.23 |
| colorectal cancer | RAS_12-61 | ARID1A | Any mutation | 376 | 32 | TMB quintile 4 | 0.01 | -0.69 | 0.72 | 1499.94 | 1.00 | 400 | 360 | 16 | 16 | TRUE | 0.01 |
| colorectal cancer | RAS_12-61 | ARID1A | Any mutation | 346 | 116 | TMB quintile 5 | -0.90 | -1.32 | -0.49 | 1398.54 | 1.00 | 232 | 306 | 76 | 40 | TRUE | 4.74 |
| colorectal cancer | RAS_12-61 | ARID1A | Any mutation | 52 | 155 | TMB quintile 6 | -0.12 | -0.78 | 0.54 | 1445.74 | 1.00 | 39 | 14 | 117 | 38 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 159 | 12 | TMB quintile 3 | -0.30 | -1.48 | 0.73 | 1391.96 | 1.00 | 458 | 156 | 9 | 3 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 267 | 56 | TMB quintile 4 | -0.24 | -0.86 | 0.32 | 1252.07 | 1.00 | 459 | 250 | 39 | 17 | TRUE | 0.38 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 484 | 187 | TMB quintile 5 | -0.34 | -0.66 | -0.01 | 1442.97 | 1.00 | 632 | 424 | 127 | 60 | TRUE | 1.37 |
| pancreatic cancer | RAS_12-61 | ARID1A | Any mutation | 277 | 13 | TMB quintile 2 | -0.81 | -1.67 | 0.05 | 1670.97 | 1.00 | 64 | 269 | 5 | 8 | TRUE | 1.16 |
| pancreatic cancer | RAS_12-61 | ARID1A | Any mutation | 458 | 44 | TMB quintile 3 | -0.18 | -0.87 | 0.61 | 1488.26 | 1.00 | 60 | 420 | 6 | 38 | TRUE | 0.20 |
| pancreatic cancer | RAS_12-61 | ARID1A | Any mutation | 245 | 45 | TMB quintile 4 | -0.07 | -0.80 | 0.69 | 1242.73 | 1.00 | 33 | 207 | 7 | 38 | TRUE | 0.07 |
| pancreatic cancer | RAS_12-61 | ARID1A | Any mutation | 39 | 17 | TMB quintile 5 | 0.15 | -0.84 | 1.13 | 1471.87 | 1.00 | 14 | 27 | 5 | 12 | TRUE | 0.12 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 26 | 28 | TMB quintile 3 | 0.30 | -0.82 | 1.31 | 1489.28 | 1.00 | 192 | 22 | 24 | 4 | TRUE | 0.23 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 52 | 77 | TMB quintile 4 | 0.96 | 0.35 | 1.53 | 1485.78 | 1.00 | 135 | 26 | 51 | 26 | TRUE | 2.78 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 99 | 307 | TMB quintile 5 | 0.42 | -0.17 | 1.03 | 1451.48 | 1.00 | 56 | 15 | 223 | 84 | TRUE | 0.77 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 19 | 108 | TMB quintile 6 | 1.37 | -0.32 | 3.53 | 1501.13 | 1.00 | 9 | 0 | 89 | 19 | TRUE | 0.81 |
| cancer of unknown primary | RAS_12-61 | ARID1A | Any mutation | 94 | 93 | TMB overall | 0.03 | -1.23 | 1.37 | 1445.79 | 1.00 | 205 | 73 | 72 | 21 | TRUE | 0.02 |
| colorectal cancer | RAS_12-61 | ARID1A | Any mutation | 774 | 303 | TMB overall | -0.33 | -2.22 | 1.52 | 1271.87 | 1.00 | 671 | 680 | 209 | 94 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 910 | 255 | TMB overall | -0.26 | -1.43 | 0.92 | 1595.70 | 1.00 | 1549 | 830 | 175 | 80 | TRUE | 0.18 |
| pancreatic cancer | RAS_12-61 | ARID1A | Any mutation | 1019 | 119 | TMB overall | -0.23 | -1.08 | 0.66 | 1542.74 | 1.00 | 171 | 923 | 23 | 96 | TRUE | 0.22 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 196 | 520 | TMB overall | 0.76 | -0.83 | 2.50 | 1433.39 | 1.00 | 392 | 63 | 387 | 133 | TRUE | 0.44 |
| colorectal cancer | RAS_12-61 | PIK3R1 | Any mutation | 375 | 22 | TMB quintile 4 | 0.05 | -0.74 | 0.87 | 1622.91 | 1.00 | 406 | 364 | 11 | 11 | TRUE | 0.05 |
| colorectal cancer | RAS_12-61 | PIK3R1 | Any mutation | 339 | 29 | TMB quintile 5 | 0.15 | -0.54 | 0.87 | 1561.82 | 1.00 | 278 | 322 | 12 | 17 | TRUE | 0.17 |
| colorectal cancer | RAS_12-61 | PIK3R1 | Any mutation | 41 | 56 | TMB quintile 6 | 0.22 | -0.49 | 0.90 | 1423.68 | 1.00 | 75 | 25 | 40 | 16 | TRUE | 0.27 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 26 | 40 | TMB quintile 3 | -0.96 | -2.16 | 0.04 | 1474.23 | 1.00 | 181 | 24 | 38 | 2 | TRUE | 1.01 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 50 | 68 | TMB quintile 4 | -0.74 | -1.47 | -0.01 | 1493.97 | 1.00 | 132 | 41 | 59 | 9 | TRUE | 1.32 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 82 | 117 | TMB quintile 5 | 0.05 | -0.44 | 0.56 | 1374.08 | 1.00 | 127 | 47 | 82 | 35 | TRUE | 0.08 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 10 | 37 | TMB quintile 6 | -1.45 | -2.92 | -0.23 | 1557.87 | 1.00 | 26 | 9 | 36 | 1 | TRUE | 1.44 |
| colorectal cancer | RAS_12-61 | PIK3R1 | Any mutation | 755 | 107 | TMB overall | 0.15 | -1.45 | 1.67 | 1537.68 | 1.00 | 759 | 711 | 63 | 44 | TRUE | 0.07 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 168 | 262 | TMB overall | -0.77 | -1.77 | 0.17 | 1520.38 | 1.00 | 466 | 121 | 215 | 47 | TRUE | 0.92 |
| melanoma | RAS_12-61 | IKZF1 | Any mutation | 162 | 57 | TMB quintile 5 | 0.02 | -0.55 | 0.55 | 1470.11 | 1.00 | 210 | 139 | 34 | 23 | TRUE | 0.02 |
| melanoma | RAS_12-61 | IKZF1 | Any mutation | 12 | 44 | TMB quintile 6 | 0.58 | -0.52 | 1.84 | 1455.51 | 1.00 | 38 | 4 | 36 | 8 | TRUE | 0.48 |
| melanoma | RAS_12-61 | IKZF1 | Any mutation | 174 | 101 | TMB overall | 0.28 | -1.94 | 2.59 | 1645.64 | 1.00 | 248 | 143 | 70 | 31 | TRUE | 0.09 |
| colorectal cancer | RAS_12-61 | FAT1 | Any mutation | 375 | 17 | TMB quintile 4 | -0.39 | -1.40 | 0.54 | 1705.48 | 1.00 | 407 | 368 | 10 | 7 | FALSE | 0.37 |
| colorectal cancer | RAS_12-61 | FAT1 | Any mutation | 340 | 64 | TMB quintile 5 | -1.04 | -1.58 | -0.50 | 1416.09 | 1.00 | 251 | 320 | 44 | 20 | FALSE | 3.86 |
| colorectal cancer | RAS_12-61 | FAT1 | Any mutation | 54 | 145 | TMB quintile 6 | -0.30 | -0.92 | 0.35 | 1657.29 | 1.00 | 44 | 19 | 110 | 35 | FALSE | 0.44 |
| melanoma | RAS_12-61 | FAT1 | Any mutation | 163 | 86 | TMB quintile 5 | 0.09 | -0.38 | 0.56 | 1532.54 | 1.00 | 195 | 127 | 50 | 36 | FALSE | 0.15 |
| melanoma | RAS_12-61 | FAT1 | Any mutation | 11 | 50 | TMB quintile 6 | 0.61 | -0.58 | 1.83 | 1527.28 | 1.00 | 36 | 3 | 42 | 8 | FALSE | 0.49 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 159 | 16 | TMB quintile 3 | 0.07 | -1.06 | 1.14 | 1426.96 | 1.00 | 456 | 154 | 11 | 5 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 267 | 43 | TMB quintile 4 | -0.49 | -1.19 | 0.19 | 1472.28 | 1.00 | 468 | 256 | 32 | 11 | FALSE | 0.79 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 479 | 227 | TMB quintile 5 | -0.22 | -0.52 | 0.08 | 1289.22 | 1.00 | 618 | 401 | 149 | 78 | FALSE | 0.83 |
| uterine cancer | RAS_12-61 | FAT1 | Any mutation | 71 | 49 | TMB quintile 5 | -0.27 | -1.03 | 0.42 | 1533.54 | 1.00 | 165 | 60 | 38 | 11 | FALSE | 0.34 |
| uterine cancer | RAS_12-61 | FAT1 | Any mutation | 15 | 115 | TMB quintile 6 | -0.51 | -1.72 | 0.88 | 1399.44 | 1.00 | 14 | 3 | 103 | 12 | FALSE | 0.35 |
| colorectal cancer | RAS_12-61 | FAT1 | Any mutation | 769 | 226 | TMB overall | -0.59 | -2.72 | 1.43 | 1470.64 | 1.00 | 702 | 707 | 164 | 62 | FALSE | 0.25 |
| melanoma | RAS_12-61 | FAT1 | Any mutation | 174 | 136 | TMB overall | 0.34 | -1.94 | 2.54 | 1447.46 | 1.00 | 231 | 130 | 92 | 44 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 906 | 300 | TMB overall | -0.20 | -1.84 | 1.45 | 1397.78 | 1.00 | 1549 | 811 | 205 | 95 | FALSE | 0.09 |
| uterine cancer | RAS_12-61 | FAT1 | Any mutation | 86 | 164 | TMB overall | -0.38 | -3.24 | 2.42 | 1320.37 | 1.00 | 179 | 63 | 141 | 23 | FALSE | 0.10 |
| colorectal cancer | RAS_12-61 | CIC | Any mutation | 375 | 17 | TMB quintile 4 | 0.05 | -0.87 | 1.02 | 1399.58 | 1.00 | 409 | 366 | 8 | 9 | TRUE | 0.04 |
| colorectal cancer | RAS_12-61 | CIC | Any mutation | 341 | 40 | TMB quintile 5 | -0.62 | -1.31 | 0.01 | 1198.72 | 1.00 | 266 | 325 | 24 | 16 | TRUE | 1.19 |
| colorectal cancer | RAS_12-61 | CIC | Any mutation | 40 | 79 | TMB quintile 6 | -0.53 | -1.19 | 0.14 | 1450.18 | 1.00 | 61 | 25 | 64 | 15 | TRUE | 0.87 |
| colorectal cancer | RAS_12-61 | CIC | Any mutation | 756 | 136 | TMB overall | -0.38 | -2.06 | 1.45 | 1516.20 | 1.00 | 736 | 716 | 96 | 40 | TRUE | 0.18 |
| colorectal cancer | RAS_12-61 | NCOR1 | Any mutation | 375 | 16 | TMB quintile 4 | -0.29 | -1.23 | 0.68 | 1680.75 | 1.00 | 407 | 368 | 9 | 7 | FALSE | 0.26 |
| colorectal cancer | RAS_12-61 | NCOR1 | Any mutation | 339 | 32 | TMB quintile 5 | -0.96 | -1.73 | -0.28 | 1421.65 | 1.00 | 271 | 329 | 22 | 10 | FALSE | 1.98 |
| colorectal cancer | RAS_12-61 | NCOR1 | Any mutation | 42 | 81 | TMB quintile 6 | 0.23 | -0.47 | 0.87 | 1219.03 | 1.00 | 62 | 19 | 58 | 23 | FALSE | 0.29 |
| non-small cell lung cancer | RAS_12-61 | NCOR1 | Any mutation | 267 | 21 | TMB quintile 4 | -0.76 | -1.74 | 0.01 | 1356.98 | 1.00 | 479 | 263 | 17 | 4 | FALSE | 1.08 |
| non-small cell lung cancer | RAS_12-61 | NCOR1 | Any mutation | 477 | 71 | TMB quintile 5 | -0.46 | -0.94 | 0.04 | 1364.70 | 1.00 | 705 | 456 | 50 | 21 | FALSE | 1.13 |
| colorectal cancer | RAS_12-61 | NCOR1 | Any mutation | 756 | 129 | TMB overall | -0.35 | -2.11 | 1.50 | 1257.91 | 1.00 | 740 | 716 | 89 | 40 | FALSE | 0.16 |
| non-small cell lung cancer | RAS_12-61 | NCOR1 | Any mutation | 744 | 92 | TMB overall | -0.60 | -1.81 | 0.51 | 1517.25 | 1.00 | 1184 | 719 | 67 | 25 | FALSE | 0.54 |
| colorectal cancer | RAS_12-61 | POLE | Any mutation | 338 | 38 | TMB quintile 5 | -0.75 | -1.40 | -0.07 | 1599.44 | 1.00 | 266 | 324 | 24 | 14 | TRUE | 1.56 |
| colorectal cancer | RAS_12-61 | POLE | Any mutation | 44 | 93 | TMB quintile 6 | 0.17 | -0.54 | 0.87 | 1484.56 | 1.00 | 57 | 18 | 67 | 26 | TRUE | 0.20 |
| non-small cell lung cancer | RAS_12-61 | POLE | Any mutation | 267 | 20 | TMB quintile 4 | 0.12 | -0.69 | 0.92 | 1591.05 | 1.00 | 483 | 259 | 12 | 8 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | POLE | Any mutation | 476 | 102 | TMB quintile 5 | 0.31 | -0.12 | 0.70 | 1578.61 | 1.00 | 698 | 430 | 56 | 46 | TRUE | 0.88 |
| uterine cancer | RAS_12-61 | POLE | Any mutation | 70 | 24 | TMB quintile 5 | -0.16 | -1.18 | 0.72 | 1691.61 | 1.00 | 176 | 64 | 18 | 6 | TRUE | 0.13 |
| uterine cancer | RAS_12-61 | POLE | Any mutation | 14 | 80 | TMB quintile 6 | 0.07 | -1.17 | 1.48 | 1433.02 | 1.00 | 20 | 3 | 69 | 11 | TRUE | 0.04 |
| colorectal cancer | RAS_12-61 | POLE | Any mutation | 382 | 131 | TMB overall | -0.28 | -2.77 | 2.32 | 1443.53 | 1.00 | 323 | 342 | 91 | 40 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | POLE | Any mutation | 743 | 122 | TMB overall | 0.19 | -1.19 | 1.53 | 1483.40 | 1.00 | 1181 | 689 | 68 | 54 | TRUE | 0.11 |
| uterine cancer | RAS_12-61 | POLE | Any mutation | 84 | 104 | TMB overall | -0.08 | -3.08 | 2.64 | 1514.27 | 1.00 | 196 | 67 | 87 | 17 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12-61 | NOTCH2 | Any mutation | 268 | 16 | TMB quintile 4 | 0.31 | -0.60 | 1.35 | 1389.23 | 1.00 | 484 | 260 | 8 | 8 | TRUE | 0.27 |
| non-small cell lung cancer | RAS_12-61 | NOTCH2 | Any mutation | 473 | 81 | TMB quintile 5 | -0.44 | -0.92 | 0.04 | 1396.05 | 1.00 | 694 | 450 | 58 | 23 | TRUE | 1.12 |
| non-small cell lung cancer | RAS_12-61 | NOTCH2 | Any mutation | 741 | 97 | TMB overall | -0.04 | -1.79 | 2.02 | 1654.11 | 1.00 | 1178 | 710 | 66 | 31 | TRUE | 0.02 |
| colorectal cancer | RAS_12-61 | TGFBR2 | Any mutation | 339 | 47 | TMB quintile 5 | -0.33 | -0.90 | 0.24 | 1476.24 | 1.00 | 267 | 317 | 25 | 22 | TRUE | 0.59 |
| colorectal cancer | RAS_12-61 | TGFBR2 | Any mutation | 38 | 57 | TMB quintile 6 | -0.20 | -0.92 | 0.54 | 1579.67 | 1.00 | 62 | 24 | 43 | 14 | TRUE | 0.23 |
| colorectal cancer | RAS_12-61 | TGFBR2 | Any mutation | 377 | 104 | TMB overall | -0.25 | -2.18 | 1.77 | 1462.49 | 1.00 | 329 | 341 | 68 | 36 | TRUE | 0.10 |
| colorectal cancer | RAS_12-61 | KMT2A | Any mutation | 375 | 16 | TMB quintile 4 | -0.50 | -1.48 | 0.41 | 1490.97 | 1.00 | 406 | 369 | 10 | 6 | FALSE | 0.53 |
| colorectal cancer | RAS_12-61 | KMT2A | Any mutation | 339 | 43 | TMB quintile 5 | -0.42 | -1.06 | 0.14 | 1374.23 | 1.00 | 267 | 320 | 24 | 19 | FALSE | 0.77 |
| colorectal cancer | RAS_12-61 | KMT2A | Any mutation | 44 | 84 | TMB quintile 6 | -0.08 | -0.75 | 0.57 | 1602.76 | 1.00 | 65 | 23 | 63 | 21 | FALSE | 0.08 |
| melanoma | RAS_12-61 | KMT2A | Any mutation | 162 | 69 | TMB quintile 5 | -0.18 | -0.71 | 0.33 | 1402.62 | 1.00 | 204 | 137 | 44 | 25 | FALSE | 0.30 |
| melanoma | RAS_12-61 | KMT2A | Any mutation | 9 | 62 | TMB quintile 6 | 0.41 | -0.90 | 1.91 | 1442.95 | 1.00 | 30 | 2 | 55 | 7 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | KMT2A | Any mutation | 267 | 16 | TMB quintile 4 | -0.32 | -1.32 | 0.62 | 1423.57 | 1.00 | 484 | 262 | 11 | 5 | FALSE | 0.31 |
| non-small cell lung cancer | RAS_12-61 | KMT2A | Any mutation | 475 | 80 | TMB quintile 5 | -0.34 | -0.83 | 0.12 | 1450.02 | 1.00 | 698 | 450 | 55 | 25 | FALSE | 0.77 |
| uterine cancer | RAS_12-61 | KMT2A | Any mutation | 70 | 27 | TMB quintile 5 | 0.04 | -0.87 | 0.89 | 1365.42 | 1.00 | 174 | 62 | 19 | 8 | FALSE | 0.04 |
| uterine cancer | RAS_12-61 | KMT2A | Any mutation | 13 | 76 | TMB quintile 6 | -0.51 | -1.66 | 0.60 | 1265.95 | 1.00 | 24 | 5 | 68 | 8 | FALSE | 0.42 |
| colorectal cancer | RAS_12-61 | KMT2A | Any mutation | 758 | 143 | TMB overall | -0.36 | -2.10 | 1.34 | 1486.57 | 1.00 | 738 | 712 | 97 | 46 | FALSE | 0.17 |
| melanoma | RAS_12-61 | KMT2A | Any mutation | 171 | 131 | TMB overall | 0.14 | -2.38 | 2.83 | 1481.36 | 1.00 | 234 | 139 | 99 | 32 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12-61 | KMT2A | Any mutation | 742 | 96 | TMB overall | -0.32 | -1.80 | 1.04 | 1466.50 | 1.00 | 1182 | 712 | 66 | 30 | FALSE | 0.19 |
| uterine cancer | RAS_12-61 | KMT2A | Any mutation | 83 | 103 | TMB overall | -0.26 | -3.23 | 2.44 | 1332.12 | 1.00 | 198 | 67 | 87 | 16 | FALSE | 0.07 |
| melanoma | RAS_12-61 | PAK7 | Any mutation | 161 | 135 | TMB quintile 5 | -0.34 | -0.78 | 0.06 | 1534.96 | 1.00 | 151 | 113 | 87 | 48 | FALSE | 0.95 |
| melanoma | RAS_12-61 | PAK7 | Any mutation | 10 | 75 | TMB quintile 6 | -1.75 | -3.06 | -0.54 | 1375.69 | 1.00 | 15 | 6 | 71 | 4 | FALSE | 2.09 |
| non-small cell lung cancer | RAS_12-61 | PAK7 | Any mutation | 267 | 13 | TMB quintile 4 | 0.00 | -1.11 | 0.96 | 1586.05 | 1.00 | 484 | 262 | 8 | 5 | FALSE | 0.00 |
| non-small cell lung cancer | RAS_12-61 | PAK7 | Any mutation | 474 | 95 | TMB quintile 5 | 0.08 | -0.34 | 0.51 | 1481.88 | 1.00 | 695 | 436 | 57 | 38 | FALSE | 0.14 |
| melanoma | RAS_12-61 | PAK7 | Any mutation | 171 | 210 | TMB overall | -0.98 | -3.36 | 1.46 | 1497.32 | 1.00 | 166 | 119 | 158 | 52 | FALSE | 0.39 |
| non-small cell lung cancer | RAS_12-61 | PAK7 | Any mutation | 741 | 108 | TMB overall | 0.03 | -1.65 | 1.57 | 1469.29 | 1.00 | 1179 | 698 | 65 | 43 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | STAG2 | Any mutation | 267 | 19 | TMB quintile 4 | 0.01 | -0.74 | 0.76 | 1278.82 | 1.00 | 483 | 260 | 12 | 7 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | STAG2 | Any mutation | 475 | 76 | TMB quintile 5 | 0.17 | -0.29 | 0.61 | 1547.47 | 1.00 | 710 | 443 | 44 | 32 | TRUE | 0.34 |
| non-small cell lung cancer | RAS_12-61 | STAG2 | Any mutation | 742 | 95 | TMB overall | 0.11 | -0.99 | 1.35 | 1550.08 | 1.00 | 1193 | 703 | 56 | 39 | TRUE | 0.07 |
| melanoma | RAS_12-61 | TERT | Any mutation | 19 | 17 | TMB quintile 2 | 1.42 | 0.37 | 2.45 | 1529.57 | 1.00 | 95 | 12 | 10 | 7 | TRUE | 2.13 |
| melanoma | RAS_12-61 | TERT | Any mutation | 17 | 29 | TMB quintile 3 | 0.25 | -0.84 | 1.22 | 1444.76 | 1.00 | 71 | 12 | 24 | 5 | TRUE | 0.19 |
| melanoma | RAS_12-61 | TERT | Any mutation | 24 | 57 | TMB quintile 4 | 0.78 | -0.14 | 1.71 | 1519.16 | 1.00 | 42 | 8 | 41 | 16 | TRUE | 1.06 |
| melanoma | RAS_12-61 | TERT | Any mutation | 180 | 396 | TMB quintile 5 | 0.61 | 0.06 | 1.20 | 1539.30 | 1.00 | 40 | 17 | 233 | 163 | TRUE | 1.38 |
| melanoma | RAS_12-61 | TERT | Any mutation | 17 | 106 | TMB quintile 6 | 1.23 | -0.23 | 3.17 | 1579.68 | 1.00 | 12 | 0 | 89 | 17 | TRUE | 0.79 |
| non-small cell lung cancer | RAS_12-61 | TERT | Any mutation | 160 | 13 | TMB quintile 3 | 0.42 | -0.45 | 1.44 | 1328.23 | 1.00 | 460 | 154 | 7 | 6 | TRUE | 0.42 |
| non-small cell lung cancer | RAS_12-61 | TERT | Any mutation | 267 | 34 | TMB quintile 4 | 0.16 | -0.47 | 0.76 | 1511.44 | 1.00 | 475 | 254 | 21 | 13 | TRUE | 0.20 |
| non-small cell lung cancer | RAS_12-61 | TERT | Any mutation | 476 | 98 | TMB quintile 5 | 0.03 | -0.40 | 0.43 | 1492.89 | 1.00 | 693 | 439 | 61 | 37 | TRUE | 0.05 |
| melanoma | RAS_12-61 | TERT | Any mutation | 257 | 605 | TMB overall | 0.84 | -0.44 | 2.14 | 1363.30 | 1.00 | 260 | 49 | 397 | 208 | TRUE | 0.71 |
| non-small cell lung cancer | RAS_12-61 | TERT | Any mutation | 903 | 145 | TMB overall | 0.21 | -0.66 | 1.15 | 1475.23 | 1.00 | 1628 | 847 | 89 | 56 | TRUE | 0.19 |
| colorectal cancer | RAS_12-61 | BRCA2 | Any mutation | 375 | 21 | TMB quintile 4 | -0.29 | -1.18 | 0.61 | 1522.67 | 1.00 | 404 | 366 | 12 | 9 | TRUE | 0.30 |
| colorectal cancer | RAS_12-61 | BRCA2 | Any mutation | 343 | 48 | TMB quintile 5 | -0.20 | -0.77 | 0.38 | 1541.17 | 1.00 | 267 | 319 | 24 | 24 | TRUE | 0.31 |
| colorectal cancer | RAS_12-61 | BRCA2 | Any mutation | 46 | 116 | TMB quintile 6 | -0.55 | -1.23 | 0.10 | 1445.70 | 1.00 | 57 | 24 | 94 | 22 | TRUE | 0.97 |
| non-small cell lung cancer | RAS_12-61 | BRCA2 | Any mutation | 267 | 23 | TMB quintile 4 | -0.29 | -1.20 | 0.61 | 1200.42 | 1.00 | 480 | 260 | 16 | 7 | TRUE | 0.27 |
| non-small cell lung cancer | RAS_12-61 | BRCA2 | Any mutation | 476 | 89 | TMB quintile 5 | -0.36 | -0.83 | 0.11 | 1497.73 | 1.00 | 691 | 448 | 61 | 28 | TRUE | 0.90 |
| uterine cancer | RAS_12-61 | BRCA2 | Any mutation | 70 | 29 | TMB quintile 5 | -0.74 | -1.83 | 0.26 | 1587.02 | 1.00 | 168 | 65 | 24 | 5 | TRUE | 0.82 |
| uterine cancer | RAS_12-61 | BRCA2 | Any mutation | 12 | 93 | TMB quintile 6 | -1.04 | -2.18 | 0.25 | 1384.13 | 1.00 | 21 | 5 | 86 | 7 | TRUE | 1.03 |
| colorectal cancer | RAS_12-61 | BRCA2 | Any mutation | 764 | 185 | TMB overall | -0.34 | -2.07 | 1.34 | 1427.76 | 1.00 | 728 | 709 | 130 | 55 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12-61 | BRCA2 | Any mutation | 744 | 126 | TMB overall | -0.19 | -2.55 | 2.31 | 1320.41 | 1.00 | 1180 | 708 | 90 | 36 | TRUE | 0.06 |
| uterine cancer | RAS_12-61 | BRCA2 | Any mutation | 82 | 122 | TMB overall | -0.82 | -3.65 | 2.06 | 1523.35 | 1.00 | 189 | 70 | 110 | 12 | TRUE | 0.26 |
| colorectal cancer | RAS_12-61 | NOTCH3 | Any mutation | 192 | 12 | TMB quintile 3 | 0.51 | -0.58 | 1.62 | 1603.70 | 1.00 | 290 | 185 | 5 | 7 | TRUE | 0.44 |
| colorectal cancer | RAS_12-61 | NOTCH3 | Any mutation | 375 | 17 | TMB quintile 4 | 0.09 | -0.90 | 1.00 | 1538.23 | 1.00 | 408 | 366 | 8 | 9 | TRUE | 0.07 |
| colorectal cancer | RAS_12-61 | NOTCH3 | Any mutation | 338 | 50 | TMB quintile 5 | -0.59 | -1.19 | -0.02 | 1398.78 | 1.00 | 263 | 318 | 30 | 20 | TRUE | 1.35 |
| colorectal cancer | RAS_12-61 | NOTCH3 | Any mutation | 40 | 120 | TMB quintile 6 | -0.48 | -1.23 | 0.19 | 1363.50 | 1.00 | 42 | 17 | 97 | 23 | TRUE | 0.74 |
| melanoma | RAS_12-61 | NOTCH3 | Any mutation | 160 | 67 | TMB quintile 5 | -0.58 | -1.14 | 0.00 | 1403.57 | 1.00 | 195 | 140 | 47 | 20 | TRUE | 1.28 |
| melanoma | RAS_12-61 | NOTCH3 | Any mutation | 9 | 57 | TMB quintile 6 | -1.30 | -2.72 | 0.00 | 1424.44 | 1.00 | 29 | 6 | 54 | 3 | TRUE | 1.21 |
| non-small cell lung cancer | RAS_12-61 | NOTCH3 | Any mutation | 267 | 21 | TMB quintile 4 | -0.14 | -1.09 | 0.74 | 1640.75 | 1.00 | 482 | 260 | 14 | 7 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | NOTCH3 | Any mutation | 474 | 82 | TMB quintile 5 | -0.21 | -0.68 | 0.24 | 1597.89 | 1.00 | 700 | 446 | 54 | 28 | TRUE | 0.43 |
| colorectal cancer | RAS_12-61 | NOTCH3 | Any mutation | 945 | 199 | TMB overall | -0.10 | -1.71 | 1.51 | 1516.18 | 1.00 | 1003 | 886 | 140 | 59 | TRUE | 0.04 |
| melanoma | RAS_12-61 | NOTCH3 | Any mutation | 169 | 124 | TMB overall | -0.93 | -3.20 | 1.40 | 1519.65 | 1.00 | 224 | 146 | 101 | 23 | TRUE | 0.38 |
| non-small cell lung cancer | RAS_12-61 | NOTCH3 | Any mutation | 742 | 114 | TMB overall | -0.03 | -2.07 | 2.21 | 1623.59 | 1.00 | 1191 | 706 | 78 | 36 | TRUE | 0.01 |
| colorectal cancer | RAS_12-61 | NOTCH4 | Any mutation | 367 | 21 | TMB quintile 4 | -0.17 | -1.02 | 0.68 | 1346.97 | 1.00 | 396 | 357 | 11 | 10 | TRUE | 0.17 |
| colorectal cancer | RAS_12-61 | NOTCH4 | Any mutation | 320 | 37 | TMB quintile 5 | -1.06 | -1.73 | -0.39 | 1326.36 | 1.00 | 244 | 309 | 26 | 11 | TRUE | 2.62 |
| colorectal cancer | RAS_12-61 | NOTCH4 | Any mutation | 42 | 59 | TMB quintile 6 | -0.34 | -1.06 | 0.39 | 1498.39 | 1.00 | 65 | 28 | 45 | 14 | TRUE | 0.45 |
| melanoma | RAS_12-61 | NOTCH4 | Any mutation | 157 | 81 | TMB quintile 5 | 0.06 | -0.42 | 0.55 | 1468.20 | 1.00 | 184 | 123 | 47 | 34 | TRUE | 0.09 |
| melanoma | RAS_12-61 | NOTCH4 | Any mutation | 12 | 64 | TMB quintile 6 | 0.47 | -0.86 | 2.06 | 1549.88 | 1.00 | 20 | 2 | 54 | 10 | TRUE | 0.28 |
| non-small cell lung cancer | RAS_12-61 | NOTCH4 | Any mutation | 267 | 17 | TMB quintile 4 | -0.87 | -2.02 | 0.10 | 1462.26 | 1.00 | 478 | 264 | 14 | 3 | TRUE | 0.95 |
| non-small cell lung cancer | RAS_12-61 | NOTCH4 | Any mutation | 473 | 107 | TMB quintile 5 | -0.26 | -0.65 | 0.12 | 1690.75 | 1.00 | 678 | 437 | 71 | 36 | TRUE | 0.70 |
| colorectal cancer | RAS_12-61 | NOTCH4 | Any mutation | 729 | 117 | TMB overall | -0.51 | -1.98 | 1.08 | 1483.09 | 1.00 | 705 | 694 | 82 | 35 | TRUE | 0.30 |
| melanoma | RAS_12-61 | NOTCH4 | Any mutation | 169 | 145 | TMB overall | 0.27 | -2.30 | 2.97 | 1523.83 | 1.00 | 204 | 125 | 101 | 44 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | NOTCH4 | Any mutation | 740 | 124 | TMB overall | -0.53 | -2.32 | 1.32 | 1555.79 | 1.00 | 1156 | 701 | 85 | 39 | TRUE | 0.27 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 83 | 12 | TMB quintile 2 | 0.80 | -0.27 | 1.82 | 1409.37 | 1.00 | 351 | 78 | 7 | 5 | FALSE | 0.90 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 159 | 50 | TMB quintile 3 | 1.10 | 0.53 | 1.66 | 1483.75 | 1.00 | 442 | 134 | 25 | 25 | FALSE | 3.82 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 269 | 129 | TMB quintile 4 | 0.62 | 0.24 | 0.99 | 1264.15 | 1.00 | 429 | 208 | 68 | 61 | FALSE | 2.96 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 480 | 336 | TMB quintile 5 | -0.14 | -0.41 | 0.14 | 1380.38 | 1.00 | 545 | 360 | 216 | 120 | FALSE | 0.52 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 991 | 527 | TMB overall | 0.59 | -0.44 | 1.56 | 1434.58 | 1.00 | 1767 | 780 | 316 | 211 | FALSE | 0.58 |
| non-small cell lung cancer | RAS_12-61 | KDM5C | Any mutation | 267 | 16 | TMB quintile 4 | -0.16 | -1.07 | 0.68 | 1346.98 | 1.00 | 484 | 262 | 11 | 5 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12-61 | KDM5C | Any mutation | 476 | 70 | TMB quintile 5 | 0.22 | -0.27 | 0.71 | 1261.96 | 1.00 | 713 | 445 | 39 | 31 | FALSE | 0.43 |
| non-small cell lung cancer | RAS_12-61 | KDM5C | Any mutation | 743 | 86 | TMB overall | 0.05 | -1.31 | 1.31 | 1322.91 | 1.00 | 1197 | 707 | 50 | 36 | FALSE | 0.03 |
| melanoma | RAS_12-61 | CDKN2A | Any mutation | 164 | 80 | TMB quintile 5 | 0.01 | -0.49 | 0.48 | 1441.90 | 1.00 | 195 | 131 | 47 | 33 | TRUE | 0.01 |
| melanoma | RAS_12-61 | CDKN2A | Any mutation | 8 | 34 | TMB quintile 6 | -1.00 | -2.57 | 0.30 | 1467.97 | 1.00 | 32 | 6 | 32 | 2 | TRUE | 0.79 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 159 | 33 | TMB quintile 3 | 0.15 | -0.62 | 0.83 | 1322.42 | 1.00 | 446 | 148 | 22 | 11 | TRUE | 0.17 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 267 | 43 | TMB quintile 4 | -0.29 | -0.93 | 0.33 | 1458.57 | 1.00 | 466 | 254 | 30 | 13 | TRUE | 0.44 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 480 | 178 | TMB quintile 5 | -0.83 | -1.19 | -0.47 | 1513.76 | 1.00 | 621 | 440 | 138 | 40 | TRUE | 4.97 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 277 | 34 | TMB quintile 2 | 1.44 | 0.57 | 2.55 | 1396.31 | 1.00 | 68 | 244 | 1 | 33 | TRUE | 2.35 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 465 | 146 | TMB quintile 3 | 1.75 | 1.02 | 2.56 | 1468.83 | 1.00 | 61 | 324 | 5 | 141 | TRUE | 5.04 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 248 | 96 | TMB quintile 4 | 1.77 | 0.98 | 2.65 | 1512.23 | 1.00 | 35 | 157 | 5 | 91 | TRUE | 4.58 |
| melanoma | RAS_12-61 | CDKN2A | Any mutation | 172 | 114 | TMB overall | -0.48 | -2.76 | 1.51 | 1477.56 | 1.00 | 227 | 137 | 79 | 35 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 906 | 254 | TMB overall | -0.30 | -1.27 | 0.65 | 1390.78 | 1.00 | 1533 | 842 | 190 | 64 | TRUE | 0.28 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 990 | 276 | TMB overall | 1.64 | 0.70 | 2.73 | 1314.82 | 1.00 | 164 | 725 | 11 | 265 | TRUE | 2.92 |
| non-small cell lung cancer | RAS_12-61 | EPHB1 | Any mutation | 267 | 19 | TMB quintile 4 | 0.13 | -0.84 | 1.03 | 1516.81 | 1.00 | 484 | 259 | 11 | 8 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | EPHB1 | Any mutation | 476 | 117 | TMB quintile 5 | -0.73 | -1.18 | -0.30 | 1525.33 | 1.00 | 665 | 447 | 88 | 29 | FALSE | 2.95 |
| non-small cell lung cancer | RAS_12-61 | EPHB1 | Any mutation | 744 | 152 | TMB overall | -0.85 | -3.55 | 1.57 | 1506.13 | 1.00 | 1157 | 707 | 115 | 37 | FALSE | 0.30 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 26 | 44 | TMB quintile 3 | -0.28 | -1.21 | 0.62 | 1529.93 | 1.00 | 177 | 21 | 39 | 5 | FALSE | 0.26 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 48 | 46 | TMB quintile 4 | -0.50 | -1.29 | 0.24 | 1414.00 | 1.00 | 143 | 41 | 39 | 7 | FALSE | 0.71 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 70 | 25 | TMB quintile 5 | -0.54 | -1.45 | 0.25 | 1188.21 | 1.00 | 172 | 65 | 20 | 5 | FALSE | 0.68 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 11 | 30 | TMB quintile 6 | -0.81 | -2.05 | 0.24 | 1514.36 | 1.00 | 35 | 9 | 28 | 2 | FALSE | 0.81 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 155 | 145 | TMB overall | -0.54 | -1.39 | 0.32 | 1469.52 | 1.00 | 527 | 136 | 126 | 19 | FALSE | 0.67 |
| colorectal cancer | RAS_12-61 | ERBB3 | Any mutation | 376 | 27 | TMB quintile 4 | -0.16 | -0.91 | 0.55 | 1278.29 | 1.00 | 401 | 364 | 15 | 12 | TRUE | 0.18 |
| colorectal cancer | RAS_12-61 | ERBB3 | Any mutation | 338 | 39 | TMB quintile 5 | 0.19 | -0.46 | 0.81 | 1504.74 | 1.00 | 273 | 315 | 16 | 23 | TRUE | 0.25 |
| colorectal cancer | RAS_12-61 | ERBB3 | Any mutation | 39 | 51 | TMB quintile 6 | 0.41 | -0.33 | 1.14 | 1359.55 | 1.00 | 79 | 23 | 35 | 16 | TRUE | 0.56 |
| colorectal cancer | RAS_12-61 | ERBB3 | Any mutation | 753 | 117 | TMB overall | 0.14 | -1.14 | 1.54 | 1434.23 | 1.00 | 753 | 702 | 66 | 51 | TRUE | 0.07 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 193 | 51 | TMB quintile 3 | 0.06 | -0.41 | 0.53 | 1468.86 | 1.00 | 267 | 171 | 29 | 22 | TRUE | 0.10 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 378 | 129 | TMB quintile 4 | 0.22 | -0.14 | 0.56 | 1493.11 | 1.00 | 358 | 310 | 61 | 68 | TRUE | 0.65 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 347 | 138 | TMB quintile 5 | 0.06 | -0.30 | 0.42 | 1339.39 | 1.00 | 232 | 273 | 64 | 74 | TRUE | 0.12 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 39 | 31 | TMB quintile 6 | -0.01 | -0.65 | 0.62 | 1598.62 | 1.00 | 86 | 31 | 23 | 8 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | SMAD4 | Any mutation | 159 | 21 | TMB quintile 3 | -0.60 | -1.35 | 0.11 | 1474.14 | 1.00 | 449 | 156 | 18 | 3 | TRUE | 0.97 |
| non-small cell lung cancer | RAS_12-61 | SMAD4 | Any mutation | 267 | 36 | TMB quintile 4 | -0.56 | -1.19 | 0.03 | 1587.08 | 1.00 | 471 | 259 | 28 | 8 | TRUE | 1.12 |
| non-small cell lung cancer | RAS_12-61 | SMAD4 | Any mutation | 474 | 49 | TMB quintile 5 | -0.42 | -0.93 | 0.10 | 1468.71 | 1.00 | 716 | 458 | 33 | 16 | TRUE | 0.92 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 277 | 37 | TMB quintile 2 | 0.52 | -0.21 | 1.32 | 1337.50 | 1.00 | 65 | 244 | 4 | 33 | TRUE | 0.73 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 461 | 119 | TMB quintile 3 | 0.56 | -0.01 | 1.15 | 1651.18 | 1.00 | 55 | 353 | 11 | 108 | TRUE | 1.20 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 242 | 82 | TMB quintile 4 | 0.94 | 0.28 | 1.66 | 1478.18 | 1.00 | 34 | 166 | 6 | 76 | TRUE | 2.04 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 40 | 25 | TMB quintile 5 | 0.99 | 0.19 | 1.91 | 1400.62 | 1.00 | 13 | 20 | 5 | 20 | TRUE | 1.58 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 957 | 349 | TMB overall | 0.08 | -0.48 | 0.65 | 1578.40 | 1.00 | 943 | 785 | 177 | 172 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | SMAD4 | Any mutation | 900 | 106 | TMB overall | -0.53 | -1.16 | 0.10 | 1570.43 | 1.00 | 1636 | 873 | 79 | 27 | TRUE | 0.99 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 1020 | 263 | TMB overall | 0.75 | -0.03 | 1.55 | 1228.21 | 1.00 | 167 | 783 | 26 | 237 | TRUE | 1.20 |
| colorectal cancer | RAS_12-61 | ATM | Any mutation | 379 | 46 | TMB quintile 4 | 0.30 | -0.26 | 0.86 | 1618.46 | 1.00 | 397 | 353 | 20 | 26 | TRUE | 0.51 |
| colorectal cancer | RAS_12-61 | ATM | Any mutation | 344 | 78 | TMB quintile 5 | -0.24 | -0.72 | 0.21 | 1652.37 | 1.00 | 251 | 306 | 40 | 38 | TRUE | 0.51 |
| colorectal cancer | RAS_12-61 | ATM | Any mutation | 44 | 94 | TMB quintile 6 | -0.08 | -0.73 | 0.57 | 1337.79 | 1.00 | 65 | 22 | 72 | 22 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 83 | 15 | TMB quintile 2 | 0.93 | 0.09 | 1.72 | 1567.32 | 1.00 | 350 | 77 | 9 | 6 | TRUE | 1.63 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 159 | 20 | TMB quintile 3 | 0.95 | 0.22 | 1.67 | 1531.45 | 1.00 | 457 | 149 | 10 | 10 | TRUE | 2.07 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 275 | 76 | TMB quintile 4 | 1.25 | 0.79 | 1.69 | 1531.37 | 1.00 | 470 | 227 | 28 | 48 | TRUE | 7.17 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 488 | 166 | TMB quintile 5 | 0.75 | 0.42 | 1.08 | 1475.29 | 1.00 | 678 | 399 | 77 | 89 | TRUE | 5.17 |
| uterine cancer | RAS_12-61 | ATM | Any mutation | 71 | 46 | TMB quintile 5 | -0.38 | -1.17 | 0.32 | 1495.95 | 1.00 | 164 | 61 | 36 | 10 | TRUE | 0.50 |
| uterine cancer | RAS_12-61 | ATM | Any mutation | 13 | 101 | TMB quintile 6 | -0.75 | -1.96 | 0.49 | 1661.20 | 1.00 | 17 | 4 | 92 | 9 | TRUE | 0.63 |
| colorectal cancer | RAS_12-61 | ATM | Any mutation | 767 | 218 | TMB overall | -0.02 | -1.44 | 1.43 | 1236.36 | 1.00 | 713 | 681 | 132 | 86 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 1005 | 277 | TMB overall | 0.98 | 0.31 | 1.70 | 1533.01 | 1.00 | 1955 | 852 | 124 | 153 | TRUE | 2.23 |
| uterine cancer | RAS_12-61 | ATM | Any mutation | 84 | 147 | TMB overall | -0.52 | -3.27 | 2.27 | 1567.72 | 1.00 | 181 | 65 | 128 | 19 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 159 | 33 | TMB quintile 3 | -1.34 | -2.24 | -0.60 | 1442.26 | 1.00 | 436 | 157 | 31 | 2 | TRUE | 2.81 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 267 | 50 | TMB quintile 4 | -1.11 | -1.77 | -0.49 | 1390.11 | 1.00 | 453 | 259 | 42 | 8 | TRUE | 3.18 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 474 | 124 | TMB quintile 5 | -0.93 | -1.36 | -0.53 | 1506.99 | 1.00 | 657 | 447 | 97 | 27 | TRUE | 4.80 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 900 | 207 | TMB overall | -1.14 | -1.85 | -0.45 | 1370.10 | 1.00 | 1546 | 863 | 170 | 37 | TRUE | 2.88 |
| cancer of unknown primary | RAS_12-61 | KMT2D | Any mutation | 40 | 14 | TMB quintile 3 | -1.65 | -3.39 | -0.14 | 1477.87 | 1.00 | 92 | 39 | 13 | 1 | FALSE | 1.26 |
| cancer of unknown primary | RAS_12-61 | KMT2D | Any mutation | 39 | 11 | TMB quintile 4 | -0.37 | -1.76 | 0.91 | 1453.61 | 1.00 | 95 | 36 | 8 | 3 | FALSE | 0.23 |
| cancer of unknown primary | RAS_12-61 | KMT2D | Any mutation | 46 | 67 | TMB quintile 5 | -0.80 | -1.56 | -0.07 | 1554.13 | 1.00 | 95 | 36 | 57 | 10 | FALSE | 1.42 |
| colorectal cancer | RAS_12-61 | KMT2D | Any mutation | 375 | 27 | TMB quintile 4 | -0.69 | -1.53 | 0.08 | 1494.38 | 1.00 | 399 | 366 | 18 | 9 | FALSE | 1.01 |
| colorectal cancer | RAS_12-61 | KMT2D | Any mutation | 344 | 104 | TMB quintile 5 | -0.78 | -1.21 | -0.35 | 1473.47 | 1.00 | 245 | 306 | 66 | 38 | FALSE | 3.34 |
| colorectal cancer | RAS_12-61 | KMT2D | Any mutation | 63 | 245 | TMB quintile 6 | -0.36 | -1.30 | 0.64 | 1467.52 | 1.00 | 13 | 6 | 188 | 57 | FALSE | 0.33 |
| melanoma | RAS_12-61 | KMT2D | Any mutation | 170 | 112 | TMB quintile 5 | 0.06 | -0.36 | 0.50 | 1430.92 | 1.00 | 187 | 124 | 66 | 46 | FALSE | 0.11 |
| melanoma | RAS_12-61 | KMT2D | Any mutation | 17 | 91 | TMB quintile 6 | 1.38 | -0.03 | 3.33 | 1540.39 | 1.00 | 27 | 1 | 75 | 16 | FALSE | 0.96 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 159 | 15 | TMB quintile 3 | -0.21 | -1.41 | 0.88 | 1448.20 | 1.00 | 456 | 155 | 11 | 4 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 267 | 42 | TMB quintile 4 | -0.26 | -0.94 | 0.36 | 1423.99 | 1.00 | 469 | 254 | 29 | 13 | FALSE | 0.35 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 481 | 251 | TMB quintile 5 | -0.77 | -1.09 | -0.45 | 1304.80 | 1.00 | 594 | 419 | 189 | 62 | FALSE | 5.57 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 48 | 14 | TMB quintile 4 | -0.72 | -2.38 | 0.63 | 1577.62 | 1.00 | 170 | 46 | 12 | 2 | FALSE | 0.46 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 75 | 129 | TMB quintile 5 | -0.34 | -0.86 | 0.18 | 1566.12 | 1.00 | 113 | 46 | 100 | 29 | FALSE | 0.71 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 15 | 109 | TMB quintile 6 | -0.80 | -1.98 | 0.38 | 1409.18 | 1.00 | 14 | 4 | 98 | 11 | FALSE | 0.73 |
| cancer of unknown primary | RAS_12-61 | KMT2D | Any mutation | 130 | 123 | TMB overall | -0.84 | -2.44 | 0.79 | 1706.85 | 1.00 | 285 | 112 | 105 | 18 | FALSE | 0.51 |
| colorectal cancer | RAS_12-61 | KMT2D | Any mutation | 782 | 376 | TMB overall | -0.62 | -3.21 | 1.66 | 1492.66 | 1.00 | 657 | 678 | 272 | 104 | FALSE | 0.22 |
| melanoma | RAS_12-61 | KMT2D | Any mutation | 187 | 203 | TMB overall | 0.71 | -1.98 | 3.79 | 1598.72 | 1.00 | 214 | 125 | 141 | 62 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 908 | 320 | TMB overall | -0.70 | -2.36 | 0.89 | 1541.45 | 1.00 | 1526 | 829 | 241 | 79 | FALSE | 0.42 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 138 | 252 | TMB overall | -0.56 | -2.70 | 1.53 | 1197.15 | 1.00 | 297 | 96 | 210 | 42 | FALSE | 0.23 |
| colorectal cancer | RAS_12-61 | TSC2 | Any mutation | 341 | 42 | TMB quintile 5 | -0.51 | -1.13 | 0.14 | 1514.97 | 1.00 | 268 | 323 | 24 | 18 | TRUE | 0.96 |
| colorectal cancer | RAS_12-61 | TSC2 | Any mutation | 39 | 56 | TMB quintile 6 | -0.23 | -0.95 | 0.49 | 1591.51 | 1.00 | 72 | 26 | 43 | 13 | TRUE | 0.27 |
| colorectal cancer | RAS_12-61 | TSC2 | Any mutation | 380 | 98 | TMB overall | -0.35 | -2.56 | 1.85 | 1248.30 | 1.00 | 340 | 349 | 67 | 31 | TRUE | 0.13 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 29 | 78 | TMB quintile 2 | -0.78 | -1.51 | -0.11 | 1573.07 | 1.00 | 49 | 19 | 68 | 10 | TRUE | 1.59 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 226 | 428 | TMB quintile 3 | -0.41 | -0.75 | -0.04 | 1504.12 | 1.00 | 84 | 74 | 276 | 152 | TRUE | 1.62 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 534 | 966 | TMB quintile 4 | 0.15 | -0.20 | 0.47 | 1474.87 | 1.00 | 83 | 69 | 501 | 465 | TRUE | 0.43 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 561 | 822 | TMB quintile 5 | 0.87 | 0.54 | 1.21 | 1113.28 | 1.00 | 93 | 58 | 319 | 503 | TRUE | 6.37 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 76 | 225 | TMB quintile 6 | 0.14 | -0.40 | 0.73 | 1294.73 | 1.00 | 36 | 11 | 160 | 65 | TRUE | 0.20 |
| melanoma | RAS_12-61 | APC | Any mutation | 160 | 67 | TMB quintile 5 | -0.49 | -1.05 | 0.06 | 1477.39 | 1.00 | 203 | 140 | 47 | 20 | TRUE | 1.07 |
| melanoma | RAS_12-61 | APC | Any mutation | 9 | 50 | TMB quintile 6 | 0.19 | -1.05 | 1.60 | 1543.49 | 1.00 | 35 | 3 | 44 | 6 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | APC | Any mutation | 159 | 20 | TMB quintile 3 | -0.34 | -1.19 | 0.47 | 1542.85 | 1.00 | 452 | 154 | 15 | 5 | TRUE | 0.38 |
| non-small cell lung cancer | RAS_12-61 | APC | Any mutation | 267 | 31 | TMB quintile 4 | -0.94 | -1.86 | -0.24 | 1490.31 | 1.00 | 468 | 263 | 27 | 4 | TRUE | 1.64 |
| non-small cell lung cancer | RAS_12-61 | APC | Any mutation | 477 | 101 | TMB quintile 5 | -0.13 | -0.56 | 0.28 | 1393.18 | 1.00 | 691 | 440 | 64 | 37 | TRUE | 0.27 |
| uterine cancer | RAS_12-61 | APC | Any mutation | 71 | 35 | TMB quintile 5 | -0.14 | -0.96 | 0.61 | 1404.99 | 1.00 | 174 | 62 | 26 | 9 | TRUE | 0.13 |
| uterine cancer | RAS_12-61 | APC | Any mutation | 16 | 84 | TMB quintile 6 | -0.81 | -1.83 | 0.27 | 1400.57 | 1.00 | 24 | 7 | 75 | 9 | TRUE | 0.87 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 1426 | 2519 | TMB overall | 0.00 | -0.59 | 0.61 | 1471.61 | 1.00 | 345 | 231 | 1324 | 1195 | TRUE | 0.01 |
| melanoma | RAS_12-61 | APC | Any mutation | 169 | 117 | TMB overall | -0.15 | -2.47 | 2.32 | 1420.95 | 1.00 | 238 | 143 | 91 | 26 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | APC | Any mutation | 903 | 152 | TMB overall | -0.47 | -1.34 | 0.35 | 1481.36 | 1.00 | 1611 | 857 | 106 | 46 | TRUE | 0.54 |
| uterine cancer | RAS_12-61 | APC | Any mutation | 87 | 119 | TMB overall | -0.43 | -2.95 | 2.16 | 1539.88 | 1.00 | 198 | 69 | 101 | 18 | TRUE | 0.12 |
| colorectal cancer | RAS_12-61 | ERBB2 | Any mutation | 375 | 17 | TMB quintile 4 | -0.37 | -1.30 | 0.49 | 1460.96 | 1.00 | 406 | 368 | 10 | 7 | TRUE | 0.38 |
| colorectal cancer | RAS_12-61 | ERBB2 | Any mutation | 338 | 33 | TMB quintile 5 | -0.46 | -1.14 | 0.20 | 1507.32 | 1.00 | 269 | 324 | 19 | 14 | TRUE | 0.74 |
| colorectal cancer | RAS_12-61 | ERBB2 | Any mutation | 38 | 42 | TMB quintile 6 | 0.18 | -0.56 | 0.96 | 1099.23 | 1.00 | 82 | 26 | 30 | 12 | TRUE | 0.19 |
| non-small cell lung cancer | RAS_12-61 | ERBB2 | Any mutation | 83 | 14 | TMB quintile 2 | -2.02 | -3.47 | -0.85 | 1471.06 | 1.00 | 344 | 83 | 14 | 0 | TRUE | 2.65 |
| non-small cell lung cancer | RAS_12-61 | ERBB2 | Any mutation | 159 | 27 | TMB quintile 3 | -1.45 | -2.46 | -0.41 | 1415.37 | 1.00 | 444 | 155 | 23 | 4 | TRUE | 2.23 |
| non-small cell lung cancer | RAS_12-61 | ERBB2 | Any mutation | 267 | 32 | TMB quintile 4 | -2.32 | -3.82 | -1.32 | 1530.93 | 1.00 | 465 | 267 | 32 | 0 | TRUE | 3.62 |
| non-small cell lung cancer | RAS_12-61 | ERBB2 | Any mutation | 474 | 40 | TMB quintile 5 | -1.73 | -2.60 | -0.97 | 1477.48 | 1.00 | 717 | 469 | 35 | 5 | TRUE | 4.48 |
| colorectal cancer | RAS_12-61 | ERBB2 | Any mutation | 751 | 92 | TMB overall | -0.22 | -1.66 | 1.22 | 1251.65 | 1.00 | 757 | 718 | 59 | 33 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | ERBB2 | Any mutation | 983 | 113 | TMB overall | -1.87 | -2.83 | -1.00 | 1308.27 | 1.00 | 1970 | 974 | 104 | 9 | TRUE | 4.10 |
| uterine cancer | RAS_12-61 | JAK1 | Any mutation | 75 | 88 | TMB quintile 5 | 0.11 | -0.44 | 0.67 | 1493.22 | 1.00 | 148 | 51 | 64 | 24 | TRUE | 0.16 |
| uterine cancer | RAS_12-61 | JAK1 | Any mutation | 14 | 52 | TMB quintile 6 | 1.00 | -0.12 | 2.44 | 1464.95 | 1.00 | 26 | 2 | 40 | 12 | TRUE | 0.88 |
| uterine cancer | RAS_12-61 | JAK1 | Any mutation | 89 | 140 | TMB overall | 0.51 | -1.45 | 2.79 | 1484.74 | 1.00 | 174 | 53 | 104 | 36 | TRUE | 0.20 |
| colorectal cancer | RAS_12-61 | ARID2 | Any mutation | 375 | 12 | TMB quintile 4 | -0.38 | -1.44 | 0.71 | 1479.65 | 1.00 | 409 | 370 | 7 | 5 | FALSE | 0.31 |
| colorectal cancer | RAS_12-61 | ARID2 | Any mutation | 339 | 31 | TMB quintile 5 | -0.14 | -0.81 | 0.59 | 1170.03 | 1.00 | 274 | 323 | 15 | 16 | FALSE | 0.16 |
| colorectal cancer | RAS_12-61 | ARID2 | Any mutation | 38 | 66 | TMB quintile 6 | -0.32 | -1.02 | 0.44 | 1324.80 | 1.00 | 64 | 24 | 52 | 14 | FALSE | 0.42 |
| melanoma | RAS_12-61 | ARID2 | Any mutation | 167 | 83 | TMB quintile 5 | 0.04 | -0.44 | 0.49 | 1397.45 | 1.00 | 200 | 133 | 49 | 34 | FALSE | 0.05 |
| melanoma | RAS_12-61 | ARID2 | Any mutation | 10 | 53 | TMB quintile 6 | 0.14 | -1.13 | 1.40 | 1339.08 | 1.00 | 43 | 4 | 47 | 6 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | ARID2 | Any mutation | 159 | 19 | TMB quintile 3 | -0.71 | -1.75 | 0.15 | 1459.06 | 1.00 | 450 | 157 | 17 | 2 | FALSE | 0.84 |
| non-small cell lung cancer | RAS_12-61 | ARID2 | Any mutation | 267 | 35 | TMB quintile 4 | -0.09 | -0.73 | 0.56 | 1352.43 | 1.00 | 475 | 254 | 22 | 13 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12-61 | ARID2 | Any mutation | 475 | 111 | TMB quintile 5 | -0.31 | -0.72 | 0.09 | 1276.89 | 1.00 | 683 | 440 | 76 | 35 | FALSE | 0.84 |
| colorectal cancer | RAS_12-61 | ARID2 | Any mutation | 752 | 109 | TMB overall | -0.27 | -2.10 | 1.69 | 1515.79 | 1.00 | 747 | 717 | 74 | 35 | FALSE | 0.11 |
| melanoma | RAS_12-61 | ARID2 | Any mutation | 177 | 136 | TMB overall | 0.09 | -2.42 | 2.43 | 1426.08 | 1.00 | 243 | 137 | 96 | 40 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | ARID2 | Any mutation | 901 | 165 | TMB overall | -0.37 | -1.26 | 0.42 | 1563.05 | 1.00 | 1608 | 851 | 115 | 50 | FALSE | 0.42 |
| colorectal cancer | RAS_12-61 | MTOR | Any mutation | 375 | 19 | TMB quintile 4 | 0.91 | 0.02 | 1.93 | 1439.80 | 1.00 | 411 | 361 | 5 | 14 | TRUE | 1.21 |
| colorectal cancer | RAS_12-61 | MTOR | Any mutation | 339 | 40 | TMB quintile 5 | 0.03 | -0.58 | 0.66 | 1484.92 | 1.00 | 270 | 317 | 18 | 22 | TRUE | 0.04 |
| colorectal cancer | RAS_12-61 | MTOR | Any mutation | 43 | 70 | TMB quintile 6 | -0.16 | -0.85 | 0.54 | 1456.75 | 1.00 | 66 | 26 | 53 | 17 | TRUE | 0.19 |
| non-small cell lung cancer | RAS_12-61 | MTOR | Any mutation | 159 | 14 | TMB quintile 3 | -0.38 | -1.46 | 0.46 | 1495.33 | 1.00 | 455 | 157 | 12 | 2 | TRUE | 0.38 |
| non-small cell lung cancer | RAS_12-61 | MTOR | Any mutation | 268 | 21 | TMB quintile 4 | 0.07 | -0.65 | 0.79 | 1592.13 | 1.00 | 483 | 259 | 12 | 9 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12-61 | MTOR | Any mutation | 476 | 70 | TMB quintile 5 | -0.05 | -0.53 | 0.41 | 1372.90 | 1.00 | 705 | 450 | 44 | 26 | TRUE | 0.07 |
| colorectal cancer | RAS_12-61 | MTOR | Any mutation | 757 | 129 | TMB overall | 0.25 | -1.53 | 2.16 | 1263.93 | 1.00 | 747 | 704 | 76 | 53 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12-61 | MTOR | Any mutation | 903 | 105 | TMB overall | -0.12 | -0.94 | 0.64 | 1591.92 | 1.00 | 1643 | 866 | 68 | 37 | TRUE | 0.12 |
| colorectal cancer | RAS_12-61 | NOTCH1 | Any mutation | 339 | 48 | TMB quintile 5 | -1.23 | -1.89 | -0.62 | 1553.89 | 1.00 | 256 | 326 | 35 | 13 | TRUE | 3.67 |
| colorectal cancer | RAS_12-61 | NOTCH1 | Any mutation | 53 | 112 | TMB quintile 6 | 0.52 | -0.15 | 1.22 | 1337.08 | 1.00 | 52 | 15 | 74 | 38 | TRUE | 0.89 |
| non-small cell lung cancer | RAS_12-61 | NOTCH1 | Any mutation | 267 | 15 | TMB quintile 4 | -0.57 | -1.61 | 0.47 | 1338.20 | 1.00 | 484 | 263 | 11 | 4 | TRUE | 0.56 |
| non-small cell lung cancer | RAS_12-61 | NOTCH1 | Any mutation | 475 | 97 | TMB quintile 5 | -0.57 | -1.03 | -0.12 | 1408.62 | 1.00 | 683 | 449 | 71 | 26 | TRUE | 1.87 |
| colorectal cancer | RAS_12-61 | NOTCH1 | Any mutation | 392 | 160 | TMB overall | -0.31 | -2.77 | 2.28 | 1465.31 | 1.00 | 308 | 341 | 109 | 51 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | NOTCH1 | Any mutation | 742 | 112 | TMB overall | -0.54 | -2.19 | 1.19 | 1346.33 | 1.00 | 1167 | 712 | 82 | 30 | TRUE | 0.28 |
| colorectal cancer | RAS_12-61 | SETD2 | Any mutation | 192 | 11 | TMB quintile 3 | -1.74 | -3.55 | -0.33 | 1519.96 | 1.00 | 286 | 191 | 10 | 1 | FALSE | 1.45 |
| colorectal cancer | RAS_12-61 | SETD2 | Any mutation | 339 | 31 | TMB quintile 5 | -1.30 | -2.12 | -0.55 | 1563.21 | 1.00 | 267 | 331 | 23 | 8 | FALSE | 2.93 |
| colorectal cancer | RAS_12-61 | SETD2 | Any mutation | 43 | 64 | TMB quintile 6 | -0.24 | -0.98 | 0.46 | 1529.46 | 1.00 | 68 | 27 | 48 | 16 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 83 | 14 | TMB quintile 2 | -1.01 | -2.57 | 0.08 | 1569.37 | 1.00 | 344 | 83 | 14 | 0 | FALSE | 0.84 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 160 | 22 | TMB quintile 3 | -0.88 | -2.14 | 0.01 | 1725.55 | 1.00 | 452 | 158 | 20 | 2 | FALSE | 1.00 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 268 | 59 | TMB quintile 4 | -0.26 | -0.82 | 0.26 | 1523.05 | 1.00 | 462 | 250 | 41 | 18 | FALSE | 0.46 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 482 | 110 | TMB quintile 5 | 0.09 | -0.30 | 0.47 | 1468.88 | 1.00 | 693 | 436 | 64 | 46 | FALSE | 0.18 |
| colorectal cancer | RAS_12-61 | SETD2 | Any mutation | 574 | 106 | TMB overall | -1.03 | -2.74 | 0.82 | 1443.95 | 1.00 | 621 | 549 | 81 | 25 | FALSE | 0.60 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 993 | 205 | TMB overall | -0.51 | -1.44 | 0.24 | 1477.44 | 1.00 | 1951 | 927 | 139 | 66 | FALSE | 0.65 |
| non-small cell lung cancer | RAS_12-61 | PBRM1 | Any mutation | 269 | 21 | TMB quintile 4 | 0.24 | -0.58 | 1.15 | 1437.62 | 1.00 | 485 | 259 | 11 | 10 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12-61 | PBRM1 | Any mutation | 474 | 79 | TMB quintile 5 | -0.51 | -1.05 | -0.04 | 1580.56 | 1.00 | 700 | 453 | 58 | 21 | TRUE | 1.30 |
| non-small cell lung cancer | RAS_12-61 | PBRM1 | Any mutation | 743 | 100 | TMB overall | -0.15 | -1.68 | 1.45 | 1473.87 | 1.00 | 1185 | 712 | 69 | 31 | TRUE | 0.07 |
| colorectal cancer | RAS_12-61 | EPHA3 | Any mutation | 376 | 17 | TMB quintile 4 | -0.14 | -1.05 | 0.77 | 1560.21 | 1.00 | 407 | 368 | 9 | 8 | FALSE | 0.12 |
| colorectal cancer | RAS_12-61 | EPHA3 | Any mutation | 338 | 41 | TMB quintile 5 | -0.01 | -0.62 | 0.61 | 1589.14 | 1.00 | 270 | 316 | 19 | 22 | FALSE | 0.01 |
| colorectal cancer | RAS_12-61 | EPHA3 | Any mutation | 40 | 44 | TMB quintile 6 | 0.06 | -0.71 | 0.84 | 1526.42 | 1.00 | 79 | 28 | 32 | 12 | FALSE | 0.06 |
| melanoma | RAS_12-61 | EPHA3 | Any mutation | 164 | 57 | TMB quintile 5 | 0.79 | 0.26 | 1.38 | 1384.78 | 1.00 | 218 | 131 | 24 | 33 | FALSE | 2.26 |
| melanoma | RAS_12-61 | EPHA3 | Any mutation | 8 | 45 | TMB quintile 6 | 0.36 | -0.95 | 1.73 | 1548.73 | 1.00 | 35 | 3 | 40 | 5 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 159 | 15 | TMB quintile 3 | 0.54 | -0.44 | 1.47 | 1340.26 | 1.00 | 458 | 153 | 9 | 6 | FALSE | 0.57 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 267 | 28 | TMB quintile 4 | 0.58 | -0.19 | 1.34 | 1498.87 | 1.00 | 481 | 253 | 14 | 14 | FALSE | 0.89 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 481 | 182 | TMB quintile 5 | 0.05 | -0.27 | 0.38 | 1416.68 | 1.00 | 650 | 409 | 110 | 72 | FALSE | 0.11 |
| colorectal cancer | RAS_12-61 | EPHA3 | Any mutation | 754 | 102 | TMB overall | -0.02 | -1.64 | 1.52 | 1583.66 | 1.00 | 756 | 712 | 60 | 42 | FALSE | 0.01 |
| melanoma | RAS_12-61 | EPHA3 | Any mutation | 172 | 102 | TMB overall | 0.50 | -2.10 | 3.08 | 1476.51 | 1.00 | 253 | 134 | 64 | 38 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 908 | 237 | TMB overall | 0.39 | -1.23 | 2.22 | 1484.21 | 1.00 | 1597 | 815 | 144 | 93 | FALSE | 0.19 |
| melanoma | RAS_12-61 | KDR | Any mutation | 160 | 64 | TMB quintile 5 | -0.16 | -0.68 | 0.37 | 1358.11 | 1.00 | 200 | 136 | 40 | 24 | TRUE | 0.25 |
| melanoma | RAS_12-61 | KDR | Any mutation | 11 | 62 | TMB quintile 6 | -0.21 | -1.35 | 1.07 | 1517.79 | 1.00 | 27 | 4 | 55 | 7 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12-61 | KDR | Any mutation | 267 | 21 | TMB quintile 4 | 0.32 | -0.52 | 1.18 | 1310.15 | 1.00 | 484 | 257 | 11 | 10 | TRUE | 0.34 |
| non-small cell lung cancer | RAS_12-61 | KDR | Any mutation | 477 | 109 | TMB quintile 5 | -0.24 | -0.67 | 0.14 | 1482.68 | 1.00 | 678 | 441 | 73 | 36 | TRUE | 0.59 |
| melanoma | RAS_12-61 | KDR | Any mutation | 171 | 126 | TMB overall | -0.21 | -2.68 | 2.32 | 1571.35 | 1.00 | 227 | 140 | 95 | 31 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | KDR | Any mutation | 744 | 130 | TMB overall | 0.03 | -1.77 | 1.94 | 1638.93 | 1.00 | 1162 | 698 | 84 | 46 | TRUE | 0.01 |
| colorectal cancer | RAS_12-61 | PTCH1 | Any mutation | 339 | 35 | TMB quintile 5 | -0.88 | -1.56 | -0.16 | 1558.77 | 1.00 | 266 | 327 | 23 | 12 | TRUE | 1.85 |
| colorectal cancer | RAS_12-61 | PTCH1 | Any mutation | 46 | 99 | TMB quintile 6 | -0.16 | -0.81 | 0.48 | 1301.68 | 1.00 | 53 | 21 | 74 | 25 | TRUE | 0.20 |
| colorectal cancer | RAS_12-61 | PTCH1 | Any mutation | 385 | 134 | TMB overall | -0.52 | -3.17 | 1.91 | 1620.20 | 1.00 | 319 | 348 | 97 | 37 | TRUE | 0.17 |
| colorectal cancer | RAS_12-61 | TET1 | Any mutation | 320 | 26 | TMB quintile 5 | -0.68 | -1.49 | 0.07 | 1375.88 | 1.00 | 255 | 310 | 16 | 10 | FALSE | 1.10 |
| colorectal cancer | RAS_12-61 | TET1 | Any mutation | 44 | 67 | TMB quintile 6 | 0.19 | -0.47 | 0.88 | 1430.54 | 1.00 | 71 | 24 | 47 | 20 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | TET1 | Any mutation | 267 | 16 | TMB quintile 4 | -0.67 | -1.85 | 0.48 | 1513.58 | 1.00 | 480 | 263 | 12 | 4 | FALSE | 0.57 |
| non-small cell lung cancer | RAS_12-61 | TET1 | Any mutation | 476 | 89 | TMB quintile 5 | -0.16 | -0.63 | 0.28 | 1437.27 | 1.00 | 694 | 444 | 57 | 32 | FALSE | 0.31 |
| colorectal cancer | RAS_12-61 | TET1 | Any mutation | 364 | 93 | TMB overall | -0.27 | -2.73 | 2.12 | 1448.67 | 1.00 | 326 | 334 | 63 | 30 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | TET1 | Any mutation | 744 | 120 | TMB overall | -0.99 | -3.58 | 1.39 | 1512.04 | 1.00 | 1178 | 708 | 84 | 36 | FALSE | 0.37 |
| uterine cancer | RAS_12-61 | FGFR2 | Any mutation | 48 | 23 | TMB quintile 4 | -1.39 | -2.63 | -0.20 | 1515.68 | 1.00 | 162 | 45 | 20 | 3 | TRUE | 1.58 |
| uterine cancer | RAS_12-61 | FGFR2 | Any mutation | 70 | 52 | TMB quintile 5 | -1.89 | -2.98 | -1.00 | 1300.89 | 1.00 | 149 | 67 | 49 | 3 | TRUE | 3.65 |
| uterine cancer | RAS_12-61 | FGFR2 | Any mutation | 10 | 18 | TMB quintile 6 | -2.00 | -3.85 | -0.64 | 1382.46 | 1.00 | 38 | 10 | 18 | 0 | TRUE | 1.84 |
| uterine cancer | RAS_12-61 | FGFR2 | Any mutation | 128 | 93 | TMB overall | -1.75 | -3.09 | -0.65 | 1455.53 | 1.00 | 349 | 122 | 87 | 6 | TRUE | 2.32 |
| non-small cell lung cancer | RAS_12-61 | TBX3 | Any mutation | 267 | 11 | TMB quintile 4 | -0.16 | -1.35 | 1.00 | 1569.09 | 1.00 | 488 | 263 | 7 | 4 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12-61 | TBX3 | Any mutation | 474 | 108 | TMB quintile 5 | -0.33 | -0.73 | 0.07 | 1570.77 | 1.00 | 683 | 440 | 74 | 34 | FALSE | 0.94 |
| non-small cell lung cancer | RAS_12-61 | TBX3 | Any mutation | 741 | 119 | TMB overall | -0.26 | -2.27 | 1.63 | 1560.57 | 1.00 | 1171 | 703 | 81 | 38 | FALSE | 0.10 |
| colorectal cancer | RAS_12-61 | SMAD3 | Any mutation | 192 | 12 | TMB quintile 3 | 0.04 | -0.91 | 0.94 | 1485.42 | 1.00 | 288 | 187 | 7 | 5 | TRUE | 0.04 |
| colorectal cancer | RAS_12-61 | SMAD3 | Any mutation | 378 | 27 | TMB quintile 4 | 0.14 | -0.53 | 0.81 | 1500.23 | 1.00 | 405 | 364 | 13 | 14 | TRUE | 0.16 |
| colorectal cancer | RAS_12-61 | SMAD3 | Any mutation | 345 | 44 | TMB quintile 5 | 0.71 | 0.13 | 1.34 | 1232.44 | 1.00 | 276 | 313 | 12 | 32 | TRUE | 1.62 |
| colorectal cancer | RAS_12-61 | SMAD3 | Any mutation | 38 | 23 | TMB quintile 6 | 0.13 | -0.78 | 0.97 | 1491.87 | 1.00 | 89 | 32 | 17 | 6 | TRUE | 0.11 |
| colorectal cancer | RAS_12-61 | SMAD3 | Any mutation | 953 | 106 | TMB overall | 0.26 | -0.58 | 1.11 | 1482.90 | 1.00 | 1058 | 896 | 49 | 57 | TRUE | 0.26 |
| melanoma | RAS_12-61 | NTRK3 | Any mutation | 164 | 58 | TMB quintile 5 | -0.16 | -0.70 | 0.43 | 1482.55 | 1.00 | 205 | 142 | 36 | 22 | FALSE | 0.23 |
| melanoma | RAS_12-61 | NTRK3 | Any mutation | 9 | 42 | TMB quintile 6 | -0.39 | -1.66 | 0.79 | 1377.48 | 1.00 | 35 | 5 | 38 | 4 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12-61 | NTRK3 | Any mutation | 269 | 31 | TMB quintile 4 | 1.04 | 0.39 | 1.74 | 1532.30 | 1.00 | 484 | 250 | 12 | 19 | FALSE | 2.47 |
| non-small cell lung cancer | RAS_12-61 | NTRK3 | Any mutation | 478 | 144 | TMB quintile 5 | 0.11 | -0.25 | 0.47 | 1601.39 | 1.00 | 673 | 419 | 85 | 59 | FALSE | 0.25 |
| melanoma | RAS_12-61 | NTRK3 | Any mutation | 173 | 100 | TMB overall | -0.27 | -2.38 | 1.89 | 1253.32 | 1.00 | 240 | 147 | 74 | 26 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12-61 | NTRK3 | Any mutation | 749 | 195 | TMB overall | 0.65 | -1.76 | 3.32 | 1499.63 | 1.00 | 1164 | 669 | 115 | 80 | FALSE | 0.22 |
| colorectal cancer | RAS_12-61 | GRIN2A | Any mutation | 375 | 30 | TMB quintile 4 | -0.53 | -1.26 | 0.16 | 1429.75 | 1.00 | 397 | 364 | 19 | 11 | FALSE | 0.82 |
| colorectal cancer | RAS_12-61 | GRIN2A | Any mutation | 339 | 42 | TMB quintile 5 | -0.59 | -1.20 | 0.04 | 1350.42 | 1.00 | 263 | 322 | 25 | 17 | FALSE | 1.19 |
| colorectal cancer | RAS_12-61 | GRIN2A | Any mutation | 38 | 59 | TMB quintile 6 | -0.38 | -1.16 | 0.36 | 1507.37 | 1.00 | 70 | 26 | 47 | 12 | FALSE | 0.51 |
| melanoma | RAS_12-61 | GRIN2A | Any mutation | 171 | 166 | TMB quintile 5 | -0.45 | -0.83 | -0.06 | 1598.11 | 1.00 | 156 | 117 | 112 | 54 | FALSE | 1.56 |
| melanoma | RAS_12-61 | GRIN2A | Any mutation | 16 | 124 | TMB quintile 6 | 0.48 | -0.98 | 2.54 | 1456.49 | 1.00 | 17 | 1 | 109 | 15 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12-61 | GRIN2A | Any mutation | 159 | 17 | TMB quintile 3 | 0.56 | -0.32 | 1.45 | 1279.02 | 1.00 | 458 | 151 | 9 | 8 | FALSE | 0.68 |
| non-small cell lung cancer | RAS_12-61 | GRIN2A | Any mutation | 267 | 39 | TMB quintile 4 | 0.25 | -0.37 | 0.86 | 1466.30 | 1.00 | 473 | 251 | 23 | 16 | FALSE | 0.37 |
| non-small cell lung cancer | RAS_12-61 | GRIN2A | Any mutation | 478 | 124 | TMB quintile 5 | -0.16 | -0.55 | 0.21 | 1421.77 | 1.00 | 672 | 436 | 82 | 42 | FALSE | 0.38 |
| colorectal cancer | RAS_12-61 | GRIN2A | Any mutation | 752 | 131 | TMB overall | -0.48 | -1.86 | 0.94 | 1552.88 | 1.00 | 730 | 712 | 91 | 40 | FALSE | 0.31 |
| melanoma | RAS_12-61 | GRIN2A | Any mutation | 187 | 290 | TMB overall | -0.03 | -2.66 | 2.90 | 1453.13 | 1.00 | 173 | 118 | 221 | 69 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | GRIN2A | Any mutation | 904 | 180 | TMB overall | 0.22 | -0.71 | 1.32 | 1351.52 | 1.00 | 1603 | 838 | 114 | 66 | FALSE | 0.18 |
| uterine cancer | RAS_12-61 | CTCF | Any mutation | 48 | 12 | TMB quintile 4 | 0.43 | -0.77 | 1.56 | 1393.78 | 1.00 | 173 | 44 | 8 | 4 | FALSE | 0.33 |
| uterine cancer | RAS_12-61 | CTCF | Any mutation | 72 | 103 | TMB quintile 5 | 0.14 | -0.40 | 0.66 | 1419.07 | 1.00 | 123 | 43 | 74 | 29 | FALSE | 0.22 |
| uterine cancer | RAS_12-61 | CTCF | Any mutation | 12 | 48 | TMB quintile 6 | 0.55 | -0.62 | 1.82 | 1463.86 | 1.00 | 24 | 3 | 39 | 9 | FALSE | 0.42 |
| uterine cancer | RAS_12-61 | CTCF | Any mutation | 132 | 163 | TMB overall | 0.39 | -1.25 | 2.19 | 1452.99 | 1.00 | 320 | 90 | 121 | 42 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 83 | 12 | TMB quintile 2 | 1.67 | 0.75 | 2.69 | 1374.88 | 1.00 | 354 | 75 | 4 | 8 | TRUE | 3.08 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 161 | 78 | TMB quintile 3 | 1.60 | 1.12 | 2.11 | 1567.43 | 1.00 | 434 | 116 | 33 | 45 | TRUE | 9.59 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 270 | 161 | TMB quintile 4 | 1.47 | 1.13 | 1.82 | 1521.33 | 1.00 | 435 | 169 | 60 | 101 | TRUE | 15.65 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 478 | 283 | TMB quintile 5 | 0.31 | 0.03 | 0.60 | 1433.19 | 1.00 | 599 | 355 | 160 | 123 | TRUE | 1.46 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 992 | 534 | TMB overall | 1.25 | 0.20 | 2.29 | 1364.53 | 1.00 | 1822 | 715 | 257 | 277 | TRUE | 1.83 |
| colorectal cancer | RAS_12-61 | ASXL1 | Any mutation | 375 | 15 | TMB quintile 4 | 0.08 | -0.90 | 1.04 | 1427.72 | 1.00 | 409 | 367 | 7 | 8 | TRUE | 0.06 |
| colorectal cancer | RAS_12-61 | ASXL1 | Any mutation | 338 | 30 | TMB quintile 5 | -0.19 | -0.90 | 0.53 | 1472.67 | 1.00 | 274 | 323 | 15 | 15 | TRUE | 0.22 |
| colorectal cancer | RAS_12-61 | ASXL1 | Any mutation | 40 | 57 | TMB quintile 6 | -0.29 | -1.04 | 0.44 | 1549.96 | 1.00 | 67 | 27 | 44 | 13 | TRUE | 0.35 |
| colorectal cancer | RAS_12-61 | ASXL1 | Any mutation | 753 | 102 | TMB overall | -0.14 | -1.93 | 1.46 | 1460.43 | 1.00 | 750 | 717 | 66 | 36 | TRUE | 0.06 |
| colorectal cancer | RAS_12-61 | EP300 | Any mutation | 338 | 39 | TMB quintile 5 | -1.15 | -1.90 | -0.48 | 1274.29 | 1.00 | 262 | 327 | 28 | 11 | TRUE | 2.95 |
| colorectal cancer | RAS_12-61 | EP300 | Any mutation | 44 | 72 | TMB quintile 6 | 0.16 | -0.56 | 0.86 | 1372.06 | 1.00 | 69 | 23 | 51 | 21 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12-61 | EP300 | Any mutation | 475 | 77 | TMB quintile 5 | -0.42 | -0.95 | 0.05 | 1239.11 | 1.00 | 700 | 452 | 54 | 23 | TRUE | 1.05 |
| uterine cancer | RAS_12-61 | EP300 | Any mutation | 71 | 39 | TMB quintile 5 | 0.18 | -0.59 | 0.90 | 1559.42 | 1.00 | 168 | 59 | 27 | 12 | TRUE | 0.20 |
| uterine cancer | RAS_12-61 | EP300 | Any mutation | 14 | 53 | TMB quintile 6 | 0.10 | -0.97 | 1.15 | 1499.22 | 1.00 | 27 | 5 | 44 | 9 | TRUE | 0.07 |
| colorectal cancer | RAS_12-61 | EP300 | Any mutation | 382 | 111 | TMB overall | -0.47 | -2.92 | 2.14 | 1048.62 | 1.00 | 331 | 350 | 79 | 32 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12-61 | EP300 | Any mutation | 475 | 77 | TMB overall | -0.37 | -4.64 | 3.84 | 1365.66 | 1.00 | 700 | 452 | 54 | 23 | TRUE | 0.08 |
| uterine cancer | RAS_12-61 | EP300 | Any mutation | 85 | 92 | TMB overall | 0.14 | -2.09 | 2.34 | 1364.63 | 1.00 | 195 | 64 | 71 | 21 | TRUE | 0.04 |
| colorectal cancer | RAS_12-61 | ERBB4 | Any mutation | 375 | 22 | TMB quintile 4 | 0.03 | -0.76 | 0.84 | 1459.39 | 1.00 | 406 | 364 | 11 | 11 | TRUE | 0.02 |
| colorectal cancer | RAS_12-61 | ERBB4 | Any mutation | 339 | 45 | TMB quintile 5 | -0.18 | -0.76 | 0.36 | 1483.44 | 1.00 | 266 | 317 | 23 | 22 | TRUE | 0.28 |
| colorectal cancer | RAS_12-61 | ERBB4 | Any mutation | 44 | 61 | TMB quintile 6 | 0.73 | 0.07 | 1.41 | 1453.12 | 1.00 | 76 | 21 | 38 | 23 | TRUE | 1.47 |
| melanoma | RAS_12-61 | ERBB4 | Any mutation | 163 | 92 | TMB quintile 5 | -0.33 | -0.82 | 0.12 | 1500.91 | 1.00 | 186 | 132 | 61 | 31 | TRUE | 0.75 |
| melanoma | RAS_12-61 | ERBB4 | Any mutation | 19 | 89 | TMB quintile 6 | 1.21 | -0.31 | 3.20 | 1498.68 | 1.00 | 19 | 1 | 71 | 18 | TRUE | 0.77 |
| non-small cell lung cancer | RAS_12-61 | ERBB4 | Any mutation | 267 | 25 | TMB quintile 4 | -0.29 | -1.19 | 0.53 | 1360.80 | 1.00 | 478 | 259 | 17 | 8 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12-61 | ERBB4 | Any mutation | 479 | 148 | TMB quintile 5 | -0.60 | -1.00 | -0.21 | 1326.57 | 1.00 | 661 | 439 | 108 | 40 | TRUE | 2.56 |
| colorectal cancer | RAS_12-61 | ERBB4 | Any mutation | 758 | 128 | TMB overall | 0.20 | -1.36 | 1.74 | 1579.96 | 1.00 | 748 | 702 | 72 | 56 | TRUE | 0.10 |
| melanoma | RAS_12-61 | ERBB4 | Any mutation | 182 | 181 | TMB overall | 0.41 | -2.35 | 3.73 | 1524.12 | 1.00 | 205 | 133 | 132 | 49 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | ERBB4 | Any mutation | 747 | 185 | TMB overall | -0.90 | -3.38 | 1.16 | 1491.76 | 1.00 | 1147 | 699 | 137 | 48 | TRUE | 0.37 |
| colorectal cancer | RAS_12-61 | MED12 | Any mutation | 376 | 18 | TMB quintile 4 | -0.02 | -0.88 | 0.85 | 1686.37 | 1.00 | 407 | 367 | 9 | 9 | TRUE | 0.01 |
| colorectal cancer | RAS_12-61 | MED12 | Any mutation | 338 | 28 | TMB quintile 5 | -0.06 | -0.78 | 0.68 | 1453.73 | 1.00 | 277 | 323 | 13 | 15 | TRUE | 0.07 |
| colorectal cancer | RAS_12-61 | MED12 | Any mutation | 41 | 59 | TMB quintile 6 | -0.08 | -0.81 | 0.63 | 1492.80 | 1.00 | 69 | 26 | 44 | 15 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | MED12 | Any mutation | 159 | 23 | TMB quintile 3 | -0.21 | -0.96 | 0.54 | 1688.04 | 1.00 | 450 | 153 | 17 | 6 | TRUE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | MED12 | Any mutation | 267 | 32 | TMB quintile 4 | -0.32 | -0.96 | 0.27 | 1410.64 | 1.00 | 472 | 258 | 23 | 9 | TRUE | 0.51 |
| non-small cell lung cancer | RAS_12-61 | MED12 | Any mutation | 478 | 101 | TMB quintile 5 | -0.20 | -0.62 | 0.17 | 1391.62 | 1.00 | 687 | 444 | 67 | 34 | TRUE | 0.50 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 14 | 13 | TMB quintile 2 | -1.64 | -4.07 | 0.17 | 1375.81 | 1.00 | 118 | 14 | 13 | 0 | TRUE | 0.87 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 26 | 16 | TMB quintile 3 | -0.43 | -1.93 | 0.95 | 1466.49 | 1.00 | 201 | 24 | 14 | 2 | TRUE | 0.25 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 48 | 20 | TMB quintile 4 | -1.06 | -2.48 | 0.13 | 1491.50 | 1.00 | 163 | 46 | 18 | 2 | TRUE | 0.95 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 70 | 31 | TMB quintile 5 | -0.21 | -1.09 | 0.62 | 1559.25 | 1.00 | 173 | 62 | 23 | 8 | TRUE | 0.21 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 11 | 58 | TMB quintile 6 | -1.83 | -3.35 | -0.57 | 1464.75 | 1.00 | 24 | 9 | 56 | 2 | TRUE | 2.02 |
| colorectal cancer | RAS_12-61 | MED12 | Any mutation | 755 | 105 | TMB overall | -0.06 | -1.65 | 1.64 | 1265.30 | 1.00 | 753 | 716 | 66 | 39 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | MED12 | Any mutation | 904 | 156 | TMB overall | -0.25 | -0.95 | 0.44 | 1544.18 | 1.00 | 1609 | 855 | 107 | 49 | TRUE | 0.31 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 169 | 138 | TMB overall | -0.99 | -2.28 | 0.22 | 1386.77 | 1.00 | 679 | 155 | 124 | 14 | TRUE | 0.92 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 83 | 29 | TMB quintile 2 | 0.32 | -0.39 | 0.94 | 1490.14 | 1.00 | 335 | 77 | 23 | 6 | FALSE | 0.46 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 159 | 46 | TMB quintile 3 | 0.42 | -0.11 | 0.93 | 1487.31 | 1.00 | 437 | 144 | 31 | 15 | FALSE | 0.92 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 268 | 90 | TMB quintile 4 | 0.80 | 0.39 | 1.23 | 1571.45 | 1.00 | 453 | 220 | 42 | 48 | FALSE | 3.87 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 483 | 200 | TMB quintile 5 | 0.77 | 0.50 | 1.06 | 1376.12 | 1.00 | 667 | 374 | 91 | 109 | FALSE | 6.81 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 993 | 365 | TMB overall | 0.58 | 0.06 | 1.07 | 1529.08 | 1.00 | 1892 | 815 | 187 | 178 | FALSE | 1.53 |
| colorectal cancer | RAS_12-61 | NF1 | Any mutation | 375 | 13 | TMB quintile 4 | -1.58 | -3.05 | -0.40 | 1395.01 | 1.00 | 406 | 373 | 11 | 2 | TRUE | 1.62 |
| colorectal cancer | RAS_12-61 | NF1 | Any mutation | 339 | 34 | TMB quintile 5 | -0.46 | -1.13 | 0.21 | 1462.02 | 1.00 | 269 | 324 | 19 | 15 | TRUE | 0.75 |
| colorectal cancer | RAS_12-61 | NF1 | Any mutation | 41 | 86 | TMB quintile 6 | -0.42 | -1.09 | 0.27 | 1450.52 | 1.00 | 65 | 24 | 69 | 17 | TRUE | 0.65 |
| melanoma | RAS_12-61 | NF1 | Any mutation | 17 | 13 | TMB quintile 3 | 0.27 | -1.30 | 1.62 | 1290.08 | 1.00 | 84 | 14 | 10 | 3 | TRUE | 0.15 |
| melanoma | RAS_12-61 | NF1 | Any mutation | 22 | 11 | TMB quintile 4 | -2.32 | -5.96 | -0.14 | 1468.91 | 1.00 | 74 | 22 | 11 | 0 | TRUE | 0.93 |
| melanoma | RAS_12-61 | NF1 | Any mutation | 165 | 162 | TMB quintile 5 | -1.06 | -1.51 | -0.63 | 1481.60 | 1.00 | 156 | 129 | 126 | 36 | TRUE | 5.47 |
| melanoma | RAS_12-61 | NF1 | Any mutation | 15 | 100 | TMB quintile 6 | 1.11 | -0.71 | 3.88 | 1442.55 | 1.00 | 12 | 0 | 85 | 15 | TRUE | 0.47 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 159 | 25 | TMB quintile 3 | -0.80 | -1.74 | 0.12 | 1423.96 | 1.00 | 447 | 155 | 21 | 4 | TRUE | 1.06 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 267 | 59 | TMB quintile 4 | -1.18 | -1.91 | -0.55 | 1497.50 | 1.00 | 452 | 259 | 51 | 8 | TRUE | 3.15 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 481 | 216 | TMB quintile 5 | -0.55 | -0.86 | -0.24 | 1654.09 | 1.00 | 623 | 420 | 155 | 61 | TRUE | 3.13 |
| uterine cancer | RAS_12-61 | NF1 | Any mutation | 70 | 38 | TMB quintile 5 | -0.80 | -1.76 | 0.09 | 1361.96 | 1.00 | 167 | 64 | 32 | 6 | TRUE | 1.04 |
| uterine cancer | RAS_12-61 | NF1 | Any mutation | 13 | 73 | TMB quintile 6 | -0.88 | -2.01 | 0.28 | 1234.41 | 1.00 | 23 | 6 | 66 | 7 | TRUE | 0.90 |
| colorectal cancer | RAS_12-61 | NF1 | Any mutation | 755 | 133 | TMB overall | -0.80 | -2.72 | 1.17 | 1511.49 | 1.00 | 740 | 721 | 99 | 34 | TRUE | 0.40 |
| melanoma | RAS_12-61 | NF1 | Any mutation | 219 | 286 | TMB overall | -0.49 | -2.62 | 1.53 | 1351.61 | 1.00 | 326 | 165 | 232 | 54 | TRUE | 0.20 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 907 | 300 | TMB overall | -0.84 | -1.89 | 0.10 | 1371.19 | 1.00 | 1522 | 834 | 227 | 73 | TRUE | 1.02 |
| uterine cancer | RAS_12-61 | NF1 | Any mutation | 83 | 111 | TMB overall | -0.83 | -3.22 | 1.42 | 1441.86 | 1.00 | 190 | 70 | 98 | 13 | TRUE | 0.31 |
| melanoma | RAS_12-61 | FLT1 | Any mutation | 161 | 60 | TMB quintile 5 | -0.16 | -0.76 | 0.43 | 1597.47 | 1.00 | 202 | 139 | 38 | 22 | FALSE | 0.22 |
| melanoma | RAS_12-61 | FLT1 | Any mutation | 14 | 56 | TMB quintile 6 | 1.85 | 0.42 | 3.74 | 1549.23 | 1.00 | 34 | 1 | 43 | 13 | FALSE | 1.47 |
| non-small cell lung cancer | RAS_12-61 | FLT1 | Any mutation | 267 | 21 | TMB quintile 4 | 0.90 | 0.07 | 1.84 | 1691.91 | 1.00 | 488 | 254 | 8 | 13 | FALSE | 1.27 |
| non-small cell lung cancer | RAS_12-61 | FLT1 | Any mutation | 477 | 99 | TMB quintile 5 | -0.42 | -0.88 | 0.01 | 1306.17 | 1.00 | 686 | 448 | 70 | 29 | FALSE | 1.19 |
| melanoma | RAS_12-61 | FLT1 | Any mutation | 175 | 116 | TMB overall | 0.75 | -2.38 | 3.75 | 1526.67 | 1.00 | 236 | 140 | 81 | 35 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12-61 | FLT1 | Any mutation | 744 | 120 | TMB overall | 0.23 | -1.91 | 2.44 | 1524.95 | 1.00 | 1174 | 702 | 78 | 42 | FALSE | 0.08 |
| uterine cancer | RAS_12-61 | RASA1 | Any mutation | 70 | 25 | TMB quintile 5 | -0.91 | -2.20 | 0.18 | 1494.60 | 1.00 | 173 | 66 | 21 | 4 | FALSE | 0.88 |
| uterine cancer | RAS_12-61 | RASA1 | Any mutation | 10 | 70 | TMB quintile 6 | -2.48 | -4.25 | -1.01 | 1366.89 | 1.00 | 21 | 8 | 68 | 2 | FALSE | 2.65 |
| uterine cancer | RAS_12-61 | RASA1 | Any mutation | 80 | 95 | TMB overall | -1.55 | -4.39 | 1.54 | 1573.71 | 1.00 | 194 | 74 | 89 | 6 | FALSE | 0.54 |
| colorectal cancer | RAS_12-61 | EPHA5 | Any mutation | 375 | 18 | TMB quintile 4 | -0.29 | -1.24 | 0.62 | 1469.44 | 1.00 | 406 | 367 | 10 | 8 | FALSE | 0.27 |
| colorectal cancer | RAS_12-61 | EPHA5 | Any mutation | 339 | 52 | TMB quintile 5 | -0.52 | -1.12 | 0.04 | 1579.25 | 1.00 | 260 | 317 | 30 | 22 | FALSE | 1.11 |
| colorectal cancer | RAS_12-61 | EPHA5 | Any mutation | 40 | 66 | TMB quintile 6 | -0.56 | -1.32 | 0.20 | 1480.43 | 1.00 | 70 | 28 | 54 | 12 | FALSE | 0.83 |
| non-small cell lung cancer | RAS_12-61 | EPHA5 | Any mutation | 267 | 48 | TMB quintile 4 | 0.44 | -0.14 | 1.02 | 1496.51 | 1.00 | 470 | 245 | 26 | 22 | FALSE | 0.86 |
| non-small cell lung cancer | RAS_12-61 | EPHA5 | Any mutation | 479 | 191 | TMB quintile 5 | 0.09 | -0.20 | 0.40 | 1427.95 | 1.00 | 649 | 402 | 114 | 77 | FALSE | 0.25 |
| colorectal cancer | RAS_12-61 | EPHA5 | Any mutation | 754 | 136 | TMB overall | -0.44 | -2.05 | 1.18 | 1206.56 | 1.00 | 736 | 712 | 94 | 42 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12-61 | EPHA5 | Any mutation | 747 | 250 | TMB overall | 0.25 | -1.45 | 2.31 | 1519.12 | 1.00 | 1129 | 647 | 150 | 100 | FALSE | 0.10 |
| colorectal cancer | RAS_12-61 | AR | Any mutation | 375 | 21 | TMB quintile 4 | -0.85 | -1.82 | -0.01 | 1364.49 | 1.01 | 401 | 369 | 15 | 6 | TRUE | 1.18 |
| colorectal cancer | RAS_12-61 | AR | Any mutation | 339 | 34 | TMB quintile 5 | -0.68 | -1.43 | 0.00 | 1529.77 | 1.00 | 268 | 326 | 21 | 13 | TRUE | 1.24 |
| colorectal cancer | RAS_12-61 | AR | Any mutation | 41 | 55 | TMB quintile 6 | 0.23 | -0.48 | 0.93 | 1292.03 | 1.00 | 73 | 24 | 38 | 17 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12-61 | AR | Any mutation | 267 | 16 | TMB quintile 4 | 0.11 | -0.82 | 1.03 | 1473.02 | 1.00 | 486 | 260 | 9 | 7 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | AR | Any mutation | 477 | 77 | TMB quintile 5 | -0.26 | -0.76 | 0.22 | 1539.07 | 1.00 | 702 | 452 | 52 | 25 | TRUE | 0.53 |
| colorectal cancer | RAS_12-61 | AR | Any mutation | 755 | 110 | TMB overall | -0.45 | -2.12 | 1.03 | 1182.09 | 1.00 | 742 | 719 | 74 | 36 | TRUE | 0.26 |
| non-small cell lung cancer | RAS_12-61 | AR | Any mutation | 744 | 93 | TMB overall | -0.07 | -1.47 | 1.65 | 1492.66 | 1.00 | 1188 | 712 | 61 | 32 | TRUE | 0.03 |
| colorectal cancer | RAS_12-61 | ROS1 | Any mutation | 375 | 14 | TMB quintile 4 | -1.25 | -2.48 | -0.13 | 1621.67 | 1.00 | 405 | 372 | 11 | 3 | TRUE | 1.46 |
| colorectal cancer | RAS_12-61 | ROS1 | Any mutation | 338 | 24 | TMB quintile 5 | -0.94 | -1.76 | -0.14 | 1478.89 | 1.00 | 272 | 330 | 16 | 8 | TRUE | 1.58 |
| colorectal cancer | RAS_12-61 | ROS1 | Any mutation | 43 | 61 | TMB quintile 6 | -0.32 | -1.09 | 0.40 | 1560.71 | 1.00 | 74 | 29 | 47 | 14 | TRUE | 0.40 |
| melanoma | RAS_12-61 | ROS1 | Any mutation | 165 | 139 | TMB quintile 5 | -0.30 | -0.71 | 0.09 | 1593.23 | 1.00 | 169 | 118 | 92 | 47 | TRUE | 0.81 |
| melanoma | RAS_12-61 | ROS1 | Any mutation | 15 | 103 | TMB quintile 6 | 0.85 | -0.57 | 2.74 | 1524.17 | 1.00 | 22 | 1 | 89 | 14 | TRUE | 0.48 |
| non-small cell lung cancer | RAS_12-61 | ROS1 | Any mutation | 267 | 13 | TMB quintile 4 | -1.72 | -3.61 | -0.34 | 1653.70 | 1.00 | 483 | 266 | 12 | 1 | TRUE | 1.46 |
| non-small cell lung cancer | RAS_12-61 | ROS1 | Any mutation | 475 | 80 | TMB quintile 5 | -0.87 | -1.41 | -0.37 | 1569.44 | 1.00 | 691 | 457 | 62 | 18 | TRUE | 3.01 |
| colorectal cancer | RAS_12-61 | ROS1 | Any mutation | 756 | 99 | TMB overall | -0.83 | -2.42 | 1.04 | 1342.92 | 1.00 | 751 | 731 | 74 | 25 | TRUE | 0.49 |
| melanoma | RAS_12-61 | ROS1 | Any mutation | 180 | 242 | TMB overall | 0.27 | -2.45 | 3.12 | 1539.36 | 1.00 | 191 | 119 | 181 | 61 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | ROS1 | Any mutation | 742 | 93 | TMB overall | -1.25 | -3.15 | 0.58 | 1397.87 | 1.00 | 1174 | 723 | 74 | 19 | TRUE | 0.77 |
| colorectal cancer | RAS_12-61 | PIK3CG | Any mutation | 375 | 16 | TMB quintile 4 | -0.78 | -1.77 | 0.18 | 1552.54 | 1.00 | 405 | 370 | 11 | 5 | FALSE | 0.96 |
| colorectal cancer | RAS_12-61 | PIK3CG | Any mutation | 338 | 38 | TMB quintile 5 | -0.43 | -1.13 | 0.23 | 1349.76 | 1.00 | 267 | 321 | 21 | 17 | FALSE | 0.70 |
| colorectal cancer | RAS_12-61 | PIK3CG | Any mutation | 41 | 45 | TMB quintile 6 | -0.34 | -1.11 | 0.44 | 1513.44 | 1.00 | 80 | 31 | 35 | 10 | FALSE | 0.41 |
| melanoma | RAS_12-61 | PIK3CG | Any mutation | 159 | 43 | TMB quintile 5 | -0.34 | -1.01 | 0.28 | 1438.42 | 1.00 | 211 | 145 | 29 | 14 | FALSE | 0.52 |
| melanoma | RAS_12-61 | PIK3CG | Any mutation | 12 | 56 | TMB quintile 6 | 1.09 | -0.19 | 2.70 | 1527.68 | 1.00 | 35 | 2 | 46 | 10 | FALSE | 0.84 |
| non-small cell lung cancer | RAS_12-61 | PIK3CG | Any mutation | 267 | 16 | TMB quintile 4 | 0.45 | -0.55 | 1.44 | 1389.46 | 1.00 | 487 | 259 | 8 | 8 | FALSE | 0.43 |
| non-small cell lung cancer | RAS_12-61 | PIK3CG | Any mutation | 478 | 150 | TMB quintile 5 | -0.17 | -0.54 | 0.16 | 1434.99 | 1.00 | 665 | 426 | 98 | 52 | FALSE | 0.47 |
| colorectal cancer | RAS_12-61 | PIK3CG | Any mutation | 754 | 99 | TMB overall | -0.51 | -1.87 | 0.97 | 1561.57 | 1.00 | 752 | 722 | 67 | 32 | FALSE | 0.33 |
| melanoma | RAS_12-61 | PIK3CG | Any mutation | 171 | 99 | TMB overall | 0.34 | -2.36 | 3.11 | 1442.64 | 1.00 | 246 | 147 | 75 | 24 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | PIK3CG | Any mutation | 745 | 166 | TMB overall | 0.14 | -1.84 | 2.10 | 1338.06 | 1.00 | 1152 | 685 | 106 | 60 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 83 | 200 | TMB quintile 2 | -4.93 | -7.08 | -3.40 | 1110.49 | 1.00 | 180 | 83 | 200 | 0 | TRUE | 6.31 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 159 | 287 | TMB quintile 3 | -4.79 | -6.53 | -3.56 | 1462.67 | 1.00 | 238 | 158 | 286 | 1 | TRUE | 9.66 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 267 | 256 | TMB quintile 4 | -4.02 | -5.09 | -3.18 | 1508.70 | 1.00 | 307 | 263 | 252 | 4 | TRUE | 15.41 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 475 | 175 | TMB quintile 5 | -1.94 | -2.50 | -1.42 | 1434.31 | 1.00 | 632 | 456 | 156 | 19 | TRUE | 12.76 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 984 | 918 | TMB overall | -3.87 | -5.40 | -2.77 | 1407.28 | 1.00 | 1357 | 960 | 894 | 24 | TRUE | 8.05 |
| colorectal cancer | RAS_12-61 | ARID1B | Any mutation | 375 | 13 | TMB quintile 4 | -0.94 | -2.08 | 0.20 | 1646.85 | 1.00 | 408 | 371 | 9 | 4 | TRUE | 0.97 |
| colorectal cancer | RAS_12-61 | ARID1B | Any mutation | 339 | 46 | TMB quintile 5 | -1.18 | -1.83 | -0.53 | 1508.99 | 1.00 | 257 | 326 | 33 | 13 | TRUE | 3.32 |
| colorectal cancer | RAS_12-61 | ARID1B | Any mutation | 37 | 79 | TMB quintile 6 | -0.94 | -1.76 | -0.22 | 1370.36 | 1.00 | 56 | 25 | 67 | 12 | TRUE | 1.78 |
| non-small cell lung cancer | RAS_12-61 | ARID1B | Any mutation | 159 | 11 | TMB quintile 3 | -0.65 | -1.89 | 0.43 | 1525.34 | 1.00 | 458 | 157 | 9 | 2 | TRUE | 0.59 |
| non-small cell lung cancer | RAS_12-61 | ARID1B | Any mutation | 267 | 16 | TMB quintile 4 | -1.01 | -2.23 | -0.06 | 1428.74 | 1.00 | 482 | 265 | 14 | 2 | TRUE | 1.14 |
| non-small cell lung cancer | RAS_12-61 | ARID1B | Any mutation | 476 | 77 | TMB quintile 5 | -0.25 | -0.73 | 0.20 | 1426.79 | 1.00 | 701 | 450 | 51 | 26 | TRUE | 0.54 |
| uterine cancer | RAS_12-61 | ARID1B | Any mutation | 74 | 59 | TMB quintile 5 | 0.03 | -0.60 | 0.65 | 1661.97 | 1.00 | 155 | 57 | 42 | 17 | TRUE | 0.03 |
| uterine cancer | RAS_12-61 | ARID1B | Any mutation | 10 | 48 | TMB quintile 6 | -0.48 | -1.71 | 0.71 | 1567.82 | 1.00 | 25 | 5 | 43 | 5 | TRUE | 0.37 |
| colorectal cancer | RAS_12-61 | ARID1B | Any mutation | 751 | 138 | TMB overall | -0.99 | -2.69 | 0.88 | 1400.45 | 1.00 | 721 | 722 | 109 | 29 | TRUE | 0.56 |
| non-small cell lung cancer | RAS_12-61 | ARID1B | Any mutation | 902 | 104 | TMB overall | -0.65 | -1.75 | 0.30 | 1497.41 | 1.00 | 1641 | 872 | 74 | 30 | TRUE | 0.66 |
| uterine cancer | RAS_12-61 | ARID1B | Any mutation | 84 | 107 | TMB overall | -0.19 | -2.40 | 1.98 | 1494.08 | 1.00 | 180 | 62 | 85 | 22 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12-61 | MET | Any mutation | 83 | 21 | TMB quintile 2 | -0.91 | -1.97 | 0.01 | 1454.42 | 1.00 | 340 | 81 | 19 | 2 | TRUE | 1.16 |
| non-small cell lung cancer | RAS_12-61 | MET | Any mutation | 159 | 30 | TMB quintile 3 | -1.00 | -1.99 | -0.18 | 1495.63 | 1.00 | 446 | 156 | 27 | 3 | TRUE | 1.55 |
| non-small cell lung cancer | RAS_12-61 | MET | Any mutation | 267 | 34 | TMB quintile 4 | -1.42 | -2.51 | -0.60 | 1577.32 | 1.00 | 469 | 265 | 32 | 2 | TRUE | 2.35 |
| non-small cell lung cancer | RAS_12-61 | MET | Any mutation | 474 | 47 | TMB quintile 5 | -0.22 | -0.80 | 0.38 | 1438.91 | 1.00 | 723 | 455 | 28 | 19 | TRUE | 0.33 |
| non-small cell lung cancer | RAS_12-61 | MET | Any mutation | 983 | 132 | TMB overall | -0.89 | -1.73 | -0.19 | 1488.74 | 1.00 | 1978 | 957 | 106 | 26 | TRUE | 1.68 |
| colorectal cancer | RAS_12-61 | BRAF | Any mutation | 192 | 27 | TMB quintile 3 | -1.97 | -3.13 | -0.94 | 1371.04 | 1.00 | 271 | 189 | 24 | 3 | TRUE | 3.37 |
| colorectal cancer | RAS_12-61 | BRAF | Any mutation | 375 | 60 | TMB quintile 4 | -2.10 | -2.83 | -1.43 | 1469.01 | 1.00 | 363 | 368 | 53 | 7 | TRUE | 8.17 |
| colorectal cancer | RAS_12-61 | BRAF | Any mutation | 339 | 104 | TMB quintile 5 | -2.88 | -3.58 | -2.25 | 1528.28 | 1.00 | 194 | 331 | 96 | 8 | TRUE | 15.97 |
| colorectal cancer | RAS_12-61 | BRAF | Any mutation | 39 | 59 | TMB quintile 6 | -1.41 | -2.28 | -0.57 | 1286.69 | 1.00 | 61 | 31 | 51 | 8 | TRUE | 3.03 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 18 | 16 | TMB quintile 2 | -2.67 | -4.80 | -0.80 | 1436.02 | 1.00 | 88 | 18 | 16 | 0 | TRUE | 2.23 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 17 | 27 | TMB quintile 3 | -2.93 | -5.12 | -1.28 | 1540.85 | 1.00 | 66 | 17 | 27 | 0 | TRUE | 2.66 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 22 | 53 | TMB quintile 4 | -2.31 | -3.53 | -1.24 | 1430.94 | 1.00 | 34 | 19 | 50 | 3 | TRUE | 4.13 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 163 | 170 | TMB quintile 5 | -2.20 | -2.70 | -1.71 | 1449.26 | 1.00 | 104 | 141 | 148 | 22 | TRUE | 17.25 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 8 | 17 | TMB quintile 6 | -2.05 | -3.90 | -0.36 | 1135.83 | 1.00 | 46 | 7 | 16 | 1 | TRUE | 1.63 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 83 | 11 | TMB quintile 2 | -1.76 | -3.80 | -0.34 | 1601.44 | 1.00 | 347 | 83 | 11 | 0 | TRUE | 1.40 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 159 | 13 | TMB quintile 3 | -1.89 | -3.88 | -0.59 | 1386.24 | 1.00 | 454 | 159 | 13 | 0 | TRUE | 1.56 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 267 | 46 | TMB quintile 4 | -1.21 | -2.04 | -0.50 | 1571.32 | 1.00 | 457 | 260 | 39 | 7 | TRUE | 2.73 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 474 | 101 | TMB quintile 5 | -0.66 | -1.11 | -0.22 | 1563.92 | 1.00 | 677 | 447 | 74 | 27 | TRUE | 2.42 |
| colorectal cancer | RAS_12-61 | BRAF | Any mutation | 945 | 250 | TMB overall | -2.08 | -3.04 | -1.08 | 1522.33 | 1.00 | 889 | 919 | 224 | 26 | TRUE | 4.57 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 228 | 283 | TMB overall | -2.42 | -3.72 | -1.20 | 1547.39 | 1.00 | 338 | 202 | 257 | 26 | TRUE | 3.94 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 983 | 171 | TMB overall | -1.37 | -2.53 | -0.36 | 1390.36 | 1.00 | 1935 | 949 | 137 | 34 | TRUE | 1.84 |
| colorectal cancer | RAS_12-61 | B2M | Any mutation | 325 | 50 | TMB quintile 5 | -0.96 | -1.54 | -0.33 | 1404.13 | 1.00 | 249 | 309 | 34 | 16 | FALSE | 2.68 |
| colorectal cancer | RAS_12-61 | B2M | Any mutation | 48 | 79 | TMB quintile 6 | 0.36 | -0.30 | 1.00 | 1463.87 | 1.00 | 67 | 22 | 53 | 26 | FALSE | 0.55 |
| colorectal cancer | RAS_12-61 | B2M | Any mutation | 373 | 129 | TMB overall | -0.30 | -2.58 | 1.88 | 1593.68 | 1.00 | 316 | 331 | 87 | 42 | FALSE | 0.10 |
| colorectal cancer | RAS_12-61 | CARD11 | Any mutation | 375 | 28 | TMB quintile 4 | 0.15 | -0.54 | 0.84 | 1496.11 | 1.00 | 403 | 360 | 13 | 15 | FALSE | 0.17 |
| colorectal cancer | RAS_12-61 | CARD11 | Any mutation | 339 | 43 | TMB quintile 5 | -0.39 | -1.01 | 0.22 | 1485.47 | 1.00 | 264 | 320 | 24 | 19 | FALSE | 0.69 |
| colorectal cancer | RAS_12-61 | CARD11 | Any mutation | 41 | 52 | TMB quintile 6 | 0.42 | -0.27 | 1.14 | 1414.43 | 1.00 | 77 | 24 | 35 | 17 | FALSE | 0.61 |
| melanoma | RAS_12-61 | CARD11 | Any mutation | 161 | 63 | TMB quintile 5 | -0.52 | -1.10 | 0.05 | 1459.98 | 1.00 | 201 | 142 | 44 | 19 | FALSE | 1.11 |
| melanoma | RAS_12-61 | CARD11 | Any mutation | 8 | 45 | TMB quintile 6 | -0.42 | -1.69 | 0.87 | 1467.29 | 1.00 | 32 | 4 | 41 | 4 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12-61 | CARD11 | Any mutation | 267 | 18 | TMB quintile 4 | 0.01 | -0.87 | 0.85 | 1489.21 | 1.00 | 484 | 260 | 11 | 7 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | CARD11 | Any mutation | 477 | 97 | TMB quintile 5 | 0.00 | -0.43 | 0.41 | 1562.89 | 1.00 | 692 | 440 | 60 | 37 | FALSE | 0.01 |
| colorectal cancer | RAS_12-61 | CARD11 | Any mutation | 755 | 123 | TMB overall | 0.07 | -1.38 | 1.49 | 1494.49 | 1.00 | 744 | 704 | 72 | 51 | FALSE | 0.03 |
| melanoma | RAS_12-61 | CARD11 | Any mutation | 169 | 108 | TMB overall | -0.44 | -2.68 | 1.91 | 1397.62 | 1.00 | 233 | 146 | 85 | 23 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12-61 | CARD11 | Any mutation | 744 | 115 | TMB overall | 0.00 | -1.41 | 1.56 | 1324.77 | 1.00 | 1176 | 700 | 71 | 44 | FALSE | 0.00 |
| non-small cell lung cancer | RAS_12-61 | INPP4B | Any mutation | 267 | 17 | TMB quintile 4 | 0.41 | -0.40 | 1.21 | 1599.14 | 1.00 | 486 | 259 | 9 | 8 | FALSE | 0.50 |
| non-small cell lung cancer | RAS_12-61 | INPP4B | Any mutation | 478 | 87 | TMB quintile 5 | 0.64 | 0.22 | 1.09 | 1602.23 | 1.00 | 713 | 432 | 41 | 46 | FALSE | 2.46 |
| non-small cell lung cancer | RAS_12-61 | INPP4B | Any mutation | 745 | 104 | TMB overall | 0.55 | -0.65 | 1.89 | 1422.54 | 1.00 | 1199 | 691 | 50 | 54 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12-61 | NFE2L2 | Any mutation | 267 | 31 | TMB quintile 4 | -0.86 | -1.60 | -0.19 | 1463.27 | 1.00 | 476 | 261 | 25 | 6 | FALSE | 1.81 |
| non-small cell lung cancer | RAS_12-61 | NFE2L2 | Any mutation | 476 | 83 | TMB quintile 5 | -0.80 | -1.30 | -0.30 | 1530.60 | 1.00 | 690 | 457 | 64 | 19 | FALSE | 2.79 |
| non-small cell lung cancer | RAS_12-61 | NFE2L2 | Any mutation | 743 | 114 | TMB overall | -0.84 | -1.73 | -0.02 | 1496.36 | 1.00 | 1166 | 718 | 89 | 25 | FALSE | 1.24 |
| colorectal cancer | RAS_12-61 | SOX9 | Any mutation | 192 | 17 | TMB quintile 3 | -0.04 | -0.87 | 0.80 | 1464.70 | 1.00 | 285 | 185 | 10 | 7 | FALSE | 0.03 |
| colorectal cancer | RAS_12-61 | SOX9 | Any mutation | 379 | 85 | TMB quintile 4 | 0.28 | -0.14 | 0.72 | 1472.84 | 1.00 | 377 | 333 | 39 | 46 | FALSE | 0.70 |
| colorectal cancer | RAS_12-61 | SOX9 | Any mutation | 345 | 107 | TMB quintile 5 | 0.04 | -0.35 | 0.48 | 1253.11 | 1.00 | 244 | 287 | 49 | 58 | FALSE | 0.08 |
| colorectal cancer | RAS_12-61 | SOX9 | Any mutation | 40 | 50 | TMB quintile 6 | 0.59 | -0.07 | 1.27 | 1409.80 | 1.00 | 78 | 22 | 32 | 18 | FALSE | 1.05 |
| colorectal cancer | RAS_12-61 | SOX9 | Any mutation | 956 | 259 | TMB overall | 0.22 | -0.68 | 1.10 | 1579.24 | 1.00 | 984 | 827 | 130 | 129 | FALSE | 0.21 |
| colorectal cancer | RAS_12-61 | SMAD2 | Any mutation | 375 | 29 | TMB quintile 4 | 0.07 | -0.58 | 0.71 | 1506.27 | 1.00 | 402 | 361 | 15 | 14 | TRUE | 0.08 |
| colorectal cancer | RAS_12-61 | SMAD2 | Any mutation | 342 | 53 | TMB quintile 5 | 0.53 | 0.01 | 1.05 | 1269.83 | 1.00 | 273 | 307 | 18 | 35 | TRUE | 1.30 |
| colorectal cancer | RAS_12-61 | SMAD2 | Any mutation | 38 | 16 | TMB quintile 6 | 0.50 | -0.43 | 1.42 | 1500.09 | 1.00 | 97 | 32 | 10 | 6 | TRUE | 0.57 |
| colorectal cancer | RAS_12-61 | SMAD2 | Any mutation | 755 | 98 | TMB overall | 0.35 | -0.57 | 1.34 | 1450.22 | 1.00 | 772 | 700 | 43 | 55 | TRUE | 0.35 |
| melanoma | RAS_12-61 | TP63 | Any mutation | 158 | 95 | TMB quintile 5 | -0.05 | -0.54 | 0.41 | 1379.15 | 1.00 | 175 | 120 | 57 | 38 | FALSE | 0.08 |
| melanoma | RAS_12-61 | TP63 | Any mutation | 8 | 69 | TMB quintile 6 | -0.93 | -2.42 | 0.49 | 1653.56 | 1.00 | 14 | 3 | 64 | 5 | FALSE | 0.67 |
| melanoma | RAS_12-61 | TP63 | Any mutation | 166 | 164 | TMB overall | -0.48 | -3.22 | 2.25 | 1433.34 | 1.00 | 189 | 123 | 121 | 43 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12-61 | GLI1 | Any mutation | 250 | 16 | TMB quintile 4 | 0.35 | -0.45 | 1.22 | 1446.86 | 1.00 | 424 | 242 | 8 | 8 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12-61 | GLI1 | Any mutation | 434 | 77 | TMB quintile 5 | 0.27 | -0.18 | 0.70 | 1631.72 | 1.00 | 630 | 400 | 43 | 34 | FALSE | 0.61 |
| non-small cell lung cancer | RAS_12-61 | GLI1 | Any mutation | 684 | 93 | TMB overall | 0.32 | -1.03 | 1.74 | 1346.75 | 1.00 | 1054 | 642 | 51 | 42 | FALSE | 0.19 |
| colorectal cancer | RAS_12-61 | ZFHX3 | Any mutation | 342 | 14 | TMB quintile 4 | 0.23 | -0.72 | 1.25 | 1579.04 | 1.00 | 372 | 334 | 6 | 8 | FALSE | 0.18 |
| colorectal cancer | RAS_12-61 | ZFHX3 | Any mutation | 314 | 63 | TMB quintile 5 | -0.40 | -0.89 | 0.11 | 1630.41 | 1.00 | 236 | 286 | 35 | 28 | FALSE | 0.90 |
| colorectal cancer | RAS_12-61 | ZFHX3 | Any mutation | 46 | 143 | TMB quintile 6 | -0.12 | -0.83 | 0.60 | 1480.36 | 1.00 | 37 | 13 | 110 | 33 | FALSE | 0.13 |
| melanoma | RAS_12-61 | ZFHX3 | Any mutation | 156 | 62 | TMB quintile 5 | -0.15 | -0.71 | 0.41 | 1249.30 | 1.00 | 196 | 133 | 39 | 23 | FALSE | 0.21 |
| melanoma | RAS_12-61 | ZFHX3 | Any mutation | 7 | 78 | TMB quintile 6 | -0.03 | -1.47 | 1.50 | 1526.26 | 1.00 | 34 | 2 | 73 | 5 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | ZFHX3 | Any mutation | 147 | 13 | TMB quintile 3 | -0.95 | -2.41 | 0.08 | 1577.24 | 1.00 | 411 | 146 | 12 | 1 | FALSE | 0.87 |
| non-small cell lung cancer | RAS_12-61 | ZFHX3 | Any mutation | 249 | 30 | TMB quintile 4 | -0.39 | -1.10 | 0.29 | 1372.07 | 1.00 | 409 | 240 | 21 | 9 | FALSE | 0.54 |
| non-small cell lung cancer | RAS_12-61 | ZFHX3 | Any mutation | 434 | 112 | TMB quintile 5 | -0.24 | -0.66 | 0.15 | 1481.59 | 1.00 | 601 | 396 | 74 | 38 | FALSE | 0.60 |
| uterine cancer | RAS_12-61 | ZFHX3 | Any mutation | 44 | 13 | TMB quintile 4 | -0.16 | -1.55 | 1.10 | 1491.90 | 1.00 | 151 | 41 | 10 | 3 | FALSE | 0.09 |
| uterine cancer | RAS_12-61 | ZFHX3 | Any mutation | 72 | 105 | TMB quintile 5 | 0.00 | -0.58 | 0.57 | 1505.04 | 1.00 | 123 | 44 | 77 | 28 | FALSE | 0.00 |
| uterine cancer | RAS_12-61 | ZFHX3 | Any mutation | 16 | 92 | TMB quintile 6 | -0.78 | -1.85 | 0.27 | 1526.79 | 1.00 | 19 | 6 | 82 | 10 | FALSE | 0.82 |
| colorectal cancer | RAS_12-61 | ZFHX3 | Any mutation | 702 | 220 | TMB overall | -0.07 | -2.08 | 2.36 | 1302.61 | 1.00 | 645 | 633 | 151 | 69 | FALSE | 0.02 |
| melanoma | RAS_12-61 | ZFHX3 | Any mutation | 163 | 140 | TMB overall | -0.13 | -2.76 | 2.77 | 1629.15 | 1.00 | 230 | 135 | 112 | 28 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | ZFHX3 | Any mutation | 830 | 155 | TMB overall | -0.52 | -1.57 | 0.40 | 1517.77 | 1.00 | 1421 | 782 | 107 | 48 | FALSE | 0.50 |
| uterine cancer | RAS_12-61 | ZFHX3 | Any mutation | 132 | 210 | TMB overall | -0.30 | -2.11 | 1.46 | 1659.21 | 1.00 | 293 | 91 | 169 | 41 | FALSE | 0.13 |
| colorectal cancer | RAS_12-61 | MGA | Any mutation | 342 | 15 | TMB quintile 4 | -0.96 | -2.12 | 0.04 | 1551.67 | 1.00 | 368 | 338 | 11 | 4 | FALSE | 1.12 |
| colorectal cancer | RAS_12-61 | MGA | Any mutation | 314 | 46 | TMB quintile 5 | -0.30 | -0.94 | 0.28 | 1564.82 | 1.00 | 241 | 292 | 24 | 22 | FALSE | 0.50 |
| colorectal cancer | RAS_12-61 | MGA | Any mutation | 39 | 58 | TMB quintile 6 | -0.11 | -0.87 | 0.59 | 1483.72 | 1.00 | 64 | 24 | 43 | 15 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | MGA | Any mutation | 147 | 14 | TMB quintile 3 | 0.21 | -0.70 | 1.12 | 1486.80 | 1.00 | 415 | 142 | 9 | 5 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12-61 | MGA | Any mutation | 249 | 24 | TMB quintile 4 | 0.12 | -0.63 | 0.89 | 1543.55 | 1.00 | 416 | 239 | 14 | 10 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12-61 | MGA | Any mutation | 437 | 140 | TMB quintile 5 | -0.02 | -0.38 | 0.34 | 1494.56 | 1.00 | 596 | 384 | 87 | 53 | FALSE | 0.04 |
| uterine cancer | RAS_12-61 | MGA | Any mutation | 66 | 24 | TMB quintile 5 | -0.40 | -1.50 | 0.56 | 1514.40 | 1.00 | 166 | 61 | 19 | 5 | FALSE | 0.35 |
| uterine cancer | RAS_12-61 | MGA | Any mutation | 16 | 82 | TMB quintile 6 | 0.28 | -0.99 | 1.66 | 1411.80 | 1.00 | 21 | 3 | 69 | 13 | FALSE | 0.17 |
| colorectal cancer | RAS_12-61 | MGA | Any mutation | 695 | 119 | TMB overall | -0.43 | -1.99 | 1.13 | 1596.72 | 1.00 | 673 | 654 | 78 | 41 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12-61 | MGA | Any mutation | 833 | 178 | TMB overall | 0.10 | -0.97 | 1.16 | 1520.38 | 1.00 | 1427 | 765 | 110 | 68 | FALSE | 0.07 |
| uterine cancer | RAS_12-61 | MGA | Any mutation | 82 | 106 | TMB overall | -0.07 | -2.99 | 2.82 | 1336.10 | 1.00 | 187 | 64 | 88 | 18 | FALSE | 0.02 |
| colorectal cancer | RAS_12-61 | KMT2B | Any mutation | 178 | 54 | TMB quintile 5 | -0.15 | -0.74 | 0.40 | 1310.33 | 1.00 | 129 | 151 | 27 | 27 | FALSE | 0.22 |
| colorectal cancer | RAS_12-61 | KMT2B | Any mutation | 26 | 115 | TMB quintile 6 | 1.49 | 0.02 | 3.49 | 1509.05 | 1.00 | 21 | 1 | 90 | 25 | FALSE | 1.02 |
| uterine cancer | RAS_12-61 | KMT2B | Any mutation | 60 | 95 | TMB quintile 5 | 0.18 | -0.37 | 0.78 | 1495.75 | 1.00 | 95 | 32 | 67 | 28 | FALSE | 0.26 |
| uterine cancer | RAS_12-61 | KMT2B | Any mutation | 11 | 67 | TMB quintile 6 | -0.28 | -1.70 | 1.30 | 1477.73 | 1.00 | 8 | 2 | 58 | 9 | FALSE | 0.15 |
| colorectal cancer | RAS_12-61 | KMT2B | Any mutation | 204 | 169 | TMB overall | 0.59 | -2.91 | 3.93 | 1420.21 | 1.00 | 150 | 152 | 117 | 52 | FALSE | 0.14 |
| uterine cancer | RAS_12-61 | KMT2B | Any mutation | 71 | 162 | TMB overall | 0.03 | -2.26 | 2.55 | 1271.45 | 1.00 | 103 | 34 | 125 | 37 | FALSE | 0.01 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 178 | 35 | TMB quintile 3 | 0.13 | -0.51 | 0.79 | 1490.09 | 1.00 | 244 | 162 | 19 | 16 | FALSE | 0.16 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 346 | 79 | TMB quintile 4 | 0.25 | -0.22 | 0.71 | 1447.39 | 1.00 | 342 | 303 | 36 | 43 | FALSE | 0.56 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 319 | 108 | TMB quintile 5 | -0.01 | -0.41 | 0.38 | 1384.87 | 1.00 | 218 | 261 | 50 | 58 | FALSE | 0.03 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 37 | 70 | TMB quintile 6 | 0.04 | -0.61 | 0.73 | 1400.15 | 1.00 | 55 | 19 | 52 | 18 | FALSE | 0.04 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 880 | 292 | TMB overall | 0.10 | -0.83 | 0.95 | 1489.43 | 1.00 | 859 | 745 | 157 | 135 | FALSE | 0.08 |
| colorectal cancer | RAS_12-61 | ANKRD11 | Any mutation | 334 | 11 | TMB quintile 4 | 0.01 | -1.11 | 1.16 | 1351.15 | 1.00 | 363 | 328 | 5 | 6 | FALSE | 0.00 |
| colorectal cancer | RAS_12-61 | ANKRD11 | Any mutation | 295 | 43 | TMB quintile 5 | -1.58 | -2.35 | -0.90 | 1340.70 | 1.00 | 215 | 286 | 34 | 9 | FALSE | 4.37 |
| colorectal cancer | RAS_12-61 | ANKRD11 | Any mutation | 41 | 86 | TMB quintile 6 | -0.14 | -0.81 | 0.52 | 1655.89 | 1.00 | 55 | 20 | 65 | 21 | FALSE | 0.17 |
| colorectal cancer | RAS_12-61 | ANKRD11 | Any mutation | 670 | 140 | TMB overall | -0.59 | -2.57 | 1.48 | 1455.58 | 1.00 | 633 | 634 | 104 | 36 | FALSE | 0.24 |
| colorectal cancer | RAS_12-61 | POLD1 | Any mutation | 315 | 20 | TMB quintile 5 | -0.26 | -1.10 | 0.65 | 1564.38 | 1.00 | 256 | 305 | 10 | 10 | TRUE | 0.25 |
| colorectal cancer | RAS_12-61 | POLD1 | Any mutation | 38 | 83 | TMB quintile 6 | -0.44 | -1.18 | 0.31 | 1571.27 | 1.00 | 52 | 21 | 66 | 17 | TRUE | 0.61 |
| colorectal cancer | RAS_12-61 | POLD1 | Any mutation | 353 | 103 | TMB overall | -0.31 | -3.15 | 2.58 | 1589.17 | 1.00 | 308 | 326 | 76 | 27 | TRUE | 0.08 |
| melanoma | RAS_12-61 | PREX2 | Any mutation | 98 | 89 | TMB quintile 5 | 0.09 | -0.44 | 0.63 | 1462.66 | 1.00 | 95 | 61 | 52 | 37 | FALSE | 0.14 |
| melanoma | RAS_12-61 | PREX2 | Any mutation | 13 | 76 | TMB quintile 6 | 0.56 | -0.96 | 2.58 | 1639.67 | 1.00 | 12 | 1 | 64 | 12 | FALSE | 0.28 |
| non-small cell lung cancer | RAS_12-61 | PREX2 | Any mutation | 140 | 14 | TMB quintile 4 | -0.33 | -1.28 | 0.62 | 1251.99 | 1.00 | 210 | 135 | 9 | 5 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12-61 | PREX2 | Any mutation | 243 | 84 | TMB quintile 5 | -0.37 | -0.86 | 0.11 | 1576.93 | 1.00 | 327 | 217 | 58 | 26 | FALSE | 0.87 |
| melanoma | RAS_12-61 | PREX2 | Any mutation | 111 | 165 | TMB overall | 0.30 | -2.42 | 3.07 | 1625.16 | 1.00 | 107 | 62 | 116 | 49 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | PREX2 | Any mutation | 383 | 98 | TMB overall | -0.34 | -1.81 | 1.04 | 1464.17 | 1.00 | 537 | 352 | 67 | 31 | FALSE | 0.19 |
| colorectal cancer | RAS_12-61 | AMER1 | Any mutation | 192 | 13 | TMB quintile 3 | 0.96 | 0.05 | 1.97 | 1418.31 | 1.00 | 291 | 183 | 4 | 9 | FALSE | 1.28 |
| colorectal cancer | RAS_12-61 | AMER1 | Any mutation | 375 | 38 | TMB quintile 4 | 0.96 | 0.31 | 1.68 | 1451.94 | 1.00 | 407 | 348 | 11 | 27 | FALSE | 2.32 |
| colorectal cancer | RAS_12-61 | AMER1 | Any mutation | 338 | 62 | TMB quintile 5 | 0.68 | 0.15 | 1.22 | 1500.48 | 1.00 | 268 | 296 | 20 | 42 | FALSE | 1.85 |
| colorectal cancer | RAS_12-61 | AMER1 | Any mutation | 43 | 55 | TMB quintile 6 | 0.81 | 0.13 | 1.50 | 1424.06 | 1.00 | 76 | 22 | 34 | 21 | FALSE | 1.66 |
| non-small cell lung cancer | RAS_12-61 | AMER1 | Any mutation | 267 | 18 | TMB quintile 4 | 0.99 | 0.08 | 1.98 | 1376.01 | 1.00 | 488 | 256 | 7 | 11 | FALSE | 1.35 |
| non-small cell lung cancer | RAS_12-61 | AMER1 | Any mutation | 479 | 107 | TMB quintile 5 | 0.48 | 0.09 | 0.88 | 1574.24 | 1.00 | 701 | 426 | 54 | 53 | FALSE | 1.75 |
| colorectal cancer | RAS_12-61 | AMER1 | Any mutation | 948 | 168 | TMB overall | 0.84 | -0.24 | 1.98 | 1204.23 | 1.00 | 1042 | 849 | 69 | 99 | FALSE | 0.85 |
| non-small cell lung cancer | RAS_12-61 | AMER1 | Any mutation | 747 | 142 | TMB overall | 0.62 | -1.96 | 3.28 | 1439.04 | 1.00 | 1199 | 682 | 77 | 65 | FALSE | 0.20 |
| melanoma | RAS_12-61 | EPHA7 | Any mutation | 157 | 89 | TMB quintile 5 | -0.05 | -0.50 | 0.39 | 1358.74 | 1.00 | 184 | 122 | 54 | 35 | FALSE | 0.08 |
| melanoma | RAS_12-61 | EPHA7 | Any mutation | 8 | 63 | TMB quintile 6 | -0.32 | -1.68 | 1.12 | 1451.82 | 1.00 | 27 | 3 | 58 | 5 | FALSE | 0.18 |
| non-small cell lung cancer | RAS_12-61 | EPHA7 | Any mutation | 249 | 14 | TMB quintile 4 | -0.25 | -1.20 | 0.70 | 1362.66 | 1.00 | 420 | 244 | 9 | 5 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12-61 | EPHA7 | Any mutation | 433 | 101 | TMB quintile 5 | -0.39 | -0.84 | 0.03 | 1532.02 | 1.00 | 607 | 402 | 70 | 31 | FALSE | 1.09 |
| melanoma | RAS_12-61 | EPHA7 | Any mutation | 165 | 152 | TMB overall | -0.20 | -2.71 | 2.22 | 1018.53 | 1.00 | 211 | 125 | 112 | 40 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | EPHA7 | Any mutation | 682 | 115 | TMB overall | -0.32 | -2.05 | 1.61 | 1365.24 | 1.00 | 1027 | 646 | 79 | 36 | FALSE | 0.15 |
| uterine cancer | RAS_12-61 | INPPL1 | Any mutation | 59 | 82 | TMB quintile 5 | 0.24 | -0.36 | 0.84 | 1570.22 | 1.00 | 93 | 33 | 56 | 26 | FALSE | 0.38 |
| uterine cancer | RAS_12-61 | INPPL1 | Any mutation | 12 | 40 | TMB quintile 6 | 0.08 | -0.94 | 1.19 | 1550.23 | 1.00 | 16 | 4 | 32 | 8 | FALSE | 0.06 |
| uterine cancer | RAS_12-61 | INPPL1 | Any mutation | 71 | 122 | TMB overall | 0.22 | -1.21 | 1.78 | 1618.38 | 1.00 | 109 | 37 | 88 | 34 | FALSE | 0.11 |
| colorectal cancer | KRAS_12-61 | SPEN | Any mutation | 341 | 11 | TMB quintile 4 | -0.47 | -1.68 | 0.61 | 1383.80 | 1.00 | 443 | 337 | 7 | 4 | FALSE | 0.36 |
| colorectal cancer | KRAS_12-61 | SPEN | Any mutation | 315 | 31 | TMB quintile 5 | -0.24 | -0.94 | 0.50 | 1659.50 | 1.00 | 298 | 301 | 17 | 14 | FALSE | 0.29 |
| colorectal cancer | KRAS_12-61 | SPEN | Any mutation | 36 | 107 | TMB quintile 6 | -0.75 | -1.48 | -0.06 | 1312.51 | 1.00 | 52 | 20 | 91 | 16 | FALSE | 1.41 |
| non-small cell lung cancer | KRAS_12-61 | SPEN | Any mutation | 262 | 15 | TMB quintile 4 | -1.25 | -2.63 | -0.16 | 1389.51 | 1.00 | 487 | 260 | 13 | 2 | FALSE | 1.28 |
| non-small cell lung cancer | KRAS_12-61 | SPEN | Any mutation | 456 | 87 | TMB quintile 5 | -0.79 | -1.29 | -0.31 | 1376.17 | 1.00 | 729 | 437 | 68 | 19 | FALSE | 2.58 |
| uterine cancer | KRAS_12-61 | SPEN | Any mutation | 63 | 37 | TMB quintile 5 | 0.70 | -0.07 | 1.45 | 1431.48 | 1.00 | 178 | 49 | 23 | 14 | FALSE | 1.19 |
| uterine cancer | KRAS_12-61 | SPEN | Any mutation | 10 | 77 | TMB quintile 6 | -0.95 | -2.23 | 0.32 | 1509.82 | 1.00 | 24 | 5 | 72 | 5 | FALSE | 0.79 |
| colorectal cancer | KRAS_12-61 | SPEN | Any mutation | 692 | 149 | TMB overall | -0.49 | -2.61 | 1.67 | 1362.35 | 1.00 | 793 | 658 | 115 | 34 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12-61 | SPEN | Any mutation | 718 | 102 | TMB overall | -1.01 | -2.69 | 0.60 | 1587.56 | 1.00 | 1216 | 697 | 81 | 21 | FALSE | 0.65 |
| uterine cancer | KRAS_12-61 | SPEN | Any mutation | 73 | 114 | TMB overall | -0.09 | -3.07 | 3.10 | 1451.64 | 1.00 | 202 | 54 | 95 | 19 | FALSE | 0.02 |
| colorectal cancer | KRAS_12-61 | KMT2C | Any mutation | 333 | 12 | TMB quintile 4 | -0.23 | -1.42 | 0.89 | 1486.42 | 1.00 | 433 | 328 | 7 | 5 | FALSE | 0.16 |
| colorectal cancer | KRAS_12-61 | KMT2C | Any mutation | 296 | 61 | TMB quintile 5 | -0.54 | -1.07 | 0.00 | 1388.37 | 1.00 | 262 | 273 | 38 | 23 | FALSE | 1.35 |
| colorectal cancer | KRAS_12-61 | KMT2C | Any mutation | 43 | 116 | TMB quintile 6 | -0.44 | -1.15 | 0.28 | 1419.46 | 1.00 | 52 | 20 | 93 | 23 | FALSE | 0.64 |
| non-small cell lung cancer | KRAS_12-61 | KMT2C | Any mutation | 155 | 13 | TMB quintile 3 | -1.05 | -2.64 | 0.09 | 1409.53 | 1.00 | 455 | 154 | 12 | 1 | FALSE | 0.90 |
| non-small cell lung cancer | KRAS_12-61 | KMT2C | Any mutation | 262 | 36 | TMB quintile 4 | -0.30 | -0.93 | 0.35 | 1495.16 | 1.00 | 474 | 251 | 25 | 11 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12-61 | KMT2C | Any mutation | 455 | 155 | TMB quintile 5 | -0.40 | -0.76 | -0.05 | 1362.25 | 1.00 | 665 | 410 | 110 | 45 | FALSE | 1.50 |
| uterine cancer | KRAS_12-61 | KMT2C | Any mutation | 60 | 42 | TMB quintile 5 | -0.64 | -1.62 | 0.21 | 1384.78 | 1.00 | 154 | 53 | 35 | 7 | FALSE | 0.79 |
| uterine cancer | KRAS_12-61 | KMT2C | Any mutation | 10 | 91 | TMB quintile 6 | -1.08 | -2.40 | 0.24 | 1523.66 | 1.00 | 18 | 4 | 85 | 6 | FALSE | 0.95 |
| colorectal cancer | KRAS_12-61 | KMT2C | Any mutation | 672 | 189 | TMB overall | -0.38 | -2.33 | 1.56 | 1392.80 | 1.00 | 747 | 621 | 138 | 51 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12-61 | KMT2C | Any mutation | 872 | 204 | TMB overall | -0.58 | -1.81 | 0.53 | 1180.93 | 1.00 | 1594 | 815 | 147 | 57 | FALSE | 0.50 |
| uterine cancer | KRAS_12-61 | KMT2C | Any mutation | 70 | 133 | TMB overall | -0.78 | -3.38 | 1.78 | 1511.52 | 1.00 | 172 | 57 | 120 | 13 | FALSE | 0.26 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 29 | 39 | TMB quintile 2 | 0.09 | -0.71 | 0.93 | 1382.81 | 1.00 | 61 | 17 | 27 | 12 | TRUE | 0.09 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 36 | 74 | TMB quintile 3 | -0.07 | -0.74 | 0.59 | 1377.89 | 1.00 | 54 | 17 | 55 | 19 | TRUE | 0.07 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 37 | 87 | TMB quintile 4 | -0.73 | -1.44 | -0.10 | 1418.97 | 1.00 | 39 | 21 | 71 | 16 | TRUE | 1.46 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 44 | 153 | TMB quintile 5 | -0.79 | -1.43 | -0.18 | 1621.22 | 1.00 | 37 | 19 | 128 | 25 | TRUE | 1.85 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 27 | 104 | TMB quintile 2 | -1.39 | -2.17 | -0.65 | 1429.48 | 1.00 | 21 | 13 | 90 | 14 | TRUE | 3.43 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 176 | 411 | TMB quintile 3 | -1.39 | -1.86 | -0.95 | 1479.35 | 1.00 | 29 | 56 | 291 | 120 | TRUE | 8.65 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 352 | 655 | TMB quintile 4 | -1.22 | -1.56 | -0.89 | 1366.41 | 1.00 | 58 | 117 | 420 | 235 | TRUE | 11.52 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 337 | 423 | TMB quintile 5 | -0.62 | -0.93 | -0.31 | 1598.88 | 1.00 | 101 | 148 | 234 | 189 | TRUE | 4.17 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 40 | 78 | TMB quintile 6 | -0.72 | -1.39 | -0.06 | 1504.12 | 1.00 | 67 | 25 | 63 | 15 | TRUE | 1.44 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 83 | 180 | TMB quintile 2 | -1.14 | -1.70 | -0.62 | 1568.84 | 1.00 | 199 | 64 | 161 | 19 | TRUE | 4.30 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 155 | 324 | TMB quintile 3 | -1.56 | -1.96 | -1.16 | 1531.26 | 1.00 | 197 | 118 | 287 | 37 | TRUE | 13.41 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 265 | 450 | TMB quintile 4 | -1.48 | -1.78 | -1.17 | 1138.62 | 1.00 | 162 | 176 | 361 | 89 | TRUE | 20.65 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 470 | 996 | TMB quintile 5 | -1.79 | -2.06 | -1.53 | 1507.02 | 1.00 | 108 | 224 | 750 | 246 | TRUE | 37.62 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 277 | 216 | TMB quintile 2 | 2.63 | 2.08 | 3.36 | 1276.87 | 1.00 | 62 | 68 | 7 | 209 | TRUE | 14.88 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 455 | 392 | TMB quintile 3 | 2.53 | 2.08 | 3.00 | 1441.98 | 1.00 | 52 | 82 | 19 | 373 | TRUE | 37.62 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 241 | 206 | TMB quintile 4 | 2.23 | 1.63 | 2.75 | 1262.21 | 1.00 | 27 | 51 | 16 | 190 | TRUE | 13.61 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 38 | 34 | TMB quintile 5 | 2.04 | 1.18 | 2.70 | 1154.40 | 1.00 | 11 | 11 | 7 | 27 | TRUE | 6.94 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 13 | 77 | TMB quintile 2 | -1.19 | -2.07 | -0.38 | 1509.14 | 1.00 | 60 | 9 | 73 | 4 | TRUE | 2.27 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 27 | 167 | TMB quintile 3 | -1.18 | -1.82 | -0.52 | 1333.73 | 1.00 | 68 | 16 | 156 | 11 | TRUE | 3.33 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 44 | 132 | TMB quintile 4 | -1.37 | -2.00 | -0.73 | 1515.84 | 1.00 | 79 | 33 | 121 | 11 | TRUE | 4.46 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 64 | 68 | TMB quintile 5 | -1.05 | -1.74 | -0.35 | 1362.39 | 1.00 | 148 | 55 | 59 | 9 | TRUE | 2.64 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 8 | 39 | TMB quintile 6 | -1.07 | -2.03 | -0.06 | 1543.52 | 1.00 | 33 | 5 | 36 | 3 | TRUE | 1.47 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 149 | 378 | TMB overall | -0.45 | -1.21 | 0.38 | 1392.60 | 1.00 | 193 | 75 | 304 | 74 | TRUE | 0.56 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 932 | 1671 | TMB overall | -1.08 | -1.79 | -0.34 | 1425.85 | 1.00 | 276 | 359 | 1098 | 573 | TRUE | 2.44 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 973 | 1950 | TMB overall | -1.48 | -2.32 | -0.57 | 1530.74 | 1.00 | 666 | 582 | 1559 | 391 | TRUE | 3.23 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 1011 | 848 | TMB overall | 2.35 | 1.77 | 2.93 | 1261.82 | 1.00 | 152 | 212 | 49 | 799 | TRUE | 37.62 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 156 | 483 | TMB overall | -1.16 | -1.83 | -0.53 | 1530.42 | 1.00 | 388 | 118 | 445 | 38 | TRUE | 3.27 |
| colorectal cancer | KRAS_12-61 | ATRX | Any mutation | 341 | 19 | TMB quintile 4 | -0.61 | -1.51 | 0.31 | 1540.09 | 1.00 | 437 | 335 | 13 | 6 | TRUE | 0.73 |
| colorectal cancer | KRAS_12-61 | ATRX | Any mutation | 313 | 35 | TMB quintile 5 | -0.45 | -1.14 | 0.22 | 1558.66 | 1.00 | 294 | 299 | 21 | 14 | TRUE | 0.71 |
| colorectal cancer | KRAS_12-61 | ATRX | Any mutation | 39 | 59 | TMB quintile 6 | -0.22 | -1.02 | 0.51 | 1444.87 | 1.00 | 75 | 26 | 46 | 13 | TRUE | 0.25 |
| non-small cell lung cancer | KRAS_12-61 | ATRX | Any mutation | 262 | 32 | TMB quintile 4 | 0.06 | -0.61 | 0.70 | 1434.30 | 1.00 | 481 | 250 | 20 | 12 | TRUE | 0.07 |
| non-small cell lung cancer | KRAS_12-61 | ATRX | Any mutation | 461 | 160 | TMB quintile 5 | 0.19 | -0.14 | 0.52 | 1091.53 | 1.00 | 693 | 396 | 95 | 65 | TRUE | 0.56 |
| uterine cancer | KRAS_12-61 | ATRX | Any mutation | 13 | 11 | TMB quintile 2 | -2.09 | -5.71 | 0.32 | 1611.39 | 1.00 | 121 | 13 | 11 | 0 | TRUE | 0.74 |
| uterine cancer | KRAS_12-61 | ATRX | Any mutation | 26 | 14 | TMB quintile 3 | -2.28 | -5.80 | 0.03 | 1335.32 | 1.00 | 201 | 26 | 14 | 0 | TRUE | 0.88 |
| uterine cancer | KRAS_12-61 | ATRX | Any mutation | 62 | 19 | TMB quintile 5 | -0.44 | -1.75 | 0.69 | 1424.87 | 1.00 | 187 | 58 | 15 | 4 | TRUE | 0.32 |
| uterine cancer | KRAS_12-61 | ATRX | Any mutation | 9 | 112 | TMB quintile 6 | -0.82 | -2.18 | 0.56 | 1542.28 | 1.00 | 25 | 3 | 106 | 6 | TRUE | 0.63 |
| colorectal cancer | KRAS_12-61 | ATRX | Any mutation | 693 | 113 | TMB overall | -0.43 | -1.91 | 1.07 | 1296.88 | 1.00 | 806 | 660 | 80 | 33 | TRUE | 0.25 |
| non-small cell lung cancer | KRAS_12-61 | ATRX | Any mutation | 723 | 192 | TMB overall | 0.11 | -1.23 | 1.37 | 1505.24 | 1.00 | 1174 | 646 | 115 | 77 | TRUE | 0.06 |
| uterine cancer | KRAS_12-61 | ATRX | Any mutation | 110 | 156 | TMB overall | -1.34 | -3.65 | 0.62 | 1466.64 | 1.00 | 534 | 100 | 146 | 10 | TRUE | 0.69 |
| colorectal cancer | KRAS_12-61 | ATR | Any mutation | 314 | 35 | TMB quintile 5 | -0.38 | -1.06 | 0.29 | 1384.79 | 1.00 | 293 | 299 | 20 | 15 | FALSE | 0.58 |
| colorectal cancer | KRAS_12-61 | ATR | Any mutation | 38 | 65 | TMB quintile 6 | -1.02 | -1.91 | -0.22 | 1501.21 | 1.00 | 76 | 30 | 57 | 8 | FALSE | 1.73 |
| non-small cell lung cancer | KRAS_12-61 | ATR | Any mutation | 155 | 12 | TMB quintile 3 | -0.44 | -1.58 | 0.59 | 1570.57 | 1.00 | 461 | 153 | 10 | 2 | FALSE | 0.37 |
| non-small cell lung cancer | KRAS_12-61 | ATR | Any mutation | 263 | 15 | TMB quintile 4 | -0.02 | -0.94 | 0.92 | 1620.33 | 1.00 | 492 | 257 | 9 | 6 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12-61 | ATR | Any mutation | 455 | 93 | TMB quintile 5 | -0.20 | -0.62 | 0.25 | 1573.66 | 1.00 | 707 | 425 | 63 | 30 | FALSE | 0.42 |
| colorectal cancer | KRAS_12-61 | ATR | Any mutation | 352 | 100 | TMB overall | -0.69 | -3.18 | 1.66 | 1541.26 | 1.00 | 369 | 329 | 77 | 23 | FALSE | 0.25 |
| non-small cell lung cancer | KRAS_12-61 | ATR | Any mutation | 873 | 120 | TMB overall | -0.22 | -1.23 | 0.86 | 1585.66 | 1.00 | 1660 | 835 | 82 | 38 | FALSE | 0.17 |
| non-small cell lung cancer | KRAS_12-61 | PDGFRA | Any mutation | 262 | 16 | TMB quintile 4 | -0.32 | -1.30 | 0.59 | 1457.59 | 1.00 | 489 | 257 | 11 | 5 | TRUE | 0.29 |
| non-small cell lung cancer | KRAS_12-61 | PDGFRA | Any mutation | 456 | 115 | TMB quintile 5 | -0.28 | -0.67 | 0.11 | 1484.33 | 1.00 | 695 | 420 | 79 | 36 | TRUE | 0.74 |
| non-small cell lung cancer | KRAS_12-61 | PDGFRA | Any mutation | 718 | 131 | TMB overall | -0.28 | -1.93 | 1.50 | 1605.59 | 1.00 | 1184 | 677 | 90 | 41 | TRUE | 0.13 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 175 | 22 | TMB quintile 3 | -0.75 | -1.78 | 0.12 | 1262.43 | 1.00 | 295 | 171 | 18 | 4 | TRUE | 0.92 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 347 | 85 | TMB quintile 4 | 0.20 | -0.24 | 0.61 | 1348.62 | 1.00 | 411 | 306 | 44 | 41 | TRUE | 0.44 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 332 | 160 | TMB quintile 5 | 0.48 | 0.14 | 0.82 | 1508.69 | 1.00 | 254 | 236 | 64 | 96 | TRUE | 2.15 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 34 | 65 | TMB quintile 6 | 0.40 | -0.29 | 1.11 | 1448.14 | 1.00 | 68 | 16 | 47 | 18 | TRUE | 0.57 |
| uterine cancer | KRAS_12-61 | FBXW7 | Any mutation | 26 | 30 | TMB quintile 3 | -0.33 | -1.62 | 0.76 | 1354.42 | 1.00 | 188 | 24 | 28 | 2 | TRUE | 0.24 |
| uterine cancer | KRAS_12-61 | FBXW7 | Any mutation | 44 | 29 | TMB quintile 4 | 0.28 | -0.58 | 1.09 | 1671.61 | 1.00 | 163 | 37 | 22 | 7 | TRUE | 0.30 |
| uterine cancer | KRAS_12-61 | FBXW7 | Any mutation | 62 | 30 | TMB quintile 5 | 0.45 | -0.32 | 1.22 | 1331.41 | 1.00 | 180 | 52 | 20 | 10 | TRUE | 0.59 |
| uterine cancer | KRAS_12-61 | FBXW7 | Any mutation | 10 | 47 | TMB quintile 6 | 0.66 | -0.43 | 1.94 | 1332.64 | 1.00 | 27 | 2 | 39 | 8 | TRUE | 0.55 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 888 | 332 | TMB overall | 0.10 | -0.90 | 1.12 | 1500.62 | 1.00 | 1028 | 729 | 173 | 159 | TRUE | 0.08 |
| uterine cancer | KRAS_12-61 | FBXW7 | Any mutation | 142 | 136 | TMB overall | 0.25 | -0.84 | 1.38 | 1226.45 | 1.00 | 558 | 115 | 109 | 27 | TRUE | 0.18 |
| uterine cancer | KRAS_12-61 | NSD1 | Any mutation | 65 | 46 | TMB quintile 5 | -0.14 | -0.94 | 0.59 | 1602.32 | 1.00 | 172 | 55 | 36 | 10 | FALSE | 0.15 |
| uterine cancer | KRAS_12-61 | NSD1 | Any mutation | 14 | 69 | TMB quintile 6 | 1.33 | -0.09 | 3.28 | 1520.88 | 1.00 | 23 | 1 | 56 | 13 | FALSE | 0.90 |
| uterine cancer | KRAS_12-61 | NSD1 | Any mutation | 79 | 115 | TMB overall | 0.48 | -2.34 | 3.24 | 1424.45 | 1.00 | 195 | 56 | 92 | 23 | FALSE | 0.14 |
| colorectal cancer | KRAS_12-61 | FLT4 | Any mutation | 341 | 20 | TMB quintile 4 | -0.49 | -1.43 | 0.37 | 1506.06 | 1.00 | 437 | 334 | 13 | 7 | TRUE | 0.55 |
| colorectal cancer | KRAS_12-61 | FLT4 | Any mutation | 314 | 40 | TMB quintile 5 | -0.78 | -1.47 | -0.11 | 1428.82 | 1.00 | 289 | 301 | 27 | 13 | TRUE | 1.56 |
| colorectal cancer | KRAS_12-61 | FLT4 | Any mutation | 37 | 72 | TMB quintile 6 | -0.20 | -0.94 | 0.50 | 1494.13 | 1.00 | 62 | 21 | 56 | 16 | TRUE | 0.23 |
| non-small cell lung cancer | KRAS_12-61 | FLT4 | Any mutation | 262 | 14 | TMB quintile 4 | 0.33 | -0.60 | 1.32 | 1475.90 | 1.00 | 493 | 255 | 7 | 7 | TRUE | 0.29 |
| non-small cell lung cancer | KRAS_12-61 | FLT4 | Any mutation | 456 | 74 | TMB quintile 5 | -0.16 | -0.70 | 0.30 | 1577.48 | 1.00 | 721 | 432 | 50 | 24 | TRUE | 0.29 |
| colorectal cancer | KRAS_12-61 | FLT4 | Any mutation | 692 | 132 | TMB overall | -0.48 | -2.13 | 1.15 | 1431.37 | 1.00 | 788 | 656 | 96 | 36 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | FLT4 | Any mutation | 718 | 88 | TMB overall | 0.07 | -1.44 | 1.76 | 1364.35 | 1.00 | 1214 | 687 | 57 | 31 | TRUE | 0.03 |
| colorectal cancer | KRAS_12-61 | PTPRD | Any mutation | 313 | 29 | TMB quintile 5 | -0.74 | -1.54 | 0.01 | 1380.51 | 1.00 | 296 | 303 | 19 | 10 | FALSE | 1.23 |
| colorectal cancer | KRAS_12-61 | PTPRD | Any mutation | 35 | 61 | TMB quintile 6 | -0.74 | -1.59 | 0.10 | 1379.48 | 1.00 | 73 | 26 | 52 | 9 | FALSE | 1.08 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 155 | 16 | TMB quintile 3 | -0.12 | -1.28 | 0.96 | 1405.60 | 1.00 | 460 | 151 | 12 | 4 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 263 | 53 | TMB quintile 4 | 0.52 | -0.02 | 1.06 | 1611.42 | 1.00 | 472 | 238 | 28 | 25 | FALSE | 1.23 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 474 | 298 | TMB quintile 5 | -0.01 | -0.27 | 0.25 | 1441.03 | 1.00 | 612 | 364 | 188 | 110 | FALSE | 0.03 |
| colorectal cancer | KRAS_12-61 | PTPRD | Any mutation | 348 | 90 | TMB overall | -0.67 | -2.90 | 1.60 | 1478.47 | 1.00 | 369 | 329 | 71 | 19 | FALSE | 0.25 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 893 | 384 | TMB overall | 0.08 | -1.48 | 1.84 | 1523.86 | 1.00 | 1551 | 753 | 244 | 140 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | PIK3C2G | Any mutation | 262 | 12 | TMB quintile 4 | -0.28 | -1.36 | 0.79 | 1427.76 | 1.00 | 489 | 258 | 8 | 4 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12-61 | PIK3C2G | Any mutation | 454 | 103 | TMB quintile 5 | -0.37 | -0.82 | 0.06 | 1279.02 | 1.00 | 698 | 424 | 73 | 30 | FALSE | 0.96 |
| non-small cell lung cancer | KRAS_12-61 | PIK3C2G | Any mutation | 716 | 115 | TMB overall | -0.32 | -2.08 | 1.51 | 1540.19 | 1.00 | 1187 | 682 | 81 | 34 | FALSE | 0.15 |
| colorectal cancer | KRAS_12-61 | CREBBP | Any mutation | 341 | 17 | TMB quintile 4 | -1.01 | -2.13 | 0.02 | 1284.12 | 1.00 | 437 | 337 | 13 | 4 | TRUE | 1.16 |
| colorectal cancer | KRAS_12-61 | CREBBP | Any mutation | 316 | 49 | TMB quintile 5 | -0.09 | -0.71 | 0.48 | 1251.98 | 1.00 | 292 | 292 | 25 | 24 | TRUE | 0.12 |
| colorectal cancer | KRAS_12-61 | CREBBP | Any mutation | 41 | 116 | TMB quintile 6 | -0.81 | -1.55 | -0.11 | 1280.26 | 1.00 | 43 | 21 | 96 | 20 | TRUE | 1.51 |
| non-small cell lung cancer | KRAS_12-61 | CREBBP | Any mutation | 155 | 11 | TMB quintile 3 | -0.14 | -1.34 | 1.00 | 1430.46 | 1.00 | 463 | 152 | 8 | 3 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12-61 | CREBBP | Any mutation | 262 | 12 | TMB quintile 4 | -0.24 | -1.29 | 0.78 | 1383.91 | 1.00 | 492 | 258 | 8 | 4 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12-61 | CREBBP | Any mutation | 454 | 106 | TMB quintile 5 | -0.25 | -0.67 | 0.19 | 1593.51 | 1.00 | 705 | 421 | 73 | 33 | TRUE | 0.59 |
| colorectal cancer | KRAS_12-61 | CREBBP | Any mutation | 698 | 182 | TMB overall | -0.60 | -2.47 | 1.42 | 1393.72 | 1.00 | 772 | 650 | 134 | 48 | TRUE | 0.28 |
| non-small cell lung cancer | KRAS_12-61 | CREBBP | Any mutation | 871 | 129 | TMB overall | -0.22 | -1.35 | 0.88 | 1526.39 | 1.00 | 1660 | 831 | 89 | 40 | TRUE | 0.16 |
| colorectal cancer | KRAS_12-61 | AXIN2 | Any mutation | 341 | 20 | TMB quintile 4 | 0.50 | -0.36 | 1.40 | 1475.20 | 1.00 | 442 | 329 | 8 | 12 | TRUE | 0.59 |
| colorectal cancer | KRAS_12-61 | AXIN2 | Any mutation | 313 | 27 | TMB quintile 5 | -0.54 | -1.31 | 0.21 | 1522.31 | 1.00 | 297 | 303 | 17 | 10 | TRUE | 0.78 |
| colorectal cancer | KRAS_12-61 | AXIN2 | Any mutation | 35 | 63 | TMB quintile 6 | -0.44 | -1.26 | 0.34 | 1531.07 | 1.00 | 71 | 24 | 52 | 11 | TRUE | 0.57 |
| colorectal cancer | KRAS_12-61 | AXIN2 | Any mutation | 689 | 110 | TMB overall | -0.14 | -1.84 | 1.59 | 1487.71 | 1.00 | 810 | 656 | 77 | 33 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | DOT1L | Any mutation | 262 | 24 | TMB quintile 4 | -0.38 | -1.20 | 0.23 | 64.31 | 1.04 | 484 | 256 | 18 | 6 | FALSE | 0.51 |
| non-small cell lung cancer | KRAS_12-61 | DOT1L | Any mutation | 455 | 75 | TMB quintile 5 | -0.21 | -0.74 | 0.21 | 65.44 | 1.04 | 718 | 431 | 51 | 24 | FALSE | 0.40 |
| non-small cell lung cancer | KRAS_12-61 | DOT1L | Any mutation | 717 | 99 | TMB overall | -0.31 | -1.38 | 0.53 | 385.66 | 1.01 | 1202 | 687 | 69 | 30 | FALSE | 0.29 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 171 | 17 | TMB quintile 3 | -0.65 | -1.79 | 0.36 | 1640.63 | 1.00 | 298 | 167 | 13 | 4 | FALSE | 0.64 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 333 | 34 | TMB quintile 4 | 0.21 | -0.47 | 0.88 | 1543.57 | 1.00 | 423 | 316 | 17 | 17 | FALSE | 0.26 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 300 | 74 | TMB quintile 5 | -0.18 | -0.65 | 0.29 | 1521.99 | 1.00 | 260 | 266 | 40 | 34 | FALSE | 0.35 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 41 | 128 | TMB quintile 6 | -0.07 | -0.78 | 0.68 | 1574.37 | 1.00 | 37 | 12 | 99 | 29 | FALSE | 0.07 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 845 | 253 | TMB overall | -0.19 | -1.60 | 1.23 | 1545.64 | 1.00 | 1018 | 761 | 169 | 84 | FALSE | 0.10 |
| colorectal cancer | KRAS_12-61 | SMARCA4 | Any mutation | 341 | 16 | TMB quintile 4 | -0.92 | -2.06 | 0.08 | 1397.44 | 1.00 | 438 | 337 | 12 | 4 | FALSE | 1.01 |
| colorectal cancer | KRAS_12-61 | SMARCA4 | Any mutation | 314 | 47 | TMB quintile 5 | -0.52 | -1.13 | 0.08 | 1592.87 | 1.00 | 287 | 296 | 29 | 18 | FALSE | 1.06 |
| colorectal cancer | KRAS_12-61 | SMARCA4 | Any mutation | 40 | 100 | TMB quintile 6 | -0.37 | -1.06 | 0.35 | 1378.50 | 1.00 | 55 | 20 | 80 | 20 | FALSE | 0.50 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 156 | 35 | TMB quintile 3 | 0.59 | -0.08 | 1.27 | 1398.27 | 1.00 | 454 | 141 | 20 | 15 | FALSE | 1.05 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 263 | 67 | TMB quintile 4 | 0.03 | -0.49 | 0.52 | 1437.98 | 1.00 | 459 | 240 | 44 | 23 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 459 | 194 | TMB quintile 5 | -0.11 | -0.44 | 0.18 | 1535.32 | 1.00 | 647 | 393 | 128 | 66 | FALSE | 0.32 |
| uterine cancer | KRAS_12-61 | SMARCA4 | Any mutation | 64 | 39 | TMB quintile 5 | -0.38 | -1.30 | 0.46 | 1388.17 | 1.00 | 176 | 57 | 32 | 7 | FALSE | 0.41 |
| uterine cancer | KRAS_12-61 | SMARCA4 | Any mutation | 12 | 52 | TMB quintile 6 | 0.50 | -0.72 | 1.76 | 1426.05 | 1.00 | 28 | 3 | 43 | 9 | FALSE | 0.37 |
| colorectal cancer | KRAS_12-61 | SMARCA4 | Any mutation | 695 | 163 | TMB overall | -0.54 | -2.26 | 1.35 | 1559.71 | 1.00 | 780 | 653 | 121 | 42 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 878 | 296 | TMB overall | 0.17 | -0.59 | 0.97 | 1488.34 | 1.00 | 1560 | 774 | 192 | 104 | FALSE | 0.18 |
| uterine cancer | KRAS_12-61 | SMARCA4 | Any mutation | 76 | 91 | TMB overall | 0.04 | -2.19 | 2.59 | 1603.64 | 1.00 | 204 | 60 | 75 | 16 | FALSE | 0.01 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 175 | 18 | TMB quintile 3 | 0.52 | -0.33 | 1.40 | 1535.52 | 1.00 | 304 | 165 | 8 | 10 | FALSE | 0.60 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 341 | 39 | TMB quintile 4 | -0.91 | -1.67 | -0.21 | 1210.87 | 1.00 | 420 | 332 | 30 | 9 | FALSE | 1.97 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 315 | 59 | TMB quintile 5 | -0.40 | -0.96 | 0.17 | 1420.34 | 1.00 | 279 | 291 | 35 | 24 | FALSE | 0.82 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 39 | 66 | TMB quintile 6 | 0.34 | -0.32 | 1.02 | 1654.50 | 1.00 | 73 | 20 | 47 | 19 | FALSE | 0.50 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 155 | 17 | TMB quintile 3 | -0.23 | -1.39 | 0.85 | 1365.07 | 1.00 | 458 | 151 | 13 | 4 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 263 | 38 | TMB quintile 4 | 0.05 | -0.63 | 0.74 | 1592.84 | 1.00 | 476 | 249 | 24 | 14 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 463 | 272 | TMB quintile 5 | -0.51 | -0.80 | -0.21 | 1516.28 | 1.00 | 615 | 388 | 197 | 75 | FALSE | 3.08 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 870 | 182 | TMB overall | -0.13 | -1.22 | 1.05 | 1588.64 | 1.00 | 1076 | 808 | 120 | 62 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 882 | 348 | TMB overall | -0.26 | -2.08 | 1.78 | 1398.80 | 1.00 | 1554 | 788 | 254 | 94 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12-61 | HGF | Any mutation | 262 | 27 | TMB quintile 4 | -0.31 | -1.20 | 0.48 | 1522.01 | 1.00 | 482 | 254 | 19 | 8 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12-61 | HGF | Any mutation | 456 | 138 | TMB quintile 5 | 0.09 | -0.26 | 0.44 | 1228.57 | 1.00 | 690 | 402 | 84 | 54 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | HGF | Any mutation | 719 | 180 | TMB overall | -0.03 | -2.08 | 2.29 | 1553.89 | 1.00 | 1179 | 656 | 117 | 63 | FALSE | 0.01 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 177 | 51 | TMB quintile 3 | 0.92 | 0.39 | 1.49 | 1574.57 | 1.00 | 292 | 147 | 21 | 30 | TRUE | 2.90 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 343 | 146 | TMB quintile 4 | 0.58 | 0.23 | 0.93 | 1374.43 | 1.00 | 388 | 263 | 66 | 80 | TRUE | 3.03 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 327 | 209 | TMB quintile 5 | 0.41 | 0.09 | 0.74 | 1510.93 | 1.00 | 231 | 208 | 90 | 119 | TRUE | 1.81 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 40 | 95 | TMB quintile 6 | 0.48 | -0.19 | 1.15 | 1408.61 | 1.00 | 58 | 14 | 69 | 26 | TRUE | 0.79 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 83 | 18 | TMB quintile 2 | -0.75 | -1.75 | 0.12 | 1614.12 | 1.00 | 341 | 82 | 17 | 1 | TRUE | 0.96 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 155 | 34 | TMB quintile 3 | -0.20 | -0.89 | 0.49 | 1388.16 | 1.00 | 446 | 146 | 25 | 9 | TRUE | 0.25 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 263 | 56 | TMB quintile 4 | -0.62 | -1.21 | -0.05 | 1484.02 | 1.00 | 456 | 251 | 44 | 12 | TRUE | 1.47 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 455 | 123 | TMB quintile 5 | -0.34 | -0.75 | 0.01 | 1510.21 | 1.00 | 691 | 418 | 86 | 37 | TRUE | 1.10 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 13 | 33 | TMB quintile 2 | -0.04 | -1.13 | 0.94 | 1461.59 | 1.00 | 103 | 10 | 30 | 3 | TRUE | 0.03 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 26 | 103 | TMB quintile 3 | 0.18 | -0.57 | 0.94 | 1518.81 | 1.00 | 134 | 14 | 91 | 12 | TRUE | 0.20 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 48 | 121 | TMB quintile 4 | 0.60 | 0.05 | 1.20 | 1542.99 | 1.00 | 107 | 18 | 91 | 30 | TRUE | 1.36 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 78 | 196 | TMB quintile 5 | 0.13 | -0.38 | 0.64 | 1602.70 | 1.00 | 92 | 29 | 147 | 49 | TRUE | 0.21 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 10 | 95 | TMB quintile 6 | -0.16 | -1.28 | 0.94 | 1380.99 | 1.00 | 13 | 2 | 87 | 8 | TRUE | 0.11 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 887 | 501 | TMB overall | 0.59 | -0.38 | 1.59 | 1324.02 | 1.00 | 969 | 632 | 246 | 255 | TRUE | 0.67 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 956 | 231 | TMB overall | -0.47 | -1.10 | 0.12 | 1479.56 | 1.00 | 1934 | 897 | 172 | 59 | TRUE | 0.89 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 175 | 548 | TMB overall | 0.13 | -0.69 | 1.04 | 1581.09 | 1.00 | 449 | 73 | 446 | 102 | TRUE | 0.12 |
| colorectal cancer | KRAS_12-61 | ALK | Any mutation | 341 | 20 | TMB quintile 4 | 0.30 | -0.53 | 1.11 | 1617.07 | 1.00 | 441 | 330 | 9 | 11 | TRUE | 0.31 |
| colorectal cancer | KRAS_12-61 | ALK | Any mutation | 313 | 42 | TMB quintile 5 | -0.20 | -0.82 | 0.41 | 1440.31 | 1.00 | 292 | 294 | 23 | 19 | TRUE | 0.27 |
| colorectal cancer | KRAS_12-61 | ALK | Any mutation | 37 | 45 | TMB quintile 6 | -0.45 | -1.34 | 0.38 | 1540.99 | 1.00 | 81 | 29 | 37 | 8 | TRUE | 0.53 |
| non-small cell lung cancer | KRAS_12-61 | ALK | Any mutation | 155 | 13 | TMB quintile 3 | -0.80 | -2.27 | 0.54 | 1464.94 | 1.00 | 461 | 153 | 11 | 2 | TRUE | 0.60 |
| non-small cell lung cancer | KRAS_12-61 | ALK | Any mutation | 262 | 22 | TMB quintile 4 | -0.06 | -1.01 | 0.75 | 1431.05 | 1.00 | 487 | 254 | 14 | 8 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | ALK | Any mutation | 454 | 118 | TMB quintile 5 | -0.12 | -0.53 | 0.28 | 1521.06 | 1.00 | 698 | 413 | 77 | 41 | TRUE | 0.26 |
| colorectal cancer | KRAS_12-61 | ALK | Any mutation | 691 | 107 | TMB overall | -0.10 | -1.53 | 1.41 | 1570.54 | 1.00 | 814 | 653 | 69 | 38 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | ALK | Any mutation | 872 | 164 | TMB overall | -0.61 | -2.24 | 0.96 | 1450.04 | 1.00 | 1654 | 821 | 113 | 51 | TRUE | 0.34 |
| colorectal cancer | KRAS_12-61 | RNF43 | Any mutation | 175 | 12 | TMB quintile 3 | -1.15 | -2.66 | 0.20 | 1174.11 | 1.01 | 302 | 173 | 10 | 2 | TRUE | 0.95 |
| colorectal cancer | KRAS_12-61 | RNF43 | Any mutation | 341 | 30 | TMB quintile 4 | -0.50 | -1.31 | 0.23 | 1443.58 | 1.00 | 431 | 331 | 20 | 10 | TRUE | 0.70 |
| colorectal cancer | KRAS_12-61 | RNF43 | Any mutation | 318 | 76 | TMB quintile 5 | -0.98 | -1.49 | -0.45 | 1591.39 | 1.00 | 268 | 296 | 54 | 22 | TRUE | 3.83 |
| colorectal cancer | KRAS_12-61 | RNF43 | Any mutation | 43 | 146 | TMB quintile 6 | -0.47 | -1.22 | 0.25 | 1407.67 | 1.00 | 35 | 14 | 117 | 29 | TRUE | 0.70 |
| colorectal cancer | KRAS_12-61 | RNF43 | Any mutation | 877 | 264 | TMB overall | -0.78 | -2.39 | 0.76 | 1551.63 | 1.00 | 1036 | 814 | 201 | 63 | TRUE | 0.50 |
| colorectal cancer | KRAS_12-61 | PTEN | Any mutation | 341 | 29 | TMB quintile 4 | 0.49 | -0.22 | 1.21 | 1379.00 | 1.00 | 439 | 324 | 12 | 17 | TRUE | 0.78 |
| colorectal cancer | KRAS_12-61 | PTEN | Any mutation | 315 | 69 | TMB quintile 5 | -0.49 | -1.01 | -0.01 | 1406.24 | 1.00 | 284 | 289 | 43 | 26 | TRUE | 1.27 |
| colorectal cancer | KRAS_12-61 | PTEN | Any mutation | 40 | 80 | TMB quintile 6 | -0.22 | -0.94 | 0.48 | 1480.73 | 1.00 | 67 | 23 | 63 | 17 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | PTEN | Any mutation | 155 | 17 | TMB quintile 3 | -1.60 | -3.00 | -0.58 | 1683.63 | 1.00 | 455 | 154 | 16 | 1 | TRUE | 2.03 |
| non-small cell lung cancer | KRAS_12-61 | PTEN | Any mutation | 262 | 27 | TMB quintile 4 | -1.90 | -3.27 | -0.95 | 1571.90 | 1.00 | 475 | 261 | 26 | 1 | TRUE | 2.82 |
| non-small cell lung cancer | KRAS_12-61 | PTEN | Any mutation | 454 | 75 | TMB quintile 5 | -1.12 | -1.74 | -0.56 | 1554.83 | 1.00 | 714 | 440 | 61 | 14 | TRUE | 3.73 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 13 | 16 | TMB quintile 2 | -0.21 | -1.90 | 1.17 | 1608.53 | 1.00 | 118 | 12 | 15 | 1 | TRUE | 0.10 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 29 | 63 | TMB quintile 3 | 0.67 | -0.10 | 1.42 | 1445.74 | 1.00 | 177 | 18 | 52 | 11 | TRUE | 1.05 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 54 | 120 | TMB quintile 4 | 0.38 | -0.17 | 0.96 | 1442.23 | 1.00 | 122 | 26 | 92 | 28 | TRUE | 0.68 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 102 | 315 | TMB quintile 5 | 0.83 | 0.22 | 1.50 | 1445.16 | 1.00 | 58 | 11 | 224 | 91 | TRUE | 1.95 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 14 | 103 | TMB quintile 6 | 1.08 | -0.37 | 2.86 | 1515.96 | 1.00 | 13 | 0 | 89 | 14 | TRUE | 0.74 |
| colorectal cancer | KRAS_12-61 | PTEN | Any mutation | 696 | 178 | TMB overall | -0.07 | -1.65 | 1.54 | 1440.01 | 1.00 | 790 | 636 | 118 | 60 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | PTEN | Any mutation | 871 | 119 | TMB overall | -1.52 | -2.65 | -0.64 | 1391.53 | 1.00 | 1644 | 855 | 103 | 16 | TRUE | 2.60 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 212 | 617 | TMB overall | 0.54 | -0.65 | 1.71 | 1432.52 | 1.00 | 488 | 67 | 472 | 145 | TRUE | 0.43 |
| colorectal cancer | KRAS_12-61 | BCOR | Any mutation | 341 | 11 | TMB quintile 4 | 0.52 | -0.56 | 1.72 | 1373.31 | 1.00 | 446 | 334 | 4 | 7 | FALSE | 0.43 |
| colorectal cancer | KRAS_12-61 | BCOR | Any mutation | 313 | 39 | TMB quintile 5 | -0.17 | -0.84 | 0.45 | 1585.33 | 1.00 | 295 | 295 | 21 | 18 | FALSE | 0.21 |
| colorectal cancer | KRAS_12-61 | BCOR | Any mutation | 37 | 57 | TMB quintile 6 | -0.22 | -0.98 | 0.52 | 1489.12 | 1.00 | 74 | 25 | 45 | 12 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12-61 | BCOR | Any mutation | 262 | 22 | TMB quintile 4 | -0.09 | -0.87 | 0.60 | 1555.64 | 1.00 | 486 | 255 | 15 | 7 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12-61 | BCOR | Any mutation | 460 | 92 | TMB quintile 5 | 0.31 | -0.09 | 0.70 | 1558.55 | 1.00 | 720 | 419 | 51 | 41 | FALSE | 0.89 |
| uterine cancer | KRAS_12-61 | BCOR | Any mutation | 44 | 19 | TMB quintile 4 | 0.22 | -0.89 | 1.21 | 1541.95 | 1.00 | 171 | 39 | 14 | 5 | FALSE | 0.17 |
| uterine cancer | KRAS_12-61 | BCOR | Any mutation | 64 | 69 | TMB quintile 5 | 0.31 | -0.32 | 0.90 | 1545.12 | 1.00 | 155 | 44 | 49 | 20 | FALSE | 0.51 |
| uterine cancer | KRAS_12-61 | BCOR | Any mutation | 7 | 46 | TMB quintile 6 | -0.89 | -2.32 | 0.40 | 1452.49 | 1.00 | 31 | 5 | 44 | 2 | FALSE | 0.69 |
| colorectal cancer | KRAS_12-61 | BCOR | Any mutation | 691 | 107 | TMB overall | 0.05 | -1.64 | 1.85 | 1507.02 | 1.00 | 815 | 654 | 70 | 37 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | BCOR | Any mutation | 722 | 114 | TMB overall | 0.11 | -1.18 | 1.23 | 1571.03 | 1.00 | 1206 | 674 | 66 | 48 | FALSE | 0.07 |
| uterine cancer | KRAS_12-61 | BCOR | Any mutation | 115 | 134 | TMB overall | -0.12 | -1.71 | 1.31 | 1592.69 | 1.00 | 357 | 88 | 107 | 27 | FALSE | 0.05 |
| colorectal cancer | KRAS_12-61 | CTNNB1 | Any mutation | 175 | 38 | TMB quintile 3 | 0.69 | 0.06 | 1.28 | 1433.21 | 1.00 | 296 | 155 | 18 | 20 | TRUE | 1.57 |
| colorectal cancer | KRAS_12-61 | CTNNB1 | Any mutation | 342 | 35 | TMB quintile 4 | 0.76 | 0.18 | 1.41 | 1199.75 | 1.00 | 438 | 319 | 12 | 23 | TRUE | 1.76 |
| colorectal cancer | KRAS_12-61 | CTNNB1 | Any mutation | 315 | 48 | TMB quintile 5 | 0.24 | -0.33 | 0.78 | 1131.79 | 1.00 | 291 | 289 | 22 | 26 | TRUE | 0.40 |
| colorectal cancer | KRAS_12-61 | CTNNB1 | Any mutation | 35 | 35 | TMB quintile 6 | 0.54 | -0.19 | 1.28 | 1389.39 | 1.00 | 84 | 24 | 24 | 11 | TRUE | 0.82 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 83 | 12 | TMB quintile 2 | -0.85 | -1.95 | 0.13 | 1473.41 | 1.00 | 347 | 82 | 11 | 1 | TRUE | 0.97 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 155 | 22 | TMB quintile 3 | -1.26 | -2.69 | -0.30 | 1493.04 | 1.00 | 449 | 155 | 22 | 0 | TRUE | 1.46 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 264 | 33 | TMB quintile 4 | -0.37 | -1.08 | 0.33 | 1521.04 | 1.00 | 479 | 253 | 22 | 11 | TRUE | 0.53 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 454 | 47 | TMB quintile 5 | -0.72 | -1.34 | -0.15 | 1267.30 | 1.00 | 733 | 443 | 36 | 11 | TRUE | 1.70 |
| uterine cancer | KRAS_12-61 | CTNNB1 | Any mutation | 26 | 28 | TMB quintile 3 | -2.19 | -3.95 | -0.98 | 1241.03 | 1.00 | 187 | 26 | 28 | 0 | TRUE | 2.54 |
| uterine cancer | KRAS_12-61 | CTNNB1 | Any mutation | 44 | 33 | TMB quintile 4 | -1.67 | -2.91 | -0.59 | 1503.11 | 1.00 | 155 | 41 | 30 | 3 | TRUE | 2.34 |
| uterine cancer | KRAS_12-61 | CTNNB1 | Any mutation | 62 | 61 | TMB quintile 5 | -2.01 | -3.10 | -1.12 | 1382.81 | 1.00 | 145 | 59 | 58 | 3 | TRUE | 3.95 |
| uterine cancer | KRAS_12-61 | CTNNB1 | Any mutation | 7 | 15 | TMB quintile 6 | -2.12 | -3.89 | -0.76 | 1252.31 | 1.00 | 41 | 7 | 15 | 0 | TRUE | 2.14 |
| colorectal cancer | KRAS_12-61 | CTNNB1 | Any mutation | 867 | 156 | TMB overall | 0.58 | -0.24 | 1.50 | 1485.59 | 1.00 | 1109 | 787 | 76 | 80 | TRUE | 0.77 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 956 | 114 | TMB overall | -0.80 | -1.67 | -0.06 | 1597.11 | 1.00 | 2008 | 933 | 91 | 23 | TRUE | 1.26 |
| uterine cancer | KRAS_12-61 | CTNNB1 | Any mutation | 139 | 137 | TMB overall | -1.98 | -3.22 | -0.99 | 1362.90 | 1.00 | 528 | 133 | 131 | 6 | TRUE | 3.25 |
| cancer of unknown primary | KRAS_12-61 | ARID1A | Any mutation | 36 | 15 | TMB quintile 4 | -0.42 | -1.67 | 0.73 | 1504.95 | 1.00 | 94 | 33 | 12 | 3 | TRUE | 0.32 |
| cancer of unknown primary | KRAS_12-61 | ARID1A | Any mutation | 43 | 62 | TMB quintile 5 | -0.55 | -1.36 | 0.17 | 1532.00 | 1.00 | 107 | 34 | 53 | 9 | TRUE | 0.79 |
| cancer of unknown primary | KRAS_12-61 | ARID1A | Any mutation | 6 | 16 | TMB quintile 6 | 0.62 | -0.79 | 2.38 | 1483.31 | 1.00 | 9 | 1 | 11 | 5 | TRUE | 0.36 |
| colorectal cancer | KRAS_12-61 | ARID1A | Any mutation | 342 | 32 | TMB quintile 4 | 0.06 | -0.66 | 0.77 | 1240.16 | 1.00 | 433 | 327 | 17 | 15 | TRUE | 0.06 |
| colorectal cancer | KRAS_12-61 | ARID1A | Any mutation | 320 | 116 | TMB quintile 5 | -0.80 | -1.21 | -0.40 | 1487.17 | 1.00 | 256 | 282 | 78 | 38 | TRUE | 3.92 |
| colorectal cancer | KRAS_12-61 | ARID1A | Any mutation | 46 | 155 | TMB quintile 6 | -0.18 | -0.93 | 0.51 | 1475.88 | 1.00 | 40 | 13 | 122 | 33 | TRUE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 155 | 12 | TMB quintile 3 | -0.27 | -1.31 | 0.78 | 1617.29 | 1.00 | 462 | 152 | 9 | 3 | TRUE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 262 | 56 | TMB quintile 4 | -0.20 | -0.80 | 0.33 | 1487.83 | 1.00 | 464 | 245 | 39 | 17 | TRUE | 0.31 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 464 | 187 | TMB quintile 5 | -0.26 | -0.56 | 0.07 | 1386.17 | 1.00 | 652 | 404 | 127 | 60 | TRUE | 0.90 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Any mutation | 277 | 13 | TMB quintile 2 | -0.83 | -1.70 | 0.03 | 1478.93 | 1.00 | 64 | 269 | 5 | 8 | TRUE | 1.19 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Any mutation | 454 | 44 | TMB quintile 3 | -0.16 | -0.82 | 0.63 | 1060.75 | 1.00 | 64 | 416 | 6 | 38 | TRUE | 0.18 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Any mutation | 243 | 45 | TMB quintile 4 | -0.15 | -0.86 | 0.55 | 1730.98 | 1.00 | 34 | 206 | 8 | 37 | TRUE | 0.18 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Any mutation | 39 | 17 | TMB quintile 5 | 0.15 | -0.75 | 1.10 | 1527.55 | 1.00 | 14 | 27 | 5 | 12 | TRUE | 0.13 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 26 | 28 | TMB quintile 3 | 0.33 | -0.86 | 1.40 | 1534.51 | 1.00 | 192 | 22 | 24 | 4 | TRUE | 0.25 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 48 | 77 | TMB quintile 4 | 1.14 | 0.50 | 1.75 | 1525.50 | 1.00 | 139 | 22 | 51 | 26 | TRUE | 3.48 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 89 | 307 | TMB quintile 5 | 0.70 | 0.03 | 1.43 | 1344.35 | 1.00 | 60 | 11 | 229 | 78 | TRUE | 1.33 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 13 | 108 | TMB quintile 6 | 1.14 | -0.55 | 3.37 | 1515.01 | 1.00 | 9 | 0 | 95 | 13 | TRUE | 0.60 |
| cancer of unknown primary | KRAS_12-61 | ARID1A | Any mutation | 85 | 93 | TMB overall | -0.07 | -1.45 | 1.47 | 1128.41 | 1.00 | 210 | 68 | 76 | 17 | TRUE | 0.03 |
| colorectal cancer | KRAS_12-61 | ARID1A | Any mutation | 708 | 303 | TMB overall | -0.30 | -2.18 | 1.65 | 1684.45 | 1.00 | 729 | 622 | 217 | 86 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 881 | 255 | TMB overall | -0.25 | -1.35 | 0.88 | 1573.44 | 1.00 | 1578 | 801 | 175 | 80 | TRUE | 0.18 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Any mutation | 1013 | 119 | TMB overall | -0.26 | -1.11 | 0.59 | 1388.84 | 1.00 | 176 | 918 | 24 | 95 | TRUE | 0.25 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 176 | 520 | TMB overall | 0.78 | -0.65 | 2.31 | 1460.03 | 1.00 | 400 | 55 | 399 | 121 | TRUE | 0.48 |
| colorectal cancer | KRAS_12-61 | PIK3R1 | Any mutation | 341 | 22 | TMB quintile 4 | -0.15 | -0.97 | 0.63 | 1492.66 | 1.00 | 438 | 332 | 13 | 9 | TRUE | 0.15 |
| colorectal cancer | KRAS_12-61 | PIK3R1 | Any mutation | 314 | 29 | TMB quintile 5 | 0.18 | -0.54 | 0.91 | 1579.34 | 1.00 | 302 | 298 | 13 | 16 | TRUE | 0.20 |
| colorectal cancer | KRAS_12-61 | PIK3R1 | Any mutation | 38 | 56 | TMB quintile 6 | 0.20 | -0.50 | 0.90 | 1660.17 | 1.00 | 77 | 23 | 41 | 15 | TRUE | 0.24 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 26 | 40 | TMB quintile 3 | -0.86 | -1.97 | 0.12 | 1613.39 | 1.00 | 181 | 24 | 38 | 2 | TRUE | 0.93 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 46 | 68 | TMB quintile 4 | -0.58 | -1.39 | 0.11 | 1536.13 | 1.00 | 136 | 37 | 59 | 9 | TRUE | 0.92 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 72 | 117 | TMB quintile 5 | 0.07 | -0.46 | 0.61 | 1549.35 | 1.00 | 133 | 41 | 86 | 31 | TRUE | 0.10 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 7 | 37 | TMB quintile 6 | -1.14 | -2.67 | 0.00 | 1549.53 | 1.00 | 29 | 6 | 36 | 1 | TRUE | 1.06 |
| colorectal cancer | KRAS_12-61 | PIK3R1 | Any mutation | 693 | 107 | TMB overall | 0.05 | -1.39 | 1.55 | 1535.30 | 1.00 | 817 | 653 | 67 | 40 | TRUE | 0.02 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 151 | 262 | TMB overall | -0.64 | -1.63 | 0.18 | 1711.71 | 1.00 | 479 | 108 | 219 | 43 | TRUE | 0.77 |
| colorectal cancer | KRAS_12-61 | FAT1 | Any mutation | 341 | 17 | TMB quintile 4 | -0.46 | -1.49 | 0.51 | 1550.24 | 1.00 | 440 | 335 | 11 | 6 | FALSE | 0.43 |
| colorectal cancer | KRAS_12-61 | FAT1 | Any mutation | 315 | 64 | TMB quintile 5 | -0.85 | -1.39 | -0.31 | 1197.60 | 1.00 | 276 | 295 | 44 | 20 | FALSE | 2.65 |
| colorectal cancer | KRAS_12-61 | FAT1 | Any mutation | 51 | 145 | TMB quintile 6 | -0.06 | -0.72 | 0.65 | 1525.31 | 1.00 | 47 | 16 | 110 | 35 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 155 | 16 | TMB quintile 3 | -0.20 | -1.33 | 0.83 | 1403.67 | 1.00 | 459 | 151 | 12 | 4 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 262 | 43 | TMB quintile 4 | -0.47 | -1.16 | 0.20 | 1518.36 | 1.00 | 473 | 251 | 32 | 11 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 459 | 227 | TMB quintile 5 | -0.18 | -0.47 | 0.12 | 1503.23 | 1.00 | 636 | 383 | 151 | 76 | FALSE | 0.61 |
| uterine cancer | KRAS_12-61 | FAT1 | Any mutation | 63 | 49 | TMB quintile 5 | -0.21 | -1.00 | 0.49 | 1478.46 | 1.00 | 172 | 53 | 39 | 10 | FALSE | 0.23 |
| uterine cancer | KRAS_12-61 | FAT1 | Any mutation | 12 | 115 | TMB quintile 6 | 0.44 | -1.14 | 2.51 | 1491.07 | 1.00 | 16 | 1 | 104 | 11 | FALSE | 0.20 |
| colorectal cancer | KRAS_12-61 | FAT1 | Any mutation | 707 | 226 | TMB overall | -0.45 | -2.40 | 1.51 | 1276.47 | 1.00 | 763 | 646 | 165 | 61 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 877 | 300 | TMB overall | -0.25 | -1.73 | 1.39 | 1429.99 | 1.00 | 1575 | 785 | 208 | 92 | FALSE | 0.13 |
| uterine cancer | KRAS_12-61 | FAT1 | Any mutation | 75 | 164 | TMB overall | 0.13 | -2.78 | 3.31 | 1513.29 | 1.00 | 188 | 54 | 143 | 21 | FALSE | 0.03 |
| colorectal cancer | KRAS_12-61 | CIC | Any mutation | 341 | 17 | TMB quintile 4 | 0.03 | -0.92 | 1.00 | 1604.64 | 1.00 | 442 | 333 | 9 | 8 | TRUE | 0.02 |
| colorectal cancer | KRAS_12-61 | CIC | Any mutation | 316 | 40 | TMB quintile 5 | -0.45 | -1.10 | 0.21 | 1541.67 | 1.00 | 291 | 300 | 24 | 16 | TRUE | 0.78 |
| colorectal cancer | KRAS_12-61 | CIC | Any mutation | 37 | 79 | TMB quintile 6 | -0.36 | -1.06 | 0.34 | 1404.55 | 1.00 | 64 | 22 | 64 | 15 | TRUE | 0.48 |
| colorectal cancer | KRAS_12-61 | CIC | Any mutation | 694 | 136 | TMB overall | -0.29 | -2.07 | 1.50 | 1428.26 | 1.00 | 797 | 655 | 97 | 39 | TRUE | 0.13 |
| colorectal cancer | KRAS_12-61 | NCOR1 | Any mutation | 341 | 16 | TMB quintile 4 | -0.36 | -1.37 | 0.55 | 1175.01 | 1.00 | 440 | 335 | 10 | 6 | FALSE | 0.33 |
| colorectal cancer | KRAS_12-61 | NCOR1 | Any mutation | 314 | 32 | TMB quintile 5 | -0.81 | -1.56 | -0.09 | 1624.14 | 1.00 | 296 | 304 | 22 | 10 | FALSE | 1.50 |
| colorectal cancer | KRAS_12-61 | NCOR1 | Any mutation | 38 | 81 | TMB quintile 6 | 0.24 | -0.47 | 0.97 | 1531.69 | 1.00 | 64 | 17 | 60 | 21 | FALSE | 0.29 |
| non-small cell lung cancer | KRAS_12-61 | NCOR1 | Any mutation | 262 | 21 | TMB quintile 4 | -0.74 | -1.66 | 0.03 | 1417.38 | 1.00 | 484 | 258 | 17 | 4 | FALSE | 1.07 |
| non-small cell lung cancer | KRAS_12-61 | NCOR1 | Any mutation | 457 | 71 | TMB quintile 5 | -0.47 | -1.01 | 0.04 | 1595.37 | 1.00 | 724 | 437 | 51 | 20 | FALSE | 1.11 |
| colorectal cancer | KRAS_12-61 | NCOR1 | Any mutation | 693 | 129 | TMB overall | -0.34 | -2.03 | 1.45 | 1571.09 | 1.00 | 800 | 656 | 92 | 37 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12-61 | NCOR1 | Any mutation | 719 | 92 | TMB overall | -0.61 | -1.84 | 0.50 | 1477.37 | 1.00 | 1208 | 695 | 68 | 24 | FALSE | 0.56 |
| colorectal cancer | KRAS_12-61 | POLE | Any mutation | 313 | 38 | TMB quintile 5 | -0.60 | -1.30 | 0.05 | 1604.88 | 1.00 | 291 | 299 | 24 | 14 | TRUE | 1.09 |
| colorectal cancer | KRAS_12-61 | POLE | Any mutation | 39 | 93 | TMB quintile 6 | 0.15 | -0.57 | 0.87 | 1720.20 | 1.00 | 59 | 16 | 70 | 23 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12-61 | POLE | Any mutation | 262 | 20 | TMB quintile 4 | 0.00 | -0.85 | 0.81 | 1451.98 | 1.00 | 487 | 255 | 13 | 7 | TRUE | 0.00 |
| non-small cell lung cancer | KRAS_12-61 | POLE | Any mutation | 456 | 102 | TMB quintile 5 | 0.33 | -0.07 | 0.72 | 1381.36 | 1.00 | 717 | 411 | 57 | 45 | TRUE | 0.95 |
| uterine cancer | KRAS_12-61 | POLE | Any mutation | 62 | 24 | TMB quintile 5 | -0.01 | -0.99 | 0.86 | 1590.15 | 1.00 | 184 | 56 | 18 | 6 | TRUE | 0.00 |
| uterine cancer | KRAS_12-61 | POLE | Any mutation | 9 | 80 | TMB quintile 6 | 0.03 | -1.41 | 1.68 | 1487.10 | 1.00 | 21 | 2 | 73 | 7 | TRUE | 0.01 |
| colorectal cancer | KRAS_12-61 | POLE | Any mutation | 352 | 131 | TMB overall | -0.21 | -2.64 | 2.21 | 1532.65 | 1.00 | 350 | 315 | 94 | 37 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | POLE | Any mutation | 718 | 122 | TMB overall | 0.20 | -1.19 | 1.50 | 1465.06 | 1.00 | 1204 | 666 | 70 | 52 | TRUE | 0.11 |
| uterine cancer | KRAS_12-61 | POLE | Any mutation | 71 | 104 | TMB overall | 0.04 | -2.99 | 3.14 | 1521.09 | 1.00 | 205 | 58 | 91 | 13 | TRUE | 0.01 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH2 | Any mutation | 263 | 16 | TMB quintile 4 | 0.08 | -0.83 | 1.03 | 1537.97 | 1.00 | 488 | 256 | 9 | 7 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH2 | Any mutation | 453 | 81 | TMB quintile 5 | -0.50 | -1.00 | -0.01 | 1528.14 | 1.00 | 712 | 432 | 60 | 21 | TRUE | 1.28 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH2 | Any mutation | 716 | 97 | TMB overall | -0.16 | -1.73 | 1.65 | 1413.15 | 1.00 | 1200 | 688 | 69 | 28 | TRUE | 0.07 |
| colorectal cancer | KRAS_12-61 | TGFBR2 | Any mutation | 314 | 47 | TMB quintile 5 | -0.24 | -0.82 | 0.34 | 1281.20 | 1.00 | 291 | 293 | 26 | 21 | TRUE | 0.37 |
| colorectal cancer | KRAS_12-61 | TGFBR2 | Any mutation | 35 | 57 | TMB quintile 6 | -0.01 | -0.83 | 0.74 | 1367.94 | 1.00 | 65 | 21 | 43 | 14 | TRUE | 0.01 |
| colorectal cancer | KRAS_12-61 | TGFBR2 | Any mutation | 349 | 104 | TMB overall | -0.14 | -2.16 | 1.98 | 1516.07 | 1.00 | 356 | 314 | 69 | 35 | TRUE | 0.05 |
| colorectal cancer | KRAS_12-61 | KMT2A | Any mutation | 341 | 16 | TMB quintile 4 | -0.62 | -1.67 | 0.31 | 1557.60 | 1.00 | 439 | 336 | 11 | 5 | FALSE | 0.69 |
| colorectal cancer | KRAS_12-61 | KMT2A | Any mutation | 314 | 43 | TMB quintile 5 | -0.36 | -0.99 | 0.25 | 1580.89 | 1.00 | 291 | 296 | 25 | 18 | FALSE | 0.58 |
| colorectal cancer | KRAS_12-61 | KMT2A | Any mutation | 41 | 84 | TMB quintile 6 | -0.04 | -0.73 | 0.66 | 1558.90 | 1.00 | 67 | 21 | 64 | 20 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12-61 | KMT2A | Any mutation | 262 | 16 | TMB quintile 4 | -0.37 | -1.34 | 0.58 | 1185.52 | 1.00 | 489 | 257 | 11 | 5 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12-61 | KMT2A | Any mutation | 455 | 80 | TMB quintile 5 | -0.44 | -0.96 | 0.05 | 1242.76 | 1.00 | 715 | 433 | 58 | 22 | FALSE | 1.12 |
| uterine cancer | KRAS_12-61 | KMT2A | Any mutation | 62 | 27 | TMB quintile 5 | 0.04 | -0.88 | 0.89 | 1457.01 | 1.00 | 181 | 55 | 20 | 7 | FALSE | 0.03 |
| uterine cancer | KRAS_12-61 | KMT2A | Any mutation | 9 | 76 | TMB quintile 6 | -0.25 | -1.64 | 1.28 | 1422.64 | 1.00 | 26 | 3 | 70 | 6 | FALSE | 0.13 |
| colorectal cancer | KRAS_12-61 | KMT2A | Any mutation | 696 | 143 | TMB overall | -0.28 | -1.86 | 1.27 | 1485.75 | 1.00 | 797 | 653 | 100 | 43 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12-61 | KMT2A | Any mutation | 717 | 96 | TMB overall | -0.40 | -1.89 | 1.17 | 1359.85 | 1.00 | 1204 | 690 | 69 | 27 | FALSE | 0.22 |
| uterine cancer | KRAS_12-61 | KMT2A | Any mutation | 71 | 103 | TMB overall | -0.03 | -2.78 | 2.81 | 1245.39 | 1.00 | 207 | 58 | 90 | 13 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12-61 | PAK7 | Any mutation | 262 | 13 | TMB quintile 4 | 0.01 | -1.01 | 1.07 | 1558.51 | 1.00 | 489 | 257 | 8 | 5 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12-61 | PAK7 | Any mutation | 454 | 95 | TMB quintile 5 | 0.11 | -0.33 | 0.51 | 1393.44 | 1.00 | 714 | 417 | 58 | 37 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12-61 | PAK7 | Any mutation | 716 | 108 | TMB overall | 0.04 | -1.68 | 1.60 | 1424.78 | 1.00 | 1203 | 674 | 66 | 42 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | STAG2 | Any mutation | 262 | 19 | TMB quintile 4 | -0.14 | -0.97 | 0.61 | 1377.81 | 1.00 | 487 | 256 | 13 | 6 | TRUE | 0.14 |
| non-small cell lung cancer | KRAS_12-61 | STAG2 | Any mutation | 455 | 76 | TMB quintile 5 | 0.16 | -0.30 | 0.61 | 1347.86 | 1.00 | 729 | 424 | 45 | 31 | TRUE | 0.30 |
| non-small cell lung cancer | KRAS_12-61 | STAG2 | Any mutation | 717 | 95 | TMB overall | -0.02 | -1.29 | 1.23 | 1478.11 | 1.00 | 1216 | 680 | 58 | 37 | TRUE | 0.01 |
| non-small cell lung cancer | KRAS_12-61 | TERT | Any mutation | 156 | 13 | TMB quintile 3 | 0.45 | -0.43 | 1.43 | 1509.15 | 1.00 | 464 | 150 | 7 | 6 | TRUE | 0.45 |
| non-small cell lung cancer | KRAS_12-61 | TERT | Any mutation | 262 | 34 | TMB quintile 4 | 0.18 | -0.45 | 0.81 | 1527.35 | 1.00 | 480 | 249 | 21 | 13 | TRUE | 0.24 |
| non-small cell lung cancer | KRAS_12-61 | TERT | Any mutation | 456 | 98 | TMB quintile 5 | 0.06 | -0.38 | 0.46 | 1492.59 | 1.00 | 712 | 420 | 62 | 36 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12-61 | TERT | Any mutation | 874 | 145 | TMB overall | 0.23 | -0.65 | 1.22 | 1377.97 | 1.00 | 1656 | 819 | 90 | 55 | TRUE | 0.22 |
| colorectal cancer | KRAS_12-61 | BRCA2 | Any mutation | 341 | 21 | TMB quintile 4 | -0.14 | -1.03 | 0.71 | 1499.10 | 1.00 | 438 | 332 | 12 | 9 | TRUE | 0.12 |
| colorectal cancer | KRAS_12-61 | BRCA2 | Any mutation | 317 | 48 | TMB quintile 5 | -0.29 | -0.86 | 0.28 | 1337.41 | 1.00 | 290 | 296 | 27 | 21 | TRUE | 0.48 |
| colorectal cancer | KRAS_12-61 | BRCA2 | Any mutation | 43 | 116 | TMB quintile 6 | -0.73 | -1.44 | -0.05 | 1416.02 | 1.00 | 57 | 24 | 97 | 19 | TRUE | 1.41 |
| non-small cell lung cancer | KRAS_12-61 | BRCA2 | Any mutation | 262 | 23 | TMB quintile 4 | -0.28 | -1.26 | 0.56 | 1488.37 | 1.00 | 485 | 255 | 16 | 7 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | BRCA2 | Any mutation | 456 | 89 | TMB quintile 5 | -0.27 | -0.75 | 0.20 | 1556.33 | 1.00 | 711 | 428 | 61 | 28 | TRUE | 0.59 |
| uterine cancer | KRAS_12-61 | BRCA2 | Any mutation | 62 | 29 | TMB quintile 5 | -0.57 | -1.62 | 0.35 | 1599.52 | 1.00 | 176 | 57 | 24 | 5 | TRUE | 0.58 |
| uterine cancer | KRAS_12-61 | BRCA2 | Any mutation | 9 | 93 | TMB quintile 6 | -1.09 | -2.45 | 0.32 | 1660.83 | 1.00 | 22 | 4 | 88 | 5 | TRUE | 0.92 |
| colorectal cancer | KRAS_12-61 | BRCA2 | Any mutation | 701 | 185 | TMB overall | -0.37 | -2.03 | 1.44 | 1463.78 | 1.00 | 785 | 652 | 136 | 49 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12-61 | BRCA2 | Any mutation | 719 | 126 | TMB overall | -0.17 | -2.37 | 2.30 | 1603.07 | 1.00 | 1205 | 683 | 90 | 36 | TRUE | 0.05 |
| uterine cancer | KRAS_12-61 | BRCA2 | Any mutation | 71 | 122 | TMB overall | -0.77 | -3.44 | 2.16 | 1602.34 | 1.00 | 198 | 61 | 112 | 10 | TRUE | 0.23 |
| colorectal cancer | KRAS_12-61 | NOTCH3 | Any mutation | 175 | 12 | TMB quintile 3 | 0.69 | -0.42 | 1.86 | 1222.22 | 1.00 | 307 | 168 | 5 | 7 | TRUE | 0.64 |
| colorectal cancer | KRAS_12-61 | NOTCH3 | Any mutation | 341 | 17 | TMB quintile 4 | 0.26 | -0.65 | 1.23 | 1581.90 | 1.00 | 442 | 332 | 8 | 9 | TRUE | 0.24 |
| colorectal cancer | KRAS_12-61 | NOTCH3 | Any mutation | 313 | 50 | TMB quintile 5 | -0.58 | -1.19 | 0.01 | 1453.81 | 1.00 | 286 | 295 | 32 | 18 | TRUE | 1.26 |
| colorectal cancer | KRAS_12-61 | NOTCH3 | Any mutation | 36 | 120 | TMB quintile 6 | -0.70 | -1.45 | 0.03 | 1508.82 | 1.00 | 42 | 17 | 101 | 19 | TRUE | 1.20 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH3 | Any mutation | 262 | 21 | TMB quintile 4 | -0.13 | -1.09 | 0.72 | 1313.06 | 1.00 | 487 | 255 | 14 | 7 | TRUE | 0.11 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH3 | Any mutation | 454 | 82 | TMB quintile 5 | -0.20 | -0.67 | 0.26 | 1391.07 | 1.00 | 719 | 427 | 55 | 27 | TRUE | 0.38 |
| colorectal cancer | KRAS_12-61 | NOTCH3 | Any mutation | 865 | 199 | TMB overall | -0.07 | -1.63 | 1.57 | 1383.47 | 1.00 | 1077 | 812 | 146 | 53 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH3 | Any mutation | 717 | 114 | TMB overall | -0.06 | -2.38 | 2.33 | 1450.15 | 1.00 | 1215 | 682 | 79 | 35 | TRUE | 0.02 |
| colorectal cancer | KRAS_12-61 | NOTCH4 | Any mutation | 333 | 21 | TMB quintile 4 | 0.00 | -0.84 | 0.81 | 1330.26 | 1.00 | 430 | 323 | 11 | 10 | TRUE | 0.00 |
| colorectal cancer | KRAS_12-61 | NOTCH4 | Any mutation | 296 | 37 | TMB quintile 5 | -1.03 | -1.82 | -0.35 | 1223.55 | 1.01 | 267 | 286 | 27 | 10 | TRUE | 2.23 |
| colorectal cancer | KRAS_12-61 | NOTCH4 | Any mutation | 39 | 59 | TMB quintile 6 | -0.19 | -0.97 | 0.53 | 1358.24 | 1.00 | 68 | 25 | 45 | 14 | TRUE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH4 | Any mutation | 262 | 17 | TMB quintile 4 | -0.86 | -1.97 | 0.15 | 1195.43 | 1.00 | 483 | 259 | 14 | 3 | TRUE | 0.93 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH4 | Any mutation | 453 | 107 | TMB quintile 5 | -0.27 | -0.71 | 0.15 | 1509.60 | 1.00 | 696 | 419 | 73 | 34 | TRUE | 0.69 |
| colorectal cancer | KRAS_12-61 | NOTCH4 | Any mutation | 668 | 117 | TMB overall | -0.40 | -1.97 | 1.19 | 1485.02 | 1.00 | 765 | 634 | 83 | 34 | TRUE | 0.21 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH4 | Any mutation | 715 | 124 | TMB overall | -0.51 | -2.17 | 1.24 | 1428.14 | 1.00 | 1179 | 678 | 87 | 37 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 83 | 12 | TMB quintile 2 | 0.80 | -0.24 | 1.77 | 1509.55 | 1.00 | 351 | 78 | 7 | 5 | FALSE | 0.91 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 155 | 50 | TMB quintile 3 | 1.13 | 0.58 | 1.71 | 1616.49 | 1.00 | 446 | 130 | 25 | 25 | FALSE | 4.12 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 264 | 129 | TMB quintile 4 | 0.66 | 0.28 | 1.03 | 1331.00 | 1.00 | 434 | 203 | 68 | 61 | FALSE | 3.23 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 460 | 336 | TMB quintile 5 | -0.12 | -0.39 | 0.13 | 1493.50 | 1.00 | 561 | 344 | 220 | 116 | FALSE | 0.44 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 962 | 527 | TMB overall | 0.61 | -0.38 | 1.64 | 1532.43 | 1.00 | 1792 | 755 | 320 | 207 | FALSE | 0.63 |
| non-small cell lung cancer | KRAS_12-61 | KDM5C | Any mutation | 262 | 16 | TMB quintile 4 | -0.10 | -1.04 | 0.73 | 1435.04 | 1.00 | 489 | 257 | 11 | 5 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12-61 | KDM5C | Any mutation | 456 | 70 | TMB quintile 5 | 0.30 | -0.16 | 0.77 | 1495.63 | 1.00 | 733 | 425 | 39 | 31 | FALSE | 0.70 |
| non-small cell lung cancer | KRAS_12-61 | KDM5C | Any mutation | 718 | 86 | TMB overall | 0.11 | -1.24 | 1.36 | 1508.84 | 1.00 | 1222 | 682 | 50 | 36 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 155 | 33 | TMB quintile 3 | 0.19 | -0.51 | 0.91 | 1451.95 | 1.00 | 450 | 144 | 22 | 11 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 262 | 43 | TMB quintile 4 | -0.25 | -0.88 | 0.36 | 1510.54 | 1.00 | 471 | 249 | 30 | 13 | TRUE | 0.36 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 460 | 178 | TMB quintile 5 | -0.76 | -1.10 | -0.41 | 1564.74 | 1.00 | 641 | 420 | 138 | 40 | TRUE | 4.52 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 277 | 34 | TMB quintile 2 | 1.47 | 0.57 | 2.56 | 1325.37 | 1.00 | 68 | 244 | 1 | 33 | TRUE | 2.47 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 461 | 146 | TMB quintile 3 | 1.83 | 1.12 | 2.64 | 1399.86 | 1.00 | 65 | 320 | 5 | 141 | TRUE | 5.67 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 246 | 96 | TMB quintile 4 | 1.81 | 0.96 | 2.68 | 1446.05 | 1.00 | 37 | 155 | 5 | 91 | TRUE | 4.50 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 877 | 254 | TMB overall | -0.30 | -1.24 | 0.69 | 1571.20 | 1.00 | 1562 | 813 | 190 | 64 | TRUE | 0.27 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 984 | 276 | TMB overall | 1.68 | 0.82 | 2.69 | 1464.28 | 1.00 | 170 | 719 | 11 | 265 | TRUE | 3.22 |
| non-small cell lung cancer | KRAS_12-61 | EPHB1 | Any mutation | 262 | 19 | TMB quintile 4 | 0.18 | -0.77 | 1.07 | 1452.36 | 1.00 | 489 | 254 | 11 | 8 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12-61 | EPHB1 | Any mutation | 456 | 117 | TMB quintile 5 | -0.65 | -1.08 | -0.22 | 1420.03 | 1.00 | 685 | 427 | 88 | 29 | FALSE | 2.55 |
| non-small cell lung cancer | KRAS_12-61 | EPHB1 | Any mutation | 719 | 152 | TMB overall | -0.82 | -3.60 | 1.71 | 1227.64 | 1.00 | 1182 | 682 | 115 | 37 | FALSE | 0.27 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 26 | 44 | TMB quintile 3 | -0.22 | -1.10 | 0.65 | 1489.23 | 1.00 | 177 | 21 | 39 | 5 | FALSE | 0.22 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 44 | 46 | TMB quintile 4 | -0.39 | -1.15 | 0.37 | 1495.59 | 1.00 | 147 | 37 | 39 | 7 | FALSE | 0.49 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 62 | 25 | TMB quintile 5 | -0.58 | -1.54 | 0.28 | 1618.57 | 1.00 | 179 | 58 | 21 | 4 | FALSE | 0.67 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 8 | 30 | TMB quintile 6 | -0.60 | -1.74 | 0.44 | 1480.89 | 1.00 | 38 | 6 | 28 | 2 | FALSE | 0.57 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 140 | 145 | TMB overall | -0.44 | -1.29 | 0.42 | 1494.78 | 1.00 | 541 | 122 | 127 | 18 | FALSE | 0.51 |
| colorectal cancer | KRAS_12-61 | ERBB3 | Any mutation | 342 | 27 | TMB quintile 4 | -0.14 | -0.87 | 0.59 | 1514.21 | 1.00 | 434 | 331 | 16 | 11 | TRUE | 0.16 |
| colorectal cancer | KRAS_12-61 | ERBB3 | Any mutation | 313 | 39 | TMB quintile 5 | 0.04 | -0.58 | 0.69 | 1624.34 | 1.00 | 295 | 293 | 19 | 20 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | ERBB3 | Any mutation | 36 | 51 | TMB quintile 6 | 0.29 | -0.44 | 1.01 | 1558.13 | 1.00 | 80 | 22 | 37 | 14 | TRUE | 0.36 |
| colorectal cancer | KRAS_12-61 | ERBB3 | Any mutation | 691 | 117 | TMB overall | 0.02 | -1.32 | 1.33 | 1447.24 | 1.00 | 809 | 646 | 72 | 45 | TRUE | 0.01 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 176 | 51 | TMB quintile 3 | 0.12 | -0.39 | 0.62 | 1484.45 | 1.00 | 284 | 154 | 29 | 22 | TRUE | 0.18 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 343 | 129 | TMB quintile 4 | -0.02 | -0.36 | 0.33 | 1372.76 | 1.00 | 380 | 288 | 74 | 55 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 320 | 138 | TMB quintile 5 | 0.00 | -0.36 | 0.36 | 1414.58 | 1.00 | 252 | 253 | 71 | 67 | TRUE | 0.00 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 36 | 31 | TMB quintile 6 | -0.19 | -0.92 | 0.43 | 1328.21 | 1.00 | 87 | 30 | 25 | 6 | TRUE | 0.24 |
| non-small cell lung cancer | KRAS_12-61 | SMAD4 | Any mutation | 155 | 21 | TMB quintile 3 | -0.55 | -1.32 | 0.14 | 1381.62 | 1.00 | 453 | 152 | 18 | 3 | TRUE | 0.87 |
| non-small cell lung cancer | KRAS_12-61 | SMAD4 | Any mutation | 262 | 36 | TMB quintile 4 | -0.52 | -1.16 | 0.08 | 1485.28 | 1.00 | 476 | 254 | 28 | 8 | TRUE | 1.01 |
| non-small cell lung cancer | KRAS_12-61 | SMAD4 | Any mutation | 454 | 49 | TMB quintile 5 | -0.35 | -0.88 | 0.21 | 1437.12 | 1.00 | 736 | 438 | 33 | 16 | TRUE | 0.67 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 277 | 37 | TMB quintile 2 | 0.54 | -0.17 | 1.39 | 1434.32 | 1.00 | 65 | 244 | 4 | 33 | TRUE | 0.78 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 457 | 119 | TMB quintile 3 | 0.64 | 0.07 | 1.23 | 1614.62 | 1.00 | 59 | 349 | 11 | 108 | TRUE | 1.49 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 240 | 82 | TMB quintile 4 | 0.99 | 0.32 | 1.76 | 1612.69 | 1.00 | 36 | 164 | 6 | 76 | TRUE | 2.29 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 40 | 25 | TMB quintile 5 | 1.03 | 0.22 | 1.90 | 1493.01 | 1.00 | 13 | 20 | 5 | 20 | TRUE | 1.80 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 875 | 349 | TMB overall | -0.03 | -0.58 | 0.48 | 1257.96 | 1.00 | 1003 | 725 | 199 | 150 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12-61 | SMAD4 | Any mutation | 871 | 106 | TMB overall | -0.47 | -1.14 | 0.11 | 1332.70 | 1.00 | 1665 | 844 | 79 | 27 | TRUE | 0.86 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 1014 | 263 | TMB overall | 0.79 | 0.07 | 1.59 | 1458.15 | 1.00 | 173 | 777 | 26 | 237 | TRUE | 1.39 |
| colorectal cancer | KRAS_12-61 | ATM | Any mutation | 345 | 46 | TMB quintile 4 | 0.20 | -0.37 | 0.76 | 1380.67 | 1.00 | 428 | 322 | 23 | 23 | TRUE | 0.30 |
| colorectal cancer | KRAS_12-61 | ATM | Any mutation | 319 | 78 | TMB quintile 5 | -0.06 | -0.51 | 0.39 | 1464.50 | 1.00 | 276 | 281 | 40 | 38 | TRUE | 0.11 |
| colorectal cancer | KRAS_12-61 | ATM | Any mutation | 41 | 94 | TMB quintile 6 | -0.02 | -0.71 | 0.62 | 1361.26 | 1.00 | 67 | 20 | 73 | 21 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 83 | 15 | TMB quintile 2 | 0.93 | 0.08 | 1.70 | 1288.57 | 1.00 | 350 | 77 | 9 | 6 | TRUE | 1.66 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 155 | 20 | TMB quintile 3 | 0.97 | 0.26 | 1.71 | 1444.95 | 1.00 | 461 | 145 | 10 | 10 | TRUE | 2.05 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 270 | 76 | TMB quintile 4 | 1.27 | 0.84 | 1.75 | 1443.19 | 1.00 | 475 | 222 | 28 | 48 | TRUE | 7.44 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 468 | 166 | TMB quintile 5 | 0.80 | 0.47 | 1.11 | 1585.09 | 1.00 | 697 | 380 | 78 | 88 | TRUE | 6.19 |
| uterine cancer | KRAS_12-61 | ATM | Any mutation | 63 | 46 | TMB quintile 5 | -0.50 | -1.31 | 0.29 | 1628.26 | 1.00 | 170 | 55 | 38 | 8 | TRUE | 0.64 |
| uterine cancer | KRAS_12-61 | ATM | Any mutation | 10 | 101 | TMB quintile 6 | -0.73 | -2.01 | 0.56 | 1511.13 | 1.00 | 18 | 3 | 94 | 7 | TRUE | 0.57 |
| colorectal cancer | KRAS_12-61 | ATM | Any mutation | 705 | 218 | TMB overall | 0.06 | -1.43 | 1.55 | 1414.94 | 1.00 | 771 | 623 | 136 | 82 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 976 | 277 | TMB overall | 1.00 | 0.30 | 1.71 | 1267.81 | 1.00 | 1983 | 824 | 125 | 152 | TRUE | 2.39 |
| uterine cancer | KRAS_12-61 | ATM | Any mutation | 73 | 147 | TMB overall | -0.64 | -3.17 | 1.97 | 1513.24 | 1.00 | 188 | 58 | 132 | 15 | TRUE | 0.21 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 155 | 33 | TMB quintile 3 | -1.36 | -2.28 | -0.59 | 1536.78 | 1.00 | 440 | 153 | 31 | 2 | TRUE | 2.84 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 262 | 50 | TMB quintile 4 | -1.22 | -1.91 | -0.58 | 1400.24 | 1.00 | 457 | 255 | 43 | 7 | TRUE | 3.58 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 454 | 124 | TMB quintile 5 | -0.98 | -1.41 | -0.56 | 1460.68 | 1.00 | 675 | 429 | 99 | 25 | TRUE | 5.20 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 871 | 207 | TMB overall | -1.19 | -1.92 | -0.51 | 1315.23 | 1.00 | 1572 | 837 | 173 | 34 | TRUE | 3.14 |
| cancer of unknown primary | KRAS_12-61 | KMT2D | Any mutation | 36 | 14 | TMB quintile 3 | -1.41 | -3.35 | 0.12 | 1568.39 | 1.00 | 96 | 35 | 13 | 1 | FALSE | 0.99 |
| cancer of unknown primary | KRAS_12-61 | KMT2D | Any mutation | 36 | 11 | TMB quintile 4 | -0.19 | -1.52 | 1.07 | 1595.29 | 1.00 | 98 | 33 | 8 | 3 | FALSE | 0.11 |
| cancer of unknown primary | KRAS_12-61 | KMT2D | Any mutation | 41 | 67 | TMB quintile 5 | -0.74 | -1.56 | 0.03 | 1477.70 | 1.00 | 99 | 32 | 58 | 9 | FALSE | 1.18 |
| colorectal cancer | KRAS_12-61 | KMT2D | Any mutation | 341 | 27 | TMB quintile 4 | -0.70 | -1.59 | 0.13 | 1238.09 | 1.00 | 432 | 333 | 19 | 8 | FALSE | 0.94 |
| colorectal cancer | KRAS_12-61 | KMT2D | Any mutation | 319 | 104 | TMB quintile 5 | -0.70 | -1.13 | -0.27 | 1448.68 | 1.00 | 268 | 283 | 68 | 36 | FALSE | 2.84 |
| colorectal cancer | KRAS_12-61 | KMT2D | Any mutation | 55 | 245 | TMB quintile 6 | -0.54 | -1.48 | 0.44 | 1179.98 | 1.00 | 13 | 6 | 196 | 49 | FALSE | 0.59 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 155 | 15 | TMB quintile 3 | -0.18 | -1.38 | 0.85 | 1420.88 | 1.00 | 460 | 151 | 11 | 4 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 262 | 42 | TMB quintile 4 | -0.23 | -0.95 | 0.44 | 1342.25 | 1.00 | 474 | 249 | 29 | 13 | FALSE | 0.29 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 459 | 251 | TMB quintile 5 | -0.80 | -1.13 | -0.50 | 1460.52 | 1.00 | 611 | 402 | 194 | 57 | FALSE | 5.98 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 44 | 14 | TMB quintile 4 | -0.59 | -2.27 | 0.72 | 1258.26 | 1.00 | 174 | 42 | 12 | 2 | FALSE | 0.36 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 67 | 129 | TMB quintile 5 | -0.24 | -0.80 | 0.29 | 1442.31 | 1.00 | 119 | 40 | 102 | 27 | FALSE | 0.41 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 12 | 109 | TMB quintile 6 | -0.66 | -1.95 | 0.74 | 1306.00 | 1.00 | 15 | 3 | 100 | 9 | FALSE | 0.47 |
| cancer of unknown primary | KRAS_12-61 | KMT2D | Any mutation | 117 | 123 | TMB overall | -0.54 | -2.18 | 1.12 | 1262.20 | 1.00 | 297 | 100 | 106 | 17 | FALSE | 0.29 |
| colorectal cancer | KRAS_12-61 | KMT2D | Any mutation | 715 | 376 | TMB overall | -0.57 | -2.81 | 1.73 | 1487.25 | 1.00 | 713 | 622 | 283 | 93 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 877 | 320 | TMB overall | -0.70 | -2.47 | 0.88 | 1581.58 | 1.00 | 1552 | 803 | 246 | 74 | FALSE | 0.41 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 123 | 252 | TMB overall | -0.52 | -2.57 | 1.49 | 1521.51 | 1.00 | 308 | 85 | 214 | 38 | FALSE | 0.21 |
| colorectal cancer | KRAS_12-61 | TSC2 | Any mutation | 316 | 42 | TMB quintile 5 | -0.45 | -1.12 | 0.19 | 1633.17 | 1.00 | 292 | 299 | 25 | 17 | TRUE | 0.77 |
| colorectal cancer | KRAS_12-61 | TSC2 | Any mutation | 36 | 56 | TMB quintile 6 | -0.38 | -1.21 | 0.39 | 1433.06 | 1.00 | 73 | 25 | 45 | 11 | TRUE | 0.46 |
| colorectal cancer | KRAS_12-61 | TSC2 | Any mutation | 352 | 98 | TMB overall | -0.39 | -2.43 | 1.64 | 1248.59 | 1.00 | 365 | 324 | 70 | 28 | TRUE | 0.16 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 28 | 78 | TMB quintile 2 | -0.74 | -1.44 | -0.06 | 1630.92 | 1.00 | 50 | 18 | 68 | 10 | TRUE | 1.44 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 207 | 428 | TMB quintile 3 | -0.43 | -0.78 | -0.06 | 1466.68 | 1.00 | 89 | 69 | 290 | 138 | TRUE | 1.72 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 482 | 966 | TMB quintile 4 | -0.03 | -0.35 | 0.31 | 1666.30 | 1.00 | 84 | 68 | 552 | 414 | TRUE | 0.07 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 519 | 822 | TMB quintile 5 | 0.74 | 0.40 | 1.07 | 1443.90 | 1.00 | 96 | 55 | 358 | 464 | TRUE | 4.88 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 69 | 225 | TMB quintile 6 | 0.00 | -0.58 | 0.59 | 1467.55 | 1.00 | 36 | 11 | 167 | 58 | TRUE | 0.00 |
| non-small cell lung cancer | KRAS_12-61 | APC | Any mutation | 155 | 20 | TMB quintile 3 | -0.32 | -1.20 | 0.51 | 1467.66 | 1.00 | 456 | 150 | 15 | 5 | TRUE | 0.34 |
| non-small cell lung cancer | KRAS_12-61 | APC | Any mutation | 262 | 31 | TMB quintile 4 | -0.91 | -1.86 | -0.12 | 1206.36 | 1.00 | 473 | 258 | 27 | 4 | TRUE | 1.44 |
| non-small cell lung cancer | KRAS_12-61 | APC | Any mutation | 457 | 101 | TMB quintile 5 | -0.15 | -0.59 | 0.27 | 1406.50 | 1.00 | 709 | 422 | 66 | 35 | TRUE | 0.32 |
| uterine cancer | KRAS_12-61 | APC | Any mutation | 63 | 35 | TMB quintile 5 | 0.05 | -0.82 | 0.85 | 1518.69 | 1.00 | 182 | 54 | 26 | 9 | TRUE | 0.04 |
| uterine cancer | KRAS_12-61 | APC | Any mutation | 11 | 84 | TMB quintile 6 | -0.81 | -2.00 | 0.38 | 1522.69 | 1.00 | 26 | 5 | 78 | 6 | TRUE | 0.72 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 1305 | 2519 | TMB overall | -0.08 | -0.71 | 0.51 | 1322.72 | 1.00 | 355 | 221 | 1435 | 1084 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12-61 | APC | Any mutation | 874 | 152 | TMB overall | -0.47 | -1.40 | 0.35 | 1362.00 | 1.00 | 1638 | 830 | 108 | 44 | TRUE | 0.57 |
| uterine cancer | KRAS_12-61 | APC | Any mutation | 74 | 119 | TMB overall | -0.38 | -2.93 | 2.26 | 1567.23 | 1.00 | 208 | 59 | 104 | 15 | TRUE | 0.11 |
| colorectal cancer | KRAS_12-61 | ERBB2 | Any mutation | 341 | 17 | TMB quintile 4 | -0.41 | -1.36 | 0.47 | 1596.79 | 1.00 | 439 | 335 | 11 | 6 | TRUE | 0.43 |
| colorectal cancer | KRAS_12-61 | ERBB2 | Any mutation | 313 | 33 | TMB quintile 5 | -0.31 | -1.01 | 0.35 | 1352.07 | 1.00 | 294 | 299 | 19 | 14 | TRUE | 0.42 |
| colorectal cancer | KRAS_12-61 | ERBB2 | Any mutation | 35 | 42 | TMB quintile 6 | 0.32 | -0.46 | 1.09 | 1572.64 | 1.00 | 85 | 23 | 30 | 12 | TRUE | 0.37 |
| non-small cell lung cancer | KRAS_12-61 | ERBB2 | Any mutation | 83 | 14 | TMB quintile 2 | -2.19 | -3.70 | -1.05 | 1497.80 | 1.00 | 344 | 83 | 14 | 0 | TRUE | 3.00 |
| non-small cell lung cancer | KRAS_12-61 | ERBB2 | Any mutation | 155 | 27 | TMB quintile 3 | -1.80 | -2.90 | -0.74 | 1487.65 | 1.00 | 447 | 152 | 24 | 3 | TRUE | 3.03 |
| non-small cell lung cancer | KRAS_12-61 | ERBB2 | Any mutation | 262 | 32 | TMB quintile 4 | -2.44 | -3.89 | -1.42 | 1583.69 | 1.00 | 470 | 262 | 32 | 0 | TRUE | 3.98 |
| non-small cell lung cancer | KRAS_12-61 | ERBB2 | Any mutation | 454 | 40 | TMB quintile 5 | -1.96 | -2.89 | -1.12 | 1653.62 | 1.00 | 736 | 450 | 36 | 4 | TRUE | 4.76 |
| colorectal cancer | KRAS_12-61 | ERBB2 | Any mutation | 689 | 92 | TMB overall | -0.16 | -1.73 | 1.18 | 1370.30 | 1.00 | 818 | 657 | 60 | 32 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12-61 | ERBB2 | Any mutation | 954 | 113 | TMB overall | -2.09 | -3.11 | -1.18 | 1513.93 | 1.00 | 1997 | 947 | 106 | 7 | TRUE | 4.74 |
| uterine cancer | KRAS_12-61 | JAK1 | Any mutation | 67 | 88 | TMB quintile 5 | 0.25 | -0.34 | 0.83 | 1335.65 | 1.00 | 155 | 44 | 65 | 23 | TRUE | 0.41 |
| uterine cancer | KRAS_12-61 | JAK1 | Any mutation | 10 | 52 | TMB quintile 6 | 1.16 | -0.20 | 3.10 | 1418.26 | 1.00 | 27 | 1 | 43 | 9 | TRUE | 0.77 |
| uterine cancer | KRAS_12-61 | JAK1 | Any mutation | 77 | 140 | TMB overall | 0.64 | -1.37 | 3.13 | 1398.95 | 1.00 | 182 | 45 | 108 | 32 | TRUE | 0.25 |
| colorectal cancer | KRAS_12-61 | ARID2 | Any mutation | 341 | 12 | TMB quintile 4 | -0.22 | -1.29 | 0.78 | 1389.53 | 1.00 | 443 | 336 | 7 | 5 | FALSE | 0.17 |
| colorectal cancer | KRAS_12-61 | ARID2 | Any mutation | 314 | 31 | TMB quintile 5 | 0.03 | -0.67 | 0.78 | 1520.25 | 1.00 | 299 | 298 | 15 | 16 | FALSE | 0.03 |
| colorectal cancer | KRAS_12-61 | ARID2 | Any mutation | 35 | 66 | TMB quintile 6 | -0.29 | -1.02 | 0.46 | 1528.30 | 1.00 | 66 | 22 | 53 | 13 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12-61 | ARID2 | Any mutation | 155 | 19 | TMB quintile 3 | -0.66 | -1.75 | 0.22 | 1488.74 | 1.00 | 454 | 153 | 17 | 2 | FALSE | 0.75 |
| non-small cell lung cancer | KRAS_12-61 | ARID2 | Any mutation | 262 | 35 | TMB quintile 4 | -0.05 | -0.70 | 0.56 | 1575.64 | 1.00 | 480 | 249 | 22 | 13 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | ARID2 | Any mutation | 455 | 111 | TMB quintile 5 | -0.23 | -0.66 | 0.16 | 1558.06 | 1.00 | 703 | 420 | 76 | 35 | FALSE | 0.59 |
| colorectal cancer | KRAS_12-61 | ARID2 | Any mutation | 690 | 109 | TMB overall | -0.12 | -1.83 | 1.78 | 1448.49 | 1.00 | 808 | 656 | 75 | 34 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | ARID2 | Any mutation | 872 | 165 | TMB overall | -0.32 | -1.23 | 0.45 | 1534.90 | 1.00 | 1637 | 822 | 115 | 50 | FALSE | 0.35 |
| colorectal cancer | KRAS_12-61 | MTOR | Any mutation | 341 | 19 | TMB quintile 4 | 1.09 | 0.17 | 2.04 | 1358.04 | 1.00 | 445 | 327 | 5 | 14 | TRUE | 1.68 |
| colorectal cancer | KRAS_12-61 | MTOR | Any mutation | 314 | 40 | TMB quintile 5 | 0.00 | -0.63 | 0.65 | 1413.09 | 1.00 | 293 | 294 | 20 | 20 | TRUE | 0.00 |
| colorectal cancer | KRAS_12-61 | MTOR | Any mutation | 40 | 70 | TMB quintile 6 | -0.12 | -0.84 | 0.61 | 1425.44 | 1.00 | 68 | 24 | 54 | 16 | TRUE | 0.13 |
| non-small cell lung cancer | KRAS_12-61 | MTOR | Any mutation | 155 | 14 | TMB quintile 3 | -0.32 | -1.31 | 0.46 | 1561.51 | 1.00 | 459 | 153 | 12 | 2 | TRUE | 0.32 |
| non-small cell lung cancer | KRAS_12-61 | MTOR | Any mutation | 263 | 21 | TMB quintile 4 | -0.04 | -0.76 | 0.63 | 1405.93 | 1.00 | 487 | 255 | 13 | 8 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | MTOR | Any mutation | 456 | 70 | TMB quintile 5 | 0.02 | -0.44 | 0.45 | 1521.65 | 1.00 | 725 | 430 | 44 | 26 | TRUE | 0.03 |
| colorectal cancer | KRAS_12-61 | MTOR | Any mutation | 695 | 129 | TMB overall | 0.32 | -1.76 | 2.20 | 1519.68 | 1.01 | 806 | 645 | 79 | 50 | TRUE | 0.13 |
| non-small cell lung cancer | KRAS_12-61 | MTOR | Any mutation | 874 | 105 | TMB overall | -0.10 | -0.92 | 0.65 | 1484.77 | 1.00 | 1671 | 838 | 69 | 36 | TRUE | 0.09 |
| colorectal cancer | KRAS_12-61 | NOTCH1 | Any mutation | 314 | 48 | TMB quintile 5 | -1.28 | -1.97 | -0.62 | 1655.92 | 1.00 | 279 | 303 | 37 | 11 | TRUE | 3.69 |
| colorectal cancer | KRAS_12-61 | NOTCH1 | Any mutation | 48 | 112 | TMB quintile 6 | 0.46 | -0.29 | 1.19 | 1547.48 | 1.00 | 53 | 14 | 78 | 34 | TRUE | 0.68 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH1 | Any mutation | 262 | 15 | TMB quintile 4 | -0.53 | -1.59 | 0.43 | 1433.44 | 1.00 | 489 | 258 | 11 | 4 | TRUE | 0.54 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH1 | Any mutation | 455 | 97 | TMB quintile 5 | -0.57 | -1.07 | -0.11 | 1414.09 | 1.00 | 702 | 430 | 72 | 25 | TRUE | 1.72 |
| colorectal cancer | KRAS_12-61 | NOTCH1 | Any mutation | 362 | 160 | TMB overall | -0.35 | -3.00 | 2.35 | 1570.22 | 1.00 | 332 | 317 | 115 | 45 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH1 | Any mutation | 717 | 112 | TMB overall | -0.58 | -2.26 | 1.08 | 1485.46 | 1.00 | 1191 | 688 | 83 | 29 | TRUE | 0.32 |
| colorectal cancer | KRAS_12-61 | SETD2 | Any mutation | 175 | 11 | TMB quintile 3 | -1.63 | -3.45 | -0.27 | 1670.94 | 1.00 | 303 | 174 | 10 | 1 | FALSE | 1.31 |
| colorectal cancer | KRAS_12-61 | SETD2 | Any mutation | 314 | 31 | TMB quintile 5 | -1.13 | -1.92 | -0.38 | 1512.06 | 1.00 | 292 | 306 | 23 | 8 | FALSE | 2.31 |
| colorectal cancer | KRAS_12-61 | SETD2 | Any mutation | 40 | 64 | TMB quintile 6 | -0.11 | -0.82 | 0.61 | 1515.71 | 1.00 | 71 | 24 | 48 | 16 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 83 | 14 | TMB quintile 2 | -0.98 | -2.49 | 0.12 | 1330.27 | 1.00 | 344 | 83 | 14 | 0 | FALSE | 0.86 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 156 | 22 | TMB quintile 3 | -0.82 | -1.87 | 0.04 | 1380.26 | 1.00 | 456 | 154 | 20 | 2 | FALSE | 1.02 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 263 | 59 | TMB quintile 4 | -0.21 | -0.76 | 0.29 | 1369.02 | 1.00 | 467 | 245 | 41 | 18 | FALSE | 0.37 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 462 | 110 | TMB quintile 5 | 0.08 | -0.30 | 0.48 | 1306.56 | 1.00 | 711 | 418 | 66 | 44 | FALSE | 0.17 |
| colorectal cancer | KRAS_12-61 | SETD2 | Any mutation | 529 | 106 | TMB overall | -0.91 | -2.60 | 0.80 | 1479.88 | 1.00 | 666 | 504 | 81 | 25 | FALSE | 0.54 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 964 | 205 | TMB overall | -0.48 | -1.38 | 0.23 | 1339.12 | 1.00 | 1978 | 900 | 141 | 64 | FALSE | 0.58 |
| non-small cell lung cancer | KRAS_12-61 | PBRM1 | Any mutation | 264 | 21 | TMB quintile 4 | 0.28 | -0.57 | 1.18 | 1348.15 | 1.00 | 490 | 254 | 11 | 10 | TRUE | 0.27 |
| non-small cell lung cancer | KRAS_12-61 | PBRM1 | Any mutation | 454 | 79 | TMB quintile 5 | -0.51 | -1.06 | 0.01 | 1408.23 | 1.00 | 719 | 434 | 59 | 20 | TRUE | 1.27 |
| non-small cell lung cancer | KRAS_12-61 | PBRM1 | Any mutation | 718 | 100 | TMB overall | -0.10 | -1.54 | 1.63 | 1422.56 | 1.00 | 1209 | 688 | 70 | 30 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | EPHA3 | Any mutation | 342 | 17 | TMB quintile 4 | -0.19 | -1.11 | 0.70 | 1388.41 | 1.00 | 440 | 335 | 10 | 7 | FALSE | 0.16 |
| colorectal cancer | KRAS_12-61 | EPHA3 | Any mutation | 313 | 41 | TMB quintile 5 | 0.04 | -0.55 | 0.65 | 1445.98 | 1.00 | 294 | 292 | 20 | 21 | FALSE | 0.04 |
| colorectal cancer | KRAS_12-61 | EPHA3 | Any mutation | 37 | 44 | TMB quintile 6 | 0.04 | -0.79 | 0.81 | 1423.97 | 1.00 | 81 | 26 | 33 | 11 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 155 | 15 | TMB quintile 3 | 0.57 | -0.44 | 1.53 | 1526.89 | 1.00 | 462 | 149 | 9 | 6 | FALSE | 0.57 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 262 | 28 | TMB quintile 4 | 0.60 | -0.11 | 1.31 | 1375.39 | 1.00 | 486 | 248 | 14 | 14 | FALSE | 0.97 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 461 | 182 | TMB quintile 5 | -0.01 | -0.35 | 0.29 | 1542.19 | 1.00 | 665 | 394 | 115 | 67 | FALSE | 0.03 |
| colorectal cancer | KRAS_12-61 | EPHA3 | Any mutation | 692 | 102 | TMB overall | -0.05 | -1.42 | 1.34 | 1420.19 | 1.00 | 815 | 653 | 63 | 39 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 879 | 237 | TMB overall | 0.38 | -1.23 | 2.16 | 1283.58 | 1.00 | 1621 | 791 | 149 | 88 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12-61 | KDR | Any mutation | 262 | 21 | TMB quintile 4 | 0.36 | -0.47 | 1.18 | 1485.43 | 1.00 | 489 | 252 | 11 | 10 | TRUE | 0.40 |
| non-small cell lung cancer | KRAS_12-61 | KDR | Any mutation | 457 | 109 | TMB quintile 5 | -0.22 | -0.62 | 0.17 | 1405.62 | 1.00 | 697 | 422 | 74 | 35 | TRUE | 0.54 |
| non-small cell lung cancer | KRAS_12-61 | KDR | Any mutation | 719 | 130 | TMB overall | 0.08 | -1.51 | 1.83 | 1205.92 | 1.00 | 1186 | 674 | 85 | 45 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | PTCH1 | Any mutation | 314 | 35 | TMB quintile 5 | -0.72 | -1.46 | -0.04 | 1522.95 | 1.00 | 291 | 302 | 23 | 12 | TRUE | 1.37 |
| colorectal cancer | KRAS_12-61 | PTCH1 | Any mutation | 43 | 99 | TMB quintile 6 | 0.03 | -0.64 | 0.70 | 1580.81 | 1.00 | 56 | 18 | 74 | 25 | TRUE | 0.03 |
| colorectal cancer | KRAS_12-61 | PTCH1 | Any mutation | 357 | 134 | TMB overall | -0.37 | -3.07 | 2.24 | 1574.61 | 1.00 | 347 | 320 | 97 | 37 | TRUE | 0.11 |
| colorectal cancer | KRAS_12-61 | TET1 | Any mutation | 296 | 26 | TMB quintile 5 | -0.69 | -1.51 | 0.12 | 1328.32 | 1.00 | 278 | 287 | 17 | 9 | FALSE | 1.02 |
| colorectal cancer | KRAS_12-61 | TET1 | Any mutation | 41 | 67 | TMB quintile 6 | 0.10 | -0.57 | 0.78 | 1517.81 | 1.00 | 72 | 23 | 49 | 18 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12-61 | TET1 | Any mutation | 262 | 16 | TMB quintile 4 | -0.64 | -1.95 | 0.45 | 1418.99 | 1.00 | 485 | 258 | 12 | 4 | FALSE | 0.55 |
| non-small cell lung cancer | KRAS_12-61 | TET1 | Any mutation | 456 | 89 | TMB quintile 5 | -0.15 | -0.63 | 0.30 | 1472.75 | 1.00 | 713 | 425 | 58 | 31 | FALSE | 0.27 |
| colorectal cancer | KRAS_12-61 | TET1 | Any mutation | 337 | 93 | TMB overall | -0.35 | -3.04 | 2.36 | 1442.95 | 1.00 | 350 | 310 | 66 | 27 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12-61 | TET1 | Any mutation | 719 | 120 | TMB overall | -1.06 | -3.92 | 1.54 | 1522.48 | 1.00 | 1202 | 684 | 85 | 35 | FALSE | 0.36 |
| uterine cancer | KRAS_12-61 | FGFR2 | Any mutation | 44 | 23 | TMB quintile 4 | -1.28 | -2.73 | 0.03 | 1492.28 | 1.00 | 166 | 41 | 20 | 3 | TRUE | 1.18 |
| uterine cancer | KRAS_12-61 | FGFR2 | Any mutation | 62 | 52 | TMB quintile 5 | -2.05 | -3.36 | -0.94 | 1463.93 | 1.00 | 156 | 60 | 50 | 2 | TRUE | 3.06 |
| uterine cancer | KRAS_12-61 | FGFR2 | Any mutation | 7 | 18 | TMB quintile 6 | -2.08 | -4.39 | -0.56 | 1429.03 | 1.00 | 41 | 7 | 18 | 0 | TRUE | 1.53 |
| uterine cancer | KRAS_12-61 | FGFR2 | Any mutation | 113 | 93 | TMB overall | -1.79 | -3.42 | -0.50 | 1306.83 | 1.00 | 363 | 108 | 88 | 5 | TRUE | 1.80 |
| non-small cell lung cancer | KRAS_12-61 | TBX3 | Any mutation | 262 | 11 | TMB quintile 4 | -0.16 | -1.28 | 0.99 | 1386.93 | 1.00 | 493 | 258 | 7 | 4 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12-61 | TBX3 | Any mutation | 454 | 108 | TMB quintile 5 | -0.28 | -0.70 | 0.14 | 1568.23 | 1.00 | 702 | 421 | 75 | 33 | FALSE | 0.73 |
| non-small cell lung cancer | KRAS_12-61 | TBX3 | Any mutation | 716 | 119 | TMB overall | -0.22 | -2.02 | 1.62 | 1454.13 | 1.00 | 1195 | 679 | 82 | 37 | FALSE | 0.09 |
| colorectal cancer | KRAS_12-61 | SMAD3 | Any mutation | 175 | 12 | TMB quintile 3 | -0.07 | -1.04 | 0.83 | 1395.61 | 1.00 | 304 | 171 | 8 | 4 | TRUE | 0.06 |
| colorectal cancer | KRAS_12-61 | SMAD3 | Any mutation | 344 | 27 | TMB quintile 4 | 0.26 | -0.35 | 0.92 | 1662.91 | 1.00 | 439 | 330 | 13 | 14 | TRUE | 0.35 |
| colorectal cancer | KRAS_12-61 | SMAD3 | Any mutation | 319 | 44 | TMB quintile 5 | 0.54 | -0.03 | 1.13 | 1490.56 | 1.00 | 298 | 291 | 16 | 28 | TRUE | 1.13 |
| colorectal cancer | KRAS_12-61 | SMAD3 | Any mutation | 35 | 23 | TMB quintile 6 | 0.22 | -0.68 | 1.08 | 1328.36 | 1.00 | 92 | 29 | 17 | 6 | TRUE | 0.22 |
| colorectal cancer | KRAS_12-61 | SMAD3 | Any mutation | 873 | 106 | TMB overall | 0.22 | -0.66 | 1.09 | 1703.37 | 1.00 | 1133 | 821 | 54 | 52 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12-61 | NTRK3 | Any mutation | 264 | 31 | TMB quintile 4 | 1.07 | 0.38 | 1.79 | 1494.35 | 1.00 | 489 | 245 | 12 | 19 | FALSE | 2.46 |
| non-small cell lung cancer | KRAS_12-61 | NTRK3 | Any mutation | 458 | 144 | TMB quintile 5 | 0.12 | -0.25 | 0.48 | 1501.54 | 1.00 | 691 | 401 | 87 | 57 | FALSE | 0.29 |
| non-small cell lung cancer | KRAS_12-61 | NTRK3 | Any mutation | 724 | 195 | TMB overall | 0.61 | -1.76 | 3.12 | 1492.45 | 1.00 | 1187 | 646 | 117 | 78 | FALSE | 0.21 |
| colorectal cancer | KRAS_12-61 | GRIN2A | Any mutation | 341 | 30 | TMB quintile 4 | -0.35 | -1.12 | 0.37 | 1255.25 | 1.00 | 431 | 330 | 19 | 11 | FALSE | 0.46 |
| colorectal cancer | KRAS_12-61 | GRIN2A | Any mutation | 314 | 42 | TMB quintile 5 | -0.43 | -1.04 | 0.16 | 1408.56 | 1.00 | 288 | 297 | 25 | 17 | FALSE | 0.78 |
| colorectal cancer | KRAS_12-61 | GRIN2A | Any mutation | 35 | 59 | TMB quintile 6 | -0.24 | -1.00 | 0.49 | 1239.74 | 1.00 | 73 | 23 | 47 | 12 | FALSE | 0.27 |
| non-small cell lung cancer | KRAS_12-61 | GRIN2A | Any mutation | 155 | 17 | TMB quintile 3 | 0.59 | -0.30 | 1.53 | 1450.31 | 1.00 | 462 | 147 | 9 | 8 | FALSE | 0.71 |
| non-small cell lung cancer | KRAS_12-61 | GRIN2A | Any mutation | 262 | 39 | TMB quintile 4 | 0.17 | -0.40 | 0.78 | 1573.86 | 1.00 | 477 | 247 | 24 | 15 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12-61 | GRIN2A | Any mutation | 458 | 124 | TMB quintile 5 | -0.09 | -0.50 | 0.29 | 1474.23 | 1.00 | 692 | 416 | 82 | 42 | FALSE | 0.19 |
| colorectal cancer | KRAS_12-61 | GRIN2A | Any mutation | 690 | 131 | TMB overall | -0.32 | -1.76 | 1.10 | 1281.30 | 1.00 | 792 | 650 | 91 | 40 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12-61 | GRIN2A | Any mutation | 875 | 180 | TMB overall | 0.21 | -0.72 | 1.19 | 1508.35 | 1.00 | 1631 | 810 | 115 | 65 | FALSE | 0.18 |
| uterine cancer | KRAS_12-61 | CTCF | Any mutation | 44 | 12 | TMB quintile 4 | -0.22 | -1.70 | 1.04 | 1178.43 | 1.00 | 175 | 42 | 10 | 2 | FALSE | 0.12 |
| uterine cancer | KRAS_12-61 | CTCF | Any mutation | 64 | 103 | TMB quintile 5 | 0.31 | -0.26 | 0.86 | 1482.19 | 1.00 | 130 | 36 | 75 | 28 | FALSE | 0.56 |
| uterine cancer | KRAS_12-61 | CTCF | Any mutation | 8 | 48 | TMB quintile 6 | 0.92 | -0.49 | 2.69 | 1496.93 | 1.00 | 26 | 1 | 41 | 7 | FALSE | 0.59 |
| uterine cancer | KRAS_12-61 | CTCF | Any mutation | 116 | 163 | TMB overall | 0.34 | -1.38 | 2.21 | 1609.10 | 1.00 | 331 | 79 | 126 | 37 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 83 | 12 | TMB quintile 2 | 1.64 | 0.69 | 2.66 | 1524.17 | 1.00 | 354 | 75 | 4 | 8 | TRUE | 2.95 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 157 | 78 | TMB quintile 3 | 1.46 | 1.00 | 1.94 | 1327.84 | 1.00 | 435 | 115 | 36 | 42 | TRUE | 8.80 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 265 | 161 | TMB quintile 4 | 1.51 | 1.14 | 1.86 | 1642.28 | 1.00 | 440 | 164 | 60 | 101 | TRUE | 37.62 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 458 | 283 | TMB quintile 5 | 0.34 | 0.07 | 0.60 | 1401.17 | 1.00 | 616 | 338 | 163 | 120 | TRUE | 1.89 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 963 | 534 | TMB overall | 1.22 | 0.25 | 2.31 | 1595.59 | 1.00 | 1845 | 692 | 263 | 271 | TRUE | 1.74 |
| colorectal cancer | KRAS_12-61 | ASXL1 | Any mutation | 341 | 15 | TMB quintile 4 | -0.55 | -1.60 | 0.41 | 1536.39 | 1.00 | 440 | 336 | 10 | 5 | TRUE | 0.55 |
| colorectal cancer | KRAS_12-61 | ASXL1 | Any mutation | 313 | 30 | TMB quintile 5 | -0.23 | -0.98 | 0.48 | 1460.78 | 1.00 | 298 | 299 | 16 | 14 | TRUE | 0.27 |
| colorectal cancer | KRAS_12-61 | ASXL1 | Any mutation | 34 | 57 | TMB quintile 6 | -1.01 | -1.83 | -0.17 | 1546.73 | 1.00 | 67 | 27 | 50 | 7 | TRUE | 1.73 |
| colorectal cancer | KRAS_12-61 | ASXL1 | Any mutation | 688 | 102 | TMB overall | -0.59 | -2.34 | 1.09 | 1445.87 | 1.00 | 805 | 662 | 76 | 26 | TRUE | 0.31 |
| colorectal cancer | KRAS_12-61 | EP300 | Any mutation | 313 | 39 | TMB quintile 5 | -1.11 | -1.85 | -0.43 | 1440.39 | 1.00 | 286 | 303 | 29 | 10 | TRUE | 2.61 |
| colorectal cancer | KRAS_12-61 | EP300 | Any mutation | 40 | 72 | TMB quintile 6 | 0.12 | -0.56 | 0.86 | 1479.33 | 1.00 | 71 | 21 | 53 | 19 | TRUE | 0.14 |
| non-small cell lung cancer | KRAS_12-61 | EP300 | Any mutation | 455 | 77 | TMB quintile 5 | -0.49 | -1.02 | 0.02 | 1398.97 | 1.00 | 718 | 434 | 56 | 21 | TRUE | 1.19 |
| uterine cancer | KRAS_12-61 | EP300 | Any mutation | 63 | 39 | TMB quintile 5 | 0.21 | -0.61 | 0.93 | 1509.17 | 1.00 | 175 | 52 | 28 | 11 | TRUE | 0.23 |
| uterine cancer | KRAS_12-61 | EP300 | Any mutation | 10 | 53 | TMB quintile 6 | -0.10 | -1.29 | 1.13 | 1530.85 | 1.00 | 28 | 4 | 47 | 6 | TRUE | 0.06 |
| colorectal cancer | KRAS_12-61 | EP300 | Any mutation | 353 | 111 | TMB overall | -0.46 | -2.81 | 1.89 | 1452.27 | 1.00 | 357 | 324 | 82 | 29 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12-61 | EP300 | Any mutation | 455 | 77 | TMB overall | -0.38 | -4.22 | 4.45 | 1454.79 | 1.00 | 718 | 434 | 56 | 21 | TRUE | 0.07 |
| uterine cancer | KRAS_12-61 | EP300 | Any mutation | 73 | 92 | TMB overall | 0.06 | -2.06 | 2.49 | 1311.05 | 1.00 | 203 | 56 | 75 | 17 | TRUE | 0.02 |
| colorectal cancer | KRAS_12-61 | ERBB4 | Any mutation | 341 | 22 | TMB quintile 4 | 0.19 | -0.59 | 0.97 | 1280.54 | 1.00 | 440 | 330 | 11 | 11 | TRUE | 0.19 |
| colorectal cancer | KRAS_12-61 | ERBB4 | Any mutation | 314 | 45 | TMB quintile 5 | -0.03 | -0.62 | 0.55 | 1744.79 | 1.00 | 291 | 292 | 23 | 22 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | ERBB4 | Any mutation | 41 | 61 | TMB quintile 6 | 0.80 | 0.13 | 1.49 | 1393.23 | 1.00 | 78 | 19 | 39 | 22 | TRUE | 1.63 |
| non-small cell lung cancer | KRAS_12-61 | ERBB4 | Any mutation | 262 | 25 | TMB quintile 4 | -0.24 | -1.14 | 0.59 | 1550.73 | 1.00 | 483 | 254 | 17 | 8 | TRUE | 0.24 |
| non-small cell lung cancer | KRAS_12-61 | ERBB4 | Any mutation | 459 | 148 | TMB quintile 5 | -0.56 | -0.93 | -0.19 | 1408.33 | 1.00 | 680 | 420 | 109 | 39 | TRUE | 2.37 |
| colorectal cancer | KRAS_12-61 | ERBB4 | Any mutation | 696 | 128 | TMB overall | 0.31 | -1.16 | 1.84 | 1243.51 | 1.00 | 809 | 641 | 73 | 55 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12-61 | ERBB4 | Any mutation | 722 | 185 | TMB overall | -0.84 | -3.12 | 1.20 | 1597.02 | 1.00 | 1171 | 675 | 138 | 47 | TRUE | 0.36 |
| colorectal cancer | KRAS_12-61 | MED12 | Any mutation | 342 | 18 | TMB quintile 4 | 0.16 | -0.73 | 1.09 | 1395.24 | 1.00 | 441 | 333 | 9 | 9 | TRUE | 0.14 |
| colorectal cancer | KRAS_12-61 | MED12 | Any mutation | 313 | 28 | TMB quintile 5 | 0.10 | -0.65 | 0.85 | 1540.04 | 1.00 | 302 | 298 | 13 | 15 | TRUE | 0.10 |
| colorectal cancer | KRAS_12-61 | MED12 | Any mutation | 38 | 59 | TMB quintile 6 | -0.05 | -0.81 | 0.68 | 1484.78 | 1.00 | 71 | 24 | 45 | 14 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | MED12 | Any mutation | 155 | 23 | TMB quintile 3 | -0.42 | -1.25 | 0.30 | 1548.84 | 1.00 | 452 | 151 | 19 | 4 | TRUE | 0.55 |
| non-small cell lung cancer | KRAS_12-61 | MED12 | Any mutation | 262 | 32 | TMB quintile 4 | -0.36 | -1.02 | 0.26 | 1380.78 | 1.00 | 477 | 253 | 23 | 9 | TRUE | 0.57 |
| non-small cell lung cancer | KRAS_12-61 | MED12 | Any mutation | 458 | 101 | TMB quintile 5 | -0.21 | -0.62 | 0.19 | 1315.75 | 1.00 | 706 | 425 | 68 | 33 | TRUE | 0.51 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 13 | 13 | TMB quintile 2 | -1.43 | -3.79 | 0.30 | 1433.88 | 1.00 | 119 | 13 | 13 | 0 | TRUE | 0.76 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 26 | 16 | TMB quintile 3 | -0.42 | -1.93 | 0.91 | 1414.21 | 1.00 | 201 | 24 | 14 | 2 | TRUE | 0.25 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 44 | 20 | TMB quintile 4 | -0.97 | -2.37 | 0.30 | 1401.30 | 1.00 | 167 | 42 | 18 | 2 | TRUE | 0.79 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 62 | 31 | TMB quintile 5 | -0.24 | -1.18 | 0.58 | 1461.25 | 1.00 | 180 | 55 | 24 | 7 | TRUE | 0.23 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 8 | 58 | TMB quintile 6 | -1.43 | -2.99 | -0.09 | 1463.77 | 1.00 | 27 | 6 | 56 | 2 | TRUE | 1.25 |
| colorectal cancer | KRAS_12-61 | MED12 | Any mutation | 693 | 105 | TMB overall | 0.07 | -1.74 | 1.68 | 1605.95 | 1.00 | 814 | 655 | 67 | 38 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | MED12 | Any mutation | 875 | 156 | TMB overall | -0.33 | -1.04 | 0.34 | 1453.44 | 1.00 | 1635 | 829 | 110 | 46 | TRUE | 0.46 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 153 | 138 | TMB overall | -0.90 | -2.28 | 0.29 | 1607.90 | 1.00 | 694 | 140 | 125 | 13 | TRUE | 0.81 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 83 | 29 | TMB quintile 2 | 0.34 | -0.38 | 0.94 | 1272.98 | 1.00 | 335 | 77 | 23 | 6 | FALSE | 0.50 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 155 | 46 | TMB quintile 3 | 0.45 | -0.02 | 0.95 | 1230.70 | 1.00 | 441 | 140 | 31 | 15 | FALSE | 1.11 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 263 | 90 | TMB quintile 4 | 0.80 | 0.42 | 1.19 | 1274.33 | 1.00 | 457 | 216 | 43 | 47 | FALSE | 4.33 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 462 | 200 | TMB quintile 5 | 0.79 | 0.48 | 1.06 | 1409.76 | 1.00 | 685 | 356 | 94 | 106 | FALSE | 7.07 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 963 | 365 | TMB overall | 0.59 | 0.07 | 1.09 | 1535.57 | 1.00 | 1918 | 789 | 191 | 174 | FALSE | 1.59 |
| colorectal cancer | KRAS_12-61 | NF1 | Any mutation | 341 | 13 | TMB quintile 4 | -1.46 | -3.09 | -0.25 | 1593.38 | 1.00 | 440 | 339 | 11 | 2 | TRUE | 1.35 |
| colorectal cancer | KRAS_12-61 | NF1 | Any mutation | 314 | 34 | TMB quintile 5 | -0.44 | -1.12 | 0.20 | 1453.55 | 1.00 | 293 | 300 | 20 | 14 | TRUE | 0.68 |
| colorectal cancer | KRAS_12-61 | NF1 | Any mutation | 38 | 86 | TMB quintile 6 | -0.39 | -1.14 | 0.33 | 1356.42 | 1.00 | 67 | 22 | 70 | 16 | TRUE | 0.51 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 155 | 25 | TMB quintile 3 | -0.81 | -1.74 | 0.11 | 1665.19 | 1.00 | 451 | 151 | 21 | 4 | TRUE | 1.07 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 262 | 59 | TMB quintile 4 | -1.19 | -1.94 | -0.56 | 1423.47 | 1.00 | 457 | 254 | 51 | 8 | TRUE | 3.15 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 460 | 216 | TMB quintile 5 | -0.65 | -0.99 | -0.34 | 1324.12 | 1.00 | 637 | 406 | 162 | 54 | TRUE | 3.99 |
| uterine cancer | KRAS_12-61 | NF1 | Any mutation | 62 | 38 | TMB quintile 5 | -0.86 | -1.93 | 0.11 | 1454.85 | 1.00 | 174 | 57 | 33 | 5 | TRUE | 1.04 |
| uterine cancer | KRAS_12-61 | NF1 | Any mutation | 8 | 73 | TMB quintile 6 | -1.02 | -2.47 | 0.39 | 1413.34 | 1.00 | 25 | 4 | 69 | 4 | TRUE | 0.79 |
| colorectal cancer | KRAS_12-61 | NF1 | Any mutation | 693 | 133 | TMB overall | -0.73 | -2.69 | 1.04 | 1584.19 | 1.00 | 800 | 661 | 101 | 32 | TRUE | 0.36 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 877 | 300 | TMB overall | -0.88 | -1.82 | 0.08 | 1655.17 | 1.00 | 1545 | 811 | 234 | 66 | TRUE | 1.21 |
| uterine cancer | KRAS_12-61 | NF1 | Any mutation | 70 | 111 | TMB overall | -0.86 | -3.44 | 1.87 | 1454.67 | 1.00 | 199 | 61 | 102 | 9 | TRUE | 0.29 |
| non-small cell lung cancer | KRAS_12-61 | FLT1 | Any mutation | 262 | 21 | TMB quintile 4 | 0.90 | 0.06 | 1.78 | 1401.14 | 1.00 | 493 | 249 | 8 | 13 | FALSE | 1.33 |
| non-small cell lung cancer | KRAS_12-61 | FLT1 | Any mutation | 457 | 99 | TMB quintile 5 | -0.33 | -0.79 | 0.10 | 1513.54 | 1.00 | 706 | 428 | 70 | 29 | FALSE | 0.85 |
| non-small cell lung cancer | KRAS_12-61 | FLT1 | Any mutation | 719 | 120 | TMB overall | 0.25 | -1.65 | 2.34 | 1484.91 | 1.00 | 1199 | 677 | 78 | 42 | FALSE | 0.10 |
| uterine cancer | KRAS_12-61 | RASA1 | Any mutation | 62 | 25 | TMB quintile 5 | -0.74 | -2.01 | 0.38 | 1564.28 | 1.00 | 181 | 58 | 21 | 4 | FALSE | 0.65 |
| uterine cancer | KRAS_12-61 | RASA1 | Any mutation | 7 | 70 | TMB quintile 6 | -1.89 | -3.62 | -0.42 | 1353.46 | 1.00 | 24 | 5 | 68 | 2 | FALSE | 1.72 |
| uterine cancer | KRAS_12-61 | RASA1 | Any mutation | 69 | 95 | TMB overall | -1.23 | -3.94 | 1.49 | 1463.26 | 1.00 | 205 | 63 | 89 | 6 | FALSE | 0.42 |
| colorectal cancer | KRAS_12-61 | EPHA5 | Any mutation | 341 | 18 | TMB quintile 4 | -0.56 | -1.53 | 0.40 | 1412.65 | 1.00 | 438 | 335 | 12 | 6 | FALSE | 0.63 |
| colorectal cancer | KRAS_12-61 | EPHA5 | Any mutation | 314 | 52 | TMB quintile 5 | -0.44 | -1.05 | 0.09 | 1620.58 | 1.00 | 284 | 293 | 31 | 21 | FALSE | 0.88 |
| colorectal cancer | KRAS_12-61 | EPHA5 | Any mutation | 37 | 66 | TMB quintile 6 | -0.90 | -1.76 | -0.13 | 1468.64 | 1.00 | 70 | 28 | 57 | 9 | FALSE | 1.52 |
| non-small cell lung cancer | KRAS_12-61 | EPHA5 | Any mutation | 262 | 48 | TMB quintile 4 | 0.36 | -0.22 | 0.92 | 1316.89 | 1.00 | 474 | 241 | 27 | 21 | FALSE | 0.67 |
| non-small cell lung cancer | KRAS_12-61 | EPHA5 | Any mutation | 458 | 191 | TMB quintile 5 | 0.01 | -0.31 | 0.33 | 1543.98 | 1.00 | 664 | 387 | 120 | 71 | FALSE | 0.03 |
| colorectal cancer | KRAS_12-61 | EPHA5 | Any mutation | 692 | 136 | TMB overall | -0.61 | -2.10 | 0.86 | 1380.56 | 1.00 | 792 | 656 | 100 | 36 | FALSE | 0.38 |
| non-small cell lung cancer | KRAS_12-61 | EPHA5 | Any mutation | 721 | 250 | TMB overall | 0.25 | -1.45 | 2.28 | 1367.42 | 1.00 | 1148 | 628 | 157 | 93 | FALSE | 0.11 |
| colorectal cancer | KRAS_12-61 | AR | Any mutation | 341 | 21 | TMB quintile 4 | -1.15 | -2.20 | -0.26 | 1618.77 | 1.00 | 433 | 337 | 17 | 4 | TRUE | 1.60 |
| colorectal cancer | KRAS_12-61 | AR | Any mutation | 314 | 34 | TMB quintile 5 | -0.53 | -1.23 | 0.11 | 1350.74 | 1.00 | 293 | 301 | 21 | 13 | TRUE | 0.93 |
| colorectal cancer | KRAS_12-61 | AR | Any mutation | 36 | 55 | TMB quintile 6 | 0.06 | -0.72 | 0.80 | 1458.42 | 1.00 | 75 | 22 | 41 | 14 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | AR | Any mutation | 262 | 16 | TMB quintile 4 | 0.12 | -0.79 | 1.05 | 1249.43 | 1.00 | 491 | 255 | 9 | 7 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12-61 | AR | Any mutation | 457 | 77 | TMB quintile 5 | -0.29 | -0.80 | 0.20 | 1365.73 | 1.00 | 720 | 434 | 54 | 23 | TRUE | 0.60 |
| colorectal cancer | KRAS_12-61 | AR | Any mutation | 691 | 110 | TMB overall | -0.52 | -1.96 | 1.04 | 1596.06 | 1.00 | 801 | 660 | 79 | 31 | TRUE | 0.32 |
| non-small cell lung cancer | KRAS_12-61 | AR | Any mutation | 719 | 93 | TMB overall | -0.11 | -1.64 | 1.30 | 1517.66 | 1.00 | 1211 | 689 | 63 | 30 | TRUE | 0.05 |
| colorectal cancer | KRAS_12-61 | ROS1 | Any mutation | 341 | 14 | TMB quintile 4 | -1.50 | -2.94 | -0.33 | 1519.95 | 1.00 | 438 | 339 | 12 | 2 | TRUE | 1.63 |
| colorectal cancer | KRAS_12-61 | ROS1 | Any mutation | 313 | 24 | TMB quintile 5 | -0.98 | -1.88 | -0.16 | 1484.01 | 1.00 | 296 | 306 | 17 | 7 | TRUE | 1.62 |
| colorectal cancer | KRAS_12-61 | ROS1 | Any mutation | 40 | 61 | TMB quintile 6 | -0.19 | -0.90 | 0.50 | 1593.15 | 1.00 | 77 | 26 | 47 | 14 | TRUE | 0.21 |
| non-small cell lung cancer | KRAS_12-61 | ROS1 | Any mutation | 262 | 13 | TMB quintile 4 | -1.75 | -3.47 | -0.49 | 1415.74 | 1.00 | 488 | 261 | 12 | 1 | TRUE | 1.58 |
| non-small cell lung cancer | KRAS_12-61 | ROS1 | Any mutation | 455 | 80 | TMB quintile 5 | -1.12 | -1.70 | -0.56 | 1522.83 | 1.00 | 707 | 441 | 66 | 14 | TRUE | 3.86 |
| colorectal cancer | KRAS_12-61 | ROS1 | Any mutation | 694 | 99 | TMB overall | -0.87 | -2.52 | 0.89 | 1529.77 | 1.00 | 811 | 671 | 76 | 23 | TRUE | 0.52 |
| non-small cell lung cancer | KRAS_12-61 | ROS1 | Any mutation | 717 | 93 | TMB overall | -1.39 | -3.32 | 0.39 | 1652.17 | 1.00 | 1195 | 702 | 78 | 15 | TRUE | 0.92 |
| colorectal cancer | KRAS_12-61 | PIK3CG | Any mutation | 341 | 16 | TMB quintile 4 | -0.62 | -1.59 | 0.32 | 1470.63 | 1.00 | 439 | 336 | 11 | 5 | FALSE | 0.69 |
| colorectal cancer | KRAS_12-61 | PIK3CG | Any mutation | 313 | 38 | TMB quintile 5 | -0.36 | -0.98 | 0.23 | 1502.96 | 1.00 | 291 | 297 | 22 | 16 | FALSE | 0.59 |
| colorectal cancer | KRAS_12-61 | PIK3CG | Any mutation | 38 | 45 | TMB quintile 6 | -0.21 | -1.08 | 0.57 | 1505.90 | 1.00 | 83 | 28 | 35 | 10 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CG | Any mutation | 262 | 16 | TMB quintile 4 | -0.03 | -1.01 | 0.92 | 1510.71 | 1.00 | 490 | 256 | 10 | 6 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CG | Any mutation | 458 | 150 | TMB quintile 5 | -0.23 | -0.62 | 0.14 | 1368.81 | 1.00 | 681 | 410 | 102 | 48 | FALSE | 0.64 |
| colorectal cancer | KRAS_12-61 | PIK3CG | Any mutation | 692 | 99 | TMB overall | -0.38 | -1.76 | 1.06 | 1264.28 | 1.00 | 813 | 661 | 68 | 31 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CG | Any mutation | 720 | 166 | TMB overall | -0.14 | -2.06 | 1.71 | 1489.69 | 1.00 | 1171 | 666 | 112 | 54 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 83 | 200 | TMB quintile 2 | -5.30 | -8.15 | -3.40 | 1465.96 | 1.00 | 180 | 83 | 200 | 0 | TRUE | 4.88 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 155 | 287 | TMB quintile 3 | -5.61 | -8.23 | -3.95 | 1456.58 | 1.00 | 241 | 155 | 287 | 0 | TRUE | 6.16 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 262 | 256 | TMB quintile 4 | -4.03 | -5.03 | -3.17 | 1481.40 | 1.00 | 312 | 258 | 252 | 4 | TRUE | 16.40 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 455 | 175 | TMB quintile 5 | -1.84 | -2.42 | -1.35 | 1596.54 | 1.00 | 652 | 436 | 156 | 19 | TRUE | 10.76 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 955 | 918 | TMB overall | -4.15 | -6.00 | -2.69 | 1338.84 | 1.00 | 1385 | 932 | 895 | 23 | TRUE | 6.22 |
| colorectal cancer | KRAS_12-61 | ARID1B | Any mutation | 341 | 13 | TMB quintile 4 | -0.76 | -2.01 | 0.30 | 1573.16 | 1.00 | 442 | 337 | 9 | 4 | TRUE | 0.71 |
| colorectal cancer | KRAS_12-61 | ARID1B | Any mutation | 314 | 46 | TMB quintile 5 | -1.14 | -1.84 | -0.48 | 1342.03 | 1.00 | 281 | 302 | 34 | 12 | TRUE | 2.99 |
| colorectal cancer | KRAS_12-61 | ARID1B | Any mutation | 34 | 79 | TMB quintile 6 | -1.07 | -1.87 | -0.27 | 1443.33 | 1.00 | 57 | 24 | 69 | 10 | TRUE | 2.12 |
| non-small cell lung cancer | KRAS_12-61 | ARID1B | Any mutation | 155 | 11 | TMB quintile 3 | -0.62 | -1.81 | 0.40 | 1467.77 | 1.00 | 462 | 153 | 9 | 2 | TRUE | 0.58 |
| non-small cell lung cancer | KRAS_12-61 | ARID1B | Any mutation | 262 | 16 | TMB quintile 4 | -0.97 | -2.20 | -0.01 | 1536.70 | 1.00 | 487 | 260 | 14 | 2 | TRUE | 1.08 |
| non-small cell lung cancer | KRAS_12-61 | ARID1B | Any mutation | 456 | 77 | TMB quintile 5 | -0.24 | -0.74 | 0.24 | 1399.91 | 1.00 | 720 | 431 | 52 | 25 | TRUE | 0.50 |
| uterine cancer | KRAS_12-61 | ARID1B | Any mutation | 66 | 59 | TMB quintile 5 | 0.24 | -0.43 | 0.88 | 1356.27 | 1.00 | 163 | 49 | 42 | 17 | TRUE | 0.34 |
| uterine cancer | KRAS_12-61 | ARID1B | Any mutation | 7 | 48 | TMB quintile 6 | -0.18 | -1.62 | 1.17 | 1461.18 | 1.00 | 27 | 3 | 44 | 4 | TRUE | 0.10 |
| colorectal cancer | KRAS_12-61 | ARID1B | Any mutation | 689 | 138 | TMB overall | -0.94 | -2.58 | 0.78 | 1458.29 | 1.00 | 780 | 663 | 112 | 26 | TRUE | 0.55 |
| non-small cell lung cancer | KRAS_12-61 | ARID1B | Any mutation | 873 | 104 | TMB overall | -0.63 | -1.77 | 0.36 | 1685.88 | 1.00 | 1669 | 844 | 75 | 29 | TRUE | 0.61 |
| uterine cancer | KRAS_12-61 | ARID1B | Any mutation | 73 | 107 | TMB overall | 0.03 | -2.23 | 2.38 | 1512.27 | 1.00 | 190 | 52 | 86 | 21 | TRUE | 0.01 |
| non-small cell lung cancer | KRAS_12-61 | MET | Any mutation | 83 | 21 | TMB quintile 2 | -0.89 | -1.91 | -0.04 | 1568.32 | 1.00 | 340 | 81 | 19 | 2 | TRUE | 1.19 |
| non-small cell lung cancer | KRAS_12-61 | MET | Any mutation | 155 | 30 | TMB quintile 3 | -0.99 | -1.94 | -0.19 | 1674.63 | 1.00 | 450 | 152 | 27 | 3 | TRUE | 1.55 |
| non-small cell lung cancer | KRAS_12-61 | MET | Any mutation | 262 | 34 | TMB quintile 4 | -1.37 | -2.49 | -0.54 | 1487.86 | 1.00 | 474 | 260 | 32 | 2 | TRUE | 2.28 |
| non-small cell lung cancer | KRAS_12-61 | MET | Any mutation | 454 | 47 | TMB quintile 5 | -0.18 | -0.81 | 0.40 | 1371.18 | 1.00 | 743 | 435 | 28 | 19 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | MET | Any mutation | 954 | 132 | TMB overall | -0.85 | -1.74 | -0.12 | 1668.12 | 1.00 | 2007 | 928 | 106 | 26 | TRUE | 1.47 |
| colorectal cancer | KRAS_12-61 | BRAF | Any mutation | 175 | 27 | TMB quintile 3 | -1.96 | -3.10 | -0.86 | 1593.05 | 1.00 | 288 | 172 | 24 | 3 | TRUE | 3.36 |
| colorectal cancer | KRAS_12-61 | BRAF | Any mutation | 341 | 60 | TMB quintile 4 | -2.32 | -3.22 | -1.52 | 1498.95 | 1.00 | 395 | 336 | 55 | 5 | TRUE | 7.12 |
| colorectal cancer | KRAS_12-61 | BRAF | Any mutation | 314 | 104 | TMB quintile 5 | -2.85 | -3.60 | -2.18 | 1562.06 | 1.00 | 218 | 307 | 97 | 7 | TRUE | 15.03 |
| colorectal cancer | KRAS_12-61 | BRAF | Any mutation | 34 | 59 | TMB quintile 6 | -2.07 | -3.10 | -1.17 | 1390.74 | 1.00 | 62 | 30 | 55 | 4 | TRUE | 4.31 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 83 | 11 | TMB quintile 2 | -1.68 | -3.38 | -0.36 | 1231.65 | 1.00 | 347 | 83 | 11 | 0 | TRUE | 1.45 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 155 | 13 | TMB quintile 3 | -1.83 | -3.68 | -0.52 | 1697.87 | 1.00 | 458 | 155 | 13 | 0 | TRUE | 1.67 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 262 | 46 | TMB quintile 4 | -1.20 | -1.96 | -0.48 | 1502.31 | 1.00 | 462 | 255 | 39 | 7 | TRUE | 2.78 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 454 | 101 | TMB quintile 5 | -0.87 | -1.36 | -0.38 | 1248.60 | 1.00 | 692 | 432 | 79 | 22 | TRUE | 3.37 |
| colorectal cancer | KRAS_12-61 | BRAF | Any mutation | 864 | 250 | TMB overall | -2.29 | -3.30 | -1.23 | 1560.23 | 1.00 | 963 | 845 | 231 | 19 | TRUE | 4.99 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 954 | 171 | TMB overall | -1.38 | -2.55 | -0.45 | 1599.38 | 1.00 | 1959 | 925 | 142 | 29 | TRUE | 2.03 |
| colorectal cancer | KRAS_12-61 | B2M | Any mutation | 301 | 50 | TMB quintile 5 | -0.79 | -1.43 | -0.21 | 1419.69 | 1.00 | 273 | 285 | 34 | 16 | FALSE | 2.04 |
| colorectal cancer | KRAS_12-61 | B2M | Any mutation | 44 | 79 | TMB quintile 6 | 0.24 | -0.44 | 0.92 | 1522.34 | 1.00 | 68 | 21 | 56 | 23 | FALSE | 0.32 |
| colorectal cancer | KRAS_12-61 | B2M | Any mutation | 345 | 129 | TMB overall | -0.24 | -2.41 | 2.01 | 1588.38 | 1.00 | 341 | 306 | 90 | 39 | FALSE | 0.08 |
| colorectal cancer | KRAS_12-61 | CARD11 | Any mutation | 341 | 28 | TMB quintile 4 | -0.10 | -0.79 | 0.66 | 1480.34 | 1.00 | 434 | 329 | 16 | 12 | FALSE | 0.10 |
| colorectal cancer | KRAS_12-61 | CARD11 | Any mutation | 314 | 43 | TMB quintile 5 | -0.34 | -0.93 | 0.27 | 1590.76 | 1.00 | 288 | 296 | 25 | 18 | FALSE | 0.57 |
| colorectal cancer | KRAS_12-61 | CARD11 | Any mutation | 38 | 52 | TMB quintile 6 | 0.41 | -0.33 | 1.12 | 1296.07 | 1.00 | 79 | 22 | 36 | 16 | FALSE | 0.58 |
| non-small cell lung cancer | KRAS_12-61 | CARD11 | Any mutation | 262 | 18 | TMB quintile 4 | 0.05 | -0.80 | 0.92 | 1428.84 | 1.00 | 489 | 255 | 11 | 7 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12-61 | CARD11 | Any mutation | 457 | 97 | TMB quintile 5 | 0.02 | -0.41 | 0.41 | 1426.90 | 1.00 | 711 | 421 | 61 | 36 | FALSE | 0.03 |
| colorectal cancer | KRAS_12-61 | CARD11 | Any mutation | 693 | 123 | TMB overall | -0.01 | -1.39 | 1.37 | 1268.36 | 1.00 | 801 | 647 | 77 | 46 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12-61 | CARD11 | Any mutation | 719 | 115 | TMB overall | 0.04 | -1.53 | 1.51 | 1481.08 | 1.00 | 1200 | 676 | 72 | 43 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | INPP4B | Any mutation | 262 | 17 | TMB quintile 4 | 0.41 | -0.45 | 1.26 | 1425.42 | 1.00 | 491 | 254 | 9 | 8 | FALSE | 0.45 |
| non-small cell lung cancer | KRAS_12-61 | INPP4B | Any mutation | 458 | 87 | TMB quintile 5 | 0.52 | 0.07 | 0.94 | 1587.98 | 1.00 | 729 | 416 | 45 | 42 | FALSE | 1.69 |
| non-small cell lung cancer | KRAS_12-61 | INPP4B | Any mutation | 720 | 104 | TMB overall | 0.44 | -0.94 | 1.69 | 1344.34 | 1.00 | 1220 | 670 | 54 | 50 | FALSE | 0.31 |
| non-small cell lung cancer | KRAS_12-61 | NFE2L2 | Any mutation | 262 | 31 | TMB quintile 4 | -0.96 | -1.69 | -0.22 | 1368.93 | 1.00 | 481 | 256 | 25 | 6 | FALSE | 2.16 |
| non-small cell lung cancer | KRAS_12-61 | NFE2L2 | Any mutation | 455 | 83 | TMB quintile 5 | -1.00 | -1.58 | -0.48 | 1383.33 | 1.00 | 707 | 440 | 68 | 15 | FALSE | 3.65 |
| non-small cell lung cancer | KRAS_12-61 | NFE2L2 | Any mutation | 717 | 114 | TMB overall | -0.95 | -1.81 | 0.08 | 1461.60 | 1.00 | 1188 | 696 | 93 | 21 | FALSE | 1.48 |
| colorectal cancer | KRAS_12-61 | SOX9 | Any mutation | 175 | 17 | TMB quintile 3 | 0.08 | -0.78 | 0.91 | 1623.62 | 1.00 | 302 | 168 | 10 | 7 | FALSE | 0.07 |
| colorectal cancer | KRAS_12-61 | SOX9 | Any mutation | 345 | 85 | TMB quintile 4 | 0.25 | -0.17 | 0.66 | 1410.14 | 1.00 | 407 | 303 | 43 | 42 | FALSE | 0.61 |
| colorectal cancer | KRAS_12-61 | SOX9 | Any mutation | 320 | 107 | TMB quintile 5 | 0.18 | -0.24 | 0.58 | 1564.57 | 1.00 | 268 | 263 | 50 | 57 | FALSE | 0.41 |
| colorectal cancer | KRAS_12-61 | SOX9 | Any mutation | 37 | 50 | TMB quintile 6 | 0.50 | -0.19 | 1.20 | 1488.46 | 1.00 | 79 | 21 | 34 | 16 | FALSE | 0.81 |
| colorectal cancer | KRAS_12-61 | SOX9 | Any mutation | 877 | 259 | TMB overall | 0.25 | -0.63 | 1.12 | 1539.54 | 1.00 | 1056 | 755 | 137 | 122 | FALSE | 0.24 |
| colorectal cancer | KRAS_12-61 | SMAD2 | Any mutation | 341 | 29 | TMB quintile 4 | 0.23 | -0.41 | 0.89 | 1508.82 | 1.00 | 436 | 327 | 15 | 14 | TRUE | 0.32 |
| colorectal cancer | KRAS_12-61 | SMAD2 | Any mutation | 317 | 53 | TMB quintile 5 | 0.60 | 0.07 | 1.12 | 1368.44 | 1.00 | 297 | 283 | 19 | 34 | TRUE | 1.58 |
| colorectal cancer | KRAS_12-61 | SMAD2 | Any mutation | 35 | 16 | TMB quintile 6 | 0.63 | -0.28 | 1.50 | 1537.59 | 1.00 | 100 | 29 | 10 | 6 | TRUE | 0.76 |
| colorectal cancer | KRAS_12-61 | SMAD2 | Any mutation | 693 | 98 | TMB overall | 0.48 | -0.50 | 1.40 | 1595.61 | 1.00 | 833 | 639 | 44 | 54 | TRUE | 0.49 |
| non-small cell lung cancer | KRAS_12-61 | GLI1 | Any mutation | 245 | 16 | TMB quintile 4 | 0.37 | -0.50 | 1.28 | 1531.13 | 1.00 | 429 | 237 | 8 | 8 | FALSE | 0.39 |
| non-small cell lung cancer | KRAS_12-61 | GLI1 | Any mutation | 417 | 77 | TMB quintile 5 | 0.27 | -0.22 | 0.74 | 1496.42 | 1.00 | 646 | 384 | 44 | 33 | FALSE | 0.60 |
| non-small cell lung cancer | KRAS_12-61 | GLI1 | Any mutation | 662 | 93 | TMB overall | 0.34 | -1.01 | 2.01 | 1526.49 | 1.00 | 1075 | 621 | 52 | 41 | FALSE | 0.20 |
| colorectal cancer | KRAS_12-61 | ZFHX3 | Any mutation | 310 | 14 | TMB quintile 4 | 0.11 | -0.96 | 1.20 | 1466.57 | 1.00 | 403 | 303 | 7 | 7 | FALSE | 0.08 |
| colorectal cancer | KRAS_12-61 | ZFHX3 | Any mutation | 290 | 63 | TMB quintile 5 | -0.32 | -0.83 | 0.19 | 1516.45 | 1.00 | 259 | 263 | 36 | 27 | FALSE | 0.63 |
| colorectal cancer | KRAS_12-61 | ZFHX3 | Any mutation | 41 | 143 | TMB quintile 6 | -0.33 | -1.04 | 0.43 | 1426.35 | 1.00 | 37 | 13 | 115 | 28 | FALSE | 0.43 |
| non-small cell lung cancer | KRAS_12-61 | ZFHX3 | Any mutation | 144 | 13 | TMB quintile 3 | -0.90 | -2.38 | 0.16 | 1629.15 | 1.00 | 414 | 143 | 12 | 1 | FALSE | 0.81 |
| non-small cell lung cancer | KRAS_12-61 | ZFHX3 | Any mutation | 244 | 30 | TMB quintile 4 | -0.37 | -1.09 | 0.31 | 1187.38 | 1.00 | 414 | 235 | 21 | 9 | FALSE | 0.52 |
| non-small cell lung cancer | KRAS_12-61 | ZFHX3 | Any mutation | 417 | 112 | TMB quintile 5 | -0.22 | -0.63 | 0.17 | 1471.94 | 1.00 | 617 | 380 | 75 | 37 | FALSE | 0.55 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Any mutation | 40 | 13 | TMB quintile 4 | -0.02 | -1.41 | 1.18 | 1441.50 | 1.00 | 155 | 37 | 10 | 3 | FALSE | 0.01 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Any mutation | 64 | 105 | TMB quintile 5 | 0.19 | -0.40 | 0.75 | 1207.59 | 1.00 | 130 | 37 | 78 | 27 | FALSE | 0.28 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Any mutation | 13 | 92 | TMB quintile 6 | -0.44 | -1.62 | 0.73 | 1511.74 | 1.00 | 21 | 4 | 83 | 9 | FALSE | 0.33 |
| colorectal cancer | KRAS_12-61 | ZFHX3 | Any mutation | 641 | 220 | TMB overall | -0.14 | -2.12 | 1.92 | 1255.55 | 1.00 | 699 | 579 | 158 | 62 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | ZFHX3 | Any mutation | 805 | 155 | TMB overall | -0.49 | -1.51 | 0.41 | 1468.29 | 1.00 | 1445 | 758 | 108 | 47 | FALSE | 0.50 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Any mutation | 117 | 210 | TMB overall | -0.07 | -2.08 | 1.84 | 1689.06 | 1.00 | 306 | 78 | 171 | 39 | FALSE | 0.03 |
| colorectal cancer | KRAS_12-61 | MGA | Any mutation | 310 | 15 | TMB quintile 4 | -0.79 | -1.96 | 0.22 | 1226.69 | 1.00 | 400 | 306 | 11 | 4 | FALSE | 0.83 |
| colorectal cancer | KRAS_12-61 | MGA | Any mutation | 290 | 46 | TMB quintile 5 | -0.12 | -0.70 | 0.48 | 1465.08 | 1.00 | 265 | 268 | 24 | 22 | FALSE | 0.17 |
| colorectal cancer | KRAS_12-61 | MGA | Any mutation | 35 | 58 | TMB quintile 6 | -0.30 | -1.09 | 0.46 | 1272.78 | 1.00 | 65 | 23 | 46 | 12 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Any mutation | 144 | 14 | TMB quintile 3 | 0.18 | -0.77 | 1.16 | 1340.77 | 1.00 | 418 | 139 | 9 | 5 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Any mutation | 244 | 24 | TMB quintile 4 | -0.12 | -0.91 | 0.67 | 1375.73 | 1.00 | 419 | 236 | 16 | 8 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Any mutation | 419 | 140 | TMB quintile 5 | -0.01 | -0.36 | 0.34 | 1549.30 | 1.00 | 612 | 368 | 89 | 51 | FALSE | 0.03 |
| uterine cancer | KRAS_12-61 | MGA | Any mutation | 58 | 24 | TMB quintile 5 | -0.50 | -1.74 | 0.52 | 1360.97 | 1.00 | 173 | 54 | 20 | 4 | FALSE | 0.42 |
| uterine cancer | KRAS_12-61 | MGA | Any mutation | 13 | 82 | TMB quintile 6 | 1.16 | -0.40 | 3.40 | 1077.73 | 1.00 | 23 | 1 | 70 | 12 | FALSE | 0.67 |
| colorectal cancer | KRAS_12-61 | MGA | Any mutation | 635 | 119 | TMB overall | -0.40 | -1.97 | 1.37 | 1506.61 | 1.00 | 730 | 597 | 81 | 38 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Any mutation | 807 | 178 | TMB overall | 0.02 | -0.99 | 1.11 | 1319.05 | 1.00 | 1449 | 743 | 114 | 64 | FALSE | 0.01 |
| uterine cancer | KRAS_12-61 | MGA | Any mutation | 71 | 106 | TMB overall | 0.26 | -2.73 | 3.39 | 1507.28 | 1.00 | 196 | 55 | 90 | 16 | FALSE | 0.06 |
| colorectal cancer | KRAS_12-61 | KMT2B | Any mutation | 163 | 54 | TMB quintile 5 | -0.04 | -0.63 | 0.54 | 1515.18 | 1.00 | 143 | 137 | 28 | 26 | FALSE | 0.05 |
| colorectal cancer | KRAS_12-61 | KMT2B | Any mutation | 24 | 115 | TMB quintile 6 | 1.43 | -0.09 | 3.53 | 1399.35 | 1.00 | 21 | 1 | 92 | 23 | FALSE | 0.91 |
| uterine cancer | KRAS_12-61 | KMT2B | Any mutation | 55 | 95 | TMB quintile 5 | 0.35 | -0.25 | 0.95 | 1510.03 | 1.00 | 99 | 28 | 68 | 27 | FALSE | 0.57 |
| uterine cancer | KRAS_12-61 | KMT2B | Any mutation | 7 | 67 | TMB quintile 6 | 1.18 | -0.87 | 4.88 | 1390.95 | 1.00 | 10 | 0 | 60 | 7 | FALSE | 0.37 |
| colorectal cancer | KRAS_12-61 | KMT2B | Any mutation | 187 | 169 | TMB overall | 0.55 | -2.80 | 3.83 | 1511.06 | 1.00 | 164 | 138 | 120 | 49 | FALSE | 0.13 |
| uterine cancer | KRAS_12-61 | KMT2B | Any mutation | 62 | 162 | TMB overall | 0.70 | -1.89 | 3.96 | 1535.70 | 1.00 | 109 | 28 | 128 | 34 | FALSE | 0.20 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 162 | 35 | TMB quintile 3 | 0.20 | -0.48 | 0.84 | 1570.36 | 1.00 | 259 | 147 | 20 | 15 | FALSE | 0.26 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 314 | 79 | TMB quintile 4 | 0.28 | -0.17 | 0.74 | 1653.62 | 1.00 | 371 | 274 | 39 | 40 | FALSE | 0.67 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 295 | 108 | TMB quintile 5 | -0.09 | -0.48 | 0.32 | 1305.08 | 1.00 | 236 | 243 | 56 | 52 | FALSE | 0.17 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 34 | 70 | TMB quintile 6 | 0.22 | -0.46 | 0.92 | 1554.18 | 1.00 | 58 | 16 | 52 | 18 | FALSE | 0.26 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 805 | 292 | TMB overall | 0.15 | -0.77 | 1.10 | 1559.03 | 1.00 | 924 | 680 | 167 | 125 | FALSE | 0.13 |
| colorectal cancer | KRAS_12-61 | ANKRD11 | Any mutation | 302 | 11 | TMB quintile 4 | 0.21 | -0.98 | 1.45 | 1665.05 | 1.00 | 395 | 296 | 5 | 6 | FALSE | 0.13 |
| colorectal cancer | KRAS_12-61 | ANKRD11 | Any mutation | 272 | 43 | TMB quintile 5 | -1.39 | -2.15 | -0.65 | 1563.46 | 1.00 | 238 | 263 | 34 | 9 | FALSE | 3.46 |
| colorectal cancer | KRAS_12-61 | ANKRD11 | Any mutation | 38 | 86 | TMB quintile 6 | 0.07 | -0.65 | 0.75 | 1775.07 | 1.00 | 58 | 17 | 65 | 21 | FALSE | 0.07 |
| colorectal cancer | KRAS_12-61 | ANKRD11 | Any mutation | 612 | 140 | TMB overall | -0.31 | -2.24 | 1.75 | 1326.89 | 1.00 | 691 | 576 | 104 | 36 | FALSE | 0.12 |
| colorectal cancer | KRAS_12-61 | POLD1 | Any mutation | 291 | 20 | TMB quintile 5 | -0.10 | -0.98 | 0.80 | 1446.83 | 1.00 | 280 | 281 | 10 | 10 | TRUE | 0.08 |
| colorectal cancer | KRAS_12-61 | POLD1 | Any mutation | 34 | 83 | TMB quintile 6 | -0.60 | -1.40 | 0.18 | 1332.14 | 1.00 | 53 | 20 | 69 | 14 | TRUE | 0.87 |
| colorectal cancer | KRAS_12-61 | POLD1 | Any mutation | 325 | 103 | TMB overall | -0.29 | -3.14 | 2.77 | 1621.37 | 1.00 | 333 | 301 | 79 | 24 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12-61 | PREX2 | Any mutation | 137 | 14 | TMB quintile 4 | -0.30 | -1.33 | 0.65 | 1529.49 | 1.00 | 213 | 132 | 9 | 5 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | PREX2 | Any mutation | 235 | 84 | TMB quintile 5 | -0.38 | -0.86 | 0.09 | 1267.54 | 1.00 | 334 | 210 | 59 | 25 | FALSE | 0.89 |
| non-small cell lung cancer | KRAS_12-61 | PREX2 | Any mutation | 372 | 98 | TMB overall | -0.37 | -1.94 | 1.14 | 1323.63 | 1.00 | 547 | 342 | 68 | 30 | FALSE | 0.20 |
| colorectal cancer | KRAS_12-61 | AMER1 | Any mutation | 175 | 13 | TMB quintile 3 | 0.80 | -0.11 | 1.75 | 1377.40 | 1.00 | 307 | 167 | 5 | 8 | FALSE | 0.98 |
| colorectal cancer | KRAS_12-61 | AMER1 | Any mutation | 341 | 38 | TMB quintile 4 | 0.69 | 0.06 | 1.34 | 1427.81 | 1.00 | 437 | 318 | 15 | 23 | FALSE | 1.44 |
| colorectal cancer | KRAS_12-61 | AMER1 | Any mutation | 313 | 62 | TMB quintile 5 | 0.54 | 0.04 | 1.07 | 1600.28 | 1.00 | 289 | 275 | 24 | 38 | FALSE | 1.37 |
| colorectal cancer | KRAS_12-61 | AMER1 | Any mutation | 40 | 55 | TMB quintile 6 | 0.81 | 0.13 | 1.51 | 1344.33 | 1.00 | 78 | 20 | 35 | 20 | FALSE | 1.61 |
| non-small cell lung cancer | KRAS_12-61 | AMER1 | Any mutation | 262 | 18 | TMB quintile 4 | 1.03 | 0.07 | 2.06 | 1459.23 | 1.00 | 493 | 251 | 7 | 11 | FALSE | 1.42 |
| non-small cell lung cancer | KRAS_12-61 | AMER1 | Any mutation | 459 | 107 | TMB quintile 5 | 0.50 | 0.10 | 0.89 | 1446.85 | 1.00 | 720 | 407 | 55 | 52 | FALSE | 1.92 |
| colorectal cancer | KRAS_12-61 | AMER1 | Any mutation | 869 | 168 | TMB overall | 0.70 | -0.37 | 1.84 | 1486.11 | 1.00 | 1111 | 780 | 79 | 89 | FALSE | 0.66 |
| non-small cell lung cancer | KRAS_12-61 | AMER1 | Any mutation | 722 | 142 | TMB overall | 0.70 | -1.69 | 3.42 | 1508.19 | 1.00 | 1223 | 658 | 78 | 64 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12-61 | EPHA7 | Any mutation | 244 | 14 | TMB quintile 4 | -0.23 | -1.23 | 0.80 | 1544.41 | 1.00 | 425 | 239 | 9 | 5 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12-61 | EPHA7 | Any mutation | 416 | 101 | TMB quintile 5 | -0.36 | -0.82 | 0.07 | 1443.37 | 1.00 | 623 | 386 | 71 | 30 | FALSE | 0.90 |
| non-small cell lung cancer | KRAS_12-61 | EPHA7 | Any mutation | 660 | 115 | TMB overall | -0.28 | -2.00 | 1.61 | 1499.60 | 1.00 | 1048 | 625 | 80 | 35 | FALSE | 0.13 |
| uterine cancer | KRAS_12-61 | INPPL1 | Any mutation | 53 | 82 | TMB quintile 5 | 0.33 | -0.30 | 0.94 | 1508.78 | 1.00 | 97 | 29 | 58 | 24 | FALSE | 0.52 |
| uterine cancer | KRAS_12-61 | INPPL1 | Any mutation | 8 | 40 | TMB quintile 6 | 0.31 | -0.94 | 1.79 | 1405.12 | 1.00 | 18 | 2 | 34 | 6 | FALSE | 0.19 |
| uterine cancer | KRAS_12-61 | INPPL1 | Any mutation | 61 | 122 | TMB overall | 0.34 | -1.33 | 2.19 | 1481.64 | 1.00 | 115 | 31 | 92 | 30 | FALSE | 0.16 |
| melanoma | NRAS_12-61 | SPEN | Any mutation | 150 | 55 | TMB quintile 5 | -0.18 | -0.79 | 0.39 | 1624.84 | 1.00 | 218 | 131 | 36 | 19 | FALSE | 0.26 |
| melanoma | NRAS_12-61 | SPEN | Any mutation | 6 | 56 | TMB quintile 6 | -1.12 | -2.80 | 0.44 | 1477.74 | 1.00 | 34 | 4 | 54 | 2 | FALSE | 0.72 |
| melanoma | NRAS_12-61 | SPEN | Any mutation | 156 | 111 | TMB overall | -0.57 | -3.30 | 2.05 | 1636.82 | 1.00 | 252 | 135 | 90 | 21 | FALSE | 0.18 |
| melanoma | NRAS_12-61 | KMT2C | Any mutation | 143 | 85 | TMB quintile 5 | -0.39 | -0.92 | 0.10 | 1497.26 | 1.00 | 186 | 117 | 59 | 26 | FALSE | 0.85 |
| melanoma | NRAS_12-61 | KMT2C | Any mutation | 7 | 54 | TMB quintile 6 | -1.04 | -2.53 | 0.31 | 1533.13 | 1.00 | 24 | 4 | 51 | 3 | FALSE | 0.82 |
| melanoma | NRAS_12-61 | KMT2C | Any mutation | 150 | 139 | TMB overall | -0.65 | -3.01 | 1.88 | 1578.54 | 1.00 | 210 | 121 | 110 | 29 | FALSE | 0.22 |
| melanoma | NRAS_12-61 | TP53 | Any mutation | 14 | 14 | TMB quintile 3 | -1.38 | -3.98 | 0.27 | 1306.19 | 1.00 | 84 | 14 | 14 | 0 | TRUE | 0.70 |
| melanoma | NRAS_12-61 | TP53 | Any mutation | 19 | 16 | TMB quintile 4 | 0.10 | -1.11 | 1.24 | 1451.24 | 1.00 | 74 | 15 | 12 | 4 | TRUE | 0.06 |
| melanoma | NRAS_12-61 | TP53 | Any mutation | 151 | 119 | TMB quintile 5 | -0.26 | -0.69 | 0.19 | 1146.54 | 1.00 | 178 | 112 | 80 | 39 | TRUE | 0.60 |
| melanoma | NRAS_12-61 | TP53 | Any mutation | 7 | 52 | TMB quintile 6 | -0.45 | -1.74 | 0.83 | 1435.36 | 1.00 | 26 | 3 | 48 | 4 | TRUE | 0.31 |
| melanoma | NRAS_12-61 | TP53 | Any mutation | 191 | 201 | TMB overall | -0.48 | -1.85 | 0.85 | 1310.19 | 1.00 | 362 | 144 | 154 | 47 | TRUE | 0.32 |
| melanoma | NRAS_12-61 | ATRX | Any mutation | 148 | 58 | TMB quintile 5 | -0.34 | -0.94 | 0.26 | 1363.85 | 1.00 | 221 | 130 | 40 | 18 | TRUE | 0.57 |
| melanoma | NRAS_12-61 | ATRX | Any mutation | 6 | 30 | TMB quintile 6 | -2.83 | -7.85 | -0.28 | 1156.20 | 1.00 | 48 | 6 | 30 | 0 | TRUE | 0.76 |
| melanoma | NRAS_12-61 | ATRX | Any mutation | 154 | 88 | TMB overall | -1.45 | -4.94 | 1.28 | 1269.60 | 1.00 | 269 | 136 | 70 | 18 | TRUE | 0.46 |
| melanoma | NRAS_12-61 | PTPRD | Any mutation | 156 | 147 | TMB quintile 5 | -0.30 | -0.73 | 0.12 | 1501.85 | 1.00 | 173 | 109 | 100 | 47 | FALSE | 0.76 |
| melanoma | NRAS_12-61 | PTPRD | Any mutation | 11 | 115 | TMB quintile 6 | 0.32 | -1.15 | 2.38 | 1336.06 | 1.00 | 20 | 1 | 105 | 10 | FALSE | 0.14 |
| melanoma | NRAS_12-61 | PTPRD | Any mutation | 167 | 262 | TMB overall | 0.02 | -2.50 | 2.96 | 1486.08 | 1.00 | 193 | 110 | 205 | 57 | FALSE | 0.00 |
| melanoma | NRAS_12-61 | PIK3C2G | Any mutation | 145 | 99 | TMB quintile 5 | 0.01 | -0.47 | 0.47 | 1551.96 | 1.00 | 185 | 108 | 62 | 37 | FALSE | 0.02 |
| melanoma | NRAS_12-61 | PIK3C2G | Any mutation | 9 | 85 | TMB quintile 6 | -0.24 | -1.60 | 1.37 | 1519.90 | 1.00 | 18 | 2 | 78 | 7 | FALSE | 0.12 |
| melanoma | NRAS_12-61 | PIK3C2G | Any mutation | 154 | 184 | TMB overall | -0.10 | -2.74 | 2.77 | 1398.98 | 1.00 | 203 | 110 | 140 | 44 | FALSE | 0.03 |
| melanoma | NRAS_12-61 | PTPRT | Any mutation | 159 | 200 | TMB quintile 5 | -0.07 | -0.45 | 0.31 | 1592.07 | 1.00 | 158 | 90 | 131 | 69 | FALSE | 0.14 |
| melanoma | NRAS_12-61 | PTPRT | Any mutation | 13 | 153 | TMB quintile 6 | 1.40 | -0.98 | 5.86 | 1406.31 | 1.00 | 13 | 0 | 140 | 13 | FALSE | 0.37 |
| melanoma | NRAS_12-61 | PTPRT | Any mutation | 172 | 353 | TMB overall | 0.54 | -2.60 | 4.72 | 1371.37 | 1.00 | 171 | 90 | 271 | 82 | FALSE | 0.12 |
| melanoma | NRAS_12-61 | ALK | Any mutation | 148 | 76 | TMB quintile 5 | -0.26 | -0.86 | 0.26 | 1502.68 | 1.00 | 205 | 124 | 52 | 24 | TRUE | 0.47 |
| melanoma | NRAS_12-61 | ALK | Any mutation | 7 | 51 | TMB quintile 6 | 0.32 | -1.16 | 1.87 | 1526.33 | 1.00 | 33 | 2 | 46 | 5 | TRUE | 0.17 |
| melanoma | NRAS_12-61 | ALK | Any mutation | 155 | 127 | TMB overall | -0.02 | -2.32 | 2.60 | 1455.46 | 1.00 | 238 | 126 | 98 | 29 | TRUE | 0.01 |
| melanoma | NRAS_12-61 | IKZF1 | Any mutation | 148 | 57 | TMB quintile 5 | -0.29 | -0.87 | 0.27 | 1312.61 | 1.00 | 219 | 130 | 39 | 18 | TRUE | 0.48 |
| melanoma | NRAS_12-61 | IKZF1 | Any mutation | 7 | 44 | TMB quintile 6 | -0.52 | -2.07 | 0.82 | 1578.36 | 1.00 | 38 | 4 | 41 | 3 | TRUE | 0.32 |
| melanoma | NRAS_12-61 | IKZF1 | Any mutation | 155 | 101 | TMB overall | -0.40 | -2.77 | 2.06 | 1430.70 | 1.00 | 257 | 134 | 80 | 21 | TRUE | 0.13 |
| melanoma | NRAS_12-61 | FAT1 | Any mutation | 149 | 86 | TMB quintile 5 | -0.29 | -0.80 | 0.20 | 1470.18 | 1.00 | 200 | 122 | 59 | 27 | FALSE | 0.58 |
| melanoma | NRAS_12-61 | FAT1 | Any mutation | 8 | 50 | TMB quintile 6 | 0.54 | -0.92 | 2.21 | 1503.78 | 1.00 | 37 | 2 | 44 | 6 | FALSE | 0.32 |
| melanoma | NRAS_12-61 | FAT1 | Any mutation | 157 | 136 | TMB overall | 0.06 | -2.49 | 2.90 | 1576.16 | 1.00 | 237 | 124 | 103 | 33 | FALSE | 0.02 |
| melanoma | NRAS_12-61 | KMT2A | Any mutation | 149 | 69 | TMB quintile 5 | -0.11 | -0.66 | 0.46 | 1609.63 | 1.00 | 216 | 125 | 45 | 24 | FALSE | 0.16 |
| melanoma | NRAS_12-61 | KMT2A | Any mutation | 6 | 62 | TMB quintile 6 | -0.12 | -1.64 | 1.57 | 1455.67 | 1.00 | 30 | 2 | 58 | 4 | FALSE | 0.06 |
| melanoma | NRAS_12-61 | KMT2A | Any mutation | 155 | 131 | TMB overall | -0.14 | -2.90 | 2.75 | 1521.02 | 1.00 | 246 | 127 | 103 | 28 | FALSE | 0.04 |
| melanoma | NRAS_12-61 | PAK7 | Any mutation | 147 | 135 | TMB quintile 5 | -0.45 | -0.87 | -0.01 | 1300.20 | 1.00 | 158 | 106 | 94 | 41 | FALSE | 1.38 |
| melanoma | NRAS_12-61 | PAK7 | Any mutation | 8 | 75 | TMB quintile 6 | -1.34 | -2.75 | 0.01 | 1379.76 | 1.00 | 17 | 4 | 71 | 4 | FALSE | 1.27 |
| melanoma | NRAS_12-61 | PAK7 | Any mutation | 155 | 210 | TMB overall | -0.85 | -3.05 | 1.64 | 1464.38 | 1.00 | 175 | 110 | 165 | 45 | FALSE | 0.34 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 16 | 17 | TMB quintile 2 | 1.74 | 0.58 | 2.84 | 1576.65 | 1.00 | 98 | 9 | 10 | 7 | TRUE | 2.61 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 14 | 29 | TMB quintile 3 | 0.54 | -0.66 | 1.70 | 1521.98 | 1.00 | 74 | 9 | 24 | 5 | TRUE | 0.45 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 21 | 57 | TMB quintile 4 | 0.99 | 0.06 | 1.96 | 1385.17 | 1.00 | 44 | 6 | 42 | 15 | TRUE | 1.36 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 164 | 396 | TMB quintile 5 | 0.45 | -0.15 | 1.07 | 1458.43 | 1.00 | 40 | 17 | 249 | 147 | TRUE | 0.85 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 11 | 106 | TMB quintile 6 | 1.05 | -0.57 | 3.06 | 1513.40 | 1.00 | 12 | 0 | 95 | 11 | TRUE | 0.61 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 226 | 605 | TMB overall | 0.94 | -0.35 | 2.32 | 1446.59 | 1.00 | 268 | 41 | 420 | 185 | TRUE | 0.76 |
| melanoma | NRAS_12-61 | NOTCH3 | Any mutation | 147 | 67 | TMB quintile 5 | -0.42 | -0.98 | 0.13 | 1365.20 | 1.00 | 208 | 127 | 47 | 20 | TRUE | 0.84 |
| melanoma | NRAS_12-61 | NOTCH3 | Any mutation | 6 | 57 | TMB quintile 6 | -2.05 | -4.34 | -0.33 | 1654.07 | 1.00 | 30 | 5 | 56 | 1 | TRUE | 1.39 |
| melanoma | NRAS_12-61 | NOTCH3 | Any mutation | 153 | 124 | TMB overall | -1.12 | -3.85 | 1.68 | 1500.00 | 1.00 | 238 | 132 | 103 | 21 | TRUE | 0.39 |
| melanoma | NRAS_12-61 | NOTCH4 | Any mutation | 143 | 81 | TMB quintile 5 | -0.21 | -0.74 | 0.31 | 1539.43 | 1.00 | 191 | 116 | 54 | 27 | TRUE | 0.37 |
| melanoma | NRAS_12-61 | NOTCH4 | Any mutation | 9 | 64 | TMB quintile 6 | 0.09 | -1.28 | 1.61 | 1403.00 | 1.00 | 20 | 2 | 57 | 7 | TRUE | 0.04 |
| melanoma | NRAS_12-61 | NOTCH4 | Any mutation | 152 | 145 | TMB overall | -0.05 | -2.52 | 2.81 | 1450.13 | 1.00 | 211 | 118 | 111 | 34 | TRUE | 0.01 |
| melanoma | NRAS_12-61 | CDKN2A | Any mutation | 151 | 80 | TMB quintile 5 | -0.03 | -0.54 | 0.46 | 1397.37 | 1.00 | 205 | 121 | 50 | 30 | TRUE | 0.04 |
| melanoma | NRAS_12-61 | CDKN2A | Any mutation | 6 | 34 | TMB quintile 6 | -0.67 | -2.24 | 0.80 | 1527.89 | 1.00 | 34 | 4 | 32 | 2 | TRUE | 0.41 |
| melanoma | NRAS_12-61 | CDKN2A | Any mutation | 157 | 114 | TMB overall | -0.35 | -2.77 | 1.73 | 1587.94 | 1.00 | 239 | 125 | 82 | 32 | TRUE | 0.11 |
| melanoma | NRAS_12-61 | KMT2D | Any mutation | 157 | 112 | TMB quintile 5 | 0.16 | -0.28 | 0.60 | 1373.20 | 1.00 | 199 | 112 | 67 | 45 | FALSE | 0.32 |
| melanoma | NRAS_12-61 | KMT2D | Any mutation | 11 | 91 | TMB quintile 6 | 0.86 | -0.58 | 2.75 | 1164.70 | 1.00 | 27 | 1 | 81 | 10 | FALSE | 0.47 |
| melanoma | NRAS_12-61 | KMT2D | Any mutation | 168 | 203 | TMB overall | 0.44 | -2.37 | 3.42 | 1295.50 | 1.00 | 226 | 113 | 148 | 55 | FALSE | 0.13 |
| colorectal cancer | NRAS_12-61 | APC | Any mutation | 19 | 428 | TMB quintile 3 | 0.31 | -0.65 | 1.26 | 1406.05 | 1.00 | 153 | 5 | 414 | 14 | TRUE | 0.27 |
| colorectal cancer | NRAS_12-61 | APC | Any mutation | 52 | 966 | TMB quintile 4 | 1.43 | 0.43 | 2.77 | 1248.86 | 1.00 | 151 | 1 | 915 | 51 | TRUE | 1.78 |
| colorectal cancer | NRAS_12-61 | APC | Any mutation | 47 | 822 | TMB quintile 5 | 0.82 | -0.04 | 1.78 | 1556.98 | 1.00 | 147 | 4 | 779 | 43 | TRUE | 1.10 |
| melanoma | NRAS_12-61 | APC | Any mutation | 147 | 67 | TMB quintile 5 | -0.62 | -1.22 | -0.03 | 1527.09 | 1.00 | 213 | 130 | 50 | 17 | TRUE | 1.41 |
| melanoma | NRAS_12-61 | APC | Any mutation | 6 | 50 | TMB quintile 6 | -0.49 | -2.00 | 1.17 | 1475.71 | 1.00 | 35 | 3 | 47 | 3 | TRUE | 0.26 |
| colorectal cancer | NRAS_12-61 | APC | Any mutation | 119 | 2519 | TMB overall | 0.36 | -0.94 | 1.56 | 1576.44 | 1.00 | 565 | 11 | 2411 | 108 | TRUE | 0.24 |
| melanoma | NRAS_12-61 | APC | Any mutation | 153 | 117 | TMB overall | -0.53 | -2.88 | 1.84 | 1478.96 | 1.00 | 248 | 133 | 97 | 20 | TRUE | 0.18 |
| melanoma | NRAS_12-61 | ARID2 | Any mutation | 154 | 83 | TMB quintile 5 | 0.05 | -0.40 | 0.54 | 1313.73 | 1.00 | 211 | 122 | 51 | 32 | FALSE | 0.08 |
| melanoma | NRAS_12-61 | ARID2 | Any mutation | 6 | 53 | TMB quintile 6 | -0.87 | -2.60 | 0.58 | 1580.34 | 1.00 | 43 | 4 | 51 | 2 | FALSE | 0.57 |
| melanoma | NRAS_12-61 | ARID2 | Any mutation | 160 | 136 | TMB overall | -0.37 | -2.81 | 2.07 | 1465.68 | 1.00 | 254 | 126 | 102 | 34 | FALSE | 0.12 |
| melanoma | NRAS_12-61 | EPHA3 | Any mutation | 149 | 57 | TMB quintile 5 | 0.49 | -0.06 | 1.08 | 1507.82 | 1.00 | 227 | 122 | 30 | 27 | FALSE | 1.05 |
| melanoma | NRAS_12-61 | EPHA3 | Any mutation | 6 | 45 | TMB quintile 6 | 0.39 | -1.03 | 2.03 | 1407.34 | 1.00 | 36 | 2 | 41 | 4 | FALSE | 0.20 |
| melanoma | NRAS_12-61 | EPHA3 | Any mutation | 155 | 102 | TMB overall | 0.39 | -2.29 | 2.98 | 1377.98 | 1.00 | 263 | 124 | 71 | 31 | FALSE | 0.12 |
| melanoma | NRAS_12-61 | KDR | Any mutation | 147 | 64 | TMB quintile 5 | -0.07 | -0.62 | 0.48 | 1577.71 | 1.00 | 212 | 124 | 41 | 23 | TRUE | 0.09 |
| melanoma | NRAS_12-61 | KDR | Any mutation | 8 | 62 | TMB quintile 6 | -0.24 | -1.62 | 1.13 | 1165.92 | 1.00 | 28 | 3 | 57 | 5 | TRUE | 0.14 |
| melanoma | NRAS_12-61 | KDR | Any mutation | 155 | 126 | TMB overall | -0.17 | -2.71 | 2.42 | 1600.96 | 1.00 | 240 | 127 | 98 | 28 | TRUE | 0.05 |
| melanoma | NRAS_12-61 | NTRK3 | Any mutation | 151 | 58 | TMB quintile 5 | -0.09 | -0.68 | 0.46 | 1475.37 | 1.00 | 217 | 130 | 37 | 21 | FALSE | 0.12 |
| melanoma | NRAS_12-61 | NTRK3 | Any mutation | 6 | 42 | TMB quintile 6 | -0.85 | -2.57 | 0.68 | 1340.31 | 1.00 | 36 | 4 | 40 | 2 | FALSE | 0.53 |
| melanoma | NRAS_12-61 | NTRK3 | Any mutation | 157 | 100 | TMB overall | -0.45 | -2.88 | 2.04 | 1104.89 | 1.00 | 253 | 134 | 77 | 23 | FALSE | 0.15 |
| melanoma | NRAS_12-61 | GRIN2A | Any mutation | 158 | 166 | TMB quintile 5 | -0.47 | -0.88 | -0.06 | 1559.47 | 1.00 | 164 | 109 | 117 | 49 | FALSE | 1.56 |
| melanoma | NRAS_12-61 | GRIN2A | Any mutation | 11 | 124 | TMB quintile 6 | 0.12 | -1.37 | 2.23 | 1358.48 | 1.00 | 17 | 1 | 114 | 10 | FALSE | 0.05 |
| melanoma | NRAS_12-61 | GRIN2A | Any mutation | 169 | 290 | TMB overall | -0.13 | -2.72 | 3.13 | 1441.03 | 1.00 | 181 | 110 | 231 | 59 | FALSE | 0.03 |
| melanoma | NRAS_12-61 | ERBB4 | Any mutation | 150 | 92 | TMB quintile 5 | -0.43 | -0.94 | 0.07 | 1537.66 | 1.00 | 195 | 123 | 65 | 27 | TRUE | 1.02 |
| melanoma | NRAS_12-61 | ERBB4 | Any mutation | 11 | 89 | TMB quintile 6 | 0.60 | -0.91 | 2.88 | 1554.90 | 1.00 | 19 | 1 | 79 | 10 | TRUE | 0.28 |
| melanoma | NRAS_12-61 | ERBB4 | Any mutation | 161 | 181 | TMB overall | 0.09 | -2.85 | 3.42 | 1450.83 | 1.00 | 214 | 124 | 144 | 37 | TRUE | 0.02 |
| melanoma | NRAS_12-61 | NF1 | Any mutation | 14 | 13 | TMB quintile 3 | -0.16 | -2.05 | 1.41 | 1615.76 | 1.00 | 86 | 12 | 11 | 2 | TRUE | 0.07 |
| melanoma | NRAS_12-61 | NF1 | Any mutation | 19 | 11 | TMB quintile 4 | -2.29 | -5.90 | -0.07 | 1343.27 | 1.00 | 77 | 19 | 11 | 0 | TRUE | 0.97 |
| melanoma | NRAS_12-61 | NF1 | Any mutation | 149 | 162 | TMB quintile 5 | -1.37 | -1.85 | -0.88 | 1353.95 | 1.00 | 162 | 123 | 136 | 26 | TRUE | 7.42 |
| melanoma | NRAS_12-61 | NF1 | Any mutation | 12 | 100 | TMB quintile 6 | 0.83 | -0.94 | 3.48 | 1533.90 | 1.00 | 12 | 0 | 88 | 12 | TRUE | 0.34 |
| melanoma | NRAS_12-61 | NF1 | Any mutation | 194 | 286 | TMB overall | -0.70 | -2.64 | 1.37 | 1660.31 | 1.00 | 337 | 154 | 246 | 40 | TRUE | 0.31 |
| melanoma | NRAS_12-61 | FLT1 | Any mutation | 148 | 60 | TMB quintile 5 | -0.20 | -0.80 | 0.40 | 1406.64 | 1.00 | 213 | 128 | 40 | 20 | FALSE | 0.30 |
| melanoma | NRAS_12-61 | FLT1 | Any mutation | 8 | 56 | TMB quintile 6 | 1.11 | -0.48 | 3.11 | 1390.56 | 1.00 | 34 | 1 | 49 | 7 | FALSE | 0.62 |
| melanoma | NRAS_12-61 | FLT1 | Any mutation | 156 | 116 | TMB overall | 0.31 | -2.57 | 3.34 | 1495.93 | 1.00 | 247 | 129 | 89 | 27 | FALSE | 0.08 |
| melanoma | NRAS_12-61 | ROS1 | Any mutation | 152 | 139 | TMB quintile 5 | -0.36 | -0.80 | 0.08 | 1331.14 | 1.00 | 177 | 110 | 97 | 42 | TRUE | 0.94 |
| melanoma | NRAS_12-61 | ROS1 | Any mutation | 12 | 103 | TMB quintile 6 | 1.98 | -0.33 | 6.15 | 1378.70 | 1.00 | 23 | 0 | 91 | 12 | TRUE | 0.62 |
| melanoma | NRAS_12-61 | ROS1 | Any mutation | 164 | 242 | TMB overall | 0.68 | -2.85 | 4.35 | 1646.44 | 1.00 | 200 | 110 | 188 | 54 | TRUE | 0.15 |
| melanoma | NRAS_12-61 | PIK3CG | Any mutation | 146 | 43 | TMB quintile 5 | -0.33 | -1.00 | 0.33 | 1551.26 | 1.00 | 223 | 133 | 30 | 13 | FALSE | 0.48 |
| melanoma | NRAS_12-61 | PIK3CG | Any mutation | 8 | 56 | TMB quintile 6 | 0.49 | -0.90 | 2.21 | 1514.24 | 1.00 | 35 | 2 | 50 | 6 | FALSE | 0.28 |
| melanoma | NRAS_12-61 | PIK3CG | Any mutation | 154 | 99 | TMB overall | 0.06 | -2.64 | 2.95 | 1595.77 | 1.00 | 258 | 135 | 80 | 19 | FALSE | 0.02 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 15 | 16 | TMB quintile 2 | -2.77 | -5.20 | -0.86 | 1153.96 | 1.00 | 91 | 15 | 16 | 0 | TRUE | 1.91 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 14 | 27 | TMB quintile 3 | -2.95 | -5.11 | -1.28 | 1546.71 | 1.00 | 69 | 14 | 27 | 0 | TRUE | 2.51 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 19 | 53 | TMB quintile 4 | -2.50 | -3.95 | -1.32 | 1455.67 | 1.00 | 36 | 17 | 51 | 2 | TRUE | 3.77 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 149 | 170 | TMB quintile 5 | -2.35 | -2.95 | -1.81 | 1409.30 | 1.00 | 113 | 132 | 153 | 17 | TRUE | 15.60 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 6 | 17 | TMB quintile 6 | -1.99 | -3.89 | -0.20 | 1126.69 | 1.00 | 48 | 5 | 16 | 1 | TRUE | 1.46 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 203 | 283 | TMB overall | -2.50 | -3.87 | -1.32 | 1524.61 | 1.00 | 357 | 183 | 263 | 20 | TRUE | 3.90 |
| melanoma | NRAS_12-61 | CARD11 | Any mutation | 148 | 63 | TMB quintile 5 | -0.54 | -1.19 | 0.00 | 1450.18 | 1.00 | 212 | 131 | 46 | 17 | FALSE | 1.12 |
| melanoma | NRAS_12-61 | CARD11 | Any mutation | 6 | 45 | TMB quintile 6 | -1.08 | -2.83 | 0.50 | 1488.90 | 1.00 | 32 | 4 | 43 | 2 | FALSE | 0.72 |
| melanoma | NRAS_12-61 | CARD11 | Any mutation | 154 | 108 | TMB overall | -0.80 | -3.23 | 1.61 | 1553.48 | 1.00 | 244 | 135 | 89 | 19 | FALSE | 0.31 |
| melanoma | NRAS_12-61 | TP63 | Any mutation | 145 | 95 | TMB quintile 5 | 0.00 | -0.50 | 0.48 | 1494.67 | 1.00 | 186 | 109 | 59 | 36 | FALSE | 0.00 |
| melanoma | NRAS_12-61 | TP63 | Any mutation | 6 | 69 | TMB quintile 6 | -1.35 | -3.01 | 0.23 | 1494.51 | 1.00 | 14 | 3 | 66 | 3 | FALSE | 1.03 |
| melanoma | NRAS_12-61 | TP63 | Any mutation | 151 | 164 | TMB overall | -0.62 | -3.14 | 2.09 | 1476.81 | 1.00 | 200 | 112 | 125 | 39 | FALSE | 0.19 |
| melanoma | NRAS_12-61 | ZFHX3 | Any mutation | 142 | 62 | TMB quintile 5 | -0.48 | -1.08 | 0.10 | 1475.16 | 1.00 | 204 | 125 | 45 | 17 | FALSE | 0.98 |
| melanoma | NRAS_12-61 | ZFHX3 | Any mutation | 6 | 78 | TMB quintile 6 | -0.28 | -1.96 | 1.46 | 1421.73 | 1.00 | 34 | 2 | 74 | 4 | FALSE | 0.13 |
| melanoma | NRAS_12-61 | ZFHX3 | Any mutation | 148 | 140 | TMB overall | -0.32 | -3.11 | 2.41 | 1524.23 | 1.00 | 238 | 127 | 119 | 21 | FALSE | 0.09 |
| melanoma | NRAS_12-61 | PREX2 | Any mutation | 91 | 89 | TMB quintile 5 | 0.06 | -0.47 | 0.62 | 1468.03 | 1.00 | 99 | 57 | 55 | 34 | FALSE | 0.08 |
| melanoma | NRAS_12-61 | PREX2 | Any mutation | 8 | 76 | TMB quintile 6 | 0.03 | -1.58 | 1.97 | 1505.82 | 1.00 | 12 | 1 | 69 | 7 | FALSE | 0.01 |
| melanoma | NRAS_12-61 | PREX2 | Any mutation | 99 | 165 | TMB overall | 0.06 | -2.51 | 2.94 | 1551.18 | 1.00 | 111 | 58 | 124 | 41 | FALSE | 0.01 |
| melanoma | NRAS_12-61 | EPHA7 | Any mutation | 144 | 89 | TMB quintile 5 | -0.11 | -0.60 | 0.35 | 1445.16 | 1.00 | 193 | 113 | 58 | 31 | FALSE | 0.19 |
| melanoma | NRAS_12-61 | EPHA7 | Any mutation | 6 | 63 | TMB quintile 6 | -0.82 | -2.34 | 0.64 | 1457.34 | 1.00 | 27 | 3 | 60 | 3 | FALSE | 0.56 |
| melanoma | NRAS_12-61 | EPHA7 | Any mutation | 150 | 152 | TMB overall | -0.47 | -2.91 | 2.02 | 1481.47 | 1.00 | 220 | 116 | 118 | 34 | FALSE | 0.15 |
| colorectal cancer | RAS_12 | SPEN | Any mutation | 282 | 11 | TMB quintile 4 | -0.19 | -1.41 | 0.98 | 1330.93 | 1.00 | 502 | 278 | 7 | 4 | FALSE | 0.12 |
| colorectal cancer | RAS_12 | SPEN | Any mutation | 235 | 31 | TMB quintile 5 | 0.01 | -0.73 | 0.69 | 1464.28 | 1.00 | 376 | 223 | 19 | 12 | FALSE | 0.01 |
| colorectal cancer | RAS_12 | SPEN | Any mutation | 20 | 107 | TMB quintile 6 | -0.44 | -1.29 | 0.42 | 1425.33 | 1.00 | 62 | 10 | 97 | 10 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12 | SPEN | Any mutation | 231 | 15 | TMB quintile 4 | -1.12 | -2.40 | -0.03 | 1376.11 | 1.00 | 518 | 229 | 13 | 2 | FALSE | 1.14 |
| non-small cell lung cancer | RAS_12 | SPEN | Any mutation | 397 | 87 | TMB quintile 5 | -0.88 | -1.47 | -0.33 | 1194.19 | 1.00 | 784 | 382 | 72 | 15 | FALSE | 2.64 |
| uterine cancer | RAS_12 | SPEN | Any mutation | 53 | 37 | TMB quintile 5 | 0.62 | -0.22 | 1.36 | 1497.05 | 1.00 | 185 | 42 | 26 | 11 | FALSE | 0.90 |
| colorectal cancer | RAS_12 | SPEN | Any mutation | 537 | 149 | TMB overall | -0.21 | -2.23 | 1.77 | 1344.70 | 1.00 | 940 | 511 | 123 | 26 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12 | SPEN | Any mutation | 628 | 102 | TMB overall | -0.98 | -2.56 | 0.59 | 1376.40 | 1.00 | 1302 | 611 | 85 | 17 | FALSE | 0.70 |
| uterine cancer | RAS_12 | SPEN | Any mutation | 58 | 114 | TMB overall | 1.13 | -2.10 | 4.99 | 1416.78 | 1.00 | 214 | 42 | 98 | 16 | FALSE | 0.29 |
| colorectal cancer | RAS_12 | KMT2C | Any mutation | 275 | 12 | TMB quintile 4 | -0.31 | -1.48 | 0.87 | 1473.44 | 1.00 | 490 | 271 | 8 | 4 | FALSE | 0.22 |
| colorectal cancer | RAS_12 | KMT2C | Any mutation | 218 | 61 | TMB quintile 5 | -0.72 | -1.36 | -0.11 | 1419.09 | 1.00 | 331 | 204 | 47 | 14 | FALSE | 1.67 |
| colorectal cancer | RAS_12 | KMT2C | Any mutation | 26 | 116 | TMB quintile 6 | -0.05 | -0.88 | 0.78 | 1526.56 | 1.00 | 62 | 10 | 100 | 16 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12 | KMT2C | Any mutation | 130 | 13 | TMB quintile 3 | -0.84 | -2.33 | 0.31 | 1449.33 | 1.00 | 480 | 129 | 12 | 1 | FALSE | 0.69 |
| non-small cell lung cancer | RAS_12 | KMT2C | Any mutation | 231 | 36 | TMB quintile 4 | -0.12 | -0.81 | 0.56 | 1646.83 | 1.00 | 505 | 220 | 25 | 11 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12 | KMT2C | Any mutation | 397 | 155 | TMB quintile 5 | -0.32 | -0.71 | 0.04 | 1505.04 | 1.00 | 719 | 356 | 114 | 41 | FALSE | 1.04 |
| uterine cancer | RAS_12 | KMT2C | Any mutation | 51 | 42 | TMB quintile 5 | -0.60 | -1.60 | 0.31 | 1459.02 | 1.00 | 162 | 45 | 36 | 6 | FALSE | 0.67 |
| colorectal cancer | RAS_12 | KMT2C | Any mutation | 519 | 189 | TMB overall | -0.34 | -2.37 | 1.66 | 1384.95 | 1.00 | 883 | 485 | 155 | 34 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12 | KMT2C | Any mutation | 758 | 204 | TMB overall | -0.39 | -1.62 | 0.71 | 1448.49 | 1.00 | 1704 | 705 | 151 | 53 | FALSE | 0.31 |
| uterine cancer | RAS_12 | KMT2C | Any mutation | 54 | 133 | TMB overall | -0.68 | -3.74 | 2.45 | 1499.19 | 1.00 | 183 | 46 | 125 | 8 | FALSE | 0.19 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 23 | 39 | TMB quintile 2 | -0.12 | -0.89 | 0.73 | 1543.96 | 1.00 | 64 | 14 | 30 | 9 | TRUE | 0.11 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 34 | 74 | TMB quintile 3 | -0.20 | -0.87 | 0.46 | 1308.47 | 1.00 | 54 | 17 | 57 | 17 | TRUE | 0.25 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 36 | 87 | TMB quintile 4 | -0.69 | -1.40 | -0.03 | 1552.45 | 1.00 | 40 | 20 | 71 | 16 | TRUE | 1.33 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 38 | 153 | TMB quintile 5 | -0.62 | -1.30 | 0.01 | 1421.31 | 1.00 | 41 | 15 | 130 | 23 | TRUE | 1.23 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 17 | 104 | TMB quintile 2 | -1.42 | -2.28 | -0.58 | 1213.63 | 1.00 | 25 | 9 | 96 | 8 | TRUE | 3.04 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 148 | 411 | TMB quintile 3 | -1.27 | -1.74 | -0.81 | 1584.58 | 1.00 | 37 | 48 | 311 | 100 | TRUE | 7.46 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 291 | 655 | TMB quintile 4 | -1.18 | -1.51 | -0.85 | 1376.75 | 1.00 | 73 | 102 | 466 | 189 | TRUE | 11.06 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 253 | 423 | TMB quintile 5 | -0.60 | -0.92 | -0.28 | 1590.76 | 1.00 | 134 | 115 | 285 | 138 | TRUE | 3.61 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 24 | 78 | TMB quintile 6 | -0.72 | -1.51 | 0.08 | 1527.21 | 1.00 | 77 | 15 | 69 | 9 | TRUE | 1.10 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 75 | 180 | TMB quintile 2 | -1.21 | -1.79 | -0.68 | 1518.52 | 1.00 | 204 | 59 | 164 | 16 | TRUE | 4.56 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 130 | 324 | TMB quintile 3 | -1.40 | -1.82 | -1.01 | 1431.86 | 1.00 | 218 | 97 | 291 | 33 | TRUE | 10.80 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 232 | 450 | TMB quintile 4 | -1.54 | -1.87 | -1.22 | 1391.22 | 1.00 | 178 | 160 | 378 | 72 | TRUE | 20.34 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 411 | 996 | TMB quintile 5 | -1.72 | -1.99 | -1.45 | 1478.98 | 1.00 | 130 | 202 | 787 | 209 | TRUE | 36.59 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 252 | 216 | TMB quintile 2 | 1.75 | 1.35 | 2.23 | 1466.03 | 1.00 | 68 | 62 | 26 | 190 | TRUE | 14.61 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 421 | 392 | TMB quintile 3 | 1.78 | 1.42 | 2.13 | 1212.17 | 1.00 | 59 | 75 | 46 | 346 | TRUE | 36.59 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 217 | 206 | TMB quintile 4 | 1.48 | 1.01 | 1.90 | 1494.66 | 1.00 | 30 | 48 | 37 | 169 | TRUE | 9.66 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 34 | 34 | TMB quintile 5 | 1.48 | 0.85 | 2.01 | 1434.09 | 1.00 | 13 | 9 | 9 | 25 | TRUE | 6.12 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 13 | 77 | TMB quintile 2 | -1.48 | -2.64 | -0.48 | 1555.57 | 1.00 | 59 | 10 | 74 | 3 | TRUE | 2.36 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 25 | 167 | TMB quintile 3 | -1.25 | -1.99 | -0.51 | 1440.06 | 1.00 | 69 | 15 | 157 | 10 | TRUE | 3.06 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 40 | 132 | TMB quintile 4 | -1.67 | -2.39 | -0.94 | 1566.86 | 1.00 | 80 | 32 | 124 | 8 | TRUE | 5.15 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 53 | 68 | TMB quintile 5 | -0.90 | -1.67 | -0.18 | 1420.21 | 1.00 | 159 | 44 | 59 | 9 | TRUE | 1.68 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 135 | 378 | TMB overall | -0.51 | -1.28 | 0.29 | 1381.91 | 1.00 | 200 | 68 | 311 | 67 | TRUE | 0.69 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 733 | 1671 | TMB overall | -1.05 | -1.79 | -0.26 | 1238.34 | 1.00 | 346 | 289 | 1227 | 444 | TRUE | 2.17 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 848 | 1950 | TMB overall | -1.47 | -2.25 | -0.69 | 1539.73 | 1.00 | 730 | 518 | 1620 | 330 | TRUE | 3.82 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 924 | 848 | TMB overall | 1.62 | 1.18 | 2.07 | 1479.49 | 1.00 | 170 | 194 | 118 | 730 | TRUE | 12.22 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 133 | 483 | TMB overall | -1.40 | -2.18 | -0.66 | 1441.65 | 1.00 | 403 | 103 | 453 | 30 | TRUE | 3.33 |
| colorectal cancer | RAS_12 | ATRX | Any mutation | 282 | 19 | TMB quintile 4 | -0.10 | -1.05 | 0.73 | 1271.31 | 1.00 | 497 | 275 | 12 | 7 | TRUE | 0.08 |
| colorectal cancer | RAS_12 | ATRX | Any mutation | 233 | 35 | TMB quintile 5 | -0.18 | -0.91 | 0.50 | 1564.09 | 1.00 | 372 | 221 | 23 | 12 | TRUE | 0.22 |
| colorectal cancer | RAS_12 | ATRX | Any mutation | 20 | 59 | TMB quintile 6 | -0.92 | -2.06 | 0.08 | 1486.05 | 1.00 | 85 | 16 | 55 | 4 | TRUE | 1.08 |
| non-small cell lung cancer | RAS_12 | ATRX | Any mutation | 231 | 32 | TMB quintile 4 | -0.12 | -0.85 | 0.50 | 1593.47 | 1.00 | 509 | 222 | 23 | 9 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12 | ATRX | Any mutation | 403 | 160 | TMB quintile 5 | 0.24 | -0.10 | 0.58 | 1466.34 | 1.00 | 745 | 344 | 101 | 59 | TRUE | 0.76 |
| uterine cancer | RAS_12 | ATRX | Any mutation | 13 | 11 | TMB quintile 2 | -2.48 | -6.36 | 0.27 | 1135.56 | 1.00 | 121 | 13 | 11 | 0 | TRUE | 0.85 |
| uterine cancer | RAS_12 | ATRX | Any mutation | 24 | 14 | TMB quintile 3 | -2.62 | -6.30 | -0.06 | 1557.62 | 1.00 | 203 | 24 | 14 | 0 | TRUE | 0.97 |
| uterine cancer | RAS_12 | ATRX | Any mutation | 52 | 19 | TMB quintile 5 | -0.68 | -2.29 | 0.57 | 1448.43 | 1.00 | 196 | 49 | 16 | 3 | TRUE | 0.46 |
| colorectal cancer | RAS_12 | ATRX | Any mutation | 535 | 113 | TMB overall | -0.45 | -2.09 | 1.26 | 1519.21 | 1.00 | 954 | 512 | 90 | 23 | TRUE | 0.22 |
| non-small cell lung cancer | RAS_12 | ATRX | Any mutation | 634 | 192 | TMB overall | 0.05 | -1.43 | 1.35 | 1511.64 | 1.00 | 1254 | 566 | 124 | 68 | TRUE | 0.03 |
| uterine cancer | RAS_12 | ATRX | Any mutation | 91 | 156 | TMB overall | -1.83 | -4.23 | 0.30 | 1328.31 | 1.00 | 547 | 87 | 152 | 4 | TRUE | 0.95 |
| colorectal cancer | RAS_12 | ATR | Any mutation | 233 | 35 | TMB quintile 5 | -1.14 | -2.10 | -0.33 | 1496.19 | 1.00 | 365 | 227 | 29 | 6 | FALSE | 1.99 |
| colorectal cancer | RAS_12 | ATR | Any mutation | 23 | 65 | TMB quintile 6 | -0.48 | -1.42 | 0.45 | 1459.35 | 1.00 | 90 | 16 | 58 | 7 | FALSE | 0.49 |
| non-small cell lung cancer | RAS_12 | ATR | Any mutation | 130 | 12 | TMB quintile 3 | -0.47 | -1.78 | 0.57 | 1565.41 | 1.00 | 486 | 128 | 10 | 2 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12 | ATR | Any mutation | 231 | 15 | TMB quintile 4 | -0.57 | -1.60 | 0.35 | 1500.80 | 1.00 | 521 | 228 | 12 | 3 | FALSE | 0.60 |
| non-small cell lung cancer | RAS_12 | ATR | Any mutation | 397 | 93 | TMB quintile 5 | -0.22 | -0.68 | 0.23 | 1466.13 | 1.00 | 761 | 371 | 67 | 26 | FALSE | 0.46 |
| colorectal cancer | RAS_12 | ATR | Any mutation | 256 | 100 | TMB overall | -0.78 | -2.92 | 1.48 | 1515.35 | 1.00 | 455 | 243 | 87 | 13 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12 | ATR | Any mutation | 758 | 120 | TMB overall | -0.41 | -1.49 | 0.51 | 1735.55 | 1.00 | 1768 | 727 | 89 | 31 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12 | PDGFRA | Any mutation | 231 | 16 | TMB quintile 4 | -0.15 | -1.15 | 0.84 | 1533.24 | 1.00 | 520 | 226 | 11 | 5 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12 | PDGFRA | Any mutation | 398 | 115 | TMB quintile 5 | -0.23 | -0.64 | 0.16 | 1455.75 | 1.00 | 749 | 366 | 83 | 32 | TRUE | 0.57 |
| non-small cell lung cancer | RAS_12 | PDGFRA | Any mutation | 629 | 131 | TMB overall | -0.20 | -1.95 | 1.57 | 1258.45 | 1.00 | 1269 | 592 | 94 | 37 | TRUE | 0.09 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 147 | 22 | TMB quintile 3 | -0.64 | -1.67 | 0.22 | 1496.75 | 1.00 | 323 | 143 | 18 | 4 | TRUE | 0.77 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 285 | 85 | TMB quintile 4 | -0.10 | -0.57 | 0.36 | 1436.16 | 1.00 | 461 | 256 | 56 | 29 | TRUE | 0.17 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 249 | 160 | TMB quintile 5 | 0.31 | -0.03 | 0.66 | 1429.45 | 1.00 | 312 | 178 | 89 | 71 | TRUE | 1.12 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 20 | 65 | TMB quintile 6 | -0.43 | -1.37 | 0.44 | 1392.66 | 1.00 | 71 | 13 | 58 | 7 | TRUE | 0.45 |
| uterine cancer | RAS_12 | FBXW7 | Any mutation | 24 | 30 | TMB quintile 3 | -0.84 | -2.55 | 0.44 | 1398.05 | 1.00 | 189 | 23 | 29 | 1 | TRUE | 0.56 |
| uterine cancer | RAS_12 | FBXW7 | Any mutation | 40 | 29 | TMB quintile 4 | -0.08 | -1.05 | 0.86 | 1707.89 | 1.00 | 165 | 35 | 24 | 5 | TRUE | 0.06 |
| uterine cancer | RAS_12 | FBXW7 | Any mutation | 52 | 30 | TMB quintile 5 | 0.66 | -0.14 | 1.41 | 1615.39 | 1.00 | 190 | 42 | 20 | 10 | TRUE | 1.00 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 701 | 332 | TMB overall | -0.24 | -1.25 | 0.77 | 1442.03 | 1.00 | 1167 | 590 | 221 | 111 | TRUE | 0.19 |
| uterine cancer | RAS_12 | FBXW7 | Any mutation | 120 | 136 | TMB overall | 0.13 | -1.27 | 1.51 | 1344.13 | 1.00 | 573 | 100 | 116 | 20 | TRUE | 0.07 |
| uterine cancer | RAS_12 | NSD1 | Any mutation | 55 | 46 | TMB quintile 5 | 0.10 | -0.67 | 0.87 | 1408.26 | 1.00 | 182 | 45 | 36 | 10 | FALSE | 0.10 |
| uterine cancer | RAS_12 | NSD1 | Any mutation | 59 | 115 | TMB overall | 0.68 | -2.46 | 4.37 | 1632.64 | 1.00 | 206 | 45 | 101 | 14 | FALSE | 0.16 |
| colorectal cancer | RAS_12 | FLT4 | Any mutation | 282 | 20 | TMB quintile 4 | -0.15 | -1.03 | 0.70 | 1492.50 | 1.00 | 496 | 275 | 13 | 7 | TRUE | 0.13 |
| colorectal cancer | RAS_12 | FLT4 | Any mutation | 234 | 40 | TMB quintile 5 | -0.49 | -1.25 | 0.20 | 1497.15 | 1.00 | 367 | 223 | 29 | 11 | TRUE | 0.75 |
| colorectal cancer | RAS_12 | FLT4 | Any mutation | 23 | 72 | TMB quintile 6 | 0.18 | -0.74 | 1.04 | 1421.03 | 1.00 | 72 | 11 | 60 | 12 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12 | FLT4 | Any mutation | 231 | 14 | TMB quintile 4 | 0.53 | -0.48 | 1.61 | 1510.38 | 1.00 | 524 | 224 | 7 | 7 | TRUE | 0.50 |
| non-small cell lung cancer | RAS_12 | FLT4 | Any mutation | 398 | 74 | TMB quintile 5 | -0.23 | -0.77 | 0.27 | 1431.24 | 1.00 | 775 | 378 | 54 | 20 | TRUE | 0.41 |
| colorectal cancer | RAS_12 | FLT4 | Any mutation | 539 | 132 | TMB overall | -0.16 | -1.91 | 1.45 | 1345.91 | 1.00 | 935 | 509 | 102 | 30 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12 | FLT4 | Any mutation | 629 | 88 | TMB overall | 0.14 | -1.40 | 2.11 | 1624.96 | 1.00 | 1299 | 602 | 61 | 27 | TRUE | 0.06 |
| colorectal cancer | RAS_12 | PTPRD | Any mutation | 233 | 29 | TMB quintile 5 | -0.71 | -1.58 | 0.09 | 1350.90 | 1.00 | 373 | 226 | 22 | 7 | FALSE | 1.01 |
| colorectal cancer | RAS_12 | PTPRD | Any mutation | 20 | 61 | TMB quintile 6 | -0.49 | -1.55 | 0.46 | 1466.55 | 1.00 | 85 | 14 | 55 | 6 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 130 | 16 | TMB quintile 3 | -0.31 | -1.65 | 0.90 | 1489.09 | 1.00 | 484 | 127 | 13 | 3 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 232 | 53 | TMB quintile 4 | 0.39 | -0.20 | 0.97 | 1569.60 | 1.00 | 499 | 211 | 32 | 21 | FALSE | 0.73 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 409 | 298 | TMB quintile 5 | -0.16 | -0.46 | 0.12 | 1620.47 | 1.00 | 655 | 321 | 210 | 88 | FALSE | 0.55 |
| colorectal cancer | RAS_12 | PTPRD | Any mutation | 253 | 90 | TMB overall | -0.60 | -2.80 | 1.75 | 1344.67 | 1.00 | 458 | 240 | 77 | 13 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 771 | 384 | TMB overall | -0.32 | -2.28 | 1.64 | 1332.38 | 1.00 | 1645 | 659 | 272 | 112 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12 | PIK3C2G | Any mutation | 231 | 12 | TMB quintile 4 | -0.49 | -1.78 | 0.66 | 1270.23 | 1.00 | 519 | 228 | 9 | 3 | FALSE | 0.37 |
| non-small cell lung cancer | RAS_12 | PIK3C2G | Any mutation | 396 | 103 | TMB quintile 5 | -0.49 | -0.96 | -0.02 | 1437.20 | 1.00 | 750 | 372 | 79 | 24 | FALSE | 1.37 |
| non-small cell lung cancer | RAS_12 | PIK3C2G | Any mutation | 627 | 115 | TMB overall | -0.49 | -2.41 | 1.38 | 1379.55 | 1.00 | 1269 | 600 | 88 | 27 | FALSE | 0.22 |
| colorectal cancer | RAS_12 | CREBBP | Any mutation | 282 | 17 | TMB quintile 4 | -1.02 | -2.30 | 0.04 | 1515.42 | 1.00 | 495 | 279 | 14 | 3 | TRUE | 1.03 |
| colorectal cancer | RAS_12 | CREBBP | Any mutation | 236 | 49 | TMB quintile 5 | -0.26 | -0.85 | 0.33 | 1458.09 | 1.00 | 364 | 220 | 33 | 16 | TRUE | 0.39 |
| colorectal cancer | RAS_12 | CREBBP | Any mutation | 28 | 116 | TMB quintile 6 | -0.04 | -0.81 | 0.79 | 1402.39 | 1.00 | 54 | 10 | 98 | 18 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12 | CREBBP | Any mutation | 130 | 11 | TMB quintile 3 | 0.03 | -1.21 | 1.10 | 1528.10 | 1.00 | 488 | 127 | 8 | 3 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12 | CREBBP | Any mutation | 231 | 12 | TMB quintile 4 | -0.07 | -1.15 | 0.95 | 1347.92 | 1.00 | 523 | 227 | 8 | 4 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12 | CREBBP | Any mutation | 396 | 106 | TMB quintile 5 | -0.31 | -0.76 | 0.12 | 1547.36 | 1.00 | 757 | 369 | 79 | 27 | TRUE | 0.73 |
| colorectal cancer | RAS_12 | CREBBP | Any mutation | 546 | 182 | TMB overall | -0.44 | -2.40 | 1.37 | 1375.61 | 1.00 | 913 | 509 | 145 | 37 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12 | CREBBP | Any mutation | 757 | 129 | TMB overall | -0.11 | -1.23 | 1.17 | 1583.09 | 1.00 | 1768 | 723 | 95 | 34 | TRUE | 0.06 |
| colorectal cancer | RAS_12 | AXIN2 | Any mutation | 282 | 20 | TMB quintile 4 | 0.39 | -0.49 | 1.26 | 1474.30 | 1.00 | 499 | 272 | 10 | 10 | TRUE | 0.42 |
| colorectal cancer | RAS_12 | AXIN2 | Any mutation | 233 | 27 | TMB quintile 5 | -0.78 | -1.74 | 0.09 | 1299.78 | 1.00 | 373 | 227 | 21 | 6 | TRUE | 1.00 |
| colorectal cancer | RAS_12 | AXIN2 | Any mutation | 20 | 63 | TMB quintile 6 | -1.06 | -2.21 | -0.09 | 1143.37 | 1.00 | 79 | 16 | 59 | 4 | TRUE | 1.25 |
| colorectal cancer | RAS_12 | AXIN2 | Any mutation | 535 | 110 | TMB overall | -0.49 | -2.27 | 1.21 | 1417.64 | 1.00 | 951 | 515 | 90 | 20 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12 | DOT1L | Any mutation | 231 | 24 | TMB quintile 4 | -0.30 | -1.12 | 0.42 | 1329.60 | 1.00 | 515 | 225 | 18 | 6 | FALSE | 0.36 |
| non-small cell lung cancer | RAS_12 | DOT1L | Any mutation | 397 | 75 | TMB quintile 5 | -0.17 | -0.64 | 0.33 | 1387.05 | 1.00 | 774 | 375 | 53 | 22 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12 | DOT1L | Any mutation | 628 | 99 | TMB overall | -0.22 | -1.10 | 0.72 | 1387.91 | 1.00 | 1289 | 600 | 71 | 28 | FALSE | 0.18 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 143 | 17 | TMB quintile 3 | -0.46 | -1.54 | 0.57 | 1428.65 | 1.00 | 326 | 139 | 13 | 4 | FALSE | 0.39 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 275 | 34 | TMB quintile 4 | 0.04 | -0.69 | 0.75 | 1435.56 | 1.00 | 477 | 262 | 21 | 13 | FALSE | 0.04 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 221 | 74 | TMB quintile 5 | -0.24 | -0.76 | 0.25 | 1516.30 | 1.00 | 329 | 197 | 50 | 24 | FALSE | 0.45 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 25 | 128 | TMB quintile 6 | -0.41 | -1.29 | 0.44 | 1265.99 | 1.00 | 40 | 9 | 112 | 16 | FALSE | 0.46 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 664 | 253 | TMB overall | -0.29 | -1.75 | 1.18 | 1285.54 | 1.00 | 1172 | 607 | 196 | 57 | FALSE | 0.16 |
| colorectal cancer | RAS_12 | SMARCA4 | Any mutation | 282 | 16 | TMB quintile 4 | -0.61 | -1.78 | 0.44 | 1683.54 | 1.00 | 497 | 278 | 12 | 4 | FALSE | 0.55 |
| colorectal cancer | RAS_12 | SMARCA4 | Any mutation | 234 | 47 | TMB quintile 5 | -0.28 | -0.91 | 0.37 | 1295.70 | 1.00 | 364 | 219 | 32 | 15 | FALSE | 0.41 |
| colorectal cancer | RAS_12 | SMARCA4 | Any mutation | 24 | 100 | TMB quintile 6 | 0.02 | -0.81 | 0.92 | 1483.95 | 1.00 | 65 | 10 | 86 | 14 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 131 | 35 | TMB quintile 3 | 0.82 | 0.14 | 1.51 | 1436.40 | 1.00 | 479 | 116 | 20 | 15 | FALSE | 1.71 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 232 | 67 | TMB quintile 4 | 0.15 | -0.40 | 0.63 | 1488.12 | 1.00 | 489 | 210 | 45 | 22 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 400 | 194 | TMB quintile 5 | -0.09 | -0.45 | 0.23 | 1401.36 | 1.00 | 698 | 342 | 136 | 58 | FALSE | 0.22 |
| uterine cancer | RAS_12 | SMARCA4 | Any mutation | 54 | 39 | TMB quintile 5 | -0.23 | -1.14 | 0.60 | 1443.73 | 1.00 | 186 | 47 | 32 | 7 | FALSE | 0.22 |
| colorectal cancer | RAS_12 | SMARCA4 | Any mutation | 540 | 163 | TMB overall | -0.29 | -2.18 | 1.74 | 1451.98 | 1.00 | 926 | 507 | 130 | 33 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 763 | 296 | TMB overall | 0.27 | -0.63 | 1.17 | 1433.58 | 1.00 | 1666 | 668 | 201 | 95 | FALSE | 0.26 |
| uterine cancer | RAS_12 | SMARCA4 | Any mutation | 56 | 91 | TMB overall | -0.44 | -3.24 | 2.45 | 1543.55 | 1.00 | 216 | 48 | 83 | 8 | FALSE | 0.12 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 147 | 18 | TMB quintile 3 | 0.36 | -0.54 | 1.19 | 1373.22 | 1.00 | 330 | 139 | 10 | 8 | FALSE | 0.37 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 282 | 39 | TMB quintile 4 | -1.26 | -2.17 | -0.48 | 1559.68 | 1.00 | 475 | 277 | 34 | 5 | FALSE | 2.41 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 235 | 59 | TMB quintile 5 | -0.59 | -1.21 | -0.03 | 1686.03 | 1.00 | 350 | 220 | 44 | 15 | FALSE | 1.28 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 22 | 66 | TMB quintile 6 | 0.21 | -0.62 | 1.00 | 1430.87 | 1.00 | 82 | 11 | 55 | 11 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 130 | 17 | TMB quintile 3 | -0.02 | -1.19 | 0.98 | 1383.80 | 1.00 | 483 | 126 | 13 | 4 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 231 | 38 | TMB quintile 4 | -0.13 | -0.85 | 0.60 | 1596.06 | 1.00 | 505 | 220 | 27 | 11 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 405 | 272 | TMB quintile 5 | -0.40 | -0.72 | -0.08 | 1518.09 | 1.00 | 667 | 336 | 203 | 69 | FALSE | 1.85 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 686 | 182 | TMB overall | -0.34 | -1.56 | 0.86 | 1454.35 | 1.00 | 1237 | 647 | 143 | 39 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 766 | 348 | TMB overall | -0.51 | -2.80 | 1.47 | 1642.53 | 1.00 | 1660 | 682 | 264 | 84 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12 | HGF | Any mutation | 231 | 27 | TMB quintile 4 | -0.31 | -1.26 | 0.52 | 1350.17 | 1.00 | 512 | 224 | 20 | 7 | FALSE | 0.31 |
| non-small cell lung cancer | RAS_12 | HGF | Any mutation | 398 | 138 | TMB quintile 5 | -0.24 | -0.64 | 0.15 | 1534.26 | 1.00 | 733 | 359 | 99 | 39 | FALSE | 0.61 |
| non-small cell lung cancer | RAS_12 | HGF | Any mutation | 629 | 180 | TMB overall | -0.71 | -3.43 | 1.84 | 1457.46 | 1.00 | 1252 | 583 | 134 | 46 | FALSE | 0.23 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 149 | 51 | TMB quintile 3 | 0.75 | 0.17 | 1.32 | 1501.96 | 1.00 | 315 | 124 | 26 | 25 | TRUE | 1.99 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 285 | 146 | TMB quintile 4 | 0.53 | 0.19 | 0.88 | 1218.96 | 1.00 | 434 | 217 | 78 | 68 | TRUE | 2.48 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 240 | 209 | TMB quintile 5 | 0.07 | -0.27 | 0.40 | 1463.41 | 1.00 | 278 | 161 | 130 | 79 | TRUE | 0.17 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 23 | 95 | TMB quintile 6 | -0.31 | -1.09 | 0.45 | 1691.74 | 1.00 | 60 | 12 | 84 | 11 | TRUE | 0.35 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 75 | 18 | TMB quintile 2 | -0.69 | -1.62 | 0.14 | 1575.56 | 1.00 | 349 | 74 | 17 | 1 | TRUE | 0.89 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 130 | 34 | TMB quintile 3 | -0.49 | -1.23 | 0.15 | 1236.16 | 1.00 | 467 | 125 | 29 | 5 | TRUE | 0.77 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 232 | 56 | TMB quintile 4 | -0.55 | -1.13 | 0.00 | 1620.40 | 1.00 | 486 | 221 | 45 | 11 | TRUE | 1.26 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 397 | 123 | TMB quintile 5 | -0.16 | -0.57 | 0.22 | 1523.15 | 1.00 | 749 | 360 | 86 | 37 | TRUE | 0.37 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 13 | 33 | TMB quintile 2 | -0.29 | -1.47 | 0.80 | 1319.51 | 1.00 | 102 | 11 | 31 | 2 | TRUE | 0.21 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 24 | 103 | TMB quintile 3 | 0.05 | -0.76 | 0.84 | 1518.12 | 1.00 | 134 | 14 | 93 | 10 | TRUE | 0.04 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 45 | 121 | TMB quintile 4 | 0.70 | 0.08 | 1.33 | 1500.56 | 1.00 | 109 | 16 | 92 | 29 | TRUE | 1.53 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 66 | 196 | TMB quintile 5 | 0.48 | -0.10 | 1.02 | 1488.46 | 1.00 | 101 | 20 | 150 | 46 | TRUE | 1.05 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 697 | 501 | TMB overall | 0.26 | -0.71 | 1.21 | 1436.49 | 1.00 | 1087 | 514 | 318 | 183 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 834 | 231 | TMB overall | -0.47 | -1.11 | 0.10 | 1408.89 | 1.00 | 2051 | 780 | 177 | 54 | TRUE | 0.90 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 152 | 548 | TMB overall | 0.17 | -0.73 | 1.06 | 1380.41 | 1.00 | 461 | 61 | 457 | 91 | TRUE | 0.15 |
| colorectal cancer | RAS_12 | ALK | Any mutation | 282 | 20 | TMB quintile 4 | -0.69 | -1.69 | 0.23 | 1408.50 | 1.00 | 494 | 277 | 15 | 5 | TRUE | 0.77 |
| colorectal cancer | RAS_12 | ALK | Any mutation | 233 | 42 | TMB quintile 5 | -0.87 | -1.64 | -0.20 | 1259.35 | 1.00 | 362 | 224 | 33 | 9 | TRUE | 1.69 |
| colorectal cancer | RAS_12 | ALK | Any mutation | 20 | 45 | TMB quintile 6 | -0.98 | -2.21 | 0.07 | 1315.47 | 1.00 | 93 | 17 | 42 | 3 | TRUE | 1.03 |
| non-small cell lung cancer | RAS_12 | ALK | Any mutation | 130 | 13 | TMB quintile 3 | -0.55 | -2.12 | 0.81 | 1272.61 | 1.00 | 486 | 128 | 11 | 2 | TRUE | 0.33 |
| non-small cell lung cancer | RAS_12 | ALK | Any mutation | 231 | 22 | TMB quintile 4 | 0.17 | -0.70 | 1.03 | 1526.47 | 1.00 | 518 | 223 | 14 | 8 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12 | ALK | Any mutation | 396 | 118 | TMB quintile 5 | -0.06 | -0.48 | 0.34 | 1450.07 | 1.00 | 752 | 359 | 81 | 37 | TRUE | 0.10 |
| colorectal cancer | RAS_12 | ALK | Any mutation | 535 | 107 | TMB overall | -0.82 | -2.27 | 0.60 | 1426.13 | 1.00 | 949 | 518 | 90 | 17 | TRUE | 0.60 |
| non-small cell lung cancer | RAS_12 | ALK | Any mutation | 757 | 164 | TMB overall | -0.34 | -2.33 | 1.59 | 1535.41 | 1.00 | 1765 | 710 | 117 | 47 | TRUE | 0.14 |
| colorectal cancer | RAS_12 | RNF43 | Any mutation | 147 | 12 | TMB quintile 3 | -0.98 | -2.44 | 0.29 | 1273.21 | 1.00 | 330 | 145 | 10 | 2 | TRUE | 0.76 |
| colorectal cancer | RAS_12 | RNF43 | Any mutation | 282 | 30 | TMB quintile 4 | -0.53 | -1.38 | 0.27 | 1136.47 | 1.00 | 488 | 274 | 22 | 8 | TRUE | 0.70 |
| colorectal cancer | RAS_12 | RNF43 | Any mutation | 238 | 76 | TMB quintile 5 | -0.91 | -1.50 | -0.38 | 1553.53 | 1.00 | 342 | 222 | 60 | 16 | TRUE | 2.75 |
| colorectal cancer | RAS_12 | RNF43 | Any mutation | 25 | 146 | TMB quintile 6 | -0.58 | -1.40 | 0.29 | 1583.08 | 1.00 | 40 | 9 | 130 | 16 | TRUE | 0.77 |
| colorectal cancer | RAS_12 | RNF43 | Any mutation | 692 | 264 | TMB overall | -0.73 | -2.26 | 0.87 | 1427.03 | 1.00 | 1200 | 650 | 222 | 42 | TRUE | 0.45 |
| colorectal cancer | RAS_12 | PTEN | Any mutation | 282 | 29 | TMB quintile 4 | -0.05 | -0.82 | 0.69 | 1434.13 | 1.00 | 492 | 271 | 18 | 11 | TRUE | 0.05 |
| colorectal cancer | RAS_12 | PTEN | Any mutation | 233 | 69 | TMB quintile 5 | -0.88 | -1.51 | -0.32 | 1518.80 | 1.00 | 354 | 219 | 55 | 14 | TRUE | 2.50 |
| colorectal cancer | RAS_12 | PTEN | Any mutation | 24 | 80 | TMB quintile 6 | -0.30 | -1.12 | 0.50 | 1362.78 | 1.00 | 76 | 14 | 70 | 10 | TRUE | 0.32 |
| non-small cell lung cancer | RAS_12 | PTEN | Any mutation | 130 | 17 | TMB quintile 3 | -1.46 | -2.78 | -0.36 | 1368.57 | 1.00 | 480 | 129 | 16 | 1 | TRUE | 1.79 |
| non-small cell lung cancer | RAS_12 | PTEN | Any mutation | 231 | 27 | TMB quintile 4 | -1.73 | -3.18 | -0.75 | 1413.16 | 1.00 | 506 | 230 | 26 | 1 | TRUE | 2.31 |
| non-small cell lung cancer | RAS_12 | PTEN | Any mutation | 396 | 75 | TMB quintile 5 | -1.02 | -1.61 | -0.42 | 1470.63 | 1.00 | 771 | 383 | 62 | 13 | TRUE | 2.94 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 13 | 16 | TMB quintile 2 | -0.29 | -2.07 | 1.22 | 1365.96 | 1.00 | 118 | 12 | 15 | 1 | TRUE | 0.14 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 26 | 63 | TMB quintile 3 | 0.48 | -0.38 | 1.30 | 1402.04 | 1.00 | 178 | 17 | 54 | 9 | TRUE | 0.57 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 49 | 120 | TMB quintile 4 | 0.50 | -0.10 | 1.07 | 1415.63 | 1.00 | 126 | 22 | 93 | 27 | TRUE | 1.02 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 82 | 315 | TMB quintile 5 | 0.51 | -0.14 | 1.19 | 1602.83 | 1.00 | 58 | 11 | 244 | 71 | TRUE | 0.87 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 6 | 103 | TMB quintile 6 | 0.39 | -1.18 | 2.35 | 1345.39 | 1.00 | 13 | 0 | 97 | 6 | TRUE | 0.18 |
| colorectal cancer | RAS_12 | PTEN | Any mutation | 539 | 178 | TMB overall | -0.43 | -1.99 | 1.18 | 1451.88 | 1.00 | 922 | 504 | 143 | 35 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12 | PTEN | Any mutation | 757 | 119 | TMB overall | -1.39 | -2.58 | -0.44 | 1453.38 | 1.00 | 1757 | 742 | 104 | 15 | TRUE | 2.03 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 176 | 617 | TMB overall | 0.30 | -1.02 | 1.67 | 1552.00 | 1.00 | 493 | 62 | 503 | 114 | TRUE | 0.19 |
| colorectal cancer | RAS_12 | BCOR | Any mutation | 282 | 11 | TMB quintile 4 | 0.49 | -0.64 | 1.66 | 1484.50 | 1.00 | 504 | 276 | 5 | 6 | FALSE | 0.41 |
| colorectal cancer | RAS_12 | BCOR | Any mutation | 233 | 39 | TMB quintile 5 | 0.04 | -0.65 | 0.70 | 1401.70 | 1.00 | 372 | 218 | 24 | 15 | FALSE | 0.04 |
| colorectal cancer | RAS_12 | BCOR | Any mutation | 23 | 57 | TMB quintile 6 | -0.77 | -1.79 | 0.15 | 1517.27 | 1.00 | 81 | 18 | 52 | 5 | FALSE | 0.90 |
| non-small cell lung cancer | RAS_12 | BCOR | Any mutation | 231 | 22 | TMB quintile 4 | 0.02 | -0.77 | 0.71 | 1406.88 | 1.00 | 517 | 224 | 15 | 7 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12 | BCOR | Any mutation | 401 | 92 | TMB quintile 5 | 0.27 | -0.16 | 0.70 | 1346.08 | 1.00 | 773 | 366 | 57 | 35 | FALSE | 0.65 |
| uterine cancer | RAS_12 | BCOR | Any mutation | 40 | 19 | TMB quintile 4 | 0.10 | -1.08 | 1.17 | 1560.75 | 1.00 | 174 | 36 | 15 | 4 | FALSE | 0.07 |
| uterine cancer | RAS_12 | BCOR | Any mutation | 54 | 69 | TMB quintile 5 | 0.33 | -0.32 | 0.96 | 1437.63 | 1.00 | 162 | 37 | 52 | 17 | FALSE | 0.51 |
| colorectal cancer | RAS_12 | BCOR | Any mutation | 538 | 107 | TMB overall | -0.08 | -2.00 | 2.03 | 1534.32 | 1.00 | 957 | 512 | 81 | 26 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12 | BCOR | Any mutation | 632 | 114 | TMB overall | 0.14 | -1.01 | 1.26 | 1530.74 | 1.00 | 1290 | 590 | 72 | 42 | FALSE | 0.10 |
| uterine cancer | RAS_12 | BCOR | Any mutation | 96 | 134 | TMB overall | 0.00 | -1.80 | 1.67 | 1727.63 | 1.00 | 371 | 74 | 112 | 22 | FALSE | 0.00 |
| colorectal cancer | RAS_12 | CTNNB1 | Any mutation | 147 | 38 | TMB quintile 3 | 0.60 | -0.06 | 1.25 | 1536.77 | 1.00 | 321 | 130 | 21 | 17 | TRUE | 1.14 |
| colorectal cancer | RAS_12 | CTNNB1 | Any mutation | 283 | 35 | TMB quintile 4 | 0.62 | 0.00 | 1.25 | 1583.99 | 1.00 | 493 | 264 | 16 | 19 | TRUE | 1.21 |
| colorectal cancer | RAS_12 | CTNNB1 | Any mutation | 235 | 48 | TMB quintile 5 | 0.12 | -0.44 | 0.66 | 1513.17 | 1.00 | 364 | 216 | 29 | 19 | TRUE | 0.18 |
| colorectal cancer | RAS_12 | CTNNB1 | Any mutation | 21 | 35 | TMB quintile 6 | -0.17 | -1.24 | 0.72 | 1515.51 | 1.00 | 91 | 17 | 31 | 4 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 75 | 12 | TMB quintile 2 | -0.86 | -1.89 | 0.04 | 1564.86 | 1.00 | 355 | 74 | 11 | 1 | TRUE | 1.08 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 130 | 22 | TMB quintile 3 | -1.12 | -2.33 | -0.25 | 1324.29 | 1.00 | 474 | 130 | 22 | 0 | TRUE | 1.44 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 233 | 33 | TMB quintile 4 | -0.58 | -1.24 | 0.07 | 1488.28 | 1.00 | 507 | 225 | 25 | 8 | TRUE | 1.03 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 396 | 47 | TMB quintile 5 | -0.70 | -1.36 | -0.10 | 1436.45 | 1.00 | 790 | 386 | 37 | 10 | TRUE | 1.55 |
| uterine cancer | RAS_12 | CTNNB1 | Any mutation | 24 | 28 | TMB quintile 3 | -2.22 | -4.26 | -0.85 | 1314.78 | 1.01 | 189 | 24 | 28 | 0 | TRUE | 1.91 |
| uterine cancer | RAS_12 | CTNNB1 | Any mutation | 40 | 33 | TMB quintile 4 | -1.48 | -2.78 | -0.29 | 1483.89 | 1.00 | 159 | 37 | 30 | 3 | TRUE | 1.72 |
| uterine cancer | RAS_12 | CTNNB1 | Any mutation | 52 | 61 | TMB quintile 5 | -2.12 | -3.42 | -1.08 | 1491.72 | 1.00 | 154 | 50 | 59 | 2 | TRUE | 3.34 |
| colorectal cancer | RAS_12 | CTNNB1 | Any mutation | 686 | 156 | TMB overall | 0.29 | -0.52 | 1.15 | 1646.67 | 1.00 | 1269 | 627 | 97 | 59 | TRUE | 0.31 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 834 | 114 | TMB overall | -0.81 | -1.57 | -0.11 | 1378.73 | 1.00 | 2126 | 815 | 95 | 19 | TRUE | 1.50 |
| uterine cancer | RAS_12 | CTNNB1 | Any mutation | 118 | 137 | TMB overall | -1.96 | -3.35 | -0.81 | 1462.75 | 1.00 | 548 | 113 | 132 | 5 | TRUE | 2.58 |
| cancer of unknown primary | RAS_12 | ARID1A | Any mutation | 35 | 15 | TMB quintile 4 | -0.04 | -1.21 | 0.99 | 1558.12 | 1.00 | 96 | 31 | 11 | 4 | TRUE | 0.02 |
| cancer of unknown primary | RAS_12 | ARID1A | Any mutation | 37 | 62 | TMB quintile 5 | -0.32 | -1.09 | 0.46 | 1355.88 | 1.00 | 113 | 28 | 53 | 9 | TRUE | 0.38 |
| cancer of unknown primary | RAS_12 | ARID1A | Any mutation | 7 | 16 | TMB quintile 6 | 0.41 | -0.84 | 1.85 | 1381.37 | 1.00 | 8 | 2 | 11 | 5 | TRUE | 0.26 |
| colorectal cancer | RAS_12 | ARID1A | Any mutation | 283 | 32 | TMB quintile 4 | 0.36 | -0.33 | 1.04 | 1681.44 | 1.00 | 492 | 268 | 17 | 15 | TRUE | 0.52 |
| colorectal cancer | RAS_12 | ARID1A | Any mutation | 238 | 116 | TMB quintile 5 | -0.81 | -1.30 | -0.35 | 1357.58 | 1.00 | 326 | 212 | 90 | 26 | TRUE | 3.05 |
| colorectal cancer | RAS_12 | ARID1A | Any mutation | 29 | 155 | TMB quintile 6 | -0.32 | -1.16 | 0.54 | 1503.14 | 1.00 | 44 | 9 | 135 | 20 | TRUE | 0.34 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 130 | 12 | TMB quintile 3 | -0.15 | -1.32 | 0.93 | 1446.40 | 1.00 | 487 | 127 | 9 | 3 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 231 | 56 | TMB quintile 4 | -0.48 | -1.12 | 0.08 | 1557.98 | 1.00 | 490 | 219 | 44 | 12 | TRUE | 0.91 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 405 | 187 | TMB quintile 5 | -0.28 | -0.63 | 0.06 | 1504.12 | 1.00 | 702 | 354 | 136 | 51 | TRUE | 0.96 |
| pancreatic cancer | RAS_12 | ARID1A | Any mutation | 252 | 13 | TMB quintile 2 | -0.95 | -1.85 | -0.09 | 1545.83 | 1.00 | 87 | 246 | 7 | 6 | TRUE | 1.46 |
| pancreatic cancer | RAS_12 | ARID1A | Any mutation | 420 | 44 | TMB quintile 3 | 0.04 | -0.59 | 0.77 | 1380.15 | 1.00 | 97 | 383 | 7 | 37 | TRUE | 0.05 |
| pancreatic cancer | RAS_12 | ARID1A | Any mutation | 219 | 45 | TMB quintile 4 | -0.16 | -0.81 | 0.45 | 1318.27 | 1.00 | 54 | 186 | 12 | 33 | TRUE | 0.21 |
| pancreatic cancer | RAS_12 | ARID1A | Any mutation | 35 | 17 | TMB quintile 5 | 0.00 | -0.87 | 0.90 | 1268.29 | 1.00 | 16 | 25 | 7 | 10 | TRUE | 0.00 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 24 | 28 | TMB quintile 3 | 0.41 | -0.77 | 1.46 | 1510.42 | 1.00 | 194 | 20 | 24 | 4 | TRUE | 0.33 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 44 | 77 | TMB quintile 4 | 1.24 | 0.60 | 1.92 | 1561.53 | 1.00 | 142 | 19 | 52 | 25 | TRUE | 3.61 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 74 | 307 | TMB quintile 5 | 0.70 | 0.01 | 1.47 | 1357.29 | 1.00 | 62 | 9 | 242 | 65 | TRUE | 1.18 |
| cancer of unknown primary | RAS_12 | ARID1A | Any mutation | 79 | 93 | TMB overall | 0.01 | -1.40 | 1.33 | 1621.44 | 1.00 | 217 | 61 | 75 | 18 | TRUE | 0.01 |
| colorectal cancer | RAS_12 | ARID1A | Any mutation | 550 | 303 | TMB overall | -0.24 | -2.13 | 1.68 | 1575.86 | 1.00 | 862 | 489 | 242 | 61 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 766 | 255 | TMB overall | -0.30 | -1.45 | 0.88 | 1465.39 | 1.00 | 1679 | 700 | 189 | 66 | TRUE | 0.22 |
| pancreatic cancer | RAS_12 | ARID1A | Any mutation | 926 | 119 | TMB overall | -0.28 | -1.13 | 0.56 | 1396.39 | 1.00 | 254 | 840 | 33 | 86 | TRUE | 0.29 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 145 | 520 | TMB overall | 0.60 | -1.12 | 2.35 | 1427.25 | 1.00 | 407 | 48 | 423 | 97 | TRUE | 0.31 |
| colorectal cancer | RAS_12 | PIK3R1 | Any mutation | 282 | 22 | TMB quintile 4 | -0.04 | -0.87 | 0.76 | 1596.99 | 1.00 | 496 | 274 | 14 | 8 | TRUE | 0.03 |
| colorectal cancer | RAS_12 | PIK3R1 | Any mutation | 234 | 29 | TMB quintile 5 | 0.38 | -0.37 | 1.13 | 1351.96 | 1.00 | 380 | 220 | 15 | 14 | TRUE | 0.50 |
| colorectal cancer | RAS_12 | PIK3R1 | Any mutation | 22 | 56 | TMB quintile 6 | -0.20 | -1.15 | 0.64 | 1533.39 | 1.00 | 85 | 15 | 49 | 7 | TRUE | 0.17 |
| uterine cancer | RAS_12 | PIK3R1 | Any mutation | 24 | 40 | TMB quintile 3 | -0.86 | -2.07 | 0.20 | 1482.31 | 1.00 | 183 | 22 | 38 | 2 | TRUE | 0.86 |
| uterine cancer | RAS_12 | PIK3R1 | Any mutation | 42 | 68 | TMB quintile 4 | -0.52 | -1.30 | 0.18 | 1217.74 | 1.00 | 140 | 33 | 59 | 9 | TRUE | 0.77 |
| uterine cancer | RAS_12 | PIK3R1 | Any mutation | 58 | 117 | TMB quintile 5 | -0.43 | -1.05 | 0.14 | 1548.88 | 1.00 | 135 | 39 | 98 | 19 | TRUE | 0.83 |
| colorectal cancer | RAS_12 | PIK3R1 | Any mutation | 538 | 107 | TMB overall | 0.01 | -1.57 | 1.48 | 1477.86 | 1.00 | 961 | 509 | 78 | 29 | TRUE | 0.01 |
| uterine cancer | RAS_12 | PIK3R1 | Any mutation | 126 | 262 | TMB overall | -0.76 | -1.84 | 0.22 | 1411.60 | 1.00 | 491 | 96 | 232 | 30 | TRUE | 0.81 |
| colorectal cancer | RAS_12 | FAT1 | Any mutation | 282 | 17 | TMB quintile 4 | -0.20 | -1.26 | 0.79 | 1479.70 | 1.00 | 499 | 276 | 11 | 6 | FALSE | 0.16 |
| colorectal cancer | RAS_12 | FAT1 | Any mutation | 235 | 64 | TMB quintile 5 | -0.83 | -1.47 | -0.25 | 1504.50 | 1.00 | 350 | 221 | 50 | 14 | FALSE | 2.17 |
| colorectal cancer | RAS_12 | FAT1 | Any mutation | 25 | 145 | TMB quintile 6 | -0.86 | -1.68 | -0.07 | 1104.18 | 1.00 | 51 | 12 | 132 | 13 | FALSE | 1.40 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 130 | 16 | TMB quintile 3 | 0.05 | -1.12 | 1.09 | 1630.74 | 1.00 | 484 | 126 | 12 | 4 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 231 | 43 | TMB quintile 4 | -0.29 | -1.00 | 0.39 | 1422.34 | 1.00 | 504 | 220 | 32 | 11 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 401 | 227 | TMB quintile 5 | -0.26 | -0.58 | 0.05 | 1350.79 | 1.00 | 681 | 338 | 164 | 63 | FALSE | 1.00 |
| uterine cancer | RAS_12 | FAT1 | Any mutation | 53 | 49 | TMB quintile 5 | 0.06 | -0.77 | 0.83 | 1479.48 | 1.00 | 182 | 43 | 39 | 10 | FALSE | 0.06 |
| colorectal cancer | RAS_12 | FAT1 | Any mutation | 542 | 226 | TMB overall | -0.65 | -2.93 | 1.46 | 1433.84 | 1.00 | 900 | 509 | 193 | 33 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 762 | 300 | TMB overall | -0.42 | -2.17 | 1.36 | 1099.14 | 1.00 | 1676 | 684 | 222 | 78 | FALSE | 0.19 |
| uterine cancer | RAS_12 | FAT1 | Any mutation | 57 | 164 | TMB overall | 0.40 | -2.96 | 4.35 | 1489.82 | 1.00 | 199 | 43 | 150 | 14 | FALSE | 0.08 |
| colorectal cancer | RAS_12 | CIC | Any mutation | 282 | 17 | TMB quintile 4 | 0.09 | -0.83 | 1.02 | 1467.52 | 1.00 | 500 | 275 | 10 | 7 | TRUE | 0.07 |
| colorectal cancer | RAS_12 | CIC | Any mutation | 235 | 40 | TMB quintile 5 | -0.24 | -0.87 | 0.39 | 1242.74 | 1.00 | 369 | 222 | 27 | 13 | TRUE | 0.33 |
| colorectal cancer | RAS_12 | CIC | Any mutation | 22 | 79 | TMB quintile 6 | -0.14 | -0.98 | 0.68 | 1599.25 | 1.00 | 74 | 12 | 69 | 10 | TRUE | 0.13 |
| colorectal cancer | RAS_12 | CIC | Any mutation | 539 | 136 | TMB overall | -0.09 | -1.87 | 1.63 | 1365.68 | 1.00 | 943 | 509 | 106 | 30 | TRUE | 0.04 |
| colorectal cancer | RAS_12 | NCOR1 | Any mutation | 282 | 16 | TMB quintile 4 | -0.63 | -1.77 | 0.37 | 1517.07 | 1.00 | 497 | 278 | 12 | 4 | FALSE | 0.59 |
| colorectal cancer | RAS_12 | NCOR1 | Any mutation | 234 | 32 | TMB quintile 5 | -0.78 | -1.65 | -0.03 | 1401.38 | 1.00 | 373 | 227 | 25 | 7 | FALSE | 1.21 |
| colorectal cancer | RAS_12 | NCOR1 | Any mutation | 23 | 81 | TMB quintile 6 | 0.23 | -0.63 | 1.08 | 1559.50 | 1.00 | 71 | 10 | 68 | 13 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12 | NCOR1 | Any mutation | 231 | 21 | TMB quintile 4 | -0.58 | -1.54 | 0.22 | 1307.68 | 1.00 | 515 | 227 | 17 | 4 | FALSE | 0.72 |
| non-small cell lung cancer | RAS_12 | NCOR1 | Any mutation | 399 | 71 | TMB quintile 5 | -0.32 | -0.84 | 0.18 | 1457.82 | 1.00 | 781 | 380 | 52 | 19 | FALSE | 0.63 |
| colorectal cancer | RAS_12 | NCOR1 | Any mutation | 539 | 129 | TMB overall | -0.37 | -2.21 | 1.56 | 1590.00 | 1.00 | 941 | 515 | 105 | 24 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12 | NCOR1 | Any mutation | 630 | 92 | TMB overall | -0.44 | -1.50 | 0.65 | 1378.47 | 1.00 | 1296 | 607 | 69 | 23 | FALSE | 0.39 |
| colorectal cancer | RAS_12 | POLE | Any mutation | 233 | 38 | TMB quintile 5 | -0.56 | -1.34 | 0.14 | 1683.51 | 1.00 | 367 | 223 | 28 | 10 | TRUE | 0.87 |
| colorectal cancer | RAS_12 | POLE | Any mutation | 23 | 93 | TMB quintile 6 | 0.01 | -0.85 | 0.89 | 1603.34 | 1.00 | 65 | 10 | 80 | 13 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12 | POLE | Any mutation | 231 | 20 | TMB quintile 4 | 0.14 | -0.70 | 0.97 | 1573.26 | 1.00 | 518 | 224 | 13 | 7 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12 | POLE | Any mutation | 398 | 102 | TMB quintile 5 | 0.33 | -0.07 | 0.73 | 1458.08 | 1.00 | 770 | 358 | 62 | 40 | TRUE | 0.95 |
| uterine cancer | RAS_12 | POLE | Any mutation | 52 | 24 | TMB quintile 5 | 0.27 | -0.75 | 1.26 | 1590.20 | 1.00 | 194 | 46 | 18 | 6 | TRUE | 0.22 |
| colorectal cancer | RAS_12 | POLE | Any mutation | 256 | 131 | TMB overall | -0.27 | -2.83 | 2.46 | 1614.36 | 1.00 | 432 | 233 | 108 | 23 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12 | POLE | Any mutation | 629 | 122 | TMB overall | 0.23 | -1.30 | 1.59 | 1644.97 | 1.00 | 1288 | 582 | 75 | 47 | TRUE | 0.13 |
| uterine cancer | RAS_12 | POLE | Any mutation | 55 | 104 | TMB overall | 0.71 | -2.87 | 4.91 | 1489.78 | 1.00 | 217 | 46 | 95 | 9 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12 | NOTCH2 | Any mutation | 231 | 16 | TMB quintile 4 | 0.01 | -0.90 | 0.95 | 1461.68 | 1.00 | 519 | 225 | 10 | 6 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12 | NOTCH2 | Any mutation | 395 | 81 | TMB quintile 5 | -0.49 | -1.05 | 0.03 | 1529.19 | 1.00 | 767 | 377 | 63 | 18 | TRUE | 1.13 |
| non-small cell lung cancer | RAS_12 | NOTCH2 | Any mutation | 626 | 97 | TMB overall | -0.27 | -1.80 | 1.48 | 1509.19 | 1.00 | 1286 | 602 | 73 | 24 | TRUE | 0.14 |
| colorectal cancer | RAS_12 | TGFBR2 | Any mutation | 234 | 47 | TMB quintile 5 | -0.39 | -1.02 | 0.22 | 1456.69 | 1.00 | 364 | 220 | 33 | 14 | TRUE | 0.64 |
| colorectal cancer | RAS_12 | TGFBR2 | Any mutation | 21 | 57 | TMB quintile 6 | -0.39 | -1.35 | 0.55 | 1387.55 | 1.00 | 72 | 14 | 50 | 7 | TRUE | 0.38 |
| colorectal cancer | RAS_12 | TGFBR2 | Any mutation | 255 | 104 | TMB overall | -0.30 | -2.53 | 2.12 | 1576.20 | 1.00 | 436 | 234 | 83 | 21 | TRUE | 0.11 |
| colorectal cancer | RAS_12 | KMT2A | Any mutation | 282 | 16 | TMB quintile 4 | -0.36 | -1.46 | 0.60 | 1340.73 | 1.00 | 498 | 277 | 11 | 5 | FALSE | 0.32 |
| colorectal cancer | RAS_12 | KMT2A | Any mutation | 233 | 43 | TMB quintile 5 | -0.48 | -1.18 | 0.16 | 1432.84 | 1.00 | 366 | 221 | 31 | 12 | FALSE | 0.79 |
| colorectal cancer | RAS_12 | KMT2A | Any mutation | 21 | 84 | TMB quintile 6 | -0.52 | -1.44 | 0.35 | 1332.93 | 1.00 | 75 | 13 | 76 | 8 | FALSE | 0.60 |
| non-small cell lung cancer | RAS_12 | KMT2A | Any mutation | 231 | 16 | TMB quintile 4 | -0.24 | -1.21 | 0.72 | 1412.41 | 1.00 | 520 | 226 | 11 | 5 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12 | KMT2A | Any mutation | 396 | 80 | TMB quintile 5 | -0.49 | -1.00 | 0.01 | 1464.66 | 1.00 | 770 | 378 | 62 | 18 | FALSE | 1.15 |
| uterine cancer | RAS_12 | KMT2A | Any mutation | 52 | 27 | TMB quintile 5 | -0.53 | -1.71 | 0.52 | 1526.94 | 1.00 | 188 | 48 | 23 | 4 | FALSE | 0.46 |
| colorectal cancer | RAS_12 | KMT2A | Any mutation | 536 | 143 | TMB overall | -0.46 | -2.32 | 1.27 | 1456.79 | 1.00 | 939 | 511 | 118 | 25 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12 | KMT2A | Any mutation | 627 | 96 | TMB overall | -0.38 | -1.83 | 1.00 | 1665.65 | 1.00 | 1290 | 604 | 73 | 23 | FALSE | 0.22 |
| uterine cancer | RAS_12 | KMT2A | Any mutation | 55 | 103 | TMB overall | -0.47 | -3.69 | 2.89 | 1488.74 | 1.00 | 216 | 49 | 97 | 6 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12 | PAK7 | Any mutation | 231 | 13 | TMB quintile 4 | -0.14 | -1.22 | 0.86 | 1438.98 | 1.00 | 519 | 227 | 9 | 4 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12 | PAK7 | Any mutation | 396 | 95 | TMB quintile 5 | -0.03 | -0.46 | 0.40 | 1556.39 | 1.00 | 765 | 366 | 65 | 30 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12 | PAK7 | Any mutation | 627 | 108 | TMB overall | -0.09 | -1.78 | 1.56 | 1560.56 | 1.00 | 1284 | 593 | 74 | 34 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12 | STAG2 | Any mutation | 231 | 19 | TMB quintile 4 | -0.01 | -0.88 | 0.72 | 1507.18 | 1.00 | 518 | 225 | 13 | 6 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12 | STAG2 | Any mutation | 397 | 76 | TMB quintile 5 | 0.16 | -0.32 | 0.62 | 1274.45 | 1.00 | 783 | 370 | 49 | 27 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12 | STAG2 | Any mutation | 628 | 95 | TMB overall | 0.08 | -1.22 | 1.28 | 1562.07 | 1.00 | 1301 | 595 | 62 | 33 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12 | TERT | Any mutation | 131 | 13 | TMB quintile 3 | 0.61 | -0.28 | 1.65 | 1636.52 | 1.00 | 489 | 125 | 7 | 6 | TRUE | 0.64 |
| non-small cell lung cancer | RAS_12 | TERT | Any mutation | 231 | 34 | TMB quintile 4 | 0.13 | -0.55 | 0.76 | 1720.77 | 1.00 | 509 | 220 | 23 | 11 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12 | TERT | Any mutation | 398 | 98 | TMB quintile 5 | 0.03 | -0.40 | 0.44 | 1428.33 | 1.00 | 765 | 367 | 67 | 31 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12 | TERT | Any mutation | 760 | 145 | TMB overall | 0.27 | -0.58 | 1.28 | 1673.66 | 1.00 | 1763 | 712 | 97 | 48 | TRUE | 0.24 |
| colorectal cancer | RAS_12 | BRCA2 | Any mutation | 282 | 21 | TMB quintile 4 | -0.48 | -1.45 | 0.42 | 1374.22 | 1.00 | 494 | 276 | 15 | 6 | TRUE | 0.51 |
| colorectal cancer | RAS_12 | BRCA2 | Any mutation | 235 | 48 | TMB quintile 5 | -0.42 | -1.05 | 0.21 | 1399.18 | 1.00 | 365 | 221 | 34 | 14 | TRUE | 0.72 |
| colorectal cancer | RAS_12 | BRCA2 | Any mutation | 21 | 116 | TMB quintile 6 | -0.94 | -1.86 | -0.10 | 1679.27 | 1.00 | 68 | 13 | 108 | 8 | TRUE | 1.43 |
| non-small cell lung cancer | RAS_12 | BRCA2 | Any mutation | 231 | 23 | TMB quintile 4 | -0.12 | -1.04 | 0.68 | 1354.93 | 1.00 | 516 | 224 | 16 | 7 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12 | BRCA2 | Any mutation | 398 | 89 | TMB quintile 5 | -0.24 | -0.72 | 0.21 | 1472.32 | 1.00 | 766 | 373 | 64 | 25 | TRUE | 0.50 |
| uterine cancer | RAS_12 | BRCA2 | Any mutation | 52 | 29 | TMB quintile 5 | -0.60 | -1.79 | 0.40 | 1430.79 | 1.00 | 185 | 48 | 25 | 4 | TRUE | 0.55 |
| colorectal cancer | RAS_12 | BRCA2 | Any mutation | 538 | 185 | TMB overall | -0.59 | -2.48 | 1.21 | 1456.91 | 1.00 | 927 | 510 | 157 | 28 | TRUE | 0.27 |
| non-small cell lung cancer | RAS_12 | BRCA2 | Any mutation | 629 | 126 | TMB overall | -0.60 | -3.47 | 1.93 | 1727.78 | 1.00 | 1291 | 597 | 94 | 32 | TRUE | 0.18 |
| uterine cancer | RAS_12 | BRCA2 | Any mutation | 55 | 122 | TMB overall | -0.66 | -3.85 | 2.57 | 1661.75 | 1.00 | 210 | 49 | 116 | 6 | TRUE | 0.17 |
| colorectal cancer | RAS_12 | NOTCH3 | Any mutation | 147 | 12 | TMB quintile 3 | 0.57 | -0.57 | 1.67 | 1492.79 | 1.00 | 334 | 141 | 6 | 6 | TRUE | 0.51 |
| colorectal cancer | RAS_12 | NOTCH3 | Any mutation | 282 | 17 | TMB quintile 4 | 0.10 | -0.90 | 1.03 | 1469.14 | 1.00 | 499 | 275 | 10 | 7 | TRUE | 0.08 |
| colorectal cancer | RAS_12 | NOTCH3 | Any mutation | 233 | 50 | TMB quintile 5 | -0.92 | -1.63 | -0.24 | 1312.92 | 1.00 | 358 | 223 | 40 | 10 | TRUE | 1.99 |
| colorectal cancer | RAS_12 | NOTCH3 | Any mutation | 22 | 120 | TMB quintile 6 | -0.96 | -1.85 | -0.10 | 1250.33 | 1.00 | 47 | 12 | 110 | 10 | TRUE | 1.52 |
| non-small cell lung cancer | RAS_12 | NOTCH3 | Any mutation | 231 | 21 | TMB quintile 4 | -0.22 | -1.19 | 0.72 | 1466.42 | 1.00 | 517 | 225 | 15 | 6 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12 | NOTCH3 | Any mutation | 396 | 82 | TMB quintile 5 | -0.23 | -0.80 | 0.25 | 1393.31 | 1.00 | 773 | 373 | 59 | 23 | TRUE | 0.42 |
| colorectal cancer | RAS_12 | NOTCH3 | Any mutation | 684 | 199 | TMB overall | -0.28 | -1.81 | 1.42 | 1511.46 | 1.00 | 1238 | 651 | 166 | 33 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12 | NOTCH3 | Any mutation | 627 | 114 | TMB overall | -0.56 | -3.24 | 2.26 | 1470.96 | 1.00 | 1299 | 598 | 85 | 29 | TRUE | 0.16 |
| colorectal cancer | RAS_12 | NOTCH4 | Any mutation | 275 | 21 | TMB quintile 4 | -0.68 | -1.65 | 0.22 | 1170.62 | 1.00 | 483 | 270 | 16 | 5 | TRUE | 0.79 |
| colorectal cancer | RAS_12 | NOTCH4 | Any mutation | 218 | 37 | TMB quintile 5 | -0.39 | -1.11 | 0.28 | 1455.36 | 1.00 | 346 | 207 | 26 | 11 | TRUE | 0.55 |
| colorectal cancer | RAS_12 | NOTCH4 | Any mutation | 22 | 59 | TMB quintile 6 | -0.39 | -1.33 | 0.56 | 1414.09 | 1.00 | 78 | 15 | 52 | 7 | TRUE | 0.38 |
| non-small cell lung cancer | RAS_12 | NOTCH4 | Any mutation | 231 | 17 | TMB quintile 4 | -0.75 | -1.91 | 0.26 | 1351.24 | 1.00 | 514 | 228 | 14 | 3 | TRUE | 0.78 |
| non-small cell lung cancer | RAS_12 | NOTCH4 | Any mutation | 395 | 107 | TMB quintile 5 | -0.29 | -0.74 | 0.14 | 1247.35 | 1.00 | 749 | 366 | 78 | 29 | TRUE | 0.68 |
| colorectal cancer | RAS_12 | NOTCH4 | Any mutation | 515 | 117 | TMB overall | -0.49 | -2.06 | 1.05 | 1495.15 | 1.00 | 907 | 492 | 94 | 23 | TRUE | 0.28 |
| non-small cell lung cancer | RAS_12 | NOTCH4 | Any mutation | 626 | 124 | TMB overall | -0.51 | -2.24 | 1.08 | 1091.97 | 1.00 | 1263 | 594 | 92 | 32 | TRUE | 0.28 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 75 | 12 | TMB quintile 2 | 0.52 | -0.58 | 1.54 | 1394.97 | 1.00 | 358 | 71 | 8 | 4 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 130 | 50 | TMB quintile 3 | 0.65 | 0.06 | 1.23 | 1428.56 | 1.00 | 463 | 113 | 33 | 17 | FALSE | 1.50 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 233 | 129 | TMB quintile 4 | 0.50 | 0.12 | 0.85 | 1443.46 | 1.00 | 455 | 182 | 78 | 51 | FALSE | 2.08 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 400 | 336 | TMB quintile 5 | -0.18 | -0.46 | 0.09 | 1450.88 | 1.00 | 602 | 303 | 239 | 97 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 838 | 527 | TMB overall | 0.37 | -0.65 | 1.39 | 1375.84 | 1.00 | 1878 | 669 | 358 | 169 | FALSE | 0.33 |
| non-small cell lung cancer | RAS_12 | KDM5C | Any mutation | 231 | 16 | TMB quintile 4 | -0.19 | -1.23 | 0.67 | 1475.90 | 1.00 | 519 | 227 | 12 | 4 | FALSE | 0.16 |
| non-small cell lung cancer | RAS_12 | KDM5C | Any mutation | 398 | 70 | TMB quintile 5 | 0.26 | -0.23 | 0.77 | 1641.43 | 1.00 | 787 | 371 | 43 | 27 | FALSE | 0.51 |
| non-small cell lung cancer | RAS_12 | KDM5C | Any mutation | 629 | 86 | TMB overall | 0.06 | -1.31 | 1.24 | 1572.48 | 1.00 | 1306 | 598 | 55 | 31 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 130 | 33 | TMB quintile 3 | 0.41 | -0.33 | 1.17 | 1457.73 | 1.00 | 475 | 119 | 22 | 11 | TRUE | 0.54 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 231 | 43 | TMB quintile 4 | -0.26 | -0.93 | 0.36 | 1332.85 | 1.00 | 500 | 220 | 32 | 11 | TRUE | 0.38 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 402 | 178 | TMB quintile 5 | -0.71 | -1.12 | -0.34 | 1370.54 | 1.00 | 694 | 367 | 143 | 35 | TRUE | 3.52 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 252 | 34 | TMB quintile 2 | 0.85 | 0.17 | 1.69 | 1469.34 | 1.00 | 90 | 222 | 4 | 30 | TRUE | 1.66 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 427 | 146 | TMB quintile 3 | 1.20 | 0.68 | 1.75 | 1467.86 | 1.00 | 91 | 294 | 13 | 133 | TRUE | 4.87 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 223 | 96 | TMB quintile 4 | 1.24 | 0.68 | 1.86 | 1498.72 | 1.00 | 54 | 138 | 11 | 85 | TRUE | 4.30 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 763 | 254 | TMB overall | -0.20 | -1.22 | 0.79 | 1453.14 | 1.00 | 1669 | 706 | 197 | 57 | TRUE | 0.16 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 902 | 276 | TMB overall | 1.10 | 0.37 | 1.89 | 1459.11 | 1.00 | 235 | 654 | 28 | 248 | TRUE | 2.41 |
| non-small cell lung cancer | RAS_12 | EPHB1 | Any mutation | 231 | 19 | TMB quintile 4 | 0.16 | -0.78 | 1.10 | 1438.91 | 1.00 | 519 | 224 | 12 | 7 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12 | EPHB1 | Any mutation | 398 | 117 | TMB quintile 5 | -0.69 | -1.13 | -0.24 | 1420.42 | 1.00 | 738 | 374 | 93 | 24 | FALSE | 2.46 |
| non-small cell lung cancer | RAS_12 | EPHB1 | Any mutation | 629 | 152 | TMB overall | -0.68 | -3.70 | 2.32 | 1450.06 | 1.00 | 1266 | 598 | 121 | 31 | FALSE | 0.19 |
| uterine cancer | RAS_12 | PPP2R1A | Any mutation | 24 | 44 | TMB quintile 3 | -0.43 | -1.49 | 0.55 | 1457.77 | 1.00 | 178 | 20 | 40 | 4 | FALSE | 0.38 |
| uterine cancer | RAS_12 | PPP2R1A | Any mutation | 40 | 46 | TMB quintile 4 | -0.52 | -1.41 | 0.27 | 1554.66 | 1.00 | 150 | 34 | 40 | 6 | FALSE | 0.64 |
| uterine cancer | RAS_12 | PPP2R1A | Any mutation | 52 | 25 | TMB quintile 5 | -0.76 | -1.85 | 0.23 | 1631.00 | 1.00 | 188 | 49 | 22 | 3 | FALSE | 0.82 |
| uterine cancer | RAS_12 | PPP2R1A | Any mutation | 118 | 145 | TMB overall | -0.71 | -1.86 | 0.32 | 1512.00 | 1.00 | 558 | 105 | 132 | 13 | FALSE | 0.71 |
| colorectal cancer | RAS_12 | ERBB3 | Any mutation | 283 | 27 | TMB quintile 4 | 0.10 | -0.71 | 0.88 | 1383.81 | 1.00 | 493 | 272 | 16 | 11 | TRUE | 0.10 |
| colorectal cancer | RAS_12 | ERBB3 | Any mutation | 233 | 39 | TMB quintile 5 | -0.11 | -0.79 | 0.57 | 1457.58 | 1.00 | 369 | 219 | 25 | 14 | TRUE | 0.13 |
| colorectal cancer | RAS_12 | ERBB3 | Any mutation | 20 | 51 | TMB quintile 6 | -0.72 | -1.89 | 0.28 | 1179.63 | 1.00 | 86 | 16 | 47 | 4 | TRUE | 0.73 |
| colorectal cancer | RAS_12 | ERBB3 | Any mutation | 536 | 117 | TMB overall | -0.26 | -1.89 | 1.16 | 1436.86 | 1.00 | 948 | 507 | 88 | 29 | TRUE | 0.14 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 148 | 51 | TMB quintile 3 | 0.21 | -0.29 | 0.74 | 1535.77 | 1.00 | 309 | 129 | 32 | 19 | TRUE | 0.36 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 284 | 129 | TMB quintile 4 | 0.15 | -0.20 | 0.51 | 1370.50 | 1.00 | 434 | 234 | 79 | 50 | TRUE | 0.38 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 241 | 138 | TMB quintile 5 | 0.12 | -0.24 | 0.48 | 1623.03 | 1.00 | 318 | 187 | 84 | 54 | TRUE | 0.28 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 21 | 31 | TMB quintile 6 | -0.07 | -0.84 | 0.63 | 1378.64 | 1.00 | 100 | 17 | 27 | 4 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12 | SMAD4 | Any mutation | 130 | 21 | TMB quintile 3 | -0.45 | -1.18 | 0.23 | 1581.37 | 1.00 | 478 | 127 | 18 | 3 | TRUE | 0.65 |
| non-small cell lung cancer | RAS_12 | SMAD4 | Any mutation | 231 | 36 | TMB quintile 4 | -0.40 | -1.03 | 0.20 | 1453.57 | 1.00 | 507 | 223 | 28 | 8 | TRUE | 0.68 |
| non-small cell lung cancer | RAS_12 | SMAD4 | Any mutation | 396 | 49 | TMB quintile 5 | -0.36 | -0.89 | 0.17 | 1505.68 | 1.00 | 791 | 383 | 36 | 13 | TRUE | 0.74 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 252 | 37 | TMB quintile 2 | 0.36 | -0.28 | 1.08 | 1404.63 | 1.00 | 88 | 221 | 6 | 31 | TRUE | 0.52 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 422 | 119 | TMB quintile 3 | 0.27 | -0.20 | 0.71 | 1354.41 | 1.00 | 84 | 324 | 21 | 98 | TRUE | 0.60 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 217 | 82 | TMB quintile 4 | 0.45 | -0.09 | 1.02 | 1212.18 | 1.00 | 50 | 150 | 15 | 67 | TRUE | 0.94 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 35 | 25 | TMB quintile 5 | 0.59 | -0.19 | 1.34 | 1532.14 | 1.00 | 15 | 18 | 8 | 17 | TRUE | 0.82 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 694 | 349 | TMB overall | 0.09 | -0.50 | 0.64 | 1357.38 | 1.00 | 1161 | 567 | 222 | 127 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12 | SMAD4 | Any mutation | 757 | 106 | TMB overall | -0.41 | -1.08 | 0.22 | 1480.93 | 1.00 | 1776 | 733 | 82 | 24 | TRUE | 0.69 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 926 | 263 | TMB overall | 0.41 | -0.31 | 1.16 | 1165.33 | 1.00 | 237 | 713 | 50 | 213 | TRUE | 0.58 |
| colorectal cancer | RAS_12 | ATM | Any mutation | 285 | 46 | TMB quintile 4 | 0.26 | -0.33 | 0.85 | 1173.13 | 1.00 | 485 | 265 | 26 | 20 | TRUE | 0.41 |
| colorectal cancer | RAS_12 | ATM | Any mutation | 238 | 78 | TMB quintile 5 | -0.10 | -0.58 | 0.39 | 1515.69 | 1.00 | 347 | 210 | 50 | 28 | TRUE | 0.16 |
| colorectal cancer | RAS_12 | ATM | Any mutation | 22 | 94 | TMB quintile 6 | -0.68 | -1.55 | 0.17 | 1565.90 | 1.00 | 73 | 14 | 86 | 8 | TRUE | 0.94 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 75 | 15 | TMB quintile 2 | 0.83 | -0.03 | 1.65 | 1481.87 | 1.00 | 357 | 70 | 10 | 5 | TRUE | 1.30 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 130 | 20 | TMB quintile 3 | 0.83 | 0.07 | 1.57 | 1320.57 | 1.00 | 484 | 122 | 12 | 8 | TRUE | 1.56 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 239 | 76 | TMB quintile 4 | 1.28 | 0.84 | 1.74 | 1572.61 | 1.00 | 503 | 194 | 31 | 45 | TRUE | 7.60 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 409 | 166 | TMB quintile 5 | 0.70 | 0.38 | 1.03 | 1404.03 | 1.00 | 744 | 333 | 90 | 76 | TRUE | 4.60 |
| uterine cancer | RAS_12 | ATM | Any mutation | 53 | 46 | TMB quintile 5 | -0.23 | -1.15 | 0.58 | 1538.51 | 1.00 | 180 | 45 | 38 | 8 | TRUE | 0.23 |
| colorectal cancer | RAS_12 | ATM | Any mutation | 545 | 218 | TMB overall | -0.15 | -1.71 | 1.51 | 1465.13 | 1.00 | 905 | 489 | 162 | 56 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 853 | 277 | TMB overall | 0.91 | 0.20 | 1.59 | 1522.40 | 1.00 | 2088 | 719 | 143 | 134 | TRUE | 1.93 |
| uterine cancer | RAS_12 | ATM | Any mutation | 57 | 147 | TMB overall | -0.34 | -3.03 | 2.80 | 1381.90 | 1.00 | 200 | 46 | 136 | 11 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 130 | 33 | TMB quintile 3 | -1.33 | -2.32 | -0.53 | 1427.95 | 1.00 | 465 | 128 | 31 | 2 | TRUE | 2.51 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 231 | 50 | TMB quintile 4 | -1.25 | -1.99 | -0.61 | 1349.62 | 1.00 | 487 | 225 | 44 | 6 | TRUE | 3.29 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 396 | 124 | TMB quintile 5 | -1.09 | -1.58 | -0.61 | 1457.68 | 1.00 | 727 | 377 | 105 | 19 | TRUE | 4.94 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 757 | 207 | TMB overall | -1.22 | -2.03 | -0.52 | 1149.76 | 1.01 | 1679 | 730 | 180 | 27 | TRUE | 3.05 |
| cancer of unknown primary | RAS_12 | KMT2D | Any mutation | 34 | 14 | TMB quintile 3 | -1.44 | -3.23 | 0.04 | 1337.99 | 1.00 | 98 | 33 | 13 | 1 | FALSE | 1.08 |
| cancer of unknown primary | RAS_12 | KMT2D | Any mutation | 35 | 11 | TMB quintile 4 | -0.24 | -1.66 | 1.08 | 1365.82 | 1.00 | 99 | 32 | 8 | 3 | FALSE | 0.14 |
| cancer of unknown primary | RAS_12 | KMT2D | Any mutation | 35 | 67 | TMB quintile 5 | -0.89 | -1.79 | -0.10 | 1465.87 | 1.00 | 103 | 28 | 60 | 7 | FALSE | 1.37 |
| colorectal cancer | RAS_12 | KMT2D | Any mutation | 282 | 27 | TMB quintile 4 | -0.53 | -1.42 | 0.27 | 1594.19 | 1.00 | 490 | 275 | 20 | 7 | FALSE | 0.65 |
| colorectal cancer | RAS_12 | KMT2D | Any mutation | 239 | 104 | TMB quintile 5 | -0.58 | -1.07 | -0.10 | 1400.11 | 1.00 | 339 | 212 | 77 | 27 | FALSE | 1.78 |
| colorectal cancer | RAS_12 | KMT2D | Any mutation | 34 | 245 | TMB quintile 6 | -0.23 | -1.32 | 1.05 | 1416.71 | 1.00 | 16 | 3 | 214 | 31 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 130 | 15 | TMB quintile 3 | 0.05 | -1.20 | 1.15 | 1606.11 | 1.00 | 485 | 126 | 11 | 4 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 231 | 42 | TMB quintile 4 | -0.26 | -0.98 | 0.41 | 1383.15 | 1.00 | 503 | 220 | 31 | 11 | FALSE | 0.33 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 400 | 251 | TMB quintile 5 | -0.75 | -1.08 | -0.41 | 1501.29 | 1.00 | 663 | 350 | 201 | 50 | FALSE | 4.72 |
| uterine cancer | RAS_12 | KMT2D | Any mutation | 40 | 14 | TMB quintile 4 | -0.54 | -2.22 | 0.82 | 1613.80 | 1.00 | 178 | 38 | 12 | 2 | FALSE | 0.31 |
| uterine cancer | RAS_12 | KMT2D | Any mutation | 54 | 129 | TMB quintile 5 | -0.60 | -1.26 | 0.05 | 1309.47 | 1.00 | 123 | 36 | 111 | 18 | FALSE | 1.20 |
| cancer of unknown primary | RAS_12 | KMT2D | Any mutation | 109 | 123 | TMB overall | -0.74 | -2.32 | 0.88 | 1404.13 | 1.00 | 303 | 94 | 108 | 15 | FALSE | 0.45 |
| colorectal cancer | RAS_12 | KMT2D | Any mutation | 555 | 376 | TMB overall | -0.46 | -2.89 | 2.11 | 1427.20 | 1.00 | 845 | 490 | 311 | 65 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 761 | 320 | TMB overall | -0.52 | -2.33 | 1.18 | 1511.26 | 1.00 | 1659 | 696 | 255 | 65 | FALSE | 0.26 |
| uterine cancer | RAS_12 | KMT2D | Any mutation | 98 | 252 | TMB overall | -0.59 | -2.83 | 1.56 | 1588.87 | 1.00 | 318 | 75 | 229 | 23 | FALSE | 0.23 |
| colorectal cancer | RAS_12 | TSC2 | Any mutation | 236 | 42 | TMB quintile 5 | -0.45 | -1.16 | 0.20 | 1525.73 | 1.00 | 367 | 224 | 30 | 12 | TRUE | 0.72 |
| colorectal cancer | RAS_12 | TSC2 | Any mutation | 21 | 56 | TMB quintile 6 | -0.03 | -0.93 | 0.85 | 1644.13 | 1.00 | 85 | 13 | 48 | 8 | TRUE | 0.02 |
| colorectal cancer | RAS_12 | TSC2 | Any mutation | 257 | 98 | TMB overall | -0.21 | -2.62 | 2.03 | 1641.21 | 1.00 | 452 | 237 | 78 | 20 | TRUE | 0.07 |
| colorectal cancer | RAS_12 | APC | Any mutation | 18 | 78 | TMB quintile 2 | -0.88 | -1.77 | -0.10 | 1260.65 | 1.00 | 55 | 13 | 73 | 5 | TRUE | 1.40 |
| colorectal cancer | RAS_12 | APC | Any mutation | 176 | 428 | TMB quintile 3 | -0.16 | -0.52 | 0.22 | 1248.02 | 1.00 | 106 | 52 | 304 | 124 | TRUE | 0.40 |
| colorectal cancer | RAS_12 | APC | Any mutation | 395 | 966 | TMB quintile 4 | -0.08 | -0.42 | 0.27 | 1529.70 | 1.00 | 94 | 58 | 629 | 337 | TRUE | 0.19 |
| colorectal cancer | RAS_12 | APC | Any mutation | 379 | 822 | TMB quintile 5 | 0.40 | 0.03 | 0.75 | 1599.35 | 1.00 | 104 | 47 | 490 | 332 | TRUE | 1.56 |
| colorectal cancer | RAS_12 | APC | Any mutation | 42 | 225 | TMB quintile 6 | 0.24 | -0.45 | 0.98 | 1473.02 | 1.00 | 43 | 4 | 187 | 38 | TRUE | 0.28 |
| non-small cell lung cancer | RAS_12 | APC | Any mutation | 130 | 20 | TMB quintile 3 | -0.23 | -1.12 | 0.71 | 1582.72 | 1.00 | 481 | 125 | 15 | 5 | TRUE | 0.21 |
| non-small cell lung cancer | RAS_12 | APC | Any mutation | 231 | 31 | TMB quintile 4 | -0.99 | -1.93 | -0.22 | 1370.37 | 1.00 | 503 | 228 | 28 | 3 | TRUE | 1.57 |
| non-small cell lung cancer | RAS_12 | APC | Any mutation | 399 | 101 | TMB quintile 5 | -0.37 | -0.83 | 0.06 | 1511.47 | 1.00 | 758 | 373 | 75 | 26 | TRUE | 1.00 |
| uterine cancer | RAS_12 | APC | Any mutation | 52 | 35 | TMB quintile 5 | -0.24 | -1.28 | 0.63 | 1448.60 | 1.00 | 190 | 46 | 29 | 6 | TRUE | 0.21 |
| colorectal cancer | RAS_12 | APC | Any mutation | 1010 | 2519 | TMB overall | -0.10 | -0.76 | 0.54 | 1440.22 | 1.00 | 402 | 174 | 1683 | 836 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12 | APC | Any mutation | 760 | 152 | TMB overall | -0.53 | -1.40 | 0.38 | 1319.67 | 1.00 | 1742 | 726 | 118 | 34 | TRUE | 0.63 |
| uterine cancer | RAS_12 | APC | Any mutation | 57 | 119 | TMB overall | -0.01 | -2.79 | 3.00 | 1454.78 | 1.00 | 220 | 47 | 109 | 10 | TRUE | 0.00 |
| colorectal cancer | RAS_12 | ERBB2 | Any mutation | 282 | 17 | TMB quintile 4 | -0.68 | -1.75 | 0.32 | 1480.80 | 1.00 | 496 | 278 | 13 | 4 | TRUE | 0.69 |
| colorectal cancer | RAS_12 | ERBB2 | Any mutation | 233 | 33 | TMB quintile 5 | -0.82 | -1.68 | -0.04 | 1405.70 | 1.00 | 367 | 226 | 26 | 7 | TRUE | 1.29 |
| colorectal cancer | RAS_12 | ERBB2 | Any mutation | 20 | 42 | TMB quintile 6 | 0.20 | -0.81 | 1.17 | 1625.72 | 1.00 | 95 | 13 | 35 | 7 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12 | ERBB2 | Any mutation | 75 | 14 | TMB quintile 2 | -2.88 | -4.45 | -1.53 | 1513.45 | 1.00 | 352 | 75 | 14 | 0 | TRUE | 3.89 |
| non-small cell lung cancer | RAS_12 | ERBB2 | Any mutation | 130 | 27 | TMB quintile 3 | -2.60 | -4.14 | -1.31 | 1452.42 | 1.00 | 471 | 128 | 25 | 2 | TRUE | 3.64 |
| non-small cell lung cancer | RAS_12 | ERBB2 | Any mutation | 231 | 32 | TMB quintile 4 | -2.97 | -4.59 | -1.75 | 1583.24 | 1.00 | 501 | 231 | 32 | 0 | TRUE | 4.26 |
| non-small cell lung cancer | RAS_12 | ERBB2 | Any mutation | 396 | 40 | TMB quintile 5 | -2.88 | -4.36 | -1.69 | 1348.67 | 1.00 | 791 | 395 | 39 | 1 | TRUE | 4.53 |
| colorectal cancer | RAS_12 | ERBB2 | Any mutation | 535 | 92 | TMB overall | -0.45 | -1.97 | 1.08 | 1423.22 | 1.00 | 958 | 517 | 74 | 18 | TRUE | 0.25 |
| non-small cell lung cancer | RAS_12 | ERBB2 | Any mutation | 832 | 113 | TMB overall | -2.82 | -4.31 | -1.66 | 1412.86 | 1.00 | 2115 | 829 | 110 | 3 | TRUE | 4.68 |
| uterine cancer | RAS_12 | JAK1 | Any mutation | 56 | 88 | TMB quintile 5 | 0.01 | -0.62 | 0.62 | 1612.69 | 1.00 | 160 | 39 | 71 | 17 | TRUE | 0.01 |
| uterine cancer | RAS_12 | JAK1 | Any mutation | 59 | 140 | TMB overall | 0.41 | -2.23 | 3.88 | 1456.48 | 1.00 | 188 | 39 | 120 | 20 | TRUE | 0.11 |
| colorectal cancer | RAS_12 | ARID2 | Any mutation | 282 | 12 | TMB quintile 4 | -0.64 | -1.98 | 0.59 | 1447.56 | 1.00 | 500 | 279 | 9 | 3 | FALSE | 0.49 |
| colorectal cancer | RAS_12 | ARID2 | Any mutation | 234 | 31 | TMB quintile 5 | 0.14 | -0.62 | 0.85 | 1499.15 | 1.00 | 376 | 221 | 18 | 13 | FALSE | 0.15 |
| colorectal cancer | RAS_12 | ARID2 | Any mutation | 20 | 66 | TMB quintile 6 | -0.42 | -1.38 | 0.46 | 1353.76 | 1.00 | 75 | 13 | 59 | 7 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12 | ARID2 | Any mutation | 130 | 19 | TMB quintile 3 | -0.79 | -2.00 | 0.12 | 1276.29 | 1.00 | 478 | 129 | 18 | 1 | FALSE | 0.85 |
| non-small cell lung cancer | RAS_12 | ARID2 | Any mutation | 231 | 35 | TMB quintile 4 | -0.13 | -0.82 | 0.57 | 1453.13 | 1.00 | 509 | 220 | 24 | 11 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12 | ARID2 | Any mutation | 397 | 111 | TMB quintile 5 | -0.22 | -0.62 | 0.20 | 1438.46 | 1.00 | 757 | 366 | 80 | 31 | FALSE | 0.51 |
| colorectal cancer | RAS_12 | ARID2 | Any mutation | 536 | 109 | TMB overall | -0.28 | -2.22 | 1.66 | 1427.54 | 1.00 | 951 | 513 | 86 | 23 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12 | ARID2 | Any mutation | 758 | 165 | TMB overall | -0.38 | -1.29 | 0.40 | 1446.70 | 1.00 | 1744 | 715 | 122 | 43 | FALSE | 0.41 |
| colorectal cancer | RAS_12 | MTOR | Any mutation | 282 | 19 | TMB quintile 4 | 0.95 | 0.04 | 1.95 | 1590.77 | 1.00 | 502 | 270 | 7 | 12 | TRUE | 1.36 |
| colorectal cancer | RAS_12 | MTOR | Any mutation | 234 | 40 | TMB quintile 5 | -0.23 | -0.96 | 0.42 | 1286.38 | 1.01 | 366 | 221 | 27 | 13 | TRUE | 0.29 |
| colorectal cancer | RAS_12 | MTOR | Any mutation | 22 | 70 | TMB quintile 6 | -0.74 | -1.76 | 0.21 | 1095.70 | 1.00 | 76 | 16 | 64 | 6 | TRUE | 0.83 |
| non-small cell lung cancer | RAS_12 | MTOR | Any mutation | 130 | 14 | TMB quintile 3 | -0.35 | -1.45 | 0.53 | 1455.86 | 1.00 | 484 | 128 | 12 | 2 | TRUE | 0.32 |
| non-small cell lung cancer | RAS_12 | MTOR | Any mutation | 231 | 21 | TMB quintile 4 | -0.42 | -1.24 | 0.36 | 1396.43 | 1.00 | 515 | 227 | 17 | 4 | TRUE | 0.49 |
| non-small cell lung cancer | RAS_12 | MTOR | Any mutation | 398 | 70 | TMB quintile 5 | 0.09 | -0.39 | 0.55 | 1419.05 | 1.00 | 782 | 373 | 45 | 25 | TRUE | 0.16 |
| colorectal cancer | RAS_12 | MTOR | Any mutation | 538 | 129 | TMB overall | 0.00 | -1.91 | 1.94 | 1555.62 | 1.00 | 944 | 507 | 98 | 31 | TRUE | 0.00 |
| non-small cell lung cancer | RAS_12 | MTOR | Any mutation | 759 | 105 | TMB overall | -0.22 | -1.10 | 0.58 | 1511.81 | 1.00 | 1781 | 728 | 74 | 31 | TRUE | 0.22 |
| colorectal cancer | RAS_12 | NOTCH1 | Any mutation | 233 | 48 | TMB quintile 5 | -1.31 | -2.15 | -0.56 | 1274.82 | 1.00 | 356 | 226 | 41 | 7 | TRUE | 2.93 |
| colorectal cancer | RAS_12 | NOTCH1 | Any mutation | 28 | 112 | TMB quintile 6 | 0.39 | -0.46 | 1.35 | 1427.93 | 1.00 | 59 | 8 | 92 | 20 | TRUE | 0.43 |
| non-small cell lung cancer | RAS_12 | NOTCH1 | Any mutation | 231 | 15 | TMB quintile 4 | -0.67 | -1.81 | 0.37 | 1441.33 | 1.00 | 519 | 228 | 12 | 3 | TRUE | 0.64 |
| non-small cell lung cancer | RAS_12 | NOTCH1 | Any mutation | 397 | 97 | TMB quintile 5 | -0.48 | -0.98 | -0.01 | 1512.71 | 1.00 | 758 | 374 | 74 | 23 | TRUE | 1.27 |
| colorectal cancer | RAS_12 | NOTCH1 | Any mutation | 261 | 160 | TMB overall | -0.42 | -3.10 | 2.54 | 1670.93 | 1.00 | 415 | 234 | 133 | 27 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12 | NOTCH1 | Any mutation | 628 | 112 | TMB overall | -0.56 | -2.24 | 1.17 | 1641.20 | 1.00 | 1277 | 602 | 86 | 26 | TRUE | 0.30 |
| colorectal cancer | RAS_12 | SETD2 | Any mutation | 147 | 11 | TMB quintile 3 | -2.84 | -6.05 | -0.76 | 1461.60 | 1.00 | 330 | 147 | 11 | 0 | FALSE | 1.49 |
| colorectal cancer | RAS_12 | SETD2 | Any mutation | 233 | 31 | TMB quintile 5 | -1.93 | -3.23 | -0.83 | 1485.33 | 1.00 | 368 | 230 | 28 | 3 | FALSE | 2.81 |
| colorectal cancer | RAS_12 | SETD2 | Any mutation | 22 | 64 | TMB quintile 6 | -1.14 | -2.22 | -0.20 | 1432.72 | 1.00 | 78 | 17 | 59 | 5 | FALSE | 1.50 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 75 | 14 | TMB quintile 2 | -0.87 | -2.30 | 0.15 | 1569.97 | 1.00 | 352 | 75 | 14 | 0 | FALSE | 0.77 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 131 | 22 | TMB quintile 3 | -0.72 | -1.74 | 0.17 | 1490.42 | 1.00 | 481 | 129 | 20 | 2 | FALSE | 0.83 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 232 | 59 | TMB quintile 4 | -0.27 | -0.84 | 0.25 | 1474.83 | 1.00 | 495 | 217 | 44 | 15 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 403 | 110 | TMB quintile 5 | 0.05 | -0.36 | 0.45 | 1553.32 | 1.00 | 764 | 365 | 72 | 38 | FALSE | 0.09 |
| colorectal cancer | RAS_12 | SETD2 | Any mutation | 402 | 106 | TMB overall | -1.92 | -4.13 | 0.00 | 1539.47 | 1.00 | 776 | 394 | 98 | 8 | FALSE | 1.24 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 841 | 205 | TMB overall | -0.45 | -1.31 | 0.28 | 1503.03 | 1.00 | 2092 | 786 | 150 | 55 | FALSE | 0.56 |
| non-small cell lung cancer | RAS_12 | PBRM1 | Any mutation | 233 | 21 | TMB quintile 4 | 0.24 | -0.55 | 1.12 | 1129.43 | 1.00 | 520 | 224 | 12 | 9 | TRUE | 0.24 |
| non-small cell lung cancer | RAS_12 | PBRM1 | Any mutation | 396 | 79 | TMB quintile 5 | -0.36 | -0.93 | 0.17 | 1558.69 | 1.00 | 776 | 377 | 60 | 19 | TRUE | 0.74 |
| non-small cell lung cancer | RAS_12 | PBRM1 | Any mutation | 629 | 100 | TMB overall | -0.07 | -1.55 | 1.39 | 1267.79 | 1.00 | 1296 | 601 | 72 | 28 | TRUE | 0.03 |
| colorectal cancer | RAS_12 | EPHA3 | Any mutation | 283 | 17 | TMB quintile 4 | -0.42 | -1.46 | 0.51 | 1395.08 | 1.00 | 497 | 278 | 12 | 5 | FALSE | 0.41 |
| colorectal cancer | RAS_12 | EPHA3 | Any mutation | 233 | 41 | TMB quintile 5 | -0.18 | -0.84 | 0.46 | 1318.79 | 1.00 | 367 | 219 | 27 | 14 | FALSE | 0.23 |
| colorectal cancer | RAS_12 | EPHA3 | Any mutation | 20 | 44 | TMB quintile 6 | -0.58 | -1.74 | 0.44 | 1505.82 | 1.00 | 91 | 16 | 40 | 4 | FALSE | 0.55 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 130 | 15 | TMB quintile 3 | 0.48 | -0.68 | 1.50 | 1598.14 | 1.00 | 486 | 125 | 10 | 5 | FALSE | 0.41 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 231 | 28 | TMB quintile 4 | 0.50 | -0.28 | 1.26 | 1340.17 | 1.00 | 515 | 219 | 16 | 12 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 403 | 182 | TMB quintile 5 | -0.06 | -0.39 | 0.26 | 1550.65 | 1.00 | 713 | 346 | 125 | 57 | FALSE | 0.13 |
| colorectal cancer | RAS_12 | EPHA3 | Any mutation | 536 | 102 | TMB overall | -0.40 | -1.81 | 1.20 | 1420.20 | 1.00 | 955 | 513 | 79 | 23 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 764 | 237 | TMB overall | 0.02 | -1.83 | 1.82 | 1635.30 | 1.00 | 1722 | 690 | 163 | 74 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12 | KDR | Any mutation | 231 | 21 | TMB quintile 4 | 0.53 | -0.24 | 1.37 | 1393.03 | 1.00 | 520 | 221 | 11 | 10 | TRUE | 0.68 |
| non-small cell lung cancer | RAS_12 | KDR | Any mutation | 399 | 109 | TMB quintile 5 | -0.17 | -0.63 | 0.25 | 1581.58 | 1.00 | 751 | 368 | 78 | 31 | TRUE | 0.36 |
| non-small cell lung cancer | RAS_12 | KDR | Any mutation | 630 | 130 | TMB overall | 0.14 | -1.46 | 1.93 | 1419.82 | 1.00 | 1271 | 589 | 89 | 41 | TRUE | 0.06 |
| colorectal cancer | RAS_12 | PTCH1 | Any mutation | 233 | 35 | TMB quintile 5 | -1.17 | -2.09 | -0.36 | 1301.98 | 1.00 | 366 | 227 | 29 | 6 | TRUE | 2.07 |
| colorectal cancer | RAS_12 | PTCH1 | Any mutation | 21 | 99 | TMB quintile 6 | -0.49 | -1.39 | 0.40 | 1612.07 | 1.00 | 63 | 11 | 89 | 10 | TRUE | 0.57 |
| colorectal cancer | RAS_12 | PTCH1 | Any mutation | 254 | 134 | TMB overall | -0.78 | -3.35 | 1.80 | 1481.29 | 1.00 | 429 | 238 | 118 | 16 | TRUE | 0.27 |
| colorectal cancer | RAS_12 | TET1 | Any mutation | 218 | 26 | TMB quintile 5 | -0.96 | -1.99 | -0.06 | 1284.85 | 1.00 | 352 | 213 | 21 | 5 | FALSE | 1.30 |
| colorectal cancer | RAS_12 | TET1 | Any mutation | 21 | 67 | TMB quintile 6 | -0.24 | -1.16 | 0.66 | 1511.15 | 1.00 | 82 | 13 | 59 | 8 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12 | TET1 | Any mutation | 231 | 16 | TMB quintile 4 | -0.81 | -2.32 | 0.35 | 1404.74 | 1.00 | 515 | 228 | 13 | 3 | FALSE | 0.64 |
| non-small cell lung cancer | RAS_12 | TET1 | Any mutation | 397 | 89 | TMB quintile 5 | -0.18 | -0.69 | 0.28 | 1444.17 | 1.00 | 767 | 371 | 63 | 26 | FALSE | 0.34 |
| colorectal cancer | RAS_12 | TET1 | Any mutation | 239 | 93 | TMB overall | -0.58 | -2.96 | 1.82 | 1461.91 | 1.00 | 434 | 226 | 80 | 13 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12 | TET1 | Any mutation | 628 | 120 | TMB overall | -0.87 | -3.85 | 2.39 | 1521.71 | 1.00 | 1287 | 599 | 91 | 29 | FALSE | 0.25 |
| uterine cancer | RAS_12 | FGFR2 | Any mutation | 40 | 23 | TMB quintile 4 | -1.61 | -3.35 | -0.11 | 1343.10 | 1.00 | 169 | 38 | 21 | 2 | TRUE | 1.31 |
| uterine cancer | RAS_12 | FGFR2 | Any mutation | 52 | 52 | TMB quintile 5 | -2.54 | -4.44 | -1.24 | 1361.07 | 1.00 | 165 | 51 | 51 | 1 | TRUE | 2.83 |
| uterine cancer | RAS_12 | FGFR2 | Any mutation | 94 | 93 | TMB overall | -2.12 | -4.11 | -0.41 | 1482.10 | 1.00 | 380 | 91 | 90 | 3 | TRUE | 1.72 |
| non-small cell lung cancer | RAS_12 | TBX3 | Any mutation | 231 | 11 | TMB quintile 4 | 0.01 | -1.21 | 1.16 | 1514.49 | 1.00 | 524 | 227 | 7 | 4 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12 | TBX3 | Any mutation | 396 | 108 | TMB quintile 5 | -0.22 | -0.66 | 0.22 | 1695.43 | 1.00 | 757 | 366 | 78 | 30 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12 | TBX3 | Any mutation | 627 | 119 | TMB overall | -0.09 | -1.93 | 1.89 | 1293.03 | 1.00 | 1281 | 593 | 85 | 34 | FALSE | 0.03 |
| colorectal cancer | RAS_12 | SMAD3 | Any mutation | 147 | 12 | TMB quintile 3 | -0.37 | -1.52 | 0.68 | 1474.43 | 1.00 | 330 | 145 | 10 | 2 | TRUE | 0.29 |
| colorectal cancer | RAS_12 | SMAD3 | Any mutation | 285 | 27 | TMB quintile 4 | 0.25 | -0.44 | 0.91 | 1441.58 | 1.00 | 496 | 273 | 15 | 12 | TRUE | 0.33 |
| colorectal cancer | RAS_12 | SMAD3 | Any mutation | 239 | 44 | TMB quintile 5 | 0.49 | -0.09 | 1.05 | 1347.24 | 1.00 | 372 | 217 | 22 | 22 | TRUE | 1.04 |
| colorectal cancer | RAS_12 | SMAD3 | Any mutation | 21 | 23 | TMB quintile 6 | 0.42 | -0.61 | 1.30 | 1325.44 | 1.00 | 105 | 16 | 18 | 5 | TRUE | 0.40 |
| colorectal cancer | RAS_12 | SMAD3 | Any mutation | 692 | 106 | TMB overall | 0.19 | -0.76 | 1.10 | 1453.36 | 1.00 | 1303 | 651 | 65 | 41 | TRUE | 0.17 |
| non-small cell lung cancer | RAS_12 | NTRK3 | Any mutation | 233 | 31 | TMB quintile 4 | 1.16 | 0.47 | 1.90 | 1334.07 | 1.00 | 519 | 215 | 13 | 18 | FALSE | 2.77 |
| non-small cell lung cancer | RAS_12 | NTRK3 | Any mutation | 400 | 144 | TMB quintile 5 | 0.08 | -0.30 | 0.46 | 1446.88 | 1.00 | 741 | 351 | 95 | 49 | FALSE | 0.18 |
| non-small cell lung cancer | RAS_12 | NTRK3 | Any mutation | 633 | 195 | TMB overall | -0.03 | -3.11 | 2.87 | 1507.32 | 1.00 | 1267 | 566 | 128 | 67 | FALSE | 0.01 |
| colorectal cancer | RAS_12 | GRIN2A | Any mutation | 282 | 30 | TMB quintile 4 | -0.38 | -1.16 | 0.34 | 1464.91 | 1.00 | 488 | 273 | 21 | 9 | FALSE | 0.50 |
| colorectal cancer | RAS_12 | GRIN2A | Any mutation | 234 | 42 | TMB quintile 5 | -0.36 | -1.04 | 0.26 | 1296.58 | 1.00 | 364 | 221 | 29 | 13 | FALSE | 0.55 |
| colorectal cancer | RAS_12 | GRIN2A | Any mutation | 20 | 59 | TMB quintile 6 | -1.27 | -2.46 | -0.22 | 1360.04 | 1.00 | 79 | 17 | 56 | 3 | FALSE | 1.58 |
| non-small cell lung cancer | RAS_12 | GRIN2A | Any mutation | 130 | 17 | TMB quintile 3 | 0.13 | -0.76 | 0.96 | 1430.70 | 1.00 | 484 | 125 | 12 | 5 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12 | GRIN2A | Any mutation | 231 | 39 | TMB quintile 4 | -0.01 | -0.67 | 0.58 | 1445.47 | 1.00 | 505 | 219 | 27 | 12 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12 | GRIN2A | Any mutation | 400 | 124 | TMB quintile 5 | -0.14 | -0.54 | 0.25 | 1426.51 | 1.00 | 744 | 364 | 88 | 36 | FALSE | 0.32 |
| colorectal cancer | RAS_12 | GRIN2A | Any mutation | 536 | 131 | TMB overall | -0.62 | -2.20 | 0.92 | 1409.85 | 1.00 | 931 | 511 | 106 | 25 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12 | GRIN2A | Any mutation | 761 | 180 | TMB overall | -0.01 | -0.86 | 0.84 | 1449.17 | 1.00 | 1733 | 708 | 127 | 53 | FALSE | 0.01 |
| uterine cancer | RAS_12 | CTCF | Any mutation | 40 | 12 | TMB quintile 4 | 0.15 | -1.32 | 1.41 | 1389.92 | 1.00 | 180 | 37 | 9 | 3 | FALSE | 0.09 |
| uterine cancer | RAS_12 | CTCF | Any mutation | 54 | 103 | TMB quintile 5 | 0.02 | -0.58 | 0.60 | 1432.65 | 1.00 | 133 | 33 | 82 | 21 | FALSE | 0.02 |
| uterine cancer | RAS_12 | CTCF | Any mutation | 96 | 163 | TMB overall | -0.19 | -2.32 | 1.89 | 1492.04 | 1.00 | 339 | 71 | 138 | 25 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 75 | 12 | TMB quintile 2 | 1.46 | 0.53 | 2.51 | 1531.69 | 1.00 | 361 | 68 | 5 | 7 | TRUE | 2.39 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 132 | 78 | TMB quintile 3 | 1.19 | 0.69 | 1.67 | 1403.06 | 1.00 | 451 | 99 | 45 | 33 | TRUE | 5.96 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 234 | 161 | TMB quintile 4 | 1.46 | 1.10 | 1.83 | 1393.31 | 1.00 | 462 | 142 | 69 | 92 | TRUE | 14.45 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 400 | 283 | TMB quintile 5 | 0.22 | -0.07 | 0.49 | 1463.30 | 1.00 | 654 | 300 | 183 | 100 | TRUE | 0.89 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 841 | 534 | TMB overall | 1.08 | 0.15 | 2.03 | 1505.13 | 1.00 | 1928 | 609 | 302 | 232 | TRUE | 1.67 |
| colorectal cancer | RAS_12 | ASXL1 | Any mutation | 282 | 15 | TMB quintile 4 | -0.01 | -1.07 | 0.93 | 1426.24 | 1.00 | 500 | 276 | 9 | 6 | TRUE | 0.01 |
| colorectal cancer | RAS_12 | ASXL1 | Any mutation | 233 | 30 | TMB quintile 5 | -0.52 | -1.39 | 0.28 | 1569.32 | 1.00 | 372 | 225 | 22 | 8 | TRUE | 0.66 |
| colorectal cancer | RAS_12 | ASXL1 | Any mutation | 22 | 57 | TMB quintile 6 | -0.12 | -1.03 | 0.75 | 1326.72 | 1.00 | 80 | 14 | 49 | 8 | TRUE | 0.10 |
| colorectal cancer | RAS_12 | ASXL1 | Any mutation | 537 | 102 | TMB overall | -0.20 | -1.84 | 1.37 | 1610.71 | 1.00 | 952 | 515 | 80 | 22 | TRUE | 0.09 |
| colorectal cancer | RAS_12 | EP300 | Any mutation | 233 | 39 | TMB quintile 5 | -0.76 | -1.58 | -0.04 | 1551.29 | 1.00 | 365 | 224 | 30 | 9 | TRUE | 1.27 |
| colorectal cancer | RAS_12 | EP300 | Any mutation | 23 | 72 | TMB quintile 6 | -0.31 | -1.20 | 0.54 | 1421.08 | 1.00 | 78 | 14 | 63 | 9 | TRUE | 0.31 |
| non-small cell lung cancer | RAS_12 | EP300 | Any mutation | 397 | 77 | TMB quintile 5 | -0.28 | -0.84 | 0.22 | 995.37 | 1.00 | 776 | 376 | 56 | 21 | TRUE | 0.54 |
| uterine cancer | RAS_12 | EP300 | Any mutation | 53 | 39 | TMB quintile 5 | 0.00 | -0.91 | 0.78 | 1573.62 | 1.00 | 182 | 45 | 31 | 8 | TRUE | 0.00 |
| colorectal cancer | RAS_12 | EP300 | Any mutation | 256 | 111 | TMB overall | -0.45 | -2.84 | 2.30 | 1365.80 | 1.00 | 443 | 238 | 93 | 18 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12 | EP300 | Any mutation | 397 | 77 | TMB overall | -0.21 | -4.01 | 4.03 | 1360.93 | 1.00 | 776 | 376 | 56 | 21 | TRUE | 0.04 |
| uterine cancer | RAS_12 | EP300 | Any mutation | 56 | 92 | TMB overall | -0.02 | -2.75 | 3.01 | 1599.06 | 1.00 | 213 | 46 | 82 | 10 | TRUE | 0.01 |
| colorectal cancer | RAS_12 | ERBB4 | Any mutation | 282 | 22 | TMB quintile 4 | -0.08 | -0.92 | 0.77 | 1636.68 | 1.00 | 496 | 274 | 14 | 8 | TRUE | 0.06 |
| colorectal cancer | RAS_12 | ERBB4 | Any mutation | 234 | 45 | TMB quintile 5 | 0.10 | -0.55 | 0.71 | 1452.79 | 1.00 | 367 | 216 | 27 | 18 | TRUE | 0.13 |
| colorectal cancer | RAS_12 | ERBB4 | Any mutation | 21 | 61 | TMB quintile 6 | -0.06 | -0.97 | 0.80 | 1393.46 | 1.00 | 84 | 13 | 53 | 8 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12 | ERBB4 | Any mutation | 231 | 25 | TMB quintile 4 | -0.03 | -0.92 | 0.80 | 1637.57 | 1.00 | 514 | 223 | 17 | 8 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12 | ERBB4 | Any mutation | 400 | 148 | TMB quintile 5 | -0.65 | -1.08 | -0.25 | 1527.82 | 1.00 | 731 | 369 | 117 | 31 | TRUE | 2.63 |
| colorectal cancer | RAS_12 | ERBB4 | Any mutation | 537 | 128 | TMB overall | -0.01 | -1.65 | 1.56 | 1493.19 | 1.00 | 947 | 503 | 94 | 34 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12 | ERBB4 | Any mutation | 631 | 185 | TMB overall | -0.58 | -3.34 | 2.19 | 1407.24 | 1.00 | 1254 | 592 | 146 | 39 | TRUE | 0.17 |
| colorectal cancer | RAS_12 | MED12 | Any mutation | 283 | 18 | TMB quintile 4 | 0.43 | -0.46 | 1.34 | 1530.44 | 1.00 | 500 | 274 | 9 | 9 | TRUE | 0.46 |
| colorectal cancer | RAS_12 | MED12 | Any mutation | 233 | 28 | TMB quintile 5 | 0.04 | -0.76 | 0.80 | 1489.45 | 1.00 | 378 | 222 | 17 | 11 | TRUE | 0.04 |
| colorectal cancer | RAS_12 | MED12 | Any mutation | 21 | 59 | TMB quintile 6 | -0.71 | -1.77 | 0.21 | 1624.33 | 1.00 | 79 | 16 | 54 | 5 | TRUE | 0.77 |
| non-small cell lung cancer | RAS_12 | MED12 | Any mutation | 130 | 23 | TMB quintile 3 | -0.36 | -1.20 | 0.44 | 1455.95 | 1.00 | 477 | 126 | 19 | 4 | TRUE | 0.42 |
| non-small cell lung cancer | RAS_12 | MED12 | Any mutation | 231 | 32 | TMB quintile 4 | -0.27 | -0.96 | 0.41 | 1396.88 | 1.00 | 508 | 222 | 23 | 9 | TRUE | 0.35 |
| non-small cell lung cancer | RAS_12 | MED12 | Any mutation | 399 | 101 | TMB quintile 5 | -0.41 | -0.87 | 0.03 | 1381.56 | 1.00 | 756 | 375 | 77 | 24 | TRUE | 1.13 |
| uterine cancer | RAS_12 | MED12 | Any mutation | 13 | 13 | TMB quintile 2 | -1.77 | -4.26 | 0.15 | 1587.55 | 1.00 | 119 | 13 | 13 | 0 | TRUE | 0.92 |
| uterine cancer | RAS_12 | MED12 | Any mutation | 24 | 16 | TMB quintile 3 | -0.37 | -2.04 | 1.06 | 1293.33 | 1.00 | 203 | 22 | 14 | 2 | TRUE | 0.20 |
| uterine cancer | RAS_12 | MED12 | Any mutation | 40 | 20 | TMB quintile 4 | -1.51 | -3.42 | -0.03 | 1355.23 | 1.00 | 170 | 39 | 19 | 1 | TRUE | 1.16 |
| uterine cancer | RAS_12 | MED12 | Any mutation | 52 | 31 | TMB quintile 5 | -0.26 | -1.25 | 0.69 | 1367.39 | 1.00 | 189 | 46 | 25 | 6 | TRUE | 0.22 |
| colorectal cancer | RAS_12 | MED12 | Any mutation | 537 | 105 | TMB overall | -0.05 | -1.76 | 1.79 | 1269.56 | 1.00 | 957 | 512 | 80 | 25 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12 | MED12 | Any mutation | 760 | 156 | TMB overall | -0.35 | -1.10 | 0.39 | 1385.83 | 1.00 | 1741 | 723 | 119 | 37 | TRUE | 0.44 |
| uterine cancer | RAS_12 | MED12 | Any mutation | 131 | 138 | TMB overall | -1.18 | -2.70 | 0.27 | 1412.73 | 1.00 | 712 | 122 | 129 | 9 | TRUE | 0.94 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 75 | 29 | TMB quintile 2 | 0.25 | -0.44 | 0.85 | 1544.67 | 1.00 | 342 | 70 | 24 | 5 | FALSE | 0.35 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 130 | 46 | TMB quintile 3 | 0.36 | -0.22 | 0.87 | 1486.67 | 1.00 | 463 | 118 | 34 | 12 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 232 | 90 | TMB quintile 4 | 0.73 | 0.33 | 1.12 | 1086.91 | 1.00 | 483 | 190 | 48 | 42 | FALSE | 3.50 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 403 | 200 | TMB quintile 5 | 0.65 | 0.35 | 0.93 | 1358.26 | 1.00 | 727 | 314 | 111 | 89 | FALSE | 4.92 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 840 | 365 | TMB overall | 0.51 | 0.01 | 1.02 | 1494.55 | 1.00 | 2015 | 692 | 217 | 148 | FALSE | 1.33 |
| colorectal cancer | RAS_12 | NF1 | Any mutation | 282 | 13 | TMB quintile 4 | -1.84 | -3.79 | -0.32 | 1422.87 | 1.00 | 498 | 281 | 12 | 1 | TRUE | 1.43 |
| colorectal cancer | RAS_12 | NF1 | Any mutation | 234 | 34 | TMB quintile 5 | -0.18 | -0.93 | 0.52 | 1387.51 | 1.00 | 371 | 222 | 22 | 12 | TRUE | 0.20 |
| colorectal cancer | RAS_12 | NF1 | Any mutation | 21 | 86 | TMB quintile 6 | -0.78 | -1.76 | 0.15 | 1547.37 | 1.00 | 75 | 14 | 79 | 7 | TRUE | 0.98 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 130 | 25 | TMB quintile 3 | -0.97 | -2.03 | 0.01 | 1431.61 | 1.00 | 475 | 127 | 22 | 3 | TRUE | 1.20 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 231 | 59 | TMB quintile 4 | -1.48 | -2.34 | -0.74 | 1384.89 | 1.00 | 485 | 226 | 54 | 5 | TRUE | 3.65 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 400 | 216 | TMB quintile 5 | -0.82 | -1.18 | -0.45 | 1570.45 | 1.00 | 684 | 359 | 175 | 41 | TRUE | 4.93 |
| uterine cancer | RAS_12 | NF1 | Any mutation | 52 | 38 | TMB quintile 5 | -0.65 | -1.78 | 0.30 | 1354.41 | 1.00 | 184 | 47 | 33 | 5 | TRUE | 0.67 |
| colorectal cancer | RAS_12 | NF1 | Any mutation | 537 | 133 | TMB overall | -0.87 | -2.91 | 1.15 | 1647.52 | 1.00 | 944 | 517 | 113 | 20 | TRUE | 0.42 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 761 | 300 | TMB overall | -1.08 | -2.09 | 0.01 | 1339.83 | 1.00 | 1644 | 712 | 251 | 49 | TRUE | 1.39 |
| uterine cancer | RAS_12 | NF1 | Any mutation | 54 | 111 | TMB overall | -0.82 | -3.82 | 2.42 | 1523.41 | 1.00 | 212 | 48 | 105 | 6 | TRUE | 0.22 |
| non-small cell lung cancer | RAS_12 | FLT1 | Any mutation | 231 | 21 | TMB quintile 4 | 0.51 | -0.31 | 1.33 | 1587.41 | 1.00 | 521 | 221 | 11 | 10 | FALSE | 0.61 |
| non-small cell lung cancer | RAS_12 | FLT1 | Any mutation | 399 | 99 | TMB quintile 5 | -0.23 | -0.69 | 0.21 | 1578.98 | 1.00 | 762 | 372 | 72 | 27 | FALSE | 0.49 |
| non-small cell lung cancer | RAS_12 | FLT1 | Any mutation | 630 | 120 | TMB overall | 0.14 | -1.56 | 1.81 | 1534.42 | 1.00 | 1283 | 593 | 83 | 37 | FALSE | 0.06 |
| uterine cancer | RAS_12 | RASA1 | Any mutation | 52 | 25 | TMB quintile 5 | -0.51 | -1.83 | 0.61 | 1292.71 | 1.00 | 191 | 48 | 21 | 4 | FALSE | 0.37 |
| uterine cancer | RAS_12 | RASA1 | Any mutation | 54 | 95 | TMB overall | -1.80 | -6.00 | 1.77 | 1475.33 | 1.00 | 218 | 50 | 91 | 4 | FALSE | 0.44 |
| colorectal cancer | RAS_12 | EPHA5 | Any mutation | 282 | 18 | TMB quintile 4 | -0.53 | -1.62 | 0.37 | 1631.23 | 1.00 | 496 | 277 | 13 | 5 | FALSE | 0.52 |
| colorectal cancer | RAS_12 | EPHA5 | Any mutation | 234 | 52 | TMB quintile 5 | -0.16 | -0.77 | 0.41 | 1351.44 | 1.00 | 361 | 216 | 34 | 18 | FALSE | 0.22 |
| colorectal cancer | RAS_12 | EPHA5 | Any mutation | 20 | 66 | TMB quintile 6 | -0.54 | -1.53 | 0.34 | 1500.28 | 1.00 | 84 | 14 | 60 | 6 | FALSE | 0.57 |
| non-small cell lung cancer | RAS_12 | EPHA5 | Any mutation | 231 | 48 | TMB quintile 4 | 0.28 | -0.34 | 0.86 | 1441.02 | 1.00 | 502 | 213 | 30 | 18 | FALSE | 0.44 |
| non-small cell lung cancer | RAS_12 | EPHA5 | Any mutation | 400 | 191 | TMB quintile 5 | 0.04 | -0.28 | 0.35 | 1336.24 | 1.00 | 714 | 337 | 128 | 63 | FALSE | 0.09 |
| colorectal cancer | RAS_12 | EPHA5 | Any mutation | 536 | 136 | TMB overall | -0.42 | -2.02 | 1.10 | 1506.24 | 1.00 | 941 | 507 | 107 | 29 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12 | EPHA5 | Any mutation | 631 | 250 | TMB overall | -0.20 | -2.65 | 2.08 | 1427.79 | 1.00 | 1226 | 550 | 169 | 81 | FALSE | 0.06 |
| colorectal cancer | RAS_12 | AR | Any mutation | 282 | 21 | TMB quintile 4 | -0.94 | -2.02 | -0.01 | 1556.42 | 1.00 | 492 | 278 | 17 | 4 | TRUE | 1.15 |
| colorectal cancer | RAS_12 | AR | Any mutation | 233 | 34 | TMB quintile 5 | -1.07 | -1.99 | -0.24 | 1545.80 | 1.00 | 367 | 227 | 28 | 6 | TRUE | 1.75 |
| colorectal cancer | RAS_12 | AR | Any mutation | 20 | 55 | TMB quintile 6 | -0.01 | -0.97 | 0.92 | 1254.79 | 1.00 | 85 | 12 | 47 | 8 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12 | AR | Any mutation | 231 | 16 | TMB quintile 4 | 0.30 | -0.59 | 1.23 | 1434.57 | 1.00 | 522 | 224 | 9 | 7 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12 | AR | Any mutation | 399 | 77 | TMB quintile 5 | -0.15 | -0.69 | 0.34 | 1480.89 | 1.00 | 777 | 377 | 55 | 22 | TRUE | 0.24 |
| colorectal cancer | RAS_12 | AR | Any mutation | 535 | 110 | TMB overall | -0.65 | -2.30 | 0.99 | 1420.91 | 1.00 | 944 | 517 | 92 | 18 | TRUE | 0.37 |
| non-small cell lung cancer | RAS_12 | AR | Any mutation | 630 | 93 | TMB overall | 0.07 | -1.42 | 1.67 | 1629.69 | 1.00 | 1299 | 601 | 64 | 29 | TRUE | 0.03 |
| colorectal cancer | RAS_12 | ROS1 | Any mutation | 282 | 14 | TMB quintile 4 | -1.46 | -3.12 | -0.20 | 1261.22 | 1.00 | 497 | 280 | 12 | 2 | TRUE | 1.39 |
| colorectal cancer | RAS_12 | ROS1 | Any mutation | 233 | 24 | TMB quintile 5 | -1.01 | -2.05 | -0.05 | 1637.77 | 1.00 | 374 | 228 | 19 | 5 | TRUE | 1.28 |
| colorectal cancer | RAS_12 | ROS1 | Any mutation | 20 | 61 | TMB quintile 6 | -1.85 | -3.49 | -0.60 | 1483.22 | 1.00 | 85 | 18 | 59 | 2 | TRUE | 2.01 |
| non-small cell lung cancer | RAS_12 | ROS1 | Any mutation | 231 | 13 | TMB quintile 4 | -2.84 | -7.15 | -0.71 | 1341.98 | 1.00 | 518 | 231 | 13 | 0 | TRUE | 0.99 |
| non-small cell lung cancer | RAS_12 | ROS1 | Any mutation | 397 | 80 | TMB quintile 5 | -1.14 | -1.81 | -0.52 | 1364.95 | 1.00 | 763 | 385 | 68 | 12 | TRUE | 3.32 |
| colorectal cancer | RAS_12 | ROS1 | Any mutation | 535 | 99 | TMB overall | -1.37 | -3.06 | 0.54 | 1427.50 | 1.00 | 956 | 526 | 90 | 9 | TRUE | 0.89 |
| non-small cell lung cancer | RAS_12 | ROS1 | Any mutation | 628 | 93 | TMB overall | -1.87 | -5.03 | 0.36 | 1557.43 | 1.00 | 1281 | 616 | 81 | 12 | TRUE | 0.80 |
| colorectal cancer | RAS_12 | PIK3CG | Any mutation | 282 | 16 | TMB quintile 4 | -0.58 | -1.67 | 0.42 | 1598.88 | 1.00 | 497 | 278 | 12 | 4 | FALSE | 0.55 |
| colorectal cancer | RAS_12 | PIK3CG | Any mutation | 233 | 38 | TMB quintile 5 | 0.04 | -0.64 | 0.73 | 1365.61 | 1.00 | 370 | 218 | 23 | 15 | FALSE | 0.04 |
| colorectal cancer | RAS_12 | PIK3CG | Any mutation | 22 | 45 | TMB quintile 6 | -0.40 | -1.44 | 0.46 | 1417.73 | 1.00 | 94 | 17 | 40 | 5 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12 | PIK3CG | Any mutation | 231 | 16 | TMB quintile 4 | 0.36 | -0.55 | 1.34 | 1559.01 | 1.00 | 522 | 224 | 9 | 7 | FALSE | 0.33 |
| non-small cell lung cancer | RAS_12 | PIK3CG | Any mutation | 400 | 150 | TMB quintile 5 | -0.19 | -0.58 | 0.20 | 1506.57 | 1.00 | 733 | 358 | 108 | 42 | FALSE | 0.48 |
| colorectal cancer | RAS_12 | PIK3CG | Any mutation | 537 | 99 | TMB overall | -0.33 | -1.91 | 1.17 | 1444.32 | 1.00 | 961 | 513 | 75 | 24 | FALSE | 0.17 |
| non-small cell lung cancer | RAS_12 | PIK3CG | Any mutation | 631 | 166 | TMB overall | 0.08 | -1.84 | 2.22 | 1411.55 | 1.00 | 1255 | 582 | 117 | 49 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 75 | 200 | TMB quintile 2 | -5.16 | -8.31 | -3.39 | 1438.36 | 1.00 | 188 | 75 | 200 | 0 | TRUE | 4.55 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 130 | 287 | TMB quintile 3 | -5.41 | -8.23 | -3.66 | 1301.21 | 1.00 | 266 | 130 | 287 | 0 | TRUE | 5.19 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 231 | 256 | TMB quintile 4 | -4.45 | -5.99 | -3.33 | 1422.67 | 1.00 | 341 | 229 | 254 | 2 | TRUE | 10.72 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 396 | 175 | TMB quintile 5 | -2.04 | -2.71 | -1.47 | 1457.75 | 1.00 | 706 | 382 | 161 | 14 | TRUE | 9.57 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 832 | 918 | TMB overall | -4.21 | -5.96 | -2.77 | 1346.59 | 1.00 | 1501 | 816 | 902 | 16 | TRUE | 6.60 |
| colorectal cancer | RAS_12 | ARID1B | Any mutation | 282 | 13 | TMB quintile 4 | -0.54 | -1.81 | 0.60 | 1283.46 | 1.00 | 501 | 278 | 9 | 4 | TRUE | 0.42 |
| colorectal cancer | RAS_12 | ARID1B | Any mutation | 234 | 46 | TMB quintile 5 | -0.98 | -1.74 | -0.25 | 1251.51 | 1.00 | 358 | 225 | 37 | 9 | TRUE | 2.01 |
| colorectal cancer | RAS_12 | ARID1B | Any mutation | 20 | 79 | TMB quintile 6 | -1.50 | -2.72 | -0.46 | 1439.21 | 1.00 | 65 | 16 | 75 | 4 | TRUE | 2.02 |
| non-small cell lung cancer | RAS_12 | ARID1B | Any mutation | 130 | 11 | TMB quintile 3 | -0.40 | -1.60 | 0.64 | 1481.66 | 1.00 | 487 | 128 | 9 | 2 | TRUE | 0.32 |
| non-small cell lung cancer | RAS_12 | ARID1B | Any mutation | 231 | 16 | TMB quintile 4 | -0.80 | -1.96 | 0.19 | 1445.92 | 1.00 | 518 | 229 | 14 | 2 | TRUE | 0.84 |
| non-small cell lung cancer | RAS_12 | ARID1B | Any mutation | 398 | 77 | TMB quintile 5 | -0.03 | -0.54 | 0.44 | 1503.49 | 1.00 | 778 | 373 | 52 | 25 | TRUE | 0.05 |
| uterine cancer | RAS_12 | ARID1B | Any mutation | 55 | 59 | TMB quintile 5 | 0.37 | -0.27 | 1.01 | 1625.11 | 1.00 | 172 | 40 | 44 | 15 | TRUE | 0.56 |
| colorectal cancer | RAS_12 | ARID1B | Any mutation | 536 | 138 | TMB overall | -0.96 | -2.80 | 0.87 | 1430.26 | 1.00 | 924 | 519 | 121 | 17 | TRUE | 0.53 |
| non-small cell lung cancer | RAS_12 | ARID1B | Any mutation | 759 | 104 | TMB overall | -0.40 | -1.49 | 0.58 | 1505.04 | 1.00 | 1783 | 730 | 75 | 29 | TRUE | 0.37 |
| uterine cancer | RAS_12 | ARID1B | Any mutation | 57 | 107 | TMB overall | 0.56 | -2.26 | 4.00 | 1477.01 | 1.00 | 202 | 40 | 90 | 17 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12 | MET | Any mutation | 75 | 21 | TMB quintile 2 | -0.87 | -2.04 | 0.06 | 1378.11 | 1.00 | 348 | 73 | 19 | 2 | TRUE | 1.02 |
| non-small cell lung cancer | RAS_12 | MET | Any mutation | 130 | 30 | TMB quintile 3 | -1.06 | -2.17 | -0.20 | 1593.17 | 1.00 | 474 | 128 | 28 | 2 | TRUE | 1.50 |
| non-small cell lung cancer | RAS_12 | MET | Any mutation | 231 | 34 | TMB quintile 4 | -1.49 | -2.81 | -0.56 | 1538.13 | 1.00 | 504 | 230 | 33 | 1 | TRUE | 2.06 |
| non-small cell lung cancer | RAS_12 | MET | Any mutation | 396 | 47 | TMB quintile 5 | -0.17 | -0.80 | 0.44 | 1471.87 | 1.00 | 799 | 379 | 30 | 17 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12 | MET | Any mutation | 832 | 132 | TMB overall | -0.89 | -1.88 | -0.18 | 1375.80 | 1.00 | 2125 | 810 | 110 | 22 | TRUE | 1.49 |
| colorectal cancer | RAS_12 | BRAF | Any mutation | 147 | 27 | TMB quintile 3 | -2.48 | -4.03 | -1.22 | 1454.73 | 1.00 | 314 | 146 | 26 | 1 | TRUE | 3.31 |
| colorectal cancer | RAS_12 | BRAF | Any mutation | 282 | 60 | TMB quintile 4 | -2.47 | -3.53 | -1.55 | 1485.02 | 1.00 | 452 | 279 | 57 | 3 | TRUE | 5.64 |
| colorectal cancer | RAS_12 | BRAF | Any mutation | 234 | 104 | TMB quintile 5 | -2.38 | -3.11 | -1.69 | 1406.58 | 1.00 | 298 | 227 | 97 | 7 | TRUE | 9.65 |
| colorectal cancer | RAS_12 | BRAF | Any mutation | 21 | 59 | TMB quintile 6 | -1.94 | -3.24 | -0.86 | 1548.50 | 1.00 | 74 | 18 | 56 | 3 | TRUE | 2.86 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 75 | 11 | TMB quintile 2 | -1.72 | -3.45 | -0.43 | 1479.39 | 1.00 | 355 | 75 | 11 | 0 | TRUE | 1.52 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 130 | 13 | TMB quintile 3 | -1.79 | -3.54 | -0.50 | 1466.07 | 1.00 | 483 | 130 | 13 | 0 | TRUE | 1.66 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 231 | 46 | TMB quintile 4 | -1.23 | -2.08 | -0.48 | 1538.94 | 1.00 | 492 | 225 | 40 | 6 | TRUE | 2.61 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 396 | 101 | TMB quintile 5 | -0.99 | -1.51 | -0.50 | 1419.32 | 1.00 | 745 | 379 | 84 | 17 | TRUE | 3.75 |
| colorectal cancer | RAS_12 | BRAF | Any mutation | 684 | 250 | TMB overall | -2.29 | -3.37 | -1.26 | 1512.17 | 1.00 | 1138 | 670 | 236 | 14 | TRUE | 4.61 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 832 | 171 | TMB overall | -1.43 | -2.56 | -0.51 | 1451.20 | 1.00 | 2075 | 809 | 148 | 23 | TRUE | 2.24 |
| colorectal cancer | RAS_12 | B2M | Any mutation | 222 | 50 | TMB quintile 5 | -0.57 | -1.27 | 0.11 | 1589.97 | 1.00 | 349 | 209 | 37 | 13 | FALSE | 1.03 |
| colorectal cancer | RAS_12 | B2M | Any mutation | 26 | 79 | TMB quintile 6 | -0.10 | -0.88 | 0.74 | 1422.38 | 1.00 | 75 | 14 | 67 | 12 | FALSE | 0.09 |
| colorectal cancer | RAS_12 | B2M | Any mutation | 248 | 129 | TMB overall | -0.34 | -2.54 | 1.84 | 1595.82 | 1.00 | 424 | 223 | 104 | 25 | FALSE | 0.12 |
| colorectal cancer | RAS_12 | CARD11 | Any mutation | 282 | 28 | TMB quintile 4 | 0.07 | -0.70 | 0.82 | 1377.22 | 1.00 | 492 | 271 | 17 | 11 | FALSE | 0.07 |
| colorectal cancer | RAS_12 | CARD11 | Any mutation | 234 | 43 | TMB quintile 5 | -0.23 | -0.88 | 0.38 | 1664.82 | 1.00 | 364 | 220 | 29 | 14 | FALSE | 0.33 |
| colorectal cancer | RAS_12 | CARD11 | Any mutation | 21 | 52 | TMB quintile 6 | 0.16 | -0.71 | 1.01 | 1402.17 | 1.00 | 88 | 13 | 44 | 8 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12 | CARD11 | Any mutation | 231 | 18 | TMB quintile 4 | 0.16 | -0.70 | 1.04 | 1251.86 | 1.00 | 520 | 224 | 11 | 7 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12 | CARD11 | Any mutation | 398 | 97 | TMB quintile 5 | -0.20 | -0.70 | 0.24 | 1548.35 | 1.00 | 761 | 371 | 70 | 27 | FALSE | 0.42 |
| colorectal cancer | RAS_12 | CARD11 | Any mutation | 537 | 123 | TMB overall | -0.03 | -1.65 | 1.36 | 1551.55 | 1.00 | 944 | 504 | 90 | 33 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12 | CARD11 | Any mutation | 629 | 115 | TMB overall | -0.05 | -1.58 | 1.69 | 1426.21 | 1.00 | 1281 | 595 | 81 | 34 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12 | INPP4B | Any mutation | 231 | 17 | TMB quintile 4 | 0.56 | -0.32 | 1.39 | 1507.03 | 1.00 | 522 | 223 | 9 | 8 | FALSE | 0.70 |
| non-small cell lung cancer | RAS_12 | INPP4B | Any mutation | 399 | 87 | TMB quintile 5 | 0.56 | 0.11 | 1.01 | 1332.17 | 1.00 | 784 | 361 | 49 | 38 | FALSE | 1.87 |
| non-small cell lung cancer | RAS_12 | INPP4B | Any mutation | 630 | 104 | TMB overall | 0.55 | -0.90 | 1.93 | 1480.85 | 1.00 | 1306 | 584 | 58 | 46 | FALSE | 0.37 |
| non-small cell lung cancer | RAS_12 | NFE2L2 | Any mutation | 231 | 31 | TMB quintile 4 | -0.92 | -1.69 | -0.17 | 1572.12 | 1.00 | 511 | 226 | 26 | 5 | FALSE | 1.80 |
| non-small cell lung cancer | RAS_12 | NFE2L2 | Any mutation | 397 | 83 | TMB quintile 5 | -0.90 | -1.45 | -0.40 | 1421.64 | 1.00 | 764 | 383 | 69 | 14 | FALSE | 3.02 |
| non-small cell lung cancer | RAS_12 | NFE2L2 | Any mutation | 628 | 114 | TMB overall | -0.90 | -1.82 | 0.04 | 1428.88 | 1.00 | 1275 | 609 | 95 | 19 | FALSE | 1.31 |
| colorectal cancer | RAS_12 | SOX9 | Any mutation | 147 | 17 | TMB quintile 3 | -0.10 | -1.05 | 0.80 | 1492.80 | 1.00 | 328 | 142 | 12 | 5 | FALSE | 0.08 |
| colorectal cancer | RAS_12 | SOX9 | Any mutation | 286 | 85 | TMB quintile 4 | 0.24 | -0.20 | 0.68 | 1302.10 | 1.00 | 459 | 251 | 50 | 35 | FALSE | 0.53 |
| colorectal cancer | RAS_12 | SOX9 | Any mutation | 239 | 107 | TMB quintile 5 | 0.07 | -0.38 | 0.48 | 1571.04 | 1.00 | 333 | 198 | 66 | 41 | FALSE | 0.12 |
| colorectal cancer | RAS_12 | SOX9 | Any mutation | 21 | 50 | TMB quintile 6 | 0.69 | -0.12 | 1.55 | 1410.92 | 1.00 | 90 | 10 | 39 | 11 | FALSE | 0.98 |
| colorectal cancer | RAS_12 | SOX9 | Any mutation | 693 | 259 | TMB overall | 0.22 | -0.78 | 1.23 | 1315.58 | 1.00 | 1210 | 601 | 167 | 92 | FALSE | 0.19 |
| colorectal cancer | RAS_12 | SMAD2 | Any mutation | 282 | 29 | TMB quintile 4 | 0.31 | -0.37 | 0.94 | 1593.32 | 1.00 | 494 | 269 | 16 | 13 | TRUE | 0.46 |
| colorectal cancer | RAS_12 | SMAD2 | Any mutation | 236 | 53 | TMB quintile 5 | 0.49 | -0.06 | 1.01 | 1525.01 | 1.00 | 370 | 210 | 27 | 26 | TRUE | 1.11 |
| colorectal cancer | RAS_12 | SMAD2 | Any mutation | 20 | 16 | TMB quintile 6 | 0.07 | -1.17 | 1.11 | 1234.96 | 1.00 | 111 | 18 | 14 | 2 | TRUE | 0.04 |
| colorectal cancer | RAS_12 | SMAD2 | Any mutation | 538 | 98 | TMB overall | 0.29 | -0.81 | 1.32 | 1299.88 | 1.00 | 975 | 497 | 57 | 41 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12 | GLI1 | Any mutation | 218 | 16 | TMB quintile 4 | 0.53 | -0.34 | 1.48 | 1462.81 | 1.00 | 456 | 210 | 8 | 8 | FALSE | 0.60 |
| non-small cell lung cancer | RAS_12 | GLI1 | Any mutation | 365 | 77 | TMB quintile 5 | 0.26 | -0.23 | 0.72 | 1403.82 | 1.00 | 694 | 336 | 48 | 29 | FALSE | 0.55 |
| non-small cell lung cancer | RAS_12 | GLI1 | Any mutation | 583 | 93 | TMB overall | 0.39 | -1.03 | 1.71 | 1635.87 | 1.00 | 1150 | 546 | 56 | 37 | FALSE | 0.23 |
| colorectal cancer | RAS_12 | ZFHX3 | Any mutation | 259 | 14 | TMB quintile 4 | 0.16 | -0.91 | 1.20 | 1384.94 | 1.00 | 453 | 253 | 8 | 6 | FALSE | 0.12 |
| colorectal cancer | RAS_12 | ZFHX3 | Any mutation | 217 | 63 | TMB quintile 5 | -0.46 | -1.04 | 0.10 | 1571.56 | 1.00 | 323 | 199 | 45 | 18 | FALSE | 0.91 |
| colorectal cancer | RAS_12 | ZFHX3 | Any mutation | 25 | 143 | TMB quintile 6 | 0.94 | -0.10 | 2.25 | 1410.11 | 1.00 | 47 | 3 | 121 | 22 | FALSE | 0.92 |
| non-small cell lung cancer | RAS_12 | ZFHX3 | Any mutation | 120 | 13 | TMB quintile 3 | -0.81 | -2.22 | 0.25 | 1647.80 | 1.00 | 438 | 119 | 12 | 1 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12 | ZFHX3 | Any mutation | 217 | 30 | TMB quintile 4 | -0.35 | -1.07 | 0.33 | 1389.85 | 1.00 | 440 | 209 | 22 | 8 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12 | ZFHX3 | Any mutation | 365 | 112 | TMB quintile 5 | -0.28 | -0.72 | 0.13 | 1315.07 | 1.00 | 663 | 334 | 81 | 31 | FALSE | 0.70 |
| uterine cancer | RAS_12 | ZFHX3 | Any mutation | 37 | 13 | TMB quintile 4 | 0.07 | -1.26 | 1.32 | 1390.28 | 1.00 | 158 | 34 | 10 | 3 | FALSE | 0.04 |
| uterine cancer | RAS_12 | ZFHX3 | Any mutation | 52 | 105 | TMB quintile 5 | -0.01 | -0.63 | 0.62 | 1230.35 | 1.00 | 135 | 32 | 85 | 20 | FALSE | 0.02 |
| colorectal cancer | RAS_12 | ZFHX3 | Any mutation | 501 | 220 | TMB overall | 0.21 | -2.01 | 2.39 | 1459.60 | 1.00 | 823 | 455 | 174 | 46 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12 | ZFHX3 | Any mutation | 702 | 155 | TMB overall | -0.48 | -1.51 | 0.46 | 1453.56 | 1.00 | 1541 | 662 | 115 | 40 | FALSE | 0.48 |
| uterine cancer | RAS_12 | ZFHX3 | Any mutation | 93 | 210 | TMB overall | -0.08 | -2.18 | 2.01 | 1436.72 | 1.00 | 317 | 67 | 184 | 26 | FALSE | 0.03 |
| colorectal cancer | RAS_12 | MGA | Any mutation | 259 | 15 | TMB quintile 4 | -1.34 | -2.76 | -0.14 | 1183.88 | 1.00 | 449 | 257 | 13 | 2 | FALSE | 1.36 |
| colorectal cancer | RAS_12 | MGA | Any mutation | 218 | 46 | TMB quintile 5 | -0.10 | -0.71 | 0.50 | 1466.92 | 1.00 | 332 | 201 | 29 | 17 | FALSE | 0.12 |
| colorectal cancer | RAS_12 | MGA | Any mutation | 19 | 58 | TMB quintile 6 | -0.76 | -1.80 | 0.22 | 1440.96 | 1.00 | 74 | 14 | 53 | 5 | FALSE | 0.85 |
| non-small cell lung cancer | RAS_12 | MGA | Any mutation | 120 | 14 | TMB quintile 3 | 0.18 | -0.86 | 1.19 | 1657.47 | 1.00 | 441 | 116 | 10 | 4 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12 | MGA | Any mutation | 217 | 24 | TMB quintile 4 | 0.16 | -0.63 | 0.92 | 1556.04 | 1.00 | 447 | 208 | 15 | 9 | FALSE | 0.17 |
| non-small cell lung cancer | RAS_12 | MGA | Any mutation | 367 | 140 | TMB quintile 5 | -0.01 | -0.36 | 0.35 | 1478.92 | 1.00 | 658 | 322 | 95 | 45 | FALSE | 0.01 |
| uterine cancer | RAS_12 | MGA | Any mutation | 48 | 24 | TMB quintile 5 | -1.86 | -4.12 | -0.25 | 1561.37 | 1.00 | 180 | 47 | 23 | 1 | FALSE | 1.21 |
| uterine cancer | RAS_12 | MGA | Any mutation | 6 | 82 | TMB quintile 6 | 0.09 | -1.68 | 2.22 | 1470.54 | 1.00 | 23 | 1 | 77 | 5 | FALSE | 0.03 |
| colorectal cancer | RAS_12 | MGA | Any mutation | 496 | 119 | TMB overall | -0.72 | -2.40 | 1.00 | 1483.58 | 1.00 | 855 | 472 | 95 | 24 | FALSE | 0.41 |
| non-small cell lung cancer | RAS_12 | MGA | Any mutation | 704 | 178 | TMB overall | 0.13 | -0.86 | 1.27 | 1566.28 | 1.00 | 1546 | 646 | 120 | 58 | FALSE | 0.09 |
| uterine cancer | RAS_12 | MGA | Any mutation | 54 | 106 | TMB overall | -0.87 | -4.05 | 2.67 | 1338.87 | 1.00 | 203 | 48 | 100 | 6 | FALSE | 0.21 |
| colorectal cancer | RAS_12 | KMT2B | Any mutation | 122 | 54 | TMB quintile 5 | -0.19 | -0.81 | 0.39 | 1488.68 | 1.00 | 176 | 104 | 36 | 18 | FALSE | 0.27 |
| colorectal cancer | RAS_12 | KMT2B | Any mutation | 13 | 115 | TMB quintile 6 | 0.68 | -0.91 | 2.73 | 1314.83 | 1.00 | 21 | 1 | 103 | 12 | FALSE | 0.33 |
| colorectal cancer | RAS_12 | KMT2B | Any mutation | 135 | 169 | TMB overall | 0.22 | -2.82 | 3.67 | 1243.88 | 1.00 | 197 | 105 | 139 | 30 | FALSE | 0.05 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 133 | 35 | TMB quintile 3 | 0.13 | -0.54 | 0.80 | 1317.64 | 1.00 | 285 | 121 | 23 | 12 | FALSE | 0.15 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 262 | 79 | TMB quintile 4 | 0.34 | -0.11 | 0.82 | 1564.52 | 1.00 | 418 | 227 | 44 | 35 | FALSE | 0.82 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 221 | 108 | TMB quintile 5 | 0.03 | -0.38 | 0.43 | 1513.15 | 1.00 | 299 | 180 | 67 | 41 | FALSE | 0.06 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 20 | 70 | TMB quintile 6 | 0.36 | -0.45 | 1.19 | 1578.09 | 1.00 | 66 | 8 | 58 | 12 | FALSE | 0.42 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 636 | 292 | TMB overall | 0.21 | -0.77 | 1.13 | 1569.29 | 1.00 | 1068 | 536 | 192 | 100 | FALSE | 0.19 |
| colorectal cancer | RAS_12 | ANKRD11 | Any mutation | 252 | 11 | TMB quintile 4 | -0.30 | -1.57 | 0.90 | 1500.55 | 1.00 | 443 | 248 | 7 | 4 | FALSE | 0.20 |
| colorectal cancer | RAS_12 | ANKRD11 | Any mutation | 202 | 43 | TMB quintile 5 | -1.40 | -2.31 | -0.59 | 1461.17 | 1.00 | 305 | 196 | 37 | 6 | FALSE | 2.80 |
| colorectal cancer | RAS_12 | ANKRD11 | Any mutation | 22 | 86 | TMB quintile 6 | -0.65 | -1.58 | 0.19 | 1527.16 | 1.00 | 62 | 13 | 77 | 9 | FALSE | 0.83 |
| colorectal cancer | RAS_12 | ANKRD11 | Any mutation | 476 | 140 | TMB overall | -0.79 | -2.84 | 1.10 | 1481.92 | 1.00 | 810 | 457 | 121 | 19 | FALSE | 0.36 |
| colorectal cancer | RAS_12 | POLD1 | Any mutation | 219 | 20 | TMB quintile 5 | -0.22 | -1.22 | 0.68 | 1551.78 | 1.00 | 349 | 212 | 13 | 7 | TRUE | 0.18 |
| colorectal cancer | RAS_12 | POLD1 | Any mutation | 20 | 83 | TMB quintile 6 | -0.41 | -1.35 | 0.56 | 1451.75 | 1.00 | 62 | 11 | 74 | 9 | TRUE | 0.40 |
| colorectal cancer | RAS_12 | POLD1 | Any mutation | 239 | 103 | TMB overall | -0.41 | -3.62 | 2.41 | 1496.10 | 1.00 | 411 | 223 | 87 | 16 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12 | PREX2 | Any mutation | 120 | 14 | TMB quintile 4 | -0.15 | -1.11 | 0.85 | 1528.37 | 1.00 | 230 | 115 | 9 | 5 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12 | PREX2 | Any mutation | 206 | 84 | TMB quintile 5 | -0.35 | -0.87 | 0.17 | 1601.59 | 1.00 | 360 | 184 | 62 | 22 | FALSE | 0.74 |
| non-small cell lung cancer | RAS_12 | PREX2 | Any mutation | 326 | 98 | TMB overall | -0.23 | -1.63 | 1.36 | 1490.55 | 1.00 | 590 | 299 | 71 | 27 | FALSE | 0.11 |
| colorectal cancer | RAS_12 | AMER1 | Any mutation | 147 | 13 | TMB quintile 3 | 0.19 | -0.81 | 1.18 | 1397.33 | 1.00 | 332 | 142 | 8 | 5 | FALSE | 0.15 |
| colorectal cancer | RAS_12 | AMER1 | Any mutation | 282 | 38 | TMB quintile 4 | 0.84 | 0.21 | 1.48 | 1434.16 | 1.00 | 495 | 260 | 16 | 22 | FALSE | 1.95 |
| colorectal cancer | RAS_12 | AMER1 | Any mutation | 233 | 62 | TMB quintile 5 | 0.37 | -0.13 | 0.91 | 1511.87 | 1.00 | 359 | 205 | 34 | 28 | FALSE | 0.80 |
| colorectal cancer | RAS_12 | AMER1 | Any mutation | 20 | 55 | TMB quintile 6 | -0.22 | -1.18 | 0.65 | 1446.02 | 1.00 | 84 | 14 | 49 | 6 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12 | AMER1 | Any mutation | 231 | 18 | TMB quintile 4 | 1.22 | 0.30 | 2.16 | 1468.15 | 1.00 | 524 | 220 | 7 | 11 | FALSE | 2.03 |
| non-small cell lung cancer | RAS_12 | AMER1 | Any mutation | 399 | 107 | TMB quintile 5 | 0.36 | -0.06 | 0.75 | 1541.29 | 1.00 | 771 | 356 | 64 | 43 | FALSE | 1.07 |
| colorectal cancer | RAS_12 | AMER1 | Any mutation | 682 | 168 | TMB overall | 0.31 | -0.86 | 1.44 | 1483.07 | 1.00 | 1270 | 621 | 107 | 61 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12 | AMER1 | Any mutation | 630 | 142 | TMB overall | 0.16 | -3.15 | 3.21 | 1453.57 | 1.00 | 1305 | 576 | 88 | 54 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12 | EPHA7 | Any mutation | 217 | 14 | TMB quintile 4 | -0.08 | -1.15 | 0.86 | 1594.35 | 1.00 | 452 | 212 | 9 | 5 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12 | EPHA7 | Any mutation | 364 | 101 | TMB quintile 5 | -0.30 | -0.79 | 0.14 | 1532.50 | 1.00 | 672 | 337 | 74 | 27 | FALSE | 0.69 |
| non-small cell lung cancer | RAS_12 | EPHA7 | Any mutation | 581 | 115 | TMB overall | -0.15 | -1.81 | 1.75 | 1534.72 | 1.00 | 1124 | 549 | 83 | 32 | FALSE | 0.06 |
| colorectal cancer | KRAS_12 | SPEN | Any mutation | 271 | 11 | TMB quintile 4 | -0.04 | -1.29 | 1.06 | 1456.64 | 1.00 | 513 | 267 | 7 | 4 | FALSE | 0.03 |
| colorectal cancer | KRAS_12 | SPEN | Any mutation | 229 | 31 | TMB quintile 5 | 0.06 | -0.68 | 0.84 | 1519.57 | 1.00 | 382 | 217 | 19 | 12 | FALSE | 0.06 |
| colorectal cancer | KRAS_12 | SPEN | Any mutation | 18 | 107 | TMB quintile 6 | -0.45 | -1.40 | 0.53 | 1537.10 | 1.00 | 63 | 9 | 98 | 9 | FALSE | 0.44 |
| non-small cell lung cancer | KRAS_12 | SPEN | Any mutation | 230 | 15 | TMB quintile 4 | -1.11 | -2.57 | 0.01 | 1486.62 | 1.00 | 519 | 228 | 13 | 2 | FALSE | 1.07 |
| non-small cell lung cancer | KRAS_12 | SPEN | Any mutation | 396 | 87 | TMB quintile 5 | -0.87 | -1.45 | -0.32 | 1472.29 | 1.00 | 785 | 381 | 72 | 15 | FALSE | 2.54 |
| uterine cancer | KRAS_12 | SPEN | Any mutation | 50 | 37 | TMB quintile 5 | 0.71 | -0.06 | 1.44 | 1697.85 | 1.00 | 188 | 39 | 26 | 11 | FALSE | 1.18 |
| colorectal cancer | KRAS_12 | SPEN | Any mutation | 518 | 149 | TMB overall | -0.13 | -2.22 | 1.93 | 1716.65 | 1.00 | 958 | 493 | 124 | 25 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12 | SPEN | Any mutation | 626 | 102 | TMB overall | -0.97 | -2.56 | 0.78 | 1332.35 | 1.00 | 1304 | 609 | 85 | 17 | FALSE | 0.61 |
| uterine cancer | KRAS_12 | SPEN | Any mutation | 55 | 114 | TMB overall | 1.18 | -2.26 | 4.90 | 1432.12 | 1.00 | 217 | 39 | 98 | 16 | FALSE | 0.29 |
| colorectal cancer | KRAS_12 | KMT2C | Any mutation | 264 | 12 | TMB quintile 4 | -0.26 | -1.48 | 0.89 | 1427.65 | 1.00 | 501 | 260 | 8 | 4 | FALSE | 0.17 |
| colorectal cancer | KRAS_12 | KMT2C | Any mutation | 212 | 61 | TMB quintile 5 | -0.78 | -1.42 | -0.17 | 1652.82 | 1.00 | 336 | 199 | 48 | 13 | FALSE | 1.76 |
| colorectal cancer | KRAS_12 | KMT2C | Any mutation | 23 | 116 | TMB quintile 6 | -0.08 | -0.94 | 0.79 | 982.26 | 1.00 | 63 | 9 | 102 | 14 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12 | KMT2C | Any mutation | 130 | 13 | TMB quintile 3 | -0.86 | -2.43 | 0.25 | 1461.57 | 1.00 | 480 | 129 | 12 | 1 | FALSE | 0.71 |
| non-small cell lung cancer | KRAS_12 | KMT2C | Any mutation | 230 | 36 | TMB quintile 4 | -0.11 | -0.84 | 0.57 | 1439.69 | 1.00 | 506 | 219 | 25 | 11 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12 | KMT2C | Any mutation | 396 | 155 | TMB quintile 5 | -0.30 | -0.68 | 0.07 | 1300.03 | 1.00 | 720 | 355 | 114 | 41 | FALSE | 0.92 |
| uterine cancer | KRAS_12 | KMT2C | Any mutation | 48 | 42 | TMB quintile 5 | -0.51 | -1.50 | 0.34 | 1527.83 | 1.00 | 165 | 42 | 36 | 6 | FALSE | 0.54 |
| colorectal cancer | KRAS_12 | KMT2C | Any mutation | 499 | 189 | TMB overall | -0.39 | -2.57 | 1.67 | 1492.50 | 1.00 | 900 | 468 | 158 | 31 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12 | KMT2C | Any mutation | 756 | 204 | TMB overall | -0.42 | -1.59 | 0.63 | 1565.65 | 1.00 | 1706 | 703 | 151 | 53 | FALSE | 0.33 |
| uterine cancer | KRAS_12 | KMT2C | Any mutation | 51 | 133 | TMB overall | -0.60 | -3.42 | 2.43 | 1275.31 | 1.00 | 186 | 43 | 125 | 8 | FALSE | 0.17 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 23 | 39 | TMB quintile 2 | -0.07 | -0.86 | 0.82 | 1448.09 | 1.00 | 64 | 14 | 30 | 9 | TRUE | 0.06 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 32 | 74 | TMB quintile 3 | -0.07 | -0.73 | 0.63 | 1099.01 | 1.00 | 56 | 15 | 57 | 17 | TRUE | 0.08 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 34 | 87 | TMB quintile 4 | -0.66 | -1.38 | 0.00 | 1230.29 | 1.00 | 41 | 19 | 72 | 15 | TRUE | 1.18 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 37 | 153 | TMB quintile 5 | -0.64 | -1.27 | 0.03 | 1481.01 | 1.00 | 41 | 15 | 131 | 22 | TRUE | 1.23 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 17 | 104 | TMB quintile 2 | -1.43 | -2.27 | -0.60 | 1381.12 | 1.00 | 25 | 9 | 96 | 8 | TRUE | 3.07 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 145 | 411 | TMB quintile 3 | -1.26 | -1.74 | -0.81 | 1494.44 | 1.00 | 38 | 47 | 313 | 98 | TRUE | 7.02 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 280 | 655 | TMB quintile 4 | -1.18 | -1.52 | -0.83 | 1389.62 | 1.00 | 76 | 99 | 474 | 181 | TRUE | 10.57 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 247 | 423 | TMB quintile 5 | -0.60 | -0.90 | -0.28 | 1511.09 | 1.00 | 136 | 113 | 289 | 134 | TRUE | 3.76 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 20 | 78 | TMB quintile 6 | -1.06 | -1.94 | -0.17 | 1558.71 | 1.00 | 78 | 14 | 72 | 6 | TRUE | 1.70 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 75 | 180 | TMB quintile 2 | -1.21 | -1.80 | -0.66 | 1523.89 | 1.00 | 204 | 59 | 164 | 16 | TRUE | 4.54 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 130 | 324 | TMB quintile 3 | -1.40 | -1.80 | -0.97 | 1323.14 | 1.00 | 218 | 97 | 291 | 33 | TRUE | 10.49 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 231 | 450 | TMB quintile 4 | -1.56 | -1.87 | -1.24 | 1604.00 | 1.00 | 178 | 160 | 379 | 71 | TRUE | 21.15 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 410 | 996 | TMB quintile 5 | -1.70 | -1.97 | -1.44 | 1553.89 | 1.00 | 131 | 201 | 787 | 209 | TRUE | 36.18 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 252 | 216 | TMB quintile 2 | 1.75 | 1.35 | 2.23 | 1589.93 | 1.00 | 68 | 62 | 26 | 190 | TRUE | 14.18 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 420 | 392 | TMB quintile 3 | 1.79 | 1.44 | 2.16 | 1443.54 | 1.00 | 60 | 74 | 46 | 346 | TRUE | 36.18 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 217 | 206 | TMB quintile 4 | 1.48 | 0.95 | 1.91 | 1417.71 | 1.00 | 30 | 48 | 37 | 169 | TRUE | 8.64 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 34 | 34 | TMB quintile 5 | 1.47 | 0.84 | 2.05 | 1573.08 | 1.00 | 13 | 9 | 9 | 25 | TRUE | 6.06 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 12 | 77 | TMB quintile 2 | -1.47 | -2.45 | -0.47 | 1527.94 | 1.00 | 60 | 9 | 74 | 3 | TRUE | 2.47 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 25 | 167 | TMB quintile 3 | -1.30 | -2.05 | -0.60 | 1757.59 | 1.00 | 69 | 15 | 157 | 10 | TRUE | 3.40 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 39 | 132 | TMB quintile 4 | -1.65 | -2.40 | -0.93 | 1343.80 | 1.00 | 81 | 31 | 124 | 8 | TRUE | 5.06 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 50 | 68 | TMB quintile 5 | -1.26 | -2.08 | -0.49 | 1503.92 | 1.00 | 159 | 44 | 62 | 6 | TRUE | 2.74 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 129 | 378 | TMB overall | -0.41 | -1.18 | 0.33 | 1415.21 | 1.00 | 204 | 64 | 313 | 65 | TRUE | 0.55 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 709 | 1671 | TMB overall | -1.09 | -1.88 | -0.32 | 1464.24 | 1.00 | 353 | 282 | 1244 | 427 | TRUE | 2.25 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 846 | 1950 | TMB overall | -1.46 | -2.27 | -0.67 | 1493.14 | 1.00 | 731 | 517 | 1621 | 329 | TRUE | 3.60 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 923 | 848 | TMB overall | 1.62 | 1.16 | 2.10 | 1600.17 | 1.00 | 171 | 193 | 118 | 730 | TRUE | 10.67 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 128 | 483 | TMB overall | -1.48 | -2.30 | -0.68 | 1474.44 | 1.00 | 405 | 101 | 456 | 27 | TRUE | 3.65 |
| colorectal cancer | KRAS_12 | ATRX | Any mutation | 271 | 19 | TMB quintile 4 | -0.29 | -1.25 | 0.61 | 1560.87 | 1.00 | 507 | 265 | 13 | 6 | TRUE | 0.27 |
| colorectal cancer | KRAS_12 | ATRX | Any mutation | 227 | 35 | TMB quintile 5 | -0.14 | -0.87 | 0.57 | 1414.62 | 1.00 | 378 | 215 | 23 | 12 | TRUE | 0.16 |
| colorectal cancer | KRAS_12 | ATRX | Any mutation | 18 | 59 | TMB quintile 6 | -1.11 | -2.30 | -0.02 | 1503.66 | 1.00 | 86 | 15 | 56 | 3 | TRUE | 1.21 |
| non-small cell lung cancer | KRAS_12 | ATRX | Any mutation | 230 | 32 | TMB quintile 4 | -0.10 | -0.83 | 0.59 | 1351.47 | 1.00 | 510 | 221 | 23 | 9 | TRUE | 0.11 |
| non-small cell lung cancer | KRAS_12 | ATRX | Any mutation | 402 | 160 | TMB quintile 5 | 0.24 | -0.12 | 0.56 | 1499.52 | 1.00 | 746 | 343 | 101 | 59 | TRUE | 0.77 |
| uterine cancer | KRAS_12 | ATRX | Any mutation | 12 | 11 | TMB quintile 2 | -2.50 | -6.61 | 0.16 | 1519.36 | 1.00 | 122 | 12 | 11 | 0 | TRUE | 0.81 |
| uterine cancer | KRAS_12 | ATRX | Any mutation | 24 | 14 | TMB quintile 3 | -2.66 | -6.63 | -0.10 | 1516.97 | 1.00 | 203 | 24 | 14 | 0 | TRUE | 0.97 |
| uterine cancer | KRAS_12 | ATRX | Any mutation | 49 | 19 | TMB quintile 5 | -0.57 | -2.08 | 0.66 | 1488.54 | 1.00 | 199 | 46 | 16 | 3 | TRUE | 0.38 |
| colorectal cancer | KRAS_12 | ATRX | Any mutation | 516 | 113 | TMB overall | -0.52 | -2.20 | 1.18 | 1541.24 | 1.00 | 971 | 495 | 92 | 21 | TRUE | 0.28 |
| non-small cell lung cancer | KRAS_12 | ATRX | Any mutation | 632 | 192 | TMB overall | 0.08 | -1.36 | 1.51 | 1617.23 | 1.00 | 1256 | 564 | 124 | 68 | TRUE | 0.04 |
| uterine cancer | KRAS_12 | ATRX | Any mutation | 87 | 156 | TMB overall | -1.81 | -4.27 | 0.32 | 1509.57 | 1.00 | 551 | 83 | 152 | 4 | TRUE | 0.94 |
| colorectal cancer | KRAS_12 | ATR | Any mutation | 227 | 35 | TMB quintile 5 | -1.13 | -2.08 | -0.32 | 1300.43 | 1.00 | 371 | 221 | 29 | 6 | FALSE | 1.92 |
| colorectal cancer | KRAS_12 | ATR | Any mutation | 20 | 65 | TMB quintile 6 | -0.78 | -1.92 | 0.18 | 1502.24 | 1.00 | 91 | 15 | 60 | 5 | FALSE | 0.85 |
| non-small cell lung cancer | KRAS_12 | ATR | Any mutation | 130 | 12 | TMB quintile 3 | -0.45 | -1.70 | 0.58 | 1483.75 | 1.00 | 486 | 128 | 10 | 2 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12 | ATR | Any mutation | 230 | 15 | TMB quintile 4 | -0.55 | -1.66 | 0.42 | 1489.26 | 1.00 | 522 | 227 | 12 | 3 | FALSE | 0.53 |
| non-small cell lung cancer | KRAS_12 | ATR | Any mutation | 396 | 93 | TMB quintile 5 | -0.22 | -0.69 | 0.22 | 1409.24 | 1.00 | 762 | 370 | 67 | 26 | FALSE | 0.45 |
| colorectal cancer | KRAS_12 | ATR | Any mutation | 247 | 100 | TMB overall | -0.90 | -2.96 | 1.31 | 1614.30 | 1.00 | 462 | 236 | 89 | 11 | FALSE | 0.38 |
| non-small cell lung cancer | KRAS_12 | ATR | Any mutation | 756 | 120 | TMB overall | -0.38 | -1.37 | 0.60 | 1364.97 | 1.00 | 1770 | 725 | 89 | 31 | FALSE | 0.33 |
| non-small cell lung cancer | KRAS_12 | PDGFRA | Any mutation | 230 | 16 | TMB quintile 4 | -0.12 | -1.16 | 0.86 | 1473.24 | 1.00 | 521 | 225 | 11 | 5 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12 | PDGFRA | Any mutation | 397 | 115 | TMB quintile 5 | -0.22 | -0.63 | 0.17 | 1511.50 | 1.00 | 750 | 365 | 83 | 32 | TRUE | 0.51 |
| non-small cell lung cancer | KRAS_12 | PDGFRA | Any mutation | 627 | 131 | TMB overall | -0.16 | -2.01 | 1.78 | 1354.99 | 1.00 | 1271 | 590 | 94 | 37 | TRUE | 0.07 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 144 | 22 | TMB quintile 3 | -0.63 | -1.55 | 0.25 | 1513.56 | 1.00 | 326 | 140 | 18 | 4 | TRUE | 0.74 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 274 | 85 | TMB quintile 4 | -0.15 | -0.65 | 0.29 | 1377.06 | 1.00 | 470 | 247 | 58 | 27 | TRUE | 0.28 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 243 | 160 | TMB quintile 5 | 0.35 | -0.02 | 0.69 | 1412.16 | 1.00 | 317 | 173 | 90 | 70 | TRUE | 1.29 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 18 | 65 | TMB quintile 6 | -0.28 | -1.20 | 0.56 | 1543.18 | 1.00 | 73 | 11 | 58 | 7 | TRUE | 0.26 |
| uterine cancer | KRAS_12 | FBXW7 | Any mutation | 24 | 30 | TMB quintile 3 | -0.80 | -2.38 | 0.44 | 1620.51 | 1.00 | 189 | 23 | 29 | 1 | TRUE | 0.57 |
| uterine cancer | KRAS_12 | FBXW7 | Any mutation | 39 | 29 | TMB quintile 4 | -0.02 | -1.09 | 0.89 | 1609.87 | 1.00 | 166 | 34 | 24 | 5 | TRUE | 0.01 |
| uterine cancer | KRAS_12 | FBXW7 | Any mutation | 49 | 30 | TMB quintile 5 | 0.60 | -0.26 | 1.38 | 1426.88 | 1.00 | 192 | 40 | 21 | 9 | TRUE | 0.83 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 679 | 332 | TMB overall | -0.19 | -1.18 | 0.79 | 1470.05 | 1.00 | 1186 | 571 | 224 | 108 | TRUE | 0.15 |
| uterine cancer | KRAS_12 | FBXW7 | Any mutation | 116 | 136 | TMB overall | 0.11 | -1.23 | 1.51 | 1267.62 | 1.00 | 576 | 97 | 117 | 19 | TRUE | 0.06 |
| uterine cancer | KRAS_12 | NSD1 | Any mutation | 52 | 46 | TMB quintile 5 | 0.17 | -0.64 | 0.96 | 1665.57 | 1.00 | 185 | 42 | 36 | 10 | FALSE | 0.18 |
| uterine cancer | KRAS_12 | NSD1 | Any mutation | 56 | 115 | TMB overall | 0.68 | -2.53 | 4.44 | 1443.47 | 1.00 | 209 | 42 | 101 | 14 | FALSE | 0.16 |
| colorectal cancer | KRAS_12 | FLT4 | Any mutation | 271 | 20 | TMB quintile 4 | -0.52 | -1.65 | 0.42 | 1512.14 | 1.00 | 505 | 266 | 15 | 5 | TRUE | 0.50 |
| colorectal cancer | KRAS_12 | FLT4 | Any mutation | 228 | 40 | TMB quintile 5 | -0.43 | -1.15 | 0.25 | 1436.86 | 1.00 | 373 | 217 | 29 | 11 | TRUE | 0.65 |
| colorectal cancer | KRAS_12 | FLT4 | Any mutation | 21 | 72 | TMB quintile 6 | 0.38 | -0.45 | 1.22 | 1501.96 | 1.00 | 74 | 9 | 60 | 12 | TRUE | 0.41 |
| non-small cell lung cancer | KRAS_12 | FLT4 | Any mutation | 230 | 14 | TMB quintile 4 | 0.51 | -0.57 | 1.58 | 1490.65 | 1.00 | 525 | 223 | 7 | 7 | TRUE | 0.47 |
| non-small cell lung cancer | KRAS_12 | FLT4 | Any mutation | 397 | 74 | TMB quintile 5 | -0.22 | -0.75 | 0.27 | 1491.07 | 1.00 | 776 | 377 | 54 | 20 | TRUE | 0.40 |
| colorectal cancer | KRAS_12 | FLT4 | Any mutation | 520 | 132 | TMB overall | -0.17 | -1.83 | 1.71 | 1528.81 | 1.00 | 952 | 492 | 104 | 28 | TRUE | 0.07 |
| non-small cell lung cancer | KRAS_12 | FLT4 | Any mutation | 627 | 88 | TMB overall | 0.12 | -1.71 | 2.09 | 1339.44 | 1.00 | 1301 | 600 | 61 | 27 | TRUE | 0.05 |
| colorectal cancer | KRAS_12 | PTPRD | Any mutation | 227 | 29 | TMB quintile 5 | -0.68 | -1.56 | 0.16 | 1354.05 | 1.00 | 379 | 220 | 22 | 7 | FALSE | 0.93 |
| colorectal cancer | KRAS_12 | PTPRD | Any mutation | 18 | 61 | TMB quintile 6 | -0.63 | -1.76 | 0.41 | 1456.50 | 1.00 | 86 | 13 | 56 | 5 | FALSE | 0.60 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 130 | 16 | TMB quintile 3 | -0.33 | -1.66 | 0.82 | 1473.50 | 1.00 | 484 | 127 | 13 | 3 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 231 | 53 | TMB quintile 4 | 0.39 | -0.20 | 0.96 | 1491.09 | 1.00 | 500 | 210 | 32 | 21 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 408 | 298 | TMB quintile 5 | -0.15 | -0.42 | 0.12 | 1422.13 | 1.00 | 656 | 320 | 210 | 88 | FALSE | 0.53 |
| colorectal cancer | KRAS_12 | PTPRD | Any mutation | 245 | 90 | TMB overall | -0.64 | -2.95 | 1.72 | 1531.73 | 1.00 | 465 | 233 | 78 | 12 | FALSE | 0.23 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 769 | 384 | TMB overall | -0.30 | -2.35 | 1.63 | 1522.47 | 1.00 | 1647 | 657 | 272 | 112 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | PIK3C2G | Any mutation | 230 | 12 | TMB quintile 4 | -0.47 | -1.74 | 0.72 | 1398.68 | 1.00 | 520 | 227 | 9 | 3 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12 | PIK3C2G | Any mutation | 395 | 103 | TMB quintile 5 | -0.50 | -0.98 | -0.05 | 1586.81 | 1.00 | 751 | 371 | 79 | 24 | FALSE | 1.41 |
| non-small cell lung cancer | KRAS_12 | PIK3C2G | Any mutation | 625 | 115 | TMB overall | -0.45 | -2.34 | 1.75 | 1439.69 | 1.00 | 1271 | 598 | 88 | 27 | FALSE | 0.19 |
| colorectal cancer | KRAS_12 | CREBBP | Any mutation | 271 | 17 | TMB quintile 4 | -0.98 | -2.31 | 0.16 | 1502.42 | 1.00 | 506 | 268 | 14 | 3 | TRUE | 0.98 |
| colorectal cancer | KRAS_12 | CREBBP | Any mutation | 230 | 49 | TMB quintile 5 | -0.22 | -0.82 | 0.41 | 1426.92 | 1.00 | 370 | 214 | 33 | 16 | TRUE | 0.32 |
| colorectal cancer | KRAS_12 | CREBBP | Any mutation | 22 | 116 | TMB quintile 6 | -0.49 | -1.38 | 0.38 | 1254.05 | 1.00 | 54 | 10 | 104 | 12 | TRUE | 0.58 |
| non-small cell lung cancer | KRAS_12 | CREBBP | Any mutation | 130 | 11 | TMB quintile 3 | 0.02 | -1.14 | 1.17 | 1466.08 | 1.00 | 488 | 127 | 8 | 3 | TRUE | 0.01 |
| non-small cell lung cancer | KRAS_12 | CREBBP | Any mutation | 230 | 12 | TMB quintile 4 | -0.07 | -1.11 | 0.94 | 1583.93 | 1.00 | 524 | 226 | 8 | 4 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12 | CREBBP | Any mutation | 395 | 106 | TMB quintile 5 | -0.32 | -0.78 | 0.13 | 1407.43 | 1.00 | 758 | 368 | 79 | 27 | TRUE | 0.77 |
| colorectal cancer | KRAS_12 | CREBBP | Any mutation | 523 | 182 | TMB overall | -0.56 | -2.61 | 1.51 | 1469.83 | 1.00 | 930 | 492 | 151 | 31 | TRUE | 0.25 |
| non-small cell lung cancer | KRAS_12 | CREBBP | Any mutation | 755 | 129 | TMB overall | -0.12 | -1.34 | 1.10 | 1445.64 | 1.00 | 1770 | 721 | 95 | 34 | TRUE | 0.08 |
| colorectal cancer | KRAS_12 | AXIN2 | Any mutation | 271 | 20 | TMB quintile 4 | 0.48 | -0.45 | 1.41 | 1492.35 | 1.00 | 510 | 261 | 10 | 10 | TRUE | 0.51 |
| colorectal cancer | KRAS_12 | AXIN2 | Any mutation | 227 | 27 | TMB quintile 5 | -0.75 | -1.74 | 0.10 | 1609.34 | 1.00 | 379 | 221 | 21 | 6 | TRUE | 0.98 |
| colorectal cancer | KRAS_12 | AXIN2 | Any mutation | 18 | 63 | TMB quintile 6 | -0.88 | -1.98 | 0.10 | 1453.68 | 1.00 | 81 | 14 | 59 | 4 | TRUE | 0.97 |
| colorectal cancer | KRAS_12 | AXIN2 | Any mutation | 516 | 110 | TMB overall | -0.40 | -2.21 | 1.37 | 1507.25 | 1.00 | 970 | 496 | 90 | 20 | TRUE | 0.18 |
| non-small cell lung cancer | KRAS_12 | DOT1L | Any mutation | 230 | 24 | TMB quintile 4 | -0.31 | -1.05 | 0.38 | 1522.29 | 1.00 | 516 | 224 | 18 | 6 | FALSE | 0.39 |
| non-small cell lung cancer | KRAS_12 | DOT1L | Any mutation | 396 | 75 | TMB quintile 5 | -0.16 | -0.65 | 0.32 | 1550.79 | 1.00 | 775 | 374 | 53 | 22 | FALSE | 0.28 |
| non-small cell lung cancer | KRAS_12 | DOT1L | Any mutation | 626 | 99 | TMB overall | -0.24 | -1.26 | 0.70 | 1510.15 | 1.00 | 1291 | 598 | 71 | 28 | FALSE | 0.20 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 140 | 17 | TMB quintile 3 | -0.40 | -1.52 | 0.65 | 1158.39 | 1.00 | 329 | 136 | 13 | 4 | FALSE | 0.32 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 264 | 34 | TMB quintile 4 | 0.12 | -0.55 | 0.76 | 1455.89 | 1.00 | 488 | 251 | 21 | 13 | FALSE | 0.13 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 215 | 74 | TMB quintile 5 | -0.17 | -0.70 | 0.33 | 1504.40 | 1.00 | 335 | 191 | 50 | 24 | FALSE | 0.29 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 23 | 128 | TMB quintile 6 | -0.14 | -1.02 | 0.80 | 1539.97 | 1.00 | 42 | 7 | 112 | 16 | FALSE | 0.12 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 642 | 253 | TMB overall | -0.12 | -1.54 | 1.29 | 1445.38 | 1.00 | 1194 | 585 | 196 | 57 | FALSE | 0.06 |
| colorectal cancer | KRAS_12 | SMARCA4 | Any mutation | 271 | 16 | TMB quintile 4 | -0.57 | -1.74 | 0.44 | 1374.94 | 1.00 | 508 | 267 | 12 | 4 | FALSE | 0.50 |
| colorectal cancer | KRAS_12 | SMARCA4 | Any mutation | 228 | 47 | TMB quintile 5 | -0.24 | -0.88 | 0.37 | 1504.92 | 1.00 | 370 | 213 | 32 | 15 | FALSE | 0.34 |
| colorectal cancer | KRAS_12 | SMARCA4 | Any mutation | 22 | 100 | TMB quintile 6 | -0.18 | -1.08 | 0.69 | 1379.86 | 1.00 | 65 | 10 | 88 | 12 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 131 | 35 | TMB quintile 3 | 0.81 | 0.15 | 1.51 | 1471.32 | 1.00 | 479 | 116 | 20 | 15 | FALSE | 1.67 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 231 | 67 | TMB quintile 4 | 0.15 | -0.34 | 0.66 | 1577.00 | 1.00 | 490 | 209 | 45 | 22 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 399 | 194 | TMB quintile 5 | -0.11 | -0.43 | 0.19 | 1371.69 | 1.00 | 698 | 342 | 137 | 57 | FALSE | 0.30 |
| uterine cancer | KRAS_12 | SMARCA4 | Any mutation | 51 | 39 | TMB quintile 5 | -0.17 | -1.12 | 0.69 | 1364.35 | 1.00 | 189 | 44 | 32 | 7 | FALSE | 0.15 |
| colorectal cancer | KRAS_12 | SMARCA4 | Any mutation | 521 | 163 | TMB overall | -0.29 | -2.19 | 1.62 | 1458.43 | 1.00 | 943 | 490 | 132 | 31 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 761 | 296 | TMB overall | 0.30 | -0.62 | 1.26 | 1496.06 | 1.00 | 1667 | 667 | 202 | 94 | FALSE | 0.28 |
| uterine cancer | KRAS_12 | SMARCA4 | Any mutation | 53 | 91 | TMB overall | -0.47 | -3.26 | 2.61 | 1528.65 | 1.00 | 219 | 45 | 83 | 8 | FALSE | 0.13 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 144 | 18 | TMB quintile 3 | 0.35 | -0.53 | 1.24 | 1474.43 | 1.00 | 333 | 136 | 10 | 8 | FALSE | 0.35 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 271 | 39 | TMB quintile 4 | -1.20 | -2.17 | -0.39 | 1458.66 | 1.00 | 486 | 266 | 34 | 5 | FALSE | 2.17 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 229 | 59 | TMB quintile 5 | -0.57 | -1.18 | 0.02 | 1555.37 | 1.00 | 356 | 214 | 44 | 15 | FALSE | 1.18 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 19 | 66 | TMB quintile 6 | -0.10 | -1.06 | 0.77 | 1457.15 | 1.00 | 82 | 11 | 58 | 8 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 130 | 17 | TMB quintile 3 | -0.02 | -1.23 | 1.01 | 1454.06 | 1.00 | 483 | 126 | 13 | 4 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 230 | 38 | TMB quintile 4 | -0.12 | -0.84 | 0.56 | 1499.41 | 1.00 | 506 | 219 | 27 | 11 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 404 | 272 | TMB quintile 5 | -0.39 | -0.69 | -0.10 | 1483.13 | 1.00 | 668 | 335 | 203 | 69 | FALSE | 2.02 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 663 | 182 | TMB overall | -0.38 | -1.55 | 0.83 | 1689.89 | 1.00 | 1257 | 627 | 146 | 36 | FALSE | 0.28 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 764 | 348 | TMB overall | -0.52 | -2.56 | 1.59 | 1514.31 | 1.00 | 1662 | 680 | 264 | 84 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12 | HGF | Any mutation | 230 | 27 | TMB quintile 4 | -0.31 | -1.25 | 0.52 | 1464.92 | 1.00 | 513 | 223 | 20 | 7 | FALSE | 0.31 |
| non-small cell lung cancer | KRAS_12 | HGF | Any mutation | 397 | 138 | TMB quintile 5 | -0.22 | -0.60 | 0.17 | 1645.70 | 1.00 | 734 | 358 | 99 | 39 | FALSE | 0.57 |
| non-small cell lung cancer | KRAS_12 | HGF | Any mutation | 627 | 180 | TMB overall | -0.65 | -3.56 | 1.89 | 1704.76 | 1.00 | 1254 | 581 | 134 | 46 | FALSE | 0.20 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 146 | 51 | TMB quintile 3 | 0.81 | 0.24 | 1.39 | 1570.74 | 1.00 | 318 | 121 | 26 | 25 | TRUE | 2.31 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 273 | 146 | TMB quintile 4 | 0.54 | 0.17 | 0.88 | 1438.83 | 1.00 | 444 | 207 | 80 | 66 | TRUE | 2.51 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 234 | 209 | TMB quintile 5 | 0.06 | -0.29 | 0.39 | 1584.30 | 1.00 | 282 | 157 | 132 | 77 | TRUE | 0.14 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 21 | 95 | TMB quintile 6 | -0.13 | -0.99 | 0.68 | 1367.60 | 1.00 | 62 | 10 | 84 | 11 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 75 | 18 | TMB quintile 2 | -0.68 | -1.69 | 0.13 | 1527.70 | 1.00 | 349 | 74 | 17 | 1 | TRUE | 0.86 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 130 | 34 | TMB quintile 3 | -0.49 | -1.25 | 0.20 | 1570.08 | 1.00 | 467 | 125 | 29 | 5 | TRUE | 0.75 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 231 | 56 | TMB quintile 4 | -0.53 | -1.15 | 0.04 | 1634.10 | 1.00 | 487 | 220 | 45 | 11 | TRUE | 1.15 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 396 | 123 | TMB quintile 5 | -0.16 | -0.57 | 0.23 | 1439.45 | 1.00 | 750 | 359 | 86 | 37 | TRUE | 0.36 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 12 | 33 | TMB quintile 2 | -0.23 | -1.46 | 0.86 | 1561.07 | 1.00 | 103 | 10 | 31 | 2 | TRUE | 0.16 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 24 | 103 | TMB quintile 3 | 0.07 | -0.73 | 0.86 | 1516.67 | 1.00 | 134 | 14 | 93 | 10 | TRUE | 0.07 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 43 | 121 | TMB quintile 4 | 0.64 | 0.03 | 1.33 | 1294.59 | 1.00 | 109 | 16 | 94 | 27 | TRUE | 1.32 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 63 | 196 | TMB quintile 5 | 0.47 | -0.05 | 1.06 | 1394.57 | 1.00 | 102 | 19 | 152 | 44 | TRUE | 1.00 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 674 | 501 | TMB overall | 0.34 | -0.69 | 1.38 | 1530.05 | 1.00 | 1106 | 495 | 322 | 179 | TRUE | 0.29 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 832 | 231 | TMB overall | -0.47 | -1.11 | 0.11 | 1545.60 | 1.00 | 2053 | 778 | 177 | 54 | TRUE | 0.87 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 146 | 548 | TMB overall | 0.17 | -0.78 | 1.12 | 1440.93 | 1.00 | 463 | 59 | 461 | 87 | TRUE | 0.14 |
| colorectal cancer | KRAS_12 | ALK | Any mutation | 271 | 20 | TMB quintile 4 | -0.90 | -1.98 | 0.09 | 1383.22 | 1.00 | 504 | 267 | 16 | 4 | TRUE | 1.04 |
| colorectal cancer | KRAS_12 | ALK | Any mutation | 227 | 42 | TMB quintile 5 | -0.83 | -1.61 | -0.14 | 1518.12 | 1.00 | 368 | 218 | 33 | 9 | TRUE | 1.55 |
| colorectal cancer | KRAS_12 | ALK | Any mutation | 18 | 45 | TMB quintile 6 | -0.91 | -2.10 | 0.21 | 1457.58 | 1.00 | 95 | 15 | 42 | 3 | TRUE | 0.86 |
| non-small cell lung cancer | KRAS_12 | ALK | Any mutation | 130 | 13 | TMB quintile 3 | -0.56 | -2.09 | 0.76 | 1339.75 | 1.00 | 486 | 128 | 11 | 2 | TRUE | 0.36 |
| non-small cell lung cancer | KRAS_12 | ALK | Any mutation | 230 | 22 | TMB quintile 4 | 0.19 | -0.69 | 1.05 | 1568.39 | 1.00 | 519 | 222 | 14 | 8 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12 | ALK | Any mutation | 395 | 118 | TMB quintile 5 | -0.05 | -0.46 | 0.35 | 1446.00 | 1.00 | 753 | 358 | 81 | 37 | TRUE | 0.10 |
| colorectal cancer | KRAS_12 | ALK | Any mutation | 516 | 107 | TMB overall | -0.89 | -2.48 | 0.54 | 1400.16 | 1.00 | 967 | 500 | 91 | 16 | TRUE | 0.65 |
| non-small cell lung cancer | KRAS_12 | ALK | Any mutation | 755 | 164 | TMB overall | -0.35 | -2.16 | 1.44 | 1551.80 | 1.00 | 1767 | 708 | 117 | 47 | TRUE | 0.15 |
| colorectal cancer | KRAS_12 | RNF43 | Any mutation | 144 | 12 | TMB quintile 3 | -0.95 | -2.54 | 0.27 | 1410.54 | 1.00 | 333 | 142 | 10 | 2 | TRUE | 0.74 |
| colorectal cancer | KRAS_12 | RNF43 | Any mutation | 271 | 30 | TMB quintile 4 | -0.45 | -1.31 | 0.30 | 1443.36 | 1.00 | 499 | 263 | 22 | 8 | TRUE | 0.57 |
| colorectal cancer | KRAS_12 | RNF43 | Any mutation | 232 | 76 | TMB quintile 5 | -0.87 | -1.50 | -0.29 | 1483.07 | 1.00 | 348 | 216 | 60 | 16 | TRUE | 2.38 |
| colorectal cancer | KRAS_12 | RNF43 | Any mutation | 21 | 146 | TMB quintile 6 | -0.68 | -1.59 | 0.21 | 1499.70 | 1.00 | 41 | 8 | 133 | 13 | TRUE | 0.86 |
| colorectal cancer | KRAS_12 | RNF43 | Any mutation | 668 | 264 | TMB overall | -0.72 | -2.33 | 0.87 | 1493.27 | 1.00 | 1221 | 629 | 225 | 39 | TRUE | 0.43 |
| colorectal cancer | KRAS_12 | PTEN | Any mutation | 271 | 29 | TMB quintile 4 | 0.00 | -0.78 | 0.75 | 1391.80 | 1.00 | 503 | 260 | 18 | 11 | TRUE | 0.00 |
| colorectal cancer | KRAS_12 | PTEN | Any mutation | 227 | 69 | TMB quintile 5 | -0.85 | -1.46 | -0.27 | 1497.69 | 1.00 | 360 | 213 | 55 | 14 | TRUE | 2.28 |
| colorectal cancer | KRAS_12 | PTEN | Any mutation | 20 | 80 | TMB quintile 6 | -0.82 | -1.81 | 0.07 | 1630.94 | 1.00 | 76 | 14 | 74 | 6 | TRUE | 1.05 |
| non-small cell lung cancer | KRAS_12 | PTEN | Any mutation | 130 | 17 | TMB quintile 3 | -1.45 | -2.80 | -0.39 | 1441.05 | 1.00 | 480 | 129 | 16 | 1 | TRUE | 1.81 |
| non-small cell lung cancer | KRAS_12 | PTEN | Any mutation | 230 | 27 | TMB quintile 4 | -1.72 | -3.12 | -0.76 | 1568.70 | 1.00 | 507 | 229 | 26 | 1 | TRUE | 2.43 |
| non-small cell lung cancer | KRAS_12 | PTEN | Any mutation | 395 | 75 | TMB quintile 5 | -1.00 | -1.64 | -0.37 | 1507.90 | 1.00 | 772 | 382 | 62 | 13 | TRUE | 2.75 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 12 | 16 | TMB quintile 2 | -0.22 | -2.04 | 1.26 | 1582.49 | 1.00 | 119 | 11 | 15 | 1 | TRUE | 0.10 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 26 | 63 | TMB quintile 3 | 0.51 | -0.30 | 1.34 | 1596.72 | 1.00 | 178 | 17 | 54 | 9 | TRUE | 0.63 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 48 | 120 | TMB quintile 4 | 0.49 | -0.14 | 1.09 | 1218.58 | 1.00 | 126 | 22 | 94 | 26 | TRUE | 0.89 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 79 | 315 | TMB quintile 5 | 0.70 | -0.01 | 1.45 | 1669.53 | 1.00 | 60 | 9 | 245 | 70 | TRUE | 1.24 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 6 | 103 | TMB quintile 6 | 0.45 | -1.15 | 2.26 | 1536.69 | 1.00 | 13 | 0 | 97 | 6 | TRUE | 0.22 |
| colorectal cancer | KRAS_12 | PTEN | Any mutation | 518 | 178 | TMB overall | -0.58 | -2.23 | 0.97 | 1435.43 | 1.00 | 939 | 487 | 147 | 31 | TRUE | 0.33 |
| non-small cell lung cancer | KRAS_12 | PTEN | Any mutation | 755 | 119 | TMB overall | -1.37 | -2.39 | -0.49 | 1551.81 | 1.00 | 1759 | 740 | 104 | 15 | TRUE | 2.26 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 171 | 617 | TMB overall | 0.42 | -0.78 | 1.63 | 1596.86 | 1.00 | 496 | 59 | 505 | 112 | TRUE | 0.29 |
| colorectal cancer | KRAS_12 | BCOR | Any mutation | 271 | 11 | TMB quintile 4 | 0.56 | -0.59 | 1.64 | 1374.66 | 1.00 | 515 | 265 | 5 | 6 | FALSE | 0.45 |
| colorectal cancer | KRAS_12 | BCOR | Any mutation | 227 | 39 | TMB quintile 5 | 0.06 | -0.61 | 0.69 | 1398.70 | 1.00 | 378 | 212 | 24 | 15 | FALSE | 0.07 |
| colorectal cancer | KRAS_12 | BCOR | Any mutation | 18 | 57 | TMB quintile 6 | -2.11 | -4.20 | -0.65 | 1491.53 | 1.00 | 82 | 17 | 56 | 1 | FALSE | 1.66 |
| non-small cell lung cancer | KRAS_12 | BCOR | Any mutation | 230 | 22 | TMB quintile 4 | 0.05 | -0.71 | 0.79 | 1185.68 | 1.00 | 518 | 223 | 15 | 7 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12 | BCOR | Any mutation | 400 | 92 | TMB quintile 5 | 0.27 | -0.14 | 0.73 | 571.14 | 1.00 | 774 | 365 | 57 | 35 | FALSE | 0.67 |
| uterine cancer | KRAS_12 | BCOR | Any mutation | 39 | 19 | TMB quintile 4 | 0.11 | -1.07 | 1.14 | 1571.42 | 1.00 | 175 | 35 | 15 | 4 | FALSE | 0.07 |
| uterine cancer | KRAS_12 | BCOR | Any mutation | 51 | 69 | TMB quintile 5 | 0.32 | -0.31 | 0.94 | 1404.91 | 1.00 | 164 | 35 | 53 | 16 | FALSE | 0.48 |
| colorectal cancer | KRAS_12 | BCOR | Any mutation | 516 | 107 | TMB overall | -0.46 | -2.71 | 1.64 | 1418.14 | 1.00 | 975 | 494 | 85 | 22 | FALSE | 0.17 |
| non-small cell lung cancer | KRAS_12 | BCOR | Any mutation | 630 | 114 | TMB overall | 0.16 | -1.09 | 1.41 | 1427.36 | 1.00 | 1292 | 588 | 72 | 42 | FALSE | 0.09 |
| uterine cancer | KRAS_12 | BCOR | Any mutation | 92 | 134 | TMB overall | 0.02 | -1.70 | 1.87 | 1218.46 | 1.00 | 374 | 71 | 113 | 21 | FALSE | 0.01 |
| colorectal cancer | KRAS_12 | CTNNB1 | Any mutation | 144 | 38 | TMB quintile 3 | 0.62 | 0.01 | 1.25 | 1362.95 | 1.00 | 324 | 127 | 21 | 17 | TRUE | 1.29 |
| colorectal cancer | KRAS_12 | CTNNB1 | Any mutation | 272 | 35 | TMB quintile 4 | 0.69 | 0.09 | 1.31 | 1572.06 | 1.00 | 504 | 253 | 16 | 19 | TRUE | 1.53 |
| colorectal cancer | KRAS_12 | CTNNB1 | Any mutation | 229 | 48 | TMB quintile 5 | 0.00 | -0.57 | 0.56 | 1491.62 | 1.00 | 368 | 212 | 31 | 17 | TRUE | 0.00 |
| colorectal cancer | KRAS_12 | CTNNB1 | Any mutation | 19 | 35 | TMB quintile 6 | -0.04 | -1.09 | 0.85 | 1429.96 | 1.00 | 93 | 15 | 31 | 4 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 75 | 12 | TMB quintile 2 | -0.83 | -1.90 | 0.06 | 1604.77 | 1.00 | 355 | 74 | 11 | 1 | TRUE | 1.04 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 130 | 22 | TMB quintile 3 | -1.09 | -2.27 | -0.23 | 1437.66 | 1.00 | 474 | 130 | 22 | 0 | TRUE | 1.49 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 232 | 33 | TMB quintile 4 | -0.58 | -1.29 | 0.12 | 1379.77 | 1.00 | 508 | 224 | 25 | 8 | TRUE | 0.98 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 395 | 47 | TMB quintile 5 | -0.70 | -1.32 | -0.10 | 1604.31 | 1.00 | 791 | 385 | 37 | 10 | TRUE | 1.58 |
| uterine cancer | KRAS_12 | CTNNB1 | Any mutation | 24 | 28 | TMB quintile 3 | -2.16 | -4.09 | -0.75 | 1433.95 | 1.00 | 189 | 24 | 28 | 0 | TRUE | 1.84 |
| uterine cancer | KRAS_12 | CTNNB1 | Any mutation | 39 | 33 | TMB quintile 4 | -1.47 | -2.70 | -0.30 | 1351.22 | 1.00 | 160 | 36 | 30 | 3 | TRUE | 1.80 |
| uterine cancer | KRAS_12 | CTNNB1 | Any mutation | 49 | 61 | TMB quintile 5 | -2.04 | -3.29 | -1.01 | 1419.36 | 1.00 | 157 | 47 | 59 | 2 | TRUE | 3.19 |
| colorectal cancer | KRAS_12 | CTNNB1 | Any mutation | 664 | 156 | TMB overall | 0.32 | -0.61 | 1.31 | 1555.59 | 1.00 | 1289 | 607 | 99 | 57 | TRUE | 0.31 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 832 | 114 | TMB overall | -0.80 | -1.53 | -0.10 | 1316.70 | 1.00 | 2128 | 813 | 95 | 19 | TRUE | 1.51 |
| uterine cancer | KRAS_12 | CTNNB1 | Any mutation | 114 | 137 | TMB overall | -1.91 | -3.32 | -0.74 | 1379.03 | 1.00 | 552 | 109 | 132 | 5 | TRUE | 2.49 |
| cancer of unknown primary | KRAS_12 | ARID1A | Any mutation | 33 | 15 | TMB quintile 4 | -0.28 | -1.53 | 0.81 | 1511.55 | 1.00 | 97 | 30 | 12 | 3 | TRUE | 0.20 |
| cancer of unknown primary | KRAS_12 | ARID1A | Any mutation | 36 | 62 | TMB quintile 5 | -0.44 | -1.28 | 0.32 | 1509.98 | 1.00 | 113 | 28 | 54 | 8 | TRUE | 0.54 |
| cancer of unknown primary | KRAS_12 | ARID1A | Any mutation | 6 | 16 | TMB quintile 6 | 0.68 | -0.62 | 2.33 | 1556.19 | 1.00 | 9 | 1 | 11 | 5 | TRUE | 0.41 |
| colorectal cancer | KRAS_12 | ARID1A | Any mutation | 272 | 32 | TMB quintile 4 | 0.42 | -0.32 | 1.09 | 1428.33 | 1.00 | 503 | 257 | 17 | 15 | TRUE | 0.61 |
| colorectal cancer | KRAS_12 | ARID1A | Any mutation | 232 | 116 | TMB quintile 5 | -0.76 | -1.22 | -0.32 | 1439.90 | 1.00 | 332 | 206 | 90 | 26 | TRUE | 2.97 |
| colorectal cancer | KRAS_12 | ARID1A | Any mutation | 24 | 155 | TMB quintile 6 | -0.60 | -1.46 | 0.23 | 1256.40 | 1.00 | 44 | 9 | 140 | 15 | TRUE | 0.77 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 130 | 12 | TMB quintile 3 | -0.15 | -1.28 | 1.00 | 1382.16 | 1.00 | 487 | 127 | 9 | 3 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 230 | 56 | TMB quintile 4 | -0.47 | -1.11 | 0.10 | 1561.57 | 1.00 | 491 | 218 | 44 | 12 | TRUE | 0.87 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 404 | 187 | TMB quintile 5 | -0.28 | -0.61 | 0.06 | 1581.29 | 1.00 | 703 | 353 | 136 | 51 | TRUE | 1.02 |
| pancreatic cancer | KRAS_12 | ARID1A | Any mutation | 252 | 13 | TMB quintile 2 | -0.93 | -1.87 | -0.07 | 1561.65 | 1.00 | 87 | 246 | 7 | 6 | TRUE | 1.42 |
| pancreatic cancer | KRAS_12 | ARID1A | Any mutation | 419 | 44 | TMB quintile 3 | 0.05 | -0.60 | 0.79 | 1457.71 | 1.00 | 98 | 382 | 7 | 37 | TRUE | 0.06 |
| pancreatic cancer | KRAS_12 | ARID1A | Any mutation | 219 | 45 | TMB quintile 4 | -0.16 | -0.83 | 0.52 | 1462.40 | 1.00 | 54 | 186 | 12 | 33 | TRUE | 0.20 |
| pancreatic cancer | KRAS_12 | ARID1A | Any mutation | 35 | 17 | TMB quintile 5 | 0.00 | -0.96 | 0.92 | 1457.23 | 1.00 | 16 | 25 | 7 | 10 | TRUE | 0.00 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 24 | 28 | TMB quintile 3 | 0.41 | -0.78 | 1.47 | 1506.07 | 1.00 | 194 | 20 | 24 | 4 | TRUE | 0.33 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 43 | 77 | TMB quintile 4 | 1.31 | 0.65 | 1.96 | 1380.47 | 1.00 | 143 | 18 | 52 | 25 | TRUE | 4.07 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 71 | 307 | TMB quintile 5 | 0.95 | 0.19 | 1.78 | 1519.98 | 1.00 | 64 | 7 | 243 | 64 | TRUE | 1.73 |
| cancer of unknown primary | KRAS_12 | ARID1A | Any mutation | 75 | 93 | TMB overall | -0.03 | -1.57 | 1.36 | 1381.42 | 1.00 | 219 | 59 | 77 | 16 | TRUE | 0.02 |
| colorectal cancer | KRAS_12 | ARID1A | Any mutation | 528 | 303 | TMB overall | -0.30 | -2.31 | 1.67 | 1436.90 | 1.00 | 879 | 472 | 247 | 56 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 764 | 255 | TMB overall | -0.32 | -1.43 | 0.89 | 1461.90 | 1.00 | 1681 | 698 | 189 | 66 | TRUE | 0.24 |
| pancreatic cancer | KRAS_12 | ARID1A | Any mutation | 925 | 119 | TMB overall | -0.27 | -1.18 | 0.64 | 1574.42 | 1.00 | 255 | 839 | 33 | 86 | TRUE | 0.26 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 141 | 520 | TMB overall | 0.72 | -1.03 | 2.38 | 1451.86 | 1.00 | 410 | 45 | 424 | 96 | TRUE | 0.38 |
| colorectal cancer | KRAS_12 | PIK3R1 | Any mutation | 271 | 22 | TMB quintile 4 | 0.01 | -0.91 | 0.86 | 1379.88 | 1.00 | 507 | 263 | 14 | 8 | TRUE | 0.01 |
| colorectal cancer | KRAS_12 | PIK3R1 | Any mutation | 228 | 29 | TMB quintile 5 | 0.43 | -0.29 | 1.16 | 1340.33 | 1.00 | 386 | 214 | 15 | 14 | TRUE | 0.60 |
| colorectal cancer | KRAS_12 | PIK3R1 | Any mutation | 20 | 56 | TMB quintile 6 | -0.29 | -1.24 | 0.59 | 1693.26 | 1.00 | 86 | 14 | 50 | 6 | TRUE | 0.26 |
| uterine cancer | KRAS_12 | PIK3R1 | Any mutation | 24 | 40 | TMB quintile 3 | -0.86 | -2.07 | 0.16 | 1544.18 | 1.00 | 183 | 22 | 38 | 2 | TRUE | 0.90 |
| uterine cancer | KRAS_12 | PIK3R1 | Any mutation | 41 | 68 | TMB quintile 4 | -0.48 | -1.21 | 0.22 | 1605.77 | 1.00 | 141 | 32 | 59 | 9 | TRUE | 0.72 |
| uterine cancer | KRAS_12 | PIK3R1 | Any mutation | 54 | 117 | TMB quintile 5 | -0.48 | -1.07 | 0.10 | 1493.86 | 1.00 | 137 | 37 | 100 | 17 | TRUE | 0.95 |
| colorectal cancer | KRAS_12 | PIK3R1 | Any mutation | 519 | 107 | TMB overall | 0.06 | -1.68 | 1.72 | 1473.64 | 1.00 | 979 | 491 | 79 | 28 | TRUE | 0.03 |
| uterine cancer | KRAS_12 | PIK3R1 | Any mutation | 121 | 262 | TMB overall | -0.78 | -1.89 | 0.12 | 1506.42 | 1.00 | 494 | 93 | 234 | 28 | TRUE | 0.91 |
| colorectal cancer | KRAS_12 | FAT1 | Any mutation | 271 | 17 | TMB quintile 4 | -0.13 | -1.17 | 0.87 | 1264.28 | 1.00 | 510 | 265 | 11 | 6 | FALSE | 0.10 |
| colorectal cancer | KRAS_12 | FAT1 | Any mutation | 229 | 64 | TMB quintile 5 | -0.77 | -1.40 | -0.18 | 1545.50 | 1.00 | 356 | 215 | 50 | 14 | FALSE | 1.95 |
| colorectal cancer | KRAS_12 | FAT1 | Any mutation | 23 | 145 | TMB quintile 6 | -0.68 | -1.49 | 0.24 | 1391.53 | 1.00 | 53 | 10 | 132 | 13 | FALSE | 0.92 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 130 | 16 | TMB quintile 3 | 0.03 | -1.11 | 1.06 | 1460.13 | 1.00 | 484 | 126 | 12 | 4 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 230 | 43 | TMB quintile 4 | -0.28 | -1.00 | 0.40 | 1515.35 | 1.00 | 505 | 219 | 32 | 11 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 400 | 227 | TMB quintile 5 | -0.25 | -0.57 | 0.08 | 1512.29 | 1.00 | 682 | 337 | 164 | 63 | FALSE | 0.88 |
| uterine cancer | KRAS_12 | FAT1 | Any mutation | 50 | 49 | TMB quintile 5 | 0.17 | -0.64 | 0.90 | 1628.97 | 1.00 | 185 | 40 | 39 | 10 | FALSE | 0.17 |
| colorectal cancer | KRAS_12 | FAT1 | Any mutation | 523 | 226 | TMB overall | -0.49 | -2.62 | 1.60 | 1455.30 | 1.00 | 919 | 490 | 193 | 33 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 760 | 300 | TMB overall | -0.42 | -2.31 | 1.44 | 1540.66 | 1.00 | 1678 | 682 | 222 | 78 | FALSE | 0.18 |
| uterine cancer | KRAS_12 | FAT1 | Any mutation | 54 | 164 | TMB overall | 0.45 | -2.90 | 4.12 | 1351.00 | 1.00 | 202 | 40 | 150 | 14 | FALSE | 0.10 |
| colorectal cancer | KRAS_12 | CIC | Any mutation | 271 | 17 | TMB quintile 4 | -0.06 | -1.00 | 0.88 | 1451.63 | 1.00 | 510 | 265 | 11 | 6 | TRUE | 0.05 |
| colorectal cancer | KRAS_12 | CIC | Any mutation | 229 | 40 | TMB quintile 5 | -0.20 | -0.86 | 0.44 | 1508.54 | 1.00 | 375 | 216 | 27 | 13 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | CIC | Any mutation | 20 | 79 | TMB quintile 6 | 0.07 | -0.83 | 0.94 | 1490.88 | 1.00 | 76 | 10 | 69 | 10 | TRUE | 0.06 |
| colorectal cancer | KRAS_12 | CIC | Any mutation | 520 | 136 | TMB overall | -0.06 | -1.86 | 1.72 | 1374.98 | 1.00 | 961 | 491 | 107 | 29 | TRUE | 0.03 |
| colorectal cancer | KRAS_12 | NCOR1 | Any mutation | 271 | 16 | TMB quintile 4 | -0.56 | -1.72 | 0.48 | 1346.86 | 1.00 | 508 | 267 | 12 | 4 | FALSE | 0.51 |
| colorectal cancer | KRAS_12 | NCOR1 | Any mutation | 228 | 32 | TMB quintile 5 | -0.77 | -1.64 | 0.04 | 1502.24 | 1.00 | 379 | 221 | 25 | 7 | FALSE | 1.13 |
| colorectal cancer | KRAS_12 | NCOR1 | Any mutation | 20 | 81 | TMB quintile 6 | 0.14 | -0.75 | 1.00 | 1570.02 | 1.00 | 72 | 9 | 70 | 11 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | NCOR1 | Any mutation | 230 | 21 | TMB quintile 4 | -0.55 | -1.46 | 0.18 | 1418.77 | 1.00 | 516 | 226 | 17 | 4 | FALSE | 0.73 |
| non-small cell lung cancer | KRAS_12 | NCOR1 | Any mutation | 398 | 71 | TMB quintile 5 | -0.31 | -0.83 | 0.18 | 1404.97 | 1.00 | 782 | 379 | 52 | 19 | FALSE | 0.62 |
| colorectal cancer | KRAS_12 | NCOR1 | Any mutation | 519 | 129 | TMB overall | -0.37 | -2.23 | 1.59 | 1551.55 | 1.00 | 959 | 497 | 107 | 22 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12 | NCOR1 | Any mutation | 628 | 92 | TMB overall | -0.45 | -1.65 | 0.57 | 1557.04 | 1.00 | 1298 | 605 | 69 | 23 | FALSE | 0.35 |
| colorectal cancer | KRAS_12 | POLE | Any mutation | 227 | 38 | TMB quintile 5 | -0.52 | -1.26 | 0.15 | 1497.80 | 1.00 | 373 | 217 | 28 | 10 | TRUE | 0.82 |
| colorectal cancer | KRAS_12 | POLE | Any mutation | 19 | 93 | TMB quintile 6 | -0.16 | -1.07 | 0.75 | 1421.68 | 1.00 | 66 | 9 | 83 | 10 | TRUE | 0.14 |
| non-small cell lung cancer | KRAS_12 | POLE | Any mutation | 230 | 20 | TMB quintile 4 | -0.03 | -0.96 | 0.82 | 1327.37 | 1.00 | 518 | 224 | 14 | 6 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12 | POLE | Any mutation | 397 | 102 | TMB quintile 5 | 0.33 | -0.09 | 0.74 | 1389.32 | 1.00 | 771 | 357 | 62 | 40 | TRUE | 0.90 |
| uterine cancer | KRAS_12 | POLE | Any mutation | 49 | 24 | TMB quintile 5 | 0.37 | -0.64 | 1.33 | 1518.09 | 1.00 | 197 | 43 | 18 | 6 | TRUE | 0.34 |
| colorectal cancer | KRAS_12 | POLE | Any mutation | 246 | 131 | TMB overall | -0.31 | -2.84 | 2.37 | 1393.68 | 1.00 | 439 | 226 | 111 | 20 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12 | POLE | Any mutation | 627 | 122 | TMB overall | 0.14 | -1.24 | 1.37 | 1372.55 | 1.00 | 1289 | 581 | 76 | 46 | TRUE | 0.08 |
| uterine cancer | KRAS_12 | POLE | Any mutation | 52 | 104 | TMB overall | 0.67 | -2.83 | 4.58 | 1504.39 | 1.00 | 220 | 43 | 95 | 9 | TRUE | 0.14 |
| non-small cell lung cancer | KRAS_12 | NOTCH2 | Any mutation | 230 | 16 | TMB quintile 4 | -0.26 | -1.19 | 0.69 | 1349.09 | 1.00 | 519 | 225 | 11 | 5 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12 | NOTCH2 | Any mutation | 394 | 81 | TMB quintile 5 | -0.58 | -1.15 | -0.05 | 1467.98 | 1.00 | 767 | 377 | 64 | 17 | TRUE | 1.49 |
| non-small cell lung cancer | KRAS_12 | NOTCH2 | Any mutation | 624 | 97 | TMB overall | -0.42 | -1.78 | 1.16 | 1545.99 | 1.00 | 1286 | 602 | 75 | 22 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | TGFBR2 | Any mutation | 228 | 47 | TMB quintile 5 | -0.34 | -1.00 | 0.31 | 1254.64 | 1.00 | 370 | 214 | 33 | 14 | TRUE | 0.52 |
| colorectal cancer | KRAS_12 | TGFBR2 | Any mutation | 19 | 57 | TMB quintile 6 | -0.21 | -1.14 | 0.75 | 1550.96 | 1.00 | 74 | 12 | 50 | 7 | TRUE | 0.18 |
| colorectal cancer | KRAS_12 | TGFBR2 | Any mutation | 247 | 104 | TMB overall | -0.18 | -2.25 | 2.25 | 1072.81 | 1.00 | 444 | 226 | 83 | 21 | TRUE | 0.06 |
| colorectal cancer | KRAS_12 | KMT2A | Any mutation | 271 | 16 | TMB quintile 4 | -0.29 | -1.34 | 0.69 | 1498.16 | 1.00 | 509 | 266 | 11 | 5 | FALSE | 0.23 |
| colorectal cancer | KRAS_12 | KMT2A | Any mutation | 227 | 43 | TMB quintile 5 | -0.44 | -1.14 | 0.23 | 1579.19 | 1.00 | 372 | 215 | 31 | 12 | FALSE | 0.67 |
| colorectal cancer | KRAS_12 | KMT2A | Any mutation | 19 | 84 | TMB quintile 6 | -0.58 | -1.52 | 0.39 | 1409.35 | 1.00 | 76 | 12 | 77 | 7 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12 | KMT2A | Any mutation | 230 | 16 | TMB quintile 4 | -0.20 | -1.16 | 0.75 | 1432.05 | 1.00 | 521 | 225 | 11 | 5 | FALSE | 0.17 |
| non-small cell lung cancer | KRAS_12 | KMT2A | Any mutation | 395 | 80 | TMB quintile 5 | -0.50 | -1.03 | 0.00 | 1504.14 | 1.00 | 771 | 377 | 62 | 18 | FALSE | 1.20 |
| uterine cancer | KRAS_12 | KMT2A | Any mutation | 49 | 27 | TMB quintile 5 | -0.44 | -1.62 | 0.61 | 1395.63 | 1.00 | 191 | 45 | 23 | 4 | FALSE | 0.36 |
| colorectal cancer | KRAS_12 | KMT2A | Any mutation | 517 | 143 | TMB overall | -0.43 | -2.29 | 1.45 | 1387.73 | 1.00 | 957 | 493 | 119 | 24 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12 | KMT2A | Any mutation | 625 | 96 | TMB overall | -0.35 | -1.88 | 1.39 | 1433.58 | 1.00 | 1292 | 602 | 73 | 23 | FALSE | 0.19 |
| uterine cancer | KRAS_12 | KMT2A | Any mutation | 52 | 103 | TMB overall | -0.45 | -3.57 | 2.89 | 1618.80 | 1.00 | 219 | 46 | 97 | 6 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12 | PAK7 | Any mutation | 230 | 13 | TMB quintile 4 | -0.11 | -1.16 | 0.88 | 1633.77 | 1.00 | 520 | 226 | 9 | 4 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12 | PAK7 | Any mutation | 395 | 95 | TMB quintile 5 | -0.03 | -0.48 | 0.42 | 1520.77 | 1.00 | 766 | 365 | 65 | 30 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12 | PAK7 | Any mutation | 625 | 108 | TMB overall | -0.09 | -1.83 | 1.61 | 1575.02 | 1.00 | 1286 | 591 | 74 | 34 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12 | STAG2 | Any mutation | 230 | 19 | TMB quintile 4 | 0.02 | -0.80 | 0.77 | 1542.43 | 1.00 | 519 | 224 | 13 | 6 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12 | STAG2 | Any mutation | 396 | 76 | TMB quintile 5 | 0.16 | -0.31 | 0.62 | 1449.52 | 1.00 | 784 | 369 | 49 | 27 | TRUE | 0.30 |
| non-small cell lung cancer | KRAS_12 | STAG2 | Any mutation | 626 | 95 | TMB overall | 0.08 | -1.06 | 1.28 | 1596.35 | 1.00 | 1303 | 593 | 62 | 33 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12 | TERT | Any mutation | 131 | 13 | TMB quintile 3 | 0.60 | -0.34 | 1.61 | 1489.35 | 1.00 | 489 | 125 | 7 | 6 | TRUE | 0.66 |
| non-small cell lung cancer | KRAS_12 | TERT | Any mutation | 230 | 34 | TMB quintile 4 | 0.15 | -0.54 | 0.80 | 1552.23 | 1.00 | 510 | 219 | 23 | 11 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12 | TERT | Any mutation | 397 | 98 | TMB quintile 5 | 0.04 | -0.39 | 0.46 | 1318.15 | 1.00 | 766 | 366 | 67 | 31 | TRUE | 0.07 |
| non-small cell lung cancer | KRAS_12 | TERT | Any mutation | 758 | 145 | TMB overall | 0.25 | -0.64 | 1.35 | 1445.36 | 1.00 | 1765 | 710 | 97 | 48 | TRUE | 0.22 |
| colorectal cancer | KRAS_12 | BRCA2 | Any mutation | 271 | 21 | TMB quintile 4 | -0.44 | -1.46 | 0.48 | 1493.29 | 1.00 | 505 | 265 | 15 | 6 | TRUE | 0.45 |
| colorectal cancer | KRAS_12 | BRCA2 | Any mutation | 229 | 48 | TMB quintile 5 | -0.38 | -0.98 | 0.23 | 1545.65 | 1.00 | 371 | 215 | 34 | 14 | TRUE | 0.65 |
| colorectal cancer | KRAS_12 | BRCA2 | Any mutation | 19 | 116 | TMB quintile 6 | -1.23 | -2.26 | -0.26 | 1473.59 | 1.00 | 68 | 13 | 110 | 6 | TRUE | 1.80 |
| non-small cell lung cancer | KRAS_12 | BRCA2 | Any mutation | 230 | 23 | TMB quintile 4 | -0.09 | -1.01 | 0.80 | 1407.66 | 1.00 | 517 | 223 | 16 | 7 | TRUE | 0.07 |
| non-small cell lung cancer | KRAS_12 | BRCA2 | Any mutation | 397 | 89 | TMB quintile 5 | -0.23 | -0.73 | 0.24 | 1502.82 | 1.00 | 767 | 372 | 64 | 25 | TRUE | 0.45 |
| uterine cancer | KRAS_12 | BRCA2 | Any mutation | 49 | 29 | TMB quintile 5 | -0.56 | -1.71 | 0.48 | 1566.50 | 1.00 | 188 | 45 | 25 | 4 | TRUE | 0.48 |
| colorectal cancer | KRAS_12 | BRCA2 | Any mutation | 519 | 185 | TMB overall | -0.66 | -2.56 | 1.21 | 1386.83 | 1.00 | 944 | 493 | 159 | 26 | TRUE | 0.32 |
| non-small cell lung cancer | KRAS_12 | BRCA2 | Any mutation | 627 | 126 | TMB overall | -0.59 | -3.48 | 2.25 | 1493.52 | 1.00 | 1293 | 595 | 94 | 32 | TRUE | 0.17 |
| uterine cancer | KRAS_12 | BRCA2 | Any mutation | 52 | 122 | TMB overall | -0.60 | -3.47 | 2.49 | 1449.25 | 1.00 | 213 | 46 | 116 | 6 | TRUE | 0.16 |
| colorectal cancer | KRAS_12 | NOTCH3 | Any mutation | 144 | 12 | TMB quintile 3 | 0.62 | -0.51 | 1.69 | 1375.25 | 1.00 | 337 | 138 | 6 | 6 | TRUE | 0.54 |
| colorectal cancer | KRAS_12 | NOTCH3 | Any mutation | 271 | 17 | TMB quintile 4 | 0.14 | -0.85 | 1.09 | 1577.37 | 1.00 | 510 | 264 | 10 | 7 | TRUE | 0.11 |
| colorectal cancer | KRAS_12 | NOTCH3 | Any mutation | 227 | 50 | TMB quintile 5 | -0.86 | -1.57 | -0.21 | 1327.10 | 1.00 | 364 | 217 | 40 | 10 | TRUE | 1.82 |
| colorectal cancer | KRAS_12 | NOTCH3 | Any mutation | 19 | 120 | TMB quintile 6 | -1.31 | -2.27 | -0.40 | 1292.16 | 1.00 | 47 | 12 | 113 | 7 | TRUE | 2.16 |
| non-small cell lung cancer | KRAS_12 | NOTCH3 | Any mutation | 230 | 21 | TMB quintile 4 | -0.18 | -1.22 | 0.77 | 1366.61 | 1.00 | 518 | 224 | 15 | 6 | TRUE | 0.14 |
| non-small cell lung cancer | KRAS_12 | NOTCH3 | Any mutation | 395 | 82 | TMB quintile 5 | -0.23 | -0.69 | 0.27 | 1431.25 | 1.00 | 774 | 372 | 59 | 23 | TRUE | 0.46 |
| colorectal cancer | KRAS_12 | NOTCH3 | Any mutation | 661 | 199 | TMB overall | -0.34 | -2.02 | 1.37 | 1453.12 | 1.00 | 1258 | 631 | 169 | 30 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12 | NOTCH3 | Any mutation | 625 | 114 | TMB overall | -0.54 | -3.35 | 1.94 | 1466.08 | 1.00 | 1301 | 596 | 85 | 29 | TRUE | 0.17 |
| colorectal cancer | KRAS_12 | NOTCH4 | Any mutation | 264 | 21 | TMB quintile 4 | -0.64 | -1.60 | 0.28 | 1616.89 | 1.00 | 494 | 259 | 16 | 5 | TRUE | 0.74 |
| colorectal cancer | KRAS_12 | NOTCH4 | Any mutation | 212 | 37 | TMB quintile 5 | -0.50 | -1.25 | 0.22 | 1312.35 | 1.00 | 351 | 202 | 27 | 10 | TRUE | 0.71 |
| colorectal cancer | KRAS_12 | NOTCH4 | Any mutation | 20 | 59 | TMB quintile 6 | -0.26 | -1.20 | 0.65 | 1484.43 | 1.00 | 80 | 13 | 52 | 7 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12 | NOTCH4 | Any mutation | 230 | 17 | TMB quintile 4 | -0.71 | -1.88 | 0.30 | 1467.14 | 1.00 | 515 | 227 | 14 | 3 | TRUE | 0.71 |
| non-small cell lung cancer | KRAS_12 | NOTCH4 | Any mutation | 394 | 107 | TMB quintile 5 | -0.29 | -0.75 | 0.11 | 1396.98 | 1.00 | 750 | 365 | 78 | 29 | TRUE | 0.71 |
| colorectal cancer | KRAS_12 | NOTCH4 | Any mutation | 496 | 117 | TMB overall | -0.45 | -1.97 | 1.16 | 1348.35 | 1.00 | 925 | 474 | 95 | 22 | TRUE | 0.25 |
| non-small cell lung cancer | KRAS_12 | NOTCH4 | Any mutation | 624 | 124 | TMB overall | -0.47 | -2.27 | 1.22 | 1428.26 | 1.00 | 1265 | 592 | 92 | 32 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 75 | 12 | TMB quintile 2 | 0.54 | -0.57 | 1.59 | 1466.38 | 1.00 | 358 | 71 | 8 | 4 | FALSE | 0.49 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 130 | 50 | TMB quintile 3 | 0.66 | 0.05 | 1.24 | 1465.21 | 1.00 | 463 | 113 | 33 | 17 | FALSE | 1.53 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 232 | 129 | TMB quintile 4 | 0.51 | 0.10 | 0.90 | 1412.45 | 1.00 | 456 | 181 | 78 | 51 | FALSE | 1.95 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 399 | 336 | TMB quintile 5 | -0.18 | -0.45 | 0.08 | 1476.94 | 1.00 | 603 | 302 | 239 | 97 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 836 | 527 | TMB overall | 0.36 | -0.61 | 1.39 | 1332.64 | 1.00 | 1880 | 667 | 358 | 169 | FALSE | 0.33 |
| non-small cell lung cancer | KRAS_12 | KDM5C | Any mutation | 230 | 16 | TMB quintile 4 | -0.17 | -1.17 | 0.71 | 1413.85 | 1.00 | 520 | 226 | 12 | 4 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12 | KDM5C | Any mutation | 397 | 70 | TMB quintile 5 | 0.27 | -0.20 | 0.74 | 1139.34 | 1.00 | 788 | 370 | 43 | 27 | FALSE | 0.58 |
| non-small cell lung cancer | KRAS_12 | KDM5C | Any mutation | 627 | 86 | TMB overall | 0.07 | -1.20 | 1.26 | 1617.33 | 1.00 | 1308 | 596 | 55 | 31 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 130 | 33 | TMB quintile 3 | 0.41 | -0.38 | 1.15 | 1414.20 | 1.00 | 475 | 119 | 22 | 11 | TRUE | 0.53 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 230 | 43 | TMB quintile 4 | -0.26 | -0.90 | 0.39 | 1388.29 | 1.00 | 501 | 219 | 32 | 11 | TRUE | 0.37 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 401 | 178 | TMB quintile 5 | -0.71 | -1.10 | -0.33 | 1699.07 | 1.00 | 695 | 366 | 143 | 35 | TRUE | 3.57 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 252 | 34 | TMB quintile 2 | 0.85 | 0.21 | 1.60 | 1389.07 | 1.00 | 90 | 222 | 4 | 30 | TRUE | 1.77 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 426 | 146 | TMB quintile 3 | 1.22 | 0.72 | 1.75 | 1505.76 | 1.00 | 92 | 293 | 13 | 133 | TRUE | 5.39 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 223 | 96 | TMB quintile 4 | 1.25 | 0.64 | 1.87 | 1521.07 | 1.00 | 54 | 138 | 11 | 85 | TRUE | 4.31 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 761 | 254 | TMB overall | -0.21 | -1.22 | 0.80 | 1343.53 | 1.00 | 1671 | 704 | 197 | 57 | TRUE | 0.17 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 901 | 276 | TMB overall | 1.10 | 0.34 | 1.92 | 1640.75 | 1.00 | 236 | 653 | 28 | 248 | TRUE | 2.30 |
| non-small cell lung cancer | KRAS_12 | EPHB1 | Any mutation | 230 | 19 | TMB quintile 4 | 0.16 | -0.84 | 1.09 | 1354.28 | 1.00 | 520 | 223 | 12 | 7 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12 | EPHB1 | Any mutation | 397 | 117 | TMB quintile 5 | -0.68 | -1.13 | -0.21 | 1467.24 | 1.00 | 739 | 373 | 93 | 24 | FALSE | 2.38 |
| non-small cell lung cancer | KRAS_12 | EPHB1 | Any mutation | 627 | 152 | TMB overall | -0.64 | -3.80 | 2.19 | 1402.80 | 1.00 | 1268 | 596 | 121 | 31 | FALSE | 0.18 |
| uterine cancer | KRAS_12 | PPP2R1A | Any mutation | 24 | 44 | TMB quintile 3 | -0.45 | -1.53 | 0.57 | 1350.51 | 1.00 | 178 | 20 | 40 | 4 | FALSE | 0.39 |
| uterine cancer | KRAS_12 | PPP2R1A | Any mutation | 39 | 46 | TMB quintile 4 | -0.51 | -1.38 | 0.29 | 1623.82 | 1.00 | 151 | 33 | 40 | 6 | FALSE | 0.61 |
| uterine cancer | KRAS_12 | PPP2R1A | Any mutation | 49 | 25 | TMB quintile 5 | -0.99 | -2.21 | 0.04 | 1565.00 | 1.00 | 190 | 47 | 23 | 2 | FALSE | 1.06 |
| uterine cancer | KRAS_12 | PPP2R1A | Any mutation | 114 | 145 | TMB overall | -0.79 | -2.06 | 0.22 | 1520.05 | 1.00 | 561 | 102 | 133 | 12 | FALSE | 0.79 |
| colorectal cancer | KRAS_12 | ERBB3 | Any mutation | 272 | 27 | TMB quintile 4 | 0.15 | -0.61 | 0.90 | 1553.39 | 1.00 | 504 | 261 | 16 | 11 | TRUE | 0.16 |
| colorectal cancer | KRAS_12 | ERBB3 | Any mutation | 227 | 39 | TMB quintile 5 | -0.08 | -0.77 | 0.56 | 1625.57 | 1.00 | 375 | 213 | 25 | 14 | TRUE | 0.09 |
| colorectal cancer | KRAS_12 | ERBB3 | Any mutation | 18 | 51 | TMB quintile 6 | -0.90 | -2.11 | 0.15 | 1536.36 | 1.00 | 87 | 15 | 48 | 3 | TRUE | 0.90 |
| colorectal cancer | KRAS_12 | ERBB3 | Any mutation | 517 | 117 | TMB overall | -0.24 | -1.86 | 1.29 | 1268.66 | 1.01 | 966 | 489 | 89 | 28 | TRUE | 0.12 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 145 | 51 | TMB quintile 3 | 0.20 | -0.31 | 0.72 | 1437.30 | 1.00 | 312 | 126 | 32 | 19 | TRUE | 0.35 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 273 | 129 | TMB quintile 4 | 0.14 | -0.24 | 0.49 | 1535.70 | 1.00 | 443 | 225 | 81 | 48 | TRUE | 0.35 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 233 | 138 | TMB quintile 5 | 0.00 | -0.38 | 0.36 | 1681.46 | 1.00 | 321 | 184 | 89 | 49 | TRUE | 0.00 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 19 | 31 | TMB quintile 6 | -0.20 | -1.08 | 0.60 | 1490.26 | 1.00 | 101 | 16 | 28 | 3 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12 | SMAD4 | Any mutation | 130 | 21 | TMB quintile 3 | -0.44 | -1.21 | 0.28 | 1481.03 | 1.00 | 478 | 127 | 18 | 3 | TRUE | 0.64 |
| non-small cell lung cancer | KRAS_12 | SMAD4 | Any mutation | 230 | 36 | TMB quintile 4 | -0.39 | -1.01 | 0.20 | 1441.50 | 1.00 | 508 | 222 | 28 | 8 | TRUE | 0.68 |
| non-small cell lung cancer | KRAS_12 | SMAD4 | Any mutation | 395 | 49 | TMB quintile 5 | -0.35 | -0.92 | 0.15 | 1492.58 | 1.00 | 792 | 382 | 36 | 13 | TRUE | 0.72 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 252 | 37 | TMB quintile 2 | 0.38 | -0.27 | 1.14 | 1399.94 | 1.00 | 88 | 221 | 6 | 31 | TRUE | 0.52 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 421 | 119 | TMB quintile 3 | 0.28 | -0.23 | 0.75 | 1581.43 | 1.00 | 85 | 323 | 21 | 98 | TRUE | 0.60 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 217 | 82 | TMB quintile 4 | 0.47 | -0.08 | 1.02 | 1453.20 | 1.00 | 50 | 150 | 15 | 67 | TRUE | 0.97 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 35 | 25 | TMB quintile 5 | 0.62 | -0.17 | 1.41 | 1545.09 | 1.00 | 15 | 18 | 8 | 17 | TRUE | 0.93 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 670 | 349 | TMB overall | 0.03 | -0.57 | 0.68 | 1431.62 | 1.00 | 1177 | 551 | 230 | 119 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12 | SMAD4 | Any mutation | 755 | 106 | TMB overall | -0.39 | -1.04 | 0.21 | 1527.72 | 1.00 | 1778 | 731 | 82 | 24 | TRUE | 0.66 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 925 | 263 | TMB overall | 0.44 | -0.21 | 1.16 | 1383.14 | 1.00 | 238 | 712 | 50 | 213 | TRUE | 0.67 |
| colorectal cancer | KRAS_12 | ATM | Any mutation | 274 | 46 | TMB quintile 4 | 0.23 | -0.38 | 0.82 | 1464.89 | 1.00 | 495 | 255 | 27 | 19 | TRUE | 0.35 |
| colorectal cancer | KRAS_12 | ATM | Any mutation | 232 | 78 | TMB quintile 5 | -0.05 | -0.57 | 0.44 | 1338.46 | 1.00 | 353 | 204 | 50 | 28 | TRUE | 0.08 |
| colorectal cancer | KRAS_12 | ATM | Any mutation | 20 | 94 | TMB quintile 6 | -0.53 | -1.48 | 0.33 | 1508.50 | 1.00 | 75 | 12 | 86 | 8 | TRUE | 0.60 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 75 | 15 | TMB quintile 2 | 0.81 | -0.01 | 1.63 | 1131.34 | 1.00 | 357 | 70 | 10 | 5 | TRUE | 1.27 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 130 | 20 | TMB quintile 3 | 0.84 | 0.07 | 1.55 | 1555.80 | 1.00 | 484 | 122 | 12 | 8 | TRUE | 1.58 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 238 | 76 | TMB quintile 4 | 1.28 | 0.86 | 1.74 | 1347.89 | 1.00 | 504 | 193 | 31 | 45 | TRUE | 7.28 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 408 | 166 | TMB quintile 5 | 0.70 | 0.37 | 1.02 | 1480.88 | 1.00 | 745 | 332 | 90 | 76 | TRUE | 4.66 |
| uterine cancer | KRAS_12 | ATM | Any mutation | 50 | 46 | TMB quintile 5 | -0.17 | -1.05 | 0.60 | 1508.83 | 1.00 | 183 | 42 | 38 | 8 | TRUE | 0.17 |
| colorectal cancer | KRAS_12 | ATM | Any mutation | 526 | 218 | TMB overall | -0.13 | -1.68 | 1.40 | 1592.98 | 1.00 | 923 | 471 | 163 | 55 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 851 | 277 | TMB overall | 0.91 | 0.22 | 1.63 | 1413.03 | 1.00 | 2090 | 717 | 143 | 134 | TRUE | 1.96 |
| uterine cancer | KRAS_12 | ATM | Any mutation | 54 | 147 | TMB overall | -0.35 | -3.26 | 2.80 | 1247.13 | 1.00 | 203 | 43 | 136 | 11 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 130 | 33 | TMB quintile 3 | -1.33 | -2.18 | -0.53 | 1429.42 | 1.00 | 465 | 128 | 31 | 2 | TRUE | 2.69 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 230 | 50 | TMB quintile 4 | -1.24 | -1.97 | -0.56 | 1501.61 | 1.00 | 488 | 224 | 44 | 6 | TRUE | 3.24 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 395 | 124 | TMB quintile 5 | -1.08 | -1.55 | -0.63 | 1542.18 | 1.00 | 728 | 376 | 105 | 19 | TRUE | 5.20 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 755 | 207 | TMB overall | -1.21 | -1.94 | -0.55 | 1466.68 | 1.00 | 1681 | 728 | 180 | 27 | TRUE | 3.15 |
| cancer of unknown primary | KRAS_12 | KMT2D | Any mutation | 32 | 14 | TMB quintile 3 | -1.29 | -3.15 | 0.16 | 1502.51 | 1.00 | 100 | 31 | 13 | 1 | FALSE | 0.85 |
| cancer of unknown primary | KRAS_12 | KMT2D | Any mutation | 33 | 11 | TMB quintile 4 | -0.10 | -1.61 | 1.12 | 1323.21 | 1.00 | 101 | 30 | 8 | 3 | FALSE | 0.05 |
| cancer of unknown primary | KRAS_12 | KMT2D | Any mutation | 34 | 67 | TMB quintile 5 | -0.78 | -1.60 | 0.01 | 1542.49 | 1.00 | 104 | 27 | 60 | 7 | FALSE | 1.18 |
| colorectal cancer | KRAS_12 | KMT2D | Any mutation | 271 | 27 | TMB quintile 4 | -0.51 | -1.38 | 0.31 | 1551.01 | 1.00 | 501 | 264 | 20 | 7 | FALSE | 0.62 |
| colorectal cancer | KRAS_12 | KMT2D | Any mutation | 233 | 104 | TMB quintile 5 | -0.60 | -1.07 | -0.13 | 1346.51 | 1.00 | 344 | 207 | 78 | 26 | FALSE | 1.79 |
| colorectal cancer | KRAS_12 | KMT2D | Any mutation | 28 | 245 | TMB quintile 6 | -0.44 | -1.51 | 0.81 | 1323.94 | 1.00 | 16 | 3 | 220 | 25 | FALSE | 0.33 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 130 | 15 | TMB quintile 3 | 0.03 | -1.25 | 1.12 | 1463.43 | 1.00 | 485 | 126 | 11 | 4 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 230 | 42 | TMB quintile 4 | -0.27 | -1.00 | 0.42 | 1518.10 | 1.00 | 504 | 219 | 31 | 11 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 399 | 251 | TMB quintile 5 | -0.75 | -1.09 | -0.42 | 1453.04 | 1.00 | 664 | 349 | 201 | 50 | FALSE | 5.08 |
| uterine cancer | KRAS_12 | KMT2D | Any mutation | 39 | 14 | TMB quintile 4 | -0.48 | -2.08 | 0.90 | 1250.76 | 1.00 | 179 | 37 | 12 | 2 | FALSE | 0.27 |
| uterine cancer | KRAS_12 | KMT2D | Any mutation | 51 | 129 | TMB quintile 5 | -0.50 | -1.14 | 0.12 | 1456.26 | 1.00 | 126 | 33 | 111 | 18 | FALSE | 0.90 |
| cancer of unknown primary | KRAS_12 | KMT2D | Any mutation | 103 | 123 | TMB overall | -0.52 | -2.22 | 1.14 | 1285.87 | 1.00 | 309 | 88 | 108 | 15 | FALSE | 0.26 |
| colorectal cancer | KRAS_12 | KMT2D | Any mutation | 532 | 376 | TMB overall | -0.50 | -2.90 | 1.94 | 1524.47 | 1.00 | 861 | 474 | 318 | 58 | FALSE | 0.17 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 759 | 320 | TMB overall | -0.52 | -2.46 | 1.37 | 1396.36 | 1.00 | 1661 | 694 | 255 | 65 | FALSE | 0.23 |
| uterine cancer | KRAS_12 | KMT2D | Any mutation | 94 | 252 | TMB overall | -0.57 | -2.57 | 1.57 | 1424.04 | 1.00 | 322 | 71 | 229 | 23 | FALSE | 0.23 |
| colorectal cancer | KRAS_12 | TSC2 | Any mutation | 230 | 42 | TMB quintile 5 | -0.42 | -1.16 | 0.26 | 1585.27 | 1.00 | 373 | 218 | 30 | 12 | TRUE | 0.62 |
| colorectal cancer | KRAS_12 | TSC2 | Any mutation | 19 | 56 | TMB quintile 6 | -0.05 | -1.06 | 0.92 | 1634.08 | 1.00 | 86 | 12 | 49 | 7 | TRUE | 0.03 |
| colorectal cancer | KRAS_12 | TSC2 | Any mutation | 249 | 98 | TMB overall | -0.21 | -2.40 | 2.10 | 1508.82 | 1.00 | 459 | 230 | 79 | 19 | TRUE | 0.07 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 18 | 78 | TMB quintile 2 | -0.91 | -1.77 | -0.14 | 1476.08 | 1.00 | 55 | 13 | 73 | 5 | TRUE | 1.55 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 173 | 428 | TMB quintile 3 | -0.19 | -0.55 | 0.18 | 1554.34 | 1.00 | 106 | 52 | 307 | 121 | TRUE | 0.52 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 382 | 966 | TMB quintile 4 | -0.14 | -0.47 | 0.20 | 1287.33 | 1.00 | 94 | 58 | 642 | 324 | TRUE | 0.38 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 369 | 822 | TMB quintile 5 | 0.38 | 0.02 | 0.75 | 1468.25 | 1.00 | 105 | 46 | 499 | 323 | TRUE | 1.38 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 37 | 225 | TMB quintile 6 | 0.10 | -0.63 | 0.92 | 1543.10 | 1.00 | 43 | 4 | 192 | 33 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12 | APC | Any mutation | 130 | 20 | TMB quintile 3 | -0.21 | -1.08 | 0.71 | 1476.88 | 1.00 | 481 | 125 | 15 | 5 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12 | APC | Any mutation | 230 | 31 | TMB quintile 4 | -1.00 | -2.06 | -0.18 | 1439.45 | 1.00 | 504 | 227 | 28 | 3 | TRUE | 1.46 |
| non-small cell lung cancer | KRAS_12 | APC | Any mutation | 398 | 101 | TMB quintile 5 | -0.36 | -0.80 | 0.05 | 1549.53 | 1.00 | 759 | 372 | 75 | 26 | TRUE | 0.97 |
| uterine cancer | KRAS_12 | APC | Any mutation | 49 | 35 | TMB quintile 5 | -0.14 | -1.13 | 0.72 | 1619.92 | 1.00 | 193 | 43 | 29 | 6 | TRUE | 0.11 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 979 | 2519 | TMB overall | -0.17 | -0.84 | 0.52 | 1537.18 | 1.00 | 403 | 173 | 1713 | 806 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12 | APC | Any mutation | 758 | 152 | TMB overall | -0.51 | -1.44 | 0.34 | 1530.22 | 1.00 | 1744 | 724 | 118 | 34 | TRUE | 0.58 |
| uterine cancer | KRAS_12 | APC | Any mutation | 54 | 119 | TMB overall | 0.00 | -2.79 | 2.98 | 1530.28 | 1.00 | 223 | 44 | 109 | 10 | TRUE | 0.00 |
| colorectal cancer | KRAS_12 | ERBB2 | Any mutation | 271 | 17 | TMB quintile 4 | -0.63 | -1.75 | 0.34 | 1474.56 | 1.00 | 507 | 267 | 13 | 4 | TRUE | 0.64 |
| colorectal cancer | KRAS_12 | ERBB2 | Any mutation | 227 | 33 | TMB quintile 5 | -0.78 | -1.62 | -0.01 | 1666.11 | 1.00 | 373 | 220 | 26 | 7 | TRUE | 1.22 |
| colorectal cancer | KRAS_12 | ERBB2 | Any mutation | 18 | 42 | TMB quintile 6 | 0.35 | -0.63 | 1.33 | 1438.92 | 1.00 | 97 | 11 | 35 | 7 | TRUE | 0.31 |
| non-small cell lung cancer | KRAS_12 | ERBB2 | Any mutation | 75 | 14 | TMB quintile 2 | -2.86 | -4.39 | -1.48 | 1429.48 | 1.00 | 352 | 75 | 14 | 0 | TRUE | 3.72 |
| non-small cell lung cancer | KRAS_12 | ERBB2 | Any mutation | 130 | 27 | TMB quintile 3 | -2.56 | -4.03 | -1.20 | 1563.66 | 1.00 | 471 | 128 | 25 | 2 | TRUE | 3.36 |
| non-small cell lung cancer | KRAS_12 | ERBB2 | Any mutation | 230 | 32 | TMB quintile 4 | -2.95 | -4.59 | -1.70 | 1456.30 | 1.00 | 502 | 230 | 32 | 0 | TRUE | 4.38 |
| non-small cell lung cancer | KRAS_12 | ERBB2 | Any mutation | 395 | 40 | TMB quintile 5 | -2.87 | -4.38 | -1.73 | 1473.14 | 1.00 | 792 | 394 | 39 | 1 | TRUE | 4.59 |
| colorectal cancer | KRAS_12 | ERBB2 | Any mutation | 516 | 92 | TMB overall | -0.36 | -2.02 | 1.26 | 1457.33 | 1.00 | 977 | 498 | 74 | 18 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12 | ERBB2 | Any mutation | 830 | 113 | TMB overall | -2.81 | -4.33 | -1.65 | 1443.75 | 1.00 | 2117 | 827 | 110 | 3 | TRUE | 4.58 |
| uterine cancer | KRAS_12 | JAK1 | Any mutation | 53 | 88 | TMB quintile 5 | 0.08 | -0.54 | 0.73 | 1490.89 | 1.00 | 163 | 36 | 71 | 17 | TRUE | 0.09 |
| uterine cancer | KRAS_12 | JAK1 | Any mutation | 56 | 140 | TMB overall | 0.51 | -2.25 | 4.15 | 1489.19 | 1.00 | 191 | 36 | 120 | 20 | TRUE | 0.14 |
| colorectal cancer | KRAS_12 | ARID2 | Any mutation | 271 | 12 | TMB quintile 4 | -0.60 | -1.91 | 0.60 | 1387.48 | 1.00 | 511 | 268 | 9 | 3 | FALSE | 0.46 |
| colorectal cancer | KRAS_12 | ARID2 | Any mutation | 228 | 31 | TMB quintile 5 | 0.18 | -0.52 | 0.89 | 1535.57 | 1.00 | 382 | 215 | 18 | 13 | FALSE | 0.22 |
| colorectal cancer | KRAS_12 | ARID2 | Any mutation | 18 | 66 | TMB quintile 6 | -0.48 | -1.50 | 0.50 | 1575.56 | 1.00 | 76 | 12 | 60 | 6 | FALSE | 0.46 |
| non-small cell lung cancer | KRAS_12 | ARID2 | Any mutation | 130 | 19 | TMB quintile 3 | -0.80 | -2.05 | 0.14 | 1530.59 | 1.00 | 478 | 129 | 18 | 1 | FALSE | 0.76 |
| non-small cell lung cancer | KRAS_12 | ARID2 | Any mutation | 230 | 35 | TMB quintile 4 | -0.10 | -0.80 | 0.57 | 1588.20 | 1.00 | 510 | 219 | 24 | 11 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12 | ARID2 | Any mutation | 396 | 111 | TMB quintile 5 | -0.22 | -0.67 | 0.20 | 1577.16 | 1.00 | 758 | 365 | 80 | 31 | FALSE | 0.51 |
| colorectal cancer | KRAS_12 | ARID2 | Any mutation | 517 | 109 | TMB overall | -0.31 | -2.26 | 1.64 | 1335.03 | 1.00 | 969 | 495 | 87 | 22 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12 | ARID2 | Any mutation | 756 | 165 | TMB overall | -0.37 | -1.30 | 0.46 | 1497.57 | 1.00 | 1746 | 713 | 122 | 43 | FALSE | 0.39 |
| colorectal cancer | KRAS_12 | MTOR | Any mutation | 271 | 19 | TMB quintile 4 | 1.00 | 0.09 | 1.97 | 1620.75 | 1.00 | 513 | 259 | 7 | 12 | TRUE | 1.48 |
| colorectal cancer | KRAS_12 | MTOR | Any mutation | 228 | 40 | TMB quintile 5 | -0.22 | -0.91 | 0.41 | 1411.14 | 1.00 | 372 | 215 | 27 | 13 | TRUE | 0.28 |
| colorectal cancer | KRAS_12 | MTOR | Any mutation | 20 | 70 | TMB quintile 6 | -0.61 | -1.61 | 0.29 | 1372.24 | 1.00 | 78 | 14 | 64 | 6 | TRUE | 0.67 |
| non-small cell lung cancer | KRAS_12 | MTOR | Any mutation | 130 | 14 | TMB quintile 3 | -0.34 | -1.32 | 0.56 | 1399.95 | 1.00 | 484 | 128 | 12 | 2 | TRUE | 0.33 |
| non-small cell lung cancer | KRAS_12 | MTOR | Any mutation | 230 | 21 | TMB quintile 4 | -0.40 | -1.24 | 0.36 | 1354.25 | 1.00 | 516 | 226 | 17 | 4 | TRUE | 0.48 |
| non-small cell lung cancer | KRAS_12 | MTOR | Any mutation | 397 | 70 | TMB quintile 5 | 0.10 | -0.40 | 0.58 | 1290.96 | 1.00 | 783 | 372 | 45 | 25 | TRUE | 0.16 |
| colorectal cancer | KRAS_12 | MTOR | Any mutation | 519 | 129 | TMB overall | 0.04 | -2.02 | 2.00 | 1576.15 | 1.00 | 963 | 488 | 98 | 31 | TRUE | 0.01 |
| non-small cell lung cancer | KRAS_12 | MTOR | Any mutation | 757 | 105 | TMB overall | -0.20 | -1.11 | 0.58 | 1294.36 | 1.00 | 1783 | 726 | 74 | 31 | TRUE | 0.20 |
| colorectal cancer | KRAS_12 | NOTCH1 | Any mutation | 227 | 48 | TMB quintile 5 | -1.29 | -2.22 | -0.53 | 1388.06 | 1.00 | 362 | 220 | 41 | 7 | TRUE | 2.59 |
| colorectal cancer | KRAS_12 | NOTCH1 | Any mutation | 24 | 112 | TMB quintile 6 | 0.34 | -0.55 | 1.35 | 1342.57 | 1.00 | 60 | 7 | 95 | 17 | TRUE | 0.33 |
| non-small cell lung cancer | KRAS_12 | NOTCH1 | Any mutation | 230 | 15 | TMB quintile 4 | -0.68 | -1.87 | 0.36 | 1538.46 | 1.00 | 520 | 227 | 12 | 3 | TRUE | 0.64 |
| non-small cell lung cancer | KRAS_12 | NOTCH1 | Any mutation | 396 | 97 | TMB quintile 5 | -0.46 | -0.94 | 0.00 | 1417.57 | 1.00 | 759 | 373 | 74 | 23 | TRUE | 1.21 |
| colorectal cancer | KRAS_12 | NOTCH1 | Any mutation | 251 | 160 | TMB overall | -0.41 | -2.98 | 2.39 | 1433.22 | 1.00 | 422 | 227 | 136 | 24 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12 | NOTCH1 | Any mutation | 626 | 112 | TMB overall | -0.54 | -2.14 | 1.19 | 1561.13 | 1.00 | 1279 | 600 | 86 | 26 | TRUE | 0.28 |
| colorectal cancer | KRAS_12 | SETD2 | Any mutation | 144 | 11 | TMB quintile 3 | -2.88 | -6.22 | -0.71 | 1483.93 | 1.00 | 333 | 144 | 11 | 0 | FALSE | 1.41 |
| colorectal cancer | KRAS_12 | SETD2 | Any mutation | 227 | 31 | TMB quintile 5 | -1.84 | -3.17 | -0.77 | 1484.46 | 1.00 | 374 | 224 | 28 | 3 | FALSE | 2.59 |
| colorectal cancer | KRAS_12 | SETD2 | Any mutation | 20 | 64 | TMB quintile 6 | -1.00 | -2.10 | 0.03 | 1400.58 | 1.00 | 80 | 15 | 59 | 5 | FALSE | 1.19 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 75 | 14 | TMB quintile 2 | -0.88 | -2.34 | 0.18 | 1325.72 | 1.00 | 352 | 75 | 14 | 0 | FALSE | 0.77 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 131 | 22 | TMB quintile 3 | -0.71 | -1.75 | 0.14 | 1595.62 | 1.00 | 481 | 129 | 20 | 2 | FALSE | 0.83 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 231 | 59 | TMB quintile 4 | -0.27 | -0.86 | 0.27 | 1278.88 | 1.00 | 496 | 216 | 44 | 15 | FALSE | 0.47 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 402 | 110 | TMB quintile 5 | 0.03 | -0.38 | 0.42 | 1369.27 | 1.00 | 765 | 364 | 72 | 38 | FALSE | 0.06 |
| colorectal cancer | KRAS_12 | SETD2 | Any mutation | 391 | 106 | TMB overall | -1.84 | -3.91 | 0.07 | 1563.19 | 1.00 | 787 | 383 | 98 | 8 | FALSE | 1.12 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 839 | 205 | TMB overall | -0.46 | -1.31 | 0.25 | 1414.99 | 1.00 | 2094 | 784 | 150 | 55 | FALSE | 0.61 |
| non-small cell lung cancer | KRAS_12 | PBRM1 | Any mutation | 232 | 21 | TMB quintile 4 | 0.26 | -0.59 | 1.16 | 1272.62 | 1.00 | 521 | 223 | 12 | 9 | TRUE | 0.25 |
| non-small cell lung cancer | KRAS_12 | PBRM1 | Any mutation | 395 | 79 | TMB quintile 5 | -0.36 | -0.92 | 0.14 | 1139.64 | 1.00 | 777 | 376 | 60 | 19 | TRUE | 0.74 |
| non-small cell lung cancer | KRAS_12 | PBRM1 | Any mutation | 627 | 100 | TMB overall | -0.06 | -1.62 | 1.33 | 1548.15 | 1.00 | 1298 | 599 | 72 | 28 | TRUE | 0.03 |
| colorectal cancer | KRAS_12 | EPHA3 | Any mutation | 272 | 17 | TMB quintile 4 | -0.38 | -1.42 | 0.58 | 1581.51 | 1.00 | 508 | 267 | 12 | 5 | FALSE | 0.34 |
| colorectal cancer | KRAS_12 | EPHA3 | Any mutation | 227 | 41 | TMB quintile 5 | -0.14 | -0.84 | 0.50 | 1498.29 | 1.00 | 373 | 213 | 27 | 14 | FALSE | 0.17 |
| colorectal cancer | KRAS_12 | EPHA3 | Any mutation | 18 | 44 | TMB quintile 6 | -0.45 | -1.58 | 0.59 | 1511.84 | 1.00 | 93 | 14 | 40 | 4 | FALSE | 0.39 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 130 | 15 | TMB quintile 3 | 0.45 | -0.66 | 1.48 | 1471.65 | 1.00 | 486 | 125 | 10 | 5 | FALSE | 0.38 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 230 | 28 | TMB quintile 4 | 0.49 | -0.29 | 1.26 | 1439.05 | 1.00 | 516 | 218 | 16 | 12 | FALSE | 0.68 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 402 | 182 | TMB quintile 5 | -0.06 | -0.40 | 0.29 | 1501.24 | 1.00 | 714 | 345 | 125 | 57 | FALSE | 0.13 |
| colorectal cancer | KRAS_12 | EPHA3 | Any mutation | 517 | 102 | TMB overall | -0.34 | -1.77 | 1.21 | 1337.68 | 1.00 | 974 | 494 | 79 | 23 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 762 | 237 | TMB overall | 0.03 | -1.93 | 1.89 | 1294.55 | 1.00 | 1724 | 688 | 163 | 74 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12 | KDR | Any mutation | 230 | 21 | TMB quintile 4 | 0.52 | -0.34 | 1.43 | 1386.26 | 1.00 | 521 | 220 | 11 | 10 | TRUE | 0.63 |
| non-small cell lung cancer | KRAS_12 | KDR | Any mutation | 398 | 109 | TMB quintile 5 | -0.17 | -0.62 | 0.27 | 1499.05 | 1.00 | 752 | 367 | 78 | 31 | TRUE | 0.34 |
| non-small cell lung cancer | KRAS_12 | KDR | Any mutation | 628 | 130 | TMB overall | 0.17 | -1.49 | 1.87 | 1271.63 | 1.00 | 1273 | 587 | 89 | 41 | TRUE | 0.08 |
| colorectal cancer | KRAS_12 | PTCH1 | Any mutation | 227 | 35 | TMB quintile 5 | -1.11 | -2.11 | -0.26 | 1213.33 | 1.00 | 372 | 221 | 29 | 6 | TRUE | 1.82 |
| colorectal cancer | KRAS_12 | PTCH1 | Any mutation | 19 | 99 | TMB quintile 6 | -0.28 | -1.20 | 0.70 | 1493.77 | 1.00 | 65 | 9 | 89 | 10 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | PTCH1 | Any mutation | 246 | 134 | TMB overall | -0.64 | -3.48 | 2.33 | 1558.85 | 1.00 | 437 | 230 | 118 | 16 | TRUE | 0.18 |
| colorectal cancer | KRAS_12 | TET1 | Any mutation | 212 | 26 | TMB quintile 5 | -0.92 | -1.92 | -0.01 | 1454.61 | 1.00 | 358 | 207 | 21 | 5 | FALSE | 1.17 |
| colorectal cancer | KRAS_12 | TET1 | Any mutation | 19 | 67 | TMB quintile 6 | -0.32 | -1.32 | 0.61 | 1551.69 | 1.00 | 83 | 12 | 60 | 7 | FALSE | 0.28 |
| non-small cell lung cancer | KRAS_12 | TET1 | Any mutation | 230 | 16 | TMB quintile 4 | -0.78 | -2.18 | 0.43 | 1450.34 | 1.00 | 516 | 227 | 13 | 3 | FALSE | 0.60 |
| non-small cell lung cancer | KRAS_12 | TET1 | Any mutation | 396 | 89 | TMB quintile 5 | -0.18 | -0.66 | 0.30 | 1459.65 | 1.00 | 768 | 370 | 63 | 26 | FALSE | 0.33 |
| colorectal cancer | KRAS_12 | TET1 | Any mutation | 231 | 93 | TMB overall | -0.54 | -3.09 | 1.99 | 1526.30 | 1.00 | 441 | 219 | 81 | 12 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12 | TET1 | Any mutation | 626 | 120 | TMB overall | -0.89 | -3.88 | 2.10 | 1607.41 | 1.00 | 1289 | 597 | 91 | 29 | FALSE | 0.26 |
| uterine cancer | KRAS_12 | FGFR2 | Any mutation | 39 | 23 | TMB quintile 4 | -1.59 | -3.43 | -0.07 | 1455.43 | 1.00 | 170 | 37 | 21 | 2 | TRUE | 1.25 |
| uterine cancer | KRAS_12 | FGFR2 | Any mutation | 49 | 52 | TMB quintile 5 | -2.45 | -4.26 | -1.10 | 1411.88 | 1.00 | 168 | 48 | 51 | 1 | TRUE | 2.60 |
| uterine cancer | KRAS_12 | FGFR2 | Any mutation | 90 | 93 | TMB overall | -2.09 | -4.04 | -0.38 | 1488.91 | 1.00 | 384 | 87 | 90 | 3 | TRUE | 1.68 |
| non-small cell lung cancer | KRAS_12 | TBX3 | Any mutation | 230 | 11 | TMB quintile 4 | 0.05 | -1.05 | 1.18 | 1555.28 | 1.00 | 525 | 226 | 7 | 4 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12 | TBX3 | Any mutation | 395 | 108 | TMB quintile 5 | -0.21 | -0.65 | 0.24 | 1404.26 | 1.00 | 758 | 365 | 78 | 30 | FALSE | 0.46 |
| non-small cell lung cancer | KRAS_12 | TBX3 | Any mutation | 625 | 119 | TMB overall | -0.08 | -2.02 | 1.97 | 1429.38 | 1.00 | 1283 | 591 | 85 | 34 | FALSE | 0.03 |
| colorectal cancer | KRAS_12 | SMAD3 | Any mutation | 144 | 12 | TMB quintile 3 | -0.40 | -1.58 | 0.66 | 1437.81 | 1.00 | 333 | 142 | 10 | 2 | TRUE | 0.31 |
| colorectal cancer | KRAS_12 | SMAD3 | Any mutation | 274 | 27 | TMB quintile 4 | 0.33 | -0.39 | 1.04 | 1558.86 | 1.00 | 507 | 262 | 15 | 12 | TRUE | 0.44 |
| colorectal cancer | KRAS_12 | SMAD3 | Any mutation | 233 | 44 | TMB quintile 5 | 0.54 | -0.05 | 1.12 | 1349.28 | 1.00 | 378 | 211 | 22 | 22 | TRUE | 1.16 |
| colorectal cancer | KRAS_12 | SMAD3 | Any mutation | 19 | 23 | TMB quintile 6 | 0.54 | -0.51 | 1.46 | 1452.78 | 1.00 | 107 | 14 | 18 | 5 | TRUE | 0.55 |
| colorectal cancer | KRAS_12 | SMAD3 | Any mutation | 670 | 106 | TMB overall | 0.26 | -0.69 | 1.27 | 1583.23 | 1.00 | 1325 | 629 | 65 | 41 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12 | NTRK3 | Any mutation | 232 | 31 | TMB quintile 4 | 1.16 | 0.42 | 1.88 | 1438.91 | 1.00 | 520 | 214 | 13 | 18 | FALSE | 2.73 |
| non-small cell lung cancer | KRAS_12 | NTRK3 | Any mutation | 399 | 144 | TMB quintile 5 | 0.08 | -0.30 | 0.44 | 1388.46 | 1.00 | 742 | 350 | 95 | 49 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12 | NTRK3 | Any mutation | 631 | 195 | TMB overall | -0.05 | -3.33 | 3.15 | 1248.12 | 1.00 | 1269 | 564 | 128 | 67 | FALSE | 0.01 |
| colorectal cancer | KRAS_12 | GRIN2A | Any mutation | 271 | 30 | TMB quintile 4 | -0.32 | -1.11 | 0.44 | 1330.08 | 1.00 | 499 | 262 | 21 | 9 | FALSE | 0.37 |
| colorectal cancer | KRAS_12 | GRIN2A | Any mutation | 228 | 42 | TMB quintile 5 | -0.31 | -1.00 | 0.35 | 1267.43 | 1.00 | 370 | 215 | 29 | 13 | FALSE | 0.44 |
| colorectal cancer | KRAS_12 | GRIN2A | Any mutation | 18 | 59 | TMB quintile 6 | -1.13 | -2.35 | -0.07 | 1578.91 | 1.00 | 81 | 15 | 56 | 3 | FALSE | 1.28 |
| non-small cell lung cancer | KRAS_12 | GRIN2A | Any mutation | 130 | 17 | TMB quintile 3 | 0.13 | -0.70 | 1.01 | 1412.84 | 1.00 | 484 | 125 | 12 | 5 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | GRIN2A | Any mutation | 230 | 39 | TMB quintile 4 | 0.00 | -0.68 | 0.59 | 1483.76 | 1.00 | 506 | 218 | 27 | 12 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12 | GRIN2A | Any mutation | 399 | 124 | TMB quintile 5 | -0.12 | -0.53 | 0.26 | 1505.98 | 1.00 | 745 | 363 | 88 | 36 | FALSE | 0.27 |
| colorectal cancer | KRAS_12 | GRIN2A | Any mutation | 517 | 131 | TMB overall | -0.57 | -2.16 | 1.02 | 1489.79 | 1.00 | 950 | 492 | 106 | 25 | FALSE | 0.33 |
| non-small cell lung cancer | KRAS_12 | GRIN2A | Any mutation | 759 | 180 | TMB overall | 0.01 | -0.81 | 0.90 | 1565.06 | 1.00 | 1735 | 706 | 127 | 53 | FALSE | 0.01 |
| uterine cancer | KRAS_12 | CTCF | Any mutation | 39 | 12 | TMB quintile 4 | -0.32 | -1.99 | 1.07 | 1532.20 | 1.00 | 180 | 37 | 10 | 2 | FALSE | 0.17 |
| uterine cancer | KRAS_12 | CTCF | Any mutation | 51 | 103 | TMB quintile 5 | 0.14 | -0.49 | 0.75 | 1498.03 | 1.00 | 136 | 30 | 82 | 21 | FALSE | 0.18 |
| uterine cancer | KRAS_12 | CTCF | Any mutation | 92 | 163 | TMB overall | -0.29 | -2.33 | 1.83 | 1435.03 | 1.00 | 342 | 68 | 139 | 24 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 75 | 12 | TMB quintile 2 | 1.45 | 0.49 | 2.48 | 1390.38 | 1.00 | 361 | 68 | 5 | 7 | TRUE | 2.39 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 132 | 78 | TMB quintile 3 | 1.19 | 0.71 | 1.66 | 1474.37 | 1.00 | 451 | 99 | 45 | 33 | TRUE | 5.81 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 233 | 161 | TMB quintile 4 | 1.47 | 1.12 | 1.81 | 1417.81 | 1.00 | 463 | 141 | 69 | 92 | TRUE | 14.88 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 399 | 283 | TMB quintile 5 | 0.22 | -0.06 | 0.50 | 1406.91 | 1.00 | 655 | 299 | 183 | 100 | TRUE | 0.92 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 839 | 534 | TMB overall | 1.06 | 0.14 | 2.03 | 1240.78 | 1.00 | 1930 | 607 | 302 | 232 | TRUE | 1.52 |
| colorectal cancer | KRAS_12 | ASXL1 | Any mutation | 271 | 15 | TMB quintile 4 | -0.27 | -1.29 | 0.68 | 1626.50 | 1.00 | 510 | 266 | 10 | 5 | TRUE | 0.22 |
| colorectal cancer | KRAS_12 | ASXL1 | Any mutation | 227 | 30 | TMB quintile 5 | -0.71 | -1.60 | 0.10 | 1526.02 | 1.00 | 377 | 220 | 23 | 7 | TRUE | 1.01 |
| colorectal cancer | KRAS_12 | ASXL1 | Any mutation | 18 | 57 | TMB quintile 6 | -0.87 | -2.08 | 0.15 | 1451.51 | 1.00 | 80 | 14 | 53 | 4 | TRUE | 0.88 |
| colorectal cancer | KRAS_12 | ASXL1 | Any mutation | 516 | 102 | TMB overall | -0.58 | -2.28 | 1.10 | 1419.31 | 1.00 | 967 | 500 | 86 | 16 | TRUE | 0.30 |
| colorectal cancer | KRAS_12 | EP300 | Any mutation | 227 | 39 | TMB quintile 5 | -0.73 | -1.53 | 0.01 | 1444.67 | 1.00 | 371 | 218 | 30 | 9 | TRUE | 1.20 |
| colorectal cancer | KRAS_12 | EP300 | Any mutation | 20 | 72 | TMB quintile 6 | -0.50 | -1.47 | 0.46 | 1337.30 | 1.00 | 79 | 13 | 65 | 7 | TRUE | 0.51 |
| non-small cell lung cancer | KRAS_12 | EP300 | Any mutation | 396 | 77 | TMB quintile 5 | -0.27 | -0.78 | 0.22 | 1416.17 | 1.00 | 777 | 375 | 56 | 21 | TRUE | 0.53 |
| uterine cancer | KRAS_12 | EP300 | Any mutation | 50 | 39 | TMB quintile 5 | 0.07 | -0.82 | 0.87 | 1284.33 | 1.00 | 185 | 42 | 31 | 8 | TRUE | 0.06 |
| colorectal cancer | KRAS_12 | EP300 | Any mutation | 247 | 111 | TMB overall | -0.58 | -2.93 | 1.71 | 1506.15 | 1.00 | 450 | 231 | 95 | 16 | TRUE | 0.21 |
| non-small cell lung cancer | KRAS_12 | EP300 | Any mutation | 396 | 77 | TMB overall | -0.26 | -4.64 | 4.20 | 1369.58 | 1.00 | 777 | 375 | 56 | 21 | TRUE | 0.05 |
| uterine cancer | KRAS_12 | EP300 | Any mutation | 53 | 92 | TMB overall | -0.05 | -2.71 | 2.78 | 1655.75 | 1.00 | 216 | 43 | 82 | 10 | TRUE | 0.01 |
| colorectal cancer | KRAS_12 | ERBB4 | Any mutation | 271 | 22 | TMB quintile 4 | 0.02 | -0.82 | 0.82 | 1547.62 | 1.00 | 507 | 263 | 14 | 8 | TRUE | 0.02 |
| colorectal cancer | KRAS_12 | ERBB4 | Any mutation | 228 | 45 | TMB quintile 5 | 0.15 | -0.46 | 0.77 | 1616.48 | 1.00 | 373 | 210 | 27 | 18 | TRUE | 0.20 |
| colorectal cancer | KRAS_12 | ERBB4 | Any mutation | 19 | 61 | TMB quintile 6 | 0.12 | -0.80 | 1.05 | 1530.01 | 1.00 | 86 | 11 | 53 | 8 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12 | ERBB4 | Any mutation | 230 | 25 | TMB quintile 4 | -0.04 | -0.93 | 0.79 | 1461.90 | 1.00 | 515 | 222 | 17 | 8 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12 | ERBB4 | Any mutation | 399 | 148 | TMB quintile 5 | -0.65 | -1.09 | -0.25 | 1599.96 | 1.00 | 732 | 368 | 117 | 31 | TRUE | 2.64 |
| colorectal cancer | KRAS_12 | ERBB4 | Any mutation | 518 | 128 | TMB overall | 0.09 | -1.36 | 1.70 | 1558.56 | 1.00 | 966 | 484 | 94 | 34 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12 | ERBB4 | Any mutation | 629 | 185 | TMB overall | -0.64 | -3.38 | 2.22 | 1444.21 | 1.00 | 1256 | 590 | 146 | 39 | TRUE | 0.20 |
| colorectal cancer | KRAS_12 | MED12 | Any mutation | 272 | 18 | TMB quintile 4 | 0.48 | -0.46 | 1.40 | 1426.29 | 1.00 | 511 | 263 | 9 | 9 | TRUE | 0.51 |
| colorectal cancer | KRAS_12 | MED12 | Any mutation | 227 | 28 | TMB quintile 5 | 0.08 | -0.71 | 0.82 | 1471.05 | 1.00 | 384 | 216 | 17 | 11 | TRUE | 0.07 |
| colorectal cancer | KRAS_12 | MED12 | Any mutation | 19 | 59 | TMB quintile 6 | -0.86 | -2.08 | 0.13 | 1401.91 | 1.00 | 80 | 15 | 55 | 4 | TRUE | 0.88 |
| non-small cell lung cancer | KRAS_12 | MED12 | Any mutation | 130 | 23 | TMB quintile 3 | -0.35 | -1.17 | 0.42 | 1360.84 | 1.00 | 477 | 126 | 19 | 4 | TRUE | 0.41 |
| non-small cell lung cancer | KRAS_12 | MED12 | Any mutation | 230 | 32 | TMB quintile 4 | -0.25 | -0.91 | 0.44 | 1541.02 | 1.00 | 509 | 221 | 23 | 9 | TRUE | 0.34 |
| non-small cell lung cancer | KRAS_12 | MED12 | Any mutation | 398 | 101 | TMB quintile 5 | -0.40 | -0.82 | 0.03 | 1211.46 | 1.00 | 757 | 374 | 77 | 24 | TRUE | 1.14 |
| uterine cancer | KRAS_12 | MED12 | Any mutation | 12 | 13 | TMB quintile 2 | -1.61 | -4.18 | 0.32 | 1416.89 | 1.00 | 120 | 12 | 13 | 0 | TRUE | 0.81 |
| uterine cancer | KRAS_12 | MED12 | Any mutation | 24 | 16 | TMB quintile 3 | -0.41 | -2.10 | 1.03 | 1523.01 | 1.00 | 203 | 22 | 14 | 2 | TRUE | 0.22 |
| uterine cancer | KRAS_12 | MED12 | Any mutation | 39 | 20 | TMB quintile 4 | -1.41 | -3.22 | 0.10 | 1562.17 | 1.00 | 171 | 38 | 19 | 1 | TRUE | 1.03 |
| uterine cancer | KRAS_12 | MED12 | Any mutation | 49 | 31 | TMB quintile 5 | -0.19 | -1.22 | 0.72 | 1396.20 | 1.00 | 192 | 43 | 25 | 6 | TRUE | 0.16 |
| colorectal cancer | KRAS_12 | MED12 | Any mutation | 518 | 105 | TMB overall | -0.08 | -1.77 | 1.72 | 1213.94 | 1.00 | 975 | 494 | 81 | 24 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12 | MED12 | Any mutation | 758 | 156 | TMB overall | -0.34 | -1.04 | 0.43 | 1485.53 | 1.00 | 1743 | 721 | 119 | 37 | TRUE | 0.44 |
| uterine cancer | KRAS_12 | MED12 | Any mutation | 126 | 138 | TMB overall | -1.10 | -2.58 | 0.26 | 1614.28 | 1.00 | 717 | 117 | 129 | 9 | TRUE | 0.87 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 75 | 29 | TMB quintile 2 | 0.24 | -0.46 | 0.86 | 1433.39 | 1.00 | 342 | 70 | 24 | 5 | FALSE | 0.33 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 130 | 46 | TMB quintile 3 | 0.36 | -0.16 | 0.90 | 1428.79 | 1.00 | 463 | 118 | 34 | 12 | FALSE | 0.75 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 231 | 90 | TMB quintile 4 | 0.74 | 0.33 | 1.12 | 1411.98 | 1.00 | 484 | 189 | 48 | 42 | FALSE | 3.54 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 402 | 200 | TMB quintile 5 | 0.64 | 0.36 | 0.94 | 1354.14 | 1.00 | 728 | 313 | 111 | 89 | FALSE | 4.81 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 838 | 365 | TMB overall | 0.49 | -0.03 | 1.00 | 1397.44 | 1.00 | 2017 | 690 | 217 | 148 | FALSE | 1.31 |
| colorectal cancer | KRAS_12 | NF1 | Any mutation | 271 | 13 | TMB quintile 4 | -1.75 | -3.73 | -0.26 | 1497.82 | 1.00 | 509 | 270 | 12 | 1 | TRUE | 1.31 |
| colorectal cancer | KRAS_12 | NF1 | Any mutation | 228 | 34 | TMB quintile 5 | -0.13 | -0.86 | 0.57 | 1432.00 | 1.00 | 377 | 216 | 22 | 12 | TRUE | 0.14 |
| colorectal cancer | KRAS_12 | NF1 | Any mutation | 19 | 86 | TMB quintile 6 | -0.66 | -1.63 | 0.28 | 1189.40 | 1.00 | 77 | 12 | 79 | 7 | TRUE | 0.74 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 130 | 25 | TMB quintile 3 | -0.96 | -2.09 | 0.02 | 1619.52 | 1.00 | 475 | 127 | 22 | 3 | TRUE | 1.15 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 230 | 59 | TMB quintile 4 | -1.48 | -2.34 | -0.68 | 1575.78 | 1.00 | 486 | 225 | 54 | 5 | TRUE | 3.42 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 399 | 216 | TMB quintile 5 | -0.81 | -1.17 | -0.45 | 1262.00 | 1.00 | 685 | 358 | 175 | 41 | TRUE | 5.30 |
| uterine cancer | KRAS_12 | NF1 | Any mutation | 49 | 38 | TMB quintile 5 | -0.57 | -1.61 | 0.36 | 1444.98 | 1.00 | 187 | 44 | 33 | 5 | TRUE | 0.59 |
| colorectal cancer | KRAS_12 | NF1 | Any mutation | 518 | 133 | TMB overall | -0.80 | -2.66 | 1.14 | 1367.85 | 1.00 | 963 | 498 | 113 | 20 | TRUE | 0.38 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 759 | 300 | TMB overall | -1.07 | -2.03 | -0.13 | 1504.34 | 1.00 | 1646 | 710 | 251 | 49 | TRUE | 1.50 |
| uterine cancer | KRAS_12 | NF1 | Any mutation | 51 | 111 | TMB overall | -0.86 | -3.72 | 2.24 | 1545.92 | 1.00 | 215 | 45 | 105 | 6 | TRUE | 0.25 |
| non-small cell lung cancer | KRAS_12 | FLT1 | Any mutation | 230 | 21 | TMB quintile 4 | 0.53 | -0.35 | 1.40 | 1524.35 | 1.00 | 522 | 220 | 11 | 10 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12 | FLT1 | Any mutation | 398 | 99 | TMB quintile 5 | -0.21 | -0.70 | 0.22 | 1573.09 | 1.00 | 763 | 371 | 72 | 27 | FALSE | 0.44 |
| non-small cell lung cancer | KRAS_12 | FLT1 | Any mutation | 628 | 120 | TMB overall | 0.16 | -1.43 | 1.80 | 1545.13 | 1.00 | 1285 | 591 | 83 | 37 | FALSE | 0.07 |
| uterine cancer | KRAS_12 | RASA1 | Any mutation | 49 | 25 | TMB quintile 5 | -0.42 | -1.75 | 0.67 | 1482.06 | 1.00 | 194 | 45 | 21 | 4 | FALSE | 0.30 |
| uterine cancer | KRAS_12 | RASA1 | Any mutation | 51 | 95 | TMB overall | -1.68 | -5.87 | 2.11 | 1617.61 | 1.00 | 221 | 47 | 91 | 4 | FALSE | 0.41 |
| colorectal cancer | KRAS_12 | EPHA5 | Any mutation | 271 | 18 | TMB quintile 4 | -0.76 | -1.94 | 0.29 | 1516.89 | 1.00 | 506 | 267 | 14 | 4 | FALSE | 0.78 |
| colorectal cancer | KRAS_12 | EPHA5 | Any mutation | 228 | 52 | TMB quintile 5 | -0.13 | -0.73 | 0.47 | 1694.67 | 1.00 | 367 | 210 | 34 | 18 | FALSE | 0.18 |
| colorectal cancer | KRAS_12 | EPHA5 | Any mutation | 18 | 66 | TMB quintile 6 | -0.96 | -2.17 | 0.12 | 1412.82 | 1.00 | 84 | 14 | 62 | 4 | FALSE | 1.01 |
| non-small cell lung cancer | KRAS_12 | EPHA5 | Any mutation | 230 | 48 | TMB quintile 4 | 0.20 | -0.38 | 0.81 | 1152.81 | 1.00 | 502 | 213 | 31 | 17 | FALSE | 0.30 |
| non-small cell lung cancer | KRAS_12 | EPHA5 | Any mutation | 399 | 191 | TMB quintile 5 | 0.04 | -0.29 | 0.35 | 1539.92 | 1.00 | 715 | 336 | 128 | 63 | FALSE | 0.11 |
| colorectal cancer | KRAS_12 | EPHA5 | Any mutation | 517 | 136 | TMB overall | -0.61 | -2.27 | 1.06 | 1661.25 | 1.00 | 957 | 491 | 110 | 26 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12 | EPHA5 | Any mutation | 629 | 250 | TMB overall | -0.27 | -2.67 | 1.85 | 1642.40 | 1.00 | 1227 | 549 | 170 | 80 | FALSE | 0.09 |
| colorectal cancer | KRAS_12 | AR | Any mutation | 271 | 21 | TMB quintile 4 | -0.88 | -1.93 | 0.07 | 1606.97 | 1.00 | 503 | 267 | 17 | 4 | TRUE | 1.03 |
| colorectal cancer | KRAS_12 | AR | Any mutation | 227 | 34 | TMB quintile 5 | -1.01 | -1.93 | -0.22 | 1447.22 | 1.00 | 373 | 221 | 28 | 6 | TRUE | 1.66 |
| colorectal cancer | KRAS_12 | AR | Any mutation | 18 | 55 | TMB quintile 6 | 0.20 | -0.77 | 1.11 | 1540.14 | 1.00 | 87 | 10 | 47 | 8 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12 | AR | Any mutation | 230 | 16 | TMB quintile 4 | 0.31 | -0.56 | 1.28 | 1425.07 | 1.00 | 523 | 223 | 9 | 7 | TRUE | 0.29 |
| non-small cell lung cancer | KRAS_12 | AR | Any mutation | 398 | 77 | TMB quintile 5 | -0.14 | -0.64 | 0.37 | 1686.87 | 1.00 | 778 | 376 | 55 | 22 | TRUE | 0.24 |
| colorectal cancer | KRAS_12 | AR | Any mutation | 516 | 110 | TMB overall | -0.59 | -2.28 | 1.05 | 1385.53 | 1.00 | 963 | 498 | 92 | 18 | TRUE | 0.32 |
| non-small cell lung cancer | KRAS_12 | AR | Any mutation | 628 | 93 | TMB overall | 0.05 | -1.42 | 1.58 | 1458.51 | 1.00 | 1301 | 599 | 64 | 29 | TRUE | 0.03 |
| colorectal cancer | KRAS_12 | ROS1 | Any mutation | 271 | 14 | TMB quintile 4 | -1.39 | -2.98 | -0.05 | 1449.56 | 1.00 | 508 | 269 | 12 | 2 | TRUE | 1.24 |
| colorectal cancer | KRAS_12 | ROS1 | Any mutation | 227 | 24 | TMB quintile 5 | -1.23 | -2.36 | -0.25 | 1502.53 | 1.00 | 379 | 223 | 20 | 4 | TRUE | 1.60 |
| colorectal cancer | KRAS_12 | ROS1 | Any mutation | 18 | 61 | TMB quintile 6 | -1.73 | -3.30 | -0.52 | 1537.93 | 1.00 | 87 | 16 | 59 | 2 | TRUE | 1.81 |
| non-small cell lung cancer | KRAS_12 | ROS1 | Any mutation | 230 | 13 | TMB quintile 4 | -2.85 | -7.18 | -0.81 | 1459.03 | 1.00 | 519 | 230 | 13 | 0 | TRUE | 1.06 |
| non-small cell lung cancer | KRAS_12 | ROS1 | Any mutation | 396 | 80 | TMB quintile 5 | -1.14 | -1.78 | -0.51 | 1412.68 | 1.00 | 764 | 384 | 68 | 12 | TRUE | 3.21 |
| colorectal cancer | KRAS_12 | ROS1 | Any mutation | 516 | 99 | TMB overall | -1.45 | -3.31 | 0.24 | 1241.95 | 1.00 | 974 | 508 | 91 | 8 | TRUE | 0.96 |
| non-small cell lung cancer | KRAS_12 | ROS1 | Any mutation | 626 | 93 | TMB overall | -1.86 | -4.86 | 0.32 | 1478.31 | 1.00 | 1283 | 614 | 81 | 12 | TRUE | 0.84 |
| colorectal cancer | KRAS_12 | PIK3CG | Any mutation | 271 | 16 | TMB quintile 4 | -0.53 | -1.64 | 0.50 | 1507.69 | 1.00 | 508 | 267 | 12 | 4 | FALSE | 0.48 |
| colorectal cancer | KRAS_12 | PIK3CG | Any mutation | 227 | 38 | TMB quintile 5 | 0.09 | -0.59 | 0.77 | 1447.68 | 1.00 | 376 | 212 | 23 | 15 | FALSE | 0.11 |
| colorectal cancer | KRAS_12 | PIK3CG | Any mutation | 20 | 45 | TMB quintile 6 | -0.28 | -1.40 | 0.70 | 1533.74 | 1.00 | 96 | 15 | 40 | 5 | FALSE | 0.23 |
| non-small cell lung cancer | KRAS_12 | PIK3CG | Any mutation | 230 | 16 | TMB quintile 4 | 0.15 | -0.86 | 1.08 | 1463.86 | 1.00 | 522 | 224 | 10 | 6 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | PIK3CG | Any mutation | 399 | 150 | TMB quintile 5 | -0.21 | -0.61 | 0.18 | 1504.92 | 1.00 | 734 | 357 | 108 | 42 | FALSE | 0.55 |
| colorectal cancer | KRAS_12 | PIK3CG | Any mutation | 518 | 99 | TMB overall | -0.23 | -1.84 | 1.31 | 1541.21 | 1.00 | 980 | 494 | 75 | 24 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12 | PIK3CG | Any mutation | 629 | 166 | TMB overall | -0.01 | -1.92 | 2.20 | 1441.73 | 1.00 | 1256 | 581 | 118 | 48 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 75 | 200 | TMB quintile 2 | -5.21 | -8.31 | -3.41 | 1553.87 | 1.00 | 188 | 75 | 200 | 0 | TRUE | 4.25 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 130 | 287 | TMB quintile 3 | -5.47 | -8.52 | -3.70 | 1345.05 | 1.00 | 266 | 130 | 287 | 0 | TRUE | 4.90 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 230 | 256 | TMB quintile 4 | -4.49 | -6.02 | -3.41 | 1490.33 | 1.00 | 342 | 228 | 254 | 2 | TRUE | 11.28 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 395 | 175 | TMB quintile 5 | -2.05 | -2.73 | -1.45 | 1157.05 | 1.00 | 707 | 381 | 161 | 14 | TRUE | 9.29 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 830 | 918 | TMB overall | -4.20 | -6.05 | -2.84 | 1418.43 | 1.00 | 1503 | 814 | 902 | 16 | TRUE | 6.52 |
| colorectal cancer | KRAS_12 | ARID1B | Any mutation | 271 | 13 | TMB quintile 4 | -0.47 | -1.69 | 0.72 | 1578.69 | 1.00 | 512 | 267 | 9 | 4 | TRUE | 0.35 |
| colorectal cancer | KRAS_12 | ARID1B | Any mutation | 228 | 46 | TMB quintile 5 | -1.11 | -1.91 | -0.39 | 1548.42 | 1.00 | 363 | 220 | 38 | 8 | TRUE | 2.41 |
| colorectal cancer | KRAS_12 | ARID1B | Any mutation | 18 | 79 | TMB quintile 6 | -2.14 | -3.68 | -0.90 | 1413.15 | 1.00 | 65 | 16 | 77 | 2 | TRUE | 2.71 |
| non-small cell lung cancer | KRAS_12 | ARID1B | Any mutation | 130 | 11 | TMB quintile 3 | -0.38 | -1.58 | 0.66 | 1379.75 | 1.00 | 487 | 128 | 9 | 2 | TRUE | 0.30 |
| non-small cell lung cancer | KRAS_12 | ARID1B | Any mutation | 230 | 16 | TMB quintile 4 | -0.75 | -1.94 | 0.19 | 1379.49 | 1.00 | 519 | 228 | 14 | 2 | TRUE | 0.81 |
| non-small cell lung cancer | KRAS_12 | ARID1B | Any mutation | 397 | 77 | TMB quintile 5 | -0.03 | -0.52 | 0.46 | 1517.89 | 1.00 | 779 | 372 | 52 | 25 | TRUE | 0.04 |
| uterine cancer | KRAS_12 | ARID1B | Any mutation | 52 | 59 | TMB quintile 5 | 0.47 | -0.23 | 1.14 | 1481.06 | 1.00 | 175 | 37 | 44 | 15 | TRUE | 0.74 |
| colorectal cancer | KRAS_12 | ARID1B | Any mutation | 517 | 138 | TMB overall | -1.23 | -3.14 | 0.75 | 1494.92 | 1.00 | 940 | 503 | 124 | 14 | TRUE | 0.67 |
| non-small cell lung cancer | KRAS_12 | ARID1B | Any mutation | 757 | 104 | TMB overall | -0.39 | -1.43 | 0.64 | 1367.52 | 1.00 | 1785 | 728 | 75 | 29 | TRUE | 0.34 |
| uterine cancer | KRAS_12 | ARID1B | Any mutation | 54 | 107 | TMB overall | 0.72 | -2.04 | 4.34 | 1558.21 | 1.00 | 205 | 37 | 90 | 17 | TRUE | 0.18 |
| non-small cell lung cancer | KRAS_12 | MET | Any mutation | 75 | 21 | TMB quintile 2 | -0.86 | -1.94 | 0.09 | 1662.00 | 1.00 | 348 | 73 | 19 | 2 | TRUE | 1.05 |
| non-small cell lung cancer | KRAS_12 | MET | Any mutation | 130 | 30 | TMB quintile 3 | -1.08 | -2.15 | -0.21 | 1511.76 | 1.00 | 474 | 128 | 28 | 2 | TRUE | 1.53 |
| non-small cell lung cancer | KRAS_12 | MET | Any mutation | 230 | 34 | TMB quintile 4 | -1.47 | -2.79 | -0.53 | 1499.53 | 1.00 | 505 | 229 | 33 | 1 | TRUE | 2.03 |
| non-small cell lung cancer | KRAS_12 | MET | Any mutation | 395 | 47 | TMB quintile 5 | -0.17 | -0.80 | 0.47 | 1604.47 | 1.00 | 800 | 378 | 30 | 17 | TRUE | 0.21 |
| non-small cell lung cancer | KRAS_12 | MET | Any mutation | 830 | 132 | TMB overall | -0.88 | -1.73 | -0.13 | 1543.41 | 1.00 | 2127 | 808 | 110 | 22 | TRUE | 1.51 |
| colorectal cancer | KRAS_12 | BRAF | Any mutation | 144 | 27 | TMB quintile 3 | -2.69 | -4.29 | -1.41 | 1383.98 | 1.00 | 317 | 143 | 26 | 1 | TRUE | 3.50 |
| colorectal cancer | KRAS_12 | BRAF | Any mutation | 271 | 60 | TMB quintile 4 | -2.81 | -4.08 | -1.77 | 1502.16 | 1.00 | 462 | 269 | 58 | 2 | TRUE | 5.68 |
| colorectal cancer | KRAS_12 | BRAF | Any mutation | 228 | 104 | TMB quintile 5 | -2.41 | -3.21 | -1.72 | 1519.53 | 1.00 | 304 | 221 | 97 | 7 | TRUE | 9.54 |
| colorectal cancer | KRAS_12 | BRAF | Any mutation | 18 | 59 | TMB quintile 6 | -2.71 | -4.31 | -1.35 | 1596.45 | 1.00 | 75 | 17 | 58 | 1 | TRUE | 3.51 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 75 | 11 | TMB quintile 2 | -1.68 | -3.47 | -0.41 | 1456.35 | 1.00 | 355 | 75 | 11 | 0 | TRUE | 1.56 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 130 | 13 | TMB quintile 3 | -1.77 | -3.37 | -0.52 | 1259.68 | 1.00 | 483 | 130 | 13 | 0 | TRUE | 1.81 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 230 | 46 | TMB quintile 4 | -1.21 | -2.04 | -0.50 | 1462.90 | 1.00 | 493 | 224 | 40 | 6 | TRUE | 2.65 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 395 | 101 | TMB quintile 5 | -1.05 | -1.62 | -0.55 | 1536.92 | 1.00 | 745 | 379 | 85 | 16 | TRUE | 3.93 |
| colorectal cancer | KRAS_12 | BRAF | Any mutation | 661 | 250 | TMB overall | -2.62 | -3.83 | -1.54 | 1648.47 | 1.00 | 1158 | 650 | 239 | 11 | TRUE | 5.17 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 830 | 171 | TMB overall | -1.41 | -2.45 | -0.48 | 1353.61 | 1.00 | 2076 | 808 | 149 | 22 | TRUE | 2.31 |
| colorectal cancer | KRAS_12 | B2M | Any mutation | 216 | 50 | TMB quintile 5 | -0.51 | -1.17 | 0.11 | 1506.54 | 1.00 | 355 | 203 | 37 | 13 | FALSE | 0.90 |
| colorectal cancer | KRAS_12 | B2M | Any mutation | 23 | 79 | TMB quintile 6 | -0.21 | -1.07 | 0.66 | 1417.97 | 1.00 | 76 | 13 | 69 | 10 | FALSE | 0.20 |
| colorectal cancer | KRAS_12 | B2M | Any mutation | 239 | 129 | TMB overall | -0.34 | -2.85 | 2.03 | 1382.78 | 1.00 | 431 | 216 | 106 | 23 | FALSE | 0.12 |
| colorectal cancer | KRAS_12 | CARD11 | Any mutation | 271 | 28 | TMB quintile 4 | 0.00 | -0.79 | 0.73 | 1643.57 | 1.00 | 502 | 261 | 18 | 10 | FALSE | 0.00 |
| colorectal cancer | KRAS_12 | CARD11 | Any mutation | 228 | 43 | TMB quintile 5 | -0.20 | -0.86 | 0.41 | 1452.96 | 1.00 | 370 | 214 | 29 | 14 | FALSE | 0.27 |
| colorectal cancer | KRAS_12 | CARD11 | Any mutation | 19 | 52 | TMB quintile 6 | 0.29 | -0.60 | 1.20 | 1621.35 | 1.00 | 90 | 11 | 44 | 8 | FALSE | 0.27 |
| non-small cell lung cancer | KRAS_12 | CARD11 | Any mutation | 230 | 18 | TMB quintile 4 | 0.16 | -0.75 | 1.08 | 1484.57 | 1.00 | 521 | 223 | 11 | 7 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12 | CARD11 | Any mutation | 397 | 97 | TMB quintile 5 | -0.19 | -0.64 | 0.29 | 1409.15 | 1.00 | 762 | 370 | 70 | 27 | FALSE | 0.39 |
| colorectal cancer | KRAS_12 | CARD11 | Any mutation | 518 | 123 | TMB overall | 0.04 | -1.32 | 1.47 | 1509.31 | 1.00 | 962 | 486 | 91 | 32 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12 | CARD11 | Any mutation | 627 | 115 | TMB overall | -0.01 | -1.81 | 1.62 | 1387.39 | 1.00 | 1283 | 593 | 81 | 34 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12 | INPP4B | Any mutation | 230 | 17 | TMB quintile 4 | 0.58 | -0.28 | 1.44 | 1209.28 | 1.00 | 523 | 222 | 9 | 8 | FALSE | 0.73 |
| non-small cell lung cancer | KRAS_12 | INPP4B | Any mutation | 398 | 87 | TMB quintile 5 | 0.57 | 0.10 | 0.99 | 1502.11 | 1.00 | 785 | 360 | 49 | 38 | FALSE | 1.92 |
| non-small cell lung cancer | KRAS_12 | INPP4B | Any mutation | 628 | 104 | TMB overall | 0.56 | -0.84 | 2.05 | 1508.66 | 1.00 | 1308 | 582 | 58 | 46 | FALSE | 0.37 |
| non-small cell lung cancer | KRAS_12 | NFE2L2 | Any mutation | 230 | 31 | TMB quintile 4 | -0.92 | -1.73 | -0.23 | 1434.00 | 1.00 | 512 | 225 | 26 | 5 | FALSE | 1.85 |
| non-small cell lung cancer | KRAS_12 | NFE2L2 | Any mutation | 396 | 83 | TMB quintile 5 | -0.90 | -1.43 | -0.39 | 1529.20 | 1.00 | 765 | 382 | 69 | 14 | FALSE | 3.08 |
| non-small cell lung cancer | KRAS_12 | NFE2L2 | Any mutation | 626 | 114 | TMB overall | -0.91 | -1.90 | 0.04 | 1544.12 | 1.00 | 1277 | 607 | 95 | 19 | FALSE | 1.19 |
| colorectal cancer | KRAS_12 | SOX9 | Any mutation | 144 | 17 | TMB quintile 3 | -0.06 | -1.00 | 0.76 | 1637.89 | 1.00 | 331 | 139 | 12 | 5 | FALSE | 0.05 |
| colorectal cancer | KRAS_12 | SOX9 | Any mutation | 275 | 85 | TMB quintile 4 | 0.25 | -0.23 | 0.68 | 1564.52 | 1.00 | 469 | 241 | 51 | 34 | FALSE | 0.53 |
| colorectal cancer | KRAS_12 | SOX9 | Any mutation | 233 | 107 | TMB quintile 5 | 0.12 | -0.32 | 0.52 | 1519.70 | 1.00 | 339 | 192 | 66 | 41 | FALSE | 0.24 |
| colorectal cancer | KRAS_12 | SOX9 | Any mutation | 19 | 50 | TMB quintile 6 | 0.66 | -0.14 | 1.52 | 1618.62 | 1.00 | 91 | 9 | 40 | 10 | FALSE | 0.90 |
| colorectal cancer | KRAS_12 | SOX9 | Any mutation | 671 | 259 | TMB overall | 0.22 | -0.78 | 1.27 | 1588.90 | 1.00 | 1230 | 581 | 169 | 90 | FALSE | 0.18 |
| colorectal cancer | KRAS_12 | SMAD2 | Any mutation | 271 | 29 | TMB quintile 4 | 0.38 | -0.32 | 1.06 | 1711.09 | 1.00 | 505 | 258 | 16 | 13 | TRUE | 0.57 |
| colorectal cancer | KRAS_12 | SMAD2 | Any mutation | 230 | 53 | TMB quintile 5 | 0.56 | 0.04 | 1.11 | 1521.56 | 1.00 | 376 | 204 | 27 | 26 | TRUE | 1.40 |
| colorectal cancer | KRAS_12 | SMAD2 | Any mutation | 18 | 16 | TMB quintile 6 | 0.14 | -1.10 | 1.22 | 1411.16 | 1.00 | 113 | 16 | 14 | 2 | TRUE | 0.09 |
| colorectal cancer | KRAS_12 | SMAD2 | Any mutation | 519 | 98 | TMB overall | 0.38 | -0.72 | 1.50 | 1412.80 | 1.00 | 994 | 478 | 57 | 41 | TRUE | 0.32 |
| non-small cell lung cancer | KRAS_12 | GLI1 | Any mutation | 217 | 16 | TMB quintile 4 | 0.53 | -0.35 | 1.42 | 1545.61 | 1.00 | 457 | 209 | 8 | 8 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12 | GLI1 | Any mutation | 364 | 77 | TMB quintile 5 | 0.27 | -0.19 | 0.71 | 1442.02 | 1.00 | 695 | 335 | 48 | 29 | FALSE | 0.61 |
| non-small cell lung cancer | KRAS_12 | GLI1 | Any mutation | 581 | 93 | TMB overall | 0.38 | -1.01 | 1.79 | 1457.16 | 1.00 | 1152 | 544 | 56 | 37 | FALSE | 0.24 |
| colorectal cancer | KRAS_12 | ZFHX3 | Any mutation | 248 | 14 | TMB quintile 4 | 0.21 | -0.85 | 1.20 | 1482.64 | 1.00 | 464 | 242 | 8 | 6 | FALSE | 0.16 |
| colorectal cancer | KRAS_12 | ZFHX3 | Any mutation | 212 | 63 | TMB quintile 5 | -0.39 | -0.95 | 0.15 | 1474.69 | 1.00 | 328 | 194 | 45 | 18 | FALSE | 0.78 |
| colorectal cancer | KRAS_12 | ZFHX3 | Any mutation | 22 | 143 | TMB quintile 6 | 0.77 | -0.24 | 1.96 | 1614.66 | 1.00 | 47 | 3 | 124 | 19 | FALSE | 0.75 |
| non-small cell lung cancer | KRAS_12 | ZFHX3 | Any mutation | 120 | 13 | TMB quintile 3 | -0.82 | -2.23 | 0.24 | 1402.76 | 1.00 | 438 | 119 | 12 | 1 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12 | ZFHX3 | Any mutation | 216 | 30 | TMB quintile 4 | -0.34 | -1.07 | 0.37 | 1593.74 | 1.00 | 441 | 208 | 22 | 8 | FALSE | 0.45 |
| non-small cell lung cancer | KRAS_12 | ZFHX3 | Any mutation | 364 | 112 | TMB quintile 5 | -0.28 | -0.73 | 0.14 | 1379.08 | 1.00 | 664 | 333 | 81 | 31 | FALSE | 0.65 |
| uterine cancer | KRAS_12 | ZFHX3 | Any mutation | 36 | 13 | TMB quintile 4 | 0.12 | -1.27 | 1.47 | 1450.17 | 1.00 | 159 | 33 | 10 | 3 | FALSE | 0.06 |
| uterine cancer | KRAS_12 | ZFHX3 | Any mutation | 49 | 105 | TMB quintile 5 | 0.10 | -0.52 | 0.69 | 1673.57 | 1.00 | 138 | 29 | 85 | 20 | FALSE | 0.13 |
| colorectal cancer | KRAS_12 | ZFHX3 | Any mutation | 482 | 220 | TMB overall | 0.23 | -1.90 | 2.54 | 1351.59 | 1.00 | 839 | 439 | 177 | 43 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12 | ZFHX3 | Any mutation | 700 | 155 | TMB overall | -0.47 | -1.58 | 0.55 | 1296.38 | 1.00 | 1543 | 660 | 115 | 40 | FALSE | 0.44 |
| uterine cancer | KRAS_12 | ZFHX3 | Any mutation | 89 | 210 | TMB overall | -0.03 | -1.89 | 1.80 | 1544.08 | 1.00 | 321 | 63 | 184 | 26 | FALSE | 0.01 |
| colorectal cancer | KRAS_12 | MGA | Any mutation | 248 | 15 | TMB quintile 4 | -1.32 | -2.86 | -0.08 | 1399.77 | 1.00 | 460 | 246 | 13 | 2 | FALSE | 1.24 |
| colorectal cancer | KRAS_12 | MGA | Any mutation | 213 | 46 | TMB quintile 5 | -0.07 | -0.72 | 0.55 | 1212.90 | 1.00 | 337 | 196 | 29 | 17 | FALSE | 0.08 |
| colorectal cancer | KRAS_12 | MGA | Any mutation | 16 | 58 | TMB quintile 6 | -1.18 | -2.57 | -0.02 | 1396.44 | 1.00 | 75 | 13 | 55 | 3 | FALSE | 1.21 |
| non-small cell lung cancer | KRAS_12 | MGA | Any mutation | 120 | 14 | TMB quintile 3 | 0.15 | -0.91 | 1.14 | 1350.48 | 1.00 | 441 | 116 | 10 | 4 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | MGA | Any mutation | 216 | 24 | TMB quintile 4 | 0.01 | -0.78 | 0.70 | 1216.58 | 1.00 | 447 | 208 | 16 | 8 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12 | MGA | Any mutation | 366 | 140 | TMB quintile 5 | 0.00 | -0.39 | 0.36 | 1344.58 | 1.00 | 659 | 321 | 95 | 45 | FALSE | 0.01 |
| uterine cancer | KRAS_12 | MGA | Any mutation | 45 | 24 | TMB quintile 5 | -1.80 | -4.03 | -0.14 | 1369.22 | 1.00 | 183 | 44 | 23 | 1 | FALSE | 1.12 |
| uterine cancer | KRAS_12 | MGA | Any mutation | 6 | 82 | TMB quintile 6 | 0.12 | -1.73 | 2.26 | 1448.61 | 1.00 | 23 | 1 | 77 | 5 | FALSE | 0.04 |
| colorectal cancer | KRAS_12 | MGA | Any mutation | 477 | 119 | TMB overall | -0.86 | -2.68 | 0.76 | 1460.29 | 1.00 | 872 | 455 | 97 | 22 | FALSE | 0.48 |
| non-small cell lung cancer | KRAS_12 | MGA | Any mutation | 702 | 178 | TMB overall | 0.05 | -0.96 | 1.13 | 1485.49 | 1.00 | 1547 | 645 | 121 | 57 | FALSE | 0.04 |
| uterine cancer | KRAS_12 | MGA | Any mutation | 51 | 106 | TMB overall | -0.66 | -3.91 | 2.95 | 1525.56 | 1.00 | 206 | 45 | 100 | 6 | FALSE | 0.16 |
| colorectal cancer | KRAS_12 | KMT2B | Any mutation | 118 | 54 | TMB quintile 5 | -0.13 | -0.76 | 0.45 | 1439.36 | 1.00 | 180 | 100 | 36 | 18 | FALSE | 0.16 |
| colorectal cancer | KRAS_12 | KMT2B | Any mutation | 11 | 115 | TMB quintile 6 | 0.52 | -1.04 | 2.53 | 1467.76 | 1.00 | 21 | 1 | 105 | 10 | FALSE | 0.24 |
| colorectal cancer | KRAS_12 | KMT2B | Any mutation | 129 | 169 | TMB overall | 0.11 | -3.08 | 3.31 | 1501.50 | 1.00 | 201 | 101 | 141 | 28 | FALSE | 0.03 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 130 | 35 | TMB quintile 3 | 0.07 | -0.63 | 0.75 | 1470.92 | 1.00 | 287 | 119 | 24 | 11 | FALSE | 0.08 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 251 | 79 | TMB quintile 4 | 0.37 | -0.09 | 0.80 | 1380.79 | 1.00 | 428 | 217 | 45 | 34 | FALSE | 0.94 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 216 | 108 | TMB quintile 5 | -0.01 | -0.42 | 0.39 | 1374.56 | 1.01 | 302 | 177 | 69 | 39 | FALSE | 0.02 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 18 | 70 | TMB quintile 6 | 0.56 | -0.34 | 1.49 | 1654.01 | 1.00 | 68 | 6 | 58 | 12 | FALSE | 0.67 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 615 | 292 | TMB overall | 0.26 | -0.60 | 1.28 | 1565.68 | 1.00 | 1085 | 519 | 196 | 96 | FALSE | 0.23 |
| colorectal cancer | KRAS_12 | ANKRD11 | Any mutation | 241 | 11 | TMB quintile 4 | -0.18 | -1.46 | 0.96 | 1483.38 | 1.00 | 454 | 237 | 7 | 4 | FALSE | 0.11 |
| colorectal cancer | KRAS_12 | ANKRD11 | Any mutation | 197 | 43 | TMB quintile 5 | -1.33 | -2.27 | -0.53 | 1410.67 | 1.00 | 310 | 191 | 37 | 6 | FALSE | 2.63 |
| colorectal cancer | KRAS_12 | ANKRD11 | Any mutation | 20 | 86 | TMB quintile 6 | -0.43 | -1.37 | 0.44 | 1471.89 | 1.00 | 64 | 11 | 77 | 9 | FALSE | 0.45 |
| colorectal cancer | KRAS_12 | ANKRD11 | Any mutation | 458 | 140 | TMB overall | -0.65 | -2.69 | 1.34 | 1429.90 | 1.00 | 828 | 439 | 121 | 19 | FALSE | 0.29 |
| colorectal cancer | KRAS_12 | POLD1 | Any mutation | 214 | 20 | TMB quintile 5 | -0.19 | -1.11 | 0.67 | 1387.66 | 1.00 | 354 | 207 | 13 | 7 | TRUE | 0.16 |
| colorectal cancer | KRAS_12 | POLD1 | Any mutation | 17 | 83 | TMB quintile 6 | -0.56 | -1.64 | 0.41 | 1430.87 | 1.00 | 63 | 10 | 76 | 7 | TRUE | 0.54 |
| colorectal cancer | KRAS_12 | POLD1 | Any mutation | 231 | 103 | TMB overall | -0.29 | -3.29 | 2.78 | 1506.18 | 1.00 | 417 | 217 | 89 | 14 | TRUE | 0.07 |
| non-small cell lung cancer | KRAS_12 | PREX2 | Any mutation | 119 | 14 | TMB quintile 4 | -0.12 | -1.08 | 0.88 | 1512.57 | 1.00 | 231 | 114 | 9 | 5 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12 | PREX2 | Any mutation | 205 | 84 | TMB quintile 5 | -0.33 | -0.84 | 0.17 | 1367.89 | 1.00 | 361 | 183 | 62 | 22 | FALSE | 0.69 |
| non-small cell lung cancer | KRAS_12 | PREX2 | Any mutation | 324 | 98 | TMB overall | -0.25 | -1.81 | 1.28 | 1439.60 | 1.00 | 592 | 297 | 71 | 27 | FALSE | 0.12 |
| colorectal cancer | KRAS_12 | AMER1 | Any mutation | 144 | 13 | TMB quintile 3 | 0.23 | -0.81 | 1.20 | 1352.32 | 1.00 | 335 | 139 | 8 | 5 | FALSE | 0.18 |
| colorectal cancer | KRAS_12 | AMER1 | Any mutation | 271 | 38 | TMB quintile 4 | 0.80 | 0.15 | 1.40 | 1317.95 | 1.00 | 505 | 250 | 17 | 21 | FALSE | 1.91 |
| colorectal cancer | KRAS_12 | AMER1 | Any mutation | 227 | 62 | TMB quintile 5 | 0.34 | -0.18 | 0.86 | 1529.01 | 1.00 | 364 | 200 | 35 | 27 | FALSE | 0.71 |
| colorectal cancer | KRAS_12 | AMER1 | Any mutation | 18 | 55 | TMB quintile 6 | -0.30 | -1.27 | 0.58 | 1290.78 | 1.00 | 85 | 13 | 50 | 5 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12 | AMER1 | Any mutation | 230 | 18 | TMB quintile 4 | 1.19 | 0.25 | 2.21 | 1453.19 | 1.00 | 525 | 219 | 7 | 11 | FALSE | 1.82 |
| non-small cell lung cancer | KRAS_12 | AMER1 | Any mutation | 398 | 107 | TMB quintile 5 | 0.38 | -0.04 | 0.77 | 1387.03 | 1.00 | 772 | 355 | 64 | 43 | FALSE | 1.20 |
| colorectal cancer | KRAS_12 | AMER1 | Any mutation | 660 | 168 | TMB overall | 0.26 | -0.97 | 1.35 | 1444.74 | 1.00 | 1289 | 602 | 110 | 58 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12 | AMER1 | Any mutation | 628 | 142 | TMB overall | 0.12 | -3.45 | 3.37 | 1551.98 | 1.00 | 1307 | 574 | 88 | 54 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12 | EPHA7 | Any mutation | 216 | 14 | TMB quintile 4 | -0.04 | -1.10 | 1.01 | 1518.38 | 1.00 | 453 | 211 | 9 | 5 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12 | EPHA7 | Any mutation | 363 | 101 | TMB quintile 5 | -0.29 | -0.76 | 0.13 | 1542.52 | 1.00 | 673 | 336 | 74 | 27 | FALSE | 0.69 |
| non-small cell lung cancer | KRAS_12 | EPHA7 | Any mutation | 579 | 115 | TMB overall | -0.16 | -1.79 | 1.69 | 1527.52 | 1.00 | 1126 | 547 | 83 | 32 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | SPEN | Any mutation | 42 | 15 | TMB quintile 4 | -2.17 | -6.64 | 0.22 | 1467.47 | 1.00 | 705 | 42 | 15 | 0 | FALSE | 0.70 |
| non-small cell lung cancer | RAS_12C | SPEN | Any mutation | 93 | 87 | TMB quintile 5 | -1.58 | -3.39 | -0.26 | 1525.58 | 1.00 | 1075 | 91 | 85 | 2 | FALSE | 1.33 |
| non-small cell lung cancer | RAS_12C | SPEN | Any mutation | 135 | 102 | TMB overall | -1.79 | -4.68 | 0.52 | 1446.55 | 1.00 | 1780 | 133 | 100 | 2 | FALSE | 0.76 |
| non-small cell lung cancer | RAS_12C | KMT2C | Any mutation | 18 | 13 | TMB quintile 3 | -0.48 | -2.73 | 1.18 | 1472.07 | 1.00 | 591 | 18 | 13 | 0 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12C | KMT2C | Any mutation | 42 | 36 | TMB quintile 4 | 0.18 | -1.07 | 1.21 | 1520.50 | 1.00 | 686 | 39 | 33 | 3 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | KMT2C | Any mutation | 94 | 155 | TMB quintile 5 | -0.09 | -0.76 | 0.53 | 1411.57 | 1.00 | 992 | 83 | 144 | 11 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12C | KMT2C | Any mutation | 154 | 204 | TMB overall | -0.13 | -1.62 | 1.22 | 1494.97 | 1.00 | 2269 | 140 | 190 | 14 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 13 | 180 | TMB quintile 2 | -0.96 | -1.95 | 0.02 | 1490.55 | 1.00 | 254 | 9 | 176 | 4 | TRUE | 1.24 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 18 | 324 | TMB quintile 3 | -1.77 | -2.84 | -0.88 | 1325.65 | 1.00 | 299 | 16 | 322 | 2 | TRUE | 3.30 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 42 | 450 | TMB quintile 4 | -1.36 | -2.03 | -0.72 | 1484.38 | 1.00 | 307 | 31 | 439 | 11 | TRUE | 4.44 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 97 | 996 | TMB quintile 5 | -1.03 | -1.42 | -0.64 | 1686.06 | 1.00 | 287 | 45 | 944 | 52 | TRUE | 6.30 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 170 | 1950 | TMB overall | -1.28 | -2.11 | -0.45 | 1553.32 | 1.00 | 1147 | 101 | 1881 | 69 | TRUE | 2.53 |
| non-small cell lung cancer | RAS_12C | ATRX | Any mutation | 42 | 32 | TMB quintile 4 | -0.15 | -1.44 | 1.00 | 1599.22 | 1.00 | 691 | 40 | 30 | 2 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12C | ATRX | Any mutation | 94 | 160 | TMB quintile 5 | -0.36 | -1.06 | 0.27 | 1427.92 | 1.00 | 1004 | 85 | 151 | 9 | TRUE | 0.55 |
| non-small cell lung cancer | RAS_12C | ATRX | Any mutation | 136 | 192 | TMB overall | -0.22 | -1.91 | 1.42 | 1401.00 | 1.00 | 1695 | 125 | 181 | 11 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12C | ATR | Any mutation | 18 | 12 | TMB quintile 3 | 0.18 | -1.76 | 1.75 | 1492.52 | 1.00 | 597 | 17 | 11 | 1 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | ATR | Any mutation | 42 | 15 | TMB quintile 4 | -0.63 | -3.04 | 0.93 | 1456.77 | 1.00 | 707 | 42 | 15 | 0 | FALSE | 0.28 |
| non-small cell lung cancer | RAS_12C | ATR | Any mutation | 93 | 93 | TMB quintile 5 | 0.09 | -0.70 | 0.84 | 1576.66 | 1.00 | 1047 | 85 | 85 | 8 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | ATR | Any mutation | 153 | 120 | TMB overall | -0.12 | -1.69 | 1.21 | 1436.64 | 1.00 | 2351 | 144 | 111 | 9 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12C | PDGFRA | Any mutation | 42 | 16 | TMB quintile 4 | 0.69 | -0.74 | 1.87 | 1410.97 | 1.00 | 706 | 40 | 14 | 2 | TRUE | 0.51 |
| non-small cell lung cancer | RAS_12C | PDGFRA | Any mutation | 95 | 115 | TMB quintile 5 | 0.56 | -0.06 | 1.14 | 1518.78 | 1.00 | 1034 | 81 | 101 | 14 | TRUE | 1.16 |
| non-small cell lung cancer | RAS_12C | PDGFRA | Any mutation | 137 | 131 | TMB overall | 0.56 | -1.36 | 2.39 | 1445.57 | 1.00 | 1740 | 121 | 115 | 16 | TRUE | 0.24 |
| non-small cell lung cancer | RAS_12C | FLT4 | Any mutation | 42 | 14 | TMB quintile 4 | -0.13 | -1.97 | 1.47 | 1567.40 | 1.00 | 707 | 41 | 13 | 1 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12C | FLT4 | Any mutation | 93 | 74 | TMB quintile 5 | -0.17 | -1.13 | 0.67 | 1538.83 | 1.00 | 1065 | 88 | 69 | 5 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12C | FLT4 | Any mutation | 135 | 88 | TMB overall | -0.12 | -1.93 | 1.80 | 1584.67 | 1.00 | 1772 | 129 | 82 | 6 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12C | PTPRD | Any mutation | 18 | 16 | TMB quintile 3 | -1.52 | -5.75 | 1.02 | 1464.57 | 1.00 | 593 | 18 | 16 | 0 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12C | PTPRD | Any mutation | 42 | 53 | TMB quintile 4 | -0.65 | -2.39 | 0.65 | 1318.31 | 1.00 | 670 | 40 | 51 | 2 | FALSE | 0.40 |
| non-small cell lung cancer | RAS_12C | PTPRD | Any mutation | 98 | 298 | TMB quintile 5 | 0.16 | -0.30 | 0.63 | 1611.07 | 1.00 | 904 | 72 | 272 | 26 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12C | PTPRD | Any mutation | 158 | 384 | TMB overall | -0.83 | -3.47 | 1.10 | 1628.15 | 1.00 | 2174 | 130 | 356 | 28 | FALSE | 0.33 |
| non-small cell lung cancer | RAS_12C | PIK3C2G | Any mutation | 42 | 12 | TMB quintile 4 | -0.23 | -2.43 | 1.54 | 1559.36 | 1.00 | 706 | 41 | 11 | 1 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | PIK3C2G | Any mutation | 94 | 103 | TMB quintile 5 | -0.58 | -1.56 | 0.23 | 1311.54 | 1.00 | 1033 | 89 | 98 | 5 | FALSE | 0.66 |
| non-small cell lung cancer | RAS_12C | PIK3C2G | Any mutation | 136 | 115 | TMB overall | -0.37 | -2.62 | 1.85 | 1517.34 | 1.00 | 1739 | 130 | 109 | 6 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12C | CREBBP | Any mutation | 18 | 11 | TMB quintile 3 | -0.92 | -3.68 | 1.37 | 1451.81 | 1.00 | 597 | 18 | 11 | 0 | TRUE | 0.30 |
| non-small cell lung cancer | RAS_12C | CREBBP | Any mutation | 42 | 12 | TMB quintile 4 | 0.32 | -1.52 | 1.96 | 1649.20 | 1.00 | 710 | 40 | 10 | 2 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12C | CREBBP | Any mutation | 93 | 106 | TMB quintile 5 | -1.01 | -2.19 | -0.05 | 1565.87 | 1.00 | 1036 | 90 | 103 | 3 | TRUE | 1.20 |
| non-small cell lung cancer | RAS_12C | CREBBP | Any mutation | 153 | 129 | TMB overall | -0.49 | -2.41 | 1.37 | 1522.11 | 1.00 | 2343 | 148 | 124 | 5 | TRUE | 0.22 |
| non-small cell lung cancer | RAS_12C | DOT1L | Any mutation | 42 | 24 | TMB quintile 4 | -0.73 | -2.51 | 0.67 | 1027.46 | 1.00 | 699 | 41 | 23 | 1 | FALSE | 0.43 |
| non-small cell lung cancer | RAS_12C | DOT1L | Any mutation | 93 | 75 | TMB quintile 5 | -0.80 | -2.10 | 0.21 | 1498.20 | 1.00 | 1059 | 90 | 72 | 3 | FALSE | 0.75 |
| non-small cell lung cancer | RAS_12C | DOT1L | Any mutation | 135 | 99 | TMB overall | -0.78 | -2.37 | 0.66 | 1793.95 | 1.00 | 1758 | 131 | 95 | 4 | FALSE | 0.47 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Any mutation | 18 | 35 | TMB quintile 3 | 0.44 | -0.78 | 1.65 | 1473.55 | 1.00 | 579 | 16 | 33 | 2 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Any mutation | 43 | 67 | TMB quintile 4 | 1.03 | 0.23 | 1.81 | 1530.21 | 1.00 | 666 | 33 | 57 | 10 | FALSE | 2.15 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Any mutation | 95 | 194 | TMB quintile 5 | -0.34 | -1.04 | 0.26 | 1318.60 | 1.00 | 955 | 85 | 184 | 10 | FALSE | 0.53 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Any mutation | 156 | 296 | TMB overall | 0.39 | -0.78 | 1.67 | 1540.84 | 1.00 | 2200 | 134 | 274 | 22 | FALSE | 0.28 |
| non-small cell lung cancer | RAS_12C | PTPRT | Any mutation | 18 | 17 | TMB quintile 3 | 0.91 | -1.01 | 2.38 | 1532.23 | 1.00 | 593 | 16 | 15 | 2 | FALSE | 0.51 |
| non-small cell lung cancer | RAS_12C | PTPRT | Any mutation | 42 | 38 | TMB quintile 4 | -1.04 | -3.29 | 0.57 | 1522.39 | 1.00 | 684 | 41 | 37 | 1 | FALSE | 0.53 |
| non-small cell lung cancer | RAS_12C | PTPRT | Any mutation | 94 | 272 | TMB quintile 5 | -1.03 | -1.80 | -0.37 | 1415.53 | 1.00 | 918 | 85 | 263 | 9 | FALSE | 2.29 |
| non-small cell lung cancer | RAS_12C | PTPRT | Any mutation | 154 | 348 | TMB overall | -0.59 | -2.86 | 1.62 | 1385.74 | 1.00 | 2200 | 142 | 336 | 12 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12C | HGF | Any mutation | 42 | 27 | TMB quintile 4 | -0.03 | -1.86 | 1.36 | 1357.31 | 1.00 | 696 | 40 | 25 | 2 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12C | HGF | Any mutation | 94 | 138 | TMB quintile 5 | -0.39 | -1.18 | 0.30 | 1597.53 | 1.00 | 1006 | 86 | 130 | 8 | FALSE | 0.50 |
| non-small cell lung cancer | RAS_12C | HGF | Any mutation | 136 | 180 | TMB overall | -0.51 | -3.31 | 2.06 | 1478.89 | 1.00 | 1709 | 126 | 170 | 10 | FALSE | 0.16 |
| non-small cell lung cancer | RAS_12C | PIK3CA | Any mutation | 13 | 18 | TMB quintile 2 | 0.07 | -1.09 | 1.20 | 1314.03 | 1.00 | 411 | 12 | 17 | 1 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12C | PIK3CA | Any mutation | 18 | 34 | TMB quintile 3 | 0.21 | -0.86 | 1.28 | 1470.28 | 1.00 | 576 | 16 | 32 | 2 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12C | PIK3CA | Any mutation | 43 | 56 | TMB quintile 4 | -0.16 | -1.21 | 0.66 | 1526.98 | 1.00 | 666 | 41 | 54 | 2 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12C | PIK3CA | Any mutation | 93 | 123 | TMB quintile 5 | 0.09 | -0.55 | 0.69 | 1398.69 | 1.00 | 1026 | 83 | 113 | 10 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12C | PIK3CA | Any mutation | 167 | 231 | TMB overall | 0.04 | -0.82 | 0.84 | 1325.41 | 1.00 | 2679 | 152 | 216 | 15 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12C | ALK | Any mutation | 18 | 13 | TMB quintile 3 | -1.93 | -6.71 | 0.88 | 1474.68 | 1.00 | 596 | 18 | 13 | 0 | TRUE | 0.49 |
| non-small cell lung cancer | RAS_12C | ALK | Any mutation | 42 | 22 | TMB quintile 4 | -2.28 | -6.57 | 0.27 | 1258.60 | 1.00 | 699 | 42 | 22 | 0 | TRUE | 0.66 |
| non-small cell lung cancer | RAS_12C | ALK | Any mutation | 93 | 118 | TMB quintile 5 | 0.26 | -0.43 | 0.85 | 1406.04 | 1.00 | 1030 | 81 | 106 | 12 | TRUE | 0.36 |
| non-small cell lung cancer | RAS_12C | ALK | Any mutation | 153 | 164 | TMB overall | -1.37 | -4.27 | 0.89 | 1427.07 | 1.00 | 2334 | 141 | 152 | 12 | TRUE | 0.53 |
| non-small cell lung cancer | RAS_12C | PTEN | Any mutation | 18 | 17 | TMB quintile 3 | -5.56 | -12.21 | -1.34 | 979.98 | 1.00 | 591 | 18 | 17 | 0 | TRUE | 1.29 |
| non-small cell lung cancer | RAS_12C | PTEN | Any mutation | 42 | 27 | TMB quintile 4 | -5.60 | -12.08 | -1.56 | 1029.91 | 1.00 | 694 | 42 | 27 | 0 | TRUE | 1.31 |
| non-small cell lung cancer | RAS_12C | PTEN | Any mutation | 93 | 75 | TMB quintile 5 | -5.65 | -12.04 | -1.83 | 1079.35 | 1.00 | 1061 | 93 | 75 | 0 | TRUE | 1.38 |
| non-small cell lung cancer | RAS_12C | PTEN | Any mutation | 153 | 119 | TMB overall | -5.55 | -11.86 | -1.63 | 1019.86 | 1.00 | 2346 | 153 | 119 | 0 | TRUE | 1.34 |
| non-small cell lung cancer | RAS_12C | BCOR | Any mutation | 42 | 22 | TMB quintile 4 | -0.26 | -2.17 | 0.99 | 1251.80 | 1.00 | 700 | 41 | 21 | 1 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12C | BCOR | Any mutation | 95 | 92 | TMB quintile 5 | 0.07 | -0.72 | 0.75 | 1483.10 | 1.00 | 1052 | 87 | 84 | 8 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | BCOR | Any mutation | 137 | 114 | TMB overall | -0.10 | -1.87 | 1.38 | 1396.11 | 1.00 | 1752 | 128 | 105 | 9 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12C | CTNNB1 | Any mutation | 13 | 12 | TMB quintile 2 | -0.28 | -1.59 | 0.87 | 1611.22 | 1.00 | 417 | 12 | 11 | 1 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12C | CTNNB1 | Any mutation | 18 | 22 | TMB quintile 3 | -0.50 | -1.86 | 0.66 | 1358.58 | 1.00 | 586 | 18 | 22 | 0 | TRUE | 0.35 |
| non-small cell lung cancer | RAS_12C | CTNNB1 | Any mutation | 42 | 33 | TMB quintile 4 | -0.45 | -1.78 | 0.64 | 1594.46 | 1.00 | 691 | 41 | 32 | 1 | TRUE | 0.34 |
| non-small cell lung cancer | RAS_12C | CTNNB1 | Any mutation | 93 | 47 | TMB quintile 5 | -0.35 | -1.40 | 0.56 | 1378.86 | 1.00 | 1086 | 90 | 44 | 3 | TRUE | 0.30 |
| non-small cell lung cancer | RAS_12C | CTNNB1 | Any mutation | 166 | 114 | TMB overall | -0.39 | -1.52 | 0.58 | 1419.86 | 1.00 | 2780 | 161 | 109 | 5 | TRUE | 0.33 |
| non-small cell lung cancer | RAS_12C | ARID1A | Any mutation | 18 | 12 | TMB quintile 3 | 0.11 | -1.77 | 1.83 | 1520.38 | 1.00 | 597 | 17 | 11 | 1 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12C | ARID1A | Any mutation | 42 | 56 | TMB quintile 4 | -0.88 | -2.55 | 0.42 | 1474.24 | 1.00 | 668 | 41 | 55 | 1 | TRUE | 0.62 |
| non-small cell lung cancer | RAS_12C | ARID1A | Any mutation | 95 | 187 | TMB quintile 5 | -0.07 | -0.70 | 0.49 | 1583.19 | 1.00 | 975 | 81 | 173 | 14 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12C | ARID1A | Any mutation | 155 | 255 | TMB overall | -0.27 | -1.76 | 1.19 | 1598.57 | 1.00 | 2240 | 139 | 239 | 16 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12C | FAT1 | Any mutation | 18 | 16 | TMB quintile 3 | -0.08 | -2.51 | 1.85 | 1495.15 | 1.00 | 593 | 17 | 15 | 1 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12C | FAT1 | Any mutation | 42 | 43 | TMB quintile 4 | -1.11 | -3.02 | 0.46 | 1327.55 | 1.00 | 683 | 41 | 42 | 1 | FALSE | 0.66 |
| non-small cell lung cancer | RAS_12C | FAT1 | Any mutation | 93 | 227 | TMB quintile 5 | -0.68 | -1.40 | -0.04 | 1392.99 | 1.00 | 936 | 83 | 217 | 10 | FALSE | 1.35 |
| non-small cell lung cancer | RAS_12C | FAT1 | Any mutation | 153 | 300 | TMB overall | -0.72 | -2.87 | 1.21 | 1484.66 | 1.00 | 2219 | 141 | 288 | 12 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12C | NCOR1 | Any mutation | 42 | 21 | TMB quintile 4 | 0.05 | -1.33 | 1.29 | 1354.81 | 1.00 | 702 | 40 | 19 | 2 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | NCOR1 | Any mutation | 93 | 71 | TMB quintile 5 | -0.27 | -1.32 | 0.62 | 1480.79 | 1.00 | 1072 | 89 | 67 | 4 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12C | NCOR1 | Any mutation | 135 | 92 | TMB overall | -0.09 | -1.61 | 1.41 | 1542.20 | 1.00 | 1774 | 129 | 86 | 6 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12C | POLE | Any mutation | 42 | 20 | TMB quintile 4 | 0.44 | -0.83 | 1.63 | 1318.09 | 1.00 | 702 | 40 | 18 | 2 | TRUE | 0.31 |
| non-small cell lung cancer | RAS_12C | POLE | Any mutation | 93 | 102 | TMB quintile 5 | 0.42 | -0.25 | 1.00 | 1338.45 | 1.00 | 1046 | 82 | 91 | 11 | TRUE | 0.72 |
| non-small cell lung cancer | RAS_12C | POLE | Any mutation | 135 | 122 | TMB overall | 0.39 | -1.26 | 1.83 | 1263.12 | 1.00 | 1748 | 122 | 109 | 13 | TRUE | 0.21 |
| non-small cell lung cancer | RAS_12C | NOTCH2 | Any mutation | 42 | 16 | TMB quintile 4 | -0.42 | -2.34 | 1.13 | 1385.66 | 1.00 | 703 | 41 | 15 | 1 | TRUE | 0.20 |
| non-small cell lung cancer | RAS_12C | NOTCH2 | Any mutation | 93 | 81 | TMB quintile 5 | -0.54 | -1.59 | 0.39 | 1248.53 | 1.00 | 1055 | 89 | 77 | 4 | TRUE | 0.54 |
| non-small cell lung cancer | RAS_12C | NOTCH2 | Any mutation | 135 | 97 | TMB overall | -0.45 | -2.55 | 1.41 | 1395.53 | 1.00 | 1758 | 130 | 92 | 5 | TRUE | 0.19 |
| non-small cell lung cancer | RAS_12C | KMT2A | Any mutation | 42 | 16 | TMB quintile 4 | -1.35 | -5.49 | 0.72 | 1391.55 | 1.00 | 704 | 42 | 16 | 0 | FALSE | 0.40 |
| non-small cell lung cancer | RAS_12C | KMT2A | Any mutation | 93 | 80 | TMB quintile 5 | -0.38 | -1.40 | 0.54 | 1521.52 | 1.00 | 1060 | 88 | 75 | 5 | FALSE | 0.35 |
| non-small cell lung cancer | RAS_12C | KMT2A | Any mutation | 135 | 96 | TMB overall | -0.80 | -3.53 | 1.30 | 1466.95 | 1.00 | 1764 | 130 | 91 | 5 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12C | PAK7 | Any mutation | 42 | 13 | TMB quintile 4 | -1.47 | -5.36 | 0.79 | 1514.02 | 1.00 | 704 | 42 | 13 | 0 | FALSE | 0.43 |
| non-small cell lung cancer | RAS_12C | PAK7 | Any mutation | 93 | 95 | TMB quintile 5 | -0.57 | -1.66 | 0.33 | 1471.56 | 1.00 | 1043 | 88 | 90 | 5 | FALSE | 0.58 |
| non-small cell lung cancer | RAS_12C | PAK7 | Any mutation | 135 | 108 | TMB overall | -0.96 | -3.84 | 1.26 | 1346.37 | 1.00 | 1747 | 130 | 103 | 5 | FALSE | 0.35 |
| non-small cell lung cancer | RAS_12C | STAG2 | Any mutation | 42 | 19 | TMB quintile 4 | -1.48 | -5.22 | 0.47 | 1331.09 | 1.00 | 701 | 42 | 19 | 0 | TRUE | 0.49 |
| non-small cell lung cancer | RAS_12C | STAG2 | Any mutation | 93 | 76 | TMB quintile 5 | -0.66 | -2.00 | 0.44 | 1368.04 | 1.00 | 1064 | 89 | 72 | 4 | TRUE | 0.57 |
| non-small cell lung cancer | RAS_12C | STAG2 | Any mutation | 135 | 95 | TMB overall | -1.01 | -3.44 | 0.83 | 1264.60 | 1.00 | 1765 | 131 | 91 | 4 | TRUE | 0.43 |
| non-small cell lung cancer | RAS_12C | TERT | Any mutation | 18 | 13 | TMB quintile 3 | 0.45 | -1.04 | 1.79 | 1532.04 | 1.00 | 597 | 17 | 12 | 1 | TRUE | 0.26 |
| non-small cell lung cancer | RAS_12C | TERT | Any mutation | 42 | 34 | TMB quintile 4 | 0.40 | -0.76 | 1.37 | 1387.77 | 1.00 | 690 | 39 | 31 | 3 | TRUE | 0.33 |
| non-small cell lung cancer | RAS_12C | TERT | Any mutation | 94 | 98 | TMB quintile 5 | 0.25 | -0.49 | 0.90 | 1590.28 | 1.00 | 1047 | 85 | 89 | 9 | TRUE | 0.32 |
| non-small cell lung cancer | RAS_12C | TERT | Any mutation | 154 | 145 | TMB overall | 0.37 | -0.79 | 1.58 | 1583.44 | 1.00 | 2334 | 141 | 132 | 13 | TRUE | 0.28 |
| non-small cell lung cancer | RAS_12C | BRCA2 | Any mutation | 42 | 23 | TMB quintile 4 | 0.02 | -1.87 | 1.41 | 1552.28 | 1.00 | 700 | 40 | 21 | 2 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12C | BRCA2 | Any mutation | 93 | 89 | TMB quintile 5 | -1.01 | -2.34 | 0.04 | 1259.59 | 1.00 | 1049 | 90 | 86 | 3 | TRUE | 1.01 |
| non-small cell lung cancer | RAS_12C | BRCA2 | Any mutation | 135 | 126 | TMB overall | -0.74 | -3.56 | 1.90 | 1568.45 | 1.00 | 1758 | 130 | 121 | 5 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12C | NOTCH3 | Any mutation | 42 | 21 | TMB quintile 4 | 0.30 | -1.33 | 1.65 | 1520.56 | 1.00 | 702 | 40 | 19 | 2 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12C | NOTCH3 | Any mutation | 93 | 82 | TMB quintile 5 | 0.07 | -0.79 | 0.84 | 1417.83 | 1.00 | 1060 | 86 | 75 | 7 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12C | NOTCH3 | Any mutation | 135 | 114 | TMB overall | -0.14 | -2.79 | 2.24 | 1267.24 | 1.00 | 1771 | 126 | 105 | 9 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12C | NOTCH4 | Any mutation | 42 | 17 | TMB quintile 4 | -1.66 | -5.60 | 0.55 | 1380.53 | 1.00 | 700 | 42 | 17 | 0 | TRUE | 0.50 |
| non-small cell lung cancer | RAS_12C | NOTCH4 | Any mutation | 93 | 107 | TMB quintile 5 | -0.49 | -1.42 | 0.33 | 1545.10 | 1.00 | 1028 | 87 | 101 | 6 | TRUE | 0.56 |
| non-small cell lung cancer | RAS_12C | NOTCH4 | Any mutation | 135 | 124 | TMB overall | -1.00 | -3.77 | 1.14 | 1642.40 | 1.00 | 1728 | 129 | 118 | 6 | TRUE | 0.37 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 13 | 12 | TMB quintile 2 | -0.09 | -2.11 | 1.62 | 1354.90 | 1.00 | 416 | 13 | 12 | 0 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 18 | 50 | TMB quintile 3 | 0.90 | -0.24 | 1.93 | 1456.95 | 1.00 | 562 | 14 | 46 | 4 | FALSE | 0.98 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 43 | 129 | TMB quintile 4 | 0.86 | 0.23 | 1.49 | 1423.57 | 1.00 | 608 | 29 | 115 | 14 | FALSE | 2.07 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 95 | 336 | TMB quintile 5 | -0.11 | -0.58 | 0.36 | 1471.08 | 1.00 | 833 | 72 | 313 | 23 | FALSE | 0.18 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 169 | 527 | TMB overall | 0.39 | -0.84 | 1.47 | 1381.53 | 1.00 | 2419 | 128 | 486 | 41 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12C | KDM5C | Any mutation | 42 | 16 | TMB quintile 4 | -0.95 | -5.54 | 0.94 | 1206.24 | 1.00 | 704 | 42 | 16 | 0 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12C | KDM5C | Any mutation | 94 | 70 | TMB quintile 5 | 0.33 | -0.49 | 1.12 | 1481.56 | 1.00 | 1072 | 86 | 62 | 8 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12C | KDM5C | Any mutation | 136 | 86 | TMB overall | -0.29 | -3.11 | 1.61 | 1200.16 | 1.00 | 1776 | 128 | 78 | 8 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Any mutation | 18 | 33 | TMB quintile 3 | -1.21 | -3.28 | 0.33 | 1336.07 | 1.00 | 576 | 18 | 33 | 0 | TRUE | 0.70 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Any mutation | 42 | 43 | TMB quintile 4 | -0.96 | -2.56 | 0.36 | 1305.09 | 1.00 | 679 | 41 | 42 | 1 | TRUE | 0.74 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Any mutation | 95 | 178 | TMB quintile 5 | -0.60 | -1.34 | 0.05 | 1372.64 | 1.00 | 975 | 86 | 169 | 9 | TRUE | 1.05 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Any mutation | 155 | 254 | TMB overall | -0.92 | -2.45 | 0.33 | 1491.67 | 1.00 | 2230 | 145 | 244 | 10 | TRUE | 0.73 |
| non-small cell lung cancer | RAS_12C | EPHB1 | Any mutation | 42 | 19 | TMB quintile 4 | -2.82 | -8.11 | 0.32 | 1415.72 | 1.00 | 701 | 42 | 19 | 0 | FALSE | 0.70 |
| non-small cell lung cancer | RAS_12C | EPHB1 | Any mutation | 93 | 117 | TMB quintile 5 | -0.83 | -1.93 | 0.06 | 1221.42 | 1.01 | 1024 | 88 | 112 | 5 | FALSE | 0.98 |
| non-small cell lung cancer | RAS_12C | EPHB1 | Any mutation | 135 | 152 | TMB overall | -1.79 | -5.58 | 1.17 | 1541.32 | 1.00 | 1734 | 130 | 147 | 5 | FALSE | 0.56 |
| non-small cell lung cancer | RAS_12C | SMAD4 | Any mutation | 18 | 21 | TMB quintile 3 | -0.02 | -1.43 | 1.26 | 1563.00 | 1.00 | 588 | 17 | 20 | 1 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12C | SMAD4 | Any mutation | 42 | 36 | TMB quintile 4 | -0.55 | -2.62 | 0.72 | 1467.31 | 1.00 | 688 | 42 | 36 | 0 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12C | SMAD4 | Any mutation | 93 | 49 | TMB quintile 5 | 0.23 | -0.65 | 1.09 | 1506.97 | 1.00 | 1087 | 87 | 43 | 6 | TRUE | 0.22 |
| non-small cell lung cancer | RAS_12C | SMAD4 | Any mutation | 153 | 106 | TMB overall | -0.12 | -1.49 | 0.92 | 1470.90 | 1.00 | 2363 | 146 | 99 | 7 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 13 | 15 | TMB quintile 2 | 0.19 | -1.57 | 1.52 | 1464.73 | 1.00 | 414 | 13 | 15 | 0 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 18 | 20 | TMB quintile 3 | 0.50 | -0.86 | 1.76 | 1547.10 | 1.00 | 589 | 17 | 19 | 1 | TRUE | 0.35 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 43 | 76 | TMB quintile 4 | 0.61 | -0.20 | 1.33 | 1425.64 | 1.00 | 661 | 36 | 69 | 7 | TRUE | 0.89 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 99 | 166 | TMB quintile 5 | 0.86 | 0.35 | 1.31 | 1621.54 | 1.00 | 1003 | 74 | 141 | 25 | TRUE | 3.25 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 173 | 277 | TMB overall | 0.52 | -0.52 | 1.45 | 1384.59 | 1.00 | 2667 | 140 | 244 | 33 | TRUE | 0.55 |
| non-small cell lung cancer | RAS_12C | RB1 | Any mutation | 18 | 33 | TMB quintile 3 | -0.90 | -2.45 | 0.54 | 1447.01 | 1.00 | 576 | 17 | 32 | 1 | TRUE | 0.65 |
| non-small cell lung cancer | RAS_12C | RB1 | Any mutation | 42 | 50 | TMB quintile 4 | -1.36 | -3.07 | -0.14 | 1431.52 | 1.00 | 670 | 42 | 50 | 0 | TRUE | 1.09 |
| non-small cell lung cancer | RAS_12C | RB1 | Any mutation | 93 | 124 | TMB quintile 5 | -0.89 | -1.86 | -0.06 | 1319.49 | 1.00 | 1016 | 88 | 119 | 5 | TRUE | 1.26 |
| non-small cell lung cancer | RAS_12C | RB1 | Any mutation | 153 | 207 | TMB overall | -1.04 | -2.36 | 0.10 | 1351.78 | 1.00 | 2262 | 147 | 201 | 6 | TRUE | 1.00 |
| non-small cell lung cancer | RAS_12C | KMT2D | Any mutation | 18 | 15 | TMB quintile 3 | -1.66 | -5.17 | 0.89 | 1515.75 | 1.00 | 593 | 18 | 15 | 0 | FALSE | 0.55 |
| non-small cell lung cancer | RAS_12C | KMT2D | Any mutation | 42 | 42 | TMB quintile 4 | -1.20 | -3.26 | 0.43 | 1473.45 | 1.00 | 682 | 41 | 41 | 1 | FALSE | 0.68 |
| non-small cell lung cancer | RAS_12C | KMT2D | Any mutation | 94 | 251 | TMB quintile 5 | -0.62 | -1.27 | -0.02 | 1529.91 | 1.00 | 931 | 82 | 239 | 12 | FALSE | 1.26 |
| non-small cell lung cancer | RAS_12C | KMT2D | Any mutation | 154 | 320 | TMB overall | -1.23 | -3.71 | 0.82 | 1487.65 | 1.00 | 2214 | 141 | 307 | 13 | FALSE | 0.59 |
| non-small cell lung cancer | RAS_12C | APC | Any mutation | 18 | 20 | TMB quintile 3 | -1.00 | -3.83 | 0.81 | 1510.10 | 1.00 | 588 | 18 | 20 | 0 | TRUE | 0.39 |
| non-small cell lung cancer | RAS_12C | APC | Any mutation | 42 | 31 | TMB quintile 4 | -1.18 | -4.20 | 0.40 | 1322.18 | 1.00 | 689 | 42 | 31 | 0 | TRUE | 0.52 |
| non-small cell lung cancer | RAS_12C | APC | Any mutation | 96 | 101 | TMB quintile 5 | -0.03 | -0.80 | 0.69 | 1432.04 | 1.00 | 1044 | 87 | 92 | 9 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12C | APC | Any mutation | 156 | 152 | TMB overall | -0.73 | -3.02 | 0.63 | 1477.06 | 1.00 | 2321 | 147 | 143 | 9 | TRUE | 0.38 |
| non-small cell lung cancer | RAS_12C | ERBB2 | Any mutation | 13 | 14 | TMB quintile 2 | -5.53 | -12.07 | -1.42 | 1287.96 | 1.00 | 414 | 13 | 14 | 0 | TRUE | 1.30 |
| non-small cell lung cancer | RAS_12C | ERBB2 | Any mutation | 18 | 27 | TMB quintile 3 | -5.53 | -12.25 | -1.53 | 1308.00 | 1.00 | 581 | 18 | 27 | 0 | TRUE | 1.30 |
| non-small cell lung cancer | RAS_12C | ERBB2 | Any mutation | 42 | 32 | TMB quintile 4 | -5.53 | -12.25 | -1.52 | 1251.21 | 1.00 | 690 | 42 | 32 | 0 | TRUE | 1.30 |
| non-small cell lung cancer | RAS_12C | ERBB2 | Any mutation | 93 | 40 | TMB quintile 5 | -5.53 | -12.06 | -1.53 | 1256.05 | 1.00 | 1093 | 93 | 40 | 0 | TRUE | 1.31 |
| non-small cell lung cancer | RAS_12C | ERBB2 | Any mutation | 166 | 113 | TMB overall | -5.53 | -12.04 | -1.55 | 1268.25 | 1.00 | 2778 | 166 | 113 | 0 | TRUE | 1.32 |
| non-small cell lung cancer | RAS_12C | ARID2 | Any mutation | 18 | 19 | TMB quintile 3 | -0.47 | -2.43 | 1.00 | 1414.82 | 1.00 | 589 | 18 | 19 | 0 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12C | ARID2 | Any mutation | 42 | 35 | TMB quintile 4 | -0.14 | -1.50 | 0.92 | 1467.96 | 1.00 | 689 | 40 | 33 | 2 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | ARID2 | Any mutation | 94 | 111 | TMB quintile 5 | 0.01 | -0.73 | 0.69 | 1528.66 | 1.00 | 1038 | 85 | 102 | 9 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12C | ARID2 | Any mutation | 154 | 165 | TMB overall | -0.20 | -1.55 | 0.95 | 1348.15 | 1.00 | 2316 | 143 | 154 | 11 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12C | MTOR | Any mutation | 18 | 14 | TMB quintile 3 | -0.07 | -2.11 | 1.39 | 1450.61 | 1.00 | 594 | 18 | 14 | 0 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12C | MTOR | Any mutation | 42 | 21 | TMB quintile 4 | 0.05 | -1.57 | 1.23 | 1572.66 | 1.00 | 701 | 41 | 20 | 1 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12C | MTOR | Any mutation | 95 | 70 | TMB quintile 5 | 0.60 | -0.12 | 1.23 | 1519.89 | 1.00 | 1070 | 85 | 60 | 10 | TRUE | 1.05 |
| non-small cell lung cancer | RAS_12C | MTOR | Any mutation | 155 | 105 | TMB overall | 0.22 | -1.23 | 1.34 | 1648.58 | 1.00 | 2365 | 144 | 94 | 11 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12C | NOTCH1 | Any mutation | 42 | 15 | TMB quintile 4 | -0.21 | -2.05 | 1.36 | 1410.88 | 1.00 | 706 | 41 | 14 | 1 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12C | NOTCH1 | Any mutation | 94 | 97 | TMB quintile 5 | -0.29 | -1.23 | 0.48 | 1557.11 | 1.00 | 1044 | 88 | 91 | 6 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12C | NOTCH1 | Any mutation | 136 | 112 | TMB overall | -0.22 | -2.25 | 1.73 | 1521.52 | 1.00 | 1750 | 129 | 105 | 7 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 13 | 14 | TMB quintile 2 | -0.69 | -2.79 | 0.82 | 1386.93 | 1.00 | 414 | 13 | 14 | 0 | FALSE | 0.34 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 18 | 22 | TMB quintile 3 | -0.73 | -2.92 | 0.73 | 1216.45 | 1.00 | 592 | 18 | 22 | 0 | FALSE | 0.36 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 42 | 59 | TMB quintile 4 | -0.80 | -2.39 | 0.34 | 1500.35 | 1.00 | 671 | 41 | 58 | 1 | FALSE | 0.63 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 96 | 110 | TMB quintile 5 | 0.11 | -0.59 | 0.77 | 1016.19 | 1.01 | 1044 | 85 | 99 | 11 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 169 | 205 | TMB overall | -0.54 | -2.03 | 0.55 | 1375.92 | 1.00 | 2721 | 157 | 193 | 12 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12C | PBRM1 | Any mutation | 42 | 21 | TMB quintile 4 | -0.24 | -1.73 | 1.04 | 1290.95 | 1.00 | 703 | 41 | 20 | 1 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12C | PBRM1 | Any mutation | 93 | 79 | TMB quintile 5 | -0.07 | -0.98 | 0.70 | 1452.79 | 1.00 | 1066 | 87 | 73 | 6 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12C | PBRM1 | Any mutation | 135 | 100 | TMB overall | -0.15 | -1.64 | 1.33 | 1626.45 | 1.00 | 1769 | 128 | 93 | 7 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12C | EPHA3 | Any mutation | 18 | 15 | TMB quintile 3 | -1.34 | -4.91 | 1.15 | 1489.46 | 1.00 | 593 | 18 | 15 | 0 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12C | EPHA3 | Any mutation | 42 | 28 | TMB quintile 4 | -0.14 | -1.80 | 1.22 | 1533.77 | 1.00 | 694 | 40 | 26 | 2 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | EPHA3 | Any mutation | 94 | 182 | TMB quintile 5 | -0.33 | -1.07 | 0.29 | 1522.34 | 1.00 | 976 | 83 | 171 | 11 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12C | EPHA3 | Any mutation | 154 | 237 | TMB overall | -0.73 | -2.99 | 1.22 | 1531.56 | 1.00 | 2271 | 141 | 224 | 13 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12C | KDR | Any mutation | 42 | 21 | TMB quintile 4 | 0.64 | -0.62 | 1.88 | 1502.75 | 1.00 | 702 | 39 | 18 | 3 | TRUE | 0.50 |
| non-small cell lung cancer | RAS_12C | KDR | Any mutation | 95 | 109 | TMB quintile 5 | -0.01 | -0.81 | 0.69 | 1488.12 | 1.00 | 1032 | 87 | 101 | 8 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12C | KDR | Any mutation | 137 | 130 | TMB overall | 0.31 | -1.53 | 2.00 | 1488.99 | 1.00 | 1734 | 126 | 119 | 11 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12C | TET1 | Any mutation | 42 | 16 | TMB quintile 4 | -3.03 | -9.55 | 0.37 | 1510.15 | 1.00 | 701 | 42 | 16 | 0 | FALSE | 0.61 |
| non-small cell lung cancer | RAS_12C | TET1 | Any mutation | 93 | 89 | TMB quintile 5 | -0.27 | -1.28 | 0.51 | 1573.59 | 1.00 | 1051 | 87 | 83 | 6 | FALSE | 0.25 |
| non-small cell lung cancer | RAS_12C | TET1 | Any mutation | 135 | 120 | TMB overall | -1.63 | -5.74 | 1.56 | 1504.82 | 1.00 | 1757 | 129 | 114 | 6 | FALSE | 0.44 |
| non-small cell lung cancer | RAS_12C | TBX3 | Any mutation | 42 | 11 | TMB quintile 4 | 0.73 | -1.12 | 2.35 | 1705.74 | 1.00 | 711 | 40 | 9 | 2 | FALSE | 0.39 |
| non-small cell lung cancer | RAS_12C | TBX3 | Any mutation | 93 | 108 | TMB quintile 5 | -0.52 | -1.47 | 0.28 | 1336.17 | 1.00 | 1035 | 88 | 103 | 5 | FALSE | 0.60 |
| non-small cell lung cancer | RAS_12C | TBX3 | Any mutation | 135 | 119 | TMB overall | 0.16 | -2.08 | 2.64 | 1536.45 | 1.00 | 1746 | 128 | 112 | 7 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12C | NTRK3 | Any mutation | 42 | 31 | TMB quintile 4 | 0.81 | -0.42 | 1.80 | 1494.67 | 1.00 | 696 | 38 | 27 | 4 | FALSE | 0.80 |
| non-small cell lung cancer | RAS_12C | NTRK3 | Any mutation | 93 | 144 | TMB quintile 5 | 0.30 | -0.33 | 0.88 | 1451.32 | 1.00 | 1013 | 79 | 130 | 14 | FALSE | 0.50 |
| non-small cell lung cancer | RAS_12C | NTRK3 | Any mutation | 135 | 195 | TMB overall | 0.13 | -2.77 | 2.88 | 1376.06 | 1.00 | 1716 | 117 | 177 | 18 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12C | GRIN2A | Any mutation | 18 | 17 | TMB quintile 3 | 1.14 | -0.25 | 2.60 | 1493.38 | 1.00 | 594 | 15 | 14 | 3 | FALSE | 0.90 |
| non-small cell lung cancer | RAS_12C | GRIN2A | Any mutation | 42 | 39 | TMB quintile 4 | -0.26 | -1.76 | 0.86 | 1404.73 | 1.00 | 683 | 41 | 38 | 1 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12C | GRIN2A | Any mutation | 94 | 124 | TMB quintile 5 | 0.21 | -0.40 | 0.77 | 1392.57 | 1.00 | 1025 | 83 | 113 | 11 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12C | GRIN2A | Any mutation | 154 | 180 | TMB overall | 0.34 | -0.97 | 1.62 | 1293.85 | 1.00 | 2302 | 139 | 165 | 15 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 13 | 12 | TMB quintile 2 | 0.78 | -0.90 | 2.29 | 1159.42 | 1.00 | 417 | 12 | 11 | 1 | TRUE | 0.49 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 19 | 78 | TMB quintile 3 | 1.43 | 0.46 | 2.32 | 1587.91 | 1.00 | 539 | 11 | 70 | 8 | TRUE | 2.64 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 42 | 161 | TMB quintile 4 | 0.99 | 0.36 | 1.59 | 1426.70 | 1.00 | 579 | 25 | 144 | 17 | TRUE | 2.71 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 94 | 283 | TMB quintile 5 | 0.10 | -0.41 | 0.56 | 1422.23 | 1.00 | 882 | 72 | 261 | 22 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 168 | 534 | TMB overall | 0.81 | -0.29 | 1.93 | 1513.44 | 1.00 | 2417 | 120 | 486 | 48 | TRUE | 0.83 |
| non-small cell lung cancer | RAS_12C | EP300 | Any mutation | 93 | 77 | TMB quintile 5 | 0.14 | -0.78 | 0.91 | 1526.01 | 1.00 | 1066 | 86 | 70 | 7 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12C | EP300 | Any mutation | 93 | 77 | TMB overall | 0.12 | -4.55 | 4.56 | 1546.11 | 1.00 | 1066 | 86 | 70 | 7 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12C | ERBB4 | Any mutation | 42 | 25 | TMB quintile 4 | 0.00 | -1.88 | 1.42 | 1395.02 | 1.00 | 697 | 40 | 23 | 2 | TRUE | 0.00 |
| non-small cell lung cancer | RAS_12C | ERBB4 | Any mutation | 94 | 148 | TMB quintile 5 | -0.60 | -1.43 | 0.11 | 1280.39 | 1.00 | 1013 | 87 | 141 | 7 | TRUE | 0.87 |
| non-small cell lung cancer | RAS_12C | ERBB4 | Any mutation | 136 | 185 | TMB overall | -0.53 | -3.09 | 1.69 | 1472.03 | 1.00 | 1719 | 127 | 176 | 9 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12C | MED12 | Any mutation | 18 | 23 | TMB quintile 3 | -1.15 | -3.14 | 0.32 | 1440.89 | 1.00 | 585 | 18 | 23 | 0 | TRUE | 0.71 |
| non-small cell lung cancer | RAS_12C | MED12 | Any mutation | 42 | 32 | TMB quintile 4 | -0.94 | -2.51 | 0.40 | 1403.80 | 1.00 | 689 | 41 | 31 | 1 | TRUE | 0.69 |
| non-small cell lung cancer | RAS_12C | MED12 | Any mutation | 93 | 101 | TMB quintile 5 | -0.89 | -1.94 | 0.00 | 1520.14 | 1.00 | 1042 | 89 | 97 | 4 | TRUE | 1.11 |
| non-small cell lung cancer | RAS_12C | MED12 | Any mutation | 153 | 156 | TMB overall | -0.99 | -2.50 | 0.20 | 1457.03 | 1.00 | 2316 | 148 | 151 | 5 | TRUE | 0.80 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 13 | 29 | TMB quintile 2 | -0.39 | -2.13 | 0.84 | 1353.53 | 1.00 | 399 | 13 | 29 | 0 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 18 | 46 | TMB quintile 3 | -0.50 | -2.35 | 0.67 | 1377.76 | 1.00 | 563 | 18 | 46 | 0 | FALSE | 0.29 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 43 | 90 | TMB quintile 4 | 0.58 | -0.16 | 1.33 | 1483.58 | 1.00 | 640 | 33 | 80 | 10 | FALSE | 0.89 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 95 | 200 | TMB quintile 5 | -0.02 | -0.60 | 0.53 | 1586.02 | 1.00 | 961 | 80 | 185 | 15 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 169 | 365 | TMB overall | -0.09 | -1.17 | 0.77 | 1314.28 | 1.00 | 2563 | 144 | 340 | 25 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | NF1 | Any mutation | 18 | 25 | TMB quintile 3 | -0.59 | -2.30 | 1.05 | 1580.95 | 1.00 | 585 | 17 | 24 | 1 | TRUE | 0.31 |
| non-small cell lung cancer | RAS_12C | NF1 | Any mutation | 42 | 59 | TMB quintile 4 | -1.10 | -2.69 | 0.17 | 1425.56 | 1.00 | 670 | 41 | 58 | 1 | TRUE | 0.88 |
| non-small cell lung cancer | RAS_12C | NF1 | Any mutation | 95 | 216 | TMB quintile 5 | -0.88 | -1.72 | -0.18 | 1317.83 | 1.00 | 956 | 87 | 208 | 8 | TRUE | 1.65 |
| non-small cell lung cancer | RAS_12C | NF1 | Any mutation | 155 | 300 | TMB overall | -0.86 | -2.31 | 0.57 | 1612.50 | 1.00 | 2211 | 145 | 290 | 10 | TRUE | 0.66 |
| non-small cell lung cancer | RAS_12C | FLT1 | Any mutation | 42 | 21 | TMB quintile 4 | -1.57 | -5.18 | 0.50 | 1398.29 | 1.00 | 700 | 42 | 21 | 0 | FALSE | 0.54 |
| non-small cell lung cancer | RAS_12C | FLT1 | Any mutation | 93 | 99 | TMB quintile 5 | -0.65 | -1.72 | 0.23 | 1381.44 | 1.00 | 1046 | 88 | 94 | 5 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12C | FLT1 | Any mutation | 135 | 120 | TMB overall | -1.07 | -3.67 | 0.93 | 1400.62 | 1.00 | 1746 | 130 | 115 | 5 | FALSE | 0.47 |
| non-small cell lung cancer | RAS_12C | EPHA5 | Any mutation | 42 | 48 | TMB quintile 4 | 0.28 | -0.92 | 1.26 | 1473.95 | 1.00 | 677 | 38 | 44 | 4 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12C | EPHA5 | Any mutation | 93 | 191 | TMB quintile 5 | 0.12 | -0.52 | 0.67 | 1513.79 | 1.00 | 974 | 77 | 175 | 16 | FALSE | 0.17 |
| non-small cell lung cancer | RAS_12C | EPHA5 | Any mutation | 135 | 250 | TMB overall | 0.00 | -1.85 | 1.85 | 1617.66 | 1.00 | 1661 | 115 | 230 | 20 | FALSE | 0.00 |
| non-small cell lung cancer | RAS_12C | AR | Any mutation | 42 | 16 | TMB quintile 4 | -1.48 | -5.26 | 0.43 | 1288.36 | 1.00 | 704 | 42 | 16 | 0 | TRUE | 0.51 |
| non-small cell lung cancer | RAS_12C | AR | Any mutation | 94 | 77 | TMB quintile 5 | -0.66 | -1.87 | 0.30 | 1517.59 | 1.00 | 1064 | 90 | 73 | 4 | TRUE | 0.63 |
| non-small cell lung cancer | RAS_12C | AR | Any mutation | 136 | 93 | TMB overall | -1.07 | -3.69 | 0.83 | 1511.45 | 1.00 | 1768 | 132 | 89 | 4 | TRUE | 0.47 |
| non-small cell lung cancer | RAS_12C | ROS1 | Any mutation | 42 | 13 | TMB quintile 4 | -1.76 | -5.53 | 0.47 | 1445.90 | 1.00 | 707 | 42 | 13 | 0 | TRUE | 0.59 |
| non-small cell lung cancer | RAS_12C | ROS1 | Any mutation | 94 | 80 | TMB quintile 5 | -1.00 | -2.33 | 0.11 | 1448.48 | 1.00 | 1057 | 91 | 77 | 3 | TRUE | 0.96 |
| non-small cell lung cancer | RAS_12C | ROS1 | Any mutation | 136 | 93 | TMB overall | -1.33 | -4.18 | 0.69 | 1525.47 | 1.00 | 1764 | 133 | 90 | 3 | TRUE | 0.56 |
| non-small cell lung cancer | RAS_12C | PIK3CG | Any mutation | 42 | 16 | TMB quintile 4 | -0.29 | -2.27 | 1.32 | 1508.44 | 1.00 | 705 | 41 | 15 | 1 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12C | PIK3CG | Any mutation | 95 | 150 | TMB quintile 5 | -0.33 | -1.12 | 0.34 | 1601.18 | 1.00 | 1005 | 86 | 141 | 9 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12C | PIK3CG | Any mutation | 137 | 166 | TMB overall | -0.27 | -2.48 | 1.78 | 1340.62 | 1.00 | 1710 | 127 | 156 | 10 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12C | EGFR | Any mutation | 13 | 200 | TMB quintile 2 | -3.48 | -6.12 | -1.75 | 1316.25 | 1.00 | 250 | 13 | 200 | 0 | TRUE | 2.62 |
| non-small cell lung cancer | RAS_12C | EGFR | Any mutation | 18 | 287 | TMB quintile 3 | -3.59 | -6.35 | -1.80 | 1479.16 | 1.00 | 378 | 18 | 287 | 0 | TRUE | 2.60 |
| non-small cell lung cancer | RAS_12C | EGFR | Any mutation | 42 | 256 | TMB quintile 4 | -3.67 | -6.32 | -1.96 | 1262.19 | 1.00 | 528 | 42 | 256 | 0 | TRUE | 3.00 |
| non-small cell lung cancer | RAS_12C | EGFR | Any mutation | 93 | 175 | TMB quintile 5 | -1.72 | -2.99 | -0.67 | 1366.88 | 1.00 | 1000 | 88 | 170 | 5 | TRUE | 2.41 |
| non-small cell lung cancer | RAS_12C | EGFR | Any mutation | 166 | 918 | TMB overall | -3.08 | -5.01 | -1.66 | 1197.80 | 1.00 | 2156 | 161 | 913 | 5 | TRUE | 3.51 |
| non-small cell lung cancer | RAS_12C | ARID1B | Any mutation | 18 | 11 | TMB quintile 3 | -0.93 | -3.26 | 0.93 | 1394.11 | 1.00 | 597 | 18 | 11 | 0 | TRUE | 0.40 |
| non-small cell lung cancer | RAS_12C | ARID1B | Any mutation | 42 | 16 | TMB quintile 4 | -0.60 | -2.48 | 0.91 | 1478.24 | 1.00 | 706 | 41 | 15 | 1 | TRUE | 0.30 |
| non-small cell lung cancer | RAS_12C | ARID1B | Any mutation | 93 | 77 | TMB quintile 5 | -0.78 | -2.08 | 0.24 | 1222.05 | 1.00 | 1061 | 90 | 74 | 3 | TRUE | 0.74 |
| non-small cell lung cancer | RAS_12C | ARID1B | Any mutation | 153 | 104 | TMB overall | -0.80 | -2.54 | 0.66 | 1419.51 | 1.00 | 2364 | 149 | 100 | 4 | TRUE | 0.46 |
| non-small cell lung cancer | RAS_12C | MET | Any mutation | 13 | 21 | TMB quintile 2 | -0.88 | -2.41 | 0.43 | 1461.04 | 1.00 | 408 | 13 | 21 | 0 | TRUE | 0.67 |
| non-small cell lung cancer | RAS_12C | MET | Any mutation | 18 | 30 | TMB quintile 3 | -0.73 | -2.18 | 0.62 | 1382.15 | 1.00 | 585 | 17 | 29 | 1 | TRUE | 0.53 |
| non-small cell lung cancer | RAS_12C | MET | Any mutation | 42 | 34 | TMB quintile 4 | -0.98 | -2.52 | 0.19 | 1438.10 | 1.00 | 692 | 42 | 34 | 0 | TRUE | 0.81 |
| non-small cell lung cancer | RAS_12C | MET | Any mutation | 93 | 47 | TMB quintile 5 | -0.66 | -1.99 | 0.35 | 1473.65 | 1.00 | 1088 | 90 | 44 | 3 | TRUE | 0.60 |
| non-small cell lung cancer | RAS_12C | MET | Any mutation | 166 | 132 | TMB overall | -0.81 | -2.12 | 0.30 | 1438.23 | 1.00 | 2773 | 162 | 128 | 4 | TRUE | 0.73 |
| non-small cell lung cancer | RAS_12C | BRAF | Any mutation | 13 | 11 | TMB quintile 2 | -0.97 | -2.83 | 0.60 | 1499.35 | 1.00 | 417 | 13 | 11 | 0 | TRUE | 0.57 |
| non-small cell lung cancer | RAS_12C | BRAF | Any mutation | 18 | 13 | TMB quintile 3 | -0.95 | -2.92 | 0.68 | 1511.15 | 1.00 | 595 | 18 | 13 | 0 | TRUE | 0.51 |
| non-small cell lung cancer | RAS_12C | BRAF | Any mutation | 42 | 46 | TMB quintile 4 | -0.64 | -2.12 | 0.55 | 1339.34 | 1.00 | 677 | 40 | 44 | 2 | TRUE | 0.48 |
| non-small cell lung cancer | RAS_12C | BRAF | Any mutation | 93 | 101 | TMB quintile 5 | -0.80 | -1.89 | 0.05 | 1499.30 | 1.00 | 1035 | 89 | 97 | 4 | TRUE | 0.97 |
| non-small cell lung cancer | RAS_12C | BRAF | Any mutation | 166 | 171 | TMB overall | -0.83 | -2.21 | 0.37 | 1568.30 | 1.00 | 2724 | 160 | 165 | 6 | TRUE | 0.70 |
| non-small cell lung cancer | RAS_12C | CARD11 | Any mutation | 42 | 18 | TMB quintile 4 | 0.78 | -0.60 | 2.02 | 1427.79 | 1.00 | 705 | 39 | 15 | 3 | FALSE | 0.62 |
| non-small cell lung cancer | RAS_12C | CARD11 | Any mutation | 94 | 97 | TMB quintile 5 | -0.03 | -0.86 | 0.69 | 1257.48 | 1.00 | 1045 | 87 | 90 | 7 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | CARD11 | Any mutation | 136 | 115 | TMB overall | 0.38 | -1.53 | 2.15 | 1621.70 | 1.00 | 1750 | 126 | 105 | 10 | FALSE | 0.17 |
| non-small cell lung cancer | RAS_12C | INPP4B | Any mutation | 42 | 17 | TMB quintile 4 | -0.02 | -1.86 | 1.33 | 1330.90 | 1.00 | 704 | 41 | 16 | 1 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12C | INPP4B | Any mutation | 94 | 87 | TMB quintile 5 | 0.30 | -0.48 | 0.96 | 1380.29 | 1.00 | 1060 | 85 | 78 | 9 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12C | INPP4B | Any mutation | 136 | 104 | TMB overall | 0.12 | -1.60 | 1.71 | 1518.41 | 1.00 | 1764 | 126 | 94 | 10 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12C | NFE2L2 | Any mutation | 42 | 31 | TMB quintile 4 | -2.02 | -5.02 | -0.18 | 1312.84 | 1.00 | 695 | 42 | 31 | 0 | FALSE | 0.97 |
| non-small cell lung cancer | RAS_12C | NFE2L2 | Any mutation | 93 | 83 | TMB quintile 5 | -1.67 | -3.43 | -0.33 | 1464.11 | 1.00 | 1056 | 91 | 81 | 2 | FALSE | 1.49 |
| non-small cell lung cancer | RAS_12C | NFE2L2 | Any mutation | 135 | 114 | TMB overall | -1.81 | -4.23 | -0.02 | 1370.66 | 1.00 | 1751 | 133 | 112 | 2 | FALSE | 1.09 |
| non-small cell lung cancer | RAS_12C | GLI1 | Any mutation | 40 | 16 | TMB quintile 4 | -0.22 | -2.17 | 1.15 | 1462.51 | 1.00 | 627 | 39 | 15 | 1 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12C | GLI1 | Any mutation | 85 | 77 | TMB quintile 5 | -0.05 | -1.03 | 0.77 | 1371.53 | 1.00 | 951 | 79 | 71 | 6 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12C | GLI1 | Any mutation | 125 | 93 | TMB overall | -0.13 | -1.90 | 1.59 | 1205.74 | 1.00 | 1578 | 118 | 86 | 7 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12C | ZFHX3 | Any mutation | 18 | 13 | TMB quintile 3 | -0.74 | -3.16 | 1.04 | 1505.67 | 1.00 | 539 | 18 | 13 | 0 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12C | ZFHX3 | Any mutation | 40 | 30 | TMB quintile 4 | 0.08 | -1.23 | 1.26 | 1558.16 | 1.00 | 612 | 37 | 27 | 3 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12C | ZFHX3 | Any mutation | 84 | 112 | TMB quintile 5 | -0.76 | -1.75 | 0.06 | 1416.36 | 1.00 | 917 | 80 | 108 | 4 | FALSE | 0.96 |
| non-small cell lung cancer | RAS_12C | ZFHX3 | Any mutation | 142 | 155 | TMB overall | -0.48 | -2.06 | 0.99 | 1520.29 | 1.00 | 2068 | 135 | 148 | 7 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12C | MGA | Any mutation | 18 | 14 | TMB quintile 3 | 0.00 | -1.78 | 1.59 | 1363.39 | 1.00 | 540 | 17 | 13 | 1 | FALSE | 0.00 |
| non-small cell lung cancer | RAS_12C | MGA | Any mutation | 40 | 24 | TMB quintile 4 | -0.99 | -3.61 | 0.56 | 1258.17 | 1.00 | 615 | 40 | 24 | 0 | FALSE | 0.45 |
| non-small cell lung cancer | RAS_12C | MGA | Any mutation | 85 | 140 | TMB quintile 5 | 0.10 | -0.55 | 0.72 | 1524.90 | 1.00 | 907 | 73 | 128 | 12 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | MGA | Any mutation | 143 | 178 | TMB overall | -0.27 | -1.94 | 1.07 | 1406.70 | 1.00 | 2062 | 130 | 165 | 13 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12C | AMER1 | Any mutation | 42 | 18 | TMB quintile 4 | 1.76 | 0.52 | 2.85 | 1427.02 | 1.00 | 707 | 37 | 13 | 5 | FALSE | 2.52 |
| non-small cell lung cancer | RAS_12C | AMER1 | Any mutation | 94 | 107 | TMB quintile 5 | 0.21 | -0.49 | 0.84 | 1475.20 | 1.00 | 1043 | 84 | 97 | 10 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12C | AMER1 | Any mutation | 136 | 142 | TMB overall | 0.45 | -2.45 | 3.44 | 1565.80 | 1.00 | 1760 | 121 | 127 | 15 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | EPHA7 | Any mutation | 40 | 14 | TMB quintile 4 | -1.47 | -5.80 | 0.85 | 1396.16 | 1.00 | 624 | 40 | 14 | 0 | FALSE | 0.39 |
| non-small cell lung cancer | RAS_12C | EPHA7 | Any mutation | 84 | 101 | TMB quintile 5 | -0.22 | -1.11 | 0.56 | 1549.38 | 1.00 | 932 | 77 | 94 | 7 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12C | EPHA7 | Any mutation | 124 | 115 | TMB overall | -0.78 | -3.61 | 1.47 | 1383.94 | 1.00 | 1556 | 117 | 108 | 7 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12C | SPEN | Any mutation | 127 | 15 | TMB quintile 4 | -2.30 | -6.31 | -0.35 | 1321.48 | 1.00 | 620 | 127 | 15 | 0 | FALSE | 0.85 |
| non-small cell lung cancer | KRAS_12C | SPEN | Any mutation | 223 | 87 | TMB quintile 5 | -1.11 | -2.04 | -0.35 | 1513.93 | 1.00 | 950 | 216 | 80 | 7 | FALSE | 2.13 |
| non-small cell lung cancer | KRAS_12C | SPEN | Any mutation | 350 | 102 | TMB overall | -1.65 | -4.47 | 0.31 | 1401.47 | 1.00 | 1570 | 343 | 95 | 7 | FALSE | 0.82 |
| non-small cell lung cancer | KRAS_12C | KMT2C | Any mutation | 46 | 13 | TMB quintile 3 | -0.99 | -3.36 | 0.65 | 1516.97 | 1.00 | 563 | 46 | 13 | 0 | FALSE | 0.46 |
| non-small cell lung cancer | KRAS_12C | KMT2C | Any mutation | 127 | 36 | TMB quintile 4 | -0.16 | -1.08 | 0.66 | 1374.46 | 1.00 | 604 | 121 | 30 | 6 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | KMT2C | Any mutation | 223 | 155 | TMB quintile 5 | -0.35 | -0.83 | 0.09 | 1427.32 | 1.00 | 874 | 201 | 133 | 22 | FALSE | 0.87 |
| non-small cell lung cancer | KRAS_12C | KMT2C | Any mutation | 396 | 204 | TMB overall | -0.48 | -1.98 | 0.84 | 1479.46 | 1.00 | 2041 | 368 | 176 | 28 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 27 | 180 | TMB quintile 2 | -1.52 | -2.48 | -0.72 | 1311.48 | 1.00 | 240 | 23 | 176 | 4 | TRUE | 3.16 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 46 | 324 | TMB quintile 3 | -1.43 | -2.13 | -0.80 | 1562.51 | 1.00 | 279 | 36 | 314 | 10 | TRUE | 4.54 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 127 | 450 | TMB quintile 4 | -1.30 | -1.73 | -0.91 | 1548.76 | 1.00 | 250 | 88 | 411 | 39 | TRUE | 9.43 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 233 | 996 | TMB quintile 5 | -1.18 | -1.49 | -0.89 | 1719.58 | 1.00 | 224 | 108 | 871 | 125 | TRUE | 13.91 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 433 | 1950 | TMB overall | -1.33 | -2.16 | -0.52 | 1457.83 | 1.00 | 993 | 255 | 1772 | 178 | TRUE | 2.94 |
| non-small cell lung cancer | KRAS_12C | ATRX | Any mutation | 127 | 32 | TMB quintile 4 | 0.12 | -0.70 | 0.92 | 1361.88 | 1.00 | 610 | 121 | 26 | 6 | TRUE | 0.11 |
| non-small cell lung cancer | KRAS_12C | ATRX | Any mutation | 227 | 160 | TMB quintile 5 | 0.39 | -0.01 | 0.79 | 1401.03 | 1.00 | 900 | 189 | 122 | 38 | TRUE | 1.26 |
| non-small cell lung cancer | KRAS_12C | ATRX | Any mutation | 354 | 192 | TMB overall | 0.29 | -1.02 | 1.62 | 1500.50 | 1.00 | 1510 | 310 | 148 | 44 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12C | ATR | Any mutation | 46 | 12 | TMB quintile 3 | -0.35 | -2.06 | 1.09 | 1489.95 | 1.00 | 569 | 45 | 11 | 1 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12C | ATR | Any mutation | 127 | 15 | TMB quintile 4 | -0.76 | -2.31 | 0.46 | 1226.63 | 1.00 | 623 | 126 | 14 | 1 | FALSE | 0.57 |
| non-small cell lung cancer | KRAS_12C | ATR | Any mutation | 222 | 93 | TMB quintile 5 | -0.10 | -0.65 | 0.42 | 1656.89 | 1.00 | 926 | 206 | 77 | 16 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | ATR | Any mutation | 395 | 120 | TMB overall | -0.40 | -1.71 | 0.84 | 1431.04 | 1.00 | 2118 | 377 | 102 | 18 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12C | PDGFRA | Any mutation | 127 | 16 | TMB quintile 4 | 0.31 | -0.80 | 1.33 | 1308.52 | 1.00 | 623 | 123 | 12 | 4 | TRUE | 0.24 |
| non-small cell lung cancer | KRAS_12C | PDGFRA | Any mutation | 224 | 115 | TMB quintile 5 | 0.12 | -0.37 | 0.60 | 1457.05 | 1.00 | 914 | 201 | 92 | 23 | TRUE | 0.20 |
| non-small cell lung cancer | KRAS_12C | PDGFRA | Any mutation | 351 | 131 | TMB overall | 0.22 | -1.51 | 2.08 | 1437.94 | 1.00 | 1537 | 324 | 104 | 27 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12C | FLT4 | Any mutation | 127 | 14 | TMB quintile 4 | 0.65 | -0.46 | 1.76 | 1398.07 | 1.00 | 626 | 122 | 9 | 5 | TRUE | 0.61 |
| non-small cell lung cancer | KRAS_12C | FLT4 | Any mutation | 223 | 74 | TMB quintile 5 | -0.21 | -0.88 | 0.42 | 1469.86 | 1.00 | 941 | 212 | 63 | 11 | TRUE | 0.28 |
| non-small cell lung cancer | KRAS_12C | FLT4 | Any mutation | 350 | 88 | TMB overall | 0.20 | -1.43 | 2.07 | 1483.65 | 1.00 | 1567 | 334 | 72 | 16 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 46 | 16 | TMB quintile 3 | -0.65 | -2.95 | 1.01 | 1370.05 | 1.00 | 566 | 45 | 15 | 1 | FALSE | 0.27 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 127 | 53 | TMB quintile 4 | -0.55 | -1.49 | 0.30 | 1451.05 | 1.00 | 589 | 121 | 47 | 6 | FALSE | 0.66 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 232 | 298 | TMB quintile 5 | -0.11 | -0.45 | 0.22 | 1369.55 | 1.00 | 795 | 181 | 247 | 51 | FALSE | 0.27 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 405 | 384 | TMB overall | -0.64 | -2.64 | 1.24 | 1628.81 | 1.00 | 1957 | 347 | 326 | 58 | FALSE | 0.29 |
| non-small cell lung cancer | KRAS_12C | PIK3C2G | Any mutation | 127 | 12 | TMB quintile 4 | -0.92 | -2.92 | 0.51 | 1231.48 | 1.00 | 621 | 126 | 11 | 1 | FALSE | 0.55 |
| non-small cell lung cancer | KRAS_12C | PIK3C2G | Any mutation | 223 | 103 | TMB quintile 5 | -0.48 | -1.11 | 0.10 | 1489.30 | 1.00 | 912 | 210 | 90 | 13 | FALSE | 0.93 |
| non-small cell lung cancer | KRAS_12C | PIK3C2G | Any mutation | 350 | 115 | TMB overall | -0.67 | -2.61 | 1.26 | 1573.80 | 1.00 | 1533 | 336 | 101 | 14 | FALSE | 0.30 |
| non-small cell lung cancer | KRAS_12C | CREBBP | Any mutation | 46 | 11 | TMB quintile 3 | -0.28 | -2.03 | 1.18 | 1591.12 | 1.00 | 570 | 45 | 10 | 1 | TRUE | 0.14 |
| non-small cell lung cancer | KRAS_12C | CREBBP | Any mutation | 127 | 12 | TMB quintile 4 | -0.29 | -1.66 | 0.98 | 1445.12 | 1.00 | 625 | 125 | 10 | 2 | TRUE | 0.18 |
| non-small cell lung cancer | KRAS_12C | CREBBP | Any mutation | 222 | 106 | TMB quintile 5 | -0.56 | -1.21 | 0.00 | 1553.12 | 1.00 | 916 | 210 | 94 | 12 | TRUE | 1.13 |
| non-small cell lung cancer | KRAS_12C | CREBBP | Any mutation | 395 | 129 | TMB overall | -0.36 | -1.73 | 1.03 | 1441.56 | 1.00 | 2111 | 380 | 114 | 15 | TRUE | 0.23 |
| non-small cell lung cancer | KRAS_12C | DOT1L | Any mutation | 127 | 24 | TMB quintile 4 | -0.06 | -0.93 | 0.80 | 1459.19 | 1.00 | 618 | 122 | 19 | 5 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12C | DOT1L | Any mutation | 223 | 75 | TMB quintile 5 | -0.33 | -1.04 | 0.26 | 1356.96 | 1.00 | 936 | 213 | 65 | 10 | FALSE | 0.52 |
| non-small cell lung cancer | KRAS_12C | DOT1L | Any mutation | 350 | 99 | TMB overall | -0.20 | -1.35 | 0.93 | 1666.18 | 1.00 | 1554 | 335 | 84 | 15 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 47 | 35 | TMB quintile 3 | 0.62 | -0.36 | 1.54 | 1502.10 | 1.00 | 554 | 41 | 29 | 6 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 128 | 67 | TMB quintile 4 | 0.07 | -0.58 | 0.65 | 1412.26 | 1.00 | 583 | 116 | 55 | 12 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 224 | 194 | TMB quintile 5 | -0.31 | -0.72 | 0.10 | 1457.91 | 1.00 | 843 | 197 | 167 | 27 | FALSE | 0.88 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 399 | 296 | TMB overall | 0.12 | -0.85 | 1.16 | 1446.57 | 1.00 | 1980 | 354 | 251 | 45 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 46 | 17 | TMB quintile 3 | 1.11 | -0.27 | 2.21 | 1521.40 | 1.00 | 567 | 42 | 13 | 4 | FALSE | 1.11 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 127 | 38 | TMB quintile 4 | 0.22 | -0.61 | 1.01 | 1485.04 | 1.00 | 606 | 119 | 30 | 8 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 224 | 272 | TMB quintile 5 | -0.54 | -0.94 | -0.16 | 1272.70 | 1.00 | 812 | 191 | 239 | 33 | FALSE | 2.11 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 397 | 348 | TMB overall | -0.09 | -2.49 | 1.96 | 1340.15 | 1.00 | 1990 | 352 | 303 | 45 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12C | HGF | Any mutation | 127 | 27 | TMB quintile 4 | -0.03 | -1.18 | 0.90 | 1542.61 | 1.00 | 614 | 122 | 22 | 5 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | HGF | Any mutation | 224 | 138 | TMB quintile 5 | -0.20 | -0.74 | 0.29 | 1561.10 | 1.00 | 890 | 202 | 116 | 22 | FALSE | 0.38 |
| non-small cell lung cancer | KRAS_12C | HGF | Any mutation | 351 | 180 | TMB overall | -0.48 | -3.29 | 2.18 | 1524.55 | 1.00 | 1511 | 324 | 153 | 27 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 27 | 18 | TMB quintile 2 | -0.40 | -1.64 | 0.73 | 1393.68 | 1.00 | 397 | 26 | 17 | 1 | TRUE | 0.30 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 46 | 34 | TMB quintile 3 | -0.38 | -1.47 | 0.54 | 1404.24 | 1.00 | 548 | 44 | 32 | 2 | TRUE | 0.34 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 128 | 56 | TMB quintile 4 | -0.50 | -1.28 | 0.21 | 1458.68 | 1.00 | 585 | 122 | 50 | 6 | TRUE | 0.75 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 222 | 123 | TMB quintile 5 | -0.23 | -0.72 | 0.24 | 1359.60 | 1.00 | 906 | 203 | 104 | 19 | TRUE | 0.44 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 423 | 231 | TMB overall | -0.38 | -1.21 | 0.36 | 1393.61 | 1.00 | 2436 | 395 | 203 | 28 | TRUE | 0.46 |
| non-small cell lung cancer | KRAS_12C | ALK | Any mutation | 46 | 13 | TMB quintile 3 | -0.25 | -2.43 | 1.43 | 1457.99 | 1.00 | 569 | 45 | 12 | 1 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12C | ALK | Any mutation | 127 | 22 | TMB quintile 4 | 0.26 | -0.79 | 1.23 | 1308.50 | 1.00 | 619 | 122 | 17 | 5 | TRUE | 0.20 |
| non-small cell lung cancer | KRAS_12C | ALK | Any mutation | 222 | 118 | TMB quintile 5 | 0.20 | -0.28 | 0.65 | 1415.38 | 1.00 | 914 | 197 | 93 | 25 | TRUE | 0.39 |
| non-small cell lung cancer | KRAS_12C | ALK | Any mutation | 395 | 164 | TMB overall | -0.09 | -1.99 | 1.77 | 1529.38 | 1.00 | 2111 | 364 | 133 | 31 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12C | PTEN | Any mutation | 46 | 17 | TMB quintile 3 | -0.92 | -2.73 | 0.59 | 1394.32 | 1.00 | 564 | 45 | 16 | 1 | TRUE | 0.59 |
| non-small cell lung cancer | KRAS_12C | PTEN | Any mutation | 127 | 27 | TMB quintile 4 | -1.75 | -4.24 | -0.37 | 1445.09 | 1.00 | 609 | 127 | 27 | 0 | TRUE | 1.13 |
| non-small cell lung cancer | KRAS_12C | PTEN | Any mutation | 222 | 75 | TMB quintile 5 | -0.67 | -1.48 | -0.03 | 1355.93 | 1.00 | 941 | 213 | 66 | 9 | TRUE | 1.14 |
| non-small cell lung cancer | KRAS_12C | PTEN | Any mutation | 395 | 119 | TMB overall | -1.11 | -2.69 | 0.16 | 1434.91 | 1.00 | 2114 | 385 | 109 | 10 | TRUE | 0.90 |
| non-small cell lung cancer | KRAS_12C | BCOR | Any mutation | 127 | 22 | TMB quintile 4 | -0.53 | -1.85 | 0.45 | 1347.23 | 1.00 | 616 | 125 | 20 | 2 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12C | BCOR | Any mutation | 226 | 92 | TMB quintile 5 | 0.03 | -0.53 | 0.55 | 1351.92 | 1.00 | 931 | 208 | 74 | 18 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12C | BCOR | Any mutation | 353 | 114 | TMB overall | -0.24 | -1.89 | 1.10 | 1325.84 | 1.00 | 1547 | 333 | 94 | 20 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 27 | 12 | TMB quintile 2 | -0.60 | -1.93 | 0.60 | 1501.89 | 1.00 | 403 | 26 | 11 | 1 | TRUE | 0.45 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 46 | 22 | TMB quintile 3 | -0.94 | -2.40 | 0.20 | 1481.26 | 1.00 | 558 | 46 | 22 | 0 | TRUE | 0.82 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 128 | 33 | TMB quintile 4 | -0.57 | -1.54 | 0.30 | 1432.26 | 1.00 | 608 | 124 | 29 | 4 | TRUE | 0.65 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 222 | 47 | TMB quintile 5 | -0.70 | -1.53 | 0.10 | 1358.83 | 1.00 | 959 | 217 | 42 | 5 | TRUE | 1.06 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 423 | 114 | TMB overall | -0.70 | -1.67 | 0.24 | 1349.07 | 1.00 | 2528 | 413 | 104 | 10 | TRUE | 0.85 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 46 | 12 | TMB quintile 3 | -0.24 | -1.83 | 1.26 | 1385.31 | 1.00 | 569 | 45 | 11 | 1 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 127 | 56 | TMB quintile 4 | -0.36 | -1.14 | 0.36 | 1573.98 | 1.00 | 589 | 120 | 49 | 7 | TRUE | 0.44 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 228 | 187 | TMB quintile 5 | -0.06 | -0.46 | 0.33 | 1342.55 | 1.00 | 861 | 195 | 154 | 33 | TRUE | 0.11 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 401 | 255 | TMB overall | -0.20 | -1.50 | 1.17 | 1390.79 | 1.00 | 2019 | 360 | 214 | 41 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 46 | 16 | TMB quintile 3 | 0.22 | -1.49 | 1.66 | 1428.78 | 1.00 | 566 | 44 | 14 | 2 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 127 | 43 | TMB quintile 4 | 0.08 | -0.74 | 0.82 | 1608.45 | 1.00 | 605 | 119 | 35 | 8 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 226 | 227 | TMB quintile 5 | -0.12 | -0.49 | 0.26 | 1476.76 | 1.00 | 831 | 188 | 189 | 38 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 399 | 300 | TMB overall | -0.15 | -1.95 | 1.59 | 1423.46 | 1.00 | 2009 | 351 | 252 | 48 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12C | NCOR1 | Any mutation | 127 | 21 | TMB quintile 4 | -0.31 | -1.37 | 0.62 | 1529.82 | 1.00 | 618 | 124 | 18 | 3 | FALSE | 0.28 |
| non-small cell lung cancer | KRAS_12C | NCOR1 | Any mutation | 224 | 71 | TMB quintile 5 | -0.23 | -0.93 | 0.38 | 1577.51 | 1.00 | 948 | 213 | 60 | 11 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12C | NCOR1 | Any mutation | 351 | 92 | TMB overall | -0.26 | -1.44 | 0.97 | 1357.58 | 1.00 | 1566 | 337 | 78 | 14 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12C | POLE | Any mutation | 127 | 20 | TMB quintile 4 | -0.08 | -1.28 | 0.86 | 1564.07 | 1.00 | 618 | 124 | 17 | 3 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12C | POLE | Any mutation | 223 | 102 | TMB quintile 5 | 0.45 | -0.01 | 0.93 | 1418.06 | 1.00 | 931 | 197 | 76 | 26 | TRUE | 1.26 |
| non-small cell lung cancer | KRAS_12C | POLE | Any mutation | 350 | 122 | TMB overall | 0.21 | -1.33 | 1.82 | 1802.95 | 1.00 | 1549 | 321 | 93 | 29 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12C | NOTCH2 | Any mutation | 127 | 16 | TMB quintile 4 | -0.24 | -1.49 | 0.92 | 1477.98 | 1.00 | 620 | 124 | 13 | 3 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12C | NOTCH2 | Any mutation | 222 | 81 | TMB quintile 5 | -0.69 | -1.45 | -0.06 | 1396.19 | 1.00 | 930 | 214 | 73 | 8 | TRUE | 1.24 |
| non-small cell lung cancer | KRAS_12C | NOTCH2 | Any mutation | 349 | 97 | TMB overall | -0.46 | -2.08 | 1.19 | 1265.35 | 1.00 | 1550 | 338 | 86 | 11 | TRUE | 0.24 |
| non-small cell lung cancer | KRAS_12C | KMT2A | Any mutation | 127 | 16 | TMB quintile 4 | -0.14 | -1.30 | 0.98 | 1493.29 | 1.00 | 622 | 124 | 13 | 3 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12C | KMT2A | Any mutation | 222 | 80 | TMB quintile 5 | -0.34 | -1.00 | 0.28 | 1303.39 | 1.00 | 937 | 211 | 69 | 11 | FALSE | 0.52 |
| non-small cell lung cancer | KRAS_12C | KMT2A | Any mutation | 349 | 96 | TMB overall | -0.22 | -1.65 | 1.36 | 1534.62 | 1.00 | 1559 | 335 | 82 | 14 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12C | PAK7 | Any mutation | 127 | 13 | TMB quintile 4 | -0.35 | -1.80 | 0.96 | 1428.75 | 1.00 | 621 | 125 | 11 | 2 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12C | PAK7 | Any mutation | 222 | 95 | TMB quintile 5 | -0.47 | -1.10 | 0.11 | 1404.74 | 1.00 | 921 | 210 | 83 | 12 | FALSE | 0.86 |
| non-small cell lung cancer | KRAS_12C | PAK7 | Any mutation | 349 | 108 | TMB overall | -0.42 | -2.21 | 1.51 | 1420.11 | 1.00 | 1542 | 335 | 94 | 14 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12C | STAG2 | Any mutation | 127 | 19 | TMB quintile 4 | -0.20 | -1.20 | 0.78 | 1421.98 | 1.00 | 619 | 124 | 16 | 3 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12C | STAG2 | Any mutation | 222 | 76 | TMB quintile 5 | -0.17 | -0.84 | 0.43 | 1272.33 | 1.00 | 943 | 210 | 64 | 12 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12C | STAG2 | Any mutation | 349 | 95 | TMB overall | -0.22 | -1.60 | 0.98 | 1412.40 | 1.00 | 1562 | 334 | 80 | 15 | TRUE | 0.13 |
| non-small cell lung cancer | KRAS_12C | TERT | Any mutation | 47 | 13 | TMB quintile 3 | 0.76 | -0.40 | 1.93 | 1589.53 | 1.00 | 570 | 44 | 10 | 3 | TRUE | 0.72 |
| non-small cell lung cancer | KRAS_12C | TERT | Any mutation | 127 | 34 | TMB quintile 4 | 0.16 | -0.67 | 0.90 | 1367.32 | 1.00 | 608 | 121 | 28 | 6 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12C | TERT | Any mutation | 224 | 98 | TMB quintile 5 | 0.42 | -0.03 | 0.85 | 1489.86 | 1.00 | 932 | 200 | 74 | 24 | TRUE | 1.17 |
| non-small cell lung cancer | KRAS_12C | TERT | Any mutation | 398 | 145 | TMB overall | 0.44 | -0.58 | 1.50 | 1554.64 | 1.00 | 2110 | 365 | 112 | 33 | TRUE | 0.41 |
| non-small cell lung cancer | KRAS_12C | BRCA2 | Any mutation | 127 | 23 | TMB quintile 4 | 0.20 | -0.91 | 1.19 | 1359.43 | 1.00 | 618 | 122 | 18 | 5 | TRUE | 0.15 |
| non-small cell lung cancer | KRAS_12C | BRCA2 | Any mutation | 222 | 89 | TMB quintile 5 | -0.22 | -0.86 | 0.35 | 1477.85 | 1.00 | 931 | 208 | 75 | 14 | TRUE | 0.31 |
| non-small cell lung cancer | KRAS_12C | BRCA2 | Any mutation | 349 | 126 | TMB overall | -0.35 | -3.27 | 2.32 | 1473.71 | 1.00 | 1558 | 330 | 107 | 19 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12C | NOTCH3 | Any mutation | 127 | 21 | TMB quintile 4 | -0.01 | -1.25 | 1.02 | 1477.28 | 1.00 | 619 | 123 | 17 | 4 | TRUE | 0.01 |
| non-small cell lung cancer | KRAS_12C | NOTCH3 | Any mutation | 222 | 82 | TMB quintile 5 | -0.32 | -0.98 | 0.29 | 1558.18 | 1.00 | 936 | 210 | 70 | 12 | TRUE | 0.48 |
| non-small cell lung cancer | KRAS_12C | NOTCH3 | Any mutation | 349 | 114 | TMB overall | -0.53 | -3.43 | 2.09 | 1618.36 | 1.00 | 1564 | 333 | 98 | 16 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12C | NOTCH4 | Any mutation | 127 | 17 | TMB quintile 4 | -1.14 | -2.93 | 0.13 | 1538.82 | 1.00 | 616 | 126 | 16 | 1 | TRUE | 0.84 |
| non-small cell lung cancer | KRAS_12C | NOTCH4 | Any mutation | 222 | 107 | TMB quintile 5 | -0.57 | -1.22 | 0.01 | 1430.11 | 1.00 | 906 | 209 | 94 | 13 | TRUE | 1.19 |
| non-small cell lung cancer | KRAS_12C | NOTCH4 | Any mutation | 349 | 124 | TMB overall | -0.83 | -2.58 | 0.87 | 1551.14 | 1.00 | 1522 | 335 | 110 | 14 | TRUE | 0.47 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 27 | 12 | TMB quintile 2 | -0.44 | -2.36 | 1.05 | 1461.68 | 1.00 | 402 | 27 | 12 | 0 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 46 | 50 | TMB quintile 3 | 0.63 | -0.26 | 1.47 | 1480.68 | 1.00 | 537 | 39 | 43 | 7 | FALSE | 0.81 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 129 | 129 | TMB quintile 4 | 0.73 | 0.28 | 1.15 | 1447.46 | 1.00 | 543 | 94 | 94 | 35 | FALSE | 2.87 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 225 | 336 | TMB quintile 5 | -0.17 | -0.50 | 0.15 | 1526.47 | 1.00 | 734 | 171 | 282 | 54 | FALSE | 0.50 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 427 | 527 | TMB overall | 0.17 | -1.01 | 1.23 | 1503.61 | 1.00 | 2216 | 331 | 431 | 96 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12C | KDM5C | Any mutation | 127 | 16 | TMB quintile 4 | -0.33 | -1.55 | 0.71 | 1400.05 | 1.00 | 621 | 125 | 14 | 2 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12C | KDM5C | Any mutation | 223 | 70 | TMB quintile 5 | 0.00 | -0.66 | 0.59 | 1301.14 | 1.00 | 948 | 210 | 57 | 13 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12C | KDM5C | Any mutation | 350 | 86 | TMB overall | -0.15 | -1.62 | 1.16 | 1458.26 | 1.00 | 1569 | 335 | 71 | 15 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 46 | 33 | TMB quintile 3 | 0.11 | -0.94 | 1.07 | 1474.70 | 1.00 | 552 | 42 | 29 | 4 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 127 | 43 | TMB quintile 4 | -0.83 | -1.91 | 0.04 | 1521.52 | 1.00 | 596 | 124 | 40 | 3 | TRUE | 0.98 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 226 | 178 | TMB quintile 5 | -0.46 | -0.93 | -0.03 | 1410.71 | 1.00 | 858 | 203 | 155 | 23 | TRUE | 1.32 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 399 | 254 | TMB overall | -0.40 | -1.49 | 0.74 | 1325.58 | 1.00 | 2006 | 369 | 224 | 30 | TRUE | 0.33 |
| non-small cell lung cancer | KRAS_12C | EPHB1 | Any mutation | 127 | 19 | TMB quintile 4 | -0.30 | -1.69 | 0.84 | 1310.62 | 1.00 | 619 | 124 | 16 | 3 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12C | EPHB1 | Any mutation | 223 | 117 | TMB quintile 5 | -0.48 | -1.05 | 0.06 | 1362.03 | 1.00 | 904 | 208 | 102 | 15 | FALSE | 1.01 |
| non-small cell lung cancer | KRAS_12C | EPHB1 | Any mutation | 350 | 152 | TMB overall | -0.69 | -3.48 | 1.96 | 1497.56 | 1.00 | 1532 | 332 | 134 | 18 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | SMAD4 | Any mutation | 46 | 21 | TMB quintile 3 | -0.54 | -1.90 | 0.55 | 1260.06 | 1.00 | 560 | 45 | 20 | 1 | TRUE | 0.40 |
| non-small cell lung cancer | KRAS_12C | SMAD4 | Any mutation | 127 | 36 | TMB quintile 4 | -0.80 | -1.89 | 0.06 | 1337.80 | 1.00 | 605 | 125 | 34 | 2 | TRUE | 0.93 |
| non-small cell lung cancer | KRAS_12C | SMAD4 | Any mutation | 222 | 49 | TMB quintile 5 | -0.09 | -0.84 | 0.58 | 1568.79 | 1.00 | 962 | 212 | 39 | 10 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12C | SMAD4 | Any mutation | 395 | 106 | TMB overall | -0.47 | -1.65 | 0.56 | 1546.72 | 1.00 | 2127 | 382 | 93 | 13 | TRUE | 0.41 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 27 | 15 | TMB quintile 2 | 1.00 | -0.08 | 2.05 | 1382.47 | 1.00 | 403 | 24 | 12 | 3 | TRUE | 1.16 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 46 | 20 | TMB quintile 3 | 0.76 | -0.20 | 1.68 | 1376.01 | 1.00 | 563 | 43 | 17 | 3 | TRUE | 0.93 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 130 | 76 | TMB quintile 4 | 0.95 | 0.46 | 1.44 | 1350.65 | 1.00 | 591 | 106 | 52 | 24 | TRUE | 3.72 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 232 | 166 | TMB quintile 5 | 0.72 | 0.35 | 1.07 | 1447.59 | 1.00 | 893 | 184 | 118 | 48 | TRUE | 3.87 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 435 | 277 | TMB overall | 0.86 | 0.07 | 1.66 | 1495.51 | 1.00 | 2450 | 357 | 199 | 78 | TRUE | 1.46 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 46 | 33 | TMB quintile 3 | -1.17 | -2.63 | 0.01 | 1397.58 | 1.00 | 548 | 45 | 32 | 1 | TRUE | 1.14 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 127 | 50 | TMB quintile 4 | -1.40 | -2.56 | -0.47 | 1436.38 | 1.00 | 587 | 125 | 48 | 2 | TRUE | 2.11 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 222 | 124 | TMB quintile 5 | -0.98 | -1.64 | -0.38 | 1440.14 | 1.00 | 893 | 211 | 113 | 11 | TRUE | 2.70 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 395 | 207 | TMB overall | -1.17 | -2.23 | -0.22 | 1402.99 | 1.00 | 2028 | 381 | 193 | 14 | TRUE | 1.66 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 46 | 15 | TMB quintile 3 | -0.51 | -2.55 | 1.20 | 1647.12 | 1.00 | 566 | 45 | 14 | 1 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 127 | 42 | TMB quintile 4 | -0.28 | -1.24 | 0.52 | 1544.40 | 1.00 | 602 | 121 | 36 | 6 | FALSE | 0.28 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 224 | 251 | TMB quintile 5 | -0.47 | -0.86 | -0.07 | 1338.88 | 1.00 | 821 | 192 | 219 | 32 | FALSE | 1.67 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 397 | 320 | TMB overall | -0.56 | -2.31 | 1.18 | 1519.34 | 1.00 | 1997 | 358 | 281 | 39 | FALSE | 0.29 |
| non-small cell lung cancer | KRAS_12C | APC | Any mutation | 46 | 20 | TMB quintile 3 | -0.84 | -2.42 | 0.50 | 1522.54 | 1.00 | 561 | 45 | 19 | 1 | TRUE | 0.59 |
| non-small cell lung cancer | KRAS_12C | APC | Any mutation | 127 | 31 | TMB quintile 4 | -1.31 | -2.73 | -0.22 | 1530.62 | 1.00 | 605 | 126 | 30 | 1 | TRUE | 1.33 |
| non-small cell lung cancer | KRAS_12C | APC | Any mutation | 225 | 101 | TMB quintile 5 | -0.46 | -1.07 | 0.09 | 1600.91 | 1.00 | 920 | 211 | 87 | 14 | TRUE | 0.89 |
| non-small cell lung cancer | KRAS_12C | APC | Any mutation | 398 | 152 | TMB overall | -0.86 | -2.18 | 0.22 | 1464.27 | 1.00 | 2086 | 382 | 136 | 16 | TRUE | 0.81 |
| non-small cell lung cancer | KRAS_12C | ERBB2 | Any mutation | 27 | 14 | TMB quintile 2 | -3.38 | -6.22 | -1.19 | 1516.15 | 1.00 | 400 | 27 | 14 | 0 | TRUE | 2.12 |
| non-small cell lung cancer | KRAS_12C | ERBB2 | Any mutation | 46 | 27 | TMB quintile 3 | -3.42 | -6.27 | -1.35 | 1528.63 | 1.00 | 553 | 46 | 27 | 0 | TRUE | 2.24 |
| non-small cell lung cancer | KRAS_12C | ERBB2 | Any mutation | 127 | 32 | TMB quintile 4 | -3.49 | -6.22 | -1.56 | 1498.13 | 1.01 | 605 | 127 | 32 | 0 | TRUE | 2.38 |
| non-small cell lung cancer | KRAS_12C | ERBB2 | Any mutation | 222 | 40 | TMB quintile 5 | -3.20 | -5.70 | -1.43 | 1480.02 | 1.01 | 965 | 221 | 39 | 1 | TRUE | 2.36 |
| non-small cell lung cancer | KRAS_12C | ERBB2 | Any mutation | 422 | 113 | TMB overall | -3.36 | -5.94 | -1.50 | 1463.27 | 1.01 | 2523 | 421 | 112 | 1 | TRUE | 2.50 |
| non-small cell lung cancer | KRAS_12C | ARID2 | Any mutation | 46 | 19 | TMB quintile 3 | -0.79 | -2.65 | 0.55 | 1539.67 | 1.00 | 561 | 46 | 19 | 0 | FALSE | 0.46 |
| non-small cell lung cancer | KRAS_12C | ARID2 | Any mutation | 127 | 35 | TMB quintile 4 | -0.28 | -1.25 | 0.55 | 1214.53 | 1.00 | 607 | 122 | 30 | 5 | FALSE | 0.27 |
| non-small cell lung cancer | KRAS_12C | ARID2 | Any mutation | 223 | 111 | TMB quintile 5 | 0.02 | -0.48 | 0.50 | 1339.17 | 1.00 | 921 | 202 | 90 | 21 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12C | ARID2 | Any mutation | 396 | 165 | TMB overall | -0.35 | -1.56 | 0.63 | 1317.80 | 1.00 | 2089 | 370 | 139 | 26 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12C | MTOR | Any mutation | 46 | 14 | TMB quintile 3 | 0.08 | -1.25 | 1.16 | 1487.96 | 1.00 | 567 | 45 | 13 | 1 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12C | MTOR | Any mutation | 127 | 21 | TMB quintile 4 | 0.16 | -0.88 | 0.97 | 1450.49 | 1.00 | 619 | 123 | 17 | 4 | TRUE | 0.13 |
| non-small cell lung cancer | KRAS_12C | MTOR | Any mutation | 224 | 70 | TMB quintile 5 | 0.43 | -0.10 | 0.95 | 1557.19 | 1.00 | 949 | 206 | 52 | 18 | TRUE | 0.96 |
| non-small cell lung cancer | KRAS_12C | MTOR | Any mutation | 397 | 105 | TMB overall | 0.23 | -0.81 | 1.18 | 1399.43 | 1.00 | 2135 | 374 | 82 | 23 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12C | NOTCH1 | Any mutation | 127 | 15 | TMB quintile 4 | -0.54 | -1.97 | 0.73 | 1418.86 | 1.00 | 622 | 125 | 13 | 2 | TRUE | 0.37 |
| non-small cell lung cancer | KRAS_12C | NOTCH1 | Any mutation | 223 | 97 | TMB quintile 5 | -0.60 | -1.27 | 0.00 | 1425.49 | 1.00 | 920 | 212 | 86 | 11 | TRUE | 1.18 |
| non-small cell lung cancer | KRAS_12C | NOTCH1 | Any mutation | 350 | 112 | TMB overall | -0.58 | -2.18 | 1.23 | 1436.27 | 1.00 | 1542 | 337 | 99 | 13 | TRUE | 0.28 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 27 | 14 | TMB quintile 2 | -0.70 | -2.48 | 0.66 | 1335.08 | 1.00 | 400 | 27 | 14 | 0 | FALSE | 0.41 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 46 | 22 | TMB quintile 3 | -0.88 | -2.84 | 0.42 | 1520.08 | 1.00 | 564 | 46 | 22 | 0 | FALSE | 0.54 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 127 | 59 | TMB quintile 4 | -0.28 | -1.01 | 0.39 | 1484.02 | 1.00 | 593 | 119 | 51 | 8 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 227 | 110 | TMB quintile 5 | 0.22 | -0.26 | 0.69 | 1542.78 | 1.00 | 927 | 202 | 85 | 25 | FALSE | 0.46 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 427 | 205 | TMB overall | -0.41 | -1.54 | 0.51 | 1346.43 | 1.00 | 2484 | 394 | 172 | 33 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12C | PBRM1 | Any mutation | 127 | 21 | TMB quintile 4 | -0.32 | -1.45 | 0.59 | 1256.87 | 1.00 | 620 | 124 | 18 | 3 | TRUE | 0.27 |
| non-small cell lung cancer | KRAS_12C | PBRM1 | Any mutation | 222 | 79 | TMB quintile 5 | -0.31 | -1.00 | 0.37 | 591.82 | 1.01 | 942 | 211 | 68 | 11 | TRUE | 0.45 |
| non-small cell lung cancer | KRAS_12C | PBRM1 | Any mutation | 349 | 100 | TMB overall | -0.30 | -1.71 | 0.91 | 1025.83 | 1.00 | 1562 | 335 | 86 | 14 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 46 | 15 | TMB quintile 3 | -1.77 | -5.68 | 0.66 | 1507.70 | 1.00 | 565 | 46 | 15 | 0 | FALSE | 0.59 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 127 | 28 | TMB quintile 4 | 0.59 | -0.28 | 1.40 | 1567.92 | 1.00 | 615 | 119 | 20 | 8 | FALSE | 0.75 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 228 | 182 | TMB quintile 5 | 0.05 | -0.35 | 0.44 | 1279.37 | 1.00 | 866 | 193 | 147 | 35 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 401 | 237 | TMB overall | -0.52 | -2.87 | 1.45 | 1320.51 | 1.00 | 2054 | 358 | 194 | 43 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12C | KDR | Any mutation | 127 | 21 | TMB quintile 4 | 0.63 | -0.37 | 1.62 | 1596.80 | 1.00 | 621 | 120 | 14 | 7 | TRUE | 0.69 |
| non-small cell lung cancer | KRAS_12C | KDR | Any mutation | 224 | 109 | TMB quintile 5 | -0.24 | -0.82 | 0.28 | 1371.25 | 1.00 | 911 | 208 | 93 | 16 | TRUE | 0.39 |
| non-small cell lung cancer | KRAS_12C | KDR | Any mutation | 351 | 130 | TMB overall | 0.18 | -1.43 | 1.90 | 1380.11 | 1.00 | 1532 | 328 | 107 | 23 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12C | TET1 | Any mutation | 127 | 16 | TMB quintile 4 | -0.64 | -2.45 | 0.77 | 1235.79 | 1.00 | 618 | 125 | 14 | 2 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12C | TET1 | Any mutation | 223 | 89 | TMB quintile 5 | -0.32 | -0.96 | 0.26 | 1506.78 | 1.00 | 928 | 210 | 76 | 13 | FALSE | 0.52 |
| non-small cell lung cancer | KRAS_12C | TET1 | Any mutation | 350 | 120 | TMB overall | -0.84 | -3.80 | 2.20 | 1484.38 | 1.00 | 1551 | 335 | 105 | 15 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12C | TBX3 | Any mutation | 127 | 11 | TMB quintile 4 | 0.32 | -0.97 | 1.62 | 1523.72 | 1.00 | 627 | 124 | 8 | 3 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | TBX3 | Any mutation | 222 | 108 | TMB quintile 5 | -0.09 | -0.62 | 0.42 | 1481.46 | 1.00 | 919 | 204 | 90 | 18 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12C | TBX3 | Any mutation | 349 | 119 | TMB overall | 0.13 | -1.73 | 2.16 | 1511.63 | 1.00 | 1546 | 328 | 98 | 21 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12C | NTRK3 | Any mutation | 129 | 31 | TMB quintile 4 | 1.26 | 0.51 | 2.03 | 1595.55 | 1.00 | 618 | 116 | 18 | 13 | FALSE | 2.92 |
| non-small cell lung cancer | KRAS_12C | NTRK3 | Any mutation | 224 | 144 | TMB quintile 5 | 0.42 | 0.02 | 0.81 | 1384.69 | 1.00 | 903 | 189 | 109 | 35 | FALSE | 1.34 |
| non-small cell lung cancer | KRAS_12C | NTRK3 | Any mutation | 353 | 195 | TMB overall | 0.20 | -3.38 | 3.15 | 1391.69 | 1.00 | 1528 | 305 | 147 | 48 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12C | GRIN2A | Any mutation | 46 | 17 | TMB quintile 3 | 0.76 | -0.40 | 1.98 | 1525.23 | 1.00 | 567 | 42 | 13 | 4 | FALSE | 0.64 |
| non-small cell lung cancer | KRAS_12C | GRIN2A | Any mutation | 127 | 39 | TMB quintile 4 | -0.45 | -1.43 | 0.38 | 1431.19 | 1.00 | 601 | 123 | 35 | 4 | FALSE | 0.49 |
| non-small cell lung cancer | KRAS_12C | GRIN2A | Any mutation | 225 | 124 | TMB quintile 5 | -0.14 | -0.66 | 0.35 | 1549.03 | 1.00 | 903 | 205 | 104 | 20 | FALSE | 0.23 |
| non-small cell lung cancer | KRAS_12C | GRIN2A | Any mutation | 398 | 180 | TMB overall | 0.03 | -1.12 | 1.23 | 1525.97 | 1.00 | 2071 | 370 | 152 | 28 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 27 | 12 | TMB quintile 2 | 0.87 | -0.45 | 2.07 | 1570.94 | 1.00 | 404 | 25 | 10 | 2 | TRUE | 0.78 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 47 | 78 | TMB quintile 3 | 1.26 | 0.64 | 1.87 | 1514.75 | 1.00 | 518 | 32 | 63 | 15 | TRUE | 4.13 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 128 | 161 | TMB quintile 4 | 1.48 | 1.11 | 1.88 | 1484.40 | 1.00 | 535 | 69 | 102 | 59 | TRUE | 12.97 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 225 | 283 | TMB quintile 5 | 0.09 | -0.25 | 0.43 | 1520.18 | 1.00 | 782 | 172 | 230 | 53 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 427 | 534 | TMB overall | 0.92 | -0.14 | 1.89 | 1394.68 | 1.00 | 2239 | 298 | 405 | 129 | TRUE | 1.15 |
| non-small cell lung cancer | KRAS_12C | EP300 | Any mutation | 222 | 77 | TMB quintile 5 | -0.22 | -0.89 | 0.40 | 1121.98 | 1.00 | 942 | 210 | 65 | 12 | TRUE | 0.31 |
| non-small cell lung cancer | KRAS_12C | EP300 | Any mutation | 222 | 77 | TMB overall | -0.20 | -4.59 | 4.33 | 1391.26 | 1.00 | 942 | 210 | 65 | 12 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12C | ERBB4 | Any mutation | 127 | 25 | TMB quintile 4 | -0.65 | -2.00 | 0.42 | 1558.94 | 1.00 | 613 | 124 | 22 | 3 | TRUE | 0.53 |
| non-small cell lung cancer | KRAS_12C | ERBB4 | Any mutation | 223 | 148 | TMB quintile 5 | -1.11 | -1.79 | -0.50 | 1464.55 | 1.00 | 888 | 212 | 137 | 11 | TRUE | 3.13 |
| non-small cell lung cancer | KRAS_12C | ERBB4 | Any mutation | 350 | 185 | TMB overall | -1.10 | -3.66 | 1.39 | 1410.38 | 1.00 | 1510 | 336 | 171 | 14 | TRUE | 0.42 |
| non-small cell lung cancer | KRAS_12C | MED12 | Any mutation | 46 | 23 | TMB quintile 3 | -0.18 | -1.30 | 0.88 | 1402.97 | 1.00 | 559 | 44 | 21 | 2 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12C | MED12 | Any mutation | 127 | 32 | TMB quintile 4 | -0.34 | -1.24 | 0.50 | 1583.94 | 1.00 | 607 | 123 | 28 | 4 | TRUE | 0.36 |
| non-small cell lung cancer | KRAS_12C | MED12 | Any mutation | 225 | 101 | TMB quintile 5 | -0.26 | -0.86 | 0.24 | 1423.72 | 1.00 | 921 | 210 | 86 | 15 | TRUE | 0.46 |
| non-small cell lung cancer | KRAS_12C | MED12 | Any mutation | 398 | 156 | TMB overall | -0.26 | -1.20 | 0.66 | 1549.61 | 1.00 | 2087 | 377 | 135 | 21 | TRUE | 0.23 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 27 | 29 | TMB quintile 2 | -0.11 | -1.28 | 0.79 | 1545.40 | 1.00 | 386 | 26 | 28 | 1 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 46 | 46 | TMB quintile 3 | -0.03 | -0.92 | 0.76 | 1558.83 | 1.00 | 538 | 43 | 43 | 3 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 128 | 90 | TMB quintile 4 | 0.66 | 0.16 | 1.12 | 1452.14 | 1.00 | 570 | 103 | 65 | 25 | FALSE | 2.04 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 225 | 200 | TMB quintile 5 | 0.27 | -0.09 | 0.65 | 1164.16 | 1.00 | 859 | 182 | 157 | 43 | FALSE | 0.88 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 426 | 365 | TMB overall | 0.19 | -0.60 | 0.89 | 1390.44 | 1.00 | 2353 | 354 | 293 | 72 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 46 | 25 | TMB quintile 3 | -0.04 | -1.37 | 1.14 | 1391.60 | 1.00 | 559 | 43 | 22 | 3 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 127 | 59 | TMB quintile 4 | -0.99 | -1.95 | -0.10 | 1435.72 | 1.00 | 588 | 123 | 55 | 4 | TRUE | 1.46 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 225 | 216 | TMB quintile 5 | -0.74 | -1.24 | -0.30 | 1337.38 | 1.00 | 840 | 203 | 194 | 22 | TRUE | 2.83 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 398 | 300 | TMB overall | -0.57 | -1.71 | 0.63 | 1407.10 | 1.00 | 1987 | 369 | 271 | 29 | TRUE | 0.46 |
| non-small cell lung cancer | KRAS_12C | FLT1 | Any mutation | 127 | 21 | TMB quintile 4 | 0.67 | -0.23 | 1.54 | 1446.82 | 1.00 | 622 | 120 | 14 | 7 | FALSE | 0.83 |
| non-small cell lung cancer | KRAS_12C | FLT1 | Any mutation | 225 | 99 | TMB quintile 5 | 0.04 | -0.51 | 0.52 | 1559.66 | 1.00 | 927 | 207 | 81 | 18 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12C | FLT1 | Any mutation | 352 | 120 | TMB overall | 0.36 | -1.22 | 1.90 | 1268.01 | 1.00 | 1549 | 327 | 95 | 25 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12C | EPHA5 | Any mutation | 127 | 48 | TMB quintile 4 | 0.35 | -0.38 | 1.02 | 1434.10 | 1.00 | 599 | 116 | 37 | 11 | FALSE | 0.51 |
| non-small cell lung cancer | KRAS_12C | EPHA5 | Any mutation | 224 | 191 | TMB quintile 5 | 0.29 | -0.09 | 0.66 | 1483.99 | 1.00 | 869 | 182 | 149 | 42 | FALSE | 0.89 |
| non-small cell lung cancer | KRAS_12C | EPHA5 | Any mutation | 351 | 250 | TMB overall | -0.01 | -2.50 | 2.18 | 1240.72 | 1.00 | 1478 | 298 | 197 | 53 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12C | AR | Any mutation | 127 | 16 | TMB quintile 4 | -0.06 | -1.15 | 0.94 | 1309.40 | 1.00 | 622 | 124 | 13 | 3 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12C | AR | Any mutation | 225 | 77 | TMB quintile 5 | 0.00 | -0.62 | 0.54 | 1396.09 | 1.00 | 943 | 211 | 63 | 14 | TRUE | 0.00 |
| non-small cell lung cancer | KRAS_12C | AR | Any mutation | 352 | 93 | TMB overall | -0.04 | -1.45 | 1.38 | 1446.42 | 1.00 | 1565 | 335 | 76 | 17 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12C | ROS1 | Any mutation | 127 | 13 | TMB quintile 4 | -2.42 | -7.10 | -0.22 | 1292.34 | 1.00 | 622 | 127 | 13 | 0 | TRUE | 0.74 |
| non-small cell lung cancer | KRAS_12C | ROS1 | Any mutation | 223 | 80 | TMB quintile 5 | -1.20 | -2.10 | -0.39 | 1562.37 | 1.00 | 931 | 217 | 74 | 6 | TRUE | 2.20 |
| non-small cell lung cancer | KRAS_12C | ROS1 | Any mutation | 350 | 93 | TMB overall | -1.68 | -4.81 | 0.59 | 1402.77 | 1.00 | 1553 | 344 | 87 | 6 | TRUE | 0.71 |
| non-small cell lung cancer | KRAS_12C | PIK3CG | Any mutation | 127 | 16 | TMB quintile 4 | 0.26 | -0.88 | 1.29 | 1587.21 | 1.00 | 623 | 123 | 12 | 4 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12C | PIK3CG | Any mutation | 225 | 150 | TMB quintile 5 | -0.10 | -0.57 | 0.34 | 1463.93 | 1.00 | 891 | 200 | 125 | 25 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12C | PIK3CG | Any mutation | 352 | 166 | TMB overall | 0.06 | -2.03 | 2.24 | 1438.00 | 1.00 | 1514 | 323 | 137 | 29 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 27 | 200 | TMB quintile 2 | -4.08 | -6.61 | -2.44 | 1406.37 | 1.00 | 236 | 27 | 200 | 0 | TRUE | 3.79 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 46 | 287 | TMB quintile 3 | -4.24 | -6.82 | -2.61 | 1381.78 | 1.00 | 350 | 46 | 287 | 0 | TRUE | 4.20 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 127 | 256 | TMB quintile 4 | -4.00 | -5.75 | -2.74 | 1408.21 | 1.00 | 444 | 126 | 255 | 1 | TRUE | 6.50 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 222 | 175 | TMB quintile 5 | -2.03 | -2.93 | -1.24 | 1349.11 | 1.00 | 874 | 214 | 167 | 8 | TRUE | 5.48 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 422 | 918 | TMB overall | -3.54 | -5.25 | -2.19 | 1372.10 | 1.00 | 1904 | 413 | 909 | 9 | TRUE | 5.44 |
| non-small cell lung cancer | KRAS_12C | ARID1B | Any mutation | 46 | 11 | TMB quintile 3 | 0.30 | -1.11 | 1.61 | 1477.34 | 1.00 | 571 | 44 | 9 | 2 | TRUE | 0.18 |
| non-small cell lung cancer | KRAS_12C | ARID1B | Any mutation | 127 | 16 | TMB quintile 4 | -0.29 | -1.58 | 0.71 | 1482.33 | 1.00 | 622 | 125 | 14 | 2 | TRUE | 0.21 |
| non-small cell lung cancer | KRAS_12C | ARID1B | Any mutation | 223 | 77 | TMB quintile 5 | -0.17 | -0.83 | 0.42 | 1320.55 | 1.00 | 940 | 211 | 65 | 12 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12C | ARID1B | Any mutation | 396 | 104 | TMB overall | -0.06 | -1.30 | 1.14 | 1560.63 | 1.00 | 2133 | 380 | 88 | 16 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12C | MET | Any mutation | 27 | 21 | TMB quintile 2 | -1.43 | -3.19 | -0.10 | 1471.90 | 1.00 | 394 | 27 | 21 | 0 | TRUE | 1.12 |
| non-small cell lung cancer | KRAS_12C | MET | Any mutation | 46 | 30 | TMB quintile 3 | -1.20 | -2.64 | 0.05 | 1317.66 | 1.00 | 557 | 45 | 29 | 1 | TRUE | 1.11 |
| non-small cell lung cancer | KRAS_12C | MET | Any mutation | 127 | 34 | TMB quintile 4 | -1.76 | -3.71 | -0.57 | 1416.41 | 1.00 | 607 | 127 | 34 | 0 | TRUE | 1.50 |
| non-small cell lung cancer | KRAS_12C | MET | Any mutation | 222 | 47 | TMB quintile 5 | -0.65 | -1.59 | 0.15 | 1586.75 | 1.00 | 963 | 215 | 40 | 7 | TRUE | 0.86 |
| non-small cell lung cancer | KRAS_12C | MET | Any mutation | 422 | 132 | TMB overall | -1.24 | -2.44 | -0.22 | 1420.52 | 1.00 | 2521 | 414 | 124 | 8 | TRUE | 1.51 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 27 | 11 | TMB quintile 2 | -1.80 | -3.79 | 0.00 | 1543.12 | 1.00 | 403 | 27 | 11 | 0 | TRUE | 1.19 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 46 | 13 | TMB quintile 3 | -1.81 | -3.82 | -0.11 | 1595.41 | 1.00 | 567 | 46 | 13 | 0 | TRUE | 1.27 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 127 | 46 | TMB quintile 4 | -1.69 | -3.00 | -0.57 | 1266.29 | 1.00 | 592 | 125 | 44 | 2 | TRUE | 2.13 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 222 | 101 | TMB quintile 5 | -1.43 | -2.33 | -0.67 | 1430.58 | 1.00 | 908 | 216 | 95 | 6 | TRUE | 3.25 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 422 | 171 | TMB overall | -1.69 | -3.05 | -0.50 | 1420.81 | 1.00 | 2470 | 414 | 163 | 8 | TRUE | 2.09 |
| non-small cell lung cancer | KRAS_12C | CARD11 | Any mutation | 127 | 18 | TMB quintile 4 | 0.64 | -0.34 | 1.62 | 1468.64 | 1.00 | 623 | 121 | 12 | 6 | FALSE | 0.69 |
| non-small cell lung cancer | KRAS_12C | CARD11 | Any mutation | 223 | 97 | TMB quintile 5 | -0.08 | -0.64 | 0.45 | 1491.27 | 1.00 | 925 | 207 | 81 | 16 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12C | CARD11 | Any mutation | 350 | 115 | TMB overall | 0.22 | -1.57 | 1.98 | 1598.92 | 1.00 | 1548 | 328 | 93 | 22 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12C | INPP4B | Any mutation | 127 | 17 | TMB quintile 4 | -0.26 | -1.71 | 0.77 | 1253.11 | 1.00 | 620 | 125 | 15 | 2 | FALSE | 0.17 |
| non-small cell lung cancer | KRAS_12C | INPP4B | Any mutation | 224 | 87 | TMB quintile 5 | 0.55 | 0.06 | 1.05 | 1653.69 | 1.00 | 945 | 200 | 63 | 24 | FALSE | 1.53 |
| non-small cell lung cancer | KRAS_12C | INPP4B | Any mutation | 351 | 104 | TMB overall | 0.14 | -1.63 | 2.03 | 1411.29 | 1.00 | 1565 | 325 | 78 | 26 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12C | NFE2L2 | Any mutation | 127 | 31 | TMB quintile 4 | -0.91 | -2.04 | -0.01 | 1144.29 | 1.00 | 612 | 125 | 29 | 2 | FALSE | 1.18 |
| non-small cell lung cancer | KRAS_12C | NFE2L2 | Any mutation | 223 | 83 | TMB quintile 5 | -0.73 | -1.45 | -0.07 | 1289.54 | 1.00 | 933 | 214 | 74 | 9 | FALSE | 1.49 |
| non-small cell lung cancer | KRAS_12C | NFE2L2 | Any mutation | 350 | 114 | TMB overall | -0.79 | -1.98 | 0.23 | 1170.89 | 1.00 | 1545 | 339 | 103 | 11 | FALSE | 0.77 |
| non-small cell lung cancer | KRAS_12C | GLI1 | Any mutation | 121 | 16 | TMB quintile 4 | 0.50 | -0.45 | 1.44 | 1436.48 | 1.00 | 550 | 116 | 11 | 5 | FALSE | 0.52 |
| non-small cell lung cancer | KRAS_12C | GLI1 | Any mutation | 204 | 77 | TMB quintile 5 | 0.29 | -0.29 | 0.85 | 1469.82 | 1.00 | 843 | 187 | 60 | 17 | FALSE | 0.50 |
| non-small cell lung cancer | KRAS_12C | GLI1 | Any mutation | 325 | 93 | TMB overall | 0.40 | -1.06 | 1.89 | 1571.33 | 1.00 | 1393 | 303 | 71 | 22 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12C | ZFHX3 | Any mutation | 43 | 13 | TMB quintile 3 | -0.98 | -3.06 | 0.55 | 1347.80 | 1.00 | 514 | 43 | 13 | 0 | FALSE | 0.52 |
| non-small cell lung cancer | KRAS_12C | ZFHX3 | Any mutation | 121 | 30 | TMB quintile 4 | -0.10 | -0.98 | 0.76 | 1577.38 | 1.00 | 534 | 115 | 24 | 6 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12C | ZFHX3 | Any mutation | 203 | 112 | TMB quintile 5 | -0.57 | -1.17 | -0.01 | 1533.52 | 1.00 | 807 | 190 | 99 | 13 | FALSE | 1.24 |
| non-small cell lung cancer | KRAS_12C | ZFHX3 | Any mutation | 367 | 155 | TMB overall | -0.55 | -1.93 | 0.61 | 1387.69 | 1.00 | 1855 | 348 | 136 | 19 | FALSE | 0.41 |
| non-small cell lung cancer | KRAS_12C | MGA | Any mutation | 43 | 14 | TMB quintile 3 | -0.03 | -1.65 | 1.21 | 1223.00 | 1.00 | 515 | 42 | 13 | 1 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | MGA | Any mutation | 121 | 24 | TMB quintile 4 | 0.30 | -0.55 | 1.14 | 1579.80 | 1.00 | 540 | 115 | 18 | 6 | FALSE | 0.30 |
| non-small cell lung cancer | KRAS_12C | MGA | Any mutation | 206 | 140 | TMB quintile 5 | 0.23 | -0.20 | 0.64 | 1582.53 | 1.00 | 804 | 176 | 110 | 30 | FALSE | 0.54 |
| non-small cell lung cancer | KRAS_12C | MGA | Any mutation | 370 | 178 | TMB overall | 0.16 | -1.08 | 1.29 | 1338.13 | 1.00 | 1859 | 333 | 141 | 37 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12C | PREX2 | Any mutation | 68 | 14 | TMB quintile 4 | 0.27 | -0.83 | 1.36 | 1590.81 | 1.00 | 281 | 64 | 10 | 4 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12C | PREX2 | Any mutation | 121 | 84 | TMB quintile 5 | -0.08 | -0.69 | 0.48 | 1488.36 | 1.00 | 438 | 106 | 69 | 15 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12C | PREX2 | Any mutation | 189 | 98 | TMB overall | 0.10 | -1.45 | 1.88 | 1698.35 | 1.00 | 719 | 170 | 79 | 19 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12C | AMER1 | Any mutation | 127 | 18 | TMB quintile 4 | 1.52 | 0.58 | 2.49 | 1472.18 | 1.00 | 626 | 118 | 9 | 9 | FALSE | 2.80 |
| non-small cell lung cancer | KRAS_12C | AMER1 | Any mutation | 224 | 107 | TMB quintile 5 | 0.27 | -0.22 | 0.75 | 1484.54 | 1.00 | 927 | 200 | 83 | 24 | FALSE | 0.56 |
| non-small cell lung cancer | KRAS_12C | AMER1 | Any mutation | 351 | 142 | TMB overall | 0.30 | -2.90 | 3.20 | 1507.03 | 1.00 | 1563 | 318 | 109 | 33 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12C | EPHA7 | Any mutation | 121 | 14 | TMB quintile 4 | 0.30 | -0.82 | 1.42 | 1403.73 | 1.00 | 547 | 117 | 10 | 4 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12C | EPHA7 | Any mutation | 202 | 101 | TMB quintile 5 | -0.24 | -0.85 | 0.28 | 1584.89 | 1.00 | 822 | 187 | 86 | 15 | FALSE | 0.40 |
| non-small cell lung cancer | KRAS_12C | EPHA7 | Any mutation | 323 | 115 | TMB overall | 0.03 | -1.73 | 1.87 | 1550.76 | 1.00 | 1369 | 304 | 96 | 19 | FALSE | 0.01 |
| colorectal cancer | RAS_13 | SPEN | Any mutation | 62 | 11 | TMB quintile 4 | -2.31 | -6.77 | 0.43 | 1524.81 | 1.00 | 718 | 62 | 11 | 0 | FALSE | 0.68 |
| colorectal cancer | RAS_13 | SPEN | Any mutation | 80 | 31 | TMB quintile 5 | -1.02 | -2.84 | 0.30 | 1297.49 | 1.00 | 521 | 78 | 29 | 2 | FALSE | 0.71 |
| colorectal cancer | RAS_13 | SPEN | Any mutation | 18 | 107 | TMB quintile 6 | -0.97 | -1.90 | -0.07 | 1604.08 | 1.00 | 61 | 11 | 100 | 7 | FALSE | 1.36 |
| colorectal cancer | RAS_13 | SPEN | Any mutation | 160 | 149 | TMB overall | -1.35 | -4.10 | 1.07 | 1504.04 | 1.00 | 1300 | 151 | 140 | 9 | FALSE | 0.53 |
| colorectal cancer | RAS_13 | KMT2C | Any mutation | 61 | 12 | TMB quintile 4 | -0.32 | -2.40 | 1.38 | 1235.46 | 1.00 | 701 | 60 | 11 | 1 | FALSE | 0.13 |
| colorectal cancer | RAS_13 | KMT2C | Any mutation | 77 | 61 | TMB quintile 5 | 0.11 | -0.67 | 0.84 | 1656.28 | 1.00 | 467 | 68 | 52 | 9 | FALSE | 0.11 |
| colorectal cancer | RAS_13 | KMT2C | Any mutation | 20 | 116 | TMB quintile 6 | -0.47 | -1.40 | 0.41 | 1465.87 | 1.00 | 62 | 10 | 106 | 10 | FALSE | 0.50 |
| colorectal cancer | RAS_13 | KMT2C | Any mutation | 158 | 189 | TMB overall | -0.21 | -2.35 | 1.90 | 1232.32 | 1.00 | 1230 | 138 | 169 | 20 | FALSE | 0.07 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 10 | 104 | TMB quintile 2 | -0.58 | -1.44 | 0.24 | 1355.94 | 1.00 | 30 | 4 | 98 | 6 | TRUE | 0.76 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 25 | 411 | TMB quintile 3 | -0.86 | -1.58 | -0.21 | 1519.28 | 1.00 | 76 | 9 | 395 | 16 | TRUE | 1.87 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 64 | 655 | TMB quintile 4 | -0.28 | -0.76 | 0.25 | 1455.51 | 1.00 | 159 | 16 | 607 | 48 | TRUE | 0.57 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 84 | 423 | TMB quintile 5 | -0.29 | -0.72 | 0.12 | 1158.70 | 1.00 | 213 | 36 | 375 | 48 | TRUE | 0.73 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 20 | 78 | TMB quintile 6 | -0.12 | -0.86 | 0.65 | 1172.30 | 1.00 | 82 | 10 | 68 | 10 | TRUE | 0.12 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 203 | 1671 | TMB overall | -0.42 | -1.02 | 0.23 | 1610.91 | 1.00 | 560 | 75 | 1543 | 128 | TRUE | 0.75 |
| colorectal cancer | RAS_13 | ATRX | Any mutation | 62 | 19 | TMB quintile 4 | -1.79 | -5.00 | 0.24 | 1357.95 | 1.00 | 710 | 62 | 19 | 0 | TRUE | 0.76 |
| colorectal cancer | RAS_13 | ATRX | Any mutation | 80 | 35 | TMB quintile 5 | -1.03 | -2.58 | 0.18 | 1412.05 | 1.00 | 515 | 78 | 33 | 2 | TRUE | 0.82 |
| colorectal cancer | RAS_13 | ATRX | Any mutation | 21 | 59 | TMB quintile 6 | 0.16 | -0.77 | 1.07 | 1453.71 | 1.00 | 89 | 12 | 50 | 9 | TRUE | 0.14 |
| colorectal cancer | RAS_13 | ATRX | Any mutation | 163 | 113 | TMB overall | -0.87 | -3.01 | 0.94 | 1514.99 | 1.00 | 1314 | 152 | 102 | 11 | TRUE | 0.41 |
| colorectal cancer | RAS_13 | ATR | Any mutation | 81 | 35 | TMB quintile 5 | 0.61 | -0.28 | 1.43 | 1509.24 | 1.00 | 519 | 73 | 27 | 8 | FALSE | 0.79 |
| colorectal cancer | RAS_13 | ATR | Any mutation | 18 | 65 | TMB quintile 6 | -1.10 | -2.58 | 0.06 | 1493.11 | 1.00 | 91 | 15 | 62 | 3 | FALSE | 1.05 |
| colorectal cancer | RAS_13 | ATR | Any mutation | 99 | 100 | TMB overall | -0.23 | -2.65 | 2.41 | 1429.68 | 1.00 | 610 | 88 | 89 | 11 | FALSE | 0.07 |
| colorectal cancer | RAS_13 | FBXW7 | Any mutation | 25 | 22 | TMB quintile 3 | -0.48 | -2.47 | 0.89 | 1342.82 | 1.00 | 441 | 25 | 22 | 0 | TRUE | 0.24 |
| colorectal cancer | RAS_13 | FBXW7 | Any mutation | 64 | 85 | TMB quintile 4 | 0.46 | -0.24 | 1.10 | 1259.78 | 1.00 | 663 | 54 | 75 | 10 | TRUE | 0.75 |
| colorectal cancer | RAS_13 | FBXW7 | Any mutation | 83 | 160 | TMB quintile 5 | 0.40 | -0.10 | 0.89 | 1371.69 | 1.00 | 433 | 57 | 134 | 26 | TRUE | 0.96 |
| colorectal cancer | RAS_13 | FBXW7 | Any mutation | 17 | 65 | TMB quintile 6 | 1.30 | 0.37 | 2.35 | 1385.79 | 1.00 | 80 | 4 | 52 | 13 | TRUE | 1.97 |
| colorectal cancer | RAS_13 | FBXW7 | Any mutation | 189 | 332 | TMB overall | 0.41 | -0.73 | 1.49 | 1514.51 | 1.00 | 1617 | 140 | 283 | 49 | TRUE | 0.34 |
| colorectal cancer | RAS_13 | FLT4 | Any mutation | 62 | 20 | TMB quintile 4 | -0.09 | -1.71 | 1.21 | 1467.57 | 1.00 | 711 | 60 | 18 | 2 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | FLT4 | Any mutation | 80 | 40 | TMB quintile 5 | -0.38 | -1.52 | 0.54 | 1510.69 | 1.00 | 514 | 76 | 36 | 4 | TRUE | 0.32 |
| colorectal cancer | RAS_13 | FLT4 | Any mutation | 16 | 72 | TMB quintile 6 | -0.66 | -1.83 | 0.34 | 1362.87 | 1.00 | 72 | 11 | 67 | 5 | TRUE | 0.64 |
| colorectal cancer | RAS_13 | FLT4 | Any mutation | 158 | 132 | TMB overall | -0.40 | -2.21 | 1.48 | 1342.23 | 1.00 | 1297 | 147 | 121 | 11 | TRUE | 0.18 |
| colorectal cancer | RAS_13 | PTPRD | Any mutation | 80 | 29 | TMB quintile 5 | -0.41 | -1.73 | 0.69 | 1538.32 | 1.00 | 522 | 77 | 26 | 3 | FALSE | 0.29 |
| colorectal cancer | RAS_13 | PTPRD | Any mutation | 17 | 61 | TMB quintile 6 | -0.46 | -1.61 | 0.57 | 1565.14 | 1.00 | 87 | 12 | 56 | 5 | FALSE | 0.39 |
| colorectal cancer | RAS_13 | PTPRD | Any mutation | 97 | 90 | TMB overall | -0.41 | -2.64 | 1.86 | 1588.34 | 1.00 | 609 | 89 | 82 | 8 | FALSE | 0.15 |
| colorectal cancer | RAS_13 | CREBBP | Any mutation | 62 | 17 | TMB quintile 4 | -0.57 | -2.64 | 0.97 | 1440.84 | 1.00 | 713 | 61 | 16 | 1 | TRUE | 0.27 |
| colorectal cancer | RAS_13 | CREBBP | Any mutation | 80 | 49 | TMB quintile 5 | 0.22 | -0.61 | 1.00 | 1543.10 | 1.00 | 512 | 72 | 41 | 8 | TRUE | 0.23 |
| colorectal cancer | RAS_13 | CREBBP | Any mutation | 19 | 116 | TMB quintile 6 | -0.71 | -1.62 | 0.19 | 1394.33 | 1.00 | 54 | 10 | 107 | 9 | TRUE | 0.88 |
| colorectal cancer | RAS_13 | CREBBP | Any mutation | 161 | 182 | TMB overall | -0.34 | -2.37 | 1.75 | 1274.97 | 1.00 | 1279 | 143 | 164 | 18 | TRUE | 0.13 |
| colorectal cancer | RAS_13 | AXIN2 | Any mutation | 62 | 20 | TMB quintile 4 | -0.51 | -2.45 | 0.92 | 1501.23 | 1.00 | 710 | 61 | 19 | 1 | TRUE | 0.26 |
| colorectal cancer | RAS_13 | AXIN2 | Any mutation | 80 | 27 | TMB quintile 5 | 0.04 | -1.07 | 1.10 | 1521.22 | 1.00 | 524 | 76 | 23 | 4 | TRUE | 0.03 |
| colorectal cancer | RAS_13 | AXIN2 | Any mutation | 17 | 63 | TMB quintile 6 | 0.29 | -0.64 | 1.26 | 1568.44 | 1.00 | 86 | 9 | 55 | 8 | TRUE | 0.26 |
| colorectal cancer | RAS_13 | AXIN2 | Any mutation | 159 | 110 | TMB overall | -0.05 | -1.80 | 1.70 | 1510.37 | 1.00 | 1320 | 146 | 97 | 13 | TRUE | 0.02 |
| colorectal cancer | RAS_13 | PTPRS | Any mutation | 25 | 17 | TMB quintile 3 | -1.17 | -3.90 | 0.89 | 1491.18 | 1.00 | 440 | 25 | 17 | 0 | FALSE | 0.46 |
| colorectal cancer | RAS_13 | PTPRS | Any mutation | 61 | 34 | TMB quintile 4 | 0.56 | -0.47 | 1.48 | 1491.81 | 1.00 | 683 | 56 | 29 | 5 | FALSE | 0.58 |
| colorectal cancer | RAS_13 | PTPRS | Any mutation | 78 | 74 | TMB quintile 5 | -0.28 | -1.08 | 0.44 | 1543.72 | 1.00 | 456 | 70 | 66 | 8 | FALSE | 0.32 |
| colorectal cancer | RAS_13 | PTPRS | Any mutation | 18 | 128 | TMB quintile 6 | 0.34 | -0.67 | 1.43 | 1499.56 | 1.00 | 45 | 4 | 114 | 14 | FALSE | 0.27 |
| colorectal cancer | RAS_13 | PTPRS | Any mutation | 182 | 253 | TMB overall | -0.18 | -2.06 | 1.42 | 1517.88 | 1.00 | 1624 | 155 | 226 | 27 | FALSE | 0.08 |
| colorectal cancer | RAS_13 | SMARCA4 | Any mutation | 62 | 16 | TMB quintile 4 | -2.01 | -5.99 | 0.28 | 1447.37 | 1.00 | 713 | 62 | 16 | 0 | FALSE | 0.65 |
| colorectal cancer | RAS_13 | SMARCA4 | Any mutation | 80 | 47 | TMB quintile 5 | -0.62 | -1.77 | 0.30 | 1477.16 | 1.00 | 507 | 76 | 43 | 4 | FALSE | 0.59 |
| colorectal cancer | RAS_13 | SMARCA4 | Any mutation | 18 | 100 | TMB quintile 6 | -0.13 | -1.02 | 0.85 | 1300.48 | 1.00 | 67 | 8 | 90 | 10 | FALSE | 0.10 |
| colorectal cancer | RAS_13 | SMARCA4 | Any mutation | 160 | 163 | TMB overall | -0.87 | -3.23 | 1.20 | 1428.94 | 1.00 | 1287 | 146 | 149 | 14 | FALSE | 0.36 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 25 | 18 | TMB quintile 3 | 0.43 | -1.04 | 1.70 | 1618.32 | 1.00 | 446 | 23 | 16 | 2 | FALSE | 0.27 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 62 | 39 | TMB quintile 4 | -0.33 | -1.63 | 0.69 | 1573.44 | 1.00 | 692 | 60 | 37 | 2 | FALSE | 0.24 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 80 | 59 | TMB quintile 5 | -0.08 | -0.92 | 0.65 | 1583.73 | 1.00 | 497 | 73 | 52 | 7 | FALSE | 0.07 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 20 | 66 | TMB quintile 6 | 0.78 | -0.04 | 1.68 | 1619.53 | 1.00 | 85 | 8 | 54 | 12 | FALSE | 1.11 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 187 | 182 | TMB overall | 0.20 | -0.96 | 1.31 | 1504.57 | 1.00 | 1720 | 164 | 159 | 23 | FALSE | 0.13 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 25 | 51 | TMB quintile 3 | 0.69 | -0.24 | 1.54 | 1564.61 | 1.00 | 419 | 20 | 46 | 5 | TRUE | 0.90 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 62 | 146 | TMB quintile 4 | 0.16 | -0.44 | 0.76 | 1617.90 | 1.00 | 601 | 50 | 134 | 12 | TRUE | 0.21 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 87 | 209 | TMB quintile 5 | 0.70 | 0.25 | 1.14 | 1756.19 | 1.00 | 392 | 47 | 169 | 40 | TRUE | 2.62 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 20 | 95 | TMB quintile 6 | 1.05 | 0.17 | 1.97 | 1576.73 | 1.00 | 68 | 4 | 79 | 16 | TRUE | 1.77 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 194 | 501 | TMB overall | 0.66 | -0.23 | 1.56 | 1424.32 | 1.00 | 1480 | 121 | 428 | 73 | TRUE | 0.82 |
| colorectal cancer | RAS_13 | ALK | Any mutation | 62 | 20 | TMB quintile 4 | 1.13 | 0.07 | 2.07 | 1522.16 | 1.00 | 714 | 57 | 15 | 5 | TRUE | 1.55 |
| colorectal cancer | RAS_13 | ALK | Any mutation | 80 | 42 | TMB quintile 5 | 0.65 | -0.14 | 1.38 | 1526.40 | 1.00 | 515 | 71 | 33 | 9 | TRUE | 1.03 |
| colorectal cancer | RAS_13 | ALK | Any mutation | 19 | 45 | TMB quintile 6 | 0.30 | -0.73 | 1.21 | 1505.73 | 1.00 | 97 | 13 | 39 | 6 | TRUE | 0.27 |
| colorectal cancer | RAS_13 | ALK | Any mutation | 161 | 107 | TMB overall | 0.70 | -0.74 | 2.12 | 1428.69 | 1.00 | 1326 | 141 | 87 | 20 | TRUE | 0.49 |
| colorectal cancer | RAS_13 | RNF43 | Any mutation | 25 | 12 | TMB quintile 3 | -1.42 | -4.85 | 0.96 | 1177.72 | 1.00 | 450 | 25 | 12 | 0 | TRUE | 0.46 |
| colorectal cancer | RAS_13 | RNF43 | Any mutation | 62 | 30 | TMB quintile 4 | -0.47 | -2.06 | 0.81 | 1255.39 | 1.00 | 702 | 60 | 28 | 2 | TRUE | 0.28 |
| colorectal cancer | RAS_13 | RNF43 | Any mutation | 80 | 76 | TMB quintile 5 | -0.61 | -1.56 | 0.17 | 1411.14 | 1.00 | 490 | 74 | 70 | 6 | TRUE | 0.78 |
| colorectal cancer | RAS_13 | RNF43 | Any mutation | 22 | 146 | TMB quintile 6 | -0.09 | -0.99 | 0.91 | 1294.63 | 1.00 | 43 | 6 | 130 | 16 | TRUE | 0.06 |
| colorectal cancer | RAS_13 | RNF43 | Any mutation | 189 | 264 | TMB overall | -0.61 | -2.31 | 1.12 | 1486.04 | 1.00 | 1685 | 165 | 240 | 24 | TRUE | 0.32 |
| colorectal cancer | RAS_13 | PTEN | Any mutation | 62 | 29 | TMB quintile 4 | 0.51 | -0.60 | 1.42 | 1475.02 | 1.00 | 705 | 58 | 25 | 4 | TRUE | 0.49 |
| colorectal cancer | RAS_13 | PTEN | Any mutation | 82 | 69 | TMB quintile 5 | 0.39 | -0.30 | 1.05 | 1248.97 | 1.00 | 503 | 70 | 57 | 12 | TRUE | 0.61 |
| colorectal cancer | RAS_13 | PTEN | Any mutation | 21 | 80 | TMB quintile 6 | 0.51 | -0.37 | 1.38 | 1463.08 | 1.00 | 81 | 9 | 68 | 12 | TRUE | 0.60 |
| colorectal cancer | RAS_13 | PTEN | Any mutation | 165 | 178 | TMB overall | 0.47 | -1.03 | 1.83 | 1413.98 | 1.00 | 1289 | 137 | 150 | 28 | TRUE | 0.28 |
| colorectal cancer | RAS_13 | BCOR | Any mutation | 62 | 11 | TMB quintile 4 | -0.28 | -2.35 | 1.32 | 1488.90 | 1.00 | 719 | 61 | 10 | 1 | FALSE | 0.12 |
| colorectal cancer | RAS_13 | BCOR | Any mutation | 80 | 39 | TMB quintile 5 | -0.98 | -2.55 | 0.22 | 1408.56 | 1.00 | 512 | 78 | 37 | 2 | FALSE | 0.79 |
| colorectal cancer | RAS_13 | BCOR | Any mutation | 18 | 57 | TMB quintile 6 | 0.30 | -0.72 | 1.27 | 1254.27 | 1.00 | 89 | 10 | 49 | 8 | FALSE | 0.26 |
| colorectal cancer | RAS_13 | BCOR | Any mutation | 160 | 107 | TMB overall | -0.31 | -2.23 | 1.65 | 1165.49 | 1.00 | 1320 | 149 | 96 | 11 | FALSE | 0.12 |
| colorectal cancer | RAS_13 | CTNNB1 | Any mutation | 25 | 38 | TMB quintile 3 | 0.42 | -0.61 | 1.32 | 1596.24 | 1.00 | 429 | 22 | 35 | 3 | TRUE | 0.40 |
| colorectal cancer | RAS_13 | CTNNB1 | Any mutation | 62 | 35 | TMB quintile 4 | 0.40 | -0.50 | 1.25 | 1497.84 | 1.00 | 699 | 58 | 31 | 4 | TRUE | 0.43 |
| colorectal cancer | RAS_13 | CTNNB1 | Any mutation | 80 | 48 | TMB quintile 5 | 0.26 | -0.51 | 0.96 | 1400.16 | 1.00 | 507 | 73 | 41 | 7 | TRUE | 0.31 |
| colorectal cancer | RAS_13 | CTNNB1 | Any mutation | 16 | 35 | TMB quintile 6 | 0.84 | -0.05 | 1.75 | 1653.39 | 1.00 | 99 | 9 | 28 | 7 | TRUE | 1.16 |
| colorectal cancer | RAS_13 | CTNNB1 | Any mutation | 183 | 156 | TMB overall | 0.48 | -0.41 | 1.42 | 1536.31 | 1.00 | 1734 | 162 | 135 | 21 | TRUE | 0.54 |
| colorectal cancer | RAS_13 | ARID1A | Any mutation | 62 | 32 | TMB quintile 4 | -2.39 | -6.34 | -0.09 | 1550.39 | 1.00 | 698 | 62 | 32 | 0 | TRUE | 0.82 |
| colorectal cancer | RAS_13 | ARID1A | Any mutation | 82 | 116 | TMB quintile 5 | -0.42 | -1.14 | 0.24 | 1813.30 | 1.00 | 467 | 71 | 105 | 11 | TRUE | 0.66 |
| colorectal cancer | RAS_13 | ARID1A | Any mutation | 22 | 155 | TMB quintile 6 | 0.13 | -0.83 | 1.11 | 1409.69 | 1.00 | 48 | 5 | 138 | 17 | TRUE | 0.10 |
| colorectal cancer | RAS_13 | ARID1A | Any mutation | 166 | 303 | TMB overall | -0.84 | -3.26 | 1.26 | 1484.59 | 1.00 | 1213 | 138 | 275 | 28 | TRUE | 0.32 |
| colorectal cancer | RAS_13 | PIK3R1 | Any mutation | 62 | 22 | TMB quintile 4 | -0.70 | -2.51 | 0.68 | 1398.54 | 1.00 | 709 | 61 | 21 | 1 | TRUE | 0.39 |
| colorectal cancer | RAS_13 | PIK3R1 | Any mutation | 80 | 29 | TMB quintile 5 | -0.73 | -2.13 | 0.42 | 1460.74 | 1.00 | 522 | 78 | 27 | 2 | TRUE | 0.58 |
| colorectal cancer | RAS_13 | PIK3R1 | Any mutation | 17 | 56 | TMB quintile 6 | 0.16 | -0.83 | 1.17 | 1460.80 | 1.00 | 90 | 10 | 49 | 7 | TRUE | 0.12 |
| colorectal cancer | RAS_13 | PIK3R1 | Any mutation | 159 | 107 | TMB overall | -0.42 | -2.20 | 1.25 | 1645.27 | 1.00 | 1321 | 149 | 97 | 10 | TRUE | 0.21 |
| colorectal cancer | RAS_13 | FAT1 | Any mutation | 62 | 17 | TMB quintile 4 | -0.50 | -2.65 | 1.07 | 1447.43 | 1.00 | 714 | 61 | 16 | 1 | FALSE | 0.22 |
| colorectal cancer | RAS_13 | FAT1 | Any mutation | 80 | 64 | TMB quintile 5 | -0.39 | -1.34 | 0.42 | 1642.86 | 1.00 | 497 | 74 | 58 | 6 | FALSE | 0.41 |
| colorectal cancer | RAS_13 | FAT1 | Any mutation | 29 | 145 | TMB quintile 6 | 0.83 | -0.08 | 1.81 | 1530.35 | 1.00 | 58 | 5 | 121 | 24 | FALSE | 1.09 |
| colorectal cancer | RAS_13 | FAT1 | Any mutation | 171 | 226 | TMB overall | -0.02 | -2.15 | 2.13 | 1605.30 | 1.00 | 1269 | 140 | 195 | 31 | FALSE | 0.01 |
| colorectal cancer | RAS_13 | CIC | Any mutation | 62 | 17 | TMB quintile 4 | 0.00 | -1.72 | 1.44 | 1469.15 | 1.00 | 715 | 60 | 15 | 2 | TRUE | 0.00 |
| colorectal cancer | RAS_13 | CIC | Any mutation | 81 | 40 | TMB quintile 5 | -0.71 | -2.02 | 0.32 | 1610.28 | 1.00 | 513 | 78 | 37 | 3 | TRUE | 0.64 |
| colorectal cancer | RAS_13 | CIC | Any mutation | 17 | 79 | TMB quintile 6 | -0.81 | -1.92 | 0.21 | 1529.59 | 1.00 | 74 | 12 | 74 | 5 | TRUE | 0.88 |
| colorectal cancer | RAS_13 | CIC | Any mutation | 160 | 136 | TMB overall | -0.49 | -2.27 | 1.36 | 1396.73 | 1.00 | 1302 | 150 | 126 | 10 | TRUE | 0.23 |
| colorectal cancer | RAS_13 | NCOR1 | Any mutation | 62 | 16 | TMB quintile 4 | 0.19 | -1.53 | 1.51 | 1311.77 | 1.00 | 715 | 60 | 14 | 2 | FALSE | 0.09 |
| colorectal cancer | RAS_13 | NCOR1 | Any mutation | 80 | 32 | TMB quintile 5 | -0.40 | -1.69 | 0.62 | 1475.03 | 1.00 | 523 | 77 | 29 | 3 | FALSE | 0.30 |
| colorectal cancer | RAS_13 | NCOR1 | Any mutation | 18 | 81 | TMB quintile 6 | 0.03 | -0.96 | 0.91 | 1498.78 | 1.00 | 72 | 9 | 72 | 9 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | NCOR1 | Any mutation | 160 | 129 | TMB overall | -0.06 | -2.04 | 1.83 | 1519.32 | 1.00 | 1310 | 146 | 115 | 14 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | POLE | Any mutation | 80 | 38 | TMB quintile 5 | -0.32 | -1.53 | 0.67 | 1403.32 | 1.00 | 514 | 76 | 34 | 4 | TRUE | 0.25 |
| colorectal cancer | RAS_13 | POLE | Any mutation | 20 | 93 | TMB quintile 6 | 0.42 | -0.51 | 1.31 | 1322.68 | 1.00 | 68 | 7 | 80 | 13 | TRUE | 0.43 |
| colorectal cancer | RAS_13 | POLE | Any mutation | 100 | 131 | TMB overall | 0.04 | -2.73 | 2.69 | 1548.11 | 1.00 | 582 | 83 | 114 | 17 | TRUE | 0.01 |
| colorectal cancer | RAS_13 | TGFBR2 | Any mutation | 80 | 47 | TMB quintile 5 | 0.12 | -0.73 | 0.91 | 1542.51 | 1.00 | 511 | 73 | 40 | 7 | TRUE | 0.11 |
| colorectal cancer | RAS_13 | TGFBR2 | Any mutation | 16 | 57 | TMB quintile 6 | -0.12 | -1.18 | 0.88 | 1391.11 | 1.00 | 76 | 10 | 51 | 6 | TRUE | 0.08 |
| colorectal cancer | RAS_13 | TGFBR2 | Any mutation | 96 | 104 | TMB overall | 0.06 | -2.12 | 2.43 | 1616.66 | 1.00 | 587 | 83 | 91 | 13 | TRUE | 0.02 |
| colorectal cancer | RAS_13 | KMT2A | Any mutation | 62 | 16 | TMB quintile 4 | -1.69 | -5.76 | 0.47 | 1551.80 | 1.00 | 713 | 62 | 16 | 0 | FALSE | 0.56 |
| colorectal cancer | RAS_13 | KMT2A | Any mutation | 81 | 43 | TMB quintile 5 | 0.19 | -0.70 | 1.03 | 1255.61 | 1.00 | 513 | 74 | 36 | 7 | FALSE | 0.17 |
| colorectal cancer | RAS_13 | KMT2A | Any mutation | 21 | 84 | TMB quintile 6 | 0.14 | -0.69 | 1.08 | 1411.48 | 1.00 | 78 | 10 | 73 | 11 | FALSE | 0.12 |
| colorectal cancer | RAS_13 | KMT2A | Any mutation | 164 | 143 | TMB overall | -0.46 | -3.03 | 1.49 | 1545.21 | 1.00 | 1304 | 146 | 125 | 18 | FALSE | 0.16 |
| colorectal cancer | RAS_13 | BRCA2 | Any mutation | 62 | 21 | TMB quintile 4 | 0.44 | -0.84 | 1.57 | 1444.65 | 1.00 | 711 | 59 | 18 | 3 | TRUE | 0.31 |
| colorectal cancer | RAS_13 | BRCA2 | Any mutation | 82 | 48 | TMB quintile 5 | 0.09 | -0.82 | 0.91 | 1496.86 | 1.00 | 511 | 75 | 41 | 7 | TRUE | 0.08 |
| colorectal cancer | RAS_13 | BRCA2 | Any mutation | 23 | 116 | TMB quintile 6 | -0.24 | -1.11 | 0.61 | 1630.59 | 1.00 | 70 | 11 | 104 | 12 | TRUE | 0.23 |
| colorectal cancer | RAS_13 | BRCA2 | Any mutation | 167 | 185 | TMB overall | 0.10 | -1.75 | 2.01 | 1409.10 | 1.00 | 1292 | 145 | 163 | 22 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | NOTCH3 | Any mutation | 25 | 12 | TMB quintile 3 | 0.13 | -1.98 | 1.79 | 1569.31 | 1.00 | 451 | 24 | 11 | 1 | TRUE | 0.05 |
| colorectal cancer | RAS_13 | NOTCH3 | Any mutation | 62 | 17 | TMB quintile 4 | 0.18 | -1.31 | 1.47 | 1377.67 | 1.00 | 714 | 60 | 15 | 2 | TRUE | 0.09 |
| colorectal cancer | RAS_13 | NOTCH3 | Any mutation | 80 | 50 | TMB quintile 5 | 0.26 | -0.54 | 1.00 | 1301.99 | 1.00 | 509 | 72 | 42 | 8 | TRUE | 0.29 |
| colorectal cancer | RAS_13 | NOTCH3 | Any mutation | 17 | 120 | TMB quintile 6 | -0.03 | -1.01 | 1.02 | 1340.85 | 1.00 | 53 | 6 | 109 | 11 | TRUE | 0.02 |
| colorectal cancer | RAS_13 | NOTCH3 | Any mutation | 184 | 199 | TMB overall | 0.11 | -1.50 | 1.70 | 1551.94 | 1.00 | 1727 | 162 | 177 | 22 | TRUE | 0.05 |
| colorectal cancer | RAS_13 | NOTCH4 | Any mutation | 61 | 21 | TMB quintile 4 | 0.26 | -1.26 | 1.48 | 1402.18 | 1.00 | 695 | 58 | 18 | 3 | TRUE | 0.15 |
| colorectal cancer | RAS_13 | NOTCH4 | Any mutation | 77 | 37 | TMB quintile 5 | -2.52 | -5.80 | -0.58 | 1482.31 | 1.00 | 476 | 77 | 37 | 0 | TRUE | 1.15 |
| colorectal cancer | RAS_13 | NOTCH4 | Any mutation | 19 | 59 | TMB quintile 6 | -0.18 | -1.22 | 0.74 | 1606.04 | 1.00 | 81 | 12 | 52 | 7 | TRUE | 0.14 |
| colorectal cancer | RAS_13 | NOTCH4 | Any mutation | 157 | 117 | TMB overall | -0.77 | -2.90 | 1.25 | 1644.02 | 1.00 | 1252 | 147 | 107 | 10 | TRUE | 0.33 |
| colorectal cancer | RAS_13 | ERBB3 | Any mutation | 62 | 27 | TMB quintile 4 | -1.38 | -4.37 | 0.45 | 1372.59 | 1.00 | 703 | 62 | 27 | 0 | TRUE | 0.59 |
| colorectal cancer | RAS_13 | ERBB3 | Any mutation | 80 | 39 | TMB quintile 5 | 0.33 | -0.56 | 1.18 | 1405.38 | 1.00 | 515 | 73 | 32 | 7 | TRUE | 0.34 |
| colorectal cancer | RAS_13 | ERBB3 | Any mutation | 18 | 51 | TMB quintile 6 | 0.90 | -0.03 | 1.86 | 1362.00 | 1.00 | 94 | 8 | 41 | 10 | TRUE | 1.18 |
| colorectal cancer | RAS_13 | ERBB3 | Any mutation | 160 | 117 | TMB overall | -0.07 | -2.00 | 1.62 | 1437.23 | 1.00 | 1312 | 143 | 100 | 17 | TRUE | 0.03 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 25 | 51 | TMB quintile 3 | -0.40 | -1.32 | 0.53 | 1052.11 | 1.00 | 416 | 22 | 48 | 3 | TRUE | 0.41 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 62 | 129 | TMB quintile 4 | -0.83 | -1.61 | -0.12 | 1355.28 | 1.00 | 610 | 58 | 125 | 4 | TRUE | 1.49 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 82 | 138 | TMB quintile 5 | -0.47 | -1.01 | 0.09 | 1634.38 | 1.00 | 436 | 69 | 125 | 13 | TRUE | 1.00 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 16 | 31 | TMB quintile 6 | -0.60 | -1.55 | 0.35 | 1624.74 | 1.00 | 103 | 14 | 29 | 2 | TRUE | 0.67 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 185 | 349 | TMB overall | -0.58 | -1.30 | 0.10 | 1763.95 | 1.00 | 1565 | 163 | 327 | 22 | TRUE | 0.94 |
| colorectal cancer | RAS_13 | ATM | Any mutation | 63 | 46 | TMB quintile 4 | 0.25 | -0.72 | 1.13 | 1619.76 | 1.00 | 692 | 58 | 41 | 5 | TRUE | 0.23 |
| colorectal cancer | RAS_13 | ATM | Any mutation | 81 | 78 | TMB quintile 5 | -0.13 | -0.90 | 0.53 | 1382.18 | 1.00 | 485 | 72 | 69 | 9 | TRUE | 0.14 |
| colorectal cancer | RAS_13 | ATM | Any mutation | 21 | 94 | TMB quintile 6 | 0.45 | -0.45 | 1.38 | 1739.83 | 1.00 | 79 | 8 | 81 | 13 | TRUE | 0.52 |
| colorectal cancer | RAS_13 | ATM | Any mutation | 165 | 218 | TMB overall | 0.20 | -1.27 | 1.65 | 1522.64 | 1.00 | 1256 | 138 | 191 | 27 | TRUE | 0.11 |
| colorectal cancer | RAS_13 | KMT2D | Any mutation | 62 | 27 | TMB quintile 4 | -1.06 | -3.14 | 0.53 | 1423.63 | 1.00 | 704 | 61 | 26 | 1 | FALSE | 0.54 |
| colorectal cancer | RAS_13 | KMT2D | Any mutation | 80 | 104 | TMB quintile 5 | -0.49 | -1.29 | 0.22 | 1427.92 | 1.00 | 480 | 71 | 95 | 9 | FALSE | 0.69 |
| colorectal cancer | RAS_13 | KMT2D | Any mutation | 28 | 245 | TMB quintile 6 | -0.35 | -1.52 | 1.02 | 1406.39 | 1.00 | 16 | 3 | 220 | 25 | FALSE | 0.23 |
| colorectal cancer | RAS_13 | KMT2D | Any mutation | 170 | 376 | TMB overall | -0.63 | -3.20 | 1.89 | 1521.51 | 1.00 | 1200 | 135 | 341 | 35 | FALSE | 0.21 |
| colorectal cancer | RAS_13 | TSC2 | Any mutation | 80 | 42 | TMB quintile 5 | -0.47 | -1.64 | 0.52 | 1471.75 | 1.00 | 515 | 76 | 38 | 4 | TRUE | 0.41 |
| colorectal cancer | RAS_13 | TSC2 | Any mutation | 17 | 56 | TMB quintile 6 | -0.43 | -1.61 | 0.59 | 1490.18 | 1.00 | 86 | 12 | 51 | 5 | TRUE | 0.36 |
| colorectal cancer | RAS_13 | TSC2 | Any mutation | 97 | 98 | TMB overall | -0.39 | -2.48 | 1.89 | 1522.29 | 1.00 | 601 | 88 | 89 | 9 | TRUE | 0.14 |
| colorectal cancer | RAS_13 | APC | Any mutation | 10 | 78 | TMB quintile 2 | -0.01 | -1.00 | 0.88 | 1324.84 | 1.00 | 63 | 5 | 73 | 5 | TRUE | 0.01 |
| colorectal cancer | RAS_13 | APC | Any mutation | 26 | 428 | TMB quintile 3 | -0.56 | -1.26 | 0.15 | 1498.19 | 1.00 | 146 | 12 | 414 | 14 | TRUE | 0.92 |
| colorectal cancer | RAS_13 | APC | Any mutation | 90 | 966 | TMB quintile 4 | 0.32 | -0.26 | 0.89 | 1466.17 | 1.00 | 143 | 9 | 885 | 81 | TRUE | 0.57 |
| colorectal cancer | RAS_13 | APC | Any mutation | 139 | 822 | TMB quintile 5 | 0.90 | 0.35 | 1.50 | 1479.22 | 1.00 | 142 | 9 | 692 | 130 | TRUE | 2.64 |
| colorectal cancer | RAS_13 | APC | Any mutation | 33 | 225 | TMB quintile 6 | 0.33 | -0.38 | 1.06 | 1279.59 | 1.00 | 42 | 5 | 197 | 28 | TRUE | 0.42 |
| colorectal cancer | RAS_13 | APC | Any mutation | 298 | 2519 | TMB overall | 0.20 | -0.55 | 0.92 | 1361.14 | 1.00 | 536 | 40 | 2261 | 258 | TRUE | 0.24 |
| colorectal cancer | RAS_13 | ERBB2 | Any mutation | 62 | 17 | TMB quintile 4 | 0.31 | -1.14 | 1.49 | 1467.50 | 1.00 | 714 | 60 | 15 | 2 | TRUE | 0.19 |
| colorectal cancer | RAS_13 | ERBB2 | Any mutation | 80 | 33 | TMB quintile 5 | 0.56 | -0.32 | 1.39 | 1470.87 | 1.00 | 520 | 73 | 26 | 7 | TRUE | 0.68 |
| colorectal cancer | RAS_13 | ERBB2 | Any mutation | 17 | 42 | TMB quintile 6 | 0.42 | -0.63 | 1.36 | 1457.84 | 1.00 | 97 | 11 | 36 | 6 | TRUE | 0.39 |
| colorectal cancer | RAS_13 | ERBB2 | Any mutation | 159 | 92 | TMB overall | 0.44 | -1.02 | 1.91 | 1319.20 | 1.00 | 1331 | 144 | 77 | 15 | TRUE | 0.26 |
| colorectal cancer | RAS_13 | ARID2 | Any mutation | 62 | 12 | TMB quintile 4 | 0.37 | -1.48 | 1.81 | 1434.93 | 1.00 | 719 | 60 | 10 | 2 | FALSE | 0.19 |
| colorectal cancer | RAS_13 | ARID2 | Any mutation | 80 | 31 | TMB quintile 5 | -0.79 | -2.41 | 0.40 | 1364.86 | 1.00 | 519 | 78 | 29 | 2 | FALSE | 0.59 |
| colorectal cancer | RAS_13 | ARID2 | Any mutation | 17 | 66 | TMB quintile 6 | -0.33 | -1.37 | 0.60 | 1582.86 | 1.00 | 77 | 11 | 60 | 6 | FALSE | 0.29 |
| colorectal cancer | RAS_13 | ARID2 | Any mutation | 159 | 109 | TMB overall | -0.25 | -2.12 | 1.53 | 1480.04 | 1.00 | 1315 | 149 | 99 | 10 | FALSE | 0.10 |
| colorectal cancer | RAS_13 | MTOR | Any mutation | 62 | 19 | TMB quintile 4 | -0.45 | -2.40 | 1.04 | 1642.88 | 1.00 | 711 | 61 | 18 | 1 | TRUE | 0.22 |
| colorectal cancer | RAS_13 | MTOR | Any mutation | 80 | 40 | TMB quintile 5 | 0.30 | -0.54 | 1.06 | 1485.59 | 1.00 | 514 | 73 | 33 | 7 | TRUE | 0.33 |
| colorectal cancer | RAS_13 | MTOR | Any mutation | 20 | 70 | TMB quintile 6 | 0.51 | -0.36 | 1.35 | 1399.06 | 1.00 | 83 | 9 | 59 | 11 | TRUE | 0.60 |
| colorectal cancer | RAS_13 | MTOR | Any mutation | 162 | 129 | TMB overall | 0.16 | -1.59 | 1.79 | 1412.68 | 1.00 | 1308 | 143 | 110 | 19 | TRUE | 0.07 |
| colorectal cancer | RAS_13 | NOTCH1 | Any mutation | 81 | 48 | TMB quintile 5 | -0.61 | -1.71 | 0.34 | 1425.92 | 1.00 | 505 | 77 | 44 | 4 | TRUE | 0.61 |
| colorectal cancer | RAS_13 | NOTCH1 | Any mutation | 22 | 112 | TMB quintile 6 | 0.28 | -0.63 | 1.26 | 1611.20 | 1.00 | 60 | 7 | 97 | 15 | TRUE | 0.25 |
| colorectal cancer | RAS_13 | NOTCH1 | Any mutation | 103 | 160 | TMB overall | -0.14 | -2.82 | 2.27 | 1440.85 | 1.00 | 565 | 84 | 141 | 19 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | SETD2 | Any mutation | 25 | 11 | TMB quintile 3 | -1.02 | -4.65 | 1.03 | 1350.93 | 1.00 | 452 | 25 | 11 | 0 | FALSE | 0.31 |
| colorectal cancer | RAS_13 | SETD2 | Any mutation | 81 | 31 | TMB quintile 5 | 0.16 | -0.94 | 1.10 | 1307.82 | 1.00 | 522 | 76 | 26 | 5 | FALSE | 0.12 |
| colorectal cancer | RAS_13 | SETD2 | Any mutation | 20 | 64 | TMB quintile 6 | 0.41 | -0.46 | 1.26 | 1372.15 | 1.00 | 85 | 10 | 54 | 10 | FALSE | 0.43 |
| colorectal cancer | RAS_13 | SETD2 | Any mutation | 126 | 106 | TMB overall | -0.14 | -2.17 | 1.66 | 1405.92 | 1.00 | 1059 | 111 | 91 | 15 | FALSE | 0.05 |
| colorectal cancer | RAS_13 | EPHA3 | Any mutation | 62 | 17 | TMB quintile 4 | 0.17 | -1.29 | 1.40 | 1487.01 | 1.00 | 715 | 60 | 15 | 2 | FALSE | 0.09 |
| colorectal cancer | RAS_13 | EPHA3 | Any mutation | 80 | 41 | TMB quintile 5 | -0.08 | -1.03 | 0.78 | 1441.45 | 1.00 | 511 | 75 | 36 | 5 | FALSE | 0.06 |
| colorectal cancer | RAS_13 | EPHA3 | Any mutation | 18 | 44 | TMB quintile 6 | 0.21 | -0.77 | 1.19 | 1549.27 | 1.00 | 95 | 12 | 38 | 6 | FALSE | 0.17 |
| colorectal cancer | RAS_13 | EPHA3 | Any mutation | 160 | 102 | TMB overall | 0.13 | -1.29 | 1.57 | 1442.04 | 1.00 | 1321 | 147 | 89 | 13 | FALSE | 0.07 |
| colorectal cancer | RAS_13 | PTCH1 | Any mutation | 81 | 35 | TMB quintile 5 | 0.23 | -0.77 | 1.13 | 1518.97 | 1.00 | 518 | 75 | 29 | 6 | TRUE | 0.20 |
| colorectal cancer | RAS_13 | PTCH1 | Any mutation | 23 | 99 | TMB quintile 6 | -0.19 | -1.07 | 0.72 | 1552.17 | 1.00 | 63 | 11 | 87 | 12 | TRUE | 0.17 |
| colorectal cancer | RAS_13 | PTCH1 | Any mutation | 104 | 134 | TMB overall | -0.05 | -2.72 | 2.53 | 1579.61 | 1.00 | 581 | 86 | 116 | 18 | TRUE | 0.01 |
| colorectal cancer | RAS_13 | TET1 | Any mutation | 77 | 26 | TMB quintile 5 | 0.10 | -1.08 | 1.14 | 1654.88 | 1.00 | 492 | 73 | 22 | 4 | FALSE | 0.06 |
| colorectal cancer | RAS_13 | TET1 | Any mutation | 22 | 67 | TMB quintile 6 | 0.41 | -0.46 | 1.29 | 1567.58 | 1.00 | 84 | 11 | 56 | 11 | FALSE | 0.44 |
| colorectal cancer | RAS_13 | TET1 | Any mutation | 99 | 93 | TMB overall | 0.24 | -2.14 | 2.58 | 1430.90 | 1.00 | 576 | 84 | 78 | 15 | FALSE | 0.08 |
| colorectal cancer | RAS_13 | SMAD3 | Any mutation | 25 | 12 | TMB quintile 3 | -0.34 | -1.83 | 1.13 | 1574.15 | 1.00 | 451 | 24 | 11 | 1 | TRUE | 0.18 |
| colorectal cancer | RAS_13 | SMAD3 | Any mutation | 62 | 27 | TMB quintile 4 | -1.13 | -3.02 | 0.20 | 1570.32 | 1.00 | 707 | 62 | 27 | 0 | TRUE | 0.75 |
| colorectal cancer | RAS_13 | SMAD3 | Any mutation | 80 | 44 | TMB quintile 5 | -0.31 | -1.32 | 0.53 | 1409.15 | 1.00 | 514 | 75 | 39 | 5 | TRUE | 0.29 |
| colorectal cancer | RAS_13 | SMAD3 | Any mutation | 16 | 23 | TMB quintile 6 | -0.44 | -1.89 | 0.67 | 1419.44 | 1.00 | 107 | 14 | 21 | 2 | TRUE | 0.30 |
| colorectal cancer | RAS_13 | SMAD3 | Any mutation | 183 | 106 | TMB overall | -0.56 | -1.88 | 0.59 | 1559.38 | 1.00 | 1779 | 175 | 98 | 8 | TRUE | 0.44 |
| colorectal cancer | RAS_13 | GRIN2A | Any mutation | 62 | 30 | TMB quintile 4 | -1.69 | -4.84 | 0.12 | 1401.18 | 1.00 | 699 | 62 | 30 | 0 | FALSE | 0.69 |
| colorectal cancer | RAS_13 | GRIN2A | Any mutation | 80 | 42 | TMB quintile 5 | -0.24 | -1.32 | 0.65 | 1301.05 | 1.00 | 510 | 75 | 37 | 5 | FALSE | 0.20 |
| colorectal cancer | RAS_13 | GRIN2A | Any mutation | 17 | 59 | TMB quintile 6 | 0.04 | -0.94 | 1.00 | 1569.52 | 1.00 | 86 | 10 | 52 | 7 | FALSE | 0.03 |
| colorectal cancer | RAS_13 | GRIN2A | Any mutation | 159 | 131 | TMB overall | -0.64 | -2.62 | 1.09 | 1345.16 | 1.00 | 1295 | 147 | 119 | 12 | FALSE | 0.31 |
| colorectal cancer | RAS_13 | ASXL1 | Any mutation | 62 | 15 | TMB quintile 4 | -1.53 | -4.62 | 0.49 | 1460.85 | 1.00 | 714 | 62 | 15 | 0 | TRUE | 0.59 |
| colorectal cancer | RAS_13 | ASXL1 | Any mutation | 80 | 30 | TMB quintile 5 | 0.60 | -0.33 | 1.43 | 1367.29 | 1.00 | 524 | 73 | 23 | 7 | TRUE | 0.72 |
| colorectal cancer | RAS_13 | ASXL1 | Any mutation | 17 | 57 | TMB quintile 6 | -0.42 | -1.61 | 0.62 | 1331.75 | 1.00 | 82 | 12 | 52 | 5 | TRUE | 0.35 |
| colorectal cancer | RAS_13 | ASXL1 | Any mutation | 159 | 102 | TMB overall | -0.45 | -2.62 | 1.42 | 1583.46 | 1.00 | 1320 | 147 | 90 | 12 | TRUE | 0.18 |
| colorectal cancer | RAS_13 | EP300 | Any mutation | 80 | 39 | TMB quintile 5 | -1.65 | -3.80 | -0.20 | 1351.02 | 1.00 | 510 | 79 | 38 | 1 | TRUE | 1.15 |
| colorectal cancer | RAS_13 | EP300 | Any mutation | 19 | 72 | TMB quintile 6 | 0.03 | -0.90 | 0.95 | 1567.77 | 1.00 | 82 | 10 | 63 | 9 | TRUE | 0.02 |
| colorectal cancer | RAS_13 | EP300 | Any mutation | 99 | 111 | TMB overall | -0.76 | -3.65 | 1.89 | 1522.81 | 1.00 | 592 | 89 | 101 | 10 | TRUE | 0.24 |
| colorectal cancer | RAS_13 | ERBB4 | Any mutation | 62 | 22 | TMB quintile 4 | 0.45 | -0.84 | 1.53 | 1520.08 | 1.00 | 711 | 59 | 19 | 3 | TRUE | 0.34 |
| colorectal cancer | RAS_13 | ERBB4 | Any mutation | 80 | 45 | TMB quintile 5 | -0.34 | -1.45 | 0.53 | 1419.14 | 1.00 | 507 | 76 | 41 | 4 | TRUE | 0.30 |
| colorectal cancer | RAS_13 | ERBB4 | Any mutation | 22 | 61 | TMB quintile 6 | 1.11 | 0.22 | 2.03 | 1451.06 | 1.00 | 89 | 8 | 47 | 14 | TRUE | 1.85 |
| colorectal cancer | RAS_13 | ERBB4 | Any mutation | 164 | 128 | TMB overall | 0.43 | -1.20 | 2.11 | 1481.52 | 1.00 | 1307 | 143 | 107 | 21 | TRUE | 0.22 |
| colorectal cancer | RAS_13 | MED12 | Any mutation | 62 | 18 | TMB quintile 4 | -1.63 | -5.03 | 0.45 | 1446.43 | 1.00 | 712 | 62 | 18 | 0 | TRUE | 0.60 |
| colorectal cancer | RAS_13 | MED12 | Any mutation | 80 | 28 | TMB quintile 5 | -0.32 | -1.71 | 0.74 | 1507.91 | 1.00 | 523 | 77 | 25 | 3 | TRUE | 0.22 |
| colorectal cancer | RAS_13 | MED12 | Any mutation | 19 | 59 | TMB quintile 6 | 0.56 | -0.37 | 1.51 | 1519.92 | 1.00 | 86 | 9 | 49 | 10 | TRUE | 0.64 |
| colorectal cancer | RAS_13 | MED12 | Any mutation | 161 | 105 | TMB overall | -0.45 | -2.63 | 1.52 | 1504.88 | 1.00 | 1321 | 148 | 92 | 13 | TRUE | 0.18 |
| colorectal cancer | RAS_13 | NF1 | Any mutation | 62 | 13 | TMB quintile 4 | -0.47 | -2.64 | 1.24 | 1603.49 | 1.00 | 718 | 61 | 12 | 1 | TRUE | 0.19 |
| colorectal cancer | RAS_13 | NF1 | Any mutation | 80 | 34 | TMB quintile 5 | -0.92 | -2.55 | 0.26 | 1429.46 | 1.00 | 515 | 78 | 32 | 2 | TRUE | 0.71 |
| colorectal cancer | RAS_13 | NF1 | Any mutation | 19 | 86 | TMB quintile 6 | -0.10 | -1.04 | 0.86 | 1426.91 | 1.00 | 79 | 10 | 77 | 9 | TRUE | 0.08 |
| colorectal cancer | RAS_13 | NF1 | Any mutation | 161 | 133 | TMB overall | -0.51 | -2.59 | 1.49 | 1430.20 | 1.00 | 1312 | 149 | 121 | 12 | TRUE | 0.21 |
| colorectal cancer | RAS_13 | EPHA5 | Any mutation | 62 | 18 | TMB quintile 4 | -0.82 | -2.96 | 0.82 | 1457.06 | 1.00 | 712 | 61 | 17 | 1 | FALSE | 0.40 |
| colorectal cancer | RAS_13 | EPHA5 | Any mutation | 80 | 52 | TMB quintile 5 | -1.35 | -2.85 | -0.17 | 1534.87 | 1.00 | 499 | 78 | 50 | 2 | FALSE | 1.30 |
| colorectal cancer | RAS_13 | EPHA5 | Any mutation | 19 | 66 | TMB quintile 6 | -0.48 | -1.50 | 0.49 | 1421.25 | 1.00 | 85 | 13 | 60 | 6 | FALSE | 0.46 |
| colorectal cancer | RAS_13 | EPHA5 | Any mutation | 161 | 136 | TMB overall | -0.89 | -2.84 | 0.73 | 1410.87 | 1.00 | 1296 | 152 | 127 | 9 | FALSE | 0.50 |
| colorectal cancer | RAS_13 | AR | Any mutation | 62 | 21 | TMB quintile 4 | -0.44 | -2.27 | 0.90 | 1355.82 | 1.00 | 709 | 61 | 20 | 1 | TRUE | 0.23 |
| colorectal cancer | RAS_13 | AR | Any mutation | 81 | 34 | TMB quintile 5 | 0.30 | -0.64 | 1.11 | 1453.81 | 1.00 | 519 | 75 | 28 | 6 | TRUE | 0.29 |
| colorectal cancer | RAS_13 | AR | Any mutation | 20 | 55 | TMB quintile 6 | 0.44 | -0.45 | 1.30 | 1498.54 | 1.00 | 86 | 11 | 46 | 9 | TRUE | 0.47 |
| colorectal cancer | RAS_13 | AR | Any mutation | 163 | 110 | TMB overall | 0.07 | -1.52 | 1.49 | 1418.61 | 1.00 | 1314 | 147 | 94 | 16 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | ROS1 | Any mutation | 62 | 14 | TMB quintile 4 | -1.52 | -5.19 | 0.66 | 1285.29 | 1.00 | 715 | 62 | 14 | 0 | TRUE | 0.52 |
| colorectal cancer | RAS_13 | ROS1 | Any mutation | 80 | 24 | TMB quintile 5 | -0.62 | -2.23 | 0.69 | 1534.32 | 1.00 | 524 | 78 | 22 | 2 | TRUE | 0.40 |
| colorectal cancer | RAS_13 | ROS1 | Any mutation | 22 | 61 | TMB quintile 6 | 0.72 | -0.14 | 1.57 | 1572.23 | 1.00 | 93 | 10 | 49 | 12 | TRUE | 0.95 |
| colorectal cancer | RAS_13 | ROS1 | Any mutation | 164 | 99 | TMB overall | -0.46 | -2.81 | 1.65 | 1435.76 | 1.00 | 1332 | 150 | 85 | 14 | TRUE | 0.17 |
| colorectal cancer | RAS_13 | PIK3CG | Any mutation | 62 | 16 | TMB quintile 4 | -0.74 | -2.89 | 0.91 | 1455.85 | 1.00 | 714 | 61 | 15 | 1 | FALSE | 0.36 |
| colorectal cancer | RAS_13 | PIK3CG | Any mutation | 80 | 38 | TMB quintile 5 | -1.51 | -3.38 | -0.17 | 1534.41 | 1.00 | 509 | 79 | 37 | 1 | FALSE | 1.22 |
| colorectal cancer | RAS_13 | PIK3CG | Any mutation | 18 | 45 | TMB quintile 6 | -0.22 | -1.30 | 0.81 | 1439.39 | 1.00 | 98 | 13 | 40 | 5 | FALSE | 0.16 |
| colorectal cancer | RAS_13 | PIK3CG | Any mutation | 160 | 99 | TMB overall | -0.82 | -2.64 | 1.02 | 1529.65 | 1.00 | 1321 | 153 | 92 | 7 | FALSE | 0.43 |
| colorectal cancer | RAS_13 | ARID1B | Any mutation | 62 | 13 | TMB quintile 4 | -1.87 | -5.58 | 0.51 | 1429.81 | 1.00 | 717 | 62 | 13 | 0 | TRUE | 0.60 |
| colorectal cancer | RAS_13 | ARID1B | Any mutation | 80 | 46 | TMB quintile 5 | -0.91 | -2.21 | 0.16 | 1236.62 | 1.00 | 506 | 77 | 43 | 3 | TRUE | 0.86 |
| colorectal cancer | RAS_13 | ARID1B | Any mutation | 16 | 79 | TMB quintile 6 | -0.06 | -1.08 | 0.93 | 1658.98 | 1.00 | 73 | 8 | 71 | 8 | TRUE | 0.05 |
| colorectal cancer | RAS_13 | ARID1B | Any mutation | 158 | 138 | TMB overall | -0.87 | -3.35 | 1.28 | 1518.11 | 1.00 | 1296 | 147 | 127 | 11 | TRUE | 0.35 |
| colorectal cancer | RAS_13 | BRAF | Any mutation | 25 | 27 | TMB quintile 3 | -0.33 | -1.84 | 1.12 | 1455.70 | 1.00 | 437 | 23 | 25 | 2 | TRUE | 0.18 |
| colorectal cancer | RAS_13 | BRAF | Any mutation | 62 | 60 | TMB quintile 4 | -0.76 | -2.00 | 0.25 | 1458.58 | 1.00 | 672 | 59 | 57 | 3 | TRUE | 0.73 |
| colorectal cancer | RAS_13 | BRAF | Any mutation | 80 | 104 | TMB quintile 5 | -2.20 | -3.73 | -0.99 | 1584.11 | 1.00 | 446 | 79 | 103 | 1 | TRUE | 2.83 |
| colorectal cancer | RAS_13 | BRAF | Any mutation | 17 | 59 | TMB quintile 6 | -0.57 | -1.66 | 0.43 | 1428.31 | 1.00 | 80 | 12 | 54 | 5 | TRUE | 0.56 |
| colorectal cancer | RAS_13 | BRAF | Any mutation | 184 | 250 | TMB overall | -0.96 | -2.27 | 0.39 | 1320.68 | 1.00 | 1635 | 173 | 239 | 11 | TRUE | 0.85 |
| colorectal cancer | RAS_13 | B2M | Any mutation | 78 | 50 | TMB quintile 5 | -0.87 | -2.07 | 0.19 | 1362.61 | 1.00 | 483 | 75 | 47 | 3 | FALSE | 0.88 |
| colorectal cancer | RAS_13 | B2M | Any mutation | 21 | 79 | TMB quintile 6 | 0.83 | -0.08 | 1.77 | 1451.06 | 1.00 | 82 | 7 | 65 | 14 | FALSE | 1.14 |
| colorectal cancer | RAS_13 | B2M | Any mutation | 99 | 129 | TMB overall | -0.01 | -2.24 | 2.34 | 1468.35 | 1.00 | 565 | 82 | 112 | 17 | FALSE | 0.00 |
| colorectal cancer | RAS_13 | CARD11 | Any mutation | 62 | 28 | TMB quintile 4 | -0.24 | -1.58 | 0.91 | 1054.08 | 1.00 | 703 | 60 | 26 | 2 | FALSE | 0.15 |
| colorectal cancer | RAS_13 | CARD11 | Any mutation | 80 | 43 | TMB quintile 5 | -0.63 | -1.81 | 0.33 | 1576.20 | 1.00 | 507 | 77 | 40 | 3 | FALSE | 0.61 |
| colorectal cancer | RAS_13 | CARD11 | Any mutation | 19 | 52 | TMB quintile 6 | 0.52 | -0.41 | 1.40 | 1493.72 | 1.00 | 91 | 10 | 43 | 9 | FALSE | 0.57 |
| colorectal cancer | RAS_13 | CARD11 | Any mutation | 161 | 123 | TMB overall | -0.12 | -1.57 | 1.37 | 1249.64 | 1.00 | 1301 | 147 | 109 | 14 | FALSE | 0.06 |
| colorectal cancer | RAS_13 | SOX9 | Any mutation | 25 | 17 | TMB quintile 3 | 0.49 | -0.71 | 1.65 | 1441.99 | 1.00 | 447 | 23 | 15 | 2 | FALSE | 0.39 |
| colorectal cancer | RAS_13 | SOX9 | Any mutation | 62 | 85 | TMB quintile 4 | 0.23 | -0.49 | 0.89 | 1404.78 | 1.00 | 656 | 54 | 77 | 8 | FALSE | 0.29 |
| colorectal cancer | RAS_13 | SOX9 | Any mutation | 81 | 107 | TMB quintile 5 | 0.25 | -0.32 | 0.79 | 1403.48 | 1.00 | 466 | 65 | 91 | 16 | FALSE | 0.43 |
| colorectal cancer | RAS_13 | SOX9 | Any mutation | 18 | 50 | TMB quintile 6 | 0.55 | -0.38 | 1.42 | 1609.12 | 1.00 | 90 | 10 | 42 | 8 | FALSE | 0.66 |
| colorectal cancer | RAS_13 | SOX9 | Any mutation | 186 | 259 | TMB overall | 0.39 | -0.54 | 1.32 | 1487.61 | 1.00 | 1659 | 152 | 225 | 34 | FALSE | 0.39 |
| colorectal cancer | RAS_13 | SMAD2 | Any mutation | 62 | 29 | TMB quintile 4 | -0.24 | -1.48 | 0.72 | 1256.62 | 1.00 | 702 | 61 | 28 | 1 | TRUE | 0.17 |
| colorectal cancer | RAS_13 | SMAD2 | Any mutation | 81 | 53 | TMB quintile 5 | 0.06 | -0.76 | 0.80 | 1302.51 | 1.00 | 506 | 74 | 46 | 7 | TRUE | 0.06 |
| colorectal cancer | RAS_13 | SMAD2 | Any mutation | 17 | 16 | TMB quintile 6 | 0.53 | -0.54 | 1.64 | 1496.33 | 1.00 | 116 | 13 | 12 | 4 | TRUE | 0.47 |
| colorectal cancer | RAS_13 | SMAD2 | Any mutation | 160 | 98 | TMB overall | 0.12 | -0.94 | 1.16 | 1368.90 | 1.00 | 1324 | 148 | 86 | 12 | TRUE | 0.09 |
| colorectal cancer | RAS_13 | ZFHX3 | Any mutation | 56 | 14 | TMB quintile 4 | -0.49 | -2.90 | 1.26 | 1380.96 | 1.00 | 651 | 55 | 13 | 1 | FALSE | 0.20 |
| colorectal cancer | RAS_13 | ZFHX3 | Any mutation | 71 | 63 | TMB quintile 5 | 0.00 | -0.83 | 0.73 | 1503.29 | 1.00 | 459 | 63 | 55 | 8 | FALSE | 0.00 |
| colorectal cancer | RAS_13 | ZFHX3 | Any mutation | 21 | 143 | TMB quintile 6 | -0.79 | -1.71 | 0.18 | 1539.67 | 1.00 | 41 | 9 | 131 | 12 | FALSE | 0.99 |
| colorectal cancer | RAS_13 | ZFHX3 | Any mutation | 148 | 220 | TMB overall | -0.38 | -2.66 | 1.80 | 1390.29 | 1.00 | 1151 | 127 | 199 | 21 | FALSE | 0.13 |
| colorectal cancer | RAS_13 | MGA | Any mutation | 56 | 15 | TMB quintile 4 | 0.35 | -1.08 | 1.64 | 1468.97 | 1.00 | 652 | 54 | 13 | 2 | FALSE | 0.21 |
| colorectal cancer | RAS_13 | MGA | Any mutation | 70 | 46 | TMB quintile 5 | -0.11 | -1.09 | 0.69 | 1514.79 | 1.00 | 468 | 65 | 41 | 5 | FALSE | 0.09 |
| colorectal cancer | RAS_13 | MGA | Any mutation | 19 | 58 | TMB quintile 6 | 0.58 | -0.34 | 1.48 | 1542.92 | 1.00 | 79 | 9 | 48 | 10 | FALSE | 0.69 |
| colorectal cancer | RAS_13 | MGA | Any mutation | 145 | 119 | TMB overall | 0.27 | -1.31 | 1.93 | 1391.88 | 1.00 | 1199 | 128 | 102 | 17 | FALSE | 0.13 |
| colorectal cancer | RAS_13 | KMT2B | Any mutation | 40 | 54 | TMB quintile 5 | 0.29 | -0.62 | 1.09 | 1254.59 | 1.00 | 248 | 32 | 46 | 8 | FALSE | 0.30 |
| colorectal cancer | RAS_13 | KMT2B | Any mutation | 13 | 115 | TMB quintile 6 | 2.28 | -0.03 | 6.39 | 1283.49 | 1.00 | 22 | 0 | 102 | 13 | FALSE | 0.73 |
| colorectal cancer | RAS_13 | KMT2B | Any mutation | 53 | 169 | TMB overall | 1.05 | -2.16 | 4.90 | 1637.56 | 1.00 | 270 | 32 | 148 | 21 | FALSE | 0.27 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 25 | 35 | TMB quintile 3 | -0.22 | -1.49 | 0.89 | 1584.13 | 1.00 | 383 | 23 | 33 | 2 | FALSE | 0.14 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 57 | 79 | TMB quintile 4 | -0.16 | -1.07 | 0.58 | 1436.72 | 1.00 | 594 | 51 | 73 | 6 | FALSE | 0.15 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 72 | 108 | TMB quintile 5 | -0.07 | -0.73 | 0.53 | 1432.68 | 1.00 | 420 | 59 | 95 | 13 | FALSE | 0.08 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 16 | 70 | TMB quintile 6 | -0.32 | -1.31 | 0.61 | 1434.51 | 1.00 | 64 | 10 | 64 | 6 | FALSE | 0.30 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 170 | 292 | TMB overall | -0.16 | -1.13 | 0.80 | 1304.76 | 1.00 | 1461 | 143 | 265 | 27 | FALSE | 0.13 |
| colorectal cancer | RAS_13 | ANKRD11 | Any mutation | 55 | 11 | TMB quintile 4 | 0.49 | -1.26 | 1.95 | 1327.89 | 1.00 | 638 | 53 | 9 | 2 | FALSE | 0.26 |
| colorectal cancer | RAS_13 | ANKRD11 | Any mutation | 67 | 43 | TMB quintile 5 | -0.68 | -1.90 | 0.33 | 1409.84 | 1.00 | 437 | 64 | 40 | 3 | FALSE | 0.62 |
| colorectal cancer | RAS_13 | ANKRD11 | Any mutation | 17 | 86 | TMB quintile 6 | -0.03 | -1.00 | 0.95 | 1321.94 | 1.00 | 67 | 8 | 77 | 9 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | ANKRD11 | Any mutation | 139 | 140 | TMB overall | -0.06 | -2.03 | 1.74 | 1494.01 | 1.00 | 1142 | 125 | 126 | 14 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | POLD1 | Any mutation | 70 | 20 | TMB quintile 5 | 0.07 | -1.40 | 1.25 | 1620.24 | 1.00 | 494 | 67 | 17 | 3 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | POLD1 | Any mutation | 17 | 83 | TMB quintile 6 | 0.00 | -0.98 | 1.00 | 1503.31 | 1.00 | 65 | 8 | 74 | 9 | TRUE | 0.00 |
| colorectal cancer | RAS_13 | POLD1 | Any mutation | 87 | 103 | TMB overall | 0.01 | -2.91 | 2.86 | 1493.16 | 1.00 | 559 | 75 | 91 | 12 | TRUE | 0.00 |
| colorectal cancer | RAS_13 | AMER1 | Any mutation | 25 | 13 | TMB quintile 3 | 0.82 | -0.56 | 2.05 | 1200.36 | 1.00 | 451 | 23 | 11 | 2 | FALSE | 0.63 |
| colorectal cancer | RAS_13 | AMER1 | Any mutation | 62 | 38 | TMB quintile 4 | -0.18 | -1.45 | 0.89 | 1521.42 | 1.00 | 695 | 60 | 36 | 2 | FALSE | 0.12 |
| colorectal cancer | RAS_13 | AMER1 | Any mutation | 80 | 62 | TMB quintile 5 | 0.45 | -0.22 | 1.08 | 1469.35 | 1.00 | 495 | 69 | 51 | 11 | FALSE | 0.74 |
| colorectal cancer | RAS_13 | AMER1 | Any mutation | 21 | 55 | TMB quintile 6 | 1.16 | 0.35 | 2.05 | 1470.48 | 1.00 | 90 | 8 | 42 | 13 | FALSE | 2.12 |
| colorectal cancer | RAS_13 | AMER1 | Any mutation | 188 | 168 | TMB overall | 0.56 | -0.63 | 1.75 | 1502.25 | 1.00 | 1731 | 160 | 140 | 28 | FALSE | 0.45 |
| colorectal cancer | KRAS_13 | SPEN | Any mutation | 59 | 11 | TMB quintile 4 | -2.10 | -6.14 | 0.52 | 1502.54 | 1.00 | 721 | 59 | 11 | 0 | FALSE | 0.65 |
| colorectal cancer | KRAS_13 | SPEN | Any mutation | 76 | 31 | TMB quintile 5 | -0.97 | -2.62 | 0.36 | 1374.07 | 1.00 | 525 | 74 | 29 | 2 | FALSE | 0.68 |
| colorectal cancer | KRAS_13 | SPEN | Any mutation | 17 | 107 | TMB quintile 6 | -0.87 | -1.90 | 0.05 | 1507.18 | 1.00 | 62 | 10 | 100 | 7 | FALSE | 1.08 |
| colorectal cancer | KRAS_13 | SPEN | Any mutation | 152 | 149 | TMB overall | -1.27 | -3.90 | 1.08 | 1509.98 | 1.00 | 1308 | 143 | 140 | 9 | FALSE | 0.50 |
| colorectal cancer | KRAS_13 | KMT2C | Any mutation | 58 | 12 | TMB quintile 4 | -0.28 | -2.45 | 1.47 | 1337.53 | 1.00 | 704 | 57 | 11 | 1 | FALSE | 0.11 |
| colorectal cancer | KRAS_13 | KMT2C | Any mutation | 73 | 61 | TMB quintile 5 | 0.16 | -0.64 | 0.89 | 1385.01 | 1.00 | 471 | 64 | 52 | 9 | FALSE | 0.16 |
| colorectal cancer | KRAS_13 | KMT2C | Any mutation | 19 | 116 | TMB quintile 6 | -0.57 | -1.48 | 0.32 | 1533.76 | 1.00 | 62 | 10 | 107 | 9 | FALSE | 0.63 |
| colorectal cancer | KRAS_13 | KMT2C | Any mutation | 150 | 189 | TMB overall | -0.23 | -2.40 | 2.00 | 1439.69 | 1.00 | 1237 | 131 | 170 | 19 | FALSE | 0.08 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 10 | 104 | TMB quintile 2 | -0.57 | -1.43 | 0.26 | 1404.21 | 1.00 | 30 | 4 | 98 | 6 | TRUE | 0.75 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 23 | 411 | TMB quintile 3 | -0.83 | -1.51 | -0.14 | 1476.74 | 1.00 | 77 | 8 | 396 | 15 | TRUE | 1.76 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 61 | 655 | TMB quintile 4 | -0.29 | -0.80 | 0.22 | 1457.13 | 1.00 | 160 | 15 | 609 | 46 | TRUE | 0.58 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 80 | 423 | TMB quintile 5 | -0.36 | -0.78 | 0.09 | 1495.96 | 1.00 | 213 | 36 | 379 | 44 | TRUE | 0.96 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 19 | 78 | TMB quintile 6 | -0.20 | -0.95 | 0.54 | 1519.87 | 1.00 | 82 | 10 | 69 | 9 | TRUE | 0.22 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 193 | 1671 | TMB overall | -0.46 | -1.03 | 0.14 | 1517.37 | 1.00 | 562 | 73 | 1551 | 120 | TRUE | 0.87 |
| colorectal cancer | KRAS_13 | ATRX | Any mutation | 59 | 19 | TMB quintile 4 | -1.75 | -5.43 | 0.35 | 1244.61 | 1.00 | 713 | 59 | 19 | 0 | TRUE | 0.63 |
| colorectal cancer | KRAS_13 | ATRX | Any mutation | 76 | 35 | TMB quintile 5 | -0.97 | -2.49 | 0.26 | 1423.20 | 1.00 | 519 | 74 | 33 | 2 | TRUE | 0.76 |
| colorectal cancer | KRAS_13 | ATRX | Any mutation | 20 | 59 | TMB quintile 6 | 0.26 | -0.75 | 1.18 | 1504.91 | 1.00 | 90 | 11 | 50 | 9 | TRUE | 0.22 |
| colorectal cancer | KRAS_13 | ATRX | Any mutation | 155 | 113 | TMB overall | -0.77 | -2.94 | 1.10 | 1213.16 | 1.00 | 1322 | 144 | 102 | 11 | TRUE | 0.34 |
| colorectal cancer | KRAS_13 | ATR | Any mutation | 77 | 35 | TMB quintile 5 | 0.65 | -0.24 | 1.43 | 1541.74 | 1.00 | 523 | 69 | 27 | 8 | FALSE | 0.90 |
| colorectal cancer | KRAS_13 | ATR | Any mutation | 17 | 65 | TMB quintile 6 | -1.04 | -2.38 | 0.14 | 1313.27 | 1.00 | 92 | 14 | 62 | 3 | FALSE | 0.99 |
| colorectal cancer | KRAS_13 | ATR | Any mutation | 94 | 100 | TMB overall | -0.21 | -2.60 | 2.48 | 1490.66 | 1.00 | 615 | 83 | 89 | 11 | FALSE | 0.06 |
| colorectal cancer | KRAS_13 | FBXW7 | Any mutation | 23 | 22 | TMB quintile 3 | -0.50 | -2.55 | 1.00 | 1406.96 | 1.00 | 443 | 23 | 22 | 0 | TRUE | 0.23 |
| colorectal cancer | KRAS_13 | FBXW7 | Any mutation | 61 | 85 | TMB quintile 4 | 0.50 | -0.22 | 1.16 | 1529.32 | 1.00 | 666 | 51 | 75 | 10 | TRUE | 0.82 |
| colorectal cancer | KRAS_13 | FBXW7 | Any mutation | 79 | 160 | TMB quintile 5 | 0.48 | -0.03 | 0.95 | 1381.09 | 1.00 | 437 | 53 | 134 | 26 | TRUE | 1.24 |
| colorectal cancer | KRAS_13 | FBXW7 | Any mutation | 15 | 65 | TMB quintile 6 | 1.15 | 0.24 | 2.18 | 1480.57 | 1.00 | 80 | 4 | 54 | 11 | TRUE | 1.63 |
| colorectal cancer | KRAS_13 | FBXW7 | Any mutation | 178 | 332 | TMB overall | 0.40 | -0.79 | 1.50 | 1422.23 | 1.00 | 1626 | 131 | 285 | 47 | TRUE | 0.31 |
| colorectal cancer | KRAS_13 | FLT4 | Any mutation | 59 | 20 | TMB quintile 4 | -0.13 | -1.82 | 1.19 | 1537.71 | 1.00 | 714 | 57 | 18 | 2 | TRUE | 0.06 |
| colorectal cancer | KRAS_13 | FLT4 | Any mutation | 76 | 40 | TMB quintile 5 | -1.05 | -2.56 | 0.10 | 1411.85 | 1.00 | 516 | 74 | 38 | 2 | TRUE | 0.90 |
| colorectal cancer | KRAS_13 | FLT4 | Any mutation | 15 | 72 | TMB quintile 6 | -0.61 | -1.74 | 0.46 | 1491.04 | 1.00 | 73 | 10 | 67 | 5 | TRUE | 0.57 |
| colorectal cancer | KRAS_13 | FLT4 | Any mutation | 150 | 132 | TMB overall | -0.60 | -2.37 | 1.11 | 1419.52 | 1.00 | 1303 | 141 | 123 | 9 | TRUE | 0.30 |
| colorectal cancer | KRAS_13 | PTPRD | Any mutation | 76 | 29 | TMB quintile 5 | -0.39 | -1.67 | 0.73 | 1209.12 | 1.00 | 526 | 73 | 26 | 3 | FALSE | 0.28 |
| colorectal cancer | KRAS_13 | PTPRD | Any mutation | 16 | 61 | TMB quintile 6 | -0.66 | -1.90 | 0.42 | 1454.97 | 1.00 | 87 | 12 | 57 | 4 | FALSE | 0.58 |
| colorectal cancer | KRAS_13 | PTPRD | Any mutation | 92 | 90 | TMB overall | -0.57 | -2.99 | 1.72 | 1523.12 | 1.00 | 613 | 85 | 83 | 7 | FALSE | 0.20 |
| colorectal cancer | KRAS_13 | CREBBP | Any mutation | 59 | 17 | TMB quintile 4 | -0.56 | -2.76 | 1.15 | 1391.84 | 1.00 | 716 | 58 | 16 | 1 | TRUE | 0.25 |
| colorectal cancer | KRAS_13 | CREBBP | Any mutation | 76 | 49 | TMB quintile 5 | 0.31 | -0.53 | 1.07 | 1391.25 | 1.00 | 516 | 68 | 41 | 8 | TRUE | 0.35 |
| colorectal cancer | KRAS_13 | CREBBP | Any mutation | 18 | 116 | TMB quintile 6 | -0.58 | -1.52 | 0.36 | 1563.03 | 1.00 | 55 | 9 | 107 | 9 | TRUE | 0.64 |
| colorectal cancer | KRAS_13 | CREBBP | Any mutation | 153 | 182 | TMB overall | -0.30 | -2.42 | 1.85 | 1320.57 | 1.00 | 1287 | 135 | 164 | 18 | TRUE | 0.11 |
| colorectal cancer | KRAS_13 | AXIN2 | Any mutation | 59 | 20 | TMB quintile 4 | -0.46 | -2.31 | 1.05 | 1451.77 | 1.00 | 713 | 58 | 19 | 1 | TRUE | 0.23 |
| colorectal cancer | KRAS_13 | AXIN2 | Any mutation | 76 | 27 | TMB quintile 5 | 0.11 | -1.03 | 1.14 | 1303.28 | 1.00 | 528 | 72 | 23 | 4 | TRUE | 0.07 |
| colorectal cancer | KRAS_13 | AXIN2 | Any mutation | 16 | 63 | TMB quintile 6 | 0.16 | -0.86 | 1.17 | 1410.88 | 1.00 | 86 | 9 | 56 | 7 | TRUE | 0.12 |
| colorectal cancer | KRAS_13 | AXIN2 | Any mutation | 151 | 110 | TMB overall | -0.05 | -1.79 | 1.68 | 1602.43 | 1.00 | 1327 | 139 | 98 | 12 | TRUE | 0.02 |
| colorectal cancer | KRAS_13 | PTPRS | Any mutation | 23 | 17 | TMB quintile 3 | -1.18 | -4.20 | 0.94 | 1628.39 | 1.00 | 442 | 23 | 17 | 0 | FALSE | 0.43 |
| colorectal cancer | KRAS_13 | PTPRS | Any mutation | 58 | 34 | TMB quintile 4 | 0.59 | -0.51 | 1.54 | 1632.74 | 1.00 | 686 | 53 | 29 | 5 | FALSE | 0.59 |
| colorectal cancer | KRAS_13 | PTPRS | Any mutation | 74 | 74 | TMB quintile 5 | -0.18 | -0.96 | 0.52 | 1441.84 | 1.00 | 460 | 66 | 66 | 8 | FALSE | 0.19 |
| colorectal cancer | KRAS_13 | PTPRS | Any mutation | 17 | 128 | TMB quintile 6 | 0.27 | -0.76 | 1.40 | 1321.64 | 1.00 | 45 | 4 | 115 | 13 | FALSE | 0.21 |
| colorectal cancer | KRAS_13 | PTPRS | Any mutation | 172 | 253 | TMB overall | -0.12 | -1.90 | 1.38 | 1494.24 | 1.00 | 1633 | 146 | 227 | 26 | FALSE | 0.05 |
| colorectal cancer | KRAS_13 | SMARCA4 | Any mutation | 59 | 16 | TMB quintile 4 | -2.01 | -5.74 | 0.32 | 1414.65 | 1.00 | 716 | 59 | 16 | 0 | FALSE | 0.64 |
| colorectal cancer | KRAS_13 | SMARCA4 | Any mutation | 76 | 47 | TMB quintile 5 | -0.58 | -1.77 | 0.39 | 1319.05 | 1.00 | 511 | 72 | 43 | 4 | FALSE | 0.54 |
| colorectal cancer | KRAS_13 | SMARCA4 | Any mutation | 17 | 100 | TMB quintile 6 | -0.26 | -1.26 | 0.70 | 1392.55 | 1.00 | 67 | 8 | 91 | 9 | FALSE | 0.22 |
| colorectal cancer | KRAS_13 | SMARCA4 | Any mutation | 152 | 163 | TMB overall | -0.91 | -3.27 | 1.26 | 1443.98 | 1.00 | 1294 | 139 | 150 | 13 | FALSE | 0.37 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 23 | 18 | TMB quintile 3 | 0.56 | -0.89 | 1.78 | 1445.44 | 1.00 | 448 | 21 | 16 | 2 | FALSE | 0.37 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 59 | 39 | TMB quintile 4 | -0.26 | -1.57 | 0.79 | 1509.66 | 1.00 | 695 | 57 | 37 | 2 | FALSE | 0.18 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 76 | 59 | TMB quintile 5 | -0.01 | -0.81 | 0.70 | 1561.38 | 1.00 | 501 | 69 | 52 | 7 | FALSE | 0.01 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 19 | 66 | TMB quintile 6 | 0.91 | 0.04 | 1.80 | 1348.22 | 1.00 | 86 | 7 | 54 | 12 | FALSE | 1.36 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 177 | 182 | TMB overall | 0.28 | -0.95 | 1.49 | 1449.06 | 1.00 | 1730 | 154 | 159 | 23 | FALSE | 0.19 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 23 | 51 | TMB quintile 3 | 0.74 | -0.19 | 1.64 | 1366.87 | 1.00 | 421 | 18 | 46 | 5 | TRUE | 0.94 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 59 | 146 | TMB quintile 4 | 0.21 | -0.43 | 0.80 | 1429.12 | 1.00 | 604 | 47 | 134 | 12 | TRUE | 0.30 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 83 | 209 | TMB quintile 5 | 0.79 | 0.33 | 1.23 | 1475.65 | 1.00 | 396 | 43 | 169 | 40 | TRUE | 3.21 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 18 | 95 | TMB quintile 6 | 0.98 | 0.13 | 1.85 | 1403.06 | 1.00 | 68 | 4 | 81 | 14 | TRUE | 1.54 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 183 | 501 | TMB overall | 0.67 | -0.27 | 1.57 | 1467.57 | 1.00 | 1489 | 112 | 430 | 71 | TRUE | 0.85 |
| colorectal cancer | KRAS_13 | ALK | Any mutation | 59 | 20 | TMB quintile 4 | 1.21 | 0.10 | 2.16 | 1239.27 | 1.00 | 717 | 54 | 15 | 5 | TRUE | 1.74 |
| colorectal cancer | KRAS_13 | ALK | Any mutation | 76 | 42 | TMB quintile 5 | 0.72 | -0.01 | 1.46 | 1427.39 | 1.00 | 519 | 67 | 33 | 9 | TRUE | 1.26 |
| colorectal cancer | KRAS_13 | ALK | Any mutation | 18 | 45 | TMB quintile 6 | 0.37 | -0.60 | 1.31 | 1464.20 | 1.00 | 98 | 12 | 39 | 6 | TRUE | 0.35 |
| colorectal cancer | KRAS_13 | ALK | Any mutation | 153 | 107 | TMB overall | 0.74 | -0.76 | 2.17 | 1349.77 | 1.00 | 1334 | 133 | 87 | 20 | TRUE | 0.53 |
| colorectal cancer | KRAS_13 | RNF43 | Any mutation | 23 | 12 | TMB quintile 3 | -1.43 | -4.87 | 0.87 | 1567.24 | 1.00 | 452 | 23 | 12 | 0 | TRUE | 0.47 |
| colorectal cancer | KRAS_13 | RNF43 | Any mutation | 59 | 30 | TMB quintile 4 | -0.41 | -2.04 | 0.85 | 1565.29 | 1.00 | 705 | 57 | 28 | 2 | TRUE | 0.24 |
| colorectal cancer | KRAS_13 | RNF43 | Any mutation | 76 | 76 | TMB quintile 5 | -0.58 | -1.52 | 0.20 | 1318.93 | 1.00 | 494 | 70 | 70 | 6 | TRUE | 0.73 |
| colorectal cancer | KRAS_13 | RNF43 | Any mutation | 21 | 146 | TMB quintile 6 | -0.16 | -1.06 | 0.78 | 1414.06 | 1.00 | 43 | 6 | 131 | 15 | TRUE | 0.13 |
| colorectal cancer | KRAS_13 | RNF43 | Any mutation | 179 | 264 | TMB overall | -0.61 | -2.46 | 1.19 | 1372.66 | 1.00 | 1694 | 156 | 241 | 23 | TRUE | 0.31 |
| colorectal cancer | KRAS_13 | PTEN | Any mutation | 59 | 29 | TMB quintile 4 | 0.54 | -0.51 | 1.55 | 1529.21 | 1.00 | 708 | 55 | 25 | 4 | TRUE | 0.52 |
| colorectal cancer | KRAS_13 | PTEN | Any mutation | 78 | 69 | TMB quintile 5 | 0.34 | -0.35 | 0.99 | 1487.04 | 1.00 | 506 | 67 | 58 | 11 | TRUE | 0.49 |
| colorectal cancer | KRAS_13 | PTEN | Any mutation | 19 | 80 | TMB quintile 6 | 0.29 | -0.66 | 1.20 | 1422.20 | 1.00 | 81 | 9 | 70 | 10 | TRUE | 0.27 |
| colorectal cancer | KRAS_13 | PTEN | Any mutation | 156 | 178 | TMB overall | 0.41 | -1.01 | 2.00 | 1422.93 | 1.00 | 1295 | 131 | 153 | 25 | TRUE | 0.23 |
| colorectal cancer | KRAS_13 | BCOR | Any mutation | 59 | 11 | TMB quintile 4 | -0.21 | -2.33 | 1.41 | 1397.30 | 1.00 | 722 | 58 | 10 | 1 | FALSE | 0.08 |
| colorectal cancer | KRAS_13 | BCOR | Any mutation | 76 | 39 | TMB quintile 5 | -0.93 | -2.37 | 0.24 | 1587.01 | 1.00 | 516 | 74 | 37 | 2 | FALSE | 0.78 |
| colorectal cancer | KRAS_13 | BCOR | Any mutation | 17 | 57 | TMB quintile 6 | 0.40 | -0.54 | 1.38 | 1539.02 | 1.00 | 90 | 9 | 49 | 8 | FALSE | 0.38 |
| colorectal cancer | KRAS_13 | BCOR | Any mutation | 152 | 107 | TMB overall | -0.22 | -2.19 | 1.58 | 1523.11 | 1.00 | 1328 | 141 | 96 | 11 | FALSE | 0.09 |
| colorectal cancer | KRAS_13 | CTNNB1 | Any mutation | 23 | 38 | TMB quintile 3 | 0.51 | -0.51 | 1.43 | 1399.57 | 1.00 | 431 | 20 | 35 | 3 | TRUE | 0.50 |
| colorectal cancer | KRAS_13 | CTNNB1 | Any mutation | 59 | 35 | TMB quintile 4 | 0.45 | -0.46 | 1.26 | 1534.73 | 1.00 | 702 | 55 | 31 | 4 | TRUE | 0.52 |
| colorectal cancer | KRAS_13 | CTNNB1 | Any mutation | 76 | 48 | TMB quintile 5 | 0.32 | -0.45 | 1.01 | 1375.09 | 1.00 | 511 | 69 | 41 | 7 | TRUE | 0.40 |
| colorectal cancer | KRAS_13 | CTNNB1 | Any mutation | 15 | 35 | TMB quintile 6 | 0.92 | 0.07 | 1.86 | 1496.26 | 1.00 | 100 | 8 | 28 | 7 | TRUE | 1.38 |
| colorectal cancer | KRAS_13 | CTNNB1 | Any mutation | 173 | 156 | TMB overall | 0.56 | -0.33 | 1.42 | 1439.02 | 1.00 | 1744 | 152 | 135 | 21 | TRUE | 0.69 |
| colorectal cancer | KRAS_13 | ARID1A | Any mutation | 59 | 32 | TMB quintile 4 | -2.25 | -6.23 | -0.03 | 1593.88 | 1.00 | 701 | 59 | 32 | 0 | TRUE | 0.81 |
| colorectal cancer | KRAS_13 | ARID1A | Any mutation | 78 | 116 | TMB quintile 5 | -0.35 | -1.04 | 0.31 | 1506.07 | 1.00 | 471 | 67 | 105 | 11 | TRUE | 0.51 |
| colorectal cancer | KRAS_13 | ARID1A | Any mutation | 21 | 155 | TMB quintile 6 | 0.35 | -0.69 | 1.50 | 1383.00 | 1.00 | 49 | 4 | 138 | 17 | TRUE | 0.27 |
| colorectal cancer | KRAS_13 | ARID1A | Any mutation | 158 | 303 | TMB overall | -0.68 | -3.14 | 1.62 | 1499.60 | 1.00 | 1221 | 130 | 275 | 28 | TRUE | 0.24 |
| colorectal cancer | KRAS_13 | PIK3R1 | Any mutation | 59 | 22 | TMB quintile 4 | -0.66 | -2.68 | 0.91 | 1506.83 | 1.00 | 712 | 58 | 21 | 1 | TRUE | 0.34 |
| colorectal cancer | KRAS_13 | PIK3R1 | Any mutation | 76 | 29 | TMB quintile 5 | -0.69 | -2.13 | 0.48 | 1534.59 | 1.00 | 526 | 74 | 27 | 2 | TRUE | 0.52 |
| colorectal cancer | KRAS_13 | PIK3R1 | Any mutation | 16 | 56 | TMB quintile 6 | 0.25 | -0.76 | 1.22 | 1537.34 | 1.00 | 91 | 9 | 49 | 7 | TRUE | 0.20 |
| colorectal cancer | KRAS_13 | PIK3R1 | Any mutation | 151 | 107 | TMB overall | -0.38 | -2.19 | 1.42 | 1587.78 | 1.00 | 1329 | 141 | 97 | 10 | TRUE | 0.17 |
| colorectal cancer | KRAS_13 | FAT1 | Any mutation | 59 | 17 | TMB quintile 4 | -1.98 | -6.04 | 0.49 | 1497.92 | 1.00 | 716 | 59 | 17 | 0 | FALSE | 0.62 |
| colorectal cancer | KRAS_13 | FAT1 | Any mutation | 76 | 64 | TMB quintile 5 | -0.37 | -1.30 | 0.43 | 1393.56 | 1.00 | 501 | 70 | 58 | 6 | FALSE | 0.38 |
| colorectal cancer | KRAS_13 | FAT1 | Any mutation | 28 | 145 | TMB quintile 6 | 1.01 | 0.08 | 2.08 | 1436.68 | 1.00 | 59 | 4 | 121 | 24 | FALSE | 1.33 |
| colorectal cancer | KRAS_13 | FAT1 | Any mutation | 163 | 226 | TMB overall | -0.43 | -3.06 | 1.85 | 1579.85 | 1.00 | 1276 | 133 | 196 | 30 | FALSE | 0.14 |
| colorectal cancer | KRAS_13 | CIC | Any mutation | 59 | 17 | TMB quintile 4 | 0.06 | -1.59 | 1.47 | 1440.36 | 1.00 | 718 | 57 | 15 | 2 | TRUE | 0.03 |
| colorectal cancer | KRAS_13 | CIC | Any mutation | 77 | 40 | TMB quintile 5 | -0.64 | -1.89 | 0.40 | 1426.87 | 1.00 | 517 | 74 | 37 | 3 | TRUE | 0.57 |
| colorectal cancer | KRAS_13 | CIC | Any mutation | 16 | 79 | TMB quintile 6 | -0.76 | -1.92 | 0.21 | 1578.46 | 1.00 | 75 | 11 | 74 | 5 | TRUE | 0.79 |
| colorectal cancer | KRAS_13 | CIC | Any mutation | 152 | 136 | TMB overall | -0.40 | -2.22 | 1.55 | 1467.89 | 1.00 | 1310 | 142 | 126 | 10 | TRUE | 0.17 |
| colorectal cancer | KRAS_13 | NCOR1 | Any mutation | 59 | 16 | TMB quintile 4 | 0.27 | -1.34 | 1.57 | 1538.87 | 1.00 | 718 | 57 | 14 | 2 | FALSE | 0.14 |
| colorectal cancer | KRAS_13 | NCOR1 | Any mutation | 76 | 32 | TMB quintile 5 | -0.34 | -1.55 | 0.76 | 1164.87 | 1.00 | 527 | 73 | 29 | 3 | FALSE | 0.25 |
| colorectal cancer | KRAS_13 | NCOR1 | Any mutation | 17 | 81 | TMB quintile 6 | 0.16 | -0.81 | 1.18 | 1357.95 | 1.00 | 73 | 8 | 72 | 9 | FALSE | 0.13 |
| colorectal cancer | KRAS_13 | NCOR1 | Any mutation | 152 | 129 | TMB overall | 0.04 | -1.88 | 1.89 | 1403.20 | 1.00 | 1318 | 138 | 115 | 14 | FALSE | 0.01 |
| colorectal cancer | KRAS_13 | POLE | Any mutation | 76 | 38 | TMB quintile 5 | -0.20 | -1.36 | 0.76 | 1498.66 | 1.00 | 518 | 72 | 34 | 4 | TRUE | 0.15 |
| colorectal cancer | KRAS_13 | POLE | Any mutation | 19 | 93 | TMB quintile 6 | 0.58 | -0.30 | 1.62 | 1651.02 | 1.00 | 69 | 6 | 80 | 13 | TRUE | 0.63 |
| colorectal cancer | KRAS_13 | POLE | Any mutation | 95 | 131 | TMB overall | 0.15 | -2.57 | 2.63 | 1450.55 | 1.00 | 587 | 78 | 114 | 17 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | TGFBR2 | Any mutation | 76 | 47 | TMB quintile 5 | 0.18 | -0.67 | 0.93 | 1373.80 | 1.00 | 515 | 69 | 40 | 7 | TRUE | 0.18 |
| colorectal cancer | KRAS_13 | TGFBR2 | Any mutation | 15 | 57 | TMB quintile 6 | 0.01 | -1.05 | 1.01 | 1637.97 | 1.00 | 77 | 9 | 51 | 6 | TRUE | 0.01 |
| colorectal cancer | KRAS_13 | TGFBR2 | Any mutation | 91 | 104 | TMB overall | 0.10 | -1.98 | 2.18 | 1268.92 | 1.00 | 592 | 78 | 91 | 13 | TRUE | 0.03 |
| colorectal cancer | KRAS_13 | KMT2A | Any mutation | 59 | 16 | TMB quintile 4 | -1.63 | -5.40 | 0.57 | 1542.07 | 1.00 | 716 | 59 | 16 | 0 | FALSE | 0.51 |
| colorectal cancer | KRAS_13 | KMT2A | Any mutation | 77 | 43 | TMB quintile 5 | 0.26 | -0.64 | 1.04 | 1474.98 | 1.00 | 517 | 70 | 36 | 7 | FALSE | 0.26 |
| colorectal cancer | KRAS_13 | KMT2A | Any mutation | 20 | 84 | TMB quintile 6 | 0.23 | -0.68 | 1.14 | 1396.63 | 1.00 | 79 | 9 | 73 | 11 | FALSE | 0.21 |
| colorectal cancer | KRAS_13 | KMT2A | Any mutation | 156 | 143 | TMB overall | -0.40 | -2.91 | 1.67 | 1454.22 | 1.00 | 1312 | 138 | 125 | 18 | FALSE | 0.14 |
| colorectal cancer | KRAS_13 | BRCA2 | Any mutation | 59 | 21 | TMB quintile 4 | 0.47 | -0.90 | 1.62 | 1457.68 | 1.00 | 714 | 56 | 18 | 3 | TRUE | 0.34 |
| colorectal cancer | KRAS_13 | BRCA2 | Any mutation | 78 | 48 | TMB quintile 5 | 0.14 | -0.76 | 0.89 | 1541.15 | 1.00 | 515 | 71 | 41 | 7 | TRUE | 0.13 |
| colorectal cancer | KRAS_13 | BRCA2 | Any mutation | 22 | 116 | TMB quintile 6 | -0.30 | -1.15 | 0.52 | 1552.81 | 1.00 | 70 | 11 | 105 | 11 | TRUE | 0.32 |
| colorectal cancer | KRAS_13 | BRCA2 | Any mutation | 159 | 185 | TMB overall | 0.15 | -1.74 | 2.08 | 1337.37 | 1.00 | 1299 | 138 | 164 | 21 | TRUE | 0.06 |
| colorectal cancer | KRAS_13 | NOTCH3 | Any mutation | 23 | 12 | TMB quintile 3 | 0.16 | -1.97 | 1.93 | 1423.66 | 1.00 | 453 | 22 | 11 | 1 | TRUE | 0.06 |
| colorectal cancer | KRAS_13 | NOTCH3 | Any mutation | 59 | 17 | TMB quintile 4 | 0.21 | -1.45 | 1.50 | 1410.54 | 1.00 | 717 | 57 | 15 | 2 | TRUE | 0.11 |
| colorectal cancer | KRAS_13 | NOTCH3 | Any mutation | 76 | 50 | TMB quintile 5 | 0.13 | -0.75 | 0.91 | 1400.26 | 1.00 | 512 | 69 | 43 | 7 | TRUE | 0.12 |
| colorectal cancer | KRAS_13 | NOTCH3 | Any mutation | 16 | 120 | TMB quintile 6 | -0.10 | -1.05 | 0.90 | 1563.29 | 1.00 | 53 | 6 | 110 | 10 | TRUE | 0.08 |
| colorectal cancer | KRAS_13 | NOTCH3 | Any mutation | 174 | 199 | TMB overall | 0.10 | -1.64 | 1.81 | 1541.92 | 1.00 | 1735 | 154 | 179 | 20 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | NOTCH4 | Any mutation | 58 | 21 | TMB quintile 4 | 0.33 | -1.08 | 1.50 | 1684.38 | 1.00 | 698 | 55 | 18 | 3 | TRUE | 0.21 |
| colorectal cancer | KRAS_13 | NOTCH4 | Any mutation | 73 | 37 | TMB quintile 5 | -2.56 | -6.61 | -0.51 | 1563.14 | 1.00 | 480 | 73 | 37 | 0 | TRUE | 0.96 |
| colorectal cancer | KRAS_13 | NOTCH4 | Any mutation | 18 | 59 | TMB quintile 6 | -0.10 | -1.12 | 0.88 | 1229.96 | 1.00 | 82 | 11 | 52 | 7 | TRUE | 0.07 |
| colorectal cancer | KRAS_13 | NOTCH4 | Any mutation | 149 | 117 | TMB overall | -0.72 | -3.06 | 1.26 | 1524.68 | 1.00 | 1260 | 139 | 107 | 10 | TRUE | 0.29 |
| colorectal cancer | KRAS_13 | ERBB3 | Any mutation | 59 | 27 | TMB quintile 4 | -1.37 | -4.11 | 0.38 | 1538.53 | 1.00 | 706 | 59 | 27 | 0 | TRUE | 0.60 |
| colorectal cancer | KRAS_13 | ERBB3 | Any mutation | 76 | 39 | TMB quintile 5 | 0.16 | -0.75 | 1.03 | 1501.08 | 1.00 | 518 | 70 | 33 | 6 | TRUE | 0.14 |
| colorectal cancer | KRAS_13 | ERBB3 | Any mutation | 17 | 51 | TMB quintile 6 | 0.76 | -0.20 | 1.73 | 1363.71 | 1.00 | 94 | 8 | 42 | 9 | TRUE | 0.92 |
| colorectal cancer | KRAS_13 | ERBB3 | Any mutation | 152 | 117 | TMB overall | -0.16 | -2.16 | 1.52 | 1531.94 | 1.00 | 1318 | 137 | 102 | 15 | TRUE | 0.06 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 23 | 51 | TMB quintile 3 | -0.42 | -1.32 | 0.51 | 1438.93 | 1.00 | 418 | 20 | 48 | 3 | TRUE | 0.43 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 59 | 129 | TMB quintile 4 | -0.80 | -1.63 | -0.11 | 1585.49 | 1.00 | 613 | 55 | 125 | 4 | TRUE | 1.42 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 78 | 138 | TMB quintile 5 | -0.41 | -1.02 | 0.16 | 1447.29 | 1.00 | 440 | 65 | 125 | 13 | TRUE | 0.76 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 15 | 31 | TMB quintile 6 | -0.76 | -1.82 | 0.12 | 1396.33 | 1.00 | 103 | 14 | 30 | 1 | TRUE | 0.91 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 175 | 349 | TMB overall | -0.60 | -1.36 | 0.12 | 1308.49 | 1.00 | 1574 | 154 | 328 | 21 | TRUE | 0.96 |
| colorectal cancer | KRAS_13 | ATM | Any mutation | 60 | 46 | TMB quintile 4 | 0.05 | -1.06 | 0.93 | 1555.76 | 1.00 | 694 | 56 | 42 | 4 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | ATM | Any mutation | 77 | 78 | TMB quintile 5 | -0.07 | -0.82 | 0.58 | 1459.57 | 1.00 | 489 | 68 | 69 | 9 | TRUE | 0.07 |
| colorectal cancer | KRAS_13 | ATM | Any mutation | 20 | 94 | TMB quintile 6 | 0.37 | -0.52 | 1.26 | 1380.57 | 1.00 | 79 | 8 | 82 | 12 | TRUE | 0.40 |
| colorectal cancer | KRAS_13 | ATM | Any mutation | 157 | 218 | TMB overall | 0.10 | -1.36 | 1.48 | 1345.06 | 1.00 | 1262 | 132 | 193 | 25 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | KMT2D | Any mutation | 59 | 27 | TMB quintile 4 | -1.04 | -3.49 | 0.58 | 1523.38 | 1.00 | 707 | 58 | 26 | 1 | FALSE | 0.52 |
| colorectal cancer | KRAS_13 | KMT2D | Any mutation | 76 | 104 | TMB quintile 5 | -0.43 | -1.20 | 0.26 | 1524.06 | 1.00 | 484 | 67 | 95 | 9 | FALSE | 0.62 |
| colorectal cancer | KRAS_13 | KMT2D | Any mutation | 26 | 245 | TMB quintile 6 | -0.43 | -1.65 | 1.00 | 1485.64 | 1.00 | 16 | 3 | 222 | 23 | FALSE | 0.29 |
| colorectal cancer | KRAS_13 | KMT2D | Any mutation | 161 | 376 | TMB overall | -0.61 | -3.20 | 1.97 | 1503.29 | 1.00 | 1207 | 128 | 343 | 33 | FALSE | 0.20 |
| colorectal cancer | KRAS_13 | TSC2 | Any mutation | 76 | 42 | TMB quintile 5 | -0.42 | -1.57 | 0.61 | 1559.31 | 1.00 | 519 | 72 | 38 | 4 | TRUE | 0.37 |
| colorectal cancer | KRAS_13 | TSC2 | Any mutation | 16 | 56 | TMB quintile 6 | -0.60 | -1.81 | 0.47 | 1412.71 | 1.00 | 86 | 12 | 52 | 4 | TRUE | 0.54 |
| colorectal cancer | KRAS_13 | TSC2 | Any mutation | 92 | 98 | TMB overall | -0.43 | -2.40 | 1.78 | 1226.15 | 1.00 | 605 | 84 | 90 | 8 | TRUE | 0.16 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 10 | 78 | TMB quintile 2 | -0.06 | -0.98 | 0.90 | 1431.95 | 1.00 | 63 | 5 | 73 | 5 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 24 | 428 | TMB quintile 3 | -0.68 | -1.42 | 0.01 | 1472.70 | 1.00 | 146 | 12 | 416 | 12 | TRUE | 1.17 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 84 | 966 | TMB quintile 4 | 0.24 | -0.30 | 0.84 | 1348.73 | 1.00 | 143 | 9 | 891 | 75 | TRUE | 0.39 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 132 | 822 | TMB quintile 5 | 0.82 | 0.28 | 1.43 | 1517.83 | 1.00 | 142 | 9 | 699 | 123 | TRUE | 2.29 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 31 | 225 | TMB quintile 6 | 0.21 | -0.54 | 0.97 | 1324.22 | 1.00 | 42 | 5 | 199 | 26 | TRUE | 0.23 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 281 | 2519 | TMB overall | 0.10 | -0.58 | 0.78 | 1428.12 | 1.00 | 536 | 40 | 2278 | 241 | TRUE | 0.11 |
| colorectal cancer | KRAS_13 | ERBB2 | Any mutation | 59 | 17 | TMB quintile 4 | 0.37 | -1.11 | 1.64 | 1466.95 | 1.00 | 717 | 57 | 15 | 2 | TRUE | 0.24 |
| colorectal cancer | KRAS_13 | ERBB2 | Any mutation | 76 | 33 | TMB quintile 5 | 0.63 | -0.22 | 1.40 | 1507.80 | 1.00 | 524 | 69 | 26 | 7 | TRUE | 0.86 |
| colorectal cancer | KRAS_13 | ERBB2 | Any mutation | 16 | 42 | TMB quintile 6 | 0.52 | -0.53 | 1.52 | 1348.22 | 1.00 | 98 | 10 | 36 | 6 | TRUE | 0.51 |
| colorectal cancer | KRAS_13 | ERBB2 | Any mutation | 151 | 92 | TMB overall | 0.51 | -0.95 | 1.93 | 1468.18 | 1.00 | 1339 | 136 | 77 | 15 | TRUE | 0.31 |
| colorectal cancer | KRAS_13 | ARID2 | Any mutation | 59 | 12 | TMB quintile 4 | 0.43 | -1.32 | 1.89 | 1510.48 | 1.00 | 722 | 57 | 10 | 2 | FALSE | 0.22 |
| colorectal cancer | KRAS_13 | ARID2 | Any mutation | 76 | 31 | TMB quintile 5 | -0.74 | -2.27 | 0.42 | 1382.15 | 1.00 | 523 | 74 | 29 | 2 | FALSE | 0.56 |
| colorectal cancer | KRAS_13 | ARID2 | Any mutation | 16 | 66 | TMB quintile 6 | -0.25 | -1.36 | 0.76 | 1528.79 | 1.00 | 78 | 10 | 60 | 6 | FALSE | 0.19 |
| colorectal cancer | KRAS_13 | ARID2 | Any mutation | 151 | 109 | TMB overall | -0.22 | -2.21 | 1.70 | 1464.60 | 1.00 | 1323 | 141 | 99 | 10 | FALSE | 0.08 |
| colorectal cancer | KRAS_13 | MTOR | Any mutation | 59 | 19 | TMB quintile 4 | -0.39 | -2.21 | 1.04 | 1617.67 | 1.00 | 714 | 58 | 18 | 1 | TRUE | 0.19 |
| colorectal cancer | KRAS_13 | MTOR | Any mutation | 76 | 40 | TMB quintile 5 | 0.38 | -0.50 | 1.17 | 1643.87 | 1.00 | 518 | 69 | 33 | 7 | TRUE | 0.42 |
| colorectal cancer | KRAS_13 | MTOR | Any mutation | 19 | 70 | TMB quintile 6 | 0.42 | -0.58 | 1.39 | 1366.19 | 1.00 | 83 | 9 | 60 | 10 | TRUE | 0.42 |
| colorectal cancer | KRAS_13 | MTOR | Any mutation | 154 | 129 | TMB overall | 0.11 | -1.74 | 1.81 | 1258.87 | 1.00 | 1315 | 136 | 111 | 18 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | NOTCH1 | Any mutation | 77 | 48 | TMB quintile 5 | -0.52 | -1.62 | 0.44 | 1332.21 | 1.00 | 509 | 73 | 44 | 4 | TRUE | 0.49 |
| colorectal cancer | KRAS_13 | NOTCH1 | Any mutation | 21 | 112 | TMB quintile 6 | 0.20 | -0.68 | 1.23 | 1344.80 | 1.00 | 60 | 7 | 98 | 14 | TRUE | 0.17 |
| colorectal cancer | KRAS_13 | NOTCH1 | Any mutation | 98 | 160 | TMB overall | -0.16 | -2.74 | 2.66 | 1477.78 | 1.00 | 569 | 80 | 142 | 18 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | SETD2 | Any mutation | 23 | 11 | TMB quintile 3 | -0.92 | -4.01 | 1.24 | 1346.46 | 1.00 | 454 | 23 | 11 | 0 | FALSE | 0.29 |
| colorectal cancer | KRAS_13 | SETD2 | Any mutation | 77 | 31 | TMB quintile 5 | 0.22 | -0.88 | 1.17 | 1407.37 | 1.00 | 526 | 72 | 26 | 5 | FALSE | 0.18 |
| colorectal cancer | KRAS_13 | SETD2 | Any mutation | 19 | 64 | TMB quintile 6 | 0.54 | -0.39 | 1.44 | 1539.12 | 1.00 | 86 | 9 | 54 | 10 | FALSE | 0.62 |
| colorectal cancer | KRAS_13 | SETD2 | Any mutation | 119 | 106 | TMB overall | -0.10 | -2.35 | 1.80 | 1517.51 | 1.00 | 1066 | 104 | 91 | 15 | FALSE | 0.03 |
| colorectal cancer | KRAS_13 | EPHA3 | Any mutation | 59 | 17 | TMB quintile 4 | 0.17 | -1.29 | 1.44 | 1460.87 | 1.00 | 718 | 57 | 15 | 2 | FALSE | 0.09 |
| colorectal cancer | KRAS_13 | EPHA3 | Any mutation | 76 | 41 | TMB quintile 5 | -0.02 | -1.03 | 0.90 | 1526.61 | 1.00 | 515 | 71 | 36 | 5 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | EPHA3 | Any mutation | 17 | 44 | TMB quintile 6 | 0.03 | -1.02 | 1.07 | 1233.38 | 1.00 | 95 | 12 | 39 | 5 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | EPHA3 | Any mutation | 152 | 102 | TMB overall | 0.06 | -1.55 | 1.56 | 1285.88 | 1.00 | 1328 | 140 | 90 | 12 | FALSE | 0.03 |
| colorectal cancer | KRAS_13 | PTCH1 | Any mutation | 77 | 35 | TMB quintile 5 | 0.30 | -0.66 | 1.17 | 1633.44 | 1.00 | 522 | 71 | 29 | 6 | TRUE | 0.27 |
| colorectal cancer | KRAS_13 | PTCH1 | Any mutation | 22 | 99 | TMB quintile 6 | -0.09 | -0.95 | 0.87 | 1458.22 | 1.00 | 64 | 10 | 87 | 12 | TRUE | 0.07 |
| colorectal cancer | KRAS_13 | PTCH1 | Any mutation | 99 | 134 | TMB overall | 0.14 | -2.53 | 2.86 | 1448.10 | 1.00 | 586 | 81 | 116 | 18 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | TET1 | Any mutation | 73 | 26 | TMB quintile 5 | 0.14 | -1.02 | 1.13 | 1452.50 | 1.00 | 496 | 69 | 22 | 4 | FALSE | 0.10 |
| colorectal cancer | KRAS_13 | TET1 | Any mutation | 21 | 67 | TMB quintile 6 | 0.28 | -0.65 | 1.20 | 1407.85 | 1.00 | 84 | 11 | 57 | 10 | FALSE | 0.26 |
| colorectal cancer | KRAS_13 | TET1 | Any mutation | 94 | 93 | TMB overall | 0.19 | -2.14 | 2.78 | 1551.84 | 1.00 | 580 | 80 | 79 | 14 | FALSE | 0.06 |
| colorectal cancer | KRAS_13 | SMAD3 | Any mutation | 23 | 12 | TMB quintile 3 | -0.20 | -1.81 | 1.28 | 1612.21 | 1.00 | 453 | 22 | 11 | 1 | TRUE | 0.10 |
| colorectal cancer | KRAS_13 | SMAD3 | Any mutation | 59 | 27 | TMB quintile 4 | -1.01 | -2.93 | 0.33 | 1376.90 | 1.00 | 710 | 59 | 27 | 0 | TRUE | 0.65 |
| colorectal cancer | KRAS_13 | SMAD3 | Any mutation | 76 | 44 | TMB quintile 5 | -0.22 | -1.19 | 0.65 | 1395.78 | 1.00 | 518 | 71 | 39 | 5 | TRUE | 0.19 |
| colorectal cancer | KRAS_13 | SMAD3 | Any mutation | 15 | 23 | TMB quintile 6 | -0.35 | -1.76 | 0.94 | 1337.22 | 1.00 | 108 | 13 | 21 | 2 | TRUE | 0.22 |
| colorectal cancer | KRAS_13 | SMAD3 | Any mutation | 173 | 106 | TMB overall | -0.45 | -1.69 | 0.66 | 1427.07 | 1.00 | 1789 | 165 | 98 | 8 | TRUE | 0.35 |
| colorectal cancer | KRAS_13 | GRIN2A | Any mutation | 59 | 30 | TMB quintile 4 | -1.74 | -4.96 | 0.14 | 1435.22 | 1.00 | 702 | 59 | 30 | 0 | FALSE | 0.75 |
| colorectal cancer | KRAS_13 | GRIN2A | Any mutation | 76 | 42 | TMB quintile 5 | -0.42 | -1.47 | 0.51 | 1746.53 | 1.00 | 513 | 72 | 38 | 4 | FALSE | 0.38 |
| colorectal cancer | KRAS_13 | GRIN2A | Any mutation | 16 | 59 | TMB quintile 6 | 0.12 | -0.88 | 1.06 | 1452.07 | 1.00 | 87 | 9 | 52 | 7 | FALSE | 0.09 |
| colorectal cancer | KRAS_13 | GRIN2A | Any mutation | 151 | 131 | TMB overall | -0.64 | -2.65 | 1.14 | 1312.84 | 1.00 | 1302 | 140 | 120 | 11 | FALSE | 0.31 |
| colorectal cancer | KRAS_13 | ASXL1 | Any mutation | 59 | 15 | TMB quintile 4 | -1.78 | -5.88 | 0.47 | 1591.96 | 1.00 | 717 | 59 | 15 | 0 | TRUE | 0.57 |
| colorectal cancer | KRAS_13 | ASXL1 | Any mutation | 76 | 30 | TMB quintile 5 | 0.64 | -0.35 | 1.59 | 1772.18 | 1.00 | 528 | 69 | 23 | 7 | TRUE | 0.73 |
| colorectal cancer | KRAS_13 | ASXL1 | Any mutation | 15 | 57 | TMB quintile 6 | -0.96 | -2.24 | 0.15 | 1418.46 | 1.00 | 82 | 12 | 54 | 3 | TRUE | 0.93 |
| colorectal cancer | KRAS_13 | ASXL1 | Any mutation | 150 | 102 | TMB overall | -0.66 | -3.03 | 1.33 | 1399.99 | 1.00 | 1327 | 140 | 92 | 10 | TRUE | 0.25 |
| colorectal cancer | KRAS_13 | EP300 | Any mutation | 76 | 39 | TMB quintile 5 | -1.65 | -3.59 | -0.16 | 1311.90 | 1.00 | 514 | 75 | 38 | 1 | TRUE | 1.25 |
| colorectal cancer | KRAS_13 | EP300 | Any mutation | 18 | 72 | TMB quintile 6 | 0.16 | -0.87 | 1.16 | 1399.95 | 1.00 | 83 | 9 | 63 | 9 | TRUE | 0.12 |
| colorectal cancer | KRAS_13 | EP300 | Any mutation | 94 | 111 | TMB overall | -0.69 | -3.16 | 1.86 | 1344.52 | 1.00 | 597 | 84 | 101 | 10 | TRUE | 0.23 |
| colorectal cancer | KRAS_13 | ERBB4 | Any mutation | 59 | 22 | TMB quintile 4 | 0.51 | -0.76 | 1.63 | 1398.68 | 1.00 | 714 | 56 | 19 | 3 | TRUE | 0.40 |
| colorectal cancer | KRAS_13 | ERBB4 | Any mutation | 76 | 45 | TMB quintile 5 | -0.28 | -1.30 | 0.60 | 1602.05 | 1.00 | 511 | 72 | 41 | 4 | TRUE | 0.24 |
| colorectal cancer | KRAS_13 | ERBB4 | Any mutation | 21 | 61 | TMB quintile 6 | 1.03 | 0.15 | 1.89 | 1455.99 | 1.00 | 89 | 8 | 48 | 13 | TRUE | 1.63 |
| colorectal cancer | KRAS_13 | ERBB4 | Any mutation | 156 | 128 | TMB overall | 0.41 | -1.16 | 1.94 | 1627.55 | 1.00 | 1314 | 136 | 108 | 20 | TRUE | 0.22 |
| colorectal cancer | KRAS_13 | MED12 | Any mutation | 59 | 18 | TMB quintile 4 | -1.55 | -4.74 | 0.55 | 1530.13 | 1.00 | 715 | 59 | 18 | 0 | TRUE | 0.59 |
| colorectal cancer | KRAS_13 | MED12 | Any mutation | 76 | 28 | TMB quintile 5 | -0.27 | -1.54 | 0.81 | 1594.41 | 1.00 | 527 | 73 | 25 | 3 | TRUE | 0.19 |
| colorectal cancer | KRAS_13 | MED12 | Any mutation | 18 | 59 | TMB quintile 6 | 0.66 | -0.25 | 1.64 | 1309.32 | 1.00 | 87 | 8 | 49 | 10 | TRUE | 0.76 |
| colorectal cancer | KRAS_13 | MED12 | Any mutation | 153 | 105 | TMB overall | -0.39 | -2.55 | 1.61 | 1305.04 | 1.00 | 1329 | 140 | 92 | 13 | TRUE | 0.14 |
| colorectal cancer | KRAS_13 | NF1 | Any mutation | 59 | 13 | TMB quintile 4 | -0.40 | -2.58 | 1.23 | 1450.06 | 1.00 | 721 | 58 | 12 | 1 | TRUE | 0.17 |
| colorectal cancer | KRAS_13 | NF1 | Any mutation | 76 | 34 | TMB quintile 5 | -0.90 | -2.48 | 0.33 | 1535.77 | 1.00 | 519 | 74 | 32 | 2 | TRUE | 0.69 |
| colorectal cancer | KRAS_13 | NF1 | Any mutation | 18 | 86 | TMB quintile 6 | -0.25 | -1.23 | 0.71 | 1365.92 | 1.00 | 79 | 10 | 78 | 8 | TRUE | 0.22 |
| colorectal cancer | KRAS_13 | NF1 | Any mutation | 153 | 133 | TMB overall | -0.56 | -2.72 | 1.42 | 1431.66 | 1.00 | 1319 | 142 | 122 | 11 | TRUE | 0.23 |
| colorectal cancer | KRAS_13 | EPHA5 | Any mutation | 59 | 18 | TMB quintile 4 | -0.82 | -2.90 | 0.75 | 1429.59 | 1.00 | 715 | 58 | 17 | 1 | FALSE | 0.42 |
| colorectal cancer | KRAS_13 | EPHA5 | Any mutation | 76 | 52 | TMB quintile 5 | -1.34 | -2.73 | -0.15 | 1250.80 | 1.00 | 503 | 74 | 50 | 2 | FALSE | 1.35 |
| colorectal cancer | KRAS_13 | EPHA5 | Any mutation | 18 | 66 | TMB quintile 6 | -0.69 | -1.78 | 0.34 | 1569.65 | 1.00 | 85 | 13 | 61 | 5 | FALSE | 0.70 |
| colorectal cancer | KRAS_13 | EPHA5 | Any mutation | 153 | 136 | TMB overall | -0.93 | -2.80 | 0.85 | 1355.26 | 1.00 | 1303 | 145 | 128 | 8 | FALSE | 0.52 |
| colorectal cancer | KRAS_13 | AR | Any mutation | 59 | 21 | TMB quintile 4 | -1.51 | -4.88 | 0.36 | 1414.67 | 1.00 | 711 | 59 | 21 | 0 | TRUE | 0.58 |
| colorectal cancer | KRAS_13 | AR | Any mutation | 77 | 34 | TMB quintile 5 | 0.28 | -0.67 | 1.16 | 1751.56 | 1.00 | 523 | 71 | 28 | 6 | TRUE | 0.26 |
| colorectal cancer | KRAS_13 | AR | Any mutation | 17 | 55 | TMB quintile 6 | -0.11 | -1.21 | 0.92 | 1550.56 | 1.00 | 86 | 11 | 49 | 6 | TRUE | 0.08 |
| colorectal cancer | KRAS_13 | AR | Any mutation | 153 | 110 | TMB overall | -0.43 | -2.27 | 1.31 | 1457.80 | 1.00 | 1320 | 141 | 98 | 12 | TRUE | 0.20 |
| colorectal cancer | KRAS_13 | ROS1 | Any mutation | 59 | 14 | TMB quintile 4 | -1.49 | -5.14 | 0.77 | 1441.50 | 1.00 | 718 | 59 | 14 | 0 | TRUE | 0.50 |
| colorectal cancer | KRAS_13 | ROS1 | Any mutation | 76 | 24 | TMB quintile 5 | -0.57 | -2.08 | 0.70 | 1494.93 | 1.00 | 528 | 74 | 22 | 2 | TRUE | 0.36 |
| colorectal cancer | KRAS_13 | ROS1 | Any mutation | 21 | 61 | TMB quintile 6 | 0.82 | -0.09 | 1.81 | 1374.86 | 1.00 | 94 | 9 | 49 | 12 | TRUE | 1.07 |
| colorectal cancer | KRAS_13 | ROS1 | Any mutation | 156 | 99 | TMB overall | -0.44 | -2.87 | 1.57 | 1584.21 | 1.00 | 1340 | 142 | 85 | 14 | TRUE | 0.15 |
| colorectal cancer | KRAS_13 | PIK3CG | Any mutation | 59 | 16 | TMB quintile 4 | -0.66 | -2.76 | 0.90 | 1385.44 | 1.00 | 717 | 58 | 15 | 1 | FALSE | 0.32 |
| colorectal cancer | KRAS_13 | PIK3CG | Any mutation | 76 | 38 | TMB quintile 5 | -1.48 | -3.25 | -0.14 | 1454.21 | 1.00 | 513 | 75 | 37 | 1 | FALSE | 1.16 |
| colorectal cancer | KRAS_13 | PIK3CG | Any mutation | 17 | 45 | TMB quintile 6 | -0.14 | -1.30 | 0.89 | 1436.34 | 1.00 | 99 | 12 | 40 | 5 | FALSE | 0.10 |
| colorectal cancer | KRAS_13 | PIK3CG | Any mutation | 152 | 99 | TMB overall | -0.72 | -2.69 | 1.02 | 1456.26 | 1.00 | 1329 | 145 | 92 | 7 | FALSE | 0.37 |
| colorectal cancer | KRAS_13 | ARID1B | Any mutation | 59 | 13 | TMB quintile 4 | -1.85 | -5.87 | 0.64 | 1523.29 | 1.00 | 720 | 59 | 13 | 0 | TRUE | 0.60 |
| colorectal cancer | KRAS_13 | ARID1B | Any mutation | 76 | 46 | TMB quintile 5 | -0.82 | -2.10 | 0.29 | 1736.22 | 1.00 | 510 | 73 | 43 | 3 | TRUE | 0.74 |
| colorectal cancer | KRAS_13 | ARID1B | Any mutation | 15 | 79 | TMB quintile 6 | 0.09 | -0.95 | 1.14 | 1512.58 | 1.00 | 74 | 7 | 71 | 8 | TRUE | 0.06 |
| colorectal cancer | KRAS_13 | ARID1B | Any mutation | 150 | 138 | TMB overall | -0.82 | -3.22 | 1.26 | 1474.48 | 1.00 | 1304 | 139 | 127 | 11 | TRUE | 0.34 |
| colorectal cancer | KRAS_13 | BRAF | Any mutation | 23 | 27 | TMB quintile 3 | -0.36 | -2.07 | 1.10 | 1451.62 | 1.00 | 439 | 21 | 25 | 2 | TRUE | 0.18 |
| colorectal cancer | KRAS_13 | BRAF | Any mutation | 59 | 60 | TMB quintile 4 | -0.82 | -2.11 | 0.28 | 1331.05 | 1.00 | 675 | 56 | 57 | 3 | TRUE | 0.75 |
| colorectal cancer | KRAS_13 | BRAF | Any mutation | 76 | 104 | TMB quintile 5 | -2.86 | -5.32 | -1.39 | 1312.40 | 1.00 | 449 | 76 | 104 | 0 | TRUE | 2.34 |
| colorectal cancer | KRAS_13 | BRAF | Any mutation | 15 | 59 | TMB quintile 6 | -1.10 | -2.42 | 0.04 | 1589.26 | 1.00 | 80 | 12 | 56 | 3 | TRUE | 1.11 |
| colorectal cancer | KRAS_13 | BRAF | Any mutation | 173 | 250 | TMB overall | -1.24 | -2.66 | 0.13 | 1528.02 | 1.00 | 1643 | 165 | 242 | 8 | TRUE | 1.07 |
| colorectal cancer | KRAS_13 | B2M | Any mutation | 74 | 50 | TMB quintile 5 | -0.78 | -2.05 | 0.23 | 1452.18 | 1.00 | 487 | 71 | 47 | 3 | FALSE | 0.74 |
| colorectal cancer | KRAS_13 | B2M | Any mutation | 20 | 79 | TMB quintile 6 | 0.71 | -0.18 | 1.68 | 1374.96 | 1.00 | 82 | 7 | 66 | 13 | FALSE | 0.86 |
| colorectal cancer | KRAS_13 | B2M | Any mutation | 94 | 129 | TMB overall | -0.06 | -2.43 | 2.26 | 1464.59 | 1.00 | 569 | 78 | 113 | 16 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | CARD11 | Any mutation | 59 | 28 | TMB quintile 4 | -0.21 | -1.64 | 1.00 | 1501.20 | 1.00 | 706 | 57 | 26 | 2 | FALSE | 0.12 |
| colorectal cancer | KRAS_13 | CARD11 | Any mutation | 76 | 43 | TMB quintile 5 | -0.61 | -1.77 | 0.38 | 1506.51 | 1.00 | 511 | 73 | 40 | 3 | FALSE | 0.56 |
| colorectal cancer | KRAS_13 | CARD11 | Any mutation | 18 | 52 | TMB quintile 6 | 0.39 | -0.56 | 1.35 | 1196.92 | 1.00 | 91 | 10 | 44 | 8 | FALSE | 0.38 |
| colorectal cancer | KRAS_13 | CARD11 | Any mutation | 153 | 123 | TMB overall | -0.16 | -1.55 | 1.29 | 1586.34 | 1.00 | 1308 | 140 | 110 | 13 | FALSE | 0.08 |
| colorectal cancer | KRAS_13 | SOX9 | Any mutation | 23 | 17 | TMB quintile 3 | 0.58 | -0.64 | 1.79 | 1499.87 | 1.00 | 449 | 21 | 15 | 2 | FALSE | 0.45 |
| colorectal cancer | KRAS_13 | SOX9 | Any mutation | 59 | 85 | TMB quintile 4 | 0.30 | -0.44 | 0.99 | 1634.76 | 1.00 | 659 | 51 | 77 | 8 | FALSE | 0.38 |
| colorectal cancer | KRAS_13 | SOX9 | Any mutation | 77 | 107 | TMB quintile 5 | 0.32 | -0.24 | 0.86 | 1544.27 | 1.00 | 470 | 61 | 91 | 16 | FALSE | 0.59 |
| colorectal cancer | KRAS_13 | SOX9 | Any mutation | 17 | 50 | TMB quintile 6 | 0.45 | -0.47 | 1.30 | 1358.22 | 1.00 | 90 | 10 | 43 | 7 | FALSE | 0.49 |
| colorectal cancer | KRAS_13 | SOX9 | Any mutation | 176 | 259 | TMB overall | 0.41 | -0.55 | 1.32 | 1364.53 | 1.00 | 1668 | 143 | 226 | 33 | FALSE | 0.42 |
| colorectal cancer | KRAS_13 | SMAD2 | Any mutation | 59 | 29 | TMB quintile 4 | -0.21 | -1.62 | 0.81 | 1562.75 | 1.00 | 705 | 58 | 28 | 1 | TRUE | 0.14 |
| colorectal cancer | KRAS_13 | SMAD2 | Any mutation | 77 | 53 | TMB quintile 5 | 0.13 | -0.70 | 0.83 | 1438.64 | 1.00 | 510 | 70 | 46 | 7 | TRUE | 0.13 |
| colorectal cancer | KRAS_13 | SMAD2 | Any mutation | 16 | 16 | TMB quintile 6 | 0.58 | -0.45 | 1.68 | 1368.83 | 1.00 | 117 | 12 | 12 | 4 | TRUE | 0.54 |
| colorectal cancer | KRAS_13 | SMAD2 | Any mutation | 152 | 98 | TMB overall | 0.16 | -0.91 | 1.11 | 1482.17 | 1.00 | 1332 | 140 | 86 | 12 | TRUE | 0.12 |
| colorectal cancer | KRAS_13 | ZFHX3 | Any mutation | 53 | 14 | TMB quintile 4 | -0.47 | -2.55 | 1.24 | 1435.38 | 1.00 | 654 | 52 | 13 | 1 | FALSE | 0.19 |
| colorectal cancer | KRAS_13 | ZFHX3 | Any mutation | 67 | 63 | TMB quintile 5 | 0.06 | -0.80 | 0.86 | 1526.32 | 1.00 | 463 | 59 | 55 | 8 | FALSE | 0.05 |
| colorectal cancer | KRAS_13 | ZFHX3 | Any mutation | 19 | 143 | TMB quintile 6 | -0.97 | -1.92 | 0.00 | 1495.11 | 1.00 | 41 | 9 | 133 | 10 | FALSE | 1.33 |
| colorectal cancer | KRAS_13 | ZFHX3 | Any mutation | 139 | 220 | TMB overall | -0.43 | -2.71 | 1.84 | 1583.47 | 1.00 | 1158 | 120 | 201 | 19 | FALSE | 0.15 |
| colorectal cancer | KRAS_13 | MGA | Any mutation | 53 | 15 | TMB quintile 4 | 0.34 | -1.14 | 1.70 | 1454.47 | 1.00 | 655 | 51 | 13 | 2 | FALSE | 0.20 |
| colorectal cancer | KRAS_13 | MGA | Any mutation | 66 | 46 | TMB quintile 5 | -0.07 | -1.01 | 0.80 | 1487.02 | 1.00 | 472 | 61 | 41 | 5 | FALSE | 0.06 |
| colorectal cancer | KRAS_13 | MGA | Any mutation | 18 | 58 | TMB quintile 6 | 0.47 | -0.45 | 1.38 | 1586.01 | 1.00 | 79 | 9 | 49 | 9 | FALSE | 0.50 |
| colorectal cancer | KRAS_13 | MGA | Any mutation | 137 | 119 | TMB overall | 0.27 | -1.43 | 1.93 | 1202.80 | 1.00 | 1206 | 121 | 103 | 16 | FALSE | 0.13 |
| colorectal cancer | KRAS_13 | KMT2B | Any mutation | 39 | 54 | TMB quintile 5 | 0.35 | -0.50 | 1.16 | 1592.36 | 1.00 | 249 | 31 | 46 | 8 | FALSE | 0.39 |
| colorectal cancer | KRAS_13 | KMT2B | Any mutation | 13 | 115 | TMB quintile 6 | 2.31 | -0.03 | 6.83 | 1358.63 | 1.00 | 22 | 0 | 102 | 13 | FALSE | 0.70 |
| colorectal cancer | KRAS_13 | KMT2B | Any mutation | 52 | 169 | TMB overall | 1.27 | -1.93 | 5.51 | 1449.58 | 1.00 | 271 | 31 | 148 | 21 | FALSE | 0.32 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 23 | 35 | TMB quintile 3 | -0.13 | -1.34 | 0.95 | 1480.78 | 1.00 | 385 | 21 | 33 | 2 | FALSE | 0.08 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 54 | 79 | TMB quintile 4 | -0.25 | -1.11 | 0.54 | 1512.73 | 1.00 | 596 | 49 | 74 | 5 | FALSE | 0.25 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 68 | 108 | TMB quintile 5 | 0.01 | -0.61 | 0.60 | 1465.97 | 1.00 | 424 | 55 | 95 | 13 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 15 | 70 | TMB quintile 6 | -0.25 | -1.21 | 0.63 | 1571.50 | 1.00 | 65 | 9 | 64 | 6 | FALSE | 0.23 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 160 | 292 | TMB overall | -0.16 | -1.22 | 0.79 | 1553.63 | 1.00 | 1470 | 134 | 266 | 26 | FALSE | 0.12 |
| colorectal cancer | KRAS_13 | ANKRD11 | Any mutation | 52 | 11 | TMB quintile 4 | 0.60 | -1.13 | 2.04 | 1469.65 | 1.00 | 641 | 50 | 9 | 2 | FALSE | 0.33 |
| colorectal cancer | KRAS_13 | ANKRD11 | Any mutation | 63 | 43 | TMB quintile 5 | -0.61 | -1.76 | 0.43 | 1482.19 | 1.00 | 441 | 60 | 40 | 3 | FALSE | 0.55 |
| colorectal cancer | KRAS_13 | ANKRD11 | Any mutation | 16 | 86 | TMB quintile 6 | 0.15 | -0.86 | 1.18 | 1380.89 | 1.00 | 68 | 7 | 77 | 9 | FALSE | 0.12 |
| colorectal cancer | KRAS_13 | ANKRD11 | Any mutation | 131 | 140 | TMB overall | 0.05 | -2.05 | 2.06 | 1439.01 | 1.00 | 1150 | 117 | 126 | 14 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | POLD1 | Any mutation | 66 | 20 | TMB quintile 5 | 0.14 | -1.25 | 1.29 | 1611.89 | 1.00 | 498 | 63 | 17 | 3 | TRUE | 0.08 |
| colorectal cancer | KRAS_13 | POLD1 | Any mutation | 16 | 83 | TMB quintile 6 | -0.12 | -1.19 | 0.88 | 1394.84 | 1.00 | 65 | 8 | 75 | 8 | TRUE | 0.08 |
| colorectal cancer | KRAS_13 | POLD1 | Any mutation | 82 | 103 | TMB overall | 0.06 | -2.79 | 3.02 | 1336.61 | 1.00 | 563 | 71 | 92 | 11 | TRUE | 0.01 |
| colorectal cancer | KRAS_13 | AMER1 | Any mutation | 23 | 13 | TMB quintile 3 | 0.80 | -0.62 | 2.15 | 1441.32 | 1.00 | 453 | 21 | 11 | 2 | FALSE | 0.59 |
| colorectal cancer | KRAS_13 | AMER1 | Any mutation | 59 | 38 | TMB quintile 4 | -0.63 | -2.23 | 0.60 | 1562.62 | 1.00 | 697 | 58 | 37 | 1 | FALSE | 0.42 |
| colorectal cancer | KRAS_13 | AMER1 | Any mutation | 76 | 62 | TMB quintile 5 | 0.09 | -0.67 | 0.84 | 1579.64 | 1.00 | 496 | 68 | 54 | 8 | FALSE | 0.09 |
| colorectal cancer | KRAS_13 | AMER1 | Any mutation | 20 | 55 | TMB quintile 6 | 1.25 | 0.39 | 2.23 | 1371.63 | 1.00 | 91 | 7 | 42 | 13 | FALSE | 2.06 |
| colorectal cancer | KRAS_13 | AMER1 | Any mutation | 178 | 168 | TMB overall | 0.38 | -0.90 | 1.64 | 1587.93 | 1.00 | 1737 | 154 | 144 | 24 | FALSE | 0.26 |
| melanoma | RAS_61 | SPEN | Any mutation | 136 | 55 | TMB quintile 5 | -0.27 | -0.90 | 0.32 | 1422.20 | 1.00 | 229 | 120 | 39 | 16 | FALSE | 0.42 |
| melanoma | RAS_61 | SPEN | Any mutation | 139 | 111 | TMB overall | -0.13 | -2.94 | 3.09 | 1543.07 | 1.00 | 266 | 121 | 93 | 18 | FALSE | 0.03 |
| melanoma | RAS_61 | KMT2C | Any mutation | 131 | 85 | TMB quintile 5 | -0.44 | -1.03 | 0.07 | 1526.23 | 1.00 | 195 | 108 | 62 | 23 | FALSE | 0.94 |
| melanoma | RAS_61 | KMT2C | Any mutation | 134 | 139 | TMB overall | -1.67 | -5.43 | 1.64 | 1249.81 | 1.00 | 220 | 111 | 116 | 23 | FALSE | 0.47 |
| melanoma | RAS_61 | TP53 | Any mutation | 11 | 14 | TMB quintile 3 | -1.56 | -4.18 | 0.24 | 1448.25 | 1.00 | 87 | 11 | 14 | 0 | TRUE | 0.76 |
| melanoma | RAS_61 | TP53 | Any mutation | 17 | 16 | TMB quintile 4 | 0.20 | -1.12 | 1.44 | 1525.80 | 1.00 | 76 | 13 | 12 | 4 | TRUE | 0.12 |
| melanoma | RAS_61 | TP53 | Any mutation | 136 | 119 | TMB quintile 5 | -0.37 | -0.85 | 0.08 | 1576.28 | 1.00 | 187 | 103 | 86 | 33 | TRUE | 0.88 |
| melanoma | RAS_61 | TP53 | Any mutation | 167 | 201 | TMB overall | -0.73 | -2.28 | 0.76 | 1538.58 | 1.00 | 377 | 129 | 163 | 38 | TRUE | 0.48 |
| melanoma | RAS_61 | ATRX | Any mutation | 138 | 58 | TMB quintile 5 | -0.11 | -0.70 | 0.49 | 1432.07 | 1.00 | 232 | 119 | 39 | 19 | TRUE | 0.14 |
| melanoma | RAS_61 | ATRX | Any mutation | 141 | 88 | TMB overall | -1.16 | -5.06 | 2.03 | 1430.01 | 1.00 | 283 | 122 | 69 | 19 | TRUE | 0.31 |
| melanoma | RAS_61 | PTPRD | Any mutation | 145 | 147 | TMB quintile 5 | -0.26 | -0.73 | 0.16 | 1522.21 | 1.00 | 181 | 101 | 103 | 44 | FALSE | 0.61 |
| melanoma | RAS_61 | PTPRD | Any mutation | 6 | 115 | TMB quintile 6 | 1.18 | -1.10 | 5.44 | 1281.26 | 1.00 | 21 | 0 | 109 | 6 | FALSE | 0.31 |
| melanoma | RAS_61 | PTPRD | Any mutation | 151 | 262 | TMB overall | 0.36 | -2.74 | 3.95 | 1404.70 | 1.00 | 202 | 101 | 212 | 50 | FALSE | 0.08 |
| melanoma | RAS_61 | PIK3C2G | Any mutation | 135 | 99 | TMB quintile 5 | 0.27 | -0.22 | 0.75 | 1512.85 | 1.00 | 197 | 96 | 60 | 39 | FALSE | 0.57 |
| melanoma | RAS_61 | PIK3C2G | Any mutation | 139 | 184 | TMB overall | -0.07 | -2.86 | 2.81 | 1290.36 | 1.00 | 216 | 97 | 142 | 42 | FALSE | 0.02 |
| melanoma | RAS_61 | PTPRT | Any mutation | 147 | 200 | TMB quintile 5 | 0.02 | -0.38 | 0.39 | 1575.43 | 1.00 | 167 | 81 | 134 | 66 | FALSE | 0.04 |
| melanoma | RAS_61 | PTPRT | Any mutation | 8 | 153 | TMB quintile 6 | 0.88 | -1.58 | 4.90 | 1292.53 | 1.00 | 13 | 0 | 145 | 8 | FALSE | 0.21 |
| melanoma | RAS_61 | PTPRT | Any mutation | 155 | 353 | TMB overall | 0.37 | -2.72 | 4.00 | 1165.06 | 1.00 | 180 | 81 | 279 | 74 | FALSE | 0.08 |
| melanoma | RAS_61 | ALK | Any mutation | 137 | 76 | TMB quintile 5 | 0.01 | -0.54 | 0.53 | 1667.59 | 1.00 | 218 | 111 | 50 | 26 | TRUE | 0.02 |
| melanoma | RAS_61 | ALK | Any mutation | 141 | 127 | TMB overall | 0.15 | -2.46 | 2.92 | 1369.48 | 1.00 | 252 | 112 | 98 | 29 | TRUE | 0.04 |
| melanoma | RAS_61 | IKZF1 | Any mutation | 137 | 57 | TMB quintile 5 | -0.25 | -0.87 | 0.34 | 1602.30 | 1.00 | 229 | 120 | 40 | 17 | TRUE | 0.38 |
| melanoma | RAS_61 | IKZF1 | Any mutation | 140 | 101 | TMB overall | -0.63 | -3.30 | 2.07 | 1211.30 | 1.00 | 269 | 122 | 83 | 18 | TRUE | 0.19 |
| melanoma | RAS_61 | FAT1 | Any mutation | 137 | 86 | TMB quintile 5 | -0.34 | -0.86 | 0.17 | 1468.86 | 1.00 | 209 | 113 | 62 | 24 | FALSE | 0.70 |
| melanoma | RAS_61 | FAT1 | Any mutation | 140 | 136 | TMB overall | -0.18 | -2.85 | 2.71 | 1213.19 | 1.00 | 247 | 114 | 110 | 26 | FALSE | 0.05 |
| melanoma | RAS_61 | KMT2A | Any mutation | 138 | 69 | TMB quintile 5 | -0.12 | -0.69 | 0.44 | 1428.86 | 1.00 | 225 | 116 | 47 | 22 | FALSE | 0.16 |
| melanoma | RAS_61 | KMT2A | Any mutation | 141 | 131 | TMB overall | -0.20 | -3.03 | 3.10 | 1484.45 | 1.00 | 256 | 117 | 107 | 24 | FALSE | 0.05 |
| melanoma | RAS_61 | PAK7 | Any mutation | 135 | 135 | TMB quintile 5 | -0.40 | -0.87 | 0.02 | 1323.94 | 1.00 | 167 | 97 | 97 | 38 | FALSE | 1.10 |
| melanoma | RAS_61 | PAK7 | Any mutation | 140 | 210 | TMB overall | -0.26 | -2.62 | 2.57 | 1424.41 | 1.00 | 187 | 98 | 168 | 42 | FALSE | 0.07 |
| melanoma | RAS_61 | TERT | Any mutation | 11 | 17 | TMB quintile 2 | 2.45 | 1.18 | 3.76 | 1275.78 | 1.00 | 103 | 4 | 10 | 7 | TRUE | 3.72 |
| melanoma | RAS_61 | TERT | Any mutation | 11 | 29 | TMB quintile 3 | 0.98 | -0.24 | 2.20 | 1410.62 | 1.00 | 77 | 6 | 24 | 5 | TRUE | 0.94 |
| melanoma | RAS_61 | TERT | Any mutation | 19 | 57 | TMB quintile 4 | 1.18 | 0.20 | 2.20 | 1292.66 | 1.00 | 45 | 5 | 43 | 14 | TRUE | 1.60 |
| melanoma | RAS_61 | TERT | Any mutation | 149 | 396 | TMB quintile 5 | 0.72 | 0.12 | 1.39 | 1478.96 | 1.00 | 44 | 13 | 260 | 136 | TRUE | 1.57 |
| melanoma | RAS_61 | TERT | Any mutation | 194 | 605 | TMB overall | 1.21 | -0.27 | 2.77 | 1325.70 | 1.00 | 281 | 28 | 439 | 166 | TRUE | 0.96 |
| melanoma | RAS_61 | NOTCH3 | Any mutation | 136 | 67 | TMB quintile 5 | -0.45 | -1.08 | 0.12 | 1485.03 | 1.00 | 217 | 118 | 49 | 18 | TRUE | 0.84 |
| melanoma | RAS_61 | NOTCH3 | Any mutation | 139 | 124 | TMB overall | -1.66 | -5.48 | 1.68 | 1386.07 | 1.00 | 249 | 121 | 106 | 18 | TRUE | 0.47 |
| melanoma | RAS_61 | NOTCH4 | Any mutation | 132 | 81 | TMB quintile 5 | -0.06 | -0.59 | 0.44 | 1618.19 | 1.00 | 202 | 105 | 54 | 27 | TRUE | 0.08 |
| melanoma | RAS_61 | NOTCH4 | Any mutation | 136 | 145 | TMB overall | -0.11 | -2.87 | 3.01 | 1514.35 | 1.00 | 223 | 106 | 115 | 30 | TRUE | 0.03 |
| melanoma | RAS_61 | CDKN2A | Any mutation | 140 | 80 | TMB quintile 5 | 0.08 | -0.42 | 0.59 | 1421.26 | 1.00 | 215 | 111 | 51 | 29 | TRUE | 0.12 |
| melanoma | RAS_61 | CDKN2A | Any mutation | 143 | 114 | TMB overall | 0.15 | -2.33 | 2.86 | 1506.42 | 1.00 | 252 | 112 | 83 | 31 | TRUE | 0.04 |
| melanoma | RAS_61 | KMT2D | Any mutation | 144 | 112 | TMB quintile 5 | 0.11 | -0.32 | 0.55 | 1363.43 | 1.00 | 207 | 104 | 72 | 40 | FALSE | 0.21 |
| melanoma | RAS_61 | KMT2D | Any mutation | 7 | 91 | TMB quintile 6 | 1.75 | -0.54 | 5.67 | 1093.87 | 1.00 | 28 | 0 | 84 | 7 | FALSE | 0.54 |
| melanoma | RAS_61 | KMT2D | Any mutation | 151 | 203 | TMB overall | 0.74 | -2.72 | 4.47 | 1472.77 | 1.00 | 235 | 104 | 156 | 47 | FALSE | 0.17 |
| colorectal cancer | RAS_61 | APC | Any mutation | 24 | 428 | TMB quintile 3 | -0.48 | -1.29 | 0.38 | 1533.50 | 1.00 | 148 | 10 | 414 | 14 | TRUE | 0.59 |
| colorectal cancer | RAS_61 | APC | Any mutation | 50 | 966 | TMB quintile 4 | 0.66 | -0.22 | 1.64 | 1527.26 | 1.00 | 149 | 3 | 919 | 47 | TRUE | 0.78 |
| colorectal cancer | RAS_61 | APC | Any mutation | 49 | 822 | TMB quintile 5 | 0.77 | -0.07 | 1.72 | 1507.92 | 1.00 | 148 | 3 | 776 | 46 | TRUE | 1.03 |
| melanoma | RAS_61 | APC | Any mutation | 136 | 67 | TMB quintile 5 | -0.46 | -1.11 | 0.12 | 1530.68 | 1.00 | 224 | 119 | 50 | 17 | TRUE | 0.88 |
| colorectal cancer | RAS_61 | APC | Any mutation | 126 | 2519 | TMB overall | -0.26 | -1.48 | 0.79 | 1599.15 | 1.00 | 557 | 19 | 2412 | 107 | TRUE | 0.19 |
| melanoma | RAS_61 | APC | Any mutation | 139 | 117 | TMB overall | -0.24 | -3.04 | 2.89 | 1423.29 | 1.00 | 261 | 120 | 98 | 19 | TRUE | 0.06 |
| melanoma | RAS_61 | ARID2 | Any mutation | 143 | 83 | TMB quintile 5 | 0.21 | -0.29 | 0.71 | 1464.57 | 1.00 | 222 | 111 | 51 | 32 | FALSE | 0.38 |
| melanoma | RAS_61 | ARID2 | Any mutation | 146 | 136 | TMB overall | -0.31 | -3.02 | 2.40 | 1440.30 | 1.00 | 267 | 113 | 103 | 33 | FALSE | 0.09 |
| melanoma | RAS_61 | EPHA3 | Any mutation | 139 | 57 | TMB quintile 5 | 0.63 | 0.06 | 1.19 | 1219.12 | 1.00 | 237 | 112 | 30 | 27 | FALSE | 1.55 |
| melanoma | RAS_61 | EPHA3 | Any mutation | 142 | 102 | TMB overall | 0.40 | -2.42 | 3.53 | 1322.20 | 1.00 | 274 | 113 | 73 | 29 | FALSE | 0.11 |
| melanoma | RAS_61 | KDR | Any mutation | 135 | 64 | TMB quintile 5 | -0.25 | -0.87 | 0.33 | 1533.47 | 1.00 | 220 | 116 | 45 | 19 | TRUE | 0.39 |
| melanoma | RAS_61 | KDR | Any mutation | 139 | 126 | TMB overall | -0.50 | -3.16 | 2.25 | 1413.88 | 1.00 | 249 | 118 | 105 | 21 | TRUE | 0.15 |
| melanoma | RAS_61 | NTRK3 | Any mutation | 140 | 58 | TMB quintile 5 | -0.32 | -0.93 | 0.31 | 1354.34 | 1.00 | 224 | 123 | 41 | 17 | FALSE | 0.51 |
| melanoma | RAS_61 | NTRK3 | Any mutation | 143 | 100 | TMB overall | -0.58 | -3.56 | 2.34 | 1536.69 | 1.00 | 262 | 125 | 82 | 18 | FALSE | 0.17 |
| melanoma | RAS_61 | GRIN2A | Any mutation | 144 | 166 | TMB quintile 5 | -0.57 | -1.02 | -0.14 | 1530.87 | 1.00 | 171 | 102 | 124 | 42 | FALSE | 2.01 |
| melanoma | RAS_61 | GRIN2A | Any mutation | 6 | 124 | TMB quintile 6 | -0.52 | -2.19 | 1.51 | 1505.50 | 1.00 | 17 | 1 | 119 | 5 | FALSE | 0.24 |
| melanoma | RAS_61 | GRIN2A | Any mutation | 150 | 290 | TMB overall | -0.49 | -3.07 | 2.63 | 1226.64 | 1.00 | 188 | 103 | 243 | 47 | FALSE | 0.13 |
| melanoma | RAS_61 | ERBB4 | Any mutation | 139 | 92 | TMB quintile 5 | -0.28 | -0.78 | 0.21 | 1533.85 | 1.00 | 206 | 112 | 65 | 27 | TRUE | 0.56 |
| melanoma | RAS_61 | ERBB4 | Any mutation | 143 | 181 | TMB overall | -0.41 | -3.43 | 2.50 | 1577.19 | 1.00 | 225 | 113 | 151 | 30 | TRUE | 0.11 |
| melanoma | RAS_61 | NF1 | Any mutation | 11 | 13 | TMB quintile 3 | -0.93 | -3.18 | 1.13 | 1579.27 | 1.00 | 88 | 10 | 12 | 1 | TRUE | 0.41 |
| melanoma | RAS_61 | NF1 | Any mutation | 17 | 11 | TMB quintile 4 | -2.37 | -5.84 | -0.09 | 1710.50 | 1.00 | 79 | 17 | 11 | 0 | TRUE | 1.00 |
| melanoma | RAS_61 | NF1 | Any mutation | 137 | 162 | TMB quintile 5 | -1.59 | -2.14 | -1.07 | 1472.23 | 1.00 | 168 | 117 | 142 | 20 | TRUE | 8.39 |
| melanoma | RAS_61 | NF1 | Any mutation | 170 | 286 | TMB overall | -1.25 | -3.26 | 0.85 | 1499.92 | 1.00 | 347 | 144 | 260 | 26 | TRUE | 0.66 |
| melanoma | RAS_61 | FLT1 | Any mutation | 137 | 60 | TMB quintile 5 | -0.14 | -0.74 | 0.43 | 1476.51 | 1.00 | 223 | 118 | 41 | 19 | FALSE | 0.20 |
| melanoma | RAS_61 | FLT1 | Any mutation | 142 | 116 | TMB overall | 0.19 | -2.45 | 3.22 | 1480.97 | 1.00 | 257 | 119 | 93 | 23 | FALSE | 0.05 |
| melanoma | RAS_61 | ROS1 | Any mutation | 140 | 139 | TMB quintile 5 | -0.28 | -0.72 | 0.15 | 1471.83 | 1.00 | 187 | 100 | 99 | 40 | TRUE | 0.68 |
| melanoma | RAS_61 | ROS1 | Any mutation | 144 | 242 | TMB overall | 0.20 | -3.13 | 3.97 | 1431.26 | 1.00 | 210 | 100 | 198 | 44 | TRUE | 0.04 |
| melanoma | RAS_61 | PIK3CG | Any mutation | 135 | 43 | TMB quintile 5 | -0.48 | -1.19 | 0.19 | 1346.91 | 1.00 | 232 | 124 | 32 | 11 | FALSE | 0.74 |
| melanoma | RAS_61 | PIK3CG | Any mutation | 139 | 99 | TMB overall | -0.04 | -3.12 | 3.27 | 1461.63 | 1.00 | 268 | 125 | 85 | 14 | FALSE | 0.01 |
| melanoma | RAS_61 | BRAF | Any mutation | 10 | 16 | TMB quintile 2 | -3.09 | -5.95 | -0.83 | 1451.55 | 1.00 | 96 | 10 | 16 | 0 | TRUE | 1.84 |
| melanoma | RAS_61 | BRAF | Any mutation | 11 | 27 | TMB quintile 3 | -3.29 | -5.95 | -1.19 | 1331.11 | 1.00 | 72 | 11 | 27 | 0 | TRUE | 2.13 |
| melanoma | RAS_61 | BRAF | Any mutation | 17 | 53 | TMB quintile 4 | -3.11 | -5.06 | -1.71 | 1509.95 | 1.00 | 37 | 16 | 52 | 1 | TRUE | 3.48 |
| melanoma | RAS_61 | BRAF | Any mutation | 138 | 170 | TMB quintile 5 | -2.21 | -2.79 | -1.66 | 1466.75 | 1.00 | 124 | 121 | 153 | 17 | TRUE | 14.56 |
| melanoma | RAS_61 | BRAF | Any mutation | 179 | 283 | TMB overall | -2.92 | -4.66 | -1.52 | 1404.77 | 1.00 | 379 | 161 | 265 | 18 | TRUE | 3.52 |
| melanoma | RAS_61 | CARD11 | Any mutation | 137 | 63 | TMB quintile 5 | -0.60 | -1.24 | -0.01 | 1478.52 | 1.00 | 221 | 122 | 48 | 15 | FALSE | 1.24 |
| melanoma | RAS_61 | CARD11 | Any mutation | 140 | 108 | TMB overall | -0.79 | -3.52 | 2.12 | 1361.07 | 1.00 | 255 | 124 | 92 | 16 | FALSE | 0.24 |
| melanoma | RAS_61 | TP63 | Any mutation | 134 | 95 | TMB quintile 5 | 0.12 | -0.37 | 0.64 | 1316.90 | 1.00 | 196 | 99 | 60 | 35 | FALSE | 0.21 |
| melanoma | RAS_61 | TP63 | Any mutation | 137 | 164 | TMB overall | -0.28 | -3.50 | 2.94 | 1452.89 | 1.00 | 212 | 100 | 127 | 37 | FALSE | 0.07 |
| melanoma | RAS_61 | ZFHX3 | Any mutation | 132 | 62 | TMB quintile 5 | -0.18 | -0.80 | 0.42 | 1448.70 | 1.00 | 216 | 113 | 43 | 19 | FALSE | 0.27 |
| melanoma | RAS_61 | ZFHX3 | Any mutation | 135 | 140 | TMB overall | -0.26 | -3.33 | 2.87 | 1563.38 | 1.00 | 251 | 114 | 119 | 21 | FALSE | 0.07 |
| melanoma | RAS_61 | PREX2 | Any mutation | 87 | 89 | TMB quintile 5 | 0.18 | -0.36 | 0.77 | 1372.14 | 1.00 | 103 | 53 | 55 | 34 | FALSE | 0.27 |
| melanoma | RAS_61 | PREX2 | Any mutation | 91 | 165 | TMB overall | 0.43 | -2.84 | 4.17 | 1321.44 | 1.00 | 116 | 53 | 127 | 38 | FALSE | 0.10 |
| melanoma | RAS_61 | EPHA7 | Any mutation | 132 | 89 | TMB quintile 5 | -0.19 | -0.71 | 0.32 | 1329.84 | 1.00 | 201 | 105 | 62 | 27 | FALSE | 0.33 |
| melanoma | RAS_61 | EPHA7 | Any mutation | 135 | 152 | TMB overall | -0.29 | -2.87 | 2.50 | 1394.92 | 1.00 | 230 | 106 | 123 | 29 | FALSE | 0.08 |
| melanoma | NRAS_61 | SPEN | Any mutation | 132 | 55 | TMB quintile 5 | -0.42 | -1.06 | 0.24 | 1485.25 | 1.00 | 231 | 118 | 41 | 14 | FALSE | 0.68 |
| melanoma | NRAS_61 | SPEN | Any mutation | 135 | 111 | TMB overall | -0.24 | -3.32 | 3.29 | 1456.32 | 1.00 | 268 | 119 | 95 | 16 | FALSE | 0.06 |
| melanoma | NRAS_61 | KMT2C | Any mutation | 127 | 85 | TMB quintile 5 | -0.40 | -0.95 | 0.14 | 1172.21 | 1.00 | 199 | 104 | 62 | 23 | FALSE | 0.82 |
| melanoma | NRAS_61 | KMT2C | Any mutation | 130 | 139 | TMB overall | -1.72 | -5.64 | 1.48 | 1491.44 | 1.00 | 224 | 107 | 116 | 23 | FALSE | 0.48 |
| melanoma | NRAS_61 | TP53 | Any mutation | 10 | 14 | TMB quintile 3 | -1.51 | -4.20 | 0.34 | 1458.67 | 1.00 | 88 | 10 | 14 | 0 | TRUE | 0.72 |
| melanoma | NRAS_61 | TP53 | Any mutation | 16 | 16 | TMB quintile 4 | -0.18 | -1.54 | 1.09 | 1548.56 | 1.00 | 76 | 13 | 13 | 3 | TRUE | 0.10 |
| melanoma | NRAS_61 | TP53 | Any mutation | 132 | 119 | TMB quintile 5 | -0.37 | -0.83 | 0.07 | 1502.46 | 1.00 | 190 | 100 | 87 | 32 | TRUE | 0.94 |
| melanoma | NRAS_61 | TP53 | Any mutation | 161 | 201 | TMB overall | -0.81 | -2.30 | 0.55 | 1310.07 | 1.00 | 381 | 125 | 165 | 36 | TRUE | 0.55 |
| melanoma | NRAS_61 | ATRX | Any mutation | 133 | 58 | TMB quintile 5 | -0.21 | -0.85 | 0.38 | 1596.39 | 1.00 | 235 | 116 | 41 | 17 | TRUE | 0.31 |
| melanoma | NRAS_61 | ATRX | Any mutation | 136 | 88 | TMB overall | -1.25 | -5.23 | 1.67 | 1664.05 | 1.00 | 286 | 119 | 71 | 17 | TRUE | 0.34 |
| melanoma | NRAS_61 | PTPRD | Any mutation | 141 | 147 | TMB quintile 5 | -0.20 | -0.61 | 0.24 | 1423.96 | 1.00 | 185 | 97 | 103 | 44 | FALSE | 0.45 |
| melanoma | NRAS_61 | PTPRD | Any mutation | 6 | 115 | TMB quintile 6 | 1.17 | -1.23 | 5.55 | 1431.78 | 1.00 | 21 | 0 | 109 | 6 | FALSE | 0.29 |
| melanoma | NRAS_61 | PTPRD | Any mutation | 147 | 262 | TMB overall | 0.40 | -2.92 | 4.52 | 1337.34 | 1.00 | 206 | 97 | 212 | 50 | FALSE | 0.08 |
| melanoma | NRAS_61 | PIK3C2G | Any mutation | 130 | 99 | TMB quintile 5 | 0.19 | -0.29 | 0.66 | 1456.34 | 1.00 | 199 | 94 | 63 | 36 | FALSE | 0.35 |
| melanoma | NRAS_61 | PIK3C2G | Any mutation | 134 | 184 | TMB overall | -0.12 | -3.04 | 3.19 | 1458.03 | 1.00 | 218 | 95 | 145 | 39 | FALSE | 0.03 |
| melanoma | NRAS_61 | PTPRT | Any mutation | 143 | 200 | TMB quintile 5 | 0.01 | -0.41 | 0.40 | 1581.67 | 1.00 | 169 | 79 | 136 | 64 | FALSE | 0.02 |
| melanoma | NRAS_61 | PTPRT | Any mutation | 8 | 153 | TMB quintile 6 | 0.99 | -1.61 | 5.45 | 1362.41 | 1.00 | 13 | 0 | 145 | 8 | FALSE | 0.22 |
| melanoma | NRAS_61 | PTPRT | Any mutation | 151 | 353 | TMB overall | 0.44 | -2.45 | 4.27 | 1607.93 | 1.00 | 182 | 79 | 281 | 72 | FALSE | 0.10 |
| melanoma | NRAS_61 | ALK | Any mutation | 133 | 76 | TMB quintile 5 | -0.07 | -0.63 | 0.46 | 1416.61 | 1.00 | 220 | 109 | 52 | 24 | TRUE | 0.10 |
| melanoma | NRAS_61 | ALK | Any mutation | 137 | 127 | TMB overall | 0.07 | -2.63 | 3.03 | 1620.60 | 1.00 | 254 | 110 | 100 | 27 | TRUE | 0.02 |
| melanoma | NRAS_61 | IKZF1 | Any mutation | 133 | 57 | TMB quintile 5 | -0.30 | -0.96 | 0.28 | 1286.90 | 1.00 | 232 | 117 | 41 | 16 | TRUE | 0.48 |
| melanoma | NRAS_61 | IKZF1 | Any mutation | 136 | 101 | TMB overall | -0.60 | -3.60 | 2.27 | 1427.15 | 1.00 | 272 | 119 | 84 | 17 | TRUE | 0.18 |
| melanoma | NRAS_61 | FAT1 | Any mutation | 133 | 86 | TMB quintile 5 | -0.36 | -0.90 | 0.14 | 1490.20 | 1.00 | 212 | 110 | 63 | 23 | FALSE | 0.76 |
| melanoma | NRAS_61 | FAT1 | Any mutation | 136 | 136 | TMB overall | -0.21 | -2.78 | 2.44 | 1443.50 | 1.00 | 250 | 111 | 111 | 25 | FALSE | 0.06 |
| melanoma | NRAS_61 | KMT2A | Any mutation | 134 | 69 | TMB quintile 5 | -0.06 | -0.62 | 0.50 | 1458.74 | 1.00 | 229 | 112 | 47 | 22 | FALSE | 0.08 |
| melanoma | NRAS_61 | KMT2A | Any mutation | 137 | 131 | TMB overall | -0.20 | -3.48 | 2.72 | 1439.06 | 1.00 | 260 | 113 | 107 | 24 | FALSE | 0.05 |
| melanoma | NRAS_61 | PAK7 | Any mutation | 131 | 135 | TMB quintile 5 | -0.44 | -0.91 | 0.04 | 1403.52 | 1.00 | 169 | 95 | 99 | 36 | FALSE | 1.18 |
| melanoma | NRAS_61 | PAK7 | Any mutation | 136 | 210 | TMB overall | -0.31 | -2.80 | 2.43 | 1440.01 | 1.00 | 189 | 96 | 170 | 40 | FALSE | 0.09 |
| melanoma | NRAS_61 | TERT | Any mutation | 11 | 17 | TMB quintile 2 | 2.52 | 1.21 | 3.90 | 1415.35 | 1.00 | 103 | 4 | 10 | 7 | TRUE | 3.84 |
| melanoma | NRAS_61 | TERT | Any mutation | 10 | 29 | TMB quintile 3 | 1.19 | -0.03 | 2.45 | 1346.41 | 1.00 | 78 | 5 | 24 | 5 | TRUE | 1.23 |
| melanoma | NRAS_61 | TERT | Any mutation | 18 | 57 | TMB quintile 4 | 1.42 | 0.37 | 2.64 | 1336.79 | 1.00 | 46 | 4 | 43 | 14 | TRUE | 1.85 |
| melanoma | NRAS_61 | TERT | Any mutation | 145 | 396 | TMB quintile 5 | 0.68 | 0.06 | 1.35 | 1686.62 | 1.00 | 44 | 13 | 264 | 132 | TRUE | 1.35 |
| melanoma | NRAS_61 | TERT | Any mutation | 188 | 605 | TMB overall | 1.28 | -0.24 | 2.90 | 1520.52 | 1.00 | 283 | 26 | 443 | 162 | TRUE | 1.00 |
| melanoma | NRAS_61 | NOTCH3 | Any mutation | 132 | 67 | TMB quintile 5 | -0.40 | -0.99 | 0.18 | 1458.61 | 1.00 | 221 | 114 | 49 | 18 | TRUE | 0.73 |
| melanoma | NRAS_61 | NOTCH3 | Any mutation | 135 | 124 | TMB overall | -1.66 | -5.48 | 1.73 | 1648.44 | 1.00 | 253 | 117 | 106 | 18 | TRUE | 0.43 |
| melanoma | NRAS_61 | NOTCH4 | Any mutation | 128 | 81 | TMB quintile 5 | -0.06 | -0.59 | 0.45 | 1428.21 | 1.00 | 205 | 102 | 55 | 26 | TRUE | 0.09 |
| melanoma | NRAS_61 | NOTCH4 | Any mutation | 132 | 145 | TMB overall | -0.12 | -2.92 | 2.88 | 1389.49 | 1.00 | 226 | 103 | 116 | 29 | TRUE | 0.03 |
| melanoma | NRAS_61 | CDKN2A | Any mutation | 136 | 80 | TMB quintile 5 | 0.07 | -0.42 | 0.54 | 1515.89 | 1.00 | 218 | 108 | 52 | 28 | TRUE | 0.12 |
| melanoma | NRAS_61 | CDKN2A | Any mutation | 139 | 114 | TMB overall | 0.12 | -2.54 | 2.90 | 1500.08 | 1.00 | 255 | 109 | 84 | 30 | TRUE | 0.03 |
| melanoma | NRAS_61 | KMT2D | Any mutation | 140 | 112 | TMB quintile 5 | 0.16 | -0.30 | 0.61 | 1395.77 | 1.00 | 211 | 100 | 72 | 40 | FALSE | 0.29 |
| melanoma | NRAS_61 | KMT2D | Any mutation | 7 | 91 | TMB quintile 6 | 1.91 | -0.48 | 6.65 | 1371.49 | 1.00 | 28 | 0 | 84 | 7 | FALSE | 0.52 |
| melanoma | NRAS_61 | KMT2D | Any mutation | 147 | 203 | TMB overall | 0.89 | -2.54 | 4.64 | 1447.63 | 1.00 | 239 | 100 | 156 | 47 | FALSE | 0.21 |
| melanoma | NRAS_61 | APC | Any mutation | 132 | 67 | TMB quintile 5 | -0.50 | -1.10 | 0.05 | 1349.36 | 1.00 | 227 | 116 | 51 | 16 | TRUE | 1.04 |
| melanoma | NRAS_61 | APC | Any mutation | 135 | 117 | TMB overall | -0.27 | -2.85 | 2.61 | 1469.37 | 1.00 | 264 | 117 | 99 | 18 | TRUE | 0.07 |
| melanoma | NRAS_61 | ARID2 | Any mutation | 139 | 83 | TMB quintile 5 | 0.26 | -0.22 | 0.75 | 1304.59 | 1.00 | 226 | 107 | 51 | 32 | FALSE | 0.53 |
| melanoma | NRAS_61 | ARID2 | Any mutation | 142 | 136 | TMB overall | -0.32 | -3.35 | 2.46 | 1585.82 | 1.00 | 271 | 109 | 103 | 33 | FALSE | 0.08 |
| melanoma | NRAS_61 | EPHA3 | Any mutation | 134 | 57 | TMB quintile 5 | 0.44 | -0.10 | 0.99 | 1550.45 | 1.00 | 239 | 110 | 33 | 24 | FALSE | 0.91 |
| melanoma | NRAS_61 | EPHA3 | Any mutation | 137 | 102 | TMB overall | 0.32 | -2.52 | 3.51 | 1362.93 | 1.00 | 276 | 111 | 76 | 26 | FALSE | 0.08 |
| melanoma | NRAS_61 | KDR | Any mutation | 131 | 64 | TMB quintile 5 | -0.21 | -0.78 | 0.33 | 1509.01 | 1.00 | 224 | 112 | 45 | 19 | TRUE | 0.34 |
| melanoma | NRAS_61 | KDR | Any mutation | 135 | 126 | TMB overall | -0.49 | -3.09 | 2.22 | 1429.10 | 1.00 | 253 | 114 | 105 | 21 | TRUE | 0.15 |
| melanoma | NRAS_61 | NTRK3 | Any mutation | 136 | 58 | TMB quintile 5 | -0.26 | -0.89 | 0.34 | 1533.65 | 1.00 | 228 | 119 | 41 | 17 | FALSE | 0.40 |
| melanoma | NRAS_61 | NTRK3 | Any mutation | 139 | 100 | TMB overall | -0.52 | -3.19 | 2.21 | 1590.03 | 1.00 | 266 | 121 | 82 | 18 | FALSE | 0.15 |
| melanoma | NRAS_61 | GRIN2A | Any mutation | 140 | 166 | TMB quintile 5 | -0.60 | -1.05 | -0.18 | 1462.16 | 1.00 | 173 | 100 | 126 | 40 | FALSE | 2.25 |
| melanoma | NRAS_61 | GRIN2A | Any mutation | 6 | 124 | TMB quintile 6 | -0.57 | -2.24 | 1.37 | 1478.78 | 1.00 | 17 | 1 | 119 | 5 | FALSE | 0.27 |
| melanoma | NRAS_61 | GRIN2A | Any mutation | 146 | 290 | TMB overall | -0.52 | -3.28 | 2.57 | 1485.43 | 1.00 | 190 | 101 | 245 | 45 | FALSE | 0.15 |
| melanoma | NRAS_61 | ERBB4 | Any mutation | 135 | 92 | TMB quintile 5 | -0.36 | -0.87 | 0.11 | 1234.25 | 1.00 | 208 | 110 | 67 | 25 | TRUE | 0.82 |
| melanoma | NRAS_61 | ERBB4 | Any mutation | 139 | 181 | TMB overall | -0.45 | -3.38 | 2.49 | 1520.44 | 1.00 | 227 | 111 | 153 | 28 | TRUE | 0.12 |
| melanoma | NRAS_61 | NF1 | Any mutation | 10 | 13 | TMB quintile 3 | -0.84 | -3.26 | 1.04 | 1642.44 | 1.00 | 89 | 9 | 12 | 1 | TRUE | 0.35 |
| melanoma | NRAS_61 | NF1 | Any mutation | 16 | 11 | TMB quintile 4 | -2.35 | -5.63 | 0.00 | 1502.44 | 1.00 | 80 | 16 | 11 | 0 | TRUE | 0.88 |
| melanoma | NRAS_61 | NF1 | Any mutation | 133 | 162 | TMB quintile 5 | -1.60 | -2.11 | -1.10 | 991.41 | 1.00 | 171 | 114 | 143 | 19 | TRUE | 9.13 |
| melanoma | NRAS_61 | NF1 | Any mutation | 164 | 286 | TMB overall | -1.19 | -3.30 | 0.71 | 1351.09 | 1.00 | 352 | 139 | 261 | 25 | TRUE | 0.58 |
| melanoma | NRAS_61 | FLT1 | Any mutation | 133 | 60 | TMB quintile 5 | -0.17 | -0.77 | 0.45 | 1412.85 | 1.00 | 226 | 115 | 42 | 18 | FALSE | 0.23 |
| melanoma | NRAS_61 | FLT1 | Any mutation | 138 | 116 | TMB overall | 0.13 | -2.65 | 3.05 | 1447.70 | 1.00 | 260 | 116 | 94 | 22 | FALSE | 0.03 |
| melanoma | NRAS_61 | ROS1 | Any mutation | 136 | 139 | TMB quintile 5 | -0.32 | -0.75 | 0.09 | 1413.68 | 1.00 | 189 | 98 | 101 | 38 | TRUE | 0.86 |
| melanoma | NRAS_61 | ROS1 | Any mutation | 140 | 242 | TMB overall | 0.24 | -3.12 | 3.77 | 1348.72 | 1.00 | 212 | 98 | 200 | 42 | TRUE | 0.05 |
| melanoma | NRAS_61 | PIK3CG | Any mutation | 131 | 43 | TMB quintile 5 | -0.41 | -1.16 | 0.33 | 1095.14 | 1.00 | 236 | 120 | 32 | 11 | FALSE | 0.57 |
| melanoma | NRAS_61 | PIK3CG | Any mutation | 135 | 99 | TMB overall | -0.10 | -3.07 | 2.87 | 1577.71 | 1.00 | 272 | 121 | 85 | 14 | FALSE | 0.02 |
| melanoma | NRAS_61 | BRAF | Any mutation | 10 | 16 | TMB quintile 2 | -3.11 | -5.92 | -0.97 | 1580.64 | 1.00 | 96 | 10 | 16 | 0 | TRUE | 1.85 |
| melanoma | NRAS_61 | BRAF | Any mutation | 10 | 27 | TMB quintile 3 | -3.17 | -5.80 | -1.10 | 1752.01 | 1.00 | 73 | 10 | 27 | 0 | TRUE | 2.16 |
| melanoma | NRAS_61 | BRAF | Any mutation | 16 | 53 | TMB quintile 4 | -3.02 | -4.96 | -1.56 | 1418.15 | 1.00 | 38 | 15 | 52 | 1 | TRUE | 3.18 |
| melanoma | NRAS_61 | BRAF | Any mutation | 134 | 170 | TMB quintile 5 | -2.22 | -2.83 | -1.69 | 1491.15 | 1.00 | 127 | 118 | 154 | 16 | TRUE | 13.66 |
| melanoma | NRAS_61 | BRAF | Any mutation | 173 | 283 | TMB overall | -2.88 | -4.58 | -1.49 | 1622.44 | 1.00 | 384 | 156 | 266 | 17 | TRUE | 3.58 |
| melanoma | NRAS_61 | CARD11 | Any mutation | 133 | 63 | TMB quintile 5 | -0.57 | -1.21 | 0.06 | 1547.65 | 1.00 | 225 | 118 | 48 | 15 | FALSE | 1.15 |
| melanoma | NRAS_61 | CARD11 | Any mutation | 136 | 108 | TMB overall | -0.75 | -3.57 | 2.15 | 1477.46 | 1.00 | 259 | 120 | 92 | 16 | FALSE | 0.23 |
| melanoma | NRAS_61 | TP63 | Any mutation | 130 | 95 | TMB quintile 5 | 0.12 | -0.36 | 0.58 | 1390.02 | 1.00 | 199 | 96 | 61 | 34 | FALSE | 0.20 |
| melanoma | NRAS_61 | TP63 | Any mutation | 133 | 164 | TMB overall | -0.34 | -3.20 | 2.83 | 1524.66 | 1.00 | 215 | 97 | 128 | 36 | FALSE | 0.09 |
| melanoma | NRAS_61 | ZFHX3 | Any mutation | 127 | 62 | TMB quintile 5 | -0.31 | -0.93 | 0.23 | 1421.27 | 1.00 | 219 | 110 | 45 | 17 | FALSE | 0.52 |
| melanoma | NRAS_61 | ZFHX3 | Any mutation | 130 | 140 | TMB overall | -0.33 | -3.13 | 2.68 | 1481.72 | 1.00 | 254 | 111 | 121 | 19 | FALSE | 0.08 |
| melanoma | NRAS_61 | PREX2 | Any mutation | 85 | 89 | TMB quintile 5 | 0.24 | -0.30 | 0.77 | 1423.70 | 1.00 | 105 | 51 | 55 | 34 | FALSE | 0.41 |
| melanoma | NRAS_61 | PREX2 | Any mutation | 89 | 165 | TMB overall | 0.48 | -2.37 | 4.29 | 1434.59 | 1.00 | 118 | 51 | 127 | 38 | FALSE | 0.11 |
| melanoma | NRAS_61 | EPHA7 | Any mutation | 128 | 89 | TMB quintile 5 | -0.28 | -0.84 | 0.22 | 1684.73 | 1.00 | 203 | 103 | 64 | 25 | FALSE | 0.55 |
| melanoma | NRAS_61 | EPHA7 | Any mutation | 131 | 152 | TMB overall | -0.34 | -3.11 | 2.44 | 1275.83 | 1.00 | 232 | 104 | 125 | 27 | FALSE | 0.10 |
| colorectal cancer | RAS_12-61 | SPEN | Any mutation | 14 | 21 | Signature 10 | -1.26 | -2.62 | -0.12 | 1535.12 | 1.00 | 14 | 11 | 18 | 3 | FALSE | 1.34 |
| colorectal cancer | RAS_12-61 | SPEN | Any mutation | 173 | 18 | Signature 15 | -1.41 | -2.60 | -0.45 | 1436.70 | 1.00 | 202 | 170 | 15 | 3 | FALSE | 2.03 |
| colorectal cancer | RAS_12-61 | SPEN | Any mutation | 369 | 38 | Signature 1A | -0.34 | -1.00 | 0.31 | 1412.25 | 1.00 | 459 | 354 | 23 | 15 | FALSE | 0.49 |
| colorectal cancer | RAS_12-61 | SPEN | Any mutation | 125 | 61 | Signature 6 | -1.11 | -1.77 | -0.48 | 1215.27 | 1.00 | 153 | 113 | 49 | 12 | FALSE | 3.06 |
| melanoma | RAS_12-61 | SPEN | Any mutation | 153 | 105 | Signature 7 | -0.29 | -0.94 | 0.20 | 235.59 | 1.00 | 249 | 124 | 76 | 29 | FALSE | 0.53 |
| non-small cell lung cancer | RAS_12-61 | SPEN | Any mutation | 86 | 39 | Signature 2 | -4.13 | -9.82 | -1.47 | 1514.44 | 1.00 | 226 | 86 | 39 | 0 | FALSE | 1.29 |
| non-small cell lung cancer | RAS_12-61 | SPEN | Any mutation | 276 | 24 | Signature 4 | -0.25 | -1.15 | 0.59 | 1474.20 | 1.00 | 414 | 267 | 15 | 9 | FALSE | 0.23 |
| uterine cancer | RAS_12-61 | SPEN | Any mutation | 7 | 38 | Signature 10 | 0.74 | -0.45 | 2.10 | 1346.00 | 1.00 | 22 | 1 | 32 | 6 | FALSE | 0.60 |
| uterine cancer | RAS_12-61 | SPEN | Any mutation | 27 | 13 | Signature 15 | 0.64 | -0.46 | 1.69 | 1405.33 | 1.00 | 76 | 22 | 8 | 5 | FALSE | 0.63 |
| uterine cancer | RAS_12-61 | SPEN | Any mutation | 44 | 21 | Signature 1A | 0.02 | -1.13 | 0.97 | 1387.75 | 1.00 | 161 | 40 | 17 | 4 | FALSE | 0.02 |
| uterine cancer | RAS_12-61 | SPEN | Any mutation | 18 | 21 | Signature 6 | 0.74 | -0.36 | 1.76 | 1124.59 | 1.00 | 70 | 12 | 15 | 6 | FALSE | 0.77 |
| colorectal cancer | RAS_12-61 | SPEN | Any mutation | 681 | 138 | Signature overall | -1.03 | -2.14 | 0.13 | 1506.08 | 1.00 | 828 | 648 | 105 | 33 | FALSE | 1.18 |
| melanoma | RAS_12-61 | SPEN | Any mutation | 153 | 105 | Signature overall | -0.29 | -4.47 | 3.38 | 1407.24 | 1.00 | 249 | 124 | 76 | 29 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | SPEN | Any mutation | 362 | 63 | Signature overall | -2.00 | -6.00 | 1.25 | 1443.06 | 1.00 | 640 | 353 | 54 | 9 | FALSE | 0.59 |
| uterine cancer | RAS_12-61 | SPEN | Any mutation | 96 | 93 | Signature overall | 0.54 | -0.64 | 1.69 | 1638.83 | 1.00 | 329 | 75 | 72 | 21 | FALSE | 0.44 |
| colorectal cancer | RAS_12-61 | KMT2C | Any mutation | 17 | 32 | Signature 10 | -1.08 | -2.24 | -0.13 | 1518.64 | 1.00 | 11 | 11 | 26 | 6 | FALSE | 1.30 |
| colorectal cancer | RAS_12-61 | KMT2C | Any mutation | 169 | 22 | Signature 15 | -0.49 | -1.38 | 0.30 | 1526.87 | 1.00 | 201 | 161 | 14 | 8 | FALSE | 0.61 |
| colorectal cancer | RAS_12-61 | KMT2C | Any mutation | 362 | 60 | Signature 1A | -0.23 | -0.73 | 0.30 | 1376.47 | 1.00 | 438 | 338 | 36 | 24 | FALSE | 0.41 |
| colorectal cancer | RAS_12-61 | KMT2C | Any mutation | 119 | 65 | Signature 6 | -0.75 | -1.35 | -0.17 | 1376.96 | 1.00 | 147 | 103 | 49 | 16 | FALSE | 1.85 |
| melanoma | RAS_12-61 | KMT2C | Any mutation | 16 | 11 | Signature 11 | 0.12 | -0.90 | 1.53 | 1101.29 | 1.00 | 33 | 11 | 6 | 5 | FALSE | 0.07 |
| melanoma | RAS_12-61 | KMT2C | Any mutation | 146 | 126 | Signature 7 | -0.50 | -0.97 | -0.07 | 1326.63 | 1.00 | 206 | 116 | 96 | 30 | FALSE | 1.49 |
| non-small cell lung cancer | RAS_12-61 | KMT2C | Any mutation | 15 | 22 | Signature 13 | 0.22 | -0.74 | 1.18 | 1643.71 | 1.00 | 68 | 10 | 17 | 5 | FALSE | 0.18 |
| non-small cell lung cancer | RAS_12-61 | KMT2C | Any mutation | 87 | 40 | Signature 2 | 0.17 | -0.49 | 0.81 | 1563.97 | 1.00 | 212 | 74 | 27 | 13 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12-61 | KMT2C | Any mutation | 55 | 13 | Signature 3 | -0.59 | -1.82 | 0.35 | 1337.17 | 1.00 | 176 | 54 | 12 | 1 | FALSE | 0.58 |
| non-small cell lung cancer | RAS_12-61 | KMT2C | Any mutation | 276 | 76 | Signature 4 | -0.33 | -0.80 | 0.15 | 1480.59 | 1.00 | 380 | 252 | 52 | 24 | FALSE | 0.77 |
| uterine cancer | RAS_12-61 | KMT2C | Any mutation | 24 | 17 | Signature 15 | -0.56 | -1.83 | 0.61 | 1355.79 | 1.00 | 72 | 21 | 14 | 3 | FALSE | 0.42 |
| uterine cancer | RAS_12-61 | KMT2C | Any mutation | 42 | 20 | Signature 1A | -1.02 | -2.51 | 0.24 | 1489.72 | 1.00 | 146 | 40 | 18 | 2 | FALSE | 0.88 |
| uterine cancer | RAS_12-61 | KMT2C | Any mutation | 18 | 23 | Signature 6 | -0.66 | -1.95 | 0.45 | 1308.80 | 1.00 | 61 | 15 | 20 | 3 | FALSE | 0.56 |
| colorectal cancer | RAS_12-61 | KMT2C | Any mutation | 667 | 179 | Signature overall | -0.63 | -1.80 | 0.57 | 1357.78 | 1.00 | 797 | 613 | 125 | 54 | FALSE | 0.56 |
| melanoma | RAS_12-61 | KMT2C | Any mutation | 162 | 137 | Signature overall | -0.19 | -1.41 | 1.44 | 1115.75 | 1.00 | 239 | 127 | 102 | 35 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12-61 | KMT2C | Any mutation | 433 | 151 | Signature overall | -0.13 | -0.99 | 0.70 | 1535.16 | 1.00 | 836 | 390 | 108 | 43 | FALSE | 0.12 |
| uterine cancer | RAS_12-61 | KMT2C | Any mutation | 88 | 118 | Signature overall | -0.85 | -2.08 | 0.49 | 1339.49 | 1.00 | 297 | 78 | 108 | 10 | FALSE | 0.69 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 14 | 11 | Signature 11 | -0.25 | -1.22 | 0.77 | 1390.92 | 1.00 | 6 | 7 | 4 | 7 | TRUE | 0.21 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 14 | 28 | Signature 15 | -0.09 | -0.96 | 0.90 | 1410.66 | 1.00 | 18 | 4 | 18 | 10 | TRUE | 0.07 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 40 | 66 | Signature 1A | -0.60 | -1.22 | 0.04 | 1512.80 | 1.00 | 33 | 22 | 48 | 18 | TRUE | 1.19 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 10 | 31 | Signature 2 | -0.80 | -1.74 | 0.17 | 1406.18 | 1.00 | 20 | 6 | 27 | 4 | TRUE | 1.07 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 8 | 18 | Signature 3 | -0.90 | -2.03 | 0.06 | 1487.35 | 1.00 | 4 | 5 | 15 | 3 | TRUE | 1.07 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 25 | 70 | Signature 4 | -0.95 | -1.76 | -0.20 | 1298.74 | 1.00 | 8 | 11 | 56 | 14 | TRUE | 1.71 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 6 | 22 | Signature 6 | -0.42 | -1.39 | 0.65 | 1425.68 | 1.00 | 7 | 1 | 17 | 5 | TRUE | 0.38 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 15 | 32 | Signature 10 | -0.90 | -1.32 | -0.50 | 1387.84 | 1.00 | 5 | 4 | 21 | 11 | TRUE | 4.62 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 25 | 28 | Signature 11 | -0.75 | -1.14 | -0.28 | 1442.32 | 1.00 | 1 | 8 | 11 | 17 | TRUE | 3.28 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 179 | 311 | Signature 15 | -0.91 | -1.23 | -0.59 | 1350.90 | 1.00 | 35 | 62 | 194 | 117 | TRUE | 8.07 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 16 | 36 | Signature 17 | -0.94 | -1.39 | -0.52 | 1408.20 | 1.00 | 5 | 5 | 25 | 11 | TRUE | 4.82 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 20 | 36 | Signature 18 | -1.00 | -1.51 | -0.63 | 1185.75 | 1.00 | 2 | 10 | 26 | 10 | TRUE | 5.23 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 22 | 31 | Signature 19 | -1.00 | -1.50 | -0.60 | 1299.67 | 1.00 | 5 | 12 | 21 | 10 | TRUE | 4.96 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 385 | 655 | Signature 1A | -0.91 | -1.16 | -0.67 | 1405.60 | 1.00 | 93 | 140 | 410 | 245 | TRUE | 12.30 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 8 | 15 | Signature 1B | -0.93 | -1.40 | -0.50 | 1567.84 | 1.00 | 4 | 3 | 10 | 5 | TRUE | 4.62 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 48 | 56 | Signature 2 | -0.93 | -1.36 | -0.52 | 1215.26 | 1.00 | 6 | 23 | 31 | 25 | TRUE | 5.21 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 14 | 23 | Signature 20 | -0.90 | -1.31 | -0.50 | 1447.53 | 1.00 | 6 | 5 | 14 | 9 | TRUE | 4.75 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 9 | 20 | Signature 21 | -0.99 | -1.51 | -0.58 | 1346.67 | 1.00 | 4 | 4 | 15 | 5 | TRUE | 4.48 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 17 | 35 | Signature 3 | -0.93 | -1.39 | -0.53 | 1499.54 | 1.00 | 1 | 6 | 24 | 11 | TRUE | 4.99 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 22 | 36 | Signature 4 | -0.90 | -1.36 | -0.49 | 1412.92 | 1.00 | 2 | 8 | 22 | 14 | TRUE | 4.64 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 139 | 236 | Signature 6 | -0.74 | -1.05 | -0.34 | 1002.17 | 1.00 | 65 | 47 | 144 | 92 | TRUE | 4.13 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 16 | 28 | Signature 7 | -0.95 | -1.40 | -0.56 | 1259.49 | 1.00 | 5 | 7 | 19 | 9 | TRUE | 4.98 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 15 | 13 | Signature 8 | -0.86 | -1.30 | -0.38 | 1592.07 | 1.00 | 3 | 7 | 5 | 8 | TRUE | 3.96 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 18 | 16 | Signature R2 | -0.78 | -1.17 | -0.33 | 1391.80 | 1.00 | 0 | 7 | 5 | 11 | TRUE | 3.52 |
| melanoma | RAS_12-61 | TP53 | Any mutation | 16 | 14 | Signature 11 | -0.02 | -0.84 | 0.94 | 1420.57 | 1.00 | 31 | 12 | 10 | 4 | TRUE | 0.01 |
| melanoma | RAS_12-61 | TP53 | Any mutation | 16 | 14 | Signature 1A | 0.46 | -0.49 | 1.76 | 1173.86 | 1.00 | 44 | 9 | 7 | 7 | TRUE | 0.35 |
| melanoma | RAS_12-61 | TP53 | Any mutation | 152 | 150 | Signature 7 | -0.29 | -0.70 | 0.13 | 1403.53 | 1.00 | 203 | 112 | 110 | 40 | TRUE | 0.76 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 23 | 12 | Signature 11 | -1.28 | -2.12 | -0.49 | 1168.55 | 1.00 | 13 | 19 | 8 | 4 | TRUE | 2.59 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 17 | 79 | Signature 13 | -0.84 | -1.54 | -0.12 | 1387.22 | 1.00 | 26 | 5 | 67 | 12 | TRUE | 1.61 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 21 | 36 | Signature 14 | -1.09 | -1.81 | -0.36 | 1639.01 | 1.00 | 12 | 12 | 27 | 9 | TRUE | 2.48 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 32 | 87 | Signature 15 | -1.12 | -1.73 | -0.51 | 1503.27 | 1.00 | 35 | 18 | 73 | 14 | TRUE | 3.31 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 12 | 39 | Signature 16 | -0.81 | -1.60 | 0.00 | 1564.51 | 1.00 | 20 | 4 | 31 | 8 | TRUE | 1.32 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 19 | 29 | Signature 17 | -1.53 | -2.30 | -0.74 | 1536.58 | 1.00 | 5 | 14 | 24 | 5 | TRUE | 3.99 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 70 | 92 | Signature 18 | -1.04 | -1.60 | -0.53 | 1484.06 | 1.00 | 25 | 39 | 61 | 31 | TRUE | 4.07 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 16 | 31 | Signature 19 | -1.19 | -1.99 | -0.43 | 1487.05 | 1.00 | 24 | 11 | 26 | 5 | TRUE | 2.48 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 50 | 149 | Signature 1A | -0.94 | -1.50 | -0.40 | 1523.44 | 1.00 | 94 | 30 | 129 | 20 | TRUE | 3.14 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 7 | 18 | Signature 1B | -0.84 | -1.64 | 0.06 | 1294.98 | 1.00 | 8 | 2 | 13 | 5 | TRUE | 1.23 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 88 | 223 | Signature 2 | -0.76 | -1.18 | -0.31 | 1696.30 | 1.00 | 83 | 41 | 176 | 47 | TRUE | 3.25 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 16 | 46 | Signature 20 | -1.28 | -2.06 | -0.53 | 1399.01 | 1.00 | 21 | 10 | 40 | 6 | TRUE | 3.05 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 11 | 37 | Signature 21 | -1.79 | -2.67 | -0.97 | 1454.84 | 1.00 | 19 | 10 | 36 | 1 | TRUE | 4.27 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 58 | 161 | Signature 3 | -1.06 | -1.57 | -0.54 | 1382.99 | 1.00 | 63 | 32 | 135 | 26 | TRUE | 4.27 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 279 | 522 | Signature 4 | -1.70 | -2.04 | -1.39 | 1368.51 | 1.00 | 74 | 152 | 395 | 127 | TRUE | 23.08 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 13 | 36 | Signature 6 | -1.22 | -2.05 | -0.47 | 1417.71 | 1.00 | 10 | 7 | 30 | 6 | TRUE | 2.61 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 27 | 71 | Signature 7 | -1.05 | -1.71 | -0.41 | 1534.27 | 1.00 | 27 | 14 | 58 | 13 | TRUE | 2.73 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 29 | 35 | Signature 8 | -1.03 | -1.69 | -0.33 | 1486.57 | 1.00 | 11 | 17 | 23 | 12 | TRUE | 2.45 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 158 | 85 | Signature R2 | -1.38 | -1.91 | -0.89 | 1479.99 | 1.00 | 12 | 109 | 36 | 49 | TRUE | 6.69 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 7 | 15 | Signature R3 | -1.52 | -2.49 | -0.56 | 1254.47 | 1.00 | 11 | 6 | 14 | 1 | TRUE | 2.79 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 23 | 57 | Signature U1 | -1.51 | -2.28 | -0.78 | 1449.71 | 1.00 | 38 | 18 | 52 | 5 | TRUE | 4.16 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 12 | 32 | Signature U2 | -1.47 | -2.31 | -0.67 | 1392.98 | 1.00 | 7 | 8 | 28 | 4 | TRUE | 3.38 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 117 | 94 | Signature 11 | 2.50 | 1.92 | 3.12 | 1242.24 | 1.00 | 5 | 26 | 3 | 91 | TRUE | 15.65 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 113 | 98 | Signature 15 | 2.28 | 1.65 | 2.82 | 1176.57 | 1.00 | 10 | 25 | 10 | 88 | TRUE | 14.15 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 25 | 19 | Signature 16 | 2.40 | 1.78 | 3.09 | 1310.15 | 1.00 | 6 | 6 | 0 | 19 | TRUE | 12.93 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 52 | 41 | Signature 17 | 2.57 | 1.92 | 3.23 | 1169.69 | 1.00 | 3 | 11 | 0 | 41 | TRUE | 14.51 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 15 | 14 | Signature 18 | 2.31 | 1.64 | 2.94 | 1447.34 | 1.00 | 6 | 3 | 2 | 12 | TRUE | 11.37 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 15 | 16 | Signature 19 | 2.28 | 1.68 | 2.91 | 1347.40 | 1.00 | 8 | 2 | 3 | 13 | TRUE | 12.44 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 221 | 172 | Signature 1A | 2.27 | 1.77 | 2.78 | 1376.32 | 1.00 | 22 | 59 | 10 | 162 | TRUE | 31.05 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 16 | 12 | Signature 1B | 2.29 | 1.60 | 2.98 | 1350.47 | 1.00 | 4 | 5 | 1 | 11 | TRUE | 10.83 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 33 | 29 | Signature 2 | 2.41 | 1.82 | 3.07 | 1246.90 | 1.00 | 11 | 6 | 2 | 27 | TRUE | 13.37 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 26 | 21 | Signature 21 | 2.40 | 1.78 | 3.04 | 1387.12 | 1.00 | 5 | 6 | 1 | 20 | TRUE | 13.03 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 81 | 66 | Signature 3 | 2.40 | 1.86 | 2.98 | 1362.23 | 1.00 | 13 | 19 | 4 | 62 | TRUE | 31.05 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 64 | 58 | Signature 4 | 2.64 | 2.04 | 3.33 | 1290.80 | 1.00 | 7 | 8 | 2 | 56 | TRUE | 14.95 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 61 | 53 | Signature 6 | 2.42 | 1.82 | 3.05 | 1220.12 | 1.00 | 9 | 12 | 4 | 49 | TRUE | 14.61 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 26 | 25 | Signature 7 | 2.54 | 1.92 | 3.26 | 1067.42 | 1.00 | 8 | 2 | 1 | 24 | TRUE | 13.12 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 49 | 37 | Signature 8 | 2.50 | 1.88 | 3.17 | 1241.89 | 1.00 | 3 | 12 | 0 | 37 | TRUE | 14.19 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 23 | 19 | Signature R3 | 2.47 | 1.83 | 3.16 | 1377.68 | 1.00 | 1 | 5 | 1 | 18 | TRUE | 12.56 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 12 | 11 | Signature U1 | 2.36 | 1.68 | 3.09 | 1155.62 | 1.00 | 10 | 1 | 0 | 11 | TRUE | 10.97 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 26 | 53 | Signature 15 | -1.64 | -2.55 | -0.86 | 1469.82 | 1.00 | 34 | 21 | 48 | 5 | TRUE | 3.93 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 46 | 113 | Signature 1A | -0.93 | -1.54 | -0.33 | 1490.60 | 1.00 | 88 | 29 | 96 | 17 | TRUE | 2.61 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 7 | 19 | Signature 2 | -1.90 | -3.15 | -0.86 | 1452.56 | 1.00 | 22 | 7 | 19 | 0 | TRUE | 2.91 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 10 | 19 | Signature 20 | -1.35 | -2.36 | -0.40 | 1523.35 | 1.00 | 18 | 7 | 16 | 3 | TRUE | 2.16 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 11 | 30 | Signature 3 | -1.39 | -2.35 | -0.49 | 1470.97 | 1.00 | 10 | 7 | 26 | 4 | TRUE | 2.50 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 17 | 45 | Signature 6 | -1.91 | -2.98 | -1.03 | 1366.59 | 1.00 | 46 | 16 | 44 | 1 | TRUE | 3.77 |
| cancer of unknown primary | RAS_12-61 | TP53 | Any mutation | 122 | 287 | Signature overall | -0.66 | -1.29 | -0.03 | 1420.70 | 1.00 | 114 | 60 | 225 | 62 | TRUE | 1.38 |
| colorectal cancer | RAS_12-61 | TP53 | Any mutation | 968 | 1607 | Signature overall | -0.90 | -1.16 | -0.66 | 1355.23 | 1.00 | 242 | 358 | 997 | 610 | TRUE | 12.07 |
| melanoma | RAS_12-61 | TP53 | Any mutation | 184 | 178 | Signature overall | 0.04 | -0.78 | 1.08 | 1230.00 | 1.00 | 278 | 133 | 127 | 51 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Any mutation | 994 | 1927 | Signature overall | -1.23 | -1.53 | -0.92 | 1169.64 | 1.00 | 648 | 582 | 1515 | 412 | TRUE | 13.68 |
| pancreatic cancer | RAS_12-61 | TP53 | Any mutation | 949 | 785 | Signature overall | 2.41 | 1.99 | 2.84 | 1202.91 | 1.00 | 131 | 208 | 44 | 741 | TRUE | 31.05 |
| uterine cancer | RAS_12-61 | TP53 | Any mutation | 122 | 356 | Signature overall | -1.61 | -2.35 | -0.97 | 1526.05 | 1.00 | 266 | 92 | 326 | 30 | TRUE | 5.43 |
| colorectal cancer | RAS_12-61 | ATRX | Any mutation | 15 | 19 | Signature 10 | -1.17 | -2.46 | -0.04 | 1511.49 | 1.00 | 14 | 12 | 16 | 3 | TRUE | 1.23 |
| colorectal cancer | RAS_12-61 | ATRX | Any mutation | 371 | 46 | Signature 1A | -0.50 | -1.10 | 0.09 | 1472.35 | 1.00 | 450 | 355 | 30 | 16 | TRUE | 0.97 |
| colorectal cancer | RAS_12-61 | ATRX | Any mutation | 123 | 29 | Signature 6 | -0.83 | -1.68 | -0.08 | 1507.34 | 1.00 | 169 | 116 | 22 | 7 | TRUE | 1.31 |
| melanoma | RAS_12-61 | ATRX | Any mutation | 150 | 76 | Signature 7 | -0.55 | -1.16 | 0.10 | 267.98 | 1.01 | 260 | 133 | 59 | 17 | TRUE | 1.09 |
| non-small cell lung cancer | RAS_12-61 | ATRX | Any mutation | 69 | 12 | Signature 18 | 0.00 | -0.72 | 0.81 | 1509.54 | 1.00 | 76 | 63 | 6 | 6 | TRUE | 0.00 |
| non-small cell lung cancer | RAS_12-61 | ATRX | Any mutation | 86 | 28 | Signature 2 | -0.01 | -0.64 | 0.65 | 1615.85 | 1.00 | 221 | 78 | 20 | 8 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | ATRX | Any mutation | 279 | 88 | Signature 4 | -0.06 | -0.49 | 0.38 | 1460.47 | 1.00 | 383 | 247 | 56 | 32 | TRUE | 0.11 |
| uterine cancer | RAS_12-61 | ATRX | Any mutation | 6 | 11 | Signature 14 | -0.66 | -2.38 | 1.10 | 1403.24 | 1.00 | 10 | 4 | 9 | 2 | TRUE | 0.33 |
| uterine cancer | RAS_12-61 | ATRX | Any mutation | 44 | 12 | Signature 1A | -0.60 | -2.32 | 0.77 | 1367.31 | 1.00 | 165 | 42 | 10 | 2 | TRUE | 0.35 |
| uterine cancer | RAS_12-61 | ATRX | Any mutation | 17 | 13 | Signature 6 | -2.36 | -5.89 | -0.12 | 1584.35 | 1.00 | 71 | 17 | 13 | 0 | TRUE | 0.98 |
| colorectal cancer | RAS_12-61 | ATRX | Any mutation | 509 | 94 | Signature overall | -0.81 | -2.22 | 0.54 | 1471.67 | 1.00 | 633 | 483 | 68 | 26 | TRUE | 0.65 |
| melanoma | RAS_12-61 | ATRX | Any mutation | 150 | 76 | Signature overall | -0.44 | -4.33 | 3.83 | 1371.28 | 1.00 | 260 | 133 | 59 | 17 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | ATRX | Any mutation | 434 | 128 | Signature overall | -0.03 | -0.67 | 0.63 | 1672.01 | 1.00 | 680 | 388 | 82 | 46 | TRUE | 0.03 |
| uterine cancer | RAS_12-61 | ATRX | Any mutation | 71 | 123 | Signature overall | -0.86 | -2.99 | 1.19 | 1438.37 | 1.00 | 261 | 63 | 115 | 8 | TRUE | 0.38 |
| colorectal cancer | RAS_12-61 | ATR | Any mutation | 15 | 28 | Signature 10 | -1.31 | -2.64 | -0.12 | 1435.26 | 1.00 | 13 | 11 | 24 | 4 | FALSE | 1.40 |
| colorectal cancer | RAS_12-61 | ATR | Any mutation | 174 | 12 | Signature 15 | -0.15 | -1.22 | 0.92 | 1464.79 | 1.00 | 208 | 168 | 6 | 6 | FALSE | 0.11 |
| colorectal cancer | RAS_12-61 | ATR | Any mutation | 369 | 32 | Signature 1A | -0.49 | -1.20 | 0.18 | 1472.05 | 1.00 | 456 | 358 | 21 | 11 | FALSE | 0.75 |
| colorectal cancer | RAS_12-61 | ATR | Any mutation | 125 | 28 | Signature 6 | -0.92 | -1.84 | -0.06 | 1467.04 | 1.00 | 173 | 119 | 22 | 6 | FALSE | 1.41 |
| non-small cell lung cancer | RAS_12-61 | ATR | Any mutation | 15 | 11 | Signature 13 | -0.22 | -1.38 | 1.00 | 1494.83 | 1.00 | 74 | 13 | 9 | 2 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12-61 | ATR | Any mutation | 86 | 16 | Signature 2 | -0.29 | -1.24 | 0.62 | 1390.65 | 1.00 | 226 | 82 | 12 | 4 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12-61 | ATR | Any mutation | 276 | 60 | Signature 4 | -0.48 | -1.06 | 0.07 | 1474.26 | 1.00 | 385 | 259 | 43 | 17 | FALSE | 1.01 |
| colorectal cancer | RAS_12-61 | ATR | Any mutation | 683 | 100 | Signature overall | -0.72 | -2.06 | 0.69 | 1426.34 | 1.00 | 850 | 656 | 73 | 27 | FALSE | 0.54 |
| non-small cell lung cancer | RAS_12-61 | ATR | Any mutation | 377 | 87 | Signature overall | -0.30 | -1.22 | 0.69 | 1375.44 | 1.00 | 685 | 354 | 64 | 23 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12-61 | PDGFRA | Any mutation | 86 | 20 | Signature 2 | -0.04 | -0.93 | 0.84 | 1532.22 | 1.00 | 224 | 80 | 14 | 6 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12-61 | PDGFRA | Any mutation | 277 | 70 | Signature 4 | -0.25 | -0.76 | 0.24 | 1375.22 | 1.00 | 384 | 254 | 47 | 23 | TRUE | 0.48 |
| non-small cell lung cancer | RAS_12-61 | PDGFRA | Any mutation | 363 | 90 | Signature overall | -0.14 | -1.33 | 1.13 | 1411.23 | 1.00 | 608 | 334 | 61 | 29 | TRUE | 0.09 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 13 | 17 | Signature 10 | -0.25 | -1.62 | 0.69 | 1449.15 | 1.00 | 10 | 10 | 14 | 3 | TRUE | 0.18 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 176 | 48 | Signature 15 | 0.16 | -0.37 | 0.63 | 1450.23 | 1.00 | 192 | 152 | 24 | 24 | TRUE | 0.27 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 382 | 144 | Signature 1A | 0.40 | 0.07 | 0.75 | 1442.95 | 1.00 | 417 | 305 | 67 | 77 | TRUE | 1.66 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 128 | 78 | Signature 6 | 0.52 | 0.05 | 1.01 | 1287.01 | 1.00 | 153 | 88 | 38 | 40 | TRUE | 1.51 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 6 | 31 | Signature 10 | 0.86 | -0.34 | 2.40 | 1390.42 | 1.00 | 18 | 0 | 25 | 6 | TRUE | 0.61 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 26 | 17 | Signature 15 | -0.23 | -1.42 | 0.79 | 1470.67 | 1.00 | 69 | 23 | 14 | 3 | TRUE | 0.17 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 44 | 35 | Signature 1A | -0.14 | -1.03 | 0.72 | 1544.08 | 1.00 | 147 | 38 | 29 | 6 | TRUE | 0.13 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 17 | 18 | Signature 6 | 0.50 | -0.58 | 1.52 | 1449.88 | 1.00 | 67 | 12 | 13 | 5 | TRUE | 0.45 |
| colorectal cancer | RAS_12-61 | FBXW7 | Any mutation | 699 | 287 | Signature overall | 0.21 | -0.58 | 0.86 | 1323.12 | 1.00 | 772 | 555 | 143 | 144 | TRUE | 0.24 |
| uterine cancer | RAS_12-61 | FBXW7 | Any mutation | 93 | 101 | Signature overall | 0.24 | -0.85 | 1.38 | 1482.55 | 1.00 | 301 | 73 | 81 | 20 | TRUE | 0.17 |
| uterine cancer | RAS_12-61 | NSD1 | Any mutation | 46 | 22 | Signature 1A | 0.36 | -0.64 | 1.31 | 1481.18 | 1.00 | 161 | 40 | 16 | 6 | FALSE | 0.33 |
| uterine cancer | RAS_12-61 | NSD1 | Any mutation | 20 | 29 | Signature 6 | 0.73 | -0.31 | 1.65 | 1416.10 | 1.00 | 66 | 12 | 21 | 8 | FALSE | 0.82 |
| uterine cancer | RAS_12-61 | NSD1 | Any mutation | 70 | 88 | Signature overall | 0.73 | -0.96 | 2.64 | 1603.13 | 1.00 | 244 | 52 | 70 | 18 | FALSE | 0.36 |
| colorectal cancer | RAS_12-61 | FLT4 | Any mutation | 13 | 14 | Signature 10 | -1.44 | -3.14 | -0.07 | 1627.19 | 1.00 | 15 | 12 | 13 | 1 | TRUE | 1.24 |
| colorectal cancer | RAS_12-61 | FLT4 | Any mutation | 174 | 14 | Signature 15 | -0.43 | -1.39 | 0.44 | 1594.53 | 1.00 | 204 | 168 | 8 | 6 | TRUE | 0.43 |
| colorectal cancer | RAS_12-61 | FLT4 | Any mutation | 371 | 54 | Signature 1A | -0.08 | -0.65 | 0.46 | 1346.98 | 1.00 | 448 | 347 | 30 | 24 | TRUE | 0.11 |
| colorectal cancer | RAS_12-61 | FLT4 | Any mutation | 123 | 51 | Signature 6 | -1.03 | -1.77 | -0.40 | 1394.30 | 1.00 | 153 | 113 | 41 | 10 | TRUE | 2.50 |
| non-small cell lung cancer | RAS_12-61 | FLT4 | Any mutation | 86 | 11 | Signature 2 | -0.95 | -2.61 | 0.20 | 1454.89 | 1.00 | 228 | 85 | 10 | 1 | TRUE | 0.76 |
| non-small cell lung cancer | RAS_12-61 | FLT4 | Any mutation | 275 | 36 | Signature 4 | -0.48 | -1.20 | 0.22 | 1463.66 | 1.00 | 404 | 264 | 25 | 11 | TRUE | 0.72 |
| colorectal cancer | RAS_12-61 | FLT4 | Any mutation | 681 | 133 | Signature overall | -0.74 | -1.88 | 0.34 | 1502.12 | 1.00 | 820 | 640 | 92 | 41 | TRUE | 0.76 |
| non-small cell lung cancer | RAS_12-61 | FLT4 | Any mutation | 361 | 47 | Signature overall | -0.72 | -2.30 | 0.65 | 1590.53 | 1.00 | 632 | 349 | 35 | 12 | TRUE | 0.46 |
| colorectal cancer | RAS_12-61 | PTPRD | Any mutation | 14 | 19 | Signature 10 | -0.94 | -2.12 | 0.18 | 1567.13 | 1.00 | 15 | 11 | 16 | 3 | FALSE | 0.89 |
| colorectal cancer | RAS_12-61 | PTPRD | Any mutation | 173 | 14 | Signature 15 | -0.35 | -1.31 | 0.64 | 1576.16 | 1.00 | 206 | 167 | 8 | 6 | FALSE | 0.32 |
| colorectal cancer | RAS_12-61 | PTPRD | Any mutation | 368 | 31 | Signature 1A | -0.57 | -1.29 | 0.16 | 1621.41 | 1.00 | 459 | 358 | 21 | 10 | FALSE | 0.93 |
| colorectal cancer | RAS_12-61 | PTPRD | Any mutation | 123 | 31 | Signature 6 | -0.69 | -1.47 | 0.06 | 1406.42 | 1.00 | 170 | 115 | 23 | 8 | FALSE | 1.12 |
| melanoma | RAS_12-61 | PTPRD | Any mutation | 160 | 247 | Signature 7 | -0.64 | -1.02 | -0.25 | 1275.95 | 1.00 | 186 | 104 | 191 | 56 | FALSE | 3.07 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 71 | 22 | Signature 18 | 0.80 | 0.03 | 1.63 | 1330.51 | 1.00 | 75 | 56 | 7 | 15 | FALSE | 1.29 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 48 | 12 | Signature 1A | 0.17 | -0.92 | 1.26 | 1508.93 | 1.00 | 209 | 45 | 9 | 3 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 86 | 33 | Signature 2 | 0.29 | -0.44 | 0.95 | 1520.47 | 1.00 | 217 | 75 | 22 | 11 | FALSE | 0.39 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 16 | 12 | Signature 20 | -0.10 | -1.35 | 0.93 | 1531.29 | 1.00 | 53 | 14 | 10 | 2 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 56 | 18 | Signature 3 | 0.72 | -0.13 | 1.54 | 1507.59 | 1.00 | 177 | 48 | 10 | 8 | FALSE | 1.02 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 293 | 195 | Signature 4 | -0.01 | -0.35 | 0.31 | 1413.37 | 1.00 | 334 | 218 | 120 | 75 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 157 | 18 | Signature R2 | -0.50 | -1.38 | 0.35 | 1442.03 | 1.00 | 36 | 146 | 7 | 11 | FALSE | 0.59 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 12 | 11 | Signature U2 | 0.14 | -1.10 | 1.20 | 1528.07 | 1.00 | 26 | 9 | 8 | 3 | FALSE | 0.09 |
| colorectal cancer | RAS_12-61 | PTPRD | Any mutation | 678 | 95 | Signature overall | -0.64 | -1.70 | 0.52 | 1584.83 | 1.00 | 850 | 651 | 68 | 27 | FALSE | 0.59 |
| melanoma | RAS_12-61 | PTPRD | Any mutation | 160 | 247 | Signature overall | -0.54 | -4.43 | 3.70 | 1453.07 | 1.00 | 186 | 104 | 191 | 56 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | PTPRD | Any mutation | 739 | 321 | Signature overall | 0.20 | -0.50 | 0.87 | 1533.34 | 1.00 | 1127 | 611 | 193 | 128 | FALSE | 0.25 |
| melanoma | RAS_12-61 | PIK3C2G | Any mutation | 153 | 174 | Signature 7 | -0.46 | -0.87 | -0.05 | 888.73 | 1.00 | 195 | 108 | 129 | 45 | FALSE | 1.63 |
| non-small cell lung cancer | RAS_12-61 | PIK3C2G | Any mutation | 86 | 17 | Signature 2 | -0.69 | -1.79 | 0.25 | 1462.34 | 1.00 | 223 | 83 | 14 | 3 | FALSE | 0.72 |
| non-small cell lung cancer | RAS_12-61 | PIK3C2G | Any mutation | 275 | 57 | Signature 4 | -0.70 | -1.33 | -0.10 | 1527.80 | 1.00 | 388 | 261 | 43 | 14 | FALSE | 1.59 |
| melanoma | RAS_12-61 | PIK3C2G | Any mutation | 153 | 174 | Signature overall | -0.38 | -4.56 | 4.07 | 1445.06 | 1.00 | 195 | 108 | 129 | 45 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | PIK3C2G | Any mutation | 361 | 74 | Signature overall | -0.70 | -2.04 | 0.62 | 1542.08 | 1.00 | 611 | 344 | 57 | 17 | FALSE | 0.56 |
| colorectal cancer | RAS_12-61 | CREBBP | Any mutation | 13 | 15 | Signature 10 | -1.10 | -2.50 | 0.10 | 1568.17 | 1.00 | 15 | 11 | 13 | 2 | TRUE | 1.02 |
| colorectal cancer | RAS_12-61 | CREBBP | Any mutation | 173 | 27 | Signature 15 | -0.91 | -1.70 | -0.13 | 1437.02 | 1.00 | 197 | 166 | 20 | 7 | TRUE | 1.65 |
| colorectal cancer | RAS_12-61 | CREBBP | Any mutation | 372 | 45 | Signature 1A | 0.11 | -0.48 | 0.70 | 1476.13 | 1.00 | 456 | 349 | 22 | 23 | TRUE | 0.15 |
| colorectal cancer | RAS_12-61 | CREBBP | Any mutation | 132 | 80 | Signature 6 | -1.05 | -1.67 | -0.52 | 1432.08 | 1.00 | 140 | 115 | 63 | 17 | TRUE | 3.62 |
| non-small cell lung cancer | RAS_12-61 | CREBBP | Any mutation | 48 | 12 | Signature 1A | 0.06 | -0.81 | 0.92 | 1266.65 | 1.00 | 209 | 45 | 9 | 3 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | CREBBP | Any mutation | 86 | 15 | Signature 2 | -0.23 | -1.10 | 0.59 | 1486.63 | 1.00 | 225 | 84 | 13 | 2 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12-61 | CREBBP | Any mutation | 56 | 11 | Signature 3 | 0.15 | -0.67 | 1.01 | 1369.28 | 1.00 | 180 | 52 | 7 | 4 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12-61 | CREBBP | Any mutation | 275 | 44 | Signature 4 | 0.04 | -0.54 | 0.60 | 1588.29 | 1.00 | 405 | 258 | 27 | 17 | TRUE | 0.05 |
| colorectal cancer | RAS_12-61 | CREBBP | Any mutation | 690 | 167 | Signature overall | -0.71 | -1.77 | 0.33 | 1551.45 | 1.00 | 808 | 641 | 118 | 49 | TRUE | 0.73 |
| non-small cell lung cancer | RAS_12-61 | CREBBP | Any mutation | 465 | 82 | Signature overall | 0.00 | -0.70 | 0.69 | 1393.68 | 1.00 | 1019 | 439 | 56 | 26 | TRUE | 0.00 |
| colorectal cancer | RAS_12-61 | AXIN2 | Any mutation | 173 | 17 | Signature 15 | -0.63 | -1.47 | 0.26 | 1566.46 | 1.00 | 203 | 167 | 11 | 6 | TRUE | 0.82 |
| colorectal cancer | RAS_12-61 | AXIN2 | Any mutation | 368 | 36 | Signature 1A | -0.41 | -1.03 | 0.24 | 1495.17 | 1.00 | 459 | 354 | 22 | 14 | TRUE | 0.67 |
| colorectal cancer | RAS_12-61 | AXIN2 | Any mutation | 124 | 40 | Signature 6 | -1.09 | -1.94 | -0.34 | 1379.62 | 1.00 | 163 | 118 | 34 | 6 | TRUE | 2.14 |
| colorectal cancer | RAS_12-61 | AXIN2 | Any mutation | 665 | 93 | Signature overall | -0.71 | -1.63 | 0.17 | 1574.81 | 1.00 | 825 | 639 | 67 | 26 | TRUE | 0.95 |
| non-small cell lung cancer | RAS_12-61 | DOT1L | Any mutation | 86 | 16 | Signature 2 | -0.39 | -1.44 | 0.48 | 1424.48 | 1.00 | 225 | 83 | 13 | 3 | FALSE | 0.37 |
| non-small cell lung cancer | RAS_12-61 | DOT1L | Any mutation | 275 | 38 | Signature 4 | -0.17 | -0.79 | 0.46 | 1318.64 | 1.00 | 404 | 261 | 24 | 14 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | DOT1L | Any mutation | 361 | 54 | Signature overall | -0.29 | -1.53 | 0.90 | 1249.92 | 1.00 | 629 | 344 | 37 | 17 | FALSE | 0.21 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 14 | 16 | Signature 10 | -1.05 | -2.26 | 0.03 | 1412.59 | 1.00 | 12 | 12 | 14 | 2 | FALSE | 1.10 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 171 | 38 | Signature 15 | -0.30 | -0.90 | 0.32 | 1496.45 | 1.00 | 189 | 155 | 22 | 16 | FALSE | 0.46 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 360 | 95 | Signature 1A | -0.10 | -0.52 | 0.33 | 1485.71 | 1.00 | 420 | 319 | 54 | 41 | FALSE | 0.20 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 123 | 83 | Signature 6 | -0.91 | -1.48 | -0.37 | 1398.33 | 1.00 | 140 | 105 | 65 | 18 | FALSE | 2.86 |
| colorectal cancer | RAS_12-61 | PTPRS | Any mutation | 668 | 232 | Signature overall | -0.60 | -1.48 | 0.20 | 1431.63 | 1.00 | 761 | 591 | 155 | 77 | FALSE | 0.77 |
| colorectal cancer | RAS_12-61 | SMARCA4 | Any mutation | 174 | 22 | Signature 15 | -0.45 | -1.13 | 0.28 | 1545.38 | 1.00 | 204 | 165 | 13 | 9 | FALSE | 0.70 |
| colorectal cancer | RAS_12-61 | SMARCA4 | Any mutation | 373 | 74 | Signature 1A | -0.41 | -0.88 | 0.05 | 1387.82 | 1.00 | 439 | 346 | 47 | 27 | FALSE | 1.07 |
| colorectal cancer | RAS_12-61 | SMARCA4 | Any mutation | 124 | 52 | Signature 6 | -1.04 | -1.80 | -0.40 | 1644.52 | 1.00 | 158 | 116 | 44 | 8 | FALSE | 2.45 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 15 | 11 | Signature 13 | 0.40 | -0.70 | 1.51 | 1360.44 | 1.00 | 75 | 12 | 8 | 3 | FALSE | 0.33 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 69 | 14 | Signature 18 | 0.72 | -0.15 | 1.69 | 1390.77 | 1.00 | 78 | 59 | 4 | 10 | FALSE | 0.90 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 48 | 17 | Signature 1A | 0.19 | -0.76 | 1.11 | 1485.30 | 1.00 | 207 | 44 | 13 | 4 | FALSE | 0.16 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 88 | 33 | Signature 2 | -0.08 | -0.88 | 0.63 | 1504.16 | 1.00 | 218 | 80 | 25 | 8 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 56 | 16 | Signature 3 | 0.63 | -0.33 | 1.48 | 1631.15 | 1.00 | 179 | 49 | 9 | 7 | FALSE | 0.77 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 276 | 104 | Signature 4 | -0.34 | -0.77 | 0.08 | 1487.00 | 1.00 | 361 | 244 | 72 | 32 | FALSE | 0.91 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 25 | 15 | Signature 7 | 0.18 | -0.73 | 1.10 | 1479.21 | 1.00 | 72 | 21 | 11 | 4 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 156 | 15 | Signature R2 | -0.25 | -1.12 | 0.66 | 1451.47 | 1.00 | 37 | 146 | 5 | 10 | FALSE | 0.23 |
| uterine cancer | RAS_12-61 | SMARCA4 | Any mutation | 28 | 14 | Signature 15 | 0.13 | -0.84 | 1.10 | 1337.89 | 1.00 | 76 | 23 | 9 | 5 | FALSE | 0.10 |
| uterine cancer | RAS_12-61 | SMARCA4 | Any mutation | 44 | 21 | Signature 1A | -0.36 | -1.36 | 0.58 | 1379.42 | 1.00 | 159 | 41 | 18 | 3 | FALSE | 0.34 |
| uterine cancer | RAS_12-61 | SMARCA4 | Any mutation | 19 | 30 | Signature 6 | -0.27 | -1.20 | 0.65 | 1509.10 | 1.00 | 66 | 15 | 26 | 4 | FALSE | 0.24 |
| colorectal cancer | RAS_12-61 | SMARCA4 | Any mutation | 671 | 148 | Signature overall | -0.63 | -1.46 | 0.14 | 1590.23 | 1.00 | 801 | 627 | 104 | 44 | FALSE | 0.91 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Any mutation | 733 | 225 | Signature overall | 0.17 | -0.51 | 0.83 | 1529.27 | 1.00 | 1227 | 655 | 147 | 78 | FALSE | 0.22 |
| uterine cancer | RAS_12-61 | SMARCA4 | Any mutation | 94 | 76 | Signature overall | -0.17 | -1.12 | 0.76 | 1355.24 | 1.00 | 328 | 81 | 63 | 13 | FALSE | 0.14 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 17 | 23 | Signature 10 | -0.88 | -1.93 | 0.22 | 1299.77 | 1.00 | 12 | 12 | 18 | 5 | FALSE | 0.98 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 173 | 25 | Signature 15 | -1.35 | -2.32 | -0.49 | 1284.42 | 1.00 | 192 | 169 | 21 | 4 | FALSE | 2.38 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 369 | 66 | Signature 1A | 0.03 | -0.48 | 0.50 | 1526.68 | 1.00 | 443 | 338 | 35 | 31 | FALSE | 0.04 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 125 | 43 | Signature 6 | -0.52 | -1.19 | 0.11 | 1529.93 | 1.00 | 159 | 112 | 30 | 13 | FALSE | 0.91 |
| melanoma | RAS_12-61 | PTPRT | Any mutation | 17 | 12 | Signature 11 | -0.32 | -1.56 | 0.85 | 1555.30 | 1.00 | 34 | 14 | 9 | 3 | FALSE | 0.22 |
| melanoma | RAS_12-61 | PTPRT | Any mutation | 177 | 346 | Signature 7 | -0.12 | -0.46 | 0.23 | 1455.27 | 1.00 | 167 | 77 | 246 | 100 | FALSE | 0.31 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 15 | 11 | Signature 13 | 0.27 | -1.02 | 1.59 | 1488.06 | 1.00 | 77 | 12 | 8 | 3 | FALSE | 0.17 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 68 | 17 | Signature 18 | -0.67 | -1.63 | 0.24 | 1547.91 | 1.00 | 71 | 63 | 12 | 5 | FALSE | 0.77 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 48 | 11 | Signature 1A | -1.25 | -3.08 | 0.17 | 1461.39 | 1.00 | 210 | 48 | 11 | 0 | FALSE | 0.86 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 87 | 30 | Signature 2 | 0.86 | 0.16 | 1.64 | 1523.88 | 1.00 | 224 | 72 | 15 | 15 | FALSE | 1.66 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 56 | 19 | Signature 3 | -0.54 | -1.73 | 0.47 | 1466.64 | 1.00 | 173 | 53 | 16 | 3 | FALSE | 0.49 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 279 | 179 | Signature 4 | -0.86 | -1.24 | -0.48 | 1562.07 | 1.00 | 328 | 238 | 138 | 41 | FALSE | 5.19 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 158 | 23 | Signature R2 | -0.51 | -1.33 | 0.32 | 1503.82 | 1.00 | 37 | 143 | 8 | 15 | FALSE | 0.64 |
| colorectal cancer | RAS_12-61 | PTPRT | Any mutation | 684 | 157 | Signature overall | -0.70 | -1.82 | 0.29 | 1465.00 | 1.00 | 806 | 631 | 104 | 53 | FALSE | 0.75 |
| melanoma | RAS_12-61 | PTPRT | Any mutation | 194 | 358 | Signature overall | -0.22 | -2.07 | 1.67 | 1528.53 | 1.00 | 201 | 91 | 255 | 103 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | PTPRT | Any mutation | 711 | 290 | Signature overall | -0.37 | -1.19 | 0.44 | 1701.51 | 1.00 | 1120 | 629 | 208 | 82 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12-61 | HGF | Any mutation | 86 | 20 | Signature 2 | 0.58 | -0.35 | 1.48 | 1274.64 | 1.00 | 227 | 77 | 11 | 9 | FALSE | 0.66 |
| non-small cell lung cancer | RAS_12-61 | HGF | Any mutation | 275 | 89 | Signature 4 | -0.31 | -0.77 | 0.17 | 1348.83 | 1.00 | 376 | 246 | 60 | 29 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12-61 | HGF | Any mutation | 157 | 12 | Signature R2 | -1.08 | -2.21 | 0.02 | 1706.91 | 1.00 | 37 | 151 | 6 | 6 | FALSE | 1.23 |
| non-small cell lung cancer | RAS_12-61 | HGF | Any mutation | 518 | 121 | Signature overall | -0.28 | -1.81 | 1.20 | 1434.24 | 1.00 | 640 | 474 | 77 | 44 | FALSE | 0.14 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 14 | 23 | Signature 10 | 0.11 | -0.85 | 0.91 | 1353.05 | 1.00 | 12 | 8 | 17 | 6 | TRUE | 0.10 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 173 | 63 | Signature 15 | 0.26 | -0.22 | 0.70 | 1428.07 | 1.00 | 186 | 141 | 31 | 32 | TRUE | 0.57 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 20 | 19 | Signature 18 | 0.22 | -0.58 | 0.92 | 1313.06 | 1.00 | 16 | 13 | 12 | 7 | TRUE | 0.25 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 379 | 191 | Signature 1A | 0.51 | 0.21 | 0.81 | 1447.17 | 1.00 | 398 | 275 | 87 | 104 | TRUE | 2.89 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 50 | 43 | Signature 2 | 1.07 | 0.45 | 1.78 | 1581.69 | 1.00 | 24 | 18 | 11 | 32 | TRUE | 2.86 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 132 | 95 | Signature 6 | 0.45 | 0.00 | 0.86 | 1584.72 | 1.00 | 145 | 86 | 49 | 46 | TRUE | 1.40 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 16 | 13 | Signature 13 | 0.93 | -0.17 | 2.03 | 1430.91 | 1.00 | 76 | 10 | 7 | 6 | TRUE | 1.01 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 48 | 13 | Signature 1A | 0.03 | -1.09 | 1.05 | 1454.17 | 1.00 | 209 | 45 | 10 | 3 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 87 | 82 | Signature 2 | 0.12 | -0.42 | 0.62 | 1416.39 | 1.00 | 184 | 64 | 59 | 23 | TRUE | 0.19 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 16 | 16 | Signature 20 | -0.08 | -1.28 | 0.96 | 1606.32 | 1.00 | 48 | 13 | 13 | 3 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 56 | 15 | Signature 3 | -1.07 | -2.54 | 0.07 | 1614.74 | 1.00 | 172 | 56 | 15 | 0 | TRUE | 0.96 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 275 | 38 | Signature 4 | -0.45 | -1.11 | 0.16 | 1468.01 | 1.00 | 401 | 264 | 27 | 11 | TRUE | 0.77 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 8 | 63 | Signature 10 | 0.54 | -0.45 | 1.63 | 1515.94 | 1.00 | 7 | 0 | 55 | 8 | TRUE | 0.50 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 29 | 50 | Signature 15 | 0.05 | -0.73 | 0.78 | 1470.72 | 1.00 | 50 | 18 | 39 | 11 | TRUE | 0.04 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 54 | 138 | Signature 1A | 0.98 | 0.40 | 1.57 | 1821.23 | 1.00 | 100 | 14 | 98 | 40 | TRUE | 2.93 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 8 | 30 | Signature 2 | 0.37 | -0.68 | 1.43 | 1478.77 | 1.00 | 17 | 3 | 25 | 5 | TRUE | 0.31 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 10 | 25 | Signature 20 | 0.24 | -0.81 | 1.26 | 1433.43 | 1.00 | 14 | 5 | 20 | 5 | TRUE | 0.19 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 12 | 21 | Signature 3 | 1.10 | 0.11 | 2.18 | 1463.07 | 1.00 | 23 | 3 | 12 | 9 | TRUE | 1.46 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 24 | 85 | Signature 6 | 0.68 | -0.10 | 1.51 | 1234.80 | 1.00 | 34 | 5 | 66 | 19 | TRUE | 1.00 |
| colorectal cancer | RAS_12-61 | PIK3CA | Any mutation | 768 | 434 | Signature overall | 0.44 | -0.08 | 0.94 | 1386.86 | 1.00 | 781 | 541 | 207 | 227 | TRUE | 1.04 |
| non-small cell lung cancer | RAS_12-61 | PIK3CA | Any mutation | 498 | 177 | Signature overall | -0.08 | -0.89 | 0.68 | 1557.93 | 1.00 | 1090 | 452 | 131 | 46 | TRUE | 0.07 |
| uterine cancer | RAS_12-61 | PIK3CA | Any mutation | 151 | 459 | Signature overall | 0.47 | -0.16 | 1.13 | 1647.06 | 1.00 | 306 | 50 | 358 | 101 | TRUE | 0.82 |
| colorectal cancer | RAS_12-61 | ALK | Any mutation | 14 | 13 | Signature 10 | -0.47 | -1.77 | 0.58 | 1467.63 | 1.00 | 15 | 11 | 10 | 3 | TRUE | 0.36 |
| colorectal cancer | RAS_12-61 | ALK | Any mutation | 173 | 16 | Signature 15 | 0.51 | -0.33 | 1.45 | 1533.29 | 1.00 | 207 | 162 | 5 | 11 | TRUE | 0.57 |
| colorectal cancer | RAS_12-61 | ALK | Any mutation | 370 | 35 | Signature 1A | -0.24 | -0.90 | 0.39 | 1537.62 | 1.00 | 457 | 356 | 21 | 14 | TRUE | 0.32 |
| colorectal cancer | RAS_12-61 | ALK | Any mutation | 123 | 37 | Signature 6 | -0.80 | -1.62 | -0.07 | 1393.97 | 1.00 | 166 | 115 | 29 | 8 | TRUE | 1.37 |
| melanoma | RAS_12-61 | ALK | Any mutation | 151 | 117 | Signature 7 | -0.25 | -0.69 | 0.19 | 344.75 | 1.01 | 237 | 118 | 84 | 33 | TRUE | 0.53 |
| non-small cell lung cancer | RAS_12-61 | ALK | Any mutation | 86 | 24 | Signature 2 | 0.30 | -0.46 | 1.08 | 1459.00 | 1.00 | 225 | 77 | 15 | 9 | TRUE | 0.36 |
| non-small cell lung cancer | RAS_12-61 | ALK | Any mutation | 275 | 72 | Signature 4 | -0.06 | -0.56 | 0.46 | 1597.67 | 1.00 | 386 | 249 | 46 | 26 | TRUE | 0.08 |
| colorectal cancer | RAS_12-61 | ALK | Any mutation | 680 | 101 | Signature overall | -0.24 | -1.29 | 0.81 | 1465.46 | 1.00 | 845 | 644 | 65 | 36 | TRUE | 0.19 |
| melanoma | RAS_12-61 | ALK | Any mutation | 151 | 117 | Signature overall | -0.23 | -4.74 | 3.67 | 1600.80 | 1.00 | 237 | 118 | 84 | 33 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12-61 | ALK | Any mutation | 361 | 96 | Signature overall | 0.14 | -0.95 | 1.36 | 1427.95 | 1.00 | 611 | 326 | 61 | 35 | TRUE | 0.09 |
| colorectal cancer | RAS_12-61 | RNF43 | Any mutation | 176 | 31 | Signature 15 | -0.98 | -1.75 | -0.27 | 1458.53 | 1.00 | 196 | 168 | 23 | 8 | TRUE | 2.04 |
| colorectal cancer | RAS_12-61 | RNF43 | Any mutation | 376 | 93 | Signature 1A | -0.60 | -1.04 | -0.19 | 1564.43 | 1.00 | 435 | 346 | 63 | 30 | TRUE | 2.05 |
| colorectal cancer | RAS_12-61 | RNF43 | Any mutation | 128 | 102 | Signature 6 | -1.13 | -1.70 | -0.61 | 1583.18 | 1.00 | 130 | 108 | 82 | 20 | TRUE | 4.58 |
| colorectal cancer | RAS_12-61 | RNF43 | Any mutation | 680 | 226 | Signature overall | -0.89 | -1.82 | 0.00 | 1451.68 | 1.00 | 761 | 622 | 168 | 58 | TRUE | 1.28 |
| colorectal cancer | RAS_12-61 | PTEN | Any mutation | 14 | 13 | Signature 10 | -0.34 | -1.48 | 0.60 | 1490.77 | 1.00 | 14 | 11 | 10 | 3 | TRUE | 0.27 |
| colorectal cancer | RAS_12-61 | PTEN | Any mutation | 173 | 22 | Signature 15 | 0.22 | -0.48 | 0.97 | 1409.49 | 1.00 | 204 | 160 | 9 | 13 | TRUE | 0.24 |
| colorectal cancer | RAS_12-61 | PTEN | Any mutation | 373 | 64 | Signature 1A | -0.16 | -0.64 | 0.34 | 1353.10 | 1.00 | 450 | 347 | 38 | 26 | TRUE | 0.29 |
| colorectal cancer | RAS_12-61 | PTEN | Any mutation | 128 | 57 | Signature 6 | -0.30 | -0.86 | 0.28 | 1713.04 | 1.00 | 164 | 110 | 39 | 18 | TRUE | 0.52 |
| non-small cell lung cancer | RAS_12-61 | PTEN | Any mutation | 86 | 27 | Signature 2 | -0.85 | -1.87 | 0.03 | 1338.49 | 1.00 | 218 | 82 | 23 | 4 | TRUE | 1.12 |
| non-small cell lung cancer | RAS_12-61 | PTEN | Any mutation | 275 | 27 | Signature 4 | -0.90 | -1.72 | -0.17 | 1357.84 | 1.00 | 407 | 269 | 21 | 6 | TRUE | 1.59 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 7 | 61 | Signature 10 | 0.63 | -0.33 | 1.55 | 1460.55 | 1.00 | 10 | 0 | 54 | 7 | TRUE | 0.73 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 8 | 14 | Signature 14 | 1.06 | 0.01 | 2.00 | 1463.71 | 1.00 | 10 | 2 | 8 | 6 | TRUE | 1.47 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 37 | 61 | Signature 15 | 1.11 | 0.50 | 1.82 | 1512.92 | 1.00 | 57 | 12 | 36 | 25 | TRUE | 3.05 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 63 | 155 | Signature 1A | 1.05 | 0.54 | 1.59 | 1543.66 | 1.00 | 112 | 16 | 108 | 47 | TRUE | 4.07 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 7 | 15 | Signature 1B | 1.34 | 0.41 | 2.37 | 1607.69 | 1.00 | 8 | 0 | 8 | 7 | TRUE | 2.11 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 9 | 26 | Signature 2 | 0.60 | -0.31 | 1.46 | 1471.88 | 1.00 | 24 | 4 | 21 | 5 | TRUE | 0.74 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 14 | 28 | Signature 20 | 1.28 | 0.45 | 2.19 | 1510.13 | 1.00 | 19 | 2 | 16 | 12 | TRUE | 2.38 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 14 | 17 | Signature 3 | 1.21 | 0.32 | 2.15 | 1701.63 | 1.00 | 29 | 5 | 8 | 9 | TRUE | 2.06 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 25 | 104 | Signature 6 | 0.32 | -0.46 | 1.09 | 1549.82 | 1.00 | 23 | 7 | 86 | 18 | TRUE | 0.37 |
| colorectal cancer | RAS_12-61 | PTEN | Any mutation | 688 | 156 | Signature overall | -0.13 | -0.97 | 0.68 | 1361.50 | 1.00 | 832 | 628 | 96 | 60 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | PTEN | Any mutation | 361 | 54 | Signature overall | -0.84 | -2.15 | 0.43 | 1378.75 | 1.00 | 625 | 351 | 44 | 10 | TRUE | 0.68 |
| uterine cancer | RAS_12-61 | PTEN | Any mutation | 197 | 545 | Signature overall | 0.81 | 0.31 | 1.35 | 1560.11 | 1.00 | 335 | 54 | 402 | 143 | TRUE | 2.63 |
| colorectal cancer | RAS_12-61 | BCOR | Any mutation | 13 | 11 | Signature 10 | -0.72 | -2.15 | 0.57 | 1621.58 | 1.00 | 15 | 11 | 9 | 2 | FALSE | 0.52 |
| colorectal cancer | RAS_12-61 | BCOR | Any mutation | 173 | 13 | Signature 15 | -0.42 | -1.43 | 0.56 | 1492.07 | 1.00 | 205 | 168 | 8 | 5 | FALSE | 0.39 |
| colorectal cancer | RAS_12-61 | BCOR | Any mutation | 368 | 27 | Signature 1A | 0.38 | -0.35 | 1.11 | 1702.05 | 1.00 | 466 | 352 | 11 | 16 | FALSE | 0.52 |
| colorectal cancer | RAS_12-61 | BCOR | Any mutation | 129 | 49 | Signature 6 | -0.52 | -1.21 | 0.12 | 1455.11 | 1.00 | 161 | 115 | 35 | 14 | FALSE | 0.94 |
| non-small cell lung cancer | RAS_12-61 | BCOR | Any mutation | 87 | 13 | Signature 2 | 0.22 | -0.76 | 1.11 | 1621.64 | 1.00 | 229 | 83 | 9 | 4 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12-61 | BCOR | Any mutation | 279 | 52 | Signature 4 | 0.46 | -0.06 | 0.97 | 1388.21 | 1.00 | 404 | 253 | 26 | 26 | FALSE | 1.04 |
| uterine cancer | RAS_12-61 | BCOR | Any mutation | 44 | 30 | Signature 1A | 0.24 | -0.69 | 1.06 | 1398.75 | 1.00 | 154 | 37 | 23 | 7 | FALSE | 0.23 |
| uterine cancer | RAS_12-61 | BCOR | Any mutation | 19 | 23 | Signature 6 | 1.01 | -0.04 | 1.99 | 1564.03 | 1.00 | 69 | 11 | 15 | 8 | FALSE | 1.26 |
| colorectal cancer | RAS_12-61 | BCOR | Any mutation | 683 | 100 | Signature overall | -0.32 | -1.49 | 0.82 | 1595.79 | 1.00 | 847 | 646 | 63 | 37 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | BCOR | Any mutation | 366 | 65 | Signature overall | 0.32 | -0.94 | 1.40 | 1503.30 | 1.00 | 633 | 336 | 35 | 30 | FALSE | 0.22 |
| uterine cancer | RAS_12-61 | BCOR | Any mutation | 66 | 83 | Signature overall | 0.45 | -1.16 | 1.96 | 1710.22 | 1.00 | 244 | 49 | 66 | 17 | FALSE | 0.23 |
| colorectal cancer | RAS_12-61 | CTNNB1 | Any mutation | 173 | 22 | Signature 15 | 0.51 | -0.03 | 0.87 | 13.15 | 1.09 | 202 | 162 | 11 | 11 | TRUE | 1.54 |
| colorectal cancer | RAS_12-61 | CTNNB1 | Any mutation | 371 | 61 | Signature 1A | 0.64 | 0.27 | 1.05 | 1109.97 | 1.00 | 455 | 332 | 22 | 39 | TRUE | 3.35 |
| colorectal cancer | RAS_12-61 | CTNNB1 | Any mutation | 124 | 33 | Signature 6 | 0.55 | 0.06 | 0.95 | 506.87 | 1.01 | 172 | 109 | 18 | 15 | TRUE | 1.97 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 48 | 11 | Signature 1A | -1.50 | -3.04 | -0.16 | 1408.10 | 1.00 | 208 | 47 | 10 | 1 | TRUE | 1.42 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 86 | 14 | Signature 2 | -1.64 | -3.06 | -0.42 | 1424.51 | 1.00 | 225 | 85 | 13 | 1 | TRUE | 1.83 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 56 | 17 | Signature 3 | -1.18 | -2.53 | 0.01 | 1560.67 | 1.00 | 173 | 53 | 14 | 3 | TRUE | 1.15 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 275 | 16 | Signature 4 | -2.05 | -3.61 | -0.82 | 1156.79 | 1.00 | 411 | 275 | 16 | 0 | TRUE | 2.27 |
| uterine cancer | RAS_12-61 | CTNNB1 | Any mutation | 26 | 11 | Signature 15 | -1.38 | -2.75 | -0.19 | 1424.40 | 1.00 | 74 | 25 | 10 | 1 | TRUE | 1.43 |
| uterine cancer | RAS_12-61 | CTNNB1 | Any mutation | 44 | 31 | Signature 1A | -1.43 | -2.68 | -0.32 | 1213.07 | 1.00 | 147 | 42 | 29 | 2 | TRUE | 1.80 |
| uterine cancer | RAS_12-61 | CTNNB1 | Any mutation | 17 | 19 | Signature 6 | -1.44 | -2.88 | -0.26 | 1350.36 | 1.00 | 64 | 16 | 18 | 1 | TRUE | 1.54 |
| colorectal cancer | RAS_12-61 | CTNNB1 | Any mutation | 668 | 116 | Signature overall | 0.57 | 0.12 | 0.93 | 501.98 | 1.02 | 829 | 603 | 51 | 65 | TRUE | 2.28 |
| non-small cell lung cancer | RAS_12-61 | CTNNB1 | Any mutation | 465 | 58 | Signature overall | -1.57 | -2.84 | -0.50 | 1199.50 | 1.00 | 1017 | 460 | 53 | 5 | TRUE | 2.08 |
| uterine cancer | RAS_12-61 | CTNNB1 | Any mutation | 91 | 83 | Signature overall | -1.39 | -2.63 | -0.31 | 1393.76 | 1.00 | 351 | 86 | 78 | 5 | TRUE | 1.76 |
| cancer of unknown primary | RAS_12-61 | ARID1A | Any mutation | 40 | 22 | Signature 1A | -0.51 | -1.36 | 0.32 | 1127.88 | 1.00 | 66 | 34 | 16 | 6 | TRUE | 0.63 |
| cancer of unknown primary | RAS_12-61 | ARID1A | Any mutation | 9 | 13 | Signature 2 | -0.56 | -1.61 | 0.50 | 1344.58 | 1.00 | 36 | 7 | 11 | 2 | TRUE | 0.55 |
| cancer of unknown primary | RAS_12-61 | ARID1A | Any mutation | 23 | 12 | Signature 4 | -0.55 | -1.51 | 0.40 | 1381.69 | 1.00 | 49 | 20 | 9 | 3 | TRUE | 0.60 |
| cancer of unknown primary | RAS_12-61 | ARID1A | Any mutation | 6 | 11 | Signature 6 | -0.82 | -2.22 | 0.17 | 1192.83 | 1.00 | 15 | 6 | 11 | 0 | TRUE | 0.71 |
| colorectal cancer | RAS_12-61 | ARID1A | Any mutation | 14 | 13 | Signature 10 | -0.68 | -1.62 | 0.18 | 1346.21 | 1.00 | 15 | 11 | 10 | 3 | TRUE | 0.85 |
| colorectal cancer | RAS_12-61 | ARID1A | Any mutation | 175 | 39 | Signature 15 | -0.87 | -1.51 | -0.28 | 1347.18 | 1.00 | 197 | 165 | 29 | 10 | TRUE | 2.24 |
| colorectal cancer | RAS_12-61 | ARID1A | Any mutation | 381 | 130 | Signature 1A | -0.40 | -0.77 | -0.02 | 1673.86 | 1.00 | 420 | 333 | 82 | 48 | TRUE | 1.43 |
| colorectal cancer | RAS_12-61 | ARID1A | Any mutation | 130 | 99 | Signature 6 | -0.74 | -1.21 | -0.27 | 1321.17 | 1.00 | 138 | 105 | 74 | 25 | TRUE | 2.62 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 15 | 17 | Signature 13 | -1.24 | -3.00 | 0.16 | 1388.61 | 1.00 | 68 | 15 | 17 | 0 | TRUE | 0.90 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 71 | 12 | Signature 18 | 0.70 | -0.31 | 1.85 | 1370.07 | 1.00 | 79 | 62 | 3 | 9 | TRUE | 0.72 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 90 | 52 | Signature 2 | 0.52 | -0.05 | 1.11 | 1579.78 | 1.00 | 211 | 70 | 32 | 20 | TRUE | 1.10 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 56 | 11 | Signature 3 | -0.42 | -1.68 | 0.78 | 1399.64 | 1.00 | 178 | 54 | 9 | 2 | TRUE | 0.30 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 276 | 86 | Signature 4 | -0.74 | -1.25 | -0.28 | 1552.62 | 1.00 | 364 | 255 | 65 | 21 | TRUE | 2.47 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 156 | 13 | Signature R2 | -0.43 | -1.44 | 0.59 | 1406.50 | 1.00 | 38 | 147 | 4 | 9 | TRUE | 0.39 |
| pancreatic cancer | RAS_12-61 | ARID1A | Any mutation | 118 | 12 | Signature 11 | 0.14 | -1.21 | 2.53 | 1139.65 | 1.00 | 8 | 106 | 0 | 12 | TRUE | 0.05 |
| pancreatic cancer | RAS_12-61 | ARID1A | Any mutation | 223 | 33 | Signature 1A | -0.25 | -1.20 | 0.83 | 1447.17 | 1.00 | 27 | 196 | 6 | 27 | TRUE | 0.20 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 7 | 21 | Signature 14 | 0.95 | -0.13 | 1.97 | 1528.46 | 1.00 | 9 | 2 | 16 | 5 | TRUE | 1.13 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 32 | 58 | Signature 15 | 1.14 | 0.44 | 1.84 | 1421.57 | 1.00 | 59 | 11 | 37 | 21 | TRUE | 2.84 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 60 | 133 | Signature 1A | 1.24 | 0.68 | 1.85 | 1479.85 | 1.00 | 114 | 16 | 89 | 44 | TRUE | 4.55 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 10 | 23 | Signature 2 | 1.34 | 0.32 | 2.39 | 1426.90 | 1.00 | 27 | 2 | 15 | 8 | TRUE | 2.07 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 13 | 26 | Signature 20 | 1.66 | 0.69 | 2.73 | 1188.99 | 1.00 | 20 | 1 | 14 | 12 | TRUE | 2.83 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 24 | 121 | Signature 6 | 0.70 | -0.20 | 1.56 | 1508.28 | 1.00 | 26 | 4 | 101 | 20 | TRUE | 0.93 |
| cancer of unknown primary | RAS_12-61 | ARID1A | Any mutation | 78 | 58 | Signature overall | -0.61 | -1.53 | 0.26 | 1305.05 | 1.00 | 166 | 67 | 47 | 11 | TRUE | 0.76 |
| colorectal cancer | RAS_12-61 | ARID1A | Any mutation | 700 | 281 | Signature overall | -0.67 | -1.34 | -0.10 | 1420.13 | 1.00 | 770 | 614 | 195 | 86 | TRUE | 1.50 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Any mutation | 664 | 191 | Signature overall | -0.26 | -1.22 | 0.64 | 1493.68 | 1.00 | 938 | 603 | 130 | 61 | TRUE | 0.24 |
| pancreatic cancer | RAS_12-61 | ARID1A | Any mutation | 341 | 45 | Signature overall | -0.07 | -1.55 | 1.93 | 1375.98 | 1.00 | 35 | 302 | 6 | 39 | TRUE | 0.03 |
| uterine cancer | RAS_12-61 | ARID1A | Any mutation | 152 | 445 | Signature overall | 1.04 | 0.37 | 1.70 | 1480.95 | 1.00 | 273 | 37 | 330 | 115 | TRUE | 2.66 |
| colorectal cancer | RAS_12-61 | PIK3R1 | Any mutation | 15 | 17 | Signature 10 | -0.51 | -1.71 | 0.56 | 1254.09 | 1.00 | 13 | 11 | 13 | 4 | TRUE | 0.43 |
| colorectal cancer | RAS_12-61 | PIK3R1 | Any mutation | 173 | 17 | Signature 15 | 0.11 | -0.70 | 0.99 | 1598.52 | 1.00 | 207 | 164 | 8 | 9 | TRUE | 0.10 |
| colorectal cancer | RAS_12-61 | PIK3R1 | Any mutation | 369 | 31 | Signature 1A | -0.15 | -0.86 | 0.51 | 1553.21 | 1.00 | 461 | 356 | 18 | 13 | TRUE | 0.18 |
| colorectal cancer | RAS_12-61 | PIK3R1 | Any mutation | 124 | 31 | Signature 6 | -0.18 | -0.92 | 0.55 | 1640.29 | 1.00 | 171 | 113 | 20 | 11 | TRUE | 0.20 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 29 | 32 | Signature 15 | 0.47 | -0.33 | 1.32 | 1414.74 | 1.00 | 68 | 15 | 18 | 14 | TRUE | 0.55 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 46 | 59 | Signature 1A | -0.50 | -1.24 | 0.19 | 1403.52 | 1.00 | 129 | 39 | 52 | 7 | TRUE | 0.77 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 11 | 13 | Signature 20 | 0.12 | -0.76 | 1.12 | 1385.25 | 1.00 | 24 | 6 | 8 | 5 | TRUE | 0.10 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 18 | 31 | Signature 6 | -0.60 | -1.62 | 0.18 | 1490.46 | 1.00 | 58 | 16 | 29 | 2 | TRUE | 0.69 |
| colorectal cancer | RAS_12-61 | PIK3R1 | Any mutation | 681 | 96 | Signature overall | -0.22 | -1.32 | 0.87 | 1575.26 | 1.00 | 852 | 644 | 59 | 37 | TRUE | 0.17 |
| uterine cancer | RAS_12-61 | PIK3R1 | Any mutation | 112 | 167 | Signature overall | -0.21 | -0.88 | 0.44 | 1516.73 | 1.00 | 315 | 82 | 137 | 30 | TRUE | 0.27 |
| melanoma | RAS_12-61 | IKZF1 | Any mutation | 154 | 93 | Signature 7 | -0.06 | -0.52 | 0.40 | 1456.18 | 1.00 | 250 | 124 | 63 | 30 | TRUE | 0.10 |
| melanoma | RAS_12-61 | IKZF1 | Any mutation | 154 | 93 | Signature overall | -0.11 | -4.46 | 4.08 | 1391.76 | 1.00 | 250 | 124 | 63 | 30 | TRUE | 0.02 |
| colorectal cancer | RAS_12-61 | FAT1 | Any mutation | 22 | 44 | Signature 10 | -0.85 | -1.81 | 0.06 | 1412.87 | 1.00 | 12 | 11 | 33 | 11 | FALSE | 1.12 |
| colorectal cancer | RAS_12-61 | FAT1 | Any mutation | 173 | 29 | Signature 15 | -1.85 | -3.03 | -0.88 | 1276.40 | 1.00 | 195 | 170 | 26 | 3 | FALSE | 3.21 |
| colorectal cancer | RAS_12-61 | FAT1 | Any mutation | 373 | 66 | Signature 1A | -0.40 | -0.91 | 0.09 | 1623.70 | 1.00 | 443 | 349 | 42 | 24 | FALSE | 0.91 |
| colorectal cancer | RAS_12-61 | FAT1 | Any mutation | 127 | 67 | Signature 6 | -0.71 | -1.30 | -0.15 | 1550.01 | 1.00 | 152 | 109 | 49 | 18 | FALSE | 1.87 |
| melanoma | RAS_12-61 | FAT1 | Any mutation | 153 | 128 | Signature 7 | -0.01 | -0.46 | 0.43 | 605.26 | 1.01 | 237 | 112 | 87 | 41 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 15 | 16 | Signature 13 | 0.04 | -0.94 | 0.95 | 1480.90 | 1.00 | 71 | 13 | 14 | 2 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 68 | 16 | Signature 18 | 0.58 | -0.20 | 1.38 | 1532.97 | 1.00 | 76 | 58 | 6 | 10 | FALSE | 0.80 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 48 | 13 | Signature 1A | 0.39 | -0.55 | 1.35 | 1395.19 | 1.00 | 212 | 44 | 9 | 4 | FALSE | 0.39 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 88 | 38 | Signature 2 | 0.18 | -0.47 | 0.81 | 1515.78 | 1.00 | 215 | 77 | 27 | 11 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 17 | 11 | Signature 20 | 0.73 | -0.28 | 1.71 | 1481.72 | 1.00 | 55 | 12 | 6 | 5 | FALSE | 0.84 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 56 | 13 | Signature 3 | 0.58 | -0.28 | 1.45 | 1493.14 | 1.00 | 180 | 50 | 7 | 6 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 277 | 121 | Signature 4 | -0.38 | -0.80 | 0.03 | 1444.84 | 1.00 | 353 | 242 | 86 | 35 | FALSE | 1.20 |
| uterine cancer | RAS_12-61 | FAT1 | Any mutation | 26 | 14 | Signature 15 | -0.24 | -1.54 | 0.94 | 1537.96 | 1.00 | 75 | 23 | 11 | 3 | FALSE | 0.15 |
| uterine cancer | RAS_12-61 | FAT1 | Any mutation | 44 | 24 | Signature 1A | -0.64 | -1.90 | 0.49 | 1361.06 | 1.00 | 158 | 41 | 21 | 3 | FALSE | 0.53 |
| uterine cancer | RAS_12-61 | FAT1 | Any mutation | 17 | 37 | Signature 6 | 0.01 | -1.05 | 1.00 | 1547.98 | 1.00 | 62 | 11 | 31 | 6 | FALSE | 0.01 |
| colorectal cancer | RAS_12-61 | FAT1 | Any mutation | 695 | 206 | Signature overall | -0.93 | -2.02 | 0.25 | 1451.09 | 1.00 | 802 | 639 | 150 | 56 | FALSE | 0.95 |
| melanoma | RAS_12-61 | FAT1 | Any mutation | 153 | 128 | Signature overall | -0.04 | -3.99 | 4.12 | 1500.46 | 1.00 | 237 | 112 | 87 | 41 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | FAT1 | Any mutation | 569 | 228 | Signature overall | 0.30 | -0.29 | 0.91 | 1412.36 | 1.00 | 1162 | 496 | 155 | 73 | FALSE | 0.50 |
| uterine cancer | RAS_12-61 | FAT1 | Any mutation | 92 | 149 | Signature overall | -0.17 | -1.74 | 1.49 | 1525.69 | 1.00 | 307 | 75 | 132 | 17 | FALSE | 0.08 |
| colorectal cancer | RAS_12-61 | CIC | Any mutation | 174 | 19 | Signature 15 | -0.84 | -1.61 | -0.10 | 1442.08 | 1.00 | 204 | 169 | 14 | 5 | TRUE | 1.53 |
| colorectal cancer | RAS_12-61 | CIC | Any mutation | 371 | 58 | Signature 1A | -0.37 | -0.91 | 0.14 | 1362.62 | 1.00 | 449 | 348 | 35 | 23 | TRUE | 0.77 |
| colorectal cancer | RAS_12-61 | CIC | Any mutation | 124 | 43 | Signature 6 | -1.00 | -1.75 | -0.33 | 1425.59 | 1.00 | 162 | 117 | 36 | 7 | TRUE | 2.14 |
| colorectal cancer | RAS_12-61 | CIC | Any mutation | 669 | 120 | Signature overall | -0.73 | -1.51 | -0.02 | 1522.85 | 1.00 | 815 | 634 | 85 | 35 | TRUE | 1.21 |
| colorectal cancer | RAS_12-61 | NCOR1 | Any mutation | 13 | 16 | Signature 10 | -1.04 | -2.33 | 0.06 | 1477.82 | 1.00 | 13 | 11 | 14 | 2 | FALSE | 1.07 |
| colorectal cancer | RAS_12-61 | NCOR1 | Any mutation | 173 | 22 | Signature 15 | -0.41 | -1.18 | 0.40 | 1214.62 | 1.00 | 202 | 164 | 13 | 9 | FALSE | 0.50 |
| colorectal cancer | RAS_12-61 | NCOR1 | Any mutation | 371 | 44 | Signature 1A | -0.70 | -1.34 | -0.12 | 1519.14 | 1.00 | 450 | 358 | 31 | 13 | FALSE | 1.63 |
| colorectal cancer | RAS_12-61 | NCOR1 | Any mutation | 125 | 43 | Signature 6 | -0.61 | -1.25 | 0.04 | 1464.51 | 1.00 | 165 | 113 | 31 | 12 | FALSE | 1.17 |
| non-small cell lung cancer | RAS_12-61 | NCOR1 | Any mutation | 16 | 14 | Signature 13 | 0.36 | -0.82 | 1.68 | 1635.15 | 1.00 | 76 | 12 | 10 | 4 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | NCOR1 | Any mutation | 86 | 11 | Signature 2 | -0.22 | -1.39 | 0.89 | 1474.02 | 1.00 | 233 | 83 | 8 | 3 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12-61 | NCOR1 | Any mutation | 276 | 36 | Signature 4 | -1.03 | -1.89 | -0.27 | 1469.74 | 1.00 | 398 | 270 | 30 | 6 | FALSE | 1.85 |
| colorectal cancer | RAS_12-61 | NCOR1 | Any mutation | 682 | 125 | Signature overall | -0.68 | -1.68 | 0.21 | 1334.64 | 1.00 | 830 | 646 | 89 | 36 | FALSE | 0.85 |
| non-small cell lung cancer | RAS_12-61 | NCOR1 | Any mutation | 378 | 61 | Signature overall | -0.28 | -1.57 | 0.95 | 1499.28 | 1.00 | 707 | 365 | 48 | 13 | FALSE | 0.18 |
| colorectal cancer | RAS_12-61 | POLE | Any mutation | 14 | 20 | Signature 10 | -0.82 | -2.04 | 0.32 | 1526.70 | 1.00 | 12 | 10 | 16 | 4 | TRUE | 0.74 |
| colorectal cancer | RAS_12-61 | POLE | Any mutation | 173 | 19 | Signature 15 | -0.89 | -1.81 | -0.07 | 1457.56 | 1.00 | 202 | 168 | 14 | 5 | TRUE | 1.31 |
| colorectal cancer | RAS_12-61 | POLE | Any mutation | 371 | 36 | Signature 1A | -0.02 | -0.66 | 0.63 | 1296.19 | 1.00 | 460 | 354 | 19 | 17 | TRUE | 0.02 |
| colorectal cancer | RAS_12-61 | POLE | Any mutation | 126 | 54 | Signature 6 | -0.72 | -1.40 | -0.04 | 1384.70 | 1.00 | 155 | 112 | 40 | 14 | TRUE | 1.54 |
| non-small cell lung cancer | RAS_12-61 | POLE | Any mutation | 87 | 19 | Signature 2 | 0.32 | -0.69 | 1.23 | 1502.42 | 1.00 | 227 | 80 | 12 | 7 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12-61 | POLE | Any mutation | 275 | 49 | Signature 4 | -0.35 | -0.98 | 0.24 | 1617.37 | 1.00 | 396 | 260 | 34 | 15 | TRUE | 0.60 |
| non-small cell lung cancer | RAS_12-61 | POLE | Any mutation | 156 | 11 | Signature R2 | 0.12 | -1.06 | 1.37 | 1395.44 | 1.00 | 40 | 147 | 2 | 9 | TRUE | 0.07 |
| uterine cancer | RAS_12-61 | POLE | Any mutation | 6 | 57 | Signature 10 | 1.35 | -0.73 | 4.58 | 1307.34 | 1.00 | 11 | 0 | 51 | 6 | TRUE | 0.50 |
| uterine cancer | RAS_12-61 | POLE | Any mutation | 44 | 12 | Signature 1A | 0.58 | -0.65 | 1.72 | 1567.02 | 1.00 | 168 | 40 | 8 | 4 | TRUE | 0.47 |
| uterine cancer | RAS_12-61 | POLE | Any mutation | 18 | 20 | Signature 6 | 0.55 | -0.62 | 1.73 | 1460.96 | 1.00 | 71 | 13 | 15 | 5 | TRUE | 0.45 |
| colorectal cancer | RAS_12-61 | POLE | Any mutation | 684 | 129 | Signature overall | -0.62 | -1.74 | 0.42 | 1534.16 | 1.00 | 829 | 644 | 89 | 40 | TRUE | 0.59 |
| non-small cell lung cancer | RAS_12-61 | POLE | Any mutation | 518 | 79 | Signature overall | 0.03 | -1.37 | 1.40 | 1455.33 | 1.00 | 663 | 487 | 48 | 31 | TRUE | 0.01 |
| uterine cancer | RAS_12-61 | POLE | Any mutation | 68 | 89 | Signature overall | 0.81 | -1.59 | 3.22 | 1527.79 | 1.00 | 250 | 53 | 74 | 15 | TRUE | 0.30 |
| non-small cell lung cancer | RAS_12-61 | NOTCH2 | Any mutation | 86 | 15 | Signature 2 | -0.93 | -2.21 | 0.10 | 1501.13 | 1.00 | 223 | 84 | 13 | 2 | TRUE | 0.96 |
| non-small cell lung cancer | RAS_12-61 | NOTCH2 | Any mutation | 275 | 54 | Signature 4 | -0.75 | -1.40 | -0.17 | 1245.07 | 1.00 | 396 | 262 | 41 | 13 | TRUE | 1.77 |
| non-small cell lung cancer | RAS_12-61 | NOTCH2 | Any mutation | 361 | 69 | Signature overall | -0.84 | -2.14 | 0.44 | 1510.94 | 1.00 | 619 | 346 | 54 | 15 | TRUE | 0.77 |
| colorectal cancer | RAS_12-61 | TGFBR2 | Any mutation | 174 | 11 | Signature 15 | -0.48 | -1.40 | 0.41 | 1462.07 | 1.00 | 205 | 170 | 7 | 4 | TRUE | 0.52 |
| colorectal cancer | RAS_12-61 | TGFBR2 | Any mutation | 369 | 48 | Signature 1A | -0.11 | -0.67 | 0.46 | 1437.03 | 1.00 | 453 | 348 | 27 | 21 | TRUE | 0.15 |
| colorectal cancer | RAS_12-61 | TGFBR2 | Any mutation | 123 | 43 | Signature 6 | -0.48 | -1.14 | 0.13 | 1492.05 | 1.00 | 159 | 111 | 31 | 12 | TRUE | 0.84 |
| colorectal cancer | RAS_12-61 | TGFBR2 | Any mutation | 666 | 102 | Signature overall | -0.34 | -1.29 | 0.55 | 1419.87 | 1.00 | 817 | 629 | 65 | 37 | TRUE | 0.34 |
| colorectal cancer | RAS_12-61 | KMT2A | Any mutation | 17 | 22 | Signature 10 | -0.50 | -1.54 | 0.46 | 1556.11 | 1.00 | 16 | 11 | 16 | 6 | FALSE | 0.49 |
| colorectal cancer | RAS_12-61 | KMT2A | Any mutation | 174 | 19 | Signature 15 | -1.37 | -2.45 | -0.43 | 1202.47 | 1.00 | 198 | 171 | 16 | 3 | FALSE | 2.10 |
| colorectal cancer | RAS_12-61 | KMT2A | Any mutation | 370 | 53 | Signature 1A | 0.02 | -0.53 | 0.56 | 1541.33 | 1.00 | 452 | 345 | 28 | 25 | FALSE | 0.02 |
| colorectal cancer | RAS_12-61 | KMT2A | Any mutation | 124 | 42 | Signature 6 | -1.05 | -1.84 | -0.35 | 1261.37 | 1.00 | 163 | 116 | 34 | 8 | FALSE | 2.23 |
| melanoma | RAS_12-61 | KMT2A | Any mutation | 151 | 124 | Signature 7 | -0.58 | -1.05 | -0.14 | 1332.02 | 1.00 | 237 | 123 | 96 | 28 | FALSE | 1.89 |
| non-small cell lung cancer | RAS_12-61 | KMT2A | Any mutation | 86 | 23 | Signature 2 | -0.13 | -0.97 | 0.62 | 1517.23 | 1.00 | 223 | 80 | 17 | 6 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | KMT2A | Any mutation | 275 | 37 | Signature 4 | -0.19 | -0.85 | 0.47 | 1380.38 | 1.00 | 404 | 262 | 24 | 13 | FALSE | 0.24 |
| uterine cancer | RAS_12-61 | KMT2A | Any mutation | 44 | 13 | Signature 1A | 0.79 | -0.47 | 1.96 | 1485.79 | 1.00 | 167 | 39 | 8 | 5 | FALSE | 0.70 |
| uterine cancer | RAS_12-61 | KMT2A | Any mutation | 17 | 14 | Signature 6 | -0.97 | -3.16 | 0.65 | 1526.80 | 1.00 | 68 | 16 | 13 | 1 | FALSE | 0.49 |
| colorectal cancer | RAS_12-61 | KMT2A | Any mutation | 685 | 136 | Signature overall | -0.73 | -1.78 | 0.26 | 1433.51 | 1.00 | 829 | 643 | 94 | 42 | FALSE | 0.81 |
| melanoma | RAS_12-61 | KMT2A | Any mutation | 151 | 124 | Signature overall | -0.53 | -4.16 | 3.72 | 1513.31 | 1.00 | 237 | 123 | 96 | 28 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | KMT2A | Any mutation | 361 | 60 | Signature overall | -0.17 | -1.26 | 0.84 | 1387.57 | 1.00 | 627 | 342 | 41 | 19 | FALSE | 0.12 |
| uterine cancer | RAS_12-61 | KMT2A | Any mutation | 66 | 81 | Signature overall | 0.36 | -2.18 | 3.18 | 1525.01 | 1.00 | 253 | 55 | 70 | 11 | FALSE | 0.11 |
| melanoma | RAS_12-61 | PAK7 | Any mutation | 150 | 205 | Signature 7 | -0.71 | -1.09 | -0.32 | 1138.79 | 1.01 | 168 | 102 | 157 | 48 | FALSE | 3.36 |
| non-small cell lung cancer | RAS_12-61 | PAK7 | Any mutation | 275 | 69 | Signature 4 | -0.35 | -0.88 | 0.17 | 1070.76 | 1.00 | 387 | 253 | 47 | 22 | FALSE | 0.71 |
| melanoma | RAS_12-61 | PAK7 | Any mutation | 150 | 205 | Signature overall | -0.57 | -4.58 | 3.67 | 1401.88 | 1.00 | 168 | 102 | 157 | 48 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | PAK7 | Any mutation | 275 | 69 | Signature overall | -0.32 | -4.73 | 3.95 | 1363.06 | 1.00 | 387 | 253 | 47 | 22 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | STAG2 | Any mutation | 86 | 16 | Signature 2 | 0.04 | -0.92 | 0.86 | 1403.08 | 1.00 | 227 | 82 | 12 | 4 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | STAG2 | Any mutation | 276 | 43 | Signature 4 | 0.28 | -0.31 | 0.87 | 1499.57 | 1.00 | 407 | 256 | 23 | 20 | TRUE | 0.47 |
| non-small cell lung cancer | RAS_12-61 | STAG2 | Any mutation | 362 | 59 | Signature overall | 0.15 | -0.97 | 1.24 | 1330.23 | 1.00 | 634 | 338 | 35 | 24 | TRUE | 0.10 |
| melanoma | RAS_12-61 | TERT | Any mutation | 18 | 48 | Signature 11 | 1.13 | -0.04 | 2.42 | 1544.55 | 1.00 | 11 | 2 | 32 | 16 | TRUE | 1.16 |
| melanoma | RAS_12-61 | TERT | Any mutation | 11 | 20 | Signature 19 | 1.55 | 0.17 | 3.05 | 1349.08 | 1.00 | 6 | 1 | 10 | 10 | TRUE | 1.53 |
| melanoma | RAS_12-61 | TERT | Any mutation | 13 | 17 | Signature 1A | 1.25 | 0.20 | 2.44 | 1577.90 | 1.00 | 41 | 6 | 10 | 7 | TRUE | 1.56 |
| melanoma | RAS_12-61 | TERT | Any mutation | 175 | 473 | Signature 7 | 0.89 | 0.32 | 1.45 | 1289.46 | 1.00 | 59 | 14 | 312 | 161 | TRUE | 2.57 |
| non-small cell lung cancer | RAS_12-61 | TERT | Any mutation | 87 | 23 | Signature 2 | 0.86 | 0.04 | 1.70 | 305.32 | 1.02 | 227 | 75 | 11 | 12 | TRUE | 1.32 |
| non-small cell lung cancer | RAS_12-61 | TERT | Any mutation | 276 | 54 | Signature 4 | 0.11 | -0.48 | 0.67 | 1504.62 | 1.00 | 398 | 255 | 33 | 21 | TRUE | 0.16 |
| melanoma | RAS_12-61 | TERT | Any mutation | 217 | 558 | Signature overall | 1.18 | -0.01 | 2.37 | 1509.71 | 1.00 | 117 | 23 | 364 | 194 | TRUE | 1.27 |
| non-small cell lung cancer | RAS_12-61 | TERT | Any mutation | 363 | 77 | Signature overall | 0.49 | -0.75 | 1.89 | 1494.05 | 1.00 | 625 | 330 | 44 | 33 | TRUE | 0.35 |
| colorectal cancer | RAS_12-61 | BRCA2 | Any mutation | 16 | 37 | Signature 10 | -1.72 | -2.88 | -0.58 | 1431.08 | 1.00 | 13 | 12 | 33 | 4 | TRUE | 2.41 |
| colorectal cancer | RAS_12-61 | BRCA2 | Any mutation | 173 | 17 | Signature 15 | -1.10 | -2.18 | -0.12 | 1586.96 | 1.00 | 204 | 169 | 13 | 4 | TRUE | 1.46 |
| colorectal cancer | RAS_12-61 | BRCA2 | Any mutation | 373 | 50 | Signature 1A | 0.08 | -0.48 | 0.66 | 1629.49 | 1.00 | 455 | 349 | 26 | 24 | TRUE | 0.11 |
| colorectal cancer | RAS_12-61 | BRCA2 | Any mutation | 127 | 62 | Signature 6 | -1.04 | -1.69 | -0.41 | 1390.45 | 1.00 | 154 | 114 | 49 | 13 | TRUE | 2.74 |
| non-small cell lung cancer | RAS_12-61 | BRCA2 | Any mutation | 15 | 13 | Signature 13 | -1.35 | -3.56 | 0.01 | 1500.79 | 1.00 | 72 | 15 | 13 | 0 | TRUE | 0.82 |
| non-small cell lung cancer | RAS_12-61 | BRCA2 | Any mutation | 86 | 15 | Signature 2 | -1.02 | -2.38 | 0.06 | 1449.36 | 1.00 | 226 | 84 | 13 | 2 | TRUE | 0.97 |
| non-small cell lung cancer | RAS_12-61 | BRCA2 | Any mutation | 276 | 55 | Signature 4 | -0.49 | -1.05 | 0.06 | 1526.88 | 1.00 | 395 | 259 | 38 | 17 | TRUE | 1.03 |
| uterine cancer | RAS_12-61 | BRCA2 | Any mutation | 44 | 15 | Signature 1A | 0.57 | -0.60 | 1.66 | 1553.58 | 1.00 | 165 | 39 | 10 | 5 | TRUE | 0.50 |
| uterine cancer | RAS_12-61 | BRCA2 | Any mutation | 17 | 22 | Signature 6 | -1.43 | -3.57 | 0.09 | 1574.77 | 1.00 | 66 | 16 | 21 | 1 | TRUE | 0.89 |
| colorectal cancer | RAS_12-61 | BRCA2 | Any mutation | 689 | 166 | Signature overall | -0.93 | -2.21 | 0.42 | 1524.74 | 1.00 | 826 | 644 | 121 | 45 | TRUE | 0.82 |
| non-small cell lung cancer | RAS_12-61 | BRCA2 | Any mutation | 377 | 83 | Signature overall | -0.92 | -2.33 | 0.22 | 1219.63 | 1.00 | 693 | 358 | 64 | 19 | TRUE | 0.81 |
| uterine cancer | RAS_12-61 | BRCA2 | Any mutation | 66 | 102 | Signature overall | 0.08 | -2.52 | 2.68 | 1509.80 | 1.00 | 246 | 55 | 91 | 11 | TRUE | 0.02 |
| colorectal cancer | RAS_12-61 | NOTCH3 | Any mutation | 173 | 27 | Signature 15 | -0.43 | -1.13 | 0.26 | 1515.45 | 1.00 | 201 | 162 | 16 | 11 | TRUE | 0.62 |
| colorectal cancer | RAS_12-61 | NOTCH3 | Any mutation | 369 | 70 | Signature 1A | -0.67 | -1.21 | -0.18 | 1339.21 | 1.00 | 439 | 348 | 49 | 21 | TRUE | 1.98 |
| colorectal cancer | RAS_12-61 | NOTCH3 | Any mutation | 125 | 72 | Signature 6 | -0.99 | -1.59 | -0.44 | 1623.38 | 1.00 | 148 | 111 | 58 | 14 | TRUE | 3.09 |
| melanoma | RAS_12-61 | NOTCH3 | Any mutation | 149 | 116 | Signature 7 | -1.01 | -1.57 | -0.50 | 1283.56 | 1.00 | 229 | 129 | 96 | 20 | TRUE | 3.65 |
| non-small cell lung cancer | RAS_12-61 | NOTCH3 | Any mutation | 68 | 11 | Signature 18 | 0.28 | -0.57 | 1.24 | 1661.16 | 1.00 | 79 | 61 | 4 | 7 | TRUE | 0.27 |
| non-small cell lung cancer | RAS_12-61 | NOTCH3 | Any mutation | 86 | 15 | Signature 2 | -0.06 | -0.88 | 0.77 | 1588.20 | 1.00 | 228 | 82 | 11 | 4 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | NOTCH3 | Any mutation | 275 | 48 | Signature 4 | -0.19 | -0.77 | 0.37 | 1556.68 | 1.00 | 399 | 260 | 33 | 15 | TRUE | 0.30 |
| colorectal cancer | RAS_12-61 | NOTCH3 | Any mutation | 667 | 169 | Signature overall | -0.69 | -1.48 | 0.20 | 1620.53 | 1.00 | 788 | 621 | 123 | 46 | TRUE | 0.94 |
| melanoma | RAS_12-61 | NOTCH3 | Any mutation | 149 | 116 | Signature overall | -0.89 | -4.87 | 3.51 | 1577.77 | 1.00 | 229 | 129 | 96 | 20 | TRUE | 0.19 |
| non-small cell lung cancer | RAS_12-61 | NOTCH3 | Any mutation | 429 | 74 | Signature overall | 0.01 | -0.73 | 0.76 | 1515.55 | 1.00 | 706 | 403 | 48 | 26 | TRUE | 0.01 |
| colorectal cancer | RAS_12-61 | NOTCH4 | Any mutation | 169 | 18 | Signature 15 | -0.90 | -1.79 | -0.19 | 1409.85 | 1.00 | 196 | 165 | 14 | 4 | TRUE | 1.61 |
| colorectal cancer | RAS_12-61 | NOTCH4 | Any mutation | 357 | 43 | Signature 1A | -0.62 | -1.19 | -0.06 | 1534.38 | 1.00 | 440 | 343 | 29 | 14 | TRUE | 1.53 |
| colorectal cancer | RAS_12-61 | NOTCH4 | Any mutation | 121 | 41 | Signature 6 | -0.61 | -1.24 | 0.01 | 1458.40 | 1.00 | 158 | 110 | 30 | 11 | TRUE | 1.25 |
| melanoma | RAS_12-61 | NOTCH4 | Any mutation | 148 | 141 | Signature 7 | -0.19 | -0.63 | 0.22 | 1290.16 | 1.00 | 207 | 106 | 99 | 42 | TRUE | 0.43 |
| non-small cell lung cancer | RAS_12-61 | NOTCH4 | Any mutation | 275 | 74 | Signature 4 | -0.48 | -1.01 | 0.01 | 1126.78 | 1.00 | 381 | 253 | 52 | 22 | TRUE | 1.24 |
| colorectal cancer | RAS_12-61 | NOTCH4 | Any mutation | 647 | 102 | Signature overall | -0.71 | -1.53 | -0.02 | 1415.90 | 1.00 | 794 | 618 | 73 | 29 | TRUE | 1.22 |
| melanoma | RAS_12-61 | NOTCH4 | Any mutation | 148 | 141 | Signature overall | -0.11 | -3.98 | 4.14 | 1492.59 | 1.00 | 207 | 106 | 99 | 42 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12-61 | NOTCH4 | Any mutation | 275 | 74 | Signature overall | -0.46 | -4.55 | 3.52 | 1553.25 | 1.00 | 381 | 253 | 52 | 22 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 15 | 20 | Signature 13 | -0.08 | -1.08 | 0.81 | 1533.62 | 1.00 | 65 | 13 | 18 | 2 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 21 | 12 | Signature 14 | 0.18 | -0.73 | 1.05 | 1625.07 | 1.00 | 27 | 17 | 8 | 4 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 32 | 16 | Signature 15 | 0.67 | -0.13 | 1.48 | 1456.23 | 1.00 | 96 | 25 | 9 | 7 | FALSE | 1.01 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 10 | 12 | Signature 16 | 0.18 | -0.81 | 1.14 | 1535.40 | 1.00 | 40 | 8 | 10 | 2 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 69 | 34 | Signature 18 | 0.37 | -0.25 | 1.03 | 1513.70 | 1.00 | 66 | 52 | 17 | 17 | FALSE | 0.58 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 17 | 11 | Signature 19 | 0.81 | -0.13 | 1.70 | 1469.38 | 1.00 | 41 | 11 | 5 | 6 | FALSE | 1.10 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 48 | 27 | Signature 1A | 0.52 | -0.22 | 1.28 | 1549.05 | 1.00 | 201 | 40 | 19 | 8 | FALSE | 0.79 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 86 | 55 | Signature 2 | 0.03 | -0.55 | 0.58 | 1541.04 | 1.00 | 200 | 72 | 41 | 14 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 16 | 13 | Signature 20 | 0.61 | -0.33 | 1.54 | 1652.03 | 1.00 | 53 | 11 | 8 | 5 | FALSE | 0.72 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 56 | 31 | Signature 3 | 0.54 | -0.13 | 1.21 | 1338.19 | 1.00 | 167 | 45 | 20 | 11 | FALSE | 0.96 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 279 | 175 | Signature 4 | -0.06 | -0.40 | 0.30 | 1431.24 | 1.00 | 320 | 214 | 110 | 65 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 25 | 14 | Signature 7 | 0.09 | -0.79 | 0.94 | 1414.18 | 1.00 | 73 | 22 | 11 | 3 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 157 | 45 | Signature R2 | 0.20 | -0.41 | 0.80 | 1599.95 | 1.00 | 32 | 123 | 11 | 34 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 23 | 11 | Signature U1 | 1.03 | 0.16 | 1.97 | 1391.66 | 1.00 | 84 | 16 | 4 | 7 | FALSE | 1.61 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Any mutation | 854 | 476 | Signature overall | 0.37 | -0.04 | 0.80 | 1405.03 | 1.00 | 1465 | 669 | 291 | 185 | FALSE | 1.05 |
| non-small cell lung cancer | RAS_12-61 | KDM5C | Any mutation | 86 | 15 | Signature 2 | -0.40 | -1.86 | 0.64 | 1463.67 | 1.00 | 226 | 84 | 13 | 2 | FALSE | 0.26 |
| non-small cell lung cancer | RAS_12-61 | KDM5C | Any mutation | 276 | 41 | Signature 4 | 0.50 | -0.09 | 1.14 | 1121.91 | 1.00 | 409 | 254 | 19 | 22 | FALSE | 0.97 |
| non-small cell lung cancer | RAS_12-61 | KDM5C | Any mutation | 362 | 56 | Signature overall | 0.07 | -1.58 | 1.53 | 1495.52 | 1.00 | 635 | 338 | 32 | 24 | FALSE | 0.03 |
| melanoma | RAS_12-61 | CDKN2A | Any mutation | 152 | 108 | Signature 7 | -0.27 | -0.73 | 0.18 | 1094.78 | 1.00 | 229 | 121 | 77 | 31 | TRUE | 0.60 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 15 | 12 | Signature 13 | -1.15 | -2.91 | 0.25 | 1565.53 | 1.00 | 71 | 15 | 12 | 0 | TRUE | 0.82 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 32 | 11 | Signature 15 | -0.91 | -2.46 | 0.38 | 1350.52 | 1.00 | 94 | 31 | 10 | 1 | TRUE | 0.68 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 48 | 18 | Signature 1A | 0.62 | -0.37 | 1.57 | 1400.94 | 1.00 | 207 | 41 | 11 | 7 | TRUE | 0.69 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 86 | 22 | Signature 2 | -1.40 | -2.78 | -0.30 | 1585.86 | 1.00 | 218 | 85 | 21 | 1 | TRUE | 1.54 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 57 | 20 | Signature 3 | 0.07 | -0.85 | 0.93 | 1465.99 | 1.00 | 173 | 51 | 14 | 6 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 278 | 90 | Signature 4 | -0.62 | -1.12 | -0.15 | 1133.66 | 1.00 | 366 | 254 | 66 | 24 | TRUE | 1.93 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 156 | 11 | Signature R2 | -0.16 | -1.20 | 0.96 | 1301.26 | 1.00 | 40 | 147 | 2 | 9 | TRUE | 0.11 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 119 | 30 | Signature 11 | 1.53 | 0.79 | 2.30 | 1365.92 | 1.00 | 7 | 90 | 1 | 29 | TRUE | 4.85 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 114 | 27 | Signature 15 | 1.37 | 0.51 | 2.07 | 48.01 | 1.04 | 15 | 92 | 5 | 22 | TRUE | 3.49 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 51 | 11 | Signature 17 | 1.54 | 0.72 | 2.38 | 1346.27 | 1.01 | 3 | 40 | 0 | 11 | TRUE | 4.35 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 225 | 67 | Signature 1A | 1.61 | 0.92 | 2.36 | 1465.02 | 1.00 | 29 | 160 | 2 | 65 | TRUE | 6.03 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 85 | 23 | Signature 3 | 1.57 | 0.87 | 2.41 | 1328.95 | 1.00 | 17 | 62 | 0 | 23 | TRUE | 4.93 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 65 | 25 | Signature 4 | 1.71 | 0.98 | 2.59 | 1290.02 | 1.00 | 9 | 40 | 0 | 25 | TRUE | 5.38 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 61 | 26 | Signature 6 | 1.70 | 1.02 | 2.63 | 106.00 | 1.03 | 13 | 35 | 0 | 26 | TRUE | 5.09 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 49 | 11 | Signature 8 | 1.55 | 0.76 | 2.33 | 1313.10 | 1.01 | 3 | 38 | 0 | 11 | TRUE | 4.52 |
| melanoma | RAS_12-61 | CDKN2A | Any mutation | 152 | 108 | Signature overall | -0.28 | -4.50 | 3.57 | 1506.01 | 1.00 | 229 | 121 | 77 | 31 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Any mutation | 672 | 184 | Signature overall | -0.50 | -1.38 | 0.28 | 1605.19 | 1.00 | 1169 | 624 | 136 | 48 | TRUE | 0.62 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Any mutation | 769 | 220 | Signature overall | 1.58 | 0.90 | 2.32 | 1309.33 | 1.00 | 96 | 557 | 8 | 212 | TRUE | 5.76 |
| non-small cell lung cancer | RAS_12-61 | EPHB1 | Any mutation | 86 | 17 | Signature 2 | -0.48 | -1.48 | 0.53 | 1248.85 | 1.00 | 226 | 82 | 13 | 4 | FALSE | 0.45 |
| non-small cell lung cancer | RAS_12-61 | EPHB1 | Any mutation | 277 | 79 | Signature 4 | -0.75 | -1.30 | -0.23 | 1477.38 | 1.00 | 377 | 258 | 60 | 19 | FALSE | 2.28 |
| non-small cell lung cancer | RAS_12-61 | EPHB1 | Any mutation | 363 | 96 | Signature overall | -0.62 | -2.30 | 1.06 | 1344.51 | 1.00 | 603 | 340 | 73 | 23 | FALSE | 0.37 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 26 | 20 | Signature 15 | -1.02 | -2.22 | 0.02 | 1468.64 | 1.00 | 66 | 24 | 18 | 2 | FALSE | 1.15 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 44 | 25 | Signature 1A | -0.84 | -2.02 | 0.17 | 1530.67 | 1.00 | 155 | 41 | 22 | 3 | FALSE | 0.90 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 11 | 14 | Signature 3 | -0.83 | -2.18 | 0.28 | 1576.61 | 1.00 | 22 | 9 | 12 | 2 | FALSE | 0.77 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 17 | 17 | Signature 6 | -0.55 | -1.71 | 0.57 | 1552.57 | 1.00 | 71 | 14 | 14 | 3 | FALSE | 0.45 |
| uterine cancer | RAS_12-61 | PPP2R1A | Any mutation | 99 | 96 | Signature overall | -0.88 | -1.93 | 0.07 | 1655.55 | 1.00 | 346 | 89 | 86 | 10 | FALSE | 1.07 |
| colorectal cancer | RAS_12-61 | ERBB3 | Any mutation | 173 | 18 | Signature 15 | -0.06 | -0.74 | 0.60 | 1482.16 | 1.00 | 201 | 166 | 11 | 7 | TRUE | 0.07 |
| colorectal cancer | RAS_12-61 | ERBB3 | Any mutation | 370 | 46 | Signature 1A | 0.02 | -0.49 | 0.52 | 1322.72 | 1.00 | 457 | 350 | 26 | 20 | TRUE | 0.03 |
| colorectal cancer | RAS_12-61 | ERBB3 | Any mutation | 124 | 34 | Signature 6 | 0.32 | -0.26 | 0.93 | 1430.03 | 1.00 | 175 | 107 | 17 | 17 | TRUE | 0.53 |
| colorectal cancer | RAS_12-61 | ERBB3 | Any mutation | 667 | 98 | Signature overall | 0.10 | -0.51 | 0.73 | 1318.60 | 1.00 | 833 | 623 | 54 | 44 | TRUE | 0.13 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 14 | 17 | Signature 10 | 0.25 | -0.33 | 0.81 | 1448.24 | 1.00 | 14 | 8 | 11 | 6 | TRUE | 0.41 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 175 | 60 | Signature 15 | 0.16 | -0.22 | 0.58 | 1400.09 | 1.00 | 185 | 145 | 30 | 30 | TRUE | 0.36 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 16 | 11 | Signature 17 | 0.18 | -0.40 | 0.75 | 1622.79 | 1.00 | 23 | 12 | 7 | 4 | TRUE | 0.27 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 22 | 12 | Signature 19 | 0.29 | -0.22 | 0.86 | 1422.28 | 1.00 | 19 | 15 | 5 | 7 | TRUE | 0.54 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 375 | 122 | Signature 1A | 0.11 | -0.19 | 0.41 | 1552.66 | 1.00 | 415 | 318 | 65 | 57 | TRUE | 0.32 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 46 | 11 | Signature 2 | 0.16 | -0.41 | 0.68 | 1447.07 | 1.00 | 32 | 39 | 4 | 7 | TRUE | 0.24 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 125 | 57 | Signature 6 | 0.07 | -0.38 | 0.47 | 1384.80 | 1.00 | 159 | 103 | 35 | 22 | TRUE | 0.14 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 16 | 11 | Signature 7 | 0.29 | -0.24 | 0.91 | 1340.35 | 1.00 | 19 | 10 | 5 | 6 | TRUE | 0.50 |
| non-small cell lung cancer | RAS_12-61 | SMAD4 | Any mutation | 48 | 17 | Signature 1A | -0.18 | -1.38 | 0.84 | 1558.45 | 1.00 | 205 | 46 | 15 | 2 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12-61 | SMAD4 | Any mutation | 86 | 21 | Signature 2 | 0.71 | -0.14 | 1.56 | 1529.10 | 1.00 | 227 | 76 | 11 | 10 | TRUE | 1.01 |
| non-small cell lung cancer | RAS_12-61 | SMAD4 | Any mutation | 275 | 16 | Signature 4 | -0.08 | -1.03 | 0.74 | 1653.44 | 1.00 | 417 | 269 | 10 | 6 | TRUE | 0.06 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 117 | 25 | Signature 11 | 0.41 | -0.17 | 0.98 | 973.16 | 1.00 | 7 | 93 | 1 | 24 | TRUE | 0.77 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 113 | 31 | Signature 15 | 0.44 | -0.13 | 1.03 | 857.36 | 1.00 | 17 | 85 | 3 | 28 | TRUE | 0.86 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 52 | 12 | Signature 17 | 0.43 | -0.16 | 1.07 | 1024.19 | 1.00 | 3 | 40 | 0 | 12 | TRUE | 0.81 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 222 | 56 | Signature 1A | 0.46 | -0.08 | 1.04 | 993.58 | 1.00 | 28 | 169 | 3 | 53 | TRUE | 0.95 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 33 | 12 | Signature 2 | 0.35 | -0.31 | 0.95 | 930.29 | 1.00 | 8 | 26 | 5 | 7 | TRUE | 0.56 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 82 | 24 | Signature 3 | 0.44 | -0.12 | 1.02 | 973.12 | 1.00 | 14 | 61 | 3 | 21 | TRUE | 0.86 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 64 | 15 | Signature 4 | 0.41 | -0.20 | 1.01 | 954.73 | 1.00 | 8 | 50 | 1 | 14 | TRUE | 0.74 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 61 | 15 | Signature 6 | 0.35 | -0.27 | 0.97 | 811.26 | 1.00 | 9 | 50 | 4 | 11 | TRUE | 0.57 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 50 | 15 | Signature 8 | 0.49 | -0.10 | 1.11 | 1136.17 | 1.00 | 3 | 35 | 0 | 15 | TRUE | 0.97 |
| colorectal cancer | RAS_12-61 | SMAD4 | Any mutation | 789 | 301 | Signature overall | 0.19 | -0.18 | 0.54 | 1421.09 | 1.00 | 866 | 650 | 162 | 139 | TRUE | 0.54 |
| non-small cell lung cancer | RAS_12-61 | SMAD4 | Any mutation | 409 | 54 | Signature overall | 0.16 | -0.91 | 1.20 | 1602.91 | 1.00 | 849 | 391 | 36 | 18 | TRUE | 0.11 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Any mutation | 794 | 205 | Signature overall | 0.42 | -0.10 | 0.96 | 914.26 | 1.00 | 97 | 609 | 20 | 185 | TRUE | 0.93 |
| colorectal cancer | RAS_12-61 | ATM | Any mutation | 20 | 39 | Signature 10 | -0.61 | -1.62 | 0.31 | 1386.99 | 1.00 | 12 | 10 | 29 | 10 | TRUE | 0.68 |
| colorectal cancer | RAS_12-61 | ATM | Any mutation | 175 | 32 | Signature 15 | -0.15 | -0.84 | 0.55 | 1407.87 | 1.00 | 197 | 161 | 18 | 14 | TRUE | 0.17 |
| colorectal cancer | RAS_12-61 | ATM | Any mutation | 372 | 77 | Signature 1A | 0.19 | -0.25 | 0.65 | 1420.90 | 1.00 | 444 | 334 | 39 | 38 | TRUE | 0.39 |
| colorectal cancer | RAS_12-61 | ATM | Any mutation | 124 | 48 | Signature 6 | -1.08 | -1.85 | -0.36 | 1408.46 | 1.00 | 157 | 115 | 39 | 9 | TRUE | 2.31 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 15 | 12 | Signature 13 | 0.96 | -0.12 | 2.03 | 1383.49 | 1.00 | 75 | 11 | 8 | 4 | TRUE | 1.14 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 68 | 11 | Signature 18 | 0.53 | -0.44 | 1.44 | 1510.50 | 1.00 | 78 | 62 | 5 | 6 | TRUE | 0.57 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 88 | 27 | Signature 2 | 0.83 | 0.11 | 1.54 | 1124.85 | 1.00 | 224 | 76 | 15 | 12 | TRUE | 1.63 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 56 | 13 | Signature 3 | 0.72 | -0.24 | 1.60 | 1313.69 | 1.00 | 179 | 51 | 8 | 5 | TRUE | 0.90 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 287 | 95 | Signature 4 | 0.77 | 0.36 | 1.19 | 1555.39 | 1.00 | 390 | 234 | 42 | 53 | TRUE | 3.54 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 157 | 25 | Signature R2 | 0.68 | -0.18 | 1.58 | 1466.30 | 1.00 | 38 | 136 | 4 | 21 | TRUE | 0.89 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 14 | 12 | Signature U2 | 1.65 | 0.58 | 2.71 | 1542.91 | 1.00 | 29 | 6 | 4 | 8 | TRUE | 2.62 |
| uterine cancer | RAS_12-61 | ATM | Any mutation | 6 | 11 | Signature 14 | -0.40 | -2.04 | 1.25 | 1357.48 | 1.00 | 10 | 4 | 9 | 2 | TRUE | 0.20 |
| uterine cancer | RAS_12-61 | ATM | Any mutation | 44 | 23 | Signature 1A | -0.29 | -1.42 | 0.76 | 1546.39 | 1.00 | 160 | 40 | 19 | 4 | TRUE | 0.23 |
| uterine cancer | RAS_12-61 | ATM | Any mutation | 18 | 24 | Signature 6 | -0.49 | -1.79 | 0.68 | 1536.81 | 1.00 | 67 | 15 | 21 | 3 | TRUE | 0.35 |
| colorectal cancer | RAS_12-61 | ATM | Any mutation | 691 | 196 | Signature overall | -0.41 | -1.55 | 0.72 | 1450.26 | 1.00 | 810 | 620 | 125 | 71 | TRUE | 0.33 |
| non-small cell lung cancer | RAS_12-61 | ATM | Any mutation | 685 | 195 | Signature overall | 0.87 | 0.13 | 1.57 | 1475.80 | 1.00 | 1013 | 576 | 86 | 109 | TRUE | 1.84 |
| uterine cancer | RAS_12-61 | ATM | Any mutation | 73 | 121 | Signature overall | -0.24 | -1.73 | 1.31 | 1536.68 | 1.00 | 250 | 59 | 107 | 14 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 15 | 11 | Signature 13 | -0.41 | -1.36 | 0.66 | 1590.99 | 1.00 | 77 | 12 | 8 | 3 | TRUE | 0.36 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 68 | 11 | Signature 18 | -0.63 | -1.51 | 0.22 | 1512.33 | 1.00 | 75 | 64 | 7 | 4 | TRUE | 0.84 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 48 | 16 | Signature 1A | -0.75 | -1.68 | 0.14 | 1388.19 | 1.00 | 204 | 46 | 14 | 2 | TRUE | 0.96 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 86 | 28 | Signature 2 | -0.82 | -1.63 | -0.09 | 1272.99 | 1.00 | 214 | 82 | 24 | 4 | TRUE | 1.37 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 56 | 18 | Signature 3 | -1.21 | -2.27 | -0.27 | 1493.42 | 1.00 | 169 | 56 | 18 | 0 | TRUE | 1.65 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 275 | 67 | Signature 4 | -0.83 | -1.37 | -0.35 | 1310.38 | 1.00 | 379 | 260 | 52 | 15 | TRUE | 2.74 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Any mutation | 548 | 151 | Signature overall | -0.78 | -1.45 | -0.15 | 1497.67 | 1.00 | 1118 | 520 | 123 | 28 | TRUE | 1.70 |
| cancer of unknown primary | RAS_12-61 | KMT2D | Any mutation | 38 | 18 | Signature 1A | -1.43 | -2.68 | -0.34 | 1464.09 | 1.00 | 65 | 35 | 15 | 3 | FALSE | 1.77 |
| cancer of unknown primary | RAS_12-61 | KMT2D | Any mutation | 23 | 15 | Signature 4 | -1.50 | -2.84 | -0.23 | 1598.75 | 1.00 | 46 | 21 | 13 | 2 | FALSE | 1.58 |
| cancer of unknown primary | RAS_12-61 | KMT2D | Any mutation | 6 | 13 | Signature 6 | -2.00 | -3.93 | -0.49 | 1532.30 | 1.00 | 13 | 6 | 13 | 0 | FALSE | 1.68 |
| colorectal cancer | RAS_12-61 | KMT2D | Any mutation | 14 | 19 | Signature 10 | -1.09 | -2.17 | -0.17 | 1533.82 | 1.00 | 12 | 11 | 16 | 3 | FALSE | 1.45 |
| colorectal cancer | RAS_12-61 | KMT2D | Any mutation | 174 | 55 | Signature 15 | -1.20 | -1.86 | -0.57 | 1502.53 | 1.00 | 190 | 163 | 44 | 11 | FALSE | 3.73 |
| colorectal cancer | RAS_12-61 | KMT2D | Any mutation | 380 | 128 | Signature 1A | -0.53 | -0.92 | -0.16 | 1346.63 | 1.00 | 427 | 337 | 85 | 43 | FALSE | 2.23 |
| colorectal cancer | RAS_12-61 | KMT2D | Any mutation | 139 | 142 | Signature 6 | -0.89 | -1.32 | -0.47 | 1516.69 | 1.00 | 127 | 104 | 107 | 35 | FALSE | 4.30 |
| melanoma | RAS_12-61 | KMT2D | Any mutation | 16 | 13 | Signature 11 | -0.25 | -0.99 | 0.76 | 247.60 | 1.01 | 30 | 12 | 9 | 4 | FALSE | 0.26 |
| melanoma | RAS_12-61 | KMT2D | Any mutation | 166 | 184 | Signature 7 | -0.30 | -0.65 | 0.11 | 76.53 | 1.03 | 223 | 115 | 133 | 51 | FALSE | 0.85 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 15 | 16 | Signature 13 | -1.30 | -2.99 | 0.01 | 1389.94 | 1.00 | 68 | 15 | 16 | 0 | FALSE | 1.11 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 68 | 16 | Signature 18 | -0.85 | -1.83 | 0.09 | 1452.12 | 1.00 | 72 | 64 | 12 | 4 | FALSE | 1.05 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 50 | 22 | Signature 1A | -0.10 | -1.12 | 0.81 | 1526.95 | 1.00 | 202 | 45 | 17 | 5 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 87 | 46 | Signature 2 | -0.26 | -0.95 | 0.41 | 1481.63 | 1.00 | 209 | 76 | 35 | 11 | FALSE | 0.34 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 56 | 13 | Signature 3 | -1.03 | -2.43 | 0.08 | 1336.20 | 1.00 | 175 | 55 | 12 | 1 | FALSE | 0.99 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 278 | 129 | Signature 4 | -0.74 | -1.16 | -0.33 | 1377.30 | 1.00 | 350 | 246 | 97 | 32 | FALSE | 3.37 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 156 | 13 | Signature R2 | -0.16 | -1.12 | 0.90 | 1444.14 | 1.00 | 40 | 145 | 2 | 11 | FALSE | 0.12 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 8 | 24 | Signature 14 | 0.04 | -0.96 | 1.09 | 1416.86 | 1.00 | 9 | 3 | 19 | 5 | FALSE | 0.03 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 27 | 27 | Signature 15 | 0.17 | -0.66 | 0.98 | 1315.74 | 1.00 | 68 | 19 | 19 | 8 | FALSE | 0.16 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 45 | 61 | Signature 1A | -0.25 | -0.98 | 0.42 | 1478.15 | 1.00 | 135 | 35 | 51 | 10 | FALSE | 0.32 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 10 | 13 | Signature 20 | 0.18 | -0.80 | 1.35 | 1464.11 | 1.00 | 24 | 6 | 9 | 4 | FALSE | 0.13 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 19 | 63 | Signature 6 | -0.18 | -1.00 | 0.57 | 1164.93 | 1.00 | 44 | 10 | 54 | 9 | FALSE | 0.18 |
| cancer of unknown primary | RAS_12-61 | KMT2D | Any mutation | 72 | 76 | Signature overall | -1.65 | -2.88 | -0.50 | 1472.84 | 1.00 | 153 | 66 | 70 | 6 | FALSE | 2.13 |
| colorectal cancer | RAS_12-61 | KMT2D | Any mutation | 707 | 344 | Signature overall | -0.93 | -1.69 | -0.21 | 1582.53 | 1.00 | 756 | 615 | 252 | 92 | FALSE | 1.88 |
| melanoma | RAS_12-61 | KMT2D | Any mutation | 182 | 197 | Signature overall | -0.28 | -1.17 | 0.78 | 650.84 | 1.00 | 253 | 127 | 142 | 55 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | KMT2D | Any mutation | 710 | 255 | Signature overall | -0.63 | -1.41 | 0.16 | 1335.57 | 1.00 | 1116 | 646 | 191 | 64 | FALSE | 0.96 |
| uterine cancer | RAS_12-61 | KMT2D | Any mutation | 114 | 233 | Signature overall | -0.02 | -0.78 | 0.75 | 1408.23 | 1.00 | 299 | 74 | 193 | 40 | FALSE | 0.02 |
| colorectal cancer | RAS_12-61 | TSC2 | Any mutation | 173 | 11 | Signature 15 | -0.08 | -1.12 | 1.00 | 1418.04 | 1.00 | 207 | 167 | 5 | 6 | TRUE | 0.06 |
| colorectal cancer | RAS_12-61 | TSC2 | Any mutation | 371 | 36 | Signature 1A | -0.18 | -0.80 | 0.45 | 1325.31 | 1.00 | 460 | 356 | 21 | 15 | TRUE | 0.24 |
| colorectal cancer | RAS_12-61 | TSC2 | Any mutation | 123 | 44 | Signature 6 | -0.84 | -1.59 | -0.15 | 1546.31 | 1.00 | 162 | 114 | 35 | 9 | TRUE | 1.58 |
| colorectal cancer | RAS_12-61 | TSC2 | Any mutation | 667 | 91 | Signature overall | -0.39 | -1.48 | 0.74 | 1568.07 | 1.00 | 829 | 637 | 61 | 30 | TRUE | 0.32 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 32 | 94 | Signature 10 | 0.27 | -0.24 | 0.80 | 1479.69 | 1.00 | 3 | 0 | 62 | 32 | TRUE | 0.52 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 31 | 39 | Signature 11 | 0.29 | -0.26 | 0.81 | 1322.13 | 1.00 | 1 | 9 | 17 | 22 | TRUE | 0.54 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 18 | 25 | Signature 14 | 0.60 | 0.08 | 1.19 | 1350.25 | 1.00 | 2 | 1 | 8 | 17 | TRUE | 1.47 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 266 | 469 | Signature 15 | 0.54 | 0.17 | 0.90 | 1368.19 | 1.00 | 55 | 28 | 231 | 238 | TRUE | 2.51 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 23 | 46 | Signature 17 | 0.24 | -0.32 | 0.78 | 1523.60 | 1.00 | 11 | 4 | 27 | 19 | TRUE | 0.43 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 28 | 63 | Signature 18 | 0.15 | -0.39 | 0.66 | 1312.22 | 1.00 | 3 | 5 | 40 | 23 | TRUE | 0.25 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 27 | 38 | Signature 19 | 0.13 | -0.46 | 0.66 | 1451.55 | 1.00 | 8 | 10 | 21 | 17 | TRUE | 0.20 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 537 | 962 | Signature 1A | 0.23 | -0.03 | 0.50 | 1482.35 | 1.00 | 129 | 92 | 517 | 445 | TRUE | 1.05 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 14 | 22 | Signature 1B | 0.43 | -0.13 | 1.01 | 1551.68 | 1.00 | 7 | 1 | 9 | 13 | TRUE | 0.87 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 66 | 95 | Signature 2 | 0.49 | 0.02 | 0.99 | 1358.58 | 1.00 | 8 | 9 | 38 | 57 | TRUE | 1.34 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 20 | 34 | Signature 20 | 0.29 | -0.24 | 0.83 | 1523.40 | 1.00 | 4 | 4 | 18 | 16 | TRUE | 0.54 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 13 | 25 | Signature 21 | 0.41 | -0.12 | 1.03 | 1475.88 | 1.00 | 10 | 0 | 12 | 13 | TRUE | 0.82 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 25 | 42 | Signature 3 | 0.42 | -0.14 | 0.97 | 1375.52 | 1.00 | 8 | 3 | 20 | 22 | TRUE | 0.89 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 29 | 49 | Signature 4 | 0.26 | -0.28 | 0.76 | 1486.11 | 1.00 | 5 | 6 | 26 | 23 | TRUE | 0.49 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 184 | 355 | Signature 6 | 0.26 | -0.08 | 0.60 | 1532.31 | 1.00 | 62 | 33 | 204 | 151 | TRUE | 0.89 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 23 | 40 | Signature 7 | 0.38 | -0.14 | 0.98 | 1464.45 | 1.00 | 9 | 3 | 20 | 20 | TRUE | 0.76 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 21 | 30 | Signature 8 | 0.55 | 0.00 | 1.15 | 1419.88 | 1.00 | 1 | 2 | 11 | 19 | TRUE | 1.31 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 23 | 20 | Signature R2 | 0.47 | -0.12 | 1.06 | 1126.22 | 1.00 | 2 | 7 | 4 | 16 | TRUE | 0.95 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 12 | 14 | Signature U1 | 0.30 | -0.31 | 0.84 | 1496.08 | 1.00 | 2 | 4 | 6 | 8 | TRUE | 0.50 |
| melanoma | RAS_12-61 | APC | Any mutation | 149 | 102 | Signature 7 | -0.60 | -1.11 | -0.09 | 1463.88 | 1.00 | 241 | 126 | 79 | 23 | TRUE | 1.67 |
| non-small cell lung cancer | RAS_12-61 | APC | Any mutation | 48 | 13 | Signature 1A | -0.20 | -1.33 | 0.78 | 1633.16 | 1.00 | 207 | 46 | 11 | 2 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12-61 | APC | Any mutation | 89 | 23 | Signature 2 | 0.26 | -0.49 | 1.09 | 1438.33 | 1.00 | 224 | 80 | 14 | 9 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12-61 | APC | Any mutation | 275 | 50 | Signature 4 | -0.38 | -0.97 | 0.17 | 1477.35 | 1.00 | 395 | 261 | 36 | 14 | TRUE | 0.70 |
| uterine cancer | RAS_12-61 | APC | Any mutation | 9 | 63 | Signature 10 | 1.52 | -0.35 | 4.30 | 1339.71 | 1.00 | 17 | 0 | 54 | 9 | TRUE | 0.71 |
| uterine cancer | RAS_12-61 | APC | Any mutation | 45 | 18 | Signature 1A | 0.38 | -0.77 | 1.40 | 1328.48 | 1.00 | 166 | 40 | 13 | 5 | TRUE | 0.32 |
| uterine cancer | RAS_12-61 | APC | Any mutation | 17 | 15 | Signature 6 | -0.28 | -1.97 | 1.14 | 1322.65 | 1.00 | 72 | 15 | 13 | 2 | TRUE | 0.14 |
| colorectal cancer | RAS_12-61 | APC | Any mutation | 1392 | 2462 | Signature overall | 0.35 | 0.08 | 0.63 | 1525.15 | 1.00 | 330 | 221 | 1291 | 1171 | TRUE | 1.88 |
| melanoma | RAS_12-61 | APC | Any mutation | 149 | 102 | Signature overall | -0.43 | -4.40 | 3.98 | 1447.56 | 1.00 | 241 | 126 | 79 | 23 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | APC | Any mutation | 412 | 86 | Signature overall | -0.10 | -1.04 | 0.84 | 1656.57 | 1.00 | 826 | 387 | 61 | 25 | TRUE | 0.08 |
| uterine cancer | RAS_12-61 | APC | Any mutation | 71 | 96 | Signature overall | 0.54 | -1.78 | 3.00 | 1338.73 | 1.00 | 255 | 55 | 80 | 16 | TRUE | 0.19 |
| colorectal cancer | RAS_12-61 | ERBB2 | Any mutation | 369 | 47 | Signature 1A | -0.46 | -1.02 | 0.07 | 1336.01 | 1.00 | 450 | 353 | 31 | 16 | TRUE | 0.98 |
| colorectal cancer | RAS_12-61 | ERBB2 | Any mutation | 123 | 29 | Signature 6 | -0.40 | -1.05 | 0.24 | 1125.53 | 1.00 | 172 | 114 | 20 | 9 | TRUE | 0.65 |
| non-small cell lung cancer | RAS_12-61 | ERBB2 | Any mutation | 48 | 15 | Signature 1A | -0.86 | -2.11 | 0.29 | 1565.49 | 1.00 | 205 | 46 | 13 | 2 | TRUE | 0.79 |
| non-small cell lung cancer | RAS_12-61 | ERBB2 | Any mutation | 86 | 12 | Signature 2 | -1.12 | -2.48 | 0.02 | 1413.99 | 1.00 | 227 | 85 | 11 | 1 | TRUE | 1.13 |
| non-small cell lung cancer | RAS_12-61 | ERBB2 | Any mutation | 275 | 19 | Signature 4 | -1.02 | -2.04 | -0.11 | 1384.82 | 1.00 | 414 | 271 | 15 | 4 | TRUE | 1.38 |
| colorectal cancer | RAS_12-61 | ERBB2 | Any mutation | 492 | 76 | Signature overall | -0.44 | -1.27 | 0.40 | 1336.19 | 1.00 | 622 | 467 | 51 | 25 | TRUE | 0.50 |
| non-small cell lung cancer | RAS_12-61 | ERBB2 | Any mutation | 409 | 46 | Signature overall | -0.99 | -2.14 | 0.17 | 1362.05 | 1.00 | 846 | 402 | 39 | 7 | TRUE | 1.04 |
| uterine cancer | RAS_12-61 | JAK1 | Any mutation | 29 | 14 | Signature 15 | 1.03 | 0.09 | 2.01 | 1388.93 | 1.00 | 77 | 22 | 7 | 7 | TRUE | 1.45 |
| uterine cancer | RAS_12-61 | JAK1 | Any mutation | 47 | 35 | Signature 1A | 1.05 | 0.34 | 1.82 | 1414.74 | 1.00 | 156 | 33 | 21 | 14 | TRUE | 2.29 |
| uterine cancer | RAS_12-61 | JAK1 | Any mutation | 18 | 42 | Signature 6 | 0.69 | -0.20 | 1.57 | 1370.36 | 1.00 | 58 | 9 | 33 | 9 | TRUE | 0.89 |
| uterine cancer | RAS_12-61 | JAK1 | Any mutation | 99 | 117 | Signature overall | 0.90 | -0.11 | 1.99 | 1419.63 | 1.00 | 314 | 65 | 83 | 34 | TRUE | 1.05 |
| colorectal cancer | RAS_12-61 | ARID2 | Any mutation | 13 | 16 | Signature 10 | -0.72 | -1.99 | 0.44 | 1262.23 | 1.00 | 13 | 10 | 13 | 3 | FALSE | 0.63 |
| colorectal cancer | RAS_12-61 | ARID2 | Any mutation | 173 | 19 | Signature 15 | -0.81 | -1.75 | 0.01 | 1590.67 | 1.00 | 201 | 168 | 14 | 5 | FALSE | 1.11 |
| colorectal cancer | RAS_12-61 | ARID2 | Any mutation | 370 | 42 | Signature 1A | -0.09 | -0.68 | 0.52 | 1493.87 | 1.00 | 457 | 351 | 23 | 19 | FALSE | 0.11 |
| colorectal cancer | RAS_12-61 | ARID2 | Any mutation | 123 | 27 | Signature 6 | -0.55 | -1.35 | 0.17 | 1377.75 | 1.00 | 171 | 115 | 19 | 8 | FALSE | 0.77 |
| melanoma | RAS_12-61 | ARID2 | Any mutation | 157 | 109 | Signature 7 | -0.04 | -0.51 | 0.40 | 1305.21 | 1.00 | 249 | 121 | 73 | 36 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | ARID2 | Any mutation | 68 | 11 | Signature 18 | -0.11 | -0.92 | 0.82 | 1435.39 | 1.00 | 77 | 62 | 5 | 6 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12-61 | ARID2 | Any mutation | 86 | 18 | Signature 2 | -0.26 | -1.07 | 0.52 | 1398.32 | 1.00 | 226 | 81 | 13 | 5 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12-61 | ARID2 | Any mutation | 56 | 16 | Signature 3 | -0.52 | -1.43 | 0.33 | 1519.32 | 1.00 | 173 | 54 | 14 | 2 | FALSE | 0.62 |
| non-small cell lung cancer | RAS_12-61 | ARID2 | Any mutation | 276 | 67 | Signature 4 | -0.55 | -1.07 | -0.05 | 1264.66 | 1.00 | 385 | 259 | 50 | 17 | FALSE | 1.44 |
| colorectal cancer | RAS_12-61 | ARID2 | Any mutation | 679 | 104 | Signature overall | -0.51 | -1.50 | 0.43 | 1486.52 | 1.00 | 842 | 644 | 69 | 35 | FALSE | 0.51 |
| melanoma | RAS_12-61 | ARID2 | Any mutation | 161 | 128 | Signature overall | -1.24 | -4.86 | 1.35 | 1411.62 | 1.00 | 263 | 125 | 92 | 36 | FALSE | 0.37 |
| non-small cell lung cancer | RAS_12-61 | ARID2 | Any mutation | 486 | 112 | Signature overall | -0.37 | -1.04 | 0.32 | 1467.37 | 1.00 | 861 | 456 | 82 | 30 | FALSE | 0.52 |
| colorectal cancer | RAS_12-61 | MTOR | Any mutation | 13 | 12 | Signature 10 | -1.04 | -2.55 | 0.08 | 1440.06 | 1.00 | 15 | 12 | 11 | 1 | TRUE | 0.89 |
| colorectal cancer | RAS_12-61 | MTOR | Any mutation | 173 | 17 | Signature 15 | -0.39 | -1.22 | 0.46 | 1338.98 | 1.00 | 204 | 166 | 10 | 7 | TRUE | 0.43 |
| colorectal cancer | RAS_12-61 | MTOR | Any mutation | 372 | 48 | Signature 1A | -0.06 | -0.62 | 0.48 | 1552.65 | 1.00 | 453 | 350 | 26 | 22 | TRUE | 0.09 |
| colorectal cancer | RAS_12-61 | MTOR | Any mutation | 126 | 45 | Signature 6 | -0.63 | -1.31 | -0.01 | 1557.17 | 1.00 | 161 | 114 | 33 | 12 | TRUE | 1.23 |
| non-small cell lung cancer | RAS_12-61 | MTOR | Any mutation | 275 | 41 | Signature 4 | -0.01 | -0.68 | 0.61 | 1408.31 | 1.00 | 402 | 259 | 25 | 16 | TRUE | 0.01 |
| colorectal cancer | RAS_12-61 | MTOR | Any mutation | 684 | 122 | Signature overall | -0.52 | -1.53 | 0.41 | 1422.37 | 1.00 | 833 | 642 | 80 | 42 | TRUE | 0.55 |
| non-small cell lung cancer | RAS_12-61 | MTOR | Any mutation | 275 | 41 | Signature overall | 0.08 | -4.38 | 4.57 | 1397.77 | 1.00 | 402 | 259 | 25 | 16 | TRUE | 0.01 |
| colorectal cancer | RAS_12-61 | NOTCH1 | Any mutation | 13 | 11 | Signature 10 | -1.94 | -4.35 | -0.30 | 1605.26 | 1.00 | 15 | 13 | 11 | 0 | TRUE | 1.33 |
| colorectal cancer | RAS_12-61 | NOTCH1 | Any mutation | 175 | 17 | Signature 15 | -1.06 | -2.19 | -0.12 | 1400.66 | 1.00 | 203 | 171 | 13 | 4 | TRUE | 1.38 |
| colorectal cancer | RAS_12-61 | NOTCH1 | Any mutation | 375 | 47 | Signature 1A | 0.13 | -0.45 | 0.72 | 1363.63 | 1.00 | 454 | 351 | 23 | 24 | TRUE | 0.18 |
| colorectal cancer | RAS_12-61 | NOTCH1 | Any mutation | 131 | 82 | Signature 6 | -0.51 | -1.05 | 0.01 | 1698.99 | 1.00 | 146 | 106 | 57 | 25 | TRUE | 1.20 |
| non-small cell lung cancer | RAS_12-61 | NOTCH1 | Any mutation | 86 | 12 | Signature 2 | -0.88 | -2.23 | 0.35 | 1353.47 | 1.00 | 228 | 84 | 10 | 2 | TRUE | 0.76 |
| non-small cell lung cancer | RAS_12-61 | NOTCH1 | Any mutation | 275 | 54 | Signature 4 | -0.98 | -1.66 | -0.30 | 1556.78 | 1.00 | 387 | 264 | 43 | 11 | TRUE | 2.28 |
| colorectal cancer | RAS_12-61 | NOTCH1 | Any mutation | 694 | 157 | Signature overall | -0.85 | -2.32 | 0.21 | 1600.24 | 1.00 | 818 | 641 | 104 | 53 | TRUE | 0.76 |
| non-small cell lung cancer | RAS_12-61 | NOTCH1 | Any mutation | 361 | 66 | Signature overall | -0.92 | -2.36 | 0.57 | 1410.62 | 1.00 | 615 | 348 | 53 | 13 | TRUE | 0.63 |
| colorectal cancer | RAS_12-61 | SETD2 | Any mutation | 17 | 22 | Signature 10 | -0.65 | -1.68 | 0.38 | 1411.69 | 1.00 | 13 | 11 | 16 | 6 | FALSE | 0.64 |
| colorectal cancer | RAS_12-61 | SETD2 | Any mutation | 174 | 13 | Signature 15 | -1.11 | -2.36 | 0.00 | 1417.35 | 1.00 | 203 | 171 | 10 | 3 | FALSE | 1.22 |
| colorectal cancer | RAS_12-61 | SETD2 | Any mutation | 368 | 31 | Signature 1A | -0.63 | -1.42 | 0.06 | 1470.74 | 1.00 | 458 | 358 | 21 | 10 | FALSE | 1.05 |
| colorectal cancer | RAS_12-61 | SETD2 | Any mutation | 125 | 39 | Signature 6 | -1.01 | -1.79 | -0.29 | 1443.70 | 1.00 | 161 | 117 | 31 | 8 | FALSE | 2.05 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 16 | 16 | Signature 13 | 0.02 | -1.22 | 1.08 | 1516.60 | 1.00 | 72 | 13 | 13 | 3 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 88 | 44 | Signature 2 | 0.13 | -0.51 | 0.79 | 1472.17 | 1.00 | 218 | 75 | 31 | 13 | FALSE | 0.16 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 57 | 15 | Signature 3 | -0.26 | -1.36 | 0.76 | 1409.75 | 1.00 | 176 | 54 | 12 | 3 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 278 | 55 | Signature 4 | -0.28 | -0.87 | 0.25 | 1449.47 | 1.00 | 392 | 260 | 37 | 18 | FALSE | 0.49 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 158 | 14 | Signature R2 | -0.07 | -1.02 | 0.96 | 1665.58 | 1.00 | 39 | 147 | 3 | 11 | FALSE | 0.05 |
| colorectal cancer | RAS_12-61 | SETD2 | Any mutation | 684 | 105 | Signature overall | -0.83 | -1.96 | 0.28 | 1213.41 | 1.00 | 835 | 657 | 78 | 27 | FALSE | 0.84 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Any mutation | 597 | 144 | Signature overall | -0.09 | -0.98 | 0.80 | 1463.44 | 1.00 | 897 | 549 | 96 | 48 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12-61 | PBRM1 | Any mutation | 86 | 20 | Signature 2 | -0.33 | -1.29 | 0.59 | 1439.94 | 1.00 | 228 | 81 | 15 | 5 | TRUE | 0.30 |
| non-small cell lung cancer | RAS_12-61 | PBRM1 | Any mutation | 275 | 27 | Signature 4 | -0.75 | -1.61 | 0.04 | 1457.29 | 1.00 | 407 | 269 | 21 | 6 | TRUE | 1.13 |
| non-small cell lung cancer | RAS_12-61 | PBRM1 | Any mutation | 361 | 47 | Signature overall | -0.53 | -2.01 | 0.85 | 1388.94 | 1.00 | 635 | 350 | 36 | 11 | TRUE | 0.35 |
| colorectal cancer | RAS_12-61 | EPHA3 | Any mutation | 15 | 14 | Signature 10 | -0.14 | -1.27 | 0.88 | 1289.02 | 1.00 | 17 | 11 | 10 | 4 | FALSE | 0.09 |
| colorectal cancer | RAS_12-61 | EPHA3 | Any mutation | 173 | 13 | Signature 15 | -0.34 | -1.32 | 0.51 | 1396.24 | 1.00 | 204 | 168 | 8 | 5 | FALSE | 0.33 |
| colorectal cancer | RAS_12-61 | EPHA3 | Any mutation | 369 | 42 | Signature 1A | 0.21 | -0.38 | 0.79 | 1319.32 | 1.00 | 458 | 347 | 20 | 22 | FALSE | 0.31 |
| colorectal cancer | RAS_12-61 | EPHA3 | Any mutation | 124 | 26 | Signature 6 | -0.37 | -1.20 | 0.34 | 1612.40 | 1.00 | 171 | 116 | 18 | 8 | FALSE | 0.45 |
| melanoma | RAS_12-61 | EPHA3 | Any mutation | 151 | 97 | Signature 7 | 0.15 | -0.30 | 0.62 | 1323.88 | 1.00 | 254 | 117 | 63 | 34 | FALSE | 0.29 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 68 | 13 | Signature 18 | -0.21 | -1.14 | 0.69 | 1500.44 | 1.00 | 75 | 63 | 8 | 5 | FALSE | 0.18 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 88 | 27 | Signature 2 | 0.35 | -0.41 | 1.06 | 1375.49 | 1.00 | 222 | 78 | 17 | 10 | FALSE | 0.44 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 57 | 18 | Signature 3 | 0.48 | -0.40 | 1.33 | 1330.49 | 1.00 | 177 | 50 | 11 | 7 | FALSE | 0.56 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 278 | 112 | Signature 4 | -0.13 | -0.57 | 0.30 | 1514.96 | 1.00 | 363 | 238 | 72 | 40 | FALSE | 0.26 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 157 | 13 | Signature R2 | -0.29 | -1.20 | 0.67 | 1403.79 | 1.00 | 38 | 148 | 4 | 9 | FALSE | 0.26 |
| colorectal cancer | RAS_12-61 | EPHA3 | Any mutation | 681 | 95 | Signature overall | -0.16 | -1.07 | 0.71 | 1423.93 | 1.00 | 850 | 642 | 56 | 39 | FALSE | 0.14 |
| melanoma | RAS_12-61 | EPHA3 | Any mutation | 151 | 97 | Signature overall | 0.07 | -4.42 | 4.20 | 1404.92 | 1.00 | 254 | 117 | 63 | 34 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12-61 | EPHA3 | Any mutation | 648 | 183 | Signature overall | 0.04 | -0.81 | 0.86 | 1410.74 | 1.00 | 875 | 577 | 112 | 71 | FALSE | 0.03 |
| melanoma | RAS_12-61 | KDR | Any mutation | 151 | 121 | Signature 7 | -0.51 | -1.00 | -0.06 | 1361.53 | 1.00 | 231 | 122 | 92 | 29 | TRUE | 1.47 |
| non-small cell lung cancer | RAS_12-61 | KDR | Any mutation | 86 | 12 | Signature 2 | 0.43 | -0.70 | 1.54 | 1515.26 | 1.00 | 231 | 81 | 7 | 5 | TRUE | 0.35 |
| non-small cell lung cancer | RAS_12-61 | KDR | Any mutation | 57 | 11 | Signature 3 | 0.92 | -0.20 | 2.15 | 1492.04 | 1.00 | 182 | 51 | 5 | 6 | TRUE | 0.91 |
| non-small cell lung cancer | RAS_12-61 | KDR | Any mutation | 276 | 76 | Signature 4 | -0.77 | -1.36 | -0.22 | 1469.03 | 1.00 | 373 | 259 | 59 | 17 | TRUE | 1.98 |
| melanoma | RAS_12-61 | KDR | Any mutation | 151 | 121 | Signature overall | -0.39 | -4.30 | 3.71 | 1443.56 | 1.00 | 231 | 122 | 92 | 29 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12-61 | KDR | Any mutation | 419 | 99 | Signature overall | 0.20 | -1.11 | 1.60 | 1580.19 | 1.00 | 786 | 391 | 71 | 28 | TRUE | 0.11 |
| colorectal cancer | RAS_12-61 | PTCH1 | Any mutation | 13 | 11 | Signature 10 | -1.13 | -2.56 | 0.00 | 1327.19 | 1.00 | 15 | 12 | 10 | 1 | TRUE | 1.07 |
| colorectal cancer | RAS_12-61 | PTCH1 | Any mutation | 173 | 14 | Signature 15 | -0.89 | -1.89 | -0.02 | 1630.70 | 1.00 | 205 | 169 | 10 | 4 | TRUE | 1.25 |
| colorectal cancer | RAS_12-61 | PTCH1 | Any mutation | 371 | 55 | Signature 1A | -0.52 | -1.10 | -0.01 | 1579.46 | 1.00 | 447 | 352 | 36 | 19 | TRUE | 1.21 |
| colorectal cancer | RAS_12-61 | PTCH1 | Any mutation | 130 | 53 | Signature 6 | -0.71 | -1.28 | -0.13 | 1632.45 | 1.00 | 160 | 116 | 39 | 14 | TRUE | 1.78 |
| colorectal cancer | RAS_12-61 | PTCH1 | Any mutation | 687 | 133 | Signature overall | -0.81 | -1.77 | 0.03 | 1415.65 | 1.00 | 827 | 649 | 95 | 38 | TRUE | 1.16 |
| colorectal cancer | RAS_12-61 | TET1 | Any mutation | 19 | 27 | Signature 10 | -0.59 | -1.70 | 0.41 | 1414.38 | 1.00 | 12 | 11 | 19 | 8 | FALSE | 0.58 |
| colorectal cancer | RAS_12-61 | TET1 | Any mutation | 169 | 18 | Signature 15 | -1.66 | -3.00 | -0.58 | 1377.05 | 1.00 | 196 | 167 | 16 | 2 | FALSE | 2.10 |
| colorectal cancer | RAS_12-61 | TET1 | Any mutation | 357 | 25 | Signature 1A | -0.31 | -1.10 | 0.46 | 1589.42 | 1.00 | 451 | 347 | 15 | 10 | FALSE | 0.35 |
| colorectal cancer | RAS_12-61 | TET1 | Any mutation | 119 | 28 | Signature 6 | -0.60 | -1.41 | 0.24 | 1358.14 | 1.00 | 167 | 111 | 20 | 8 | FALSE | 0.79 |
| non-small cell lung cancer | RAS_12-61 | TET1 | Any mutation | 86 | 12 | Signature 2 | 0.96 | -0.26 | 2.19 | 1561.83 | 1.00 | 231 | 79 | 5 | 7 | FALSE | 0.93 |
| non-small cell lung cancer | RAS_12-61 | TET1 | Any mutation | 278 | 60 | Signature 4 | -0.36 | -0.95 | 0.20 | 1557.66 | 1.00 | 390 | 260 | 42 | 18 | FALSE | 0.68 |
| colorectal cancer | RAS_12-61 | TET1 | Any mutation | 664 | 98 | Signature overall | -0.78 | -2.04 | 0.45 | 1451.60 | 1.00 | 826 | 636 | 70 | 28 | FALSE | 0.66 |
| non-small cell lung cancer | RAS_12-61 | TET1 | Any mutation | 364 | 72 | Signature overall | 0.23 | -1.82 | 2.22 | 1670.97 | 1.00 | 621 | 339 | 47 | 25 | FALSE | 0.08 |
| uterine cancer | RAS_12-61 | FGFR2 | Any mutation | 44 | 26 | Signature 1A | -2.10 | -4.07 | -0.70 | 1357.19 | 1.00 | 153 | 43 | 25 | 1 | TRUE | 1.90 |
| uterine cancer | RAS_12-61 | FGFR2 | Any mutation | 17 | 22 | Signature 6 | -1.98 | -3.94 | -0.42 | 1416.72 | 1.00 | 63 | 16 | 21 | 1 | TRUE | 1.63 |
| uterine cancer | RAS_12-61 | FGFR2 | Any mutation | 61 | 48 | Signature overall | -2.05 | -4.16 | -0.45 | 1540.66 | 1.00 | 216 | 59 | 46 | 2 | TRUE | 1.53 |
| non-small cell lung cancer | RAS_12-61 | TBX3 | Any mutation | 275 | 75 | Signature 4 | -0.95 | -1.56 | -0.40 | 1386.64 | 1.00 | 376 | 259 | 59 | 16 | FALSE | 2.80 |
| non-small cell lung cancer | RAS_12-61 | TBX3 | Any mutation | 156 | 15 | Signature R2 | -0.68 | -1.68 | 0.37 | 1530.74 | 1.00 | 38 | 146 | 5 | 10 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12-61 | TBX3 | Any mutation | 431 | 90 | Signature overall | -0.78 | -2.62 | 1.25 | 1473.11 | 1.00 | 414 | 405 | 64 | 26 | FALSE | 0.38 |
| colorectal cancer | RAS_12-61 | SMAD3 | Any mutation | 176 | 21 | Signature 15 | 0.37 | -0.17 | 0.88 | 1276.37 | 1.00 | 204 | 164 | 9 | 12 | TRUE | 0.79 |
| colorectal cancer | RAS_12-61 | SMAD3 | Any mutation | 373 | 38 | Signature 1A | 0.35 | -0.16 | 0.82 | 1169.31 | 1.00 | 460 | 352 | 17 | 21 | TRUE | 0.80 |
| colorectal cancer | RAS_12-61 | SMAD3 | Any mutation | 124 | 20 | Signature 6 | 0.34 | -0.22 | 0.86 | 1193.36 | 1.00 | 176 | 116 | 12 | 8 | TRUE | 0.66 |
| colorectal cancer | RAS_12-61 | SMAD3 | Any mutation | 673 | 79 | Signature overall | 0.36 | -0.17 | 0.84 | 1160.93 | 1.00 | 840 | 632 | 38 | 41 | TRUE | 0.76 |
| melanoma | RAS_12-61 | NTRK3 | Any mutation | 152 | 93 | Signature 7 | -0.50 | -1.02 | 0.01 | 1006.38 | 1.00 | 244 | 129 | 70 | 23 | FALSE | 1.30 |
| non-small cell lung cancer | RAS_12-61 | NTRK3 | Any mutation | 88 | 15 | Signature 2 | 1.17 | 0.24 | 2.10 | 1553.89 | 1.00 | 232 | 79 | 6 | 9 | FALSE | 1.80 |
| non-small cell lung cancer | RAS_12-61 | NTRK3 | Any mutation | 56 | 14 | Signature 3 | 0.56 | -0.52 | 1.57 | 1460.19 | 1.00 | 179 | 51 | 9 | 5 | FALSE | 0.54 |
| non-small cell lung cancer | RAS_12-61 | NTRK3 | Any mutation | 279 | 105 | Signature 4 | -0.37 | -0.84 | 0.07 | 1594.95 | 1.00 | 371 | 247 | 73 | 32 | FALSE | 0.96 |
| non-small cell lung cancer | RAS_12-61 | NTRK3 | Any mutation | 157 | 18 | Signature R2 | 0.78 | -0.30 | 1.99 | 1656.07 | 1.00 | 40 | 141 | 2 | 16 | FALSE | 0.75 |
| melanoma | RAS_12-61 | NTRK3 | Any mutation | 152 | 93 | Signature overall | -0.43 | -4.24 | 3.87 | 1453.95 | 1.00 | 244 | 129 | 70 | 23 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | NTRK3 | Any mutation | 580 | 152 | Signature overall | 0.52 | -0.64 | 1.75 | 1495.88 | 1.00 | 822 | 518 | 90 | 62 | FALSE | 0.41 |
| colorectal cancer | RAS_12-61 | GRIN2A | Any mutation | 14 | 18 | Signature 10 | -0.70 | -1.89 | 0.45 | 1568.21 | 1.00 | 14 | 10 | 14 | 4 | FALSE | 0.64 |
| colorectal cancer | RAS_12-61 | GRIN2A | Any mutation | 173 | 12 | Signature 15 | -1.00 | -2.12 | 0.01 | 1421.96 | 1.00 | 206 | 170 | 9 | 3 | FALSE | 1.17 |
| colorectal cancer | RAS_12-61 | GRIN2A | Any mutation | 369 | 43 | Signature 1A | -0.69 | -1.35 | -0.09 | 1447.67 | 1.00 | 447 | 356 | 30 | 13 | FALSE | 1.49 |
| colorectal cancer | RAS_12-61 | GRIN2A | Any mutation | 123 | 43 | Signature 6 | -0.62 | -1.28 | 0.00 | 1454.97 | 1.00 | 160 | 111 | 31 | 12 | FALSE | 1.22 |
| melanoma | RAS_12-61 | GRIN2A | Any mutation | 16 | 13 | Signature 11 | -0.28 | -1.47 | 0.90 | 1332.21 | 1.00 | 31 | 12 | 9 | 4 | FALSE | 0.20 |
| melanoma | RAS_12-61 | GRIN2A | Any mutation | 167 | 278 | Signature 7 | -0.58 | -0.95 | -0.20 | 1486.56 | 1.00 | 181 | 102 | 213 | 65 | FALSE | 2.71 |
| non-small cell lung cancer | RAS_12-61 | GRIN2A | Any mutation | 86 | 15 | Signature 2 | -0.58 | -1.79 | 0.50 | 1441.34 | 1.00 | 226 | 83 | 12 | 3 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12-61 | GRIN2A | Any mutation | 277 | 76 | Signature 4 | -0.73 | -1.28 | -0.21 | 1529.86 | 1.00 | 376 | 258 | 57 | 19 | FALSE | 2.10 |
| non-small cell lung cancer | RAS_12-61 | GRIN2A | Any mutation | 156 | 13 | Signature R2 | -0.52 | -1.54 | 0.59 | 1326.87 | 1.00 | 38 | 147 | 4 | 9 | FALSE | 0.47 |
| colorectal cancer | RAS_12-61 | GRIN2A | Any mutation | 679 | 116 | Signature overall | -0.74 | -1.84 | 0.25 | 1556.65 | 1.00 | 827 | 647 | 84 | 32 | FALSE | 0.80 |
| melanoma | RAS_12-61 | GRIN2A | Any mutation | 183 | 291 | Signature overall | -0.44 | -2.07 | 1.15 | 1576.97 | 1.00 | 212 | 114 | 222 | 69 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | GRIN2A | Any mutation | 519 | 104 | Signature overall | -0.58 | -1.90 | 0.69 | 1498.39 | 1.00 | 640 | 488 | 73 | 31 | FALSE | 0.43 |
| uterine cancer | RAS_12-61 | CTCF | Any mutation | 27 | 18 | Signature 15 | 0.73 | -0.16 | 1.66 | 955.16 | 1.00 | 73 | 19 | 10 | 8 | FALSE | 0.96 |
| uterine cancer | RAS_12-61 | CTCF | Any mutation | 46 | 49 | Signature 1A | 0.81 | 0.14 | 1.49 | 1504.15 | 1.00 | 145 | 29 | 32 | 17 | FALSE | 1.79 |
| uterine cancer | RAS_12-61 | CTCF | Any mutation | 17 | 40 | Signature 6 | -0.10 | -1.07 | 0.80 | 1594.10 | 1.00 | 49 | 12 | 35 | 5 | FALSE | 0.07 |
| uterine cancer | RAS_12-61 | CTCF | Any mutation | 93 | 123 | Signature overall | 0.39 | -0.57 | 1.31 | 1494.03 | 1.00 | 290 | 62 | 92 | 31 | FALSE | 0.40 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 23 | 11 | Signature 11 | 1.62 | 0.69 | 2.58 | 1286.46 | 1.00 | 20 | 13 | 1 | 10 | TRUE | 3.15 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 32 | 19 | Signature 15 | 1.43 | 0.58 | 2.27 | 1474.23 | 1.00 | 96 | 21 | 8 | 11 | TRUE | 3.26 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 10 | 11 | Signature 16 | 0.61 | -0.44 | 1.64 | 1656.09 | 1.00 | 41 | 8 | 9 | 2 | TRUE | 0.61 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 69 | 38 | Signature 18 | 0.95 | 0.31 | 1.58 | 1455.24 | 1.00 | 68 | 46 | 15 | 23 | TRUE | 2.41 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 17 | 17 | Signature 19 | 0.84 | -0.01 | 1.75 | 1366.81 | 1.00 | 35 | 11 | 11 | 6 | TRUE | 1.25 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 48 | 21 | Signature 1A | 1.68 | 0.89 | 2.46 | 1413.45 | 1.00 | 210 | 35 | 8 | 13 | TRUE | 4.66 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 87 | 55 | Signature 2 | 0.35 | -0.23 | 0.92 | 1482.86 | 1.00 | 207 | 71 | 39 | 16 | TRUE | 0.61 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 16 | 13 | Signature 20 | 1.60 | 0.66 | 2.55 | 1473.71 | 1.00 | 56 | 8 | 5 | 8 | TRUE | 3.16 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 56 | 37 | Signature 3 | 0.88 | 0.25 | 1.55 | 1464.76 | 1.00 | 164 | 42 | 23 | 14 | TRUE | 2.16 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 276 | 163 | Signature 4 | 0.46 | 0.12 | 0.79 | 1528.49 | 1.00 | 341 | 200 | 87 | 76 | TRUE | 2.10 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 30 | 13 | Signature 8 | 0.96 | 0.09 | 1.86 | 1396.13 | 1.00 | 29 | 22 | 5 | 8 | TRUE | 1.51 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 157 | 61 | Signature R2 | 0.96 | 0.30 | 1.64 | 1487.73 | 1.00 | 33 | 105 | 9 | 52 | TRUE | 2.27 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 23 | 13 | Signature U1 | 1.33 | 0.47 | 2.24 | 1555.49 | 1.00 | 82 | 16 | 6 | 7 | TRUE | 2.53 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Any mutation | 844 | 472 | Signature overall | 1.05 | 0.59 | 1.54 | 1281.52 | 1.00 | 1382 | 598 | 226 | 246 | TRUE | 4.72 |
| colorectal cancer | RAS_12-61 | ASXL1 | Any mutation | 13 | 11 | Signature 10 | -1.04 | -2.71 | 0.26 | 1589.98 | 1.00 | 13 | 12 | 10 | 1 | TRUE | 0.76 |
| colorectal cancer | RAS_12-61 | ASXL1 | Any mutation | 173 | 14 | Signature 15 | -0.53 | -1.50 | 0.36 | 1527.47 | 1.00 | 205 | 168 | 9 | 5 | TRUE | 0.57 |
| colorectal cancer | RAS_12-61 | ASXL1 | Any mutation | 368 | 31 | Signature 1A | -0.46 | -1.18 | 0.21 | 1464.59 | 1.00 | 459 | 357 | 20 | 11 | TRUE | 0.70 |
| colorectal cancer | RAS_12-61 | ASXL1 | Any mutation | 126 | 34 | Signature 6 | 0.07 | -0.58 | 0.74 | 1304.96 | 1.00 | 171 | 111 | 19 | 15 | TRUE | 0.08 |
| colorectal cancer | RAS_12-61 | ASXL1 | Any mutation | 680 | 90 | Signature overall | -0.50 | -1.58 | 0.49 | 1621.38 | 1.00 | 848 | 648 | 58 | 32 | TRUE | 0.48 |
| colorectal cancer | RAS_12-61 | EP300 | Any mutation | 174 | 18 | Signature 15 | -0.70 | -1.51 | 0.11 | 1216.29 | 1.00 | 202 | 169 | 13 | 5 | TRUE | 1.08 |
| colorectal cancer | RAS_12-61 | EP300 | Any mutation | 368 | 36 | Signature 1A | -0.34 | -0.98 | 0.30 | 1399.08 | 1.00 | 457 | 354 | 22 | 14 | TRUE | 0.56 |
| colorectal cancer | RAS_12-61 | EP300 | Any mutation | 128 | 51 | Signature 6 | -0.46 | -1.07 | 0.14 | 1334.25 | 1.00 | 162 | 113 | 36 | 15 | TRUE | 0.85 |
| non-small cell lung cancer | RAS_12-61 | EP300 | Any mutation | 15 | 11 | Signature 13 | -0.09 | -1.38 | 1.07 | 1393.41 | 1.00 | 76 | 13 | 9 | 2 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | EP300 | Any mutation | 87 | 20 | Signature 2 | -0.51 | -1.51 | 0.36 | 1613.61 | 1.00 | 226 | 84 | 17 | 3 | TRUE | 0.55 |
| non-small cell lung cancer | RAS_12-61 | EP300 | Any mutation | 276 | 30 | Signature 4 | -0.10 | -0.81 | 0.60 | 1355.19 | 1.00 | 409 | 264 | 18 | 12 | TRUE | 0.11 |
| uterine cancer | RAS_12-61 | EP300 | Any mutation | 45 | 21 | Signature 1A | 0.38 | -0.59 | 1.37 | 1508.42 | 1.00 | 160 | 39 | 15 | 6 | TRUE | 0.36 |
| uterine cancer | RAS_12-61 | EP300 | Any mutation | 17 | 20 | Signature 6 | 0.26 | -0.95 | 1.36 | 1384.46 | 1.00 | 67 | 13 | 16 | 4 | TRUE | 0.18 |
| colorectal cancer | RAS_12-61 | EP300 | Any mutation | 670 | 105 | Signature overall | -0.49 | -1.49 | 0.38 | 1312.41 | 1.00 | 821 | 636 | 71 | 34 | TRUE | 0.53 |
| non-small cell lung cancer | RAS_12-61 | EP300 | Any mutation | 378 | 61 | Signature overall | -0.24 | -1.25 | 0.76 | 1462.41 | 1.00 | 711 | 361 | 44 | 17 | TRUE | 0.18 |
| uterine cancer | RAS_12-61 | EP300 | Any mutation | 67 | 74 | Signature overall | 0.42 | -1.21 | 2.17 | 1428.57 | 1.00 | 247 | 53 | 60 | 14 | TRUE | 0.21 |
| colorectal cancer | RAS_12-61 | ERBB4 | Any mutation | 17 | 18 | Signature 10 | -0.06 | -1.05 | 0.90 | 1316.84 | 1.00 | 14 | 11 | 12 | 6 | TRUE | 0.04 |
| colorectal cancer | RAS_12-61 | ERBB4 | Any mutation | 174 | 23 | Signature 15 | -0.38 | -1.17 | 0.36 | 1346.05 | 1.00 | 199 | 166 | 15 | 8 | TRUE | 0.47 |
| colorectal cancer | RAS_12-61 | ERBB4 | Any mutation | 369 | 43 | Signature 1A | -0.04 | -0.60 | 0.56 | 1522.65 | 1.00 | 455 | 350 | 24 | 19 | TRUE | 0.05 |
| colorectal cancer | RAS_12-61 | ERBB4 | Any mutation | 125 | 31 | Signature 6 | 0.26 | -0.41 | 0.94 | 1560.58 | 1.00 | 174 | 110 | 16 | 15 | TRUE | 0.35 |
| melanoma | RAS_12-61 | ERBB4 | Any mutation | 160 | 171 | Signature 7 | -0.60 | -1.00 | -0.22 | 964.18 | 1.00 | 207 | 119 | 130 | 41 | TRUE | 2.43 |
| non-small cell lung cancer | RAS_12-61 | ERBB4 | Any mutation | 48 | 11 | Signature 1A | 0.30 | -0.90 | 1.44 | 1498.59 | 1.00 | 211 | 44 | 7 | 4 | TRUE | 0.21 |
| non-small cell lung cancer | RAS_12-61 | ERBB4 | Any mutation | 86 | 17 | Signature 2 | -0.74 | -2.08 | 0.24 | 1388.23 | 1.00 | 226 | 84 | 15 | 2 | TRUE | 0.66 |
| non-small cell lung cancer | RAS_12-61 | ERBB4 | Any mutation | 279 | 97 | Signature 4 | -0.36 | -0.80 | 0.07 | 1555.24 | 1.00 | 375 | 249 | 67 | 30 | TRUE | 0.97 |
| colorectal cancer | RAS_12-61 | ERBB4 | Any mutation | 685 | 115 | Signature overall | -0.05 | -0.96 | 0.83 | 1471.74 | 1.00 | 842 | 637 | 67 | 48 | TRUE | 0.04 |
| melanoma | RAS_12-61 | ERBB4 | Any mutation | 160 | 171 | Signature overall | -0.52 | -4.26 | 3.41 | 1485.83 | 1.00 | 207 | 119 | 130 | 41 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | ERBB4 | Any mutation | 413 | 125 | Signature overall | -0.29 | -1.45 | 0.92 | 1561.85 | 1.00 | 812 | 377 | 89 | 36 | TRUE | 0.20 |
| colorectal cancer | RAS_12-61 | MED12 | Any mutation | 173 | 11 | Signature 15 | -1.00 | -2.25 | 0.02 | 1291.67 | 1.00 | 204 | 171 | 9 | 2 | TRUE | 1.05 |
| colorectal cancer | RAS_12-61 | MED12 | Any mutation | 369 | 34 | Signature 1A | 0.17 | -0.48 | 0.84 | 1446.27 | 1.00 | 463 | 351 | 16 | 18 | TRUE | 0.21 |
| colorectal cancer | RAS_12-61 | MED12 | Any mutation | 127 | 42 | Signature 6 | -0.59 | -1.27 | 0.06 | 1678.43 | 1.00 | 164 | 116 | 31 | 11 | TRUE | 1.05 |
| non-small cell lung cancer | RAS_12-61 | MED12 | Any mutation | 86 | 25 | Signature 2 | -0.36 | -1.21 | 0.45 | 1440.02 | 1.00 | 220 | 80 | 19 | 6 | TRUE | 0.40 |
| non-small cell lung cancer | RAS_12-61 | MED12 | Any mutation | 277 | 72 | Signature 4 | -0.58 | -1.12 | -0.06 | 1371.65 | 1.00 | 382 | 258 | 53 | 19 | TRUE | 1.52 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 26 | 13 | Signature 15 | -0.42 | -1.79 | 0.81 | 1277.19 | 1.00 | 72 | 23 | 10 | 3 | TRUE | 0.28 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 44 | 18 | Signature 1A | -0.94 | -2.50 | 0.32 | 1485.37 | 1.00 | 160 | 42 | 16 | 2 | TRUE | 0.73 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 17 | 14 | Signature 6 | -1.11 | -2.87 | 0.42 | 1395.70 | 1.00 | 71 | 16 | 13 | 1 | TRUE | 0.76 |
| colorectal cancer | RAS_12-61 | MED12 | Any mutation | 669 | 87 | Signature overall | -0.47 | -1.60 | 0.53 | 1603.22 | 1.00 | 831 | 638 | 56 | 31 | TRUE | 0.41 |
| non-small cell lung cancer | RAS_12-61 | MED12 | Any mutation | 363 | 97 | Signature overall | -0.47 | -1.51 | 0.66 | 1536.43 | 1.00 | 602 | 338 | 72 | 25 | TRUE | 0.40 |
| uterine cancer | RAS_12-61 | MED12 | Any mutation | 91 | 87 | Signature overall | -0.86 | -2.33 | 0.56 | 1438.08 | 1.00 | 319 | 83 | 79 | 8 | TRUE | 0.61 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 15 | 11 | Signature 13 | 0.67 | -0.29 | 1.61 | 1428.92 | 1.00 | 76 | 12 | 8 | 3 | FALSE | 0.75 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 33 | 11 | Signature 15 | 0.77 | -0.16 | 1.66 | 1420.60 | 1.00 | 99 | 28 | 6 | 5 | FALSE | 1.02 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 69 | 17 | Signature 18 | 0.48 | -0.34 | 1.27 | 1544.43 | 1.00 | 74 | 60 | 8 | 9 | FALSE | 0.62 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 48 | 21 | Signature 1A | 0.73 | -0.02 | 1.52 | 1397.01 | 1.00 | 204 | 41 | 14 | 7 | FALSE | 1.18 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 86 | 32 | Signature 2 | 0.89 | 0.23 | 1.56 | 1513.34 | 1.00 | 221 | 71 | 17 | 15 | FALSE | 2.12 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 58 | 30 | Signature 3 | 0.45 | -0.27 | 1.12 | 1504.81 | 1.00 | 167 | 49 | 21 | 9 | FALSE | 0.67 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 281 | 128 | Signature 4 | 0.79 | 0.41 | 1.16 | 1722.65 | 1.00 | 374 | 211 | 58 | 70 | FALSE | 4.49 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 156 | 20 | Signature R2 | 0.40 | -0.39 | 1.20 | 1537.86 | 1.00 | 38 | 140 | 4 | 16 | FALSE | 0.47 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 23 | 15 | Signature U1 | 0.70 | -0.14 | 1.57 | 1517.35 | 1.00 | 79 | 18 | 10 | 5 | FALSE | 0.94 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Any mutation | 769 | 285 | Signature overall | 0.65 | 0.12 | 1.20 | 1379.80 | 1.00 | 1332 | 630 | 146 | 139 | FALSE | 1.80 |
| colorectal cancer | RAS_12-61 | NF1 | Any mutation | 16 | 24 | Signature 10 | -0.98 | -2.16 | 0.09 | 1542.03 | 1.00 | 13 | 11 | 19 | 5 | TRUE | 1.10 |
| colorectal cancer | RAS_12-61 | NF1 | Any mutation | 173 | 21 | Signature 15 | -1.54 | -2.66 | -0.61 | 1466.52 | 1.00 | 198 | 170 | 18 | 3 | TRUE | 2.46 |
| colorectal cancer | RAS_12-61 | NF1 | Any mutation | 370 | 40 | Signature 1A | -0.32 | -0.99 | 0.32 | 1549.15 | 1.00 | 456 | 354 | 24 | 16 | TRUE | 0.49 |
| colorectal cancer | RAS_12-61 | NF1 | Any mutation | 123 | 44 | Signature 6 | -1.29 | -2.13 | -0.56 | 1438.31 | 1.00 | 162 | 116 | 37 | 7 | TRUE | 2.79 |
| melanoma | RAS_12-61 | NF1 | Any mutation | 16 | 17 | Signature 11 | -0.95 | -2.06 | 0.06 | 1287.75 | 1.01 | 31 | 13 | 14 | 3 | TRUE | 1.18 |
| melanoma | RAS_12-61 | NF1 | Any mutation | 160 | 242 | Signature 7 | -0.97 | -1.36 | -0.59 | 279.91 | 1.01 | 177 | 114 | 196 | 46 | TRUE | 5.74 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 68 | 13 | Signature 18 | -0.26 | -1.23 | 0.66 | 1510.35 | 1.00 | 76 | 62 | 7 | 6 | TRUE | 0.24 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 48 | 13 | Signature 1A | -0.59 | -1.69 | 0.54 | 1124.98 | 1.00 | 207 | 46 | 11 | 2 | TRUE | 0.53 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 88 | 39 | Signature 2 | -0.48 | -1.23 | 0.19 | 1575.79 | 1.00 | 210 | 80 | 31 | 8 | TRUE | 0.74 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 16 | 13 | Signature 20 | -0.60 | -1.83 | 0.56 | 1508.01 | 1.00 | 51 | 14 | 11 | 2 | TRUE | 0.50 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 56 | 15 | Signature 3 | -1.06 | -2.36 | 0.00 | 1548.99 | 1.00 | 174 | 55 | 14 | 1 | TRUE | 1.12 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 278 | 113 | Signature 4 | -0.53 | -0.96 | -0.11 | 1216.73 | 1.00 | 368 | 246 | 81 | 32 | TRUE | 1.86 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 25 | 11 | Signature 7 | -1.25 | -2.67 | -0.04 | 1546.56 | 1.00 | 72 | 25 | 11 | 0 | TRUE | 1.19 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 157 | 12 | Signature R2 | -0.65 | -1.58 | 0.25 | 1481.32 | 1.00 | 38 | 149 | 4 | 8 | TRUE | 0.76 |
| uterine cancer | RAS_12-61 | NF1 | Any mutation | 46 | 21 | Signature 1A | 0.33 | -0.68 | 1.25 | 1532.62 | 1.00 | 163 | 40 | 15 | 6 | TRUE | 0.30 |
| uterine cancer | RAS_12-61 | NF1 | Any mutation | 17 | 24 | Signature 6 | -0.36 | -1.68 | 0.83 | 1552.29 | 1.00 | 64 | 14 | 21 | 3 | TRUE | 0.25 |
| colorectal cancer | RAS_12-61 | NF1 | Any mutation | 682 | 129 | Signature overall | -1.03 | -2.19 | 0.05 | 1640.40 | 1.00 | 829 | 651 | 98 | 31 | TRUE | 1.18 |
| melanoma | RAS_12-61 | NF1 | Any mutation | 176 | 259 | Signature overall | -0.95 | -2.21 | 0.36 | 1451.92 | 1.00 | 208 | 127 | 210 | 49 | TRUE | 0.94 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Any mutation | 736 | 229 | Signature overall | -0.69 | -1.36 | -0.05 | 1431.27 | 1.00 | 1196 | 677 | 170 | 59 | TRUE | 1.35 |
| uterine cancer | RAS_12-61 | NF1 | Any mutation | 67 | 92 | Signature overall | -0.06 | -1.90 | 1.79 | 1388.38 | 1.00 | 244 | 55 | 80 | 12 | TRUE | 0.02 |
| melanoma | RAS_12-61 | FLT1 | Any mutation | 154 | 110 | Signature 7 | -0.17 | -0.64 | 0.27 | 1353.17 | 1.00 | 241 | 121 | 77 | 33 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12-61 | FLT1 | Any mutation | 69 | 13 | Signature 18 | 0.46 | -0.42 | 1.41 | 1043.62 | 1.00 | 77 | 61 | 5 | 8 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12-61 | FLT1 | Any mutation | 86 | 12 | Signature 2 | 0.31 | -0.60 | 1.28 | 1480.77 | 1.00 | 231 | 81 | 7 | 5 | FALSE | 0.28 |
| non-small cell lung cancer | RAS_12-61 | FLT1 | Any mutation | 278 | 64 | Signature 4 | -0.16 | -0.68 | 0.35 | 1387.83 | 1.00 | 391 | 257 | 43 | 21 | FALSE | 0.28 |
| melanoma | RAS_12-61 | FLT1 | Any mutation | 154 | 110 | Signature overall | -0.27 | -4.85 | 4.13 | 1365.98 | 1.00 | 241 | 121 | 77 | 33 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | FLT1 | Any mutation | 433 | 89 | Signature overall | 0.19 | -0.66 | 1.16 | 1495.73 | 1.00 | 699 | 399 | 55 | 34 | FALSE | 0.17 |
| uterine cancer | RAS_12-61 | RASA1 | Any mutation | 44 | 20 | Signature 1A | -2.19 | -4.62 | -0.41 | 1543.21 | 1.00 | 161 | 43 | 19 | 1 | FALSE | 1.39 |
| uterine cancer | RAS_12-61 | RASA1 | Any mutation | 17 | 12 | Signature 6 | -1.84 | -4.48 | 0.33 | 1520.51 | 1.00 | 71 | 16 | 11 | 1 | FALSE | 0.89 |
| uterine cancer | RAS_12-61 | RASA1 | Any mutation | 64 | 78 | Signature overall | -2.43 | -5.14 | -0.25 | 1438.96 | 1.00 | 247 | 62 | 76 | 2 | FALSE | 1.26 |
| colorectal cancer | RAS_12-61 | EPHA5 | Any mutation | 16 | 26 | Signature 10 | -1.38 | -2.59 | -0.27 | 1548.76 | 1.00 | 11 | 12 | 22 | 4 | FALSE | 1.68 |
| colorectal cancer | RAS_12-61 | EPHA5 | Any mutation | 173 | 18 | Signature 15 | -1.15 | -2.26 | -0.18 | 1569.85 | 1.00 | 202 | 169 | 14 | 4 | FALSE | 1.49 |
| colorectal cancer | RAS_12-61 | EPHA5 | Any mutation | 369 | 49 | Signature 1A | -0.08 | -0.66 | 0.47 | 1656.43 | 1.00 | 451 | 347 | 27 | 22 | FALSE | 0.11 |
| colorectal cancer | RAS_12-61 | EPHA5 | Any mutation | 123 | 36 | Signature 6 | -1.25 | -2.13 | -0.45 | 1366.32 | 1.00 | 163 | 117 | 30 | 6 | FALSE | 2.59 |
| non-small cell lung cancer | RAS_12-61 | EPHA5 | Any mutation | 69 | 24 | Signature 18 | 0.27 | -0.51 | 1.02 | 1443.46 | 1.00 | 71 | 57 | 12 | 12 | FALSE | 0.31 |
| non-small cell lung cancer | RAS_12-61 | EPHA5 | Any mutation | 87 | 30 | Signature 2 | 0.54 | -0.20 | 1.24 | 1319.15 | 1.00 | 222 | 75 | 18 | 12 | FALSE | 0.82 |
| non-small cell lung cancer | RAS_12-61 | EPHA5 | Any mutation | 56 | 19 | Signature 3 | 0.67 | -0.18 | 1.50 | 1535.68 | 1.00 | 179 | 48 | 11 | 8 | FALSE | 0.92 |
| non-small cell lung cancer | RAS_12-61 | EPHA5 | Any mutation | 278 | 109 | Signature 4 | 0.03 | -0.41 | 0.44 | 1380.58 | 1.00 | 372 | 236 | 67 | 42 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | EPHA5 | Any mutation | 156 | 12 | Signature R2 | -0.32 | -1.23 | 0.62 | 1464.90 | 1.00 | 39 | 148 | 4 | 8 | FALSE | 0.29 |
| colorectal cancer | RAS_12-61 | EPHA5 | Any mutation | 681 | 129 | Signature overall | -0.95 | -2.33 | 0.34 | 1398.12 | 1.00 | 827 | 645 | 93 | 36 | FALSE | 0.86 |
| non-small cell lung cancer | RAS_12-61 | EPHA5 | Any mutation | 646 | 194 | Signature overall | 0.24 | -0.52 | 1.05 | 1381.38 | 1.00 | 883 | 564 | 112 | 82 | FALSE | 0.27 |
| colorectal cancer | RAS_12-61 | AR | Any mutation | 174 | 21 | Signature 15 | -0.65 | -1.41 | 0.03 | 1503.48 | 1.00 | 200 | 168 | 15 | 6 | TRUE | 1.13 |
| colorectal cancer | RAS_12-61 | AR | Any mutation | 368 | 33 | Signature 1A | -0.54 | -1.17 | 0.04 | 1176.42 | 1.00 | 455 | 357 | 22 | 11 | TRUE | 1.12 |
| colorectal cancer | RAS_12-61 | AR | Any mutation | 125 | 37 | Signature 6 | -0.37 | -0.97 | 0.27 | 1499.47 | 1.00 | 166 | 113 | 25 | 12 | TRUE | 0.62 |
| non-small cell lung cancer | RAS_12-61 | AR | Any mutation | 277 | 56 | Signature 4 | -0.32 | -0.89 | 0.21 | 76.12 | 1.04 | 394 | 259 | 38 | 18 | TRUE | 0.54 |
| colorectal cancer | RAS_12-61 | AR | Any mutation | 667 | 91 | Signature overall | -0.52 | -1.24 | 0.17 | 1397.49 | 1.00 | 821 | 638 | 62 | 29 | TRUE | 0.81 |
| non-small cell lung cancer | RAS_12-61 | AR | Any mutation | 277 | 56 | Signature overall | -0.19 | -4.40 | 4.54 | 1345.73 | 1.00 | 394 | 259 | 38 | 18 | TRUE | 0.03 |
| colorectal cancer | RAS_12-61 | ROS1 | Any mutation | 19 | 30 | Signature 10 | -0.77 | -1.83 | 0.27 | 1434.75 | 1.00 | 12 | 11 | 22 | 8 | TRUE | 0.83 |
| colorectal cancer | RAS_12-61 | ROS1 | Any mutation | 368 | 28 | Signature 1A | -0.59 | -1.41 | 0.20 | 1456.61 | 1.00 | 460 | 359 | 19 | 9 | TRUE | 0.85 |
| colorectal cancer | RAS_12-61 | ROS1 | Any mutation | 123 | 26 | Signature 6 | -0.88 | -1.82 | 0.00 | 1048.69 | 1.00 | 168 | 117 | 20 | 6 | TRUE | 1.26 |
| melanoma | RAS_12-61 | ROS1 | Any mutation | 16 | 11 | Signature 11 | 0.34 | -0.83 | 1.71 | 1491.68 | 1.00 | 33 | 11 | 6 | 5 | TRUE | 0.21 |
| melanoma | RAS_12-61 | ROS1 | Any mutation | 160 | 231 | Signature 7 | -0.57 | -0.96 | -0.19 | 1181.68 | 1.00 | 195 | 107 | 178 | 53 | TRUE | 2.55 |
| non-small cell lung cancer | RAS_12-61 | ROS1 | Any mutation | 86 | 14 | Signature 2 | -1.10 | -2.35 | 0.13 | 1532.73 | 1.00 | 227 | 84 | 12 | 2 | TRUE | 1.11 |
| non-small cell lung cancer | RAS_12-61 | ROS1 | Any mutation | 275 | 42 | Signature 4 | -1.21 | -2.07 | -0.49 | 1237.01 | 1.00 | 394 | 268 | 35 | 7 | TRUE | 2.45 |
| colorectal cancer | RAS_12-61 | ROS1 | Any mutation | 510 | 84 | Signature overall | -0.70 | -2.35 | 0.99 | 1346.33 | 1.01 | 640 | 487 | 61 | 23 | TRUE | 0.40 |
| melanoma | RAS_12-61 | ROS1 | Any mutation | 176 | 242 | Signature overall | -0.12 | -1.93 | 1.87 | 1525.45 | 1.00 | 228 | 118 | 184 | 58 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | ROS1 | Any mutation | 361 | 56 | Signature overall | -1.13 | -2.51 | 0.29 | 1610.46 | 1.00 | 621 | 352 | 47 | 9 | TRUE | 0.90 |
| colorectal cancer | RAS_12-61 | PIK3CG | Any mutation | 16 | 22 | Signature 10 | -0.53 | -1.65 | 0.50 | 1393.13 | 1.00 | 12 | 10 | 16 | 6 | FALSE | 0.46 |
| colorectal cancer | RAS_12-61 | PIK3CG | Any mutation | 173 | 17 | Signature 15 | -0.55 | -1.51 | 0.30 | 1387.47 | 1.00 | 203 | 167 | 11 | 6 | FALSE | 0.62 |
| colorectal cancer | RAS_12-61 | PIK3CG | Any mutation | 368 | 29 | Signature 1A | -0.77 | -1.56 | -0.02 | 1487.61 | 1.00 | 456 | 360 | 21 | 8 | FALSE | 1.27 |
| colorectal cancer | RAS_12-61 | PIK3CG | Any mutation | 124 | 29 | Signature 6 | -0.32 | -1.12 | 0.45 | 1458.93 | 1.00 | 171 | 114 | 19 | 10 | FALSE | 0.39 |
| melanoma | RAS_12-61 | PIK3CG | Any mutation | 151 | 92 | Signature 7 | -0.64 | -1.21 | 0.10 | 281.85 | 1.00 | 250 | 131 | 72 | 20 | FALSE | 1.50 |
| non-small cell lung cancer | RAS_12-61 | PIK3CG | Any mutation | 15 | 13 | Signature 13 | -0.76 | -2.60 | 0.75 | 1371.12 | 1.00 | 72 | 14 | 12 | 1 | FALSE | 0.43 |
| non-small cell lung cancer | RAS_12-61 | PIK3CG | Any mutation | 88 | 18 | Signature 2 | 1.42 | 0.48 | 2.39 | 1350.87 | 1.00 | 232 | 76 | 6 | 12 | FALSE | 2.44 |
| non-small cell lung cancer | RAS_12-61 | PIK3CG | Any mutation | 276 | 75 | Signature 4 | -0.34 | -0.84 | 0.18 | 1607.27 | 1.00 | 382 | 252 | 51 | 24 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12-61 | PIK3CG | Any mutation | 156 | 12 | Signature R2 | -1.40 | -2.57 | -0.34 | 1377.79 | 1.00 | 36 | 151 | 7 | 5 | FALSE | 1.85 |
| colorectal cancer | RAS_12-61 | PIK3CG | Any mutation | 681 | 97 | Signature overall | -0.56 | -1.74 | 0.50 | 1639.98 | 1.00 | 842 | 651 | 67 | 30 | FALSE | 0.49 |
| melanoma | RAS_12-61 | PIK3CG | Any mutation | 151 | 92 | Signature overall | -0.50 | -4.77 | 3.79 | 1203.51 | 1.00 | 250 | 131 | 72 | 20 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12-61 | PIK3CG | Any mutation | 535 | 118 | Signature overall | -0.26 | -1.73 | 1.18 | 1251.78 | 1.00 | 722 | 493 | 76 | 42 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 15 | 23 | Signature 13 | -3.09 | -4.10 | -2.10 | 1472.16 | 1.00 | 63 | 14 | 22 | 1 | TRUE | 8.60 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 21 | 12 | Signature 14 | -3.09 | -4.06 | -2.17 | 1561.41 | 1.00 | 26 | 20 | 11 | 1 | TRUE | 9.60 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 33 | 54 | Signature 15 | -2.90 | -3.80 | -1.99 | 1516.48 | 1.00 | 61 | 30 | 51 | 3 | TRUE | 10.15 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 10 | 19 | Signature 16 | -3.27 | -4.28 | -2.32 | 1209.39 | 1.00 | 32 | 10 | 19 | 0 | TRUE | 9.99 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 19 | 21 | Signature 17 | -3.18 | -4.20 | -2.23 | 1461.93 | 1.00 | 13 | 18 | 20 | 1 | TRUE | 9.49 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 68 | 29 | Signature 18 | -3.45 | -4.45 | -2.59 | 1598.46 | 1.00 | 57 | 68 | 29 | 0 | TRUE | 12.06 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 16 | 16 | Signature 19 | -3.25 | -4.32 | -2.32 | 1369.05 | 1.00 | 31 | 16 | 16 | 0 | TRUE | 9.67 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 48 | 197 | Signature 1A | -3.71 | -4.69 | -2.87 | 1707.74 | 1.00 | 93 | 48 | 197 | 0 | TRUE | 14.73 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 86 | 79 | Signature 2 | -3.32 | -4.27 | -2.44 | 1434.18 | 1.00 | 176 | 85 | 78 | 1 | TRUE | 11.80 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 16 | 35 | Signature 20 | -3.35 | -4.39 | -2.38 | 1527.73 | 1.00 | 33 | 16 | 35 | 0 | TRUE | 10.08 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 11 | 29 | Signature 21 | -3.30 | -4.30 | -2.33 | 1519.32 | 1.00 | 29 | 11 | 29 | 0 | TRUE | 10.06 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 56 | 89 | Signature 3 | -2.90 | -3.73 | -2.06 | 1479.79 | 1.00 | 110 | 52 | 85 | 4 | TRUE | 11.47 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 275 | 114 | Signature 4 | -2.67 | -3.36 | -2.01 | 1644.60 | 1.00 | 343 | 266 | 105 | 9 | TRUE | 14.20 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 13 | 18 | Signature 6 | -3.08 | -4.08 | -2.12 | 1491.17 | 1.00 | 28 | 12 | 17 | 1 | TRUE | 9.49 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 25 | 34 | Signature 7 | -3.35 | -4.33 | -2.40 | 1506.40 | 1.00 | 53 | 25 | 34 | 0 | TRUE | 10.80 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 29 | 14 | Signature 8 | -3.14 | -4.08 | -2.19 | 1593.70 | 1.00 | 22 | 28 | 13 | 1 | TRUE | 10.02 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 7 | 11 | Signature R3 | -3.26 | -4.33 | -2.24 | 1738.32 | 1.00 | 14 | 7 | 11 | 0 | TRUE | 8.67 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 23 | 46 | Signature U1 | -3.38 | -4.40 | -2.49 | 1384.92 | 1.00 | 47 | 23 | 46 | 0 | TRUE | 10.87 |
| non-small cell lung cancer | RAS_12-61 | EGFR | Any mutation | 775 | 853 | Signature overall | -3.21 | -3.78 | -2.70 | 1452.32 | 1.00 | 1245 | 753 | 831 | 22 | TRUE | 31.05 |
| colorectal cancer | RAS_12-61 | ARID1B | Any mutation | 173 | 22 | Signature 15 | -1.10 | -1.88 | -0.31 | 1402.04 | 1.00 | 200 | 167 | 16 | 6 | TRUE | 2.24 |
| colorectal cancer | RAS_12-61 | ARID1B | Any mutation | 369 | 53 | Signature 1A | -1.05 | -1.67 | -0.45 | 1711.02 | 1.00 | 445 | 356 | 40 | 13 | TRUE | 3.22 |
| colorectal cancer | RAS_12-61 | ARID1B | Any mutation | 123 | 46 | Signature 6 | -1.49 | -2.31 | -0.79 | 1330.70 | 1.01 | 155 | 118 | 41 | 5 | TRUE | 3.75 |
| non-small cell lung cancer | RAS_12-61 | ARID1B | Any mutation | 86 | 13 | Signature 2 | 0.08 | -0.97 | 1.20 | 1419.98 | 1.00 | 230 | 81 | 8 | 5 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | ARID1B | Any mutation | 275 | 42 | Signature 4 | -0.76 | -1.53 | -0.05 | 1466.38 | 1.00 | 396 | 266 | 33 | 9 | TRUE | 1.36 |
| uterine cancer | RAS_12-61 | ARID1B | Any mutation | 44 | 17 | Signature 1A | 0.34 | -0.72 | 1.32 | 1502.32 | 1.00 | 164 | 39 | 12 | 5 | TRUE | 0.29 |
| uterine cancer | RAS_12-61 | ARID1B | Any mutation | 18 | 39 | Signature 6 | -0.09 | -1.05 | 0.92 | 1643.06 | 1.00 | 55 | 12 | 33 | 6 | TRUE | 0.06 |
| colorectal cancer | RAS_12-61 | ARID1B | Any mutation | 665 | 121 | Signature overall | -1.19 | -1.96 | -0.43 | 1420.47 | 1.00 | 800 | 641 | 97 | 24 | TRUE | 2.71 |
| non-small cell lung cancer | RAS_12-61 | ARID1B | Any mutation | 361 | 55 | Signature overall | -0.33 | -1.75 | 1.40 | 1317.13 | 1.00 | 626 | 347 | 41 | 14 | TRUE | 0.16 |
| uterine cancer | RAS_12-61 | ARID1B | Any mutation | 65 | 78 | Signature overall | 0.17 | -1.37 | 1.69 | 1250.96 | 1.00 | 245 | 52 | 65 | 13 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | MET | Any mutation | 86 | 23 | Signature 2 | -0.92 | -1.92 | -0.08 | 1520.32 | 1.00 | 220 | 84 | 21 | 2 | TRUE | 1.25 |
| non-small cell lung cancer | RAS_12-61 | MET | Any mutation | 56 | 11 | Signature 3 | -0.70 | -1.81 | 0.26 | 1559.43 | 1.00 | 179 | 54 | 9 | 2 | TRUE | 0.78 |
| non-small cell lung cancer | RAS_12-61 | MET | Any mutation | 275 | 34 | Signature 4 | -0.61 | -1.31 | 0.06 | 1412.37 | 1.00 | 407 | 265 | 24 | 10 | TRUE | 1.07 |
| non-small cell lung cancer | RAS_12-61 | MET | Any mutation | 417 | 68 | Signature overall | -0.75 | -1.69 | 0.09 | 1483.70 | 1.00 | 806 | 403 | 54 | 14 | TRUE | 1.01 |
| colorectal cancer | RAS_12-61 | BRAF | Any mutation | 173 | 48 | Signature 15 | -2.10 | -2.71 | -1.52 | 1547.74 | 1.00 | 172 | 167 | 42 | 6 | TRUE | 11.79 |
| colorectal cancer | RAS_12-61 | BRAF | Any mutation | 369 | 99 | Signature 1A | -2.11 | -2.66 | -1.61 | 1302.09 | 1.00 | 391 | 358 | 88 | 11 | TRUE | 14.54 |
| colorectal cancer | RAS_12-61 | BRAF | Any mutation | 125 | 60 | Signature 6 | -2.19 | -2.84 | -1.61 | 1180.92 | 1.00 | 136 | 121 | 56 | 4 | TRUE | 11.64 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 16 | 25 | Signature 11 | -1.86 | -3.18 | -0.78 | 1458.49 | 1.00 | 18 | 13 | 22 | 3 | TRUE | 2.69 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 12 | 11 | Signature 1A | -2.38 | -4.52 | -0.92 | 1488.02 | 1.00 | 40 | 12 | 11 | 0 | TRUE | 1.97 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 151 | 191 | Signature 7 | -1.99 | -2.54 | -1.51 | 1506.42 | 1.00 | 144 | 130 | 170 | 21 | TRUE | 14.35 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 68 | 11 | Signature 18 | -1.10 | -2.17 | -0.27 | 1710.94 | 1.00 | 72 | 67 | 10 | 1 | TRUE | 1.67 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 86 | 20 | Signature 2 | -0.90 | -1.74 | -0.16 | 1545.11 | 1.00 | 221 | 83 | 17 | 3 | TRUE | 1.54 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 56 | 20 | Signature 3 | -0.84 | -1.78 | -0.03 | 1601.35 | 1.00 | 170 | 53 | 17 | 3 | TRUE | 1.31 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 275 | 50 | Signature 4 | -0.77 | -1.33 | -0.20 | 1381.40 | 1.00 | 392 | 262 | 37 | 13 | TRUE | 2.09 |
| colorectal cancer | RAS_12-61 | BRAF | Any mutation | 667 | 207 | Signature overall | -2.13 | -2.69 | -1.61 | 1409.86 | 1.00 | 699 | 646 | 186 | 21 | TRUE | 13.17 |
| melanoma | RAS_12-61 | BRAF | Any mutation | 179 | 227 | Signature overall | -2.06 | -3.55 | -0.78 | 1610.25 | 1.00 | 202 | 155 | 203 | 24 | TRUE | 2.66 |
| non-small cell lung cancer | RAS_12-61 | BRAF | Any mutation | 485 | 101 | Signature overall | -0.90 | -1.64 | -0.23 | 1494.46 | 1.00 | 855 | 465 | 81 | 20 | TRUE | 1.99 |
| colorectal cancer | RAS_12-61 | B2M | Any mutation | 14 | 14 | Signature 10 | -0.94 | -2.25 | 0.14 | 1604.09 | 1.00 | 15 | 12 | 12 | 2 | FALSE | 0.93 |
| colorectal cancer | RAS_12-61 | B2M | Any mutation | 171 | 20 | Signature 15 | -0.93 | -1.79 | -0.10 | 1591.60 | 1.00 | 198 | 166 | 15 | 5 | FALSE | 1.48 |
| colorectal cancer | RAS_12-61 | B2M | Any mutation | 361 | 46 | Signature 1A | -0.59 | -1.20 | -0.03 | 1568.59 | 1.00 | 447 | 346 | 31 | 15 | FALSE | 1.32 |
| colorectal cancer | RAS_12-61 | B2M | Any mutation | 126 | 51 | Signature 6 | -0.38 | -0.95 | 0.22 | 1196.92 | 1.00 | 161 | 109 | 34 | 17 | FALSE | 0.68 |
| colorectal cancer | RAS_12-61 | B2M | Any mutation | 672 | 131 | Signature overall | -0.71 | -1.66 | 0.17 | 1585.75 | 1.00 | 821 | 633 | 92 | 39 | FALSE | 0.94 |
| colorectal cancer | RAS_12-61 | CARD11 | Any mutation | 173 | 14 | Signature 15 | -0.41 | -1.20 | 0.35 | 1385.04 | 1.00 | 203 | 168 | 9 | 5 | FALSE | 0.54 |
| colorectal cancer | RAS_12-61 | CARD11 | Any mutation | 371 | 58 | Signature 1A | -0.09 | -0.61 | 0.37 | 1457.09 | 1.00 | 447 | 345 | 32 | 26 | FALSE | 0.14 |
| colorectal cancer | RAS_12-61 | CARD11 | Any mutation | 125 | 38 | Signature 6 | -0.34 | -1.00 | 0.26 | 1336.06 | 1.00 | 167 | 114 | 27 | 11 | FALSE | 0.51 |
| melanoma | RAS_12-61 | CARD11 | Any mutation | 148 | 107 | Signature 7 | -0.74 | -1.26 | -0.23 | 1483.01 | 1.00 | 234 | 126 | 85 | 22 | FALSE | 2.46 |
| non-small cell lung cancer | RAS_12-61 | CARD11 | Any mutation | 88 | 16 | Signature 2 | 0.43 | -0.43 | 1.45 | 1308.95 | 1.00 | 229 | 81 | 9 | 7 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12-61 | CARD11 | Any mutation | 275 | 63 | Signature 4 | -0.03 | -0.55 | 0.49 | 1175.05 | 1.00 | 391 | 252 | 40 | 23 | FALSE | 0.04 |
| colorectal cancer | RAS_12-61 | CARD11 | Any mutation | 669 | 110 | Signature overall | -0.28 | -0.99 | 0.39 | 1464.85 | 1.00 | 817 | 627 | 68 | 42 | FALSE | 0.38 |
| melanoma | RAS_12-61 | CARD11 | Any mutation | 148 | 107 | Signature overall | -0.70 | -4.77 | 3.54 | 1592.24 | 1.00 | 234 | 126 | 85 | 22 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12-61 | CARD11 | Any mutation | 363 | 79 | Signature overall | 0.18 | -1.05 | 1.62 | 1460.16 | 1.00 | 620 | 333 | 49 | 30 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12-61 | INPP4B | Any mutation | 87 | 15 | Signature 2 | 0.84 | -0.14 | 1.92 | 1476.83 | 1.00 | 232 | 79 | 7 | 8 | FALSE | 0.97 |
| non-small cell lung cancer | RAS_12-61 | INPP4B | Any mutation | 277 | 60 | Signature 4 | 0.21 | -0.34 | 0.73 | 1291.84 | 1.00 | 398 | 252 | 35 | 25 | FALSE | 0.35 |
| non-small cell lung cancer | RAS_12-61 | INPP4B | Any mutation | 364 | 75 | Signature overall | 0.50 | -0.98 | 2.07 | 1538.26 | 1.00 | 630 | 331 | 42 | 33 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12-61 | NFE2L2 | Any mutation | 16 | 15 | Signature 13 | -0.03 | -1.32 | 1.13 | 1497.94 | 1.00 | 73 | 13 | 12 | 3 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12-61 | NFE2L2 | Any mutation | 86 | 32 | Signature 2 | -0.61 | -1.62 | 0.22 | 1584.59 | 1.00 | 218 | 81 | 27 | 5 | FALSE | 0.73 |
| non-small cell lung cancer | RAS_12-61 | NFE2L2 | Any mutation | 276 | 20 | Signature 4 | -0.33 | -1.26 | 0.46 | 1241.50 | 1.00 | 414 | 269 | 13 | 7 | FALSE | 0.34 |
| non-small cell lung cancer | RAS_12-61 | NFE2L2 | Any mutation | 378 | 67 | Signature overall | -0.31 | -1.48 | 0.84 | 1495.64 | 1.00 | 705 | 363 | 52 | 15 | FALSE | 0.22 |
| colorectal cancer | RAS_12-61 | SOX9 | Any mutation | 175 | 40 | Signature 15 | 0.37 | -0.07 | 0.88 | 1326.60 | 1.00 | 196 | 151 | 16 | 24 | FALSE | 0.87 |
| colorectal cancer | RAS_12-61 | SOX9 | Any mutation | 373 | 105 | Signature 1A | 0.30 | -0.07 | 0.67 | 1532.56 | 1.00 | 430 | 319 | 51 | 54 | FALSE | 1.02 |
| colorectal cancer | RAS_12-61 | SOX9 | Any mutation | 125 | 59 | Signature 6 | 0.16 | -0.36 | 0.60 | 1380.03 | 1.00 | 156 | 103 | 37 | 22 | FALSE | 0.31 |
| colorectal cancer | RAS_12-61 | SOX9 | Any mutation | 673 | 204 | Signature overall | 0.28 | -0.21 | 0.76 | 1434.59 | 1.00 | 782 | 573 | 104 | 100 | FALSE | 0.56 |
| colorectal cancer | RAS_12-61 | SMAD2 | Any mutation | 173 | 16 | Signature 15 | 0.44 | -0.14 | 1.00 | 1048.97 | 1.01 | 204 | 165 | 8 | 8 | TRUE | 0.93 |
| colorectal cancer | RAS_12-61 | SMAD2 | Any mutation | 371 | 33 | Signature 1A | 0.51 | 0.00 | 1.08 | 1086.25 | 1.00 | 468 | 349 | 11 | 22 | TRUE | 1.25 |
| colorectal cancer | RAS_12-61 | SMAD2 | Any mutation | 123 | 17 | Signature 6 | 0.43 | -0.21 | 1.00 | 839.42 | 1.01 | 179 | 117 | 11 | 6 | TRUE | 0.83 |
| colorectal cancer | RAS_12-61 | SMAD2 | Any mutation | 667 | 66 | Signature overall | 0.46 | -0.10 | 0.99 | 912.70 | 1.01 | 851 | 631 | 30 | 36 | TRUE | 1.06 |
| melanoma | RAS_12-61 | TP63 | Any mutation | 143 | 152 | Signature 7 | -0.59 | -1.04 | -0.13 | 1450.14 | 1.00 | 194 | 107 | 116 | 36 | FALSE | 1.94 |
| melanoma | RAS_12-61 | TP63 | Any mutation | 143 | 152 | Signature overall | -0.57 | -5.08 | 3.78 | 1418.15 | 1.00 | 194 | 107 | 116 | 36 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12-61 | GLI1 | Any mutation | 259 | 44 | Signature 4 | 0.10 | -0.52 | 0.71 | 1313.07 | 1.00 | 353 | 240 | 25 | 19 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12-61 | GLI1 | Any mutation | 259 | 44 | Signature overall | 0.05 | -4.10 | 4.12 | 1418.66 | 1.00 | 353 | 240 | 25 | 19 | FALSE | 0.01 |
| colorectal cancer | RAS_12-61 | ZFHX3 | Any mutation | 17 | 17 | Signature 10 | -0.48 | -1.42 | 0.42 | 1527.11 | 1.00 | 10 | 11 | 11 | 6 | FALSE | 0.52 |
| colorectal cancer | RAS_12-61 | ZFHX3 | Any mutation | 158 | 31 | Signature 15 | -0.91 | -1.65 | -0.24 | 1567.58 | 1.00 | 178 | 150 | 23 | 8 | FALSE | 1.97 |
| colorectal cancer | RAS_12-61 | ZFHX3 | Any mutation | 350 | 80 | Signature 1A | -0.70 | -1.18 | -0.23 | 1507.00 | 1.00 | 403 | 326 | 56 | 24 | FALSE | 2.44 |
| colorectal cancer | RAS_12-61 | ZFHX3 | Any mutation | 119 | 81 | Signature 6 | -0.78 | -1.31 | -0.26 | 1589.12 | 1.00 | 136 | 99 | 61 | 20 | FALSE | 2.33 |
| melanoma | RAS_12-61 | ZFHX3 | Any mutation | 143 | 90 | Signature 7 | -0.44 | -0.98 | 0.06 | 1446.53 | 1.00 | 238 | 120 | 67 | 23 | FALSE | 1.02 |
| non-small cell lung cancer | RAS_12-61 | ZFHX3 | Any mutation | 81 | 18 | Signature 2 | -0.56 | -1.61 | 0.41 | 1464.06 | 1.00 | 195 | 77 | 14 | 4 | FALSE | 0.55 |
| non-small cell lung cancer | RAS_12-61 | ZFHX3 | Any mutation | 259 | 61 | Signature 4 | -0.43 | -0.98 | 0.12 | 1491.64 | 1.00 | 338 | 239 | 41 | 20 | FALSE | 0.92 |
| non-small cell lung cancer | RAS_12-61 | ZFHX3 | Any mutation | 139 | 14 | Signature R2 | -1.41 | -2.61 | -0.36 | 1205.11 | 1.00 | 30 | 133 | 8 | 6 | FALSE | 1.93 |
| uterine cancer | RAS_12-61 | ZFHX3 | Any mutation | 6 | 21 | Signature 14 | 0.12 | -1.30 | 1.49 | 1489.53 | 1.00 | 6 | 2 | 17 | 4 | FALSE | 0.06 |
| uterine cancer | RAS_12-61 | ZFHX3 | Any mutation | 25 | 13 | Signature 15 | 0.66 | -0.40 | 1.75 | 1513.77 | 1.00 | 71 | 19 | 7 | 6 | FALSE | 0.68 |
| uterine cancer | RAS_12-61 | ZFHX3 | Any mutation | 46 | 56 | Signature 1A | 0.35 | -0.28 | 0.99 | 1595.75 | 1.00 | 127 | 31 | 41 | 15 | FALSE | 0.55 |
| uterine cancer | RAS_12-61 | ZFHX3 | Any mutation | 17 | 45 | Signature 6 | 0.14 | -0.84 | 1.04 | 1516.85 | 1.00 | 48 | 9 | 37 | 8 | FALSE | 0.11 |
| colorectal cancer | RAS_12-61 | ZFHX3 | Any mutation | 644 | 209 | Signature overall | -0.70 | -1.43 | 0.06 | 1630.10 | 1.00 | 727 | 586 | 151 | 58 | FALSE | 1.17 |
| melanoma | RAS_12-61 | ZFHX3 | Any mutation | 146 | 129 | Signature overall | -1.84 | -5.86 | 1.27 | 1294.48 | 1.00 | 252 | 123 | 106 | 23 | FALSE | 0.53 |
| non-small cell lung cancer | RAS_12-61 | ZFHX3 | Any mutation | 479 | 93 | Signature overall | -0.78 | -2.16 | 0.64 | 1530.11 | 1.00 | 563 | 449 | 63 | 30 | FALSE | 0.57 |
| uterine cancer | RAS_12-61 | ZFHX3 | Any mutation | 99 | 184 | Signature overall | 0.22 | -0.85 | 1.26 | 1412.98 | 1.00 | 270 | 63 | 148 | 36 | FALSE | 0.17 |
| colorectal cancer | RAS_12-61 | MGA | Any mutation | 17 | 15 | Signature 10 | -0.35 | -1.45 | 0.62 | 1548.31 | 1.00 | 11 | 12 | 10 | 5 | FALSE | 0.29 |
| colorectal cancer | RAS_12-61 | MGA | Any mutation | 156 | 16 | Signature 15 | -0.66 | -1.51 | 0.19 | 1489.00 | 1.00 | 181 | 151 | 11 | 5 | FALSE | 0.87 |
| colorectal cancer | RAS_12-61 | MGA | Any mutation | 348 | 42 | Signature 1A | -0.27 | -0.89 | 0.32 | 1348.24 | 1.00 | 420 | 331 | 25 | 17 | FALSE | 0.42 |
| colorectal cancer | RAS_12-61 | MGA | Any mutation | 116 | 36 | Signature 6 | -0.56 | -1.28 | 0.14 | 1253.77 | 1.00 | 151 | 106 | 26 | 10 | FALSE | 0.92 |
| non-small cell lung cancer | RAS_12-61 | MGA | Any mutation | 81 | 28 | Signature 2 | -0.76 | -1.80 | 0.17 | 1413.95 | 1.00 | 196 | 77 | 24 | 4 | FALSE | 0.88 |
| non-small cell lung cancer | RAS_12-61 | MGA | Any mutation | 261 | 79 | Signature 4 | -0.08 | -0.55 | 0.41 | 1542.46 | 1.00 | 332 | 230 | 48 | 31 | FALSE | 0.14 |
| non-small cell lung cancer | RAS_12-61 | MGA | Any mutation | 139 | 13 | Signature R2 | 0.07 | -0.94 | 1.29 | 1400.31 | 1.00 | 36 | 128 | 2 | 11 | FALSE | 0.05 |
| uterine cancer | RAS_12-61 | MGA | Any mutation | 7 | 49 | Signature 10 | 1.26 | -0.62 | 4.14 | 1381.67 | 1.00 | 20 | 0 | 42 | 7 | FALSE | 0.54 |
| uterine cancer | RAS_12-61 | MGA | Any mutation | 41 | 19 | Signature 1A | -0.41 | -1.83 | 0.70 | 1452.88 | 1.00 | 147 | 38 | 16 | 3 | FALSE | 0.28 |
| uterine cancer | RAS_12-61 | MGA | Any mutation | 16 | 14 | Signature 6 | -1.00 | -3.03 | 0.57 | 1639.44 | 1.00 | 63 | 15 | 13 | 1 | FALSE | 0.54 |
| colorectal cancer | RAS_12-61 | MGA | Any mutation | 637 | 109 | Signature overall | -0.47 | -1.37 | 0.40 | 1482.28 | 1.00 | 763 | 600 | 72 | 37 | FALSE | 0.52 |
| non-small cell lung cancer | RAS_12-61 | MGA | Any mutation | 481 | 120 | Signature overall | -0.25 | -1.51 | 1.14 | 1571.48 | 1.00 | 564 | 435 | 74 | 46 | FALSE | 0.16 |
| uterine cancer | RAS_12-61 | MGA | Any mutation | 64 | 82 | Signature overall | -0.04 | -2.05 | 2.05 | 1549.25 | 1.00 | 230 | 53 | 71 | 11 | FALSE | 0.01 |
| colorectal cancer | RAS_12-61 | KMT2B | Any mutation | 91 | 18 | Signature 15 | -0.91 | -1.83 | 0.02 | 1300.63 | 1.00 | 95 | 86 | 13 | 5 | FALSE | 1.29 |
| colorectal cancer | RAS_12-61 | KMT2B | Any mutation | 212 | 64 | Signature 1A | -0.51 | -1.04 | 0.00 | 1309.91 | 1.00 | 219 | 189 | 41 | 23 | FALSE | 1.27 |
| colorectal cancer | RAS_12-61 | KMT2B | Any mutation | 74 | 86 | Signature 6 | -0.82 | -1.44 | -0.28 | 1359.54 | 1.00 | 68 | 53 | 65 | 21 | FALSE | 2.30 |
| uterine cancer | RAS_12-61 | KMT2B | Any mutation | 20 | 15 | Signature 15 | 0.58 | -0.33 | 1.55 | 1521.48 | 1.00 | 42 | 13 | 8 | 7 | FALSE | 0.67 |
| uterine cancer | RAS_12-61 | KMT2B | Any mutation | 40 | 51 | Signature 1A | 0.52 | -0.13 | 1.15 | 1439.08 | 1.00 | 98 | 24 | 35 | 16 | FALSE | 0.95 |
| uterine cancer | RAS_12-61 | KMT2B | Any mutation | 8 | 13 | Signature 20 | 0.17 | -0.98 | 1.22 | 1472.76 | 1.00 | 14 | 5 | 10 | 3 | FALSE | 0.11 |
| uterine cancer | RAS_12-61 | KMT2B | Any mutation | 13 | 39 | Signature 6 | 0.63 | -0.24 | 1.61 | 1433.43 | 1.00 | 40 | 4 | 30 | 9 | FALSE | 0.78 |
| colorectal cancer | RAS_12-61 | KMT2B | Any mutation | 377 | 168 | Signature overall | -0.76 | -1.82 | 0.27 | 1417.68 | 1.00 | 382 | 328 | 119 | 49 | FALSE | 0.80 |
| uterine cancer | RAS_12-61 | KMT2B | Any mutation | 87 | 152 | Signature overall | 0.28 | -0.56 | 1.09 | 1450.59 | 1.00 | 212 | 50 | 115 | 37 | FALSE | 0.31 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 159 | 48 | Signature 15 | 0.10 | -0.37 | 0.61 | 1556.07 | 1.00 | 169 | 135 | 24 | 24 | FALSE | 0.17 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 354 | 115 | Signature 1A | 0.03 | -0.32 | 0.39 | 1471.19 | 1.00 | 385 | 302 | 63 | 52 | FALSE | 0.06 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 43 | 12 | Signature 2 | 0.45 | -0.23 | 1.47 | 1619.12 | 1.00 | 28 | 32 | 1 | 11 | FALSE | 0.54 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 117 | 69 | Signature 6 | -0.27 | -0.84 | 0.25 | 1307.30 | 1.00 | 131 | 97 | 49 | 20 | FALSE | 0.50 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Any mutation | 673 | 244 | Signature overall | 0.08 | -0.40 | 0.66 | 1489.91 | 1.00 | 713 | 566 | 137 | 107 | FALSE | 0.12 |
| colorectal cancer | RAS_12-61 | ANKRD11 | Any mutation | 15 | 12 | Signature 10 | -0.59 | -1.71 | 0.48 | 1436.61 | 1.00 | 12 | 11 | 8 | 4 | FALSE | 0.55 |
| colorectal cancer | RAS_12-61 | ANKRD11 | Any mutation | 152 | 17 | Signature 15 | -1.06 | -2.04 | -0.20 | 1286.48 | 1.00 | 178 | 148 | 13 | 4 | FALSE | 1.68 |
| colorectal cancer | RAS_12-61 | ANKRD11 | Any mutation | 337 | 47 | Signature 1A | -0.92 | -1.52 | -0.35 | 1337.50 | 1.00 | 402 | 325 | 35 | 12 | FALSE | 2.61 |
| colorectal cancer | RAS_12-61 | ANKRD11 | Any mutation | 113 | 57 | Signature 6 | -0.96 | -1.54 | -0.37 | 1402.14 | 1.00 | 139 | 101 | 45 | 12 | FALSE | 2.58 |
| colorectal cancer | RAS_12-61 | ANKRD11 | Any mutation | 617 | 133 | Signature overall | -0.88 | -1.72 | -0.07 | 1449.59 | 1.00 | 731 | 585 | 101 | 32 | FALSE | 1.38 |
| colorectal cancer | RAS_12-61 | POLD1 | Any mutation | 156 | 15 | Signature 15 | -1.34 | -2.48 | -0.37 | 1615.92 | 1.00 | 184 | 154 | 13 | 2 | TRUE | 1.91 |
| colorectal cancer | RAS_12-61 | POLD1 | Any mutation | 350 | 43 | Signature 1A | -0.53 | -1.16 | 0.07 | 1644.27 | 1.00 | 420 | 334 | 27 | 16 | TRUE | 1.05 |
| colorectal cancer | RAS_12-61 | POLD1 | Any mutation | 116 | 44 | Signature 6 | -1.08 | -1.85 | -0.40 | 1496.35 | 1.00 | 148 | 108 | 36 | 8 | TRUE | 2.57 |
| colorectal cancer | RAS_12-61 | POLD1 | Any mutation | 622 | 102 | Signature overall | -0.98 | -1.94 | -0.04 | 1485.07 | 1.00 | 752 | 596 | 76 | 26 | TRUE | 1.35 |
| melanoma | RAS_12-61 | PREX2 | Any mutation | 102 | 158 | Signature 7 | -0.31 | -0.77 | 0.17 | 1322.27 | 1.00 | 109 | 58 | 114 | 44 | FALSE | 0.72 |
| non-small cell lung cancer | RAS_12-61 | PREX2 | Any mutation | 154 | 52 | Signature 4 | -0.37 | -1.02 | 0.26 | 680.97 | 1.00 | 182 | 136 | 34 | 18 | FALSE | 0.60 |
| melanoma | RAS_12-61 | PREX2 | Any mutation | 102 | 158 | Signature overall | -0.27 | -4.52 | 3.62 | 1388.25 | 1.00 | 109 | 58 | 114 | 44 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | PREX2 | Any mutation | 154 | 52 | Signature overall | -0.31 | -4.30 | 3.68 | 1636.82 | 1.00 | 182 | 136 | 34 | 18 | FALSE | 0.06 |
| colorectal cancer | RAS_12-61 | AMER1 | Any mutation | 173 | 34 | Signature 15 | 0.72 | 0.29 | 1.18 | 1102.98 | 1.00 | 199 | 153 | 14 | 20 | FALSE | 2.70 |
| colorectal cancer | RAS_12-61 | AMER1 | Any mutation | 372 | 61 | Signature 1A | 0.74 | 0.34 | 1.17 | 1004.23 | 1.00 | 458 | 332 | 21 | 40 | FALSE | 3.24 |
| colorectal cancer | RAS_12-61 | AMER1 | Any mutation | 125 | 36 | Signature 6 | 0.73 | 0.26 | 1.17 | 1062.38 | 1.00 | 173 | 107 | 18 | 18 | FALSE | 2.67 |
| non-small cell lung cancer | RAS_12-61 | AMER1 | Any mutation | 86 | 11 | Signature 2 | 1.24 | 0.11 | 2.45 | 1351.40 | 1.00 | 234 | 79 | 4 | 7 | FALSE | 1.40 |
| non-small cell lung cancer | RAS_12-61 | AMER1 | Any mutation | 278 | 83 | Signature 4 | -0.02 | -0.51 | 0.43 | 1409.21 | 1.00 | 389 | 247 | 52 | 31 | FALSE | 0.03 |
| colorectal cancer | RAS_12-61 | AMER1 | Any mutation | 670 | 131 | Signature overall | 0.72 | 0.28 | 1.15 | 1093.34 | 1.00 | 830 | 592 | 53 | 78 | FALSE | 2.81 |
| non-small cell lung cancer | RAS_12-61 | AMER1 | Any mutation | 364 | 94 | Signature overall | 0.61 | -1.35 | 2.84 | 1568.55 | 1.00 | 623 | 326 | 56 | 38 | FALSE | 0.25 |
| melanoma | RAS_12-61 | EPHA7 | Any mutation | 146 | 141 | Signature 7 | -0.36 | -0.78 | 0.07 | 454.34 | 1.00 | 216 | 109 | 104 | 37 | FALSE | 0.95 |
| non-small cell lung cancer | RAS_12-61 | EPHA7 | Any mutation | 50 | 13 | Signature 3 | -0.46 | -1.70 | 0.77 | 1487.57 | 1.00 | 157 | 47 | 10 | 3 | FALSE | 0.33 |
| non-small cell lung cancer | RAS_12-61 | EPHA7 | Any mutation | 257 | 51 | Signature 4 | -0.91 | -1.58 | -0.28 | 1250.35 | 1.00 | 339 | 246 | 40 | 11 | FALSE | 2.16 |
| melanoma | RAS_12-61 | EPHA7 | Any mutation | 146 | 141 | Signature overall | -0.28 | -4.47 | 3.84 | 1371.22 | 1.00 | 216 | 109 | 104 | 37 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12-61 | EPHA7 | Any mutation | 307 | 64 | Signature overall | -0.67 | -2.11 | 0.98 | 1566.74 | 1.00 | 496 | 293 | 50 | 14 | FALSE | 0.40 |
| uterine cancer | RAS_12-61 | INPPL1 | Any mutation | 38 | 38 | Signature 1A | 0.82 | 0.14 | 1.52 | 1434.03 | 1.00 | 96 | 23 | 23 | 15 | FALSE | 1.62 |
| uterine cancer | RAS_12-61 | INPPL1 | Any mutation | 8 | 13 | Signature 20 | 0.64 | -0.40 | 1.69 | 1234.38 | 1.00 | 12 | 4 | 9 | 4 | FALSE | 0.63 |
| uterine cancer | RAS_12-61 | INPPL1 | Any mutation | 14 | 40 | Signature 6 | 0.56 | -0.29 | 1.42 | 1336.24 | 1.00 | 40 | 6 | 32 | 8 | FALSE | 0.71 |
| uterine cancer | RAS_12-61 | INPPL1 | Any mutation | 60 | 91 | Signature overall | 0.68 | -0.31 | 1.64 | 1325.75 | 1.00 | 148 | 33 | 64 | 27 | FALSE | 0.80 |
| colorectal cancer | KRAS_12-61 | SPEN | Any mutation | 13 | 21 | Signature 10 | -1.13 | -2.42 | 0.02 | 1547.21 | 1.00 | 15 | 10 | 18 | 3 | FALSE | 1.15 |
| colorectal cancer | KRAS_12-61 | SPEN | Any mutation | 164 | 18 | Signature 15 | -1.29 | -2.40 | -0.30 | 1476.66 | 1.00 | 211 | 161 | 15 | 3 | FALSE | 1.81 |
| colorectal cancer | KRAS_12-61 | SPEN | Any mutation | 332 | 38 | Signature 1A | -0.27 | -0.94 | 0.39 | 1185.39 | 1.00 | 495 | 318 | 24 | 14 | FALSE | 0.36 |
| colorectal cancer | KRAS_12-61 | SPEN | Any mutation | 113 | 61 | Signature 6 | -0.92 | -1.60 | -0.28 | 1410.82 | 1.00 | 165 | 101 | 49 | 12 | FALSE | 2.27 |
| non-small cell lung cancer | KRAS_12-61 | SPEN | Any mutation | 84 | 39 | Signature 2 | -4.04 | -9.81 | -1.43 | 1274.92 | 1.00 | 228 | 84 | 39 | 0 | FALSE | 1.14 |
| non-small cell lung cancer | KRAS_12-61 | SPEN | Any mutation | 267 | 24 | Signature 4 | -0.20 | -1.14 | 0.70 | 1440.18 | 1.00 | 423 | 258 | 15 | 9 | FALSE | 0.18 |
| uterine cancer | KRAS_12-61 | SPEN | Any mutation | 27 | 13 | Signature 15 | 0.57 | -0.53 | 1.71 | 1406.28 | 1.00 | 76 | 22 | 8 | 5 | FALSE | 0.51 |
| uterine cancer | KRAS_12-61 | SPEN | Any mutation | 39 | 21 | Signature 1A | -0.18 | -1.40 | 0.90 | 1591.67 | 1.00 | 165 | 36 | 18 | 3 | FALSE | 0.13 |
| uterine cancer | KRAS_12-61 | SPEN | Any mutation | 18 | 21 | Signature 6 | 0.68 | -0.35 | 1.71 | 1260.71 | 1.00 | 70 | 12 | 15 | 6 | FALSE | 0.68 |
| colorectal cancer | KRAS_12-61 | SPEN | Any mutation | 622 | 138 | Signature overall | -0.91 | -2.11 | 0.25 | 1667.16 | 1.00 | 886 | 590 | 106 | 32 | FALSE | 0.93 |
| non-small cell lung cancer | KRAS_12-61 | SPEN | Any mutation | 351 | 63 | Signature overall | -1.86 | -5.74 | 1.43 | 1518.15 | 1.00 | 651 | 342 | 54 | 9 | FALSE | 0.51 |
| uterine cancer | KRAS_12-61 | SPEN | Any mutation | 88 | 93 | Signature overall | 0.32 | -0.92 | 1.64 | 1451.54 | 1.00 | 333 | 71 | 76 | 17 | FALSE | 0.21 |
| colorectal cancer | KRAS_12-61 | KMT2C | Any mutation | 16 | 32 | Signature 10 | -0.96 | -2.05 | 0.11 | 1370.17 | 1.01 | 12 | 10 | 26 | 6 | FALSE | 1.14 |
| colorectal cancer | KRAS_12-61 | KMT2C | Any mutation | 160 | 22 | Signature 15 | -0.39 | -1.24 | 0.43 | 1568.40 | 1.00 | 210 | 152 | 14 | 8 | FALSE | 0.45 |
| colorectal cancer | KRAS_12-61 | KMT2C | Any mutation | 325 | 60 | Signature 1A | -0.11 | -0.65 | 0.43 | 1508.26 | 1.00 | 474 | 302 | 37 | 23 | FALSE | 0.16 |
| colorectal cancer | KRAS_12-61 | KMT2C | Any mutation | 107 | 65 | Signature 6 | -0.87 | -1.52 | -0.22 | 1402.53 | 1.00 | 156 | 94 | 52 | 13 | FALSE | 2.05 |
| non-small cell lung cancer | KRAS_12-61 | KMT2C | Any mutation | 14 | 22 | Signature 13 | 0.02 | -0.99 | 1.04 | 1570.44 | 1.00 | 68 | 10 | 18 | 4 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12-61 | KMT2C | Any mutation | 85 | 40 | Signature 2 | 0.16 | -0.52 | 0.81 | 1508.39 | 1.00 | 214 | 72 | 27 | 13 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | KMT2C | Any mutation | 53 | 13 | Signature 3 | -0.65 | -1.83 | 0.34 | 1358.38 | 1.00 | 178 | 52 | 12 | 1 | FALSE | 0.60 |
| non-small cell lung cancer | KRAS_12-61 | KMT2C | Any mutation | 266 | 76 | Signature 4 | -0.45 | -0.98 | 0.06 | 1662.79 | 1.00 | 387 | 245 | 55 | 21 | FALSE | 1.06 |
| uterine cancer | KRAS_12-61 | KMT2C | Any mutation | 24 | 17 | Signature 15 | -0.53 | -1.87 | 0.70 | 1657.08 | 1.00 | 72 | 21 | 14 | 3 | FALSE | 0.39 |
| uterine cancer | KRAS_12-61 | KMT2C | Any mutation | 37 | 20 | Signature 1A | -0.86 | -2.32 | 0.32 | 1254.96 | 1.00 | 151 | 35 | 18 | 2 | FALSE | 0.70 |
| uterine cancer | KRAS_12-61 | KMT2C | Any mutation | 18 | 23 | Signature 6 | -0.60 | -1.92 | 0.55 | 1456.92 | 1.00 | 61 | 15 | 20 | 3 | FALSE | 0.47 |
| colorectal cancer | KRAS_12-61 | KMT2C | Any mutation | 608 | 179 | Signature overall | -0.58 | -1.71 | 0.51 | 1328.21 | 1.00 | 852 | 558 | 129 | 50 | FALSE | 0.53 |
| non-small cell lung cancer | KRAS_12-61 | KMT2C | Any mutation | 418 | 151 | Signature overall | -0.22 | -1.03 | 0.55 | 1255.81 | 1.00 | 847 | 379 | 112 | 39 | FALSE | 0.23 |
| uterine cancer | KRAS_12-61 | KMT2C | Any mutation | 82 | 118 | Signature overall | -0.69 | -2.09 | 0.61 | 1547.10 | 1.00 | 303 | 72 | 108 | 10 | FALSE | 0.50 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 13 | 11 | Signature 11 | -0.03 | -1.05 | 1.11 | 1406.66 | 1.00 | 7 | 6 | 4 | 7 | TRUE | 0.02 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 14 | 28 | Signature 15 | 0.07 | -0.84 | 1.04 | 1561.60 | 1.00 | 18 | 4 | 18 | 10 | TRUE | 0.06 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 37 | 66 | Signature 1A | -0.50 | -1.18 | 0.20 | 1645.61 | 1.00 | 35 | 20 | 49 | 17 | TRUE | 0.80 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 7 | 31 | Signature 2 | -0.93 | -2.02 | 0.09 | 1507.15 | 1.00 | 21 | 5 | 29 | 2 | TRUE | 1.06 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 7 | 18 | Signature 3 | -0.71 | -1.73 | 0.28 | 1396.99 | 1.00 | 5 | 4 | 15 | 3 | TRUE | 0.77 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 23 | 70 | Signature 4 | -0.85 | -1.71 | -0.09 | 1405.68 | 1.00 | 9 | 10 | 57 | 13 | TRUE | 1.45 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 6 | 22 | Signature 6 | -0.27 | -1.24 | 0.81 | 1482.87 | 1.00 | 7 | 1 | 17 | 5 | TRUE | 0.22 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 14 | 32 | Signature 10 | -0.94 | -1.41 | -0.49 | 1442.63 | 1.00 | 5 | 4 | 22 | 10 | TRUE | 4.33 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 25 | 28 | Signature 11 | -0.75 | -1.18 | -0.27 | 1209.69 | 1.00 | 1 | 8 | 11 | 17 | TRUE | 3.02 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 170 | 311 | Signature 15 | -0.97 | -1.31 | -0.64 | 1490.63 | 1.00 | 36 | 61 | 202 | 109 | TRUE | 8.11 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 14 | 36 | Signature 17 | -1.00 | -1.49 | -0.56 | 1454.46 | 1.00 | 5 | 5 | 27 | 9 | TRUE | 4.80 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 18 | 36 | Signature 18 | -1.01 | -1.50 | -0.57 | 1254.87 | 1.00 | 4 | 8 | 26 | 10 | TRUE | 4.86 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 21 | 31 | Signature 19 | -1.05 | -1.59 | -0.60 | 1380.81 | 1.00 | 5 | 12 | 22 | 9 | TRUE | 4.71 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 347 | 655 | Signature 1A | -0.96 | -1.21 | -0.70 | 1219.83 | 1.00 | 102 | 131 | 439 | 216 | TRUE | 13.00 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 8 | 15 | Signature 1B | -0.96 | -1.49 | -0.49 | 1223.07 | 1.00 | 4 | 3 | 10 | 5 | TRUE | 4.13 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 46 | 56 | Signature 2 | -0.98 | -1.44 | -0.57 | 1375.82 | 1.00 | 6 | 23 | 33 | 23 | TRUE | 4.96 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 13 | 23 | Signature 20 | -0.95 | -1.45 | -0.47 | 1391.40 | 1.00 | 6 | 5 | 15 | 8 | TRUE | 4.23 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 9 | 20 | Signature 21 | -1.01 | -1.50 | -0.54 | 1326.76 | 1.00 | 4 | 4 | 15 | 5 | TRUE | 4.50 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 15 | 35 | Signature 3 | -1.00 | -1.48 | -0.55 | 1103.47 | 1.00 | 1 | 6 | 26 | 9 | TRUE | 4.79 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 20 | 36 | Signature 4 | -0.92 | -1.39 | -0.48 | 1357.57 | 1.00 | 3 | 7 | 23 | 13 | TRUE | 4.28 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 125 | 236 | Signature 6 | -0.74 | -1.08 | -0.31 | 807.29 | 1.00 | 69 | 43 | 154 | 82 | TRUE | 3.71 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 15 | 28 | Signature 7 | -1.00 | -1.50 | -0.55 | 1280.95 | 1.00 | 5 | 7 | 20 | 8 | TRUE | 4.67 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 14 | 13 | Signature 8 | -0.86 | -1.36 | -0.38 | 1543.06 | 1.00 | 4 | 6 | 5 | 8 | TRUE | 3.29 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 17 | 16 | Signature R2 | -0.82 | -1.29 | -0.32 | 1286.09 | 1.00 | 0 | 7 | 6 | 10 | TRUE | 3.22 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 22 | 12 | Signature 11 | -1.48 | -2.32 | -0.66 | 1369.87 | 1.00 | 13 | 19 | 9 | 3 | TRUE | 3.28 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 16 | 79 | Signature 13 | -0.94 | -1.67 | -0.21 | 1552.08 | 1.00 | 26 | 5 | 68 | 11 | TRUE | 1.97 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 21 | 36 | Signature 14 | -1.12 | -1.88 | -0.39 | 1514.15 | 1.00 | 12 | 12 | 27 | 9 | TRUE | 2.49 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 31 | 87 | Signature 15 | -1.21 | -1.85 | -0.57 | 1501.65 | 1.00 | 35 | 18 | 74 | 13 | TRUE | 3.66 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 11 | 39 | Signature 16 | -0.91 | -1.72 | -0.07 | 1472.19 | 1.00 | 20 | 4 | 32 | 7 | TRUE | 1.61 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 19 | 29 | Signature 17 | -1.59 | -2.37 | -0.80 | 1264.86 | 1.00 | 5 | 14 | 24 | 5 | TRUE | 4.10 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 68 | 92 | Signature 18 | -1.06 | -1.61 | -0.54 | 1477.68 | 1.00 | 26 | 38 | 62 | 30 | TRUE | 4.09 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 16 | 31 | Signature 19 | -1.21 | -2.00 | -0.46 | 1419.19 | 1.00 | 24 | 11 | 26 | 5 | TRUE | 2.65 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 49 | 149 | Signature 1A | -1.01 | -1.58 | -0.46 | 1304.59 | 1.00 | 94 | 30 | 130 | 19 | TRUE | 3.50 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 86 | 223 | Signature 2 | -0.82 | -1.28 | -0.36 | 1391.65 | 1.00 | 83 | 41 | 178 | 45 | TRUE | 3.28 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 15 | 46 | Signature 20 | -1.42 | -2.23 | -0.64 | 1463.89 | 1.00 | 21 | 10 | 41 | 5 | TRUE | 3.41 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 11 | 37 | Signature 21 | -1.84 | -2.74 | -0.98 | 1492.48 | 1.00 | 19 | 10 | 36 | 1 | TRUE | 4.28 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 56 | 161 | Signature 3 | -1.15 | -1.63 | -0.61 | 1620.70 | 1.00 | 63 | 32 | 137 | 24 | TRUE | 5.08 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 270 | 522 | Signature 4 | -1.74 | -2.08 | -1.42 | 1073.10 | 1.00 | 76 | 150 | 402 | 120 | TRUE | 25.20 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 13 | 36 | Signature 6 | -1.26 | -2.05 | -0.52 | 1485.73 | 1.00 | 10 | 7 | 30 | 6 | TRUE | 2.88 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 26 | 71 | Signature 7 | -1.02 | -1.66 | -0.40 | 1524.47 | 1.00 | 28 | 13 | 58 | 13 | TRUE | 2.77 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 29 | 35 | Signature 8 | -1.04 | -1.74 | -0.38 | 1390.77 | 1.00 | 11 | 17 | 23 | 12 | TRUE | 2.51 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 155 | 85 | Signature R2 | -1.47 | -2.00 | -0.98 | 1498.35 | 1.00 | 12 | 109 | 39 | 46 | TRUE | 7.49 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 7 | 15 | Signature R3 | -1.58 | -2.53 | -0.69 | 1432.92 | 1.00 | 11 | 6 | 14 | 1 | TRUE | 3.12 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 21 | 57 | Signature U1 | -1.49 | -2.25 | -0.75 | 1349.54 | 1.00 | 40 | 16 | 52 | 5 | TRUE | 3.95 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 12 | 32 | Signature U2 | -1.50 | -2.34 | -0.70 | 1541.50 | 1.00 | 7 | 8 | 28 | 4 | TRUE | 3.63 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 116 | 94 | Signature 11 | 2.46 | 1.91 | 2.98 | 1047.16 | 1.00 | 5 | 26 | 4 | 90 | TRUE | 30.91 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 113 | 98 | Signature 15 | 2.31 | 1.74 | 2.82 | 1244.04 | 1.00 | 10 | 25 | 10 | 88 | TRUE | 30.91 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 24 | 19 | Signature 16 | 2.42 | 1.79 | 3.04 | 1056.61 | 1.00 | 7 | 5 | 0 | 19 | TRUE | 14.02 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 52 | 41 | Signature 17 | 2.54 | 1.96 | 3.20 | 1228.20 | 1.00 | 3 | 11 | 0 | 41 | TRUE | 15.35 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 15 | 14 | Signature 18 | 2.31 | 1.72 | 2.93 | 1215.11 | 1.00 | 6 | 3 | 2 | 12 | TRUE | 13.01 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 15 | 16 | Signature 19 | 2.31 | 1.69 | 2.90 | 1328.17 | 1.00 | 8 | 2 | 3 | 13 | TRUE | 12.89 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 218 | 172 | Signature 1A | 2.28 | 1.76 | 2.76 | 1063.43 | 1.00 | 24 | 57 | 11 | 161 | TRUE | 30.91 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 16 | 12 | Signature 1B | 2.31 | 1.67 | 2.91 | 1464.03 | 1.00 | 4 | 5 | 1 | 11 | TRUE | 12.65 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 33 | 29 | Signature 2 | 2.40 | 1.86 | 3.06 | 1114.39 | 1.00 | 11 | 6 | 2 | 27 | TRUE | 14.75 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 25 | 21 | Signature 21 | 2.41 | 1.77 | 3.01 | 1190.39 | 1.00 | 6 | 5 | 1 | 20 | TRUE | 14.10 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 80 | 66 | Signature 3 | 2.39 | 1.84 | 2.96 | 909.93 | 1.00 | 14 | 18 | 4 | 62 | TRUE | 30.91 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 64 | 58 | Signature 4 | 2.61 | 2.04 | 3.25 | 1246.48 | 1.00 | 7 | 8 | 2 | 56 | TRUE | 30.91 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 61 | 53 | Signature 6 | 2.43 | 1.88 | 3.01 | 1336.78 | 1.00 | 9 | 12 | 4 | 49 | TRUE | 30.91 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 26 | 25 | Signature 7 | 2.51 | 1.92 | 3.24 | 1050.21 | 1.00 | 8 | 2 | 1 | 24 | TRUE | 13.56 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 49 | 37 | Signature 8 | 2.49 | 1.94 | 3.09 | 1126.76 | 1.00 | 3 | 12 | 0 | 37 | TRUE | 30.91 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 23 | 19 | Signature R3 | 2.47 | 1.85 | 3.13 | 1092.48 | 1.00 | 1 | 5 | 1 | 18 | TRUE | 13.32 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 12 | 11 | Signature U1 | 2.36 | 1.74 | 3.04 | 1134.88 | 1.00 | 10 | 1 | 0 | 11 | TRUE | 12.82 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 26 | 53 | Signature 15 | -1.68 | -2.53 | -0.91 | 1390.06 | 1.00 | 34 | 21 | 48 | 5 | TRUE | 4.19 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 40 | 113 | Signature 1A | -1.26 | -1.91 | -0.60 | 1555.87 | 1.00 | 89 | 28 | 101 | 12 | TRUE | 3.74 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 6 | 19 | Signature 2 | -1.92 | -3.17 | -0.94 | 1513.96 | 1.00 | 23 | 6 | 19 | 0 | TRUE | 3.02 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 9 | 19 | Signature 20 | -1.41 | -2.40 | -0.36 | 1463.16 | 1.00 | 19 | 6 | 16 | 3 | TRUE | 2.27 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 10 | 30 | Signature 3 | -1.59 | -2.62 | -0.69 | 1676.65 | 1.00 | 10 | 7 | 27 | 3 | TRUE | 3.02 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 17 | 45 | Signature 6 | -1.94 | -3.04 | -1.05 | 1385.48 | 1.00 | 46 | 16 | 44 | 1 | TRUE | 3.91 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Any mutation | 110 | 287 | Signature overall | -0.53 | -1.18 | 0.18 | 1533.18 | 1.00 | 122 | 52 | 229 | 58 | TRUE | 0.92 |
| colorectal cancer | KRAS_12-61 | TP53 | Any mutation | 891 | 1607 | Signature overall | -0.94 | -1.21 | -0.68 | 1204.82 | 1.00 | 260 | 340 | 1056 | 551 | TRUE | 12.01 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Any mutation | 964 | 1927 | Signature overall | -1.31 | -1.62 | -0.99 | 1431.53 | 1.00 | 654 | 576 | 1539 | 388 | TRUE | 15.64 |
| pancreatic cancer | KRAS_12-61 | TP53 | Any mutation | 942 | 785 | Signature overall | 2.41 | 2.02 | 2.82 | 860.75 | 1.00 | 136 | 203 | 46 | 739 | TRUE | 30.91 |
| uterine cancer | KRAS_12-61 | TP53 | Any mutation | 112 | 356 | Signature overall | -1.72 | -2.46 | -1.07 | 1507.88 | 1.00 | 270 | 88 | 332 | 24 | TRUE | 5.89 |
| colorectal cancer | KRAS_12-61 | ATRX | Any mutation | 14 | 19 | Signature 10 | -1.03 | -2.42 | 0.14 | 1380.88 | 1.00 | 15 | 11 | 16 | 3 | TRUE | 0.97 |
| colorectal cancer | KRAS_12-61 | ATRX | Any mutation | 334 | 46 | Signature 1A | -0.32 | -0.94 | 0.27 | 1375.37 | 1.00 | 487 | 318 | 30 | 16 | TRUE | 0.51 |
| colorectal cancer | KRAS_12-61 | ATRX | Any mutation | 111 | 29 | Signature 6 | -0.84 | -1.81 | 0.04 | 1401.64 | 1.00 | 180 | 105 | 23 | 6 | TRUE | 1.15 |
| non-small cell lung cancer | KRAS_12-61 | ATRX | Any mutation | 67 | 12 | Signature 18 | 0.06 | -0.68 | 0.84 | 1417.16 | 1.00 | 78 | 61 | 6 | 6 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | ATRX | Any mutation | 84 | 28 | Signature 2 | 0.04 | -0.61 | 0.68 | 1366.68 | 1.00 | 223 | 76 | 20 | 8 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12-61 | ATRX | Any mutation | 270 | 88 | Signature 4 | -0.01 | -0.44 | 0.41 | 1647.39 | 1.00 | 392 | 238 | 56 | 32 | TRUE | 0.02 |
| uterine cancer | KRAS_12-61 | ATRX | Any mutation | 6 | 11 | Signature 14 | -0.64 | -2.55 | 1.12 | 1456.53 | 1.00 | 10 | 4 | 9 | 2 | TRUE | 0.31 |
| uterine cancer | KRAS_12-61 | ATRX | Any mutation | 39 | 12 | Signature 1A | -0.48 | -2.17 | 0.98 | 1487.06 | 1.00 | 170 | 37 | 10 | 2 | TRUE | 0.26 |
| uterine cancer | KRAS_12-61 | ATRX | Any mutation | 17 | 13 | Signature 6 | -2.38 | -5.86 | -0.11 | 1317.34 | 1.00 | 71 | 17 | 13 | 0 | TRUE | 0.93 |
| colorectal cancer | KRAS_12-61 | ATRX | Any mutation | 459 | 94 | Signature overall | -0.72 | -2.17 | 0.75 | 1280.19 | 1.00 | 682 | 434 | 69 | 25 | TRUE | 0.51 |
| non-small cell lung cancer | KRAS_12-61 | ATRX | Any mutation | 421 | 128 | Signature overall | 0.03 | -0.66 | 0.67 | 1695.58 | 1.00 | 693 | 375 | 82 | 46 | TRUE | 0.03 |
| uterine cancer | KRAS_12-61 | ATRX | Any mutation | 65 | 123 | Signature overall | -0.88 | -3.03 | 1.20 | 1533.22 | 1.00 | 266 | 58 | 116 | 7 | TRUE | 0.38 |
| colorectal cancer | KRAS_12-61 | ATR | Any mutation | 14 | 28 | Signature 10 | -1.14 | -2.32 | -0.03 | 1462.29 | 1.00 | 14 | 10 | 24 | 4 | FALSE | 1.25 |
| colorectal cancer | KRAS_12-61 | ATR | Any mutation | 165 | 12 | Signature 15 | -0.04 | -1.09 | 1.06 | 1400.82 | 1.00 | 217 | 159 | 6 | 6 | FALSE | 0.02 |
| colorectal cancer | KRAS_12-61 | ATR | Any mutation | 331 | 32 | Signature 1A | -0.74 | -1.55 | -0.02 | 1415.44 | 1.00 | 491 | 323 | 24 | 8 | FALSE | 1.23 |
| colorectal cancer | KRAS_12-61 | ATR | Any mutation | 113 | 28 | Signature 6 | -0.78 | -1.75 | 0.08 | 1598.13 | 1.00 | 185 | 107 | 22 | 6 | FALSE | 1.04 |
| non-small cell lung cancer | KRAS_12-61 | ATR | Any mutation | 14 | 11 | Signature 13 | -0.12 | -1.38 | 1.07 | 1553.09 | 1.00 | 75 | 12 | 9 | 2 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12-61 | ATR | Any mutation | 84 | 16 | Signature 2 | -0.23 | -1.16 | 0.73 | 1414.05 | 1.00 | 228 | 80 | 12 | 4 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | ATR | Any mutation | 267 | 60 | Signature 4 | -0.41 | -0.98 | 0.14 | 1315.76 | 1.00 | 394 | 250 | 43 | 17 | FALSE | 0.78 |
| colorectal cancer | KRAS_12-61 | ATR | Any mutation | 623 | 100 | Signature overall | -0.68 | -2.00 | 0.62 | 1379.38 | 1.00 | 907 | 599 | 76 | 24 | FALSE | 0.51 |
| non-small cell lung cancer | KRAS_12-61 | ATR | Any mutation | 365 | 87 | Signature overall | -0.25 | -1.21 | 0.85 | 1484.74 | 1.00 | 697 | 342 | 64 | 23 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | PDGFRA | Any mutation | 84 | 20 | Signature 2 | -0.18 | -1.04 | 0.66 | 1371.00 | 1.00 | 225 | 79 | 15 | 5 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12-61 | PDGFRA | Any mutation | 268 | 70 | Signature 4 | -0.21 | -0.69 | 0.26 | 1515.38 | 1.00 | 393 | 245 | 47 | 23 | TRUE | 0.40 |
| non-small cell lung cancer | KRAS_12-61 | PDGFRA | Any mutation | 352 | 90 | Signature overall | -0.19 | -1.29 | 0.93 | 1361.38 | 1.00 | 618 | 324 | 62 | 28 | TRUE | 0.13 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 12 | 17 | Signature 10 | -0.16 | -1.39 | 0.72 | 1376.32 | 1.00 | 11 | 9 | 14 | 3 | TRUE | 0.11 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 167 | 48 | Signature 15 | 0.25 | -0.28 | 0.79 | 1558.04 | 1.00 | 201 | 143 | 24 | 24 | TRUE | 0.44 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 345 | 144 | Signature 1A | 0.47 | 0.13 | 0.80 | 1401.21 | 1.00 | 450 | 272 | 71 | 73 | TRUE | 2.20 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 115 | 78 | Signature 6 | 0.38 | -0.11 | 0.85 | 1504.68 | 1.00 | 160 | 81 | 44 | 34 | TRUE | 0.93 |
| uterine cancer | KRAS_12-61 | FBXW7 | Any mutation | 26 | 17 | Signature 15 | -0.26 | -1.40 | 0.84 | 1462.43 | 1.00 | 69 | 23 | 14 | 3 | TRUE | 0.19 |
| uterine cancer | KRAS_12-61 | FBXW7 | Any mutation | 39 | 35 | Signature 1A | -0.05 | -0.97 | 0.78 | 1517.43 | 1.00 | 152 | 33 | 29 | 6 | TRUE | 0.04 |
| uterine cancer | KRAS_12-61 | FBXW7 | Any mutation | 17 | 18 | Signature 6 | 0.50 | -0.61 | 1.60 | 1568.93 | 1.00 | 67 | 12 | 13 | 5 | TRUE | 0.43 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Any mutation | 639 | 287 | Signature overall | 0.24 | -0.48 | 0.89 | 1396.66 | 1.00 | 822 | 505 | 153 | 134 | TRUE | 0.31 |
| uterine cancer | KRAS_12-61 | FBXW7 | Any mutation | 86 | 101 | Signature overall | 0.19 | -0.92 | 1.51 | 1511.06 | 1.00 | 306 | 68 | 83 | 18 | TRUE | 0.13 |
| uterine cancer | KRAS_12-61 | NSD1 | Any mutation | 41 | 22 | Signature 1A | 0.53 | -0.47 | 1.46 | 1359.46 | 1.00 | 166 | 35 | 16 | 6 | FALSE | 0.55 |
| uterine cancer | KRAS_12-61 | NSD1 | Any mutation | 20 | 29 | Signature 6 | 0.75 | -0.24 | 1.76 | 1445.56 | 1.00 | 66 | 12 | 21 | 8 | FALSE | 0.91 |
| uterine cancer | KRAS_12-61 | NSD1 | Any mutation | 64 | 88 | Signature overall | 0.73 | -1.04 | 2.70 | 1183.90 | 1.00 | 249 | 47 | 71 | 17 | FALSE | 0.33 |
| colorectal cancer | KRAS_12-61 | FLT4 | Any mutation | 12 | 14 | Signature 10 | -1.33 | -2.90 | -0.04 | 1474.87 | 1.00 | 16 | 11 | 13 | 1 | TRUE | 1.17 |
| colorectal cancer | KRAS_12-61 | FLT4 | Any mutation | 165 | 14 | Signature 15 | -0.41 | -1.39 | 0.56 | 1502.60 | 1.00 | 213 | 159 | 8 | 6 | TRUE | 0.40 |
| colorectal cancer | KRAS_12-61 | FLT4 | Any mutation | 334 | 54 | Signature 1A | -0.38 | -0.94 | 0.20 | 1451.30 | 1.00 | 479 | 316 | 36 | 18 | TRUE | 0.72 |
| colorectal cancer | KRAS_12-61 | FLT4 | Any mutation | 111 | 51 | Signature 6 | -1.02 | -1.78 | -0.33 | 1566.03 | 1.00 | 164 | 102 | 42 | 9 | TRUE | 2.27 |
| non-small cell lung cancer | KRAS_12-61 | FLT4 | Any mutation | 84 | 11 | Signature 2 | -0.86 | -2.37 | 0.32 | 1295.73 | 1.00 | 230 | 83 | 10 | 1 | TRUE | 0.67 |
| non-small cell lung cancer | KRAS_12-61 | FLT4 | Any mutation | 266 | 36 | Signature 4 | -0.42 | -1.15 | 0.28 | 1607.22 | 1.00 | 413 | 255 | 25 | 11 | TRUE | 0.59 |
| colorectal cancer | KRAS_12-61 | FLT4 | Any mutation | 622 | 133 | Signature overall | -0.79 | -1.95 | 0.26 | 1451.02 | 1.00 | 872 | 588 | 99 | 34 | TRUE | 0.82 |
| non-small cell lung cancer | KRAS_12-61 | FLT4 | Any mutation | 350 | 47 | Signature overall | -0.62 | -2.19 | 0.73 | 1493.71 | 1.00 | 643 | 338 | 35 | 12 | TRUE | 0.41 |
| colorectal cancer | KRAS_12-61 | PTPRD | Any mutation | 13 | 19 | Signature 10 | -0.87 | -2.22 | 0.30 | 1403.81 | 1.00 | 16 | 10 | 16 | 3 | FALSE | 0.77 |
| colorectal cancer | KRAS_12-61 | PTPRD | Any mutation | 164 | 14 | Signature 15 | -0.51 | -1.55 | 0.46 | 1393.38 | 1.00 | 214 | 159 | 9 | 5 | FALSE | 0.49 |
| colorectal cancer | KRAS_12-61 | PTPRD | Any mutation | 331 | 31 | Signature 1A | -0.43 | -1.13 | 0.33 | 1437.14 | 1.00 | 496 | 321 | 21 | 10 | FALSE | 0.62 |
| colorectal cancer | KRAS_12-61 | PTPRD | Any mutation | 111 | 31 | Signature 6 | -0.88 | -1.83 | -0.08 | 1356.47 | 1.00 | 180 | 105 | 25 | 6 | FALSE | 1.34 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 69 | 22 | Signature 18 | 0.70 | -0.11 | 1.50 | 1381.97 | 1.00 | 76 | 55 | 8 | 14 | FALSE | 1.10 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 47 | 12 | Signature 1A | 0.21 | -0.86 | 1.18 | 1447.63 | 1.00 | 210 | 44 | 9 | 3 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 84 | 33 | Signature 2 | 0.32 | -0.41 | 0.98 | 1472.51 | 1.00 | 219 | 73 | 22 | 11 | FALSE | 0.45 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 15 | 12 | Signature 20 | -0.05 | -1.26 | 1.07 | 1529.03 | 1.00 | 54 | 13 | 10 | 2 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 54 | 18 | Signature 3 | 0.75 | -0.15 | 1.63 | 1361.64 | 1.00 | 179 | 46 | 10 | 8 | FALSE | 1.02 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 283 | 195 | Signature 4 | -0.05 | -0.39 | 0.29 | 1395.63 | 1.00 | 340 | 212 | 124 | 71 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 155 | 18 | Signature R2 | -0.45 | -1.29 | 0.36 | 1418.57 | 1.00 | 38 | 144 | 7 | 11 | FALSE | 0.51 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 12 | 11 | Signature U2 | 0.17 | -0.99 | 1.33 | 1482.47 | 1.00 | 26 | 9 | 8 | 3 | FALSE | 0.12 |
| colorectal cancer | KRAS_12-61 | PTPRD | Any mutation | 619 | 95 | Signature overall | -0.64 | -1.73 | 0.43 | 1457.28 | 1.00 | 906 | 595 | 71 | 24 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12-61 | PTPRD | Any mutation | 719 | 321 | Signature overall | 0.20 | -0.48 | 0.88 | 1459.92 | 1.00 | 1142 | 596 | 198 | 123 | FALSE | 0.25 |
| non-small cell lung cancer | KRAS_12-61 | PIK3C2G | Any mutation | 84 | 17 | Signature 2 | -0.94 | -2.16 | 0.12 | 1169.64 | 1.00 | 224 | 82 | 15 | 2 | FALSE | 0.98 |
| non-small cell lung cancer | KRAS_12-61 | PIK3C2G | Any mutation | 266 | 57 | Signature 4 | -0.70 | -1.35 | -0.06 | 900.96 | 1.00 | 397 | 252 | 43 | 14 | FALSE | 1.59 |
| non-small cell lung cancer | KRAS_12-61 | PIK3C2G | Any mutation | 350 | 74 | Signature overall | -0.82 | -2.14 | 0.26 | 1480.84 | 1.00 | 621 | 334 | 58 | 16 | FALSE | 0.71 |
| colorectal cancer | KRAS_12-61 | CREBBP | Any mutation | 12 | 15 | Signature 10 | -1.04 | -2.41 | 0.14 | 1350.91 | 1.00 | 16 | 10 | 13 | 2 | TRUE | 0.97 |
| colorectal cancer | KRAS_12-61 | CREBBP | Any mutation | 164 | 27 | Signature 15 | -0.84 | -1.66 | -0.05 | 1556.29 | 1.00 | 206 | 157 | 20 | 7 | TRUE | 1.39 |
| colorectal cancer | KRAS_12-61 | CREBBP | Any mutation | 334 | 45 | Signature 1A | 0.13 | -0.46 | 0.74 | 1400.36 | 1.00 | 492 | 313 | 24 | 21 | TRUE | 0.17 |
| colorectal cancer | KRAS_12-61 | CREBBP | Any mutation | 117 | 80 | Signature 6 | -1.20 | -1.85 | -0.61 | 1542.58 | 1.00 | 151 | 104 | 67 | 13 | TRUE | 3.77 |
| non-small cell lung cancer | KRAS_12-61 | CREBBP | Any mutation | 47 | 12 | Signature 1A | 0.11 | -0.81 | 0.97 | 1538.97 | 1.00 | 210 | 44 | 9 | 3 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12-61 | CREBBP | Any mutation | 84 | 15 | Signature 2 | -0.21 | -1.15 | 0.56 | 1526.91 | 1.00 | 227 | 82 | 13 | 2 | TRUE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | CREBBP | Any mutation | 54 | 11 | Signature 3 | 0.19 | -0.68 | 1.07 | 1583.10 | 1.00 | 182 | 50 | 7 | 4 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12-61 | CREBBP | Any mutation | 266 | 44 | Signature 4 | 0.08 | -0.48 | 0.63 | 1590.95 | 1.00 | 414 | 249 | 27 | 17 | TRUE | 0.11 |
| colorectal cancer | KRAS_12-61 | CREBBP | Any mutation | 627 | 167 | Signature overall | -0.72 | -1.77 | 0.30 | 1594.78 | 1.00 | 865 | 584 | 124 | 43 | TRUE | 0.77 |
| non-small cell lung cancer | KRAS_12-61 | CREBBP | Any mutation | 451 | 82 | Signature overall | 0.05 | -0.66 | 0.73 | 1627.33 | 1.00 | 1033 | 425 | 56 | 26 | TRUE | 0.05 |
| colorectal cancer | KRAS_12-61 | AXIN2 | Any mutation | 164 | 17 | Signature 15 | -0.51 | -1.41 | 0.34 | 1696.09 | 1.00 | 212 | 158 | 11 | 6 | TRUE | 0.60 |
| colorectal cancer | KRAS_12-61 | AXIN2 | Any mutation | 331 | 36 | Signature 1A | -0.24 | -0.88 | 0.44 | 1416.25 | 1.00 | 496 | 317 | 22 | 14 | TRUE | 0.32 |
| colorectal cancer | KRAS_12-61 | AXIN2 | Any mutation | 112 | 40 | Signature 6 | -1.09 | -2.06 | -0.31 | 1536.20 | 1.00 | 174 | 107 | 35 | 5 | TRUE | 1.89 |
| colorectal cancer | KRAS_12-61 | AXIN2 | Any mutation | 607 | 93 | Signature overall | -0.60 | -1.54 | 0.37 | 1438.44 | 1.00 | 882 | 582 | 68 | 25 | TRUE | 0.67 |
| non-small cell lung cancer | KRAS_12-61 | DOT1L | Any mutation | 84 | 16 | Signature 2 | -0.38 | -1.38 | 0.52 | 1543.81 | 1.00 | 227 | 81 | 13 | 3 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12-61 | DOT1L | Any mutation | 266 | 38 | Signature 4 | -0.22 | -0.89 | 0.39 | 1459.38 | 1.00 | 412 | 253 | 25 | 13 | FALSE | 0.30 |
| non-small cell lung cancer | KRAS_12-61 | DOT1L | Any mutation | 350 | 54 | Signature overall | -0.31 | -1.48 | 0.70 | 1518.64 | 1.00 | 639 | 334 | 38 | 16 | FALSE | 0.24 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 13 | 16 | Signature 10 | -0.94 | -2.40 | 0.08 | 1371.02 | 1.00 | 13 | 11 | 14 | 2 | FALSE | 0.88 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 162 | 38 | Signature 15 | -0.18 | -0.81 | 0.45 | 1450.28 | 1.00 | 198 | 146 | 22 | 16 | FALSE | 0.24 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 323 | 95 | Signature 1A | 0.10 | -0.32 | 0.54 | 1497.97 | 1.00 | 457 | 282 | 54 | 41 | FALSE | 0.20 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 112 | 83 | Signature 6 | -0.90 | -1.50 | -0.33 | 1595.76 | 1.00 | 149 | 96 | 67 | 16 | FALSE | 2.56 |
| colorectal cancer | KRAS_12-61 | PTPRS | Any mutation | 610 | 232 | Signature overall | -0.48 | -1.44 | 0.33 | 1341.29 | 1.00 | 817 | 535 | 157 | 75 | FALSE | 0.56 |
| colorectal cancer | KRAS_12-61 | SMARCA4 | Any mutation | 165 | 22 | Signature 15 | -0.37 | -1.10 | 0.42 | 1514.28 | 1.00 | 213 | 156 | 13 | 9 | FALSE | 0.47 |
| colorectal cancer | KRAS_12-61 | SMARCA4 | Any mutation | 336 | 74 | Signature 1A | -0.36 | -0.86 | 0.14 | 1512.68 | 1.00 | 474 | 311 | 49 | 25 | FALSE | 0.81 |
| colorectal cancer | KRAS_12-61 | SMARCA4 | Any mutation | 112 | 52 | Signature 6 | -1.21 | -2.05 | -0.50 | 1360.95 | 1.00 | 168 | 106 | 46 | 6 | FALSE | 2.54 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 14 | 11 | Signature 13 | 0.10 | -1.02 | 1.22 | 1582.72 | 1.00 | 75 | 12 | 9 | 2 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 67 | 14 | Signature 18 | 0.73 | -0.14 | 1.64 | 1378.08 | 1.00 | 80 | 57 | 4 | 10 | FALSE | 0.97 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 47 | 17 | Signature 1A | -0.03 | -1.02 | 0.94 | 1561.82 | 1.00 | 207 | 44 | 14 | 3 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 86 | 33 | Signature 2 | -0.07 | -0.84 | 0.62 | 1603.36 | 1.00 | 220 | 78 | 25 | 8 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 54 | 16 | Signature 3 | 0.63 | -0.27 | 1.54 | 1534.69 | 1.00 | 181 | 47 | 9 | 7 | FALSE | 0.78 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 267 | 104 | Signature 4 | -0.29 | -0.74 | 0.12 | 1413.11 | 1.00 | 370 | 235 | 72 | 32 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 24 | 15 | Signature 7 | -0.06 | -1.13 | 0.90 | 1636.45 | 1.00 | 72 | 21 | 12 | 3 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 154 | 15 | Signature R2 | -0.27 | -1.11 | 0.60 | 1590.94 | 1.00 | 39 | 144 | 5 | 10 | FALSE | 0.27 |
| uterine cancer | KRAS_12-61 | SMARCA4 | Any mutation | 28 | 14 | Signature 15 | 0.15 | -0.86 | 1.19 | 1437.09 | 1.00 | 76 | 23 | 9 | 5 | FALSE | 0.11 |
| uterine cancer | KRAS_12-61 | SMARCA4 | Any mutation | 39 | 21 | Signature 1A | -0.49 | -1.68 | 0.50 | 1529.75 | 1.00 | 163 | 37 | 19 | 2 | FALSE | 0.44 |
| uterine cancer | KRAS_12-61 | SMARCA4 | Any mutation | 19 | 30 | Signature 6 | -0.27 | -1.37 | 0.67 | 1444.30 | 1.00 | 66 | 15 | 26 | 4 | FALSE | 0.22 |
| colorectal cancer | KRAS_12-61 | SMARCA4 | Any mutation | 613 | 148 | Signature overall | -0.64 | -1.55 | 0.21 | 1471.78 | 1.00 | 855 | 573 | 108 | 40 | FALSE | 0.87 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Any mutation | 713 | 225 | Signature overall | 0.09 | -0.57 | 0.76 | 1546.36 | 1.00 | 1244 | 638 | 150 | 75 | FALSE | 0.10 |
| uterine cancer | KRAS_12-61 | SMARCA4 | Any mutation | 88 | 76 | Signature overall | -0.20 | -1.28 | 0.80 | 1532.82 | 1.00 | 333 | 76 | 64 | 12 | FALSE | 0.16 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 16 | 23 | Signature 10 | -0.76 | -1.91 | 0.24 | 1598.08 | 1.00 | 13 | 11 | 18 | 5 | FALSE | 0.79 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 164 | 25 | Signature 15 | -1.28 | -2.24 | -0.42 | 1633.53 | 1.00 | 201 | 160 | 21 | 4 | FALSE | 2.25 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 332 | 66 | Signature 1A | -0.04 | -0.57 | 0.46 | 1662.77 | 1.00 | 476 | 305 | 39 | 27 | FALSE | 0.05 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 112 | 43 | Signature 6 | -0.59 | -1.32 | 0.05 | 1535.38 | 1.00 | 170 | 101 | 32 | 11 | FALSE | 1.05 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 14 | 11 | Signature 13 | 0.26 | -1.14 | 1.51 | 1383.92 | 1.00 | 78 | 11 | 8 | 3 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 66 | 17 | Signature 18 | -0.62 | -1.59 | 0.31 | 1543.38 | 1.00 | 73 | 61 | 12 | 5 | FALSE | 0.69 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 47 | 11 | Signature 1A | -1.21 | -2.98 | 0.15 | 1443.55 | 1.00 | 211 | 47 | 11 | 0 | FALSE | 0.88 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 85 | 30 | Signature 2 | 0.75 | -0.01 | 1.46 | 1616.51 | 1.00 | 225 | 71 | 16 | 14 | FALSE | 1.34 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 54 | 19 | Signature 3 | -0.51 | -1.60 | 0.45 | 1437.23 | 1.00 | 175 | 51 | 16 | 3 | FALSE | 0.46 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 270 | 179 | Signature 4 | -0.91 | -1.29 | -0.52 | 1560.44 | 1.00 | 334 | 232 | 141 | 38 | FALSE | 5.35 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 156 | 23 | Signature R2 | -0.45 | -1.28 | 0.40 | 1572.49 | 1.00 | 39 | 141 | 8 | 15 | FALSE | 0.54 |
| colorectal cancer | KRAS_12-61 | PTPRT | Any mutation | 624 | 157 | Signature overall | -0.66 | -1.66 | 0.28 | 1358.99 | 1.00 | 860 | 577 | 110 | 47 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12-61 | PTPRT | Any mutation | 692 | 290 | Signature overall | -0.40 | -1.20 | 0.39 | 1496.02 | 1.00 | 1135 | 614 | 212 | 78 | FALSE | 0.47 |
| non-small cell lung cancer | KRAS_12-61 | HGF | Any mutation | 84 | 20 | Signature 2 | 0.45 | -0.44 | 1.42 | 1488.76 | 1.00 | 228 | 76 | 12 | 8 | FALSE | 0.48 |
| non-small cell lung cancer | KRAS_12-61 | HGF | Any mutation | 266 | 89 | Signature 4 | -0.31 | -0.78 | 0.13 | 1593.53 | 1.00 | 384 | 238 | 61 | 28 | FALSE | 0.73 |
| non-small cell lung cancer | KRAS_12-61 | HGF | Any mutation | 155 | 12 | Signature R2 | -1.00 | -2.16 | 0.11 | 1467.85 | 1.00 | 39 | 149 | 6 | 6 | FALSE | 1.07 |
| non-small cell lung cancer | KRAS_12-61 | HGF | Any mutation | 505 | 121 | Signature overall | -0.31 | -1.90 | 1.17 | 1305.88 | 1.00 | 651 | 463 | 79 | 42 | FALSE | 0.17 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 13 | 23 | Signature 10 | 0.24 | -0.58 | 1.02 | 1336.14 | 1.00 | 13 | 7 | 17 | 6 | TRUE | 0.26 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 164 | 63 | Signature 15 | 0.26 | -0.18 | 0.74 | 1457.30 | 1.00 | 193 | 134 | 33 | 30 | TRUE | 0.56 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 18 | 19 | Signature 18 | 0.37 | -0.43 | 1.13 | 1417.64 | 1.00 | 18 | 11 | 12 | 7 | TRUE | 0.45 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 341 | 191 | Signature 1A | 0.54 | 0.24 | 0.85 | 1433.63 | 1.00 | 428 | 245 | 95 | 96 | TRUE | 3.35 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 48 | 43 | Signature 2 | 1.19 | 0.57 | 1.87 | 1425.82 | 1.00 | 26 | 16 | 11 | 32 | TRUE | 3.46 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 119 | 95 | Signature 6 | 0.51 | 0.07 | 0.96 | 1289.58 | 1.00 | 155 | 76 | 52 | 43 | TRUE | 1.62 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 15 | 13 | Signature 13 | 0.97 | -0.17 | 2.16 | 1451.29 | 1.00 | 77 | 9 | 7 | 6 | TRUE | 1.01 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 47 | 13 | Signature 1A | 0.04 | -1.10 | 1.09 | 1495.43 | 1.00 | 210 | 44 | 10 | 3 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 85 | 82 | Signature 2 | 0.17 | -0.39 | 0.68 | 1545.03 | 1.00 | 186 | 62 | 59 | 23 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 15 | 16 | Signature 20 | -0.04 | -1.22 | 1.00 | 1540.14 | 1.00 | 49 | 12 | 13 | 3 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 54 | 15 | Signature 3 | -1.03 | -2.57 | 0.14 | 1478.90 | 1.00 | 174 | 54 | 15 | 0 | TRUE | 0.89 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 266 | 38 | Signature 4 | -0.40 | -1.08 | 0.21 | 1593.98 | 1.00 | 410 | 255 | 27 | 11 | TRUE | 0.67 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 29 | 50 | Signature 15 | -0.03 | -0.81 | 0.70 | 1621.69 | 1.00 | 50 | 18 | 39 | 11 | TRUE | 0.03 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 47 | 138 | Signature 1A | 0.84 | 0.24 | 1.48 | 1298.30 | 1.00 | 101 | 13 | 104 | 34 | TRUE | 2.09 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 6 | 30 | Signature 2 | 0.00 | -1.16 | 1.12 | 1472.70 | 1.00 | 17 | 3 | 27 | 3 | TRUE | 0.00 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 9 | 25 | Signature 20 | -0.01 | -1.10 | 1.01 | 1470.13 | 1.00 | 14 | 5 | 21 | 4 | TRUE | 0.01 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 11 | 21 | Signature 3 | 1.19 | 0.10 | 2.35 | 1626.50 | 1.00 | 24 | 2 | 12 | 9 | TRUE | 1.44 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 24 | 85 | Signature 6 | 0.64 | -0.17 | 1.50 | 1018.49 | 1.00 | 34 | 5 | 66 | 19 | TRUE | 0.89 |
| colorectal cancer | KRAS_12-61 | PIK3CA | Any mutation | 703 | 434 | Signature overall | 0.52 | 0.04 | 1.00 | 1279.33 | 1.00 | 833 | 489 | 220 | 214 | TRUE | 1.45 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CA | Any mutation | 482 | 177 | Signature overall | -0.05 | -0.85 | 0.75 | 1386.01 | 1.00 | 1106 | 436 | 131 | 46 | TRUE | 0.05 |
| uterine cancer | KRAS_12-61 | PIK3CA | Any mutation | 134 | 459 | Signature overall | 0.27 | -0.42 | 0.97 | 1426.47 | 1.00 | 308 | 48 | 373 | 86 | TRUE | 0.35 |
| colorectal cancer | KRAS_12-61 | ALK | Any mutation | 13 | 13 | Signature 10 | -0.38 | -1.75 | 0.85 | 1530.69 | 1.00 | 16 | 10 | 10 | 3 | TRUE | 0.25 |
| colorectal cancer | KRAS_12-61 | ALK | Any mutation | 164 | 16 | Signature 15 | 0.64 | -0.30 | 1.62 | 1357.36 | 1.00 | 216 | 153 | 5 | 11 | TRUE | 0.72 |
| colorectal cancer | KRAS_12-61 | ALK | Any mutation | 333 | 35 | Signature 1A | -0.06 | -0.71 | 0.58 | 1568.56 | 1.00 | 494 | 319 | 21 | 14 | TRUE | 0.07 |
| colorectal cancer | KRAS_12-61 | ALK | Any mutation | 111 | 37 | Signature 6 | -0.94 | -1.86 | -0.19 | 1280.76 | 1.00 | 176 | 105 | 31 | 6 | TRUE | 1.52 |
| non-small cell lung cancer | KRAS_12-61 | ALK | Any mutation | 84 | 24 | Signature 2 | 0.13 | -0.60 | 0.95 | 1234.25 | 1.00 | 226 | 76 | 16 | 8 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12-61 | ALK | Any mutation | 266 | 72 | Signature 4 | -0.14 | -0.59 | 0.34 | 1428.50 | 1.00 | 393 | 242 | 48 | 24 | TRUE | 0.25 |
| colorectal cancer | KRAS_12-61 | ALK | Any mutation | 621 | 101 | Signature overall | -0.19 | -1.29 | 0.94 | 1418.45 | 1.00 | 902 | 587 | 67 | 34 | TRUE | 0.13 |
| non-small cell lung cancer | KRAS_12-61 | ALK | Any mutation | 350 | 96 | Signature overall | -0.01 | -1.25 | 1.18 | 1352.88 | 1.00 | 619 | 318 | 64 | 32 | TRUE | 0.01 |
| colorectal cancer | KRAS_12-61 | RNF43 | Any mutation | 167 | 31 | Signature 15 | -0.88 | -1.67 | -0.15 | 1382.79 | 1.00 | 205 | 159 | 23 | 8 | TRUE | 1.65 |
| colorectal cancer | KRAS_12-61 | RNF43 | Any mutation | 339 | 93 | Signature 1A | -0.41 | -0.85 | 0.04 | 1505.62 | 1.00 | 472 | 309 | 63 | 30 | TRUE | 1.13 |
| colorectal cancer | KRAS_12-61 | RNF43 | Any mutation | 114 | 102 | Signature 6 | -1.22 | -1.88 | -0.68 | 1469.56 | 1.00 | 140 | 98 | 86 | 16 | TRUE | 4.23 |
| colorectal cancer | KRAS_12-61 | RNF43 | Any mutation | 620 | 226 | Signature overall | -0.84 | -1.77 | 0.08 | 1493.29 | 1.00 | 817 | 566 | 172 | 54 | TRUE | 1.02 |
| colorectal cancer | KRAS_12-61 | PTEN | Any mutation | 13 | 13 | Signature 10 | -0.36 | -1.57 | 0.69 | 1447.64 | 1.00 | 15 | 10 | 10 | 3 | TRUE | 0.27 |
| colorectal cancer | KRAS_12-61 | PTEN | Any mutation | 164 | 22 | Signature 15 | 0.29 | -0.45 | 1.14 | 1549.60 | 1.00 | 213 | 151 | 9 | 13 | TRUE | 0.33 |
| colorectal cancer | KRAS_12-61 | PTEN | Any mutation | 335 | 64 | Signature 1A | -0.18 | -0.70 | 0.30 | 1314.46 | 1.00 | 485 | 312 | 41 | 23 | TRUE | 0.33 |
| colorectal cancer | KRAS_12-61 | PTEN | Any mutation | 113 | 57 | Signature 6 | -0.66 | -1.32 | -0.04 | 1490.42 | 1.00 | 173 | 101 | 45 | 12 | TRUE | 1.39 |
| non-small cell lung cancer | KRAS_12-61 | PTEN | Any mutation | 84 | 27 | Signature 2 | -0.74 | -1.77 | -0.01 | 18.16 | 1.07 | 220 | 80 | 23 | 4 | TRUE | 1.07 |
| non-small cell lung cancer | KRAS_12-61 | PTEN | Any mutation | 266 | 27 | Signature 4 | -0.75 | -1.65 | -0.17 | 7.43 | 1.13 | 416 | 260 | 21 | 6 | TRUE | 1.28 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 8 | 14 | Signature 14 | 1.11 | 0.10 | 2.12 | 1389.41 | 1.00 | 10 | 2 | 8 | 6 | TRUE | 1.51 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 37 | 61 | Signature 15 | 1.13 | 0.46 | 1.77 | 1533.86 | 1.00 | 57 | 12 | 36 | 25 | TRUE | 3.09 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 55 | 155 | Signature 1A | 1.02 | 0.45 | 1.61 | 1437.32 | 1.00 | 114 | 14 | 114 | 41 | TRUE | 3.35 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 6 | 15 | Signature 1B | 1.25 | 0.20 | 2.31 | 1541.30 | 1.00 | 8 | 0 | 9 | 6 | TRUE | 1.70 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 8 | 26 | Signature 2 | 0.51 | -0.44 | 1.33 | 1577.24 | 1.00 | 24 | 4 | 22 | 4 | TRUE | 0.56 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 12 | 28 | Signature 20 | 1.18 | 0.33 | 2.11 | 1324.56 | 1.00 | 19 | 2 | 18 | 10 | TRUE | 2.01 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 13 | 17 | Signature 3 | 1.31 | 0.42 | 2.26 | 1354.66 | 1.00 | 30 | 4 | 8 | 9 | TRUE | 2.27 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 25 | 104 | Signature 6 | 0.35 | -0.45 | 1.13 | 1600.34 | 1.00 | 23 | 7 | 86 | 18 | TRUE | 0.41 |
| colorectal cancer | KRAS_12-61 | PTEN | Any mutation | 625 | 156 | Signature overall | -0.21 | -1.18 | 0.72 | 1472.18 | 1.00 | 886 | 574 | 105 | 51 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12-61 | PTEN | Any mutation | 350 | 54 | Signature overall | -0.74 | -2.02 | 0.25 | 22.86 | 1.06 | 636 | 340 | 44 | 10 | TRUE | 0.74 |
| uterine cancer | KRAS_12-61 | PTEN | Any mutation | 179 | 545 | Signature overall | 0.80 | 0.29 | 1.33 | 1501.82 | 1.00 | 340 | 49 | 415 | 130 | TRUE | 2.45 |
| colorectal cancer | KRAS_12-61 | BCOR | Any mutation | 12 | 11 | Signature 10 | -0.63 | -2.14 | 0.61 | 1395.21 | 1.00 | 16 | 10 | 9 | 2 | FALSE | 0.43 |
| colorectal cancer | KRAS_12-61 | BCOR | Any mutation | 164 | 13 | Signature 15 | -0.32 | -1.30 | 0.60 | 1453.21 | 1.00 | 214 | 159 | 8 | 5 | FALSE | 0.28 |
| colorectal cancer | KRAS_12-61 | BCOR | Any mutation | 331 | 27 | Signature 1A | 0.56 | -0.19 | 1.30 | 1314.45 | 1.00 | 503 | 315 | 11 | 16 | FALSE | 0.85 |
| colorectal cancer | KRAS_12-61 | BCOR | Any mutation | 114 | 49 | Signature 6 | -0.91 | -1.67 | -0.23 | 1174.22 | 1.00 | 171 | 105 | 40 | 9 | FALSE | 1.89 |
| non-small cell lung cancer | KRAS_12-61 | BCOR | Any mutation | 85 | 13 | Signature 2 | 0.26 | -0.78 | 1.15 | 1171.49 | 1.00 | 231 | 81 | 9 | 4 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12-61 | BCOR | Any mutation | 270 | 52 | Signature 4 | 0.52 | -0.01 | 1.05 | 1406.79 | 1.00 | 413 | 244 | 26 | 26 | FALSE | 1.25 |
| uterine cancer | KRAS_12-61 | BCOR | Any mutation | 39 | 30 | Signature 1A | 0.16 | -0.80 | 1.07 | 1349.62 | 1.00 | 158 | 33 | 24 | 6 | FALSE | 0.14 |
| uterine cancer | KRAS_12-61 | BCOR | Any mutation | 19 | 23 | Signature 6 | 0.98 | 0.00 | 2.01 | 1492.03 | 1.00 | 69 | 11 | 15 | 8 | FALSE | 1.23 |
| colorectal cancer | KRAS_12-61 | BCOR | Any mutation | 621 | 100 | Signature overall | -0.32 | -1.54 | 0.89 | 1254.45 | 1.00 | 904 | 589 | 68 | 32 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12-61 | BCOR | Any mutation | 355 | 65 | Signature overall | 0.38 | -0.84 | 1.54 | 1548.73 | 1.00 | 644 | 325 | 35 | 30 | FALSE | 0.28 |
| uterine cancer | KRAS_12-61 | BCOR | Any mutation | 60 | 83 | Signature overall | 0.30 | -1.31 | 1.89 | 1553.79 | 1.00 | 248 | 45 | 68 | 15 | FALSE | 0.14 |
| colorectal cancer | KRAS_12-61 | CTNNB1 | Any mutation | 164 | 22 | Signature 15 | 0.41 | -0.23 | 0.96 | 1389.28 | 1.00 | 210 | 154 | 12 | 10 | TRUE | 0.76 |
| colorectal cancer | KRAS_12-61 | CTNNB1 | Any mutation | 334 | 61 | Signature 1A | 0.74 | 0.28 | 1.24 | 1452.36 | 1.00 | 491 | 296 | 23 | 38 | TRUE | 2.62 |
| colorectal cancer | KRAS_12-61 | CTNNB1 | Any mutation | 112 | 33 | Signature 6 | 0.53 | -0.04 | 1.08 | 1349.91 | 1.00 | 183 | 98 | 19 | 14 | TRUE | 1.23 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 47 | 11 | Signature 1A | -1.44 | -2.85 | -0.08 | 1556.04 | 1.00 | 209 | 46 | 10 | 1 | TRUE | 1.37 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 84 | 14 | Signature 2 | -1.62 | -3.06 | -0.37 | 1430.67 | 1.00 | 227 | 83 | 13 | 1 | TRUE | 1.80 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 54 | 17 | Signature 3 | -1.13 | -2.39 | 0.07 | 1393.83 | 1.00 | 175 | 51 | 14 | 3 | TRUE | 1.14 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 266 | 16 | Signature 4 | -2.02 | -3.63 | -0.86 | 1342.77 | 1.00 | 420 | 266 | 16 | 0 | TRUE | 2.38 |
| uterine cancer | KRAS_12-61 | CTNNB1 | Any mutation | 26 | 11 | Signature 15 | -1.63 | -3.15 | -0.32 | 273.43 | 1.02 | 74 | 25 | 10 | 1 | TRUE | 1.62 |
| uterine cancer | KRAS_12-61 | CTNNB1 | Any mutation | 39 | 31 | Signature 1A | -1.60 | -2.87 | -0.44 | 192.62 | 1.02 | 152 | 37 | 29 | 2 | TRUE | 1.92 |
| uterine cancer | KRAS_12-61 | CTNNB1 | Any mutation | 17 | 19 | Signature 6 | -1.70 | -3.31 | -0.36 | 774.55 | 1.01 | 64 | 16 | 18 | 1 | TRUE | 1.64 |
| colorectal cancer | KRAS_12-61 | CTNNB1 | Any mutation | 610 | 116 | Signature overall | 0.56 | -0.01 | 1.12 | 1390.39 | 1.00 | 884 | 548 | 54 | 62 | TRUE | 1.32 |
| non-small cell lung cancer | KRAS_12-61 | CTNNB1 | Any mutation | 451 | 58 | Signature overall | -1.55 | -2.77 | -0.44 | 1519.63 | 1.00 | 1031 | 446 | 53 | 5 | TRUE | 2.18 |
| uterine cancer | KRAS_12-61 | CTNNB1 | Any mutation | 85 | 83 | Signature overall | -1.70 | -3.05 | -0.50 | 190.49 | 1.02 | 356 | 81 | 79 | 4 | TRUE | 2.04 |
| cancer of unknown primary | KRAS_12-61 | ARID1A | Any mutation | 37 | 22 | Signature 1A | -0.77 | -1.69 | 0.15 | 1399.30 | 1.00 | 68 | 32 | 17 | 5 | TRUE | 0.97 |
| cancer of unknown primary | KRAS_12-61 | ARID1A | Any mutation | 6 | 13 | Signature 2 | -0.93 | -2.18 | 0.17 | 1240.43 | 1.00 | 38 | 5 | 12 | 1 | TRUE | 0.94 |
| cancer of unknown primary | KRAS_12-61 | ARID1A | Any mutation | 21 | 12 | Signature 4 | -0.88 | -2.00 | 0.12 | 1513.50 | 1.00 | 50 | 19 | 10 | 2 | TRUE | 1.00 |
| cancer of unknown primary | KRAS_12-61 | ARID1A | Any mutation | 6 | 11 | Signature 6 | -1.14 | -2.62 | -0.04 | 1325.41 | 1.00 | 15 | 6 | 11 | 0 | TRUE | 1.08 |
| colorectal cancer | KRAS_12-61 | ARID1A | Any mutation | 13 | 13 | Signature 10 | -0.60 | -1.57 | 0.31 | 1422.84 | 1.00 | 16 | 10 | 10 | 3 | TRUE | 0.72 |
| colorectal cancer | KRAS_12-61 | ARID1A | Any mutation | 166 | 39 | Signature 15 | -0.81 | -1.43 | -0.22 | 1479.77 | 1.00 | 206 | 156 | 29 | 10 | TRUE | 2.01 |
| colorectal cancer | KRAS_12-61 | ARID1A | Any mutation | 343 | 130 | Signature 1A | -0.37 | -0.74 | 0.02 | 1427.19 | 1.00 | 453 | 300 | 87 | 43 | TRUE | 1.23 |
| colorectal cancer | KRAS_12-61 | ARID1A | Any mutation | 115 | 99 | Signature 6 | -0.77 | -1.27 | -0.31 | 1331.24 | 1.00 | 149 | 94 | 78 | 21 | TRUE | 2.66 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 14 | 17 | Signature 13 | -1.19 | -3.00 | 0.19 | 1559.47 | 1.00 | 69 | 14 | 17 | 0 | TRUE | 0.86 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 69 | 12 | Signature 18 | 0.77 | -0.30 | 1.95 | 1584.77 | 1.00 | 81 | 60 | 3 | 9 | TRUE | 0.81 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 88 | 52 | Signature 2 | 0.56 | -0.06 | 1.16 | 1589.05 | 1.00 | 213 | 68 | 32 | 20 | TRUE | 1.17 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 54 | 11 | Signature 3 | -0.37 | -1.63 | 0.75 | 1467.40 | 1.00 | 180 | 52 | 9 | 2 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 267 | 86 | Signature 4 | -0.68 | -1.21 | -0.19 | 1474.07 | 1.00 | 373 | 246 | 65 | 21 | TRUE | 2.09 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 154 | 13 | Signature R2 | -0.39 | -1.37 | 0.60 | 1519.63 | 1.00 | 40 | 145 | 4 | 9 | TRUE | 0.35 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Any mutation | 117 | 12 | Signature 11 | -0.44 | -1.61 | 0.96 | 1260.84 | 1.00 | 8 | 106 | 1 | 11 | TRUE | 0.32 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Any mutation | 220 | 33 | Signature 1A | -0.49 | -1.32 | 0.44 | 1413.25 | 1.00 | 29 | 194 | 7 | 26 | TRUE | 0.56 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 7 | 21 | Signature 14 | 0.97 | -0.12 | 2.05 | 1470.61 | 1.00 | 9 | 2 | 16 | 5 | TRUE | 1.12 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 32 | 58 | Signature 15 | 1.15 | 0.46 | 1.89 | 1496.69 | 1.00 | 59 | 11 | 37 | 21 | TRUE | 2.71 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 52 | 133 | Signature 1A | 1.19 | 0.61 | 1.78 | 1497.49 | 1.00 | 116 | 14 | 95 | 38 | TRUE | 3.98 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 9 | 23 | Signature 2 | 1.47 | 0.49 | 2.61 | 1327.80 | 1.00 | 28 | 1 | 15 | 8 | TRUE | 2.21 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 10 | 26 | Signature 20 | 1.45 | 0.43 | 2.53 | 1438.39 | 1.00 | 20 | 1 | 17 | 9 | TRUE | 2.19 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 24 | 121 | Signature 6 | 0.73 | -0.13 | 1.59 | 1521.59 | 1.00 | 26 | 4 | 101 | 20 | TRUE | 0.99 |
| cancer of unknown primary | KRAS_12-61 | ARID1A | Any mutation | 70 | 58 | Signature overall | -0.92 | -1.92 | 0.02 | 1406.81 | 1.00 | 171 | 62 | 50 | 8 | TRUE | 1.17 |
| colorectal cancer | KRAS_12-61 | ARID1A | Any mutation | 637 | 281 | Signature overall | -0.63 | -1.30 | -0.01 | 1425.23 | 1.00 | 824 | 560 | 204 | 77 | TRUE | 1.31 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Any mutation | 646 | 191 | Signature overall | -0.22 | -1.15 | 0.68 | 1596.67 | 1.00 | 956 | 585 | 130 | 61 | TRUE | 0.19 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Any mutation | 337 | 45 | Signature overall | -0.44 | -1.74 | 1.07 | 1354.49 | 1.00 | 37 | 300 | 8 | 37 | TRUE | 0.27 |
| uterine cancer | KRAS_12-61 | ARID1A | Any mutation | 139 | 445 | Signature overall | 1.02 | 0.31 | 1.74 | 1427.05 | 1.00 | 276 | 34 | 340 | 105 | TRUE | 2.24 |
| colorectal cancer | KRAS_12-61 | PIK3R1 | Any mutation | 14 | 17 | Signature 10 | -0.42 | -1.63 | 0.68 | 1458.28 | 1.00 | 14 | 10 | 13 | 4 | TRUE | 0.32 |
| colorectal cancer | KRAS_12-61 | PIK3R1 | Any mutation | 164 | 17 | Signature 15 | 0.16 | -0.69 | 1.01 | 1462.49 | 1.00 | 216 | 155 | 8 | 9 | TRUE | 0.14 |
| colorectal cancer | KRAS_12-61 | PIK3R1 | Any mutation | 332 | 31 | Signature 1A | -0.23 | -0.95 | 0.46 | 1521.76 | 1.00 | 496 | 321 | 20 | 11 | TRUE | 0.29 |
| colorectal cancer | KRAS_12-61 | PIK3R1 | Any mutation | 112 | 31 | Signature 6 | -0.31 | -1.11 | 0.40 | 1390.18 | 1.00 | 181 | 103 | 22 | 9 | TRUE | 0.38 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 29 | 32 | Signature 15 | 0.58 | -0.26 | 1.45 | 1434.30 | 1.00 | 68 | 15 | 18 | 14 | TRUE | 0.76 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 41 | 59 | Signature 1A | -0.35 | -1.09 | 0.29 | 1263.59 | 1.00 | 134 | 34 | 52 | 7 | TRUE | 0.49 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 10 | 13 | Signature 20 | 0.29 | -0.60 | 1.35 | 1503.55 | 1.00 | 25 | 5 | 8 | 5 | TRUE | 0.25 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 18 | 31 | Signature 6 | -0.50 | -1.54 | 0.32 | 1349.13 | 1.00 | 58 | 16 | 29 | 2 | TRUE | 0.52 |
| colorectal cancer | KRAS_12-61 | PIK3R1 | Any mutation | 622 | 96 | Signature overall | -0.21 | -1.24 | 0.84 | 1344.77 | 1.00 | 907 | 589 | 63 | 33 | TRUE | 0.16 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Any mutation | 104 | 167 | Signature overall | -0.05 | -0.71 | 0.58 | 1435.38 | 1.00 | 323 | 74 | 137 | 30 | TRUE | 0.06 |
| colorectal cancer | KRAS_12-61 | FAT1 | Any mutation | 21 | 44 | Signature 10 | -0.69 | -1.70 | 0.30 | 1325.97 | 1.00 | 13 | 10 | 33 | 11 | FALSE | 0.78 |
| colorectal cancer | KRAS_12-61 | FAT1 | Any mutation | 164 | 29 | Signature 15 | -1.73 | -2.78 | -0.80 | 1505.30 | 1.00 | 204 | 161 | 26 | 3 | FALSE | 3.13 |
| colorectal cancer | KRAS_12-61 | FAT1 | Any mutation | 336 | 66 | Signature 1A | -0.28 | -0.81 | 0.24 | 1354.02 | 1.00 | 479 | 313 | 43 | 23 | FALSE | 0.52 |
| colorectal cancer | KRAS_12-61 | FAT1 | Any mutation | 115 | 67 | Signature 6 | -0.52 | -1.11 | 0.06 | 1584.09 | 1.00 | 164 | 97 | 49 | 18 | FALSE | 1.05 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 14 | 16 | Signature 13 | 0.09 | -0.94 | 1.07 | 1494.49 | 1.00 | 72 | 12 | 14 | 2 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 66 | 16 | Signature 18 | 0.57 | -0.21 | 1.41 | 1517.70 | 1.00 | 78 | 56 | 6 | 10 | FALSE | 0.80 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 47 | 13 | Signature 1A | 0.37 | -0.59 | 1.30 | 1446.17 | 1.00 | 213 | 43 | 9 | 4 | FALSE | 0.37 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 86 | 38 | Signature 2 | 0.20 | -0.49 | 0.81 | 1523.57 | 1.00 | 217 | 75 | 27 | 11 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 16 | 11 | Signature 20 | 0.55 | -0.40 | 1.46 | 1563.59 | 1.00 | 55 | 12 | 7 | 4 | FALSE | 0.60 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 54 | 13 | Signature 3 | 0.59 | -0.28 | 1.47 | 1494.64 | 1.00 | 182 | 48 | 7 | 6 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 268 | 121 | Signature 4 | -0.32 | -0.73 | 0.10 | 1470.07 | 1.00 | 362 | 233 | 86 | 35 | FALSE | 0.86 |
| uterine cancer | KRAS_12-61 | FAT1 | Any mutation | 26 | 14 | Signature 15 | -0.28 | -1.55 | 0.96 | 1419.48 | 1.00 | 75 | 23 | 11 | 3 | FALSE | 0.18 |
| uterine cancer | KRAS_12-61 | FAT1 | Any mutation | 39 | 24 | Signature 1A | -0.90 | -2.37 | 0.31 | 1519.61 | 1.00 | 162 | 37 | 22 | 2 | FALSE | 0.71 |
| uterine cancer | KRAS_12-61 | FAT1 | Any mutation | 17 | 37 | Signature 6 | 0.01 | -1.07 | 0.98 | 1529.62 | 1.00 | 62 | 11 | 31 | 6 | FALSE | 0.01 |
| colorectal cancer | KRAS_12-61 | FAT1 | Any mutation | 636 | 206 | Signature overall | -0.80 | -1.95 | 0.45 | 1549.22 | 1.00 | 860 | 581 | 151 | 55 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12-61 | FAT1 | Any mutation | 551 | 228 | Signature overall | 0.29 | -0.33 | 0.92 | 1657.84 | 1.00 | 1179 | 479 | 156 | 72 | FALSE | 0.45 |
| uterine cancer | KRAS_12-61 | FAT1 | Any mutation | 86 | 149 | Signature overall | -0.28 | -1.93 | 1.40 | 1475.38 | 1.00 | 311 | 71 | 134 | 15 | FALSE | 0.13 |
| colorectal cancer | KRAS_12-61 | CIC | Any mutation | 165 | 19 | Signature 15 | -0.73 | -1.56 | 0.00 | 1637.42 | 1.00 | 213 | 160 | 14 | 5 | TRUE | 1.25 |
| colorectal cancer | KRAS_12-61 | CIC | Any mutation | 334 | 58 | Signature 1A | -0.25 | -0.80 | 0.28 | 1468.38 | 1.00 | 485 | 312 | 36 | 22 | TRUE | 0.45 |
| colorectal cancer | KRAS_12-61 | CIC | Any mutation | 112 | 43 | Signature 6 | -0.85 | -1.63 | -0.18 | 1389.17 | 1.00 | 174 | 105 | 36 | 7 | TRUE | 1.67 |
| colorectal cancer | KRAS_12-61 | CIC | Any mutation | 611 | 120 | Signature overall | -0.60 | -1.38 | 0.20 | 1433.17 | 1.00 | 872 | 577 | 86 | 34 | TRUE | 0.91 |
| colorectal cancer | KRAS_12-61 | NCOR1 | Any mutation | 12 | 16 | Signature 10 | -0.99 | -2.36 | 0.17 | 1119.26 | 1.00 | 14 | 10 | 14 | 2 | FALSE | 0.90 |
| colorectal cancer | KRAS_12-61 | NCOR1 | Any mutation | 164 | 22 | Signature 15 | -0.32 | -1.09 | 0.44 | 1391.42 | 1.00 | 211 | 155 | 13 | 9 | FALSE | 0.39 |
| colorectal cancer | KRAS_12-61 | NCOR1 | Any mutation | 334 | 44 | Signature 1A | -0.63 | -1.25 | -0.02 | 1522.23 | 1.00 | 486 | 322 | 32 | 12 | FALSE | 1.32 |
| colorectal cancer | KRAS_12-61 | NCOR1 | Any mutation | 112 | 43 | Signature 6 | -0.64 | -1.37 | 0.04 | 1282.29 | 1.00 | 176 | 102 | 33 | 10 | FALSE | 1.14 |
| non-small cell lung cancer | KRAS_12-61 | NCOR1 | Any mutation | 15 | 14 | Signature 13 | 0.03 | -1.24 | 1.30 | 1489.30 | 1.00 | 76 | 12 | 11 | 3 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | NCOR1 | Any mutation | 84 | 11 | Signature 2 | -0.27 | -1.49 | 0.86 | 1333.89 | 1.00 | 235 | 81 | 8 | 3 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12-61 | NCOR1 | Any mutation | 267 | 36 | Signature 4 | -1.00 | -1.81 | -0.24 | 1395.28 | 1.00 | 407 | 261 | 30 | 6 | FALSE | 1.77 |
| colorectal cancer | KRAS_12-61 | NCOR1 | Any mutation | 622 | 125 | Signature overall | -0.65 | -1.59 | 0.32 | 1516.04 | 1.00 | 887 | 589 | 92 | 33 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12-61 | NCOR1 | Any mutation | 366 | 61 | Signature overall | -0.42 | -1.62 | 0.86 | 1487.72 | 1.00 | 718 | 354 | 49 | 12 | FALSE | 0.30 |
| colorectal cancer | KRAS_12-61 | POLE | Any mutation | 13 | 20 | Signature 10 | -0.74 | -2.01 | 0.46 | 1414.00 | 1.00 | 13 | 9 | 16 | 4 | TRUE | 0.63 |
| colorectal cancer | KRAS_12-61 | POLE | Any mutation | 164 | 19 | Signature 15 | -0.78 | -1.76 | 0.13 | 1478.59 | 1.00 | 211 | 159 | 14 | 5 | TRUE | 1.01 |
| colorectal cancer | KRAS_12-61 | POLE | Any mutation | 334 | 36 | Signature 1A | 0.16 | -0.49 | 0.85 | 1379.48 | 1.00 | 497 | 317 | 19 | 17 | TRUE | 0.20 |
| colorectal cancer | KRAS_12-61 | POLE | Any mutation | 112 | 54 | Signature 6 | -0.83 | -1.50 | -0.17 | 1487.10 | 1.00 | 166 | 101 | 43 | 11 | TRUE | 1.78 |
| non-small cell lung cancer | KRAS_12-61 | POLE | Any mutation | 85 | 19 | Signature 2 | 0.36 | -0.56 | 1.24 | 1463.56 | 1.00 | 229 | 78 | 12 | 7 | TRUE | 0.36 |
| non-small cell lung cancer | KRAS_12-61 | POLE | Any mutation | 266 | 49 | Signature 4 | -0.39 | -1.02 | 0.18 | 1569.16 | 1.00 | 404 | 252 | 35 | 14 | TRUE | 0.71 |
| non-small cell lung cancer | KRAS_12-61 | POLE | Any mutation | 154 | 11 | Signature R2 | 0.18 | -0.90 | 1.42 | 1447.37 | 1.00 | 42 | 145 | 2 | 9 | TRUE | 0.12 |
| uterine cancer | KRAS_12-61 | POLE | Any mutation | 39 | 12 | Signature 1A | 0.34 | -1.04 | 1.54 | 1565.78 | 1.00 | 172 | 36 | 9 | 3 | TRUE | 0.21 |
| uterine cancer | KRAS_12-61 | POLE | Any mutation | 18 | 20 | Signature 6 | 0.54 | -0.65 | 1.68 | 1406.13 | 1.00 | 71 | 13 | 15 | 5 | TRUE | 0.44 |
| colorectal cancer | KRAS_12-61 | POLE | Any mutation | 623 | 129 | Signature overall | -0.55 | -1.72 | 0.71 | 1113.06 | 1.00 | 887 | 586 | 92 | 37 | TRUE | 0.43 |
| non-small cell lung cancer | KRAS_12-61 | POLE | Any mutation | 505 | 79 | Signature overall | 0.02 | -1.29 | 1.32 | 1095.36 | 1.00 | 675 | 475 | 49 | 30 | TRUE | 0.01 |
| uterine cancer | KRAS_12-61 | POLE | Any mutation | 60 | 89 | Signature overall | 0.47 | -1.84 | 3.04 | 1586.35 | 1.00 | 254 | 49 | 78 | 11 | TRUE | 0.15 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH2 | Any mutation | 84 | 15 | Signature 2 | -0.90 | -2.10 | 0.11 | 1634.25 | 1.00 | 225 | 82 | 13 | 2 | TRUE | 1.02 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH2 | Any mutation | 266 | 54 | Signature 4 | -0.71 | -1.36 | -0.11 | 1734.62 | 1.00 | 405 | 253 | 41 | 13 | TRUE | 1.61 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH2 | Any mutation | 350 | 69 | Signature overall | -0.80 | -2.10 | 0.36 | 1471.36 | 1.00 | 630 | 335 | 54 | 15 | TRUE | 0.69 |
| colorectal cancer | KRAS_12-61 | TGFBR2 | Any mutation | 165 | 11 | Signature 15 | -0.37 | -1.29 | 0.49 | 1574.94 | 1.00 | 214 | 161 | 7 | 4 | TRUE | 0.38 |
| colorectal cancer | KRAS_12-61 | TGFBR2 | Any mutation | 332 | 48 | Signature 1A | 0.02 | -0.52 | 0.56 | 1429.55 | 1.00 | 489 | 312 | 28 | 20 | TRUE | 0.02 |
| colorectal cancer | KRAS_12-61 | TGFBR2 | Any mutation | 111 | 43 | Signature 6 | -0.30 | -0.97 | 0.33 | 1536.67 | 1.00 | 171 | 99 | 31 | 12 | TRUE | 0.42 |
| colorectal cancer | KRAS_12-61 | TGFBR2 | Any mutation | 608 | 102 | Signature overall | -0.22 | -1.15 | 0.69 | 1658.90 | 1.00 | 874 | 572 | 66 | 36 | TRUE | 0.20 |
| colorectal cancer | KRAS_12-61 | KMT2A | Any mutation | 16 | 22 | Signature 10 | -0.40 | -1.49 | 0.65 | 1303.71 | 1.00 | 17 | 10 | 16 | 6 | FALSE | 0.34 |
| colorectal cancer | KRAS_12-61 | KMT2A | Any mutation | 165 | 19 | Signature 15 | -1.25 | -2.36 | -0.30 | 1519.15 | 1.00 | 207 | 162 | 16 | 3 | FALSE | 1.77 |
| colorectal cancer | KRAS_12-61 | KMT2A | Any mutation | 333 | 53 | Signature 1A | 0.13 | -0.43 | 0.68 | 1508.47 | 1.00 | 488 | 309 | 29 | 24 | FALSE | 0.19 |
| colorectal cancer | KRAS_12-61 | KMT2A | Any mutation | 112 | 42 | Signature 6 | -1.02 | -1.85 | -0.26 | 1620.04 | 1.00 | 174 | 105 | 35 | 7 | FALSE | 1.97 |
| non-small cell lung cancer | KRAS_12-61 | KMT2A | Any mutation | 84 | 23 | Signature 2 | -0.17 | -0.98 | 0.68 | 1393.30 | 1.00 | 225 | 78 | 17 | 6 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12-61 | KMT2A | Any mutation | 266 | 37 | Signature 4 | -0.35 | -1.04 | 0.32 | 1491.56 | 1.00 | 411 | 255 | 26 | 11 | FALSE | 0.50 |
| uterine cancer | KRAS_12-61 | KMT2A | Any mutation | 39 | 13 | Signature 1A | 0.53 | -0.77 | 1.72 | 1522.84 | 1.00 | 171 | 35 | 9 | 4 | FALSE | 0.39 |
| uterine cancer | KRAS_12-61 | KMT2A | Any mutation | 17 | 14 | Signature 6 | -1.01 | -3.11 | 0.64 | 1449.97 | 1.00 | 68 | 16 | 13 | 1 | FALSE | 0.53 |
| colorectal cancer | KRAS_12-61 | KMT2A | Any mutation | 626 | 136 | Signature overall | -0.64 | -1.71 | 0.38 | 1454.88 | 1.00 | 886 | 586 | 96 | 40 | FALSE | 0.64 |
| non-small cell lung cancer | KRAS_12-61 | KMT2A | Any mutation | 350 | 60 | Signature overall | -0.25 | -1.30 | 0.85 | 1398.75 | 1.00 | 636 | 333 | 43 | 17 | FALSE | 0.18 |
| uterine cancer | KRAS_12-61 | KMT2A | Any mutation | 59 | 81 | Signature overall | 0.06 | -2.31 | 2.46 | 1343.48 | 1.00 | 257 | 51 | 73 | 8 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | PAK7 | Any mutation | 266 | 69 | Signature 4 | -0.33 | -0.93 | 0.18 | 65.17 | 1.05 | 395 | 245 | 48 | 21 | FALSE | 0.56 |
| non-small cell lung cancer | KRAS_12-61 | PAK7 | Any mutation | 266 | 69 | Signature overall | -0.27 | -4.41 | 4.29 | 1598.84 | 1.00 | 395 | 245 | 48 | 21 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | STAG2 | Any mutation | 84 | 16 | Signature 2 | 0.05 | -0.92 | 0.86 | 1402.66 | 1.00 | 229 | 80 | 12 | 4 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12-61 | STAG2 | Any mutation | 267 | 43 | Signature 4 | 0.24 | -0.35 | 0.81 | 1308.00 | 1.00 | 415 | 248 | 24 | 19 | TRUE | 0.36 |
| non-small cell lung cancer | KRAS_12-61 | STAG2 | Any mutation | 351 | 59 | Signature overall | 0.14 | -0.95 | 1.12 | 1223.55 | 1.00 | 644 | 328 | 36 | 23 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12-61 | TERT | Any mutation | 85 | 23 | Signature 2 | 0.71 | -0.06 | 1.52 | 1229.65 | 1.00 | 228 | 74 | 12 | 11 | TRUE | 1.09 |
| non-small cell lung cancer | KRAS_12-61 | TERT | Any mutation | 267 | 54 | Signature 4 | 0.18 | -0.35 | 0.70 | 1313.01 | 1.00 | 407 | 246 | 33 | 21 | TRUE | 0.28 |
| non-small cell lung cancer | KRAS_12-61 | TERT | Any mutation | 352 | 77 | Signature overall | 0.44 | -0.59 | 1.61 | 1519.38 | 1.00 | 635 | 320 | 45 | 32 | TRUE | 0.34 |
| colorectal cancer | KRAS_12-61 | BRCA2 | Any mutation | 15 | 37 | Signature 10 | -1.60 | -2.81 | -0.47 | 1386.18 | 1.00 | 14 | 11 | 33 | 4 | TRUE | 2.14 |
| colorectal cancer | KRAS_12-61 | BRCA2 | Any mutation | 164 | 17 | Signature 15 | -1.02 | -2.09 | 0.03 | 1386.64 | 1.00 | 213 | 160 | 13 | 4 | TRUE | 1.21 |
| colorectal cancer | KRAS_12-61 | BRCA2 | Any mutation | 336 | 50 | Signature 1A | 0.09 | -0.47 | 0.65 | 1462.14 | 1.00 | 490 | 314 | 28 | 22 | TRUE | 0.12 |
| colorectal cancer | KRAS_12-61 | BRCA2 | Any mutation | 114 | 62 | Signature 6 | -1.30 | -2.04 | -0.63 | 1486.02 | 1.00 | 163 | 105 | 53 | 9 | TRUE | 3.47 |
| non-small cell lung cancer | KRAS_12-61 | BRCA2 | Any mutation | 14 | 13 | Signature 13 | -1.32 | -3.57 | 0.08 | 1545.59 | 1.00 | 73 | 14 | 13 | 0 | TRUE | 0.80 |
| non-small cell lung cancer | KRAS_12-61 | BRCA2 | Any mutation | 84 | 15 | Signature 2 | -0.92 | -2.22 | 0.14 | 1404.70 | 1.00 | 228 | 82 | 13 | 2 | TRUE | 0.90 |
| non-small cell lung cancer | KRAS_12-61 | BRCA2 | Any mutation | 267 | 55 | Signature 4 | -0.43 | -1.01 | 0.15 | 1402.70 | 1.00 | 404 | 250 | 38 | 17 | TRUE | 0.82 |
| uterine cancer | KRAS_12-61 | BRCA2 | Any mutation | 39 | 15 | Signature 1A | 0.39 | -0.93 | 1.52 | 1485.32 | 1.00 | 169 | 35 | 11 | 4 | TRUE | 0.28 |
| uterine cancer | KRAS_12-61 | BRCA2 | Any mutation | 17 | 22 | Signature 6 | -1.49 | -3.65 | 0.07 | 1472.38 | 1.00 | 66 | 16 | 21 | 1 | TRUE | 0.92 |
| colorectal cancer | KRAS_12-61 | BRCA2 | Any mutation | 629 | 166 | Signature overall | -0.95 | -2.30 | 0.40 | 1565.29 | 1.00 | 880 | 590 | 127 | 39 | TRUE | 0.77 |
| non-small cell lung cancer | KRAS_12-61 | BRCA2 | Any mutation | 365 | 83 | Signature overall | -0.89 | -2.29 | 0.23 | 1235.23 | 1.00 | 705 | 346 | 64 | 19 | TRUE | 0.77 |
| uterine cancer | KRAS_12-61 | BRCA2 | Any mutation | 60 | 102 | Signature overall | -0.14 | -2.39 | 2.49 | 1577.10 | 1.00 | 250 | 51 | 93 | 9 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | NOTCH3 | Any mutation | 164 | 27 | Signature 15 | -0.48 | -1.21 | 0.26 | 1580.33 | 1.00 | 209 | 154 | 17 | 10 | TRUE | 0.73 |
| colorectal cancer | KRAS_12-61 | NOTCH3 | Any mutation | 332 | 70 | Signature 1A | -0.66 | -1.21 | -0.15 | 1456.96 | 1.00 | 474 | 313 | 51 | 19 | TRUE | 1.87 |
| colorectal cancer | KRAS_12-61 | NOTCH3 | Any mutation | 112 | 72 | Signature 6 | -1.09 | -1.77 | -0.48 | 1468.27 | 1.00 | 158 | 101 | 61 | 11 | TRUE | 3.13 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH3 | Any mutation | 66 | 11 | Signature 18 | 0.28 | -0.57 | 1.31 | 1612.82 | 1.00 | 81 | 59 | 4 | 7 | TRUE | 0.27 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH3 | Any mutation | 84 | 15 | Signature 2 | -0.06 | -0.88 | 0.71 | 1419.27 | 1.00 | 230 | 80 | 11 | 4 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH3 | Any mutation | 266 | 48 | Signature 4 | -0.23 | -0.86 | 0.34 | 1150.21 | 1.00 | 407 | 252 | 34 | 14 | TRUE | 0.34 |
| colorectal cancer | KRAS_12-61 | NOTCH3 | Any mutation | 608 | 169 | Signature overall | -0.74 | -1.63 | 0.09 | 1362.57 | 1.00 | 841 | 568 | 129 | 40 | TRUE | 1.02 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH3 | Any mutation | 416 | 74 | Signature overall | -0.01 | -0.78 | 0.77 | 1354.81 | 1.00 | 718 | 391 | 49 | 25 | TRUE | 0.01 |
| colorectal cancer | KRAS_12-61 | NOTCH4 | Any mutation | 160 | 18 | Signature 15 | -0.79 | -1.66 | -0.09 | 1455.51 | 1.00 | 205 | 156 | 14 | 4 | TRUE | 1.32 |
| colorectal cancer | KRAS_12-61 | NOTCH4 | Any mutation | 320 | 43 | Signature 1A | -0.46 | -1.07 | 0.13 | 1467.15 | 1.00 | 477 | 306 | 29 | 14 | TRUE | 0.88 |
| colorectal cancer | KRAS_12-61 | NOTCH4 | Any mutation | 110 | 41 | Signature 6 | -0.54 | -1.21 | 0.09 | 1420.62 | 1.00 | 168 | 100 | 31 | 10 | TRUE | 0.99 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH4 | Any mutation | 266 | 74 | Signature 4 | -0.48 | -1.00 | 0.04 | 817.86 | 1.01 | 389 | 245 | 53 | 21 | TRUE | 1.18 |
| colorectal cancer | KRAS_12-61 | NOTCH4 | Any mutation | 590 | 102 | Signature overall | -0.61 | -1.42 | 0.10 | 1419.51 | 1.00 | 850 | 562 | 74 | 28 | TRUE | 0.90 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH4 | Any mutation | 266 | 74 | Signature overall | -0.41 | -4.36 | 4.13 | 1151.70 | 1.00 | 389 | 245 | 53 | 21 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 14 | 20 | Signature 13 | -0.03 | -0.92 | 0.88 | 1495.09 | 1.00 | 66 | 12 | 18 | 2 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 21 | 12 | Signature 14 | 0.18 | -0.75 | 1.02 | 1524.88 | 1.00 | 27 | 17 | 8 | 4 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 31 | 16 | Signature 15 | 0.69 | -0.11 | 1.54 | 1427.27 | 1.00 | 97 | 24 | 9 | 7 | FALSE | 1.00 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 9 | 12 | Signature 16 | 0.22 | -0.89 | 1.17 | 1575.88 | 1.00 | 41 | 7 | 10 | 2 | FALSE | 0.17 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 67 | 34 | Signature 18 | 0.30 | -0.37 | 0.94 | 1438.17 | 1.00 | 67 | 51 | 18 | 16 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 17 | 11 | Signature 19 | 0.83 | -0.08 | 1.74 | 1515.99 | 1.00 | 41 | 11 | 5 | 6 | FALSE | 1.13 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 47 | 27 | Signature 1A | 0.54 | -0.22 | 1.26 | 1370.06 | 1.00 | 202 | 39 | 19 | 8 | FALSE | 0.79 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 84 | 55 | Signature 2 | -0.10 | -0.74 | 0.44 | 1287.82 | 1.00 | 200 | 72 | 43 | 12 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 15 | 13 | Signature 20 | 0.50 | -0.34 | 1.45 | 1396.22 | 1.00 | 53 | 11 | 9 | 4 | FALSE | 0.55 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 54 | 31 | Signature 3 | 0.58 | -0.12 | 1.23 | 1497.82 | 1.00 | 169 | 43 | 20 | 11 | FALSE | 1.04 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 270 | 175 | Signature 4 | 0.01 | -0.34 | 0.34 | 1457.06 | 1.00 | 329 | 205 | 110 | 65 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 24 | 14 | Signature 7 | 0.12 | -0.85 | 1.02 | 1579.54 | 1.00 | 74 | 21 | 11 | 3 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 155 | 45 | Signature R2 | 0.23 | -0.39 | 0.89 | 1434.18 | 1.00 | 34 | 121 | 11 | 34 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 21 | 11 | Signature U1 | 1.10 | 0.22 | 2.07 | 1527.50 | 1.00 | 86 | 14 | 4 | 7 | FALSE | 1.65 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Any mutation | 829 | 476 | Signature overall | 0.37 | -0.07 | 0.80 | 1377.61 | 1.00 | 1486 | 648 | 295 | 181 | FALSE | 1.05 |
| non-small cell lung cancer | KRAS_12-61 | KDM5C | Any mutation | 84 | 15 | Signature 2 | -0.36 | -1.83 | 0.70 | 1264.51 | 1.00 | 228 | 82 | 13 | 2 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12-61 | KDM5C | Any mutation | 267 | 41 | Signature 4 | 0.55 | -0.07 | 1.17 | 1567.36 | 1.00 | 418 | 245 | 19 | 22 | FALSE | 1.11 |
| non-small cell lung cancer | KRAS_12-61 | KDM5C | Any mutation | 351 | 56 | Signature overall | 0.11 | -1.50 | 1.42 | 1456.43 | 1.00 | 646 | 327 | 32 | 24 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 14 | 12 | Signature 13 | -1.11 | -2.92 | 0.37 | 1380.59 | 1.00 | 72 | 14 | 12 | 0 | TRUE | 0.75 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 31 | 11 | Signature 15 | -0.81 | -2.26 | 0.41 | 1429.86 | 1.00 | 95 | 30 | 10 | 1 | TRUE | 0.63 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 47 | 18 | Signature 1A | 0.65 | -0.30 | 1.56 | 1494.62 | 1.00 | 208 | 40 | 11 | 7 | TRUE | 0.75 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 84 | 22 | Signature 2 | -1.32 | -2.65 | -0.29 | 1283.36 | 1.00 | 220 | 83 | 21 | 1 | TRUE | 1.51 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 55 | 20 | Signature 3 | 0.13 | -0.90 | 1.07 | 1412.10 | 1.00 | 175 | 49 | 14 | 6 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 269 | 90 | Signature 4 | -0.58 | -1.09 | -0.09 | 1290.87 | 1.00 | 375 | 245 | 66 | 24 | TRUE | 1.63 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 154 | 11 | Signature R2 | -0.10 | -1.07 | 0.98 | 1462.23 | 1.00 | 42 | 145 | 2 | 9 | TRUE | 0.07 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 118 | 30 | Signature 11 | 1.61 | 0.82 | 2.53 | 1350.05 | 1.00 | 8 | 89 | 1 | 29 | TRUE | 3.67 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 114 | 27 | Signature 15 | 1.40 | 0.53 | 2.33 | 961.00 | 1.00 | 15 | 92 | 5 | 22 | TRUE | 2.71 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 51 | 11 | Signature 17 | 1.59 | 0.74 | 2.55 | 1270.56 | 1.00 | 3 | 40 | 0 | 11 | TRUE | 3.34 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 222 | 67 | Signature 1A | 1.68 | 0.96 | 2.58 | 1337.52 | 1.00 | 32 | 157 | 2 | 65 | TRUE | 4.39 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 84 | 23 | Signature 3 | 1.65 | 0.82 | 2.63 | 1412.15 | 1.00 | 18 | 61 | 0 | 23 | TRUE | 3.80 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 65 | 25 | Signature 4 | 1.79 | 0.99 | 2.78 | 1222.53 | 1.00 | 9 | 40 | 0 | 25 | TRUE | 4.24 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 61 | 26 | Signature 6 | 1.82 | 1.02 | 2.81 | 1204.56 | 1.00 | 13 | 35 | 0 | 26 | TRUE | 4.23 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 49 | 11 | Signature 8 | 1.60 | 0.75 | 2.53 | 1288.72 | 1.00 | 3 | 38 | 0 | 11 | TRUE | 3.47 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Any mutation | 654 | 184 | Signature overall | -0.44 | -1.26 | 0.39 | 1501.76 | 1.00 | 1187 | 606 | 136 | 48 | TRUE | 0.53 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Any mutation | 764 | 220 | Signature overall | 1.64 | 0.91 | 2.55 | 1255.93 | 1.00 | 101 | 552 | 8 | 212 | TRUE | 4.34 |
| non-small cell lung cancer | KRAS_12-61 | EPHB1 | Any mutation | 84 | 17 | Signature 2 | -0.39 | -1.46 | 0.70 | 1553.72 | 1.00 | 228 | 80 | 13 | 4 | FALSE | 0.34 |
| non-small cell lung cancer | KRAS_12-61 | EPHB1 | Any mutation | 268 | 79 | Signature 4 | -0.67 | -1.20 | -0.14 | 1337.45 | 1.00 | 386 | 249 | 60 | 19 | FALSE | 1.97 |
| non-small cell lung cancer | KRAS_12-61 | EPHB1 | Any mutation | 352 | 96 | Signature overall | -0.54 | -2.00 | 0.89 | 1108.08 | 1.00 | 614 | 329 | 73 | 23 | FALSE | 0.35 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 26 | 20 | Signature 15 | -1.04 | -2.27 | -0.03 | 1368.58 | 1.00 | 66 | 24 | 18 | 2 | FALSE | 1.21 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 39 | 25 | Signature 1A | -1.00 | -2.15 | 0.01 | 1451.91 | 1.00 | 159 | 37 | 23 | 2 | FALSE | 1.16 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 10 | 14 | Signature 3 | -0.82 | -2.01 | 0.41 | 1387.71 | 1.00 | 23 | 8 | 12 | 2 | FALSE | 0.73 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 17 | 17 | Signature 6 | -0.59 | -1.77 | 0.60 | 1713.93 | 1.00 | 71 | 14 | 14 | 3 | FALSE | 0.48 |
| uterine cancer | KRAS_12-61 | PPP2R1A | Any mutation | 93 | 96 | Signature overall | -0.91 | -1.94 | 0.09 | 1477.61 | 1.00 | 351 | 84 | 87 | 9 | FALSE | 1.12 |
| colorectal cancer | KRAS_12-61 | ERBB3 | Any mutation | 164 | 18 | Signature 15 | -0.15 | -0.86 | 0.46 | 1472.06 | 1.00 | 209 | 158 | 12 | 6 | TRUE | 0.19 |
| colorectal cancer | KRAS_12-61 | ERBB3 | Any mutation | 333 | 46 | Signature 1A | 0.02 | -0.44 | 0.54 | 1206.79 | 1.00 | 493 | 314 | 27 | 19 | TRUE | 0.03 |
| colorectal cancer | KRAS_12-61 | ERBB3 | Any mutation | 112 | 34 | Signature 6 | 0.18 | -0.38 | 0.78 | 1356.62 | 1.00 | 184 | 98 | 20 | 14 | TRUE | 0.26 |
| colorectal cancer | KRAS_12-61 | ERBB3 | Any mutation | 609 | 98 | Signature overall | 0.01 | -0.60 | 0.60 | 1499.93 | 1.00 | 886 | 570 | 59 | 39 | TRUE | 0.02 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 13 | 17 | Signature 10 | 0.14 | -0.47 | 0.73 | 1450.15 | 1.00 | 14 | 8 | 12 | 5 | TRUE | 0.20 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 165 | 60 | Signature 15 | 0.12 | -0.28 | 0.50 | 1318.97 | 1.00 | 193 | 137 | 32 | 28 | TRUE | 0.25 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 14 | 11 | Signature 17 | 0.00 | -0.71 | 0.60 | 1538.10 | 1.00 | 23 | 12 | 9 | 2 | TRUE | 0.00 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 21 | 12 | Signature 19 | 0.25 | -0.33 | 0.89 | 1117.40 | 1.00 | 20 | 14 | 5 | 7 | TRUE | 0.39 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 337 | 122 | Signature 1A | 0.00 | -0.34 | 0.33 | 1680.96 | 1.00 | 444 | 289 | 74 | 48 | TRUE | 0.00 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 44 | 11 | Signature 2 | 0.12 | -0.42 | 0.68 | 1560.06 | 1.00 | 34 | 37 | 4 | 7 | TRUE | 0.18 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 113 | 57 | Signature 6 | 0.03 | -0.41 | 0.45 | 1439.20 | 1.00 | 169 | 93 | 37 | 20 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 15 | 11 | Signature 7 | 0.27 | -0.33 | 0.91 | 1578.84 | 1.00 | 20 | 9 | 5 | 6 | TRUE | 0.40 |
| non-small cell lung cancer | KRAS_12-61 | SMAD4 | Any mutation | 47 | 17 | Signature 1A | -0.14 | -1.40 | 0.84 | 1535.64 | 1.00 | 206 | 45 | 15 | 2 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12-61 | SMAD4 | Any mutation | 84 | 21 | Signature 2 | 0.78 | -0.04 | 1.61 | 1436.68 | 1.00 | 229 | 74 | 11 | 10 | TRUE | 1.19 |
| non-small cell lung cancer | KRAS_12-61 | SMAD4 | Any mutation | 266 | 16 | Signature 4 | -0.02 | -0.88 | 0.80 | 1362.39 | 1.00 | 426 | 260 | 10 | 6 | TRUE | 0.01 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 116 | 25 | Signature 11 | 0.44 | -0.08 | 1.02 | 877.52 | 1.00 | 8 | 92 | 1 | 24 | TRUE | 0.92 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 113 | 31 | Signature 15 | 0.47 | -0.04 | 1.05 | 849.76 | 1.00 | 17 | 85 | 3 | 28 | TRUE | 1.02 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 52 | 12 | Signature 17 | 0.47 | -0.06 | 1.09 | 878.86 | 1.00 | 3 | 40 | 0 | 12 | TRUE | 0.94 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 219 | 56 | Signature 1A | 0.48 | -0.03 | 1.05 | 808.84 | 1.00 | 31 | 166 | 3 | 53 | TRUE | 1.07 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 33 | 12 | Signature 2 | 0.40 | -0.21 | 0.99 | 918.27 | 1.00 | 8 | 26 | 5 | 7 | TRUE | 0.73 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 81 | 24 | Signature 3 | 0.46 | -0.08 | 1.03 | 828.37 | 1.00 | 15 | 60 | 3 | 21 | TRUE | 0.98 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 64 | 15 | Signature 4 | 0.44 | -0.10 | 1.00 | 848.28 | 1.00 | 8 | 50 | 1 | 14 | TRUE | 0.91 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 61 | 15 | Signature 6 | 0.39 | -0.17 | 0.97 | 943.01 | 1.00 | 9 | 50 | 4 | 11 | TRUE | 0.74 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 50 | 15 | Signature 8 | 0.52 | -0.02 | 1.15 | 799.93 | 1.00 | 3 | 35 | 0 | 15 | TRUE | 1.07 |
| colorectal cancer | KRAS_12-61 | SMAD4 | Any mutation | 722 | 301 | Signature overall | 0.12 | -0.25 | 0.47 | 1145.96 | 1.00 | 917 | 599 | 178 | 123 | TRUE | 0.27 |
| non-small cell lung cancer | KRAS_12-61 | SMAD4 | Any mutation | 397 | 54 | Signature overall | 0.19 | -0.93 | 1.24 | 1691.58 | 1.00 | 861 | 379 | 36 | 18 | TRUE | 0.14 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Any mutation | 789 | 205 | Signature overall | 0.46 | -0.04 | 0.99 | 745.38 | 1.00 | 102 | 604 | 20 | 185 | TRUE | 1.09 |
| colorectal cancer | KRAS_12-61 | ATM | Any mutation | 19 | 39 | Signature 10 | -0.45 | -1.42 | 0.47 | 1515.78 | 1.00 | 13 | 9 | 29 | 10 | TRUE | 0.47 |
| colorectal cancer | KRAS_12-61 | ATM | Any mutation | 166 | 32 | Signature 15 | -0.18 | -0.88 | 0.48 | 1557.91 | 1.00 | 205 | 153 | 19 | 13 | TRUE | 0.21 |
| colorectal cancer | KRAS_12-61 | ATM | Any mutation | 335 | 77 | Signature 1A | 0.27 | -0.22 | 0.74 | 1427.90 | 1.00 | 479 | 299 | 41 | 36 | TRUE | 0.57 |
| colorectal cancer | KRAS_12-61 | ATM | Any mutation | 112 | 48 | Signature 6 | -1.02 | -1.81 | -0.32 | 1536.81 | 1.00 | 168 | 104 | 40 | 8 | TRUE | 2.18 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 14 | 12 | Signature 13 | 1.05 | 0.02 | 2.13 | 1346.77 | 1.00 | 76 | 10 | 8 | 4 | TRUE | 1.32 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 66 | 11 | Signature 18 | 0.60 | -0.37 | 1.56 | 1341.32 | 1.00 | 80 | 60 | 5 | 6 | TRUE | 0.66 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 86 | 27 | Signature 2 | 0.88 | 0.15 | 1.58 | 1486.51 | 1.00 | 226 | 74 | 15 | 12 | TRUE | 1.85 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 54 | 13 | Signature 3 | 0.74 | -0.22 | 1.65 | 1467.19 | 1.00 | 181 | 49 | 8 | 5 | TRUE | 0.93 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 278 | 95 | Signature 4 | 0.78 | 0.36 | 1.21 | 1541.05 | 1.00 | 398 | 226 | 43 | 52 | TRUE | 3.51 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 155 | 25 | Signature R2 | 0.71 | -0.12 | 1.53 | 1574.61 | 1.00 | 40 | 134 | 4 | 21 | TRUE | 0.98 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 14 | 12 | Signature U2 | 1.67 | 0.62 | 2.73 | 1396.05 | 1.00 | 29 | 6 | 4 | 8 | TRUE | 2.82 |
| uterine cancer | KRAS_12-61 | ATM | Any mutation | 6 | 11 | Signature 14 | -0.44 | -2.09 | 1.03 | 1447.82 | 1.00 | 10 | 4 | 9 | 2 | TRUE | 0.23 |
| uterine cancer | KRAS_12-61 | ATM | Any mutation | 39 | 23 | Signature 1A | -0.50 | -1.75 | 0.55 | 1542.16 | 1.00 | 164 | 36 | 20 | 3 | TRUE | 0.41 |
| uterine cancer | KRAS_12-61 | ATM | Any mutation | 18 | 24 | Signature 6 | -0.51 | -1.84 | 0.59 | 1482.17 | 1.00 | 67 | 15 | 21 | 3 | TRUE | 0.37 |
| colorectal cancer | KRAS_12-61 | ATM | Any mutation | 632 | 196 | Signature overall | -0.34 | -1.42 | 0.86 | 1422.03 | 1.00 | 865 | 565 | 129 | 67 | TRUE | 0.27 |
| non-small cell lung cancer | KRAS_12-61 | ATM | Any mutation | 667 | 195 | Signature overall | 0.93 | 0.22 | 1.65 | 1570.23 | 1.00 | 1030 | 559 | 87 | 108 | TRUE | 2.00 |
| uterine cancer | KRAS_12-61 | ATM | Any mutation | 67 | 121 | Signature overall | -0.34 | -1.85 | 1.24 | 1471.73 | 1.00 | 254 | 55 | 109 | 12 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 14 | 11 | Signature 13 | -0.68 | -1.68 | 0.40 | 1423.06 | 1.00 | 77 | 12 | 9 | 2 | TRUE | 0.71 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 66 | 11 | Signature 18 | -0.74 | -1.59 | 0.08 | 1447.69 | 1.00 | 77 | 62 | 7 | 4 | TRUE | 1.06 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 47 | 16 | Signature 1A | -0.84 | -1.81 | 0.06 | 1553.00 | 1.00 | 205 | 45 | 14 | 2 | TRUE | 1.09 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 84 | 28 | Signature 2 | -1.00 | -1.91 | -0.23 | 1384.12 | 1.00 | 215 | 81 | 25 | 3 | TRUE | 1.68 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 54 | 18 | Signature 3 | -1.26 | -2.31 | -0.34 | 1303.03 | 1.00 | 171 | 54 | 18 | 0 | TRUE | 1.88 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 266 | 67 | Signature 4 | -0.89 | -1.46 | -0.35 | 1407.41 | 1.00 | 387 | 252 | 53 | 14 | TRUE | 2.80 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Any mutation | 531 | 151 | Signature overall | -0.90 | -1.54 | -0.27 | 1438.49 | 1.00 | 1132 | 506 | 126 | 25 | TRUE | 2.20 |
| cancer of unknown primary | KRAS_12-61 | KMT2D | Any mutation | 35 | 18 | Signature 1A | -1.23 | -2.49 | -0.06 | 1073.38 | 1.00 | 68 | 32 | 15 | 3 | FALSE | 1.34 |
| cancer of unknown primary | KRAS_12-61 | KMT2D | Any mutation | 21 | 15 | Signature 4 | -1.31 | -2.80 | 0.03 | 1483.50 | 1.00 | 48 | 19 | 13 | 2 | FALSE | 1.19 |
| cancer of unknown primary | KRAS_12-61 | KMT2D | Any mutation | 6 | 13 | Signature 6 | -1.97 | -4.00 | -0.35 | 1184.01 | 1.00 | 13 | 6 | 13 | 0 | FALSE | 1.46 |
| colorectal cancer | KRAS_12-61 | KMT2D | Any mutation | 13 | 19 | Signature 10 | -1.04 | -2.11 | -0.06 | 1540.64 | 1.00 | 13 | 10 | 16 | 3 | FALSE | 1.41 |
| colorectal cancer | KRAS_12-61 | KMT2D | Any mutation | 165 | 55 | Signature 15 | -1.12 | -1.77 | -0.51 | 1581.57 | 1.00 | 199 | 154 | 44 | 11 | FALSE | 3.45 |
| colorectal cancer | KRAS_12-61 | KMT2D | Any mutation | 342 | 128 | Signature 1A | -0.54 | -0.92 | -0.14 | 1351.62 | 1.00 | 460 | 304 | 90 | 38 | FALSE | 2.20 |
| colorectal cancer | KRAS_12-61 | KMT2D | Any mutation | 123 | 142 | Signature 6 | -0.95 | -1.41 | -0.51 | 1337.41 | 1.00 | 137 | 94 | 113 | 29 | FALSE | 4.40 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 14 | 16 | Signature 13 | -1.35 | -2.97 | 0.01 | 1413.62 | 1.00 | 69 | 14 | 16 | 0 | FALSE | 1.16 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 66 | 16 | Signature 18 | -0.90 | -1.87 | 0.01 | 1581.09 | 1.00 | 74 | 62 | 12 | 4 | FALSE | 1.17 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 47 | 22 | Signature 1A | -0.89 | -1.98 | 0.15 | 1554.99 | 1.00 | 202 | 45 | 20 | 2 | FALSE | 0.96 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 85 | 46 | Signature 2 | -0.27 | -1.01 | 0.38 | 1479.81 | 1.00 | 211 | 74 | 35 | 11 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 54 | 13 | Signature 3 | -1.11 | -2.45 | 0.09 | 1532.95 | 1.00 | 177 | 53 | 12 | 1 | FALSE | 1.09 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 269 | 129 | Signature 4 | -0.70 | -1.15 | -0.28 | 1601.12 | 1.00 | 359 | 237 | 97 | 32 | FALSE | 2.77 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 154 | 13 | Signature R2 | -0.40 | -1.34 | 0.52 | 1638.61 | 1.00 | 41 | 144 | 3 | 10 | FALSE | 0.41 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 8 | 24 | Signature 14 | -0.01 | -1.08 | 1.03 | 1611.40 | 1.00 | 9 | 3 | 19 | 5 | FALSE | 0.01 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 27 | 27 | Signature 15 | 0.11 | -0.73 | 0.94 | 1359.35 | 1.00 | 68 | 19 | 19 | 8 | FALSE | 0.10 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 40 | 61 | Signature 1A | -0.38 | -1.10 | 0.32 | 1467.05 | 1.00 | 138 | 32 | 53 | 8 | FALSE | 0.53 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 9 | 13 | Signature 20 | -0.06 | -1.12 | 1.05 | 1586.60 | 1.00 | 24 | 6 | 10 | 3 | FALSE | 0.04 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 19 | 63 | Signature 6 | -0.25 | -1.01 | 0.55 | 1508.70 | 1.00 | 44 | 10 | 54 | 9 | FALSE | 0.27 |
| cancer of unknown primary | KRAS_12-61 | KMT2D | Any mutation | 65 | 76 | Signature overall | -1.48 | -2.89 | -0.22 | 1241.35 | 1.00 | 160 | 59 | 70 | 6 | FALSE | 1.50 |
| colorectal cancer | KRAS_12-61 | KMT2D | Any mutation | 643 | 344 | Signature overall | -0.90 | -1.63 | -0.23 | 1814.07 | 1.00 | 809 | 562 | 263 | 81 | FALSE | 1.92 |
| non-small cell lung cancer | KRAS_12-61 | KMT2D | Any mutation | 689 | 255 | Signature overall | -0.80 | -1.54 | -0.05 | 1475.58 | 1.00 | 1133 | 629 | 195 | 60 | FALSE | 1.45 |
| uterine cancer | KRAS_12-61 | KMT2D | Any mutation | 107 | 233 | Signature overall | -0.14 | -0.87 | 0.56 | 1626.89 | 1.00 | 302 | 71 | 197 | 36 | FALSE | 0.15 |
| colorectal cancer | KRAS_12-61 | TSC2 | Any mutation | 164 | 11 | Signature 15 | 0.06 | -0.95 | 1.19 | 1449.02 | 1.00 | 216 | 158 | 5 | 6 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | TSC2 | Any mutation | 334 | 36 | Signature 1A | -0.01 | -0.63 | 0.67 | 1473.16 | 1.00 | 497 | 319 | 21 | 15 | TRUE | 0.01 |
| colorectal cancer | KRAS_12-61 | TSC2 | Any mutation | 111 | 44 | Signature 6 | -1.12 | -2.03 | -0.33 | 1486.58 | 1.00 | 171 | 105 | 38 | 6 | TRUE | 1.97 |
| colorectal cancer | KRAS_12-61 | TSC2 | Any mutation | 609 | 91 | Signature overall | -0.36 | -1.58 | 1.01 | 1445.71 | 1.00 | 884 | 582 | 64 | 27 | TRUE | 0.23 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 30 | 94 | Signature 10 | 0.19 | -0.29 | 0.73 | 1389.57 | 1.00 | 3 | 0 | 64 | 30 | TRUE | 0.33 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 31 | 39 | Signature 11 | 0.24 | -0.32 | 0.73 | 1362.55 | 1.00 | 1 | 9 | 17 | 22 | TRUE | 0.42 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 13 | 25 | Signature 14 | 0.30 | -0.29 | 0.90 | 1336.58 | 1.00 | 2 | 1 | 13 | 12 | TRUE | 0.50 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 255 | 469 | Signature 15 | 0.53 | 0.19 | 0.90 | 1421.57 | 1.00 | 58 | 25 | 239 | 230 | TRUE | 2.33 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 21 | 46 | Signature 17 | 0.13 | -0.37 | 0.61 | 1404.90 | 1.00 | 11 | 4 | 29 | 17 | TRUE | 0.22 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 24 | 63 | Signature 18 | 0.01 | -0.52 | 0.49 | 1503.55 | 1.00 | 3 | 5 | 44 | 19 | TRUE | 0.01 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 26 | 38 | Signature 19 | 0.09 | -0.45 | 0.59 | 1600.28 | 1.00 | 9 | 9 | 21 | 17 | TRUE | 0.13 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 481 | 962 | Signature 1A | 0.08 | -0.19 | 0.33 | 1378.38 | 1.00 | 132 | 89 | 570 | 392 | TRUE | 0.25 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 14 | 22 | Signature 1B | 0.37 | -0.18 | 0.96 | 1251.55 | 1.00 | 7 | 1 | 9 | 13 | TRUE | 0.68 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 64 | 95 | Signature 2 | 0.41 | -0.05 | 0.89 | 1529.85 | 1.00 | 8 | 9 | 40 | 55 | TRUE | 1.05 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 18 | 34 | Signature 20 | 0.16 | -0.41 | 0.70 | 1449.45 | 1.00 | 4 | 4 | 20 | 14 | TRUE | 0.26 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 13 | 25 | Signature 21 | 0.33 | -0.23 | 0.87 | 1498.36 | 1.00 | 10 | 0 | 12 | 13 | TRUE | 0.61 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 21 | 42 | Signature 3 | 0.23 | -0.31 | 0.76 | 1438.90 | 1.00 | 8 | 3 | 24 | 18 | TRUE | 0.39 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 25 | 49 | Signature 4 | 0.16 | -0.38 | 0.67 | 1497.38 | 1.00 | 6 | 5 | 29 | 20 | TRUE | 0.25 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 166 | 355 | Signature 6 | 0.16 | -0.20 | 0.50 | 1527.70 | 1.00 | 64 | 31 | 220 | 135 | TRUE | 0.40 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 22 | 40 | Signature 7 | 0.27 | -0.24 | 0.82 | 1402.90 | 1.00 | 9 | 3 | 21 | 19 | TRUE | 0.49 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 19 | 30 | Signature 8 | 0.40 | -0.13 | 0.98 | 1439.30 | 1.00 | 1 | 2 | 13 | 17 | TRUE | 0.79 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 21 | 20 | Signature R2 | 0.31 | -0.25 | 0.85 | 1261.88 | 1.00 | 2 | 7 | 6 | 14 | TRUE | 0.56 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 10 | 14 | Signature U1 | 0.14 | -0.45 | 0.68 | 1575.37 | 1.00 | 2 | 4 | 8 | 6 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12-61 | APC | Any mutation | 47 | 13 | Signature 1A | -0.28 | -1.30 | 0.65 | 1446.58 | 1.00 | 208 | 45 | 11 | 2 | TRUE | 0.23 |
| non-small cell lung cancer | KRAS_12-61 | APC | Any mutation | 87 | 23 | Signature 2 | -0.05 | -0.84 | 0.78 | 1530.18 | 1.00 | 224 | 80 | 16 | 7 | TRUE | 0.04 |
| non-small cell lung cancer | KRAS_12-61 | APC | Any mutation | 266 | 50 | Signature 4 | -0.39 | -0.97 | 0.19 | 1499.07 | 1.00 | 404 | 252 | 36 | 14 | TRUE | 0.75 |
| uterine cancer | KRAS_12-61 | APC | Any mutation | 6 | 63 | Signature 10 | 1.16 | -0.72 | 4.18 | 1451.98 | 1.00 | 17 | 0 | 57 | 6 | TRUE | 0.47 |
| uterine cancer | KRAS_12-61 | APC | Any mutation | 40 | 18 | Signature 1A | 0.50 | -0.63 | 1.53 | 1598.31 | 1.00 | 171 | 35 | 13 | 5 | TRUE | 0.43 |
| uterine cancer | KRAS_12-61 | APC | Any mutation | 17 | 15 | Signature 6 | -0.29 | -1.94 | 1.06 | 1373.40 | 1.00 | 72 | 15 | 13 | 2 | TRUE | 0.15 |
| colorectal cancer | KRAS_12-61 | APC | Any mutation | 1274 | 2462 | Signature overall | 0.24 | -0.04 | 0.53 | 1292.68 | 1.00 | 340 | 211 | 1399 | 1063 | TRUE | 0.99 |
| non-small cell lung cancer | KRAS_12-61 | APC | Any mutation | 400 | 86 | Signature overall | -0.24 | -1.07 | 0.56 | 1685.12 | 1.00 | 836 | 377 | 63 | 23 | TRUE | 0.25 |
| uterine cancer | KRAS_12-61 | APC | Any mutation | 63 | 96 | Signature overall | 0.45 | -1.88 | 2.93 | 1454.09 | 1.00 | 260 | 50 | 83 | 13 | TRUE | 0.16 |
| colorectal cancer | KRAS_12-61 | ERBB2 | Any mutation | 332 | 47 | Signature 1A | -0.38 | -0.95 | 0.18 | 923.82 | 1.00 | 486 | 317 | 32 | 15 | TRUE | 0.72 |
| colorectal cancer | KRAS_12-61 | ERBB2 | Any mutation | 111 | 29 | Signature 6 | -0.38 | -1.08 | 0.30 | 804.20 | 1.00 | 183 | 103 | 21 | 8 | TRUE | 0.55 |
| non-small cell lung cancer | KRAS_12-61 | ERBB2 | Any mutation | 47 | 15 | Signature 1A | -0.94 | -2.20 | 0.23 | 1482.97 | 1.00 | 206 | 45 | 13 | 2 | TRUE | 0.87 |
| non-small cell lung cancer | KRAS_12-61 | ERBB2 | Any mutation | 84 | 12 | Signature 2 | -1.22 | -2.58 | -0.05 | 1457.19 | 1.00 | 229 | 83 | 11 | 1 | TRUE | 1.23 |
| non-small cell lung cancer | KRAS_12-61 | ERBB2 | Any mutation | 266 | 19 | Signature 4 | -1.21 | -2.35 | -0.23 | 1241.71 | 1.00 | 422 | 263 | 16 | 3 | TRUE | 1.59 |
| colorectal cancer | KRAS_12-61 | ERBB2 | Any mutation | 443 | 76 | Signature overall | -0.38 | -1.25 | 0.48 | 1232.02 | 1.00 | 669 | 420 | 53 | 23 | TRUE | 0.39 |
| non-small cell lung cancer | KRAS_12-61 | ERBB2 | Any mutation | 397 | 46 | Signature overall | -1.11 | -2.25 | 0.01 | 1423.65 | 1.00 | 857 | 391 | 40 | 6 | TRUE | 1.24 |
| uterine cancer | KRAS_12-61 | JAK1 | Any mutation | 29 | 14 | Signature 15 | 1.02 | 0.04 | 2.02 | 1476.41 | 1.00 | 77 | 22 | 7 | 7 | TRUE | 1.36 |
| uterine cancer | KRAS_12-61 | JAK1 | Any mutation | 42 | 35 | Signature 1A | 1.09 | 0.36 | 1.86 | 1467.34 | 1.00 | 160 | 29 | 22 | 13 | TRUE | 2.31 |
| uterine cancer | KRAS_12-61 | JAK1 | Any mutation | 18 | 42 | Signature 6 | 0.66 | -0.22 | 1.50 | 1504.77 | 1.00 | 58 | 9 | 33 | 9 | TRUE | 0.84 |
| uterine cancer | KRAS_12-61 | JAK1 | Any mutation | 92 | 117 | Signature overall | 0.80 | -0.30 | 1.97 | 1604.86 | 1.00 | 318 | 61 | 86 | 31 | TRUE | 0.80 |
| colorectal cancer | KRAS_12-61 | ARID2 | Any mutation | 12 | 16 | Signature 10 | -0.64 | -1.85 | 0.48 | 1544.77 | 1.00 | 14 | 9 | 13 | 3 | FALSE | 0.52 |
| colorectal cancer | KRAS_12-61 | ARID2 | Any mutation | 164 | 19 | Signature 15 | -0.73 | -1.67 | 0.12 | 1289.40 | 1.00 | 210 | 159 | 14 | 5 | FALSE | 0.95 |
| colorectal cancer | KRAS_12-61 | ARID2 | Any mutation | 333 | 42 | Signature 1A | 0.08 | -0.50 | 0.68 | 1660.33 | 1.00 | 494 | 314 | 23 | 19 | FALSE | 0.11 |
| colorectal cancer | KRAS_12-61 | ARID2 | Any mutation | 111 | 27 | Signature 6 | -0.52 | -1.39 | 0.26 | 1516.46 | 1.00 | 182 | 104 | 20 | 7 | FALSE | 0.66 |
| non-small cell lung cancer | KRAS_12-61 | ARID2 | Any mutation | 66 | 11 | Signature 18 | -0.07 | -0.88 | 0.76 | 1503.96 | 1.00 | 79 | 60 | 5 | 6 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | ARID2 | Any mutation | 84 | 18 | Signature 2 | -0.23 | -1.07 | 0.58 | 1466.79 | 1.00 | 228 | 79 | 13 | 5 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12-61 | ARID2 | Any mutation | 54 | 16 | Signature 3 | -0.45 | -1.38 | 0.41 | 1486.00 | 1.00 | 175 | 52 | 14 | 2 | FALSE | 0.50 |
| non-small cell lung cancer | KRAS_12-61 | ARID2 | Any mutation | 267 | 67 | Signature 4 | -0.48 | -1.02 | 0.03 | 1366.58 | 1.00 | 394 | 250 | 50 | 17 | FALSE | 1.12 |
| colorectal cancer | KRAS_12-61 | ARID2 | Any mutation | 620 | 104 | Signature overall | -0.44 | -1.54 | 0.54 | 1499.29 | 1.00 | 900 | 586 | 70 | 34 | FALSE | 0.40 |
| non-small cell lung cancer | KRAS_12-61 | ARID2 | Any mutation | 471 | 112 | Signature overall | -0.30 | -1.00 | 0.37 | 1455.67 | 1.00 | 876 | 441 | 82 | 30 | FALSE | 0.41 |
| colorectal cancer | KRAS_12-61 | MTOR | Any mutation | 12 | 12 | Signature 10 | -0.99 | -2.47 | 0.22 | 1606.77 | 1.00 | 16 | 11 | 11 | 1 | TRUE | 0.80 |
| colorectal cancer | KRAS_12-61 | MTOR | Any mutation | 164 | 17 | Signature 15 | -0.28 | -1.18 | 0.54 | 1543.98 | 1.00 | 213 | 157 | 10 | 7 | TRUE | 0.29 |
| colorectal cancer | KRAS_12-61 | MTOR | Any mutation | 335 | 48 | Signature 1A | 0.03 | -0.52 | 0.59 | 1449.53 | 1.00 | 489 | 314 | 27 | 21 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | MTOR | Any mutation | 114 | 45 | Signature 6 | -0.68 | -1.39 | -0.04 | 1396.73 | 1.00 | 171 | 104 | 35 | 10 | TRUE | 1.30 |
| non-small cell lung cancer | KRAS_12-61 | MTOR | Any mutation | 266 | 41 | Signature 4 | 0.04 | -0.62 | 0.66 | 1105.95 | 1.00 | 411 | 250 | 25 | 16 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | MTOR | Any mutation | 625 | 122 | Signature overall | -0.48 | -1.52 | 0.50 | 1359.53 | 1.00 | 889 | 586 | 83 | 39 | TRUE | 0.48 |
| non-small cell lung cancer | KRAS_12-61 | MTOR | Any mutation | 266 | 41 | Signature overall | 0.04 | -4.34 | 4.46 | 1300.35 | 1.00 | 411 | 250 | 25 | 16 | TRUE | 0.01 |
| colorectal cancer | KRAS_12-61 | NOTCH1 | Any mutation | 12 | 11 | Signature 10 | -1.89 | -4.31 | -0.28 | 1285.05 | 1.01 | 16 | 12 | 11 | 0 | TRUE | 1.17 |
| colorectal cancer | KRAS_12-61 | NOTCH1 | Any mutation | 166 | 17 | Signature 15 | -0.95 | -2.00 | 0.03 | 1331.59 | 1.00 | 212 | 162 | 13 | 4 | TRUE | 1.16 |
| colorectal cancer | KRAS_12-61 | NOTCH1 | Any mutation | 338 | 47 | Signature 1A | 0.23 | -0.37 | 0.84 | 1457.88 | 1.00 | 490 | 315 | 24 | 23 | TRUE | 0.33 |
| colorectal cancer | KRAS_12-61 | NOTCH1 | Any mutation | 117 | 82 | Signature 6 | -0.66 | -1.20 | -0.11 | 1437.54 | 1.00 | 155 | 97 | 62 | 20 | TRUE | 1.76 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH1 | Any mutation | 84 | 12 | Signature 2 | -0.89 | -2.24 | 0.33 | 1553.92 | 1.00 | 230 | 82 | 10 | 2 | TRUE | 0.80 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH1 | Any mutation | 266 | 54 | Signature 4 | -1.02 | -1.75 | -0.35 | 1600.07 | 1.00 | 395 | 256 | 44 | 10 | TRUE | 2.39 |
| colorectal cancer | KRAS_12-61 | NOTCH1 | Any mutation | 633 | 157 | Signature overall | -0.82 | -2.18 | 0.36 | 1425.95 | 1.00 | 873 | 586 | 110 | 47 | TRUE | 0.71 |
| non-small cell lung cancer | KRAS_12-61 | NOTCH1 | Any mutation | 350 | 66 | Signature overall | -0.90 | -2.29 | 0.83 | 1492.39 | 1.00 | 625 | 338 | 54 | 12 | TRUE | 0.60 |
| colorectal cancer | KRAS_12-61 | SETD2 | Any mutation | 16 | 22 | Signature 10 | -0.48 | -1.55 | 0.55 | 1230.53 | 1.00 | 14 | 10 | 16 | 6 | FALSE | 0.42 |
| colorectal cancer | KRAS_12-61 | SETD2 | Any mutation | 165 | 13 | Signature 15 | -0.97 | -2.14 | 0.08 | 1381.18 | 1.00 | 212 | 162 | 10 | 3 | FALSE | 1.05 |
| colorectal cancer | KRAS_12-61 | SETD2 | Any mutation | 331 | 31 | Signature 1A | -0.43 | -1.16 | 0.26 | 1559.53 | 1.00 | 495 | 321 | 21 | 10 | FALSE | 0.62 |
| colorectal cancer | KRAS_12-61 | SETD2 | Any mutation | 113 | 39 | Signature 6 | -0.84 | -1.59 | -0.13 | 1632.41 | 1.00 | 173 | 105 | 31 | 8 | FALSE | 1.55 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 15 | 16 | Signature 13 | 0.11 | -1.08 | 1.21 | 1370.23 | 1.00 | 73 | 12 | 13 | 3 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 86 | 44 | Signature 2 | 0.17 | -0.49 | 0.82 | 1422.28 | 1.00 | 220 | 73 | 31 | 13 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 55 | 15 | Signature 3 | -0.17 | -1.28 | 0.81 | 1321.32 | 1.00 | 178 | 52 | 12 | 3 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 269 | 55 | Signature 4 | -0.32 | -0.89 | 0.24 | 1546.19 | 1.00 | 400 | 252 | 38 | 17 | FALSE | 0.58 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 156 | 14 | Signature R2 | -0.01 | -0.95 | 0.98 | 1510.76 | 1.00 | 41 | 145 | 3 | 11 | FALSE | 0.01 |
| colorectal cancer | KRAS_12-61 | SETD2 | Any mutation | 625 | 105 | Signature overall | -0.67 | -1.87 | 0.45 | 1541.48 | 1.00 | 894 | 598 | 78 | 27 | FALSE | 0.60 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Any mutation | 581 | 144 | Signature overall | -0.03 | -0.89 | 0.84 | 1454.65 | 1.00 | 912 | 534 | 97 | 47 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | PBRM1 | Any mutation | 84 | 20 | Signature 2 | -0.31 | -1.27 | 0.62 | 1612.38 | 1.00 | 230 | 79 | 15 | 5 | TRUE | 0.28 |
| non-small cell lung cancer | KRAS_12-61 | PBRM1 | Any mutation | 266 | 27 | Signature 4 | -0.69 | -1.62 | 0.04 | 1436.90 | 1.00 | 416 | 260 | 21 | 6 | TRUE | 1.02 |
| non-small cell lung cancer | KRAS_12-61 | PBRM1 | Any mutation | 350 | 47 | Signature overall | -0.48 | -1.67 | 0.79 | 1408.90 | 1.00 | 646 | 339 | 36 | 11 | TRUE | 0.33 |
| colorectal cancer | KRAS_12-61 | EPHA3 | Any mutation | 14 | 14 | Signature 10 | -0.06 | -1.14 | 0.98 | 1384.26 | 1.00 | 18 | 10 | 10 | 4 | FALSE | 0.04 |
| colorectal cancer | KRAS_12-61 | EPHA3 | Any mutation | 164 | 13 | Signature 15 | -0.30 | -1.25 | 0.60 | 1319.82 | 1.00 | 213 | 159 | 8 | 5 | FALSE | 0.30 |
| colorectal cancer | KRAS_12-61 | EPHA3 | Any mutation | 332 | 42 | Signature 1A | 0.15 | -0.46 | 0.73 | 1350.60 | 1.00 | 492 | 313 | 23 | 19 | FALSE | 0.21 |
| colorectal cancer | KRAS_12-61 | EPHA3 | Any mutation | 112 | 26 | Signature 6 | -0.36 | -1.15 | 0.40 | 1445.12 | 1.00 | 182 | 105 | 19 | 7 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 66 | 13 | Signature 18 | -0.16 | -1.11 | 0.80 | 1581.29 | 1.00 | 77 | 61 | 8 | 5 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 86 | 27 | Signature 2 | 0.24 | -0.52 | 1.01 | 1482.58 | 1.00 | 223 | 77 | 18 | 9 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 55 | 18 | Signature 3 | 0.49 | -0.46 | 1.39 | 1677.15 | 1.00 | 179 | 48 | 11 | 7 | FALSE | 0.55 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 269 | 112 | Signature 4 | -0.15 | -0.58 | 0.27 | 1434.12 | 1.00 | 370 | 231 | 74 | 38 | FALSE | 0.33 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 155 | 13 | Signature R2 | -0.26 | -1.23 | 0.60 | 1463.00 | 1.00 | 40 | 146 | 4 | 9 | FALSE | 0.24 |
| colorectal cancer | KRAS_12-61 | EPHA3 | Any mutation | 622 | 95 | Signature overall | -0.14 | -1.04 | 0.76 | 1265.64 | 1.00 | 905 | 587 | 60 | 35 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12-61 | EPHA3 | Any mutation | 631 | 183 | Signature overall | 0.04 | -0.75 | 0.83 | 1509.70 | 1.00 | 889 | 563 | 115 | 68 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | KDR | Any mutation | 84 | 12 | Signature 2 | 0.44 | -0.59 | 1.55 | 1330.31 | 1.00 | 233 | 79 | 7 | 5 | TRUE | 0.38 |
| non-small cell lung cancer | KRAS_12-61 | KDR | Any mutation | 55 | 11 | Signature 3 | 0.98 | -0.20 | 2.15 | 1563.60 | 1.00 | 184 | 49 | 5 | 6 | TRUE | 0.96 |
| non-small cell lung cancer | KRAS_12-61 | KDR | Any mutation | 267 | 76 | Signature 4 | -0.70 | -1.30 | -0.13 | 1307.58 | 1.00 | 382 | 250 | 59 | 17 | TRUE | 1.73 |
| non-small cell lung cancer | KRAS_12-61 | KDR | Any mutation | 406 | 99 | Signature overall | 0.24 | -1.06 | 1.55 | 1391.63 | 1.00 | 799 | 378 | 71 | 28 | TRUE | 0.15 |
| colorectal cancer | KRAS_12-61 | PTCH1 | Any mutation | 12 | 11 | Signature 10 | -0.99 | -2.54 | 0.18 | 1667.48 | 1.00 | 16 | 11 | 10 | 1 | TRUE | 0.83 |
| colorectal cancer | KRAS_12-61 | PTCH1 | Any mutation | 164 | 14 | Signature 15 | -0.78 | -1.73 | 0.13 | 1377.32 | 1.00 | 214 | 160 | 10 | 4 | TRUE | 0.98 |
| colorectal cancer | KRAS_12-61 | PTCH1 | Any mutation | 334 | 55 | Signature 1A | -0.34 | -0.90 | 0.23 | 1265.19 | 1.00 | 484 | 315 | 36 | 19 | TRUE | 0.61 |
| colorectal cancer | KRAS_12-61 | PTCH1 | Any mutation | 118 | 53 | Signature 6 | -0.52 | -1.15 | 0.05 | 1491.94 | 1.00 | 172 | 104 | 39 | 14 | TRUE | 1.03 |
| colorectal cancer | KRAS_12-61 | PTCH1 | Any mutation | 628 | 133 | Signature overall | -0.66 | -1.64 | 0.22 | 1592.15 | 1.00 | 886 | 590 | 95 | 38 | TRUE | 0.83 |
| colorectal cancer | KRAS_12-61 | TET1 | Any mutation | 18 | 27 | Signature 10 | -0.50 | -1.61 | 0.57 | 1150.86 | 1.00 | 13 | 10 | 19 | 8 | FALSE | 0.43 |
| colorectal cancer | KRAS_12-61 | TET1 | Any mutation | 160 | 18 | Signature 15 | -2.05 | -3.70 | -0.78 | 1489.56 | 1.00 | 204 | 159 | 17 | 1 | FALSE | 2.28 |
| colorectal cancer | KRAS_12-61 | TET1 | Any mutation | 320 | 25 | Signature 1A | -0.17 | -0.96 | 0.57 | 1545.74 | 1.00 | 488 | 310 | 15 | 10 | FALSE | 0.18 |
| colorectal cancer | KRAS_12-61 | TET1 | Any mutation | 108 | 28 | Signature 6 | -0.83 | -1.76 | -0.03 | 1575.16 | 1.00 | 176 | 102 | 22 | 6 | FALSE | 1.21 |
| non-small cell lung cancer | KRAS_12-61 | TET1 | Any mutation | 84 | 12 | Signature 2 | 1.02 | -0.10 | 2.28 | 1354.28 | 1.00 | 233 | 77 | 5 | 7 | FALSE | 1.03 |
| non-small cell lung cancer | KRAS_12-61 | TET1 | Any mutation | 269 | 60 | Signature 4 | -0.39 | -1.00 | 0.20 | 1456.14 | 1.00 | 398 | 252 | 43 | 17 | FALSE | 0.68 |
| colorectal cancer | KRAS_12-61 | TET1 | Any mutation | 606 | 98 | Signature overall | -0.89 | -2.21 | 0.39 | 1599.98 | 1.00 | 881 | 581 | 73 | 25 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12-61 | TET1 | Any mutation | 353 | 72 | Signature overall | 0.29 | -1.70 | 2.49 | 1457.77 | 1.00 | 631 | 329 | 48 | 24 | FALSE | 0.11 |
| uterine cancer | KRAS_12-61 | FGFR2 | Any mutation | 39 | 26 | Signature 1A | -2.02 | -4.08 | -0.46 | 1345.20 | 1.00 | 158 | 38 | 25 | 1 | TRUE | 1.55 |
| uterine cancer | KRAS_12-61 | FGFR2 | Any mutation | 17 | 22 | Signature 6 | -1.98 | -3.98 | -0.46 | 1254.69 | 1.00 | 63 | 16 | 21 | 1 | TRUE | 1.51 |
| uterine cancer | KRAS_12-61 | FGFR2 | Any mutation | 56 | 48 | Signature overall | -1.98 | -4.12 | -0.34 | 1294.02 | 1.00 | 221 | 54 | 46 | 2 | TRUE | 1.40 |
| non-small cell lung cancer | KRAS_12-61 | TBX3 | Any mutation | 266 | 75 | Signature 4 | -0.97 | -1.56 | -0.39 | 1516.40 | 1.00 | 384 | 251 | 60 | 15 | FALSE | 3.01 |
| non-small cell lung cancer | KRAS_12-61 | TBX3 | Any mutation | 154 | 15 | Signature R2 | -0.63 | -1.61 | 0.38 | 1645.09 | 1.00 | 40 | 144 | 5 | 10 | FALSE | 0.64 |
| non-small cell lung cancer | KRAS_12-61 | TBX3 | Any mutation | 420 | 90 | Signature overall | -0.80 | -2.56 | 1.06 | 1432.56 | 1.00 | 424 | 395 | 65 | 25 | FALSE | 0.42 |
| colorectal cancer | KRAS_12-61 | SMAD3 | Any mutation | 167 | 21 | Signature 15 | 0.38 | -0.13 | 0.90 | 1168.02 | 1.00 | 212 | 156 | 10 | 11 | TRUE | 0.82 |
| colorectal cancer | KRAS_12-61 | SMAD3 | Any mutation | 335 | 38 | Signature 1A | 0.35 | -0.11 | 0.84 | 1230.82 | 1.00 | 496 | 316 | 19 | 19 | TRUE | 0.84 |
| colorectal cancer | KRAS_12-61 | SMAD3 | Any mutation | 112 | 20 | Signature 6 | 0.36 | -0.19 | 0.87 | 1320.52 | 1.00 | 188 | 104 | 12 | 8 | TRUE | 0.76 |
| colorectal cancer | KRAS_12-61 | SMAD3 | Any mutation | 614 | 79 | Signature overall | 0.36 | -0.12 | 0.86 | 1290.13 | 1.00 | 896 | 576 | 41 | 38 | TRUE | 0.83 |
| non-small cell lung cancer | KRAS_12-61 | NTRK3 | Any mutation | 86 | 15 | Signature 2 | 1.20 | 0.24 | 2.19 | 1451.45 | 1.00 | 234 | 77 | 6 | 9 | FALSE | 1.77 |
| non-small cell lung cancer | KRAS_12-61 | NTRK3 | Any mutation | 54 | 14 | Signature 3 | 0.61 | -0.43 | 1.61 | 1382.89 | 1.00 | 181 | 49 | 9 | 5 | FALSE | 0.61 |
| non-small cell lung cancer | KRAS_12-61 | NTRK3 | Any mutation | 270 | 105 | Signature 4 | -0.34 | -0.78 | 0.08 | 1498.79 | 1.00 | 379 | 239 | 74 | 31 | FALSE | 0.91 |
| non-small cell lung cancer | KRAS_12-61 | NTRK3 | Any mutation | 155 | 18 | Signature R2 | 0.78 | -0.28 | 2.08 | 1527.08 | 1.00 | 42 | 139 | 2 | 16 | FALSE | 0.73 |
| non-small cell lung cancer | KRAS_12-61 | NTRK3 | Any mutation | 565 | 152 | Signature overall | 0.54 | -0.71 | 1.77 | 1493.03 | 1.00 | 836 | 504 | 91 | 61 | FALSE | 0.41 |
| colorectal cancer | KRAS_12-61 | GRIN2A | Any mutation | 13 | 18 | Signature 10 | -0.53 | -1.72 | 0.52 | 1558.08 | 1.00 | 15 | 9 | 14 | 4 | FALSE | 0.46 |
| colorectal cancer | KRAS_12-61 | GRIN2A | Any mutation | 164 | 12 | Signature 15 | -0.85 | -2.05 | 0.17 | 1250.17 | 1.00 | 215 | 161 | 9 | 3 | FALSE | 0.90 |
| colorectal cancer | KRAS_12-61 | GRIN2A | Any mutation | 332 | 43 | Signature 1A | -0.49 | -1.14 | 0.15 | 1485.20 | 1.00 | 484 | 319 | 30 | 13 | FALSE | 0.88 |
| colorectal cancer | KRAS_12-61 | GRIN2A | Any mutation | 111 | 43 | Signature 6 | -0.44 | -1.08 | 0.23 | 1477.50 | 1.00 | 172 | 99 | 31 | 12 | FALSE | 0.70 |
| non-small cell lung cancer | KRAS_12-61 | GRIN2A | Any mutation | 84 | 15 | Signature 2 | -0.54 | -1.78 | 0.58 | 1469.34 | 1.00 | 228 | 81 | 12 | 3 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12-61 | GRIN2A | Any mutation | 268 | 76 | Signature 4 | -0.66 | -1.20 | -0.15 | 1599.33 | 1.00 | 385 | 249 | 57 | 19 | FALSE | 1.81 |
| non-small cell lung cancer | KRAS_12-61 | GRIN2A | Any mutation | 154 | 13 | Signature R2 | -0.44 | -1.40 | 0.58 | 1344.85 | 1.00 | 40 | 145 | 4 | 9 | FALSE | 0.40 |
| colorectal cancer | KRAS_12-61 | GRIN2A | Any mutation | 620 | 116 | Signature overall | -0.60 | -1.66 | 0.37 | 1338.53 | 1.00 | 886 | 588 | 84 | 32 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12-61 | GRIN2A | Any mutation | 506 | 104 | Signature overall | -0.54 | -1.87 | 0.74 | 1538.80 | 1.00 | 653 | 475 | 73 | 31 | FALSE | 0.39 |
| uterine cancer | KRAS_12-61 | CTCF | Any mutation | 27 | 18 | Signature 15 | 0.79 | -0.15 | 1.74 | 1485.12 | 1.00 | 73 | 19 | 10 | 8 | FALSE | 1.03 |
| uterine cancer | KRAS_12-61 | CTCF | Any mutation | 40 | 49 | Signature 1A | 0.79 | 0.11 | 1.49 | 1502.92 | 1.00 | 149 | 25 | 34 | 15 | FALSE | 1.58 |
| uterine cancer | KRAS_12-61 | CTCF | Any mutation | 17 | 40 | Signature 6 | -0.08 | -1.07 | 0.83 | 1412.35 | 1.00 | 49 | 12 | 35 | 5 | FALSE | 0.06 |
| uterine cancer | KRAS_12-61 | CTCF | Any mutation | 86 | 123 | Signature overall | 0.45 | -0.52 | 1.42 | 1398.49 | 1.00 | 295 | 57 | 94 | 29 | FALSE | 0.45 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 22 | 11 | Signature 11 | 1.70 | 0.76 | 2.70 | 1123.06 | 1.00 | 21 | 12 | 1 | 10 | TRUE | 3.25 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 31 | 19 | Signature 15 | 1.46 | 0.65 | 2.26 | 1408.35 | 1.00 | 97 | 20 | 8 | 11 | TRUE | 3.45 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 9 | 11 | Signature 16 | 0.70 | -0.39 | 1.71 | 1451.15 | 1.00 | 42 | 7 | 9 | 2 | TRUE | 0.74 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 67 | 38 | Signature 18 | 0.91 | 0.27 | 1.53 | 1455.04 | 1.00 | 69 | 45 | 16 | 22 | TRUE | 2.23 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 17 | 17 | Signature 19 | 0.84 | -0.07 | 1.68 | 1424.06 | 1.00 | 35 | 11 | 11 | 6 | TRUE | 1.20 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 47 | 21 | Signature 1A | 1.69 | 0.91 | 2.51 | 1544.69 | 1.00 | 211 | 34 | 8 | 13 | TRUE | 4.83 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 85 | 55 | Signature 2 | 0.30 | -0.26 | 0.84 | 1168.32 | 1.00 | 208 | 70 | 40 | 15 | TRUE | 0.52 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 15 | 13 | Signature 20 | 1.65 | 0.75 | 2.64 | 1304.93 | 1.00 | 57 | 7 | 5 | 8 | TRUE | 3.11 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 54 | 37 | Signature 3 | 0.93 | 0.31 | 1.54 | 1524.85 | 1.00 | 166 | 40 | 23 | 14 | TRUE | 2.41 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 267 | 163 | Signature 4 | 0.50 | 0.17 | 0.83 | 1481.65 | 1.00 | 349 | 192 | 88 | 75 | TRUE | 2.41 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 30 | 13 | Signature 8 | 0.97 | 0.04 | 1.84 | 1583.75 | 1.00 | 29 | 22 | 5 | 8 | TRUE | 1.49 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 155 | 61 | Signature R2 | 0.87 | 0.24 | 1.57 | 1509.44 | 1.00 | 34 | 104 | 10 | 51 | TRUE | 2.01 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 21 | 13 | Signature U1 | 1.22 | 0.33 | 2.16 | 1532.65 | 1.00 | 83 | 15 | 7 | 6 | TRUE | 2.06 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Any mutation | 820 | 472 | Signature overall | 1.05 | 0.60 | 1.49 | 1531.07 | 1.00 | 1401 | 579 | 231 | 241 | TRUE | 5.14 |
| colorectal cancer | KRAS_12-61 | ASXL1 | Any mutation | 12 | 11 | Signature 10 | -1.11 | -2.65 | 0.10 | 1408.24 | 1.00 | 14 | 11 | 10 | 1 | TRUE | 0.92 |
| colorectal cancer | KRAS_12-61 | ASXL1 | Any mutation | 164 | 14 | Signature 15 | -0.78 | -1.85 | 0.15 | 1492.06 | 1.00 | 213 | 160 | 10 | 4 | TRUE | 0.89 |
| colorectal cancer | KRAS_12-61 | ASXL1 | Any mutation | 331 | 31 | Signature 1A | -0.60 | -1.31 | 0.12 | 1520.74 | 1.00 | 494 | 322 | 22 | 9 | TRUE | 1.01 |
| colorectal cancer | KRAS_12-61 | ASXL1 | Any mutation | 111 | 34 | Signature 6 | -0.52 | -1.28 | 0.21 | 1529.93 | 1.00 | 180 | 102 | 25 | 9 | TRUE | 0.79 |
| colorectal cancer | KRAS_12-61 | ASXL1 | Any mutation | 618 | 90 | Signature overall | -0.75 | -1.77 | 0.14 | 1361.21 | 1.00 | 901 | 595 | 67 | 23 | TRUE | 0.89 |
| colorectal cancer | KRAS_12-61 | EP300 | Any mutation | 165 | 18 | Signature 15 | -0.86 | -1.80 | -0.04 | 1425.84 | 1.00 | 210 | 161 | 14 | 4 | TRUE | 1.31 |
| colorectal cancer | KRAS_12-61 | EP300 | Any mutation | 331 | 36 | Signature 1A | -0.32 | -0.98 | 0.33 | 1497.85 | 1.00 | 493 | 318 | 23 | 13 | TRUE | 0.46 |
| colorectal cancer | KRAS_12-61 | EP300 | Any mutation | 115 | 51 | Signature 6 | -0.51 | -1.17 | 0.10 | 1438.45 | 1.00 | 173 | 102 | 38 | 13 | TRUE | 0.92 |
| non-small cell lung cancer | KRAS_12-61 | EP300 | Any mutation | 14 | 11 | Signature 13 | -0.10 | -1.43 | 1.18 | 1535.04 | 1.00 | 77 | 12 | 9 | 2 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | EP300 | Any mutation | 85 | 20 | Signature 2 | -0.53 | -1.59 | 0.33 | 1543.99 | 1.00 | 228 | 82 | 17 | 3 | TRUE | 0.54 |
| non-small cell lung cancer | KRAS_12-61 | EP300 | Any mutation | 267 | 30 | Signature 4 | -0.18 | -0.88 | 0.49 | 1468.13 | 1.00 | 417 | 256 | 19 | 11 | TRUE | 0.22 |
| uterine cancer | KRAS_12-61 | EP300 | Any mutation | 40 | 21 | Signature 1A | 0.23 | -0.84 | 1.22 | 1602.78 | 1.00 | 164 | 35 | 16 | 5 | TRUE | 0.18 |
| uterine cancer | KRAS_12-61 | EP300 | Any mutation | 17 | 20 | Signature 6 | 0.16 | -1.14 | 1.25 | 1486.30 | 1.00 | 67 | 13 | 16 | 4 | TRUE | 0.11 |
| colorectal cancer | KRAS_12-61 | EP300 | Any mutation | 611 | 105 | Signature overall | -0.56 | -1.48 | 0.29 | 1337.04 | 1.00 | 876 | 581 | 75 | 30 | TRUE | 0.65 |
| non-small cell lung cancer | KRAS_12-61 | EP300 | Any mutation | 366 | 61 | Signature overall | -0.25 | -1.25 | 0.79 | 1305.12 | 1.00 | 722 | 350 | 45 | 16 | TRUE | 0.20 |
| uterine cancer | KRAS_12-61 | EP300 | Any mutation | 60 | 74 | Signature overall | 0.14 | -1.38 | 1.82 | 1593.14 | 1.00 | 251 | 49 | 63 | 11 | TRUE | 0.07 |
| colorectal cancer | KRAS_12-61 | ERBB4 | Any mutation | 16 | 18 | Signature 10 | 0.09 | -0.99 | 1.07 | 1386.18 | 1.00 | 15 | 10 | 12 | 6 | TRUE | 0.06 |
| colorectal cancer | KRAS_12-61 | ERBB4 | Any mutation | 165 | 23 | Signature 15 | -0.30 | -1.09 | 0.42 | 1482.05 | 1.00 | 208 | 157 | 15 | 8 | TRUE | 0.36 |
| colorectal cancer | KRAS_12-61 | ERBB4 | Any mutation | 332 | 43 | Signature 1A | 0.11 | -0.44 | 0.67 | 1514.30 | 1.00 | 492 | 313 | 24 | 19 | TRUE | 0.16 |
| colorectal cancer | KRAS_12-61 | ERBB4 | Any mutation | 113 | 31 | Signature 6 | 0.32 | -0.39 | 1.01 | 1519.99 | 1.00 | 185 | 99 | 17 | 14 | TRUE | 0.45 |
| non-small cell lung cancer | KRAS_12-61 | ERBB4 | Any mutation | 47 | 11 | Signature 1A | -0.02 | -1.21 | 1.10 | 1439.96 | 1.00 | 211 | 44 | 8 | 3 | TRUE | 0.01 |
| non-small cell lung cancer | KRAS_12-61 | ERBB4 | Any mutation | 84 | 17 | Signature 2 | -0.75 | -1.98 | 0.28 | 1572.37 | 1.00 | 228 | 82 | 15 | 2 | TRUE | 0.73 |
| non-small cell lung cancer | KRAS_12-61 | ERBB4 | Any mutation | 270 | 97 | Signature 4 | -0.31 | -0.76 | 0.14 | 1529.36 | 1.00 | 384 | 240 | 67 | 30 | TRUE | 0.73 |
| colorectal cancer | KRAS_12-61 | ERBB4 | Any mutation | 626 | 115 | Signature overall | 0.04 | -0.86 | 0.91 | 1578.22 | 1.00 | 900 | 579 | 68 | 47 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12-61 | ERBB4 | Any mutation | 401 | 125 | Signature overall | -0.35 | -1.50 | 0.85 | 1488.52 | 1.00 | 823 | 366 | 90 | 35 | TRUE | 0.26 |
| colorectal cancer | KRAS_12-61 | MED12 | Any mutation | 164 | 11 | Signature 15 | -0.91 | -2.20 | 0.11 | 1425.24 | 1.00 | 213 | 162 | 9 | 2 | TRUE | 0.90 |
| colorectal cancer | KRAS_12-61 | MED12 | Any mutation | 332 | 34 | Signature 1A | 0.22 | -0.39 | 0.86 | 1280.16 | 1.00 | 499 | 315 | 17 | 17 | TRUE | 0.31 |
| colorectal cancer | KRAS_12-61 | MED12 | Any mutation | 115 | 42 | Signature 6 | -0.42 | -1.10 | 0.20 | 1552.28 | 1.00 | 176 | 104 | 31 | 11 | TRUE | 0.67 |
| non-small cell lung cancer | KRAS_12-61 | MED12 | Any mutation | 84 | 25 | Signature 2 | -0.39 | -1.21 | 0.52 | 1482.90 | 1.00 | 222 | 78 | 19 | 6 | TRUE | 0.43 |
| non-small cell lung cancer | KRAS_12-61 | MED12 | Any mutation | 268 | 72 | Signature 4 | -0.67 | -1.24 | -0.15 | 1516.82 | 1.00 | 389 | 251 | 55 | 17 | TRUE | 1.84 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 26 | 13 | Signature 15 | -0.40 | -1.81 | 0.84 | 1270.83 | 1.00 | 72 | 23 | 10 | 3 | TRUE | 0.26 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 39 | 18 | Signature 1A | -1.35 | -3.13 | 0.10 | 1593.98 | 1.00 | 164 | 38 | 17 | 1 | TRUE | 1.00 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 17 | 14 | Signature 6 | -1.15 | -3.05 | 0.40 | 1449.36 | 1.00 | 71 | 16 | 13 | 1 | TRUE | 0.72 |
| colorectal cancer | KRAS_12-61 | MED12 | Any mutation | 611 | 87 | Signature overall | -0.36 | -1.49 | 0.71 | 1471.46 | 1.00 | 888 | 581 | 57 | 30 | TRUE | 0.28 |
| non-small cell lung cancer | KRAS_12-61 | MED12 | Any mutation | 352 | 97 | Signature overall | -0.49 | -1.47 | 0.64 | 1488.02 | 1.00 | 611 | 329 | 74 | 23 | TRUE | 0.42 |
| uterine cancer | KRAS_12-61 | MED12 | Any mutation | 85 | 87 | Signature overall | -0.89 | -2.42 | 0.60 | 1486.32 | 1.00 | 324 | 78 | 80 | 7 | TRUE | 0.62 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 14 | 11 | Signature 13 | 0.71 | -0.31 | 1.67 | 1319.04 | 1.00 | 77 | 11 | 8 | 3 | FALSE | 0.79 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 32 | 11 | Signature 15 | 0.81 | -0.10 | 1.75 | 1437.18 | 1.00 | 100 | 27 | 6 | 5 | FALSE | 1.08 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 67 | 17 | Signature 18 | 0.53 | -0.25 | 1.30 | 1590.35 | 1.00 | 76 | 58 | 8 | 9 | FALSE | 0.76 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 47 | 21 | Signature 1A | 0.75 | -0.05 | 1.56 | 1578.11 | 1.00 | 205 | 40 | 14 | 7 | FALSE | 1.16 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 84 | 32 | Signature 2 | 0.91 | 0.29 | 1.55 | 1520.09 | 1.00 | 223 | 69 | 17 | 15 | FALSE | 2.32 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 56 | 30 | Signature 3 | 0.49 | -0.26 | 1.19 | 1415.13 | 1.00 | 169 | 47 | 21 | 9 | FALSE | 0.73 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 271 | 128 | Signature 4 | 0.70 | 0.31 | 1.07 | 1389.14 | 1.00 | 380 | 205 | 62 | 66 | FALSE | 3.68 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 154 | 20 | Signature R2 | 0.41 | -0.37 | 1.20 | 1346.72 | 1.00 | 40 | 138 | 4 | 16 | FALSE | 0.53 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 21 | 15 | Signature U1 | 0.77 | -0.11 | 1.68 | 1540.03 | 1.00 | 81 | 16 | 10 | 5 | FALSE | 1.08 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Any mutation | 746 | 285 | Signature overall | 0.67 | 0.12 | 1.23 | 1452.39 | 1.00 | 1351 | 611 | 150 | 135 | FALSE | 1.83 |
| colorectal cancer | KRAS_12-61 | NF1 | Any mutation | 15 | 24 | Signature 10 | -0.87 | -2.07 | 0.16 | 1473.21 | 1.00 | 14 | 10 | 19 | 5 | TRUE | 0.88 |
| colorectal cancer | KRAS_12-61 | NF1 | Any mutation | 164 | 21 | Signature 15 | -1.49 | -2.71 | -0.48 | 1490.62 | 1.00 | 207 | 161 | 18 | 3 | TRUE | 2.10 |
| colorectal cancer | KRAS_12-61 | NF1 | Any mutation | 333 | 40 | Signature 1A | -0.12 | -0.75 | 0.52 | 1496.33 | 1.00 | 493 | 317 | 24 | 16 | TRUE | 0.15 |
| colorectal cancer | KRAS_12-61 | NF1 | Any mutation | 111 | 44 | Signature 6 | -1.49 | -2.48 | -0.66 | 1462.21 | 1.00 | 172 | 106 | 39 | 5 | TRUE | 2.98 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 66 | 13 | Signature 18 | -0.27 | -1.24 | 0.67 | 1520.84 | 1.00 | 78 | 60 | 7 | 6 | TRUE | 0.25 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 47 | 13 | Signature 1A | -0.63 | -1.80 | 0.43 | 1407.23 | 1.00 | 208 | 45 | 11 | 2 | TRUE | 0.57 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 86 | 39 | Signature 2 | -0.49 | -1.25 | 0.24 | 1379.80 | 1.00 | 212 | 78 | 31 | 8 | TRUE | 0.72 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 15 | 13 | Signature 20 | -0.94 | -2.26 | 0.27 | 1466.75 | 1.00 | 51 | 14 | 12 | 1 | TRUE | 0.84 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 54 | 15 | Signature 3 | -1.09 | -2.28 | 0.03 | 1482.99 | 1.00 | 176 | 53 | 14 | 1 | TRUE | 1.17 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 268 | 113 | Signature 4 | -0.72 | -1.18 | -0.28 | 1468.67 | 1.00 | 373 | 241 | 86 | 27 | TRUE | 2.79 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 24 | 11 | Signature 7 | -1.32 | -2.83 | -0.07 | 1374.43 | 1.00 | 73 | 24 | 11 | 0 | TRUE | 1.25 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 155 | 12 | Signature R2 | -0.67 | -1.53 | 0.24 | 1450.77 | 1.00 | 40 | 147 | 4 | 8 | TRUE | 0.83 |
| uterine cancer | KRAS_12-61 | NF1 | Any mutation | 39 | 21 | Signature 1A | -0.36 | -1.73 | 0.78 | 1378.95 | 1.00 | 167 | 36 | 18 | 3 | TRUE | 0.25 |
| uterine cancer | KRAS_12-61 | NF1 | Any mutation | 17 | 24 | Signature 6 | -0.43 | -1.81 | 0.78 | 1367.91 | 1.00 | 64 | 14 | 21 | 3 | TRUE | 0.28 |
| colorectal cancer | KRAS_12-61 | NF1 | Any mutation | 623 | 129 | Signature overall | -0.97 | -2.16 | 0.24 | 1732.86 | 1.00 | 886 | 594 | 100 | 29 | TRUE | 0.97 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Any mutation | 715 | 229 | Signature overall | -0.77 | -1.49 | -0.11 | 1445.51 | 1.00 | 1211 | 662 | 176 | 53 | TRUE | 1.57 |
| uterine cancer | KRAS_12-61 | NF1 | Any mutation | 59 | 92 | Signature overall | -0.14 | -2.11 | 2.14 | 1289.64 | 1.00 | 249 | 50 | 83 | 9 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | FLT1 | Any mutation | 67 | 13 | Signature 18 | 0.50 | -0.34 | 1.46 | 1409.66 | 1.00 | 79 | 59 | 5 | 8 | FALSE | 0.58 |
| non-small cell lung cancer | KRAS_12-61 | FLT1 | Any mutation | 84 | 12 | Signature 2 | 0.33 | -0.54 | 1.28 | 1427.70 | 1.00 | 233 | 79 | 7 | 5 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12-61 | FLT1 | Any mutation | 269 | 64 | Signature 4 | -0.09 | -0.63 | 0.42 | 1424.67 | 1.00 | 400 | 248 | 43 | 21 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12-61 | FLT1 | Any mutation | 420 | 89 | Signature overall | 0.24 | -0.63 | 1.12 | 1431.97 | 1.00 | 712 | 386 | 55 | 34 | FALSE | 0.23 |
| uterine cancer | KRAS_12-61 | RASA1 | Any mutation | 39 | 20 | Signature 1A | -1.99 | -4.49 | -0.23 | 1544.86 | 1.00 | 166 | 38 | 19 | 1 | FALSE | 1.19 |
| uterine cancer | KRAS_12-61 | RASA1 | Any mutation | 17 | 12 | Signature 6 | -1.68 | -4.25 | 0.37 | 1439.28 | 1.00 | 71 | 16 | 11 | 1 | FALSE | 0.84 |
| uterine cancer | KRAS_12-61 | RASA1 | Any mutation | 58 | 78 | Signature overall | -2.17 | -4.80 | 0.26 | 1384.34 | 1.00 | 253 | 56 | 76 | 2 | FALSE | 1.06 |
| colorectal cancer | KRAS_12-61 | EPHA5 | Any mutation | 15 | 26 | Signature 10 | -1.30 | -2.52 | -0.14 | 1588.44 | 1.00 | 12 | 11 | 22 | 4 | FALSE | 1.50 |
| colorectal cancer | KRAS_12-61 | EPHA5 | Any mutation | 164 | 18 | Signature 15 | -1.09 | -2.21 | -0.07 | 1558.63 | 1.00 | 211 | 160 | 14 | 4 | FALSE | 1.35 |
| colorectal cancer | KRAS_12-61 | EPHA5 | Any mutation | 332 | 49 | Signature 1A | -0.23 | -0.80 | 0.35 | 1491.99 | 1.00 | 484 | 314 | 31 | 18 | FALSE | 0.35 |
| colorectal cancer | KRAS_12-61 | EPHA5 | Any mutation | 111 | 36 | Signature 6 | -1.53 | -2.63 | -0.65 | 1377.90 | 1.00 | 173 | 107 | 32 | 4 | FALSE | 2.62 |
| non-small cell lung cancer | KRAS_12-61 | EPHA5 | Any mutation | 67 | 24 | Signature 18 | 0.16 | -0.63 | 0.92 | 1453.91 | 1.00 | 72 | 56 | 13 | 11 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12-61 | EPHA5 | Any mutation | 84 | 30 | Signature 2 | 0.28 | -0.49 | 1.01 | 1367.23 | 1.00 | 223 | 74 | 20 | 10 | FALSE | 0.34 |
| non-small cell lung cancer | KRAS_12-61 | EPHA5 | Any mutation | 54 | 19 | Signature 3 | 0.67 | -0.16 | 1.55 | 1411.20 | 1.00 | 181 | 46 | 11 | 8 | FALSE | 0.91 |
| non-small cell lung cancer | KRAS_12-61 | EPHA5 | Any mutation | 269 | 109 | Signature 4 | 0.03 | -0.39 | 0.44 | 1434.17 | 1.00 | 380 | 228 | 68 | 41 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | EPHA5 | Any mutation | 154 | 12 | Signature R2 | -0.29 | -1.28 | 0.67 | 1420.81 | 1.00 | 41 | 146 | 4 | 8 | FALSE | 0.26 |
| colorectal cancer | KRAS_12-61 | EPHA5 | Any mutation | 622 | 129 | Signature overall | -1.02 | -2.30 | 0.14 | 1563.50 | 1.00 | 880 | 592 | 99 | 30 | FALSE | 1.02 |
| non-small cell lung cancer | KRAS_12-61 | EPHA5 | Any mutation | 628 | 194 | Signature overall | 0.17 | -0.65 | 0.97 | 1571.37 | 1.00 | 897 | 550 | 116 | 78 | FALSE | 0.16 |
| colorectal cancer | KRAS_12-61 | AR | Any mutation | 165 | 21 | Signature 15 | -0.63 | -1.43 | 0.09 | 1218.82 | 1.00 | 209 | 159 | 15 | 6 | TRUE | 1.04 |
| colorectal cancer | KRAS_12-61 | AR | Any mutation | 331 | 33 | Signature 1A | -0.55 | -1.17 | 0.08 | 1520.76 | 1.00 | 491 | 321 | 23 | 10 | TRUE | 1.09 |
| colorectal cancer | KRAS_12-61 | AR | Any mutation | 111 | 37 | Signature 6 | -0.53 | -1.26 | 0.11 | 1278.42 | 1.00 | 177 | 102 | 28 | 9 | TRUE | 0.90 |
| non-small cell lung cancer | KRAS_12-61 | AR | Any mutation | 268 | 56 | Signature 4 | -0.37 | -0.98 | 0.21 | 1160.68 | 1.00 | 402 | 251 | 39 | 17 | TRUE | 0.66 |
| colorectal cancer | KRAS_12-61 | AR | Any mutation | 607 | 91 | Signature overall | -0.57 | -1.30 | 0.17 | 1280.45 | 1.00 | 877 | 582 | 66 | 25 | TRUE | 0.91 |
| non-small cell lung cancer | KRAS_12-61 | AR | Any mutation | 268 | 56 | Signature overall | -0.29 | -4.92 | 4.32 | 1616.67 | 1.00 | 402 | 251 | 39 | 17 | TRUE | 0.05 |
| colorectal cancer | KRAS_12-61 | ROS1 | Any mutation | 18 | 30 | Signature 10 | -0.59 | -1.69 | 0.42 | 1566.28 | 1.00 | 13 | 10 | 22 | 8 | TRUE | 0.56 |
| colorectal cancer | KRAS_12-61 | ROS1 | Any mutation | 331 | 28 | Signature 1A | -0.75 | -1.60 | 0.06 | 1408.07 | 1.00 | 495 | 324 | 21 | 7 | TRUE | 1.07 |
| colorectal cancer | KRAS_12-61 | ROS1 | Any mutation | 111 | 26 | Signature 6 | -0.73 | -1.69 | 0.12 | 1506.00 | 1.00 | 180 | 105 | 20 | 6 | TRUE | 0.91 |
| non-small cell lung cancer | KRAS_12-61 | ROS1 | Any mutation | 84 | 14 | Signature 2 | -1.70 | -3.29 | -0.42 | 1456.91 | 1.00 | 228 | 83 | 13 | 1 | TRUE | 1.70 |
| non-small cell lung cancer | KRAS_12-61 | ROS1 | Any mutation | 266 | 42 | Signature 4 | -1.63 | -2.64 | -0.82 | 1448.56 | 1.00 | 401 | 261 | 37 | 5 | TRUE | 3.32 |
| colorectal cancer | KRAS_12-61 | ROS1 | Any mutation | 460 | 84 | Signature overall | -0.67 | -2.30 | 1.02 | 1531.05 | 1.00 | 688 | 439 | 63 | 21 | TRUE | 0.35 |
| non-small cell lung cancer | KRAS_12-61 | ROS1 | Any mutation | 350 | 56 | Signature overall | -1.64 | -3.16 | -0.22 | 1549.83 | 1.00 | 629 | 344 | 50 | 6 | TRUE | 1.63 |
| colorectal cancer | KRAS_12-61 | PIK3CG | Any mutation | 15 | 22 | Signature 10 | -0.37 | -1.52 | 0.73 | 1612.23 | 1.00 | 13 | 9 | 16 | 6 | FALSE | 0.28 |
| colorectal cancer | KRAS_12-61 | PIK3CG | Any mutation | 164 | 17 | Signature 15 | -0.45 | -1.37 | 0.43 | 1382.55 | 1.00 | 212 | 158 | 11 | 6 | FALSE | 0.47 |
| colorectal cancer | KRAS_12-61 | PIK3CG | Any mutation | 331 | 29 | Signature 1A | -0.61 | -1.37 | 0.08 | 1509.47 | 1.00 | 493 | 323 | 21 | 8 | FALSE | 0.95 |
| colorectal cancer | KRAS_12-61 | PIK3CG | Any mutation | 112 | 29 | Signature 6 | -0.30 | -1.11 | 0.42 | 1421.15 | 1.00 | 182 | 103 | 20 | 9 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CG | Any mutation | 14 | 13 | Signature 13 | -0.74 | -2.56 | 0.75 | 1750.26 | 1.00 | 73 | 13 | 12 | 1 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CG | Any mutation | 86 | 18 | Signature 2 | 0.98 | 0.09 | 1.89 | 1444.69 | 1.00 | 232 | 76 | 8 | 10 | FALSE | 1.46 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CG | Any mutation | 267 | 75 | Signature 4 | -0.41 | -0.96 | 0.11 | 1632.69 | 1.00 | 389 | 245 | 53 | 22 | FALSE | 0.96 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CG | Any mutation | 154 | 12 | Signature R2 | -1.34 | -2.50 | -0.26 | 1441.77 | 1.00 | 38 | 149 | 7 | 5 | FALSE | 1.70 |
| colorectal cancer | KRAS_12-61 | PIK3CG | Any mutation | 622 | 97 | Signature overall | -0.44 | -1.61 | 0.72 | 1599.30 | 1.00 | 900 | 593 | 68 | 29 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12-61 | PIK3CG | Any mutation | 521 | 118 | Signature overall | -0.36 | -1.69 | 0.99 | 1355.54 | 1.00 | 732 | 483 | 80 | 38 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 14 | 23 | Signature 13 | -3.08 | -4.06 | -2.08 | 1412.44 | 1.00 | 64 | 13 | 22 | 1 | TRUE | 8.95 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 21 | 12 | Signature 14 | -3.09 | -4.14 | -2.04 | 1451.68 | 1.00 | 26 | 20 | 11 | 1 | TRUE | 8.43 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 32 | 54 | Signature 15 | -3.06 | -3.99 | -2.21 | 1283.88 | 1.00 | 61 | 30 | 52 | 2 | TRUE | 10.47 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 9 | 19 | Signature 16 | -3.30 | -4.36 | -2.32 | 1425.02 | 1.00 | 33 | 9 | 19 | 0 | TRUE | 9.09 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 19 | 21 | Signature 17 | -3.17 | -4.23 | -2.18 | 1416.10 | 1.00 | 13 | 18 | 20 | 1 | TRUE | 8.92 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 66 | 29 | Signature 18 | -3.46 | -4.47 | -2.57 | 1541.23 | 1.00 | 59 | 66 | 29 | 0 | TRUE | 11.73 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 16 | 16 | Signature 19 | -3.30 | -4.38 | -2.32 | 1637.15 | 1.00 | 31 | 16 | 16 | 0 | TRUE | 9.15 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 47 | 197 | Signature 1A | -3.74 | -4.73 | -2.89 | 1430.48 | 1.00 | 94 | 47 | 197 | 0 | TRUE | 15.17 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 84 | 79 | Signature 2 | -3.33 | -4.30 | -2.47 | 1432.91 | 1.00 | 178 | 83 | 78 | 1 | TRUE | 11.78 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 15 | 35 | Signature 20 | -3.34 | -4.30 | -2.38 | 1569.78 | 1.00 | 34 | 15 | 35 | 0 | TRUE | 10.11 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 11 | 29 | Signature 21 | -3.33 | -4.40 | -2.33 | 1499.78 | 1.00 | 29 | 11 | 29 | 0 | TRUE | 9.38 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 54 | 89 | Signature 3 | -2.87 | -3.68 | -2.06 | 1587.46 | 1.00 | 112 | 50 | 85 | 4 | TRUE | 11.32 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 266 | 114 | Signature 4 | -2.62 | -3.33 | -1.99 | 1357.61 | 1.00 | 352 | 257 | 105 | 9 | TRUE | 14.15 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 13 | 18 | Signature 6 | -3.07 | -4.06 | -2.02 | 1462.94 | 1.00 | 28 | 12 | 17 | 1 | TRUE | 8.63 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 24 | 34 | Signature 7 | -3.36 | -4.42 | -2.38 | 1510.96 | 1.00 | 54 | 24 | 34 | 0 | TRUE | 9.85 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 29 | 14 | Signature 8 | -3.17 | -4.22 | -2.16 | 1542.35 | 1.00 | 22 | 28 | 13 | 1 | TRUE | 9.03 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 7 | 11 | Signature R3 | -3.25 | -4.32 | -2.19 | 1540.17 | 1.00 | 14 | 7 | 11 | 0 | TRUE | 8.65 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 21 | 46 | Signature U1 | -3.39 | -4.46 | -2.49 | 1420.68 | 1.00 | 49 | 21 | 46 | 0 | TRUE | 10.83 |
| non-small cell lung cancer | KRAS_12-61 | EGFR | Any mutation | 751 | 853 | Signature overall | -3.22 | -3.75 | -2.69 | 1479.02 | 1.00 | 1268 | 730 | 832 | 21 | TRUE | 30.91 |
| colorectal cancer | KRAS_12-61 | ARID1B | Any mutation | 164 | 22 | Signature 15 | -1.01 | -1.79 | -0.22 | 1460.67 | 1.00 | 209 | 158 | 16 | 6 | TRUE | 2.01 |
| colorectal cancer | KRAS_12-61 | ARID1B | Any mutation | 332 | 53 | Signature 1A | -0.99 | -1.59 | -0.39 | 1527.49 | 1.00 | 481 | 320 | 41 | 12 | TRUE | 2.86 |
| colorectal cancer | KRAS_12-61 | ARID1B | Any mutation | 111 | 46 | Signature 6 | -1.48 | -2.35 | -0.77 | 1181.65 | 1.00 | 166 | 107 | 42 | 4 | TRUE | 3.50 |
| non-small cell lung cancer | KRAS_12-61 | ARID1B | Any mutation | 84 | 13 | Signature 2 | 0.13 | -0.96 | 1.29 | 1377.18 | 1.00 | 232 | 79 | 8 | 5 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12-61 | ARID1B | Any mutation | 266 | 42 | Signature 4 | -0.72 | -1.45 | -0.04 | 1285.69 | 1.00 | 405 | 257 | 33 | 9 | TRUE | 1.30 |
| uterine cancer | KRAS_12-61 | ARID1B | Any mutation | 39 | 17 | Signature 1A | 0.26 | -0.89 | 1.31 | 1434.02 | 1.00 | 168 | 35 | 13 | 4 | TRUE | 0.19 |
| uterine cancer | KRAS_12-61 | ARID1B | Any mutation | 18 | 39 | Signature 6 | -0.05 | -1.08 | 0.95 | 1606.00 | 1.00 | 55 | 12 | 33 | 6 | TRUE | 0.03 |
| colorectal cancer | KRAS_12-61 | ARID1B | Any mutation | 607 | 121 | Signature overall | -1.18 | -1.91 | -0.43 | 1508.35 | 1.00 | 856 | 585 | 99 | 22 | TRUE | 2.61 |
| non-small cell lung cancer | KRAS_12-61 | ARID1B | Any mutation | 350 | 55 | Signature overall | -0.29 | -1.82 | 1.34 | 1527.57 | 1.00 | 637 | 336 | 41 | 14 | TRUE | 0.15 |
| uterine cancer | KRAS_12-61 | ARID1B | Any mutation | 59 | 78 | Signature overall | 0.28 | -1.50 | 2.22 | 1484.45 | 1.00 | 250 | 47 | 66 | 12 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12-61 | MET | Any mutation | 84 | 23 | Signature 2 | -0.89 | -1.96 | -0.03 | 1236.77 | 1.00 | 222 | 82 | 21 | 2 | TRUE | 1.16 |
| non-small cell lung cancer | KRAS_12-61 | MET | Any mutation | 54 | 11 | Signature 3 | -0.64 | -1.70 | 0.32 | 1711.37 | 1.00 | 181 | 52 | 9 | 2 | TRUE | 0.66 |
| non-small cell lung cancer | KRAS_12-61 | MET | Any mutation | 266 | 34 | Signature 4 | -0.54 | -1.23 | 0.13 | 1451.35 | 1.00 | 416 | 256 | 24 | 10 | TRUE | 0.93 |
| non-small cell lung cancer | KRAS_12-61 | MET | Any mutation | 404 | 68 | Signature overall | -0.68 | -1.54 | 0.22 | 1442.34 | 1.00 | 819 | 390 | 54 | 14 | TRUE | 0.91 |
| colorectal cancer | KRAS_12-61 | BRAF | Any mutation | 164 | 48 | Signature 15 | -2.24 | -2.98 | -1.54 | 1724.17 | 1.00 | 180 | 159 | 43 | 5 | TRUE | 10.01 |
| colorectal cancer | KRAS_12-61 | BRAF | Any mutation | 332 | 99 | Signature 1A | -2.13 | -2.71 | -1.51 | 101.13 | 1.03 | 428 | 321 | 88 | 11 | TRUE | 11.72 |
| colorectal cancer | KRAS_12-61 | BRAF | Any mutation | 111 | 60 | Signature 6 | -2.70 | -4.62 | -1.90 | 101.96 | 1.03 | 146 | 111 | 60 | 0 | TRUE | 3.85 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 66 | 11 | Signature 18 | -1.22 | -2.30 | -0.35 | 1503.21 | 1.00 | 74 | 65 | 10 | 1 | TRUE | 1.84 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 84 | 20 | Signature 2 | -1.10 | -2.07 | -0.26 | 1612.86 | 1.00 | 222 | 82 | 18 | 2 | TRUE | 1.84 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 54 | 20 | Signature 3 | -1.07 | -2.05 | -0.22 | 1527.19 | 1.00 | 171 | 52 | 18 | 2 | TRUE | 1.73 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 266 | 50 | Signature 4 | -0.80 | -1.40 | -0.22 | 1384.06 | 1.00 | 401 | 253 | 37 | 13 | TRUE | 2.04 |
| colorectal cancer | KRAS_12-61 | BRAF | Any mutation | 607 | 207 | Signature overall | -2.36 | -3.32 | -1.68 | 1516.13 | 1.00 | 754 | 591 | 191 | 16 | TRUE | 7.73 |
| non-small cell lung cancer | KRAS_12-61 | BRAF | Any mutation | 470 | 101 | Signature overall | -1.05 | -1.80 | -0.35 | 1399.30 | 1.00 | 868 | 452 | 83 | 18 | TRUE | 2.36 |
| colorectal cancer | KRAS_12-61 | B2M | Any mutation | 13 | 14 | Signature 10 | -0.84 | -2.17 | 0.26 | 1268.74 | 1.00 | 16 | 11 | 12 | 2 | FALSE | 0.77 |
| colorectal cancer | KRAS_12-61 | B2M | Any mutation | 162 | 20 | Signature 15 | -0.85 | -1.79 | -0.01 | 1560.06 | 1.00 | 207 | 157 | 15 | 5 | FALSE | 1.25 |
| colorectal cancer | KRAS_12-61 | B2M | Any mutation | 324 | 46 | Signature 1A | -0.40 | -0.99 | 0.16 | 1445.21 | 1.00 | 484 | 309 | 31 | 15 | FALSE | 0.75 |
| colorectal cancer | KRAS_12-61 | B2M | Any mutation | 114 | 51 | Signature 6 | -0.47 | -1.14 | 0.14 | 1600.45 | 1.00 | 170 | 100 | 37 | 14 | FALSE | 0.86 |
| colorectal cancer | KRAS_12-61 | B2M | Any mutation | 613 | 131 | Signature overall | -0.65 | -1.52 | 0.20 | 1490.49 | 1.00 | 877 | 577 | 95 | 36 | FALSE | 0.85 |
| colorectal cancer | KRAS_12-61 | CARD11 | Any mutation | 164 | 14 | Signature 15 | -0.39 | -1.23 | 0.38 | 1525.58 | 1.00 | 212 | 159 | 9 | 5 | FALSE | 0.50 |
| colorectal cancer | KRAS_12-61 | CARD11 | Any mutation | 334 | 58 | Signature 1A | -0.05 | -0.54 | 0.48 | 1311.28 | 1.00 | 482 | 310 | 34 | 24 | FALSE | 0.07 |
| colorectal cancer | KRAS_12-61 | CARD11 | Any mutation | 113 | 38 | Signature 6 | -0.43 | -1.17 | 0.22 | 1343.23 | 1.00 | 177 | 104 | 29 | 9 | FALSE | 0.65 |
| non-small cell lung cancer | KRAS_12-61 | CARD11 | Any mutation | 86 | 16 | Signature 2 | 0.47 | -0.40 | 1.48 | 1499.97 | 1.00 | 231 | 79 | 9 | 7 | FALSE | 0.49 |
| non-small cell lung cancer | KRAS_12-61 | CARD11 | Any mutation | 266 | 63 | Signature 4 | -0.04 | -0.59 | 0.50 | 1528.29 | 1.00 | 399 | 244 | 41 | 22 | FALSE | 0.06 |
| colorectal cancer | KRAS_12-61 | CARD11 | Any mutation | 611 | 110 | Signature overall | -0.29 | -1.03 | 0.46 | 1299.75 | 1.00 | 871 | 573 | 72 | 38 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12-61 | CARD11 | Any mutation | 352 | 79 | Signature overall | 0.19 | -1.11 | 1.54 | 1611.98 | 1.00 | 630 | 323 | 50 | 29 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12-61 | INPP4B | Any mutation | 85 | 15 | Signature 2 | 0.83 | -0.11 | 1.93 | 1493.79 | 1.00 | 234 | 77 | 7 | 8 | FALSE | 0.98 |
| non-small cell lung cancer | KRAS_12-61 | INPP4B | Any mutation | 268 | 60 | Signature 4 | 0.12 | -0.40 | 0.67 | 1209.04 | 1.00 | 405 | 245 | 37 | 23 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12-61 | INPP4B | Any mutation | 353 | 75 | Signature overall | 0.48 | -0.87 | 2.02 | 1619.75 | 1.00 | 639 | 322 | 44 | 31 | FALSE | 0.28 |
| non-small cell lung cancer | KRAS_12-61 | NFE2L2 | Any mutation | 14 | 15 | Signature 13 | -0.80 | -2.39 | 0.53 | 1331.49 | 1.00 | 73 | 13 | 14 | 1 | FALSE | 0.56 |
| non-small cell lung cancer | KRAS_12-61 | NFE2L2 | Any mutation | 84 | 32 | Signature 2 | -0.67 | -1.59 | 0.18 | 1557.12 | 1.00 | 220 | 79 | 27 | 5 | FALSE | 0.84 |
| non-small cell lung cancer | KRAS_12-61 | NFE2L2 | Any mutation | 267 | 20 | Signature 4 | -0.35 | -1.23 | 0.46 | 1549.79 | 1.00 | 423 | 260 | 13 | 7 | FALSE | 0.37 |
| non-small cell lung cancer | KRAS_12-61 | NFE2L2 | Any mutation | 365 | 67 | Signature overall | -0.60 | -1.82 | 0.62 | 1490.13 | 1.00 | 716 | 352 | 54 | 13 | FALSE | 0.47 |
| colorectal cancer | KRAS_12-61 | SOX9 | Any mutation | 166 | 40 | Signature 15 | 0.47 | -0.02 | 1.06 | 1427.78 | 1.00 | 205 | 142 | 16 | 24 | FALSE | 1.05 |
| colorectal cancer | KRAS_12-61 | SOX9 | Any mutation | 336 | 105 | Signature 1A | 0.37 | 0.01 | 0.75 | 1376.79 | 1.00 | 464 | 285 | 54 | 51 | FALSE | 1.36 |
| colorectal cancer | KRAS_12-61 | SOX9 | Any mutation | 113 | 59 | Signature 6 | 0.11 | -0.42 | 0.59 | 1352.89 | 1.00 | 165 | 94 | 40 | 19 | FALSE | 0.17 |
| colorectal cancer | KRAS_12-61 | SOX9 | Any mutation | 615 | 204 | Signature overall | 0.32 | -0.24 | 0.87 | 1496.90 | 1.00 | 834 | 521 | 110 | 94 | FALSE | 0.60 |
| colorectal cancer | KRAS_12-61 | SMAD2 | Any mutation | 164 | 16 | Signature 15 | 0.55 | -0.04 | 1.05 | 565.23 | 1.01 | 213 | 156 | 8 | 8 | TRUE | 1.28 |
| colorectal cancer | KRAS_12-61 | SMAD2 | Any mutation | 334 | 33 | Signature 1A | 0.65 | 0.12 | 1.18 | 1383.28 | 1.00 | 504 | 313 | 12 | 21 | TRUE | 1.83 |
| colorectal cancer | KRAS_12-61 | SMAD2 | Any mutation | 111 | 17 | Signature 6 | 0.54 | -0.11 | 1.06 | 642.08 | 1.01 | 191 | 105 | 11 | 6 | TRUE | 1.18 |
| colorectal cancer | KRAS_12-61 | SMAD2 | Any mutation | 609 | 66 | Signature overall | 0.59 | 0.02 | 1.08 | 982.77 | 1.01 | 908 | 574 | 31 | 35 | TRUE | 1.56 |
| non-small cell lung cancer | KRAS_12-61 | GLI1 | Any mutation | 251 | 44 | Signature 4 | 0.19 | -0.44 | 0.78 | 97.20 | 1.03 | 361 | 232 | 25 | 19 | FALSE | 0.25 |
| non-small cell lung cancer | KRAS_12-61 | GLI1 | Any mutation | 251 | 44 | Signature overall | 0.18 | -4.12 | 4.59 | 1484.80 | 1.00 | 361 | 232 | 25 | 19 | FALSE | 0.03 |
| colorectal cancer | KRAS_12-61 | ZFHX3 | Any mutation | 16 | 17 | Signature 10 | -0.40 | -1.40 | 0.56 | 1522.30 | 1.00 | 11 | 10 | 11 | 6 | FALSE | 0.39 |
| colorectal cancer | KRAS_12-61 | ZFHX3 | Any mutation | 149 | 31 | Signature 15 | -0.83 | -1.57 | -0.12 | 1458.17 | 1.00 | 187 | 141 | 23 | 8 | FALSE | 1.58 |
| colorectal cancer | KRAS_12-61 | ZFHX3 | Any mutation | 315 | 80 | Signature 1A | -0.70 | -1.16 | -0.22 | 1353.63 | 1.00 | 435 | 294 | 59 | 21 | FALSE | 2.31 |
| colorectal cancer | KRAS_12-61 | ZFHX3 | Any mutation | 105 | 81 | Signature 6 | -0.85 | -1.44 | -0.30 | 1411.51 | 1.00 | 146 | 89 | 65 | 16 | FALSE | 2.42 |
| non-small cell lung cancer | KRAS_12-61 | ZFHX3 | Any mutation | 79 | 18 | Signature 2 | -0.52 | -1.76 | 0.53 | 1464.12 | 1.00 | 197 | 75 | 14 | 4 | FALSE | 0.44 |
| non-small cell lung cancer | KRAS_12-61 | ZFHX3 | Any mutation | 251 | 61 | Signature 4 | -0.36 | -0.95 | 0.17 | 1429.84 | 1.00 | 346 | 231 | 41 | 20 | FALSE | 0.70 |
| non-small cell lung cancer | KRAS_12-61 | ZFHX3 | Any mutation | 138 | 14 | Signature R2 | -1.35 | -2.55 | -0.34 | 1485.05 | 1.00 | 31 | 132 | 8 | 6 | FALSE | 1.75 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Any mutation | 6 | 21 | Signature 14 | 0.20 | -1.21 | 1.56 | 1531.79 | 1.00 | 6 | 2 | 17 | 4 | FALSE | 0.11 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Any mutation | 25 | 13 | Signature 15 | 0.74 | -0.33 | 1.80 | 1388.22 | 1.00 | 71 | 19 | 7 | 6 | FALSE | 0.74 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Any mutation | 41 | 56 | Signature 1A | 0.42 | -0.30 | 1.11 | 1568.53 | 1.00 | 131 | 27 | 42 | 14 | FALSE | 0.64 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Any mutation | 17 | 45 | Signature 6 | 0.18 | -0.77 | 1.09 | 1352.54 | 1.00 | 48 | 9 | 37 | 8 | FALSE | 0.15 |
| colorectal cancer | KRAS_12-61 | ZFHX3 | Any mutation | 585 | 209 | Signature overall | -0.71 | -1.51 | 0.06 | 1480.11 | 1.00 | 779 | 534 | 158 | 51 | FALSE | 1.14 |
| non-small cell lung cancer | KRAS_12-61 | ZFHX3 | Any mutation | 468 | 93 | Signature overall | -0.75 | -2.12 | 0.71 | 1383.26 | 1.00 | 574 | 438 | 63 | 30 | FALSE | 0.55 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Any mutation | 93 | 184 | Signature overall | 0.32 | -0.77 | 1.45 | 1373.84 | 1.00 | 275 | 58 | 149 | 35 | FALSE | 0.25 |
| colorectal cancer | KRAS_12-61 | MGA | Any mutation | 16 | 15 | Signature 10 | -0.27 | -1.39 | 0.79 | 1344.21 | 1.00 | 12 | 11 | 10 | 5 | FALSE | 0.20 |
| colorectal cancer | KRAS_12-61 | MGA | Any mutation | 147 | 16 | Signature 15 | -0.60 | -1.53 | 0.28 | 1493.29 | 1.00 | 190 | 142 | 11 | 5 | FALSE | 0.71 |
| colorectal cancer | KRAS_12-61 | MGA | Any mutation | 313 | 42 | Signature 1A | -0.10 | -0.75 | 0.48 | 1486.93 | 1.00 | 455 | 296 | 25 | 17 | FALSE | 0.13 |
| colorectal cancer | KRAS_12-61 | MGA | Any mutation | 103 | 36 | Signature 6 | -0.80 | -1.65 | -0.07 | 1614.80 | 1.00 | 161 | 96 | 29 | 7 | FALSE | 1.36 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Any mutation | 79 | 28 | Signature 2 | -0.73 | -1.75 | 0.17 | 1785.40 | 1.00 | 198 | 75 | 24 | 4 | FALSE | 0.85 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Any mutation | 252 | 79 | Signature 4 | -0.19 | -0.68 | 0.30 | 1386.27 | 1.00 | 338 | 224 | 51 | 28 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Any mutation | 138 | 13 | Signature R2 | 0.13 | -0.97 | 1.32 | 1553.03 | 1.00 | 37 | 127 | 2 | 11 | FALSE | 0.09 |
| uterine cancer | KRAS_12-61 | MGA | Any mutation | 6 | 49 | Signature 10 | 1.16 | -0.61 | 4.06 | 1486.98 | 1.00 | 20 | 0 | 43 | 6 | FALSE | 0.49 |
| uterine cancer | KRAS_12-61 | MGA | Any mutation | 36 | 19 | Signature 1A | -0.28 | -1.57 | 0.85 | 1616.05 | 1.00 | 152 | 33 | 16 | 3 | FALSE | 0.18 |
| uterine cancer | KRAS_12-61 | MGA | Any mutation | 16 | 14 | Signature 6 | -0.96 | -3.04 | 0.60 | 1597.59 | 1.00 | 63 | 15 | 13 | 1 | FALSE | 0.52 |
| colorectal cancer | KRAS_12-61 | MGA | Any mutation | 579 | 109 | Signature overall | -0.45 | -1.48 | 0.42 | 1326.56 | 1.00 | 818 | 545 | 75 | 34 | FALSE | 0.44 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Any mutation | 469 | 120 | Signature overall | -0.24 | -1.52 | 1.05 | 1490.73 | 1.00 | 573 | 426 | 77 | 43 | FALSE | 0.15 |
| uterine cancer | KRAS_12-61 | MGA | Any mutation | 58 | 82 | Signature overall | 0.01 | -2.07 | 2.34 | 1641.95 | 1.00 | 235 | 48 | 72 | 10 | FALSE | 0.00 |
| colorectal cancer | KRAS_12-61 | KMT2B | Any mutation | 85 | 18 | Signature 15 | -0.78 | -1.72 | 0.09 | 1611.48 | 1.00 | 101 | 80 | 13 | 5 | FALSE | 1.05 |
| colorectal cancer | KRAS_12-61 | KMT2B | Any mutation | 190 | 64 | Signature 1A | -0.45 | -0.98 | 0.08 | 1400.92 | 1.00 | 239 | 169 | 43 | 21 | FALSE | 0.99 |
| colorectal cancer | KRAS_12-61 | KMT2B | Any mutation | 68 | 86 | Signature 6 | -0.72 | -1.34 | -0.16 | 1282.71 | 1.00 | 73 | 48 | 66 | 20 | FALSE | 1.80 |
| uterine cancer | KRAS_12-61 | KMT2B | Any mutation | 20 | 15 | Signature 15 | 0.57 | -0.35 | 1.52 | 1415.60 | 1.00 | 42 | 13 | 8 | 7 | FALSE | 0.62 |
| uterine cancer | KRAS_12-61 | KMT2B | Any mutation | 36 | 51 | Signature 1A | 0.43 | -0.30 | 1.09 | 1468.80 | 1.00 | 100 | 22 | 37 | 14 | FALSE | 0.66 |
| uterine cancer | KRAS_12-61 | KMT2B | Any mutation | 7 | 13 | Signature 20 | -0.09 | -1.43 | 1.01 | 1637.21 | 1.00 | 14 | 5 | 11 | 2 | FALSE | 0.05 |
| uterine cancer | KRAS_12-61 | KMT2B | Any mutation | 13 | 39 | Signature 6 | 0.61 | -0.29 | 1.61 | 1577.62 | 1.00 | 40 | 4 | 30 | 9 | FALSE | 0.67 |
| colorectal cancer | KRAS_12-61 | KMT2B | Any mutation | 343 | 168 | Signature overall | -0.64 | -1.63 | 0.38 | 1552.73 | 1.00 | 413 | 297 | 122 | 46 | FALSE | 0.67 |
| uterine cancer | KRAS_12-61 | KMT2B | Any mutation | 81 | 152 | Signature overall | 0.19 | -0.68 | 1.02 | 1551.73 | 1.00 | 215 | 47 | 118 | 34 | FALSE | 0.18 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 150 | 48 | Signature 15 | 0.09 | -0.38 | 0.61 | 1499.34 | 1.00 | 176 | 128 | 26 | 22 | FALSE | 0.14 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 319 | 115 | Signature 1A | 0.08 | -0.28 | 0.44 | 1453.38 | 1.00 | 416 | 271 | 67 | 48 | FALSE | 0.17 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 41 | 12 | Signature 2 | 0.53 | -0.16 | 1.47 | 1374.69 | 1.00 | 30 | 30 | 1 | 11 | FALSE | 0.66 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 105 | 69 | Signature 6 | -0.19 | -0.77 | 0.31 | 1510.89 | 1.00 | 142 | 86 | 50 | 19 | FALSE | 0.31 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Any mutation | 615 | 244 | Signature overall | 0.12 | -0.39 | 0.70 | 1535.80 | 1.00 | 764 | 515 | 144 | 100 | FALSE | 0.17 |
| colorectal cancer | KRAS_12-61 | ANKRD11 | Any mutation | 14 | 12 | Signature 10 | -0.46 | -1.52 | 0.55 | 1575.46 | 1.00 | 13 | 10 | 8 | 4 | FALSE | 0.41 |
| colorectal cancer | KRAS_12-61 | ANKRD11 | Any mutation | 143 | 17 | Signature 15 | -0.93 | -1.79 | -0.09 | 1474.88 | 1.00 | 187 | 139 | 13 | 4 | FALSE | 1.40 |
| colorectal cancer | KRAS_12-61 | ANKRD11 | Any mutation | 302 | 47 | Signature 1A | -0.82 | -1.50 | -0.21 | 1609.75 | 1.00 | 436 | 291 | 36 | 11 | FALSE | 1.98 |
| colorectal cancer | KRAS_12-61 | ANKRD11 | Any mutation | 102 | 57 | Signature 6 | -0.78 | -1.42 | -0.20 | 1412.31 | 1.00 | 150 | 90 | 45 | 12 | FALSE | 1.89 |
| colorectal cancer | KRAS_12-61 | ANKRD11 | Any mutation | 561 | 133 | Signature overall | -0.75 | -1.64 | 0.12 | 1492.50 | 1.00 | 786 | 530 | 102 | 31 | FALSE | 1.07 |
| colorectal cancer | KRAS_12-61 | POLD1 | Any mutation | 147 | 15 | Signature 15 | -1.37 | -2.68 | -0.39 | 1402.73 | 1.00 | 193 | 145 | 13 | 2 | TRUE | 1.76 |
| colorectal cancer | KRAS_12-61 | POLD1 | Any mutation | 315 | 43 | Signature 1A | -0.33 | -0.98 | 0.33 | 1336.99 | 1.00 | 455 | 299 | 27 | 16 | TRUE | 0.51 |
| colorectal cancer | KRAS_12-61 | POLD1 | Any mutation | 103 | 44 | Signature 6 | -1.37 | -2.30 | -0.56 | 1606.66 | 1.00 | 158 | 98 | 39 | 5 | TRUE | 2.73 |
| colorectal cancer | KRAS_12-61 | POLD1 | Any mutation | 565 | 102 | Signature overall | -1.03 | -2.13 | 0.01 | 1510.08 | 1.00 | 806 | 542 | 79 | 23 | TRUE | 1.25 |
| non-small cell lung cancer | KRAS_12-61 | PREX2 | Any mutation | 148 | 52 | Signature 4 | -0.27 | -0.87 | 0.30 | 643.36 | 1.01 | 188 | 130 | 34 | 18 | FALSE | 0.40 |
| non-small cell lung cancer | KRAS_12-61 | PREX2 | Any mutation | 148 | 52 | Signature overall | -0.26 | -4.22 | 3.85 | 1369.76 | 1.00 | 188 | 130 | 34 | 18 | FALSE | 0.05 |
| colorectal cancer | KRAS_12-61 | AMER1 | Any mutation | 164 | 34 | Signature 15 | 0.66 | 0.17 | 1.10 | 1135.04 | 1.00 | 207 | 145 | 15 | 19 | FALSE | 2.32 |
| colorectal cancer | KRAS_12-61 | AMER1 | Any mutation | 335 | 61 | Signature 1A | 0.66 | 0.24 | 1.09 | 1102.79 | 1.00 | 490 | 300 | 26 | 35 | FALSE | 2.81 |
| colorectal cancer | KRAS_12-61 | AMER1 | Any mutation | 113 | 36 | Signature 6 | 0.68 | 0.21 | 1.13 | 1162.65 | 1.00 | 184 | 96 | 19 | 17 | FALSE | 2.33 |
| non-small cell lung cancer | KRAS_12-61 | AMER1 | Any mutation | 84 | 11 | Signature 2 | 0.90 | -0.21 | 2.07 | 1550.54 | 1.00 | 235 | 78 | 5 | 6 | FALSE | 0.90 |
| non-small cell lung cancer | KRAS_12-61 | AMER1 | Any mutation | 269 | 83 | Signature 4 | 0.05 | -0.43 | 0.50 | 1435.72 | 1.00 | 398 | 238 | 52 | 31 | FALSE | 0.07 |
| colorectal cancer | KRAS_12-61 | AMER1 | Any mutation | 612 | 131 | Signature overall | 0.67 | 0.24 | 1.14 | 1291.72 | 1.00 | 881 | 541 | 60 | 71 | FALSE | 2.45 |
| non-small cell lung cancer | KRAS_12-61 | AMER1 | Any mutation | 353 | 94 | Signature overall | 0.46 | -1.45 | 2.61 | 1264.36 | 1.00 | 633 | 316 | 57 | 37 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12-61 | EPHA7 | Any mutation | 48 | 13 | Signature 3 | -0.39 | -1.60 | 0.81 | 1274.03 | 1.00 | 159 | 45 | 10 | 3 | FALSE | 0.28 |
| non-small cell lung cancer | KRAS_12-61 | EPHA7 | Any mutation | 249 | 51 | Signature 4 | -0.84 | -1.53 | -0.19 | 1138.85 | 1.00 | 347 | 238 | 40 | 11 | FALSE | 1.90 |
| non-small cell lung cancer | KRAS_12-61 | EPHA7 | Any mutation | 297 | 64 | Signature overall | -0.61 | -2.10 | 0.98 | 1381.31 | 1.00 | 506 | 283 | 50 | 14 | FALSE | 0.37 |
| uterine cancer | KRAS_12-61 | INPPL1 | Any mutation | 34 | 38 | Signature 1A | 0.65 | -0.08 | 1.42 | 1273.91 | 1.00 | 98 | 21 | 25 | 13 | FALSE | 1.09 |
| uterine cancer | KRAS_12-61 | INPPL1 | Any mutation | 6 | 13 | Signature 20 | 0.23 | -1.19 | 1.29 | 1556.42 | 1.00 | 12 | 4 | 11 | 2 | FALSE | 0.15 |
| uterine cancer | KRAS_12-61 | INPPL1 | Any mutation | 14 | 40 | Signature 6 | 0.46 | -0.42 | 1.28 | 1523.68 | 1.00 | 40 | 6 | 32 | 8 | FALSE | 0.54 |
| uterine cancer | KRAS_12-61 | INPPL1 | Any mutation | 54 | 91 | Signature overall | 0.44 | -0.60 | 1.34 | 1489.37 | 1.00 | 150 | 31 | 68 | 23 | FALSE | 0.45 |
| melanoma | NRAS_12-61 | SPEN | Any mutation | 135 | 105 | Signature 7 | -0.65 | -1.21 | -0.14 | 1397.75 | 1.00 | 258 | 115 | 85 | 20 | FALSE | 1.73 |
| melanoma | NRAS_12-61 | SPEN | Any mutation | 135 | 105 | Signature overall | -0.54 | -4.50 | 4.14 | 1470.75 | 1.00 | 258 | 115 | 85 | 20 | FALSE | 0.11 |
| melanoma | NRAS_12-61 | KMT2C | Any mutation | 15 | 11 | Signature 11 | 0.21 | -1.01 | 1.73 | 919.70 | 1.01 | 34 | 10 | 6 | 5 | FALSE | 0.11 |
| melanoma | NRAS_12-61 | KMT2C | Any mutation | 129 | 126 | Signature 7 | -0.70 | -1.18 | -0.19 | 1207.60 | 1.00 | 216 | 106 | 103 | 23 | FALSE | 2.22 |
| melanoma | NRAS_12-61 | KMT2C | Any mutation | 144 | 137 | Signature overall | -0.23 | -1.48 | 1.61 | 1297.77 | 1.00 | 250 | 116 | 109 | 28 | FALSE | 0.11 |
| melanoma | NRAS_12-61 | TP53 | Any mutation | 15 | 14 | Signature 11 | -0.10 | -0.87 | 0.87 | 1173.10 | 1.00 | 32 | 11 | 10 | 4 | TRUE | 0.09 |
| melanoma | NRAS_12-61 | TP53 | Any mutation | 15 | 14 | Signature 1A | 0.15 | -0.67 | 1.35 | 354.80 | 1.01 | 44 | 9 | 8 | 6 | TRUE | 0.11 |
| melanoma | NRAS_12-61 | TP53 | Any mutation | 133 | 150 | Signature 7 | -0.35 | -0.79 | 0.08 | 1354.35 | 1.00 | 215 | 100 | 117 | 33 | TRUE | 0.92 |
| melanoma | NRAS_12-61 | TP53 | Any mutation | 163 | 178 | Signature overall | -0.10 | -0.79 | 0.79 | 457.15 | 1.00 | 291 | 120 | 135 | 43 | TRUE | 0.10 |
| melanoma | NRAS_12-61 | ATRX | Any mutation | 133 | 76 | Signature 7 | -0.57 | -1.20 | 0.00 | 1383.42 | 1.00 | 275 | 118 | 61 | 15 | TRUE | 1.20 |
| melanoma | NRAS_12-61 | ATRX | Any mutation | 133 | 76 | Signature overall | -0.48 | -4.55 | 4.09 | 1386.41 | 1.00 | 275 | 118 | 61 | 15 | TRUE | 0.09 |
| melanoma | NRAS_12-61 | PTPRD | Any mutation | 144 | 247 | Signature 7 | -0.60 | -1.00 | -0.25 | 155.26 | 1.02 | 197 | 93 | 196 | 51 | FALSE | 2.61 |
| melanoma | NRAS_12-61 | PTPRD | Any mutation | 144 | 247 | Signature overall | -0.52 | -4.26 | 3.71 | 1227.50 | 1.00 | 197 | 93 | 196 | 51 | FALSE | 0.11 |
| melanoma | NRAS_12-61 | PIK3C2G | Any mutation | 134 | 174 | Signature 7 | -0.50 | -0.94 | -0.07 | 1387.62 | 1.00 | 207 | 96 | 136 | 38 | FALSE | 1.60 |
| melanoma | NRAS_12-61 | PIK3C2G | Any mutation | 134 | 174 | Signature overall | -0.45 | -4.68 | 3.49 | 1649.12 | 1.00 | 207 | 96 | 136 | 38 | FALSE | 0.09 |
| melanoma | NRAS_12-61 | PTPRT | Any mutation | 16 | 12 | Signature 11 | -0.34 | -1.63 | 0.89 | 1669.25 | 1.00 | 35 | 13 | 9 | 3 | FALSE | 0.22 |
| melanoma | NRAS_12-61 | PTPRT | Any mutation | 150 | 346 | Signature 7 | -0.32 | -0.69 | 0.06 | 1490.81 | 1.00 | 173 | 71 | 267 | 79 | FALSE | 1.02 |
| melanoma | NRAS_12-61 | PTPRT | Any mutation | 166 | 358 | Signature overall | -0.30 | -2.04 | 1.43 | 1362.88 | 1.00 | 208 | 84 | 276 | 82 | FALSE | 0.13 |
| melanoma | NRAS_12-61 | ALK | Any mutation | 134 | 117 | Signature 7 | -0.62 | -1.13 | -0.04 | 166.67 | 1.02 | 244 | 111 | 94 | 23 | TRUE | 1.67 |
| melanoma | NRAS_12-61 | ALK | Any mutation | 134 | 117 | Signature overall | -0.52 | -5.15 | 4.01 | 1447.24 | 1.00 | 244 | 111 | 94 | 23 | TRUE | 0.10 |
| melanoma | NRAS_12-61 | IKZF1 | Any mutation | 134 | 93 | Signature 7 | -0.48 | -1.03 | 0.06 | 1531.02 | 1.00 | 260 | 114 | 73 | 20 | TRUE | 1.09 |
| melanoma | NRAS_12-61 | IKZF1 | Any mutation | 134 | 93 | Signature overall | -0.48 | -4.92 | 3.70 | 1531.45 | 1.00 | 260 | 114 | 73 | 20 | TRUE | 0.09 |
| melanoma | NRAS_12-61 | FAT1 | Any mutation | 135 | 128 | Signature 7 | -0.36 | -0.82 | 0.15 | 1100.95 | 1.00 | 244 | 105 | 98 | 30 | FALSE | 0.85 |
| melanoma | NRAS_12-61 | FAT1 | Any mutation | 135 | 128 | Signature overall | -0.26 | -4.34 | 3.91 | 1527.04 | 1.00 | 244 | 105 | 98 | 30 | FALSE | 0.05 |
| melanoma | NRAS_12-61 | KMT2A | Any mutation | 134 | 124 | Signature 7 | -0.62 | -1.11 | -0.13 | 1105.24 | 1.00 | 250 | 110 | 100 | 24 | FALSE | 1.79 |
| melanoma | NRAS_12-61 | KMT2A | Any mutation | 134 | 124 | Signature overall | -0.56 | -4.67 | 3.40 | 1661.97 | 1.00 | 250 | 110 | 100 | 24 | FALSE | 0.11 |
| melanoma | NRAS_12-61 | PAK7 | Any mutation | 134 | 205 | Signature 7 | -0.73 | -1.15 | -0.34 | 1473.87 | 1.00 | 177 | 93 | 164 | 41 | FALSE | 3.36 |
| melanoma | NRAS_12-61 | PAK7 | Any mutation | 134 | 205 | Signature overall | -0.73 | -4.82 | 3.61 | 1437.95 | 1.00 | 177 | 93 | 164 | 41 | FALSE | 0.15 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 17 | 48 | Signature 11 | 1.11 | -0.09 | 2.43 | 1560.90 | 1.00 | 11 | 2 | 33 | 15 | TRUE | 1.12 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 11 | 20 | Signature 19 | 1.59 | 0.26 | 3.00 | 1206.69 | 1.00 | 6 | 1 | 10 | 10 | TRUE | 1.60 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 12 | 17 | Signature 1A | 1.41 | 0.35 | 2.55 | 1478.36 | 1.00 | 42 | 5 | 10 | 7 | TRUE | 1.92 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 152 | 473 | Signature 7 | 0.88 | 0.27 | 1.51 | 1623.99 | 1.00 | 61 | 12 | 333 | 140 | TRUE | 2.27 |
| melanoma | NRAS_12-61 | TERT | Any mutation | 192 | 558 | Signature overall | 1.22 | 0.06 | 2.47 | 1160.72 | 1.00 | 120 | 20 | 386 | 172 | TRUE | 1.39 |
| melanoma | NRAS_12-61 | NOTCH3 | Any mutation | 132 | 116 | Signature 7 | -0.95 | -1.51 | -0.42 | 931.70 | 1.00 | 244 | 114 | 98 | 18 | TRUE | 3.14 |
| melanoma | NRAS_12-61 | NOTCH3 | Any mutation | 132 | 116 | Signature overall | -0.87 | -4.81 | 3.21 | 1524.66 | 1.00 | 244 | 114 | 98 | 18 | TRUE | 0.19 |
| melanoma | NRAS_12-61 | NOTCH4 | Any mutation | 131 | 141 | Signature 7 | -0.39 | -0.84 | 0.04 | 1522.73 | 1.00 | 215 | 98 | 108 | 33 | TRUE | 1.09 |
| melanoma | NRAS_12-61 | NOTCH4 | Any mutation | 131 | 141 | Signature overall | -0.36 | -4.34 | 3.78 | 1232.41 | 1.00 | 215 | 98 | 108 | 33 | TRUE | 0.07 |
| melanoma | NRAS_12-61 | CDKN2A | Any mutation | 136 | 108 | Signature 7 | -0.25 | -0.80 | 0.25 | 1096.73 | 1.00 | 242 | 108 | 80 | 28 | TRUE | 0.47 |
| melanoma | NRAS_12-61 | CDKN2A | Any mutation | 136 | 108 | Signature overall | -0.26 | -4.68 | 3.97 | 1463.41 | 1.00 | 242 | 108 | 80 | 28 | TRUE | 0.05 |
| melanoma | NRAS_12-61 | KMT2D | Any mutation | 15 | 13 | Signature 11 | -0.17 | -0.90 | 0.89 | 966.74 | 1.00 | 31 | 11 | 9 | 4 | FALSE | 0.16 |
| melanoma | NRAS_12-61 | KMT2D | Any mutation | 146 | 184 | Signature 7 | -0.30 | -0.66 | 0.10 | 871.00 | 1.01 | 236 | 102 | 140 | 44 | FALSE | 0.88 |
| melanoma | NRAS_12-61 | KMT2D | Any mutation | 161 | 197 | Signature overall | -0.25 | -1.22 | 0.94 | 1287.96 | 1.00 | 267 | 113 | 149 | 48 | FALSE | 0.20 |
| colorectal cancer | NRAS_12-61 | APC | Any mutation | 12 | 469 | Signature 15 | 0.23 | -0.70 | 1.16 | 1363.58 | 1.00 | 79 | 4 | 461 | 8 | TRUE | 0.20 |
| colorectal cancer | NRAS_12-61 | APC | Any mutation | 54 | 962 | Signature 1A | 1.03 | 0.33 | 1.76 | 1476.53 | 1.00 | 218 | 3 | 911 | 51 | TRUE | 2.28 |
| colorectal cancer | NRAS_12-61 | APC | Any mutation | 6 | 42 | Signature 3 | 1.18 | 0.22 | 2.21 | 1413.34 | 1.00 | 11 | 0 | 36 | 6 | TRUE | 1.72 |
| colorectal cancer | NRAS_12-61 | APC | Any mutation | 15 | 355 | Signature 6 | 0.70 | -0.14 | 1.58 | 1461.74 | 1.00 | 93 | 2 | 342 | 13 | TRUE | 0.97 |
| melanoma | NRAS_12-61 | APC | Any mutation | 132 | 102 | Signature 7 | -0.84 | -1.43 | -0.28 | 1414.25 | 1.00 | 252 | 115 | 85 | 17 | TRUE | 2.40 |
| colorectal cancer | NRAS_12-61 | APC | Any mutation | 116 | 2462 | Signature overall | 0.77 | 0.08 | 1.48 | 1381.83 | 1.00 | 540 | 11 | 2357 | 105 | TRUE | 1.50 |
| melanoma | NRAS_12-61 | APC | Any mutation | 132 | 102 | Signature overall | -0.68 | -4.77 | 3.86 | 1306.71 | 1.00 | 252 | 115 | 85 | 17 | TRUE | 0.13 |
| melanoma | NRAS_12-61 | ARID2 | Any mutation | 139 | 109 | Signature 7 | -0.07 | -0.55 | 0.41 | 1536.06 | 1.00 | 262 | 108 | 78 | 31 | FALSE | 0.10 |
| melanoma | NRAS_12-61 | ARID2 | Any mutation | 141 | 128 | Signature overall | -1.08 | -4.53 | 1.44 | 1445.30 | 1.00 | 278 | 110 | 97 | 31 | FALSE | 0.32 |
| melanoma | NRAS_12-61 | EPHA3 | Any mutation | 133 | 97 | Signature 7 | -0.04 | -0.52 | 0.42 | 1040.07 | 1.00 | 265 | 106 | 70 | 27 | FALSE | 0.06 |
| melanoma | NRAS_12-61 | EPHA3 | Any mutation | 133 | 97 | Signature overall | -0.05 | -4.36 | 4.23 | 1402.08 | 1.00 | 265 | 106 | 70 | 27 | FALSE | 0.01 |
| melanoma | NRAS_12-61 | KDR | Any mutation | 134 | 121 | Signature 7 | -0.49 | -0.98 | 0.02 | 1143.88 | 1.00 | 245 | 108 | 95 | 26 | TRUE | 1.29 |
| melanoma | NRAS_12-61 | KDR | Any mutation | 134 | 121 | Signature overall | -0.36 | -4.73 | 4.07 | 1567.36 | 1.00 | 245 | 108 | 95 | 26 | TRUE | 0.07 |
| melanoma | NRAS_12-61 | NTRK3 | Any mutation | 135 | 93 | Signature 7 | -0.50 | -1.04 | 0.01 | 1399.26 | 1.00 | 258 | 115 | 73 | 20 | FALSE | 1.15 |
| melanoma | NRAS_12-61 | NTRK3 | Any mutation | 135 | 93 | Signature overall | -0.32 | -4.70 | 4.14 | 1436.35 | 1.00 | 258 | 115 | 73 | 20 | FALSE | 0.06 |
| melanoma | NRAS_12-61 | GRIN2A | Any mutation | 15 | 13 | Signature 11 | -0.56 | -1.75 | 0.71 | 1392.22 | 1.00 | 31 | 12 | 10 | 3 | FALSE | 0.45 |
| melanoma | NRAS_12-61 | GRIN2A | Any mutation | 148 | 278 | Signature 7 | -0.63 | -1.04 | -0.23 | 1396.27 | 1.00 | 191 | 92 | 222 | 56 | FALSE | 2.74 |
| melanoma | NRAS_12-61 | GRIN2A | Any mutation | 163 | 291 | Signature overall | -0.58 | -2.08 | 0.95 | 1498.12 | 1.00 | 222 | 104 | 232 | 59 | FALSE | 0.34 |
| melanoma | NRAS_12-61 | ERBB4 | Any mutation | 138 | 171 | Signature 7 | -0.93 | -1.40 | -0.48 | 798.35 | 1.00 | 217 | 109 | 142 | 29 | TRUE | 4.13 |
| melanoma | NRAS_12-61 | ERBB4 | Any mutation | 138 | 171 | Signature overall | -0.84 | -4.86 | 3.64 | 1246.81 | 1.00 | 217 | 109 | 142 | 29 | TRUE | 0.18 |
| melanoma | NRAS_12-61 | NF1 | Any mutation | 15 | 17 | Signature 11 | -1.05 | -2.10 | 0.16 | 1212.98 | 1.00 | 32 | 12 | 14 | 3 | TRUE | 1.20 |
| melanoma | NRAS_12-61 | NF1 | Any mutation | 140 | 242 | Signature 7 | -1.27 | -1.70 | -0.87 | 1503.44 | 1.00 | 184 | 107 | 209 | 33 | TRUE | 8.43 |
| melanoma | NRAS_12-61 | NF1 | Any mutation | 155 | 259 | Signature overall | -1.19 | -2.39 | 0.21 | 1205.90 | 1.00 | 216 | 119 | 223 | 36 | TRUE | 1.20 |
| melanoma | NRAS_12-61 | FLT1 | Any mutation | 134 | 110 | Signature 7 | -0.39 | -0.89 | 0.11 | 1165.56 | 1.00 | 253 | 109 | 85 | 25 | FALSE | 0.92 |
| melanoma | NRAS_12-61 | FLT1 | Any mutation | 134 | 110 | Signature overall | -0.30 | -4.28 | 3.80 | 1404.61 | 1.00 | 253 | 109 | 85 | 25 | FALSE | 0.06 |
| melanoma | NRAS_12-61 | ROS1 | Any mutation | 15 | 11 | Signature 11 | 0.01 | -1.29 | 1.37 | 1454.88 | 1.00 | 33 | 11 | 7 | 4 | TRUE | 0.00 |
| melanoma | NRAS_12-61 | ROS1 | Any mutation | 143 | 231 | Signature 7 | -0.57 | -0.96 | -0.16 | 1541.66 | 1.00 | 206 | 96 | 184 | 47 | TRUE | 2.20 |
| melanoma | NRAS_12-61 | ROS1 | Any mutation | 158 | 242 | Signature overall | -0.30 | -1.81 | 1.45 | 1622.40 | 1.00 | 239 | 107 | 191 | 51 | TRUE | 0.16 |
| melanoma | NRAS_12-61 | PIK3CG | Any mutation | 133 | 92 | Signature 7 | -0.86 | -1.49 | -0.24 | 1114.91 | 1.00 | 263 | 118 | 77 | 15 | FALSE | 2.24 |
| melanoma | NRAS_12-61 | PIK3CG | Any mutation | 133 | 92 | Signature overall | -0.70 | -4.78 | 3.96 | 1392.90 | 1.00 | 263 | 118 | 77 | 15 | FALSE | 0.13 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 15 | 25 | Signature 11 | -1.84 | -3.11 | -0.62 | 1441.93 | 1.00 | 19 | 12 | 22 | 3 | TRUE | 2.53 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 11 | 11 | Signature 1A | -2.42 | -4.70 | -0.73 | 1512.12 | 1.00 | 41 | 11 | 11 | 0 | TRUE | 1.97 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 134 | 191 | Signature 7 | -2.19 | -2.77 | -1.67 | 1373.45 | 1.00 | 155 | 119 | 176 | 15 | TRUE | 14.01 |
| melanoma | NRAS_12-61 | BRAF | Any mutation | 160 | 227 | Signature overall | -2.14 | -3.50 | -0.97 | 1598.98 | 1.00 | 215 | 142 | 209 | 18 | TRUE | 2.98 |
| melanoma | NRAS_12-61 | CARD11 | Any mutation | 132 | 107 | Signature 7 | -0.85 | -1.43 | -0.34 | 1348.31 | 1.00 | 246 | 114 | 89 | 18 | FALSE | 2.59 |
| melanoma | NRAS_12-61 | CARD11 | Any mutation | 132 | 107 | Signature overall | -0.70 | -4.89 | 3.76 | 1497.85 | 1.00 | 246 | 114 | 89 | 18 | FALSE | 0.14 |
| melanoma | NRAS_12-61 | TP63 | Any mutation | 128 | 152 | Signature 7 | -0.57 | -1.04 | -0.10 | 1672.67 | 1.00 | 205 | 96 | 120 | 32 | FALSE | 1.72 |
| melanoma | NRAS_12-61 | TP63 | Any mutation | 128 | 152 | Signature overall | -0.49 | -4.62 | 3.88 | 1374.14 | 1.00 | 205 | 96 | 120 | 32 | FALSE | 0.10 |
| melanoma | NRAS_12-61 | ZFHX3 | Any mutation | 127 | 90 | Signature 7 | -0.78 | -1.41 | -0.24 | 1452.00 | 1.00 | 247 | 111 | 74 | 16 | FALSE | 2.00 |
| melanoma | NRAS_12-61 | ZFHX3 | Any mutation | 128 | 129 | Signature overall | -1.69 | -5.69 | 1.78 | 1601.70 | 1.00 | 263 | 112 | 113 | 16 | FALSE | 0.45 |
| melanoma | NRAS_12-61 | PREX2 | Any mutation | 90 | 158 | Signature 7 | -0.48 | -0.96 | 0.01 | 1474.10 | 1.00 | 113 | 54 | 122 | 36 | FALSE | 1.28 |
| melanoma | NRAS_12-61 | PREX2 | Any mutation | 90 | 158 | Signature overall | -0.43 | -4.37 | 3.90 | 1434.77 | 1.00 | 113 | 54 | 122 | 36 | FALSE | 0.09 |
| melanoma | NRAS_12-61 | EPHA7 | Any mutation | 130 | 141 | Signature 7 | -0.45 | -0.91 | 0.00 | 1464.13 | 1.00 | 226 | 99 | 110 | 31 | FALSE | 1.25 |
| melanoma | NRAS_12-61 | EPHA7 | Any mutation | 130 | 141 | Signature overall | -0.46 | -4.56 | 3.71 | 1540.76 | 1.00 | 226 | 99 | 110 | 31 | FALSE | 0.09 |
| colorectal cancer | RAS_12 | SPEN | Any mutation | 8 | 21 | Signature 10 | -1.39 | -3.02 | -0.02 | 1537.55 | 1.00 | 18 | 7 | 20 | 1 | FALSE | 1.14 |
| colorectal cancer | RAS_12 | SPEN | Any mutation | 101 | 18 | Signature 15 | -0.77 | -2.00 | 0.23 | 1626.20 | 1.00 | 274 | 98 | 15 | 3 | FALSE | 0.75 |
| colorectal cancer | RAS_12 | SPEN | Any mutation | 280 | 38 | Signature 1A | -0.22 | -0.90 | 0.47 | 1557.28 | 1.00 | 545 | 268 | 26 | 12 | FALSE | 0.28 |
| colorectal cancer | RAS_12 | SPEN | Any mutation | 73 | 61 | Signature 6 | -0.80 | -1.63 | -0.09 | 1522.21 | 1.00 | 201 | 65 | 53 | 8 | FALSE | 1.44 |
| non-small cell lung cancer | RAS_12 | SPEN | Any mutation | 79 | 39 | Signature 2 | -3.93 | -9.42 | -1.30 | 1474.65 | 1.00 | 233 | 79 | 39 | 0 | FALSE | 1.15 |
| non-small cell lung cancer | RAS_12 | SPEN | Any mutation | 231 | 24 | Signature 4 | 0.06 | -0.85 | 0.91 | 1316.19 | 1.00 | 459 | 222 | 15 | 9 | FALSE | 0.04 |
| uterine cancer | RAS_12 | SPEN | Any mutation | 20 | 13 | Signature 15 | 0.96 | -0.19 | 2.12 | 1475.47 | 1.00 | 83 | 15 | 8 | 5 | FALSE | 0.99 |
| uterine cancer | RAS_12 | SPEN | Any mutation | 36 | 21 | Signature 1A | -0.40 | -1.79 | 0.71 | 1458.71 | 1.00 | 167 | 34 | 19 | 2 | FALSE | 0.28 |
| uterine cancer | RAS_12 | SPEN | Any mutation | 14 | 21 | Signature 6 | 0.79 | -0.43 | 1.92 | 1470.88 | 1.00 | 73 | 9 | 16 | 5 | FALSE | 0.73 |
| colorectal cancer | RAS_12 | SPEN | Any mutation | 462 | 138 | Signature overall | -0.76 | -1.88 | 0.33 | 1593.28 | 1.00 | 1038 | 438 | 114 | 24 | FALSE | 0.74 |
| non-small cell lung cancer | RAS_12 | SPEN | Any mutation | 310 | 63 | Signature overall | -1.67 | -5.37 | 1.56 | 1392.93 | 1.00 | 692 | 301 | 54 | 9 | FALSE | 0.47 |
| uterine cancer | RAS_12 | SPEN | Any mutation | 73 | 93 | Signature overall | 0.51 | -0.85 | 2.02 | 1392.07 | 1.00 | 346 | 58 | 78 | 15 | FALSE | 0.34 |
| colorectal cancer | RAS_12 | KMT2C | Any mutation | 9 | 32 | Signature 10 | -1.41 | -2.96 | -0.11 | 1508.12 | 1.00 | 15 | 7 | 30 | 2 | FALSE | 1.32 |
| colorectal cancer | RAS_12 | KMT2C | Any mutation | 97 | 22 | Signature 15 | -0.89 | -2.04 | 0.08 | 1335.31 | 1.00 | 268 | 94 | 19 | 3 | FALSE | 0.98 |
| colorectal cancer | RAS_12 | KMT2C | Any mutation | 274 | 60 | Signature 1A | -0.29 | -0.91 | 0.28 | 1590.01 | 1.00 | 519 | 257 | 43 | 17 | FALSE | 0.49 |
| colorectal cancer | RAS_12 | KMT2C | Any mutation | 69 | 65 | Signature 6 | -0.32 | -0.98 | 0.32 | 1458.27 | 1.00 | 193 | 57 | 53 | 12 | FALSE | 0.45 |
| non-small cell lung cancer | RAS_12 | KMT2C | Any mutation | 13 | 22 | Signature 13 | 0.08 | -0.85 | 1.01 | 1657.56 | 1.00 | 69 | 9 | 18 | 4 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12 | KMT2C | Any mutation | 80 | 40 | Signature 2 | 0.16 | -0.52 | 0.81 | 1398.77 | 1.00 | 218 | 68 | 28 | 12 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12 | KMT2C | Any mutation | 49 | 13 | Signature 3 | -0.50 | -1.67 | 0.44 | 1569.36 | 1.00 | 182 | 48 | 12 | 1 | FALSE | 0.47 |
| non-small cell lung cancer | RAS_12 | KMT2C | Any mutation | 230 | 76 | Signature 4 | -0.28 | -0.78 | 0.18 | 1415.61 | 1.00 | 422 | 210 | 56 | 20 | FALSE | 0.60 |
| uterine cancer | RAS_12 | KMT2C | Any mutation | 18 | 17 | Signature 15 | -0.74 | -2.34 | 0.56 | 1533.18 | 1.00 | 77 | 16 | 15 | 2 | FALSE | 0.50 |
| uterine cancer | RAS_12 | KMT2C | Any mutation | 34 | 20 | Signature 1A | -0.84 | -2.42 | 0.49 | 1446.38 | 1.00 | 154 | 32 | 18 | 2 | FALSE | 0.61 |
| uterine cancer | RAS_12 | KMT2C | Any mutation | 13 | 23 | Signature 6 | -1.29 | -3.07 | 0.17 | 1540.33 | 1.00 | 64 | 12 | 22 | 1 | FALSE | 0.85 |
| colorectal cancer | RAS_12 | KMT2C | Any mutation | 449 | 179 | Signature overall | -0.71 | -1.89 | 0.40 | 1543.86 | 1.00 | 995 | 415 | 145 | 34 | FALSE | 0.65 |
| non-small cell lung cancer | RAS_12 | KMT2C | Any mutation | 372 | 151 | Signature overall | -0.14 | -0.84 | 0.58 | 1578.27 | 1.00 | 891 | 335 | 114 | 37 | FALSE | 0.16 |
| uterine cancer | RAS_12 | KMT2C | Any mutation | 67 | 118 | Signature overall | -0.82 | -2.32 | 0.73 | 1580.80 | 1.00 | 315 | 60 | 111 | 7 | FALSE | 0.54 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 12 | 11 | Signature 11 | 0.02 | -0.93 | 1.01 | 1374.54 | 1.00 | 8 | 5 | 4 | 7 | TRUE | 0.01 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 10 | 28 | Signature 15 | -0.15 | -1.04 | 0.79 | 1541.84 | 1.00 | 19 | 3 | 21 | 7 | TRUE | 0.13 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 34 | 66 | Signature 1A | -0.51 | -1.16 | 0.10 | 1589.68 | 1.00 | 36 | 19 | 51 | 15 | TRUE | 0.94 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 9 | 31 | Signature 2 | -0.75 | -1.63 | 0.11 | 1223.08 | 1.00 | 20 | 6 | 28 | 3 | TRUE | 1.05 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 6 | 18 | Signature 3 | -0.53 | -1.51 | 0.39 | 1691.84 | 1.00 | 6 | 3 | 15 | 3 | TRUE | 0.56 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 21 | 70 | Signature 4 | -0.60 | -1.36 | 0.12 | 1417.83 | 1.00 | 11 | 8 | 57 | 13 | TRUE | 0.94 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 9 | 32 | Signature 10 | -0.96 | -1.58 | -0.36 | 1486.09 | 1.00 | 6 | 3 | 26 | 6 | TRUE | 2.67 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 22 | 28 | Signature 11 | -0.57 | -1.14 | 0.02 | 1528.39 | 1.00 | 2 | 7 | 13 | 15 | TRUE | 1.26 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 103 | 311 | Signature 15 | -0.98 | -1.36 | -0.58 | 1485.77 | 1.00 | 58 | 39 | 247 | 64 | TRUE | 6.27 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 8 | 36 | Signature 17 | -0.96 | -1.60 | -0.36 | 1440.91 | 1.00 | 8 | 2 | 30 | 6 | TRUE | 2.60 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 17 | 36 | Signature 18 | -1.04 | -1.68 | -0.47 | 1505.98 | 1.00 | 3 | 9 | 28 | 8 | TRUE | 3.26 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 20 | 31 | Signature 19 | -1.05 | -1.68 | -0.49 | 1528.78 | 1.00 | 5 | 12 | 23 | 8 | TRUE | 3.18 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 294 | 655 | Signature 1A | -0.83 | -1.11 | -0.55 | 1490.45 | 1.00 | 123 | 110 | 471 | 184 | TRUE | 8.49 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 7 | 15 | Signature 1B | -0.90 | -1.62 | -0.26 | 1392.15 | 1.00 | 4 | 3 | 11 | 4 | TRUE | 2.04 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 38 | 56 | Signature 2 | -0.98 | -1.53 | -0.47 | 1502.63 | 1.00 | 9 | 20 | 38 | 18 | TRUE | 3.52 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 9 | 23 | Signature 20 | -0.85 | -1.48 | -0.23 | 1538.23 | 1.00 | 8 | 3 | 17 | 6 | TRUE | 2.12 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 7 | 20 | Signature 21 | -0.87 | -1.51 | -0.20 | 1458.21 | 1.00 | 6 | 2 | 15 | 5 | TRUE | 2.10 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 14 | 35 | Signature 3 | -0.89 | -1.49 | -0.32 | 1415.96 | 1.00 | 2 | 5 | 26 | 9 | TRUE | 2.49 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 18 | 36 | Signature 4 | -0.86 | -1.49 | -0.29 | 1501.07 | 1.00 | 3 | 7 | 25 | 11 | TRUE | 2.45 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 84 | 236 | Signature 6 | -0.55 | -0.98 | -0.12 | 1449.44 | 1.00 | 84 | 28 | 180 | 56 | TRUE | 1.78 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 15 | 28 | Signature 7 | -0.89 | -1.56 | -0.32 | 1436.21 | 1.00 | 5 | 7 | 20 | 8 | TRUE | 2.34 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 14 | 13 | Signature 8 | -0.66 | -1.28 | -0.03 | 1358.16 | 1.00 | 4 | 6 | 5 | 8 | TRUE | 1.46 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 17 | 16 | Signature R2 | -0.61 | -1.22 | -0.01 | 1487.54 | 1.00 | 0 | 7 | 6 | 10 | TRUE | 1.30 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 22 | 12 | Signature 11 | -1.44 | -2.30 | -0.63 | 1521.87 | 1.00 | 13 | 19 | 9 | 3 | TRUE | 3.17 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 15 | 79 | Signature 13 | -0.81 | -1.54 | -0.04 | 1446.59 | 1.00 | 27 | 4 | 68 | 11 | TRUE | 1.48 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 17 | 36 | Signature 14 | -1.15 | -1.94 | -0.39 | 1566.77 | 1.00 | 14 | 10 | 29 | 7 | TRUE | 2.43 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 20 | 87 | Signature 15 | -1.39 | -2.11 | -0.73 | 1336.37 | 1.00 | 40 | 13 | 80 | 7 | TRUE | 3.98 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 10 | 39 | Signature 16 | -0.83 | -1.69 | -0.03 | 1534.56 | 1.00 | 21 | 3 | 32 | 7 | TRUE | 1.33 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 58 | 92 | Signature 18 | -0.95 | -1.50 | -0.41 | 1407.72 | 1.00 | 32 | 32 | 66 | 26 | TRUE | 3.10 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 14 | 31 | Signature 19 | -1.10 | -1.92 | -0.31 | 1388.83 | 1.00 | 26 | 9 | 26 | 5 | TRUE | 2.10 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 46 | 149 | Signature 1A | -0.98 | -1.54 | -0.43 | 1398.09 | 1.00 | 96 | 28 | 131 | 18 | TRUE | 3.30 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 81 | 223 | Signature 2 | -0.81 | -1.26 | -0.38 | 1451.33 | 1.00 | 85 | 39 | 181 | 42 | TRUE | 3.46 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 13 | 46 | Signature 20 | -1.44 | -2.30 | -0.62 | 1585.03 | 1.00 | 22 | 9 | 42 | 4 | TRUE | 3.32 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 9 | 37 | Signature 21 | -1.73 | -2.66 | -0.84 | 1526.86 | 1.00 | 21 | 8 | 36 | 1 | TRUE | 3.85 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 52 | 161 | Signature 3 | -1.16 | -1.70 | -0.65 | 1518.17 | 1.00 | 65 | 30 | 139 | 22 | TRUE | 4.62 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 233 | 522 | Signature 4 | -1.70 | -2.02 | -1.39 | 1433.23 | 1.00 | 92 | 134 | 423 | 99 | TRUE | 25.06 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 11 | 36 | Signature 6 | -1.25 | -2.05 | -0.43 | 1404.80 | 1.00 | 11 | 6 | 31 | 5 | TRUE | 2.60 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 22 | 71 | Signature 7 | -1.36 | -2.06 | -0.68 | 1467.38 | 1.00 | 27 | 14 | 63 | 8 | TRUE | 3.94 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 26 | 35 | Signature 8 | -1.24 | -2.01 | -0.50 | 1640.98 | 1.00 | 11 | 17 | 26 | 9 | TRUE | 3.07 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 145 | 85 | Signature R2 | -1.39 | -1.93 | -0.89 | 1362.02 | 1.00 | 18 | 103 | 43 | 42 | TRUE | 6.60 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 6 | 15 | Signature R3 | -1.48 | -2.48 | -0.56 | 1380.62 | 1.00 | 12 | 5 | 14 | 1 | TRUE | 2.61 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 17 | 57 | Signature U1 | -1.76 | -2.58 | -0.96 | 1495.48 | 1.00 | 41 | 15 | 55 | 2 | TRUE | 4.61 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 9 | 32 | Signature U2 | -1.65 | -2.61 | -0.82 | 1532.56 | 1.00 | 8 | 7 | 30 | 2 | TRUE | 3.59 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 115 | 94 | Signature 11 | 1.88 | 1.02 | 2.76 | 1341.54 | 1.00 | 5 | 26 | 5 | 89 | TRUE | 4.82 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 109 | 98 | Signature 15 | 1.43 | 0.68 | 2.17 | 1452.66 | 1.00 | 10 | 25 | 14 | 84 | TRUE | 3.80 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 23 | 19 | Signature 16 | 2.15 | 1.16 | 3.32 | 1523.66 | 1.00 | 7 | 5 | 1 | 18 | TRUE | 4.20 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 12 | 41 | Signature 17 | 0.22 | -0.75 | 1.16 | 1541.36 | 1.00 | 9 | 5 | 34 | 7 | TRUE | 0.18 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 14 | 14 | Signature 18 | 2.08 | 1.06 | 3.21 | 1464.12 | 1.00 | 7 | 2 | 2 | 12 | TRUE | 3.89 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 14 | 16 | Signature 19 | 1.90 | 0.86 | 2.99 | 1333.67 | 1.00 | 8 | 2 | 4 | 12 | TRUE | 3.54 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 201 | 172 | Signature 1A | 1.41 | 0.86 | 1.96 | 1305.77 | 1.00 | 28 | 53 | 24 | 148 | TRUE | 6.11 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 16 | 12 | Signature 1B | 1.88 | 0.75 | 3.00 | 1723.36 | 1.00 | 4 | 5 | 1 | 11 | TRUE | 3.14 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 33 | 29 | Signature 2 | 2.31 | 1.36 | 3.33 | 1369.60 | 1.00 | 11 | 6 | 2 | 27 | TRUE | 5.47 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 25 | 21 | Signature 21 | 2.22 | 1.21 | 3.41 | 1462.55 | 1.00 | 6 | 5 | 1 | 20 | TRUE | 4.41 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 79 | 66 | Signature 3 | 2.10 | 1.34 | 2.94 | 1464.15 | 1.00 | 14 | 18 | 5 | 61 | TRUE | 6.64 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 61 | 58 | Signature 4 | 2.41 | 1.55 | 3.29 | 1411.67 | 1.00 | 8 | 7 | 4 | 54 | TRUE | 7.18 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 54 | 53 | Signature 6 | 1.68 | 0.89 | 2.50 | 1580.63 | 1.00 | 10 | 11 | 10 | 43 | TRUE | 4.61 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 23 | 25 | Signature 7 | 2.42 | 1.45 | 3.52 | 1458.87 | 1.00 | 9 | 1 | 3 | 22 | TRUE | 5.05 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 49 | 37 | Signature 8 | 2.26 | 1.29 | 3.27 | 1481.00 | 1.00 | 3 | 12 | 0 | 37 | TRUE | 5.03 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 21 | 19 | Signature R3 | 2.29 | 1.28 | 3.42 | 1525.38 | 1.00 | 3 | 3 | 1 | 18 | TRUE | 4.39 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 11 | 11 | Signature U1 | 2.22 | 1.20 | 3.36 | 1206.42 | 1.00 | 10 | 1 | 1 | 10 | TRUE | 4.08 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 19 | 53 | Signature 15 | -1.81 | -2.83 | -0.97 | 1470.19 | 1.00 | 39 | 16 | 50 | 3 | TRUE | 3.95 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 37 | 113 | Signature 1A | -1.19 | -1.87 | -0.50 | 1499.24 | 1.00 | 92 | 25 | 101 | 12 | TRUE | 3.13 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 6 | 19 | Signature 2 | -2.02 | -3.39 | -1.00 | 1299.24 | 1.00 | 23 | 6 | 19 | 0 | TRUE | 2.93 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 7 | 19 | Signature 20 | -1.80 | -3.10 | -0.76 | 1576.30 | 1.00 | 19 | 6 | 18 | 1 | TRUE | 2.67 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 11 | 30 | Signature 3 | -1.49 | -2.51 | -0.50 | 1570.80 | 1.00 | 10 | 7 | 26 | 4 | TRUE | 2.57 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 13 | 45 | Signature 6 | -2.20 | -3.59 | -1.18 | 1456.15 | 1.00 | 49 | 13 | 45 | 0 | TRUE | 3.55 |
| cancer of unknown primary | RAS_12 | TP53 | Any mutation | 100 | 287 | Signature overall | -0.48 | -1.05 | 0.14 | 1364.23 | 1.00 | 127 | 47 | 234 | 53 | TRUE | 0.93 |
| colorectal cancer | RAS_12 | TP53 | Any mutation | 696 | 1607 | Signature overall | -0.85 | -1.17 | -0.54 | 1549.72 | 1.00 | 330 | 270 | 1181 | 426 | TRUE | 7.30 |
| non-small cell lung cancer | RAS_12 | TP53 | Any mutation | 838 | 1927 | Signature overall | -1.30 | -1.63 | -1.01 | 1393.48 | 1.00 | 718 | 512 | 1601 | 326 | TRUE | 15.39 |
| pancreatic cancer | RAS_12 | TP53 | Any mutation | 860 | 785 | Signature overall | 1.93 | 1.44 | 2.45 | 1367.55 | 1.00 | 152 | 187 | 112 | 673 | TRUE | 13.26 |
| uterine cancer | RAS_12 | TP53 | Any mutation | 96 | 356 | Signature overall | -1.82 | -2.59 | -1.11 | 1432.15 | 1.00 | 282 | 76 | 336 | 20 | TRUE | 5.74 |
| colorectal cancer | RAS_12 | ATRX | Any mutation | 8 | 19 | Signature 10 | -2.42 | -5.27 | -0.48 | 1592.20 | 1.00 | 18 | 8 | 19 | 0 | TRUE | 1.26 |
| colorectal cancer | RAS_12 | ATRX | Any mutation | 279 | 46 | Signature 1A | -0.71 | -1.49 | -0.05 | 1524.43 | 1.00 | 536 | 269 | 36 | 10 | TRUE | 1.28 |
| colorectal cancer | RAS_12 | ATRX | Any mutation | 72 | 29 | Signature 6 | -0.89 | -2.03 | 0.07 | 1566.13 | 1.00 | 217 | 68 | 25 | 4 | TRUE | 1.00 |
| non-small cell lung cancer | RAS_12 | ATRX | Any mutation | 58 | 12 | Signature 18 | 0.14 | -0.59 | 0.89 | 1425.18 | 1.00 | 87 | 52 | 6 | 6 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12 | ATRX | Any mutation | 79 | 28 | Signature 2 | 0.09 | -0.55 | 0.76 | 1626.62 | 1.00 | 228 | 71 | 20 | 8 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12 | ATRX | Any mutation | 234 | 88 | Signature 4 | -0.01 | -0.43 | 0.44 | 1472.62 | 1.00 | 423 | 207 | 61 | 27 | TRUE | 0.02 |
| uterine cancer | RAS_12 | ATRX | Any mutation | 36 | 12 | Signature 1A | -4.06 | -8.58 | -0.89 | 1526.60 | 1.00 | 171 | 36 | 12 | 0 | TRUE | 1.39 |
| uterine cancer | RAS_12 | ATRX | Any mutation | 13 | 13 | Signature 6 | -3.97 | -8.66 | -0.71 | 1524.76 | 1.00 | 75 | 13 | 13 | 0 | TRUE | 1.28 |
| colorectal cancer | RAS_12 | ATRX | Any mutation | 359 | 94 | Signature overall | -1.30 | -3.18 | 0.34 | 1507.06 | 1.00 | 771 | 345 | 80 | 14 | TRUE | 0.84 |
| non-small cell lung cancer | RAS_12 | ATRX | Any mutation | 371 | 128 | Signature overall | 0.08 | -0.52 | 0.73 | 1363.56 | 1.00 | 738 | 330 | 87 | 41 | TRUE | 0.09 |
| uterine cancer | RAS_12 | ATRX | Any mutation | 53 | 123 | Signature overall | -3.46 | -7.03 | -0.55 | 1557.08 | 1.00 | 272 | 52 | 122 | 1 | TRUE | 1.45 |
| colorectal cancer | RAS_12 | ATR | Any mutation | 8 | 28 | Signature 10 | -1.89 | -3.82 | -0.50 | 1633.10 | 1.00 | 17 | 7 | 27 | 1 | FALSE | 1.62 |
| colorectal cancer | RAS_12 | ATR | Any mutation | 101 | 12 | Signature 15 | -1.46 | -3.27 | 0.03 | 1536.47 | 1.00 | 276 | 100 | 11 | 1 | FALSE | 1.12 |
| colorectal cancer | RAS_12 | ATR | Any mutation | 280 | 32 | Signature 1A | -0.58 | -1.44 | 0.19 | 1433.55 | 1.00 | 542 | 272 | 24 | 8 | FALSE | 0.78 |
| colorectal cancer | RAS_12 | ATR | Any mutation | 74 | 28 | Signature 6 | -0.81 | -1.92 | 0.14 | 1336.89 | 1.00 | 222 | 70 | 24 | 4 | FALSE | 0.89 |
| non-small cell lung cancer | RAS_12 | ATR | Any mutation | 13 | 11 | Signature 13 | -0.19 | -1.35 | 1.12 | 1452.13 | 1.00 | 76 | 11 | 9 | 2 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12 | ATR | Any mutation | 79 | 16 | Signature 2 | -0.27 | -1.19 | 0.67 | 1239.22 | 1.00 | 233 | 75 | 12 | 4 | FALSE | 0.25 |
| non-small cell lung cancer | RAS_12 | ATR | Any mutation | 230 | 60 | Signature 4 | -0.60 | -1.21 | -0.01 | 1526.77 | 1.00 | 426 | 218 | 48 | 12 | FALSE | 1.30 |
| colorectal cancer | RAS_12 | ATR | Any mutation | 463 | 100 | Signature overall | -1.16 | -2.76 | 0.24 | 1567.44 | 1.00 | 1057 | 449 | 86 | 14 | FALSE | 0.93 |
| non-small cell lung cancer | RAS_12 | ATR | Any mutation | 322 | 87 | Signature overall | -0.36 | -1.32 | 0.64 | 1560.87 | 1.00 | 735 | 304 | 69 | 18 | FALSE | 0.33 |
| non-small cell lung cancer | RAS_12 | PDGFRA | Any mutation | 79 | 20 | Signature 2 | -0.15 | -0.96 | 0.68 | 1342.35 | 1.00 | 230 | 74 | 15 | 5 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12 | PDGFRA | Any mutation | 232 | 70 | Signature 4 | -0.18 | -0.76 | 0.32 | 1451.05 | 1.00 | 426 | 212 | 50 | 20 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12 | PDGFRA | Any mutation | 311 | 90 | Signature overall | -0.17 | -1.20 | 0.81 | 1228.93 | 1.00 | 656 | 286 | 65 | 25 | TRUE | 0.13 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 8 | 17 | Signature 10 | -0.15 | -1.30 | 0.78 | 1552.82 | 1.00 | 14 | 6 | 15 | 2 | TRUE | 0.12 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 104 | 48 | Signature 15 | 0.16 | -0.42 | 0.71 | 1586.35 | 1.00 | 255 | 89 | 33 | 15 | TRUE | 0.23 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 289 | 144 | Signature 1A | 0.13 | -0.22 | 0.48 | 1334.61 | 1.00 | 485 | 237 | 92 | 52 | TRUE | 0.32 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 76 | 78 | Signature 6 | 0.37 | -0.11 | 0.90 | 1521.57 | 1.00 | 189 | 52 | 54 | 24 | TRUE | 0.85 |
| uterine cancer | RAS_12 | FBXW7 | Any mutation | 19 | 17 | Signature 15 | -0.43 | -1.84 | 0.73 | 1580.79 | 1.00 | 75 | 17 | 15 | 2 | TRUE | 0.30 |
| uterine cancer | RAS_12 | FBXW7 | Any mutation | 36 | 35 | Signature 1A | -0.06 | -1.01 | 0.79 | 1359.42 | 1.00 | 155 | 30 | 29 | 6 | TRUE | 0.05 |
| uterine cancer | RAS_12 | FBXW7 | Any mutation | 13 | 18 | Signature 6 | -0.26 | -1.54 | 0.95 | 1549.06 | 1.00 | 68 | 11 | 16 | 2 | TRUE | 0.15 |
| colorectal cancer | RAS_12 | FBXW7 | Any mutation | 477 | 287 | Signature overall | 0.13 | -0.60 | 0.80 | 1484.55 | 1.00 | 943 | 384 | 194 | 93 | TRUE | 0.15 |
| uterine cancer | RAS_12 | FBXW7 | Any mutation | 71 | 101 | Signature overall | -0.13 | -1.34 | 1.07 | 1496.02 | 1.00 | 316 | 58 | 88 | 13 | TRUE | 0.08 |
| uterine cancer | RAS_12 | NSD1 | Any mutation | 37 | 22 | Signature 1A | 0.06 | -1.16 | 1.03 | 1567.77 | 1.00 | 168 | 33 | 18 | 4 | FALSE | 0.04 |
| uterine cancer | RAS_12 | NSD1 | Any mutation | 16 | 29 | Signature 6 | 0.80 | -0.32 | 1.90 | 1423.31 | 1.00 | 69 | 9 | 22 | 7 | FALSE | 0.83 |
| uterine cancer | RAS_12 | NSD1 | Any mutation | 55 | 88 | Signature overall | 0.47 | -1.47 | 2.60 | 1314.97 | 1.00 | 254 | 42 | 75 | 13 | FALSE | 0.20 |
| colorectal cancer | RAS_12 | FLT4 | Any mutation | 8 | 14 | Signature 10 | -0.89 | -2.50 | 0.50 | 1455.20 | 1.00 | 20 | 7 | 13 | 1 | TRUE | 0.60 |
| colorectal cancer | RAS_12 | FLT4 | Any mutation | 102 | 14 | Signature 15 | 0.26 | -0.77 | 1.30 | 1479.71 | 1.00 | 276 | 96 | 8 | 6 | TRUE | 0.21 |
| colorectal cancer | RAS_12 | FLT4 | Any mutation | 282 | 54 | Signature 1A | -0.16 | -0.74 | 0.39 | 1612.36 | 1.00 | 530 | 265 | 37 | 17 | TRUE | 0.25 |
| colorectal cancer | RAS_12 | FLT4 | Any mutation | 72 | 51 | Signature 6 | -1.01 | -1.92 | -0.24 | 1495.92 | 1.00 | 199 | 67 | 46 | 5 | TRUE | 1.69 |
| non-small cell lung cancer | RAS_12 | FLT4 | Any mutation | 79 | 11 | Signature 2 | -0.84 | -2.26 | 0.20 | 1549.75 | 1.00 | 235 | 78 | 10 | 1 | TRUE | 0.72 |
| non-small cell lung cancer | RAS_12 | FLT4 | Any mutation | 230 | 36 | Signature 4 | -0.51 | -1.31 | 0.26 | 1466.30 | 1.00 | 447 | 221 | 27 | 9 | TRUE | 0.70 |
| colorectal cancer | RAS_12 | FLT4 | Any mutation | 464 | 133 | Signature overall | -0.45 | -1.63 | 0.64 | 1608.80 | 1.00 | 1025 | 435 | 104 | 29 | TRUE | 0.38 |
| non-small cell lung cancer | RAS_12 | FLT4 | Any mutation | 309 | 47 | Signature overall | -0.67 | -2.01 | 0.48 | 1462.10 | 1.00 | 682 | 299 | 37 | 10 | TRUE | 0.52 |
| colorectal cancer | RAS_12 | PTPRD | Any mutation | 8 | 19 | Signature 10 | -1.25 | -2.95 | 0.23 | 1203.69 | 1.00 | 19 | 7 | 18 | 1 | FALSE | 0.89 |
| colorectal cancer | RAS_12 | PTPRD | Any mutation | 101 | 14 | Signature 15 | 0.35 | -0.70 | 1.38 | 1615.98 | 1.00 | 278 | 95 | 8 | 6 | FALSE | 0.28 |
| colorectal cancer | RAS_12 | PTPRD | Any mutation | 279 | 31 | Signature 1A | -0.60 | -1.41 | 0.16 | 1624.84 | 1.00 | 545 | 272 | 24 | 7 | FALSE | 0.84 |
| colorectal cancer | RAS_12 | PTPRD | Any mutation | 72 | 31 | Signature 6 | -0.76 | -1.87 | 0.16 | 1345.30 | 1.00 | 217 | 68 | 27 | 4 | FALSE | 0.88 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 60 | 22 | Signature 18 | 0.55 | -0.20 | 1.36 | 1361.14 | 1.00 | 83 | 48 | 10 | 12 | FALSE | 0.78 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 44 | 12 | Signature 1A | 0.18 | -0.91 | 1.20 | 1499.31 | 1.00 | 213 | 41 | 9 | 3 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 79 | 33 | Signature 2 | 0.12 | -0.66 | 0.85 | 1583.13 | 1.00 | 222 | 70 | 24 | 9 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 13 | 12 | Signature 20 | -0.04 | -1.31 | 1.15 | 1424.84 | 1.00 | 56 | 11 | 10 | 2 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 50 | 18 | Signature 3 | 0.42 | -0.50 | 1.28 | 1470.33 | 1.00 | 181 | 44 | 12 | 6 | FALSE | 0.45 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 240 | 195 | Signature 4 | -0.24 | -0.61 | 0.11 | 1594.82 | 1.00 | 366 | 186 | 141 | 54 | FALSE | 0.76 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 145 | 18 | Signature R2 | -0.32 | -1.16 | 0.48 | 1497.11 | 1.00 | 48 | 134 | 7 | 11 | FALSE | 0.34 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 9 | 11 | Signature U2 | 0.00 | -1.18 | 1.18 | 1575.18 | 1.00 | 28 | 7 | 9 | 2 | FALSE | 0.00 |
| colorectal cancer | RAS_12 | PTPRD | Any mutation | 460 | 95 | Signature overall | -0.54 | -1.75 | 0.67 | 1498.90 | 1.00 | 1059 | 442 | 77 | 18 | FALSE | 0.41 |
| non-small cell lung cancer | RAS_12 | PTPRD | Any mutation | 640 | 321 | Signature overall | 0.09 | -0.56 | 0.72 | 1386.96 | 1.00 | 1197 | 541 | 222 | 99 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12 | PIK3C2G | Any mutation | 79 | 17 | Signature 2 | -0.97 | -2.09 | 0.08 | 1369.47 | 1.00 | 229 | 77 | 15 | 2 | FALSE | 1.13 |
| non-small cell lung cancer | RAS_12 | PIK3C2G | Any mutation | 230 | 57 | Signature 4 | -0.79 | -1.46 | -0.20 | 1480.25 | 1.00 | 430 | 219 | 46 | 11 | FALSE | 1.85 |
| non-small cell lung cancer | RAS_12 | PIK3C2G | Any mutation | 309 | 74 | Signature overall | -0.88 | -2.04 | 0.18 | 1517.44 | 1.00 | 659 | 296 | 61 | 13 | FALSE | 0.87 |
| colorectal cancer | RAS_12 | CREBBP | Any mutation | 8 | 15 | Signature 10 | -1.06 | -2.74 | 0.31 | 1256.07 | 1.00 | 19 | 7 | 14 | 1 | TRUE | 0.77 |
| colorectal cancer | RAS_12 | CREBBP | Any mutation | 101 | 27 | Signature 15 | -0.80 | -1.85 | 0.06 | 1485.11 | 1.00 | 266 | 97 | 23 | 4 | TRUE | 0.98 |
| colorectal cancer | RAS_12 | CREBBP | Any mutation | 283 | 45 | Signature 1A | 0.13 | -0.49 | 0.74 | 1480.37 | 1.00 | 540 | 265 | 27 | 18 | TRUE | 0.17 |
| colorectal cancer | RAS_12 | CREBBP | Any mutation | 79 | 80 | Signature 6 | -0.80 | -1.47 | -0.13 | 1416.29 | 1.00 | 187 | 68 | 69 | 11 | TRUE | 1.66 |
| non-small cell lung cancer | RAS_12 | CREBBP | Any mutation | 44 | 12 | Signature 1A | 0.09 | -0.69 | 0.90 | 1293.61 | 1.00 | 213 | 41 | 9 | 3 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12 | CREBBP | Any mutation | 79 | 15 | Signature 2 | -0.16 | -1.06 | 0.56 | 1327.37 | 1.00 | 232 | 77 | 13 | 2 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12 | CREBBP | Any mutation | 50 | 11 | Signature 3 | 0.06 | -0.75 | 0.81 | 1402.32 | 1.00 | 185 | 47 | 8 | 3 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12 | CREBBP | Any mutation | 230 | 44 | Signature 4 | 0.09 | -0.52 | 0.60 | 1507.34 | 1.00 | 448 | 215 | 29 | 15 | TRUE | 0.12 |
| colorectal cancer | RAS_12 | CREBBP | Any mutation | 471 | 167 | Signature overall | -0.64 | -1.73 | 0.31 | 1414.65 | 1.00 | 1012 | 437 | 133 | 34 | TRUE | 0.65 |
| non-small cell lung cancer | RAS_12 | CREBBP | Any mutation | 403 | 82 | Signature overall | 0.01 | -0.67 | 0.66 | 1320.59 | 1.00 | 1078 | 380 | 59 | 23 | TRUE | 0.02 |
| colorectal cancer | RAS_12 | AXIN2 | Any mutation | 101 | 17 | Signature 15 | -0.24 | -1.31 | 0.83 | 1617.73 | 1.00 | 274 | 96 | 12 | 5 | TRUE | 0.18 |
| colorectal cancer | RAS_12 | AXIN2 | Any mutation | 279 | 36 | Signature 1A | -0.42 | -1.18 | 0.29 | 1504.88 | 1.00 | 544 | 269 | 26 | 10 | TRUE | 0.58 |
| colorectal cancer | RAS_12 | AXIN2 | Any mutation | 72 | 40 | Signature 6 | -2.44 | -5.34 | -0.84 | 1583.44 | 1.00 | 209 | 72 | 40 | 0 | TRUE | 1.34 |
| colorectal cancer | RAS_12 | AXIN2 | Any mutation | 452 | 93 | Signature overall | -1.02 | -2.76 | 0.43 | 1494.82 | 1.00 | 1027 | 437 | 78 | 15 | TRUE | 0.72 |
| non-small cell lung cancer | RAS_12 | DOT1L | Any mutation | 79 | 16 | Signature 2 | -0.28 | -1.25 | 0.54 | 1518.20 | 1.00 | 232 | 76 | 13 | 3 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12 | DOT1L | Any mutation | 230 | 38 | Signature 4 | -0.12 | -0.84 | 0.51 | 1576.40 | 1.00 | 447 | 218 | 26 | 12 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12 | DOT1L | Any mutation | 309 | 54 | Signature overall | -0.21 | -1.25 | 0.71 | 1357.06 | 1.00 | 679 | 294 | 39 | 15 | FALSE | 0.16 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 8 | 16 | Signature 10 | -1.46 | -3.42 | -0.06 | 1431.81 | 1.00 | 16 | 8 | 16 | 0 | FALSE | 1.07 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 98 | 38 | Signature 15 | 0.06 | -0.68 | 0.78 | 1639.96 | 1.00 | 258 | 86 | 26 | 12 | FALSE | 0.06 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 273 | 95 | Signature 1A | -0.14 | -0.59 | 0.31 | 1576.47 | 1.00 | 496 | 243 | 65 | 30 | FALSE | 0.26 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 72 | 83 | Signature 6 | -0.98 | -1.68 | -0.27 | 1492.90 | 1.00 | 182 | 63 | 74 | 9 | FALSE | 2.20 |
| colorectal cancer | RAS_12 | PTPRS | Any mutation | 451 | 232 | Signature overall | -0.63 | -1.71 | 0.26 | 1428.91 | 1.00 | 952 | 400 | 181 | 51 | FALSE | 0.67 |
| colorectal cancer | RAS_12 | SMARCA4 | Any mutation | 102 | 22 | Signature 15 | -0.12 | -0.89 | 0.75 | 1473.08 | 1.00 | 274 | 95 | 15 | 7 | FALSE | 0.12 |
| colorectal cancer | RAS_12 | SMARCA4 | Any mutation | 282 | 74 | Signature 1A | -0.35 | -0.83 | 0.14 | 1594.74 | 1.00 | 523 | 262 | 54 | 20 | FALSE | 0.77 |
| colorectal cancer | RAS_12 | SMARCA4 | Any mutation | 73 | 52 | Signature 6 | -0.80 | -1.65 | -0.12 | 1627.70 | 1.00 | 206 | 68 | 47 | 5 | FALSE | 1.39 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 13 | 11 | Signature 13 | 0.17 | -0.93 | 1.29 | 1555.38 | 1.00 | 76 | 11 | 9 | 2 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 57 | 14 | Signature 18 | 0.18 | -0.66 | 1.01 | 1545.73 | 1.00 | 86 | 51 | 8 | 6 | FALSE | 0.16 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 44 | 17 | Signature 1A | 0.04 | -0.97 | 0.92 | 1508.54 | 1.00 | 210 | 41 | 14 | 3 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 81 | 33 | Signature 2 | 0.00 | -0.78 | 0.74 | 1504.36 | 1.00 | 225 | 73 | 25 | 8 | FALSE | 0.00 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 50 | 16 | Signature 3 | 0.69 | -0.23 | 1.56 | 1346.42 | 1.00 | 185 | 43 | 9 | 7 | FALSE | 0.88 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 231 | 104 | Signature 4 | -0.21 | -0.66 | 0.20 | 1638.71 | 1.00 | 403 | 202 | 75 | 29 | FALSE | 0.44 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 21 | 15 | Signature 7 | 0.28 | -0.69 | 1.22 | 1582.78 | 1.00 | 76 | 17 | 11 | 4 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 144 | 15 | Signature R2 | -0.09 | -0.92 | 0.72 | 1494.44 | 1.00 | 49 | 134 | 5 | 10 | FALSE | 0.08 |
| uterine cancer | RAS_12 | SMARCA4 | Any mutation | 19 | 14 | Signature 15 | -0.39 | -1.71 | 0.76 | 1425.91 | 1.00 | 82 | 17 | 12 | 2 | FALSE | 0.28 |
| uterine cancer | RAS_12 | SMARCA4 | Any mutation | 36 | 21 | Signature 1A | -0.57 | -1.75 | 0.48 | 1533.07 | 1.00 | 166 | 34 | 19 | 2 | FALSE | 0.50 |
| uterine cancer | RAS_12 | SMARCA4 | Any mutation | 15 | 30 | Signature 6 | -0.44 | -1.55 | 0.54 | 1501.61 | 1.00 | 69 | 12 | 27 | 3 | FALSE | 0.39 |
| colorectal cancer | RAS_12 | SMARCA4 | Any mutation | 457 | 148 | Signature overall | -0.43 | -1.23 | 0.40 | 1481.94 | 1.00 | 1003 | 425 | 116 | 32 | FALSE | 0.52 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Any mutation | 641 | 225 | Signature overall | 0.13 | -0.43 | 0.72 | 1450.69 | 1.00 | 1310 | 572 | 156 | 69 | FALSE | 0.18 |
| uterine cancer | RAS_12 | SMARCA4 | Any mutation | 71 | 76 | Signature overall | -0.42 | -1.53 | 0.68 | 1449.59 | 1.00 | 346 | 63 | 68 | 8 | FALSE | 0.35 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 8 | 23 | Signature 10 | -2.41 | -5.08 | -0.71 | 1428.75 | 1.00 | 16 | 8 | 23 | 0 | FALSE | 1.49 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 101 | 25 | Signature 15 | -1.95 | -3.82 | -0.60 | 1480.68 | 1.00 | 261 | 100 | 24 | 1 | FALSE | 1.88 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 280 | 66 | Signature 1A | -0.31 | -0.86 | 0.20 | 1608.23 | 1.00 | 520 | 261 | 47 | 19 | FALSE | 0.61 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 74 | 43 | Signature 6 | -0.54 | -1.34 | 0.21 | 1527.38 | 1.00 | 205 | 66 | 35 | 8 | FALSE | 0.75 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 13 | 11 | Signature 13 | 0.32 | -0.94 | 1.62 | 1663.20 | 1.00 | 79 | 10 | 8 | 3 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 57 | 17 | Signature 18 | -0.38 | -1.36 | 0.58 | 1305.91 | 1.00 | 82 | 52 | 12 | 5 | FALSE | 0.36 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 44 | 11 | Signature 1A | -1.03 | -2.69 | 0.33 | 1356.10 | 1.00 | 214 | 44 | 11 | 0 | FALSE | 0.74 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 80 | 30 | Signature 2 | 0.69 | -0.10 | 1.39 | 1507.94 | 1.00 | 229 | 67 | 17 | 13 | FALSE | 1.14 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 50 | 19 | Signature 3 | -0.72 | -1.92 | 0.38 | 1620.60 | 1.00 | 178 | 48 | 17 | 2 | FALSE | 0.67 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 234 | 179 | Signature 4 | -0.81 | -1.22 | -0.42 | 1213.78 | 1.00 | 366 | 200 | 145 | 34 | FALSE | 4.01 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 146 | 23 | Signature R2 | -0.24 | -1.11 | 0.57 | 1255.54 | 1.00 | 49 | 131 | 8 | 15 | FALSE | 0.24 |
| colorectal cancer | RAS_12 | PTPRT | Any mutation | 463 | 157 | Signature overall | -1.25 | -2.81 | 0.02 | 1430.80 | 1.00 | 1002 | 435 | 129 | 28 | FALSE | 1.14 |
| non-small cell lung cancer | RAS_12 | PTPRT | Any mutation | 624 | 290 | Signature overall | -0.30 | -1.13 | 0.50 | 1558.55 | 1.00 | 1197 | 552 | 218 | 72 | FALSE | 0.33 |
| non-small cell lung cancer | RAS_12 | HGF | Any mutation | 79 | 20 | Signature 2 | 0.26 | -0.70 | 1.16 | 1682.92 | 1.00 | 232 | 72 | 13 | 7 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12 | HGF | Any mutation | 230 | 89 | Signature 4 | -0.44 | -0.95 | 0.05 | 1427.95 | 1.00 | 414 | 208 | 67 | 22 | FALSE | 1.10 |
| non-small cell lung cancer | RAS_12 | HGF | Any mutation | 145 | 12 | Signature R2 | -1.09 | -2.12 | -0.06 | 1487.82 | 1.00 | 48 | 140 | 7 | 5 | FALSE | 1.40 |
| non-small cell lung cancer | RAS_12 | HGF | Any mutation | 454 | 121 | Signature overall | -0.43 | -1.79 | 0.91 | 1549.60 | 1.00 | 694 | 420 | 87 | 34 | FALSE | 0.28 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 9 | 23 | Signature 10 | 0.00 | -0.91 | 0.78 | 1375.39 | 1.00 | 15 | 5 | 19 | 4 | TRUE | 0.00 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 101 | 63 | Signature 15 | -0.02 | -0.58 | 0.52 | 1512.55 | 1.00 | 242 | 85 | 47 | 16 | TRUE | 0.03 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 17 | 19 | Signature 18 | 0.08 | -0.77 | 0.90 | 1555.53 | 1.00 | 18 | 11 | 13 | 6 | TRUE | 0.07 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 286 | 191 | Signature 1A | 0.37 | 0.06 | 0.70 | 1521.66 | 1.00 | 464 | 209 | 114 | 77 | TRUE | 1.68 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 39 | 43 | Signature 2 | 0.82 | 0.20 | 1.53 | 1531.07 | 1.00 | 28 | 14 | 18 | 25 | TRUE | 1.80 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 75 | 95 | Signature 6 | -0.03 | -0.54 | 0.48 | 1577.88 | 1.00 | 177 | 54 | 74 | 21 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 14 | 13 | Signature 13 | 1.09 | 0.03 | 2.30 | 1467.93 | 1.00 | 78 | 8 | 7 | 6 | TRUE | 1.25 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 44 | 13 | Signature 1A | 0.19 | -0.81 | 1.15 | 1527.44 | 1.00 | 213 | 41 | 10 | 3 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 80 | 82 | Signature 2 | 0.14 | -0.43 | 0.65 | 1532.87 | 1.00 | 189 | 59 | 61 | 21 | TRUE | 0.20 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 13 | 16 | Signature 20 | 0.13 | -1.00 | 1.20 | 1430.61 | 1.00 | 51 | 10 | 13 | 3 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 50 | 15 | Signature 3 | -0.87 | -2.41 | 0.31 | 1436.80 | 1.00 | 178 | 50 | 15 | 0 | TRUE | 0.69 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 230 | 38 | Signature 4 | -0.17 | -0.86 | 0.47 | 1419.81 | 1.00 | 446 | 219 | 27 | 11 | TRUE | 0.21 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 22 | 50 | Signature 15 | 0.32 | -0.47 | 1.10 | 1639.65 | 1.00 | 56 | 12 | 40 | 10 | TRUE | 0.38 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 42 | 138 | Signature 1A | 0.94 | 0.29 | 1.61 | 1357.19 | 1.00 | 103 | 11 | 107 | 31 | TRUE | 2.29 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 7 | 30 | Signature 2 | 0.62 | -0.45 | 1.70 | 1434.41 | 1.00 | 18 | 2 | 25 | 5 | TRUE | 0.59 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 8 | 25 | Signature 20 | 0.32 | -0.80 | 1.32 | 1263.23 | 1.01 | 15 | 4 | 21 | 4 | TRUE | 0.25 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 12 | 21 | Signature 3 | 1.21 | 0.24 | 2.21 | 1280.24 | 1.00 | 23 | 3 | 12 | 9 | TRUE | 1.75 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 20 | 85 | Signature 6 | 0.90 | -0.01 | 1.77 | 1496.72 | 1.00 | 36 | 3 | 68 | 17 | TRUE | 1.33 |
| colorectal cancer | RAS_12 | PIK3CA | Any mutation | 527 | 434 | Signature overall | 0.20 | -0.32 | 0.71 | 1547.74 | 1.00 | 944 | 378 | 285 | 149 | TRUE | 0.34 |
| non-small cell lung cancer | RAS_12 | PIK3CA | Any mutation | 431 | 177 | Signature overall | 0.09 | -0.71 | 0.85 | 1520.63 | 1.00 | 1155 | 387 | 133 | 44 | TRUE | 0.08 |
| uterine cancer | RAS_12 | PIK3CA | Any mutation | 117 | 459 | Signature overall | 0.50 | -0.21 | 1.25 | 1422.57 | 1.00 | 319 | 37 | 379 | 80 | TRUE | 0.75 |
| colorectal cancer | RAS_12 | ALK | Any mutation | 8 | 13 | Signature 10 | -2.00 | -4.66 | -0.15 | 1440.86 | 1.00 | 18 | 8 | 13 | 0 | TRUE | 1.10 |
| colorectal cancer | RAS_12 | ALK | Any mutation | 101 | 16 | Signature 15 | 0.05 | -1.02 | 1.06 | 1360.54 | 1.00 | 274 | 95 | 10 | 6 | TRUE | 0.04 |
| colorectal cancer | RAS_12 | ALK | Any mutation | 279 | 35 | Signature 1A | -0.69 | -1.51 | 0.05 | 1540.19 | 1.00 | 542 | 271 | 27 | 8 | TRUE | 1.07 |
| colorectal cancer | RAS_12 | ALK | Any mutation | 72 | 37 | Signature 6 | -2.03 | -3.80 | -0.76 | 1247.75 | 1.00 | 210 | 71 | 36 | 1 | TRUE | 2.02 |
| non-small cell lung cancer | RAS_12 | ALK | Any mutation | 79 | 24 | Signature 2 | 0.23 | -0.42 | 0.94 | 1552.07 | 1.00 | 231 | 71 | 16 | 8 | TRUE | 0.28 |
| non-small cell lung cancer | RAS_12 | ALK | Any mutation | 230 | 72 | Signature 4 | 0.04 | -0.47 | 0.53 | 1368.49 | 1.00 | 428 | 207 | 49 | 23 | TRUE | 0.05 |
| colorectal cancer | RAS_12 | ALK | Any mutation | 460 | 101 | Signature overall | -1.15 | -2.64 | 0.18 | 1459.59 | 1.00 | 1044 | 445 | 86 | 15 | TRUE | 1.03 |
| non-small cell lung cancer | RAS_12 | ALK | Any mutation | 309 | 96 | Signature overall | 0.14 | -0.80 | 1.16 | 1458.45 | 1.00 | 659 | 278 | 65 | 31 | TRUE | 0.11 |
| colorectal cancer | RAS_12 | RNF43 | Any mutation | 104 | 31 | Signature 15 | -0.35 | -1.12 | 0.48 | 1347.68 | 1.00 | 268 | 96 | 23 | 8 | TRUE | 0.40 |
| colorectal cancer | RAS_12 | RNF43 | Any mutation | 284 | 93 | Signature 1A | -0.80 | -1.33 | -0.31 | 1607.36 | 1.00 | 515 | 266 | 75 | 18 | TRUE | 2.68 |
| colorectal cancer | RAS_12 | RNF43 | Any mutation | 74 | 102 | Signature 6 | -1.22 | -1.95 | -0.60 | 1548.72 | 1.00 | 173 | 65 | 93 | 9 | TRUE | 3.38 |
| colorectal cancer | RAS_12 | RNF43 | Any mutation | 462 | 226 | Signature overall | -0.78 | -1.82 | 0.35 | 1339.30 | 1.00 | 956 | 427 | 191 | 35 | TRUE | 0.86 |
| colorectal cancer | RAS_12 | PTEN | Any mutation | 8 | 13 | Signature 10 | -0.81 | -2.24 | 0.34 | 1634.02 | 1.00 | 18 | 7 | 12 | 1 | TRUE | 0.67 |
| colorectal cancer | RAS_12 | PTEN | Any mutation | 101 | 22 | Signature 15 | 0.07 | -0.80 | 0.90 | 1463.95 | 1.00 | 271 | 93 | 14 | 8 | TRUE | 0.06 |
| colorectal cancer | RAS_12 | PTEN | Any mutation | 280 | 64 | Signature 1A | -0.86 | -1.50 | -0.26 | 1508.45 | 1.00 | 528 | 269 | 53 | 11 | TRUE | 2.20 |
| colorectal cancer | RAS_12 | PTEN | Any mutation | 75 | 57 | Signature 6 | -0.54 | -1.25 | 0.14 | 1300.88 | 1.00 | 208 | 66 | 48 | 9 | TRUE | 0.86 |
| non-small cell lung cancer | RAS_12 | PTEN | Any mutation | 79 | 27 | Signature 2 | -0.74 | -1.73 | 0.20 | 1505.23 | 1.00 | 225 | 75 | 23 | 4 | TRUE | 0.88 |
| non-small cell lung cancer | RAS_12 | PTEN | Any mutation | 230 | 27 | Signature 4 | -0.85 | -1.76 | -0.03 | 1645.06 | 1.00 | 451 | 225 | 22 | 5 | TRUE | 1.20 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 27 | 61 | Signature 15 | 1.00 | 0.28 | 1.69 | 1461.40 | 1.00 | 61 | 8 | 42 | 19 | TRUE | 2.20 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 49 | 155 | Signature 1A | 0.74 | 0.19 | 1.32 | 1540.41 | 1.00 | 113 | 15 | 121 | 34 | TRUE | 1.96 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 8 | 26 | Signature 2 | 0.60 | -0.36 | 1.56 | 1367.68 | 1.00 | 25 | 3 | 21 | 5 | TRUE | 0.64 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 10 | 28 | Signature 20 | 0.91 | -0.03 | 1.90 | 1418.49 | 1.00 | 19 | 2 | 20 | 8 | TRUE | 1.22 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 14 | 17 | Signature 3 | 1.13 | 0.33 | 2.06 | 1392.00 | 1.00 | 29 | 5 | 8 | 9 | TRUE | 1.83 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 19 | 104 | Signature 6 | 0.15 | -0.63 | 1.01 | 1508.92 | 1.00 | 24 | 6 | 91 | 13 | TRUE | 0.14 |
| colorectal cancer | RAS_12 | PTEN | Any mutation | 464 | 156 | Signature overall | -0.53 | -1.52 | 0.41 | 1400.24 | 1.00 | 1025 | 435 | 127 | 29 | TRUE | 0.58 |
| non-small cell lung cancer | RAS_12 | PTEN | Any mutation | 309 | 54 | Signature overall | -0.79 | -2.04 | 0.44 | 1244.68 | 1.00 | 676 | 300 | 45 | 9 | TRUE | 0.64 |
| uterine cancer | RAS_12 | PTEN | Any mutation | 146 | 545 | Signature overall | 0.52 | -0.03 | 1.09 | 1546.03 | 1.00 | 344 | 45 | 444 | 101 | TRUE | 1.16 |
| colorectal cancer | RAS_12 | BCOR | Any mutation | 8 | 11 | Signature 10 | -0.79 | -2.48 | 0.70 | 1472.41 | 1.00 | 19 | 7 | 10 | 1 | FALSE | 0.49 |
| colorectal cancer | RAS_12 | BCOR | Any mutation | 101 | 13 | Signature 15 | -0.10 | -1.23 | 0.94 | 1444.95 | 1.00 | 276 | 97 | 9 | 4 | FALSE | 0.07 |
| colorectal cancer | RAS_12 | BCOR | Any mutation | 279 | 27 | Signature 1A | 0.28 | -0.44 | 1.04 | 1578.01 | 1.00 | 551 | 267 | 15 | 12 | FALSE | 0.34 |
| colorectal cancer | RAS_12 | BCOR | Any mutation | 75 | 49 | Signature 6 | -1.19 | -2.21 | -0.36 | 1552.70 | 1.00 | 205 | 71 | 45 | 4 | FALSE | 1.86 |
| non-small cell lung cancer | RAS_12 | BCOR | Any mutation | 80 | 13 | Signature 2 | 0.37 | -0.49 | 1.18 | 1205.49 | 1.00 | 236 | 76 | 9 | 4 | FALSE | 0.41 |
| non-small cell lung cancer | RAS_12 | BCOR | Any mutation | 233 | 52 | Signature 4 | 0.53 | -0.02 | 1.02 | 942.20 | 1.01 | 447 | 210 | 29 | 23 | FALSE | 1.37 |
| uterine cancer | RAS_12 | BCOR | Any mutation | 36 | 30 | Signature 1A | 0.04 | -1.03 | 0.95 | 1568.34 | 1.00 | 160 | 31 | 25 | 5 | FALSE | 0.03 |
| uterine cancer | RAS_12 | BCOR | Any mutation | 15 | 23 | Signature 6 | 1.18 | 0.06 | 2.33 | 1335.66 | 1.00 | 72 | 8 | 16 | 7 | FALSE | 1.39 |
| colorectal cancer | RAS_12 | BCOR | Any mutation | 463 | 100 | Signature overall | -0.44 | -1.70 | 0.72 | 1553.02 | 1.00 | 1051 | 442 | 79 | 21 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12 | BCOR | Any mutation | 313 | 65 | Signature overall | 0.47 | -0.59 | 1.48 | 1598.16 | 1.00 | 683 | 286 | 38 | 27 | FALSE | 0.43 |
| uterine cancer | RAS_12 | BCOR | Any mutation | 52 | 83 | Signature overall | 0.50 | -1.26 | 2.61 | 1599.63 | 1.00 | 254 | 39 | 70 | 13 | FALSE | 0.23 |
| colorectal cancer | RAS_12 | CTNNB1 | Any mutation | 101 | 22 | Signature 15 | 0.12 | -0.60 | 0.78 | 1369.08 | 1.01 | 269 | 95 | 16 | 6 | TRUE | 0.13 |
| colorectal cancer | RAS_12 | CTNNB1 | Any mutation | 282 | 61 | Signature 1A | 0.45 | -0.02 | 0.95 | 1486.70 | 1.00 | 534 | 253 | 32 | 29 | TRUE | 1.18 |
| colorectal cancer | RAS_12 | CTNNB1 | Any mutation | 73 | 33 | Signature 6 | 0.03 | -0.76 | 0.65 | 1440.34 | 1.00 | 214 | 67 | 27 | 6 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 44 | 11 | Signature 1A | -1.29 | -2.66 | -0.03 | 1632.38 | 1.00 | 212 | 43 | 10 | 1 | TRUE | 1.24 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 79 | 14 | Signature 2 | -1.45 | -2.82 | -0.31 | 1690.49 | 1.00 | 232 | 78 | 13 | 1 | TRUE | 1.58 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 50 | 17 | Signature 3 | -1.02 | -2.32 | 0.16 | 1538.87 | 1.00 | 179 | 47 | 14 | 3 | TRUE | 0.96 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 230 | 16 | Signature 4 | -1.78 | -3.52 | -0.65 | 1528.61 | 1.00 | 456 | 230 | 16 | 0 | TRUE | 1.91 |
| uterine cancer | RAS_12 | CTNNB1 | Any mutation | 19 | 11 | Signature 15 | -2.01 | -4.00 | -0.51 | 1588.73 | 1.00 | 80 | 19 | 11 | 0 | TRUE | 1.65 |
| uterine cancer | RAS_12 | CTNNB1 | Any mutation | 36 | 31 | Signature 1A | -1.67 | -3.26 | -0.38 | 1363.31 | 1.00 | 155 | 34 | 29 | 2 | TRUE | 1.66 |
| uterine cancer | RAS_12 | CTNNB1 | Any mutation | 13 | 19 | Signature 6 | -1.70 | -3.42 | -0.30 | 1376.84 | 1.00 | 68 | 12 | 18 | 1 | TRUE | 1.47 |
| colorectal cancer | RAS_12 | CTNNB1 | Any mutation | 456 | 116 | Signature overall | 0.20 | -0.54 | 0.87 | 1499.94 | 1.00 | 1017 | 415 | 75 | 41 | TRUE | 0.26 |
| non-small cell lung cancer | RAS_12 | CTNNB1 | Any mutation | 403 | 58 | Signature overall | -1.38 | -2.62 | -0.38 | 1705.31 | 1.00 | 1079 | 398 | 53 | 5 | TRUE | 1.79 |
| uterine cancer | RAS_12 | CTNNB1 | Any mutation | 70 | 83 | Signature overall | -1.81 | -3.42 | -0.50 | 1434.46 | 1.00 | 370 | 67 | 80 | 3 | TRUE | 1.87 |
| cancer of unknown primary | RAS_12 | ARID1A | Any mutation | 34 | 22 | Signature 1A | -0.37 | -1.24 | 0.57 | 1480.86 | 1.00 | 72 | 28 | 16 | 6 | TRUE | 0.37 |
| cancer of unknown primary | RAS_12 | ARID1A | Any mutation | 8 | 13 | Signature 2 | -0.45 | -1.42 | 0.65 | 1414.10 | 1.00 | 37 | 6 | 11 | 2 | TRUE | 0.41 |
| cancer of unknown primary | RAS_12 | ARID1A | Any mutation | 19 | 12 | Signature 4 | -0.54 | -1.61 | 0.39 | 1542.62 | 1.00 | 52 | 17 | 10 | 2 | TRUE | 0.54 |
| colorectal cancer | RAS_12 | ARID1A | Any mutation | 8 | 13 | Signature 10 | -0.88 | -2.02 | 0.11 | 1409.65 | 1.00 | 19 | 7 | 12 | 1 | TRUE | 0.96 |
| colorectal cancer | RAS_12 | ARID1A | Any mutation | 102 | 39 | Signature 15 | -0.90 | -1.70 | -0.22 | 1454.56 | 1.00 | 265 | 97 | 34 | 5 | TRUE | 1.82 |
| colorectal cancer | RAS_12 | ARID1A | Any mutation | 286 | 130 | Signature 1A | -0.59 | -1.01 | -0.18 | 1409.08 | 1.00 | 497 | 256 | 100 | 30 | TRUE | 2.25 |
| colorectal cancer | RAS_12 | ARID1A | Any mutation | 78 | 99 | Signature 6 | -0.61 | -1.17 | -0.05 | 1339.03 | 1.00 | 181 | 62 | 83 | 16 | TRUE | 1.53 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 13 | 17 | Signature 13 | -1.12 | -2.78 | 0.23 | 1407.60 | 1.00 | 70 | 13 | 17 | 0 | TRUE | 0.85 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 60 | 12 | Signature 18 | 0.64 | -0.43 | 1.67 | 1680.70 | 1.00 | 89 | 52 | 4 | 8 | TRUE | 0.64 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 83 | 52 | Signature 2 | 0.45 | -0.19 | 1.08 | 1621.79 | 1.00 | 216 | 65 | 34 | 18 | TRUE | 0.78 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 50 | 11 | Signature 3 | -0.34 | -1.66 | 0.87 | 1459.15 | 1.00 | 184 | 48 | 9 | 2 | TRUE | 0.22 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 231 | 86 | Signature 4 | -0.88 | -1.44 | -0.35 | 1364.38 | 1.00 | 403 | 216 | 71 | 15 | TRUE | 2.63 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 144 | 13 | Signature R2 | -0.21 | -1.13 | 0.73 | 1597.98 | 1.00 | 50 | 135 | 4 | 9 | TRUE | 0.18 |
| pancreatic cancer | RAS_12 | ARID1A | Any mutation | 116 | 12 | Signature 11 | -0.13 | -1.40 | 1.49 | 1427.88 | 1.00 | 9 | 105 | 1 | 11 | TRUE | 0.07 |
| pancreatic cancer | RAS_12 | ARID1A | Any mutation | 203 | 33 | Signature 1A | -0.20 | -1.02 | 0.66 | 1424.76 | 1.00 | 45 | 178 | 8 | 25 | TRUE | 0.19 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 24 | 58 | Signature 15 | 1.11 | 0.30 | 1.96 | 1300.77 | 1.00 | 62 | 8 | 42 | 16 | TRUE | 2.06 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 46 | 133 | Signature 1A | 1.00 | 0.38 | 1.62 | 1429.24 | 1.00 | 116 | 14 | 101 | 32 | TRUE | 2.73 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 9 | 23 | Signature 2 | 1.51 | 0.42 | 2.72 | 1461.15 | 1.00 | 28 | 1 | 15 | 8 | TRUE | 2.04 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 8 | 26 | Signature 20 | 1.30 | 0.17 | 2.45 | 1544.54 | 1.00 | 20 | 1 | 19 | 7 | TRUE | 1.65 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 18 | 121 | Signature 6 | 0.86 | -0.14 | 1.88 | 1455.42 | 1.00 | 28 | 2 | 105 | 16 | TRUE | 1.05 |
| cancer of unknown primary | RAS_12 | ARID1A | Any mutation | 66 | 58 | Signature overall | -0.50 | -1.46 | 0.37 | 1379.71 | 1.00 | 177 | 56 | 48 | 10 | TRUE | 0.56 |
| colorectal cancer | RAS_12 | ARID1A | Any mutation | 474 | 281 | Signature overall | -0.75 | -1.44 | -0.08 | 1380.71 | 1.00 | 962 | 422 | 229 | 52 | TRUE | 1.58 |
| non-small cell lung cancer | RAS_12 | ARID1A | Any mutation | 581 | 191 | Signature overall | -0.24 | -1.15 | 0.63 | 1565.56 | 1.00 | 1012 | 529 | 139 | 52 | TRUE | 0.23 |
| pancreatic cancer | RAS_12 | ARID1A | Any mutation | 319 | 45 | Signature overall | -0.15 | -1.77 | 1.66 | 1411.47 | 1.00 | 54 | 283 | 9 | 36 | TRUE | 0.06 |
| uterine cancer | RAS_12 | ARID1A | Any mutation | 110 | 445 | Signature overall | 0.90 | 0.18 | 1.68 | 1519.44 | 1.00 | 282 | 28 | 363 | 82 | TRUE | 1.72 |
| colorectal cancer | RAS_12 | PIK3R1 | Any mutation | 10 | 17 | Signature 10 | -0.41 | -1.75 | 0.82 | 1500.28 | 1.00 | 17 | 7 | 14 | 3 | TRUE | 0.28 |
| colorectal cancer | RAS_12 | PIK3R1 | Any mutation | 101 | 17 | Signature 15 | 0.37 | -0.56 | 1.28 | 1263.40 | 1.00 | 277 | 94 | 10 | 7 | TRUE | 0.36 |
| colorectal cancer | RAS_12 | PIK3R1 | Any mutation | 280 | 31 | Signature 1A | -0.14 | -0.89 | 0.60 | 1587.26 | 1.00 | 547 | 270 | 21 | 10 | TRUE | 0.15 |
| colorectal cancer | RAS_12 | PIK3R1 | Any mutation | 72 | 31 | Signature 6 | -0.89 | -2.00 | 0.08 | 1487.22 | 1.00 | 215 | 69 | 28 | 3 | TRUE | 1.01 |
| uterine cancer | RAS_12 | PIK3R1 | Any mutation | 21 | 32 | Signature 15 | -0.11 | -0.91 | 0.88 | 764.05 | 1.01 | 71 | 12 | 23 | 9 | TRUE | 0.08 |
| uterine cancer | RAS_12 | PIK3R1 | Any mutation | 37 | 59 | Signature 1A | -0.81 | -1.69 | -0.09 | 1006.44 | 1.00 | 135 | 33 | 55 | 4 | TRUE | 1.34 |
| uterine cancer | RAS_12 | PIK3R1 | Any mutation | 7 | 13 | Signature 20 | -0.52 | -1.46 | 0.42 | 1409.61 | 1.00 | 25 | 5 | 11 | 2 | TRUE | 0.59 |
| uterine cancer | RAS_12 | PIK3R1 | Any mutation | 13 | 31 | Signature 6 | -0.96 | -2.31 | -0.13 | 1018.86 | 1.00 | 61 | 13 | 31 | 0 | TRUE | 1.06 |
| colorectal cancer | RAS_12 | PIK3R1 | Any mutation | 463 | 96 | Signature overall | -0.25 | -1.32 | 0.82 | 1422.33 | 1.00 | 1056 | 440 | 73 | 23 | TRUE | 0.18 |
| uterine cancer | RAS_12 | PIK3R1 | Any mutation | 83 | 167 | Signature overall | -0.61 | -1.33 | 0.05 | 1391.01 | 1.00 | 331 | 66 | 150 | 17 | TRUE | 1.08 |
| colorectal cancer | RAS_12 | FAT1 | Any mutation | 10 | 44 | Signature 10 | -1.50 | -2.78 | -0.27 | 1260.56 | 1.00 | 16 | 7 | 41 | 3 | FALSE | 1.72 |
| colorectal cancer | RAS_12 | FAT1 | Any mutation | 101 | 29 | Signature 15 | -1.56 | -2.79 | -0.48 | 1495.80 | 1.00 | 266 | 99 | 27 | 2 | FALSE | 1.99 |
| colorectal cancer | RAS_12 | FAT1 | Any mutation | 283 | 66 | Signature 1A | -0.65 | -1.25 | -0.05 | 1420.09 | 1.00 | 524 | 268 | 51 | 15 | FALSE | 1.46 |
| colorectal cancer | RAS_12 | FAT1 | Any mutation | 73 | 67 | Signature 6 | -0.83 | -1.62 | -0.11 | 1526.00 | 1.00 | 197 | 64 | 58 | 9 | FALSE | 1.53 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 13 | 16 | Signature 13 | 0.08 | -0.94 | 1.03 | 1251.98 | 1.00 | 73 | 11 | 14 | 2 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 57 | 16 | Signature 18 | 0.54 | -0.25 | 1.36 | 1479.51 | 1.00 | 86 | 48 | 7 | 9 | FALSE | 0.73 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 44 | 13 | Signature 1A | 0.34 | -0.52 | 1.24 | 1688.32 | 1.00 | 216 | 40 | 9 | 4 | FALSE | 0.34 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 81 | 38 | Signature 2 | 0.13 | -0.58 | 0.79 | 1323.80 | 1.00 | 221 | 71 | 28 | 10 | FALSE | 0.16 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 14 | 11 | Signature 20 | 0.53 | -0.38 | 1.49 | 1321.92 | 1.00 | 57 | 10 | 7 | 4 | FALSE | 0.55 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 50 | 13 | Signature 3 | 0.21 | -0.64 | 1.06 | 1545.01 | 1.00 | 184 | 46 | 9 | 4 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 232 | 121 | Signature 4 | -0.44 | -0.91 | 0.00 | 1555.84 | 1.00 | 390 | 205 | 94 | 27 | FALSE | 1.29 |
| uterine cancer | RAS_12 | FAT1 | Any mutation | 19 | 14 | Signature 15 | -1.01 | -2.99 | 0.54 | 1435.08 | 1.00 | 80 | 18 | 13 | 1 | FALSE | 0.59 |
| uterine cancer | RAS_12 | FAT1 | Any mutation | 36 | 24 | Signature 1A | -0.92 | -2.38 | 0.35 | 1368.56 | 1.00 | 165 | 34 | 22 | 2 | FALSE | 0.73 |
| uterine cancer | RAS_12 | FAT1 | Any mutation | 13 | 37 | Signature 6 | 0.08 | -1.14 | 1.23 | 1400.82 | 1.00 | 65 | 8 | 32 | 5 | FALSE | 0.05 |
| colorectal cancer | RAS_12 | FAT1 | Any mutation | 467 | 206 | Signature overall | -1.10 | -2.36 | 0.11 | 1289.21 | 1.00 | 1003 | 438 | 177 | 29 | FALSE | 1.11 |
| non-small cell lung cancer | RAS_12 | FAT1 | Any mutation | 491 | 228 | Signature overall | 0.20 | -0.38 | 0.79 | 1465.41 | 1.00 | 1227 | 431 | 168 | 60 | FALSE | 0.29 |
| uterine cancer | RAS_12 | FAT1 | Any mutation | 71 | 149 | Signature overall | -0.46 | -2.17 | 1.28 | 1373.25 | 1.00 | 322 | 60 | 138 | 11 | FALSE | 0.23 |
| colorectal cancer | RAS_12 | CIC | Any mutation | 102 | 19 | Signature 15 | -0.50 | -1.32 | 0.33 | 1399.54 | 1.00 | 275 | 98 | 15 | 4 | TRUE | 0.63 |
| colorectal cancer | RAS_12 | CIC | Any mutation | 280 | 58 | Signature 1A | -0.38 | -0.93 | 0.17 | 1555.59 | 1.00 | 533 | 264 | 42 | 16 | TRUE | 0.76 |
| colorectal cancer | RAS_12 | CIC | Any mutation | 73 | 43 | Signature 6 | -0.68 | -1.53 | 0.03 | 1396.86 | 1.00 | 211 | 68 | 38 | 5 | TRUE | 1.07 |
| colorectal cancer | RAS_12 | CIC | Any mutation | 455 | 120 | Signature overall | -0.51 | -1.32 | 0.30 | 1464.10 | 1.00 | 1019 | 430 | 95 | 25 | TRUE | 0.70 |
| colorectal cancer | RAS_12 | NCOR1 | Any mutation | 8 | 16 | Signature 10 | -1.10 | -2.60 | 0.09 | 1398.93 | 1.00 | 17 | 7 | 15 | 1 | FALSE | 0.96 |
| colorectal cancer | RAS_12 | NCOR1 | Any mutation | 101 | 22 | Signature 15 | -0.47 | -1.42 | 0.36 | 1537.61 | 1.00 | 270 | 96 | 17 | 5 | FALSE | 0.50 |
| colorectal cancer | RAS_12 | NCOR1 | Any mutation | 281 | 44 | Signature 1A | -0.76 | -1.49 | -0.10 | 1354.27 | 1.00 | 536 | 272 | 35 | 9 | FALSE | 1.47 |
| colorectal cancer | RAS_12 | NCOR1 | Any mutation | 73 | 43 | Signature 6 | -0.73 | -1.61 | 0.07 | 1066.31 | 1.00 | 211 | 67 | 37 | 6 | FALSE | 1.05 |
| non-small cell lung cancer | RAS_12 | NCOR1 | Any mutation | 14 | 14 | Signature 13 | 0.09 | -1.19 | 1.35 | 1305.04 | 1.00 | 77 | 11 | 11 | 3 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12 | NCOR1 | Any mutation | 79 | 11 | Signature 2 | -0.23 | -1.44 | 0.93 | 1423.17 | 1.00 | 240 | 76 | 8 | 3 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12 | NCOR1 | Any mutation | 231 | 36 | Signature 4 | -0.97 | -1.92 | -0.18 | 1519.27 | 1.00 | 442 | 226 | 31 | 5 | FALSE | 1.58 |
| colorectal cancer | RAS_12 | NCOR1 | Any mutation | 463 | 125 | Signature overall | -0.75 | -1.77 | 0.24 | 1526.31 | 1.00 | 1034 | 442 | 104 | 21 | FALSE | 0.81 |
| non-small cell lung cancer | RAS_12 | NCOR1 | Any mutation | 324 | 61 | Signature overall | -0.39 | -1.56 | 0.91 | 1497.23 | 1.00 | 759 | 313 | 50 | 11 | FALSE | 0.28 |
| colorectal cancer | RAS_12 | POLE | Any mutation | 8 | 20 | Signature 10 | -1.46 | -3.14 | -0.12 | 1520.64 | 1.00 | 15 | 7 | 19 | 1 | TRUE | 1.21 |
| colorectal cancer | RAS_12 | POLE | Any mutation | 101 | 19 | Signature 15 | -0.50 | -1.63 | 0.54 | 1560.29 | 1.00 | 273 | 97 | 15 | 4 | TRUE | 0.45 |
| colorectal cancer | RAS_12 | POLE | Any mutation | 280 | 36 | Signature 1A | -0.14 | -0.83 | 0.56 | 1492.53 | 1.00 | 546 | 268 | 24 | 12 | TRUE | 0.16 |
| colorectal cancer | RAS_12 | POLE | Any mutation | 74 | 54 | Signature 6 | -1.03 | -1.92 | -0.25 | 1308.51 | 1.00 | 199 | 68 | 48 | 6 | TRUE | 1.78 |
| non-small cell lung cancer | RAS_12 | POLE | Any mutation | 80 | 19 | Signature 2 | 0.19 | -0.71 | 1.12 | 1384.34 | 1.00 | 233 | 74 | 13 | 6 | TRUE | 0.17 |
| non-small cell lung cancer | RAS_12 | POLE | Any mutation | 230 | 49 | Signature 4 | -0.38 | -1.03 | 0.21 | 1467.64 | 1.00 | 438 | 218 | 37 | 12 | TRUE | 0.64 |
| non-small cell lung cancer | RAS_12 | POLE | Any mutation | 144 | 11 | Signature R2 | 0.29 | -0.78 | 1.48 | 1447.31 | 1.00 | 52 | 135 | 2 | 9 | TRUE | 0.21 |
| uterine cancer | RAS_12 | POLE | Any mutation | 36 | 12 | Signature 1A | 0.34 | -1.15 | 1.63 | 1367.97 | 1.00 | 175 | 33 | 9 | 3 | TRUE | 0.20 |
| uterine cancer | RAS_12 | POLE | Any mutation | 13 | 20 | Signature 6 | 0.18 | -1.25 | 1.51 | 1300.91 | 1.00 | 74 | 10 | 17 | 3 | TRUE | 0.10 |
| colorectal cancer | RAS_12 | POLE | Any mutation | 463 | 129 | Signature overall | -0.79 | -2.09 | 0.40 | 1561.31 | 1.00 | 1033 | 440 | 106 | 23 | TRUE | 0.70 |
| non-small cell lung cancer | RAS_12 | POLE | Any mutation | 454 | 79 | Signature overall | 0.03 | -1.20 | 1.22 | 1545.63 | 1.00 | 723 | 427 | 52 | 27 | TRUE | 0.02 |
| uterine cancer | RAS_12 | POLE | Any mutation | 51 | 89 | Signature overall | 0.26 | -2.09 | 2.76 | 1443.53 | 1.00 | 260 | 43 | 81 | 8 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12 | NOTCH2 | Any mutation | 79 | 15 | Signature 2 | -0.94 | -2.08 | 0.08 | 1356.43 | 1.00 | 230 | 77 | 13 | 2 | TRUE | 1.04 |
| non-small cell lung cancer | RAS_12 | NOTCH2 | Any mutation | 230 | 54 | Signature 4 | -0.92 | -1.67 | -0.27 | 1408.95 | 1.00 | 437 | 221 | 45 | 9 | TRUE | 1.99 |
| non-small cell lung cancer | RAS_12 | NOTCH2 | Any mutation | 309 | 69 | Signature overall | -0.92 | -2.23 | 0.26 | 1261.11 | 1.00 | 667 | 298 | 58 | 11 | TRUE | 0.90 |
| colorectal cancer | RAS_12 | TGFBR2 | Any mutation | 102 | 11 | Signature 15 | -0.58 | -1.69 | 0.45 | 1556.26 | 1.00 | 275 | 100 | 9 | 2 | TRUE | 0.52 |
| colorectal cancer | RAS_12 | TGFBR2 | Any mutation | 280 | 48 | Signature 1A | -0.29 | -0.95 | 0.30 | 1478.56 | 1.00 | 535 | 266 | 34 | 14 | TRUE | 0.44 |
| colorectal cancer | RAS_12 | TGFBR2 | Any mutation | 72 | 43 | Signature 6 | -0.61 | -1.46 | 0.15 | 1415.39 | 1.00 | 204 | 66 | 37 | 6 | TRUE | 0.88 |
| colorectal cancer | RAS_12 | TGFBR2 | Any mutation | 454 | 102 | Signature overall | -0.48 | -1.43 | 0.46 | 1577.55 | 1.00 | 1014 | 432 | 80 | 22 | TRUE | 0.50 |
| colorectal cancer | RAS_12 | KMT2A | Any mutation | 9 | 22 | Signature 10 | -1.13 | -2.52 | 0.07 | 1403.26 | 1.00 | 20 | 7 | 20 | 2 | FALSE | 1.05 |
| colorectal cancer | RAS_12 | KMT2A | Any mutation | 101 | 19 | Signature 15 | -1.58 | -3.14 | -0.35 | 1531.74 | 1.00 | 269 | 100 | 18 | 1 | FALSE | 1.58 |
| colorectal cancer | RAS_12 | KMT2A | Any mutation | 279 | 53 | Signature 1A | -0.19 | -0.82 | 0.40 | 1197.11 | 1.00 | 535 | 262 | 36 | 17 | FALSE | 0.26 |
| colorectal cancer | RAS_12 | KMT2A | Any mutation | 72 | 42 | Signature 6 | -1.42 | -2.54 | -0.45 | 1330.60 | 1.00 | 210 | 69 | 39 | 3 | FALSE | 2.11 |
| non-small cell lung cancer | RAS_12 | KMT2A | Any mutation | 79 | 23 | Signature 2 | -0.14 | -0.94 | 0.66 | 1593.59 | 1.00 | 230 | 73 | 17 | 6 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12 | KMT2A | Any mutation | 230 | 37 | Signature 4 | -0.35 | -1.09 | 0.31 | 1468.14 | 1.00 | 445 | 221 | 28 | 9 | FALSE | 0.52 |
| uterine cancer | RAS_12 | KMT2A | Any mutation | 36 | 13 | Signature 1A | -0.46 | -2.18 | 1.01 | 1495.44 | 1.00 | 172 | 34 | 11 | 2 | FALSE | 0.23 |
| uterine cancer | RAS_12 | KMT2A | Any mutation | 13 | 14 | Signature 6 | -2.46 | -6.92 | 0.00 | 1501.12 | 1.00 | 71 | 13 | 14 | 0 | FALSE | 0.79 |
| colorectal cancer | RAS_12 | KMT2A | Any mutation | 461 | 136 | Signature overall | -1.06 | -2.25 | 0.01 | 1387.04 | 1.00 | 1034 | 438 | 113 | 23 | FALSE | 1.15 |
| non-small cell lung cancer | RAS_12 | KMT2A | Any mutation | 309 | 60 | Signature overall | -0.24 | -1.27 | 0.82 | 1521.54 | 1.00 | 675 | 294 | 45 | 15 | FALSE | 0.17 |
| uterine cancer | RAS_12 | KMT2A | Any mutation | 51 | 81 | Signature overall | -0.92 | -4.03 | 1.77 | 1501.76 | 1.00 | 261 | 47 | 77 | 4 | FALSE | 0.28 |
| non-small cell lung cancer | RAS_12 | PAK7 | Any mutation | 230 | 69 | Signature 4 | -0.62 | -1.24 | -0.05 | 1324.16 | 1.00 | 425 | 215 | 54 | 15 | FALSE | 1.38 |
| non-small cell lung cancer | RAS_12 | PAK7 | Any mutation | 230 | 69 | Signature overall | -0.47 | -4.39 | 3.57 | 1210.89 | 1.00 | 425 | 215 | 54 | 15 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12 | STAG2 | Any mutation | 79 | 16 | Signature 2 | 0.08 | -0.84 | 0.90 | 1445.19 | 1.00 | 234 | 75 | 12 | 4 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12 | STAG2 | Any mutation | 231 | 43 | Signature 4 | 0.18 | -0.43 | 0.76 | 1265.66 | 1.00 | 448 | 215 | 27 | 16 | TRUE | 0.27 |
| non-small cell lung cancer | RAS_12 | STAG2 | Any mutation | 310 | 59 | Signature overall | 0.13 | -0.88 | 1.10 | 1347.82 | 1.00 | 682 | 290 | 39 | 20 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12 | TERT | Any mutation | 80 | 23 | Signature 2 | 0.76 | -0.07 | 1.65 | 1395.23 | 1.00 | 233 | 69 | 12 | 11 | TRUE | 1.05 |
| non-small cell lung cancer | RAS_12 | TERT | Any mutation | 231 | 54 | Signature 4 | -0.01 | -0.61 | 0.53 | 1568.53 | 1.00 | 438 | 215 | 38 | 16 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12 | TERT | Any mutation | 311 | 77 | Signature overall | 0.37 | -0.87 | 1.77 | 1399.20 | 1.00 | 671 | 284 | 50 | 27 | TRUE | 0.23 |
| colorectal cancer | RAS_12 | BRCA2 | Any mutation | 8 | 37 | Signature 10 | -3.05 | -5.87 | -1.15 | 1660.14 | 1.00 | 17 | 8 | 37 | 0 | TRUE | 1.99 |
| colorectal cancer | RAS_12 | BRCA2 | Any mutation | 101 | 17 | Signature 15 | -0.87 | -2.23 | 0.29 | 1617.97 | 1.00 | 275 | 98 | 14 | 3 | TRUE | 0.75 |
| colorectal cancer | RAS_12 | BRCA2 | Any mutation | 280 | 50 | Signature 1A | -0.48 | -1.16 | 0.15 | 1188.11 | 1.00 | 537 | 267 | 37 | 13 | TRUE | 0.81 |
| colorectal cancer | RAS_12 | BRCA2 | Any mutation | 72 | 62 | Signature 6 | -1.96 | -3.17 | -0.94 | 1181.00 | 1.00 | 199 | 69 | 59 | 3 | TRUE | 3.13 |
| non-small cell lung cancer | RAS_12 | BRCA2 | Any mutation | 13 | 13 | Signature 13 | -1.37 | -3.79 | 0.06 | 1328.12 | 1.00 | 74 | 13 | 13 | 0 | TRUE | 0.79 |
| non-small cell lung cancer | RAS_12 | BRCA2 | Any mutation | 79 | 15 | Signature 2 | -1.24 | -2.94 | -0.09 | 1186.25 | 1.00 | 232 | 78 | 14 | 1 | TRUE | 1.05 |
| non-small cell lung cancer | RAS_12 | BRCA2 | Any mutation | 231 | 55 | Signature 4 | -0.35 | -0.99 | 0.23 | 1400.12 | 1.00 | 439 | 215 | 39 | 16 | TRUE | 0.57 |
| uterine cancer | RAS_12 | BRCA2 | Any mutation | 36 | 15 | Signature 1A | -0.07 | -1.49 | 1.22 | 1459.15 | 1.00 | 171 | 33 | 12 | 3 | TRUE | 0.04 |
| uterine cancer | RAS_12 | BRCA2 | Any mutation | 13 | 22 | Signature 6 | -2.94 | -7.38 | -0.50 | 1524.40 | 1.00 | 69 | 13 | 22 | 0 | TRUE | 0.98 |
| colorectal cancer | RAS_12 | BRCA2 | Any mutation | 461 | 166 | Signature overall | -1.55 | -3.31 | 0.03 | 1587.88 | 1.00 | 1028 | 442 | 147 | 19 | TRUE | 1.26 |
| non-small cell lung cancer | RAS_12 | BRCA2 | Any mutation | 323 | 83 | Signature overall | -0.98 | -2.53 | 0.16 | 1430.99 | 1.00 | 745 | 306 | 66 | 17 | TRUE | 0.83 |
| uterine cancer | RAS_12 | BRCA2 | Any mutation | 51 | 102 | Signature overall | -0.98 | -3.83 | 2.08 | 1502.17 | 1.00 | 255 | 46 | 97 | 5 | TRUE | 0.30 |
| colorectal cancer | RAS_12 | NOTCH3 | Any mutation | 101 | 27 | Signature 15 | -0.39 | -1.24 | 0.47 | 1582.35 | 1.00 | 269 | 94 | 20 | 7 | TRUE | 0.43 |
| colorectal cancer | RAS_12 | NOTCH3 | Any mutation | 280 | 70 | Signature 1A | -0.87 | -1.49 | -0.30 | 1545.56 | 1.00 | 520 | 267 | 57 | 13 | TRUE | 2.41 |
| colorectal cancer | RAS_12 | NOTCH3 | Any mutation | 73 | 72 | Signature 6 | -1.49 | -2.46 | -0.69 | 1561.98 | 1.00 | 190 | 69 | 68 | 4 | TRUE | 3.10 |
| non-small cell lung cancer | RAS_12 | NOTCH3 | Any mutation | 57 | 11 | Signature 18 | 0.07 | -0.73 | 1.01 | 1406.85 | 1.00 | 89 | 51 | 5 | 6 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12 | NOTCH3 | Any mutation | 79 | 15 | Signature 2 | -0.28 | -1.16 | 0.47 | 1490.58 | 1.00 | 234 | 76 | 12 | 3 | TRUE | 0.30 |
| non-small cell lung cancer | RAS_12 | NOTCH3 | Any mutation | 230 | 48 | Signature 4 | -0.34 | -0.99 | 0.26 | 1442.62 | 1.00 | 440 | 219 | 37 | 11 | TRUE | 0.55 |
| colorectal cancer | RAS_12 | NOTCH3 | Any mutation | 454 | 169 | Signature overall | -0.91 | -2.00 | 0.07 | 1506.26 | 1.00 | 979 | 430 | 145 | 24 | TRUE | 1.11 |
| non-small cell lung cancer | RAS_12 | NOTCH3 | Any mutation | 366 | 74 | Signature overall | -0.18 | -0.95 | 0.58 | 1458.09 | 1.00 | 763 | 346 | 54 | 20 | TRUE | 0.19 |
| colorectal cancer | RAS_12 | NOTCH4 | Any mutation | 97 | 18 | Signature 15 | -0.65 | -1.62 | 0.23 | 1637.94 | 1.00 | 267 | 94 | 15 | 3 | TRUE | 0.80 |
| colorectal cancer | RAS_12 | NOTCH4 | Any mutation | 270 | 43 | Signature 1A | -0.59 | -1.26 | 0.00 | 1310.50 | 1.00 | 523 | 260 | 33 | 10 | TRUE | 1.16 |
| colorectal cancer | RAS_12 | NOTCH4 | Any mutation | 70 | 41 | Signature 6 | -0.59 | -1.37 | 0.12 | 1410.99 | 1.00 | 204 | 64 | 35 | 6 | TRUE | 0.92 |
| non-small cell lung cancer | RAS_12 | NOTCH4 | Any mutation | 230 | 74 | Signature 4 | -0.40 | -0.95 | 0.14 | 828.44 | 1.00 | 423 | 211 | 55 | 19 | TRUE | 0.78 |
| colorectal cancer | RAS_12 | NOTCH4 | Any mutation | 437 | 102 | Signature overall | -0.60 | -1.45 | 0.26 | 1499.58 | 1.00 | 994 | 418 | 83 | 19 | TRUE | 0.79 |
| non-small cell lung cancer | RAS_12 | NOTCH4 | Any mutation | 230 | 74 | Signature overall | -0.43 | -4.73 | 3.80 | 1348.80 | 1.00 | 423 | 211 | 55 | 19 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 13 | 20 | Signature 13 | -0.10 | -1.17 | 0.80 | 1554.89 | 1.00 | 67 | 11 | 18 | 2 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 17 | 12 | Signature 14 | 0.05 | -0.99 | 0.98 | 1531.89 | 1.00 | 30 | 14 | 9 | 3 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 20 | 16 | Signature 15 | 0.35 | -0.56 | 1.26 | 1311.33 | 1.00 | 105 | 16 | 12 | 4 | FALSE | 0.36 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 8 | 12 | Signature 16 | 0.12 | -0.89 | 1.16 | 1490.44 | 1.00 | 42 | 6 | 10 | 2 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 58 | 34 | Signature 18 | -0.09 | -0.81 | 0.55 | 1296.13 | 1.00 | 71 | 47 | 23 | 11 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 15 | 11 | Signature 19 | 0.41 | -0.44 | 1.34 | 1502.14 | 1.00 | 41 | 11 | 7 | 4 | FALSE | 0.41 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 44 | 27 | Signature 1A | 0.51 | -0.26 | 1.30 | 1498.08 | 1.00 | 205 | 36 | 19 | 8 | FALSE | 0.74 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 79 | 55 | Signature 2 | -0.09 | -0.73 | 0.51 | 1621.04 | 1.00 | 205 | 67 | 43 | 12 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 13 | 13 | Signature 20 | 0.24 | -0.70 | 1.18 | 1465.12 | 1.00 | 54 | 10 | 10 | 3 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 50 | 31 | Signature 3 | 0.50 | -0.25 | 1.17 | 1592.90 | 1.00 | 172 | 40 | 21 | 10 | FALSE | 0.77 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 232 | 175 | Signature 4 | -0.20 | -0.56 | 0.15 | 1505.19 | 1.00 | 352 | 182 | 125 | 50 | FALSE | 0.57 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 21 | 14 | Signature 7 | -0.32 | -1.40 | 0.61 | 1483.38 | 1.00 | 75 | 20 | 13 | 1 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 145 | 45 | Signature R2 | 0.08 | -0.56 | 0.71 | 1481.89 | 1.00 | 41 | 114 | 14 | 31 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 17 | 11 | Signature U1 | 1.14 | 0.19 | 2.11 | 1516.03 | 1.00 | 90 | 10 | 4 | 7 | FALSE | 1.71 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Any mutation | 732 | 476 | Signature overall | 0.19 | -0.23 | 0.63 | 1474.95 | 1.00 | 1550 | 584 | 328 | 148 | FALSE | 0.40 |
| non-small cell lung cancer | RAS_12 | KDM5C | Any mutation | 79 | 15 | Signature 2 | -0.21 | -1.68 | 0.73 | 1451.52 | 1.00 | 233 | 77 | 13 | 2 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12 | KDM5C | Any mutation | 231 | 41 | Signature 4 | 0.46 | -0.15 | 1.07 | 1492.36 | 1.00 | 451 | 212 | 22 | 19 | FALSE | 0.83 |
| non-small cell lung cancer | RAS_12 | KDM5C | Any mutation | 310 | 56 | Signature overall | 0.11 | -1.30 | 1.30 | 1502.04 | 1.00 | 684 | 289 | 35 | 21 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 13 | 12 | Signature 13 | -0.97 | -2.59 | 0.38 | 1351.75 | 1.00 | 73 | 13 | 12 | 0 | TRUE | 0.69 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 20 | 11 | Signature 15 | -0.54 | -2.02 | 0.71 | 1470.19 | 1.00 | 106 | 19 | 10 | 1 | TRUE | 0.37 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 44 | 18 | Signature 1A | 0.47 | -0.56 | 1.44 | 1304.34 | 1.00 | 210 | 38 | 12 | 6 | TRUE | 0.45 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 79 | 22 | Signature 2 | -1.19 | -2.49 | -0.16 | 1435.31 | 1.00 | 225 | 78 | 21 | 1 | TRUE | 1.26 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 51 | 20 | Signature 3 | 0.20 | -0.73 | 1.06 | 1289.42 | 1.00 | 179 | 45 | 14 | 6 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 233 | 90 | Signature 4 | -0.58 | -1.10 | -0.07 | 1481.75 | 1.00 | 407 | 213 | 70 | 20 | TRUE | 1.57 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 144 | 11 | Signature R2 | 0.04 | -0.96 | 1.11 | 1675.73 | 1.00 | 52 | 135 | 2 | 9 | TRUE | 0.03 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 117 | 30 | Signature 11 | 1.30 | 0.00 | 2.67 | 1394.56 | 1.00 | 9 | 88 | 1 | 29 | TRUE | 1.31 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 110 | 27 | Signature 15 | 0.48 | -0.53 | 1.51 | 1514.60 | 1.00 | 19 | 88 | 5 | 22 | TRUE | 0.46 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 12 | 11 | Signature 17 | 0.27 | -0.96 | 1.44 | 1402.71 | 1.00 | 33 | 10 | 9 | 2 | TRUE | 0.18 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 205 | 67 | Signature 1A | 1.11 | 0.38 | 1.91 | 1630.92 | 1.00 | 44 | 145 | 7 | 60 | TRUE | 2.27 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 83 | 23 | Signature 3 | 1.88 | 0.68 | 3.40 | 1458.78 | 1.00 | 19 | 60 | 0 | 23 | TRUE | 2.25 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 62 | 25 | Signature 4 | 2.10 | 0.90 | 3.63 | 1380.94 | 1.00 | 12 | 37 | 0 | 25 | TRUE | 2.53 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 54 | 26 | Signature 6 | 2.43 | 1.17 | 4.04 | 1542.89 | 1.00 | 20 | 28 | 0 | 26 | TRUE | 3.15 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 49 | 11 | Signature 8 | 1.43 | 0.06 | 2.99 | 1475.85 | 1.00 | 3 | 38 | 0 | 11 | TRUE | 1.17 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Any mutation | 584 | 184 | Signature overall | -0.37 | -1.22 | 0.37 | 1390.06 | 1.00 | 1252 | 541 | 141 | 43 | TRUE | 0.44 |
| pancreatic cancer | RAS_12 | CDKN2A | Any mutation | 692 | 220 | Signature overall | 1.39 | 0.51 | 2.42 | 1422.67 | 1.00 | 159 | 494 | 22 | 198 | TRUE | 2.48 |
| non-small cell lung cancer | RAS_12 | EPHB1 | Any mutation | 79 | 17 | Signature 2 | -0.37 | -1.44 | 0.69 | 1640.51 | 1.00 | 233 | 75 | 13 | 4 | FALSE | 0.31 |
| non-small cell lung cancer | RAS_12 | EPHB1 | Any mutation | 232 | 79 | Signature 4 | -0.66 | -1.25 | -0.12 | 1420.38 | 1.00 | 419 | 216 | 63 | 16 | FALSE | 1.63 |
| non-small cell lung cancer | RAS_12 | EPHB1 | Any mutation | 311 | 96 | Signature overall | -0.49 | -1.80 | 0.99 | 1633.28 | 1.00 | 652 | 291 | 76 | 20 | FALSE | 0.32 |
| uterine cancer | RAS_12 | PPP2R1A | Any mutation | 19 | 20 | Signature 15 | -1.16 | -2.65 | -0.09 | 1378.71 | 1.00 | 72 | 18 | 19 | 1 | FALSE | 1.15 |
| uterine cancer | RAS_12 | PPP2R1A | Any mutation | 36 | 25 | Signature 1A | -0.76 | -1.87 | 0.25 | 1420.89 | 1.00 | 163 | 33 | 22 | 3 | FALSE | 0.76 |
| uterine cancer | RAS_12 | PPP2R1A | Any mutation | 11 | 14 | Signature 3 | -0.84 | -2.06 | 0.29 | 1285.74 | 1.00 | 22 | 9 | 12 | 2 | FALSE | 0.77 |
| uterine cancer | RAS_12 | PPP2R1A | Any mutation | 13 | 17 | Signature 6 | -0.69 | -1.97 | 0.54 | 1140.86 | 1.00 | 74 | 11 | 15 | 2 | FALSE | 0.54 |
| uterine cancer | RAS_12 | PPP2R1A | Any mutation | 80 | 96 | Signature overall | -0.91 | -1.92 | 0.04 | 1451.78 | 1.00 | 363 | 72 | 88 | 8 | FALSE | 1.11 |
| colorectal cancer | RAS_12 | ERBB3 | Any mutation | 101 | 18 | Signature 15 | -0.45 | -1.34 | 0.33 | 1421.72 | 1.00 | 269 | 98 | 15 | 3 | TRUE | 0.53 |
| colorectal cancer | RAS_12 | ERBB3 | Any mutation | 280 | 46 | Signature 1A | -0.41 | -1.01 | 0.14 | 1091.12 | 1.00 | 538 | 269 | 35 | 11 | TRUE | 0.76 |
| colorectal cancer | RAS_12 | ERBB3 | Any mutation | 72 | 34 | Signature 6 | -0.04 | -0.74 | 0.70 | 1599.90 | 1.00 | 219 | 63 | 25 | 9 | TRUE | 0.04 |
| colorectal cancer | RAS_12 | ERBB3 | Any mutation | 453 | 98 | Signature overall | -0.29 | -1.06 | 0.50 | 1066.15 | 1.00 | 1026 | 430 | 75 | 23 | TRUE | 0.33 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 8 | 17 | Signature 10 | 0.13 | -0.64 | 0.81 | 1377.83 | 1.00 | 17 | 5 | 14 | 3 | TRUE | 0.14 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 102 | 60 | Signature 15 | 0.28 | -0.18 | 0.76 | 1525.76 | 1.00 | 248 | 82 | 40 | 20 | TRUE | 0.60 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 8 | 11 | Signature 17 | 0.11 | -0.71 | 0.86 | 1460.43 | 1.00 | 29 | 6 | 9 | 2 | TRUE | 0.11 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 20 | 12 | Signature 19 | 0.36 | -0.35 | 1.08 | 1516.00 | 1.00 | 20 | 14 | 6 | 6 | TRUE | 0.48 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 286 | 122 | Signature 1A | 0.16 | -0.21 | 0.54 | 1510.36 | 1.00 | 492 | 241 | 77 | 45 | TRUE | 0.42 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 36 | 11 | Signature 2 | 0.02 | -0.70 | 0.67 | 1406.28 | 1.00 | 39 | 32 | 7 | 4 | TRUE | 0.02 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 73 | 57 | Signature 6 | 0.11 | -0.45 | 0.62 | 1418.86 | 1.00 | 203 | 59 | 43 | 14 | TRUE | 0.15 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 15 | 11 | Signature 7 | 0.46 | -0.27 | 1.23 | 1524.81 | 1.00 | 20 | 9 | 5 | 6 | TRUE | 0.64 |
| non-small cell lung cancer | RAS_12 | SMAD4 | Any mutation | 44 | 17 | Signature 1A | -0.17 | -1.45 | 0.90 | 1580.06 | 1.00 | 209 | 42 | 15 | 2 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12 | SMAD4 | Any mutation | 79 | 21 | Signature 2 | 0.76 | -0.12 | 1.65 | 1391.13 | 1.00 | 234 | 69 | 11 | 10 | TRUE | 1.03 |
| non-small cell lung cancer | RAS_12 | SMAD4 | Any mutation | 230 | 16 | Signature 4 | -0.47 | -1.54 | 0.42 | 1620.77 | 1.00 | 459 | 227 | 13 | 3 | TRUE | 0.45 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 115 | 25 | Signature 11 | 0.30 | -0.65 | 1.30 | 1490.86 | 1.00 | 9 | 91 | 1 | 24 | TRUE | 0.27 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 109 | 31 | Signature 15 | 0.35 | -0.43 | 1.20 | 1376.57 | 1.00 | 20 | 82 | 4 | 27 | TRUE | 0.39 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 12 | 12 | Signature 17 | -0.97 | -2.35 | 0.14 | 1384.92 | 1.00 | 31 | 12 | 12 | 0 | TRUE | 0.93 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 201 | 56 | Signature 1A | 0.00 | -0.62 | 0.64 | 1432.88 | 1.00 | 40 | 157 | 12 | 44 | TRUE | 0.00 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 33 | 12 | Signature 2 | -0.28 | -1.32 | 0.71 | 1546.69 | 1.00 | 8 | 26 | 5 | 7 | TRUE | 0.23 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 80 | 24 | Signature 3 | 0.38 | -0.50 | 1.33 | 1293.88 | 1.00 | 16 | 59 | 3 | 21 | TRUE | 0.41 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 61 | 15 | Signature 4 | 0.37 | -0.61 | 1.40 | 1351.78 | 1.00 | 11 | 47 | 1 | 14 | TRUE | 0.34 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 54 | 15 | Signature 6 | -0.17 | -1.07 | 0.76 | 1553.84 | 1.00 | 15 | 44 | 5 | 10 | TRUE | 0.15 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 50 | 15 | Signature 8 | 0.53 | -0.56 | 1.65 | 1514.09 | 1.00 | 3 | 35 | 0 | 15 | TRUE | 0.45 |
| colorectal cancer | RAS_12 | SMAD4 | Any mutation | 548 | 301 | Signature overall | 0.20 | -0.27 | 0.66 | 1430.65 | 1.00 | 1068 | 448 | 201 | 100 | TRUE | 0.41 |
| non-small cell lung cancer | RAS_12 | SMAD4 | Any mutation | 353 | 54 | Signature overall | 0.04 | -1.17 | 1.08 | 1489.94 | 1.00 | 902 | 338 | 39 | 15 | TRUE | 0.03 |
| pancreatic cancer | RAS_12 | SMAD4 | Any mutation | 715 | 205 | Signature overall | 0.06 | -0.63 | 0.71 | 1460.06 | 1.00 | 153 | 553 | 43 | 162 | TRUE | 0.07 |
| colorectal cancer | RAS_12 | ATM | Any mutation | 10 | 39 | Signature 10 | -0.92 | -2.08 | 0.21 | 1359.04 | 1.00 | 16 | 6 | 35 | 4 | TRUE | 0.93 |
| colorectal cancer | RAS_12 | ATM | Any mutation | 102 | 32 | Signature 15 | -0.58 | -1.51 | 0.24 | 1487.08 | 1.00 | 262 | 96 | 26 | 6 | TRUE | 0.69 |
| colorectal cancer | RAS_12 | ATM | Any mutation | 282 | 77 | Signature 1A | -0.04 | -0.58 | 0.45 | 1473.17 | 1.00 | 522 | 256 | 51 | 26 | TRUE | 0.06 |
| colorectal cancer | RAS_12 | ATM | Any mutation | 73 | 48 | Signature 6 | -1.04 | -2.00 | -0.16 | 1674.91 | 1.00 | 204 | 68 | 43 | 5 | TRUE | 1.62 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 13 | 12 | Signature 13 | 0.77 | -0.33 | 1.85 | 1398.86 | 1.00 | 76 | 10 | 9 | 3 | TRUE | 0.80 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 57 | 11 | Signature 18 | 0.70 | -0.24 | 1.64 | 1521.48 | 1.00 | 89 | 51 | 5 | 6 | TRUE | 0.84 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 81 | 27 | Signature 2 | 0.88 | 0.18 | 1.55 | 1293.52 | 1.00 | 231 | 69 | 15 | 12 | TRUE | 1.84 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 50 | 13 | Signature 3 | 0.58 | -0.43 | 1.55 | 1418.55 | 1.00 | 184 | 46 | 9 | 4 | TRUE | 0.63 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 241 | 95 | Signature 4 | 0.74 | 0.32 | 1.14 | 1315.82 | 1.00 | 429 | 195 | 49 | 46 | TRUE | 3.24 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 145 | 25 | Signature R2 | 0.52 | -0.27 | 1.31 | 1552.77 | 1.00 | 48 | 126 | 6 | 19 | TRUE | 0.71 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 11 | 12 | Signature U2 | 1.59 | 0.56 | 2.76 | 1322.94 | 1.00 | 31 | 4 | 5 | 7 | TRUE | 2.31 |
| uterine cancer | RAS_12 | ATM | Any mutation | 36 | 23 | Signature 1A | -0.58 | -1.95 | 0.61 | 1578.16 | 1.00 | 167 | 33 | 20 | 3 | TRUE | 0.44 |
| uterine cancer | RAS_12 | ATM | Any mutation | 14 | 24 | Signature 6 | -0.84 | -2.38 | 0.52 | 1320.48 | 1.00 | 70 | 12 | 22 | 2 | TRUE | 0.59 |
| colorectal cancer | RAS_12 | ATM | Any mutation | 467 | 196 | Signature overall | -0.65 | -1.84 | 0.49 | 1333.84 | 1.00 | 1004 | 426 | 155 | 41 | TRUE | 0.56 |
| non-small cell lung cancer | RAS_12 | ATM | Any mutation | 598 | 195 | Signature overall | 0.82 | 0.15 | 1.53 | 1466.28 | 1.00 | 1088 | 501 | 98 | 97 | TRUE | 1.73 |
| uterine cancer | RAS_12 | ATM | Any mutation | 56 | 121 | Signature overall | -0.85 | -2.55 | 0.80 | 1353.81 | 1.00 | 261 | 48 | 113 | 8 | TRUE | 0.48 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 13 | 11 | Signature 13 | -0.79 | -1.71 | 0.33 | 1551.19 | 1.00 | 78 | 11 | 9 | 2 | TRUE | 0.91 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 57 | 11 | Signature 18 | -0.87 | -1.76 | 0.00 | 1347.19 | 1.00 | 85 | 54 | 8 | 3 | TRUE | 1.33 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 44 | 16 | Signature 1A | -0.91 | -1.83 | -0.01 | 1444.03 | 1.00 | 208 | 42 | 14 | 2 | TRUE | 1.32 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 79 | 28 | Signature 2 | -1.01 | -1.84 | -0.23 | 1593.61 | 1.00 | 220 | 76 | 25 | 3 | TRUE | 1.94 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 50 | 18 | Signature 3 | -1.24 | -2.25 | -0.38 | 1509.64 | 1.00 | 175 | 50 | 18 | 0 | TRUE | 2.06 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 230 | 67 | Signature 4 | -1.03 | -1.65 | -0.47 | 1535.50 | 1.00 | 419 | 220 | 57 | 10 | TRUE | 3.16 |
| non-small cell lung cancer | RAS_12 | RB1 | Any mutation | 473 | 151 | Signature overall | -0.97 | -1.60 | -0.32 | 1516.71 | 1.00 | 1185 | 453 | 131 | 20 | TRUE | 2.53 |
| cancer of unknown primary | RAS_12 | KMT2D | Any mutation | 32 | 18 | Signature 1A | -1.50 | -2.89 | -0.31 | 1540.02 | 1.00 | 70 | 30 | 16 | 2 | FALSE | 1.61 |
| cancer of unknown primary | RAS_12 | KMT2D | Any mutation | 19 | 15 | Signature 4 | -1.28 | -2.80 | 0.00 | 1523.59 | 1.00 | 50 | 17 | 13 | 2 | FALSE | 1.14 |
| colorectal cancer | RAS_12 | KMT2D | Any mutation | 8 | 19 | Signature 10 | -1.17 | -2.48 | -0.13 | 1461.56 | 1.00 | 16 | 7 | 18 | 1 | FALSE | 1.29 |
| colorectal cancer | RAS_12 | KMT2D | Any mutation | 102 | 55 | Signature 15 | -0.86 | -1.58 | -0.18 | 1359.20 | 1.00 | 259 | 94 | 47 | 8 | FALSE | 1.86 |
| colorectal cancer | RAS_12 | KMT2D | Any mutation | 288 | 128 | Signature 1A | -0.61 | -1.05 | -0.21 | 1408.61 | 1.00 | 505 | 259 | 99 | 29 | FALSE | 2.42 |
| colorectal cancer | RAS_12 | KMT2D | Any mutation | 82 | 142 | Signature 6 | -0.80 | -1.30 | -0.29 | 1477.69 | 1.00 | 169 | 62 | 122 | 20 | FALSE | 2.68 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 13 | 16 | Signature 13 | -1.30 | -2.78 | -0.03 | 1304.07 | 1.00 | 70 | 13 | 16 | 0 | FALSE | 1.19 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 57 | 16 | Signature 18 | -0.95 | -1.98 | -0.02 | 1345.96 | 1.00 | 82 | 54 | 13 | 3 | FALSE | 1.22 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 44 | 22 | Signature 1A | -0.82 | -1.98 | 0.28 | 1163.67 | 1.00 | 205 | 42 | 20 | 2 | FALSE | 0.83 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 80 | 46 | Signature 2 | -0.19 | -0.92 | 0.48 | 1492.28 | 1.00 | 216 | 69 | 35 | 11 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 50 | 13 | Signature 3 | -0.98 | -2.33 | 0.18 | 1609.79 | 1.00 | 181 | 49 | 12 | 1 | FALSE | 0.92 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 232 | 129 | Signature 4 | -0.69 | -1.13 | -0.25 | 1515.05 | 1.00 | 391 | 205 | 102 | 27 | FALSE | 2.70 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 144 | 13 | Signature R2 | -0.24 | -1.13 | 0.68 | 1401.02 | 1.00 | 51 | 134 | 3 | 10 | FALSE | 0.22 |
| uterine cancer | RAS_12 | KMT2D | Any mutation | 20 | 27 | Signature 15 | -0.09 | -1.11 | 0.86 | 1404.28 | 1.00 | 73 | 14 | 21 | 6 | FALSE | 0.07 |
| uterine cancer | RAS_12 | KMT2D | Any mutation | 36 | 61 | Signature 1A | -0.72 | -1.54 | 0.06 | 1289.81 | 1.00 | 140 | 30 | 55 | 6 | FALSE | 1.05 |
| uterine cancer | RAS_12 | KMT2D | Any mutation | 7 | 13 | Signature 20 | -0.88 | -2.23 | 0.37 | 1397.42 | 1.00 | 24 | 6 | 12 | 1 | FALSE | 0.72 |
| uterine cancer | RAS_12 | KMT2D | Any mutation | 14 | 63 | Signature 6 | -0.77 | -1.76 | 0.14 | 1561.07 | 1.00 | 45 | 9 | 58 | 5 | FALSE | 0.98 |
| cancer of unknown primary | RAS_12 | KMT2D | Any mutation | 59 | 76 | Signature overall | -1.54 | -2.90 | -0.31 | 1518.49 | 1.00 | 165 | 54 | 71 | 5 | FALSE | 1.68 |
| colorectal cancer | RAS_12 | KMT2D | Any mutation | 480 | 344 | Signature overall | -0.85 | -1.68 | -0.07 | 1326.03 | 1.00 | 949 | 422 | 286 | 58 | FALSE | 1.52 |
| non-small cell lung cancer | RAS_12 | KMT2D | Any mutation | 620 | 255 | Signature overall | -0.73 | -1.46 | -0.01 | 1385.53 | 1.00 | 1196 | 566 | 201 | 54 | FALSE | 1.33 |
| uterine cancer | RAS_12 | KMT2D | Any mutation | 83 | 233 | Signature overall | -0.71 | -1.56 | 0.16 | 1488.66 | 1.00 | 311 | 62 | 212 | 21 | FALSE | 0.96 |
| colorectal cancer | RAS_12 | TSC2 | Any mutation | 101 | 11 | Signature 15 | 0.27 | -0.81 | 1.43 | 1331.51 | 1.00 | 278 | 96 | 6 | 5 | TRUE | 0.20 |
| colorectal cancer | RAS_12 | TSC2 | Any mutation | 281 | 36 | Signature 1A | -0.32 | -1.03 | 0.34 | 1406.47 | 1.00 | 545 | 271 | 26 | 10 | TRUE | 0.44 |
| colorectal cancer | RAS_12 | TSC2 | Any mutation | 72 | 44 | Signature 6 | -0.94 | -1.95 | -0.09 | 1550.72 | 1.00 | 208 | 68 | 40 | 4 | TRUE | 1.34 |
| colorectal cancer | RAS_12 | TSC2 | Any mutation | 454 | 91 | Signature overall | -0.35 | -1.66 | 0.95 | 1444.02 | 1.00 | 1031 | 435 | 72 | 19 | TRUE | 0.23 |
| colorectal cancer | RAS_12 | APC | Any mutation | 16 | 94 | Signature 10 | -0.09 | -0.77 | 0.65 | 1510.42 | 1.00 | 3 | 0 | 78 | 16 | TRUE | 0.09 |
| colorectal cancer | RAS_12 | APC | Any mutation | 27 | 39 | Signature 11 | -0.05 | -0.79 | 0.64 | 1444.71 | 1.00 | 1 | 9 | 21 | 18 | TRUE | 0.05 |
| colorectal cancer | RAS_12 | APC | Any mutation | 13 | 25 | Signature 14 | 0.40 | -0.35 | 1.19 | 1453.62 | 1.00 | 2 | 1 | 13 | 12 | TRUE | 0.53 |
| colorectal cancer | RAS_12 | APC | Any mutation | 156 | 469 | Signature 15 | 0.35 | -0.06 | 0.80 | 1402.14 | 1.00 | 67 | 16 | 329 | 140 | TRUE | 0.97 |
| colorectal cancer | RAS_12 | APC | Any mutation | 11 | 46 | Signature 17 | -0.31 | -1.06 | 0.40 | 1408.69 | 1.00 | 11 | 4 | 39 | 7 | TRUE | 0.38 |
| colorectal cancer | RAS_12 | APC | Any mutation | 23 | 63 | Signature 18 | -0.13 | -0.83 | 0.54 | 1475.12 | 1.00 | 3 | 5 | 45 | 18 | TRUE | 0.15 |
| colorectal cancer | RAS_12 | APC | Any mutation | 24 | 38 | Signature 19 | -0.17 | -0.86 | 0.50 | 1500.96 | 1.00 | 8 | 10 | 24 | 14 | TRUE | 0.21 |
| colorectal cancer | RAS_12 | APC | Any mutation | 406 | 962 | Signature 1A | 0.10 | -0.19 | 0.39 | 1541.34 | 1.00 | 149 | 72 | 628 | 334 | TRUE | 0.30 |
| colorectal cancer | RAS_12 | APC | Any mutation | 12 | 22 | Signature 1B | 0.40 | -0.37 | 1.16 | 1380.88 | 1.00 | 7 | 1 | 11 | 11 | TRUE | 0.52 |
| colorectal cancer | RAS_12 | APC | Any mutation | 51 | 95 | Signature 2 | 0.41 | -0.19 | 1.04 | 1423.26 | 1.00 | 11 | 6 | 50 | 45 | TRUE | 0.70 |
| colorectal cancer | RAS_12 | APC | Any mutation | 13 | 34 | Signature 20 | -0.02 | -0.80 | 0.73 | 1472.09 | 1.00 | 5 | 3 | 24 | 10 | TRUE | 0.02 |
| colorectal cancer | RAS_12 | APC | Any mutation | 11 | 25 | Signature 21 | 0.41 | -0.34 | 1.17 | 1619.76 | 1.00 | 10 | 0 | 14 | 11 | TRUE | 0.52 |
| colorectal cancer | RAS_12 | APC | Any mutation | 19 | 42 | Signature 3 | 0.20 | -0.48 | 0.90 | 1672.84 | 1.00 | 8 | 3 | 26 | 16 | TRUE | 0.25 |
| colorectal cancer | RAS_12 | APC | Any mutation | 22 | 49 | Signature 4 | 0.03 | -0.67 | 0.69 | 1563.85 | 1.00 | 6 | 5 | 32 | 17 | TRUE | 0.03 |
| colorectal cancer | RAS_12 | APC | Any mutation | 109 | 355 | Signature 6 | 0.28 | -0.14 | 0.74 | 1295.76 | 1.00 | 79 | 16 | 262 | 93 | TRUE | 0.65 |
| colorectal cancer | RAS_12 | APC | Any mutation | 21 | 40 | Signature 7 | 0.34 | -0.34 | 1.00 | 1322.49 | 1.00 | 9 | 3 | 22 | 18 | TRUE | 0.50 |
| colorectal cancer | RAS_12 | APC | Any mutation | 19 | 30 | Signature 8 | 0.47 | -0.26 | 1.16 | 1441.21 | 1.00 | 1 | 2 | 13 | 17 | TRUE | 0.71 |
| colorectal cancer | RAS_12 | APC | Any mutation | 22 | 20 | Signature R2 | 0.48 | -0.25 | 1.25 | 1367.21 | 1.00 | 3 | 6 | 4 | 16 | TRUE | 0.69 |
| colorectal cancer | RAS_12 | APC | Any mutation | 10 | 14 | Signature U1 | 0.05 | -0.78 | 0.83 | 1444.69 | 1.00 | 2 | 4 | 8 | 6 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12 | APC | Any mutation | 44 | 13 | Signature 1A | -0.38 | -1.45 | 0.67 | 1353.94 | 1.00 | 211 | 42 | 11 | 2 | TRUE | 0.33 |
| non-small cell lung cancer | RAS_12 | APC | Any mutation | 82 | 23 | Signature 2 | -0.10 | -0.88 | 0.72 | 1532.65 | 1.00 | 229 | 75 | 16 | 7 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12 | APC | Any mutation | 230 | 50 | Signature 4 | -0.75 | -1.47 | -0.06 | 1491.59 | 1.00 | 434 | 222 | 42 | 8 | TRUE | 1.48 |
| uterine cancer | RAS_12 | APC | Any mutation | 36 | 18 | Signature 1A | -0.53 | -2.04 | 0.74 | 1556.66 | 1.00 | 172 | 34 | 16 | 2 | TRUE | 0.33 |
| uterine cancer | RAS_12 | APC | Any mutation | 13 | 15 | Signature 6 | -0.08 | -1.74 | 1.36 | 1557.62 | 1.00 | 76 | 11 | 13 | 2 | TRUE | 0.04 |
| colorectal cancer | RAS_12 | APC | Any mutation | 985 | 2462 | Signature overall | 0.16 | -0.19 | 0.51 | 1517.04 | 1.00 | 385 | 166 | 1643 | 819 | TRUE | 0.45 |
| non-small cell lung cancer | RAS_12 | APC | Any mutation | 356 | 86 | Signature overall | -0.40 | -1.26 | 0.41 | 1310.73 | 1.00 | 874 | 339 | 69 | 17 | TRUE | 0.45 |
| uterine cancer | RAS_12 | APC | Any mutation | 53 | 96 | Signature overall | 0.02 | -2.18 | 2.30 | 1593.20 | 1.00 | 265 | 45 | 88 | 8 | TRUE | 0.01 |
| colorectal cancer | RAS_12 | ERBB2 | Any mutation | 279 | 47 | Signature 1A | -0.93 | -1.66 | -0.24 | 1483.64 | 1.00 | 532 | 271 | 39 | 8 | TRUE | 1.98 |
| colorectal cancer | RAS_12 | ERBB2 | Any mutation | 72 | 29 | Signature 6 | -0.81 | -1.73 | 0.06 | 1504.16 | 1.00 | 218 | 68 | 25 | 4 | TRUE | 1.11 |
| non-small cell lung cancer | RAS_12 | ERBB2 | Any mutation | 44 | 15 | Signature 1A | -1.76 | -3.53 | -0.35 | 1393.17 | 1.00 | 208 | 43 | 14 | 1 | TRUE | 1.52 |
| non-small cell lung cancer | RAS_12 | ERBB2 | Any mutation | 79 | 12 | Signature 2 | -2.05 | -3.88 | -0.60 | 1494.64 | 1.00 | 233 | 79 | 12 | 0 | TRUE | 1.81 |
| non-small cell lung cancer | RAS_12 | ERBB2 | Any mutation | 230 | 19 | Signature 4 | -1.80 | -3.28 | -0.58 | 1440.54 | 1.00 | 457 | 228 | 17 | 2 | TRUE | 1.99 |
| colorectal cancer | RAS_12 | ERBB2 | Any mutation | 351 | 76 | Signature overall | -0.85 | -2.11 | 0.39 | 1562.84 | 1.00 | 750 | 339 | 64 | 12 | TRUE | 0.73 |
| non-small cell lung cancer | RAS_12 | ERBB2 | Any mutation | 353 | 46 | Signature overall | -1.84 | -3.36 | -0.52 | 1462.96 | 1.00 | 898 | 350 | 43 | 3 | TRUE | 1.92 |
| uterine cancer | RAS_12 | JAK1 | Any mutation | 20 | 14 | Signature 15 | 0.53 | -0.62 | 1.60 | 1486.62 | 1.00 | 83 | 16 | 10 | 4 | TRUE | 0.47 |
| uterine cancer | RAS_12 | JAK1 | Any mutation | 38 | 35 | Signature 1A | 0.39 | -0.40 | 1.14 | 1593.05 | 1.00 | 159 | 30 | 27 | 8 | TRUE | 0.47 |
| uterine cancer | RAS_12 | JAK1 | Any mutation | 14 | 42 | Signature 6 | 0.30 | -0.67 | 1.31 | 1310.81 | 1.00 | 59 | 8 | 36 | 6 | TRUE | 0.26 |
| uterine cancer | RAS_12 | JAK1 | Any mutation | 74 | 117 | Signature overall | 0.42 | -0.66 | 1.57 | 1364.75 | 1.00 | 325 | 54 | 97 | 20 | TRUE | 0.34 |
| colorectal cancer | RAS_12 | ARID2 | Any mutation | 8 | 16 | Signature 10 | -0.61 | -1.96 | 0.58 | 1478.70 | 1.00 | 17 | 6 | 14 | 2 | FALSE | 0.47 |
| colorectal cancer | RAS_12 | ARID2 | Any mutation | 101 | 19 | Signature 15 | -0.72 | -1.90 | 0.30 | 1550.64 | 1.00 | 271 | 98 | 16 | 3 | FALSE | 0.74 |
| colorectal cancer | RAS_12 | ARID2 | Any mutation | 280 | 42 | Signature 1A | -0.12 | -0.79 | 0.53 | 1643.65 | 1.00 | 542 | 266 | 28 | 14 | FALSE | 0.15 |
| colorectal cancer | RAS_12 | ARID2 | Any mutation | 72 | 27 | Signature 6 | -0.62 | -1.67 | 0.28 | 1466.32 | 1.00 | 218 | 68 | 23 | 4 | FALSE | 0.70 |
| non-small cell lung cancer | RAS_12 | ARID2 | Any mutation | 57 | 11 | Signature 18 | 0.01 | -0.80 | 0.94 | 1005.78 | 1.01 | 88 | 51 | 5 | 6 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12 | ARID2 | Any mutation | 79 | 18 | Signature 2 | -0.18 | -0.93 | 0.64 | 1598.60 | 1.00 | 233 | 74 | 13 | 5 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12 | ARID2 | Any mutation | 50 | 16 | Signature 3 | -0.52 | -1.44 | 0.30 | 1522.98 | 1.00 | 178 | 49 | 15 | 1 | FALSE | 0.60 |
| non-small cell lung cancer | RAS_12 | ARID2 | Any mutation | 231 | 67 | Signature 4 | -0.42 | -0.97 | 0.07 | 1595.96 | 1.00 | 428 | 216 | 52 | 15 | FALSE | 0.94 |
| colorectal cancer | RAS_12 | ARID2 | Any mutation | 461 | 104 | Signature overall | -0.53 | -1.60 | 0.50 | 1399.33 | 1.00 | 1048 | 438 | 81 | 23 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12 | ARID2 | Any mutation | 417 | 112 | Signature overall | -0.27 | -0.98 | 0.40 | 1556.53 | 1.00 | 927 | 390 | 85 | 27 | FALSE | 0.36 |
| colorectal cancer | RAS_12 | MTOR | Any mutation | 8 | 12 | Signature 10 | -1.36 | -3.39 | 0.00 | 1308.53 | 1.00 | 19 | 8 | 12 | 0 | TRUE | 0.93 |
| colorectal cancer | RAS_12 | MTOR | Any mutation | 101 | 17 | Signature 15 | -0.55 | -1.50 | 0.42 | 1550.53 | 1.00 | 273 | 97 | 13 | 4 | TRUE | 0.57 |
| colorectal cancer | RAS_12 | MTOR | Any mutation | 282 | 48 | Signature 1A | -0.46 | -1.12 | 0.17 | 1486.91 | 1.00 | 534 | 269 | 35 | 13 | TRUE | 0.82 |
| colorectal cancer | RAS_12 | MTOR | Any mutation | 72 | 45 | Signature 6 | -0.92 | -1.79 | -0.14 | 1519.97 | 1.00 | 208 | 67 | 40 | 5 | TRUE | 1.51 |
| non-small cell lung cancer | RAS_12 | MTOR | Any mutation | 230 | 41 | Signature 4 | 0.18 | -0.50 | 0.84 | 1322.15 | 1.00 | 446 | 215 | 26 | 15 | TRUE | 0.23 |
| colorectal cancer | RAS_12 | MTOR | Any mutation | 463 | 122 | Signature overall | -0.82 | -1.84 | 0.16 | 1388.32 | 1.00 | 1034 | 441 | 100 | 22 | TRUE | 0.97 |
| non-small cell lung cancer | RAS_12 | MTOR | Any mutation | 230 | 41 | Signature overall | 0.12 | -4.02 | 4.44 | 1451.38 | 1.00 | 446 | 215 | 26 | 15 | TRUE | 0.02 |
| colorectal cancer | RAS_12 | NOTCH1 | Any mutation | 8 | 11 | Signature 10 | -1.42 | -3.40 | 0.01 | 1485.60 | 1.00 | 20 | 8 | 11 | 0 | TRUE | 0.99 |
| colorectal cancer | RAS_12 | NOTCH1 | Any mutation | 103 | 17 | Signature 15 | -0.48 | -1.54 | 0.48 | 1531.78 | 1.00 | 275 | 99 | 13 | 4 | TRUE | 0.45 |
| colorectal cancer | RAS_12 | NOTCH1 | Any mutation | 281 | 47 | Signature 1A | -0.37 | -1.01 | 0.24 | 1557.43 | 1.00 | 537 | 268 | 34 | 13 | TRUE | 0.61 |
| colorectal cancer | RAS_12 | NOTCH1 | Any mutation | 76 | 82 | Signature 6 | -0.68 | -1.32 | -0.03 | 1437.82 | 1.00 | 188 | 64 | 70 | 12 | TRUE | 1.40 |
| non-small cell lung cancer | RAS_12 | NOTCH1 | Any mutation | 79 | 12 | Signature 2 | -0.97 | -2.28 | 0.27 | 1484.70 | 1.00 | 235 | 77 | 10 | 2 | TRUE | 0.91 |
| non-small cell lung cancer | RAS_12 | NOTCH1 | Any mutation | 230 | 54 | Signature 4 | -1.22 | -2.05 | -0.50 | 1331.28 | 1.00 | 428 | 223 | 47 | 7 | TRUE | 2.58 |
| colorectal cancer | RAS_12 | NOTCH1 | Any mutation | 468 | 157 | Signature overall | -0.74 | -1.89 | 0.28 | 1518.96 | 1.00 | 1020 | 439 | 128 | 29 | TRUE | 0.77 |
| non-small cell lung cancer | RAS_12 | NOTCH1 | Any mutation | 309 | 66 | Signature overall | -1.12 | -2.63 | 0.25 | 1093.27 | 1.00 | 663 | 300 | 57 | 9 | TRUE | 0.91 |
| colorectal cancer | RAS_12 | SETD2 | Any mutation | 9 | 22 | Signature 10 | -1.43 | -2.90 | -0.14 | 1563.90 | 1.00 | 17 | 7 | 20 | 2 | FALSE | 1.30 |
| colorectal cancer | RAS_12 | SETD2 | Any mutation | 101 | 13 | Signature 15 | -1.64 | -3.33 | -0.25 | 1320.38 | 1.00 | 274 | 100 | 12 | 1 | FALSE | 1.46 |
| colorectal cancer | RAS_12 | SETD2 | Any mutation | 279 | 31 | Signature 1A | -1.41 | -2.47 | -0.50 | 1371.22 | 1.00 | 541 | 275 | 27 | 4 | FALSE | 2.23 |
| colorectal cancer | RAS_12 | SETD2 | Any mutation | 73 | 39 | Signature 6 | -1.51 | -2.69 | -0.45 | 1365.07 | 1.00 | 208 | 70 | 36 | 3 | FALSE | 2.06 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 14 | 16 | Signature 13 | 0.13 | -1.01 | 1.19 | 1448.81 | 1.00 | 74 | 11 | 13 | 3 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 81 | 44 | Signature 2 | 0.05 | -0.61 | 0.71 | 1446.68 | 1.00 | 223 | 70 | 33 | 11 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 51 | 15 | Signature 3 | -0.14 | -1.22 | 0.87 | 1231.63 | 1.00 | 182 | 48 | 12 | 3 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 232 | 55 | Signature 4 | -0.26 | -0.91 | 0.32 | 1335.81 | 1.00 | 435 | 217 | 40 | 15 | FALSE | 0.41 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 146 | 14 | Signature R2 | -0.08 | -0.98 | 0.84 | 1558.90 | 1.00 | 50 | 136 | 4 | 10 | FALSE | 0.06 |
| colorectal cancer | RAS_12 | SETD2 | Any mutation | 462 | 105 | Signature overall | -1.49 | -2.79 | -0.26 | 1531.49 | 1.00 | 1040 | 452 | 95 | 10 | FALSE | 1.64 |
| non-small cell lung cancer | RAS_12 | SETD2 | Any mutation | 524 | 144 | Signature overall | -0.06 | -0.91 | 0.78 | 1551.72 | 1.00 | 964 | 482 | 102 | 42 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12 | PBRM1 | Any mutation | 79 | 20 | Signature 2 | -0.21 | -1.22 | 0.73 | 1394.74 | 1.00 | 235 | 74 | 15 | 5 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12 | PBRM1 | Any mutation | 230 | 27 | Signature 4 | -0.47 | -1.37 | 0.29 | 1482.18 | 1.00 | 452 | 224 | 21 | 6 | TRUE | 0.60 |
| non-small cell lung cancer | RAS_12 | PBRM1 | Any mutation | 309 | 47 | Signature overall | -0.32 | -1.50 | 0.88 | 1467.31 | 1.00 | 687 | 298 | 36 | 11 | TRUE | 0.23 |
| colorectal cancer | RAS_12 | EPHA3 | Any mutation | 8 | 14 | Signature 10 | -0.97 | -2.65 | 0.40 | 1384.01 | 1.00 | 21 | 7 | 13 | 1 | FALSE | 0.70 |
| colorectal cancer | RAS_12 | EPHA3 | Any mutation | 101 | 13 | Signature 15 | -0.81 | -2.12 | 0.26 | 1388.48 | 1.00 | 273 | 99 | 11 | 2 | FALSE | 0.76 |
| colorectal cancer | RAS_12 | EPHA3 | Any mutation | 280 | 42 | Signature 1A | -0.26 | -0.93 | 0.37 | 1542.40 | 1.00 | 538 | 267 | 29 | 13 | FALSE | 0.37 |
| colorectal cancer | RAS_12 | EPHA3 | Any mutation | 72 | 26 | Signature 6 | -0.87 | -1.96 | 0.07 | 1835.44 | 1.00 | 218 | 69 | 23 | 3 | FALSE | 1.03 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 57 | 13 | Signature 18 | -0.25 | -1.21 | 0.67 | 1506.80 | 1.00 | 85 | 53 | 9 | 4 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 81 | 27 | Signature 2 | 0.13 | -0.64 | 0.92 | 1506.48 | 1.00 | 227 | 73 | 19 | 8 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 51 | 18 | Signature 3 | 0.52 | -0.35 | 1.42 | 1537.55 | 1.00 | 183 | 44 | 11 | 7 | FALSE | 0.60 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 233 | 112 | Signature 4 | -0.35 | -0.77 | 0.07 | 1530.06 | 1.00 | 397 | 204 | 83 | 29 | FALSE | 0.95 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 145 | 13 | Signature R2 | -0.34 | -1.21 | 0.56 | 1507.01 | 1.00 | 49 | 137 | 5 | 8 | FALSE | 0.35 |
| colorectal cancer | RAS_12 | EPHA3 | Any mutation | 461 | 95 | Signature overall | -0.73 | -1.86 | 0.37 | 1438.06 | 1.00 | 1050 | 442 | 76 | 19 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12 | EPHA3 | Any mutation | 567 | 183 | Signature overall | -0.05 | -0.80 | 0.78 | 1514.26 | 1.00 | 941 | 511 | 127 | 56 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12 | KDR | Any mutation | 79 | 12 | Signature 2 | 0.56 | -0.49 | 1.67 | 1610.18 | 1.00 | 238 | 74 | 7 | 5 | TRUE | 0.50 |
| non-small cell lung cancer | RAS_12 | KDR | Any mutation | 51 | 11 | Signature 3 | 1.05 | -0.18 | 2.22 | 1522.75 | 1.00 | 188 | 45 | 5 | 6 | TRUE | 1.09 |
| non-small cell lung cancer | RAS_12 | KDR | Any mutation | 231 | 76 | Signature 4 | -0.81 | -1.43 | -0.20 | 1431.93 | 1.00 | 414 | 218 | 63 | 13 | TRUE | 1.97 |
| non-small cell lung cancer | RAS_12 | KDR | Any mutation | 361 | 99 | Signature overall | 0.28 | -0.99 | 1.82 | 1505.68 | 1.00 | 840 | 337 | 75 | 24 | TRUE | 0.16 |
| colorectal cancer | RAS_12 | PTCH1 | Any mutation | 8 | 11 | Signature 10 | -1.14 | -2.64 | 0.28 | 1433.08 | 1.00 | 20 | 7 | 10 | 1 | TRUE | 0.95 |
| colorectal cancer | RAS_12 | PTCH1 | Any mutation | 101 | 14 | Signature 15 | -1.10 | -2.27 | 0.00 | 1354.75 | 1.00 | 275 | 99 | 12 | 2 | TRUE | 1.21 |
| colorectal cancer | RAS_12 | PTCH1 | Any mutation | 279 | 55 | Signature 1A | -0.94 | -1.60 | -0.26 | 1404.14 | 1.00 | 530 | 269 | 45 | 10 | TRUE | 2.28 |
| colorectal cancer | RAS_12 | PTCH1 | Any mutation | 73 | 53 | Signature 6 | -1.34 | -2.29 | -0.54 | 1505.95 | 1.00 | 207 | 69 | 49 | 4 | TRUE | 2.50 |
| colorectal cancer | RAS_12 | PTCH1 | Any mutation | 461 | 133 | Signature overall | -1.14 | -2.17 | -0.11 | 1621.90 | 1.00 | 1032 | 444 | 116 | 17 | TRUE | 1.60 |
| colorectal cancer | RAS_12 | TET1 | Any mutation | 8 | 27 | Signature 10 | -2.08 | -4.10 | -0.54 | 1685.97 | 1.00 | 16 | 7 | 26 | 1 | FALSE | 1.67 |
| colorectal cancer | RAS_12 | TET1 | Any mutation | 97 | 18 | Signature 15 | -2.66 | -5.47 | -0.81 | 1520.84 | 1.00 | 266 | 97 | 18 | 0 | FALSE | 1.57 |
| colorectal cancer | RAS_12 | TET1 | Any mutation | 270 | 25 | Signature 1A | -0.66 | -1.69 | 0.20 | 1450.62 | 1.00 | 534 | 264 | 19 | 6 | FALSE | 0.73 |
| colorectal cancer | RAS_12 | TET1 | Any mutation | 69 | 28 | Signature 6 | -0.57 | -1.62 | 0.39 | 1459.49 | 1.00 | 214 | 64 | 23 | 5 | FALSE | 0.54 |
| non-small cell lung cancer | RAS_12 | TET1 | Any mutation | 79 | 12 | Signature 2 | 1.07 | -0.15 | 2.37 | 1469.57 | 1.00 | 238 | 72 | 5 | 7 | FALSE | 1.06 |
| non-small cell lung cancer | RAS_12 | TET1 | Any mutation | 232 | 60 | Signature 4 | -0.41 | -1.02 | 0.17 | 1528.08 | 1.00 | 432 | 218 | 46 | 14 | FALSE | 0.73 |
| colorectal cancer | RAS_12 | TET1 | Any mutation | 444 | 98 | Signature overall | -1.45 | -3.19 | 0.07 | 1440.82 | 1.00 | 1030 | 432 | 86 | 12 | FALSE | 1.05 |
| non-small cell lung cancer | RAS_12 | TET1 | Any mutation | 311 | 72 | Signature overall | 0.33 | -1.64 | 2.49 | 1500.97 | 1.00 | 670 | 290 | 51 | 21 | FALSE | 0.13 |
| uterine cancer | RAS_12 | FGFR2 | Any mutation | 36 | 26 | Signature 1A | -2.59 | -5.13 | -0.69 | 1059.05 | 1.00 | 161 | 35 | 25 | 1 | TRUE | 1.61 |
| uterine cancer | RAS_12 | FGFR2 | Any mutation | 13 | 22 | Signature 6 | -3.00 | -6.56 | -0.75 | 1294.83 | 1.00 | 66 | 13 | 22 | 0 | TRUE | 1.39 |
| uterine cancer | RAS_12 | FGFR2 | Any mutation | 49 | 48 | Signature overall | -2.74 | -5.51 | -0.53 | 1249.35 | 1.00 | 227 | 48 | 47 | 1 | TRUE | 1.46 |
| non-small cell lung cancer | RAS_12 | TBX3 | Any mutation | 230 | 75 | Signature 4 | -1.01 | -1.64 | -0.43 | 1590.49 | 1.00 | 417 | 218 | 63 | 12 | FALSE | 2.96 |
| non-small cell lung cancer | RAS_12 | TBX3 | Any mutation | 144 | 15 | Signature R2 | -0.41 | -1.40 | 0.64 | 1610.27 | 1.00 | 50 | 134 | 5 | 10 | FALSE | 0.36 |
| non-small cell lung cancer | RAS_12 | TBX3 | Any mutation | 374 | 90 | Signature overall | -0.74 | -2.49 | 1.20 | 1560.85 | 1.00 | 467 | 352 | 68 | 22 | FALSE | 0.39 |
| colorectal cancer | RAS_12 | SMAD3 | Any mutation | 104 | 21 | Signature 15 | 0.30 | -0.33 | 0.91 | 1352.46 | 1.00 | 271 | 97 | 14 | 7 | TRUE | 0.48 |
| colorectal cancer | RAS_12 | SMAD3 | Any mutation | 283 | 38 | Signature 1A | 0.26 | -0.24 | 0.78 | 1514.90 | 1.00 | 544 | 268 | 23 | 15 | TRUE | 0.49 |
| colorectal cancer | RAS_12 | SMAD3 | Any mutation | 73 | 20 | Signature 6 | 0.32 | -0.35 | 0.95 | 1527.33 | 1.00 | 225 | 67 | 14 | 6 | TRUE | 0.47 |
| colorectal cancer | RAS_12 | SMAD3 | Any mutation | 460 | 79 | Signature overall | 0.29 | -0.30 | 0.88 | 1369.85 | 1.00 | 1040 | 432 | 51 | 28 | TRUE | 0.48 |
| non-small cell lung cancer | RAS_12 | NTRK3 | Any mutation | 80 | 15 | Signature 2 | 0.81 | -0.19 | 1.80 | 1642.67 | 1.00 | 238 | 73 | 8 | 7 | FALSE | 0.95 |
| non-small cell lung cancer | RAS_12 | NTRK3 | Any mutation | 50 | 14 | Signature 3 | 0.67 | -0.38 | 1.68 | 1445.04 | 1.00 | 185 | 45 | 9 | 5 | FALSE | 0.69 |
| non-small cell lung cancer | RAS_12 | NTRK3 | Any mutation | 234 | 105 | Signature 4 | -0.35 | -0.83 | 0.10 | 1598.93 | 1.00 | 410 | 208 | 79 | 26 | FALSE | 0.87 |
| non-small cell lung cancer | RAS_12 | NTRK3 | Any mutation | 145 | 18 | Signature R2 | 0.92 | -0.11 | 2.13 | 1316.92 | 1.00 | 52 | 129 | 2 | 16 | FALSE | 0.98 |
| non-small cell lung cancer | RAS_12 | NTRK3 | Any mutation | 509 | 152 | Signature overall | 0.51 | -0.53 | 1.71 | 1603.12 | 1.00 | 885 | 455 | 98 | 54 | FALSE | 0.44 |
| colorectal cancer | RAS_12 | GRIN2A | Any mutation | 8 | 18 | Signature 10 | -1.28 | -3.01 | 0.14 | 1554.59 | 1.00 | 17 | 7 | 17 | 1 | FALSE | 0.97 |
| colorectal cancer | RAS_12 | GRIN2A | Any mutation | 101 | 12 | Signature 15 | -0.48 | -1.74 | 0.70 | 1428.79 | 1.00 | 278 | 98 | 9 | 3 | FALSE | 0.36 |
| colorectal cancer | RAS_12 | GRIN2A | Any mutation | 280 | 43 | Signature 1A | -0.60 | -1.37 | 0.07 | 1581.11 | 1.00 | 533 | 270 | 33 | 10 | FALSE | 1.00 |
| colorectal cancer | RAS_12 | GRIN2A | Any mutation | 72 | 43 | Signature 6 | -0.74 | -1.64 | 0.07 | 1468.22 | 1.00 | 205 | 66 | 37 | 6 | FALSE | 1.06 |
| non-small cell lung cancer | RAS_12 | GRIN2A | Any mutation | 79 | 15 | Signature 2 | -0.52 | -1.70 | 0.59 | 1504.37 | 1.00 | 233 | 76 | 12 | 3 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12 | GRIN2A | Any mutation | 232 | 76 | Signature 4 | -0.68 | -1.27 | -0.14 | 1467.04 | 1.00 | 418 | 216 | 60 | 16 | FALSE | 1.69 |
| non-small cell lung cancer | RAS_12 | GRIN2A | Any mutation | 144 | 13 | Signature R2 | -0.77 | -1.77 | 0.25 | 1507.09 | 1.00 | 48 | 137 | 6 | 7 | FALSE | 0.88 |
| colorectal cancer | RAS_12 | GRIN2A | Any mutation | 461 | 116 | Signature overall | -0.77 | -1.95 | 0.41 | 1573.16 | 1.00 | 1033 | 441 | 96 | 20 | FALSE | 0.72 |
| non-small cell lung cancer | RAS_12 | GRIN2A | Any mutation | 455 | 104 | Signature overall | -0.65 | -1.88 | 0.62 | 1573.93 | 1.00 | 699 | 429 | 78 | 26 | FALSE | 0.52 |
| uterine cancer | RAS_12 | CTCF | Any mutation | 19 | 18 | Signature 15 | 0.32 | -0.71 | 1.27 | 1523.98 | 1.00 | 78 | 14 | 13 | 5 | FALSE | 0.27 |
| uterine cancer | RAS_12 | CTCF | Any mutation | 37 | 49 | Signature 1A | 0.31 | -0.38 | 1.05 | 1421.86 | 1.00 | 148 | 26 | 38 | 11 | FALSE | 0.39 |
| uterine cancer | RAS_12 | CTCF | Any mutation | 13 | 40 | Signature 6 | -0.43 | -1.58 | 0.60 | 1493.39 | 1.00 | 51 | 10 | 37 | 3 | FALSE | 0.36 |
| uterine cancer | RAS_12 | CTCF | Any mutation | 70 | 123 | Signature overall | -0.04 | -1.08 | 0.95 | 1507.41 | 1.00 | 301 | 51 | 104 | 19 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 22 | 11 | Signature 11 | 1.56 | 0.63 | 2.60 | 1485.63 | 1.00 | 21 | 12 | 1 | 10 | TRUE | 2.81 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 20 | 19 | Signature 15 | 0.79 | -0.06 | 1.63 | 1411.38 | 1.00 | 102 | 15 | 14 | 5 | TRUE | 1.15 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 8 | 11 | Signature 16 | 0.64 | -0.33 | 1.62 | 1301.70 | 1.00 | 43 | 6 | 9 | 2 | TRUE | 0.68 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 58 | 38 | Signature 18 | 0.49 | -0.15 | 1.15 | 1527.21 | 1.00 | 72 | 42 | 22 | 16 | TRUE | 0.87 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 15 | 17 | Signature 19 | 0.88 | -0.02 | 1.81 | 1442.07 | 1.00 | 37 | 9 | 11 | 6 | TRUE | 1.28 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 44 | 21 | Signature 1A | 1.54 | 0.78 | 2.30 | 1621.20 | 1.00 | 213 | 32 | 9 | 12 | TRUE | 4.08 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 80 | 55 | Signature 2 | 0.26 | -0.35 | 0.84 | 1530.11 | 1.00 | 212 | 66 | 41 | 14 | TRUE | 0.40 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 13 | 13 | Signature 20 | 1.26 | 0.33 | 2.19 | 1673.11 | 1.00 | 57 | 7 | 7 | 6 | TRUE | 2.04 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 50 | 37 | Signature 3 | 0.77 | 0.12 | 1.39 | 1588.07 | 1.00 | 168 | 38 | 25 | 12 | TRUE | 1.66 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 231 | 163 | Signature 4 | 0.37 | 0.01 | 0.72 | 1535.89 | 1.00 | 372 | 169 | 101 | 62 | TRUE | 1.38 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 27 | 13 | Signature 8 | 0.98 | 0.10 | 1.85 | 1376.91 | 1.00 | 32 | 19 | 5 | 8 | TRUE | 1.55 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 145 | 61 | Signature R2 | 0.75 | 0.15 | 1.36 | 1466.87 | 1.00 | 41 | 97 | 13 | 48 | TRUE | 1.85 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 17 | 13 | Signature U1 | 1.25 | 0.34 | 2.15 | 1643.00 | 1.00 | 87 | 11 | 7 | 6 | TRUE | 2.13 |
| non-small cell lung cancer | RAS_12 | STK11 | Any mutation | 730 | 472 | Signature overall | 0.88 | 0.41 | 1.32 | 1560.80 | 1.00 | 1457 | 523 | 265 | 207 | TRUE | 3.78 |
| colorectal cancer | RAS_12 | ASXL1 | Any mutation | 8 | 11 | Signature 10 | -1.90 | -4.74 | -0.14 | 1373.65 | 1.00 | 17 | 8 | 11 | 0 | TRUE | 0.97 |
| colorectal cancer | RAS_12 | ASXL1 | Any mutation | 101 | 14 | Signature 15 | -2.09 | -4.77 | -0.44 | 1485.49 | 1.00 | 272 | 101 | 14 | 0 | TRUE | 1.19 |
| colorectal cancer | RAS_12 | ASXL1 | Any mutation | 279 | 31 | Signature 1A | -0.55 | -1.42 | 0.19 | 1493.88 | 1.00 | 545 | 271 | 23 | 8 | TRUE | 0.76 |
| colorectal cancer | RAS_12 | ASXL1 | Any mutation | 74 | 34 | Signature 6 | -0.21 | -1.07 | 0.57 | 1298.57 | 1.00 | 216 | 66 | 26 | 8 | TRUE | 0.21 |
| colorectal cancer | RAS_12 | ASXL1 | Any mutation | 462 | 90 | Signature overall | -1.16 | -2.80 | 0.16 | 1564.01 | 1.00 | 1050 | 446 | 74 | 16 | TRUE | 0.89 |
| colorectal cancer | RAS_12 | EP300 | Any mutation | 101 | 18 | Signature 15 | -0.96 | -2.03 | 0.03 | 1508.30 | 1.00 | 272 | 99 | 16 | 2 | TRUE | 1.14 |
| colorectal cancer | RAS_12 | EP300 | Any mutation | 279 | 36 | Signature 1A | -0.58 | -1.37 | 0.14 | 1442.47 | 1.00 | 541 | 270 | 27 | 9 | TRUE | 0.92 |
| colorectal cancer | RAS_12 | EP300 | Any mutation | 74 | 51 | Signature 6 | -0.70 | -1.45 | 0.02 | 1371.31 | 1.00 | 208 | 67 | 44 | 7 | TRUE | 1.22 |
| non-small cell lung cancer | RAS_12 | EP300 | Any mutation | 13 | 11 | Signature 13 | -0.14 | -1.48 | 1.20 | 1608.44 | 1.00 | 78 | 11 | 9 | 2 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12 | EP300 | Any mutation | 79 | 20 | Signature 2 | -1.01 | -2.45 | 0.09 | 1582.93 | 1.00 | 232 | 78 | 19 | 1 | TRUE | 0.90 |
| non-small cell lung cancer | RAS_12 | EP300 | Any mutation | 231 | 30 | Signature 4 | -0.02 | -0.80 | 0.74 | 1662.19 | 1.00 | 453 | 220 | 19 | 11 | TRUE | 0.02 |
| uterine cancer | RAS_12 | EP300 | Any mutation | 37 | 21 | Signature 1A | -0.24 | -1.56 | 0.89 | 1500.93 | 1.00 | 165 | 34 | 18 | 3 | TRUE | 0.16 |
| uterine cancer | RAS_12 | EP300 | Any mutation | 13 | 20 | Signature 6 | 0.07 | -1.32 | 1.36 | 1449.56 | 1.00 | 70 | 10 | 17 | 3 | TRUE | 0.04 |
| colorectal cancer | RAS_12 | EP300 | Any mutation | 454 | 105 | Signature overall | -0.73 | -1.70 | 0.25 | 1397.46 | 1.00 | 1021 | 436 | 87 | 18 | TRUE | 0.85 |
| non-small cell lung cancer | RAS_12 | EP300 | Any mutation | 323 | 61 | Signature overall | -0.35 | -1.55 | 0.84 | 1391.15 | 1.00 | 763 | 309 | 47 | 14 | TRUE | 0.25 |
| uterine cancer | RAS_12 | EP300 | Any mutation | 52 | 74 | Signature overall | 0.06 | -1.71 | 1.96 | 1536.90 | 1.00 | 256 | 44 | 66 | 8 | TRUE | 0.02 |
| colorectal cancer | RAS_12 | ERBB4 | Any mutation | 8 | 18 | Signature 10 | -0.97 | -2.67 | 0.34 | 1398.65 | 1.00 | 18 | 7 | 17 | 1 | TRUE | 0.70 |
| colorectal cancer | RAS_12 | ERBB4 | Any mutation | 102 | 23 | Signature 15 | -0.38 | -1.34 | 0.50 | 1445.00 | 1.00 | 268 | 97 | 18 | 5 | TRUE | 0.39 |
| colorectal cancer | RAS_12 | ERBB4 | Any mutation | 280 | 43 | Signature 1A | -0.13 | -0.79 | 0.50 | 1351.64 | 1.00 | 539 | 266 | 29 | 14 | TRUE | 0.16 |
| colorectal cancer | RAS_12 | ERBB4 | Any mutation | 72 | 31 | Signature 6 | -0.16 | -1.07 | 0.67 | 1614.25 | 1.00 | 219 | 65 | 24 | 7 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12 | ERBB4 | Any mutation | 44 | 11 | Signature 1A | -0.03 | -1.20 | 1.22 | 1631.65 | 1.00 | 214 | 41 | 8 | 3 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12 | ERBB4 | Any mutation | 79 | 17 | Signature 2 | -0.71 | -1.91 | 0.36 | 1589.93 | 1.00 | 233 | 77 | 15 | 2 | TRUE | 0.65 |
| non-small cell lung cancer | RAS_12 | ERBB4 | Any mutation | 233 | 97 | Signature 4 | -0.52 | -1.04 | -0.03 | 1558.28 | 1.00 | 413 | 211 | 75 | 22 | TRUE | 1.38 |
| colorectal cancer | RAS_12 | ERBB4 | Any mutation | 462 | 115 | Signature overall | -0.41 | -1.50 | 0.56 | 1639.72 | 1.00 | 1044 | 435 | 88 | 27 | TRUE | 0.35 |
| non-small cell lung cancer | RAS_12 | ERBB4 | Any mutation | 356 | 125 | Signature overall | -0.42 | -1.50 | 0.72 | 1568.43 | 1.00 | 860 | 329 | 98 | 27 | TRUE | 0.34 |
| colorectal cancer | RAS_12 | MED12 | Any mutation | 101 | 11 | Signature 15 | -0.65 | -1.92 | 0.50 | 1460.50 | 1.00 | 276 | 99 | 9 | 2 | TRUE | 0.52 |
| colorectal cancer | RAS_12 | MED12 | Any mutation | 280 | 34 | Signature 1A | 0.02 | -0.68 | 0.72 | 1632.65 | 1.00 | 547 | 267 | 21 | 13 | TRUE | 0.02 |
| colorectal cancer | RAS_12 | MED12 | Any mutation | 73 | 42 | Signature 6 | -1.18 | -2.27 | -0.22 | 1552.25 | 1.00 | 210 | 70 | 39 | 3 | TRUE | 1.60 |
| non-small cell lung cancer | RAS_12 | MED12 | Any mutation | 79 | 25 | Signature 2 | -0.41 | -1.25 | 0.53 | 1367.19 | 1.00 | 227 | 73 | 19 | 6 | TRUE | 0.43 |
| non-small cell lung cancer | RAS_12 | MED12 | Any mutation | 231 | 72 | Signature 4 | -0.84 | -1.46 | -0.27 | 1330.26 | 1.00 | 421 | 219 | 60 | 12 | TRUE | 2.17 |
| uterine cancer | RAS_12 | MED12 | Any mutation | 19 | 13 | Signature 15 | -0.75 | -2.47 | 0.64 | 1549.96 | 1.00 | 78 | 17 | 11 | 2 | TRUE | 0.44 |
| uterine cancer | RAS_12 | MED12 | Any mutation | 36 | 18 | Signature 1A | -1.51 | -3.68 | 0.02 | 1415.91 | 1.00 | 167 | 35 | 17 | 1 | TRUE | 1.00 |
| uterine cancer | RAS_12 | MED12 | Any mutation | 13 | 14 | Signature 6 | -1.24 | -3.44 | 0.46 | 1621.29 | 1.00 | 75 | 12 | 13 | 1 | TRUE | 0.70 |
| colorectal cancer | RAS_12 | MED12 | Any mutation | 454 | 87 | Signature overall | -0.59 | -1.92 | 0.72 | 1460.93 | 1.00 | 1033 | 436 | 69 | 18 | TRUE | 0.44 |
| non-small cell lung cancer | RAS_12 | MED12 | Any mutation | 310 | 97 | Signature overall | -0.62 | -1.61 | 0.61 | 1278.02 | 1.00 | 648 | 292 | 79 | 18 | TRUE | 0.56 |
| uterine cancer | RAS_12 | MED12 | Any mutation | 69 | 87 | Signature overall | -1.36 | -3.29 | 0.30 | 1515.95 | 1.00 | 337 | 65 | 83 | 4 | TRUE | 0.88 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 13 | 11 | Signature 13 | 0.65 | -0.33 | 1.67 | 1456.54 | 1.00 | 78 | 10 | 8 | 3 | FALSE | 0.72 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 21 | 11 | Signature 15 | 0.59 | -0.44 | 1.54 | 1501.72 | 1.00 | 109 | 18 | 8 | 3 | FALSE | 0.62 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 58 | 17 | Signature 18 | 0.61 | -0.17 | 1.35 | 1655.02 | 1.00 | 85 | 49 | 8 | 9 | FALSE | 0.93 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 44 | 21 | Signature 1A | 0.28 | -0.57 | 1.07 | 1429.17 | 1.00 | 205 | 40 | 17 | 4 | FALSE | 0.29 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 79 | 32 | Signature 2 | 0.83 | 0.15 | 1.50 | 1207.77 | 1.00 | 227 | 65 | 18 | 14 | FALSE | 1.84 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 52 | 30 | Signature 3 | 0.52 | -0.21 | 1.21 | 1495.64 | 1.00 | 173 | 43 | 21 | 9 | FALSE | 0.84 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 234 | 128 | Signature 4 | 0.53 | 0.15 | 0.90 | 1488.64 | 1.00 | 405 | 180 | 74 | 54 | FALSE | 2.20 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 144 | 20 | Signature R2 | 0.34 | -0.41 | 1.08 | 1548.22 | 1.00 | 49 | 129 | 5 | 15 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 17 | 15 | Signature U1 | 0.43 | -0.51 | 1.28 | 1459.14 | 1.00 | 83 | 14 | 12 | 3 | FALSE | 0.44 |
| non-small cell lung cancer | RAS_12 | RBM10 | Any mutation | 662 | 285 | Signature overall | 0.53 | 0.01 | 1.09 | 1578.16 | 1.00 | 1414 | 548 | 171 | 114 | FALSE | 1.28 |
| colorectal cancer | RAS_12 | NF1 | Any mutation | 8 | 24 | Signature 10 | -1.80 | -3.56 | -0.33 | 1372.99 | 1.00 | 17 | 7 | 23 | 1 | TRUE | 1.60 |
| colorectal cancer | RAS_12 | NF1 | Any mutation | 101 | 21 | Signature 15 | -1.41 | -2.81 | -0.26 | 1486.90 | 1.00 | 269 | 99 | 19 | 2 | TRUE | 1.49 |
| colorectal cancer | RAS_12 | NF1 | Any mutation | 281 | 40 | Signature 1A | -0.34 | -1.07 | 0.35 | 1445.72 | 1.00 | 541 | 269 | 28 | 12 | TRUE | 0.45 |
| colorectal cancer | RAS_12 | NF1 | Any mutation | 72 | 44 | Signature 6 | -1.84 | -3.22 | -0.77 | 1286.78 | 1.00 | 208 | 70 | 42 | 2 | TRUE | 2.54 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 57 | 13 | Signature 18 | -0.16 | -1.14 | 0.76 | 1353.38 | 1.00 | 87 | 51 | 7 | 6 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 44 | 13 | Signature 1A | -0.64 | -1.79 | 0.39 | 1459.41 | 1.00 | 211 | 42 | 11 | 2 | TRUE | 0.58 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 81 | 39 | Signature 2 | -0.58 | -1.42 | 0.19 | 1662.28 | 1.00 | 216 | 74 | 32 | 7 | TRUE | 0.84 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 13 | 13 | Signature 20 | -0.90 | -2.14 | 0.26 | 1519.66 | 1.00 | 53 | 12 | 12 | 1 | TRUE | 0.83 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 50 | 15 | Signature 3 | -1.07 | -2.21 | 0.03 | 1433.50 | 1.00 | 180 | 49 | 14 | 1 | TRUE | 1.18 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 231 | 113 | Signature 4 | -0.89 | -1.38 | -0.40 | 1537.58 | 1.00 | 403 | 211 | 93 | 20 | TRUE | 3.56 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 21 | 11 | Signature 7 | -1.23 | -2.64 | 0.03 | 1528.32 | 1.00 | 76 | 21 | 11 | 0 | TRUE | 1.18 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 145 | 12 | Signature R2 | -0.90 | -1.78 | -0.03 | 1412.85 | 1.00 | 48 | 139 | 6 | 6 | TRUE | 1.36 |
| uterine cancer | RAS_12 | NF1 | Any mutation | 36 | 21 | Signature 1A | -0.33 | -1.75 | 0.86 | 1537.04 | 1.00 | 170 | 33 | 18 | 3 | TRUE | 0.21 |
| uterine cancer | RAS_12 | NF1 | Any mutation | 13 | 24 | Signature 6 | -0.68 | -2.31 | 0.72 | 1660.83 | 1.00 | 67 | 11 | 22 | 2 | TRUE | 0.43 |
| colorectal cancer | RAS_12 | NF1 | Any mutation | 462 | 129 | Signature overall | -1.35 | -2.64 | -0.10 | 1409.42 | 1.00 | 1035 | 445 | 112 | 17 | TRUE | 1.41 |
| non-small cell lung cancer | RAS_12 | NF1 | Any mutation | 642 | 229 | Signature overall | -0.80 | -1.47 | -0.13 | 1621.46 | 1.00 | 1274 | 599 | 186 | 43 | TRUE | 1.71 |
| uterine cancer | RAS_12 | NF1 | Any mutation | 50 | 92 | Signature overall | -0.42 | -2.37 | 1.88 | 1532.10 | 1.00 | 255 | 44 | 86 | 6 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12 | FLT1 | Any mutation | 58 | 13 | Signature 18 | 0.42 | -0.42 | 1.42 | 1436.81 | 1.00 | 87 | 51 | 6 | 7 | FALSE | 0.46 |
| non-small cell lung cancer | RAS_12 | FLT1 | Any mutation | 79 | 12 | Signature 2 | 0.34 | -0.51 | 1.26 | 1310.60 | 1.00 | 238 | 74 | 7 | 5 | FALSE | 0.34 |
| non-small cell lung cancer | RAS_12 | FLT1 | Any mutation | 233 | 64 | Signature 4 | -0.09 | -0.61 | 0.43 | 1307.78 | 1.00 | 433 | 215 | 46 | 18 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12 | FLT1 | Any mutation | 370 | 89 | Signature overall | 0.22 | -0.65 | 1.13 | 1416.28 | 1.00 | 758 | 340 | 59 | 30 | FALSE | 0.22 |
| uterine cancer | RAS_12 | RASA1 | Any mutation | 36 | 20 | Signature 1A | -2.44 | -5.64 | -0.26 | 1597.18 | 1.00 | 169 | 35 | 19 | 1 | FALSE | 1.16 |
| uterine cancer | RAS_12 | RASA1 | Any mutation | 13 | 12 | Signature 6 | -3.78 | -9.13 | -0.41 | 1432.76 | 1.00 | 74 | 13 | 12 | 0 | FALSE | 1.07 |
| uterine cancer | RAS_12 | RASA1 | Any mutation | 50 | 78 | Signature overall | -3.16 | -6.80 | -0.20 | 1481.06 | 1.00 | 260 | 49 | 77 | 1 | FALSE | 1.22 |
| colorectal cancer | RAS_12 | EPHA5 | Any mutation | 8 | 26 | Signature 10 | -2.66 | -5.43 | -0.77 | 1537.80 | 1.00 | 15 | 8 | 26 | 0 | FALSE | 1.67 |
| colorectal cancer | RAS_12 | EPHA5 | Any mutation | 101 | 18 | Signature 15 | -0.87 | -2.19 | 0.32 | 1326.20 | 1.00 | 273 | 98 | 15 | 3 | FALSE | 0.77 |
| colorectal cancer | RAS_12 | EPHA5 | Any mutation | 280 | 49 | Signature 1A | 0.05 | -0.58 | 0.65 | 1618.08 | 1.00 | 536 | 262 | 31 | 18 | FALSE | 0.06 |
| colorectal cancer | RAS_12 | EPHA5 | Any mutation | 72 | 36 | Signature 6 | -1.37 | -2.57 | -0.30 | 1634.01 | 1.00 | 211 | 69 | 33 | 3 | FALSE | 1.75 |
| non-small cell lung cancer | RAS_12 | EPHA5 | Any mutation | 58 | 24 | Signature 18 | 0.04 | -0.78 | 0.78 | 1347.24 | 1.00 | 79 | 49 | 15 | 9 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12 | EPHA5 | Any mutation | 79 | 30 | Signature 2 | 0.21 | -0.56 | 0.96 | 1255.55 | 1.00 | 227 | 70 | 21 | 9 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12 | EPHA5 | Any mutation | 50 | 19 | Signature 3 | 0.53 | -0.39 | 1.42 | 1575.52 | 1.00 | 184 | 43 | 12 | 7 | FALSE | 0.61 |
| non-small cell lung cancer | RAS_12 | EPHA5 | Any mutation | 233 | 109 | Signature 4 | 0.00 | -0.43 | 0.43 | 1454.16 | 1.00 | 410 | 198 | 74 | 35 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12 | EPHA5 | Any mutation | 144 | 12 | Signature R2 | -0.37 | -1.31 | 0.49 | 1321.77 | 1.00 | 50 | 137 | 5 | 7 | FALSE | 0.39 |
| colorectal cancer | RAS_12 | EPHA5 | Any mutation | 461 | 129 | Signature overall | -1.18 | -2.73 | 0.25 | 1681.39 | 1.00 | 1035 | 437 | 105 | 24 | FALSE | 0.94 |
| non-small cell lung cancer | RAS_12 | EPHA5 | Any mutation | 564 | 194 | Signature overall | 0.09 | -0.68 | 0.86 | 1288.44 | 1.00 | 950 | 497 | 127 | 67 | FALSE | 0.09 |
| colorectal cancer | RAS_12 | AR | Any mutation | 101 | 21 | Signature 15 | -0.96 | -1.91 | -0.09 | 1385.23 | 1.00 | 269 | 99 | 19 | 2 | TRUE | 1.39 |
| colorectal cancer | RAS_12 | AR | Any mutation | 279 | 33 | Signature 1A | -0.76 | -1.53 | -0.05 | 1412.21 | 1.00 | 540 | 272 | 26 | 7 | TRUE | 1.38 |
| colorectal cancer | RAS_12 | AR | Any mutation | 72 | 37 | Signature 6 | -0.63 | -1.43 | 0.16 | 1249.88 | 1.00 | 213 | 66 | 31 | 6 | TRUE | 0.95 |
| non-small cell lung cancer | RAS_12 | AR | Any mutation | 232 | 56 | Signature 4 | -0.26 | -0.89 | 0.36 | 1286.26 | 1.00 | 437 | 216 | 40 | 16 | TRUE | 0.38 |
| colorectal cancer | RAS_12 | AR | Any mutation | 452 | 91 | Signature overall | -0.77 | -1.59 | 0.02 | 1412.23 | 1.00 | 1022 | 437 | 76 | 15 | TRUE | 1.18 |
| non-small cell lung cancer | RAS_12 | AR | Any mutation | 232 | 56 | Signature overall | -0.19 | -4.34 | 4.22 | 1425.46 | 1.00 | 437 | 216 | 40 | 16 | TRUE | 0.03 |
| colorectal cancer | RAS_12 | ROS1 | Any mutation | 8 | 30 | Signature 10 | -2.26 | -4.27 | -0.63 | 1407.81 | 1.00 | 16 | 7 | 29 | 1 | TRUE | 1.82 |
| colorectal cancer | RAS_12 | ROS1 | Any mutation | 279 | 28 | Signature 1A | -1.30 | -2.41 | -0.35 | 1388.11 | 1.00 | 544 | 275 | 24 | 4 | TRUE | 1.86 |
| colorectal cancer | RAS_12 | ROS1 | Any mutation | 72 | 26 | Signature 6 | -1.14 | -2.43 | 0.01 | 1401.86 | 1.00 | 216 | 69 | 23 | 3 | TRUE | 1.17 |
| non-small cell lung cancer | RAS_12 | ROS1 | Any mutation | 79 | 14 | Signature 2 | -1.89 | -3.44 | -0.58 | 1451.85 | 1.00 | 233 | 78 | 13 | 1 | TRUE | 2.04 |
| non-small cell lung cancer | RAS_12 | ROS1 | Any mutation | 230 | 42 | Signature 4 | -1.95 | -3.14 | -0.99 | 1373.54 | 1.00 | 435 | 227 | 39 | 3 | TRUE | 3.39 |
| colorectal cancer | RAS_12 | ROS1 | Any mutation | 359 | 84 | Signature overall | -1.55 | -3.57 | 0.26 | 1315.60 | 1.00 | 776 | 351 | 76 | 8 | TRUE | 0.99 |
| non-small cell lung cancer | RAS_12 | ROS1 | Any mutation | 309 | 56 | Signature overall | -1.91 | -3.46 | -0.65 | 1403.32 | 1.00 | 668 | 305 | 52 | 4 | TRUE | 2.10 |
| colorectal cancer | RAS_12 | PIK3CG | Any mutation | 10 | 22 | Signature 10 | -0.31 | -1.56 | 0.90 | 1384.66 | 1.00 | 16 | 6 | 18 | 4 | FALSE | 0.21 |
| colorectal cancer | RAS_12 | PIK3CG | Any mutation | 101 | 17 | Signature 15 | 0.18 | -0.80 | 1.13 | 1460.16 | 1.00 | 275 | 95 | 11 | 6 | FALSE | 0.14 |
| colorectal cancer | RAS_12 | PIK3CG | Any mutation | 279 | 29 | Signature 1A | -0.86 | -1.81 | -0.01 | 1564.84 | 1.00 | 542 | 274 | 24 | 5 | FALSE | 1.23 |
| colorectal cancer | RAS_12 | PIK3CG | Any mutation | 72 | 29 | Signature 6 | -0.23 | -1.10 | 0.64 | 1200.58 | 1.00 | 219 | 66 | 23 | 6 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12 | PIK3CG | Any mutation | 13 | 13 | Signature 13 | -0.60 | -2.46 | 0.85 | 1565.17 | 1.00 | 74 | 12 | 12 | 1 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12 | PIK3CG | Any mutation | 81 | 18 | Signature 2 | 1.06 | 0.15 | 1.94 | 1388.09 | 1.00 | 237 | 71 | 8 | 10 | FALSE | 1.62 |
| non-small cell lung cancer | RAS_12 | PIK3CG | Any mutation | 231 | 75 | Signature 4 | -0.31 | -0.88 | 0.21 | 1423.99 | 1.00 | 423 | 211 | 55 | 20 | FALSE | 0.60 |
| non-small cell lung cancer | RAS_12 | PIK3CG | Any mutation | 144 | 12 | Signature R2 | -1.06 | -2.20 | 0.06 | 1363.53 | 1.00 | 48 | 139 | 7 | 5 | FALSE | 1.21 |
| colorectal cancer | RAS_12 | PIK3CG | Any mutation | 462 | 97 | Signature overall | -0.28 | -1.45 | 1.00 | 1489.50 | 1.00 | 1052 | 441 | 76 | 21 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12 | PIK3CG | Any mutation | 469 | 118 | Signature overall | -0.22 | -1.54 | 1.16 | 1570.65 | 1.00 | 782 | 433 | 82 | 36 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 13 | 23 | Signature 13 | -3.24 | -4.35 | -2.15 | 1458.66 | 1.00 | 65 | 12 | 22 | 1 | TRUE | 8.29 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 17 | 12 | Signature 14 | -3.24 | -4.24 | -2.19 | 1364.61 | 1.00 | 30 | 16 | 11 | 1 | TRUE | 8.94 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 20 | 54 | Signature 15 | -3.49 | -4.56 | -2.52 | 1476.40 | 1.00 | 71 | 20 | 54 | 0 | TRUE | 10.18 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 8 | 19 | Signature 16 | -3.45 | -4.60 | -2.41 | 1412.09 | 1.00 | 34 | 8 | 19 | 0 | TRUE | 9.06 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 57 | 29 | Signature 18 | -3.55 | -4.60 | -2.60 | 1449.22 | 1.00 | 68 | 57 | 29 | 0 | TRUE | 11.16 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 14 | 16 | Signature 19 | -3.44 | -4.54 | -2.42 | 1355.33 | 1.00 | 33 | 14 | 16 | 0 | TRUE | 9.40 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 44 | 197 | Signature 1A | -3.81 | -4.85 | -2.92 | 1417.69 | 1.00 | 97 | 44 | 197 | 0 | TRUE | 14.16 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 79 | 79 | Signature 2 | -3.42 | -4.41 | -2.50 | 1403.48 | 1.00 | 183 | 78 | 78 | 1 | TRUE | 11.64 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 13 | 35 | Signature 20 | -3.48 | -4.54 | -2.48 | 1398.65 | 1.00 | 36 | 13 | 35 | 0 | TRUE | 9.87 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 9 | 29 | Signature 21 | -3.47 | -4.64 | -2.47 | 1385.19 | 1.00 | 31 | 9 | 29 | 0 | TRUE | 9.93 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 50 | 89 | Signature 3 | -3.12 | -4.03 | -2.25 | 1448.59 | 1.00 | 115 | 47 | 86 | 3 | TRUE | 10.87 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 230 | 114 | Signature 4 | -2.81 | -3.62 | -2.05 | 1568.83 | 1.00 | 386 | 223 | 107 | 7 | TRUE | 11.65 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 11 | 18 | Signature 6 | -3.46 | -4.55 | -2.40 | 1493.32 | 1.00 | 29 | 11 | 18 | 0 | TRUE | 9.20 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 21 | 34 | Signature 7 | -3.52 | -4.63 | -2.46 | 1482.04 | 1.00 | 57 | 21 | 34 | 0 | TRUE | 9.56 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 26 | 14 | Signature 8 | -3.29 | -4.33 | -2.28 | 1364.10 | 1.00 | 25 | 25 | 13 | 1 | TRUE | 9.59 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 6 | 11 | Signature R3 | -3.43 | -4.56 | -2.41 | 1453.57 | 1.00 | 15 | 6 | 11 | 0 | TRUE | 9.39 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 17 | 46 | Signature U1 | -3.51 | -4.62 | -2.56 | 1468.34 | 1.00 | 53 | 17 | 46 | 0 | TRUE | 10.40 |
| non-small cell lung cancer | RAS_12 | EGFR | Any mutation | 641 | 853 | Signature overall | -3.40 | -4.03 | -2.81 | 1366.82 | 1.00 | 1371 | 627 | 839 | 14 | TRUE | 25.75 |
| colorectal cancer | RAS_12 | ARID1B | Any mutation | 101 | 22 | Signature 15 | -1.29 | -2.39 | -0.25 | 1259.27 | 1.00 | 269 | 98 | 19 | 3 | TRUE | 1.81 |
| colorectal cancer | RAS_12 | ARID1B | Any mutation | 280 | 53 | Signature 1A | -1.25 | -2.02 | -0.59 | 1453.92 | 1.00 | 529 | 272 | 45 | 8 | TRUE | 3.22 |
| colorectal cancer | RAS_12 | ARID1B | Any mutation | 72 | 46 | Signature 6 | -1.86 | -3.26 | -0.91 | 1311.59 | 1.00 | 202 | 71 | 45 | 1 | TRUE | 2.72 |
| non-small cell lung cancer | RAS_12 | ARID1B | Any mutation | 79 | 13 | Signature 2 | 0.15 | -0.85 | 1.29 | 1241.81 | 1.00 | 237 | 74 | 8 | 5 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12 | ARID1B | Any mutation | 230 | 42 | Signature 4 | -0.45 | -1.19 | 0.21 | 1477.46 | 1.00 | 441 | 221 | 33 | 9 | TRUE | 0.65 |
| uterine cancer | RAS_12 | ARID1B | Any mutation | 36 | 17 | Signature 1A | -0.09 | -1.37 | 1.06 | 1524.79 | 1.00 | 170 | 33 | 14 | 3 | TRUE | 0.05 |
| uterine cancer | RAS_12 | ARID1B | Any mutation | 13 | 39 | Signature 6 | -0.22 | -1.36 | 0.88 | 1428.26 | 1.00 | 58 | 9 | 35 | 4 | TRUE | 0.15 |
| colorectal cancer | RAS_12 | ARID1B | Any mutation | 453 | 121 | Signature overall | -1.45 | -2.47 | -0.49 | 1101.66 | 1.00 | 1000 | 441 | 109 | 12 | TRUE | 2.47 |
| non-small cell lung cancer | RAS_12 | ARID1B | Any mutation | 309 | 55 | Signature overall | -0.16 | -1.35 | 1.17 | 1431.65 | 1.00 | 678 | 295 | 41 | 14 | TRUE | 0.09 |
| uterine cancer | RAS_12 | ARID1B | Any mutation | 50 | 78 | Signature overall | -0.05 | -1.86 | 2.04 | 1446.86 | 1.00 | 255 | 42 | 70 | 8 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12 | MET | Any mutation | 79 | 23 | Signature 2 | -1.00 | -2.20 | -0.08 | 1449.27 | 1.00 | 226 | 78 | 22 | 1 | TRUE | 1.18 |
| non-small cell lung cancer | RAS_12 | MET | Any mutation | 50 | 11 | Signature 3 | -0.65 | -1.68 | 0.35 | 1560.80 | 1.00 | 185 | 48 | 9 | 2 | TRUE | 0.67 |
| non-small cell lung cancer | RAS_12 | MET | Any mutation | 230 | 34 | Signature 4 | -0.56 | -1.31 | 0.11 | 1465.39 | 1.00 | 451 | 221 | 25 | 9 | TRUE | 0.92 |
| non-small cell lung cancer | RAS_12 | MET | Any mutation | 359 | 68 | Signature overall | -0.74 | -1.67 | 0.10 | 1429.56 | 1.00 | 862 | 347 | 56 | 12 | TRUE | 0.92 |
| colorectal cancer | RAS_12 | BRAF | Any mutation | 101 | 48 | Signature 15 | -2.08 | -2.89 | -1.31 | 1497.33 | 1.00 | 241 | 98 | 45 | 3 | TRUE | 6.73 |
| colorectal cancer | RAS_12 | BRAF | Any mutation | 280 | 99 | Signature 1A | -2.09 | -2.79 | -1.47 | 1564.45 | 1.00 | 476 | 273 | 92 | 7 | TRUE | 9.11 |
| colorectal cancer | RAS_12 | BRAF | Any mutation | 73 | 60 | Signature 6 | -2.15 | -3.02 | -1.39 | 1426.95 | 1.00 | 186 | 71 | 58 | 2 | TRUE | 6.44 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 57 | 11 | Signature 18 | -1.21 | -2.23 | -0.39 | 1408.17 | 1.00 | 83 | 56 | 10 | 1 | TRUE | 2.04 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 79 | 20 | Signature 2 | -1.15 | -2.00 | -0.35 | 1423.91 | 1.00 | 227 | 77 | 18 | 2 | TRUE | 2.15 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 50 | 20 | Signature 3 | -1.21 | -2.19 | -0.41 | 1347.37 | 1.00 | 174 | 49 | 19 | 1 | TRUE | 2.06 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 230 | 50 | Signature 4 | -0.96 | -1.63 | -0.32 | 1456.72 | 1.00 | 434 | 220 | 40 | 10 | TRUE | 2.40 |
| colorectal cancer | RAS_12 | BRAF | Any mutation | 454 | 207 | Signature overall | -2.11 | -2.89 | -1.38 | 1464.60 | 1.00 | 903 | 442 | 195 | 12 | TRUE | 7.30 |
| non-small cell lung cancer | RAS_12 | BRAF | Any mutation | 416 | 101 | Signature overall | -1.12 | -1.89 | -0.43 | 1421.83 | 1.00 | 918 | 402 | 87 | 14 | TRUE | 2.63 |
| colorectal cancer | RAS_12 | B2M | Any mutation | 8 | 14 | Signature 10 | -1.48 | -3.56 | -0.11 | 1378.01 | 1.00 | 19 | 8 | 14 | 0 | FALSE | 1.04 |
| colorectal cancer | RAS_12 | B2M | Any mutation | 99 | 20 | Signature 15 | -0.64 | -1.69 | 0.28 | 1474.14 | 1.00 | 269 | 95 | 16 | 4 | FALSE | 0.68 |
| colorectal cancer | RAS_12 | B2M | Any mutation | 272 | 46 | Signature 1A | -0.80 | -1.49 | -0.14 | 1490.26 | 1.00 | 530 | 263 | 37 | 9 | FALSE | 1.64 |
| colorectal cancer | RAS_12 | B2M | Any mutation | 73 | 51 | Signature 6 | -0.51 | -1.30 | 0.20 | 1440.25 | 1.00 | 206 | 64 | 42 | 9 | FALSE | 0.75 |
| colorectal cancer | RAS_12 | B2M | Any mutation | 452 | 131 | Signature overall | -0.85 | -1.98 | 0.13 | 1469.30 | 1.00 | 1024 | 430 | 109 | 22 | FALSE | 0.99 |
| colorectal cancer | RAS_12 | CARD11 | Any mutation | 101 | 14 | Signature 15 | -0.45 | -1.54 | 0.44 | 1523.08 | 1.00 | 273 | 98 | 11 | 3 | FALSE | 0.45 |
| colorectal cancer | RAS_12 | CARD11 | Any mutation | 281 | 58 | Signature 1A | -0.13 | -0.66 | 0.39 | 1380.84 | 1.00 | 530 | 262 | 39 | 19 | FALSE | 0.20 |
| colorectal cancer | RAS_12 | CARD11 | Any mutation | 72 | 38 | Signature 6 | -0.70 | -1.67 | 0.08 | 1346.11 | 1.00 | 213 | 68 | 34 | 4 | FALSE | 0.95 |
| non-small cell lung cancer | RAS_12 | CARD11 | Any mutation | 81 | 16 | Signature 2 | 0.48 | -0.48 | 1.53 | 1397.84 | 1.00 | 236 | 74 | 9 | 7 | FALSE | 0.45 |
| non-small cell lung cancer | RAS_12 | CARD11 | Any mutation | 230 | 63 | Signature 4 | -0.28 | -0.88 | 0.28 | 1374.00 | 1.00 | 429 | 214 | 47 | 16 | FALSE | 0.47 |
| colorectal cancer | RAS_12 | CARD11 | Any mutation | 454 | 110 | Signature overall | -0.42 | -1.32 | 0.44 | 1573.20 | 1.00 | 1016 | 428 | 84 | 26 | FALSE | 0.47 |
| non-small cell lung cancer | RAS_12 | CARD11 | Any mutation | 311 | 79 | Signature overall | 0.08 | -1.43 | 1.48 | 1646.35 | 1.00 | 665 | 288 | 56 | 23 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12 | INPP4B | Any mutation | 80 | 15 | Signature 2 | 0.90 | -0.09 | 1.97 | 1436.92 | 1.00 | 239 | 72 | 7 | 8 | FALSE | 1.03 |
| non-small cell lung cancer | RAS_12 | INPP4B | Any mutation | 231 | 60 | Signature 4 | 0.06 | -0.52 | 0.60 | 1483.75 | 1.00 | 438 | 212 | 41 | 19 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12 | INPP4B | Any mutation | 311 | 75 | Signature overall | 0.50 | -1.00 | 2.24 | 1550.15 | 1.00 | 677 | 284 | 48 | 27 | FALSE | 0.28 |
| non-small cell lung cancer | RAS_12 | NFE2L2 | Any mutation | 13 | 15 | Signature 13 | -0.73 | -2.32 | 0.52 | 1449.28 | 1.00 | 74 | 12 | 14 | 1 | FALSE | 0.50 |
| non-small cell lung cancer | RAS_12 | NFE2L2 | Any mutation | 79 | 32 | Signature 2 | -0.60 | -1.54 | 0.25 | 1383.47 | 1.00 | 225 | 74 | 27 | 5 | FALSE | 0.73 |
| non-small cell lung cancer | RAS_12 | NFE2L2 | Any mutation | 231 | 20 | Signature 4 | -0.37 | -1.33 | 0.49 | 1493.04 | 1.00 | 458 | 225 | 14 | 6 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12 | NFE2L2 | Any mutation | 323 | 67 | Signature overall | -0.59 | -1.90 | 0.64 | 1235.27 | 1.00 | 757 | 311 | 55 | 12 | FALSE | 0.46 |
| colorectal cancer | RAS_12 | SOX9 | Any mutation | 103 | 40 | Signature 15 | -0.04 | -0.62 | 0.52 | 1541.48 | 1.00 | 254 | 93 | 30 | 10 | FALSE | 0.05 |
| colorectal cancer | RAS_12 | SOX9 | Any mutation | 283 | 105 | Signature 1A | 0.43 | 0.02 | 0.82 | 1244.39 | 1.00 | 513 | 236 | 58 | 47 | FALSE | 1.45 |
| colorectal cancer | RAS_12 | SOX9 | Any mutation | 72 | 59 | Signature 6 | -0.17 | -0.82 | 0.40 | 1510.40 | 1.00 | 197 | 62 | 49 | 10 | FALSE | 0.23 |
| colorectal cancer | RAS_12 | SOX9 | Any mutation | 458 | 204 | Signature overall | 0.07 | -0.60 | 0.69 | 1568.33 | 1.00 | 964 | 391 | 137 | 67 | FALSE | 0.08 |
| colorectal cancer | RAS_12 | SMAD2 | Any mutation | 101 | 16 | Signature 15 | 0.38 | -0.38 | 1.04 | 1439.90 | 1.00 | 273 | 96 | 11 | 5 | TRUE | 0.55 |
| colorectal cancer | RAS_12 | SMAD2 | Any mutation | 281 | 33 | Signature 1A | 0.56 | 0.00 | 1.16 | 1403.19 | 1.00 | 553 | 264 | 16 | 17 | TRUE | 1.24 |
| colorectal cancer | RAS_12 | SMAD2 | Any mutation | 72 | 17 | Signature 6 | 0.37 | -0.40 | 1.03 | 1421.47 | 1.00 | 228 | 68 | 13 | 4 | TRUE | 0.52 |
| colorectal cancer | RAS_12 | SMAD2 | Any mutation | 454 | 66 | Signature overall | 0.44 | -0.18 | 1.06 | 1394.62 | 1.00 | 1054 | 428 | 40 | 26 | TRUE | 0.76 |
| non-small cell lung cancer | RAS_12 | GLI1 | Any mutation | 219 | 44 | Signature 4 | 0.28 | -0.36 | 0.89 | 1414.94 | 1.00 | 392 | 201 | 26 | 18 | FALSE | 0.43 |
| non-small cell lung cancer | RAS_12 | GLI1 | Any mutation | 219 | 44 | Signature overall | 0.26 | -3.97 | 4.35 | 1501.72 | 1.00 | 392 | 201 | 26 | 18 | FALSE | 0.05 |
| colorectal cancer | RAS_12 | ZFHX3 | Any mutation | 9 | 17 | Signature 10 | -0.85 | -2.10 | 0.23 | 1455.73 | 1.00 | 14 | 7 | 15 | 2 | FALSE | 0.82 |
| colorectal cancer | RAS_12 | ZFHX3 | Any mutation | 92 | 31 | Signature 15 | -0.61 | -1.42 | 0.16 | 1427.30 | 1.00 | 242 | 86 | 25 | 6 | FALSE | 0.87 |
| colorectal cancer | RAS_12 | ZFHX3 | Any mutation | 265 | 80 | Signature 1A | -0.76 | -1.29 | -0.24 | 1618.26 | 1.00 | 480 | 249 | 64 | 16 | FALSE | 2.38 |
| colorectal cancer | RAS_12 | ZFHX3 | Any mutation | 72 | 81 | Signature 6 | -0.70 | -1.37 | -0.10 | 1517.73 | 1.00 | 175 | 60 | 69 | 12 | FALSE | 1.47 |
| non-small cell lung cancer | RAS_12 | ZFHX3 | Any mutation | 75 | 18 | Signature 2 | -0.75 | -1.90 | 0.39 | 1423.36 | 1.00 | 200 | 72 | 15 | 3 | FALSE | 0.69 |
| non-small cell lung cancer | RAS_12 | ZFHX3 | Any mutation | 219 | 61 | Signature 4 | -0.41 | -1.01 | 0.17 | 1533.14 | 1.00 | 375 | 202 | 44 | 17 | FALSE | 0.75 |
| non-small cell lung cancer | RAS_12 | ZFHX3 | Any mutation | 129 | 14 | Signature R2 | -1.11 | -2.16 | -0.10 | 1564.59 | 1.00 | 40 | 123 | 8 | 6 | FALSE | 1.46 |
| uterine cancer | RAS_12 | ZFHX3 | Any mutation | 19 | 13 | Signature 15 | 0.77 | -0.46 | 1.93 | 1329.37 | 1.00 | 76 | 14 | 8 | 5 | FALSE | 0.70 |
| uterine cancer | RAS_12 | ZFHX3 | Any mutation | 33 | 56 | Signature 1A | -0.68 | -1.66 | 0.17 | 1253.57 | 1.00 | 130 | 28 | 51 | 5 | FALSE | 0.82 |
| uterine cancer | RAS_12 | ZFHX3 | Any mutation | 13 | 45 | Signature 6 | 0.59 | -0.51 | 1.68 | 1309.22 | 1.00 | 52 | 5 | 37 | 8 | FALSE | 0.54 |
| colorectal cancer | RAS_12 | ZFHX3 | Any mutation | 438 | 209 | Signature overall | -0.71 | -1.58 | 0.12 | 1449.74 | 1.00 | 911 | 402 | 173 | 36 | FALSE | 1.02 |
| non-small cell lung cancer | RAS_12 | ZFHX3 | Any mutation | 423 | 93 | Signature overall | -0.74 | -2.03 | 0.55 | 1402.49 | 1.00 | 615 | 397 | 67 | 26 | FALSE | 0.61 |
| uterine cancer | RAS_12 | ZFHX3 | Any mutation | 71 | 184 | Signature overall | 0.04 | -1.07 | 1.27 | 1456.81 | 1.00 | 284 | 49 | 162 | 22 | FALSE | 0.03 |
| colorectal cancer | RAS_12 | MGA | Any mutation | 8 | 15 | Signature 10 | -1.68 | -3.73 | -0.16 | 1464.53 | 1.00 | 15 | 8 | 15 | 0 | FALSE | 1.13 |
| colorectal cancer | RAS_12 | MGA | Any mutation | 91 | 16 | Signature 15 | -0.71 | -1.87 | 0.35 | 1304.09 | 1.00 | 244 | 88 | 13 | 3 | FALSE | 0.68 |
| colorectal cancer | RAS_12 | MGA | Any mutation | 264 | 42 | Signature 1A | -0.25 | -0.94 | 0.42 | 1472.65 | 1.00 | 500 | 251 | 29 | 13 | FALSE | 0.34 |
| colorectal cancer | RAS_12 | MGA | Any mutation | 70 | 36 | Signature 6 | -0.60 | -1.52 | 0.24 | 1381.60 | 1.00 | 193 | 64 | 30 | 6 | FALSE | 0.75 |
| non-small cell lung cancer | RAS_12 | MGA | Any mutation | 75 | 28 | Signature 2 | -0.65 | -1.64 | 0.24 | 1707.23 | 1.00 | 202 | 71 | 24 | 4 | FALSE | 0.77 |
| non-small cell lung cancer | RAS_12 | MGA | Any mutation | 220 | 79 | Signature 4 | -0.23 | -0.75 | 0.25 | 1512.76 | 1.00 | 366 | 196 | 55 | 24 | FALSE | 0.43 |
| non-small cell lung cancer | RAS_12 | MGA | Any mutation | 129 | 13 | Signature R2 | 0.00 | -1.06 | 1.08 | 1359.15 | 1.00 | 45 | 119 | 3 | 10 | FALSE | 0.00 |
| uterine cancer | RAS_12 | MGA | Any mutation | 33 | 19 | Signature 1A | -3.45 | -9.32 | -0.51 | 1375.31 | 1.00 | 152 | 33 | 19 | 0 | FALSE | 0.89 |
| uterine cancer | RAS_12 | MGA | Any mutation | 12 | 14 | Signature 6 | -3.22 | -9.37 | -0.24 | 1172.00 | 1.00 | 66 | 12 | 14 | 0 | FALSE | 0.76 |
| colorectal cancer | RAS_12 | MGA | Any mutation | 433 | 109 | Signature overall | -0.76 | -2.03 | 0.30 | 1394.86 | 1.00 | 952 | 411 | 87 | 22 | FALSE | 0.73 |
| non-small cell lung cancer | RAS_12 | MGA | Any mutation | 424 | 120 | Signature overall | -0.28 | -1.53 | 0.98 | 1521.25 | 1.00 | 613 | 386 | 82 | 38 | FALSE | 0.19 |
| uterine cancer | RAS_12 | MGA | Any mutation | 50 | 82 | Signature overall | -1.66 | -5.52 | 1.48 | 1348.09 | 1.00 | 238 | 45 | 77 | 5 | FALSE | 0.47 |
| colorectal cancer | RAS_12 | KMT2B | Any mutation | 51 | 18 | Signature 15 | -1.51 | -2.95 | -0.32 | 1453.70 | 1.00 | 131 | 50 | 17 | 1 | FALSE | 1.56 |
| colorectal cancer | RAS_12 | KMT2B | Any mutation | 158 | 64 | Signature 1A | -0.57 | -1.18 | 0.00 | 1462.80 | 1.00 | 266 | 142 | 48 | 16 | FALSE | 1.25 |
| colorectal cancer | RAS_12 | KMT2B | Any mutation | 49 | 86 | Signature 6 | -0.97 | -1.65 | -0.29 | 1513.00 | 1.00 | 84 | 37 | 74 | 12 | FALSE | 2.23 |
| colorectal cancer | RAS_12 | KMT2B | Any mutation | 258 | 168 | Signature overall | -1.01 | -2.34 | 0.11 | 1306.69 | 1.00 | 481 | 229 | 139 | 29 | FALSE | 1.01 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 93 | 48 | Signature 15 | 0.27 | -0.29 | 0.84 | 1111.06 | 1.00 | 227 | 77 | 32 | 16 | FALSE | 0.45 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 268 | 115 | Signature 1A | 0.04 | -0.35 | 0.42 | 1552.42 | 1.00 | 458 | 229 | 76 | 39 | FALSE | 0.08 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 35 | 12 | Signature 2 | 0.70 | -0.07 | 1.77 | 1540.30 | 1.00 | 35 | 25 | 2 | 10 | FALSE | 0.86 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 70 | 69 | Signature 6 | -0.23 | -0.83 | 0.33 | 1361.83 | 1.00 | 170 | 58 | 57 | 12 | FALSE | 0.36 |
| colorectal cancer | RAS_12 | TCF7L2 | Any mutation | 466 | 244 | Signature overall | 0.18 | -0.42 | 0.83 | 1524.78 | 1.00 | 890 | 389 | 167 | 77 | FALSE | 0.25 |
| colorectal cancer | RAS_12 | ANKRD11 | Any mutation | 10 | 12 | Signature 10 | -0.68 | -2.06 | 0.58 | 1605.42 | 1.00 | 16 | 7 | 9 | 3 | FALSE | 0.52 |
| colorectal cancer | RAS_12 | ANKRD11 | Any mutation | 87 | 17 | Signature 15 | -1.53 | -2.92 | -0.34 | 1605.26 | 1.00 | 240 | 86 | 16 | 1 | FALSE | 1.69 |
| colorectal cancer | RAS_12 | ANKRD11 | Any mutation | 255 | 47 | Signature 1A | -0.92 | -1.63 | -0.25 | 1417.46 | 1.00 | 481 | 246 | 38 | 9 | FALSE | 2.01 |
| colorectal cancer | RAS_12 | ANKRD11 | Any mutation | 66 | 57 | Signature 6 | -1.66 | -2.70 | -0.77 | 1336.08 | 1.00 | 177 | 63 | 54 | 3 | FALSE | 3.02 |
| colorectal cancer | RAS_12 | ANKRD11 | Any mutation | 418 | 133 | Signature overall | -1.19 | -2.22 | -0.20 | 1603.18 | 1.00 | 914 | 402 | 117 | 16 | FALSE | 1.61 |
| colorectal cancer | RAS_12 | POLD1 | Any mutation | 91 | 15 | Signature 15 | -1.77 | -3.85 | -0.49 | 1500.57 | 1.00 | 247 | 91 | 15 | 0 | TRUE | 1.31 |
| colorectal cancer | RAS_12 | POLD1 | Any mutation | 266 | 43 | Signature 1A | -0.39 | -1.06 | 0.27 | 1410.06 | 1.00 | 501 | 253 | 30 | 13 | TRUE | 0.59 |
| colorectal cancer | RAS_12 | POLD1 | Any mutation | 70 | 44 | Signature 6 | -1.18 | -2.20 | -0.29 | 1387.10 | 1.00 | 190 | 66 | 40 | 4 | TRUE | 1.79 |
| colorectal cancer | RAS_12 | POLD1 | Any mutation | 427 | 102 | Signature overall | -1.10 | -2.42 | 0.04 | 1463.31 | 1.00 | 938 | 410 | 85 | 17 | TRUE | 1.11 |
| non-small cell lung cancer | RAS_12 | PREX2 | Any mutation | 126 | 52 | Signature 4 | -0.18 | -0.80 | 0.43 | 1584.78 | 1.00 | 208 | 110 | 36 | 16 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12 | PREX2 | Any mutation | 126 | 52 | Signature overall | -0.20 | -4.34 | 3.78 | 1513.51 | 1.00 | 208 | 110 | 36 | 16 | FALSE | 0.04 |
| colorectal cancer | RAS_12 | AMER1 | Any mutation | 101 | 34 | Signature 15 | 0.21 | -0.41 | 0.76 | 1381.58 | 1.00 | 261 | 91 | 24 | 10 | FALSE | 0.32 |
| colorectal cancer | RAS_12 | AMER1 | Any mutation | 279 | 61 | Signature 1A | 0.35 | -0.10 | 0.81 | 1421.12 | 1.00 | 538 | 252 | 34 | 27 | FALSE | 0.89 |
| colorectal cancer | RAS_12 | AMER1 | Any mutation | 72 | 36 | Signature 6 | 0.16 | -0.45 | 0.70 | 1481.27 | 1.00 | 216 | 64 | 28 | 8 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12 | AMER1 | Any mutation | 79 | 11 | Signature 2 | 0.61 | -0.59 | 1.81 | 1546.10 | 1.00 | 239 | 74 | 6 | 5 | FALSE | 0.50 |
| non-small cell lung cancer | RAS_12 | AMER1 | Any mutation | 232 | 83 | Signature 4 | -0.20 | -0.69 | 0.27 | 1403.74 | 1.00 | 427 | 209 | 60 | 23 | FALSE | 0.38 |
| colorectal cancer | RAS_12 | AMER1 | Any mutation | 452 | 131 | Signature overall | 0.24 | -0.34 | 0.79 | 1430.19 | 1.00 | 1015 | 407 | 86 | 45 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12 | AMER1 | Any mutation | 311 | 94 | Signature overall | 0.19 | -1.70 | 2.20 | 1486.09 | 1.00 | 666 | 283 | 66 | 28 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12 | EPHA7 | Any mutation | 44 | 13 | Signature 3 | -0.36 | -1.61 | 0.91 | 1560.88 | 1.00 | 163 | 41 | 10 | 3 | FALSE | 0.25 |
| non-small cell lung cancer | RAS_12 | EPHA7 | Any mutation | 217 | 51 | Signature 4 | -0.85 | -1.59 | -0.21 | 1461.68 | 1.00 | 377 | 208 | 42 | 9 | FALSE | 1.75 |
| non-small cell lung cancer | RAS_12 | EPHA7 | Any mutation | 261 | 64 | Signature overall | -0.61 | -2.10 | 0.80 | 1494.10 | 1.00 | 540 | 249 | 52 | 12 | FALSE | 0.37 |
| colorectal cancer | KRAS_12 | SPEN | Any mutation | 8 | 21 | Signature 10 | -1.37 | -3.08 | 0.02 | 1401.47 | 1.00 | 18 | 7 | 20 | 1 | FALSE | 1.10 |
| colorectal cancer | KRAS_12 | SPEN | Any mutation | 99 | 18 | Signature 15 | -0.76 | -2.01 | 0.31 | 1455.31 | 1.00 | 276 | 96 | 15 | 3 | FALSE | 0.70 |
| colorectal cancer | KRAS_12 | SPEN | Any mutation | 271 | 38 | Signature 1A | -0.30 | -0.97 | 0.38 | 1480.99 | 1.00 | 553 | 260 | 27 | 11 | FALSE | 0.40 |
| colorectal cancer | KRAS_12 | SPEN | Any mutation | 70 | 61 | Signature 6 | -0.75 | -1.53 | 0.03 | 1394.65 | 1.00 | 204 | 62 | 53 | 8 | FALSE | 1.24 |
| non-small cell lung cancer | KRAS_12 | SPEN | Any mutation | 79 | 39 | Signature 2 | -4.10 | -9.65 | -1.43 | 1551.72 | 1.00 | 233 | 79 | 39 | 0 | FALSE | 1.16 |
| non-small cell lung cancer | KRAS_12 | SPEN | Any mutation | 231 | 24 | Signature 4 | 0.05 | -0.84 | 0.89 | 1435.17 | 1.00 | 459 | 222 | 15 | 9 | FALSE | 0.04 |
| uterine cancer | KRAS_12 | SPEN | Any mutation | 20 | 13 | Signature 15 | 0.97 | -0.21 | 2.20 | 1493.99 | 1.00 | 83 | 15 | 8 | 5 | FALSE | 0.97 |
| uterine cancer | KRAS_12 | SPEN | Any mutation | 34 | 21 | Signature 1A | -0.35 | -1.75 | 0.78 | 1623.14 | 1.00 | 169 | 32 | 19 | 2 | FALSE | 0.23 |
| uterine cancer | KRAS_12 | SPEN | Any mutation | 14 | 21 | Signature 6 | 0.81 | -0.33 | 1.91 | 1383.08 | 1.00 | 73 | 9 | 16 | 5 | FALSE | 0.82 |
| colorectal cancer | KRAS_12 | SPEN | Any mutation | 448 | 138 | Signature overall | -0.80 | -2.07 | 0.42 | 1429.28 | 1.00 | 1051 | 425 | 115 | 23 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12 | SPEN | Any mutation | 310 | 63 | Signature overall | -1.70 | -5.67 | 1.59 | 1336.26 | 1.00 | 692 | 301 | 54 | 9 | FALSE | 0.47 |
| uterine cancer | KRAS_12 | SPEN | Any mutation | 71 | 93 | Signature overall | 0.54 | -0.85 | 2.07 | 1673.33 | 1.00 | 348 | 56 | 78 | 15 | FALSE | 0.34 |
| colorectal cancer | KRAS_12 | KMT2C | Any mutation | 9 | 32 | Signature 10 | -1.43 | -2.92 | -0.08 | 1261.33 | 1.00 | 15 | 7 | 30 | 2 | FALSE | 1.38 |
| colorectal cancer | KRAS_12 | KMT2C | Any mutation | 95 | 22 | Signature 15 | -0.91 | -2.12 | 0.11 | 1450.78 | 1.00 | 270 | 92 | 19 | 3 | FALSE | 0.98 |
| colorectal cancer | KRAS_12 | KMT2C | Any mutation | 265 | 60 | Signature 1A | -0.36 | -0.99 | 0.21 | 1525.61 | 1.00 | 527 | 249 | 44 | 16 | FALSE | 0.62 |
| colorectal cancer | KRAS_12 | KMT2C | Any mutation | 65 | 65 | Signature 6 | -0.51 | -1.26 | 0.17 | 1520.21 | 1.00 | 195 | 55 | 55 | 10 | FALSE | 0.78 |
| non-small cell lung cancer | KRAS_12 | KMT2C | Any mutation | 13 | 22 | Signature 13 | 0.12 | -0.75 | 1.12 | 1250.62 | 1.00 | 69 | 9 | 18 | 4 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12 | KMT2C | Any mutation | 80 | 40 | Signature 2 | 0.15 | -0.57 | 0.79 | 1476.12 | 1.00 | 218 | 68 | 28 | 12 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12 | KMT2C | Any mutation | 49 | 13 | Signature 3 | -0.50 | -1.62 | 0.41 | 1569.20 | 1.00 | 182 | 48 | 12 | 1 | FALSE | 0.48 |
| non-small cell lung cancer | KRAS_12 | KMT2C | Any mutation | 230 | 76 | Signature 4 | -0.29 | -0.80 | 0.18 | 1365.45 | 1.00 | 422 | 210 | 56 | 20 | FALSE | 0.61 |
| uterine cancer | KRAS_12 | KMT2C | Any mutation | 18 | 17 | Signature 15 | -0.70 | -2.34 | 0.65 | 1424.99 | 1.00 | 77 | 16 | 15 | 2 | FALSE | 0.44 |
| uterine cancer | KRAS_12 | KMT2C | Any mutation | 32 | 20 | Signature 1A | -0.77 | -2.30 | 0.52 | 1570.25 | 1.00 | 156 | 30 | 18 | 2 | FALSE | 0.55 |
| uterine cancer | KRAS_12 | KMT2C | Any mutation | 13 | 23 | Signature 6 | -1.30 | -3.16 | 0.21 | 1463.97 | 1.00 | 64 | 12 | 22 | 1 | FALSE | 0.90 |
| colorectal cancer | KRAS_12 | KMT2C | Any mutation | 434 | 179 | Signature overall | -0.78 | -1.96 | 0.47 | 1201.75 | 1.00 | 1007 | 403 | 148 | 31 | FALSE | 0.71 |
| non-small cell lung cancer | KRAS_12 | KMT2C | Any mutation | 372 | 151 | Signature overall | -0.13 | -0.91 | 0.61 | 1291.09 | 1.00 | 891 | 335 | 114 | 37 | FALSE | 0.14 |
| uterine cancer | KRAS_12 | KMT2C | Any mutation | 65 | 118 | Signature overall | -0.79 | -2.35 | 0.69 | 1514.61 | 1.00 | 317 | 58 | 111 | 7 | FALSE | 0.52 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 12 | 11 | Signature 11 | 0.06 | -0.87 | 1.11 | 1295.26 | 1.00 | 8 | 5 | 4 | 7 | TRUE | 0.05 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 10 | 28 | Signature 15 | -0.13 | -0.98 | 0.86 | 1533.36 | 1.00 | 19 | 3 | 21 | 7 | TRUE | 0.11 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 32 | 66 | Signature 1A | -0.50 | -1.17 | 0.19 | 1393.24 | 1.00 | 37 | 18 | 52 | 14 | TRUE | 0.80 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 7 | 31 | Signature 2 | -0.79 | -1.77 | 0.09 | 1489.69 | 1.00 | 21 | 5 | 29 | 2 | TRUE | 1.01 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 6 | 18 | Signature 3 | -0.50 | -1.51 | 0.45 | 1679.61 | 1.00 | 6 | 3 | 15 | 3 | TRUE | 0.49 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 20 | 70 | Signature 4 | -0.49 | -1.25 | 0.28 | 1511.25 | 1.00 | 12 | 7 | 57 | 13 | TRUE | 0.66 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 9 | 32 | Signature 10 | -0.94 | -1.58 | -0.35 | 1455.30 | 1.00 | 6 | 3 | 26 | 6 | TRUE | 2.59 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 22 | 28 | Signature 11 | -0.59 | -1.19 | 0.00 | 1450.07 | 1.00 | 2 | 7 | 13 | 15 | TRUE | 1.31 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 101 | 311 | Signature 15 | -1.00 | -1.42 | -0.61 | 1397.78 | 1.00 | 58 | 39 | 249 | 62 | TRUE | 6.29 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 7 | 36 | Signature 17 | -1.03 | -1.68 | -0.42 | 1436.66 | 1.00 | 8 | 2 | 31 | 5 | TRUE | 2.90 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 16 | 36 | Signature 18 | -1.02 | -1.70 | -0.43 | 1289.49 | 1.00 | 4 | 8 | 28 | 8 | TRUE | 2.88 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 19 | 31 | Signature 19 | -1.10 | -1.74 | -0.56 | 1474.13 | 1.00 | 5 | 12 | 24 | 7 | TRUE | 3.53 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 285 | 655 | Signature 1A | -0.81 | -1.09 | -0.52 | 1533.08 | 1.00 | 127 | 106 | 476 | 179 | TRUE | 8.02 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 7 | 15 | Signature 1B | -0.90 | -1.57 | -0.28 | 1250.48 | 1.00 | 4 | 3 | 11 | 4 | TRUE | 2.18 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 37 | 56 | Signature 2 | -1.03 | -1.62 | -0.54 | 1426.37 | 1.00 | 9 | 20 | 39 | 17 | TRUE | 3.77 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 9 | 23 | Signature 20 | -0.86 | -1.50 | -0.23 | 1668.61 | 1.00 | 8 | 3 | 17 | 6 | TRUE | 2.17 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 7 | 20 | Signature 21 | -0.88 | -1.52 | -0.26 | 1573.88 | 1.00 | 6 | 2 | 15 | 5 | TRUE | 2.23 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 14 | 35 | Signature 3 | -0.89 | -1.54 | -0.31 | 1476.67 | 1.00 | 2 | 5 | 26 | 9 | TRUE | 2.46 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 18 | 36 | Signature 4 | -0.86 | -1.47 | -0.29 | 1472.80 | 1.00 | 3 | 7 | 25 | 11 | TRUE | 2.46 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 79 | 236 | Signature 6 | -0.60 | -1.04 | -0.14 | 1445.34 | 1.00 | 85 | 27 | 184 | 52 | TRUE | 2.09 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 14 | 28 | Signature 7 | -0.97 | -1.60 | -0.36 | 1377.44 | 1.00 | 5 | 7 | 21 | 7 | TRUE | 2.74 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 14 | 13 | Signature 8 | -0.68 | -1.27 | -0.02 | 1462.64 | 1.00 | 4 | 6 | 5 | 8 | TRUE | 1.49 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 16 | 16 | Signature R2 | -0.71 | -1.32 | -0.08 | 1532.36 | 1.00 | 0 | 7 | 7 | 9 | TRUE | 1.57 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 21 | 12 | Signature 11 | -1.60 | -2.49 | -0.74 | 1385.95 | 1.00 | 13 | 19 | 10 | 2 | TRUE | 3.40 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 15 | 79 | Signature 13 | -0.79 | -1.51 | -0.09 | 1425.69 | 1.00 | 27 | 4 | 68 | 11 | TRUE | 1.46 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 17 | 36 | Signature 14 | -1.15 | -1.91 | -0.40 | 1579.31 | 1.00 | 14 | 10 | 29 | 7 | TRUE | 2.43 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 20 | 87 | Signature 15 | -1.40 | -2.12 | -0.69 | 1706.80 | 1.00 | 40 | 13 | 80 | 7 | TRUE | 3.87 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 10 | 39 | Signature 16 | -0.82 | -1.59 | 0.04 | 1337.96 | 1.00 | 21 | 3 | 32 | 7 | TRUE | 1.27 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 58 | 92 | Signature 18 | -0.95 | -1.49 | -0.42 | 1414.93 | 1.00 | 32 | 32 | 66 | 26 | TRUE | 3.22 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 14 | 31 | Signature 19 | -1.10 | -1.93 | -0.30 | 1641.68 | 1.00 | 26 | 9 | 26 | 5 | TRUE | 2.09 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 46 | 149 | Signature 1A | -0.99 | -1.52 | -0.47 | 1595.07 | 1.00 | 96 | 28 | 131 | 18 | TRUE | 3.43 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 81 | 223 | Signature 2 | -0.81 | -1.26 | -0.36 | 1283.90 | 1.00 | 85 | 39 | 181 | 42 | TRUE | 3.28 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 13 | 46 | Signature 20 | -1.44 | -2.28 | -0.66 | 1468.68 | 1.00 | 22 | 9 | 42 | 4 | TRUE | 3.24 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 9 | 37 | Signature 21 | -1.75 | -2.65 | -0.86 | 1520.47 | 1.00 | 21 | 8 | 36 | 1 | TRUE | 3.90 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 52 | 161 | Signature 3 | -1.16 | -1.70 | -0.64 | 1353.69 | 1.00 | 65 | 30 | 139 | 22 | TRUE | 4.69 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 233 | 522 | Signature 4 | -1.71 | -2.03 | -1.39 | 1543.04 | 1.00 | 92 | 134 | 423 | 99 | TRUE | 24.34 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 11 | 36 | Signature 6 | -1.25 | -2.08 | -0.45 | 1439.73 | 1.00 | 11 | 6 | 31 | 5 | TRUE | 2.61 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 21 | 71 | Signature 7 | -1.34 | -2.04 | -0.63 | 1569.12 | 1.00 | 28 | 13 | 63 | 8 | TRUE | 3.74 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 26 | 35 | Signature 8 | -1.24 | -1.98 | -0.56 | 1338.86 | 1.00 | 11 | 17 | 26 | 9 | TRUE | 3.13 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 145 | 85 | Signature R2 | -1.39 | -1.86 | -0.89 | 1517.27 | 1.00 | 18 | 103 | 43 | 42 | TRUE | 7.28 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 6 | 15 | Signature R3 | -1.51 | -2.55 | -0.57 | 1393.83 | 1.00 | 12 | 5 | 14 | 1 | TRUE | 2.75 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 17 | 57 | Signature U1 | -1.78 | -2.67 | -0.99 | 1519.40 | 1.00 | 41 | 15 | 55 | 2 | TRUE | 4.71 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 9 | 32 | Signature U2 | -1.66 | -2.58 | -0.82 | 1413.48 | 1.00 | 8 | 7 | 30 | 2 | TRUE | 3.55 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 115 | 94 | Signature 11 | 1.88 | 1.05 | 2.70 | 1410.53 | 1.00 | 5 | 26 | 5 | 89 | TRUE | 5.22 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 109 | 98 | Signature 15 | 1.45 | 0.73 | 2.17 | 1503.29 | 1.00 | 10 | 25 | 14 | 84 | TRUE | 3.93 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 23 | 19 | Signature 16 | 2.15 | 1.13 | 3.25 | 1371.01 | 1.00 | 7 | 5 | 1 | 18 | TRUE | 4.15 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 12 | 41 | Signature 17 | 0.23 | -0.75 | 1.12 | 1507.43 | 1.00 | 9 | 5 | 34 | 7 | TRUE | 0.21 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 14 | 14 | Signature 18 | 2.06 | 1.02 | 3.13 | 1471.60 | 1.00 | 7 | 2 | 2 | 12 | TRUE | 3.70 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 14 | 16 | Signature 19 | 1.92 | 0.94 | 2.99 | 1567.69 | 1.00 | 8 | 2 | 4 | 12 | TRUE | 3.61 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 201 | 172 | Signature 1A | 1.40 | 0.85 | 1.91 | 1504.60 | 1.00 | 28 | 53 | 24 | 148 | TRUE | 6.43 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 16 | 12 | Signature 1B | 1.88 | 0.80 | 3.09 | 1487.33 | 1.00 | 4 | 5 | 1 | 11 | TRUE | 3.04 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 33 | 29 | Signature 2 | 2.29 | 1.38 | 3.31 | 1445.60 | 1.00 | 11 | 6 | 2 | 27 | TRUE | 5.51 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 25 | 21 | Signature 21 | 2.24 | 1.26 | 3.38 | 1418.47 | 1.00 | 6 | 5 | 1 | 20 | TRUE | 4.39 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 78 | 66 | Signature 3 | 2.16 | 1.38 | 2.96 | 1491.97 | 1.00 | 15 | 17 | 5 | 61 | TRUE | 7.13 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 61 | 58 | Signature 4 | 2.42 | 1.51 | 3.36 | 1396.56 | 1.00 | 8 | 7 | 4 | 54 | TRUE | 6.83 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 54 | 53 | Signature 6 | 1.67 | 0.87 | 2.54 | 1333.36 | 1.00 | 10 | 11 | 10 | 43 | TRUE | 4.09 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 23 | 25 | Signature 7 | 2.43 | 1.46 | 3.54 | 1418.94 | 1.00 | 9 | 1 | 3 | 22 | TRUE | 5.30 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 49 | 37 | Signature 8 | 2.28 | 1.29 | 3.34 | 1335.80 | 1.00 | 3 | 12 | 0 | 37 | TRUE | 4.94 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 21 | 19 | Signature R3 | 2.30 | 1.26 | 3.52 | 1555.04 | 1.00 | 3 | 3 | 1 | 18 | TRUE | 4.39 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 11 | 11 | Signature U1 | 2.21 | 1.16 | 3.36 | 1405.65 | 1.00 | 10 | 1 | 1 | 10 | TRUE | 4.11 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 19 | 53 | Signature 15 | -1.89 | -2.87 | -1.02 | 1431.82 | 1.00 | 39 | 16 | 50 | 3 | TRUE | 4.11 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 35 | 113 | Signature 1A | -1.43 | -2.15 | -0.75 | 1568.42 | 1.00 | 92 | 25 | 103 | 10 | TRUE | 4.12 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 7 | 19 | Signature 20 | -1.89 | -3.06 | -0.87 | 1143.78 | 1.00 | 19 | 6 | 18 | 1 | TRUE | 3.04 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 10 | 30 | Signature 3 | -1.72 | -2.75 | -0.81 | 1513.68 | 1.00 | 10 | 7 | 27 | 3 | TRUE | 3.25 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 13 | 45 | Signature 6 | -2.23 | -3.59 | -1.20 | 1216.99 | 1.00 | 49 | 13 | 45 | 0 | TRUE | 3.53 |
| cancer of unknown primary | KRAS_12 | TP53 | Any mutation | 95 | 287 | Signature overall | -0.45 | -1.06 | 0.15 | 1354.02 | 1.00 | 130 | 44 | 236 | 51 | TRUE | 0.82 |
| colorectal cancer | KRAS_12 | TP53 | Any mutation | 674 | 1607 | Signature overall | -0.88 | -1.18 | -0.58 | 1442.06 | 1.00 | 336 | 264 | 1197 | 410 | TRUE | 7.85 |
| non-small cell lung cancer | KRAS_12 | TP53 | Any mutation | 836 | 1927 | Signature overall | -1.31 | -1.64 | -1.00 | 1521.57 | 1.00 | 719 | 511 | 1602 | 325 | TRUE | 15.24 |
| pancreatic cancer | KRAS_12 | TP53 | Any mutation | 859 | 785 | Signature overall | 1.94 | 1.44 | 2.46 | 1517.62 | 1.00 | 153 | 186 | 112 | 673 | TRUE | 12.46 |
| uterine cancer | KRAS_12 | TP53 | Any mutation | 92 | 356 | Signature overall | -1.93 | -2.77 | -1.20 | 1182.88 | 1.00 | 283 | 75 | 339 | 17 | TRUE | 5.80 |
| colorectal cancer | KRAS_12 | ATRX | Any mutation | 8 | 19 | Signature 10 | -2.47 | -5.61 | -0.58 | 1499.52 | 1.00 | 18 | 8 | 19 | 0 | TRUE | 1.22 |
| colorectal cancer | KRAS_12 | ATRX | Any mutation | 270 | 46 | Signature 1A | -0.68 | -1.42 | 0.00 | 1481.01 | 1.00 | 545 | 260 | 36 | 10 | TRUE | 1.19 |
| colorectal cancer | KRAS_12 | ATRX | Any mutation | 69 | 29 | Signature 6 | -1.13 | -2.31 | -0.08 | 1321.87 | 1.00 | 219 | 66 | 26 | 3 | TRUE | 1.28 |
| non-small cell lung cancer | KRAS_12 | ATRX | Any mutation | 58 | 12 | Signature 18 | 0.12 | -0.58 | 0.89 | 1499.75 | 1.00 | 87 | 52 | 6 | 6 | TRUE | 0.13 |
| non-small cell lung cancer | KRAS_12 | ATRX | Any mutation | 79 | 28 | Signature 2 | 0.08 | -0.58 | 0.73 | 1778.05 | 1.00 | 228 | 71 | 20 | 8 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12 | ATRX | Any mutation | 234 | 88 | Signature 4 | -0.01 | -0.48 | 0.43 | 1515.10 | 1.00 | 423 | 207 | 61 | 27 | TRUE | 0.02 |
| uterine cancer | KRAS_12 | ATRX | Any mutation | 34 | 12 | Signature 1A | -4.00 | -9.06 | -0.75 | 1506.22 | 1.00 | 173 | 34 | 12 | 0 | TRUE | 1.20 |
| uterine cancer | KRAS_12 | ATRX | Any mutation | 13 | 13 | Signature 6 | -3.90 | -8.68 | -0.76 | 1577.43 | 1.00 | 75 | 13 | 13 | 0 | TRUE | 1.25 |
| colorectal cancer | KRAS_12 | ATRX | Any mutation | 347 | 94 | Signature overall | -1.42 | -3.38 | 0.16 | 1554.77 | 1.00 | 782 | 334 | 81 | 13 | TRUE | 0.94 |
| non-small cell lung cancer | KRAS_12 | ATRX | Any mutation | 371 | 128 | Signature overall | 0.07 | -0.56 | 0.74 | 1518.57 | 1.00 | 738 | 330 | 87 | 41 | TRUE | 0.08 |
| uterine cancer | KRAS_12 | ATRX | Any mutation | 51 | 123 | Signature overall | -3.40 | -6.85 | -0.50 | 1423.60 | 1.00 | 274 | 50 | 122 | 1 | TRUE | 1.48 |
| colorectal cancer | KRAS_12 | ATR | Any mutation | 8 | 28 | Signature 10 | -1.96 | -3.84 | -0.37 | 1291.86 | 1.00 | 17 | 7 | 27 | 1 | FALSE | 1.66 |
| colorectal cancer | KRAS_12 | ATR | Any mutation | 99 | 12 | Signature 15 | -1.54 | -3.42 | -0.10 | 1420.89 | 1.00 | 278 | 98 | 11 | 1 | FALSE | 1.15 |
| colorectal cancer | KRAS_12 | ATR | Any mutation | 270 | 32 | Signature 1A | -0.90 | -1.88 | -0.07 | 1390.21 | 1.00 | 550 | 264 | 26 | 6 | FALSE | 1.29 |
| colorectal cancer | KRAS_12 | ATR | Any mutation | 71 | 28 | Signature 6 | -0.82 | -1.99 | 0.22 | 1703.82 | 1.00 | 225 | 67 | 24 | 4 | FALSE | 0.86 |
| non-small cell lung cancer | KRAS_12 | ATR | Any mutation | 13 | 11 | Signature 13 | -0.21 | -1.42 | 0.96 | 1284.40 | 1.00 | 76 | 11 | 9 | 2 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12 | ATR | Any mutation | 79 | 16 | Signature 2 | -0.25 | -1.23 | 0.69 | 1477.61 | 1.00 | 233 | 75 | 12 | 4 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12 | ATR | Any mutation | 230 | 60 | Signature 4 | -0.61 | -1.24 | -0.03 | 1042.77 | 1.00 | 426 | 218 | 48 | 12 | FALSE | 1.28 |
| colorectal cancer | KRAS_12 | ATR | Any mutation | 448 | 100 | Signature overall | -1.29 | -2.76 | 0.16 | 1414.22 | 1.00 | 1070 | 436 | 88 | 12 | FALSE | 1.09 |
| non-small cell lung cancer | KRAS_12 | ATR | Any mutation | 322 | 87 | Signature overall | -0.35 | -1.35 | 0.67 | 1259.20 | 1.00 | 735 | 304 | 69 | 18 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12 | PDGFRA | Any mutation | 79 | 20 | Signature 2 | -0.13 | -0.95 | 0.67 | 1561.42 | 1.00 | 230 | 74 | 15 | 5 | TRUE | 0.13 |
| non-small cell lung cancer | KRAS_12 | PDGFRA | Any mutation | 232 | 70 | Signature 4 | -0.18 | -0.70 | 0.34 | 1285.85 | 1.00 | 426 | 212 | 50 | 20 | TRUE | 0.30 |
| non-small cell lung cancer | KRAS_12 | PDGFRA | Any mutation | 311 | 90 | Signature overall | -0.16 | -1.22 | 0.95 | 1534.25 | 1.00 | 656 | 286 | 65 | 25 | TRUE | 0.12 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 8 | 17 | Signature 10 | -0.13 | -1.29 | 0.75 | 1513.72 | 1.00 | 14 | 6 | 15 | 2 | TRUE | 0.10 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 102 | 48 | Signature 15 | 0.17 | -0.42 | 0.75 | 1363.64 | 1.00 | 257 | 87 | 33 | 15 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 280 | 144 | Signature 1A | 0.16 | -0.18 | 0.52 | 1502.03 | 1.00 | 493 | 229 | 93 | 51 | TRUE | 0.41 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 73 | 78 | Signature 6 | 0.30 | -0.21 | 0.80 | 1554.65 | 1.00 | 190 | 51 | 56 | 22 | TRUE | 0.60 |
| uterine cancer | KRAS_12 | FBXW7 | Any mutation | 19 | 17 | Signature 15 | -0.41 | -1.78 | 0.75 | 1477.95 | 1.00 | 75 | 17 | 15 | 2 | TRUE | 0.29 |
| uterine cancer | KRAS_12 | FBXW7 | Any mutation | 34 | 35 | Signature 1A | 0.02 | -0.84 | 0.84 | 1220.85 | 1.00 | 157 | 28 | 29 | 6 | TRUE | 0.01 |
| uterine cancer | KRAS_12 | FBXW7 | Any mutation | 13 | 18 | Signature 6 | -0.27 | -1.52 | 0.95 | 1346.25 | 1.00 | 68 | 11 | 16 | 2 | TRUE | 0.17 |
| colorectal cancer | KRAS_12 | FBXW7 | Any mutation | 463 | 287 | Signature overall | 0.13 | -0.56 | 0.78 | 1584.83 | 1.00 | 954 | 373 | 197 | 90 | TRUE | 0.16 |
| uterine cancer | KRAS_12 | FBXW7 | Any mutation | 69 | 101 | Signature overall | -0.10 | -1.17 | 1.14 | 1463.36 | 1.00 | 318 | 56 | 88 | 13 | TRUE | 0.06 |
| uterine cancer | KRAS_12 | NSD1 | Any mutation | 35 | 22 | Signature 1A | 0.16 | -0.98 | 1.21 | 1551.67 | 1.00 | 170 | 31 | 18 | 4 | FALSE | 0.11 |
| uterine cancer | KRAS_12 | NSD1 | Any mutation | 16 | 29 | Signature 6 | 0.82 | -0.27 | 1.88 | 1432.87 | 1.00 | 69 | 9 | 22 | 7 | FALSE | 0.90 |
| uterine cancer | KRAS_12 | NSD1 | Any mutation | 53 | 88 | Signature overall | 0.50 | -1.35 | 2.36 | 1459.33 | 1.00 | 256 | 40 | 75 | 13 | FALSE | 0.22 |
| colorectal cancer | KRAS_12 | FLT4 | Any mutation | 8 | 14 | Signature 10 | -0.95 | -2.77 | 0.46 | 1408.08 | 1.00 | 20 | 7 | 13 | 1 | TRUE | 0.64 |
| colorectal cancer | KRAS_12 | FLT4 | Any mutation | 100 | 14 | Signature 15 | 0.25 | -0.75 | 1.33 | 1480.89 | 1.00 | 278 | 94 | 8 | 6 | TRUE | 0.19 |
| colorectal cancer | KRAS_12 | FLT4 | Any mutation | 273 | 54 | Signature 1A | -0.21 | -0.86 | 0.36 | 1118.90 | 1.00 | 538 | 257 | 38 | 16 | TRUE | 0.32 |
| colorectal cancer | KRAS_12 | FLT4 | Any mutation | 69 | 51 | Signature 6 | -1.18 | -2.21 | -0.34 | 1446.26 | 1.00 | 201 | 65 | 47 | 4 | TRUE | 1.83 |
| non-small cell lung cancer | KRAS_12 | FLT4 | Any mutation | 79 | 11 | Signature 2 | -0.81 | -2.39 | 0.22 | 434.51 | 1.01 | 235 | 78 | 10 | 1 | TRUE | 0.66 |
| non-small cell lung cancer | KRAS_12 | FLT4 | Any mutation | 230 | 36 | Signature 4 | -0.48 | -1.32 | 0.20 | 729.32 | 1.00 | 447 | 221 | 27 | 9 | TRUE | 0.68 |
| colorectal cancer | KRAS_12 | FLT4 | Any mutation | 450 | 133 | Signature overall | -0.52 | -1.71 | 0.63 | 1484.76 | 1.00 | 1037 | 423 | 106 | 27 | TRUE | 0.44 |
| non-small cell lung cancer | KRAS_12 | FLT4 | Any mutation | 309 | 47 | Signature overall | -0.63 | -2.23 | 0.49 | 1048.82 | 1.00 | 682 | 299 | 37 | 10 | TRUE | 0.42 |
| colorectal cancer | KRAS_12 | PTPRD | Any mutation | 8 | 19 | Signature 10 | -1.33 | -3.06 | 0.01 | 1462.98 | 1.00 | 19 | 7 | 18 | 1 | FALSE | 1.06 |
| colorectal cancer | KRAS_12 | PTPRD | Any mutation | 99 | 14 | Signature 15 | 0.08 | -1.04 | 1.15 | 1346.90 | 1.00 | 279 | 94 | 9 | 5 | FALSE | 0.05 |
| colorectal cancer | KRAS_12 | PTPRD | Any mutation | 270 | 31 | Signature 1A | -0.60 | -1.45 | 0.17 | 1564.10 | 1.00 | 554 | 263 | 24 | 7 | FALSE | 0.83 |
| colorectal cancer | KRAS_12 | PTPRD | Any mutation | 69 | 31 | Signature 6 | -1.03 | -2.26 | -0.05 | 1487.85 | 1.00 | 219 | 66 | 28 | 3 | FALSE | 1.17 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 60 | 22 | Signature 18 | 0.55 | -0.25 | 1.30 | 1437.35 | 1.00 | 83 | 48 | 10 | 12 | FALSE | 0.76 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 44 | 12 | Signature 1A | 0.17 | -0.89 | 1.18 | 1335.32 | 1.00 | 213 | 41 | 9 | 3 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 79 | 33 | Signature 2 | 0.13 | -0.64 | 0.84 | 1386.53 | 1.00 | 222 | 70 | 24 | 9 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 13 | 12 | Signature 20 | 0.00 | -1.15 | 1.09 | 1520.53 | 1.00 | 56 | 11 | 10 | 2 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 50 | 18 | Signature 3 | 0.40 | -0.50 | 1.27 | 1414.52 | 1.00 | 181 | 44 | 12 | 6 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 240 | 195 | Signature 4 | -0.25 | -0.61 | 0.09 | 1584.52 | 1.00 | 366 | 186 | 141 | 54 | FALSE | 0.80 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 145 | 18 | Signature R2 | -0.32 | -1.14 | 0.51 | 1470.43 | 1.00 | 48 | 134 | 7 | 11 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 9 | 11 | Signature U2 | -0.01 | -1.20 | 1.11 | 1324.78 | 1.00 | 28 | 7 | 9 | 2 | FALSE | 0.01 |
| colorectal cancer | KRAS_12 | PTPRD | Any mutation | 446 | 95 | Signature overall | -0.73 | -2.01 | 0.58 | 1414.75 | 1.00 | 1071 | 430 | 79 | 16 | FALSE | 0.57 |
| non-small cell lung cancer | KRAS_12 | PTPRD | Any mutation | 640 | 321 | Signature overall | 0.09 | -0.53 | 0.78 | 1430.83 | 1.00 | 1197 | 541 | 222 | 99 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12 | PIK3C2G | Any mutation | 79 | 17 | Signature 2 | -0.92 | -2.04 | 0.05 | 1496.82 | 1.00 | 229 | 77 | 15 | 2 | FALSE | 1.08 |
| non-small cell lung cancer | KRAS_12 | PIK3C2G | Any mutation | 230 | 57 | Signature 4 | -0.81 | -1.46 | -0.17 | 1539.75 | 1.00 | 430 | 219 | 46 | 11 | FALSE | 1.82 |
| non-small cell lung cancer | KRAS_12 | PIK3C2G | Any mutation | 309 | 74 | Signature overall | -0.84 | -2.07 | 0.27 | 1462.00 | 1.00 | 659 | 296 | 61 | 13 | FALSE | 0.81 |
| colorectal cancer | KRAS_12 | CREBBP | Any mutation | 8 | 15 | Signature 10 | -1.10 | -2.72 | 0.28 | 1528.49 | 1.00 | 19 | 7 | 14 | 1 | TRUE | 0.82 |
| colorectal cancer | KRAS_12 | CREBBP | Any mutation | 99 | 27 | Signature 15 | -0.83 | -1.80 | 0.08 | 1579.32 | 1.00 | 268 | 95 | 23 | 4 | TRUE | 1.05 |
| colorectal cancer | KRAS_12 | CREBBP | Any mutation | 273 | 45 | Signature 1A | -0.03 | -0.63 | 0.56 | 1475.15 | 1.00 | 548 | 257 | 29 | 16 | TRUE | 0.03 |
| colorectal cancer | KRAS_12 | CREBBP | Any mutation | 73 | 80 | Signature 6 | -1.22 | -2.02 | -0.48 | 1580.88 | 1.00 | 189 | 66 | 73 | 7 | TRUE | 2.72 |
| non-small cell lung cancer | KRAS_12 | CREBBP | Any mutation | 44 | 12 | Signature 1A | 0.08 | -0.77 | 0.87 | 1474.04 | 1.00 | 213 | 41 | 9 | 3 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12 | CREBBP | Any mutation | 79 | 15 | Signature 2 | -0.16 | -0.99 | 0.56 | 1453.64 | 1.00 | 232 | 77 | 13 | 2 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12 | CREBBP | Any mutation | 50 | 11 | Signature 3 | 0.06 | -0.76 | 0.80 | 1546.63 | 1.00 | 185 | 47 | 8 | 3 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12 | CREBBP | Any mutation | 230 | 44 | Signature 4 | 0.07 | -0.51 | 0.64 | 1410.16 | 1.00 | 448 | 215 | 29 | 15 | TRUE | 0.09 |
| colorectal cancer | KRAS_12 | CREBBP | Any mutation | 453 | 167 | Signature overall | -0.76 | -1.86 | 0.31 | 1685.77 | 1.00 | 1024 | 425 | 139 | 28 | TRUE | 0.79 |
| non-small cell lung cancer | KRAS_12 | CREBBP | Any mutation | 403 | 82 | Signature overall | 0.01 | -0.68 | 0.64 | 1486.90 | 1.00 | 1078 | 380 | 59 | 23 | TRUE | 0.01 |
| colorectal cancer | KRAS_12 | AXIN2 | Any mutation | 99 | 17 | Signature 15 | -0.19 | -1.29 | 0.81 | 1599.77 | 1.00 | 276 | 94 | 12 | 5 | TRUE | 0.14 |
| colorectal cancer | KRAS_12 | AXIN2 | Any mutation | 270 | 36 | Signature 1A | -0.35 | -1.07 | 0.34 | 1468.08 | 1.00 | 553 | 260 | 26 | 10 | TRUE | 0.47 |
| colorectal cancer | KRAS_12 | AXIN2 | Any mutation | 69 | 40 | Signature 6 | -2.35 | -5.20 | -0.83 | 1436.58 | 1.00 | 212 | 69 | 40 | 0 | TRUE | 1.41 |
| colorectal cancer | KRAS_12 | AXIN2 | Any mutation | 438 | 93 | Signature overall | -0.92 | -2.67 | 0.51 | 1288.46 | 1.00 | 1041 | 423 | 78 | 15 | TRUE | 0.63 |
| non-small cell lung cancer | KRAS_12 | DOT1L | Any mutation | 79 | 16 | Signature 2 | -0.24 | -1.21 | 0.58 | 1440.19 | 1.00 | 232 | 76 | 13 | 3 | FALSE | 0.23 |
| non-small cell lung cancer | KRAS_12 | DOT1L | Any mutation | 230 | 38 | Signature 4 | -0.12 | -0.78 | 0.48 | 1603.80 | 1.00 | 447 | 218 | 26 | 12 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12 | DOT1L | Any mutation | 309 | 54 | Signature overall | -0.18 | -1.14 | 0.72 | 1576.03 | 1.00 | 679 | 294 | 39 | 15 | FALSE | 0.15 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 8 | 16 | Signature 10 | -1.45 | -3.63 | -0.02 | 1598.46 | 1.00 | 16 | 8 | 16 | 0 | FALSE | 0.93 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 96 | 38 | Signature 15 | 0.10 | -0.61 | 0.78 | 1320.02 | 1.00 | 260 | 84 | 26 | 12 | FALSE | 0.11 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 264 | 95 | Signature 1A | -0.07 | -0.55 | 0.37 | 1516.83 | 1.00 | 505 | 234 | 65 | 30 | FALSE | 0.12 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 69 | 83 | Signature 6 | -0.90 | -1.59 | -0.26 | 1581.63 | 1.00 | 185 | 60 | 74 | 9 | FALSE | 2.03 |
| colorectal cancer | KRAS_12 | PTPRS | Any mutation | 437 | 232 | Signature overall | -0.57 | -1.72 | 0.32 | 1356.28 | 1.00 | 966 | 386 | 181 | 51 | FALSE | 0.57 |
| colorectal cancer | KRAS_12 | SMARCA4 | Any mutation | 100 | 22 | Signature 15 | -0.13 | -0.97 | 0.79 | 1481.89 | 1.00 | 276 | 93 | 15 | 7 | FALSE | 0.12 |
| colorectal cancer | KRAS_12 | SMARCA4 | Any mutation | 273 | 74 | Signature 1A | -0.37 | -0.90 | 0.12 | 1524.65 | 1.00 | 531 | 254 | 55 | 19 | FALSE | 0.81 |
| colorectal cancer | KRAS_12 | SMARCA4 | Any mutation | 70 | 52 | Signature 6 | -0.95 | -1.92 | -0.20 | 1541.77 | 1.00 | 208 | 66 | 48 | 4 | FALSE | 1.56 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 13 | 11 | Signature 13 | 0.13 | -1.02 | 1.20 | 1502.63 | 1.00 | 76 | 11 | 9 | 2 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 57 | 14 | Signature 18 | 0.16 | -0.72 | 1.03 | 1632.32 | 1.00 | 86 | 51 | 8 | 6 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 44 | 17 | Signature 1A | 0.01 | -0.98 | 0.96 | 1611.56 | 1.00 | 210 | 41 | 14 | 3 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 81 | 33 | Signature 2 | -0.01 | -0.80 | 0.69 | 1446.82 | 1.00 | 225 | 73 | 25 | 8 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 50 | 16 | Signature 3 | 0.66 | -0.24 | 1.55 | 1425.86 | 1.00 | 185 | 43 | 9 | 7 | FALSE | 0.83 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 231 | 104 | Signature 4 | -0.21 | -0.64 | 0.22 | 1498.06 | 1.00 | 403 | 202 | 75 | 29 | FALSE | 0.45 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 20 | 15 | Signature 7 | 0.05 | -1.00 | 1.04 | 1615.90 | 1.00 | 76 | 17 | 12 | 3 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 144 | 15 | Signature R2 | -0.11 | -0.98 | 0.74 | 1412.04 | 1.00 | 49 | 134 | 5 | 10 | FALSE | 0.10 |
| uterine cancer | KRAS_12 | SMARCA4 | Any mutation | 19 | 14 | Signature 15 | -0.38 | -1.57 | 0.78 | 1576.96 | 1.00 | 82 | 17 | 12 | 2 | FALSE | 0.27 |
| uterine cancer | KRAS_12 | SMARCA4 | Any mutation | 34 | 21 | Signature 1A | -0.53 | -1.69 | 0.50 | 1450.77 | 1.00 | 168 | 32 | 19 | 2 | FALSE | 0.47 |
| uterine cancer | KRAS_12 | SMARCA4 | Any mutation | 15 | 30 | Signature 6 | -0.40 | -1.56 | 0.59 | 1674.36 | 1.00 | 69 | 12 | 27 | 3 | FALSE | 0.33 |
| colorectal cancer | KRAS_12 | SMARCA4 | Any mutation | 443 | 148 | Signature overall | -0.47 | -1.31 | 0.43 | 1613.71 | 1.00 | 1015 | 413 | 118 | 30 | FALSE | 0.54 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Any mutation | 640 | 225 | Signature overall | 0.08 | -0.56 | 0.72 | 1568.09 | 1.00 | 1310 | 572 | 157 | 68 | FALSE | 0.10 |
| uterine cancer | KRAS_12 | SMARCA4 | Any mutation | 69 | 76 | Signature overall | -0.39 | -1.51 | 0.66 | 1498.46 | 1.00 | 348 | 61 | 68 | 8 | FALSE | 0.32 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 8 | 23 | Signature 10 | -2.43 | -4.87 | -0.74 | 1501.07 | 1.00 | 16 | 8 | 23 | 0 | FALSE | 1.56 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 99 | 25 | Signature 15 | -1.96 | -3.72 | -0.66 | 1401.01 | 1.00 | 263 | 98 | 24 | 1 | FALSE | 1.98 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 271 | 66 | Signature 1A | -0.38 | -0.99 | 0.17 | 1512.89 | 1.00 | 528 | 253 | 48 | 18 | FALSE | 0.70 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 70 | 43 | Signature 6 | -0.83 | -1.77 | 0.04 | 1430.22 | 1.00 | 207 | 64 | 37 | 6 | FALSE | 1.16 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 13 | 11 | Signature 13 | 0.31 | -1.02 | 1.55 | 1334.05 | 1.00 | 79 | 10 | 8 | 3 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 57 | 17 | Signature 18 | -0.39 | -1.34 | 0.62 | 1275.95 | 1.00 | 82 | 52 | 12 | 5 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 44 | 11 | Signature 1A | -1.02 | -2.73 | 0.28 | 1475.34 | 1.00 | 214 | 44 | 11 | 0 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 80 | 30 | Signature 2 | 0.69 | -0.05 | 1.40 | 1515.64 | 1.00 | 229 | 67 | 17 | 13 | FALSE | 1.20 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 50 | 19 | Signature 3 | -0.68 | -1.95 | 0.38 | 1242.27 | 1.01 | 178 | 48 | 17 | 2 | FALSE | 0.63 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 234 | 179 | Signature 4 | -0.80 | -1.24 | -0.41 | 1539.60 | 1.00 | 366 | 200 | 145 | 34 | FALSE | 3.92 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 146 | 23 | Signature R2 | -0.25 | -1.08 | 0.56 | 1229.78 | 1.00 | 49 | 131 | 8 | 15 | FALSE | 0.27 |
| colorectal cancer | KRAS_12 | PTPRT | Any mutation | 448 | 157 | Signature overall | -1.39 | -2.85 | -0.19 | 1431.58 | 1.00 | 1014 | 423 | 132 | 25 | FALSE | 1.41 |
| non-small cell lung cancer | KRAS_12 | PTPRT | Any mutation | 624 | 290 | Signature overall | -0.31 | -1.13 | 0.45 | 1519.65 | 1.00 | 1197 | 552 | 218 | 72 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12 | HGF | Any mutation | 79 | 20 | Signature 2 | 0.28 | -0.65 | 1.13 | 1540.43 | 1.00 | 232 | 72 | 13 | 7 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12 | HGF | Any mutation | 230 | 89 | Signature 4 | -0.43 | -0.95 | 0.05 | 1520.09 | 1.00 | 414 | 208 | 67 | 22 | FALSE | 1.02 |
| non-small cell lung cancer | KRAS_12 | HGF | Any mutation | 145 | 12 | Signature R2 | -1.05 | -2.14 | -0.06 | 1530.65 | 1.00 | 48 | 140 | 7 | 5 | FALSE | 1.26 |
| non-small cell lung cancer | KRAS_12 | HGF | Any mutation | 454 | 121 | Signature overall | -0.38 | -1.72 | 0.99 | 1441.41 | 1.00 | 694 | 420 | 87 | 34 | FALSE | 0.23 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 9 | 23 | Signature 10 | 0.06 | -0.82 | 0.92 | 1617.61 | 1.00 | 15 | 5 | 19 | 4 | TRUE | 0.05 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 99 | 63 | Signature 15 | 0.01 | -0.53 | 0.55 | 1402.09 | 1.00 | 244 | 83 | 47 | 16 | TRUE | 0.02 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 16 | 19 | Signature 18 | 0.19 | -0.63 | 1.00 | 1450.46 | 1.00 | 19 | 10 | 13 | 6 | TRUE | 0.19 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 276 | 191 | Signature 1A | 0.36 | 0.03 | 0.66 | 1431.47 | 1.00 | 471 | 202 | 117 | 74 | TRUE | 1.57 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 38 | 43 | Signature 2 | 0.88 | 0.23 | 1.54 | 1455.99 | 1.00 | 29 | 13 | 18 | 25 | TRUE | 2.06 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 72 | 95 | Signature 6 | 0.05 | -0.46 | 0.55 | 1469.65 | 1.00 | 180 | 51 | 74 | 21 | TRUE | 0.07 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 14 | 13 | Signature 13 | 1.08 | -0.06 | 2.28 | 1260.66 | 1.00 | 78 | 8 | 7 | 6 | TRUE | 1.20 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 44 | 13 | Signature 1A | 0.16 | -0.95 | 1.18 | 1496.81 | 1.00 | 213 | 41 | 10 | 3 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 80 | 82 | Signature 2 | 0.14 | -0.43 | 0.67 | 1425.35 | 1.00 | 189 | 59 | 61 | 21 | TRUE | 0.21 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 13 | 16 | Signature 20 | 0.13 | -0.97 | 1.19 | 1521.78 | 1.00 | 51 | 10 | 13 | 3 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 50 | 15 | Signature 3 | -0.89 | -2.46 | 0.27 | 1429.57 | 1.00 | 178 | 50 | 15 | 0 | TRUE | 0.73 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 230 | 38 | Signature 4 | -0.18 | -0.83 | 0.43 | 1429.53 | 1.00 | 446 | 219 | 27 | 11 | TRUE | 0.24 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 22 | 50 | Signature 15 | 0.32 | -0.51 | 1.13 | 1513.21 | 1.00 | 56 | 12 | 40 | 10 | TRUE | 0.35 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 40 | 138 | Signature 1A | 0.86 | 0.22 | 1.52 | 1476.29 | 1.00 | 103 | 11 | 109 | 29 | TRUE | 1.98 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 8 | 25 | Signature 20 | 0.28 | -0.84 | 1.35 | 1425.99 | 1.00 | 15 | 4 | 21 | 4 | TRUE | 0.20 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 11 | 21 | Signature 3 | 1.34 | 0.29 | 2.53 | 1530.71 | 1.00 | 24 | 2 | 12 | 9 | TRUE | 1.78 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 20 | 85 | Signature 6 | 0.93 | 0.05 | 1.87 | 1405.05 | 1.00 | 36 | 3 | 68 | 17 | TRUE | 1.36 |
| colorectal cancer | KRAS_12 | PIK3CA | Any mutation | 510 | 434 | Signature overall | 0.27 | -0.28 | 0.78 | 1449.21 | 1.00 | 958 | 364 | 288 | 146 | TRUE | 0.48 |
| non-small cell lung cancer | KRAS_12 | PIK3CA | Any mutation | 431 | 177 | Signature overall | 0.07 | -0.72 | 0.79 | 1461.66 | 1.00 | 1155 | 387 | 133 | 44 | TRUE | 0.06 |
| uterine cancer | KRAS_12 | PIK3CA | Any mutation | 112 | 459 | Signature overall | 0.47 | -0.24 | 1.18 | 1394.09 | 1.00 | 320 | 36 | 383 | 76 | TRUE | 0.67 |
| colorectal cancer | KRAS_12 | ALK | Any mutation | 8 | 13 | Signature 10 | -2.43 | -5.86 | -0.39 | 1360.21 | 1.00 | 18 | 8 | 13 | 0 | TRUE | 1.10 |
| colorectal cancer | KRAS_12 | ALK | Any mutation | 99 | 16 | Signature 15 | 0.14 | -0.99 | 1.18 | 1299.11 | 1.00 | 276 | 93 | 10 | 6 | TRUE | 0.10 |
| colorectal cancer | KRAS_12 | ALK | Any mutation | 270 | 35 | Signature 1A | -0.62 | -1.46 | 0.14 | 1410.26 | 1.00 | 551 | 262 | 27 | 8 | TRUE | 0.94 |
| colorectal cancer | KRAS_12 | ALK | Any mutation | 69 | 37 | Signature 6 | -2.88 | -6.02 | -1.08 | 1316.24 | 1.00 | 212 | 69 | 37 | 0 | TRUE | 1.64 |
| non-small cell lung cancer | KRAS_12 | ALK | Any mutation | 79 | 24 | Signature 2 | 0.22 | -0.48 | 1.07 | 1501.99 | 1.00 | 231 | 71 | 16 | 8 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12 | ALK | Any mutation | 230 | 72 | Signature 4 | 0.04 | -0.46 | 0.55 | 1457.71 | 1.00 | 428 | 207 | 49 | 23 | TRUE | 0.06 |
| colorectal cancer | KRAS_12 | ALK | Any mutation | 446 | 101 | Signature overall | -1.42 | -3.30 | 0.07 | 1416.42 | 1.00 | 1057 | 432 | 87 | 14 | TRUE | 1.00 |
| non-small cell lung cancer | KRAS_12 | ALK | Any mutation | 309 | 96 | Signature overall | 0.14 | -0.82 | 1.25 | 1255.80 | 1.00 | 659 | 278 | 65 | 31 | TRUE | 0.10 |
| colorectal cancer | KRAS_12 | RNF43 | Any mutation | 102 | 31 | Signature 15 | -0.30 | -1.18 | 0.59 | 1451.02 | 1.00 | 270 | 94 | 23 | 8 | TRUE | 0.30 |
| colorectal cancer | KRAS_12 | RNF43 | Any mutation | 275 | 93 | Signature 1A | -0.76 | -1.30 | -0.26 | 1531.28 | 1.00 | 524 | 257 | 75 | 18 | TRUE | 2.32 |
| colorectal cancer | KRAS_12 | RNF43 | Any mutation | 69 | 102 | Signature 6 | -1.54 | -2.40 | -0.80 | 1430.48 | 1.00 | 175 | 63 | 96 | 6 | TRUE | 3.94 |
| colorectal cancer | KRAS_12 | RNF43 | Any mutation | 446 | 226 | Signature overall | -0.83 | -1.98 | 0.26 | 1362.24 | 1.00 | 969 | 414 | 194 | 32 | TRUE | 0.85 |
| colorectal cancer | KRAS_12 | PTEN | Any mutation | 8 | 13 | Signature 10 | -0.90 | -2.40 | 0.37 | 1470.10 | 1.00 | 18 | 7 | 12 | 1 | TRUE | 0.73 |
| colorectal cancer | KRAS_12 | PTEN | Any mutation | 99 | 22 | Signature 15 | 0.06 | -0.85 | 0.95 | 1530.98 | 1.00 | 273 | 91 | 14 | 8 | TRUE | 0.05 |
| colorectal cancer | KRAS_12 | PTEN | Any mutation | 270 | 64 | Signature 1A | -1.04 | -1.74 | -0.41 | 1755.45 | 1.00 | 536 | 261 | 55 | 9 | TRUE | 2.68 |
| colorectal cancer | KRAS_12 | PTEN | Any mutation | 71 | 57 | Signature 6 | -0.77 | -1.53 | -0.04 | 1414.13 | 1.00 | 210 | 64 | 50 | 7 | TRUE | 1.33 |
| non-small cell lung cancer | KRAS_12 | PTEN | Any mutation | 79 | 27 | Signature 2 | -0.76 | -1.76 | 0.14 | 1276.73 | 1.00 | 225 | 75 | 23 | 4 | TRUE | 0.91 |
| non-small cell lung cancer | KRAS_12 | PTEN | Any mutation | 230 | 27 | Signature 4 | -0.82 | -1.76 | 0.00 | 1417.50 | 1.00 | 451 | 225 | 22 | 5 | TRUE | 1.21 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 27 | 61 | Signature 15 | 1.02 | 0.30 | 1.73 | 1352.66 | 1.00 | 61 | 8 | 42 | 19 | TRUE | 2.24 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 47 | 155 | Signature 1A | 0.78 | 0.21 | 1.35 | 1423.28 | 1.00 | 114 | 14 | 122 | 33 | TRUE | 2.03 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 7 | 26 | Signature 2 | 0.48 | -0.45 | 1.49 | 1450.01 | 1.00 | 25 | 3 | 22 | 4 | TRUE | 0.48 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 10 | 28 | Signature 20 | 0.91 | 0.00 | 1.90 | 1573.07 | 1.00 | 19 | 2 | 20 | 8 | TRUE | 1.23 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 13 | 17 | Signature 3 | 1.22 | 0.30 | 2.17 | 1423.84 | 1.00 | 30 | 4 | 8 | 9 | TRUE | 2.04 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 19 | 104 | Signature 6 | 0.15 | -0.74 | 0.99 | 1490.77 | 1.00 | 24 | 6 | 91 | 13 | TRUE | 0.14 |
| colorectal cancer | KRAS_12 | PTEN | Any mutation | 448 | 156 | Signature overall | -0.65 | -1.64 | 0.29 | 1446.84 | 1.00 | 1037 | 423 | 131 | 25 | TRUE | 0.74 |
| non-small cell lung cancer | KRAS_12 | PTEN | Any mutation | 309 | 54 | Signature overall | -0.74 | -2.08 | 0.68 | 1431.85 | 1.00 | 676 | 300 | 45 | 9 | TRUE | 0.53 |
| uterine cancer | KRAS_12 | PTEN | Any mutation | 142 | 545 | Signature overall | 0.54 | 0.00 | 1.09 | 1358.31 | 1.00 | 346 | 43 | 446 | 99 | TRUE | 1.23 |
| colorectal cancer | KRAS_12 | BCOR | Any mutation | 8 | 11 | Signature 10 | -1.20 | -3.24 | 0.55 | 1400.32 | 1.00 | 19 | 7 | 10 | 1 | FALSE | 0.68 |
| colorectal cancer | KRAS_12 | BCOR | Any mutation | 99 | 13 | Signature 15 | -0.07 | -1.29 | 1.05 | 1216.44 | 1.00 | 278 | 95 | 9 | 4 | FALSE | 0.04 |
| colorectal cancer | KRAS_12 | BCOR | Any mutation | 270 | 27 | Signature 1A | 0.36 | -0.41 | 1.13 | 1473.05 | 1.00 | 560 | 258 | 15 | 12 | FALSE | 0.45 |
| colorectal cancer | KRAS_12 | BCOR | Any mutation | 69 | 49 | Signature 6 | -2.95 | -5.78 | -1.22 | 1439.85 | 1.00 | 207 | 69 | 49 | 0 | FALSE | 1.93 |
| non-small cell lung cancer | KRAS_12 | BCOR | Any mutation | 80 | 13 | Signature 2 | 0.34 | -0.60 | 1.22 | 1289.78 | 1.00 | 236 | 76 | 9 | 4 | FALSE | 0.34 |
| non-small cell lung cancer | KRAS_12 | BCOR | Any mutation | 233 | 52 | Signature 4 | 0.52 | -0.02 | 1.05 | 1440.07 | 1.00 | 447 | 210 | 29 | 23 | FALSE | 1.22 |
| uterine cancer | KRAS_12 | BCOR | Any mutation | 34 | 30 | Signature 1A | -0.15 | -1.23 | 0.85 | 1451.10 | 1.00 | 161 | 30 | 26 | 4 | FALSE | 0.11 |
| uterine cancer | KRAS_12 | BCOR | Any mutation | 15 | 23 | Signature 6 | 1.15 | -0.03 | 2.38 | 1348.83 | 1.00 | 72 | 8 | 16 | 7 | FALSE | 1.22 |
| colorectal cancer | KRAS_12 | BCOR | Any mutation | 446 | 100 | Signature overall | -0.94 | -2.70 | 0.61 | 1615.38 | 1.00 | 1064 | 429 | 83 | 17 | FALSE | 0.58 |
| non-small cell lung cancer | KRAS_12 | BCOR | Any mutation | 313 | 65 | Signature overall | 0.42 | -0.74 | 1.46 | 1462.72 | 1.00 | 683 | 286 | 38 | 27 | FALSE | 0.32 |
| uterine cancer | KRAS_12 | BCOR | Any mutation | 50 | 83 | Signature overall | 0.42 | -1.32 | 2.36 | 1458.17 | 1.00 | 255 | 38 | 71 | 12 | FALSE | 0.18 |
| colorectal cancer | KRAS_12 | CTNNB1 | Any mutation | 99 | 22 | Signature 15 | 0.13 | -0.55 | 0.78 | 1361.26 | 1.00 | 271 | 93 | 16 | 6 | TRUE | 0.15 |
| colorectal cancer | KRAS_12 | CTNNB1 | Any mutation | 273 | 61 | Signature 1A | 0.44 | -0.04 | 0.89 | 1257.77 | 1.00 | 542 | 245 | 33 | 28 | TRUE | 1.16 |
| colorectal cancer | KRAS_12 | CTNNB1 | Any mutation | 70 | 33 | Signature 6 | 0.06 | -0.71 | 0.68 | 1562.90 | 1.00 | 217 | 64 | 27 | 6 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 44 | 11 | Signature 1A | -1.33 | -2.79 | -0.09 | 1563.10 | 1.00 | 212 | 43 | 10 | 1 | TRUE | 1.29 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 79 | 14 | Signature 2 | -1.46 | -2.85 | -0.29 | 1382.18 | 1.00 | 232 | 78 | 13 | 1 | TRUE | 1.62 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 50 | 17 | Signature 3 | -1.03 | -2.26 | 0.20 | 1334.03 | 1.00 | 179 | 47 | 14 | 3 | TRUE | 1.03 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 230 | 16 | Signature 4 | -1.78 | -3.25 | -0.62 | 1489.01 | 1.00 | 456 | 230 | 16 | 0 | TRUE | 2.07 |
| uterine cancer | KRAS_12 | CTNNB1 | Any mutation | 19 | 11 | Signature 15 | -1.95 | -3.91 | -0.44 | 1389.39 | 1.00 | 80 | 19 | 11 | 0 | TRUE | 1.52 |
| uterine cancer | KRAS_12 | CTNNB1 | Any mutation | 34 | 31 | Signature 1A | -1.60 | -3.15 | -0.35 | 1346.65 | 1.00 | 157 | 32 | 29 | 2 | TRUE | 1.57 |
| uterine cancer | KRAS_12 | CTNNB1 | Any mutation | 13 | 19 | Signature 6 | -1.71 | -3.42 | -0.30 | 1372.71 | 1.00 | 68 | 12 | 18 | 1 | TRUE | 1.44 |
| colorectal cancer | KRAS_12 | CTNNB1 | Any mutation | 442 | 116 | Signature overall | 0.22 | -0.46 | 0.84 | 1497.94 | 1.00 | 1030 | 402 | 76 | 40 | TRUE | 0.30 |
| non-small cell lung cancer | KRAS_12 | CTNNB1 | Any mutation | 403 | 58 | Signature overall | -1.39 | -2.62 | -0.34 | 1470.23 | 1.00 | 1079 | 398 | 53 | 5 | TRUE | 1.87 |
| uterine cancer | KRAS_12 | CTNNB1 | Any mutation | 68 | 83 | Signature overall | -1.78 | -3.28 | -0.53 | 1403.44 | 1.00 | 372 | 65 | 80 | 3 | TRUE | 1.77 |
| cancer of unknown primary | KRAS_12 | ARID1A | Any mutation | 32 | 22 | Signature 1A | -0.55 | -1.47 | 0.34 | 1344.46 | 1.00 | 73 | 27 | 17 | 5 | TRUE | 0.63 |
| cancer of unknown primary | KRAS_12 | ARID1A | Any mutation | 6 | 13 | Signature 2 | -0.71 | -1.94 | 0.48 | 1384.67 | 1.00 | 38 | 5 | 12 | 1 | TRUE | 0.64 |
| cancer of unknown primary | KRAS_12 | ARID1A | Any mutation | 18 | 12 | Signature 4 | -0.67 | -1.74 | 0.37 | 1453.63 | 1.00 | 53 | 16 | 10 | 2 | TRUE | 0.69 |
| colorectal cancer | KRAS_12 | ARID1A | Any mutation | 8 | 13 | Signature 10 | -0.92 | -2.08 | 0.11 | 1472.08 | 1.00 | 19 | 7 | 12 | 1 | TRUE | 1.05 |
| colorectal cancer | KRAS_12 | ARID1A | Any mutation | 100 | 39 | Signature 15 | -0.92 | -1.68 | -0.16 | 1624.57 | 1.00 | 267 | 95 | 34 | 5 | TRUE | 1.82 |
| colorectal cancer | KRAS_12 | ARID1A | Any mutation | 277 | 130 | Signature 1A | -0.61 | -1.04 | -0.18 | 1316.56 | 1.00 | 505 | 248 | 101 | 29 | TRUE | 2.26 |
| colorectal cancer | KRAS_12 | ARID1A | Any mutation | 72 | 99 | Signature 6 | -0.86 | -1.43 | -0.31 | 1563.01 | 1.00 | 183 | 60 | 87 | 12 | TRUE | 2.57 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 13 | 17 | Signature 13 | -1.10 | -2.84 | 0.23 | 1501.91 | 1.00 | 70 | 13 | 17 | 0 | TRUE | 0.80 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 60 | 12 | Signature 18 | 0.66 | -0.29 | 1.69 | 1533.61 | 1.00 | 89 | 52 | 4 | 8 | TRUE | 0.69 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 83 | 52 | Signature 2 | 0.48 | -0.13 | 1.09 | 1560.64 | 1.00 | 216 | 65 | 34 | 18 | TRUE | 0.93 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 50 | 11 | Signature 3 | -0.34 | -1.62 | 0.80 | 1437.61 | 1.00 | 184 | 48 | 9 | 2 | TRUE | 0.24 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 231 | 86 | Signature 4 | -0.85 | -1.44 | -0.32 | 1382.40 | 1.00 | 403 | 216 | 71 | 15 | TRUE | 2.59 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 144 | 13 | Signature R2 | -0.22 | -1.15 | 0.73 | 1526.42 | 1.00 | 50 | 135 | 4 | 9 | TRUE | 0.19 |
| pancreatic cancer | KRAS_12 | ARID1A | Any mutation | 116 | 12 | Signature 11 | -0.13 | -1.36 | 1.46 | 1429.53 | 1.00 | 9 | 105 | 1 | 11 | TRUE | 0.07 |
| pancreatic cancer | KRAS_12 | ARID1A | Any mutation | 203 | 33 | Signature 1A | -0.18 | -0.99 | 0.74 | 1506.67 | 1.00 | 45 | 178 | 8 | 25 | TRUE | 0.17 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 24 | 58 | Signature 15 | 1.15 | 0.34 | 2.01 | 1632.07 | 1.00 | 62 | 8 | 42 | 16 | TRUE | 2.23 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 44 | 133 | Signature 1A | 1.07 | 0.39 | 1.73 | 1378.59 | 1.00 | 117 | 13 | 102 | 31 | TRUE | 2.74 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 8 | 23 | Signature 2 | 1.77 | 0.68 | 3.25 | 1413.79 | 1.00 | 29 | 0 | 15 | 8 | TRUE | 2.17 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 8 | 26 | Signature 20 | 1.39 | 0.30 | 2.58 | 1525.97 | 1.00 | 20 | 1 | 19 | 7 | TRUE | 1.73 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 18 | 121 | Signature 6 | 0.94 | -0.02 | 1.97 | 1388.56 | 1.00 | 28 | 2 | 105 | 16 | TRUE | 1.19 |
| cancer of unknown primary | KRAS_12 | ARID1A | Any mutation | 61 | 58 | Signature overall | -0.69 | -1.70 | 0.22 | 1432.84 | 1.00 | 180 | 53 | 50 | 8 | TRUE | 0.80 |
| colorectal cancer | KRAS_12 | ARID1A | Any mutation | 457 | 281 | Signature overall | -0.83 | -1.50 | -0.16 | 1598.64 | 1.00 | 974 | 410 | 234 | 47 | TRUE | 1.81 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Any mutation | 581 | 191 | Signature overall | -0.22 | -1.09 | 0.65 | 1479.30 | 1.00 | 1012 | 529 | 139 | 52 | TRUE | 0.21 |
| pancreatic cancer | KRAS_12 | ARID1A | Any mutation | 319 | 45 | Signature overall | -0.14 | -1.73 | 1.63 | 1291.11 | 1.00 | 54 | 283 | 9 | 36 | TRUE | 0.06 |
| uterine cancer | KRAS_12 | ARID1A | Any mutation | 107 | 445 | Signature overall | 0.99 | 0.22 | 1.77 | 1591.69 | 1.00 | 284 | 26 | 364 | 81 | TRUE | 1.90 |
| colorectal cancer | KRAS_12 | PIK3R1 | Any mutation | 10 | 17 | Signature 10 | -0.37 | -1.81 | 0.82 | 1611.21 | 1.00 | 17 | 7 | 14 | 3 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | PIK3R1 | Any mutation | 99 | 17 | Signature 15 | 0.41 | -0.52 | 1.37 | 1530.45 | 1.00 | 279 | 92 | 10 | 7 | TRUE | 0.41 |
| colorectal cancer | KRAS_12 | PIK3R1 | Any mutation | 271 | 31 | Signature 1A | -0.22 | -0.97 | 0.49 | 1565.14 | 1.00 | 555 | 262 | 22 | 9 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | PIK3R1 | Any mutation | 69 | 31 | Signature 6 | -0.89 | -2.04 | 0.09 | 1572.09 | 1.00 | 218 | 66 | 28 | 3 | TRUE | 0.97 |
| uterine cancer | KRAS_12 | PIK3R1 | Any mutation | 21 | 32 | Signature 15 | -0.10 | -0.92 | 0.88 | 903.38 | 1.00 | 71 | 12 | 23 | 9 | TRUE | 0.08 |
| uterine cancer | KRAS_12 | PIK3R1 | Any mutation | 35 | 59 | Signature 1A | -0.80 | -1.66 | -0.07 | 1124.90 | 1.00 | 137 | 31 | 55 | 4 | TRUE | 1.33 |
| uterine cancer | KRAS_12 | PIK3R1 | Any mutation | 7 | 13 | Signature 20 | -0.52 | -1.49 | 0.42 | 1506.29 | 1.00 | 25 | 5 | 11 | 2 | TRUE | 0.58 |
| uterine cancer | KRAS_12 | PIK3R1 | Any mutation | 13 | 31 | Signature 6 | -0.93 | -2.25 | -0.04 | 1393.70 | 1.00 | 61 | 13 | 31 | 0 | TRUE | 0.99 |
| colorectal cancer | KRAS_12 | PIK3R1 | Any mutation | 449 | 96 | Signature overall | -0.26 | -1.44 | 0.93 | 1645.63 | 1.00 | 1069 | 427 | 74 | 22 | TRUE | 0.18 |
| uterine cancer | KRAS_12 | PIK3R1 | Any mutation | 81 | 167 | Signature overall | -0.60 | -1.31 | 0.05 | 1273.35 | 1.00 | 333 | 64 | 150 | 17 | TRUE | 1.02 |
| colorectal cancer | KRAS_12 | FAT1 | Any mutation | 10 | 44 | Signature 10 | -1.47 | -2.82 | -0.32 | 1291.39 | 1.00 | 16 | 7 | 41 | 3 | FALSE | 1.69 |
| colorectal cancer | KRAS_12 | FAT1 | Any mutation | 99 | 29 | Signature 15 | -1.55 | -2.84 | -0.43 | 1543.88 | 1.00 | 268 | 97 | 27 | 2 | FALSE | 2.03 |
| colorectal cancer | KRAS_12 | FAT1 | Any mutation | 274 | 66 | Signature 1A | -0.60 | -1.24 | 0.01 | 1152.91 | 1.00 | 533 | 259 | 51 | 15 | FALSE | 1.30 |
| colorectal cancer | KRAS_12 | FAT1 | Any mutation | 70 | 67 | Signature 6 | -0.77 | -1.49 | -0.09 | 1303.60 | 1.00 | 200 | 61 | 58 | 9 | FALSE | 1.42 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 13 | 16 | Signature 13 | 0.08 | -0.93 | 0.99 | 1472.23 | 1.00 | 73 | 11 | 14 | 2 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 57 | 16 | Signature 18 | 0.52 | -0.21 | 1.30 | 1380.16 | 1.00 | 86 | 48 | 7 | 9 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 44 | 13 | Signature 1A | 0.36 | -0.55 | 1.26 | 1418.97 | 1.00 | 216 | 40 | 9 | 4 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 81 | 38 | Signature 2 | 0.13 | -0.53 | 0.78 | 1610.52 | 1.00 | 221 | 71 | 28 | 10 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 14 | 11 | Signature 20 | 0.52 | -0.43 | 1.52 | 1601.87 | 1.00 | 57 | 10 | 7 | 4 | FALSE | 0.53 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 50 | 13 | Signature 3 | 0.25 | -0.64 | 1.13 | 1455.46 | 1.00 | 184 | 46 | 9 | 4 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 232 | 121 | Signature 4 | -0.45 | -0.88 | -0.02 | 1354.61 | 1.00 | 390 | 205 | 94 | 27 | FALSE | 1.42 |
| uterine cancer | KRAS_12 | FAT1 | Any mutation | 19 | 14 | Signature 15 | -1.07 | -3.00 | 0.47 | 1573.42 | 1.00 | 80 | 18 | 13 | 1 | FALSE | 0.66 |
| uterine cancer | KRAS_12 | FAT1 | Any mutation | 34 | 24 | Signature 1A | -0.86 | -2.44 | 0.40 | 1463.07 | 1.00 | 167 | 32 | 22 | 2 | FALSE | 0.63 |
| uterine cancer | KRAS_12 | FAT1 | Any mutation | 13 | 37 | Signature 6 | 0.04 | -1.19 | 1.21 | 1542.98 | 1.00 | 65 | 8 | 32 | 5 | FALSE | 0.02 |
| colorectal cancer | KRAS_12 | FAT1 | Any mutation | 453 | 206 | Signature overall | -1.09 | -2.25 | 0.04 | 1536.97 | 1.00 | 1017 | 424 | 177 | 29 | FALSE | 1.21 |
| non-small cell lung cancer | KRAS_12 | FAT1 | Any mutation | 491 | 228 | Signature overall | 0.19 | -0.37 | 0.79 | 1658.26 | 1.00 | 1227 | 431 | 168 | 60 | FALSE | 0.28 |
| uterine cancer | KRAS_12 | FAT1 | Any mutation | 69 | 149 | Signature overall | -0.52 | -2.19 | 1.23 | 1570.00 | 1.00 | 324 | 58 | 138 | 11 | FALSE | 0.28 |
| colorectal cancer | KRAS_12 | CIC | Any mutation | 100 | 19 | Signature 15 | -0.49 | -1.29 | 0.33 | 1333.30 | 1.00 | 277 | 96 | 15 | 4 | TRUE | 0.61 |
| colorectal cancer | KRAS_12 | CIC | Any mutation | 271 | 58 | Signature 1A | -0.38 | -0.95 | 0.13 | 1397.35 | 1.00 | 541 | 256 | 43 | 15 | TRUE | 0.79 |
| colorectal cancer | KRAS_12 | CIC | Any mutation | 70 | 43 | Signature 6 | -0.66 | -1.47 | 0.07 | 1514.31 | 1.00 | 214 | 65 | 38 | 5 | TRUE | 1.03 |
| colorectal cancer | KRAS_12 | CIC | Any mutation | 441 | 120 | Signature overall | -0.52 | -1.27 | 0.26 | 1514.48 | 1.00 | 1032 | 417 | 96 | 24 | TRUE | 0.70 |
| colorectal cancer | KRAS_12 | NCOR1 | Any mutation | 8 | 16 | Signature 10 | -1.18 | -2.76 | 0.07 | 1200.85 | 1.00 | 17 | 7 | 15 | 1 | FALSE | 0.98 |
| colorectal cancer | KRAS_12 | NCOR1 | Any mutation | 99 | 22 | Signature 15 | -0.49 | -1.41 | 0.40 | 1390.44 | 1.00 | 272 | 94 | 17 | 5 | FALSE | 0.53 |
| colorectal cancer | KRAS_12 | NCOR1 | Any mutation | 272 | 44 | Signature 1A | -0.74 | -1.49 | -0.06 | 1608.52 | 1.00 | 545 | 263 | 35 | 9 | FALSE | 1.38 |
| colorectal cancer | KRAS_12 | NCOR1 | Any mutation | 69 | 43 | Signature 6 | -1.05 | -2.05 | -0.22 | 1417.08 | 1.00 | 213 | 65 | 39 | 4 | FALSE | 1.58 |
| non-small cell lung cancer | KRAS_12 | NCOR1 | Any mutation | 14 | 14 | Signature 13 | 0.05 | -1.23 | 1.35 | 1514.77 | 1.00 | 77 | 11 | 11 | 3 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12 | NCOR1 | Any mutation | 79 | 11 | Signature 2 | -0.22 | -1.49 | 0.95 | 1332.43 | 1.00 | 240 | 76 | 8 | 3 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12 | NCOR1 | Any mutation | 231 | 36 | Signature 4 | -0.94 | -1.86 | -0.15 | 1274.08 | 1.00 | 442 | 226 | 31 | 5 | FALSE | 1.48 |
| colorectal cancer | KRAS_12 | NCOR1 | Any mutation | 448 | 125 | Signature overall | -0.84 | -1.92 | 0.20 | 1762.17 | 1.00 | 1047 | 429 | 106 | 19 | FALSE | 0.94 |
| non-small cell lung cancer | KRAS_12 | NCOR1 | Any mutation | 324 | 61 | Signature overall | -0.37 | -1.55 | 0.86 | 1367.04 | 1.00 | 759 | 313 | 50 | 11 | FALSE | 0.25 |
| colorectal cancer | KRAS_12 | POLE | Any mutation | 8 | 20 | Signature 10 | -1.58 | -3.41 | -0.05 | 1498.27 | 1.00 | 15 | 7 | 19 | 1 | TRUE | 1.19 |
| colorectal cancer | KRAS_12 | POLE | Any mutation | 99 | 19 | Signature 15 | -0.51 | -1.68 | 0.50 | 1322.53 | 1.00 | 275 | 95 | 15 | 4 | TRUE | 0.46 |
| colorectal cancer | KRAS_12 | POLE | Any mutation | 271 | 36 | Signature 1A | -0.11 | -0.81 | 0.57 | 1234.59 | 1.00 | 555 | 259 | 24 | 12 | TRUE | 0.11 |
| colorectal cancer | KRAS_12 | POLE | Any mutation | 69 | 54 | Signature 6 | -1.61 | -2.85 | -0.61 | 1474.73 | 1.00 | 201 | 66 | 51 | 3 | TRUE | 2.43 |
| non-small cell lung cancer | KRAS_12 | POLE | Any mutation | 80 | 19 | Signature 2 | 0.21 | -0.74 | 1.10 | 1573.17 | 1.00 | 233 | 74 | 13 | 6 | TRUE | 0.18 |
| non-small cell lung cancer | KRAS_12 | POLE | Any mutation | 230 | 49 | Signature 4 | -0.39 | -1.06 | 0.20 | 1356.93 | 1.00 | 438 | 218 | 37 | 12 | TRUE | 0.64 |
| non-small cell lung cancer | KRAS_12 | POLE | Any mutation | 144 | 11 | Signature R2 | 0.30 | -0.77 | 1.49 | 1351.95 | 1.00 | 52 | 135 | 2 | 9 | TRUE | 0.22 |
| uterine cancer | KRAS_12 | POLE | Any mutation | 34 | 12 | Signature 1A | 0.42 | -1.06 | 1.68 | 1253.41 | 1.00 | 177 | 31 | 9 | 3 | TRUE | 0.27 |
| uterine cancer | KRAS_12 | POLE | Any mutation | 13 | 20 | Signature 6 | 0.17 | -1.38 | 1.53 | 1604.98 | 1.00 | 74 | 10 | 17 | 3 | TRUE | 0.08 |
| colorectal cancer | KRAS_12 | POLE | Any mutation | 447 | 129 | Signature overall | -0.91 | -2.37 | 0.40 | 1495.06 | 1.00 | 1046 | 427 | 109 | 20 | TRUE | 0.70 |
| non-small cell lung cancer | KRAS_12 | POLE | Any mutation | 454 | 79 | Signature overall | 0.04 | -1.16 | 1.35 | 1435.51 | 1.00 | 723 | 427 | 52 | 27 | TRUE | 0.02 |
| uterine cancer | KRAS_12 | POLE | Any mutation | 49 | 89 | Signature overall | 0.32 | -2.14 | 2.73 | 1185.35 | 1.00 | 262 | 41 | 81 | 8 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12 | NOTCH2 | Any mutation | 79 | 15 | Signature 2 | -0.95 | -2.08 | 0.10 | 1228.27 | 1.00 | 230 | 77 | 13 | 2 | TRUE | 1.05 |
| non-small cell lung cancer | KRAS_12 | NOTCH2 | Any mutation | 230 | 54 | Signature 4 | -0.92 | -1.65 | -0.25 | 1605.76 | 1.00 | 437 | 221 | 45 | 9 | TRUE | 2.00 |
| non-small cell lung cancer | KRAS_12 | NOTCH2 | Any mutation | 309 | 69 | Signature overall | -0.94 | -2.15 | 0.29 | 1324.42 | 1.00 | 667 | 298 | 58 | 11 | TRUE | 0.89 |
| colorectal cancer | KRAS_12 | TGFBR2 | Any mutation | 100 | 11 | Signature 15 | -0.56 | -1.70 | 0.43 | 1648.17 | 1.00 | 277 | 98 | 9 | 2 | TRUE | 0.52 |
| colorectal cancer | KRAS_12 | TGFBR2 | Any mutation | 271 | 48 | Signature 1A | -0.24 | -0.84 | 0.39 | 1441.79 | 1.00 | 544 | 257 | 34 | 14 | TRUE | 0.35 |
| colorectal cancer | KRAS_12 | TGFBR2 | Any mutation | 69 | 43 | Signature 6 | -0.55 | -1.36 | 0.19 | 1411.78 | 1.00 | 207 | 63 | 37 | 6 | TRUE | 0.77 |
| colorectal cancer | KRAS_12 | TGFBR2 | Any mutation | 440 | 102 | Signature overall | -0.44 | -1.45 | 0.49 | 1378.42 | 1.00 | 1028 | 418 | 80 | 22 | TRUE | 0.43 |
| colorectal cancer | KRAS_12 | KMT2A | Any mutation | 9 | 22 | Signature 10 | -1.20 | -2.64 | 0.05 | 1466.24 | 1.00 | 20 | 7 | 20 | 2 | FALSE | 1.07 |
| colorectal cancer | KRAS_12 | KMT2A | Any mutation | 99 | 19 | Signature 15 | -1.64 | -3.31 | -0.41 | 1379.04 | 1.00 | 271 | 98 | 18 | 1 | FALSE | 1.63 |
| colorectal cancer | KRAS_12 | KMT2A | Any mutation | 270 | 53 | Signature 1A | -0.14 | -0.79 | 0.44 | 1344.29 | 1.00 | 544 | 253 | 36 | 17 | FALSE | 0.19 |
| colorectal cancer | KRAS_12 | KMT2A | Any mutation | 69 | 42 | Signature 6 | -1.71 | -3.10 | -0.60 | 1257.57 | 1.00 | 212 | 67 | 40 | 2 | FALSE | 2.17 |
| non-small cell lung cancer | KRAS_12 | KMT2A | Any mutation | 79 | 23 | Signature 2 | -0.13 | -0.93 | 0.74 | 1534.70 | 1.00 | 230 | 73 | 17 | 6 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | KMT2A | Any mutation | 230 | 37 | Signature 4 | -0.36 | -1.04 | 0.28 | 1337.27 | 1.00 | 445 | 221 | 28 | 9 | FALSE | 0.54 |
| uterine cancer | KRAS_12 | KMT2A | Any mutation | 34 | 13 | Signature 1A | -0.37 | -2.22 | 1.14 | 1212.38 | 1.00 | 174 | 32 | 11 | 2 | FALSE | 0.18 |
| uterine cancer | KRAS_12 | KMT2A | Any mutation | 13 | 14 | Signature 6 | -2.48 | -6.88 | -0.02 | 1429.97 | 1.00 | 71 | 13 | 14 | 0 | FALSE | 0.78 |
| colorectal cancer | KRAS_12 | KMT2A | Any mutation | 447 | 136 | Signature overall | -1.13 | -2.44 | 0.10 | 1384.06 | 1.00 | 1047 | 425 | 114 | 22 | FALSE | 1.17 |
| non-small cell lung cancer | KRAS_12 | KMT2A | Any mutation | 309 | 60 | Signature overall | -0.25 | -1.23 | 0.71 | 1386.28 | 1.00 | 675 | 294 | 45 | 15 | FALSE | 0.21 |
| uterine cancer | KRAS_12 | KMT2A | Any mutation | 49 | 81 | Signature overall | -0.84 | -3.62 | 1.88 | 1622.86 | 1.00 | 263 | 45 | 77 | 4 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12 | PAK7 | Any mutation | 230 | 69 | Signature 4 | -0.61 | -1.20 | -0.04 | 1338.75 | 1.00 | 425 | 215 | 54 | 15 | FALSE | 1.37 |
| non-small cell lung cancer | KRAS_12 | PAK7 | Any mutation | 230 | 69 | Signature overall | -0.65 | -5.14 | 3.43 | 1326.65 | 1.00 | 425 | 215 | 54 | 15 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12 | STAG2 | Any mutation | 79 | 16 | Signature 2 | 0.06 | -0.85 | 0.83 | 1418.32 | 1.00 | 234 | 75 | 12 | 4 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12 | STAG2 | Any mutation | 231 | 43 | Signature 4 | 0.18 | -0.41 | 0.76 | 1149.92 | 1.00 | 448 | 215 | 27 | 16 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12 | STAG2 | Any mutation | 310 | 59 | Signature overall | 0.13 | -0.77 | 0.98 | 1156.62 | 1.00 | 682 | 290 | 39 | 20 | TRUE | 0.11 |
| non-small cell lung cancer | KRAS_12 | TERT | Any mutation | 80 | 23 | Signature 2 | 0.76 | -0.06 | 1.68 | 1494.23 | 1.00 | 233 | 69 | 12 | 11 | TRUE | 1.03 |
| non-small cell lung cancer | KRAS_12 | TERT | Any mutation | 231 | 54 | Signature 4 | -0.01 | -0.64 | 0.57 | 1073.36 | 1.00 | 438 | 215 | 38 | 16 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12 | TERT | Any mutation | 311 | 77 | Signature overall | 0.35 | -0.94 | 1.64 | 1546.34 | 1.00 | 671 | 284 | 50 | 27 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | BRCA2 | Any mutation | 8 | 37 | Signature 10 | -3.21 | -6.07 | -1.25 | 1344.90 | 1.00 | 17 | 8 | 37 | 0 | TRUE | 1.98 |
| colorectal cancer | KRAS_12 | BRCA2 | Any mutation | 99 | 17 | Signature 15 | -0.89 | -2.25 | 0.30 | 1420.03 | 1.00 | 277 | 96 | 14 | 3 | TRUE | 0.75 |
| colorectal cancer | KRAS_12 | BRCA2 | Any mutation | 271 | 50 | Signature 1A | -0.53 | -1.21 | 0.12 | 1389.65 | 1.00 | 545 | 259 | 38 | 12 | TRUE | 0.93 |
| colorectal cancer | KRAS_12 | BRCA2 | Any mutation | 69 | 62 | Signature 6 | -2.31 | -3.89 | -1.11 | 1349.59 | 1.00 | 201 | 67 | 60 | 2 | TRUE | 3.05 |
| non-small cell lung cancer | KRAS_12 | BRCA2 | Any mutation | 13 | 13 | Signature 13 | -1.31 | -3.69 | 0.19 | 1506.10 | 1.00 | 74 | 13 | 13 | 0 | TRUE | 0.72 |
| non-small cell lung cancer | KRAS_12 | BRCA2 | Any mutation | 79 | 15 | Signature 2 | -1.24 | -2.91 | -0.05 | 1417.76 | 1.00 | 232 | 78 | 14 | 1 | TRUE | 1.05 |
| non-small cell lung cancer | KRAS_12 | BRCA2 | Any mutation | 231 | 55 | Signature 4 | -0.34 | -0.94 | 0.26 | 1533.51 | 1.00 | 439 | 215 | 39 | 16 | TRUE | 0.56 |
| uterine cancer | KRAS_12 | BRCA2 | Any mutation | 34 | 15 | Signature 1A | 0.03 | -1.55 | 1.25 | 1408.88 | 1.00 | 173 | 31 | 12 | 3 | TRUE | 0.01 |
| uterine cancer | KRAS_12 | BRCA2 | Any mutation | 13 | 22 | Signature 6 | -2.87 | -7.28 | -0.33 | 1375.91 | 1.00 | 69 | 13 | 22 | 0 | TRUE | 0.90 |
| colorectal cancer | KRAS_12 | BRCA2 | Any mutation | 447 | 166 | Signature overall | -1.71 | -3.46 | -0.20 | 1443.63 | 1.00 | 1040 | 430 | 149 | 17 | TRUE | 1.38 |
| non-small cell lung cancer | KRAS_12 | BRCA2 | Any mutation | 323 | 83 | Signature overall | -0.93 | -2.48 | 0.32 | 1524.69 | 1.00 | 745 | 306 | 66 | 17 | TRUE | 0.76 |
| uterine cancer | KRAS_12 | BRCA2 | Any mutation | 49 | 102 | Signature overall | -0.85 | -3.79 | 2.28 | 1375.88 | 1.00 | 257 | 44 | 97 | 5 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | NOTCH3 | Any mutation | 99 | 27 | Signature 15 | -0.36 | -1.26 | 0.51 | 1486.56 | 1.00 | 271 | 92 | 20 | 7 | TRUE | 0.36 |
| colorectal cancer | KRAS_12 | NOTCH3 | Any mutation | 271 | 70 | Signature 1A | -0.94 | -1.57 | -0.34 | 1470.09 | 1.00 | 528 | 259 | 58 | 12 | TRUE | 2.46 |
| colorectal cancer | KRAS_12 | NOTCH3 | Any mutation | 69 | 72 | Signature 6 | -1.97 | -3.27 | -0.97 | 1581.59 | 1.00 | 192 | 67 | 70 | 2 | TRUE | 3.13 |
| non-small cell lung cancer | KRAS_12 | NOTCH3 | Any mutation | 57 | 11 | Signature 18 | 0.06 | -0.70 | 0.99 | 1142.81 | 1.00 | 89 | 51 | 5 | 6 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12 | NOTCH3 | Any mutation | 79 | 15 | Signature 2 | -0.25 | -1.07 | 0.53 | 1261.03 | 1.00 | 234 | 76 | 12 | 3 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12 | NOTCH3 | Any mutation | 230 | 48 | Signature 4 | -0.34 | -0.99 | 0.23 | 1398.72 | 1.00 | 440 | 219 | 37 | 11 | TRUE | 0.55 |
| colorectal cancer | KRAS_12 | NOTCH3 | Any mutation | 439 | 169 | Signature overall | -1.09 | -2.29 | 0.04 | 1471.54 | 1.00 | 991 | 418 | 148 | 21 | TRUE | 1.22 |
| non-small cell lung cancer | KRAS_12 | NOTCH3 | Any mutation | 366 | 74 | Signature overall | -0.17 | -0.91 | 0.57 | 1295.49 | 1.00 | 763 | 346 | 54 | 20 | TRUE | 0.19 |
| colorectal cancer | KRAS_12 | NOTCH4 | Any mutation | 95 | 18 | Signature 15 | -0.61 | -1.49 | 0.21 | 1376.91 | 1.00 | 269 | 92 | 15 | 3 | TRUE | 0.77 |
| colorectal cancer | KRAS_12 | NOTCH4 | Any mutation | 261 | 43 | Signature 1A | -0.53 | -1.21 | 0.11 | 1540.24 | 1.00 | 532 | 251 | 33 | 10 | TRUE | 0.94 |
| colorectal cancer | KRAS_12 | NOTCH4 | Any mutation | 67 | 41 | Signature 6 | -0.53 | -1.35 | 0.19 | 1564.05 | 1.00 | 207 | 61 | 35 | 6 | TRUE | 0.76 |
| non-small cell lung cancer | KRAS_12 | NOTCH4 | Any mutation | 230 | 74 | Signature 4 | -0.39 | -0.96 | 0.17 | 1088.85 | 1.00 | 423 | 211 | 55 | 19 | TRUE | 0.77 |
| colorectal cancer | KRAS_12 | NOTCH4 | Any mutation | 423 | 102 | Signature overall | -0.56 | -1.44 | 0.22 | 1571.54 | 1.00 | 1008 | 404 | 83 | 19 | TRUE | 0.73 |
| non-small cell lung cancer | KRAS_12 | NOTCH4 | Any mutation | 230 | 74 | Signature overall | -0.39 | -4.51 | 4.03 | 1586.31 | 1.00 | 423 | 211 | 55 | 19 | TRUE | 0.07 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 13 | 20 | Signature 13 | -0.11 | -1.13 | 0.89 | 1539.34 | 1.00 | 67 | 11 | 18 | 2 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 17 | 12 | Signature 14 | 0.02 | -0.96 | 0.92 | 1535.30 | 1.00 | 30 | 14 | 9 | 3 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 20 | 16 | Signature 15 | 0.35 | -0.56 | 1.27 | 1450.13 | 1.00 | 105 | 16 | 12 | 4 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 8 | 12 | Signature 16 | 0.16 | -0.85 | 1.13 | 1389.75 | 1.00 | 42 | 6 | 10 | 2 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 58 | 34 | Signature 18 | -0.07 | -0.80 | 0.60 | 1353.06 | 1.00 | 71 | 47 | 23 | 11 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 15 | 11 | Signature 19 | 0.42 | -0.52 | 1.37 | 1611.26 | 1.00 | 41 | 11 | 7 | 4 | FALSE | 0.40 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 44 | 27 | Signature 1A | 0.53 | -0.25 | 1.32 | 995.40 | 1.00 | 205 | 36 | 19 | 8 | FALSE | 0.75 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 79 | 55 | Signature 2 | -0.09 | -0.71 | 0.51 | 1547.69 | 1.00 | 205 | 67 | 43 | 12 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 13 | 13 | Signature 20 | 0.24 | -0.71 | 1.22 | 1382.40 | 1.00 | 54 | 10 | 10 | 3 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 50 | 31 | Signature 3 | 0.48 | -0.21 | 1.18 | 1430.54 | 1.00 | 172 | 40 | 21 | 10 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 232 | 175 | Signature 4 | -0.19 | -0.56 | 0.15 | 1465.94 | 1.00 | 352 | 182 | 125 | 50 | FALSE | 0.52 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 20 | 14 | Signature 7 | -0.33 | -1.39 | 0.64 | 1504.82 | 1.00 | 76 | 19 | 13 | 1 | FALSE | 0.28 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 145 | 45 | Signature R2 | 0.08 | -0.52 | 0.72 | 1452.06 | 1.00 | 41 | 114 | 14 | 31 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 17 | 11 | Signature U1 | 1.13 | 0.18 | 2.12 | 1607.80 | 1.00 | 90 | 10 | 4 | 7 | FALSE | 1.73 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Any mutation | 731 | 476 | Signature overall | 0.19 | -0.25 | 0.63 | 1425.95 | 1.00 | 1551 | 583 | 328 | 148 | FALSE | 0.40 |
| non-small cell lung cancer | KRAS_12 | KDM5C | Any mutation | 79 | 15 | Signature 2 | -0.21 | -1.66 | 0.80 | 1333.69 | 1.00 | 233 | 77 | 13 | 2 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12 | KDM5C | Any mutation | 231 | 41 | Signature 4 | 0.45 | -0.18 | 1.10 | 1409.39 | 1.00 | 451 | 212 | 22 | 19 | FALSE | 0.78 |
| non-small cell lung cancer | KRAS_12 | KDM5C | Any mutation | 310 | 56 | Signature overall | 0.11 | -1.44 | 1.25 | 1534.88 | 1.00 | 684 | 289 | 35 | 21 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 13 | 12 | Signature 13 | -0.96 | -2.73 | 0.45 | 1461.78 | 1.00 | 73 | 13 | 12 | 0 | TRUE | 0.64 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 20 | 11 | Signature 15 | -0.54 | -1.88 | 0.66 | 1599.83 | 1.00 | 106 | 19 | 10 | 1 | TRUE | 0.37 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 44 | 18 | Signature 1A | 0.49 | -0.54 | 1.46 | 1377.94 | 1.00 | 210 | 38 | 12 | 6 | TRUE | 0.48 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 79 | 22 | Signature 2 | -1.21 | -2.56 | -0.12 | 1457.23 | 1.00 | 225 | 78 | 21 | 1 | TRUE | 1.30 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 51 | 20 | Signature 3 | 0.21 | -0.71 | 1.07 | 1501.38 | 1.00 | 179 | 45 | 14 | 6 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 233 | 90 | Signature 4 | -0.57 | -1.12 | -0.06 | 1468.39 | 1.00 | 407 | 213 | 70 | 20 | TRUE | 1.48 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 144 | 11 | Signature R2 | 0.03 | -0.94 | 1.11 | 1577.23 | 1.00 | 52 | 135 | 2 | 9 | TRUE | 0.02 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 117 | 30 | Signature 11 | 1.31 | 0.08 | 2.71 | 1534.27 | 1.00 | 9 | 88 | 1 | 29 | TRUE | 1.30 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 110 | 27 | Signature 15 | 0.49 | -0.47 | 1.48 | 1346.13 | 1.00 | 19 | 88 | 5 | 22 | TRUE | 0.47 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 12 | 11 | Signature 17 | 0.26 | -1.05 | 1.49 | 1310.71 | 1.00 | 33 | 10 | 9 | 2 | TRUE | 0.16 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 205 | 67 | Signature 1A | 1.10 | 0.35 | 1.94 | 1470.62 | 1.00 | 44 | 145 | 7 | 60 | TRUE | 2.16 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 82 | 23 | Signature 3 | 1.88 | 0.66 | 3.39 | 1373.65 | 1.00 | 20 | 59 | 0 | 23 | TRUE | 2.06 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 62 | 25 | Signature 4 | 2.07 | 0.77 | 3.61 | 1517.11 | 1.00 | 12 | 37 | 0 | 25 | TRUE | 2.46 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 54 | 26 | Signature 6 | 2.43 | 1.26 | 4.04 | 1549.87 | 1.00 | 20 | 28 | 0 | 26 | TRUE | 3.23 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 49 | 11 | Signature 8 | 1.37 | -0.10 | 2.93 | 1625.28 | 1.00 | 3 | 38 | 0 | 11 | TRUE | 1.12 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Any mutation | 584 | 184 | Signature overall | -0.36 | -1.23 | 0.39 | 1425.01 | 1.00 | 1252 | 541 | 141 | 43 | TRUE | 0.42 |
| pancreatic cancer | KRAS_12 | CDKN2A | Any mutation | 691 | 220 | Signature overall | 1.36 | 0.44 | 2.32 | 1551.47 | 1.00 | 160 | 493 | 22 | 198 | TRUE | 2.33 |
| non-small cell lung cancer | KRAS_12 | EPHB1 | Any mutation | 79 | 17 | Signature 2 | -0.36 | -1.37 | 0.68 | 1622.45 | 1.00 | 233 | 75 | 13 | 4 | FALSE | 0.31 |
| non-small cell lung cancer | KRAS_12 | EPHB1 | Any mutation | 232 | 79 | Signature 4 | -0.67 | -1.26 | -0.11 | 1453.28 | 1.00 | 419 | 216 | 63 | 16 | FALSE | 1.65 |
| non-small cell lung cancer | KRAS_12 | EPHB1 | Any mutation | 311 | 96 | Signature overall | -0.53 | -1.87 | 0.80 | 1549.78 | 1.00 | 652 | 291 | 76 | 20 | FALSE | 0.36 |
| uterine cancer | KRAS_12 | PPP2R1A | Any mutation | 19 | 20 | Signature 15 | -1.16 | -2.57 | -0.01 | 1439.91 | 1.00 | 72 | 18 | 19 | 1 | FALSE | 1.15 |
| uterine cancer | KRAS_12 | PPP2R1A | Any mutation | 34 | 25 | Signature 1A | -1.00 | -2.14 | 0.07 | 1313.43 | 1.00 | 164 | 32 | 23 | 2 | FALSE | 1.08 |
| uterine cancer | KRAS_12 | PPP2R1A | Any mutation | 10 | 14 | Signature 3 | -0.83 | -2.08 | 0.37 | 1500.90 | 1.00 | 23 | 8 | 12 | 2 | FALSE | 0.74 |
| uterine cancer | KRAS_12 | PPP2R1A | Any mutation | 13 | 17 | Signature 6 | -0.77 | -2.06 | 0.47 | 1490.40 | 1.00 | 74 | 11 | 15 | 2 | FALSE | 0.65 |
| uterine cancer | KRAS_12 | PPP2R1A | Any mutation | 77 | 96 | Signature overall | -0.99 | -2.07 | 0.03 | 1482.81 | 1.00 | 365 | 70 | 89 | 7 | FALSE | 1.25 |
| colorectal cancer | KRAS_12 | ERBB3 | Any mutation | 99 | 18 | Signature 15 | -0.43 | -1.28 | 0.35 | 1505.23 | 1.00 | 271 | 96 | 15 | 3 | TRUE | 0.54 |
| colorectal cancer | KRAS_12 | ERBB3 | Any mutation | 271 | 46 | Signature 1A | -0.38 | -0.95 | 0.19 | 1512.84 | 1.00 | 547 | 260 | 35 | 11 | TRUE | 0.71 |
| colorectal cancer | KRAS_12 | ERBB3 | Any mutation | 69 | 34 | Signature 6 | -0.12 | -0.77 | 0.60 | 1417.49 | 1.00 | 221 | 61 | 26 | 8 | TRUE | 0.13 |
| colorectal cancer | KRAS_12 | ERBB3 | Any mutation | 439 | 98 | Signature overall | -0.31 | -1.03 | 0.39 | 1482.42 | 1.00 | 1039 | 417 | 76 | 22 | TRUE | 0.38 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 8 | 17 | Signature 10 | 0.12 | -0.67 | 0.89 | 1467.67 | 1.00 | 17 | 5 | 14 | 3 | TRUE | 0.12 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 100 | 60 | Signature 15 | 0.29 | -0.22 | 0.79 | 1279.29 | 1.00 | 250 | 80 | 40 | 20 | TRUE | 0.62 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 7 | 11 | Signature 17 | -0.01 | -0.90 | 0.76 | 1253.76 | 1.00 | 29 | 6 | 10 | 1 | TRUE | 0.01 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 19 | 12 | Signature 19 | 0.35 | -0.40 | 1.11 | 1581.18 | 1.00 | 21 | 13 | 6 | 6 | TRUE | 0.45 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 276 | 122 | Signature 1A | 0.10 | -0.24 | 0.46 | 1539.82 | 1.00 | 499 | 234 | 80 | 42 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 35 | 11 | Signature 2 | 0.00 | -0.75 | 0.68 | 1492.77 | 1.00 | 40 | 31 | 7 | 4 | TRUE | 0.00 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 70 | 57 | Signature 6 | 0.06 | -0.50 | 0.61 | 1418.46 | 1.00 | 205 | 57 | 44 | 13 | TRUE | 0.08 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 14 | 11 | Signature 7 | 0.46 | -0.25 | 1.29 | 1571.90 | 1.00 | 21 | 8 | 5 | 6 | TRUE | 0.64 |
| non-small cell lung cancer | KRAS_12 | SMAD4 | Any mutation | 44 | 17 | Signature 1A | -0.20 | -1.42 | 0.80 | 1575.37 | 1.00 | 209 | 42 | 15 | 2 | TRUE | 0.14 |
| non-small cell lung cancer | KRAS_12 | SMAD4 | Any mutation | 79 | 21 | Signature 2 | 0.78 | -0.07 | 1.72 | 1312.98 | 1.00 | 234 | 69 | 11 | 10 | TRUE | 1.05 |
| non-small cell lung cancer | KRAS_12 | SMAD4 | Any mutation | 230 | 16 | Signature 4 | -0.49 | -1.58 | 0.43 | 1374.04 | 1.00 | 459 | 227 | 13 | 3 | TRUE | 0.48 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 115 | 25 | Signature 11 | 0.29 | -0.66 | 1.30 | 1257.76 | 1.00 | 9 | 91 | 1 | 24 | TRUE | 0.25 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 109 | 31 | Signature 15 | 0.33 | -0.50 | 1.20 | 1245.61 | 1.00 | 20 | 82 | 4 | 27 | TRUE | 0.35 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 12 | 12 | Signature 17 | -0.98 | -2.46 | 0.19 | 1431.13 | 1.00 | 31 | 12 | 12 | 0 | TRUE | 0.81 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 201 | 56 | Signature 1A | -0.02 | -0.62 | 0.62 | 1574.89 | 1.00 | 40 | 157 | 12 | 44 | TRUE | 0.02 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 33 | 12 | Signature 2 | -0.29 | -1.38 | 0.68 | 1404.03 | 1.00 | 8 | 26 | 5 | 7 | TRUE | 0.24 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 79 | 24 | Signature 3 | 0.44 | -0.46 | 1.40 | 1560.89 | 1.00 | 17 | 58 | 3 | 21 | TRUE | 0.45 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 61 | 15 | Signature 4 | 0.38 | -0.57 | 1.46 | 1382.68 | 1.00 | 11 | 47 | 1 | 14 | TRUE | 0.34 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 54 | 15 | Signature 6 | -0.17 | -1.05 | 0.78 | 1504.09 | 1.00 | 15 | 44 | 5 | 10 | TRUE | 0.14 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 50 | 15 | Signature 8 | 0.57 | -0.49 | 1.73 | 1373.81 | 1.00 | 3 | 35 | 0 | 15 | TRUE | 0.51 |
| colorectal cancer | KRAS_12 | SMAD4 | Any mutation | 529 | 301 | Signature overall | 0.17 | -0.27 | 0.64 | 1150.23 | 1.00 | 1082 | 434 | 206 | 95 | TRUE | 0.34 |
| non-small cell lung cancer | KRAS_12 | SMAD4 | Any mutation | 353 | 54 | Signature overall | 0.02 | -1.12 | 1.13 | 1349.18 | 1.00 | 902 | 338 | 39 | 15 | TRUE | 0.01 |
| pancreatic cancer | KRAS_12 | SMAD4 | Any mutation | 714 | 205 | Signature overall | 0.06 | -0.61 | 0.72 | 1491.54 | 1.00 | 154 | 552 | 43 | 162 | TRUE | 0.06 |
| colorectal cancer | KRAS_12 | ATM | Any mutation | 10 | 39 | Signature 10 | -0.91 | -2.18 | 0.28 | 1403.50 | 1.00 | 16 | 6 | 35 | 4 | TRUE | 0.87 |
| colorectal cancer | KRAS_12 | ATM | Any mutation | 100 | 32 | Signature 15 | -0.56 | -1.49 | 0.30 | 1421.45 | 1.00 | 264 | 94 | 26 | 6 | TRUE | 0.69 |
| colorectal cancer | KRAS_12 | ATM | Any mutation | 273 | 77 | Signature 1A | 0.02 | -0.48 | 0.51 | 1588.31 | 1.00 | 531 | 247 | 51 | 26 | TRUE | 0.02 |
| colorectal cancer | KRAS_12 | ATM | Any mutation | 70 | 48 | Signature 6 | -0.97 | -1.90 | -0.16 | 1431.69 | 1.00 | 207 | 65 | 43 | 5 | TRUE | 1.47 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 13 | 12 | Signature 13 | 0.76 | -0.32 | 1.80 | 1527.38 | 1.00 | 76 | 10 | 9 | 3 | TRUE | 0.79 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 57 | 11 | Signature 18 | 0.69 | -0.24 | 1.61 | 1434.35 | 1.00 | 89 | 51 | 5 | 6 | TRUE | 0.82 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 81 | 27 | Signature 2 | 0.90 | 0.18 | 1.63 | 1410.58 | 1.00 | 231 | 69 | 15 | 12 | TRUE | 1.89 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 50 | 13 | Signature 3 | 0.58 | -0.36 | 1.55 | 1441.22 | 1.00 | 184 | 46 | 9 | 4 | TRUE | 0.65 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 241 | 95 | Signature 4 | 0.75 | 0.31 | 1.18 | 1469.83 | 1.00 | 429 | 195 | 49 | 46 | TRUE | 3.16 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 145 | 25 | Signature R2 | 0.50 | -0.28 | 1.33 | 1600.46 | 1.00 | 48 | 126 | 6 | 19 | TRUE | 0.64 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 11 | 12 | Signature U2 | 1.57 | 0.59 | 2.64 | 1364.93 | 1.00 | 31 | 4 | 5 | 7 | TRUE | 2.44 |
| uterine cancer | KRAS_12 | ATM | Any mutation | 34 | 23 | Signature 1A | -0.46 | -1.85 | 0.72 | 1474.04 | 1.00 | 169 | 31 | 20 | 3 | TRUE | 0.32 |
| uterine cancer | KRAS_12 | ATM | Any mutation | 14 | 24 | Signature 6 | -0.81 | -2.44 | 0.55 | 1443.09 | 1.00 | 70 | 12 | 22 | 2 | TRUE | 0.54 |
| colorectal cancer | KRAS_12 | ATM | Any mutation | 453 | 196 | Signature overall | -0.61 | -1.77 | 0.52 | 1230.68 | 1.00 | 1018 | 412 | 155 | 41 | TRUE | 0.53 |
| non-small cell lung cancer | KRAS_12 | ATM | Any mutation | 598 | 195 | Signature overall | 0.80 | 0.12 | 1.48 | 1546.04 | 1.00 | 1088 | 501 | 98 | 97 | TRUE | 1.64 |
| uterine cancer | KRAS_12 | ATM | Any mutation | 54 | 121 | Signature overall | -0.80 | -2.56 | 0.89 | 1476.30 | 1.00 | 263 | 46 | 113 | 8 | TRUE | 0.45 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 13 | 11 | Signature 13 | -0.79 | -1.75 | 0.15 | 1459.69 | 1.00 | 78 | 11 | 9 | 2 | TRUE | 0.97 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 57 | 11 | Signature 18 | -0.87 | -1.74 | 0.01 | 1481.36 | 1.00 | 85 | 54 | 8 | 3 | TRUE | 1.29 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 44 | 16 | Signature 1A | -0.92 | -1.86 | 0.02 | 1439.84 | 1.00 | 208 | 42 | 14 | 2 | TRUE | 1.30 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 79 | 28 | Signature 2 | -1.00 | -1.86 | -0.26 | 1480.84 | 1.00 | 220 | 76 | 25 | 3 | TRUE | 1.83 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 50 | 18 | Signature 3 | -1.22 | -2.28 | -0.34 | 1699.84 | 1.00 | 175 | 50 | 18 | 0 | TRUE | 1.90 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 230 | 67 | Signature 4 | -1.03 | -1.65 | -0.48 | 1526.36 | 1.00 | 419 | 220 | 57 | 10 | TRUE | 3.25 |
| non-small cell lung cancer | KRAS_12 | RB1 | Any mutation | 473 | 151 | Signature overall | -0.97 | -1.62 | -0.36 | 1406.94 | 1.00 | 1185 | 453 | 131 | 20 | TRUE | 2.47 |
| cancer of unknown primary | KRAS_12 | KMT2D | Any mutation | 30 | 18 | Signature 1A | -1.43 | -2.89 | -0.17 | 1400.51 | 1.00 | 72 | 28 | 16 | 2 | FALSE | 1.42 |
| cancer of unknown primary | KRAS_12 | KMT2D | Any mutation | 18 | 15 | Signature 4 | -1.21 | -2.76 | 0.10 | 1502.49 | 1.00 | 51 | 16 | 13 | 2 | FALSE | 1.04 |
| colorectal cancer | KRAS_12 | KMT2D | Any mutation | 8 | 19 | Signature 10 | -1.25 | -2.58 | -0.16 | 1496.77 | 1.00 | 16 | 7 | 18 | 1 | FALSE | 1.36 |
| colorectal cancer | KRAS_12 | KMT2D | Any mutation | 100 | 55 | Signature 15 | -0.86 | -1.60 | -0.22 | 1490.38 | 1.00 | 261 | 92 | 47 | 8 | FALSE | 1.87 |
| colorectal cancer | KRAS_12 | KMT2D | Any mutation | 278 | 128 | Signature 1A | -0.73 | -1.17 | -0.29 | 1429.68 | 1.00 | 512 | 252 | 102 | 26 | FALSE | 2.89 |
| colorectal cancer | KRAS_12 | KMT2D | Any mutation | 76 | 142 | Signature 6 | -1.00 | -1.56 | -0.47 | 1615.80 | 1.00 | 171 | 60 | 126 | 16 | FALSE | 3.46 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 13 | 16 | Signature 13 | -1.26 | -2.82 | 0.01 | 1445.90 | 1.00 | 70 | 13 | 16 | 0 | FALSE | 1.05 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 57 | 16 | Signature 18 | -0.91 | -1.98 | 0.06 | 1521.64 | 1.00 | 82 | 54 | 13 | 3 | FALSE | 1.06 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 44 | 22 | Signature 1A | -0.80 | -1.98 | 0.14 | 1569.86 | 1.00 | 205 | 42 | 20 | 2 | FALSE | 0.81 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 80 | 46 | Signature 2 | -0.19 | -0.85 | 0.47 | 1480.71 | 1.00 | 216 | 69 | 35 | 11 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 50 | 13 | Signature 3 | -1.01 | -2.26 | 0.12 | 1449.96 | 1.00 | 181 | 49 | 12 | 1 | FALSE | 0.96 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 232 | 129 | Signature 4 | -0.69 | -1.13 | -0.26 | 1465.05 | 1.00 | 391 | 205 | 102 | 27 | FALSE | 2.68 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 144 | 13 | Signature R2 | -0.23 | -1.14 | 0.76 | 1457.84 | 1.00 | 51 | 134 | 3 | 10 | FALSE | 0.20 |
| uterine cancer | KRAS_12 | KMT2D | Any mutation | 20 | 27 | Signature 15 | -0.06 | -1.05 | 0.85 | 1287.29 | 1.00 | 73 | 14 | 21 | 6 | FALSE | 0.05 |
| uterine cancer | KRAS_12 | KMT2D | Any mutation | 34 | 61 | Signature 1A | -0.68 | -1.52 | 0.14 | 1590.79 | 1.00 | 142 | 28 | 55 | 6 | FALSE | 0.93 |
| uterine cancer | KRAS_12 | KMT2D | Any mutation | 7 | 13 | Signature 20 | -0.87 | -2.28 | 0.39 | 1553.97 | 1.00 | 24 | 6 | 12 | 1 | FALSE | 0.71 |
| uterine cancer | KRAS_12 | KMT2D | Any mutation | 14 | 63 | Signature 6 | -0.75 | -1.70 | 0.17 | 1538.37 | 1.00 | 45 | 9 | 58 | 5 | FALSE | 0.95 |
| cancer of unknown primary | KRAS_12 | KMT2D | Any mutation | 56 | 76 | Signature overall | -1.48 | -2.94 | -0.15 | 1465.47 | 1.00 | 168 | 51 | 71 | 5 | FALSE | 1.43 |
| colorectal cancer | KRAS_12 | KMT2D | Any mutation | 462 | 344 | Signature overall | -0.94 | -1.74 | -0.18 | 1539.30 | 1.00 | 960 | 411 | 293 | 51 | FALSE | 1.73 |
| non-small cell lung cancer | KRAS_12 | KMT2D | Any mutation | 620 | 255 | Signature overall | -0.73 | -1.50 | -0.04 | 1463.82 | 1.00 | 1196 | 566 | 201 | 54 | FALSE | 1.29 |
| uterine cancer | KRAS_12 | KMT2D | Any mutation | 81 | 233 | Signature overall | -0.67 | -1.61 | 0.21 | 1420.48 | 1.00 | 313 | 60 | 212 | 21 | FALSE | 0.87 |
| colorectal cancer | KRAS_12 | TSC2 | Any mutation | 99 | 11 | Signature 15 | 0.30 | -0.85 | 1.56 | 1364.00 | 1.00 | 280 | 94 | 6 | 5 | TRUE | 0.20 |
| colorectal cancer | KRAS_12 | TSC2 | Any mutation | 272 | 36 | Signature 1A | -0.26 | -0.97 | 0.45 | 1251.56 | 1.00 | 554 | 262 | 26 | 10 | TRUE | 0.33 |
| colorectal cancer | KRAS_12 | TSC2 | Any mutation | 69 | 44 | Signature 6 | -1.14 | -2.20 | -0.22 | 1356.70 | 1.00 | 210 | 66 | 41 | 3 | TRUE | 1.56 |
| colorectal cancer | KRAS_12 | TSC2 | Any mutation | 440 | 91 | Signature overall | -0.37 | -1.59 | 0.89 | 1520.57 | 1.00 | 1044 | 422 | 73 | 18 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 16 | 94 | Signature 10 | -0.12 | -0.83 | 0.63 | 1569.56 | 1.00 | 3 | 0 | 78 | 16 | TRUE | 0.13 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 27 | 39 | Signature 11 | -0.04 | -0.77 | 0.66 | 1474.84 | 1.00 | 1 | 9 | 21 | 18 | TRUE | 0.04 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 10 | 25 | Signature 14 | 0.20 | -0.51 | 0.94 | 1604.19 | 1.00 | 2 | 1 | 16 | 9 | TRUE | 0.23 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 154 | 469 | Signature 15 | 0.32 | -0.09 | 0.78 | 1474.74 | 1.00 | 67 | 16 | 331 | 138 | TRUE | 0.79 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 10 | 46 | Signature 17 | -0.38 | -1.18 | 0.27 | 1558.30 | 1.00 | 11 | 4 | 40 | 6 | TRUE | 0.52 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 22 | 63 | Signature 18 | -0.15 | -0.88 | 0.50 | 1455.28 | 1.00 | 3 | 5 | 46 | 17 | TRUE | 0.18 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 23 | 38 | Signature 19 | -0.10 | -0.75 | 0.52 | 1494.17 | 1.00 | 9 | 9 | 24 | 14 | TRUE | 0.12 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 392 | 962 | Signature 1A | 0.05 | -0.24 | 0.33 | 1492.34 | 1.00 | 149 | 72 | 642 | 320 | TRUE | 0.13 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 12 | 22 | Signature 1B | 0.37 | -0.38 | 1.10 | 1295.53 | 1.00 | 7 | 1 | 11 | 11 | TRUE | 0.49 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 50 | 95 | Signature 2 | 0.36 | -0.24 | 0.94 | 1394.27 | 1.00 | 11 | 6 | 51 | 44 | TRUE | 0.63 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 13 | 34 | Signature 20 | -0.03 | -0.72 | 0.66 | 1500.44 | 1.00 | 5 | 3 | 24 | 10 | TRUE | 0.03 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 11 | 25 | Signature 21 | 0.38 | -0.29 | 1.17 | 1383.19 | 1.00 | 10 | 0 | 14 | 11 | TRUE | 0.50 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 19 | 42 | Signature 3 | 0.19 | -0.49 | 0.87 | 1387.95 | 1.00 | 8 | 3 | 26 | 16 | TRUE | 0.23 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 22 | 49 | Signature 4 | 0.03 | -0.64 | 0.68 | 1512.76 | 1.00 | 6 | 5 | 32 | 17 | TRUE | 0.03 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 104 | 355 | Signature 6 | 0.20 | -0.28 | 0.65 | 1531.24 | 1.00 | 79 | 16 | 267 | 88 | TRUE | 0.42 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 20 | 40 | Signature 7 | 0.27 | -0.42 | 0.98 | 1542.26 | 1.00 | 9 | 3 | 23 | 17 | TRUE | 0.35 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 19 | 30 | Signature 8 | 0.47 | -0.23 | 1.16 | 1314.87 | 1.00 | 1 | 2 | 13 | 17 | TRUE | 0.71 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 20 | 20 | Signature R2 | 0.32 | -0.42 | 1.01 | 1316.72 | 1.00 | 3 | 6 | 6 | 14 | TRUE | 0.41 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 10 | 14 | Signature U1 | 0.03 | -0.76 | 0.79 | 1652.24 | 1.00 | 2 | 4 | 8 | 6 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12 | APC | Any mutation | 44 | 13 | Signature 1A | -0.41 | -1.45 | 0.59 | 1442.46 | 1.00 | 211 | 42 | 11 | 2 | TRUE | 0.37 |
| non-small cell lung cancer | KRAS_12 | APC | Any mutation | 82 | 23 | Signature 2 | -0.10 | -0.96 | 0.73 | 1442.39 | 1.00 | 229 | 75 | 16 | 7 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12 | APC | Any mutation | 230 | 50 | Signature 4 | -0.75 | -1.50 | -0.11 | 1489.91 | 1.00 | 434 | 222 | 42 | 8 | TRUE | 1.43 |
| uterine cancer | KRAS_12 | APC | Any mutation | 34 | 18 | Signature 1A | -0.47 | -2.15 | 0.82 | 1451.53 | 1.00 | 174 | 32 | 16 | 2 | TRUE | 0.27 |
| uterine cancer | KRAS_12 | APC | Any mutation | 13 | 15 | Signature 6 | -0.11 | -1.81 | 1.43 | 1514.91 | 1.00 | 76 | 11 | 13 | 2 | TRUE | 0.05 |
| colorectal cancer | KRAS_12 | APC | Any mutation | 954 | 2462 | Signature overall | 0.13 | -0.21 | 0.46 | 1334.12 | 1.00 | 386 | 165 | 1673 | 789 | TRUE | 0.34 |
| non-small cell lung cancer | KRAS_12 | APC | Any mutation | 356 | 86 | Signature overall | -0.41 | -1.29 | 0.52 | 1545.09 | 1.00 | 874 | 339 | 69 | 17 | TRUE | 0.42 |
| uterine cancer | KRAS_12 | APC | Any mutation | 51 | 96 | Signature overall | 0.06 | -2.11 | 2.36 | 1497.11 | 1.00 | 267 | 43 | 88 | 8 | TRUE | 0.02 |
| colorectal cancer | KRAS_12 | ERBB2 | Any mutation | 270 | 47 | Signature 1A | -0.88 | -1.61 | -0.18 | 1580.04 | 1.00 | 541 | 262 | 39 | 8 | TRUE | 1.77 |
| colorectal cancer | KRAS_12 | ERBB2 | Any mutation | 69 | 29 | Signature 6 | -0.76 | -1.74 | 0.14 | 1343.29 | 1.00 | 221 | 65 | 25 | 4 | TRUE | 0.97 |
| non-small cell lung cancer | KRAS_12 | ERBB2 | Any mutation | 44 | 15 | Signature 1A | -1.75 | -3.48 | -0.33 | 1483.79 | 1.00 | 208 | 43 | 14 | 1 | TRUE | 1.56 |
| non-small cell lung cancer | KRAS_12 | ERBB2 | Any mutation | 79 | 12 | Signature 2 | -2.06 | -4.03 | -0.69 | 1327.56 | 1.00 | 233 | 79 | 12 | 0 | TRUE | 1.83 |
| non-small cell lung cancer | KRAS_12 | ERBB2 | Any mutation | 230 | 19 | Signature 4 | -1.81 | -3.33 | -0.65 | 1362.99 | 1.00 | 457 | 228 | 17 | 2 | TRUE | 2.09 |
| colorectal cancer | KRAS_12 | ERBB2 | Any mutation | 339 | 76 | Signature overall | -0.82 | -2.05 | 0.27 | 1314.86 | 1.00 | 762 | 327 | 64 | 12 | TRUE | 0.82 |
| non-small cell lung cancer | KRAS_12 | ERBB2 | Any mutation | 353 | 46 | Signature overall | -1.86 | -3.46 | -0.59 | 1374.23 | 1.00 | 898 | 350 | 43 | 3 | TRUE | 1.96 |
| uterine cancer | KRAS_12 | JAK1 | Any mutation | 20 | 14 | Signature 15 | 0.55 | -0.59 | 1.61 | 1569.03 | 1.00 | 83 | 16 | 10 | 4 | TRUE | 0.49 |
| uterine cancer | KRAS_12 | JAK1 | Any mutation | 36 | 35 | Signature 1A | 0.48 | -0.38 | 1.28 | 1482.29 | 1.00 | 161 | 28 | 27 | 8 | TRUE | 0.58 |
| uterine cancer | KRAS_12 | JAK1 | Any mutation | 14 | 42 | Signature 6 | 0.30 | -0.73 | 1.28 | 1555.26 | 1.00 | 59 | 8 | 36 | 6 | TRUE | 0.25 |
| uterine cancer | KRAS_12 | JAK1 | Any mutation | 72 | 117 | Signature overall | 0.45 | -0.60 | 1.59 | 1493.84 | 1.00 | 327 | 52 | 97 | 20 | TRUE | 0.37 |
| colorectal cancer | KRAS_12 | ARID2 | Any mutation | 8 | 16 | Signature 10 | -0.62 | -2.00 | 0.66 | 1599.32 | 1.00 | 17 | 6 | 14 | 2 | FALSE | 0.44 |
| colorectal cancer | KRAS_12 | ARID2 | Any mutation | 99 | 19 | Signature 15 | -0.69 | -1.79 | 0.28 | 1608.84 | 1.00 | 273 | 96 | 16 | 3 | FALSE | 0.72 |
| colorectal cancer | KRAS_12 | ARID2 | Any mutation | 271 | 42 | Signature 1A | -0.07 | -0.71 | 0.55 | 1388.80 | 1.00 | 551 | 257 | 28 | 14 | FALSE | 0.09 |
| colorectal cancer | KRAS_12 | ARID2 | Any mutation | 69 | 27 | Signature 6 | -0.79 | -1.89 | 0.17 | 1492.79 | 1.00 | 220 | 66 | 24 | 3 | FALSE | 0.88 |
| non-small cell lung cancer | KRAS_12 | ARID2 | Any mutation | 57 | 11 | Signature 18 | 0.00 | -0.78 | 0.87 | 1474.07 | 1.00 | 88 | 51 | 5 | 6 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12 | ARID2 | Any mutation | 79 | 18 | Signature 2 | -0.19 | -0.93 | 0.52 | 1513.65 | 1.00 | 233 | 74 | 13 | 5 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12 | ARID2 | Any mutation | 50 | 16 | Signature 3 | -0.51 | -1.51 | 0.25 | 1442.66 | 1.00 | 178 | 49 | 15 | 1 | FALSE | 0.60 |
| non-small cell lung cancer | KRAS_12 | ARID2 | Any mutation | 231 | 67 | Signature 4 | -0.41 | -0.97 | 0.10 | 1452.37 | 1.00 | 428 | 216 | 52 | 15 | FALSE | 0.87 |
| colorectal cancer | KRAS_12 | ARID2 | Any mutation | 447 | 104 | Signature overall | -0.54 | -1.64 | 0.56 | 1501.21 | 1.00 | 1061 | 425 | 82 | 22 | FALSE | 0.48 |
| non-small cell lung cancer | KRAS_12 | ARID2 | Any mutation | 417 | 112 | Signature overall | -0.28 | -0.94 | 0.36 | 1412.99 | 1.00 | 927 | 390 | 85 | 27 | FALSE | 0.40 |
| colorectal cancer | KRAS_12 | MTOR | Any mutation | 8 | 12 | Signature 10 | -1.30 | -3.29 | 0.09 | 1519.51 | 1.00 | 19 | 8 | 12 | 0 | TRUE | 0.90 |
| colorectal cancer | KRAS_12 | MTOR | Any mutation | 99 | 17 | Signature 15 | -0.47 | -1.51 | 0.50 | 1564.61 | 1.00 | 275 | 95 | 13 | 4 | TRUE | 0.44 |
| colorectal cancer | KRAS_12 | MTOR | Any mutation | 273 | 48 | Signature 1A | -0.39 | -1.05 | 0.24 | 1359.64 | 1.00 | 543 | 260 | 35 | 13 | TRUE | 0.66 |
| colorectal cancer | KRAS_12 | MTOR | Any mutation | 69 | 45 | Signature 6 | -0.88 | -1.84 | -0.07 | 1455.85 | 1.00 | 211 | 64 | 40 | 5 | TRUE | 1.29 |
| non-small cell lung cancer | KRAS_12 | MTOR | Any mutation | 230 | 41 | Signature 4 | 0.18 | -0.47 | 0.83 | 586.81 | 1.00 | 446 | 215 | 26 | 15 | TRUE | 0.24 |
| colorectal cancer | KRAS_12 | MTOR | Any mutation | 449 | 122 | Signature overall | -0.74 | -1.82 | 0.25 | 1596.42 | 1.00 | 1048 | 427 | 100 | 22 | TRUE | 0.79 |
| non-small cell lung cancer | KRAS_12 | MTOR | Any mutation | 230 | 41 | Signature overall | 0.08 | -4.31 | 4.00 | 1693.59 | 1.00 | 446 | 215 | 26 | 15 | TRUE | 0.02 |
| colorectal cancer | KRAS_12 | NOTCH1 | Any mutation | 8 | 11 | Signature 10 | -1.47 | -3.51 | 0.10 | 1480.18 | 1.00 | 20 | 8 | 11 | 0 | TRUE | 0.98 |
| colorectal cancer | KRAS_12 | NOTCH1 | Any mutation | 101 | 17 | Signature 15 | -0.46 | -1.61 | 0.48 | 1416.06 | 1.00 | 277 | 97 | 13 | 4 | TRUE | 0.42 |
| colorectal cancer | KRAS_12 | NOTCH1 | Any mutation | 272 | 47 | Signature 1A | -0.36 | -1.05 | 0.27 | 1245.11 | 1.00 | 546 | 259 | 34 | 13 | TRUE | 0.56 |
| colorectal cancer | KRAS_12 | NOTCH1 | Any mutation | 71 | 82 | Signature 6 | -0.94 | -1.71 | -0.25 | 1436.45 | 1.00 | 190 | 62 | 73 | 9 | TRUE | 1.92 |
| non-small cell lung cancer | KRAS_12 | NOTCH1 | Any mutation | 79 | 12 | Signature 2 | -0.98 | -2.36 | 0.30 | 1374.70 | 1.00 | 235 | 77 | 10 | 2 | TRUE | 0.87 |
| non-small cell lung cancer | KRAS_12 | NOTCH1 | Any mutation | 230 | 54 | Signature 4 | -1.22 | -2.03 | -0.51 | 1455.62 | 1.00 | 428 | 223 | 47 | 7 | TRUE | 2.61 |
| colorectal cancer | KRAS_12 | NOTCH1 | Any mutation | 452 | 157 | Signature overall | -0.79 | -2.00 | 0.22 | 1414.31 | 1.00 | 1033 | 426 | 131 | 26 | TRUE | 0.81 |
| non-small cell lung cancer | KRAS_12 | NOTCH1 | Any mutation | 309 | 66 | Signature overall | -1.08 | -2.52 | 0.53 | 1449.87 | 1.00 | 663 | 300 | 57 | 9 | TRUE | 0.86 |
| colorectal cancer | KRAS_12 | SETD2 | Any mutation | 9 | 22 | Signature 10 | -1.44 | -2.93 | -0.10 | 1517.05 | 1.00 | 17 | 7 | 20 | 2 | FALSE | 1.33 |
| colorectal cancer | KRAS_12 | SETD2 | Any mutation | 99 | 13 | Signature 15 | -1.61 | -3.32 | -0.18 | 1528.89 | 1.00 | 276 | 98 | 12 | 1 | FALSE | 1.36 |
| colorectal cancer | KRAS_12 | SETD2 | Any mutation | 270 | 31 | Signature 1A | -1.35 | -2.40 | -0.44 | 1488.82 | 1.00 | 550 | 266 | 27 | 4 | FALSE | 2.20 |
| colorectal cancer | KRAS_12 | SETD2 | Any mutation | 70 | 39 | Signature 6 | -1.45 | -2.65 | -0.48 | 1482.25 | 1.00 | 211 | 67 | 36 | 3 | FALSE | 2.07 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 14 | 16 | Signature 13 | 0.10 | -1.08 | 1.25 | 1576.23 | 1.00 | 74 | 11 | 13 | 3 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 81 | 44 | Signature 2 | 0.02 | -0.72 | 0.70 | 1559.21 | 1.00 | 223 | 70 | 33 | 11 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 51 | 15 | Signature 3 | -0.16 | -1.25 | 0.86 | 1398.97 | 1.00 | 182 | 48 | 12 | 3 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 232 | 55 | Signature 4 | -0.27 | -0.88 | 0.27 | 1545.08 | 1.00 | 435 | 217 | 40 | 15 | FALSE | 0.44 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 146 | 14 | Signature R2 | -0.10 | -1.01 | 0.81 | 1491.63 | 1.00 | 50 | 136 | 4 | 10 | FALSE | 0.09 |
| colorectal cancer | KRAS_12 | SETD2 | Any mutation | 448 | 105 | Signature overall | -1.44 | -2.73 | -0.12 | 1712.81 | 1.00 | 1054 | 438 | 95 | 10 | FALSE | 1.58 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Any mutation | 524 | 144 | Signature overall | -0.09 | -0.97 | 0.82 | 1428.10 | 1.00 | 964 | 482 | 102 | 42 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12 | PBRM1 | Any mutation | 79 | 20 | Signature 2 | -0.20 | -1.11 | 0.72 | 1518.37 | 1.00 | 235 | 74 | 15 | 5 | TRUE | 0.18 |
| non-small cell lung cancer | KRAS_12 | PBRM1 | Any mutation | 230 | 27 | Signature 4 | -0.48 | -1.34 | 0.29 | 1383.10 | 1.00 | 452 | 224 | 21 | 6 | TRUE | 0.62 |
| non-small cell lung cancer | KRAS_12 | PBRM1 | Any mutation | 309 | 47 | Signature overall | -0.35 | -1.54 | 0.89 | 1462.58 | 1.00 | 687 | 298 | 36 | 11 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | EPHA3 | Any mutation | 8 | 14 | Signature 10 | -0.94 | -2.58 | 0.36 | 1483.88 | 1.00 | 21 | 7 | 13 | 1 | FALSE | 0.65 |
| colorectal cancer | KRAS_12 | EPHA3 | Any mutation | 99 | 13 | Signature 15 | -0.80 | -2.06 | 0.24 | 1587.44 | 1.00 | 275 | 97 | 11 | 2 | FALSE | 0.76 |
| colorectal cancer | KRAS_12 | EPHA3 | Any mutation | 271 | 42 | Signature 1A | -0.20 | -0.81 | 0.45 | 1464.12 | 1.00 | 547 | 258 | 29 | 13 | FALSE | 0.27 |
| colorectal cancer | KRAS_12 | EPHA3 | Any mutation | 69 | 26 | Signature 6 | -0.84 | -1.98 | 0.11 | 1364.93 | 1.00 | 221 | 66 | 23 | 3 | FALSE | 0.93 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 57 | 13 | Signature 18 | -0.25 | -1.25 | 0.70 | 1444.15 | 1.00 | 85 | 53 | 9 | 4 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 81 | 27 | Signature 2 | 0.12 | -0.63 | 0.87 | 1488.45 | 1.00 | 227 | 73 | 19 | 8 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 51 | 18 | Signature 3 | 0.52 | -0.42 | 1.46 | 1579.31 | 1.00 | 183 | 44 | 11 | 7 | FALSE | 0.59 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 233 | 112 | Signature 4 | -0.34 | -0.80 | 0.07 | 1480.34 | 1.00 | 397 | 204 | 83 | 29 | FALSE | 0.96 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 145 | 13 | Signature R2 | -0.33 | -1.22 | 0.56 | 1271.74 | 1.00 | 49 | 137 | 5 | 8 | FALSE | 0.33 |
| colorectal cancer | KRAS_12 | EPHA3 | Any mutation | 447 | 95 | Signature overall | -0.69 | -1.83 | 0.34 | 1453.47 | 1.00 | 1064 | 428 | 76 | 19 | FALSE | 0.67 |
| non-small cell lung cancer | KRAS_12 | EPHA3 | Any mutation | 567 | 183 | Signature overall | -0.05 | -0.83 | 0.79 | 1393.72 | 1.00 | 941 | 511 | 127 | 56 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12 | KDR | Any mutation | 79 | 12 | Signature 2 | 0.53 | -0.55 | 1.61 | 1430.27 | 1.00 | 238 | 74 | 7 | 5 | TRUE | 0.46 |
| non-small cell lung cancer | KRAS_12 | KDR | Any mutation | 51 | 11 | Signature 3 | 1.05 | -0.10 | 2.34 | 1098.47 | 1.00 | 188 | 45 | 5 | 6 | TRUE | 1.04 |
| non-small cell lung cancer | KRAS_12 | KDR | Any mutation | 231 | 76 | Signature 4 | -0.79 | -1.44 | -0.21 | 1462.14 | 1.00 | 414 | 218 | 63 | 13 | TRUE | 1.86 |
| non-small cell lung cancer | KRAS_12 | KDR | Any mutation | 361 | 99 | Signature overall | 0.25 | -1.09 | 1.76 | 1500.37 | 1.00 | 840 | 337 | 75 | 24 | TRUE | 0.14 |
| colorectal cancer | KRAS_12 | PTCH1 | Any mutation | 8 | 11 | Signature 10 | -1.10 | -2.62 | 0.24 | 1437.41 | 1.00 | 20 | 7 | 10 | 1 | TRUE | 0.92 |
| colorectal cancer | KRAS_12 | PTCH1 | Any mutation | 99 | 14 | Signature 15 | -1.03 | -2.19 | 0.02 | 1483.13 | 1.00 | 277 | 97 | 12 | 2 | TRUE | 1.17 |
| colorectal cancer | KRAS_12 | PTCH1 | Any mutation | 270 | 55 | Signature 1A | -0.89 | -1.60 | -0.25 | 1320.31 | 1.00 | 539 | 260 | 45 | 10 | TRUE | 2.03 |
| colorectal cancer | KRAS_12 | PTCH1 | Any mutation | 70 | 53 | Signature 6 | -1.25 | -2.19 | -0.45 | 1571.14 | 1.00 | 210 | 66 | 49 | 4 | TRUE | 2.25 |
| colorectal cancer | KRAS_12 | PTCH1 | Any mutation | 447 | 133 | Signature overall | -1.05 | -2.01 | -0.14 | 1513.35 | 1.00 | 1046 | 430 | 116 | 17 | TRUE | 1.48 |
| colorectal cancer | KRAS_12 | TET1 | Any mutation | 8 | 27 | Signature 10 | -2.11 | -4.19 | -0.46 | 1461.82 | 1.00 | 16 | 7 | 26 | 1 | FALSE | 1.60 |
| colorectal cancer | KRAS_12 | TET1 | Any mutation | 95 | 18 | Signature 15 | -2.63 | -5.62 | -0.75 | 1316.56 | 1.00 | 268 | 95 | 18 | 0 | FALSE | 1.48 |
| colorectal cancer | KRAS_12 | TET1 | Any mutation | 261 | 25 | Signature 1A | -0.62 | -1.63 | 0.25 | 1565.54 | 1.00 | 543 | 255 | 19 | 6 | FALSE | 0.71 |
| colorectal cancer | KRAS_12 | TET1 | Any mutation | 66 | 28 | Signature 6 | -0.80 | -1.92 | 0.22 | 1261.59 | 1.00 | 216 | 62 | 24 | 4 | FALSE | 0.81 |
| non-small cell lung cancer | KRAS_12 | TET1 | Any mutation | 79 | 12 | Signature 2 | 1.09 | -0.15 | 2.35 | 1431.53 | 1.00 | 238 | 72 | 5 | 7 | FALSE | 1.07 |
| non-small cell lung cancer | KRAS_12 | TET1 | Any mutation | 232 | 60 | Signature 4 | -0.42 | -1.05 | 0.16 | 1492.14 | 1.00 | 432 | 218 | 46 | 14 | FALSE | 0.75 |
| colorectal cancer | KRAS_12 | TET1 | Any mutation | 430 | 98 | Signature overall | -1.50 | -3.19 | -0.04 | 1513.12 | 1.00 | 1043 | 419 | 87 | 11 | FALSE | 1.19 |
| non-small cell lung cancer | KRAS_12 | TET1 | Any mutation | 311 | 72 | Signature overall | 0.29 | -1.88 | 2.52 | 1465.82 | 1.00 | 670 | 290 | 51 | 21 | FALSE | 0.10 |
| uterine cancer | KRAS_12 | FGFR2 | Any mutation | 34 | 26 | Signature 1A | -2.52 | -5.33 | -0.70 | 538.13 | 1.00 | 163 | 33 | 25 | 1 | TRUE | 1.38 |
| uterine cancer | KRAS_12 | FGFR2 | Any mutation | 13 | 22 | Signature 6 | -2.92 | -6.36 | -0.72 | 647.60 | 1.00 | 66 | 13 | 22 | 0 | TRUE | 1.39 |
| uterine cancer | KRAS_12 | FGFR2 | Any mutation | 47 | 48 | Signature overall | -2.67 | -5.76 | -0.46 | 574.81 | 1.00 | 229 | 46 | 47 | 1 | TRUE | 1.30 |
| non-small cell lung cancer | KRAS_12 | TBX3 | Any mutation | 230 | 75 | Signature 4 | -1.01 | -1.67 | -0.43 | 1489.50 | 1.00 | 417 | 218 | 63 | 12 | FALSE | 2.85 |
| non-small cell lung cancer | KRAS_12 | TBX3 | Any mutation | 144 | 15 | Signature R2 | -0.40 | -1.36 | 0.62 | 1250.64 | 1.00 | 50 | 134 | 5 | 10 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12 | TBX3 | Any mutation | 374 | 90 | Signature overall | -0.69 | -2.61 | 1.32 | 1372.46 | 1.00 | 467 | 352 | 68 | 22 | FALSE | 0.34 |
| colorectal cancer | KRAS_12 | SMAD3 | Any mutation | 102 | 21 | Signature 15 | 0.33 | -0.29 | 0.94 | 1339.56 | 1.00 | 273 | 95 | 14 | 7 | TRUE | 0.56 |
| colorectal cancer | KRAS_12 | SMAD3 | Any mutation | 274 | 38 | Signature 1A | 0.31 | -0.21 | 0.83 | 1577.61 | 1.00 | 553 | 259 | 23 | 15 | TRUE | 0.61 |
| colorectal cancer | KRAS_12 | SMAD3 | Any mutation | 70 | 20 | Signature 6 | 0.35 | -0.31 | 0.96 | 1450.65 | 1.00 | 228 | 64 | 14 | 6 | TRUE | 0.57 |
| colorectal cancer | KRAS_12 | SMAD3 | Any mutation | 446 | 79 | Signature overall | 0.33 | -0.19 | 0.91 | 1355.17 | 1.00 | 1054 | 418 | 51 | 28 | TRUE | 0.63 |
| non-small cell lung cancer | KRAS_12 | NTRK3 | Any mutation | 80 | 15 | Signature 2 | 0.82 | -0.13 | 1.74 | 1440.57 | 1.00 | 238 | 73 | 8 | 7 | FALSE | 1.02 |
| non-small cell lung cancer | KRAS_12 | NTRK3 | Any mutation | 50 | 14 | Signature 3 | 0.66 | -0.42 | 1.66 | 1482.90 | 1.00 | 185 | 45 | 9 | 5 | FALSE | 0.66 |
| non-small cell lung cancer | KRAS_12 | NTRK3 | Any mutation | 234 | 105 | Signature 4 | -0.37 | -0.81 | 0.04 | 1469.26 | 1.00 | 410 | 208 | 79 | 26 | FALSE | 1.01 |
| non-small cell lung cancer | KRAS_12 | NTRK3 | Any mutation | 145 | 18 | Signature R2 | 0.90 | -0.10 | 1.98 | 1402.25 | 1.00 | 52 | 129 | 2 | 16 | FALSE | 1.00 |
| non-small cell lung cancer | KRAS_12 | NTRK3 | Any mutation | 509 | 152 | Signature overall | 0.50 | -0.63 | 1.69 | 1498.02 | 1.00 | 885 | 455 | 98 | 54 | FALSE | 0.40 |
| colorectal cancer | KRAS_12 | GRIN2A | Any mutation | 8 | 18 | Signature 10 | -1.26 | -2.88 | 0.09 | 1637.48 | 1.00 | 17 | 7 | 17 | 1 | FALSE | 1.01 |
| colorectal cancer | KRAS_12 | GRIN2A | Any mutation | 99 | 12 | Signature 15 | -0.41 | -1.65 | 0.76 | 1476.35 | 1.00 | 280 | 96 | 9 | 3 | FALSE | 0.31 |
| colorectal cancer | KRAS_12 | GRIN2A | Any mutation | 271 | 43 | Signature 1A | -0.54 | -1.27 | 0.15 | 1310.09 | 1.00 | 542 | 261 | 33 | 10 | FALSE | 0.88 |
| colorectal cancer | KRAS_12 | GRIN2A | Any mutation | 69 | 43 | Signature 6 | -0.68 | -1.56 | 0.15 | 1498.35 | 1.00 | 208 | 63 | 37 | 6 | FALSE | 0.94 |
| non-small cell lung cancer | KRAS_12 | GRIN2A | Any mutation | 79 | 15 | Signature 2 | -0.51 | -1.70 | 0.58 | 1325.38 | 1.00 | 233 | 76 | 12 | 3 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12 | GRIN2A | Any mutation | 232 | 76 | Signature 4 | -0.66 | -1.23 | -0.10 | 1422.13 | 1.00 | 418 | 216 | 60 | 16 | FALSE | 1.69 |
| non-small cell lung cancer | KRAS_12 | GRIN2A | Any mutation | 144 | 13 | Signature R2 | -0.75 | -1.69 | 0.20 | 1487.85 | 1.00 | 48 | 137 | 6 | 7 | FALSE | 0.93 |
| colorectal cancer | KRAS_12 | GRIN2A | Any mutation | 447 | 116 | Signature overall | -0.69 | -1.86 | 0.49 | 1450.17 | 1.00 | 1047 | 427 | 96 | 20 | FALSE | 0.61 |
| non-small cell lung cancer | KRAS_12 | GRIN2A | Any mutation | 455 | 104 | Signature overall | -0.66 | -2.05 | 0.56 | 1619.09 | 1.00 | 699 | 429 | 78 | 26 | FALSE | 0.52 |
| uterine cancer | KRAS_12 | CTCF | Any mutation | 19 | 18 | Signature 15 | 0.34 | -0.68 | 1.38 | 1493.02 | 1.00 | 78 | 14 | 13 | 5 | FALSE | 0.30 |
| uterine cancer | KRAS_12 | CTCF | Any mutation | 35 | 49 | Signature 1A | 0.40 | -0.39 | 1.14 | 1529.17 | 1.00 | 150 | 24 | 38 | 11 | FALSE | 0.52 |
| uterine cancer | KRAS_12 | CTCF | Any mutation | 13 | 40 | Signature 6 | -0.40 | -1.64 | 0.56 | 1589.62 | 1.00 | 51 | 10 | 37 | 3 | FALSE | 0.33 |
| uterine cancer | KRAS_12 | CTCF | Any mutation | 68 | 123 | Signature overall | -0.03 | -1.05 | 0.91 | 1464.27 | 1.00 | 303 | 49 | 104 | 19 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 21 | 11 | Signature 11 | 1.62 | 0.75 | 2.65 | 1482.68 | 1.00 | 22 | 11 | 1 | 10 | TRUE | 3.08 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 20 | 19 | Signature 15 | 0.81 | -0.07 | 1.64 | 1804.38 | 1.00 | 102 | 15 | 14 | 5 | TRUE | 1.20 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 8 | 11 | Signature 16 | 0.62 | -0.40 | 1.59 | 1575.96 | 1.00 | 43 | 6 | 9 | 2 | TRUE | 0.62 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 58 | 38 | Signature 18 | 0.48 | -0.19 | 1.11 | 1481.84 | 1.00 | 72 | 42 | 22 | 16 | TRUE | 0.81 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 15 | 17 | Signature 19 | 0.90 | 0.00 | 1.72 | 1478.68 | 1.00 | 37 | 9 | 11 | 6 | TRUE | 1.39 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 44 | 21 | Signature 1A | 1.56 | 0.78 | 2.36 | 1361.93 | 1.00 | 213 | 32 | 9 | 12 | TRUE | 4.20 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 80 | 55 | Signature 2 | 0.26 | -0.34 | 0.84 | 1499.60 | 1.00 | 212 | 66 | 41 | 14 | TRUE | 0.42 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 13 | 13 | Signature 20 | 1.28 | 0.34 | 2.22 | 1439.95 | 1.00 | 57 | 7 | 7 | 6 | TRUE | 2.13 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 50 | 37 | Signature 3 | 0.76 | 0.09 | 1.38 | 1584.09 | 1.00 | 168 | 38 | 25 | 12 | TRUE | 1.62 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 231 | 163 | Signature 4 | 0.37 | 0.01 | 0.71 | 1365.80 | 1.00 | 372 | 169 | 101 | 62 | TRUE | 1.42 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 27 | 13 | Signature 8 | 1.00 | 0.12 | 1.88 | 1349.36 | 1.00 | 32 | 19 | 5 | 8 | TRUE | 1.57 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 145 | 61 | Signature R2 | 0.76 | 0.13 | 1.42 | 1484.92 | 1.00 | 41 | 97 | 13 | 48 | TRUE | 1.85 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 17 | 13 | Signature U1 | 1.25 | 0.37 | 2.18 | 1512.43 | 1.00 | 87 | 11 | 7 | 6 | TRUE | 2.25 |
| non-small cell lung cancer | KRAS_12 | STK11 | Any mutation | 729 | 472 | Signature overall | 0.89 | 0.43 | 1.36 | 1411.99 | 1.00 | 1458 | 522 | 265 | 207 | TRUE | 3.73 |
| colorectal cancer | KRAS_12 | ASXL1 | Any mutation | 8 | 11 | Signature 10 | -2.06 | -4.71 | -0.31 | 1607.06 | 1.00 | 17 | 8 | 11 | 0 | TRUE | 1.16 |
| colorectal cancer | KRAS_12 | ASXL1 | Any mutation | 99 | 14 | Signature 15 | -2.15 | -4.64 | -0.51 | 1615.55 | 1.00 | 274 | 99 | 14 | 0 | TRUE | 1.40 |
| colorectal cancer | KRAS_12 | ASXL1 | Any mutation | 270 | 31 | Signature 1A | -0.93 | -1.84 | -0.11 | 1478.06 | 1.00 | 552 | 264 | 25 | 6 | TRUE | 1.45 |
| colorectal cancer | KRAS_12 | ASXL1 | Any mutation | 69 | 34 | Signature 6 | -0.84 | -1.83 | 0.10 | 1514.32 | 1.00 | 218 | 64 | 29 | 5 | TRUE | 1.04 |
| colorectal cancer | KRAS_12 | ASXL1 | Any mutation | 446 | 90 | Signature overall | -1.49 | -2.96 | -0.24 | 1558.63 | 1.00 | 1061 | 435 | 79 | 11 | TRUE | 1.37 |
| colorectal cancer | KRAS_12 | EP300 | Any mutation | 99 | 18 | Signature 15 | -1.00 | -2.18 | 0.06 | 1399.39 | 1.00 | 274 | 97 | 16 | 2 | TRUE | 1.15 |
| colorectal cancer | KRAS_12 | EP300 | Any mutation | 270 | 36 | Signature 1A | -0.56 | -1.30 | 0.12 | 1601.11 | 1.00 | 550 | 261 | 27 | 9 | TRUE | 0.89 |
| colorectal cancer | KRAS_12 | EP300 | Any mutation | 70 | 51 | Signature 6 | -0.96 | -1.84 | -0.19 | 1481.32 | 1.00 | 210 | 65 | 46 | 5 | TRUE | 1.63 |
| non-small cell lung cancer | KRAS_12 | EP300 | Any mutation | 13 | 11 | Signature 13 | -0.11 | -1.44 | 1.27 | 1379.23 | 1.00 | 78 | 11 | 9 | 2 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12 | EP300 | Any mutation | 79 | 20 | Signature 2 | -1.02 | -2.57 | 0.05 | 1606.27 | 1.00 | 232 | 78 | 19 | 1 | TRUE | 0.89 |
| non-small cell lung cancer | KRAS_12 | EP300 | Any mutation | 231 | 30 | Signature 4 | -0.04 | -0.78 | 0.67 | 1524.64 | 1.00 | 453 | 220 | 19 | 11 | TRUE | 0.04 |
| uterine cancer | KRAS_12 | EP300 | Any mutation | 35 | 21 | Signature 1A | -0.20 | -1.44 | 0.91 | 1525.58 | 1.00 | 167 | 32 | 18 | 3 | TRUE | 0.13 |
| uterine cancer | KRAS_12 | EP300 | Any mutation | 13 | 20 | Signature 6 | 0.12 | -1.25 | 1.37 | 1380.32 | 1.00 | 70 | 10 | 17 | 3 | TRUE | 0.07 |
| colorectal cancer | KRAS_12 | EP300 | Any mutation | 439 | 105 | Signature overall | -0.84 | -1.90 | 0.12 | 1353.27 | 1.00 | 1034 | 423 | 89 | 16 | TRUE | 0.98 |
| non-small cell lung cancer | KRAS_12 | EP300 | Any mutation | 323 | 61 | Signature overall | -0.40 | -1.69 | 0.80 | 1589.13 | 1.00 | 763 | 309 | 47 | 14 | TRUE | 0.28 |
| uterine cancer | KRAS_12 | EP300 | Any mutation | 50 | 74 | Signature overall | 0.10 | -1.63 | 2.18 | 1464.39 | 1.00 | 258 | 42 | 66 | 8 | TRUE | 0.04 |
| colorectal cancer | KRAS_12 | ERBB4 | Any mutation | 8 | 18 | Signature 10 | -0.94 | -2.63 | 0.36 | 1614.19 | 1.00 | 18 | 7 | 17 | 1 | TRUE | 0.65 |
| colorectal cancer | KRAS_12 | ERBB4 | Any mutation | 100 | 23 | Signature 15 | -0.34 | -1.31 | 0.51 | 1241.54 | 1.00 | 270 | 95 | 18 | 5 | TRUE | 0.33 |
| colorectal cancer | KRAS_12 | ERBB4 | Any mutation | 271 | 43 | Signature 1A | -0.08 | -0.70 | 0.54 | 1560.97 | 1.00 | 548 | 257 | 29 | 14 | TRUE | 0.10 |
| colorectal cancer | KRAS_12 | ERBB4 | Any mutation | 69 | 31 | Signature 6 | -0.10 | -0.96 | 0.69 | 1595.04 | 1.00 | 222 | 62 | 24 | 7 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12 | ERBB4 | Any mutation | 44 | 11 | Signature 1A | -0.04 | -1.35 | 1.26 | 1529.59 | 1.00 | 214 | 41 | 8 | 3 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12 | ERBB4 | Any mutation | 79 | 17 | Signature 2 | -0.74 | -1.99 | 0.31 | 1550.90 | 1.00 | 233 | 77 | 15 | 2 | TRUE | 0.69 |
| non-small cell lung cancer | KRAS_12 | ERBB4 | Any mutation | 233 | 97 | Signature 4 | -0.51 | -1.01 | -0.06 | 1311.60 | 1.00 | 413 | 211 | 75 | 22 | TRUE | 1.46 |
| colorectal cancer | KRAS_12 | ERBB4 | Any mutation | 448 | 115 | Signature overall | -0.37 | -1.50 | 0.70 | 1545.00 | 1.00 | 1058 | 421 | 88 | 27 | TRUE | 0.30 |
| non-small cell lung cancer | KRAS_12 | ERBB4 | Any mutation | 356 | 125 | Signature overall | -0.43 | -1.60 | 0.71 | 1507.03 | 1.00 | 860 | 329 | 98 | 27 | TRUE | 0.35 |
| colorectal cancer | KRAS_12 | MED12 | Any mutation | 99 | 11 | Signature 15 | -0.64 | -1.96 | 0.53 | 1468.05 | 1.00 | 278 | 97 | 9 | 2 | TRUE | 0.52 |
| colorectal cancer | KRAS_12 | MED12 | Any mutation | 271 | 34 | Signature 1A | -0.05 | -0.79 | 0.67 | 1573.89 | 1.00 | 555 | 259 | 22 | 12 | TRUE | 0.05 |
| colorectal cancer | KRAS_12 | MED12 | Any mutation | 70 | 42 | Signature 6 | -1.11 | -2.26 | -0.18 | 1445.15 | 1.00 | 213 | 67 | 39 | 3 | TRUE | 1.48 |
| non-small cell lung cancer | KRAS_12 | MED12 | Any mutation | 79 | 25 | Signature 2 | -0.41 | -1.24 | 0.52 | 1350.78 | 1.00 | 227 | 73 | 19 | 6 | TRUE | 0.45 |
| non-small cell lung cancer | KRAS_12 | MED12 | Any mutation | 231 | 72 | Signature 4 | -0.84 | -1.47 | -0.26 | 948.69 | 1.00 | 421 | 219 | 60 | 12 | TRUE | 2.18 |
| uterine cancer | KRAS_12 | MED12 | Any mutation | 19 | 13 | Signature 15 | -0.70 | -2.54 | 0.82 | 1648.64 | 1.00 | 78 | 17 | 11 | 2 | TRUE | 0.39 |
| uterine cancer | KRAS_12 | MED12 | Any mutation | 34 | 18 | Signature 1A | -1.47 | -3.45 | 0.15 | 1498.53 | 1.00 | 169 | 33 | 17 | 1 | TRUE | 0.98 |
| uterine cancer | KRAS_12 | MED12 | Any mutation | 13 | 14 | Signature 6 | -1.17 | -3.27 | 0.50 | 1558.01 | 1.00 | 75 | 12 | 13 | 1 | TRUE | 0.65 |
| colorectal cancer | KRAS_12 | MED12 | Any mutation | 440 | 87 | Signature overall | -0.60 | -1.84 | 0.53 | 1539.40 | 1.00 | 1046 | 423 | 70 | 17 | TRUE | 0.52 |
| non-small cell lung cancer | KRAS_12 | MED12 | Any mutation | 310 | 97 | Signature overall | -0.63 | -1.73 | 0.64 | 1420.33 | 1.00 | 648 | 292 | 79 | 18 | TRUE | 0.53 |
| uterine cancer | KRAS_12 | MED12 | Any mutation | 67 | 87 | Signature overall | -1.33 | -3.31 | 0.39 | 1404.24 | 1.00 | 339 | 63 | 83 | 4 | TRUE | 0.83 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 13 | 11 | Signature 13 | 0.62 | -0.39 | 1.63 | 1404.32 | 1.00 | 78 | 10 | 8 | 3 | FALSE | 0.67 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 21 | 11 | Signature 15 | 0.55 | -0.50 | 1.52 | 1508.72 | 1.00 | 109 | 18 | 8 | 3 | FALSE | 0.56 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 58 | 17 | Signature 18 | 0.63 | -0.18 | 1.46 | 1429.06 | 1.00 | 85 | 49 | 8 | 9 | FALSE | 0.94 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 44 | 21 | Signature 1A | 0.30 | -0.60 | 1.09 | 1380.06 | 1.00 | 205 | 40 | 17 | 4 | FALSE | 0.31 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 79 | 32 | Signature 2 | 0.83 | 0.20 | 1.48 | 1587.11 | 1.00 | 227 | 65 | 18 | 14 | FALSE | 1.96 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 52 | 30 | Signature 3 | 0.52 | -0.21 | 1.24 | 1550.18 | 1.00 | 173 | 43 | 21 | 9 | FALSE | 0.82 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 234 | 128 | Signature 4 | 0.53 | 0.15 | 0.87 | 1645.37 | 1.00 | 405 | 180 | 74 | 54 | FALSE | 2.18 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 144 | 20 | Signature R2 | 0.33 | -0.49 | 1.10 | 1389.88 | 1.00 | 49 | 129 | 5 | 15 | FALSE | 0.40 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 17 | 15 | Signature U1 | 0.44 | -0.53 | 1.36 | 1457.86 | 1.00 | 83 | 14 | 12 | 3 | FALSE | 0.45 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Any mutation | 662 | 285 | Signature overall | 0.53 | -0.03 | 1.06 | 1595.89 | 1.00 | 1414 | 548 | 171 | 114 | FALSE | 1.22 |
| colorectal cancer | KRAS_12 | NF1 | Any mutation | 8 | 24 | Signature 10 | -1.82 | -3.69 | -0.35 | 1570.10 | 1.00 | 17 | 7 | 23 | 1 | TRUE | 1.52 |
| colorectal cancer | KRAS_12 | NF1 | Any mutation | 99 | 21 | Signature 15 | -1.35 | -2.90 | -0.22 | 1462.22 | 1.00 | 271 | 97 | 19 | 2 | TRUE | 1.37 |
| colorectal cancer | KRAS_12 | NF1 | Any mutation | 272 | 40 | Signature 1A | -0.31 | -1.03 | 0.37 | 1495.46 | 1.00 | 550 | 260 | 28 | 12 | TRUE | 0.41 |
| colorectal cancer | KRAS_12 | NF1 | Any mutation | 69 | 44 | Signature 6 | -1.80 | -3.21 | -0.70 | 1434.23 | 1.00 | 211 | 67 | 42 | 2 | TRUE | 2.33 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 57 | 13 | Signature 18 | -0.14 | -1.11 | 0.75 | 1545.03 | 1.00 | 87 | 51 | 7 | 6 | TRUE | 0.11 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 44 | 13 | Signature 1A | -0.61 | -1.79 | 0.51 | 1533.20 | 1.00 | 211 | 42 | 11 | 2 | TRUE | 0.52 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 81 | 39 | Signature 2 | -0.57 | -1.40 | 0.19 | 1429.74 | 1.00 | 216 | 74 | 32 | 7 | TRUE | 0.81 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 13 | 13 | Signature 20 | -0.89 | -2.20 | 0.33 | 1239.14 | 1.00 | 53 | 12 | 12 | 1 | TRUE | 0.77 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 50 | 15 | Signature 3 | -1.07 | -2.28 | 0.00 | 1501.25 | 1.00 | 180 | 49 | 14 | 1 | TRUE | 1.13 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 231 | 113 | Signature 4 | -0.87 | -1.39 | -0.39 | 1317.88 | 1.00 | 403 | 211 | 93 | 20 | TRUE | 3.25 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 20 | 11 | Signature 7 | -1.21 | -2.54 | -0.02 | 1467.47 | 1.00 | 77 | 20 | 11 | 0 | TRUE | 1.22 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 145 | 12 | Signature R2 | -0.92 | -1.81 | -0.04 | 1388.14 | 1.00 | 48 | 139 | 6 | 6 | TRUE | 1.35 |
| uterine cancer | KRAS_12 | NF1 | Any mutation | 34 | 21 | Signature 1A | -0.28 | -1.65 | 0.92 | 1626.03 | 1.00 | 172 | 31 | 18 | 3 | TRUE | 0.17 |
| uterine cancer | KRAS_12 | NF1 | Any mutation | 13 | 24 | Signature 6 | -0.68 | -2.30 | 0.76 | 1520.34 | 1.00 | 67 | 11 | 22 | 2 | TRUE | 0.43 |
| colorectal cancer | KRAS_12 | NF1 | Any mutation | 448 | 129 | Signature overall | -1.31 | -2.78 | -0.11 | 1438.67 | 1.00 | 1049 | 431 | 112 | 17 | TRUE | 1.28 |
| non-small cell lung cancer | KRAS_12 | NF1 | Any mutation | 641 | 229 | Signature overall | -0.78 | -1.51 | -0.09 | 1599.84 | 1.00 | 1275 | 598 | 186 | 43 | TRUE | 1.52 |
| uterine cancer | KRAS_12 | NF1 | Any mutation | 48 | 92 | Signature overall | -0.46 | -2.74 | 1.75 | 1459.59 | 1.00 | 257 | 42 | 86 | 6 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12 | FLT1 | Any mutation | 58 | 13 | Signature 18 | 0.42 | -0.41 | 1.31 | 1587.11 | 1.00 | 87 | 51 | 6 | 7 | FALSE | 0.47 |
| non-small cell lung cancer | KRAS_12 | FLT1 | Any mutation | 79 | 12 | Signature 2 | 0.33 | -0.54 | 1.27 | 1359.36 | 1.00 | 238 | 74 | 7 | 5 | FALSE | 0.34 |
| non-small cell lung cancer | KRAS_12 | FLT1 | Any mutation | 233 | 64 | Signature 4 | -0.07 | -0.66 | 0.47 | 1465.61 | 1.00 | 433 | 215 | 46 | 18 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12 | FLT1 | Any mutation | 370 | 89 | Signature overall | 0.23 | -0.58 | 1.14 | 1545.80 | 1.00 | 758 | 340 | 59 | 30 | FALSE | 0.23 |
| uterine cancer | KRAS_12 | RASA1 | Any mutation | 34 | 20 | Signature 1A | -2.26 | -5.21 | -0.14 | 1548.09 | 1.00 | 171 | 33 | 19 | 1 | FALSE | 1.08 |
| uterine cancer | KRAS_12 | RASA1 | Any mutation | 13 | 12 | Signature 6 | -3.67 | -8.36 | -0.57 | 1489.25 | 1.00 | 74 | 13 | 12 | 0 | FALSE | 1.08 |
| uterine cancer | KRAS_12 | RASA1 | Any mutation | 48 | 78 | Signature overall | -3.07 | -6.95 | -0.18 | 1593.53 | 1.00 | 262 | 47 | 77 | 1 | FALSE | 1.19 |
| colorectal cancer | KRAS_12 | EPHA5 | Any mutation | 8 | 26 | Signature 10 | -2.72 | -5.37 | -0.87 | 1356.71 | 1.00 | 15 | 8 | 26 | 0 | FALSE | 1.76 |
| colorectal cancer | KRAS_12 | EPHA5 | Any mutation | 99 | 18 | Signature 15 | -0.86 | -2.10 | 0.19 | 1300.39 | 1.00 | 275 | 96 | 15 | 3 | FALSE | 0.80 |
| colorectal cancer | KRAS_12 | EPHA5 | Any mutation | 271 | 49 | Signature 1A | -0.10 | -0.74 | 0.50 | 1501.44 | 1.00 | 543 | 255 | 33 | 16 | FALSE | 0.13 |
| colorectal cancer | KRAS_12 | EPHA5 | Any mutation | 69 | 36 | Signature 6 | -1.68 | -3.25 | -0.50 | 1423.59 | 1.00 | 213 | 67 | 34 | 2 | FALSE | 1.81 |
| non-small cell lung cancer | KRAS_12 | EPHA5 | Any mutation | 58 | 24 | Signature 18 | 0.05 | -0.70 | 0.83 | 1343.60 | 1.00 | 79 | 49 | 15 | 9 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12 | EPHA5 | Any mutation | 79 | 30 | Signature 2 | 0.23 | -0.53 | 0.95 | 1574.85 | 1.00 | 227 | 70 | 21 | 9 | FALSE | 0.27 |
| non-small cell lung cancer | KRAS_12 | EPHA5 | Any mutation | 50 | 19 | Signature 3 | 0.53 | -0.34 | 1.47 | 1470.32 | 1.00 | 184 | 43 | 12 | 7 | FALSE | 0.61 |
| non-small cell lung cancer | KRAS_12 | EPHA5 | Any mutation | 233 | 109 | Signature 4 | -0.01 | -0.43 | 0.40 | 1431.24 | 1.00 | 410 | 198 | 74 | 35 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12 | EPHA5 | Any mutation | 144 | 12 | Signature R2 | -0.38 | -1.32 | 0.56 | 1427.18 | 1.00 | 50 | 137 | 5 | 7 | FALSE | 0.38 |
| colorectal cancer | KRAS_12 | EPHA5 | Any mutation | 447 | 129 | Signature overall | -1.30 | -2.85 | 0.18 | 1231.61 | 1.00 | 1046 | 426 | 108 | 21 | FALSE | 1.04 |
| non-small cell lung cancer | KRAS_12 | EPHA5 | Any mutation | 564 | 194 | Signature overall | 0.07 | -0.66 | 0.81 | 1440.14 | 1.00 | 950 | 497 | 127 | 67 | FALSE | 0.07 |
| colorectal cancer | KRAS_12 | AR | Any mutation | 99 | 21 | Signature 15 | -0.94 | -2.04 | -0.01 | 1379.23 | 1.00 | 271 | 97 | 19 | 2 | TRUE | 1.21 |
| colorectal cancer | KRAS_12 | AR | Any mutation | 270 | 33 | Signature 1A | -0.70 | -1.46 | -0.01 | 1457.65 | 1.00 | 549 | 263 | 26 | 7 | TRUE | 1.27 |
| colorectal cancer | KRAS_12 | AR | Any mutation | 69 | 37 | Signature 6 | -0.58 | -1.33 | 0.20 | 1538.74 | 1.00 | 216 | 63 | 31 | 6 | TRUE | 0.86 |
| non-small cell lung cancer | KRAS_12 | AR | Any mutation | 232 | 56 | Signature 4 | -0.23 | -0.82 | 0.33 | 1060.09 | 1.01 | 437 | 216 | 40 | 16 | TRUE | 0.37 |
| colorectal cancer | KRAS_12 | AR | Any mutation | 438 | 91 | Signature overall | -0.74 | -1.59 | 0.06 | 1489.80 | 1.00 | 1036 | 423 | 76 | 15 | TRUE | 1.10 |
| non-small cell lung cancer | KRAS_12 | AR | Any mutation | 232 | 56 | Signature overall | -0.20 | -4.63 | 4.33 | 1264.76 | 1.00 | 437 | 216 | 40 | 16 | TRUE | 0.04 |
| colorectal cancer | KRAS_12 | ROS1 | Any mutation | 8 | 30 | Signature 10 | -2.31 | -4.39 | -0.69 | 1450.30 | 1.00 | 16 | 7 | 29 | 1 | TRUE | 1.78 |
| colorectal cancer | KRAS_12 | ROS1 | Any mutation | 270 | 28 | Signature 1A | -1.55 | -2.82 | -0.51 | 1511.35 | 1.00 | 552 | 267 | 25 | 3 | TRUE | 2.07 |
| colorectal cancer | KRAS_12 | ROS1 | Any mutation | 69 | 26 | Signature 6 | -1.13 | -2.55 | 0.06 | 1418.49 | 1.00 | 219 | 66 | 23 | 3 | TRUE | 1.05 |
| non-small cell lung cancer | KRAS_12 | ROS1 | Any mutation | 79 | 14 | Signature 2 | -1.86 | -3.36 | -0.54 | 1624.81 | 1.00 | 233 | 78 | 13 | 1 | TRUE | 1.91 |
| non-small cell lung cancer | KRAS_12 | ROS1 | Any mutation | 230 | 42 | Signature 4 | -1.93 | -3.13 | -0.88 | 1526.17 | 1.00 | 435 | 227 | 39 | 3 | TRUE | 3.07 |
| colorectal cancer | KRAS_12 | ROS1 | Any mutation | 347 | 84 | Signature overall | -1.60 | -3.48 | 0.30 | 1495.08 | 1.00 | 787 | 340 | 77 | 7 | TRUE | 1.00 |
| non-small cell lung cancer | KRAS_12 | ROS1 | Any mutation | 309 | 56 | Signature overall | -1.89 | -3.39 | -0.43 | 1417.88 | 1.00 | 668 | 305 | 52 | 4 | TRUE | 1.81 |
| colorectal cancer | KRAS_12 | PIK3CG | Any mutation | 10 | 22 | Signature 10 | -0.32 | -1.62 | 0.81 | 1646.03 | 1.00 | 16 | 6 | 18 | 4 | FALSE | 0.21 |
| colorectal cancer | KRAS_12 | PIK3CG | Any mutation | 99 | 17 | Signature 15 | 0.22 | -0.86 | 1.21 | 1491.24 | 1.00 | 277 | 93 | 11 | 6 | FALSE | 0.17 |
| colorectal cancer | KRAS_12 | PIK3CG | Any mutation | 270 | 29 | Signature 1A | -0.79 | -1.70 | 0.00 | 1337.94 | 1.00 | 551 | 265 | 24 | 5 | FALSE | 1.15 |
| colorectal cancer | KRAS_12 | PIK3CG | Any mutation | 69 | 29 | Signature 6 | -0.18 | -1.08 | 0.69 | 1549.42 | 1.00 | 222 | 63 | 23 | 6 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12 | PIK3CG | Any mutation | 13 | 13 | Signature 13 | -0.61 | -2.34 | 0.76 | 1506.93 | 1.00 | 74 | 12 | 12 | 1 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12 | PIK3CG | Any mutation | 81 | 18 | Signature 2 | 1.05 | 0.13 | 1.98 | 1259.15 | 1.00 | 237 | 71 | 8 | 10 | FALSE | 1.57 |
| non-small cell lung cancer | KRAS_12 | PIK3CG | Any mutation | 231 | 75 | Signature 4 | -0.32 | -0.85 | 0.18 | 1347.29 | 1.00 | 423 | 211 | 55 | 20 | FALSE | 0.65 |
| non-small cell lung cancer | KRAS_12 | PIK3CG | Any mutation | 144 | 12 | Signature R2 | -1.06 | -2.17 | 0.01 | 1463.48 | 1.00 | 48 | 139 | 7 | 5 | FALSE | 1.18 |
| colorectal cancer | KRAS_12 | PIK3CG | Any mutation | 448 | 97 | Signature overall | -0.26 | -1.44 | 0.96 | 1523.34 | 1.00 | 1066 | 427 | 76 | 21 | FALSE | 0.17 |
| non-small cell lung cancer | KRAS_12 | PIK3CG | Any mutation | 469 | 118 | Signature overall | -0.24 | -1.55 | 1.05 | 1532.41 | 1.00 | 782 | 433 | 82 | 36 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 13 | 23 | Signature 13 | -3.25 | -4.31 | -2.22 | 1531.00 | 1.00 | 65 | 12 | 22 | 1 | TRUE | 8.74 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 17 | 12 | Signature 14 | -3.24 | -4.36 | -2.19 | 1534.17 | 1.00 | 30 | 16 | 11 | 1 | TRUE | 8.68 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 20 | 54 | Signature 15 | -3.51 | -4.58 | -2.53 | 1367.78 | 1.00 | 71 | 20 | 54 | 0 | TRUE | 10.22 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 8 | 19 | Signature 16 | -3.45 | -4.60 | -2.44 | 1532.51 | 1.00 | 34 | 8 | 19 | 0 | TRUE | 9.78 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 57 | 29 | Signature 18 | -3.58 | -4.68 | -2.60 | 1481.34 | 1.00 | 68 | 57 | 29 | 0 | TRUE | 11.26 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 14 | 16 | Signature 19 | -3.47 | -4.63 | -2.49 | 1185.71 | 1.00 | 33 | 14 | 16 | 0 | TRUE | 9.45 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 44 | 197 | Signature 1A | -3.81 | -4.83 | -2.92 | 1532.92 | 1.00 | 97 | 44 | 197 | 0 | TRUE | 14.13 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 79 | 79 | Signature 2 | -3.46 | -4.52 | -2.56 | 1453.15 | 1.00 | 183 | 78 | 78 | 1 | TRUE | 11.83 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 13 | 35 | Signature 20 | -3.51 | -4.57 | -2.51 | 1525.14 | 1.00 | 36 | 13 | 35 | 0 | TRUE | 10.42 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 9 | 29 | Signature 21 | -3.49 | -4.62 | -2.41 | 1481.22 | 1.00 | 31 | 9 | 29 | 0 | TRUE | 9.22 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 50 | 89 | Signature 3 | -3.12 | -4.13 | -2.19 | 1392.14 | 1.00 | 115 | 47 | 86 | 3 | TRUE | 9.96 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 230 | 114 | Signature 4 | -2.83 | -3.65 | -2.12 | 1552.83 | 1.00 | 386 | 223 | 107 | 7 | TRUE | 12.73 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 11 | 18 | Signature 6 | -3.48 | -4.55 | -2.47 | 1468.05 | 1.00 | 29 | 11 | 18 | 0 | TRUE | 9.80 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 20 | 34 | Signature 7 | -3.50 | -4.64 | -2.44 | 1429.76 | 1.00 | 58 | 20 | 34 | 0 | TRUE | 10.12 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 26 | 14 | Signature 8 | -3.29 | -4.34 | -2.23 | 1489.66 | 1.00 | 25 | 25 | 13 | 1 | TRUE | 9.28 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 6 | 11 | Signature R3 | -3.43 | -4.60 | -2.33 | 1429.75 | 1.00 | 15 | 6 | 11 | 0 | TRUE | 8.67 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 17 | 46 | Signature U1 | -3.51 | -4.65 | -2.41 | 1374.40 | 1.00 | 53 | 17 | 46 | 0 | TRUE | 9.73 |
| non-small cell lung cancer | KRAS_12 | EGFR | Any mutation | 640 | 853 | Signature overall | -3.41 | -4.07 | -2.82 | 1427.29 | 1.00 | 1372 | 626 | 839 | 14 | TRUE | 24.98 |
| colorectal cancer | KRAS_12 | ARID1B | Any mutation | 99 | 22 | Signature 15 | -1.34 | -2.48 | -0.24 | 1379.12 | 1.00 | 271 | 96 | 19 | 3 | TRUE | 1.70 |
| colorectal cancer | KRAS_12 | ARID1B | Any mutation | 271 | 53 | Signature 1A | -1.41 | -2.27 | -0.65 | 1380.04 | 1.00 | 537 | 264 | 46 | 7 | TRUE | 3.22 |
| colorectal cancer | KRAS_12 | ARID1B | Any mutation | 69 | 46 | Signature 6 | -2.34 | -4.24 | -1.16 | 1384.17 | 1.00 | 204 | 69 | 46 | 0 | TRUE | 2.38 |
| non-small cell lung cancer | KRAS_12 | ARID1B | Any mutation | 79 | 13 | Signature 2 | 0.14 | -0.80 | 1.33 | 1470.64 | 1.00 | 237 | 74 | 8 | 5 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12 | ARID1B | Any mutation | 230 | 42 | Signature 4 | -0.46 | -1.24 | 0.24 | 1433.96 | 1.00 | 441 | 221 | 33 | 9 | TRUE | 0.66 |
| uterine cancer | KRAS_12 | ARID1B | Any mutation | 34 | 17 | Signature 1A | -0.02 | -1.34 | 1.10 | 1391.14 | 1.00 | 172 | 31 | 14 | 3 | TRUE | 0.01 |
| uterine cancer | KRAS_12 | ARID1B | Any mutation | 13 | 39 | Signature 6 | -0.26 | -1.45 | 0.83 | 1560.68 | 1.00 | 58 | 9 | 35 | 4 | TRUE | 0.18 |
| colorectal cancer | KRAS_12 | ARID1B | Any mutation | 439 | 121 | Signature overall | -1.69 | -2.94 | -0.59 | 1379.97 | 1.00 | 1012 | 429 | 111 | 10 | TRUE | 2.22 |
| non-small cell lung cancer | KRAS_12 | ARID1B | Any mutation | 309 | 55 | Signature overall | -0.15 | -1.42 | 1.31 | 1696.88 | 1.00 | 678 | 295 | 41 | 14 | TRUE | 0.08 |
| uterine cancer | KRAS_12 | ARID1B | Any mutation | 48 | 78 | Signature overall | -0.07 | -1.88 | 1.96 | 1424.27 | 1.00 | 257 | 40 | 70 | 8 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12 | MET | Any mutation | 79 | 23 | Signature 2 | -0.99 | -2.27 | -0.07 | 1447.62 | 1.00 | 226 | 78 | 22 | 1 | TRUE | 1.13 |
| non-small cell lung cancer | KRAS_12 | MET | Any mutation | 50 | 11 | Signature 3 | -0.64 | -1.66 | 0.30 | 1533.67 | 1.00 | 185 | 48 | 9 | 2 | TRUE | 0.70 |
| non-small cell lung cancer | KRAS_12 | MET | Any mutation | 230 | 34 | Signature 4 | -0.55 | -1.26 | 0.18 | 1560.60 | 1.00 | 451 | 221 | 25 | 9 | TRUE | 0.85 |
| non-small cell lung cancer | KRAS_12 | MET | Any mutation | 359 | 68 | Signature overall | -0.73 | -1.71 | 0.14 | 1500.09 | 1.00 | 862 | 347 | 56 | 12 | TRUE | 0.95 |
| colorectal cancer | KRAS_12 | BRAF | Any mutation | 99 | 48 | Signature 15 | -2.19 | -3.16 | -1.31 | 1414.90 | 1.00 | 243 | 96 | 45 | 3 | TRUE | 5.81 |
| colorectal cancer | KRAS_12 | BRAF | Any mutation | 271 | 99 | Signature 1A | -2.19 | -2.92 | -1.50 | 1456.98 | 1.00 | 485 | 264 | 92 | 7 | TRUE | 8.89 |
| colorectal cancer | KRAS_12 | BRAF | Any mutation | 69 | 60 | Signature 6 | -2.56 | -3.86 | -1.66 | 1397.94 | 1.00 | 188 | 69 | 60 | 0 | TRUE | 4.52 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 57 | 11 | Signature 18 | -1.20 | -2.12 | -0.38 | 1266.98 | 1.00 | 83 | 56 | 10 | 1 | TRUE | 2.07 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 79 | 20 | Signature 2 | -1.15 | -2.05 | -0.39 | 1429.89 | 1.00 | 227 | 77 | 18 | 2 | TRUE | 2.20 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 50 | 20 | Signature 3 | -1.22 | -2.19 | -0.40 | 1489.60 | 1.00 | 174 | 49 | 19 | 1 | TRUE | 2.16 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 230 | 50 | Signature 4 | -0.96 | -1.64 | -0.33 | 1417.05 | 1.00 | 434 | 220 | 40 | 10 | TRUE | 2.42 |
| colorectal cancer | KRAS_12 | BRAF | Any mutation | 439 | 207 | Signature overall | -2.31 | -3.24 | -1.52 | 1505.11 | 1.00 | 916 | 429 | 197 | 10 | TRUE | 6.77 |
| non-small cell lung cancer | KRAS_12 | BRAF | Any mutation | 416 | 101 | Signature overall | -1.13 | -1.89 | -0.47 | 1372.42 | 1.00 | 918 | 402 | 87 | 14 | TRUE | 2.67 |
| colorectal cancer | KRAS_12 | B2M | Any mutation | 8 | 14 | Signature 10 | -1.47 | -3.33 | -0.07 | 1510.84 | 1.00 | 19 | 8 | 14 | 0 | FALSE | 1.13 |
| colorectal cancer | KRAS_12 | B2M | Any mutation | 97 | 20 | Signature 15 | -0.64 | -1.65 | 0.34 | 1481.10 | 1.00 | 271 | 93 | 16 | 4 | FALSE | 0.68 |
| colorectal cancer | KRAS_12 | B2M | Any mutation | 263 | 46 | Signature 1A | -0.76 | -1.51 | -0.14 | 1411.59 | 1.00 | 539 | 254 | 37 | 9 | FALSE | 1.49 |
| colorectal cancer | KRAS_12 | B2M | Any mutation | 69 | 51 | Signature 6 | -0.72 | -1.49 | 0.07 | 1431.72 | 1.00 | 208 | 62 | 44 | 7 | FALSE | 1.18 |
| colorectal cancer | KRAS_12 | B2M | Any mutation | 437 | 131 | Signature overall | -0.90 | -1.99 | 0.10 | 1453.39 | 1.00 | 1037 | 417 | 111 | 20 | FALSE | 1.05 |
| colorectal cancer | KRAS_12 | CARD11 | Any mutation | 99 | 14 | Signature 15 | -0.45 | -1.38 | 0.44 | 1658.42 | 1.00 | 275 | 96 | 11 | 3 | FALSE | 0.46 |
| colorectal cancer | KRAS_12 | CARD11 | Any mutation | 272 | 58 | Signature 1A | -0.17 | -0.74 | 0.39 | 1449.00 | 1.00 | 538 | 254 | 40 | 18 | FALSE | 0.26 |
| colorectal cancer | KRAS_12 | CARD11 | Any mutation | 69 | 38 | Signature 6 | -0.67 | -1.55 | 0.12 | 1565.08 | 1.00 | 216 | 65 | 34 | 4 | FALSE | 0.93 |
| non-small cell lung cancer | KRAS_12 | CARD11 | Any mutation | 81 | 16 | Signature 2 | 0.46 | -0.52 | 1.53 | 1215.01 | 1.00 | 236 | 74 | 9 | 7 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12 | CARD11 | Any mutation | 230 | 63 | Signature 4 | -0.28 | -0.88 | 0.27 | 1422.53 | 1.00 | 429 | 214 | 47 | 16 | FALSE | 0.47 |
| colorectal cancer | KRAS_12 | CARD11 | Any mutation | 440 | 110 | Signature overall | -0.42 | -1.36 | 0.47 | 1539.22 | 1.00 | 1029 | 415 | 85 | 25 | FALSE | 0.44 |
| non-small cell lung cancer | KRAS_12 | CARD11 | Any mutation | 311 | 79 | Signature overall | 0.07 | -1.46 | 1.50 | 1485.11 | 1.00 | 665 | 288 | 56 | 23 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12 | INPP4B | Any mutation | 80 | 15 | Signature 2 | 0.91 | -0.05 | 2.08 | 1225.70 | 1.00 | 239 | 72 | 7 | 8 | FALSE | 1.05 |
| non-small cell lung cancer | KRAS_12 | INPP4B | Any mutation | 231 | 60 | Signature 4 | 0.07 | -0.51 | 0.61 | 1076.57 | 1.00 | 438 | 212 | 41 | 19 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12 | INPP4B | Any mutation | 311 | 75 | Signature overall | 0.49 | -1.04 | 2.15 | 1534.42 | 1.00 | 677 | 284 | 48 | 27 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12 | NFE2L2 | Any mutation | 13 | 15 | Signature 13 | -0.72 | -2.30 | 0.66 | 1525.72 | 1.00 | 74 | 12 | 14 | 1 | FALSE | 0.48 |
| non-small cell lung cancer | KRAS_12 | NFE2L2 | Any mutation | 79 | 32 | Signature 2 | -0.61 | -1.57 | 0.28 | 1409.03 | 1.00 | 225 | 74 | 27 | 5 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12 | NFE2L2 | Any mutation | 231 | 20 | Signature 4 | -0.38 | -1.28 | 0.49 | 1491.52 | 1.00 | 458 | 225 | 14 | 6 | FALSE | 0.40 |
| non-small cell lung cancer | KRAS_12 | NFE2L2 | Any mutation | 323 | 67 | Signature overall | -0.56 | -1.77 | 0.73 | 1540.24 | 1.00 | 757 | 311 | 55 | 12 | FALSE | 0.43 |
| colorectal cancer | KRAS_12 | SOX9 | Any mutation | 101 | 40 | Signature 15 | -0.04 | -0.67 | 0.55 | 1242.58 | 1.00 | 256 | 91 | 30 | 10 | FALSE | 0.04 |
| colorectal cancer | KRAS_12 | SOX9 | Any mutation | 274 | 105 | Signature 1A | 0.43 | 0.04 | 0.84 | 1519.31 | 1.00 | 521 | 228 | 59 | 46 | FALSE | 1.46 |
| colorectal cancer | KRAS_12 | SOX9 | Any mutation | 69 | 59 | Signature 6 | -0.22 | -0.94 | 0.40 | 1452.66 | 1.00 | 199 | 60 | 50 | 9 | FALSE | 0.29 |
| colorectal cancer | KRAS_12 | SOX9 | Any mutation | 444 | 204 | Signature overall | 0.04 | -0.66 | 0.70 | 1370.10 | 1.00 | 976 | 379 | 139 | 65 | FALSE | 0.05 |
| colorectal cancer | KRAS_12 | SMAD2 | Any mutation | 99 | 16 | Signature 15 | 0.43 | -0.29 | 1.07 | 1485.23 | 1.00 | 275 | 94 | 11 | 5 | TRUE | 0.64 |
| colorectal cancer | KRAS_12 | SMAD2 | Any mutation | 272 | 33 | Signature 1A | 0.59 | 0.02 | 1.16 | 1461.45 | 1.00 | 562 | 255 | 16 | 17 | TRUE | 1.38 |
| colorectal cancer | KRAS_12 | SMAD2 | Any mutation | 69 | 17 | Signature 6 | 0.41 | -0.35 | 1.04 | 1528.46 | 1.00 | 231 | 65 | 13 | 4 | TRUE | 0.57 |
| colorectal cancer | KRAS_12 | SMAD2 | Any mutation | 440 | 66 | Signature overall | 0.47 | -0.22 | 1.08 | 1397.66 | 1.00 | 1068 | 414 | 40 | 26 | TRUE | 0.82 |
| non-small cell lung cancer | KRAS_12 | GLI1 | Any mutation | 219 | 44 | Signature 4 | 0.29 | -0.38 | 0.90 | 1374.42 | 1.00 | 392 | 201 | 26 | 18 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12 | GLI1 | Any mutation | 219 | 44 | Signature overall | 0.32 | -4.09 | 4.77 | 1405.90 | 1.00 | 392 | 201 | 26 | 18 | FALSE | 0.06 |
| colorectal cancer | KRAS_12 | ZFHX3 | Any mutation | 9 | 17 | Signature 10 | -0.88 | -2.15 | 0.21 | 1439.58 | 1.00 | 14 | 7 | 15 | 2 | FALSE | 0.85 |
| colorectal cancer | KRAS_12 | ZFHX3 | Any mutation | 90 | 31 | Signature 15 | -0.59 | -1.43 | 0.16 | 1524.94 | 1.00 | 244 | 84 | 25 | 6 | FALSE | 0.83 |
| colorectal cancer | KRAS_12 | ZFHX3 | Any mutation | 257 | 80 | Signature 1A | -0.80 | -1.35 | -0.25 | 1449.02 | 1.00 | 487 | 242 | 65 | 15 | FALSE | 2.38 |
| colorectal cancer | KRAS_12 | ZFHX3 | Any mutation | 68 | 81 | Signature 6 | -0.84 | -1.48 | -0.21 | 1530.20 | 1.00 | 177 | 58 | 71 | 10 | FALSE | 2.02 |
| non-small cell lung cancer | KRAS_12 | ZFHX3 | Any mutation | 75 | 18 | Signature 2 | -0.73 | -1.88 | 0.30 | 1465.79 | 1.00 | 200 | 72 | 15 | 3 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12 | ZFHX3 | Any mutation | 219 | 61 | Signature 4 | -0.40 | -0.96 | 0.20 | 1567.73 | 1.00 | 375 | 202 | 44 | 17 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12 | ZFHX3 | Any mutation | 129 | 14 | Signature R2 | -1.14 | -2.19 | -0.14 | 1410.44 | 1.00 | 40 | 123 | 8 | 6 | FALSE | 1.56 |
| uterine cancer | KRAS_12 | ZFHX3 | Any mutation | 19 | 13 | Signature 15 | 0.75 | -0.44 | 1.90 | 1359.75 | 1.00 | 76 | 14 | 8 | 5 | FALSE | 0.71 |
| uterine cancer | KRAS_12 | ZFHX3 | Any mutation | 31 | 56 | Signature 1A | -0.59 | -1.56 | 0.29 | 1588.43 | 1.00 | 132 | 26 | 51 | 5 | FALSE | 0.66 |
| uterine cancer | KRAS_12 | ZFHX3 | Any mutation | 13 | 45 | Signature 6 | 0.59 | -0.47 | 1.67 | 1278.34 | 1.00 | 52 | 5 | 37 | 8 | FALSE | 0.55 |
| colorectal cancer | KRAS_12 | ZFHX3 | Any mutation | 424 | 209 | Signature overall | -0.76 | -1.64 | 0.09 | 1446.77 | 1.00 | 922 | 391 | 176 | 33 | FALSE | 1.14 |
| non-small cell lung cancer | KRAS_12 | ZFHX3 | Any mutation | 423 | 93 | Signature overall | -0.73 | -2.02 | 0.55 | 1508.52 | 1.00 | 615 | 397 | 67 | 26 | FALSE | 0.59 |
| uterine cancer | KRAS_12 | ZFHX3 | Any mutation | 69 | 184 | Signature overall | 0.08 | -1.20 | 1.34 | 1534.35 | 1.00 | 286 | 47 | 162 | 22 | FALSE | 0.05 |
| colorectal cancer | KRAS_12 | MGA | Any mutation | 8 | 15 | Signature 10 | -1.77 | -4.18 | -0.22 | 1591.32 | 1.00 | 15 | 8 | 15 | 0 | FALSE | 1.05 |
| colorectal cancer | KRAS_12 | MGA | Any mutation | 89 | 16 | Signature 15 | -0.71 | -1.94 | 0.39 | 1530.40 | 1.00 | 246 | 86 | 13 | 3 | FALSE | 0.63 |
| colorectal cancer | KRAS_12 | MGA | Any mutation | 256 | 42 | Signature 1A | -0.23 | -0.90 | 0.40 | 1425.86 | 1.00 | 508 | 243 | 29 | 13 | FALSE | 0.31 |
| colorectal cancer | KRAS_12 | MGA | Any mutation | 66 | 36 | Signature 6 | -0.96 | -2.06 | -0.05 | 1468.52 | 1.00 | 195 | 62 | 32 | 4 | FALSE | 1.28 |
| non-small cell lung cancer | KRAS_12 | MGA | Any mutation | 75 | 28 | Signature 2 | -0.66 | -1.68 | 0.24 | 1155.66 | 1.00 | 202 | 71 | 24 | 4 | FALSE | 0.74 |
| non-small cell lung cancer | KRAS_12 | MGA | Any mutation | 220 | 79 | Signature 4 | -0.20 | -0.72 | 0.27 | 1361.30 | 1.00 | 366 | 196 | 55 | 24 | FALSE | 0.38 |
| non-small cell lung cancer | KRAS_12 | MGA | Any mutation | 129 | 13 | Signature R2 | -0.01 | -0.98 | 1.05 | 1441.71 | 1.00 | 45 | 119 | 3 | 10 | FALSE | 0.01 |
| uterine cancer | KRAS_12 | MGA | Any mutation | 31 | 19 | Signature 1A | -3.39 | -10.07 | -0.54 | 1232.35 | 1.00 | 154 | 31 | 19 | 0 | FALSE | 0.84 |
| uterine cancer | KRAS_12 | MGA | Any mutation | 12 | 14 | Signature 6 | -3.16 | -8.78 | -0.12 | 1251.17 | 1.00 | 66 | 12 | 14 | 0 | FALSE | 0.81 |
| colorectal cancer | KRAS_12 | MGA | Any mutation | 419 | 109 | Signature overall | -0.92 | -2.20 | 0.25 | 1478.81 | 1.00 | 964 | 399 | 89 | 20 | FALSE | 0.87 |
| non-small cell lung cancer | KRAS_12 | MGA | Any mutation | 424 | 120 | Signature overall | -0.27 | -1.39 | 0.86 | 1401.64 | 1.00 | 613 | 386 | 82 | 38 | FALSE | 0.19 |
| uterine cancer | KRAS_12 | MGA | Any mutation | 48 | 82 | Signature overall | -1.67 | -5.41 | 1.58 | 1383.43 | 1.00 | 240 | 43 | 77 | 5 | FALSE | 0.47 |
| colorectal cancer | KRAS_12 | KMT2B | Any mutation | 50 | 18 | Signature 15 | -1.52 | -3.16 | -0.30 | 1538.62 | 1.00 | 132 | 49 | 17 | 1 | FALSE | 1.45 |
| colorectal cancer | KRAS_12 | KMT2B | Any mutation | 152 | 64 | Signature 1A | -0.62 | -1.22 | 0.00 | 1452.55 | 1.00 | 271 | 137 | 49 | 15 | FALSE | 1.34 |
| colorectal cancer | KRAS_12 | KMT2B | Any mutation | 48 | 86 | Signature 6 | -1.07 | -1.82 | -0.42 | 1675.65 | 1.00 | 84 | 37 | 75 | 11 | FALSE | 2.55 |
| colorectal cancer | KRAS_12 | KMT2B | Any mutation | 250 | 168 | Signature overall | -1.06 | -2.35 | 0.09 | 1343.48 | 1.00 | 487 | 223 | 141 | 27 | FALSE | 1.09 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 91 | 48 | Signature 15 | 0.21 | -0.34 | 0.77 | 1420.01 | 1.00 | 228 | 76 | 33 | 15 | FALSE | 0.33 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 260 | 115 | Signature 1A | 0.05 | -0.33 | 0.45 | 1392.98 | 1.00 | 465 | 222 | 77 | 38 | FALSE | 0.10 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 34 | 12 | Signature 2 | 0.69 | -0.09 | 1.70 | 1571.68 | 1.00 | 36 | 24 | 2 | 10 | FALSE | 0.87 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 67 | 69 | Signature 6 | -0.16 | -0.76 | 0.39 | 1487.63 | 1.00 | 173 | 55 | 57 | 12 | FALSE | 0.23 |
| colorectal cancer | KRAS_12 | TCF7L2 | Any mutation | 452 | 244 | Signature overall | 0.20 | -0.38 | 0.86 | 1338.18 | 1.00 | 902 | 377 | 169 | 75 | FALSE | 0.28 |
| colorectal cancer | KRAS_12 | ANKRD11 | Any mutation | 10 | 12 | Signature 10 | -0.65 | -1.88 | 0.56 | 1394.35 | 1.00 | 16 | 7 | 9 | 3 | FALSE | 0.52 |
| colorectal cancer | KRAS_12 | ANKRD11 | Any mutation | 85 | 17 | Signature 15 | -1.47 | -2.89 | -0.34 | 1505.42 | 1.00 | 242 | 84 | 16 | 1 | FALSE | 1.59 |
| colorectal cancer | KRAS_12 | ANKRD11 | Any mutation | 247 | 47 | Signature 1A | -0.87 | -1.62 | -0.16 | 1479.84 | 1.00 | 489 | 238 | 38 | 9 | FALSE | 1.76 |
| colorectal cancer | KRAS_12 | ANKRD11 | Any mutation | 63 | 57 | Signature 6 | -1.59 | -2.64 | -0.68 | 1512.18 | 1.00 | 180 | 60 | 54 | 3 | FALSE | 2.82 |
| colorectal cancer | KRAS_12 | ANKRD11 | Any mutation | 405 | 133 | Signature overall | -1.12 | -2.20 | -0.14 | 1412.70 | 1.00 | 927 | 389 | 117 | 16 | FALSE | 1.48 |
| colorectal cancer | KRAS_12 | POLD1 | Any mutation | 89 | 15 | Signature 15 | -2.05 | -4.61 | -0.54 | 1538.64 | 1.00 | 249 | 89 | 15 | 0 | TRUE | 1.34 |
| colorectal cancer | KRAS_12 | POLD1 | Any mutation | 258 | 43 | Signature 1A | -0.36 | -1.07 | 0.31 | 1345.24 | 1.00 | 509 | 245 | 30 | 13 | TRUE | 0.49 |
| colorectal cancer | KRAS_12 | POLD1 | Any mutation | 66 | 44 | Signature 6 | -1.70 | -3.04 | -0.64 | 1350.32 | 1.00 | 192 | 64 | 42 | 2 | TRUE | 2.18 |
| colorectal cancer | KRAS_12 | POLD1 | Any mutation | 413 | 102 | Signature overall | -1.33 | -2.84 | -0.11 | 1597.18 | 1.00 | 950 | 398 | 87 | 15 | TRUE | 1.20 |
| non-small cell lung cancer | KRAS_12 | PREX2 | Any mutation | 126 | 52 | Signature 4 | -0.19 | -0.82 | 0.44 | 1349.27 | 1.00 | 208 | 110 | 36 | 16 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12 | PREX2 | Any mutation | 126 | 52 | Signature overall | -0.10 | -4.06 | 4.10 | 1441.97 | 1.00 | 208 | 110 | 36 | 16 | FALSE | 0.02 |
| colorectal cancer | KRAS_12 | AMER1 | Any mutation | 99 | 34 | Signature 15 | 0.22 | -0.38 | 0.82 | 1537.93 | 1.00 | 263 | 89 | 24 | 10 | FALSE | 0.34 |
| colorectal cancer | KRAS_12 | AMER1 | Any mutation | 270 | 61 | Signature 1A | 0.30 | -0.14 | 0.76 | 1264.17 | 1.00 | 545 | 245 | 36 | 25 | FALSE | 0.72 |
| colorectal cancer | KRAS_12 | AMER1 | Any mutation | 69 | 36 | Signature 6 | 0.18 | -0.45 | 0.74 | 1435.31 | 1.00 | 219 | 61 | 28 | 8 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12 | AMER1 | Any mutation | 79 | 11 | Signature 2 | 0.59 | -0.60 | 1.85 | 1256.81 | 1.00 | 239 | 74 | 6 | 5 | FALSE | 0.47 |
| non-small cell lung cancer | KRAS_12 | AMER1 | Any mutation | 232 | 83 | Signature 4 | -0.21 | -0.72 | 0.30 | 1604.24 | 1.00 | 427 | 209 | 60 | 23 | FALSE | 0.38 |
| colorectal cancer | KRAS_12 | AMER1 | Any mutation | 438 | 131 | Signature overall | 0.23 | -0.34 | 0.78 | 1539.38 | 1.00 | 1027 | 395 | 88 | 43 | FALSE | 0.38 |
| non-small cell lung cancer | KRAS_12 | AMER1 | Any mutation | 311 | 94 | Signature overall | 0.16 | -1.76 | 2.19 | 1486.36 | 1.00 | 666 | 283 | 66 | 28 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12 | EPHA7 | Any mutation | 44 | 13 | Signature 3 | -0.36 | -1.55 | 0.82 | 1529.02 | 1.00 | 163 | 41 | 10 | 3 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12 | EPHA7 | Any mutation | 217 | 51 | Signature 4 | -0.86 | -1.61 | -0.21 | 1575.01 | 1.00 | 377 | 208 | 42 | 9 | FALSE | 1.78 |
| non-small cell lung cancer | KRAS_12 | EPHA7 | Any mutation | 261 | 64 | Signature overall | -0.59 | -2.01 | 0.89 | 1375.65 | 1.00 | 540 | 249 | 52 | 12 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12C | SPEN | Any mutation | 21 | 39 | Signature 2 | -2.57 | -7.02 | -0.23 | 1506.65 | 1.00 | 291 | 21 | 39 | 0 | FALSE | 0.89 |
| non-small cell lung cancer | RAS_12C | SPEN | Any mutation | 36 | 24 | Signature 4 | -1.41 | -4.33 | 0.76 | 1376.07 | 1.00 | 646 | 35 | 23 | 1 | FALSE | 0.57 |
| non-small cell lung cancer | RAS_12C | SPEN | Any mutation | 57 | 63 | Signature overall | -1.86 | -5.27 | 0.72 | 1442.84 | 1.00 | 937 | 56 | 62 | 1 | FALSE | 0.67 |
| non-small cell lung cancer | RAS_12C | KMT2C | Any mutation | 21 | 40 | Signature 2 | 0.15 | -0.90 | 1.13 | 1511.16 | 1.00 | 268 | 18 | 37 | 3 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12C | KMT2C | Any mutation | 36 | 76 | Signature 4 | 0.21 | -0.68 | 1.05 | 1507.10 | 1.00 | 601 | 31 | 71 | 5 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12C | KMT2C | Any mutation | 64 | 151 | Signature overall | 0.17 | -0.90 | 1.24 | 1466.66 | 1.00 | 1171 | 55 | 142 | 9 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 15 | 92 | Signature 18 | -0.37 | -1.16 | 0.42 | 1467.47 | 1.00 | 57 | 7 | 84 | 8 | TRUE | 0.44 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 21 | 223 | Signature 2 | -0.32 | -1.00 | 0.38 | 1464.91 | 1.00 | 116 | 8 | 210 | 13 | TRUE | 0.45 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 36 | 522 | Signature 4 | -1.29 | -1.92 | -0.71 | 1314.06 | 1.00 | 202 | 24 | 510 | 12 | TRUE | 4.68 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 50 | 85 | Signature R2 | -0.90 | -1.53 | -0.30 | 1629.14 | 1.00 | 82 | 39 | 74 | 11 | TRUE | 2.36 |
| non-small cell lung cancer | RAS_12C | TP53 | Any mutation | 168 | 1927 | Signature overall | -0.76 | -1.23 | -0.31 | 1527.10 | 1.00 | 1130 | 100 | 1859 | 68 | TRUE | 2.89 |
| non-small cell lung cancer | RAS_12C | ATRX | Any mutation | 15 | 12 | Signature 18 | -0.69 | -3.12 | 0.61 | 1364.70 | 1.00 | 124 | 15 | 12 | 0 | TRUE | 0.33 |
| non-small cell lung cancer | RAS_12C | ATRX | Any mutation | 21 | 28 | Signature 2 | -0.76 | -3.18 | 0.45 | 1174.58 | 1.00 | 278 | 21 | 28 | 0 | TRUE | 0.38 |
| non-small cell lung cancer | RAS_12C | ATRX | Any mutation | 37 | 88 | Signature 4 | 0.04 | -0.94 | 0.91 | 1384.45 | 1.00 | 600 | 30 | 81 | 7 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12C | ATRX | Any mutation | 73 | 128 | Signature overall | -0.47 | -2.21 | 0.66 | 1540.68 | 1.00 | 1002 | 66 | 121 | 7 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12C | ATR | Any mutation | 21 | 16 | Signature 2 | 0.41 | -0.77 | 1.56 | 1357.80 | 1.00 | 289 | 19 | 14 | 2 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12C | ATR | Any mutation | 36 | 60 | Signature 4 | 0.16 | -0.98 | 1.10 | 1001.98 | 1.00 | 611 | 33 | 57 | 3 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | ATR | Any mutation | 59 | 87 | Signature overall | 0.34 | -0.83 | 1.47 | 1366.75 | 1.00 | 986 | 53 | 81 | 6 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12C | PDGFRA | Any mutation | 21 | 20 | Signature 2 | 0.92 | -0.27 | 1.82 | 1172.48 | 1.00 | 285 | 19 | 18 | 2 | TRUE | 1.18 |
| non-small cell lung cancer | RAS_12C | PDGFRA | Any mutation | 38 | 70 | Signature 4 | 1.23 | 0.59 | 1.92 | 180.68 | 1.03 | 611 | 27 | 59 | 11 | TRUE | 3.57 |
| non-small cell lung cancer | RAS_12C | PDGFRA | Any mutation | 59 | 90 | Signature overall | 1.06 | -0.18 | 2.12 | 1572.33 | 1.00 | 896 | 46 | 77 | 13 | TRUE | 1.27 |
| non-small cell lung cancer | RAS_12C | FLT4 | Any mutation | 21 | 11 | Signature 2 | -0.30 | -2.36 | 1.16 | 94.39 | 1.06 | 293 | 20 | 10 | 1 | TRUE | 0.13 |
| non-small cell lung cancer | RAS_12C | FLT4 | Any mutation | 36 | 36 | Signature 4 | -0.43 | -2.40 | 0.80 | 35.36 | 1.11 | 633 | 35 | 35 | 1 | TRUE | 0.20 |
| non-small cell lung cancer | RAS_12C | FLT4 | Any mutation | 57 | 47 | Signature overall | -0.38 | -2.53 | 1.14 | 70.99 | 1.06 | 926 | 55 | 45 | 2 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12C | PTPRD | Any mutation | 15 | 22 | Signature 18 | 0.06 | -1.25 | 1.17 | 1316.99 | 1.00 | 118 | 13 | 20 | 2 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | PTPRD | Any mutation | 21 | 33 | Signature 2 | 0.79 | -0.25 | 1.80 | 1441.80 | 1.00 | 276 | 16 | 28 | 5 | FALSE | 0.89 |
| non-small cell lung cancer | RAS_12C | PTPRD | Any mutation | 40 | 195 | Signature 4 | -0.13 | -0.93 | 0.55 | 1495.97 | 1.00 | 521 | 31 | 186 | 9 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12C | PTPRD | Any mutation | 50 | 18 | Signature R2 | 0.76 | -0.12 | 1.64 | 1585.58 | 1.00 | 140 | 42 | 10 | 8 | FALSE | 1.02 |
| non-small cell lung cancer | RAS_12C | PTPRD | Any mutation | 138 | 321 | Signature overall | 0.20 | -0.75 | 1.04 | 1358.61 | 1.00 | 1625 | 113 | 296 | 25 | FALSE | 0.18 |
| non-small cell lung cancer | RAS_12C | PIK3C2G | Any mutation | 21 | 17 | Signature 2 | -2.33 | -5.21 | -0.18 | 88.06 | 1.03 | 285 | 21 | 17 | 0 | FALSE | 0.97 |
| non-small cell lung cancer | RAS_12C | PIK3C2G | Any mutation | 36 | 57 | Signature 4 | -2.11 | -4.66 | -0.12 | 52.49 | 1.05 | 614 | 35 | 56 | 1 | FALSE | 0.96 |
| non-small cell lung cancer | RAS_12C | PIK3C2G | Any mutation | 57 | 74 | Signature overall | -2.20 | -4.83 | -0.07 | 66.02 | 1.04 | 899 | 56 | 73 | 1 | FALSE | 0.95 |
| non-small cell lung cancer | RAS_12C | CREBBP | Any mutation | 21 | 15 | Signature 2 | -0.75 | -2.69 | 0.74 | 1279.44 | 1.00 | 288 | 21 | 15 | 0 | TRUE | 0.39 |
| non-small cell lung cancer | RAS_12C | CREBBP | Any mutation | 36 | 44 | Signature 4 | -0.27 | -1.77 | 0.88 | 1052.36 | 1.00 | 630 | 33 | 41 | 3 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12C | CREBBP | Any mutation | 66 | 82 | Signature overall | -0.56 | -2.23 | 0.78 | 1139.39 | 1.00 | 1395 | 63 | 79 | 3 | TRUE | 0.33 |
| non-small cell lung cancer | RAS_12C | DOT1L | Any mutation | 21 | 16 | Signature 2 | -0.17 | -1.77 | 1.07 | 1208.18 | 1.00 | 288 | 20 | 15 | 1 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | DOT1L | Any mutation | 36 | 38 | Signature 4 | -0.15 | -1.56 | 0.97 | 1138.64 | 1.00 | 631 | 34 | 36 | 2 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | DOT1L | Any mutation | 57 | 54 | Signature overall | -0.17 | -1.69 | 1.06 | 1064.81 | 1.00 | 919 | 54 | 51 | 3 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Any mutation | 15 | 14 | Signature 18 | 0.44 | -0.89 | 1.61 | 1493.35 | 1.00 | 125 | 12 | 11 | 3 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Any mutation | 22 | 33 | Signature 2 | 0.37 | -0.66 | 1.39 | 1479.52 | 1.00 | 280 | 18 | 29 | 4 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Any mutation | 36 | 104 | Signature 4 | -0.11 | -1.04 | 0.70 | 1502.97 | 1.00 | 574 | 31 | 99 | 5 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Any mutation | 49 | 15 | Signature R2 | -0.79 | -2.11 | 0.30 | 1470.67 | 1.00 | 135 | 48 | 14 | 1 | FALSE | 0.67 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Any mutation | 137 | 225 | Signature overall | -0.11 | -1.08 | 0.73 | 1415.62 | 1.00 | 1759 | 123 | 211 | 14 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | PTPRT | Any mutation | 15 | 17 | Signature 18 | -0.82 | -2.55 | 0.55 | 1377.63 | 1.00 | 120 | 14 | 16 | 1 | FALSE | 0.51 |
| non-small cell lung cancer | RAS_12C | PTPRT | Any mutation | 22 | 30 | Signature 2 | -0.09 | -1.41 | 1.05 | 1479.37 | 1.00 | 277 | 19 | 27 | 3 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12C | PTPRT | Any mutation | 36 | 179 | Signature 4 | -0.43 | -1.27 | 0.36 | 1581.06 | 1.00 | 537 | 29 | 172 | 7 | FALSE | 0.54 |
| non-small cell lung cancer | RAS_12C | PTPRT | Any mutation | 49 | 23 | Signature R2 | -1.52 | -2.96 | -0.22 | 1535.01 | 1.00 | 132 | 48 | 22 | 1 | FALSE | 1.54 |
| non-small cell lung cancer | RAS_12C | PTPRT | Any mutation | 133 | 290 | Signature overall | -0.82 | -1.99 | 0.25 | 1420.83 | 1.00 | 1628 | 121 | 278 | 12 | FALSE | 0.82 |
| non-small cell lung cancer | RAS_12C | HGF | Any mutation | 21 | 20 | Signature 2 | 0.42 | -1.05 | 1.79 | 1523.85 | 1.00 | 286 | 18 | 17 | 3 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12C | HGF | Any mutation | 36 | 89 | Signature 4 | -0.31 | -1.38 | 0.66 | 1664.93 | 1.00 | 590 | 32 | 85 | 4 | FALSE | 0.25 |
| non-small cell lung cancer | RAS_12C | HGF | Any mutation | 49 | 12 | Signature R2 | -1.71 | -4.68 | 0.01 | 1355.80 | 1.00 | 139 | 49 | 12 | 0 | FALSE | 0.81 |
| non-small cell lung cancer | RAS_12C | HGF | Any mutation | 106 | 121 | Signature overall | -0.56 | -2.41 | 1.04 | 1446.85 | 1.00 | 1015 | 99 | 114 | 7 | FALSE | 0.28 |
| non-small cell lung cancer | RAS_12C | PIK3CA | Any mutation | 22 | 82 | Signature 2 | 0.36 | -0.47 | 1.19 | 1448.55 | 1.00 | 233 | 15 | 75 | 7 | TRUE | 0.40 |
| non-small cell lung cancer | RAS_12C | PIK3CA | Any mutation | 36 | 38 | Signature 4 | 0.27 | -0.84 | 1.23 | 1449.80 | 1.00 | 632 | 33 | 35 | 3 | TRUE | 0.21 |
| non-small cell lung cancer | RAS_12C | PIK3CA | Any mutation | 71 | 177 | Signature overall | 0.10 | -1.06 | 1.15 | 1529.22 | 1.00 | 1482 | 60 | 166 | 11 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12C | ALK | Any mutation | 21 | 24 | Signature 2 | 0.41 | -0.65 | 1.46 | 1344.04 | 1.00 | 284 | 18 | 21 | 3 | TRUE | 0.35 |
| non-small cell lung cancer | RAS_12C | ALK | Any mutation | 36 | 72 | Signature 4 | 0.21 | -0.76 | 1.07 | 1465.94 | 1.00 | 603 | 32 | 68 | 4 | TRUE | 0.19 |
| non-small cell lung cancer | RAS_12C | ALK | Any mutation | 57 | 96 | Signature overall | 0.30 | -0.92 | 1.43 | 1606.54 | 1.00 | 887 | 50 | 89 | 7 | TRUE | 0.19 |
| non-small cell lung cancer | RAS_12C | PTEN | Any mutation | 21 | 27 | Signature 2 | -5.25 | -12.04 | -0.89 | 1266.86 | 1.00 | 279 | 21 | 27 | 0 | TRUE | 1.14 |
| non-small cell lung cancer | RAS_12C | PTEN | Any mutation | 36 | 27 | Signature 4 | -5.19 | -11.79 | -0.70 | 1152.01 | 1.00 | 640 | 36 | 27 | 0 | TRUE | 1.13 |
| non-small cell lung cancer | RAS_12C | PTEN | Any mutation | 57 | 54 | Signature overall | -5.09 | -11.52 | -0.75 | 1307.46 | 1.00 | 919 | 57 | 54 | 0 | TRUE | 1.13 |
| non-small cell lung cancer | RAS_12C | BCOR | Any mutation | 22 | 13 | Signature 2 | 0.71 | -0.48 | 1.86 | 1611.18 | 1.00 | 292 | 20 | 11 | 2 | FALSE | 0.64 |
| non-small cell lung cancer | RAS_12C | BCOR | Any mutation | 37 | 52 | Signature 4 | 0.69 | -0.29 | 1.52 | 1363.58 | 1.00 | 625 | 32 | 47 | 5 | FALSE | 0.84 |
| non-small cell lung cancer | RAS_12C | BCOR | Any mutation | 59 | 65 | Signature overall | 0.68 | -0.72 | 1.87 | 1368.12 | 1.00 | 917 | 52 | 58 | 7 | FALSE | 0.54 |
| non-small cell lung cancer | RAS_12C | CTNNB1 | Any mutation | 21 | 14 | Signature 2 | -1.63 | -4.71 | 0.45 | 1632.29 | 1.00 | 289 | 21 | 14 | 0 | TRUE | 0.69 |
| non-small cell lung cancer | RAS_12C | CTNNB1 | Any mutation | 36 | 16 | Signature 4 | -1.64 | -4.80 | 0.56 | 1560.93 | 1.00 | 650 | 36 | 16 | 0 | TRUE | 0.67 |
| non-small cell lung cancer | RAS_12C | CTNNB1 | Any mutation | 66 | 58 | Signature overall | -1.47 | -4.28 | 0.53 | 1520.61 | 1.00 | 1412 | 65 | 57 | 1 | TRUE | 0.64 |
| non-small cell lung cancer | RAS_12C | ARID1A | Any mutation | 15 | 12 | Signature 18 | -0.74 | -2.57 | 0.70 | 1480.36 | 1.00 | 126 | 15 | 12 | 0 | TRUE | 0.42 |
| non-small cell lung cancer | RAS_12C | ARID1A | Any mutation | 23 | 52 | Signature 2 | 0.21 | -0.79 | 1.08 | 1407.64 | 1.00 | 263 | 18 | 47 | 5 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12C | ARID1A | Any mutation | 36 | 86 | Signature 4 | -0.18 | -1.24 | 0.70 | 1273.60 | 1.00 | 587 | 32 | 82 | 4 | TRUE | 0.14 |
| non-small cell lung cancer | RAS_12C | ARID1A | Any mutation | 49 | 13 | Signature R2 | -0.16 | -1.30 | 0.89 | 1347.49 | 1.00 | 139 | 46 | 10 | 3 | TRUE | 0.11 |
| non-small cell lung cancer | RAS_12C | ARID1A | Any mutation | 130 | 191 | Signature overall | -0.20 | -1.26 | 0.79 | 1392.62 | 1.00 | 1424 | 117 | 178 | 13 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12C | FAT1 | Any mutation | 15 | 16 | Signature 18 | 0.30 | -0.84 | 1.46 | 1485.21 | 1.00 | 122 | 12 | 13 | 3 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12C | FAT1 | Any mutation | 21 | 38 | Signature 2 | -0.19 | -1.41 | 0.85 | 1552.46 | 1.00 | 273 | 19 | 36 | 2 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12C | FAT1 | Any mutation | 36 | 121 | Signature 4 | -0.36 | -1.36 | 0.44 | 1378.37 | 1.00 | 563 | 32 | 117 | 4 | FALSE | 0.37 |
| non-small cell lung cancer | RAS_12C | FAT1 | Any mutation | 85 | 228 | Signature overall | -0.14 | -1.08 | 0.78 | 1595.89 | 1.00 | 1583 | 75 | 218 | 10 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12C | NCOR1 | Any mutation | 21 | 11 | Signature 2 | 0.28 | -1.52 | 1.88 | 1350.93 | 1.00 | 297 | 19 | 9 | 2 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12C | NCOR1 | Any mutation | 36 | 36 | Signature 4 | -0.46 | -2.21 | 0.83 | 1451.13 | 1.00 | 633 | 35 | 35 | 1 | FALSE | 0.25 |
| non-small cell lung cancer | RAS_12C | NCOR1 | Any mutation | 59 | 61 | Signature overall | -0.21 | -2.18 | 1.44 | 1478.95 | 1.00 | 1016 | 56 | 58 | 3 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | POLE | Any mutation | 21 | 19 | Signature 2 | 0.58 | -0.72 | 1.76 | 1526.88 | 1.00 | 289 | 18 | 16 | 3 | TRUE | 0.44 |
| non-small cell lung cancer | RAS_12C | POLE | Any mutation | 36 | 49 | Signature 4 | 0.10 | -1.10 | 1.09 | 1576.51 | 1.00 | 623 | 33 | 46 | 3 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12C | POLE | Any mutation | 49 | 11 | Signature R2 | -0.16 | -1.51 | 0.99 | 1264.41 | 1.00 | 140 | 47 | 9 | 2 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12C | POLE | Any mutation | 106 | 79 | Signature overall | 0.19 | -1.11 | 1.43 | 1487.29 | 1.00 | 1052 | 98 | 71 | 8 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12C | NOTCH2 | Any mutation | 21 | 15 | Signature 2 | -0.08 | -1.74 | 1.46 | 1144.12 | 1.00 | 288 | 19 | 13 | 2 | TRUE | 0.04 |
| non-small cell lung cancer | RAS_12C | NOTCH2 | Any mutation | 36 | 54 | Signature 4 | -0.65 | -2.56 | 0.57 | 928.78 | 1.00 | 623 | 35 | 53 | 1 | TRUE | 0.39 |
| non-small cell lung cancer | RAS_12C | NOTCH2 | Any mutation | 57 | 69 | Signature overall | -0.35 | -2.20 | 1.34 | 1374.89 | 1.00 | 911 | 54 | 66 | 3 | TRUE | 0.17 |
| non-small cell lung cancer | RAS_12C | KMT2A | Any mutation | 21 | 23 | Signature 2 | -0.78 | -2.79 | 0.69 | 577.48 | 1.00 | 283 | 20 | 22 | 1 | FALSE | 0.44 |
| non-small cell lung cancer | RAS_12C | KMT2A | Any mutation | 36 | 37 | Signature 4 | -0.83 | -2.70 | 0.62 | 559.86 | 1.00 | 631 | 35 | 36 | 1 | FALSE | 0.47 |
| non-small cell lung cancer | RAS_12C | KMT2A | Any mutation | 57 | 60 | Signature overall | -0.79 | -2.80 | 0.74 | 560.02 | 1.00 | 914 | 55 | 58 | 2 | FALSE | 0.41 |
| non-small cell lung cancer | RAS_12C | PAK7 | Any mutation | 36 | 69 | Signature 4 | -1.83 | -4.54 | 0.06 | 1376.99 | 1.00 | 605 | 35 | 68 | 1 | FALSE | 0.91 |
| non-small cell lung cancer | RAS_12C | PAK7 | Any mutation | 36 | 69 | Signature overall | -1.50 | -6.19 | 3.77 | 1283.55 | 1.00 | 605 | 35 | 68 | 1 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12C | STAG2 | Any mutation | 21 | 16 | Signature 2 | -1.03 | -3.73 | 0.54 | 582.90 | 1.00 | 288 | 21 | 16 | 0 | TRUE | 0.42 |
| non-small cell lung cancer | RAS_12C | STAG2 | Any mutation | 36 | 43 | Signature 4 | -0.70 | -2.53 | 0.63 | 723.33 | 1.01 | 629 | 34 | 41 | 2 | TRUE | 0.40 |
| non-small cell lung cancer | RAS_12C | STAG2 | Any mutation | 57 | 59 | Signature overall | -0.84 | -2.99 | 0.66 | 573.36 | 1.00 | 917 | 55 | 57 | 2 | TRUE | 0.41 |
| non-small cell lung cancer | RAS_12C | TERT | Any mutation | 21 | 23 | Signature 2 | 0.24 | -1.30 | 1.30 | 1269.36 | 1.00 | 282 | 20 | 22 | 1 | TRUE | 0.15 |
| non-small cell lung cancer | RAS_12C | TERT | Any mutation | 37 | 54 | Signature 4 | 0.56 | -0.38 | 1.46 | 444.26 | 1.01 | 622 | 31 | 48 | 6 | TRUE | 0.62 |
| non-small cell lung cancer | RAS_12C | TERT | Any mutation | 58 | 77 | Signature overall | 0.40 | -1.04 | 1.51 | 980.64 | 1.00 | 904 | 51 | 70 | 7 | TRUE | 0.26 |
| non-small cell lung cancer | RAS_12C | BRCA2 | Any mutation | 21 | 15 | Signature 2 | -1.40 | -3.88 | 0.34 | 1349.82 | 1.00 | 289 | 21 | 15 | 0 | TRUE | 0.70 |
| non-small cell lung cancer | RAS_12C | BRCA2 | Any mutation | 36 | 55 | Signature 4 | -0.98 | -2.74 | 0.35 | 986.77 | 1.00 | 620 | 34 | 53 | 2 | TRUE | 0.64 |
| non-small cell lung cancer | RAS_12C | BRCA2 | Any mutation | 59 | 83 | Signature overall | -1.22 | -3.52 | 0.39 | 1120.54 | 1.00 | 994 | 57 | 81 | 2 | TRUE | 0.66 |
| non-small cell lung cancer | RAS_12C | NOTCH3 | Any mutation | 15 | 11 | Signature 18 | 0.66 | -0.42 | 1.76 | 1347.09 | 1.00 | 128 | 12 | 8 | 3 | TRUE | 0.62 |
| non-small cell lung cancer | RAS_12C | NOTCH3 | Any mutation | 21 | 15 | Signature 2 | 0.53 | -0.58 | 1.50 | 1244.46 | 1.00 | 291 | 19 | 13 | 2 | TRUE | 0.50 |
| non-small cell lung cancer | RAS_12C | NOTCH3 | Any mutation | 36 | 48 | Signature 4 | 0.30 | -0.78 | 1.15 | 1078.74 | 1.00 | 625 | 34 | 46 | 2 | TRUE | 0.26 |
| non-small cell lung cancer | RAS_12C | NOTCH3 | Any mutation | 72 | 74 | Signature overall | 0.50 | -0.57 | 1.40 | 1289.77 | 1.00 | 1044 | 65 | 67 | 7 | TRUE | 0.50 |
| non-small cell lung cancer | RAS_12C | NOTCH4 | Any mutation | 36 | 74 | Signature 4 | -0.39 | -1.76 | 0.72 | 1098.97 | 1.00 | 601 | 33 | 71 | 3 | TRUE | 0.27 |
| non-small cell lung cancer | RAS_12C | NOTCH4 | Any mutation | 36 | 74 | Signature overall | -0.38 | -5.10 | 3.98 | 1434.05 | 1.00 | 601 | 33 | 71 | 3 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 15 | 34 | Signature 18 | 0.26 | -0.69 | 1.14 | 1474.11 | 1.00 | 107 | 11 | 30 | 4 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 21 | 55 | Signature 2 | 0.31 | -0.52 | 1.16 | 1481.95 | 1.00 | 256 | 16 | 50 | 5 | FALSE | 0.32 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 37 | 175 | Signature 4 | 0.31 | -0.36 | 0.96 | 1407.68 | 1.00 | 509 | 25 | 163 | 12 | FALSE | 0.45 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 50 | 45 | Signature R2 | 0.14 | -0.58 | 0.79 | 1444.79 | 1.00 | 116 | 39 | 34 | 11 | FALSE | 0.17 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Any mutation | 152 | 476 | Signature overall | 0.06 | -0.54 | 0.65 | 1381.39 | 1.00 | 2018 | 116 | 440 | 36 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | KDM5C | Any mutation | 21 | 15 | Signature 2 | -0.26 | -3.76 | 1.28 | 742.96 | 1.00 | 289 | 21 | 15 | 0 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | KDM5C | Any mutation | 37 | 41 | Signature 4 | 0.56 | -0.67 | 1.59 | 330.75 | 1.02 | 631 | 32 | 36 | 5 | FALSE | 0.47 |
| non-small cell lung cancer | RAS_12C | KDM5C | Any mutation | 58 | 56 | Signature overall | 0.16 | -2.34 | 1.67 | 816.58 | 1.01 | 920 | 53 | 51 | 5 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Any mutation | 21 | 22 | Signature 2 | -1.43 | -3.50 | 0.23 | 1413.60 | 1.00 | 282 | 21 | 22 | 0 | TRUE | 0.88 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Any mutation | 37 | 90 | Signature 4 | -0.55 | -1.76 | 0.49 | 1370.71 | 1.00 | 587 | 33 | 86 | 4 | TRUE | 0.47 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Any mutation | 49 | 11 | Signature R2 | -0.80 | -2.29 | 0.51 | 1533.10 | 1.00 | 140 | 47 | 9 | 2 | TRUE | 0.57 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Any mutation | 120 | 184 | Signature overall | -1.08 | -2.51 | 0.20 | 1409.85 | 1.00 | 1679 | 114 | 178 | 6 | TRUE | 0.94 |
| non-small cell lung cancer | RAS_12C | EPHB1 | Any mutation | 21 | 17 | Signature 2 | -0.18 | -1.98 | 1.36 | 1280.27 | 1.00 | 289 | 19 | 15 | 2 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12C | EPHB1 | Any mutation | 36 | 79 | Signature 4 | -1.11 | -3.08 | 0.31 | 994.81 | 1.00 | 600 | 35 | 78 | 1 | FALSE | 0.69 |
| non-small cell lung cancer | RAS_12C | EPHB1 | Any mutation | 57 | 96 | Signature overall | -0.63 | -2.63 | 1.13 | 1190.57 | 1.00 | 889 | 54 | 93 | 3 | FALSE | 0.28 |
| non-small cell lung cancer | RAS_12C | SMAD4 | Any mutation | 21 | 21 | Signature 2 | 1.32 | 0.10 | 2.41 | 1413.37 | 1.00 | 287 | 16 | 16 | 5 | TRUE | 1.58 |
| non-small cell lung cancer | RAS_12C | SMAD4 | Any mutation | 36 | 16 | Signature 4 | -0.65 | -4.56 | 1.31 | 1569.12 | 1.00 | 650 | 36 | 16 | 0 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12C | SMAD4 | Any mutation | 61 | 54 | Signature overall | 0.15 | -2.47 | 1.88 | 1348.20 | 1.00 | 1184 | 56 | 49 | 5 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 15 | 11 | Signature 18 | 0.09 | -1.27 | 1.35 | 1362.91 | 1.00 | 126 | 14 | 10 | 1 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 21 | 27 | Signature 2 | -0.16 | -1.55 | 0.99 | 1481.64 | 1.00 | 280 | 20 | 26 | 1 | TRUE | 0.10 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 40 | 95 | Signature 4 | 0.81 | 0.11 | 1.49 | 1534.41 | 1.00 | 595 | 29 | 84 | 11 | TRUE | 1.63 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 50 | 25 | Signature R2 | 0.26 | -0.62 | 1.06 | 1399.01 | 1.00 | 131 | 43 | 18 | 7 | TRUE | 0.27 |
| non-small cell lung cancer | RAS_12C | ATM | Any mutation | 134 | 195 | Signature overall | 0.27 | -0.65 | 1.12 | 1591.57 | 1.00 | 1477 | 112 | 173 | 22 | TRUE | 0.26 |
| non-small cell lung cancer | RAS_12C | RB1 | Any mutation | 15 | 11 | Signature 18 | -1.05 | -2.67 | 0.28 | 997.76 | 1.00 | 125 | 14 | 10 | 1 | TRUE | 0.82 |
| non-small cell lung cancer | RAS_12C | RB1 | Any mutation | 21 | 28 | Signature 2 | -1.08 | -2.64 | 0.18 | 922.17 | 1.00 | 276 | 20 | 27 | 1 | TRUE | 0.88 |
| non-small cell lung cancer | RAS_12C | RB1 | Any mutation | 36 | 67 | Signature 4 | -1.22 | -2.71 | -0.02 | 919.11 | 1.00 | 604 | 35 | 66 | 1 | TRUE | 1.11 |
| non-small cell lung cancer | RAS_12C | RB1 | Any mutation | 83 | 151 | Signature overall | -1.15 | -2.59 | 0.01 | 759.01 | 1.00 | 1558 | 80 | 148 | 3 | TRUE | 1.11 |
| non-small cell lung cancer | RAS_12C | KMT2D | Any mutation | 15 | 16 | Signature 18 | -0.48 | -2.15 | 0.78 | 1534.91 | 1.00 | 122 | 14 | 15 | 1 | FALSE | 0.29 |
| non-small cell lung cancer | RAS_12C | KMT2D | Any mutation | 22 | 46 | Signature 2 | 0.03 | -1.07 | 1.01 | 1397.72 | 1.00 | 267 | 18 | 42 | 4 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12C | KMT2D | Any mutation | 36 | 129 | Signature 4 | -0.38 | -1.24 | 0.46 | 1477.30 | 1.00 | 565 | 31 | 124 | 5 | FALSE | 0.40 |
| non-small cell lung cancer | RAS_12C | KMT2D | Any mutation | 49 | 13 | Signature R2 | -0.27 | -1.44 | 0.86 | 1504.78 | 1.00 | 139 | 46 | 10 | 3 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12C | KMT2D | Any mutation | 133 | 255 | Signature overall | -0.42 | -1.49 | 0.53 | 1532.78 | 1.00 | 1642 | 120 | 242 | 13 | FALSE | 0.39 |
| non-small cell lung cancer | RAS_12C | APC | Any mutation | 24 | 23 | Signature 2 | 0.89 | -0.34 | 2.02 | 1441.01 | 1.00 | 285 | 19 | 18 | 5 | TRUE | 0.86 |
| non-small cell lung cancer | RAS_12C | APC | Any mutation | 36 | 50 | Signature 4 | -0.41 | -2.22 | 0.81 | 1303.16 | 1.00 | 621 | 35 | 49 | 1 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12C | APC | Any mutation | 64 | 86 | Signature overall | 0.12 | -1.44 | 1.52 | 1443.64 | 1.00 | 1155 | 58 | 80 | 6 | TRUE | 0.06 |
| non-small cell lung cancer | RAS_12C | ERBB2 | Any mutation | 21 | 12 | Signature 2 | -4.77 | -11.51 | -0.41 | 1437.75 | 1.00 | 291 | 21 | 12 | 0 | TRUE | 0.97 |
| non-small cell lung cancer | RAS_12C | ERBB2 | Any mutation | 36 | 19 | Signature 4 | -4.82 | -11.66 | -0.53 | 1518.67 | 1.00 | 649 | 36 | 19 | 0 | TRUE | 0.99 |
| non-small cell lung cancer | RAS_12C | ERBB2 | Any mutation | 61 | 46 | Signature overall | -4.72 | -11.46 | -0.31 | 1439.57 | 1.00 | 1187 | 61 | 46 | 0 | TRUE | 0.98 |
| non-small cell lung cancer | RAS_12C | ARID2 | Any mutation | 15 | 11 | Signature 18 | -0.05 | -1.30 | 1.04 | 1397.97 | 1.00 | 125 | 14 | 10 | 1 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | ARID2 | Any mutation | 21 | 18 | Signature 2 | 0.06 | -1.25 | 1.24 | 1384.74 | 1.00 | 288 | 19 | 16 | 2 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12C | ARID2 | Any mutation | 37 | 67 | Signature 4 | -0.25 | -1.36 | 0.66 | 1373.87 | 1.00 | 609 | 35 | 65 | 2 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12C | ARID2 | Any mutation | 78 | 112 | Signature overall | -0.04 | -1.12 | 0.92 | 1393.63 | 1.00 | 1245 | 72 | 106 | 6 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | MTOR | Any mutation | 36 | 41 | Signature 4 | 0.26 | -1.16 | 1.38 | 1177.19 | 1.00 | 628 | 33 | 38 | 3 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12C | MTOR | Any mutation | 36 | 41 | Signature overall | 0.16 | -4.32 | 4.42 | 1284.34 | 1.00 | 628 | 33 | 38 | 3 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12C | NOTCH1 | Any mutation | 21 | 12 | Signature 2 | -1.42 | -4.37 | 0.95 | 1076.99 | 1.01 | 292 | 20 | 11 | 1 | TRUE | 0.56 |
| non-small cell lung cancer | RAS_12C | NOTCH1 | Any mutation | 36 | 54 | Signature 4 | -2.26 | -5.79 | -0.10 | 1336.30 | 1.00 | 615 | 36 | 54 | 0 | TRUE | 0.90 |
| non-small cell lung cancer | RAS_12C | NOTCH1 | Any mutation | 57 | 66 | Signature overall | -1.80 | -4.81 | 0.51 | 1483.00 | 1.00 | 907 | 56 | 65 | 1 | TRUE | 0.74 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 22 | 44 | Signature 2 | 0.26 | -0.85 | 1.23 | 1376.40 | 1.00 | 275 | 18 | 40 | 4 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 6 | 15 | Signature 3 | 0.78 | -0.83 | 2.33 | 1431.60 | 1.00 | 226 | 4 | 13 | 2 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 36 | 55 | Signature 4 | -0.31 | -1.59 | 0.76 | 1466.85 | 1.00 | 618 | 34 | 53 | 2 | FALSE | 0.22 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 50 | 14 | Signature R2 | -0.17 | -1.33 | 0.87 | 1485.36 | 1.00 | 139 | 47 | 11 | 3 | FALSE | 0.11 |
| non-small cell lung cancer | RAS_12C | SETD2 | Any mutation | 116 | 144 | Signature overall | 0.05 | -1.11 | 1.14 | 1536.32 | 1.00 | 1341 | 105 | 133 | 11 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | PBRM1 | Any mutation | 21 | 20 | Signature 2 | -0.16 | -1.77 | 1.11 | 888.74 | 1.00 | 289 | 20 | 19 | 1 | TRUE | 0.08 |
| non-small cell lung cancer | RAS_12C | PBRM1 | Any mutation | 36 | 27 | Signature 4 | -0.03 | -1.44 | 1.20 | 748.84 | 1.00 | 642 | 34 | 25 | 2 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12C | PBRM1 | Any mutation | 57 | 47 | Signature overall | -0.11 | -1.77 | 1.26 | 1203.37 | 1.00 | 931 | 54 | 44 | 3 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12C | EPHA3 | Any mutation | 15 | 13 | Signature 18 | -1.18 | -3.01 | 0.34 | 1548.70 | 1.00 | 123 | 15 | 13 | 0 | FALSE | 0.79 |
| non-small cell lung cancer | RAS_12C | EPHA3 | Any mutation | 21 | 27 | Signature 2 | -0.85 | -2.42 | 0.46 | 1477.97 | 1.00 | 280 | 20 | 26 | 1 | FALSE | 0.61 |
| non-small cell lung cancer | RAS_12C | EPHA3 | Any mutation | 37 | 112 | Signature 4 | -0.85 | -1.96 | 0.11 | 1285.83 | 1.00 | 567 | 34 | 109 | 3 | FALSE | 0.96 |
| non-small cell lung cancer | RAS_12C | EPHA3 | Any mutation | 49 | 13 | Signature R2 | -0.76 | -2.08 | 0.40 | 1438.86 | 1.00 | 139 | 47 | 11 | 2 | FALSE | 0.65 |
| non-small cell lung cancer | RAS_12C | EPHA3 | Any mutation | 127 | 183 | Signature overall | -0.83 | -2.00 | 0.25 | 1580.32 | 1.00 | 1332 | 120 | 176 | 7 | FALSE | 0.82 |
| non-small cell lung cancer | RAS_12C | KDR | Any mutation | 21 | 12 | Signature 2 | 0.42 | -1.18 | 1.84 | 1616.67 | 1.00 | 293 | 19 | 10 | 2 | TRUE | 0.24 |
| non-small cell lung cancer | RAS_12C | KDR | Any mutation | 37 | 76 | Signature 4 | 0.04 | -0.99 | 0.93 | 1322.77 | 1.00 | 599 | 33 | 72 | 4 | TRUE | 0.03 |
| non-small cell lung cancer | RAS_12C | KDR | Any mutation | 63 | 99 | Signature overall | 0.10 | -1.51 | 1.45 | 1535.63 | 1.00 | 1120 | 57 | 93 | 6 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12C | TET1 | Any mutation | 21 | 12 | Signature 2 | 0.63 | -0.67 | 1.91 | 1463.28 | 1.00 | 291 | 19 | 10 | 2 | FALSE | 0.46 |
| non-small cell lung cancer | RAS_12C | TET1 | Any mutation | 36 | 60 | Signature 4 | 0.35 | -0.73 | 1.31 | 1512.66 | 1.00 | 618 | 32 | 56 | 4 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12C | TET1 | Any mutation | 57 | 72 | Signature overall | 0.47 | -1.08 | 1.94 | 1464.79 | 1.00 | 909 | 51 | 66 | 6 | FALSE | 0.27 |
| non-small cell lung cancer | RAS_12C | TBX3 | Any mutation | 36 | 75 | Signature 4 | -1.42 | -3.39 | -0.02 | 1323.24 | 1.00 | 600 | 35 | 74 | 1 | FALSE | 1.00 |
| non-small cell lung cancer | RAS_12C | TBX3 | Any mutation | 49 | 15 | Signature R2 | -0.57 | -2.04 | 0.61 | 1516.63 | 1.00 | 138 | 46 | 12 | 3 | FALSE | 0.40 |
| non-small cell lung cancer | RAS_12C | TBX3 | Any mutation | 85 | 90 | Signature overall | -0.95 | -3.27 | 1.49 | 1427.19 | 1.00 | 738 | 81 | 86 | 4 | FALSE | 0.38 |
| non-small cell lung cancer | RAS_12C | NTRK3 | Any mutation | 21 | 15 | Signature 2 | 0.52 | -0.96 | 1.76 | 1417.31 | 1.00 | 292 | 19 | 13 | 2 | FALSE | 0.34 |
| non-small cell lung cancer | RAS_12C | NTRK3 | Any mutation | 36 | 105 | Signature 4 | 0.15 | -0.69 | 0.92 | 1293.99 | 1.00 | 588 | 30 | 99 | 6 | FALSE | 0.15 |
| non-small cell lung cancer | RAS_12C | NTRK3 | Any mutation | 49 | 18 | Signature R2 | 0.27 | -0.75 | 1.19 | 1420.00 | 1.00 | 137 | 44 | 13 | 5 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12C | NTRK3 | Any mutation | 111 | 152 | Signature overall | 0.37 | -0.79 | 1.59 | 1542.60 | 1.00 | 1243 | 97 | 138 | 14 | FALSE | 0.26 |
| non-small cell lung cancer | RAS_12C | GRIN2A | Any mutation | 21 | 15 | Signature 2 | -0.99 | -3.42 | 0.72 | 1613.41 | 1.00 | 288 | 21 | 15 | 0 | FALSE | 0.45 |
| non-small cell lung cancer | RAS_12C | GRIN2A | Any mutation | 36 | 76 | Signature 4 | -0.43 | -1.71 | 0.60 | 1364.65 | 1.00 | 601 | 33 | 73 | 3 | FALSE | 0.34 |
| non-small cell lung cancer | RAS_12C | GRIN2A | Any mutation | 49 | 13 | Signature R2 | 0.03 | -1.12 | 1.15 | 1567.62 | 1.00 | 140 | 45 | 9 | 4 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12C | GRIN2A | Any mutation | 106 | 104 | Signature overall | -0.46 | -2.09 | 1.07 | 1498.76 | 1.00 | 1029 | 99 | 97 | 7 | FALSE | 0.25 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 15 | 38 | Signature 18 | 0.23 | -0.74 | 1.17 | 1506.84 | 1.00 | 103 | 11 | 34 | 4 | TRUE | 0.20 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 21 | 55 | Signature 2 | -0.24 | -1.41 | 0.78 | 1411.66 | 1.00 | 259 | 19 | 53 | 2 | TRUE | 0.18 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 36 | 163 | Signature 4 | 0.57 | -0.09 | 1.22 | 1477.00 | 1.00 | 518 | 23 | 150 | 13 | TRUE | 1.03 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 50 | 61 | Signature R2 | 0.05 | -0.66 | 0.68 | 1640.69 | 1.00 | 102 | 36 | 47 | 14 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12C | STK11 | Any mutation | 147 | 472 | Signature overall | 0.22 | -0.45 | 0.88 | 1399.20 | 1.00 | 1874 | 106 | 431 | 41 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12C | EP300 | Any mutation | 21 | 20 | Signature 2 | -1.81 | -4.58 | 0.16 | 911.90 | 1.00 | 289 | 21 | 20 | 0 | TRUE | 0.86 |
| non-small cell lung cancer | RAS_12C | EP300 | Any mutation | 36 | 30 | Signature 4 | -1.51 | -3.89 | 0.40 | 984.21 | 1.00 | 638 | 35 | 29 | 1 | TRUE | 0.78 |
| non-small cell lung cancer | RAS_12C | EP300 | Any mutation | 59 | 61 | Signature overall | -1.66 | -4.24 | 0.14 | 1147.44 | 1.00 | 1014 | 58 | 60 | 1 | TRUE | 0.84 |
| non-small cell lung cancer | RAS_12C | ERBB4 | Any mutation | 21 | 17 | Signature 2 | -1.14 | -4.06 | 0.69 | 1513.87 | 1.00 | 289 | 21 | 17 | 0 | TRUE | 0.43 |
| non-small cell lung cancer | RAS_12C | ERBB4 | Any mutation | 37 | 97 | Signature 4 | 0.02 | -1.01 | 0.90 | 1512.11 | 1.00 | 593 | 31 | 91 | 6 | TRUE | 0.01 |
| non-small cell lung cancer | RAS_12C | ERBB4 | Any mutation | 62 | 125 | Signature overall | -0.65 | -2.80 | 0.95 | 1475.17 | 1.00 | 1133 | 56 | 119 | 6 | TRUE | 0.28 |
| non-small cell lung cancer | RAS_12C | MED12 | Any mutation | 21 | 25 | Signature 2 | -0.80 | -2.41 | 0.47 | 1253.50 | 1.00 | 280 | 20 | 24 | 1 | TRUE | 0.57 |
| non-small cell lung cancer | RAS_12C | MED12 | Any mutation | 36 | 72 | Signature 4 | -0.82 | -2.26 | 0.32 | 1180.74 | 1.00 | 606 | 34 | 70 | 2 | TRUE | 0.68 |
| non-small cell lung cancer | RAS_12C | MED12 | Any mutation | 57 | 97 | Signature overall | -0.81 | -2.50 | 0.49 | 1261.79 | 1.00 | 886 | 54 | 94 | 3 | TRUE | 0.54 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 16 | 17 | Signature 18 | 0.94 | -0.20 | 2.02 | 1457.44 | 1.00 | 123 | 11 | 12 | 5 | FALSE | 1.03 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 21 | 32 | Signature 2 | -0.36 | -1.74 | 0.81 | 1413.93 | 1.00 | 272 | 20 | 31 | 1 | FALSE | 0.24 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 38 | 128 | Signature 4 | 0.04 | -0.78 | 0.74 | 1582.55 | 1.00 | 554 | 31 | 121 | 7 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 49 | 20 | Signature R2 | -0.15 | -1.17 | 0.72 | 1088.85 | 1.00 | 133 | 45 | 16 | 4 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | RBM10 | Any mutation | 139 | 285 | Signature overall | 0.03 | -0.81 | 0.79 | 1518.40 | 1.00 | 1842 | 120 | 266 | 19 | FALSE | 0.02 |
| non-small cell lung cancer | RAS_12C | NF1 | Any mutation | 15 | 13 | Signature 18 | -0.23 | -1.79 | 1.11 | 1603.48 | 1.00 | 125 | 13 | 11 | 2 | TRUE | 0.12 |
| non-small cell lung cancer | RAS_12C | NF1 | Any mutation | 23 | 39 | Signature 2 | 0.26 | -0.86 | 1.32 | 1465.38 | 1.00 | 272 | 18 | 34 | 5 | TRUE | 0.20 |
| non-small cell lung cancer | RAS_12C | NF1 | Any mutation | 36 | 113 | Signature 4 | -1.38 | -2.78 | -0.25 | 1373.10 | 1.00 | 579 | 35 | 112 | 1 | TRUE | 1.48 |
| non-small cell lung cancer | RAS_12C | NF1 | Any mutation | 49 | 12 | Signature R2 | -1.06 | -2.59 | 0.16 | 1438.30 | 1.00 | 139 | 48 | 11 | 1 | TRUE | 0.88 |
| non-small cell lung cancer | RAS_12C | NF1 | Any mutation | 138 | 229 | Signature overall | -0.75 | -1.93 | 0.30 | 1329.71 | 1.00 | 1744 | 129 | 220 | 9 | TRUE | 0.76 |
| non-small cell lung cancer | RAS_12C | FLT1 | Any mutation | 15 | 13 | Signature 18 | -1.04 | -3.02 | 0.44 | 1379.01 | 1.00 | 123 | 15 | 13 | 0 | FALSE | 0.64 |
| non-small cell lung cancer | RAS_12C | FLT1 | Any mutation | 21 | 12 | Signature 2 | -0.72 | -2.33 | 0.87 | 1557.37 | 1.00 | 292 | 20 | 11 | 1 | FALSE | 0.42 |
| non-small cell lung cancer | RAS_12C | FLT1 | Any mutation | 36 | 64 | Signature 4 | -0.81 | -2.22 | 0.30 | 1416.17 | 1.00 | 614 | 34 | 62 | 2 | FALSE | 0.66 |
| non-small cell lung cancer | RAS_12C | FLT1 | Any mutation | 72 | 89 | Signature overall | -0.86 | -2.41 | 0.50 | 1499.20 | 1.00 | 1029 | 69 | 86 | 3 | FALSE | 0.61 |
| non-small cell lung cancer | RAS_12C | EPHA5 | Any mutation | 15 | 24 | Signature 18 | -0.05 | -1.35 | 1.06 | 1501.45 | 1.00 | 115 | 13 | 22 | 2 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12C | EPHA5 | Any mutation | 21 | 30 | Signature 2 | 0.52 | -0.52 | 1.49 | 1281.62 | 1.00 | 280 | 17 | 26 | 4 | FALSE | 0.48 |
| non-small cell lung cancer | RAS_12C | EPHA5 | Any mutation | 36 | 109 | Signature 4 | 0.20 | -0.67 | 0.97 | 1571.33 | 1.00 | 579 | 29 | 102 | 7 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12C | EPHA5 | Any mutation | 49 | 12 | Signature R2 | -0.01 | -1.12 | 1.04 | 1437.98 | 1.00 | 141 | 46 | 9 | 3 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12C | EPHA5 | Any mutation | 126 | 194 | Signature overall | 0.08 | -0.88 | 1.02 | 1541.57 | 1.00 | 1337 | 110 | 178 | 16 | FALSE | 0.06 |
| non-small cell lung cancer | RAS_12C | AR | Any mutation | 36 | 56 | Signature 4 | -1.67 | -4.33 | 0.17 | 813.37 | 1.01 | 618 | 35 | 55 | 1 | TRUE | 0.85 |
| non-small cell lung cancer | RAS_12C | AR | Any mutation | 36 | 56 | Signature overall | -1.52 | -5.73 | 3.12 | 929.88 | 1.01 | 618 | 35 | 55 | 1 | TRUE | 0.33 |
| non-small cell lung cancer | RAS_12C | ROS1 | Any mutation | 21 | 14 | Signature 2 | -1.89 | -4.88 | 0.20 | 745.72 | 1.00 | 290 | 21 | 14 | 0 | TRUE | 0.80 |
| non-small cell lung cancer | RAS_12C | ROS1 | Any mutation | 36 | 42 | Signature 4 | -1.69 | -4.53 | 0.23 | 706.89 | 1.00 | 627 | 35 | 41 | 1 | TRUE | 0.80 |
| non-small cell lung cancer | RAS_12C | ROS1 | Any mutation | 57 | 56 | Signature overall | -1.78 | -4.71 | 0.30 | 760.41 | 1.00 | 917 | 56 | 55 | 1 | TRUE | 0.78 |
| non-small cell lung cancer | RAS_12C | PIK3CG | Any mutation | 22 | 18 | Signature 2 | 0.31 | -1.18 | 1.65 | 1237.18 | 1.00 | 289 | 19 | 15 | 3 | FALSE | 0.17 |
| non-small cell lung cancer | RAS_12C | PIK3CG | Any mutation | 36 | 75 | Signature 4 | -0.79 | -2.21 | 0.34 | 1459.91 | 1.00 | 600 | 34 | 73 | 2 | FALSE | 0.63 |
| non-small cell lung cancer | RAS_12C | PIK3CG | Any mutation | 49 | 12 | Signature R2 | -1.03 | -2.79 | 0.29 | 1481.77 | 1.00 | 139 | 48 | 11 | 1 | FALSE | 0.73 |
| non-small cell lung cancer | RAS_12C | PIK3CG | Any mutation | 109 | 118 | Signature overall | -0.58 | -2.05 | 0.81 | 1292.51 | 1.00 | 1112 | 103 | 112 | 6 | FALSE | 0.37 |
| non-small cell lung cancer | RAS_12C | EGFR | Any mutation | 15 | 29 | Signature 18 | -2.95 | -4.58 | -1.57 | 1352.37 | 1.00 | 110 | 15 | 29 | 0 | TRUE | 3.97 |
| non-small cell lung cancer | RAS_12C | EGFR | Any mutation | 21 | 79 | Signature 2 | -2.98 | -4.52 | -1.63 | 1360.29 | 1.00 | 240 | 21 | 79 | 0 | TRUE | 4.16 |
| non-small cell lung cancer | RAS_12C | EGFR | Any mutation | 36 | 114 | Signature 4 | -2.56 | -4.05 | -1.28 | 1089.84 | 1.00 | 575 | 34 | 112 | 2 | TRUE | 3.48 |
| non-small cell lung cancer | RAS_12C | EGFR | Any mutation | 112 | 853 | Signature overall | -2.90 | -4.19 | -1.84 | 1339.34 | 1.00 | 1889 | 109 | 850 | 3 | TRUE | 5.60 |
| non-small cell lung cancer | RAS_12C | ARID1B | Any mutation | 21 | 13 | Signature 2 | -0.60 | -2.55 | 0.97 | 1374.93 | 1.00 | 291 | 20 | 12 | 1 | TRUE | 0.30 |
| non-small cell lung cancer | RAS_12C | ARID1B | Any mutation | 36 | 42 | Signature 4 | -0.76 | -2.67 | 0.62 | 1153.47 | 1.00 | 627 | 35 | 41 | 1 | TRUE | 0.43 |
| non-small cell lung cancer | RAS_12C | ARID1B | Any mutation | 57 | 55 | Signature overall | -0.67 | -2.62 | 0.89 | 1211.83 | 1.00 | 918 | 55 | 53 | 2 | TRUE | 0.34 |
| non-small cell lung cancer | RAS_12C | MET | Any mutation | 21 | 23 | Signature 2 | -1.05 | -3.21 | 0.52 | 980.84 | 1.00 | 283 | 21 | 23 | 0 | TRUE | 0.57 |
| non-small cell lung cancer | RAS_12C | MET | Any mutation | 36 | 34 | Signature 4 | -0.88 | -2.80 | 0.58 | 543.02 | 1.00 | 637 | 35 | 33 | 1 | TRUE | 0.52 |
| non-small cell lung cancer | RAS_12C | MET | Any mutation | 62 | 68 | Signature overall | -0.84 | -2.67 | 0.60 | 548.64 | 1.00 | 1149 | 60 | 66 | 2 | TRUE | 0.49 |
| non-small cell lung cancer | RAS_12C | BRAF | Any mutation | 15 | 11 | Signature 18 | -0.45 | -1.97 | 0.74 | 1348.82 | 1.00 | 124 | 15 | 11 | 0 | TRUE | 0.29 |
| non-small cell lung cancer | RAS_12C | BRAF | Any mutation | 21 | 20 | Signature 2 | -0.33 | -1.56 | 0.76 | 1211.15 | 1.00 | 284 | 20 | 19 | 1 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12C | BRAF | Any mutation | 36 | 50 | Signature 4 | -0.10 | -1.09 | 0.90 | 785.01 | 1.01 | 622 | 32 | 46 | 4 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12C | BRAF | Any mutation | 77 | 101 | Signature overall | -0.33 | -1.59 | 0.68 | 1206.52 | 1.00 | 1248 | 72 | 96 | 5 | TRUE | 0.25 |
| non-small cell lung cancer | RAS_12C | CARD11 | Any mutation | 22 | 16 | Signature 2 | 0.62 | -0.60 | 1.84 | 1187.33 | 1.00 | 291 | 19 | 13 | 3 | FALSE | 0.47 |
| non-small cell lung cancer | RAS_12C | CARD11 | Any mutation | 36 | 63 | Signature 4 | 0.10 | -1.10 | 1.04 | 1348.14 | 1.00 | 610 | 33 | 60 | 3 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | CARD11 | Any mutation | 58 | 79 | Signature overall | 0.38 | -1.08 | 1.82 | 1278.33 | 1.00 | 901 | 52 | 73 | 6 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12C | INPP4B | Any mutation | 22 | 15 | Signature 2 | 1.26 | 0.12 | 2.45 | 1429.99 | 1.00 | 293 | 18 | 11 | 4 | FALSE | 1.50 |
| non-small cell lung cancer | RAS_12C | INPP4B | Any mutation | 36 | 60 | Signature 4 | 0.74 | -0.31 | 1.58 | 1233.28 | 1.00 | 619 | 31 | 55 | 5 | FALSE | 0.93 |
| non-small cell lung cancer | RAS_12C | INPP4B | Any mutation | 58 | 75 | Signature overall | 1.00 | -0.44 | 2.34 | 1312.01 | 1.00 | 912 | 49 | 66 | 9 | FALSE | 0.83 |
| non-small cell lung cancer | RAS_12C | NFE2L2 | Any mutation | 21 | 32 | Signature 2 | -0.64 | -2.50 | 0.79 | 1435.40 | 1.00 | 280 | 19 | 30 | 2 | FALSE | 0.34 |
| non-small cell lung cancer | RAS_12C | NFE2L2 | Any mutation | 36 | 20 | Signature 4 | -1.57 | -4.57 | 0.38 | 1509.18 | 1.00 | 647 | 36 | 20 | 0 | FALSE | 0.65 |
| non-small cell lung cancer | RAS_12C | NFE2L2 | Any mutation | 59 | 67 | Signature overall | -1.16 | -3.62 | 0.77 | 1476.61 | 1.00 | 1011 | 57 | 65 | 2 | FALSE | 0.53 |
| non-small cell lung cancer | RAS_12C | GLI1 | Any mutation | 35 | 44 | Signature 4 | 0.07 | -1.40 | 1.20 | 1461.95 | 1.00 | 561 | 32 | 41 | 3 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12C | GLI1 | Any mutation | 35 | 44 | Signature overall | 0.04 | -4.10 | 4.60 | 1344.63 | 1.00 | 561 | 32 | 41 | 3 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12C | ZFHX3 | Any mutation | 19 | 18 | Signature 2 | -0.81 | -2.63 | 0.81 | 1474.00 | 1.00 | 254 | 18 | 17 | 1 | FALSE | 0.46 |
| non-small cell lung cancer | RAS_12C | ZFHX3 | Any mutation | 34 | 61 | Signature 4 | -1.20 | -2.91 | 0.11 | 1481.82 | 1.00 | 544 | 33 | 60 | 1 | FALSE | 0.90 |
| non-small cell lung cancer | RAS_12C | ZFHX3 | Any mutation | 44 | 14 | Signature R2 | -0.88 | -2.37 | 0.44 | 1418.07 | 1.00 | 121 | 42 | 12 | 2 | FALSE | 0.66 |
| non-small cell lung cancer | RAS_12C | ZFHX3 | Any mutation | 97 | 93 | Signature overall | -0.95 | -2.61 | 0.47 | 1358.70 | 1.00 | 919 | 93 | 89 | 4 | FALSE | 0.68 |
| non-small cell lung cancer | RAS_12C | MGA | Any mutation | 19 | 28 | Signature 2 | -0.46 | -1.93 | 0.84 | 1450.32 | 1.00 | 255 | 18 | 27 | 1 | FALSE | 0.28 |
| non-small cell lung cancer | RAS_12C | MGA | Any mutation | 34 | 79 | Signature 4 | 0.20 | -0.72 | 1.05 | 1562.43 | 1.00 | 534 | 28 | 73 | 6 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12C | MGA | Any mutation | 44 | 13 | Signature R2 | -0.18 | -1.45 | 0.88 | 1249.98 | 1.00 | 123 | 41 | 10 | 3 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | MGA | Any mutation | 97 | 120 | Signature overall | -0.15 | -1.51 | 1.10 | 1596.41 | 1.00 | 912 | 87 | 110 | 10 | FALSE | 0.08 |
| non-small cell lung cancer | RAS_12C | AMER1 | Any mutation | 21 | 11 | Signature 2 | 0.34 | -1.38 | 1.76 | 1496.01 | 1.00 | 293 | 20 | 10 | 1 | FALSE | 0.17 |
| non-small cell lung cancer | RAS_12C | AMER1 | Any mutation | 37 | 83 | Signature 4 | 0.73 | -0.08 | 1.50 | 1469.66 | 1.00 | 607 | 29 | 75 | 8 | FALSE | 1.11 |
| non-small cell lung cancer | RAS_12C | AMER1 | Any mutation | 58 | 94 | Signature overall | 0.49 | -1.55 | 2.23 | 1411.07 | 1.00 | 900 | 49 | 85 | 9 | FALSE | 0.21 |
| non-small cell lung cancer | RAS_12C | EPHA7 | Any mutation | 34 | 51 | Signature 4 | 0.28 | -1.05 | 1.38 | 1223.23 | 1.00 | 554 | 31 | 48 | 3 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12C | EPHA7 | Any mutation | 38 | 64 | Signature overall | 0.90 | -1.30 | 3.37 | 1460.78 | 1.00 | 756 | 33 | 59 | 5 | FALSE | 0.38 |
| non-small cell lung cancer | KRAS_12C | SPEN | Any mutation | 48 | 39 | Signature 2 | -3.19 | -8.98 | -0.58 | 1312.85 | 1.00 | 264 | 48 | 39 | 0 | FALSE | 0.84 |
| non-small cell lung cancer | KRAS_12C | SPEN | Any mutation | 101 | 24 | Signature 4 | 0.14 | -1.08 | 1.17 | 1372.66 | 1.00 | 585 | 96 | 19 | 5 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12C | SPEN | Any mutation | 149 | 63 | Signature overall | -1.34 | -5.26 | 1.81 | 1597.56 | 1.00 | 849 | 144 | 58 | 5 | FALSE | 0.37 |
| non-small cell lung cancer | KRAS_12C | KMT2C | Any mutation | 6 | 22 | Signature 13 | 0.10 | -1.18 | 1.31 | 1497.92 | 1.00 | 74 | 4 | 20 | 2 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12C | KMT2C | Any mutation | 48 | 40 | Signature 2 | 0.15 | -0.63 | 0.87 | 1303.40 | 1.00 | 245 | 41 | 33 | 7 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | KMT2C | Any mutation | 11 | 13 | Signature 3 | -0.36 | -2.07 | 1.01 | 1532.95 | 1.00 | 219 | 11 | 13 | 0 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12C | KMT2C | Any mutation | 100 | 76 | Signature 4 | -0.09 | -0.79 | 0.56 | 1571.75 | 1.00 | 542 | 90 | 66 | 10 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12C | KMT2C | Any mutation | 165 | 151 | Signature overall | -0.04 | -1.04 | 0.86 | 1355.85 | 1.00 | 1080 | 146 | 132 | 19 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 8 | 79 | Signature 13 | -0.80 | -1.73 | 0.17 | 1311.38 | 1.00 | 28 | 3 | 74 | 5 | TRUE | 0.98 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 7 | 87 | Signature 15 | -1.06 | -2.06 | -0.08 | 1291.14 | 1.00 | 49 | 4 | 84 | 3 | TRUE | 1.44 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 6 | 39 | Signature 16 | -0.08 | -1.09 | 0.96 | 1312.48 | 1.00 | 24 | 0 | 33 | 6 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 38 | 92 | Signature 18 | -0.48 | -1.12 | 0.17 | 1527.75 | 1.00 | 45 | 19 | 73 | 19 | TRUE | 0.81 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 8 | 31 | Signature 19 | -0.53 | -1.58 | 0.46 | 1362.95 | 1.00 | 31 | 4 | 27 | 4 | TRUE | 0.52 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 8 | 149 | Signature 1A | -0.65 | -1.61 | 0.23 | 1513.68 | 1.00 | 121 | 3 | 144 | 5 | TRUE | 0.78 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 50 | 223 | Signature 2 | -0.63 | -1.16 | -0.06 | 1424.88 | 1.00 | 100 | 24 | 197 | 26 | TRUE | 1.60 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 6 | 46 | Signature 20 | -1.40 | -2.46 | -0.34 | 1420.66 | 1.00 | 26 | 5 | 45 | 1 | TRUE | 1.96 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 11 | 161 | Signature 3 | -0.81 | -1.66 | 0.06 | 1326.43 | 1.00 | 90 | 5 | 155 | 6 | TRUE | 1.17 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 102 | 522 | Signature 4 | -1.17 | -1.55 | -0.76 | 1604.16 | 1.00 | 170 | 56 | 476 | 46 | TRUE | 8.04 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 6 | 36 | Signature 6 | -1.14 | -2.21 | -0.12 | 1489.21 | 1.00 | 13 | 4 | 34 | 2 | TRUE | 1.47 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 10 | 71 | Signature 7 | -1.02 | -2.00 | -0.13 | 1498.47 | 1.00 | 35 | 6 | 67 | 4 | TRUE | 1.44 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 7 | 35 | Signature 8 | -1.40 | -2.54 | -0.32 | 1206.48 | 1.00 | 22 | 6 | 34 | 1 | TRUE | 1.91 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 135 | 85 | Signature R2 | -1.05 | -1.59 | -0.54 | 1512.39 | 1.00 | 27 | 94 | 44 | 41 | TRUE | 4.12 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 7 | 57 | Signature U1 | -1.39 | -2.53 | -0.35 | 1315.92 | 1.00 | 50 | 6 | 56 | 1 | TRUE | 1.89 |
| non-small cell lung cancer | KRAS_12C | TP53 | Any mutation | 427 | 1927 | Signature overall | -1.00 | -1.41 | -0.58 | 1418.79 | 1.00 | 978 | 252 | 1752 | 175 | TRUE | 5.84 |
| non-small cell lung cancer | KRAS_12C | ATRX | Any mutation | 39 | 12 | Signature 18 | 0.54 | -0.27 | 1.35 | 1411.71 | 1.00 | 105 | 34 | 7 | 5 | TRUE | 0.73 |
| non-small cell lung cancer | KRAS_12C | ATRX | Any mutation | 48 | 28 | Signature 2 | 0.54 | -0.15 | 1.27 | 1482.73 | 1.00 | 258 | 41 | 21 | 7 | TRUE | 0.90 |
| non-small cell lung cancer | KRAS_12C | ATRX | Any mutation | 103 | 88 | Signature 4 | 0.39 | -0.13 | 0.89 | 1313.19 | 1.00 | 543 | 87 | 72 | 16 | TRUE | 0.87 |
| non-small cell lung cancer | KRAS_12C | ATRX | Any mutation | 190 | 128 | Signature overall | 0.50 | -0.20 | 1.20 | 1338.06 | 1.00 | 906 | 162 | 100 | 28 | TRUE | 0.79 |
| non-small cell lung cancer | KRAS_12C | ATR | Any mutation | 6 | 11 | Signature 13 | 0.32 | -0.83 | 1.74 | 1504.90 | 1.00 | 83 | 4 | 9 | 2 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | ATR | Any mutation | 48 | 16 | Signature 2 | 0.08 | -0.84 | 1.05 | 1301.79 | 1.00 | 263 | 45 | 13 | 3 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12C | ATR | Any mutation | 100 | 60 | Signature 4 | -0.10 | -0.87 | 0.54 | 1511.63 | 1.00 | 551 | 93 | 53 | 7 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12C | ATR | Any mutation | 154 | 87 | Signature overall | 0.10 | -0.84 | 1.15 | 1494.57 | 1.00 | 897 | 142 | 75 | 12 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12C | PDGFRA | Any mutation | 48 | 20 | Signature 2 | 0.47 | -0.42 | 1.23 | 770.85 | 1.00 | 260 | 44 | 16 | 4 | TRUE | 0.59 |
| non-small cell lung cancer | KRAS_12C | PDGFRA | Any mutation | 102 | 70 | Signature 4 | 0.59 | 0.00 | 1.14 | 844.02 | 1.00 | 552 | 86 | 54 | 16 | TRUE | 1.30 |
| non-small cell lung cancer | KRAS_12C | PDGFRA | Any mutation | 150 | 90 | Signature overall | 0.53 | -0.42 | 1.33 | 1302.13 | 1.00 | 812 | 130 | 70 | 20 | TRUE | 0.62 |
| non-small cell lung cancer | KRAS_12C | FLT4 | Any mutation | 48 | 11 | Signature 2 | -0.76 | -2.24 | 0.42 | 1323.59 | 1.00 | 266 | 47 | 10 | 1 | TRUE | 0.60 |
| non-small cell lung cancer | KRAS_12C | FLT4 | Any mutation | 100 | 36 | Signature 4 | -0.74 | -1.88 | 0.26 | 1272.36 | 1.00 | 571 | 97 | 33 | 3 | TRUE | 0.75 |
| non-small cell lung cancer | KRAS_12C | FLT4 | Any mutation | 148 | 47 | Signature overall | -0.74 | -2.12 | 0.46 | 1385.09 | 1.00 | 837 | 144 | 43 | 4 | TRUE | 0.56 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 40 | 22 | Signature 18 | 0.66 | -0.24 | 1.56 | 1531.08 | 1.00 | 100 | 31 | 13 | 9 | FALSE | 0.84 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 7 | 12 | Signature 1A | 0.34 | -1.47 | 2.01 | 1534.67 | 1.00 | 248 | 6 | 11 | 1 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 48 | 33 | Signature 2 | 0.18 | -0.74 | 1.02 | 1418.08 | 1.00 | 250 | 42 | 27 | 6 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 6 | 12 | Signature 20 | -0.74 | -2.78 | 0.83 | 1516.28 | 1.00 | 61 | 6 | 12 | 0 | FALSE | 0.37 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 11 | 18 | Signature 3 | 0.48 | -1.06 | 1.88 | 1507.44 | 1.00 | 216 | 9 | 16 | 2 | FALSE | 0.29 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 107 | 195 | Signature 4 | -0.34 | -0.87 | 0.12 | 1371.54 | 1.00 | 467 | 85 | 173 | 22 | FALSE | 0.78 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 135 | 18 | Signature R2 | -0.21 | -1.07 | 0.74 | 1447.90 | 1.00 | 58 | 124 | 7 | 11 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12C | PTPRD | Any mutation | 357 | 321 | Signature overall | -0.04 | -0.97 | 0.92 | 1597.05 | 1.00 | 1432 | 306 | 270 | 51 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12C | PIK3C2G | Any mutation | 48 | 17 | Signature 2 | -0.72 | -2.01 | 0.26 | 1402.12 | 1.00 | 259 | 47 | 16 | 1 | FALSE | 0.68 |
| non-small cell lung cancer | KRAS_12C | PIK3C2G | Any mutation | 100 | 57 | Signature 4 | -0.54 | -1.44 | 0.22 | 1113.25 | 1.00 | 555 | 94 | 51 | 6 | FALSE | 0.68 |
| non-small cell lung cancer | KRAS_12C | PIK3C2G | Any mutation | 148 | 74 | Signature overall | -0.63 | -1.80 | 0.38 | 1375.77 | 1.00 | 814 | 141 | 67 | 7 | FALSE | 0.58 |
| non-small cell lung cancer | KRAS_12C | CREBBP | Any mutation | 7 | 12 | Signature 1A | 0.16 | -1.31 | 1.56 | 1502.58 | 1.00 | 248 | 6 | 11 | 1 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12C | CREBBP | Any mutation | 48 | 15 | Signature 2 | -0.10 | -1.42 | 1.01 | 1270.82 | 1.00 | 263 | 46 | 13 | 2 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12C | CREBBP | Any mutation | 11 | 11 | Signature 3 | -0.32 | -2.06 | 1.05 | 1444.37 | 1.00 | 221 | 11 | 11 | 0 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12C | CREBBP | Any mutation | 100 | 44 | Signature 4 | 0.09 | -0.80 | 0.88 | 1631.23 | 1.00 | 570 | 93 | 37 | 7 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12C | CREBBP | Any mutation | 166 | 82 | Signature overall | -0.04 | -1.26 | 1.00 | 1481.14 | 1.00 | 1302 | 156 | 72 | 10 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12C | DOT1L | Any mutation | 48 | 16 | Signature 2 | -0.07 | -1.00 | 0.83 | 494.60 | 1.01 | 262 | 46 | 14 | 2 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12C | DOT1L | Any mutation | 100 | 38 | Signature 4 | -0.01 | -0.80 | 0.76 | 321.20 | 1.01 | 571 | 94 | 32 | 6 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12C | DOT1L | Any mutation | 148 | 54 | Signature overall | -0.04 | -1.02 | 0.80 | 386.98 | 1.01 | 833 | 140 | 46 | 8 | FALSE | 0.03 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 6 | 11 | Signature 13 | 0.02 | -1.72 | 1.42 | 1508.96 | 1.00 | 82 | 5 | 10 | 1 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 38 | 14 | Signature 18 | 0.35 | -0.68 | 1.32 | 1483.31 | 1.00 | 104 | 33 | 9 | 5 | FALSE | 0.29 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 7 | 17 | Signature 1A | 0.14 | -1.50 | 1.63 | 1453.61 | 1.00 | 245 | 6 | 16 | 1 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 50 | 33 | Signature 2 | 0.32 | -0.52 | 1.14 | 1600.37 | 1.00 | 255 | 43 | 26 | 7 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 11 | 16 | Signature 3 | -0.60 | -2.35 | 0.92 | 1445.88 | 1.00 | 217 | 11 | 16 | 0 | FALSE | 0.33 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 100 | 104 | Signature 4 | -0.36 | -1.02 | 0.25 | 1546.82 | 1.00 | 516 | 89 | 93 | 11 | FALSE | 0.58 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 9 | 15 | Signature 7 | -0.24 | -1.88 | 1.17 | 1330.95 | 1.00 | 85 | 8 | 14 | 1 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 134 | 15 | Signature R2 | -0.24 | -1.15 | 0.63 | 1552.61 | 1.00 | 58 | 125 | 6 | 9 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Any mutation | 355 | 225 | Signature overall | -0.09 | -0.97 | 0.74 | 1486.96 | 1.00 | 1562 | 320 | 190 | 35 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 6 | 11 | Signature 13 | -0.14 | -1.98 | 1.52 | 1517.67 | 1.00 | 84 | 5 | 10 | 1 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 38 | 17 | Signature 18 | -0.52 | -1.72 | 0.60 | 1430.59 | 1.00 | 99 | 35 | 14 | 3 | FALSE | 0.42 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 7 | 11 | Signature 1A | -0.73 | -2.92 | 1.09 | 1435.61 | 1.00 | 251 | 7 | 11 | 0 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 49 | 30 | Signature 2 | 0.19 | -0.75 | 1.07 | 1464.57 | 1.00 | 253 | 43 | 24 | 6 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 11 | 19 | Signature 3 | -0.33 | -2.10 | 1.25 | 1516.98 | 1.00 | 216 | 10 | 18 | 1 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 101 | 179 | Signature 4 | -0.38 | -0.95 | 0.13 | 1567.92 | 1.00 | 484 | 82 | 160 | 19 | FALSE | 0.77 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 134 | 23 | Signature R2 | -0.88 | -1.73 | -0.10 | 1526.76 | 1.00 | 56 | 124 | 13 | 10 | FALSE | 1.47 |
| non-small cell lung cancer | KRAS_12C | PTPRT | Any mutation | 346 | 290 | Signature overall | -0.41 | -1.44 | 0.60 | 1494.12 | 1.00 | 1443 | 306 | 250 | 40 | FALSE | 0.37 |
| non-small cell lung cancer | KRAS_12C | HGF | Any mutation | 48 | 20 | Signature 2 | 0.70 | -0.40 | 1.68 | 1423.45 | 1.00 | 262 | 42 | 14 | 6 | FALSE | 0.72 |
| non-small cell lung cancer | KRAS_12C | HGF | Any mutation | 100 | 89 | Signature 4 | -0.58 | -1.32 | 0.12 | 1560.65 | 1.00 | 530 | 92 | 81 | 8 | FALSE | 0.90 |
| non-small cell lung cancer | KRAS_12C | HGF | Any mutation | 135 | 12 | Signature R2 | -0.95 | -2.09 | 0.12 | 1492.30 | 1.00 | 58 | 130 | 7 | 5 | FALSE | 1.04 |
| non-small cell lung cancer | KRAS_12C | HGF | Any mutation | 283 | 121 | Signature overall | -0.27 | -1.80 | 1.35 | 1482.95 | 1.00 | 850 | 264 | 102 | 19 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 6 | 13 | Signature 13 | 0.48 | -0.97 | 1.81 | 1581.89 | 1.00 | 82 | 4 | 11 | 2 | TRUE | 0.31 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 7 | 13 | Signature 1A | 0.20 | -1.42 | 1.56 | 1439.65 | 1.00 | 248 | 6 | 12 | 1 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 49 | 82 | Signature 2 | 0.14 | -0.56 | 0.75 | 1219.80 | 1.00 | 212 | 36 | 69 | 13 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 6 | 16 | Signature 20 | -0.09 | -1.52 | 1.19 | 1520.66 | 1.00 | 56 | 5 | 15 | 1 | TRUE | 0.05 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 11 | 15 | Signature 3 | -0.42 | -2.10 | 0.92 | 1499.80 | 1.00 | 217 | 11 | 15 | 0 | TRUE | 0.23 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 100 | 38 | Signature 4 | -0.31 | -1.27 | 0.51 | 1519.20 | 1.00 | 569 | 96 | 34 | 4 | TRUE | 0.30 |
| non-small cell lung cancer | KRAS_12C | PIK3CA | Any mutation | 179 | 177 | Signature overall | 0.00 | -1.00 | 0.86 | 1423.84 | 1.00 | 1384 | 158 | 156 | 21 | TRUE | 0.00 |
| non-small cell lung cancer | KRAS_12C | ALK | Any mutation | 48 | 24 | Signature 2 | 0.44 | -0.22 | 1.09 | 993.25 | 1.00 | 259 | 43 | 19 | 5 | TRUE | 0.70 |
| non-small cell lung cancer | KRAS_12C | ALK | Any mutation | 100 | 72 | Signature 4 | 0.47 | -0.04 | 1.04 | 689.28 | 1.00 | 550 | 85 | 57 | 15 | TRUE | 1.03 |
| non-small cell lung cancer | KRAS_12C | ALK | Any mutation | 148 | 96 | Signature overall | 0.45 | -0.26 | 1.15 | 1168.90 | 1.00 | 809 | 128 | 76 | 20 | TRUE | 0.68 |
| non-small cell lung cancer | KRAS_12C | PTEN | Any mutation | 48 | 27 | Signature 2 | -0.31 | -1.42 | 0.67 | 646.02 | 1.01 | 255 | 45 | 24 | 3 | TRUE | 0.24 |
| non-small cell lung cancer | KRAS_12C | PTEN | Any mutation | 100 | 27 | Signature 4 | -0.19 | -1.22 | 0.78 | 297.14 | 1.01 | 580 | 96 | 23 | 4 | TRUE | 0.14 |
| non-small cell lung cancer | KRAS_12C | PTEN | Any mutation | 148 | 54 | Signature overall | -0.26 | -1.65 | 1.14 | 620.03 | 1.01 | 835 | 141 | 47 | 7 | TRUE | 0.15 |
| non-small cell lung cancer | KRAS_12C | BCOR | Any mutation | 49 | 13 | Signature 2 | 0.26 | -0.85 | 1.20 | 1437.33 | 1.00 | 265 | 47 | 11 | 2 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | BCOR | Any mutation | 103 | 52 | Signature 4 | 0.52 | -0.11 | 1.13 | 877.52 | 1.00 | 566 | 91 | 40 | 12 | FALSE | 0.97 |
| non-small cell lung cancer | KRAS_12C | BCOR | Any mutation | 152 | 65 | Signature overall | 0.40 | -0.82 | 1.47 | 1542.68 | 1.00 | 831 | 138 | 51 | 14 | FALSE | 0.31 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 7 | 11 | Signature 1A | -1.58 | -4.11 | 0.57 | 1512.68 | 1.00 | 248 | 7 | 11 | 0 | TRUE | 0.73 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 48 | 14 | Signature 2 | -1.33 | -3.46 | 0.38 | 1200.96 | 1.00 | 263 | 47 | 13 | 1 | TRUE | 0.80 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 11 | 17 | Signature 3 | -1.09 | -3.30 | 0.78 | 1253.04 | 1.01 | 216 | 10 | 16 | 1 | TRUE | 0.51 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 100 | 16 | Signature 4 | -1.89 | -4.30 | -0.18 | 1535.32 | 1.00 | 586 | 100 | 16 | 0 | TRUE | 1.17 |
| non-small cell lung cancer | KRAS_12C | CTNNB1 | Any mutation | 166 | 58 | Signature overall | -1.47 | -3.59 | 0.13 | 1360.63 | 1.00 | 1313 | 164 | 56 | 2 | TRUE | 0.95 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 6 | 17 | Signature 13 | -0.89 | -3.33 | 0.91 | 1551.42 | 1.00 | 77 | 6 | 17 | 0 | TRUE | 0.42 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 41 | 12 | Signature 18 | 1.09 | 0.04 | 2.22 | 1520.87 | 1.00 | 107 | 34 | 5 | 7 | TRUE | 1.34 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 51 | 52 | Signature 2 | 0.54 | -0.11 | 1.25 | 1364.40 | 1.00 | 242 | 39 | 40 | 12 | TRUE | 0.91 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 11 | 11 | Signature 3 | 0.21 | -1.66 | 1.88 | 1586.84 | 1.00 | 222 | 10 | 10 | 1 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 100 | 86 | Signature 4 | -0.97 | -1.90 | -0.16 | 1394.93 | 1.00 | 524 | 95 | 81 | 5 | TRUE | 1.51 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 134 | 13 | Signature R2 | 0.04 | -0.96 | 1.06 | 1401.28 | 1.00 | 60 | 125 | 4 | 9 | TRUE | 0.03 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Any mutation | 343 | 191 | Signature overall | 0.00 | -1.10 | 1.11 | 1458.71 | 1.00 | 1232 | 309 | 157 | 34 | TRUE | 0.00 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 6 | 16 | Signature 13 | -0.30 | -1.79 | 0.97 | 1142.29 | 1.00 | 78 | 6 | 16 | 0 | FALSE | 0.17 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 38 | 16 | Signature 18 | 0.68 | -0.27 | 1.57 | 1662.90 | 1.00 | 103 | 31 | 9 | 7 | FALSE | 0.85 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 7 | 13 | Signature 1A | 0.31 | -1.09 | 1.72 | 1338.33 | 1.00 | 250 | 6 | 12 | 1 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 50 | 38 | Signature 2 | 0.53 | -0.25 | 1.26 | 1414.01 | 1.00 | 251 | 41 | 29 | 9 | FALSE | 0.77 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 6 | 11 | Signature 20 | -0.23 | -1.78 | 1.01 | 1343.62 | 1.00 | 61 | 6 | 11 | 0 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 11 | 13 | Signature 3 | 0.18 | -1.19 | 1.46 | 1495.97 | 1.00 | 220 | 10 | 12 | 1 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 102 | 121 | Signature 4 | 0.02 | -0.53 | 0.56 | 1488.04 | 1.00 | 510 | 85 | 104 | 17 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | FAT1 | Any mutation | 220 | 228 | Signature overall | 0.18 | -0.68 | 0.96 | 1304.50 | 1.00 | 1473 | 185 | 193 | 35 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12C | NCOR1 | Any mutation | 6 | 14 | Signature 13 | 0.04 | -1.48 | 1.42 | 1478.59 | 1.00 | 83 | 5 | 13 | 1 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | NCOR1 | Any mutation | 48 | 11 | Signature 2 | 0.31 | -0.89 | 1.49 | 1544.86 | 1.00 | 271 | 45 | 8 | 3 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | NCOR1 | Any mutation | 101 | 36 | Signature 4 | -0.24 | -1.23 | 0.65 | 1552.12 | 1.00 | 571 | 97 | 32 | 4 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | NCOR1 | Any mutation | 155 | 61 | Signature overall | 0.04 | -1.15 | 1.18 | 1441.82 | 1.00 | 925 | 147 | 53 | 8 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | POLE | Any mutation | 49 | 19 | Signature 2 | 0.60 | -0.50 | 1.60 | 1321.04 | 1.00 | 263 | 44 | 14 | 5 | TRUE | 0.57 |
| non-small cell lung cancer | KRAS_12C | POLE | Any mutation | 100 | 49 | Signature 4 | 0.17 | -0.62 | 0.86 | 1342.44 | 1.00 | 564 | 92 | 41 | 8 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12C | POLE | Any mutation | 134 | 11 | Signature R2 | 0.27 | -0.82 | 1.47 | 1413.38 | 1.00 | 61 | 126 | 3 | 8 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12C | POLE | Any mutation | 283 | 79 | Signature overall | 0.33 | -1.14 | 1.67 | 1325.68 | 1.00 | 888 | 262 | 58 | 21 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12C | NOTCH2 | Any mutation | 48 | 15 | Signature 2 | -0.45 | -1.57 | 0.59 | 1169.53 | 1.00 | 261 | 46 | 13 | 2 | TRUE | 0.39 |
| non-small cell lung cancer | KRAS_12C | NOTCH2 | Any mutation | 100 | 54 | Signature 4 | -0.51 | -1.47 | 0.32 | 992.88 | 1.00 | 563 | 95 | 49 | 5 | TRUE | 0.59 |
| non-small cell lung cancer | KRAS_12C | NOTCH2 | Any mutation | 148 | 69 | Signature overall | -0.48 | -1.62 | 0.62 | 1148.59 | 1.00 | 824 | 141 | 62 | 7 | TRUE | 0.39 |
| non-small cell lung cancer | KRAS_12C | KMT2A | Any mutation | 48 | 23 | Signature 2 | 0.12 | -0.78 | 0.96 | 1314.99 | 1.00 | 260 | 43 | 18 | 5 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12C | KMT2A | Any mutation | 100 | 37 | Signature 4 | -0.10 | -1.00 | 0.65 | 1171.29 | 1.00 | 570 | 96 | 33 | 4 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12C | KMT2A | Any mutation | 148 | 60 | Signature overall | 0.00 | -0.97 | 0.88 | 1243.80 | 1.00 | 830 | 139 | 51 | 9 | FALSE | 0.00 |
| non-small cell lung cancer | KRAS_12C | PAK7 | Any mutation | 100 | 69 | Signature 4 | -0.87 | -1.92 | -0.04 | 1533.80 | 1.00 | 545 | 95 | 64 | 5 | FALSE | 1.09 |
| non-small cell lung cancer | KRAS_12C | PAK7 | Any mutation | 100 | 69 | Signature overall | -0.72 | -5.22 | 3.73 | 1532.67 | 1.00 | 545 | 95 | 64 | 5 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12C | STAG2 | Any mutation | 48 | 16 | Signature 2 | 0.12 | -0.72 | 0.88 | 290.69 | 1.02 | 263 | 46 | 14 | 2 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12C | STAG2 | Any mutation | 100 | 43 | Signature 4 | 0.23 | -0.36 | 0.93 | 7.05 | 1.15 | 572 | 91 | 34 | 9 | TRUE | 0.29 |
| non-small cell lung cancer | KRAS_12C | STAG2 | Any mutation | 148 | 59 | Signature overall | 0.17 | -0.53 | 0.95 | 48.64 | 1.04 | 835 | 137 | 48 | 11 | TRUE | 0.17 |
| non-small cell lung cancer | KRAS_12C | TERT | Any mutation | 49 | 23 | Signature 2 | 0.81 | 0.11 | 1.61 | 672.65 | 1.00 | 261 | 41 | 15 | 8 | TRUE | 1.49 |
| non-small cell lung cancer | KRAS_12C | TERT | Any mutation | 101 | 54 | Signature 4 | 0.63 | -0.01 | 1.23 | 478.68 | 1.00 | 563 | 90 | 43 | 11 | TRUE | 1.30 |
| non-small cell lung cancer | KRAS_12C | TERT | Any mutation | 150 | 77 | Signature overall | 0.71 | -0.08 | 1.51 | 668.28 | 1.00 | 824 | 131 | 58 | 19 | TRUE | 1.01 |
| non-small cell lung cancer | KRAS_12C | BRCA2 | Any mutation | 6 | 13 | Signature 13 | -0.72 | -2.62 | 0.56 | 1242.27 | 1.00 | 81 | 6 | 13 | 0 | TRUE | 0.42 |
| non-small cell lung cancer | KRAS_12C | BRCA2 | Any mutation | 48 | 15 | Signature 2 | -0.68 | -2.17 | 0.43 | 1345.18 | 1.00 | 263 | 47 | 14 | 1 | TRUE | 0.51 |
| non-small cell lung cancer | KRAS_12C | BRCA2 | Any mutation | 100 | 55 | Signature 4 | -0.19 | -1.02 | 0.53 | 1246.84 | 1.00 | 562 | 92 | 47 | 8 | TRUE | 0.20 |
| non-small cell lung cancer | KRAS_12C | BRCA2 | Any mutation | 154 | 83 | Signature overall | -0.53 | -1.85 | 0.58 | 1365.97 | 1.00 | 906 | 145 | 74 | 9 | TRUE | 0.41 |
| non-small cell lung cancer | KRAS_12C | NOTCH3 | Any mutation | 38 | 11 | Signature 18 | 0.09 | -0.84 | 1.07 | 1536.15 | 1.00 | 106 | 34 | 7 | 4 | TRUE | 0.07 |
| non-small cell lung cancer | KRAS_12C | NOTCH3 | Any mutation | 48 | 15 | Signature 2 | -0.13 | -1.13 | 0.78 | 1684.17 | 1.00 | 264 | 46 | 13 | 2 | TRUE | 0.11 |
| non-small cell lung cancer | KRAS_12C | NOTCH3 | Any mutation | 100 | 48 | Signature 4 | -0.20 | -1.02 | 0.52 | 1449.59 | 1.00 | 564 | 95 | 43 | 5 | TRUE | 0.22 |
| non-small cell lung cancer | KRAS_12C | NOTCH3 | Any mutation | 186 | 74 | Signature overall | -0.09 | -0.97 | 0.71 | 1627.62 | 1.00 | 934 | 175 | 63 | 11 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12C | NOTCH4 | Any mutation | 100 | 74 | Signature 4 | -0.55 | -1.43 | 0.24 | 1206.82 | 1.00 | 541 | 93 | 67 | 7 | TRUE | 0.69 |
| non-small cell lung cancer | KRAS_12C | NOTCH4 | Any mutation | 100 | 74 | Signature overall | -0.39 | -4.80 | 3.94 | 1546.37 | 1.00 | 541 | 93 | 67 | 7 | TRUE | 0.07 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 6 | 20 | Signature 13 | 0.21 | -0.98 | 1.35 | 1668.71 | 1.00 | 74 | 4 | 18 | 2 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 7 | 16 | Signature 15 | -0.42 | -1.94 | 0.85 | 1441.96 | 1.00 | 114 | 7 | 16 | 0 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 39 | 34 | Signature 18 | 0.27 | -0.48 | 1.00 | 1385.61 | 1.00 | 89 | 29 | 24 | 10 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 9 | 11 | Signature 19 | 0.51 | -0.67 | 1.60 | 1722.99 | 1.00 | 46 | 6 | 8 | 3 | FALSE | 0.43 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 7 | 27 | Signature 1A | 0.36 | -0.90 | 1.58 | 1520.90 | 1.00 | 236 | 5 | 25 | 2 | FALSE | 0.25 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 48 | 55 | Signature 2 | -0.15 | -0.91 | 0.60 | 1491.53 | 1.00 | 231 | 41 | 48 | 7 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 6 | 13 | Signature 20 | -0.04 | -1.37 | 1.17 | 1484.12 | 1.00 | 59 | 5 | 12 | 1 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 11 | 31 | Signature 3 | 0.12 | -1.07 | 1.24 | 1446.27 | 1.00 | 203 | 9 | 29 | 2 | FALSE | 0.07 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 101 | 175 | Signature 4 | 0.17 | -0.31 | 0.60 | 1553.97 | 1.00 | 461 | 73 | 147 | 28 | FALSE | 0.34 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 9 | 14 | Signature 7 | -0.09 | -1.43 | 1.12 | 1484.80 | 1.00 | 87 | 8 | 13 | 1 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 135 | 45 | Signature R2 | 0.04 | -0.56 | 0.63 | 1514.28 | 1.00 | 49 | 106 | 16 | 29 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 7 | 11 | Signature U1 | 0.43 | -0.86 | 1.70 | 1475.64 | 1.00 | 95 | 5 | 9 | 2 | FALSE | 0.30 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Any mutation | 393 | 476 | Signature overall | 0.04 | -0.52 | 0.62 | 1469.60 | 1.00 | 1828 | 306 | 389 | 87 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12C | KDM5C | Any mutation | 48 | 15 | Signature 2 | -1.12 | -5.55 | 0.64 | 351.03 | 1.01 | 262 | 48 | 15 | 0 | FALSE | 0.31 |
| non-small cell lung cancer | KRAS_12C | KDM5C | Any mutation | 101 | 41 | Signature 4 | 0.58 | -0.18 | 1.34 | 147.47 | 1.02 | 573 | 90 | 30 | 11 | FALSE | 0.78 |
| non-small cell lung cancer | KRAS_12C | KDM5C | Any mutation | 149 | 56 | Signature overall | -0.24 | -3.17 | 1.39 | 1211.45 | 1.00 | 835 | 138 | 45 | 11 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 6 | 12 | Signature 13 | -1.42 | -3.86 | 0.50 | 1370.96 | 1.00 | 80 | 6 | 12 | 0 | TRUE | 0.69 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 7 | 11 | Signature 15 | -1.40 | -3.73 | 0.53 | 1445.02 | 1.00 | 118 | 7 | 11 | 0 | TRUE | 0.70 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 7 | 18 | Signature 1A | -1.38 | -3.88 | 0.61 | 1568.55 | 1.00 | 241 | 7 | 18 | 0 | TRUE | 0.64 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 48 | 22 | Signature 2 | -1.33 | -3.08 | 0.06 | 1575.70 | 1.00 | 256 | 47 | 21 | 1 | TRUE | 1.00 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 11 | 20 | Signature 3 | -1.47 | -3.81 | 0.45 | 1489.12 | 1.00 | 213 | 11 | 20 | 0 | TRUE | 0.75 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 102 | 90 | Signature 4 | -0.43 | -1.13 | 0.22 | 1449.84 | 1.00 | 528 | 92 | 80 | 10 | TRUE | 0.67 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 134 | 11 | Signature R2 | -0.13 | -1.21 | 0.97 | 1566.76 | 1.00 | 61 | 126 | 3 | 8 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Any mutation | 315 | 184 | Signature overall | -1.08 | -2.49 | 0.08 | 1473.98 | 1.00 | 1497 | 296 | 165 | 19 | TRUE | 1.02 |
| non-small cell lung cancer | KRAS_12C | EPHB1 | Any mutation | 48 | 17 | Signature 2 | -0.22 | -1.36 | 0.87 | 1330.14 | 1.00 | 263 | 45 | 14 | 3 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12C | EPHB1 | Any mutation | 101 | 79 | Signature 4 | -0.51 | -1.38 | 0.17 | 545.94 | 1.00 | 541 | 94 | 72 | 7 | FALSE | 0.69 |
| non-small cell lung cancer | KRAS_12C | EPHB1 | Any mutation | 149 | 96 | Signature overall | -0.36 | -1.71 | 1.02 | 1254.33 | 1.00 | 804 | 139 | 86 | 10 | FALSE | 0.22 |
| non-small cell lung cancer | KRAS_12C | SMAD4 | Any mutation | 7 | 17 | Signature 1A | -0.52 | -3.06 | 1.34 | 1336.26 | 1.00 | 244 | 7 | 17 | 0 | TRUE | 0.18 |
| non-small cell lung cancer | KRAS_12C | SMAD4 | Any mutation | 48 | 21 | Signature 2 | 0.71 | -0.31 | 1.71 | 1462.71 | 1.00 | 261 | 42 | 15 | 6 | TRUE | 0.79 |
| non-small cell lung cancer | KRAS_12C | SMAD4 | Any mutation | 100 | 16 | Signature 4 | -0.20 | -1.69 | 0.98 | 1547.66 | 1.00 | 588 | 98 | 14 | 2 | TRUE | 0.11 |
| non-small cell lung cancer | KRAS_12C | SMAD4 | Any mutation | 155 | 54 | Signature overall | 0.02 | -1.72 | 1.54 | 1288.18 | 1.00 | 1093 | 147 | 46 | 8 | TRUE | 0.01 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 6 | 12 | Signature 13 | 0.33 | -1.29 | 1.74 | 1351.38 | 1.00 | 81 | 5 | 11 | 1 | TRUE | 0.18 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 38 | 11 | Signature 18 | 0.51 | -0.64 | 1.60 | 1309.56 | 1.00 | 106 | 34 | 7 | 4 | TRUE | 0.44 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 49 | 27 | Signature 2 | 0.66 | -0.22 | 1.48 | 1454.28 | 1.00 | 258 | 42 | 20 | 7 | TRUE | 0.89 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 11 | 13 | Signature 3 | 0.87 | -0.52 | 2.12 | 1598.30 | 1.00 | 221 | 9 | 11 | 2 | TRUE | 0.69 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 107 | 95 | Signature 4 | 0.70 | 0.22 | 1.20 | 1598.08 | 1.00 | 540 | 84 | 72 | 23 | TRUE | 2.25 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 135 | 25 | Signature R2 | 0.37 | -0.44 | 1.16 | 1554.38 | 1.00 | 57 | 117 | 7 | 18 | TRUE | 0.43 |
| non-small cell lung cancer | KRAS_12C | ATM | Any mutation | 349 | 195 | Signature overall | 0.54 | -0.32 | 1.39 | 1338.75 | 1.00 | 1296 | 293 | 139 | 56 | TRUE | 0.63 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 6 | 11 | Signature 13 | -1.24 | -3.00 | 0.28 | 1397.88 | 1.00 | 83 | 6 | 11 | 0 | TRUE | 0.86 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 38 | 11 | Signature 18 | -0.57 | -1.78 | 0.57 | 1448.85 | 1.00 | 104 | 35 | 8 | 3 | TRUE | 0.47 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 7 | 16 | Signature 1A | -1.21 | -3.00 | 0.31 | 1643.36 | 1.00 | 243 | 7 | 16 | 0 | TRUE | 0.81 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 48 | 28 | Signature 2 | -1.33 | -2.77 | -0.15 | 1605.16 | 1.00 | 249 | 47 | 27 | 1 | TRUE | 1.37 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 11 | 18 | Signature 3 | -1.26 | -3.00 | 0.26 | 1519.13 | 1.00 | 214 | 11 | 18 | 0 | TRUE | 0.94 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 100 | 67 | Signature 4 | -0.92 | -1.82 | -0.06 | 1529.30 | 1.00 | 544 | 95 | 62 | 5 | TRUE | 1.39 |
| non-small cell lung cancer | KRAS_12C | RB1 | Any mutation | 210 | 151 | Signature overall | -1.08 | -2.18 | -0.10 | 1534.71 | 1.00 | 1437 | 201 | 142 | 9 | TRUE | 1.39 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 6 | 16 | Signature 13 | -1.24 | -3.47 | 0.59 | 1649.98 | 1.00 | 77 | 6 | 16 | 0 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 38 | 16 | Signature 18 | -0.87 | -2.23 | 0.28 | 1599.12 | 1.00 | 100 | 36 | 14 | 2 | FALSE | 0.73 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 7 | 22 | Signature 1A | -1.05 | -3.26 | 0.76 | 1406.98 | 1.00 | 240 | 7 | 22 | 0 | FALSE | 0.51 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 49 | 46 | Signature 2 | 0.10 | -0.75 | 0.89 | 1445.34 | 1.00 | 244 | 41 | 38 | 8 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 11 | 13 | Signature 3 | -1.05 | -3.24 | 0.74 | 1460.10 | 1.00 | 219 | 11 | 13 | 0 | FALSE | 0.51 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 101 | 129 | Signature 4 | -0.13 | -0.70 | 0.39 | 1502.22 | 1.00 | 512 | 84 | 112 | 17 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 134 | 13 | Signature R2 | -0.12 | -1.14 | 0.92 | 1325.17 | 1.00 | 60 | 125 | 4 | 9 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12C | KMT2D | Any mutation | 346 | 255 | Signature overall | -0.60 | -1.80 | 0.47 | 1554.90 | 1.00 | 1452 | 310 | 219 | 36 | FALSE | 0.54 |
| non-small cell lung cancer | KRAS_12C | APC | Any mutation | 7 | 13 | Signature 1A | -0.65 | -3.35 | 1.23 | 1513.29 | 1.00 | 246 | 7 | 13 | 0 | TRUE | 0.23 |
| non-small cell lung cancer | KRAS_12C | APC | Any mutation | 51 | 23 | Signature 2 | 0.44 | -0.62 | 1.38 | 1480.71 | 1.00 | 259 | 45 | 17 | 6 | TRUE | 0.41 |
| non-small cell lung cancer | KRAS_12C | APC | Any mutation | 100 | 50 | Signature 4 | -0.59 | -1.64 | 0.32 | 1597.21 | 1.00 | 560 | 96 | 46 | 4 | TRUE | 0.62 |
| non-small cell lung cancer | KRAS_12C | APC | Any mutation | 158 | 86 | Signature overall | -0.25 | -2.06 | 1.18 | 1482.81 | 1.00 | 1065 | 148 | 76 | 10 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12C | ERBB2 | Any mutation | 7 | 15 | Signature 1A | -2.58 | -6.45 | 0.25 | 1185.78 | 1.00 | 244 | 7 | 15 | 0 | TRUE | 0.92 |
| non-small cell lung cancer | KRAS_12C | ERBB2 | Any mutation | 48 | 12 | Signature 2 | -2.73 | -6.32 | -0.44 | 1319.07 | 1.00 | 264 | 48 | 12 | 0 | TRUE | 1.08 |
| non-small cell lung cancer | KRAS_12C | ERBB2 | Any mutation | 100 | 19 | Signature 4 | -2.14 | -4.99 | -0.17 | 1416.75 | 1.00 | 586 | 99 | 18 | 1 | TRUE | 1.07 |
| non-small cell lung cancer | KRAS_12C | ERBB2 | Any mutation | 155 | 46 | Signature overall | -2.46 | -5.61 | -0.15 | 1315.29 | 1.00 | 1094 | 154 | 45 | 1 | TRUE | 1.12 |
| non-small cell lung cancer | KRAS_12C | ARID2 | Any mutation | 38 | 11 | Signature 18 | 0.03 | -1.12 | 1.04 | 1513.40 | 1.00 | 104 | 35 | 8 | 3 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | ARID2 | Any mutation | 48 | 18 | Signature 2 | 0.18 | -0.83 | 1.11 | 1448.55 | 1.00 | 263 | 44 | 14 | 4 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | ARID2 | Any mutation | 11 | 16 | Signature 3 | -0.02 | -1.29 | 1.25 | 1553.73 | 1.00 | 217 | 10 | 15 | 1 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12C | ARID2 | Any mutation | 101 | 67 | Signature 4 | -0.28 | -1.02 | 0.40 | 1521.49 | 1.00 | 550 | 94 | 60 | 7 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12C | ARID2 | Any mutation | 198 | 112 | Signature overall | -0.03 | -0.98 | 0.86 | 1441.44 | 1.00 | 1134 | 183 | 97 | 15 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | MTOR | Any mutation | 100 | 41 | Signature 4 | 0.53 | -0.32 | 1.24 | 1027.22 | 1.00 | 570 | 91 | 32 | 9 | TRUE | 0.75 |
| non-small cell lung cancer | KRAS_12C | MTOR | Any mutation | 100 | 41 | Signature overall | 0.51 | -3.83 | 4.86 | 1401.13 | 1.00 | 570 | 91 | 32 | 9 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12C | NOTCH1 | Any mutation | 48 | 12 | Signature 2 | -1.09 | -2.74 | 0.24 | 1253.12 | 1.00 | 265 | 47 | 11 | 1 | TRUE | 0.84 |
| non-small cell lung cancer | KRAS_12C | NOTCH1 | Any mutation | 100 | 54 | Signature 4 | -1.14 | -2.33 | -0.11 | 1057.69 | 1.00 | 554 | 97 | 51 | 3 | TRUE | 1.34 |
| non-small cell lung cancer | KRAS_12C | NOTCH1 | Any mutation | 148 | 66 | Signature overall | -1.09 | -2.63 | 0.29 | 1241.26 | 1.00 | 819 | 144 | 62 | 4 | TRUE | 0.84 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 7 | 16 | Signature 13 | 0.42 | -1.10 | 1.82 | 1381.67 | 1.00 | 80 | 5 | 14 | 2 | FALSE | 0.25 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 50 | 44 | Signature 2 | 0.41 | -0.37 | 1.17 | 1601.01 | 1.00 | 252 | 41 | 35 | 9 | FALSE | 0.53 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 12 | 15 | Signature 3 | 0.61 | -0.88 | 1.94 | 1498.67 | 1.00 | 220 | 10 | 13 | 2 | FALSE | 0.39 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 100 | 55 | Signature 4 | 0.01 | -0.79 | 0.72 | 1379.71 | 1.00 | 560 | 92 | 47 | 8 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 135 | 14 | Signature R2 | -0.51 | -1.51 | 0.50 | 1460.71 | 1.00 | 58 | 128 | 7 | 7 | FALSE | 0.49 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Any mutation | 304 | 144 | Signature overall | 0.18 | -0.96 | 1.36 | 1217.84 | 1.00 | 1170 | 276 | 116 | 28 | FALSE | 0.13 |
| non-small cell lung cancer | KRAS_12C | PBRM1 | Any mutation | 48 | 20 | Signature 2 | 0.02 | -1.05 | 0.85 | 461.85 | 1.01 | 264 | 45 | 17 | 3 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12C | PBRM1 | Any mutation | 100 | 27 | Signature 4 | 0.00 | -1.01 | 0.76 | 419.15 | 1.01 | 580 | 96 | 23 | 4 | TRUE | 0.00 |
| non-small cell lung cancer | KRAS_12C | PBRM1 | Any mutation | 148 | 47 | Signature overall | 0.03 | -1.19 | 0.98 | 456.50 | 1.01 | 844 | 141 | 40 | 7 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 38 | 13 | Signature 18 | -0.44 | -1.72 | 0.69 | 1685.58 | 1.00 | 102 | 36 | 11 | 2 | FALSE | 0.31 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 50 | 27 | Signature 2 | 0.56 | -0.36 | 1.43 | 1525.83 | 1.00 | 257 | 43 | 20 | 7 | FALSE | 0.68 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 11 | 18 | Signature 3 | 0.47 | -0.92 | 1.78 | 1527.17 | 1.00 | 218 | 9 | 16 | 2 | FALSE | 0.30 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 103 | 112 | Signature 4 | -0.11 | -0.67 | 0.45 | 1496.86 | 1.00 | 513 | 88 | 97 | 15 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 135 | 13 | Signature R2 | -0.20 | -1.16 | 0.80 | 1652.70 | 1.00 | 59 | 127 | 5 | 8 | FALSE | 0.16 |
| non-small cell lung cancer | KRAS_12C | EPHA3 | Any mutation | 337 | 183 | Signature overall | 0.06 | -0.95 | 1.15 | 1115.91 | 1.00 | 1149 | 303 | 149 | 34 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12C | KDR | Any mutation | 48 | 12 | Signature 2 | 0.62 | -0.60 | 1.79 | 1503.30 | 1.00 | 268 | 44 | 8 | 4 | TRUE | 0.51 |
| non-small cell lung cancer | KRAS_12C | KDR | Any mutation | 11 | 11 | Signature 3 | 0.23 | -1.50 | 1.74 | 1433.04 | 1.00 | 223 | 10 | 10 | 1 | TRUE | 0.10 |
| non-small cell lung cancer | KRAS_12C | KDR | Any mutation | 101 | 76 | Signature 4 | -0.42 | -1.23 | 0.26 | 1608.54 | 1.00 | 538 | 94 | 69 | 7 | TRUE | 0.55 |
| non-small cell lung cancer | KRAS_12C | KDR | Any mutation | 160 | 99 | Signature overall | 0.16 | -1.26 | 1.65 | 1490.69 | 1.00 | 1029 | 148 | 87 | 12 | TRUE | 0.09 |
| non-small cell lung cancer | KRAS_12C | TET1 | Any mutation | 48 | 12 | Signature 2 | 0.91 | -0.44 | 2.14 | 652.23 | 1.00 | 267 | 43 | 7 | 5 | FALSE | 0.79 |
| non-small cell lung cancer | KRAS_12C | TET1 | Any mutation | 101 | 60 | Signature 4 | -0.13 | -0.93 | 0.61 | 565.52 | 1.01 | 556 | 94 | 53 | 7 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12C | TET1 | Any mutation | 149 | 72 | Signature overall | 0.38 | -1.29 | 2.11 | 1409.76 | 1.00 | 823 | 137 | 60 | 12 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12C | TBX3 | Any mutation | 100 | 75 | Signature 4 | -0.75 | -1.68 | 0.08 | 1566.81 | 1.00 | 541 | 94 | 69 | 6 | FALSE | 1.04 |
| non-small cell lung cancer | KRAS_12C | TBX3 | Any mutation | 134 | 15 | Signature R2 | -0.08 | -1.06 | 1.08 | 1391.08 | 1.00 | 60 | 124 | 5 | 10 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12C | TBX3 | Any mutation | 234 | 90 | Signature overall | -0.42 | -2.59 | 2.00 | 1362.15 | 1.00 | 601 | 218 | 74 | 16 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | NTRK3 | Any mutation | 49 | 15 | Signature 2 | 1.54 | 0.50 | 2.58 | 1554.48 | 1.00 | 269 | 42 | 8 | 7 | FALSE | 2.44 |
| non-small cell lung cancer | KRAS_12C | NTRK3 | Any mutation | 11 | 14 | Signature 3 | 1.57 | 0.08 | 2.95 | 1352.01 | 1.00 | 222 | 8 | 11 | 3 | FALSE | 1.54 |
| non-small cell lung cancer | KRAS_12C | NTRK3 | Any mutation | 102 | 105 | Signature 4 | 0.15 | -0.43 | 0.68 | 1423.58 | 1.00 | 532 | 86 | 89 | 16 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | NTRK3 | Any mutation | 135 | 18 | Signature R2 | 1.00 | -0.06 | 2.09 | 1441.03 | 1.00 | 61 | 120 | 3 | 15 | FALSE | 1.16 |
| non-small cell lung cancer | KRAS_12C | NTRK3 | Any mutation | 297 | 152 | Signature overall | 1.05 | -0.33 | 2.45 | 1592.81 | 1.00 | 1084 | 256 | 111 | 41 | FALSE | 0.87 |
| non-small cell lung cancer | KRAS_12C | GRIN2A | Any mutation | 48 | 15 | Signature 2 | -0.96 | -2.79 | 0.49 | 1622.89 | 1.00 | 262 | 47 | 14 | 1 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12C | GRIN2A | Any mutation | 102 | 76 | Signature 4 | -0.49 | -1.25 | 0.20 | 1385.63 | 1.00 | 540 | 94 | 68 | 8 | FALSE | 0.73 |
| non-small cell lung cancer | KRAS_12C | GRIN2A | Any mutation | 134 | 13 | Signature R2 | -0.60 | -1.61 | 0.41 | 1368.59 | 1.00 | 58 | 127 | 6 | 7 | FALSE | 0.60 |
| non-small cell lung cancer | KRAS_12C | GRIN2A | Any mutation | 284 | 104 | Signature overall | -0.64 | -2.18 | 0.92 | 1460.57 | 1.00 | 860 | 268 | 88 | 16 | FALSE | 0.38 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 7 | 19 | Signature 15 | 0.75 | -0.56 | 1.98 | 1526.94 | 1.00 | 112 | 5 | 17 | 2 | TRUE | 0.62 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 39 | 38 | Signature 18 | 0.41 | -0.32 | 1.13 | 1665.87 | 1.00 | 86 | 28 | 27 | 11 | TRUE | 0.57 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 8 | 17 | Signature 19 | 0.70 | -0.44 | 1.86 | 1300.29 | 1.00 | 41 | 5 | 14 | 3 | TRUE | 0.62 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 7 | 21 | Signature 1A | 1.68 | 0.49 | 2.82 | 1463.79 | 1.00 | 242 | 3 | 17 | 4 | TRUE | 2.20 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 48 | 55 | Signature 2 | -0.30 | -1.16 | 0.48 | 1385.59 | 1.00 | 235 | 43 | 50 | 5 | TRUE | 0.32 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 6 | 13 | Signature 20 | 1.22 | 0.03 | 2.42 | 1451.83 | 1.00 | 61 | 3 | 10 | 3 | TRUE | 1.29 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 11 | 37 | Signature 3 | 0.95 | -0.12 | 2.02 | 1209.03 | 1.00 | 199 | 7 | 33 | 4 | TRUE | 1.12 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 100 | 163 | Signature 4 | 0.30 | -0.14 | 0.76 | 1540.27 | 1.00 | 468 | 73 | 136 | 27 | TRUE | 0.73 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 7 | 13 | Signature 8 | 1.40 | 0.21 | 2.59 | 1409.55 | 1.00 | 48 | 3 | 9 | 4 | TRUE | 1.67 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 135 | 61 | Signature R2 | 0.72 | 0.09 | 1.36 | 1303.50 | 1.00 | 49 | 89 | 15 | 46 | TRUE | 1.58 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 7 | 13 | Signature U1 | 1.22 | -0.06 | 2.42 | 1670.53 | 1.00 | 94 | 4 | 10 | 3 | TRUE | 1.33 |
| non-small cell lung cancer | KRAS_12C | STK11 | Any mutation | 382 | 472 | Signature overall | 0.81 | 0.22 | 1.42 | 1466.20 | 1.00 | 1713 | 267 | 357 | 115 | TRUE | 2.04 |
| non-small cell lung cancer | KRAS_12C | EP300 | Any mutation | 6 | 11 | Signature 13 | -0.37 | -2.06 | 1.22 | 1238.87 | 1.00 | 84 | 5 | 10 | 1 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12C | EP300 | Any mutation | 48 | 20 | Signature 2 | -1.17 | -3.25 | 0.18 | 1426.48 | 1.00 | 262 | 48 | 20 | 0 | TRUE | 0.61 |
| non-small cell lung cancer | KRAS_12C | EP300 | Any mutation | 100 | 30 | Signature 4 | -0.21 | -1.38 | 0.78 | 1259.02 | 1.00 | 578 | 95 | 25 | 5 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12C | EP300 | Any mutation | 154 | 61 | Signature overall | -0.57 | -2.17 | 0.68 | 1430.55 | 1.00 | 924 | 148 | 55 | 6 | TRUE | 0.40 |
| non-small cell lung cancer | KRAS_12C | ERBB4 | Any mutation | 7 | 11 | Signature 1A | -1.82 | -5.48 | 0.68 | 1376.76 | 1.00 | 248 | 7 | 11 | 0 | TRUE | 0.60 |
| non-small cell lung cancer | KRAS_12C | ERBB4 | Any mutation | 48 | 17 | Signature 2 | -2.35 | -6.08 | -0.30 | 1488.85 | 1.00 | 262 | 48 | 17 | 0 | TRUE | 0.96 |
| non-small cell lung cancer | KRAS_12C | ERBB4 | Any mutation | 101 | 97 | Signature 4 | -0.81 | -1.64 | -0.09 | 1425.85 | 1.00 | 531 | 93 | 89 | 8 | TRUE | 1.33 |
| non-small cell lung cancer | KRAS_12C | ERBB4 | Any mutation | 156 | 125 | Signature overall | -1.62 | -4.20 | 0.25 | 1213.19 | 1.00 | 1041 | 148 | 117 | 8 | TRUE | 0.83 |
| non-small cell lung cancer | KRAS_12C | MED12 | Any mutation | 48 | 25 | Signature 2 | -0.64 | -1.62 | 0.23 | 1083.23 | 1.00 | 254 | 46 | 23 | 2 | TRUE | 0.75 |
| non-small cell lung cancer | KRAS_12C | MED12 | Any mutation | 101 | 72 | Signature 4 | -0.57 | -1.34 | 0.14 | 1007.66 | 1.00 | 546 | 94 | 65 | 7 | TRUE | 0.87 |
| non-small cell lung cancer | KRAS_12C | MED12 | Any mutation | 149 | 97 | Signature overall | -0.60 | -1.60 | 0.35 | 1070.35 | 1.00 | 800 | 140 | 88 | 9 | TRUE | 0.64 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 6 | 11 | Signature 13 | 0.23 | -1.31 | 1.72 | 1469.54 | 1.00 | 83 | 5 | 10 | 1 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 7 | 11 | Signature 15 | 0.28 | -1.35 | 1.78 | 1477.83 | 1.00 | 121 | 6 | 10 | 1 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 39 | 17 | Signature 18 | 0.45 | -0.49 | 1.37 | 1544.50 | 1.00 | 101 | 33 | 11 | 6 | FALSE | 0.46 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 7 | 21 | Signature 1A | 0.22 | -1.45 | 1.63 | 1554.80 | 1.00 | 239 | 6 | 20 | 1 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 48 | 32 | Signature 2 | 0.78 | 0.00 | 1.54 | 1527.25 | 1.00 | 253 | 39 | 23 | 9 | FALSE | 1.31 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 11 | 30 | Signature 3 | -0.63 | -2.23 | 0.77 | 1590.56 | 1.00 | 205 | 11 | 30 | 0 | FALSE | 0.38 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 103 | 128 | Signature 4 | 0.32 | -0.18 | 0.83 | 1601.84 | 1.00 | 505 | 80 | 105 | 23 | FALSE | 0.68 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 134 | 20 | Signature R2 | 0.19 | -0.64 | 1.10 | 1487.20 | 1.00 | 58 | 120 | 6 | 14 | FALSE | 0.17 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 7 | 15 | Signature U1 | 0.04 | -1.57 | 1.40 | 1486.80 | 1.00 | 91 | 6 | 14 | 1 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Any mutation | 362 | 285 | Signature overall | 0.21 | -0.66 | 1.01 | 1340.38 | 1.00 | 1656 | 306 | 229 | 56 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 38 | 13 | Signature 18 | 0.03 | -1.16 | 1.12 | 1331.59 | 1.00 | 104 | 34 | 9 | 4 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 7 | 13 | Signature 1A | -0.77 | -2.88 | 0.98 | 1572.23 | 1.00 | 246 | 7 | 13 | 0 | TRUE | 0.36 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 50 | 39 | Signature 2 | -0.12 | -1.03 | 0.73 | 1511.45 | 1.00 | 246 | 44 | 33 | 6 | TRUE | 0.11 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 6 | 13 | Signature 20 | -0.36 | -1.99 | 1.10 | 1499.76 | 1.00 | 60 | 5 | 12 | 1 | TRUE | 0.19 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 11 | 15 | Signature 3 | -0.27 | -2.00 | 1.34 | 1676.03 | 1.00 | 219 | 10 | 14 | 1 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 100 | 113 | Signature 4 | -0.70 | -1.44 | -0.07 | 1253.08 | 1.00 | 523 | 91 | 104 | 9 | TRUE | 1.37 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 9 | 11 | Signature 7 | -0.92 | -2.96 | 0.72 | 1419.75 | 1.00 | 88 | 9 | 11 | 0 | TRUE | 0.50 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 135 | 12 | Signature R2 | -0.69 | -1.65 | 0.28 | 1296.42 | 1.00 | 58 | 129 | 6 | 6 | TRUE | 0.74 |
| non-small cell lung cancer | KRAS_12C | NF1 | Any mutation | 356 | 229 | Signature overall | -0.48 | -1.36 | 0.42 | 1535.14 | 1.01 | 1544 | 329 | 202 | 27 | TRUE | 0.51 |
| non-small cell lung cancer | KRAS_12C | FLT1 | Any mutation | 39 | 13 | Signature 18 | 0.28 | -0.66 | 1.18 | 1563.54 | 1.00 | 103 | 35 | 9 | 4 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12C | FLT1 | Any mutation | 48 | 12 | Signature 2 | 0.27 | -0.70 | 1.24 | 1128.47 | 1.00 | 267 | 45 | 9 | 3 | FALSE | 0.23 |
| non-small cell lung cancer | KRAS_12C | FLT1 | Any mutation | 102 | 64 | Signature 4 | 0.16 | -0.48 | 0.79 | 1559.76 | 1.00 | 556 | 92 | 54 | 10 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | FLT1 | Any mutation | 189 | 89 | Signature overall | 0.25 | -0.62 | 1.14 | 1589.30 | 1.00 | 926 | 172 | 72 | 17 | FALSE | 0.24 |
| non-small cell lung cancer | KRAS_12C | EPHA5 | Any mutation | 39 | 24 | Signature 18 | 0.68 | -0.23 | 1.50 | 1643.00 | 1.00 | 98 | 30 | 15 | 9 | FALSE | 0.94 |
| non-small cell lung cancer | KRAS_12C | EPHA5 | Any mutation | 48 | 30 | Signature 2 | 0.61 | -0.28 | 1.40 | 1350.56 | 1.00 | 256 | 41 | 23 | 7 | FALSE | 0.81 |
| non-small cell lung cancer | KRAS_12C | EPHA5 | Any mutation | 11 | 19 | Signature 3 | 1.44 | 0.20 | 2.68 | 1487.20 | 1.00 | 220 | 7 | 15 | 4 | FALSE | 1.60 |
| non-small cell lung cancer | KRAS_12C | EPHA5 | Any mutation | 101 | 109 | Signature 4 | 0.39 | -0.13 | 0.91 | 1354.72 | 1.00 | 527 | 81 | 89 | 20 | FALSE | 0.81 |
| non-small cell lung cancer | KRAS_12C | EPHA5 | Any mutation | 134 | 12 | Signature R2 | -0.16 | -1.18 | 0.91 | 1560.36 | 1.00 | 60 | 127 | 5 | 7 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12C | EPHA5 | Any mutation | 333 | 194 | Signature overall | 0.60 | -0.48 | 1.75 | 1545.95 | 1.00 | 1161 | 286 | 147 | 47 | FALSE | 0.55 |
| non-small cell lung cancer | KRAS_12C | AR | Any mutation | 102 | 56 | Signature 4 | 0.08 | -0.74 | 0.79 | 1289.54 | 1.00 | 560 | 93 | 47 | 9 | TRUE | 0.08 |
| non-small cell lung cancer | KRAS_12C | AR | Any mutation | 102 | 56 | Signature overall | 0.09 | -4.51 | 4.71 | 1406.41 | 1.00 | 560 | 93 | 47 | 9 | TRUE | 0.02 |
| non-small cell lung cancer | KRAS_12C | ROS1 | Any mutation | 48 | 14 | Signature 2 | -1.22 | -2.79 | -0.01 | 124.68 | 1.02 | 264 | 47 | 13 | 1 | TRUE | 0.99 |
| non-small cell lung cancer | KRAS_12C | ROS1 | Any mutation | 100 | 42 | Signature 4 | -1.23 | -2.69 | -0.17 | 93.29 | 1.03 | 564 | 98 | 40 | 2 | TRUE | 1.14 |
| non-small cell lung cancer | KRAS_12C | ROS1 | Any mutation | 148 | 56 | Signature overall | -1.21 | -2.81 | -0.03 | 106.78 | 1.03 | 828 | 145 | 53 | 3 | TRUE | 0.99 |
| non-small cell lung cancer | KRAS_12C | PIK3CG | Any mutation | 6 | 13 | Signature 13 | -1.19 | -4.25 | 0.97 | 1617.28 | 1.00 | 80 | 6 | 13 | 0 | FALSE | 0.44 |
| non-small cell lung cancer | KRAS_12C | PIK3CG | Any mutation | 50 | 18 | Signature 2 | 1.26 | 0.26 | 2.23 | 1517.56 | 1.00 | 266 | 42 | 10 | 8 | FALSE | 2.00 |
| non-small cell lung cancer | KRAS_12C | PIK3CG | Any mutation | 100 | 75 | Signature 4 | -0.26 | -1.06 | 0.43 | 1180.82 | 1.00 | 543 | 91 | 66 | 9 | FALSE | 0.32 |
| non-small cell lung cancer | KRAS_12C | PIK3CG | Any mutation | 134 | 12 | Signature R2 | -0.96 | -2.09 | 0.15 | 1443.76 | 1.00 | 58 | 129 | 7 | 5 | FALSE | 1.04 |
| non-small cell lung cancer | KRAS_12C | PIK3CG | Any mutation | 290 | 118 | Signature overall | -0.30 | -2.04 | 1.14 | 1445.07 | 1.00 | 947 | 268 | 96 | 22 | FALSE | 0.15 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 6 | 23 | Signature 13 | -2.79 | -4.15 | -1.55 | 1432.69 | 1.00 | 72 | 5 | 22 | 1 | TRUE | 4.61 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 7 | 54 | Signature 15 | -3.10 | -4.42 | -1.83 | 1431.52 | 1.00 | 84 | 7 | 54 | 0 | TRUE | 5.47 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 38 | 29 | Signature 18 | -3.19 | -4.49 | -2.08 | 1394.76 | 1.00 | 87 | 38 | 29 | 0 | TRUE | 6.47 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 8 | 16 | Signature 19 | -3.07 | -4.36 | -1.84 | 1368.91 | 1.00 | 39 | 8 | 16 | 0 | TRUE | 5.17 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 7 | 197 | Signature 1A | -3.17 | -4.48 | -2.04 | 1268.32 | 1.00 | 134 | 7 | 197 | 0 | TRUE | 6.20 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 48 | 79 | Signature 2 | -3.24 | -4.52 | -2.14 | 1391.96 | 1.00 | 213 | 48 | 79 | 0 | TRUE | 6.64 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 6 | 35 | Signature 20 | -3.07 | -4.44 | -1.82 | 1407.88 | 1.00 | 43 | 6 | 35 | 0 | TRUE | 5.20 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 11 | 89 | Signature 3 | -2.88 | -4.18 | -1.69 | 1456.31 | 1.00 | 152 | 10 | 88 | 1 | TRUE | 5.16 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 100 | 114 | Signature 4 | -2.31 | -3.30 | -1.42 | 1539.44 | 1.00 | 514 | 95 | 109 | 5 | TRUE | 5.57 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 6 | 18 | Signature 6 | -3.08 | -4.49 | -1.80 | 1537.38 | 1.00 | 34 | 6 | 18 | 0 | TRUE | 5.10 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 9 | 34 | Signature 7 | -3.09 | -4.48 | -1.86 | 1444.38 | 1.00 | 69 | 9 | 34 | 0 | TRUE | 5.29 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 7 | 14 | Signature 8 | -3.09 | -4.57 | -1.71 | 1413.72 | 1.00 | 43 | 7 | 14 | 0 | TRUE | 4.94 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 7 | 46 | Signature U1 | -3.11 | -4.41 | -1.82 | 1427.06 | 1.00 | 63 | 7 | 46 | 0 | TRUE | 5.51 |
| non-small cell lung cancer | KRAS_12C | EGFR | Any mutation | 274 | 853 | Signature overall | -3.02 | -3.97 | -2.22 | 1327.35 | 1.00 | 1731 | 267 | 846 | 7 | TRUE | 10.54 |
| non-small cell lung cancer | KRAS_12C | ARID1B | Any mutation | 48 | 13 | Signature 2 | -0.26 | -1.47 | 1.14 | 1230.66 | 1.00 | 266 | 45 | 10 | 3 | TRUE | 0.16 |
| non-small cell lung cancer | KRAS_12C | ARID1B | Any mutation | 100 | 42 | Signature 4 | -0.81 | -2.13 | 0.18 | 371.01 | 1.01 | 564 | 98 | 40 | 2 | TRUE | 0.76 |
| non-small cell lung cancer | KRAS_12C | ARID1B | Any mutation | 148 | 55 | Signature overall | -0.54 | -1.99 | 0.80 | 1056.03 | 1.01 | 830 | 143 | 50 | 5 | TRUE | 0.34 |
| non-small cell lung cancer | KRAS_12C | MET | Any mutation | 48 | 23 | Signature 2 | -1.65 | -4.13 | -0.15 | 1508.67 | 1.00 | 256 | 48 | 23 | 0 | TRUE | 1.01 |
| non-small cell lung cancer | KRAS_12C | MET | Any mutation | 11 | 11 | Signature 3 | -0.72 | -2.56 | 1.23 | 1499.60 | 1.00 | 223 | 10 | 10 | 1 | TRUE | 0.35 |
| non-small cell lung cancer | KRAS_12C | MET | Any mutation | 100 | 34 | Signature 4 | -0.85 | -2.20 | 0.22 | 1490.58 | 1.00 | 575 | 97 | 31 | 3 | TRUE | 0.78 |
| non-small cell lung cancer | KRAS_12C | MET | Any mutation | 159 | 68 | Signature overall | -1.05 | -2.78 | 0.44 | 1552.52 | 1.00 | 1054 | 155 | 64 | 4 | TRUE | 0.70 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 38 | 11 | Signature 18 | -1.46 | -3.26 | -0.17 | 1477.73 | 1.00 | 101 | 38 | 11 | 0 | TRUE | 1.13 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 48 | 20 | Signature 2 | -1.18 | -2.58 | 0.05 | 1470.72 | 1.00 | 257 | 47 | 19 | 1 | TRUE | 1.10 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 11 | 20 | Signature 3 | -0.89 | -2.40 | 0.47 | 1535.55 | 1.00 | 213 | 10 | 19 | 1 | TRUE | 0.65 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 100 | 50 | Signature 4 | -0.71 | -1.71 | 0.13 | 1555.09 | 1.00 | 559 | 95 | 45 | 5 | TRUE | 0.87 |
| non-small cell lung cancer | KRAS_12C | BRAF | Any mutation | 197 | 101 | Signature overall | -1.07 | -2.32 | 0.02 | 1396.28 | 1.00 | 1130 | 190 | 94 | 7 | TRUE | 1.13 |
| non-small cell lung cancer | KRAS_12C | CARD11 | Any mutation | 49 | 16 | Signature 2 | 0.34 | -0.59 | 1.31 | 1368.37 | 1.00 | 265 | 45 | 12 | 4 | FALSE | 0.33 |
| non-small cell lung cancer | KRAS_12C | CARD11 | Any mutation | 100 | 63 | Signature 4 | 0.19 | -0.48 | 0.81 | 1291.44 | 1.00 | 553 | 90 | 53 | 10 | FALSE | 0.25 |
| non-small cell lung cancer | KRAS_12C | CARD11 | Any mutation | 149 | 79 | Signature overall | 0.26 | -0.84 | 1.37 | 1505.84 | 1.00 | 818 | 135 | 65 | 14 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12C | INPP4B | Any mutation | 49 | 15 | Signature 2 | 0.47 | -0.47 | 1.50 | 1477.65 | 1.00 | 266 | 45 | 11 | 4 | FALSE | 0.51 |
| non-small cell lung cancer | KRAS_12C | INPP4B | Any mutation | 100 | 60 | Signature 4 | 0.38 | -0.24 | 1.00 | 1096.76 | 1.00 | 561 | 89 | 49 | 11 | FALSE | 0.63 |
| non-small cell lung cancer | KRAS_12C | INPP4B | Any mutation | 149 | 75 | Signature overall | 0.41 | -0.68 | 1.52 | 1398.83 | 1.00 | 827 | 134 | 60 | 15 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12C | NFE2L2 | Any mutation | 6 | 15 | Signature 13 | -1.10 | -3.66 | 0.60 | 1602.94 | 1.00 | 80 | 6 | 15 | 0 | FALSE | 0.52 |
| non-small cell lung cancer | KRAS_12C | NFE2L2 | Any mutation | 48 | 32 | Signature 2 | -0.42 | -1.54 | 0.58 | 1501.61 | 1.00 | 255 | 44 | 28 | 4 | FALSE | 0.36 |
| non-small cell lung cancer | KRAS_12C | NFE2L2 | Any mutation | 101 | 20 | Signature 4 | -0.67 | -1.96 | 0.51 | 1564.60 | 1.00 | 584 | 99 | 18 | 2 | FALSE | 0.53 |
| non-small cell lung cancer | KRAS_12C | NFE2L2 | Any mutation | 155 | 67 | Signature overall | -0.73 | -2.35 | 0.60 | 1450.46 | 1.00 | 919 | 149 | 61 | 6 | FALSE | 0.48 |
| non-small cell lung cancer | KRAS_12C | GLI1 | Any mutation | 98 | 44 | Signature 4 | 0.34 | -0.50 | 1.10 | 1250.32 | 1.00 | 504 | 89 | 35 | 9 | FALSE | 0.40 |
| non-small cell lung cancer | KRAS_12C | GLI1 | Any mutation | 98 | 44 | Signature overall | 0.26 | -4.22 | 4.69 | 1641.06 | 1.00 | 504 | 89 | 35 | 9 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12C | ZFHX3 | Any mutation | 45 | 18 | Signature 2 | -1.29 | -3.29 | 0.17 | 1529.56 | 1.00 | 228 | 44 | 17 | 1 | FALSE | 0.82 |
| non-small cell lung cancer | KRAS_12C | ZFHX3 | Any mutation | 97 | 61 | Signature 4 | -0.49 | -1.30 | 0.30 | 1387.09 | 1.00 | 487 | 90 | 54 | 7 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12C | ZFHX3 | Any mutation | 121 | 14 | Signature R2 | -1.33 | -2.48 | -0.31 | 1197.65 | 1.00 | 47 | 116 | 9 | 5 | FALSE | 1.85 |
| non-small cell lung cancer | KRAS_12C | ZFHX3 | Any mutation | 263 | 93 | Signature overall | -1.01 | -2.67 | 0.53 | 1444.16 | 1.00 | 762 | 250 | 80 | 13 | FALSE | 0.67 |
| non-small cell lung cancer | KRAS_12C | MGA | Any mutation | 45 | 28 | Signature 2 | -0.78 | -2.15 | 0.38 | 1479.80 | 1.00 | 230 | 43 | 26 | 2 | FALSE | 0.65 |
| non-small cell lung cancer | KRAS_12C | MGA | Any mutation | 99 | 79 | Signature 4 | 0.41 | -0.19 | 0.99 | 1497.16 | 1.00 | 480 | 82 | 62 | 17 | FALSE | 0.77 |
| non-small cell lung cancer | KRAS_12C | MGA | Any mutation | 121 | 13 | Signature R2 | -0.27 | -1.25 | 0.80 | 1483.14 | 1.00 | 51 | 113 | 5 | 8 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | MGA | Any mutation | 265 | 120 | Signature overall | -0.20 | -1.70 | 1.37 | 1454.04 | 1.00 | 761 | 238 | 93 | 27 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12C | PREX2 | Any mutation | 64 | 52 | Signature 4 | 0.42 | -0.29 | 1.12 | 1336.73 | 1.00 | 266 | 52 | 40 | 12 | FALSE | 0.60 |
| non-small cell lung cancer | KRAS_12C | PREX2 | Any mutation | 64 | 52 | Signature overall | 0.40 | -4.26 | 4.72 | 1245.25 | 1.00 | 266 | 52 | 40 | 12 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12C | AMER1 | Any mutation | 48 | 11 | Signature 2 | 0.43 | -0.85 | 1.71 | 1513.21 | 1.00 | 268 | 45 | 8 | 3 | FALSE | 0.30 |
| non-small cell lung cancer | KRAS_12C | AMER1 | Any mutation | 101 | 83 | Signature 4 | 0.07 | -0.61 | 0.65 | 1145.64 | 1.00 | 547 | 89 | 71 | 12 | FALSE | 0.08 |
| non-small cell lung cancer | KRAS_12C | AMER1 | Any mutation | 149 | 94 | Signature overall | 0.24 | -1.51 | 2.07 | 1550.65 | 1.00 | 815 | 134 | 79 | 15 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12C | EPHA7 | Any mutation | 9 | 13 | Signature 3 | 0.83 | -0.94 | 2.59 | 1418.94 | 1.00 | 197 | 7 | 11 | 2 | FALSE | 0.45 |
| non-small cell lung cancer | KRAS_12C | EPHA7 | Any mutation | 96 | 51 | Signature 4 | -0.25 | -1.16 | 0.62 | 1635.79 | 1.00 | 495 | 90 | 45 | 6 | FALSE | 0.23 |
| non-small cell lung cancer | KRAS_12C | EPHA7 | Any mutation | 105 | 64 | Signature overall | 0.32 | -1.78 | 2.58 | 1636.58 | 1.00 | 692 | 97 | 56 | 8 | FALSE | 0.11 |
| colorectal cancer | RAS_13 | SPEN | Any mutation | 58 | 18 | Signature 15 | -1.82 | -4.20 | -0.19 | 1473.72 | 1.00 | 314 | 58 | 18 | 0 | FALSE | 1.11 |
| colorectal cancer | RAS_13 | SPEN | Any mutation | 57 | 38 | Signature 1A | 0.12 | -1.15 | 1.20 | 1413.79 | 1.00 | 760 | 53 | 34 | 4 | FALSE | 0.07 |
| colorectal cancer | RAS_13 | SPEN | Any mutation | 42 | 61 | Signature 6 | -1.16 | -2.36 | -0.09 | 1535.75 | 1.00 | 227 | 39 | 58 | 3 | FALSE | 1.32 |
| colorectal cancer | RAS_13 | SPEN | Any mutation | 162 | 138 | Signature overall | -0.83 | -2.41 | 0.61 | 1472.24 | 1.00 | 1323 | 153 | 129 | 9 | FALSE | 0.56 |
| colorectal cancer | RAS_13 | KMT2C | Any mutation | 7 | 32 | Signature 10 | 0.02 | -1.36 | 1.32 | 1311.21 | 1.00 | 19 | 3 | 28 | 4 | FALSE | 0.01 |
| colorectal cancer | RAS_13 | KMT2C | Any mutation | 58 | 22 | Signature 15 | 0.31 | -0.76 | 1.24 | 1473.70 | 1.00 | 309 | 53 | 17 | 5 | FALSE | 0.26 |
| colorectal cancer | RAS_13 | KMT2C | Any mutation | 56 | 60 | Signature 1A | 0.31 | -0.66 | 1.14 | 1280.44 | 1.00 | 726 | 50 | 54 | 6 | FALSE | 0.31 |
| colorectal cancer | RAS_13 | KMT2C | Any mutation | 40 | 65 | Signature 6 | -0.82 | -1.91 | 0.11 | 1478.46 | 1.00 | 214 | 36 | 61 | 4 | FALSE | 0.96 |
| colorectal cancer | RAS_13 | KMT2C | Any mutation | 161 | 179 | Signature overall | -0.04 | -1.39 | 1.36 | 1531.62 | 1.00 | 1268 | 142 | 160 | 19 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 62 | 311 | Signature 15 | -0.42 | -0.88 | 0.01 | 1451.88 | 1.00 | 75 | 22 | 271 | 40 | TRUE | 1.17 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 58 | 655 | Signature 1A | -0.80 | -1.23 | -0.33 | 1400.76 | 1.00 | 206 | 27 | 624 | 31 | TRUE | 3.45 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 8 | 56 | Signature 2 | -0.51 | -1.14 | 0.17 | 1281.39 | 1.00 | 26 | 3 | 51 | 5 | TRUE | 0.88 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 45 | 236 | Signature 6 | -0.25 | -0.74 | 0.28 | 1483.65 | 1.00 | 97 | 15 | 206 | 30 | TRUE | 0.49 |
| colorectal cancer | RAS_13 | TP53 | Any mutation | 195 | 1607 | Signature overall | -0.58 | -0.98 | -0.18 | 1401.72 | 1.00 | 527 | 73 | 1485 | 122 | TRUE | 2.38 |
| colorectal cancer | RAS_13 | ATRX | Any mutation | 6 | 19 | Signature 10 | 0.33 | -1.18 | 1.72 | 1415.53 | 1.00 | 23 | 3 | 16 | 3 | TRUE | 0.18 |
| colorectal cancer | RAS_13 | ATRX | Any mutation | 60 | 46 | Signature 1A | 0.54 | -0.39 | 1.40 | 1559.84 | 1.00 | 751 | 54 | 40 | 6 | TRUE | 0.63 |
| colorectal cancer | RAS_13 | ATRX | Any mutation | 41 | 29 | Signature 6 | -0.54 | -2.01 | 0.57 | 1468.59 | 1.00 | 246 | 39 | 27 | 2 | TRUE | 0.39 |
| colorectal cancer | RAS_13 | ATRX | Any mutation | 107 | 94 | Signature overall | 0.09 | -1.41 | 1.57 | 1496.28 | 1.00 | 1020 | 96 | 83 | 11 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | ATR | Any mutation | 6 | 28 | Signature 10 | -0.03 | -1.56 | 1.35 | 1516.99 | 1.00 | 21 | 3 | 25 | 3 | FALSE | 0.01 |
| colorectal cancer | RAS_13 | ATR | Any mutation | 59 | 12 | Signature 15 | 1.04 | -0.17 | 2.18 | 1518.99 | 1.00 | 322 | 54 | 7 | 5 | FALSE | 1.08 |
| colorectal cancer | RAS_13 | ATR | Any mutation | 57 | 32 | Signature 1A | -0.18 | -1.68 | 1.07 | 1501.61 | 1.00 | 759 | 55 | 30 | 2 | FALSE | 0.10 |
| colorectal cancer | RAS_13 | ATR | Any mutation | 41 | 28 | Signature 6 | -0.60 | -1.95 | 0.55 | 1522.57 | 1.00 | 253 | 39 | 26 | 2 | FALSE | 0.46 |
| colorectal cancer | RAS_13 | ATR | Any mutation | 163 | 100 | Signature overall | 0.06 | -1.38 | 1.43 | 1427.45 | 1.00 | 1355 | 151 | 88 | 12 | FALSE | 0.03 |
| colorectal cancer | RAS_13 | FBXW7 | Any mutation | 58 | 48 | Signature 15 | 0.34 | -0.39 | 0.98 | 1482.68 | 1.00 | 295 | 49 | 39 | 9 | TRUE | 0.48 |
| colorectal cancer | RAS_13 | FBXW7 | Any mutation | 61 | 144 | Signature 1A | 0.83 | 0.27 | 1.37 | 1465.70 | 1.00 | 681 | 41 | 124 | 20 | TRUE | 2.56 |
| colorectal cancer | RAS_13 | FBXW7 | Any mutation | 42 | 78 | Signature 6 | 0.50 | -0.14 | 1.12 | 1510.59 | 1.00 | 213 | 28 | 64 | 14 | TRUE | 0.92 |
| colorectal cancer | RAS_13 | FBXW7 | Any mutation | 165 | 287 | Signature overall | 0.47 | -0.40 | 1.20 | 1411.38 | 1.00 | 1206 | 121 | 243 | 44 | TRUE | 0.62 |
| colorectal cancer | RAS_13 | FLT4 | Any mutation | 58 | 14 | Signature 15 | -1.63 | -4.16 | 0.05 | 1547.29 | 1.00 | 314 | 58 | 14 | 0 | TRUE | 0.91 |
| colorectal cancer | RAS_13 | FLT4 | Any mutation | 57 | 54 | Signature 1A | -0.25 | -1.42 | 0.74 | 1346.84 | 1.00 | 742 | 53 | 50 | 4 | TRUE | 0.19 |
| colorectal cancer | RAS_13 | FLT4 | Any mutation | 41 | 51 | Signature 6 | -0.31 | -1.24 | 0.53 | 1490.55 | 1.00 | 231 | 35 | 45 | 6 | TRUE | 0.31 |
| colorectal cancer | RAS_13 | FLT4 | Any mutation | 160 | 133 | Signature overall | -0.90 | -2.41 | 0.33 | 1290.30 | 1.00 | 1310 | 150 | 123 | 10 | TRUE | 0.72 |
| colorectal cancer | RAS_13 | PTPRD | Any mutation | 58 | 14 | Signature 15 | -1.36 | -3.86 | 0.23 | 1522.38 | 1.00 | 315 | 58 | 14 | 0 | FALSE | 0.71 |
| colorectal cancer | RAS_13 | PTPRD | Any mutation | 57 | 31 | Signature 1A | 0.03 | -1.20 | 1.17 | 1152.20 | 1.00 | 763 | 54 | 28 | 3 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | PTPRD | Any mutation | 41 | 31 | Signature 6 | -0.18 | -1.32 | 0.85 | 1543.88 | 1.00 | 248 | 37 | 27 | 4 | FALSE | 0.13 |
| colorectal cancer | RAS_13 | PTPRD | Any mutation | 161 | 95 | Signature overall | -0.43 | -1.96 | 0.92 | 1528.61 | 1.00 | 1349 | 152 | 86 | 9 | FALSE | 0.26 |
| colorectal cancer | RAS_13 | CREBBP | Any mutation | 58 | 27 | Signature 15 | -0.40 | -1.49 | 0.58 | 1552.35 | 1.00 | 308 | 55 | 24 | 3 | TRUE | 0.35 |
| colorectal cancer | RAS_13 | CREBBP | Any mutation | 57 | 45 | Signature 1A | 0.48 | -0.48 | 1.35 | 1256.11 | 1.00 | 754 | 51 | 39 | 6 | TRUE | 0.52 |
| colorectal cancer | RAS_13 | CREBBP | Any mutation | 43 | 80 | Signature 6 | -0.64 | -1.48 | 0.13 | 1504.76 | 1.00 | 218 | 37 | 74 | 6 | TRUE | 0.94 |
| colorectal cancer | RAS_13 | CREBBP | Any mutation | 162 | 167 | Signature overall | -0.23 | -1.32 | 0.91 | 1427.39 | 1.00 | 1303 | 146 | 151 | 16 | TRUE | 0.16 |
| colorectal cancer | RAS_13 | AXIN2 | Any mutation | 58 | 17 | Signature 15 | -1.10 | -3.62 | 0.25 | 1581.69 | 1.00 | 312 | 58 | 17 | 0 | TRUE | 0.58 |
| colorectal cancer | RAS_13 | AXIN2 | Any mutation | 57 | 36 | Signature 1A | 0.17 | -0.94 | 1.17 | 1459.96 | 1.00 | 760 | 53 | 32 | 4 | TRUE | 0.12 |
| colorectal cancer | RAS_13 | AXIN2 | Any mutation | 42 | 40 | Signature 6 | 0.03 | -0.92 | 0.88 | 1575.89 | 1.00 | 245 | 36 | 34 | 6 | TRUE | 0.03 |
| colorectal cancer | RAS_13 | AXIN2 | Any mutation | 157 | 93 | Signature overall | -0.28 | -1.82 | 0.98 | 1325.95 | 1.00 | 1317 | 147 | 83 | 10 | TRUE | 0.16 |
| colorectal cancer | RAS_13 | PTPRS | Any mutation | 59 | 38 | Signature 15 | -0.36 | -1.33 | 0.46 | 1446.82 | 1.00 | 289 | 55 | 34 | 4 | FALSE | 0.36 |
| colorectal cancer | RAS_13 | PTPRS | Any mutation | 55 | 95 | Signature 1A | 0.61 | -0.09 | 1.29 | 1376.74 | 1.00 | 696 | 43 | 83 | 12 | FALSE | 1.08 |
| colorectal cancer | RAS_13 | PTPRS | Any mutation | 41 | 83 | Signature 6 | -0.42 | -1.23 | 0.33 | 1422.42 | 1.00 | 211 | 34 | 76 | 7 | FALSE | 0.53 |
| colorectal cancer | RAS_13 | PTPRS | Any mutation | 160 | 232 | Signature overall | -0.05 | -1.00 | 0.87 | 1431.01 | 1.00 | 1217 | 135 | 207 | 25 | FALSE | 0.04 |
| colorectal cancer | RAS_13 | SMARCA4 | Any mutation | 58 | 22 | Signature 15 | -0.54 | -1.73 | 0.53 | 1461.43 | 1.00 | 313 | 56 | 20 | 2 | FALSE | 0.47 |
| colorectal cancer | RAS_13 | SMARCA4 | Any mutation | 59 | 74 | Signature 1A | 0.04 | -0.79 | 0.87 | 1439.98 | 1.00 | 733 | 52 | 67 | 7 | FALSE | 0.04 |
| colorectal cancer | RAS_13 | SMARCA4 | Any mutation | 41 | 52 | Signature 6 | -0.71 | -1.83 | 0.19 | 1396.26 | 1.00 | 236 | 38 | 49 | 3 | FALSE | 0.77 |
| colorectal cancer | RAS_13 | SMARCA4 | Any mutation | 158 | 148 | Signature overall | -0.39 | -1.56 | 0.65 | 1209.42 | 1.00 | 1282 | 146 | 136 | 12 | FALSE | 0.33 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 8 | 23 | Signature 10 | 0.57 | -0.65 | 1.69 | 1576.40 | 1.00 | 21 | 3 | 18 | 5 | FALSE | 0.47 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 58 | 25 | Signature 15 | -0.50 | -1.74 | 0.58 | 1519.82 | 1.00 | 305 | 56 | 23 | 2 | FALSE | 0.40 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 57 | 66 | Signature 1A | 0.69 | -0.10 | 1.38 | 1472.13 | 1.00 | 733 | 48 | 57 | 9 | FALSE | 1.13 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 41 | 43 | Signature 6 | -0.11 | -1.01 | 0.72 | 1397.44 | 1.00 | 235 | 36 | 38 | 5 | FALSE | 0.09 |
| colorectal cancer | RAS_13 | PTPRT | Any mutation | 164 | 157 | Signature overall | 0.16 | -0.98 | 1.22 | 1326.97 | 1.00 | 1294 | 143 | 136 | 21 | FALSE | 0.11 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 58 | 63 | Signature 15 | 0.31 | -0.35 | 0.93 | 1467.17 | 1.00 | 280 | 47 | 52 | 11 | TRUE | 0.46 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 61 | 191 | Signature 1A | 0.68 | 0.17 | 1.19 | 1496.98 | 1.00 | 634 | 39 | 169 | 22 | TRUE | 2.05 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 9 | 43 | Signature 2 | 0.84 | -0.07 | 1.79 | 1479.25 | 1.00 | 40 | 2 | 36 | 7 | TRUE | 1.08 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 47 | 95 | Signature 6 | 0.86 | 0.31 | 1.42 | 1575.90 | 1.00 | 206 | 25 | 73 | 22 | TRUE | 2.64 |
| colorectal cancer | RAS_13 | PIK3CA | Any mutation | 181 | 434 | Signature overall | 0.59 | -0.10 | 1.23 | 1448.35 | 1.00 | 1206 | 116 | 369 | 65 | TRUE | 1.11 |
| colorectal cancer | RAS_13 | ALK | Any mutation | 58 | 16 | Signature 15 | 0.33 | -0.85 | 1.29 | 1548.60 | 1.00 | 314 | 55 | 13 | 3 | TRUE | 0.26 |
| colorectal cancer | RAS_13 | ALK | Any mutation | 59 | 35 | Signature 1A | 1.06 | 0.20 | 1.89 | 1591.59 | 1.00 | 761 | 52 | 28 | 7 | TRUE | 1.91 |
| colorectal cancer | RAS_13 | ALK | Any mutation | 41 | 37 | Signature 6 | 0.39 | -0.48 | 1.21 | 1452.97 | 1.00 | 246 | 35 | 31 | 6 | TRUE | 0.43 |
| colorectal cancer | RAS_13 | ALK | Any mutation | 163 | 101 | Signature overall | 0.69 | -0.35 | 1.72 | 1369.34 | 1.00 | 1345 | 144 | 82 | 19 | TRUE | 0.72 |
| colorectal cancer | RAS_13 | RNF43 | Any mutation | 58 | 31 | Signature 15 | -2.09 | -5.08 | -0.41 | 1489.32 | 1.00 | 306 | 58 | 31 | 0 | TRUE | 1.04 |
| colorectal cancer | RAS_13 | RNF43 | Any mutation | 60 | 93 | Signature 1A | 0.76 | 0.06 | 1.43 | 1557.57 | 1.00 | 734 | 47 | 80 | 13 | TRUE | 1.50 |
| colorectal cancer | RAS_13 | RNF43 | Any mutation | 44 | 102 | Signature 6 | -0.58 | -1.36 | 0.15 | 1524.88 | 1.00 | 203 | 35 | 93 | 9 | TRUE | 0.87 |
| colorectal cancer | RAS_13 | RNF43 | Any mutation | 162 | 226 | Signature overall | -0.63 | -2.62 | 1.00 | 1518.57 | 1.00 | 1243 | 140 | 204 | 22 | TRUE | 0.31 |
| colorectal cancer | RAS_13 | PTEN | Any mutation | 58 | 22 | Signature 15 | 0.48 | -0.40 | 1.38 | 1260.43 | 1.00 | 311 | 53 | 17 | 5 | TRUE | 0.54 |
| colorectal cancer | RAS_13 | PTEN | Any mutation | 61 | 64 | Signature 1A | 1.05 | 0.33 | 1.71 | 1265.51 | 1.00 | 748 | 49 | 52 | 12 | TRUE | 2.69 |
| colorectal cancer | RAS_13 | PTEN | Any mutation | 42 | 57 | Signature 6 | 0.12 | -0.70 | 0.89 | 1569.73 | 1.00 | 239 | 35 | 50 | 7 | TRUE | 0.12 |
| colorectal cancer | RAS_13 | PTEN | Any mutation | 166 | 156 | Signature overall | 0.52 | -0.44 | 1.44 | 1437.29 | 1.00 | 1320 | 140 | 130 | 26 | TRUE | 0.56 |
| colorectal cancer | RAS_13 | BCOR | Any mutation | 58 | 13 | Signature 15 | -0.59 | -2.25 | 0.75 | 1520.93 | 1.00 | 316 | 57 | 12 | 1 | FALSE | 0.37 |
| colorectal cancer | RAS_13 | BCOR | Any mutation | 57 | 27 | Signature 1A | 0.49 | -0.63 | 1.47 | 1725.10 | 1.00 | 765 | 53 | 23 | 4 | FALSE | 0.43 |
| colorectal cancer | RAS_13 | BCOR | Any mutation | 43 | 49 | Signature 6 | -0.33 | -1.32 | 0.57 | 1498.50 | 1.00 | 238 | 38 | 44 | 5 | FALSE | 0.31 |
| colorectal cancer | RAS_13 | BCOR | Any mutation | 162 | 100 | Signature overall | -0.16 | -1.42 | 1.05 | 1564.74 | 1.00 | 1342 | 151 | 89 | 11 | FALSE | 0.10 |
| colorectal cancer | RAS_13 | CTNNB1 | Any mutation | 58 | 22 | Signature 15 | 0.28 | -0.74 | 1.11 | 1582.14 | 1.00 | 309 | 55 | 19 | 3 | TRUE | 0.26 |
| colorectal cancer | RAS_13 | CTNNB1 | Any mutation | 57 | 61 | Signature 1A | 0.86 | 0.16 | 1.55 | 1486.47 | 1.00 | 740 | 47 | 51 | 10 | TRUE | 1.87 |
| colorectal cancer | RAS_13 | CTNNB1 | Any mutation | 41 | 33 | Signature 6 | 0.68 | -0.13 | 1.40 | 1472.16 | 1.00 | 247 | 34 | 26 | 7 | TRUE | 1.09 |
| colorectal cancer | RAS_13 | CTNNB1 | Any mutation | 156 | 116 | Signature overall | 0.59 | -0.22 | 1.42 | 1540.99 | 1.00 | 1296 | 136 | 96 | 20 | TRUE | 0.79 |
| colorectal cancer | RAS_13 | ARID1A | Any mutation | 59 | 39 | Signature 15 | -0.36 | -1.28 | 0.43 | 1250.40 | 1.00 | 307 | 55 | 35 | 4 | TRUE | 0.38 |
| colorectal cancer | RAS_13 | ARID1A | Any mutation | 62 | 130 | Signature 1A | 0.36 | -0.30 | 0.99 | 1352.66 | 1.00 | 705 | 48 | 116 | 14 | TRUE | 0.58 |
| colorectal cancer | RAS_13 | ARID1A | Any mutation | 42 | 99 | Signature 6 | -0.43 | -1.20 | 0.27 | 1668.92 | 1.00 | 209 | 34 | 91 | 8 | TRUE | 0.60 |
| colorectal cancer | RAS_13 | ARID1A | Any mutation | 168 | 281 | Signature overall | -0.09 | -0.99 | 0.75 | 1410.51 | 1.00 | 1244 | 140 | 253 | 28 | TRUE | 0.08 |
| colorectal cancer | RAS_13 | PIK3R1 | Any mutation | 58 | 17 | Signature 15 | -0.43 | -1.76 | 0.70 | 1250.77 | 1.00 | 315 | 56 | 15 | 2 | TRUE | 0.30 |
| colorectal cancer | RAS_13 | PIK3R1 | Any mutation | 57 | 31 | Signature 1A | -0.27 | -1.77 | 0.85 | 1717.40 | 1.00 | 762 | 55 | 29 | 2 | TRUE | 0.17 |
| colorectal cancer | RAS_13 | PIK3R1 | Any mutation | 41 | 31 | Signature 6 | -0.15 | -1.21 | 0.84 | 1515.34 | 1.00 | 247 | 37 | 27 | 4 | TRUE | 0.11 |
| colorectal cancer | RAS_13 | PIK3R1 | Any mutation | 160 | 96 | Signature overall | -0.32 | -1.60 | 0.98 | 1528.07 | 1.00 | 1345 | 151 | 87 | 9 | TRUE | 0.21 |
| colorectal cancer | RAS_13 | FAT1 | Any mutation | 11 | 44 | Signature 10 | 0.45 | -0.73 | 1.67 | 1345.13 | 1.00 | 20 | 3 | 36 | 8 | FALSE | 0.34 |
| colorectal cancer | RAS_13 | FAT1 | Any mutation | 58 | 29 | Signature 15 | -1.13 | -2.74 | 0.10 | 1524.15 | 1.00 | 308 | 57 | 28 | 1 | FALSE | 0.89 |
| colorectal cancer | RAS_13 | FAT1 | Any mutation | 59 | 66 | Signature 1A | 0.98 | 0.23 | 1.69 | 1378.14 | 1.00 | 744 | 48 | 55 | 11 | FALSE | 2.03 |
| colorectal cancer | RAS_13 | FAT1 | Any mutation | 44 | 67 | Signature 6 | 0.00 | -0.78 | 0.72 | 1400.35 | 1.00 | 226 | 35 | 58 | 9 | FALSE | 0.00 |
| colorectal cancer | RAS_13 | FAT1 | Any mutation | 172 | 206 | Signature overall | 0.04 | -1.37 | 1.40 | 1334.71 | 1.00 | 1298 | 143 | 177 | 29 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | CIC | Any mutation | 58 | 19 | Signature 15 | -0.81 | -2.44 | 0.40 | 1481.26 | 1.00 | 316 | 57 | 18 | 1 | TRUE | 0.60 |
| colorectal cancer | RAS_13 | CIC | Any mutation | 59 | 58 | Signature 1A | 0.25 | -0.71 | 1.12 | 1428.74 | 1.00 | 745 | 52 | 51 | 7 | TRUE | 0.24 |
| colorectal cancer | RAS_13 | CIC | Any mutation | 41 | 43 | Signature 6 | -0.87 | -2.21 | 0.13 | 1218.22 | 1.00 | 240 | 39 | 41 | 2 | TRUE | 0.83 |
| colorectal cancer | RAS_13 | CIC | Any mutation | 158 | 120 | Signature overall | -0.47 | -1.77 | 0.63 | 1439.09 | 1.00 | 1301 | 148 | 110 | 10 | TRUE | 0.34 |
| colorectal cancer | RAS_13 | NCOR1 | Any mutation | 58 | 22 | Signature 15 | 0.02 | -1.06 | 1.00 | 1431.53 | 1.00 | 312 | 54 | 18 | 4 | FALSE | 0.01 |
| colorectal cancer | RAS_13 | NCOR1 | Any mutation | 58 | 44 | Signature 1A | -0.16 | -1.33 | 0.80 | 1466.52 | 1.00 | 753 | 55 | 41 | 3 | FALSE | 0.12 |
| colorectal cancer | RAS_13 | NCOR1 | Any mutation | 42 | 43 | Signature 6 | -0.19 | -1.07 | 0.69 | 1402.13 | 1.00 | 241 | 37 | 38 | 5 | FALSE | 0.17 |
| colorectal cancer | RAS_13 | NCOR1 | Any mutation | 162 | 125 | Signature overall | -0.18 | -1.31 | 0.85 | 1529.06 | 1.00 | 1327 | 149 | 112 | 13 | FALSE | 0.13 |
| colorectal cancer | RAS_13 | POLE | Any mutation | 58 | 19 | Signature 15 | -0.76 | -2.44 | 0.48 | 1520.39 | 1.00 | 313 | 57 | 18 | 1 | TRUE | 0.51 |
| colorectal cancer | RAS_13 | POLE | Any mutation | 59 | 36 | Signature 1A | 0.77 | -0.23 | 1.63 | 1529.70 | 1.00 | 761 | 53 | 30 | 6 | TRUE | 0.98 |
| colorectal cancer | RAS_13 | POLE | Any mutation | 42 | 54 | Signature 6 | 0.00 | -0.88 | 0.78 | 1271.51 | 1.00 | 232 | 35 | 47 | 7 | TRUE | 0.00 |
| colorectal cancer | RAS_13 | POLE | Any mutation | 164 | 129 | Signature overall | 0.09 | -1.28 | 1.43 | 1478.78 | 1.00 | 1326 | 147 | 112 | 17 | TRUE | 0.05 |
| colorectal cancer | RAS_13 | TGFBR2 | Any mutation | 58 | 11 | Signature 15 | 0.08 | -1.15 | 1.16 | 1516.22 | 1.00 | 319 | 56 | 9 | 2 | TRUE | 0.05 |
| colorectal cancer | RAS_13 | TGFBR2 | Any mutation | 57 | 48 | Signature 1A | 0.51 | -0.43 | 1.39 | 1396.02 | 1.00 | 750 | 51 | 42 | 6 | TRUE | 0.57 |
| colorectal cancer | RAS_13 | TGFBR2 | Any mutation | 41 | 43 | Signature 6 | -0.04 | -0.99 | 0.74 | 1604.84 | 1.00 | 234 | 36 | 38 | 5 | TRUE | 0.03 |
| colorectal cancer | RAS_13 | TGFBR2 | Any mutation | 156 | 102 | Signature overall | 0.19 | -1.03 | 1.30 | 1532.49 | 1.00 | 1303 | 143 | 89 | 13 | TRUE | 0.12 |
| colorectal cancer | RAS_13 | KMT2A | Any mutation | 7 | 22 | Signature 10 | 0.38 | -0.93 | 1.67 | 1586.14 | 1.00 | 24 | 3 | 18 | 4 | FALSE | 0.25 |
| colorectal cancer | RAS_13 | KMT2A | Any mutation | 59 | 19 | Signature 15 | -0.42 | -1.72 | 0.72 | 1437.86 | 1.00 | 312 | 57 | 17 | 2 | FALSE | 0.29 |
| colorectal cancer | RAS_13 | KMT2A | Any mutation | 59 | 53 | Signature 1A | 0.70 | -0.16 | 1.47 | 1350.71 | 1.00 | 746 | 51 | 45 | 8 | FALSE | 1.00 |
| colorectal cancer | RAS_13 | KMT2A | Any mutation | 41 | 42 | Signature 6 | -0.88 | -2.21 | 0.22 | 1461.44 | 1.00 | 240 | 39 | 40 | 2 | FALSE | 0.81 |
| colorectal cancer | RAS_13 | KMT2A | Any mutation | 166 | 136 | Signature overall | -0.02 | -1.28 | 1.26 | 1271.82 | 1.00 | 1322 | 150 | 120 | 16 | FALSE | 0.01 |
| colorectal cancer | RAS_13 | BRCA2 | Any mutation | 7 | 37 | Signature 10 | -0.03 | -1.45 | 1.40 | 1432.59 | 1.00 | 22 | 3 | 33 | 4 | TRUE | 0.02 |
| colorectal cancer | RAS_13 | BRCA2 | Any mutation | 58 | 17 | Signature 15 | -0.79 | -2.52 | 0.54 | 1656.34 | 1.00 | 316 | 57 | 16 | 1 | TRUE | 0.50 |
| colorectal cancer | RAS_13 | BRCA2 | Any mutation | 61 | 50 | Signature 1A | 1.11 | 0.31 | 1.86 | 1196.65 | 1.00 | 753 | 51 | 40 | 10 | TRUE | 2.39 |
| colorectal cancer | RAS_13 | BRCA2 | Any mutation | 43 | 62 | Signature 6 | -0.40 | -1.32 | 0.44 | 1575.57 | 1.00 | 231 | 37 | 56 | 6 | TRUE | 0.41 |
| colorectal cancer | RAS_13 | BRCA2 | Any mutation | 169 | 166 | Signature overall | 0.00 | -1.41 | 1.47 | 1657.49 | 1.00 | 1322 | 148 | 145 | 21 | TRUE | 0.00 |
| colorectal cancer | RAS_13 | NOTCH3 | Any mutation | 58 | 27 | Signature 15 | 0.14 | -0.76 | 0.97 | 1484.43 | 1.00 | 310 | 53 | 22 | 5 | TRUE | 0.13 |
| colorectal cancer | RAS_13 | NOTCH3 | Any mutation | 57 | 70 | Signature 1A | 0.15 | -0.69 | 0.91 | 1430.43 | 1.00 | 736 | 51 | 64 | 6 | TRUE | 0.15 |
| colorectal cancer | RAS_13 | NOTCH3 | Any mutation | 42 | 72 | Signature 6 | -0.10 | -0.84 | 0.59 | 1397.38 | 1.00 | 225 | 34 | 64 | 8 | TRUE | 0.11 |
| colorectal cancer | RAS_13 | NOTCH3 | Any mutation | 157 | 169 | Signature overall | 0.05 | -0.88 | 1.02 | 1358.29 | 1.00 | 1271 | 138 | 150 | 19 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | NOTCH4 | Any mutation | 58 | 18 | Signature 15 | -0.78 | -2.19 | 0.36 | 1344.11 | 1.00 | 304 | 57 | 17 | 1 | TRUE | 0.62 |
| colorectal cancer | RAS_13 | NOTCH4 | Any mutation | 55 | 43 | Signature 1A | -0.32 | -1.46 | 0.69 | 1477.25 | 1.00 | 731 | 52 | 40 | 3 | TRUE | 0.25 |
| colorectal cancer | RAS_13 | NOTCH4 | Any mutation | 41 | 41 | Signature 6 | -0.44 | -1.46 | 0.49 | 1494.90 | 1.00 | 231 | 37 | 37 | 4 | TRUE | 0.43 |
| colorectal cancer | RAS_13 | NOTCH4 | Any mutation | 154 | 102 | Signature overall | -0.50 | -1.65 | 0.67 | 1458.52 | 1.00 | 1266 | 146 | 94 | 8 | TRUE | 0.41 |
| colorectal cancer | RAS_13 | ERBB3 | Any mutation | 58 | 18 | Signature 15 | 0.33 | -0.72 | 1.16 | 1454.08 | 1.00 | 312 | 55 | 15 | 3 | TRUE | 0.30 |
| colorectal cancer | RAS_13 | ERBB3 | Any mutation | 58 | 46 | Signature 1A | 0.86 | 0.13 | 1.61 | 1555.42 | 1.00 | 757 | 50 | 38 | 8 | TRUE | 1.55 |
| colorectal cancer | RAS_13 | ERBB3 | Any mutation | 42 | 34 | Signature 6 | 0.49 | -0.35 | 1.29 | 1256.43 | 1.00 | 246 | 36 | 28 | 6 | TRUE | 0.63 |
| colorectal cancer | RAS_13 | ERBB3 | Any mutation | 158 | 98 | Signature overall | 0.55 | -0.34 | 1.43 | 1448.38 | 1.00 | 1315 | 141 | 81 | 17 | TRUE | 0.66 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 58 | 60 | Signature 15 | -0.65 | -1.46 | 0.08 | 1458.51 | 1.00 | 277 | 53 | 55 | 5 | TRUE | 1.01 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 57 | 122 | Signature 1A | -1.00 | -1.99 | -0.20 | 1532.99 | 1.00 | 678 | 55 | 120 | 2 | TRUE | 1.56 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 8 | 11 | Signature 2 | -0.06 | -1.16 | 1.26 | 1337.88 | 1.00 | 66 | 5 | 8 | 3 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 41 | 57 | Signature 6 | -0.54 | -1.33 | 0.25 | 1488.10 | 1.00 | 226 | 36 | 52 | 5 | TRUE | 0.73 |
| colorectal cancer | RAS_13 | SMAD4 | Any mutation | 173 | 301 | Signature overall | -0.54 | -1.23 | 0.19 | 1512.78 | 1.00 | 1361 | 155 | 283 | 18 | TRUE | 0.84 |
| colorectal cancer | RAS_13 | ATM | Any mutation | 9 | 39 | Signature 10 | 0.30 | -0.88 | 1.57 | 1445.80 | 1.00 | 19 | 3 | 33 | 6 | TRUE | 0.20 |
| colorectal cancer | RAS_13 | ATM | Any mutation | 59 | 32 | Signature 15 | 0.37 | -0.50 | 1.16 | 1468.11 | 1.00 | 306 | 52 | 25 | 7 | TRUE | 0.41 |
| colorectal cancer | RAS_13 | ATM | Any mutation | 58 | 77 | Signature 1A | 0.69 | 0.02 | 1.37 | 1578.03 | 1.00 | 730 | 48 | 67 | 10 | TRUE | 1.24 |
| colorectal cancer | RAS_13 | ATM | Any mutation | 41 | 48 | Signature 6 | -0.69 | -1.80 | 0.29 | 1483.48 | 1.00 | 234 | 38 | 45 | 3 | TRUE | 0.71 |
| colorectal cancer | RAS_13 | ATM | Any mutation | 167 | 196 | Signature overall | 0.19 | -0.97 | 1.45 | 1384.26 | 1.00 | 1289 | 141 | 170 | 26 | TRUE | 0.12 |
| colorectal cancer | RAS_13 | KMT2D | Any mutation | 58 | 55 | Signature 15 | -0.90 | -1.91 | -0.03 | 1456.66 | 1.00 | 298 | 55 | 52 | 3 | FALSE | 1.19 |
| colorectal cancer | RAS_13 | KMT2D | Any mutation | 60 | 128 | Signature 1A | 0.35 | -0.29 | 0.97 | 1577.59 | 1.00 | 717 | 47 | 115 | 13 | FALSE | 0.55 |
| colorectal cancer | RAS_13 | KMT2D | Any mutation | 47 | 142 | Signature 6 | -0.48 | -1.13 | 0.13 | 1532.15 | 1.00 | 197 | 34 | 129 | 13 | FALSE | 0.87 |
| colorectal cancer | RAS_13 | KMT2D | Any mutation | 170 | 344 | Signature overall | -0.32 | -1.34 | 0.62 | 1498.19 | 1.00 | 1232 | 139 | 313 | 31 | FALSE | 0.30 |
| colorectal cancer | RAS_13 | TSC2 | Any mutation | 58 | 11 | Signature 15 | -0.48 | -2.01 | 0.72 | 1450.24 | 1.00 | 317 | 57 | 10 | 1 | TRUE | 0.30 |
| colorectal cancer | RAS_13 | TSC2 | Any mutation | 58 | 36 | Signature 1A | 0.19 | -0.93 | 1.18 | 1617.85 | 1.00 | 762 | 54 | 32 | 4 | TRUE | 0.14 |
| colorectal cancer | RAS_13 | TSC2 | Any mutation | 41 | 44 | Signature 6 | -0.36 | -1.46 | 0.52 | 1450.07 | 1.00 | 239 | 37 | 40 | 4 | TRUE | 0.32 |
| colorectal cancer | RAS_13 | TSC2 | Any mutation | 157 | 91 | Signature overall | -0.20 | -1.54 | 0.98 | 1506.95 | 1.00 | 1318 | 148 | 82 | 9 | TRUE | 0.12 |
| colorectal cancer | RAS_13 | APC | Any mutation | 14 | 94 | Signature 10 | 0.73 | -0.09 | 1.60 | 1250.89 | 1.00 | 3 | 0 | 80 | 14 | TRUE | 1.07 |
| colorectal cancer | RAS_13 | APC | Any mutation | 6 | 25 | Signature 14 | 0.81 | -0.10 | 1.75 | 1458.91 | 1.00 | 3 | 0 | 19 | 6 | TRUE | 1.08 |
| colorectal cancer | RAS_13 | APC | Any mutation | 91 | 469 | Signature 15 | 0.85 | 0.28 | 1.50 | 1592.73 | 1.00 | 76 | 7 | 385 | 84 | TRUE | 2.22 |
| colorectal cancer | RAS_13 | APC | Any mutation | 82 | 962 | Signature 1A | 0.17 | -0.30 | 0.70 | 1489.98 | 1.00 | 206 | 15 | 895 | 67 | TRUE | 0.30 |
| colorectal cancer | RAS_13 | APC | Any mutation | 13 | 95 | Signature 2 | 0.49 | -0.29 | 1.30 | 1596.29 | 1.00 | 15 | 2 | 84 | 11 | TRUE | 0.63 |
| colorectal cancer | RAS_13 | APC | Any mutation | 62 | 355 | Signature 6 | 0.41 | -0.14 | 0.98 | 1544.34 | 1.00 | 83 | 12 | 305 | 50 | TRUE | 0.83 |
| colorectal cancer | RAS_13 | APC | Any mutation | 292 | 2462 | Signature overall | 0.34 | -0.17 | 0.86 | 1258.32 | 1.00 | 513 | 38 | 2208 | 254 | TRUE | 0.71 |
| colorectal cancer | RAS_13 | ERBB2 | Any mutation | 58 | 47 | Signature 1A | 0.91 | 0.09 | 1.68 | 1399.58 | 1.00 | 753 | 50 | 39 | 8 | TRUE | 1.57 |
| colorectal cancer | RAS_13 | ERBB2 | Any mutation | 41 | 29 | Signature 6 | 0.32 | -0.79 | 1.25 | 1517.44 | 1.00 | 249 | 37 | 25 | 4 | TRUE | 0.27 |
| colorectal cancer | RAS_13 | ERBB2 | Any mutation | 99 | 76 | Signature overall | 0.61 | -0.84 | 2.08 | 1517.63 | 1.00 | 1002 | 87 | 64 | 12 | TRUE | 0.36 |
| colorectal cancer | RAS_13 | ARID2 | Any mutation | 58 | 19 | Signature 15 | -0.48 | -1.80 | 0.65 | 1582.90 | 1.00 | 313 | 56 | 17 | 2 | FALSE | 0.35 |
| colorectal cancer | RAS_13 | ARID2 | Any mutation | 58 | 42 | Signature 1A | 0.10 | -1.00 | 1.04 | 1398.75 | 1.00 | 754 | 54 | 38 | 4 | FALSE | 0.07 |
| colorectal cancer | RAS_13 | ARID2 | Any mutation | 41 | 27 | Signature 6 | -0.31 | -1.51 | 0.75 | 1590.04 | 1.00 | 248 | 38 | 24 | 3 | FALSE | 0.23 |
| colorectal cancer | RAS_13 | ARID2 | Any mutation | 161 | 104 | Signature overall | -0.28 | -1.54 | 0.87 | 1428.35 | 1.00 | 1335 | 151 | 94 | 10 | FALSE | 0.19 |
| colorectal cancer | RAS_13 | MTOR | Any mutation | 58 | 17 | Signature 15 | 0.15 | -0.95 | 1.10 | 1418.22 | 1.00 | 315 | 55 | 14 | 3 | TRUE | 0.11 |
| colorectal cancer | RAS_13 | MTOR | Any mutation | 58 | 48 | Signature 1A | 0.83 | 0.05 | 1.59 | 1476.08 | 1.00 | 753 | 50 | 40 | 8 | TRUE | 1.41 |
| colorectal cancer | RAS_13 | MTOR | Any mutation | 44 | 45 | Signature 6 | 0.08 | -0.77 | 0.86 | 1323.99 | 1.00 | 237 | 38 | 39 | 6 | TRUE | 0.07 |
| colorectal cancer | RAS_13 | MTOR | Any mutation | 164 | 122 | Signature overall | 0.27 | -0.83 | 1.28 | 1567.37 | 1.00 | 1329 | 146 | 104 | 18 | TRUE | 0.22 |
| colorectal cancer | RAS_13 | NOTCH1 | Any mutation | 58 | 17 | Signature 15 | -1.73 | -4.72 | 0.08 | 1403.40 | 1.00 | 316 | 58 | 17 | 0 | TRUE | 0.84 |
| colorectal cancer | RAS_13 | NOTCH1 | Any mutation | 62 | 47 | Signature 1A | 1.25 | 0.51 | 1.95 | 1409.78 | 1.00 | 754 | 51 | 36 | 11 | TRUE | 3.00 |
| colorectal cancer | RAS_13 | NOTCH1 | Any mutation | 43 | 82 | Signature 6 | -0.42 | -1.24 | 0.34 | 1470.56 | 1.00 | 217 | 35 | 74 | 8 | TRUE | 0.52 |
| colorectal cancer | RAS_13 | NOTCH1 | Any mutation | 167 | 157 | Signature overall | -0.54 | -2.29 | 1.03 | 1395.82 | 1.00 | 1311 | 148 | 138 | 19 | TRUE | 0.28 |
| colorectal cancer | RAS_13 | SETD2 | Any mutation | 7 | 22 | Signature 10 | 0.48 | -0.88 | 1.82 | 1545.15 | 1.00 | 21 | 3 | 18 | 4 | FALSE | 0.30 |
| colorectal cancer | RAS_13 | SETD2 | Any mutation | 59 | 13 | Signature 15 | -0.05 | -1.53 | 1.13 | 1273.06 | 1.00 | 317 | 57 | 11 | 2 | FALSE | 0.03 |
| colorectal cancer | RAS_13 | SETD2 | Any mutation | 57 | 31 | Signature 1A | 1.02 | 0.05 | 1.93 | 1535.08 | 1.00 | 765 | 51 | 25 | 6 | FALSE | 1.44 |
| colorectal cancer | RAS_13 | SETD2 | Any mutation | 42 | 39 | Signature 6 | -0.55 | -1.76 | 0.46 | 1518.02 | 1.00 | 239 | 39 | 36 | 3 | FALSE | 0.49 |
| colorectal cancer | RAS_13 | SETD2 | Any mutation | 165 | 105 | Signature overall | 0.24 | -1.21 | 1.60 | 1415.16 | 1.00 | 1342 | 150 | 90 | 15 | FALSE | 0.14 |
| colorectal cancer | RAS_13 | EPHA3 | Any mutation | 6 | 14 | Signature 10 | 0.60 | -0.70 | 1.92 | 1536.32 | 1.00 | 25 | 3 | 11 | 3 | FALSE | 0.42 |
| colorectal cancer | RAS_13 | EPHA3 | Any mutation | 58 | 13 | Signature 15 | -0.32 | -1.81 | 0.81 | 1287.91 | 1.00 | 315 | 57 | 12 | 1 | FALSE | 0.20 |
| colorectal cancer | RAS_13 | EPHA3 | Any mutation | 57 | 42 | Signature 1A | 0.63 | -0.29 | 1.49 | 1370.94 | 1.00 | 754 | 51 | 36 | 6 | FALSE | 0.77 |
| colorectal cancer | RAS_13 | EPHA3 | Any mutation | 41 | 26 | Signature 6 | -0.05 | -1.16 | 0.92 | 1488.93 | 1.00 | 249 | 38 | 23 | 3 | FALSE | 0.04 |
| colorectal cancer | RAS_13 | EPHA3 | Any mutation | 162 | 95 | Signature overall | 0.23 | -0.98 | 1.36 | 1355.32 | 1.00 | 1343 | 149 | 82 | 13 | FALSE | 0.15 |
| colorectal cancer | RAS_13 | PTCH1 | Any mutation | 58 | 14 | Signature 15 | -0.16 | -1.57 | 0.95 | 1392.25 | 1.00 | 318 | 56 | 12 | 2 | TRUE | 0.09 |
| colorectal cancer | RAS_13 | PTCH1 | Any mutation | 60 | 55 | Signature 1A | 0.78 | -0.04 | 1.50 | 1566.50 | 1.00 | 748 | 51 | 46 | 9 | TRUE | 1.34 |
| colorectal cancer | RAS_13 | PTCH1 | Any mutation | 46 | 53 | Signature 6 | -0.06 | -0.96 | 0.71 | 1444.97 | 1.00 | 237 | 39 | 46 | 7 | TRUE | 0.06 |
| colorectal cancer | RAS_13 | PTCH1 | Any mutation | 168 | 133 | Signature overall | 0.00 | -1.26 | 1.15 | 1490.61 | 1.00 | 1326 | 150 | 115 | 18 | TRUE | 0.00 |
| colorectal cancer | RAS_13 | TET1 | Any mutation | 10 | 27 | Signature 10 | 0.76 | -0.50 | 2.04 | 1302.81 | 1.00 | 20 | 3 | 20 | 7 | FALSE | 0.61 |
| colorectal cancer | RAS_13 | TET1 | Any mutation | 58 | 18 | Signature 15 | -0.93 | -2.80 | 0.55 | 1271.34 | 1.00 | 306 | 57 | 17 | 1 | FALSE | 0.58 |
| colorectal cancer | RAS_13 | TET1 | Any mutation | 55 | 25 | Signature 1A | 0.97 | -0.17 | 1.96 | 1656.26 | 1.00 | 748 | 50 | 20 | 5 | FALSE | 1.12 |
| colorectal cancer | RAS_13 | TET1 | Any mutation | 40 | 28 | Signature 6 | -1.16 | -2.94 | 0.19 | 1358.53 | 1.00 | 239 | 39 | 27 | 1 | FALSE | 0.84 |
| colorectal cancer | RAS_13 | TET1 | Any mutation | 163 | 98 | Signature overall | -0.09 | -1.67 | 1.42 | 1350.55 | 1.00 | 1313 | 149 | 84 | 14 | FALSE | 0.04 |
| colorectal cancer | RAS_13 | SMAD3 | Any mutation | 58 | 21 | Signature 15 | -0.13 | -1.23 | 0.77 | 1506.74 | 1.00 | 313 | 55 | 18 | 3 | TRUE | 0.10 |
| colorectal cancer | RAS_13 | SMAD3 | Any mutation | 57 | 38 | Signature 1A | 0.03 | -0.98 | 0.95 | 1504.02 | 1.00 | 759 | 53 | 34 | 4 | TRUE | 0.02 |
| colorectal cancer | RAS_13 | SMAD3 | Any mutation | 41 | 20 | Signature 6 | -0.36 | -1.54 | 0.68 | 1560.50 | 1.00 | 252 | 40 | 19 | 1 | TRUE | 0.28 |
| colorectal cancer | RAS_13 | SMAD3 | Any mutation | 156 | 79 | Signature overall | -0.15 | -1.22 | 0.80 | 1502.07 | 1.00 | 1324 | 148 | 71 | 8 | TRUE | 0.11 |
| colorectal cancer | RAS_13 | GRIN2A | Any mutation | 58 | 12 | Signature 15 | -1.38 | -3.80 | 0.26 | 1468.73 | 1.00 | 318 | 58 | 12 | 0 | FALSE | 0.72 |
| colorectal cancer | RAS_13 | GRIN2A | Any mutation | 57 | 43 | Signature 1A | -0.53 | -1.95 | 0.59 | 1411.45 | 1.00 | 748 | 55 | 41 | 2 | FALSE | 0.37 |
| colorectal cancer | RAS_13 | GRIN2A | Any mutation | 41 | 43 | Signature 6 | -0.24 | -1.26 | 0.65 | 1391.56 | 1.00 | 235 | 36 | 38 | 5 | FALSE | 0.21 |
| colorectal cancer | RAS_13 | GRIN2A | Any mutation | 161 | 116 | Signature overall | -0.45 | -1.92 | 0.88 | 1479.15 | 1.00 | 1323 | 151 | 106 | 10 | FALSE | 0.27 |
| colorectal cancer | RAS_13 | ASXL1 | Any mutation | 58 | 14 | Signature 15 | 0.22 | -0.94 | 1.32 | 1603.95 | 1.00 | 318 | 55 | 11 | 3 | TRUE | 0.15 |
| colorectal cancer | RAS_13 | ASXL1 | Any mutation | 57 | 31 | Signature 1A | 0.22 | -0.93 | 1.21 | 1617.97 | 1.00 | 762 | 54 | 28 | 3 | TRUE | 0.17 |
| colorectal cancer | RAS_13 | ASXL1 | Any mutation | 42 | 34 | Signature 6 | 0.13 | -0.88 | 0.97 | 1463.30 | 1.00 | 245 | 37 | 29 | 5 | TRUE | 0.10 |
| colorectal cancer | RAS_13 | ASXL1 | Any mutation | 161 | 90 | Signature overall | 0.16 | -1.00 | 1.18 | 1575.62 | 1.00 | 1347 | 149 | 78 | 12 | TRUE | 0.11 |
| colorectal cancer | RAS_13 | EP300 | Any mutation | 59 | 18 | Signature 15 | -0.37 | -1.67 | 0.75 | 1242.73 | 1.00 | 314 | 57 | 16 | 2 | TRUE | 0.26 |
| colorectal cancer | RAS_13 | EP300 | Any mutation | 57 | 36 | Signature 1A | -0.07 | -1.24 | 1.00 | 1483.40 | 1.00 | 757 | 54 | 33 | 3 | TRUE | 0.05 |
| colorectal cancer | RAS_13 | EP300 | Any mutation | 43 | 51 | Signature 6 | -0.35 | -1.28 | 0.52 | 1554.45 | 1.00 | 237 | 38 | 46 | 5 | TRUE | 0.35 |
| colorectal cancer | RAS_13 | EP300 | Any mutation | 159 | 105 | Signature overall | -0.27 | -1.47 | 0.98 | 1573.36 | 1.00 | 1308 | 149 | 95 | 10 | TRUE | 0.18 |
| colorectal cancer | RAS_13 | ERBB4 | Any mutation | 8 | 18 | Signature 10 | 0.95 | -0.22 | 2.13 | 1463.35 | 1.00 | 22 | 3 | 13 | 5 | TRUE | 0.98 |
| colorectal cancer | RAS_13 | ERBB4 | Any mutation | 58 | 23 | Signature 15 | 0.01 | -1.12 | 0.93 | 1468.65 | 1.00 | 310 | 55 | 20 | 3 | TRUE | 0.01 |
| colorectal cancer | RAS_13 | ERBB4 | Any mutation | 57 | 43 | Signature 1A | 0.51 | -0.39 | 1.31 | 1550.15 | 1.00 | 753 | 52 | 38 | 5 | TRUE | 0.59 |
| colorectal cancer | RAS_13 | ERBB4 | Any mutation | 43 | 31 | Signature 6 | 0.62 | -0.26 | 1.44 | 1551.44 | 1.00 | 248 | 36 | 24 | 7 | TRUE | 0.85 |
| colorectal cancer | RAS_13 | ERBB4 | Any mutation | 166 | 115 | Signature overall | 0.53 | -0.56 | 1.53 | 1450.34 | 1.00 | 1333 | 146 | 95 | 20 | TRUE | 0.50 |
| colorectal cancer | RAS_13 | MED12 | Any mutation | 58 | 11 | Signature 15 | -0.90 | -3.34 | 0.61 | 1439.37 | 1.00 | 317 | 58 | 11 | 0 | TRUE | 0.40 |
| colorectal cancer | RAS_13 | MED12 | Any mutation | 57 | 34 | Signature 1A | 0.59 | -0.43 | 1.55 | 1265.83 | 1.00 | 762 | 52 | 29 | 5 | TRUE | 0.61 |
| colorectal cancer | RAS_13 | MED12 | Any mutation | 44 | 42 | Signature 6 | 0.21 | -0.74 | 0.98 | 1400.64 | 1.00 | 243 | 37 | 35 | 7 | TRUE | 0.20 |
| colorectal cancer | RAS_13 | MED12 | Any mutation | 159 | 87 | Signature overall | -0.06 | -1.78 | 1.21 | 1482.76 | 1.00 | 1322 | 147 | 75 | 12 | TRUE | 0.03 |
| colorectal cancer | RAS_13 | NF1 | Any mutation | 7 | 24 | Signature 10 | 0.17 | -1.15 | 1.42 | 1297.99 | 1.00 | 21 | 3 | 20 | 4 | TRUE | 0.10 |
| colorectal cancer | RAS_13 | NF1 | Any mutation | 58 | 21 | Signature 15 | -1.00 | -2.67 | 0.27 | 1503.33 | 1.00 | 311 | 57 | 20 | 1 | TRUE | 0.75 |
| colorectal cancer | RAS_13 | NF1 | Any mutation | 57 | 40 | Signature 1A | 0.18 | -0.91 | 1.20 | 1556.97 | 1.00 | 757 | 53 | 36 | 4 | TRUE | 0.14 |
| colorectal cancer | RAS_13 | NF1 | Any mutation | 41 | 44 | Signature 6 | -0.71 | -1.88 | 0.31 | 1470.32 | 1.00 | 240 | 38 | 41 | 3 | TRUE | 0.71 |
| colorectal cancer | RAS_13 | NF1 | Any mutation | 163 | 129 | Signature overall | -0.33 | -1.65 | 0.88 | 1282.73 | 1.00 | 1329 | 151 | 117 | 12 | TRUE | 0.22 |
| colorectal cancer | RAS_13 | EPHA5 | Any mutation | 7 | 26 | Signature 10 | -0.14 | -1.61 | 1.21 | 1365.66 | 1.00 | 20 | 3 | 22 | 4 | FALSE | 0.08 |
| colorectal cancer | RAS_13 | EPHA5 | Any mutation | 58 | 18 | Signature 15 | -1.97 | -4.64 | -0.23 | 1575.51 | 1.00 | 313 | 58 | 18 | 0 | FALSE | 1.10 |
| colorectal cancer | RAS_13 | EPHA5 | Any mutation | 57 | 49 | Signature 1A | -1.31 | -3.12 | 0.06 | 1483.76 | 1.00 | 742 | 56 | 48 | 1 | FALSE | 0.94 |
| colorectal cancer | RAS_13 | EPHA5 | Any mutation | 41 | 36 | Signature 6 | -0.77 | -2.16 | 0.35 | 1165.87 | 1.00 | 242 | 38 | 33 | 3 | FALSE | 0.66 |
| colorectal cancer | RAS_13 | EPHA5 | Any mutation | 163 | 129 | Signature overall | -1.01 | -2.71 | 0.47 | 1450.14 | 1.00 | 1317 | 155 | 121 | 8 | FALSE | 0.71 |
| colorectal cancer | RAS_13 | AR | Any mutation | 59 | 21 | Signature 15 | 0.01 | -1.02 | 0.91 | 1321.03 | 1.00 | 312 | 56 | 18 | 3 | TRUE | 0.01 |
| colorectal cancer | RAS_13 | AR | Any mutation | 57 | 33 | Signature 1A | 0.15 | -0.87 | 1.10 | 1547.34 | 1.00 | 758 | 54 | 30 | 3 | TRUE | 0.11 |
| colorectal cancer | RAS_13 | AR | Any mutation | 43 | 37 | Signature 6 | 0.21 | -0.70 | 1.03 | 1482.38 | 1.00 | 242 | 37 | 31 | 6 | TRUE | 0.20 |
| colorectal cancer | RAS_13 | AR | Any mutation | 159 | 91 | Signature overall | 0.12 | -0.88 | 1.06 | 1403.67 | 1.00 | 1312 | 147 | 79 | 12 | TRUE | 0.09 |
| colorectal cancer | RAS_13 | ROS1 | Any mutation | 10 | 30 | Signature 10 | 0.74 | -0.52 | 2.08 | 1390.71 | 1.00 | 20 | 3 | 23 | 7 | TRUE | 0.60 |
| colorectal cancer | RAS_13 | ROS1 | Any mutation | 57 | 28 | Signature 1A | 0.35 | -0.91 | 1.41 | 1464.86 | 1.00 | 765 | 54 | 25 | 3 | TRUE | 0.25 |
| colorectal cancer | RAS_13 | ROS1 | Any mutation | 41 | 26 | Signature 6 | -0.16 | -1.32 | 0.98 | 1582.19 | 1.00 | 247 | 38 | 23 | 3 | TRUE | 0.10 |
| colorectal cancer | RAS_13 | ROS1 | Any mutation | 108 | 84 | Signature overall | 0.32 | -1.44 | 1.98 | 1453.21 | 1.00 | 1032 | 95 | 71 | 13 | TRUE | 0.14 |
| colorectal cancer | RAS_13 | PIK3CG | Any mutation | 58 | 17 | Signature 15 | -1.79 | -4.16 | -0.05 | 1478.60 | 1.00 | 312 | 58 | 17 | 0 | FALSE | 1.00 |
| colorectal cancer | RAS_13 | PIK3CG | Any mutation | 57 | 29 | Signature 1A | -0.43 | -1.99 | 0.81 | 1500.08 | 1.00 | 761 | 55 | 27 | 2 | FALSE | 0.26 |
| colorectal cancer | RAS_13 | PIK3CG | Any mutation | 42 | 29 | Signature 6 | -0.51 | -1.80 | 0.60 | 1616.19 | 1.00 | 246 | 39 | 26 | 3 | FALSE | 0.39 |
| colorectal cancer | RAS_13 | PIK3CG | Any mutation | 162 | 97 | Signature overall | -0.82 | -2.50 | 0.71 | 1355.44 | 1.00 | 1338 | 155 | 90 | 7 | FALSE | 0.51 |
| colorectal cancer | RAS_13 | ARID1B | Any mutation | 58 | 22 | Signature 15 | -0.47 | -1.59 | 0.48 | 1408.13 | 1.00 | 311 | 56 | 20 | 2 | TRUE | 0.42 |
| colorectal cancer | RAS_13 | ARID1B | Any mutation | 57 | 53 | Signature 1A | 0.04 | -0.90 | 0.90 | 1487.54 | 1.00 | 749 | 52 | 48 | 5 | TRUE | 0.03 |
| colorectal cancer | RAS_13 | ARID1B | Any mutation | 41 | 46 | Signature 6 | -0.38 | -1.34 | 0.45 | 1472.37 | 1.00 | 236 | 37 | 42 | 4 | TRUE | 0.39 |
| colorectal cancer | RAS_13 | ARID1B | Any mutation | 156 | 121 | Signature overall | -0.26 | -1.35 | 0.77 | 1470.84 | 1.00 | 1296 | 145 | 110 | 11 | TRUE | 0.20 |
| colorectal cancer | RAS_13 | BRAF | Any mutation | 58 | 48 | Signature 15 | -1.13 | -2.16 | -0.25 | 1583.06 | 1.00 | 284 | 55 | 45 | 3 | TRUE | 1.72 |
| colorectal cancer | RAS_13 | BRAF | Any mutation | 57 | 99 | Signature 1A | -0.97 | -1.89 | -0.08 | 1427.16 | 1.00 | 696 | 53 | 95 | 4 | TRUE | 1.46 |
| colorectal cancer | RAS_13 | BRAF | Any mutation | 42 | 60 | Signature 6 | -1.34 | -2.53 | -0.44 | 1514.26 | 1.00 | 217 | 40 | 58 | 2 | TRUE | 2.01 |
| colorectal cancer | RAS_13 | BRAF | Any mutation | 157 | 207 | Signature overall | -1.14 | -2.10 | -0.26 | 1591.10 | 1.00 | 1197 | 148 | 198 | 9 | TRUE | 1.80 |
| colorectal cancer | RAS_13 | B2M | Any mutation | 58 | 20 | Signature 15 | -0.65 | -2.28 | 0.45 | 1540.10 | 1.00 | 307 | 57 | 19 | 1 | FALSE | 0.46 |
| colorectal cancer | RAS_13 | B2M | Any mutation | 57 | 46 | Signature 1A | 0.52 | -0.40 | 1.39 | 1300.76 | 1.00 | 742 | 51 | 40 | 6 | FALSE | 0.61 |
| colorectal cancer | RAS_13 | B2M | Any mutation | 43 | 51 | Signature 6 | 0.20 | -0.60 | 0.92 | 1415.84 | 1.00 | 235 | 35 | 43 | 8 | FALSE | 0.22 |
| colorectal cancer | RAS_13 | B2M | Any mutation | 163 | 131 | Signature overall | 0.07 | -1.11 | 1.14 | 1558.63 | 1.00 | 1308 | 146 | 114 | 17 | FALSE | 0.04 |
| colorectal cancer | RAS_13 | CARD11 | Any mutation | 58 | 14 | Signature 15 | -0.06 | -1.29 | 1.06 | 1284.99 | 1.00 | 315 | 56 | 12 | 2 | FALSE | 0.04 |
| colorectal cancer | RAS_13 | CARD11 | Any mutation | 58 | 58 | Signature 1A | 0.15 | -0.74 | 0.97 | 1486.49 | 1.00 | 739 | 53 | 53 | 5 | FALSE | 0.14 |
| colorectal cancer | RAS_13 | CARD11 | Any mutation | 43 | 38 | Signature 6 | 0.17 | -0.65 | 0.95 | 1432.48 | 1.00 | 244 | 37 | 32 | 6 | FALSE | 0.17 |
| colorectal cancer | RAS_13 | CARD11 | Any mutation | 159 | 110 | Signature overall | 0.10 | -0.94 | 1.11 | 1605.27 | 1.00 | 1298 | 146 | 97 | 13 | FALSE | 0.07 |
| colorectal cancer | RAS_13 | SOX9 | Any mutation | 58 | 40 | Signature 15 | 1.00 | 0.31 | 1.68 | 1464.11 | 1.00 | 303 | 44 | 26 | 14 | FALSE | 2.39 |
| colorectal cancer | RAS_13 | SOX9 | Any mutation | 58 | 105 | Signature 1A | 0.04 | -0.75 | 0.69 | 1562.19 | 1.00 | 697 | 52 | 99 | 6 | FALSE | 0.04 |
| colorectal cancer | RAS_13 | SOX9 | Any mutation | 43 | 59 | Signature 6 | 0.54 | -0.14 | 1.16 | 1442.39 | 1.00 | 227 | 32 | 48 | 11 | FALSE | 0.96 |
| colorectal cancer | RAS_13 | SOX9 | Any mutation | 159 | 204 | Signature overall | 0.52 | -0.32 | 1.32 | 1454.88 | 1.00 | 1227 | 128 | 173 | 31 | FALSE | 0.68 |
| colorectal cancer | RAS_13 | SMAD2 | Any mutation | 58 | 16 | Signature 15 | -0.01 | -1.16 | 0.95 | 1521.82 | 1.00 | 313 | 56 | 14 | 2 | TRUE | 0.01 |
| colorectal cancer | RAS_13 | SMAD2 | Any mutation | 58 | 33 | Signature 1A | 0.25 | -0.74 | 1.19 | 1560.51 | 1.00 | 763 | 54 | 29 | 4 | TRUE | 0.21 |
| colorectal cancer | RAS_13 | SMAD2 | Any mutation | 41 | 17 | Signature 6 | 0.04 | -1.04 | 1.00 | 1459.54 | 1.00 | 257 | 39 | 15 | 2 | TRUE | 0.03 |
| colorectal cancer | RAS_13 | SMAD2 | Any mutation | 157 | 66 | Signature overall | 0.09 | -0.92 | 1.05 | 1480.51 | 1.00 | 1333 | 149 | 58 | 8 | TRUE | 0.07 |
| colorectal cancer | RAS_13 | ZFHX3 | Any mutation | 7 | 17 | Signature 10 | 0.32 | -0.92 | 1.54 | 1573.17 | 1.00 | 18 | 3 | 13 | 4 | FALSE | 0.21 |
| colorectal cancer | RAS_13 | ZFHX3 | Any mutation | 52 | 31 | Signature 15 | -0.68 | -1.85 | 0.33 | 1632.66 | 1.00 | 278 | 50 | 29 | 2 | FALSE | 0.64 |
| colorectal cancer | RAS_13 | ZFHX3 | Any mutation | 56 | 80 | Signature 1A | 0.25 | -0.55 | 0.98 | 1288.08 | 1.00 | 681 | 48 | 72 | 8 | FALSE | 0.28 |
| colorectal cancer | RAS_13 | ZFHX3 | Any mutation | 37 | 81 | Signature 6 | -0.54 | -1.40 | 0.22 | 1394.45 | 1.00 | 204 | 31 | 75 | 6 | FALSE | 0.70 |
| colorectal cancer | RAS_13 | ZFHX3 | Any mutation | 152 | 209 | Signature overall | -0.17 | -1.21 | 0.89 | 1519.65 | 1.00 | 1181 | 132 | 189 | 20 | FALSE | 0.12 |
| colorectal cancer | RAS_13 | MGA | Any mutation | 8 | 15 | Signature 10 | 0.92 | -0.32 | 2.19 | 1575.14 | 1.00 | 20 | 3 | 10 | 5 | FALSE | 0.86 |
| colorectal cancer | RAS_13 | MGA | Any mutation | 51 | 16 | Signature 15 | -0.09 | -1.34 | 0.93 | 1010.31 | 1.00 | 283 | 49 | 14 | 2 | FALSE | 0.05 |
| colorectal cancer | RAS_13 | MGA | Any mutation | 54 | 42 | Signature 1A | 0.24 | -0.84 | 1.17 | 1466.72 | 1.00 | 701 | 50 | 38 | 4 | FALSE | 0.20 |
| colorectal cancer | RAS_13 | MGA | Any mutation | 36 | 36 | Signature 6 | -0.03 | -1.02 | 0.90 | 1515.06 | 1.00 | 225 | 32 | 32 | 4 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | MGA | Any mutation | 149 | 109 | Signature overall | 0.25 | -0.88 | 1.35 | 1511.11 | 1.00 | 1229 | 134 | 94 | 15 | FALSE | 0.18 |
| colorectal cancer | RAS_13 | KMT2B | Any mutation | 31 | 18 | Signature 15 | 0.26 | -0.82 | 1.30 | 1685.82 | 1.00 | 154 | 27 | 14 | 4 | FALSE | 0.20 |
| colorectal cancer | RAS_13 | KMT2B | Any mutation | 34 | 64 | Signature 1A | 0.24 | -0.66 | 1.07 | 1704.21 | 1.00 | 380 | 28 | 58 | 6 | FALSE | 0.23 |
| colorectal cancer | RAS_13 | KMT2B | Any mutation | 22 | 86 | Signature 6 | 0.02 | -0.82 | 0.84 | 1536.68 | 1.00 | 108 | 13 | 77 | 9 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | KMT2B | Any mutation | 87 | 168 | Signature overall | 0.14 | -1.02 | 1.44 | 1592.46 | 1.00 | 642 | 68 | 149 | 19 | FALSE | 0.09 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 52 | 48 | Signature 15 | 0.00 | -0.67 | 0.65 | 1419.44 | 1.00 | 259 | 45 | 41 | 7 | FALSE | 0.00 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 56 | 115 | Signature 1A | 0.08 | -0.52 | 0.63 | 1479.87 | 1.00 | 641 | 46 | 105 | 10 | FALSE | 0.10 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 6 | 12 | Signature 2 | -0.04 | -0.98 | 0.84 | 1436.63 | 1.00 | 55 | 5 | 11 | 1 | FALSE | 0.03 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 37 | 69 | Signature 6 | -0.09 | -0.79 | 0.53 | 1564.98 | 1.00 | 198 | 30 | 62 | 7 | FALSE | 0.11 |
| colorectal cancer | RAS_13 | TCF7L2 | Any mutation | 151 | 244 | Signature overall | -0.01 | -0.62 | 0.63 | 1590.57 | 1.00 | 1153 | 126 | 219 | 25 | FALSE | 0.01 |
| colorectal cancer | RAS_13 | ANKRD11 | Any mutation | 51 | 17 | Signature 15 | -0.08 | -1.21 | 0.98 | 1642.30 | 1.00 | 278 | 48 | 14 | 3 | FALSE | 0.05 |
| colorectal cancer | RAS_13 | ANKRD11 | Any mutation | 52 | 47 | Signature 1A | -0.18 | -1.27 | 0.76 | 1552.37 | 1.00 | 678 | 49 | 44 | 3 | FALSE | 0.14 |
| colorectal cancer | RAS_13 | ANKRD11 | Any mutation | 36 | 57 | Signature 6 | -0.21 | -1.08 | 0.59 | 1377.07 | 1.00 | 210 | 30 | 51 | 6 | FALSE | 0.20 |
| colorectal cancer | RAS_13 | ANKRD11 | Any mutation | 143 | 133 | Signature overall | -0.17 | -1.31 | 0.85 | 1511.19 | 1.00 | 1186 | 130 | 120 | 13 | FALSE | 0.12 |
| colorectal cancer | RAS_13 | POLD1 | Any mutation | 51 | 15 | Signature 15 | -0.20 | -1.46 | 0.90 | 1405.34 | 1.00 | 289 | 49 | 13 | 2 | TRUE | 0.13 |
| colorectal cancer | RAS_13 | POLD1 | Any mutation | 54 | 43 | Signature 1A | 0.06 | -0.94 | 1.02 | 1513.91 | 1.00 | 704 | 50 | 39 | 4 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | POLD1 | Any mutation | 36 | 44 | Signature 6 | -0.27 | -1.25 | 0.65 | 1402.48 | 1.00 | 224 | 32 | 40 | 4 | TRUE | 0.24 |
| colorectal cancer | RAS_13 | POLD1 | Any mutation | 141 | 102 | Signature overall | -0.13 | -1.31 | 0.93 | 1381.26 | 1.00 | 1217 | 131 | 92 | 10 | TRUE | 0.09 |
| colorectal cancer | RAS_13 | AMER1 | Any mutation | 58 | 34 | Signature 15 | 0.54 | -0.30 | 1.21 | 1462.36 | 1.00 | 300 | 52 | 28 | 6 | FALSE | 0.79 |
| colorectal cancer | RAS_13 | AMER1 | Any mutation | 61 | 61 | Signature 1A | 0.94 | 0.32 | 1.59 | 1367.03 | 1.00 | 740 | 50 | 50 | 11 | FALSE | 2.46 |
| colorectal cancer | RAS_13 | AMER1 | Any mutation | 42 | 36 | Signature 6 | 0.86 | 0.22 | 1.49 | 1441.13 | 1.00 | 247 | 33 | 27 | 9 | FALSE | 1.97 |
| colorectal cancer | RAS_13 | AMER1 | Any mutation | 161 | 131 | Signature overall | 0.79 | 0.07 | 1.48 | 1618.55 | 1.00 | 1287 | 135 | 105 | 26 | FALSE | 1.52 |
| colorectal cancer | KRAS_13 | SPEN | Any mutation | 57 | 18 | Signature 15 | -1.83 | -4.23 | -0.18 | 1430.38 | 1.00 | 315 | 57 | 18 | 0 | FALSE | 1.06 |
| colorectal cancer | KRAS_13 | SPEN | Any mutation | 52 | 38 | Signature 1A | 0.19 | -1.01 | 1.23 | 1466.14 | 1.00 | 765 | 48 | 34 | 4 | FALSE | 0.13 |
| colorectal cancer | KRAS_13 | SPEN | Any mutation | 39 | 61 | Signature 6 | -1.11 | -2.36 | -0.04 | 1460.09 | 1.00 | 230 | 36 | 58 | 3 | FALSE | 1.26 |
| colorectal cancer | KRAS_13 | SPEN | Any mutation | 153 | 138 | Signature overall | -0.78 | -2.31 | 0.66 | 1313.14 | 1.00 | 1332 | 144 | 129 | 9 | FALSE | 0.53 |
| colorectal cancer | KRAS_13 | KMT2C | Any mutation | 7 | 32 | Signature 10 | 0.02 | -1.42 | 1.38 | 1429.23 | 1.00 | 19 | 3 | 28 | 4 | FALSE | 0.01 |
| colorectal cancer | KRAS_13 | KMT2C | Any mutation | 57 | 22 | Signature 15 | 0.33 | -0.72 | 1.32 | 1576.41 | 1.00 | 310 | 52 | 17 | 5 | FALSE | 0.29 |
| colorectal cancer | KRAS_13 | KMT2C | Any mutation | 51 | 60 | Signature 1A | 0.40 | -0.49 | 1.24 | 1624.45 | 1.00 | 731 | 45 | 54 | 6 | FALSE | 0.43 |
| colorectal cancer | KRAS_13 | KMT2C | Any mutation | 37 | 65 | Signature 6 | -0.96 | -2.14 | 0.03 | 1382.84 | 1.00 | 216 | 34 | 62 | 3 | FALSE | 1.13 |
| colorectal cancer | KRAS_13 | KMT2C | Any mutation | 152 | 179 | Signature overall | -0.07 | -1.35 | 1.17 | 1471.06 | 1.00 | 1276 | 134 | 161 | 18 | FALSE | 0.04 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 61 | 311 | Signature 15 | -0.44 | -0.88 | 0.01 | 1486.07 | 1.00 | 75 | 22 | 272 | 39 | TRUE | 1.28 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 53 | 655 | Signature 1A | -0.82 | -1.29 | -0.38 | 1331.54 | 1.00 | 208 | 25 | 627 | 28 | TRUE | 3.49 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 8 | 56 | Signature 2 | -0.52 | -1.18 | 0.13 | 1363.82 | 1.00 | 26 | 3 | 51 | 5 | TRUE | 0.95 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 42 | 236 | Signature 6 | -0.32 | -0.82 | 0.20 | 1237.12 | 1.00 | 97 | 15 | 209 | 27 | TRUE | 0.66 |
| colorectal cancer | KRAS_13 | TP53 | Any mutation | 186 | 1607 | Signature overall | -0.61 | -1.00 | -0.19 | 1148.25 | 1.00 | 529 | 71 | 1492 | 115 | TRUE | 2.45 |
| colorectal cancer | KRAS_13 | ATRX | Any mutation | 6 | 19 | Signature 10 | 0.37 | -1.10 | 1.81 | 1488.92 | 1.00 | 23 | 3 | 16 | 3 | TRUE | 0.21 |
| colorectal cancer | KRAS_13 | ATRX | Any mutation | 55 | 46 | Signature 1A | 0.63 | -0.33 | 1.46 | 1484.98 | 1.00 | 756 | 49 | 40 | 6 | TRUE | 0.75 |
| colorectal cancer | KRAS_13 | ATRX | Any mutation | 38 | 29 | Signature 6 | -0.46 | -1.94 | 0.71 | 1489.16 | 1.00 | 249 | 36 | 27 | 2 | TRUE | 0.31 |
| colorectal cancer | KRAS_13 | ATRX | Any mutation | 99 | 94 | Signature overall | 0.16 | -1.38 | 1.78 | 1388.78 | 1.00 | 1028 | 88 | 83 | 11 | TRUE | 0.08 |
| colorectal cancer | KRAS_13 | ATR | Any mutation | 6 | 28 | Signature 10 | 0.03 | -1.47 | 1.43 | 1306.54 | 1.00 | 21 | 3 | 25 | 3 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | ATR | Any mutation | 58 | 12 | Signature 15 | 1.07 | -0.09 | 2.22 | 1506.06 | 1.00 | 323 | 53 | 7 | 5 | FALSE | 1.17 |
| colorectal cancer | KRAS_13 | ATR | Any mutation | 52 | 32 | Signature 1A | -0.10 | -1.71 | 1.14 | 1405.06 | 1.00 | 764 | 50 | 30 | 2 | FALSE | 0.05 |
| colorectal cancer | KRAS_13 | ATR | Any mutation | 38 | 28 | Signature 6 | -0.50 | -2.01 | 0.68 | 1554.28 | 1.00 | 256 | 36 | 26 | 2 | FALSE | 0.34 |
| colorectal cancer | KRAS_13 | ATR | Any mutation | 154 | 100 | Signature overall | 0.08 | -1.35 | 1.50 | 1485.13 | 1.00 | 1364 | 142 | 88 | 12 | FALSE | 0.04 |
| colorectal cancer | KRAS_13 | FBXW7 | Any mutation | 57 | 48 | Signature 15 | 0.38 | -0.35 | 1.04 | 1432.02 | 1.00 | 296 | 48 | 39 | 9 | TRUE | 0.54 |
| colorectal cancer | KRAS_13 | FBXW7 | Any mutation | 56 | 144 | Signature 1A | 0.95 | 0.41 | 1.51 | 1524.86 | 1.00 | 686 | 36 | 124 | 20 | TRUE | 3.09 |
| colorectal cancer | KRAS_13 | FBXW7 | Any mutation | 38 | 78 | Signature 6 | 0.43 | -0.26 | 1.07 | 1484.16 | 1.00 | 215 | 26 | 66 | 12 | TRUE | 0.67 |
| colorectal cancer | KRAS_13 | FBXW7 | Any mutation | 155 | 287 | Signature overall | 0.46 | -0.37 | 1.25 | 1609.39 | 1.00 | 1214 | 113 | 245 | 42 | TRUE | 0.55 |
| colorectal cancer | KRAS_13 | FLT4 | Any mutation | 57 | 14 | Signature 15 | -1.67 | -4.34 | 0.05 | 1297.06 | 1.00 | 315 | 57 | 14 | 0 | TRUE | 0.86 |
| colorectal cancer | KRAS_13 | FLT4 | Any mutation | 52 | 54 | Signature 1A | -0.53 | -1.84 | 0.64 | 1355.14 | 1.00 | 746 | 49 | 51 | 3 | TRUE | 0.40 |
| colorectal cancer | KRAS_13 | FLT4 | Any mutation | 38 | 51 | Signature 6 | -0.48 | -1.50 | 0.43 | 1536.97 | 1.00 | 233 | 33 | 46 | 5 | TRUE | 0.47 |
| colorectal cancer | KRAS_13 | FLT4 | Any mutation | 151 | 133 | Signature overall | -1.02 | -2.69 | 0.32 | 1251.78 | 1.00 | 1317 | 143 | 125 | 8 | TRUE | 0.76 |
| colorectal cancer | KRAS_13 | PTPRD | Any mutation | 57 | 14 | Signature 15 | -1.45 | -3.80 | 0.18 | 1472.31 | 1.00 | 316 | 57 | 14 | 0 | FALSE | 0.79 |
| colorectal cancer | KRAS_13 | PTPRD | Any mutation | 52 | 31 | Signature 1A | 0.09 | -1.28 | 1.27 | 1615.99 | 1.00 | 768 | 49 | 28 | 3 | FALSE | 0.05 |
| colorectal cancer | KRAS_13 | PTPRD | Any mutation | 38 | 31 | Signature 6 | -0.42 | -1.65 | 0.67 | 1457.84 | 1.00 | 250 | 35 | 28 | 3 | FALSE | 0.32 |
| colorectal cancer | KRAS_13 | PTPRD | Any mutation | 152 | 95 | Signature overall | -0.48 | -2.01 | 0.93 | 1374.40 | 1.00 | 1357 | 144 | 87 | 8 | FALSE | 0.29 |
| colorectal cancer | KRAS_13 | CREBBP | Any mutation | 57 | 27 | Signature 15 | -0.34 | -1.47 | 0.62 | 1593.47 | 1.00 | 309 | 54 | 24 | 3 | TRUE | 0.28 |
| colorectal cancer | KRAS_13 | CREBBP | Any mutation | 52 | 45 | Signature 1A | 0.57 | -0.46 | 1.44 | 1597.01 | 1.00 | 759 | 46 | 39 | 6 | TRUE | 0.63 |
| colorectal cancer | KRAS_13 | CREBBP | Any mutation | 40 | 80 | Signature 6 | -0.53 | -1.44 | 0.25 | 1656.17 | 1.00 | 221 | 34 | 74 | 6 | TRUE | 0.65 |
| colorectal cancer | KRAS_13 | CREBBP | Any mutation | 153 | 167 | Signature overall | -0.16 | -1.43 | 0.99 | 1325.80 | 1.00 | 1312 | 137 | 151 | 16 | TRUE | 0.10 |
| colorectal cancer | KRAS_13 | AXIN2 | Any mutation | 57 | 17 | Signature 15 | -1.18 | -3.84 | 0.26 | 1572.90 | 1.00 | 313 | 57 | 17 | 0 | TRUE | 0.59 |
| colorectal cancer | KRAS_13 | AXIN2 | Any mutation | 52 | 36 | Signature 1A | 0.26 | -0.84 | 1.24 | 1544.43 | 1.00 | 765 | 48 | 32 | 4 | TRUE | 0.20 |
| colorectal cancer | KRAS_13 | AXIN2 | Any mutation | 39 | 40 | Signature 6 | -0.07 | -1.03 | 0.84 | 1448.12 | 1.00 | 247 | 34 | 35 | 5 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | AXIN2 | Any mutation | 148 | 93 | Signature overall | -0.32 | -2.04 | 0.95 | 1479.39 | 1.00 | 1325 | 139 | 84 | 9 | TRUE | 0.18 |
| colorectal cancer | KRAS_13 | PTPRS | Any mutation | 58 | 38 | Signature 15 | -0.36 | -1.29 | 0.53 | 1370.61 | 1.00 | 290 | 54 | 34 | 4 | FALSE | 0.36 |
| colorectal cancer | KRAS_13 | PTPRS | Any mutation | 50 | 95 | Signature 1A | 0.72 | 0.04 | 1.38 | 1545.68 | 1.00 | 701 | 38 | 83 | 12 | FALSE | 1.41 |
| colorectal cancer | KRAS_13 | PTPRS | Any mutation | 38 | 83 | Signature 6 | -0.47 | -1.36 | 0.28 | 1314.05 | 1.00 | 213 | 32 | 77 | 6 | FALSE | 0.59 |
| colorectal cancer | KRAS_13 | PTPRS | Any mutation | 151 | 232 | Signature overall | -0.02 | -1.01 | 1.01 | 1591.64 | 1.00 | 1225 | 127 | 208 | 24 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | SMARCA4 | Any mutation | 57 | 22 | Signature 15 | -0.57 | -1.75 | 0.54 | 1380.60 | 1.00 | 314 | 55 | 20 | 2 | FALSE | 0.48 |
| colorectal cancer | KRAS_13 | SMARCA4 | Any mutation | 54 | 74 | Signature 1A | 0.13 | -0.74 | 0.93 | 1345.76 | 1.00 | 738 | 47 | 67 | 7 | FALSE | 0.12 |
| colorectal cancer | KRAS_13 | SMARCA4 | Any mutation | 38 | 52 | Signature 6 | -0.90 | -2.13 | 0.06 | 1501.28 | 1.00 | 238 | 36 | 50 | 2 | FALSE | 0.95 |
| colorectal cancer | KRAS_13 | SMARCA4 | Any mutation | 149 | 148 | Signature overall | -0.44 | -1.64 | 0.66 | 1420.97 | 1.00 | 1290 | 138 | 137 | 11 | FALSE | 0.34 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 8 | 23 | Signature 10 | 0.65 | -0.57 | 1.90 | 1516.03 | 1.00 | 21 | 3 | 18 | 5 | FALSE | 0.53 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 57 | 25 | Signature 15 | -0.43 | -1.73 | 0.63 | 1362.41 | 1.00 | 306 | 55 | 23 | 2 | FALSE | 0.33 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 52 | 66 | Signature 1A | 0.79 | -0.01 | 1.51 | 1485.57 | 1.00 | 738 | 43 | 57 | 9 | FALSE | 1.37 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 38 | 43 | Signature 6 | -0.02 | -0.92 | 0.80 | 1370.35 | 1.00 | 238 | 33 | 38 | 5 | FALSE | 0.01 |
| colorectal cancer | KRAS_13 | PTPRT | Any mutation | 155 | 157 | Signature overall | 0.23 | -0.95 | 1.33 | 1428.42 | 1.00 | 1303 | 134 | 136 | 21 | FALSE | 0.17 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 57 | 63 | Signature 15 | 0.35 | -0.31 | 0.96 | 1551.02 | 1.00 | 281 | 46 | 52 | 11 | TRUE | 0.56 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 56 | 191 | Signature 1A | 0.81 | 0.29 | 1.32 | 1439.71 | 1.00 | 639 | 34 | 169 | 22 | TRUE | 2.74 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 9 | 43 | Signature 2 | 0.87 | -0.04 | 1.82 | 1439.11 | 1.00 | 40 | 2 | 36 | 7 | TRUE | 1.19 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 43 | 95 | Signature 6 | 0.84 | 0.23 | 1.40 | 1398.72 | 1.00 | 208 | 23 | 75 | 20 | TRUE | 2.31 |
| colorectal cancer | KRAS_13 | PIK3CA | Any mutation | 171 | 434 | Signature overall | 0.62 | -0.04 | 1.28 | 1563.38 | 1.00 | 1214 | 108 | 371 | 63 | TRUE | 1.18 |
| colorectal cancer | KRAS_13 | ALK | Any mutation | 57 | 16 | Signature 15 | 0.38 | -0.77 | 1.42 | 1690.37 | 1.00 | 315 | 54 | 13 | 3 | TRUE | 0.32 |
| colorectal cancer | KRAS_13 | ALK | Any mutation | 54 | 35 | Signature 1A | 1.15 | 0.35 | 1.95 | 1564.96 | 1.00 | 766 | 47 | 28 | 7 | TRUE | 2.21 |
| colorectal cancer | KRAS_13 | ALK | Any mutation | 38 | 37 | Signature 6 | 0.49 | -0.38 | 1.31 | 1430.00 | 1.00 | 249 | 32 | 31 | 6 | TRUE | 0.59 |
| colorectal cancer | KRAS_13 | ALK | Any mutation | 154 | 101 | Signature overall | 0.76 | -0.37 | 1.78 | 1490.21 | 1.00 | 1354 | 135 | 82 | 19 | TRUE | 0.82 |
| colorectal cancer | KRAS_13 | RNF43 | Any mutation | 57 | 31 | Signature 15 | -2.19 | -5.41 | -0.37 | 1501.28 | 1.00 | 307 | 57 | 31 | 0 | TRUE | 0.98 |
| colorectal cancer | KRAS_13 | RNF43 | Any mutation | 55 | 93 | Signature 1A | 0.88 | 0.19 | 1.53 | 1512.95 | 1.00 | 739 | 42 | 80 | 13 | TRUE | 1.91 |
| colorectal cancer | KRAS_13 | RNF43 | Any mutation | 41 | 102 | Signature 6 | -0.65 | -1.48 | 0.13 | 1379.36 | 1.00 | 205 | 33 | 94 | 8 | TRUE | 0.96 |
| colorectal cancer | KRAS_13 | RNF43 | Any mutation | 153 | 226 | Signature overall | -0.62 | -2.71 | 0.95 | 1336.27 | 1.00 | 1251 | 132 | 205 | 21 | TRUE | 0.31 |
| colorectal cancer | KRAS_13 | PTEN | Any mutation | 57 | 22 | Signature 15 | 0.44 | -0.47 | 1.31 | 1424.97 | 1.00 | 312 | 52 | 17 | 5 | TRUE | 0.46 |
| colorectal cancer | KRAS_13 | PTEN | Any mutation | 56 | 64 | Signature 1A | 1.15 | 0.41 | 1.80 | 1681.44 | 1.00 | 753 | 44 | 52 | 12 | TRUE | 2.89 |
| colorectal cancer | KRAS_13 | PTEN | Any mutation | 38 | 57 | Signature 6 | -0.35 | -1.34 | 0.53 | 1541.56 | 1.00 | 240 | 34 | 53 | 4 | TRUE | 0.33 |
| colorectal cancer | KRAS_13 | PTEN | Any mutation | 156 | 156 | Signature overall | 0.41 | -0.69 | 1.42 | 1386.53 | 1.00 | 1327 | 133 | 133 | 23 | TRUE | 0.35 |
| colorectal cancer | KRAS_13 | BCOR | Any mutation | 57 | 13 | Signature 15 | -0.55 | -2.15 | 0.80 | 1587.51 | 1.00 | 317 | 56 | 12 | 1 | FALSE | 0.33 |
| colorectal cancer | KRAS_13 | BCOR | Any mutation | 52 | 27 | Signature 1A | 0.59 | -0.64 | 1.66 | 1538.53 | 1.00 | 770 | 48 | 23 | 4 | FALSE | 0.50 |
| colorectal cancer | KRAS_13 | BCOR | Any mutation | 40 | 49 | Signature 6 | -0.24 | -1.22 | 0.67 | 1550.43 | 1.00 | 241 | 35 | 44 | 5 | FALSE | 0.21 |
| colorectal cancer | KRAS_13 | BCOR | Any mutation | 153 | 100 | Signature overall | -0.06 | -1.35 | 1.16 | 1522.13 | 1.00 | 1351 | 142 | 89 | 11 | FALSE | 0.03 |
| colorectal cancer | KRAS_13 | CTNNB1 | Any mutation | 57 | 22 | Signature 15 | 0.30 | -0.85 | 1.19 | 1478.25 | 1.00 | 310 | 54 | 19 | 3 | TRUE | 0.26 |
| colorectal cancer | KRAS_13 | CTNNB1 | Any mutation | 52 | 61 | Signature 1A | 0.98 | 0.31 | 1.66 | 1419.43 | 1.00 | 745 | 42 | 51 | 10 | TRUE | 2.34 |
| colorectal cancer | KRAS_13 | CTNNB1 | Any mutation | 38 | 33 | Signature 6 | 0.75 | -0.06 | 1.51 | 1344.53 | 1.00 | 250 | 31 | 26 | 7 | TRUE | 1.25 |
| colorectal cancer | KRAS_13 | CTNNB1 | Any mutation | 147 | 116 | Signature overall | 0.68 | -0.25 | 1.50 | 1595.41 | 1.00 | 1305 | 127 | 96 | 20 | TRUE | 0.89 |
| colorectal cancer | KRAS_13 | ARID1A | Any mutation | 58 | 39 | Signature 15 | -0.31 | -1.25 | 0.49 | 1406.35 | 1.00 | 308 | 54 | 35 | 4 | TRUE | 0.31 |
| colorectal cancer | KRAS_13 | ARID1A | Any mutation | 57 | 130 | Signature 1A | 0.47 | -0.16 | 1.09 | 1520.98 | 1.00 | 710 | 43 | 116 | 14 | TRUE | 0.87 |
| colorectal cancer | KRAS_13 | ARID1A | Any mutation | 39 | 99 | Signature 6 | -0.34 | -1.08 | 0.37 | 1502.27 | 1.00 | 212 | 31 | 91 | 8 | TRUE | 0.44 |
| colorectal cancer | KRAS_13 | ARID1A | Any mutation | 159 | 281 | Signature overall | 0.00 | -0.88 | 0.83 | 1272.69 | 1.00 | 1253 | 131 | 253 | 28 | TRUE | 0.00 |
| colorectal cancer | KRAS_13 | PIK3R1 | Any mutation | 57 | 17 | Signature 15 | -0.38 | -1.76 | 0.78 | 1483.03 | 1.00 | 316 | 55 | 15 | 2 | TRUE | 0.25 |
| colorectal cancer | KRAS_13 | PIK3R1 | Any mutation | 52 | 31 | Signature 1A | -0.16 | -1.61 | 1.06 | 1355.66 | 1.00 | 767 | 50 | 29 | 2 | TRUE | 0.09 |
| colorectal cancer | KRAS_13 | PIK3R1 | Any mutation | 38 | 31 | Signature 6 | -0.08 | -1.18 | 0.93 | 1526.27 | 1.00 | 250 | 34 | 27 | 4 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | PIK3R1 | Any mutation | 151 | 96 | Signature overall | -0.26 | -1.61 | 1.05 | 1298.74 | 1.00 | 1354 | 142 | 87 | 9 | TRUE | 0.16 |
| colorectal cancer | KRAS_13 | FAT1 | Any mutation | 11 | 44 | Signature 10 | 0.47 | -0.72 | 1.72 | 1430.30 | 1.00 | 20 | 3 | 36 | 8 | FALSE | 0.34 |
| colorectal cancer | KRAS_13 | FAT1 | Any mutation | 57 | 29 | Signature 15 | -1.14 | -2.76 | 0.18 | 1399.37 | 1.00 | 309 | 56 | 28 | 1 | FALSE | 0.88 |
| colorectal cancer | KRAS_13 | FAT1 | Any mutation | 54 | 66 | Signature 1A | 0.94 | 0.10 | 1.67 | 1508.35 | 1.00 | 748 | 44 | 56 | 10 | FALSE | 1.76 |
| colorectal cancer | KRAS_13 | FAT1 | Any mutation | 41 | 67 | Signature 6 | 0.08 | -0.72 | 0.80 | 1409.05 | 1.00 | 229 | 32 | 58 | 9 | FALSE | 0.08 |
| colorectal cancer | KRAS_13 | FAT1 | Any mutation | 163 | 206 | Signature overall | 0.10 | -1.32 | 1.46 | 1446.77 | 1.00 | 1306 | 135 | 178 | 28 | FALSE | 0.05 |
| colorectal cancer | KRAS_13 | CIC | Any mutation | 57 | 19 | Signature 15 | -0.76 | -2.33 | 0.39 | 1452.77 | 1.00 | 317 | 56 | 18 | 1 | TRUE | 0.56 |
| colorectal cancer | KRAS_13 | CIC | Any mutation | 54 | 58 | Signature 1A | 0.38 | -0.56 | 1.19 | 1323.49 | 1.00 | 750 | 47 | 51 | 7 | TRUE | 0.40 |
| colorectal cancer | KRAS_13 | CIC | Any mutation | 38 | 43 | Signature 6 | -0.78 | -2.07 | 0.24 | 1171.17 | 1.00 | 243 | 36 | 41 | 2 | TRUE | 0.72 |
| colorectal cancer | KRAS_13 | CIC | Any mutation | 149 | 120 | Signature overall | -0.35 | -1.64 | 0.84 | 1220.74 | 1.00 | 1310 | 139 | 110 | 10 | TRUE | 0.24 |
| colorectal cancer | KRAS_13 | NCOR1 | Any mutation | 57 | 22 | Signature 15 | 0.07 | -1.02 | 1.04 | 1619.24 | 1.00 | 313 | 53 | 18 | 4 | FALSE | 0.05 |
| colorectal cancer | KRAS_13 | NCOR1 | Any mutation | 53 | 44 | Signature 1A | -0.06 | -1.22 | 0.88 | 1410.46 | 1.00 | 758 | 50 | 41 | 3 | FALSE | 0.04 |
| colorectal cancer | KRAS_13 | NCOR1 | Any mutation | 39 | 43 | Signature 6 | -0.10 | -1.06 | 0.74 | 1328.33 | 1.00 | 244 | 34 | 38 | 5 | FALSE | 0.08 |
| colorectal cancer | KRAS_13 | NCOR1 | Any mutation | 153 | 125 | Signature overall | -0.09 | -1.33 | 1.14 | 1407.32 | 1.00 | 1336 | 140 | 112 | 13 | FALSE | 0.06 |
| colorectal cancer | KRAS_13 | POLE | Any mutation | 57 | 19 | Signature 15 | -0.74 | -2.35 | 0.60 | 1462.85 | 1.00 | 314 | 56 | 18 | 1 | TRUE | 0.49 |
| colorectal cancer | KRAS_13 | POLE | Any mutation | 54 | 36 | Signature 1A | 0.88 | -0.14 | 1.74 | 1331.81 | 1.01 | 766 | 48 | 30 | 6 | TRUE | 1.18 |
| colorectal cancer | KRAS_13 | POLE | Any mutation | 39 | 54 | Signature 6 | 0.08 | -0.81 | 0.87 | 1502.20 | 1.00 | 235 | 32 | 47 | 7 | TRUE | 0.07 |
| colorectal cancer | KRAS_13 | POLE | Any mutation | 155 | 129 | Signature overall | 0.18 | -1.12 | 1.43 | 1474.77 | 1.00 | 1335 | 138 | 112 | 17 | TRUE | 0.11 |
| colorectal cancer | KRAS_13 | TGFBR2 | Any mutation | 57 | 11 | Signature 15 | 0.13 | -1.29 | 1.18 | 1553.54 | 1.00 | 320 | 55 | 9 | 2 | TRUE | 0.08 |
| colorectal cancer | KRAS_13 | TGFBR2 | Any mutation | 52 | 48 | Signature 1A | 0.59 | -0.30 | 1.39 | 1509.33 | 1.00 | 755 | 46 | 42 | 6 | TRUE | 0.76 |
| colorectal cancer | KRAS_13 | TGFBR2 | Any mutation | 38 | 43 | Signature 6 | 0.04 | -0.87 | 0.92 | 1367.66 | 1.00 | 237 | 33 | 38 | 5 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | TGFBR2 | Any mutation | 147 | 102 | Signature overall | 0.26 | -1.01 | 1.49 | 1494.09 | 1.00 | 1312 | 134 | 89 | 13 | TRUE | 0.17 |
| colorectal cancer | KRAS_13 | KMT2A | Any mutation | 7 | 22 | Signature 10 | 0.44 | -0.86 | 1.75 | 1450.91 | 1.00 | 24 | 3 | 18 | 4 | FALSE | 0.31 |
| colorectal cancer | KRAS_13 | KMT2A | Any mutation | 58 | 19 | Signature 15 | -0.37 | -1.69 | 0.72 | 1508.74 | 1.00 | 313 | 56 | 17 | 2 | FALSE | 0.25 |
| colorectal cancer | KRAS_13 | KMT2A | Any mutation | 54 | 53 | Signature 1A | 0.84 | 0.01 | 1.61 | 1506.85 | 1.00 | 751 | 46 | 45 | 8 | FALSE | 1.40 |
| colorectal cancer | KRAS_13 | KMT2A | Any mutation | 38 | 42 | Signature 6 | -0.78 | -2.11 | 0.28 | 1406.21 | 1.00 | 243 | 36 | 40 | 2 | FALSE | 0.70 |
| colorectal cancer | KRAS_13 | KMT2A | Any mutation | 157 | 136 | Signature overall | 0.04 | -1.26 | 1.30 | 1312.56 | 1.00 | 1331 | 141 | 120 | 16 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | BRCA2 | Any mutation | 7 | 37 | Signature 10 | -0.02 | -1.44 | 1.35 | 1478.25 | 1.00 | 22 | 3 | 33 | 4 | TRUE | 0.01 |
| colorectal cancer | KRAS_13 | BRCA2 | Any mutation | 57 | 17 | Signature 15 | -0.85 | -2.56 | 0.50 | 1493.99 | 1.00 | 317 | 56 | 16 | 1 | TRUE | 0.53 |
| colorectal cancer | KRAS_13 | BRCA2 | Any mutation | 56 | 50 | Signature 1A | 1.23 | 0.45 | 1.97 | 1452.46 | 1.00 | 758 | 46 | 40 | 10 | TRUE | 2.81 |
| colorectal cancer | KRAS_13 | BRCA2 | Any mutation | 40 | 62 | Signature 6 | -0.48 | -1.44 | 0.38 | 1451.52 | 1.00 | 233 | 35 | 57 | 5 | TRUE | 0.51 |
| colorectal cancer | KRAS_13 | BRCA2 | Any mutation | 160 | 166 | Signature overall | -0.06 | -1.53 | 1.36 | 1456.89 | 1.00 | 1330 | 140 | 146 | 20 | TRUE | 0.03 |
| colorectal cancer | KRAS_13 | NOTCH3 | Any mutation | 57 | 27 | Signature 15 | -0.06 | -0.99 | 0.85 | 1200.05 | 1.00 | 310 | 53 | 23 | 4 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | NOTCH3 | Any mutation | 52 | 70 | Signature 1A | 0.19 | -0.64 | 1.01 | 1602.13 | 1.00 | 741 | 46 | 64 | 6 | TRUE | 0.18 |
| colorectal cancer | KRAS_13 | NOTCH3 | Any mutation | 39 | 72 | Signature 6 | -0.19 | -0.97 | 0.56 | 1343.23 | 1.00 | 227 | 32 | 65 | 7 | TRUE | 0.20 |
| colorectal cancer | KRAS_13 | NOTCH3 | Any mutation | 148 | 169 | Signature overall | -0.01 | -1.06 | 1.11 | 1549.96 | 1.00 | 1278 | 131 | 152 | 17 | TRUE | 0.00 |
| colorectal cancer | KRAS_13 | NOTCH4 | Any mutation | 57 | 18 | Signature 15 | -0.72 | -2.12 | 0.42 | 1487.19 | 1.00 | 305 | 56 | 17 | 1 | TRUE | 0.57 |
| colorectal cancer | KRAS_13 | NOTCH4 | Any mutation | 50 | 43 | Signature 1A | -0.21 | -1.35 | 0.80 | 1183.13 | 1.00 | 736 | 47 | 40 | 3 | TRUE | 0.15 |
| colorectal cancer | KRAS_13 | NOTCH4 | Any mutation | 38 | 41 | Signature 6 | -0.38 | -1.32 | 0.52 | 1538.40 | 1.00 | 234 | 34 | 37 | 4 | TRUE | 0.36 |
| colorectal cancer | KRAS_13 | NOTCH4 | Any mutation | 145 | 102 | Signature overall | -0.44 | -1.59 | 0.65 | 1598.77 | 1.00 | 1275 | 137 | 94 | 8 | TRUE | 0.37 |
| colorectal cancer | KRAS_13 | ERBB3 | Any mutation | 57 | 18 | Signature 15 | 0.25 | -0.90 | 1.16 | 1410.36 | 1.00 | 313 | 54 | 15 | 3 | TRUE | 0.21 |
| colorectal cancer | KRAS_13 | ERBB3 | Any mutation | 53 | 46 | Signature 1A | 0.91 | 0.12 | 1.72 | 1570.06 | 1.00 | 762 | 45 | 38 | 8 | TRUE | 1.61 |
| colorectal cancer | KRAS_13 | ERBB3 | Any mutation | 39 | 34 | Signature 6 | 0.19 | -0.77 | 1.03 | 1530.26 | 1.00 | 247 | 35 | 30 | 4 | TRUE | 0.17 |
| colorectal cancer | KRAS_13 | ERBB3 | Any mutation | 149 | 98 | Signature overall | 0.46 | -0.59 | 1.44 | 1581.90 | 1.00 | 1322 | 134 | 83 | 15 | TRUE | 0.41 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 57 | 60 | Signature 15 | -0.65 | -1.47 | 0.08 | 1595.07 | 1.00 | 278 | 52 | 55 | 5 | TRUE | 1.01 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 52 | 122 | Signature 1A | -0.97 | -1.88 | -0.14 | 1523.10 | 1.00 | 683 | 50 | 120 | 2 | TRUE | 1.50 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 8 | 11 | Signature 2 | -0.06 | -1.17 | 1.18 | 1526.08 | 1.00 | 66 | 5 | 8 | 3 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 38 | 57 | Signature 6 | -0.63 | -1.48 | 0.17 | 1600.32 | 1.00 | 228 | 34 | 53 | 4 | TRUE | 0.90 |
| colorectal cancer | KRAS_13 | SMAD4 | Any mutation | 164 | 301 | Signature overall | -0.56 | -1.28 | 0.18 | 1557.90 | 1.00 | 1369 | 147 | 284 | 17 | TRUE | 0.90 |
| colorectal cancer | KRAS_13 | ATM | Any mutation | 9 | 39 | Signature 10 | 0.26 | -0.87 | 1.49 | 1487.16 | 1.00 | 19 | 3 | 33 | 6 | TRUE | 0.18 |
| colorectal cancer | KRAS_13 | ATM | Any mutation | 58 | 32 | Signature 15 | 0.40 | -0.49 | 1.20 | 1511.92 | 1.00 | 307 | 51 | 25 | 7 | TRUE | 0.45 |
| colorectal cancer | KRAS_13 | ATM | Any mutation | 53 | 77 | Signature 1A | 0.66 | -0.09 | 1.36 | 1263.03 | 1.00 | 734 | 44 | 68 | 9 | TRUE | 1.12 |
| colorectal cancer | KRAS_13 | ATM | Any mutation | 38 | 48 | Signature 6 | -0.94 | -2.32 | 0.18 | 1471.26 | 1.00 | 236 | 36 | 46 | 2 | TRUE | 0.88 |
| colorectal cancer | KRAS_13 | ATM | Any mutation | 158 | 196 | Signature overall | 0.10 | -1.15 | 1.31 | 1449.80 | 1.00 | 1296 | 134 | 172 | 24 | TRUE | 0.06 |
| colorectal cancer | KRAS_13 | KMT2D | Any mutation | 57 | 55 | Signature 15 | -0.92 | -2.01 | -0.04 | 1352.12 | 1.00 | 299 | 54 | 52 | 3 | FALSE | 1.17 |
| colorectal cancer | KRAS_13 | KMT2D | Any mutation | 55 | 128 | Signature 1A | 0.45 | -0.23 | 1.07 | 1344.19 | 1.00 | 722 | 42 | 115 | 13 | FALSE | 0.73 |
| colorectal cancer | KRAS_13 | KMT2D | Any mutation | 43 | 142 | Signature 6 | -0.57 | -1.29 | 0.08 | 1422.27 | 1.00 | 199 | 32 | 131 | 11 | FALSE | 1.00 |
| colorectal cancer | KRAS_13 | KMT2D | Any mutation | 160 | 344 | Signature overall | -0.31 | -1.33 | 0.70 | 1488.64 | 1.00 | 1240 | 131 | 315 | 29 | FALSE | 0.27 |
| colorectal cancer | KRAS_13 | TSC2 | Any mutation | 57 | 11 | Signature 15 | -0.49 | -2.12 | 0.82 | 1485.97 | 1.00 | 318 | 56 | 10 | 1 | TRUE | 0.29 |
| colorectal cancer | KRAS_13 | TSC2 | Any mutation | 53 | 36 | Signature 1A | 0.27 | -0.94 | 1.29 | 1441.13 | 1.00 | 767 | 49 | 32 | 4 | TRUE | 0.20 |
| colorectal cancer | KRAS_13 | TSC2 | Any mutation | 38 | 44 | Signature 6 | -0.54 | -1.75 | 0.41 | 1460.04 | 1.00 | 241 | 35 | 41 | 3 | TRUE | 0.48 |
| colorectal cancer | KRAS_13 | TSC2 | Any mutation | 148 | 91 | Signature overall | -0.24 | -1.64 | 1.07 | 1331.72 | 1.00 | 1326 | 140 | 83 | 8 | TRUE | 0.14 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 14 | 94 | Signature 10 | 0.69 | -0.12 | 1.55 | 1351.21 | 1.00 | 3 | 0 | 80 | 14 | TRUE | 1.00 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 89 | 469 | Signature 15 | 0.79 | 0.24 | 1.38 | 1679.43 | 1.00 | 76 | 7 | 387 | 82 | TRUE | 2.11 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 74 | 962 | Signature 1A | 0.04 | -0.47 | 0.56 | 1443.48 | 1.00 | 206 | 15 | 903 | 59 | TRUE | 0.06 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 13 | 95 | Signature 2 | 0.42 | -0.37 | 1.21 | 1617.12 | 1.00 | 15 | 2 | 84 | 11 | TRUE | 0.53 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 57 | 355 | Signature 6 | 0.30 | -0.28 | 0.89 | 1598.67 | 1.00 | 83 | 12 | 310 | 45 | TRUE | 0.51 |
| colorectal cancer | KRAS_13 | APC | Any mutation | 275 | 2462 | Signature overall | 0.25 | -0.25 | 0.76 | 1522.78 | 1.00 | 513 | 38 | 2225 | 237 | TRUE | 0.50 |
| colorectal cancer | KRAS_13 | ERBB2 | Any mutation | 53 | 47 | Signature 1A | 1.02 | 0.17 | 1.78 | 1490.57 | 1.00 | 758 | 45 | 39 | 8 | TRUE | 1.89 |
| colorectal cancer | KRAS_13 | ERBB2 | Any mutation | 38 | 29 | Signature 6 | 0.42 | -0.72 | 1.34 | 1422.12 | 1.00 | 252 | 34 | 25 | 4 | TRUE | 0.39 |
| colorectal cancer | KRAS_13 | ERBB2 | Any mutation | 91 | 76 | Signature overall | 0.71 | -0.77 | 2.04 | 1535.12 | 1.00 | 1010 | 79 | 64 | 12 | TRUE | 0.49 |
| colorectal cancer | KRAS_13 | ARID2 | Any mutation | 57 | 19 | Signature 15 | -0.39 | -1.71 | 0.74 | 1331.42 | 1.00 | 314 | 55 | 17 | 2 | FALSE | 0.28 |
| colorectal cancer | KRAS_13 | ARID2 | Any mutation | 53 | 42 | Signature 1A | 0.16 | -0.97 | 1.15 | 1363.79 | 1.00 | 759 | 49 | 38 | 4 | FALSE | 0.12 |
| colorectal cancer | KRAS_13 | ARID2 | Any mutation | 38 | 27 | Signature 6 | -0.21 | -1.42 | 0.79 | 1762.60 | 1.00 | 251 | 35 | 24 | 3 | FALSE | 0.15 |
| colorectal cancer | KRAS_13 | ARID2 | Any mutation | 152 | 104 | Signature overall | -0.19 | -1.49 | 1.04 | 1288.79 | 1.00 | 1344 | 142 | 94 | 10 | FALSE | 0.12 |
| colorectal cancer | KRAS_13 | MTOR | Any mutation | 57 | 17 | Signature 15 | 0.16 | -1.00 | 1.17 | 1467.56 | 1.00 | 316 | 54 | 14 | 3 | TRUE | 0.11 |
| colorectal cancer | KRAS_13 | MTOR | Any mutation | 53 | 48 | Signature 1A | 0.94 | 0.08 | 1.74 | 1378.17 | 1.00 | 758 | 45 | 40 | 8 | TRUE | 1.59 |
| colorectal cancer | KRAS_13 | MTOR | Any mutation | 41 | 45 | Signature 6 | -0.06 | -0.97 | 0.76 | 1535.99 | 1.00 | 239 | 36 | 40 | 5 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | MTOR | Any mutation | 155 | 122 | Signature overall | 0.28 | -0.83 | 1.25 | 1408.67 | 1.00 | 1337 | 138 | 105 | 17 | TRUE | 0.22 |
| colorectal cancer | KRAS_13 | NOTCH1 | Any mutation | 57 | 17 | Signature 15 | -1.81 | -4.92 | 0.04 | 1542.52 | 1.00 | 317 | 57 | 17 | 0 | TRUE | 0.78 |
| colorectal cancer | KRAS_13 | NOTCH1 | Any mutation | 57 | 47 | Signature 1A | 1.38 | 0.60 | 2.13 | 1299.02 | 1.00 | 759 | 46 | 36 | 11 | TRUE | 3.43 |
| colorectal cancer | KRAS_13 | NOTCH1 | Any mutation | 40 | 82 | Signature 6 | -0.49 | -1.36 | 0.30 | 1508.03 | 1.00 | 219 | 33 | 75 | 7 | TRUE | 0.61 |
| colorectal cancer | KRAS_13 | NOTCH1 | Any mutation | 158 | 157 | Signature overall | -0.56 | -2.57 | 0.91 | 1643.23 | 1.00 | 1319 | 140 | 139 | 18 | TRUE | 0.28 |
| colorectal cancer | KRAS_13 | SETD2 | Any mutation | 7 | 22 | Signature 10 | 0.48 | -0.85 | 1.85 | 1577.89 | 1.00 | 21 | 3 | 18 | 4 | FALSE | 0.31 |
| colorectal cancer | KRAS_13 | SETD2 | Any mutation | 58 | 13 | Signature 15 | -0.04 | -1.47 | 1.17 | 1436.58 | 1.00 | 318 | 56 | 11 | 2 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | SETD2 | Any mutation | 52 | 31 | Signature 1A | 1.12 | 0.15 | 2.00 | 1493.54 | 1.00 | 770 | 46 | 25 | 6 | FALSE | 1.77 |
| colorectal cancer | KRAS_13 | SETD2 | Any mutation | 39 | 39 | Signature 6 | -0.46 | -1.66 | 0.51 | 1504.08 | 1.00 | 242 | 36 | 36 | 3 | FALSE | 0.39 |
| colorectal cancer | KRAS_13 | SETD2 | Any mutation | 156 | 105 | Signature overall | 0.30 | -1.04 | 1.70 | 1392.46 | 1.00 | 1351 | 141 | 90 | 15 | FALSE | 0.18 |
| colorectal cancer | KRAS_13 | EPHA3 | Any mutation | 6 | 14 | Signature 10 | 0.55 | -0.85 | 1.90 | 1509.95 | 1.00 | 25 | 3 | 11 | 3 | FALSE | 0.38 |
| colorectal cancer | KRAS_13 | EPHA3 | Any mutation | 57 | 13 | Signature 15 | -0.41 | -2.05 | 0.81 | 1555.98 | 1.00 | 316 | 56 | 12 | 1 | FALSE | 0.24 |
| colorectal cancer | KRAS_13 | EPHA3 | Any mutation | 52 | 42 | Signature 1A | 0.73 | -0.22 | 1.59 | 1187.31 | 1.00 | 759 | 46 | 36 | 6 | FALSE | 0.93 |
| colorectal cancer | KRAS_13 | EPHA3 | Any mutation | 38 | 26 | Signature 6 | -0.36 | -1.67 | 0.81 | 1458.36 | 1.00 | 251 | 36 | 24 | 2 | FALSE | 0.23 |
| colorectal cancer | KRAS_13 | EPHA3 | Any mutation | 153 | 95 | Signature overall | 0.13 | -1.08 | 1.25 | 1463.64 | 1.00 | 1351 | 141 | 83 | 12 | FALSE | 0.08 |
| colorectal cancer | KRAS_13 | PTCH1 | Any mutation | 57 | 14 | Signature 15 | -0.10 | -1.41 | 1.03 | 1350.45 | 1.00 | 319 | 55 | 12 | 2 | TRUE | 0.06 |
| colorectal cancer | KRAS_13 | PTCH1 | Any mutation | 55 | 55 | Signature 1A | 0.88 | 0.07 | 1.70 | 1408.58 | 1.00 | 753 | 46 | 46 | 9 | TRUE | 1.49 |
| colorectal cancer | KRAS_13 | PTCH1 | Any mutation | 43 | 53 | Signature 6 | 0.04 | -0.86 | 0.81 | 1521.96 | 1.00 | 240 | 36 | 46 | 7 | TRUE | 0.03 |
| colorectal cancer | KRAS_13 | PTCH1 | Any mutation | 159 | 133 | Signature overall | 0.06 | -1.22 | 1.15 | 1443.55 | 1.00 | 1335 | 141 | 115 | 18 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | TET1 | Any mutation | 10 | 27 | Signature 10 | 0.73 | -0.54 | 2.11 | 1387.73 | 1.00 | 20 | 3 | 20 | 7 | FALSE | 0.55 |
| colorectal cancer | KRAS_13 | TET1 | Any mutation | 57 | 18 | Signature 15 | -1.08 | -3.11 | 0.42 | 1496.55 | 1.00 | 307 | 56 | 17 | 1 | FALSE | 0.65 |
| colorectal cancer | KRAS_13 | TET1 | Any mutation | 50 | 25 | Signature 1A | 1.10 | -0.12 | 2.12 | 1500.43 | 1.00 | 753 | 45 | 20 | 5 | FALSE | 1.31 |
| colorectal cancer | KRAS_13 | TET1 | Any mutation | 37 | 28 | Signature 6 | -2.03 | -5.11 | -0.09 | 1426.93 | 1.00 | 241 | 37 | 28 | 0 | FALSE | 0.96 |
| colorectal cancer | KRAS_13 | TET1 | Any mutation | 154 | 98 | Signature overall | -0.32 | -2.21 | 1.40 | 1406.33 | 1.00 | 1321 | 141 | 85 | 13 | FALSE | 0.14 |
| colorectal cancer | KRAS_13 | SMAD3 | Any mutation | 57 | 21 | Signature 15 | -0.07 | -1.12 | 0.84 | 1239.57 | 1.00 | 314 | 54 | 18 | 3 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | SMAD3 | Any mutation | 52 | 38 | Signature 1A | 0.14 | -0.85 | 1.09 | 1402.58 | 1.00 | 764 | 48 | 34 | 4 | TRUE | 0.11 |
| colorectal cancer | KRAS_13 | SMAD3 | Any mutation | 38 | 20 | Signature 6 | -0.32 | -1.68 | 0.66 | 1466.32 | 1.00 | 255 | 37 | 19 | 1 | TRUE | 0.23 |
| colorectal cancer | KRAS_13 | SMAD3 | Any mutation | 147 | 79 | Signature overall | -0.10 | -1.16 | 0.83 | 1510.57 | 1.00 | 1333 | 139 | 71 | 8 | TRUE | 0.08 |
| colorectal cancer | KRAS_13 | GRIN2A | Any mutation | 57 | 12 | Signature 15 | -1.40 | -3.84 | 0.22 | 1402.85 | 1.00 | 319 | 57 | 12 | 0 | FALSE | 0.75 |
| colorectal cancer | KRAS_13 | GRIN2A | Any mutation | 52 | 43 | Signature 1A | -0.50 | -1.92 | 0.67 | 1386.08 | 1.00 | 753 | 50 | 41 | 2 | FALSE | 0.34 |
| colorectal cancer | KRAS_13 | GRIN2A | Any mutation | 38 | 43 | Signature 6 | -0.41 | -1.52 | 0.59 | 1437.61 | 1.00 | 237 | 34 | 39 | 4 | FALSE | 0.36 |
| colorectal cancer | KRAS_13 | GRIN2A | Any mutation | 152 | 116 | Signature overall | -0.54 | -2.10 | 0.77 | 1416.00 | 1.00 | 1331 | 143 | 107 | 9 | FALSE | 0.35 |
| colorectal cancer | KRAS_13 | ASXL1 | Any mutation | 57 | 14 | Signature 15 | 0.16 | -1.01 | 1.23 | 1421.21 | 1.00 | 319 | 54 | 11 | 3 | TRUE | 0.11 |
| colorectal cancer | KRAS_13 | ASXL1 | Any mutation | 52 | 31 | Signature 1A | 0.21 | -0.92 | 1.24 | 1569.60 | 1.00 | 767 | 49 | 28 | 3 | TRUE | 0.15 |
| colorectal cancer | KRAS_13 | ASXL1 | Any mutation | 38 | 34 | Signature 6 | -0.26 | -1.39 | 0.70 | 1487.89 | 1.00 | 247 | 35 | 31 | 3 | TRUE | 0.20 |
| colorectal cancer | KRAS_13 | ASXL1 | Any mutation | 151 | 90 | Signature overall | 0.02 | -1.17 | 1.17 | 1589.36 | 1.00 | 1355 | 141 | 80 | 10 | TRUE | 0.01 |
| colorectal cancer | KRAS_13 | EP300 | Any mutation | 58 | 18 | Signature 15 | -0.36 | -1.72 | 0.70 | 1681.51 | 1.00 | 315 | 56 | 16 | 2 | TRUE | 0.26 |
| colorectal cancer | KRAS_13 | EP300 | Any mutation | 52 | 36 | Signature 1A | 0.00 | -1.22 | 1.03 | 1457.82 | 1.00 | 762 | 49 | 33 | 3 | TRUE | 0.00 |
| colorectal cancer | KRAS_13 | EP300 | Any mutation | 40 | 51 | Signature 6 | -0.27 | -1.22 | 0.56 | 1436.78 | 1.00 | 240 | 35 | 46 | 5 | TRUE | 0.25 |
| colorectal cancer | KRAS_13 | EP300 | Any mutation | 150 | 105 | Signature overall | -0.20 | -1.42 | 1.08 | 1632.93 | 1.00 | 1317 | 140 | 95 | 10 | TRUE | 0.14 |
| colorectal cancer | KRAS_13 | ERBB4 | Any mutation | 8 | 18 | Signature 10 | 0.92 | -0.18 | 2.12 | 1523.53 | 1.00 | 22 | 3 | 13 | 5 | TRUE | 0.92 |
| colorectal cancer | KRAS_13 | ERBB4 | Any mutation | 57 | 23 | Signature 15 | 0.03 | -1.03 | 0.99 | 1468.70 | 1.00 | 311 | 54 | 20 | 3 | TRUE | 0.02 |
| colorectal cancer | KRAS_13 | ERBB4 | Any mutation | 52 | 43 | Signature 1A | 0.60 | -0.37 | 1.46 | 1411.11 | 1.00 | 758 | 47 | 38 | 5 | TRUE | 0.69 |
| colorectal cancer | KRAS_13 | ERBB4 | Any mutation | 40 | 31 | Signature 6 | 0.51 | -0.40 | 1.34 | 1612.32 | 1.00 | 250 | 34 | 25 | 6 | TRUE | 0.60 |
| colorectal cancer | KRAS_13 | ERBB4 | Any mutation | 157 | 115 | Signature overall | 0.50 | -0.59 | 1.50 | 1473.01 | 1.00 | 1341 | 138 | 96 | 19 | TRUE | 0.45 |
| colorectal cancer | KRAS_13 | MED12 | Any mutation | 57 | 11 | Signature 15 | -0.81 | -3.32 | 0.77 | 1573.53 | 1.00 | 318 | 57 | 11 | 0 | TRUE | 0.36 |
| colorectal cancer | KRAS_13 | MED12 | Any mutation | 52 | 34 | Signature 1A | 0.67 | -0.38 | 1.61 | 1387.92 | 1.00 | 767 | 47 | 29 | 5 | TRUE | 0.73 |
| colorectal cancer | KRAS_13 | MED12 | Any mutation | 41 | 42 | Signature 6 | 0.31 | -0.60 | 1.10 | 1489.36 | 1.00 | 246 | 34 | 35 | 7 | TRUE | 0.33 |
| colorectal cancer | KRAS_13 | MED12 | Any mutation | 150 | 87 | Signature overall | 0.05 | -1.63 | 1.38 | 1425.82 | 1.00 | 1331 | 138 | 75 | 12 | TRUE | 0.02 |
| colorectal cancer | KRAS_13 | NF1 | Any mutation | 7 | 24 | Signature 10 | 0.19 | -1.11 | 1.54 | 1440.92 | 1.00 | 21 | 3 | 20 | 4 | TRUE | 0.11 |
| colorectal cancer | KRAS_13 | NF1 | Any mutation | 57 | 21 | Signature 15 | -1.03 | -2.76 | 0.29 | 1459.35 | 1.00 | 312 | 56 | 20 | 1 | TRUE | 0.74 |
| colorectal cancer | KRAS_13 | NF1 | Any mutation | 52 | 40 | Signature 1A | 0.23 | -0.94 | 1.19 | 1531.87 | 1.00 | 762 | 48 | 36 | 4 | TRUE | 0.17 |
| colorectal cancer | KRAS_13 | NF1 | Any mutation | 38 | 44 | Signature 6 | -1.00 | -2.56 | 0.16 | 1608.79 | 1.00 | 242 | 36 | 42 | 2 | TRUE | 0.86 |
| colorectal cancer | KRAS_13 | NF1 | Any mutation | 154 | 129 | Signature overall | -0.41 | -1.72 | 0.90 | 1475.35 | 1.00 | 1337 | 143 | 118 | 11 | TRUE | 0.27 |
| colorectal cancer | KRAS_13 | EPHA5 | Any mutation | 7 | 26 | Signature 10 | -0.16 | -1.56 | 1.15 | 1462.37 | 1.00 | 20 | 3 | 22 | 4 | FALSE | 0.09 |
| colorectal cancer | KRAS_13 | EPHA5 | Any mutation | 57 | 18 | Signature 15 | -1.98 | -4.45 | -0.22 | 1484.92 | 1.00 | 314 | 57 | 18 | 0 | FALSE | 1.15 |
| colorectal cancer | KRAS_13 | EPHA5 | Any mutation | 52 | 49 | Signature 1A | -1.30 | -3.22 | 0.16 | 1381.50 | 1.00 | 747 | 51 | 48 | 1 | FALSE | 0.90 |
| colorectal cancer | KRAS_13 | EPHA5 | Any mutation | 38 | 36 | Signature 6 | -1.07 | -2.58 | 0.12 | 1169.40 | 1.00 | 244 | 36 | 34 | 2 | FALSE | 0.91 |
| colorectal cancer | KRAS_13 | EPHA5 | Any mutation | 154 | 129 | Signature overall | -1.12 | -2.72 | 0.38 | 1369.12 | 1.00 | 1325 | 147 | 122 | 7 | FALSE | 0.82 |
| colorectal cancer | KRAS_13 | AR | Any mutation | 58 | 21 | Signature 15 | -0.14 | -1.27 | 0.86 | 1490.83 | 1.00 | 313 | 55 | 18 | 3 | TRUE | 0.10 |
| colorectal cancer | KRAS_13 | AR | Any mutation | 52 | 33 | Signature 1A | 0.06 | -1.05 | 1.09 | 1423.63 | 1.00 | 763 | 49 | 30 | 3 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | AR | Any mutation | 38 | 37 | Signature 6 | -0.32 | -1.37 | 0.68 | 1480.57 | 1.00 | 244 | 35 | 34 | 3 | TRUE | 0.26 |
| colorectal cancer | KRAS_13 | AR | Any mutation | 148 | 91 | Signature overall | -0.14 | -1.22 | 0.95 | 1433.10 | 1.00 | 1320 | 139 | 82 | 9 | TRUE | 0.09 |
| colorectal cancer | KRAS_13 | ROS1 | Any mutation | 10 | 30 | Signature 10 | 0.79 | -0.53 | 2.12 | 1398.62 | 1.00 | 20 | 3 | 23 | 7 | TRUE | 0.61 |
| colorectal cancer | KRAS_13 | ROS1 | Any mutation | 52 | 28 | Signature 1A | 0.42 | -0.95 | 1.55 | 1437.96 | 1.00 | 770 | 49 | 25 | 3 | TRUE | 0.30 |
| colorectal cancer | KRAS_13 | ROS1 | Any mutation | 38 | 26 | Signature 6 | -0.07 | -1.38 | 1.03 | 1444.83 | 1.00 | 250 | 35 | 23 | 3 | TRUE | 0.04 |
| colorectal cancer | KRAS_13 | ROS1 | Any mutation | 100 | 84 | Signature overall | 0.37 | -1.43 | 2.06 | 1647.82 | 1.00 | 1040 | 87 | 71 | 13 | TRUE | 0.17 |
| colorectal cancer | KRAS_13 | PIK3CG | Any mutation | 57 | 17 | Signature 15 | -1.80 | -4.22 | 0.01 | 1367.90 | 1.00 | 313 | 57 | 17 | 0 | FALSE | 0.97 |
| colorectal cancer | KRAS_13 | PIK3CG | Any mutation | 52 | 29 | Signature 1A | -0.36 | -1.94 | 0.97 | 1099.26 | 1.00 | 766 | 50 | 27 | 2 | FALSE | 0.20 |
| colorectal cancer | KRAS_13 | PIK3CG | Any mutation | 39 | 29 | Signature 6 | -0.45 | -1.74 | 0.69 | 1397.68 | 1.00 | 249 | 36 | 26 | 3 | FALSE | 0.33 |
| colorectal cancer | KRAS_13 | PIK3CG | Any mutation | 153 | 97 | Signature overall | -0.76 | -2.34 | 0.71 | 1351.35 | 1.00 | 1347 | 146 | 90 | 7 | FALSE | 0.47 |
| colorectal cancer | KRAS_13 | ARID1B | Any mutation | 57 | 22 | Signature 15 | -0.42 | -1.60 | 0.55 | 1588.83 | 1.00 | 312 | 55 | 20 | 2 | TRUE | 0.35 |
| colorectal cancer | KRAS_13 | ARID1B | Any mutation | 52 | 53 | Signature 1A | 0.13 | -0.81 | 1.07 | 1421.40 | 1.00 | 754 | 47 | 48 | 5 | TRUE | 0.11 |
| colorectal cancer | KRAS_13 | ARID1B | Any mutation | 38 | 46 | Signature 6 | -0.30 | -1.28 | 0.54 | 1730.25 | 1.00 | 239 | 34 | 42 | 4 | TRUE | 0.28 |
| colorectal cancer | KRAS_13 | ARID1B | Any mutation | 147 | 121 | Signature overall | -0.19 | -1.32 | 0.82 | 1535.42 | 1.00 | 1305 | 136 | 110 | 11 | TRUE | 0.14 |
| colorectal cancer | KRAS_13 | BRAF | Any mutation | 57 | 48 | Signature 15 | -1.62 | -2.89 | -0.54 | 1325.66 | 1.00 | 284 | 55 | 46 | 2 | TRUE | 2.02 |
| colorectal cancer | KRAS_13 | BRAF | Any mutation | 52 | 99 | Signature 1A | -1.10 | -2.28 | 0.04 | 1610.90 | 1.00 | 701 | 48 | 95 | 4 | TRUE | 1.19 |
| colorectal cancer | KRAS_13 | BRAF | Any mutation | 38 | 60 | Signature 6 | -2.24 | -4.50 | -0.91 | 1497.15 | 1.00 | 219 | 38 | 60 | 0 | TRUE | 1.87 |
| colorectal cancer | KRAS_13 | BRAF | Any mutation | 147 | 207 | Signature overall | -1.65 | -3.04 | -0.50 | 1444.41 | 1.00 | 1204 | 141 | 201 | 6 | TRUE | 1.89 |
| colorectal cancer | KRAS_13 | B2M | Any mutation | 57 | 20 | Signature 15 | -0.62 | -2.18 | 0.53 | 1581.26 | 1.00 | 308 | 56 | 19 | 1 | FALSE | 0.44 |
| colorectal cancer | KRAS_13 | B2M | Any mutation | 52 | 46 | Signature 1A | 0.59 | -0.36 | 1.43 | 1684.12 | 1.00 | 747 | 46 | 40 | 6 | FALSE | 0.70 |
| colorectal cancer | KRAS_13 | B2M | Any mutation | 40 | 51 | Signature 6 | 0.10 | -0.75 | 0.88 | 1436.24 | 1.00 | 237 | 33 | 44 | 7 | FALSE | 0.10 |
| colorectal cancer | KRAS_13 | B2M | Any mutation | 154 | 131 | Signature overall | 0.05 | -1.11 | 1.17 | 1456.52 | 1.00 | 1316 | 138 | 115 | 16 | FALSE | 0.03 |
| colorectal cancer | KRAS_13 | CARD11 | Any mutation | 57 | 14 | Signature 15 | -0.06 | -1.28 | 0.98 | 1549.26 | 1.00 | 316 | 55 | 12 | 2 | FALSE | 0.04 |
| colorectal cancer | KRAS_13 | CARD11 | Any mutation | 53 | 58 | Signature 1A | 0.19 | -0.70 | 1.00 | 1401.58 | 1.00 | 744 | 48 | 53 | 5 | FALSE | 0.18 |
| colorectal cancer | KRAS_13 | CARD11 | Any mutation | 40 | 38 | Signature 6 | 0.08 | -0.88 | 0.90 | 1359.96 | 1.00 | 246 | 35 | 33 | 5 | FALSE | 0.06 |
| colorectal cancer | KRAS_13 | CARD11 | Any mutation | 150 | 110 | Signature overall | 0.06 | -1.02 | 1.09 | 1442.93 | 1.00 | 1306 | 138 | 98 | 12 | FALSE | 0.04 |
| colorectal cancer | KRAS_13 | SOX9 | Any mutation | 57 | 40 | Signature 15 | 1.04 | 0.37 | 1.71 | 1385.68 | 1.00 | 304 | 43 | 26 | 14 | FALSE | 2.52 |
| colorectal cancer | KRAS_13 | SOX9 | Any mutation | 53 | 105 | Signature 1A | 0.12 | -0.65 | 0.80 | 1394.42 | 1.00 | 702 | 47 | 99 | 6 | FALSE | 0.12 |
| colorectal cancer | KRAS_13 | SOX9 | Any mutation | 40 | 59 | Signature 6 | 0.51 | -0.16 | 1.17 | 1470.58 | 1.00 | 229 | 30 | 49 | 10 | FALSE | 0.88 |
| colorectal cancer | KRAS_13 | SOX9 | Any mutation | 150 | 204 | Signature overall | 0.54 | -0.31 | 1.41 | 1508.05 | 1.00 | 1235 | 120 | 174 | 30 | FALSE | 0.66 |
| colorectal cancer | KRAS_13 | SMAD2 | Any mutation | 57 | 16 | Signature 15 | 0.02 | -1.14 | 1.01 | 1663.14 | 1.00 | 314 | 55 | 14 | 2 | TRUE | 0.02 |
| colorectal cancer | KRAS_13 | SMAD2 | Any mutation | 53 | 33 | Signature 1A | 0.34 | -0.58 | 1.27 | 1573.53 | 1.00 | 768 | 49 | 29 | 4 | TRUE | 0.32 |
| colorectal cancer | KRAS_13 | SMAD2 | Any mutation | 38 | 17 | Signature 6 | 0.07 | -1.00 | 1.06 | 1435.47 | 1.00 | 260 | 36 | 15 | 2 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | SMAD2 | Any mutation | 148 | 66 | Signature overall | 0.15 | -0.91 | 1.09 | 1582.09 | 1.00 | 1342 | 140 | 58 | 8 | TRUE | 0.12 |
| colorectal cancer | KRAS_13 | ZFHX3 | Any mutation | 7 | 17 | Signature 10 | 0.35 | -0.96 | 1.64 | 1582.45 | 1.00 | 18 | 3 | 13 | 4 | FALSE | 0.22 |
| colorectal cancer | KRAS_13 | ZFHX3 | Any mutation | 51 | 31 | Signature 15 | -0.73 | -1.98 | 0.28 | 1560.74 | 1.00 | 279 | 49 | 29 | 2 | FALSE | 0.69 |
| colorectal cancer | KRAS_13 | ZFHX3 | Any mutation | 51 | 80 | Signature 1A | 0.35 | -0.44 | 1.12 | 1492.82 | 1.00 | 686 | 43 | 72 | 8 | FALSE | 0.42 |
| colorectal cancer | KRAS_13 | ZFHX3 | Any mutation | 33 | 81 | Signature 6 | -0.79 | -1.71 | 0.12 | 1431.74 | 1.00 | 206 | 29 | 77 | 4 | FALSE | 1.03 |
| colorectal cancer | KRAS_13 | ZFHX3 | Any mutation | 142 | 209 | Signature overall | -0.21 | -1.34 | 0.89 | 1517.31 | 1.00 | 1189 | 124 | 191 | 18 | FALSE | 0.16 |
| colorectal cancer | KRAS_13 | MGA | Any mutation | 8 | 15 | Signature 10 | 0.96 | -0.33 | 2.28 | 1603.08 | 1.00 | 20 | 3 | 10 | 5 | FALSE | 0.87 |
| colorectal cancer | KRAS_13 | MGA | Any mutation | 50 | 16 | Signature 15 | -0.10 | -1.48 | 0.97 | 1285.99 | 1.00 | 284 | 48 | 14 | 2 | FALSE | 0.06 |
| colorectal cancer | KRAS_13 | MGA | Any mutation | 49 | 42 | Signature 1A | 0.34 | -0.74 | 1.29 | 1426.39 | 1.00 | 706 | 45 | 38 | 4 | FALSE | 0.29 |
| colorectal cancer | KRAS_13 | MGA | Any mutation | 33 | 36 | Signature 6 | -0.22 | -1.42 | 0.69 | 1496.12 | 1.00 | 227 | 30 | 33 | 3 | FALSE | 0.16 |
| colorectal cancer | KRAS_13 | MGA | Any mutation | 140 | 109 | Signature overall | 0.25 | -0.94 | 1.34 | 1485.56 | 1.00 | 1237 | 126 | 95 | 14 | FALSE | 0.18 |
| colorectal cancer | KRAS_13 | KMT2B | Any mutation | 31 | 18 | Signature 15 | 0.32 | -0.78 | 1.33 | 1552.65 | 1.00 | 154 | 27 | 14 | 4 | FALSE | 0.26 |
| colorectal cancer | KRAS_13 | KMT2B | Any mutation | 33 | 64 | Signature 1A | 0.26 | -0.55 | 1.06 | 1486.93 | 1.00 | 381 | 27 | 58 | 6 | FALSE | 0.27 |
| colorectal cancer | KRAS_13 | KMT2B | Any mutation | 21 | 86 | Signature 6 | 0.12 | -0.73 | 0.94 | 1531.22 | 1.00 | 109 | 12 | 77 | 9 | FALSE | 0.11 |
| colorectal cancer | KRAS_13 | KMT2B | Any mutation | 85 | 168 | Signature overall | 0.21 | -1.00 | 1.35 | 1539.73 | 1.00 | 644 | 66 | 149 | 19 | FALSE | 0.14 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 51 | 48 | Signature 15 | 0.00 | -0.68 | 0.64 | 1497.58 | 1.00 | 260 | 44 | 41 | 7 | FALSE | 0.00 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 51 | 115 | Signature 1A | 0.07 | -0.58 | 0.68 | 1253.56 | 1.00 | 645 | 42 | 106 | 9 | FALSE | 0.09 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 6 | 12 | Signature 2 | -0.02 | -0.91 | 0.83 | 1545.13 | 1.00 | 55 | 5 | 11 | 1 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 34 | 69 | Signature 6 | -0.03 | -0.72 | 0.64 | 1551.00 | 1.00 | 201 | 27 | 62 | 7 | FALSE | 0.03 |
| colorectal cancer | KRAS_13 | TCF7L2 | Any mutation | 142 | 244 | Signature overall | 0.00 | -0.62 | 0.65 | 1225.38 | 1.00 | 1161 | 118 | 220 | 24 | FALSE | 0.00 |
| colorectal cancer | KRAS_13 | ANKRD11 | Any mutation | 50 | 17 | Signature 15 | -0.07 | -1.27 | 0.96 | 1533.43 | 1.00 | 279 | 47 | 14 | 3 | FALSE | 0.04 |
| colorectal cancer | KRAS_13 | ANKRD11 | Any mutation | 47 | 47 | Signature 1A | -0.40 | -1.69 | 0.62 | 1409.23 | 1.00 | 682 | 45 | 45 | 2 | FALSE | 0.30 |
| colorectal cancer | KRAS_13 | ANKRD11 | Any mutation | 33 | 57 | Signature 6 | -0.12 | -1.05 | 0.69 | 1447.71 | 1.00 | 213 | 27 | 51 | 6 | FALSE | 0.11 |
| colorectal cancer | KRAS_13 | ANKRD11 | Any mutation | 134 | 133 | Signature overall | -0.22 | -1.31 | 0.87 | 1268.48 | 1.00 | 1194 | 122 | 121 | 12 | FALSE | 0.16 |
| colorectal cancer | KRAS_13 | POLD1 | Any mutation | 50 | 15 | Signature 15 | -0.22 | -1.46 | 0.92 | 1528.16 | 1.00 | 290 | 48 | 13 | 2 | TRUE | 0.15 |
| colorectal cancer | KRAS_13 | POLD1 | Any mutation | 49 | 43 | Signature 1A | 0.10 | -0.95 | 1.05 | 1442.32 | 1.00 | 709 | 45 | 39 | 4 | TRUE | 0.08 |
| colorectal cancer | KRAS_13 | POLD1 | Any mutation | 33 | 44 | Signature 6 | -0.42 | -1.55 | 0.54 | 1583.14 | 1.00 | 226 | 30 | 41 | 3 | TRUE | 0.37 |
| colorectal cancer | KRAS_13 | POLD1 | Any mutation | 132 | 102 | Signature overall | -0.20 | -1.38 | 0.95 | 1531.69 | 1.00 | 1225 | 123 | 93 | 9 | TRUE | 0.14 |
| colorectal cancer | KRAS_13 | AMER1 | Any mutation | 57 | 34 | Signature 15 | 0.46 | -0.29 | 1.17 | 1372.48 | 1.00 | 301 | 51 | 28 | 6 | FALSE | 0.67 |
| colorectal cancer | KRAS_13 | AMER1 | Any mutation | 56 | 61 | Signature 1A | 0.76 | 0.08 | 1.43 | 1231.62 | 1.00 | 743 | 47 | 52 | 9 | FALSE | 1.62 |
| colorectal cancer | KRAS_13 | AMER1 | Any mutation | 39 | 36 | Signature 6 | 0.64 | -0.18 | 1.37 | 1274.12 | 1.00 | 248 | 32 | 29 | 7 | FALSE | 1.05 |
| colorectal cancer | KRAS_13 | AMER1 | Any mutation | 152 | 131 | Signature overall | 0.62 | -0.13 | 1.33 | 1323.02 | 1.00 | 1292 | 130 | 109 | 22 | FALSE | 1.01 |
| melanoma | RAS_61 | SPEN | Any mutation | 123 | 105 | Signature 7 | -0.79 | -1.36 | -0.21 | 139.79 | 1.03 | 267 | 106 | 88 | 17 | FALSE | 2.08 |
| melanoma | RAS_61 | SPEN | Any mutation | 123 | 105 | Signature overall | -0.70 | -4.58 | 3.55 | 1485.81 | 1.00 | 267 | 106 | 88 | 17 | FALSE | 0.15 |
| melanoma | RAS_61 | KMT2C | Any mutation | 13 | 11 | Signature 11 | 0.34 | -1.02 | 2.18 | 10.56 | 1.14 | 36 | 8 | 6 | 5 | FALSE | 0.15 |
| melanoma | RAS_61 | KMT2C | Any mutation | 118 | 126 | Signature 7 | -0.94 | -1.57 | -0.44 | 44.31 | 1.04 | 221 | 101 | 109 | 17 | FALSE | 2.92 |
| melanoma | RAS_61 | KMT2C | Any mutation | 131 | 137 | Signature overall | -0.31 | -2.00 | 1.93 | 1002.96 | 1.01 | 257 | 109 | 115 | 22 | FALSE | 0.13 |
| melanoma | RAS_61 | TP53 | Any mutation | 13 | 14 | Signature 11 | -0.36 | -1.25 | 0.60 | 1525.18 | 1.00 | 33 | 10 | 11 | 3 | TRUE | 0.37 |
| melanoma | RAS_61 | TP53 | Any mutation | 9 | 14 | Signature 1A | -0.40 | -1.36 | 0.59 | 1333.96 | 1.00 | 46 | 7 | 12 | 2 | TRUE | 0.39 |
| melanoma | RAS_61 | TP53 | Any mutation | 123 | 150 | Signature 7 | -0.45 | -0.89 | 0.01 | 1358.18 | 1.00 | 222 | 93 | 120 | 30 | TRUE | 1.31 |
| melanoma | RAS_61 | TP53 | Any mutation | 145 | 178 | Signature overall | -0.40 | -1.17 | 0.42 | 1394.00 | 1.00 | 301 | 110 | 143 | 35 | TRUE | 0.51 |
| melanoma | RAS_61 | ATRX | Any mutation | 125 | 76 | Signature 7 | -0.39 | -1.00 | 0.19 | 1478.73 | 1.00 | 284 | 109 | 60 | 16 | TRUE | 0.68 |
| melanoma | RAS_61 | ATRX | Any mutation | 125 | 76 | Signature overall | -0.23 | -3.98 | 4.29 | 1335.56 | 1.00 | 284 | 109 | 60 | 16 | TRUE | 0.04 |
| melanoma | RAS_61 | PTPRD | Any mutation | 133 | 247 | Signature 7 | -0.67 | -1.07 | -0.26 | 1296.96 | 1.00 | 202 | 88 | 202 | 45 | FALSE | 2.77 |
| melanoma | RAS_61 | PTPRD | Any mutation | 133 | 247 | Signature overall | -0.55 | -4.50 | 3.90 | 1458.38 | 1.00 | 202 | 88 | 202 | 45 | FALSE | 0.11 |
| melanoma | RAS_61 | PIK3C2G | Any mutation | 124 | 174 | Signature 7 | -0.47 | -0.95 | -0.02 | 635.16 | 1.00 | 215 | 88 | 138 | 36 | FALSE | 1.41 |
| melanoma | RAS_61 | PIK3C2G | Any mutation | 124 | 174 | Signature overall | -0.35 | -4.06 | 3.72 | 1380.31 | 1.00 | 215 | 88 | 138 | 36 | FALSE | 0.07 |
| melanoma | RAS_61 | PTPRT | Any mutation | 14 | 12 | Signature 11 | -0.17 | -1.46 | 1.17 | 1402.90 | 1.00 | 37 | 11 | 9 | 3 | FALSE | 0.09 |
| melanoma | RAS_61 | PTPRT | Any mutation | 138 | 346 | Signature 7 | -0.37 | -0.74 | 0.01 | 1448.34 | 1.00 | 177 | 67 | 275 | 71 | FALSE | 1.24 |
| melanoma | RAS_61 | PTPRT | Any mutation | 152 | 358 | Signature overall | -0.30 | -2.20 | 1.63 | 1347.62 | 1.00 | 214 | 78 | 284 | 74 | FALSE | 0.13 |
| melanoma | RAS_61 | ALK | Any mutation | 125 | 117 | Signature 7 | -0.52 | -1.04 | -0.02 | 1048.86 | 1.00 | 253 | 102 | 94 | 23 | TRUE | 1.25 |
| melanoma | RAS_61 | ALK | Any mutation | 125 | 117 | Signature overall | -0.41 | -4.12 | 3.52 | 1520.98 | 1.00 | 253 | 102 | 94 | 23 | TRUE | 0.09 |
| melanoma | RAS_61 | IKZF1 | Any mutation | 124 | 93 | Signature 7 | -0.60 | -1.23 | -0.05 | 1117.14 | 1.00 | 267 | 107 | 76 | 17 | TRUE | 1.36 |
| melanoma | RAS_61 | IKZF1 | Any mutation | 124 | 93 | Signature overall | -0.50 | -4.28 | 3.71 | 1542.51 | 1.00 | 267 | 107 | 76 | 17 | TRUE | 0.10 |
| melanoma | RAS_61 | FAT1 | Any mutation | 123 | 128 | Signature 7 | -0.56 | -1.07 | -0.03 | 1424.04 | 1.00 | 250 | 99 | 104 | 24 | FALSE | 1.44 |
| melanoma | RAS_61 | FAT1 | Any mutation | 123 | 128 | Signature overall | -0.46 | -4.54 | 3.74 | 1492.57 | 1.00 | 250 | 99 | 104 | 24 | FALSE | 0.09 |
| melanoma | RAS_61 | KMT2A | Any mutation | 125 | 124 | Signature 7 | -0.78 | -1.34 | -0.26 | 1288.92 | 1.00 | 255 | 105 | 104 | 20 | FALSE | 2.33 |
| melanoma | RAS_61 | KMT2A | Any mutation | 125 | 124 | Signature overall | -0.70 | -4.99 | 3.66 | 1365.54 | 1.00 | 255 | 105 | 104 | 20 | FALSE | 0.14 |
| melanoma | RAS_61 | PAK7 | Any mutation | 124 | 205 | Signature 7 | -0.73 | -1.16 | -0.30 | 1435.03 | 1.00 | 184 | 86 | 167 | 38 | FALSE | 3.12 |
| melanoma | RAS_61 | PAK7 | Any mutation | 124 | 205 | Signature overall | -0.63 | -4.41 | 3.60 | 1485.59 | 1.00 | 184 | 86 | 167 | 38 | FALSE | 0.13 |
| melanoma | RAS_61 | TERT | Any mutation | 15 | 48 | Signature 11 | 1.51 | 0.24 | 3.01 | 1501.45 | 1.00 | 12 | 1 | 34 | 14 | TRUE | 1.44 |
| melanoma | RAS_61 | TERT | Any mutation | 10 | 20 | Signature 19 | 2.14 | 0.61 | 4.25 | 1527.76 | 1.00 | 7 | 0 | 10 | 10 | TRUE | 1.67 |
| melanoma | RAS_61 | TERT | Any mutation | 9 | 17 | Signature 1A | 1.31 | 0.09 | 2.55 | 1290.59 | 1.00 | 43 | 4 | 12 | 5 | TRUE | 1.44 |
| melanoma | RAS_61 | TERT | Any mutation | 136 | 473 | Signature 7 | 0.76 | 0.12 | 1.41 | 1387.87 | 1.00 | 61 | 12 | 349 | 124 | TRUE | 1.66 |
| melanoma | RAS_61 | TERT | Any mutation | 170 | 558 | Signature overall | 1.41 | 0.13 | 2.83 | 1435.39 | 1.00 | 123 | 17 | 405 | 153 | TRUE | 1.36 |
| melanoma | RAS_61 | NOTCH3 | Any mutation | 123 | 116 | Signature 7 | -1.09 | -1.67 | -0.52 | 1236.14 | 1.00 | 250 | 108 | 101 | 15 | TRUE | 3.67 |
| melanoma | RAS_61 | NOTCH3 | Any mutation | 123 | 116 | Signature overall | -0.93 | -4.60 | 3.22 | 1485.95 | 1.00 | 250 | 108 | 101 | 15 | TRUE | 0.21 |
| melanoma | RAS_61 | NOTCH4 | Any mutation | 120 | 141 | Signature 7 | -0.41 | -0.87 | 0.04 | 906.14 | 1.00 | 223 | 90 | 111 | 30 | TRUE | 1.20 |
| melanoma | RAS_61 | NOTCH4 | Any mutation | 120 | 141 | Signature overall | -0.38 | -3.95 | 3.61 | 1551.11 | 1.00 | 223 | 90 | 111 | 30 | TRUE | 0.08 |
| melanoma | RAS_61 | CDKN2A | Any mutation | 127 | 108 | Signature 7 | -0.20 | -0.68 | 0.26 | 1568.37 | 1.00 | 250 | 100 | 81 | 27 | TRUE | 0.36 |
| melanoma | RAS_61 | CDKN2A | Any mutation | 127 | 108 | Signature overall | -0.24 | -4.59 | 3.95 | 1379.82 | 1.00 | 250 | 100 | 81 | 27 | TRUE | 0.04 |
| melanoma | RAS_61 | KMT2D | Any mutation | 13 | 13 | Signature 11 | -0.41 | -1.31 | 0.59 | 1333.27 | 1.00 | 32 | 10 | 10 | 3 | FALSE | 0.42 |
| melanoma | RAS_61 | KMT2D | Any mutation | 134 | 184 | Signature 7 | -0.44 | -0.84 | -0.03 | 645.99 | 1.00 | 241 | 97 | 147 | 37 | FALSE | 1.51 |
| melanoma | RAS_61 | KMT2D | Any mutation | 147 | 197 | Signature overall | -0.42 | -1.38 | 0.64 | 1445.03 | 1.00 | 273 | 107 | 157 | 40 | FALSE | 0.37 |
| colorectal cancer | RAS_61 | APC | Any mutation | 20 | 469 | Signature 15 | -0.11 | -0.93 | 0.63 | 1315.88 | 1.00 | 77 | 6 | 455 | 14 | TRUE | 0.11 |
| colorectal cancer | RAS_61 | APC | Any mutation | 8 | 46 | Signature 17 | 0.78 | -0.13 | 1.75 | 1272.79 | 1.00 | 15 | 0 | 38 | 8 | TRUE | 0.99 |
| colorectal cancer | RAS_61 | APC | Any mutation | 50 | 962 | Signature 1A | 0.46 | -0.16 | 1.12 | 1294.15 | 1.00 | 216 | 5 | 917 | 45 | TRUE | 0.82 |
| colorectal cancer | RAS_61 | APC | Any mutation | 6 | 42 | Signature 3 | 0.67 | -0.21 | 1.63 | 1363.77 | 1.00 | 11 | 0 | 36 | 6 | TRUE | 0.78 |
| colorectal cancer | RAS_61 | APC | Any mutation | 16 | 355 | Signature 6 | -0.10 | -0.91 | 0.66 | 1397.09 | 1.00 | 89 | 6 | 345 | 10 | TRUE | 0.10 |
| melanoma | RAS_61 | APC | Any mutation | 123 | 102 | Signature 7 | -0.74 | -1.35 | -0.26 | 32.58 | 1.07 | 260 | 107 | 86 | 16 | TRUE | 1.95 |
| colorectal cancer | RAS_61 | APC | Any mutation | 123 | 2462 | Signature overall | 0.25 | -0.33 | 0.83 | 1302.61 | 1.00 | 532 | 19 | 2358 | 104 | TRUE | 0.39 |
| melanoma | RAS_61 | APC | Any mutation | 123 | 102 | Signature overall | -0.74 | -4.47 | 3.14 | 1423.93 | 1.00 | 260 | 107 | 86 | 16 | TRUE | 0.18 |
| melanoma | RAS_61 | ARID2 | Any mutation | 130 | 109 | Signature 7 | 0.01 | -0.48 | 0.49 | 1534.78 | 1.00 | 270 | 100 | 79 | 30 | FALSE | 0.01 |
| melanoma | RAS_61 | ARID2 | Any mutation | 130 | 128 | Signature overall | -0.68 | -5.27 | 3.52 | 1467.72 | 1.00 | 288 | 100 | 98 | 30 | FALSE | 0.13 |
| melanoma | RAS_61 | EPHA3 | Any mutation | 125 | 97 | Signature 7 | 0.01 | -0.54 | 0.49 | 1255.22 | 1.00 | 272 | 99 | 71 | 26 | FALSE | 0.01 |
| melanoma | RAS_61 | EPHA3 | Any mutation | 125 | 97 | Signature overall | 0.01 | -4.61 | 4.36 | 1510.08 | 1.00 | 272 | 99 | 71 | 26 | FALSE | 0.00 |
| melanoma | RAS_61 | KDR | Any mutation | 123 | 121 | Signature 7 | -0.75 | -1.31 | -0.24 | 1350.09 | 1.00 | 250 | 103 | 101 | 20 | TRUE | 2.21 |
| melanoma | RAS_61 | KDR | Any mutation | 123 | 121 | Signature overall | -0.66 | -4.57 | 3.42 | 1510.15 | 1.00 | 250 | 103 | 101 | 20 | TRUE | 0.14 |
| melanoma | RAS_61 | NTRK3 | Any mutation | 126 | 93 | Signature 7 | -0.80 | -1.39 | -0.24 | 1197.35 | 1.00 | 262 | 111 | 78 | 15 | FALSE | 2.12 |
| melanoma | RAS_61 | NTRK3 | Any mutation | 126 | 93 | Signature overall | -0.61 | -4.84 | 4.11 | 1392.21 | 1.00 | 262 | 111 | 78 | 15 | FALSE | 0.12 |
| melanoma | RAS_61 | GRIN2A | Any mutation | 13 | 13 | Signature 11 | -0.84 | -2.12 | 0.46 | 1469.01 | 1.00 | 32 | 11 | 11 | 2 | FALSE | 0.73 |
| melanoma | RAS_61 | GRIN2A | Any mutation | 134 | 278 | Signature 7 | -0.82 | -1.21 | -0.43 | 1265.49 | 1.00 | 195 | 88 | 232 | 46 | FALSE | 4.42 |
| melanoma | RAS_61 | GRIN2A | Any mutation | 147 | 291 | Signature overall | -0.85 | -2.27 | 0.58 | 1366.56 | 1.00 | 227 | 99 | 243 | 48 | FALSE | 0.61 |
| melanoma | RAS_61 | ERBB4 | Any mutation | 125 | 171 | Signature 7 | -1.15 | -1.66 | -0.69 | 1506.91 | 1.00 | 223 | 103 | 149 | 22 | TRUE | 5.44 |
| melanoma | RAS_61 | ERBB4 | Any mutation | 125 | 171 | Signature overall | -0.91 | -4.93 | 4.03 | 1433.43 | 1.00 | 223 | 103 | 149 | 22 | TRUE | 0.18 |
| melanoma | RAS_61 | NF1 | Any mutation | 13 | 17 | Signature 11 | -1.45 | -2.73 | -0.11 | 1551.02 | 1.00 | 33 | 11 | 15 | 2 | TRUE | 1.54 |
| melanoma | RAS_61 | NF1 | Any mutation | 126 | 242 | Signature 7 | -1.75 | -2.26 | -1.27 | 1524.19 | 1.00 | 186 | 105 | 221 | 21 | TRUE | 11.49 |
| melanoma | RAS_61 | NF1 | Any mutation | 139 | 259 | Signature overall | -1.56 | -2.94 | 0.05 | 1394.70 | 1.00 | 219 | 116 | 236 | 23 | TRUE | 1.56 |
| melanoma | RAS_61 | FLT1 | Any mutation | 125 | 110 | Signature 7 | -0.54 | -1.08 | -0.03 | 1288.31 | 1.00 | 258 | 104 | 89 | 21 | FALSE | 1.40 |
| melanoma | RAS_61 | FLT1 | Any mutation | 125 | 110 | Signature overall | -0.47 | -4.48 | 3.66 | 1400.88 | 1.00 | 258 | 104 | 89 | 21 | FALSE | 0.09 |
| melanoma | RAS_61 | ROS1 | Any mutation | 13 | 11 | Signature 11 | 0.21 | -1.10 | 1.63 | 1326.47 | 1.00 | 35 | 9 | 7 | 4 | TRUE | 0.12 |
| melanoma | RAS_61 | ROS1 | Any mutation | 128 | 231 | Signature 7 | -0.77 | -1.21 | -0.33 | 1360.41 | 1.00 | 211 | 91 | 194 | 37 | TRUE | 3.49 |
| melanoma | RAS_61 | ROS1 | Any mutation | 141 | 242 | Signature overall | -0.28 | -1.96 | 1.73 | 1562.87 | 1.00 | 246 | 100 | 201 | 41 | TRUE | 0.12 |
| melanoma | RAS_61 | PIK3CG | Any mutation | 123 | 92 | Signature 7 | -1.28 | -2.02 | -0.60 | 897.80 | 1.00 | 268 | 113 | 82 | 10 | FALSE | 3.48 |
| melanoma | RAS_61 | PIK3CG | Any mutation | 123 | 92 | Signature overall | -1.10 | -5.51 | 3.35 | 1565.59 | 1.00 | 268 | 113 | 82 | 10 | FALSE | 0.25 |
| melanoma | RAS_61 | BRAF | Any mutation | 13 | 25 | Signature 11 | -2.05 | -3.52 | -0.77 | 1492.04 | 1.00 | 20 | 11 | 23 | 2 | TRUE | 2.65 |
| melanoma | RAS_61 | BRAF | Any mutation | 9 | 11 | Signature 1A | -2.50 | -4.85 | -0.80 | 1386.87 | 1.00 | 43 | 9 | 11 | 0 | TRUE | 1.89 |
| melanoma | RAS_61 | BRAF | Any mutation | 125 | 191 | Signature 7 | -2.15 | -2.78 | -1.60 | 1688.86 | 1.00 | 163 | 111 | 177 | 14 | TRUE | 11.99 |
| melanoma | RAS_61 | BRAF | Any mutation | 147 | 227 | Signature overall | -2.22 | -3.78 | -0.94 | 1222.72 | 1.00 | 226 | 131 | 211 | 16 | TRUE | 2.82 |
| melanoma | RAS_61 | CARD11 | Any mutation | 123 | 107 | Signature 7 | -0.98 | -1.59 | -0.45 | 941.72 | 1.00 | 252 | 108 | 92 | 15 | FALSE | 3.19 |
| melanoma | RAS_61 | CARD11 | Any mutation | 123 | 107 | Signature overall | -0.81 | -4.68 | 3.49 | 1427.85 | 1.00 | 252 | 108 | 92 | 15 | FALSE | 0.18 |
| melanoma | RAS_61 | TP63 | Any mutation | 119 | 152 | Signature 7 | -0.54 | -1.00 | -0.06 | 1405.63 | 1.00 | 212 | 89 | 122 | 30 | FALSE | 1.58 |
| melanoma | RAS_61 | TP63 | Any mutation | 119 | 152 | Signature overall | -0.44 | -4.42 | 3.77 | 1429.88 | 1.00 | 212 | 89 | 122 | 30 | FALSE | 0.08 |
| melanoma | RAS_61 | ZFHX3 | Any mutation | 119 | 90 | Signature 7 | -0.66 | -1.27 | -0.08 | 1492.75 | 1.00 | 255 | 103 | 74 | 16 | FALSE | 1.45 |
| melanoma | RAS_61 | ZFHX3 | Any mutation | 119 | 129 | Signature overall | -1.38 | -6.08 | 3.16 | 1488.10 | 1.00 | 272 | 103 | 113 | 16 | FALSE | 0.27 |
| melanoma | RAS_61 | PREX2 | Any mutation | 84 | 158 | Signature 7 | -0.51 | -1.03 | -0.01 | 1113.52 | 1.00 | 116 | 51 | 125 | 33 | FALSE | 1.34 |
| melanoma | RAS_61 | PREX2 | Any mutation | 84 | 158 | Signature overall | -0.50 | -4.83 | 3.73 | 1568.19 | 1.00 | 116 | 51 | 125 | 33 | FALSE | 0.10 |
| melanoma | RAS_61 | EPHA7 | Any mutation | 120 | 141 | Signature 7 | -0.61 | -1.10 | -0.13 | 1169.46 | 1.00 | 231 | 94 | 115 | 26 | FALSE | 1.88 |
| melanoma | RAS_61 | EPHA7 | Any mutation | 120 | 141 | Signature overall | -0.59 | -4.69 | 3.68 | 1370.94 | 1.00 | 231 | 94 | 115 | 26 | FALSE | 0.12 |
| melanoma | NRAS_61 | SPEN | Any mutation | 119 | 105 | Signature 7 | -0.88 | -1.51 | -0.29 | 772.13 | 1.01 | 269 | 104 | 90 | 15 | FALSE | 2.30 |
| melanoma | NRAS_61 | SPEN | Any mutation | 119 | 105 | Signature overall | -0.81 | -5.06 | 3.66 | 1534.92 | 1.00 | 269 | 104 | 90 | 15 | FALSE | 0.17 |
| melanoma | NRAS_61 | KMT2C | Any mutation | 13 | 11 | Signature 11 | 0.54 | -0.90 | 2.14 | 1208.96 | 1.00 | 36 | 8 | 6 | 5 | FALSE | 0.29 |
| melanoma | NRAS_61 | KMT2C | Any mutation | 114 | 126 | Signature 7 | -0.93 | -1.51 | -0.37 | 1332.90 | 1.00 | 225 | 97 | 109 | 17 | FALSE | 2.88 |
| melanoma | NRAS_61 | KMT2C | Any mutation | 127 | 137 | Signature overall | -0.17 | -1.89 | 1.91 | 1475.11 | 1.00 | 261 | 105 | 115 | 22 | FALSE | 0.07 |
| melanoma | NRAS_61 | TP53 | Any mutation | 13 | 14 | Signature 11 | -0.42 | -1.39 | 0.50 | 1527.09 | 1.00 | 33 | 10 | 11 | 3 | TRUE | 0.43 |
| melanoma | NRAS_61 | TP53 | Any mutation | 8 | 14 | Signature 1A | -0.60 | -1.68 | 0.33 | 1490.38 | 1.00 | 46 | 7 | 13 | 1 | TRUE | 0.59 |
| melanoma | NRAS_61 | TP53 | Any mutation | 119 | 150 | Signature 7 | -0.49 | -0.97 | -0.01 | 1312.91 | 1.00 | 225 | 90 | 121 | 29 | TRUE | 1.37 |
| melanoma | NRAS_61 | TP53 | Any mutation | 140 | 178 | Signature overall | -0.51 | -1.29 | 0.27 | 1480.99 | 1.00 | 304 | 107 | 145 | 33 | TRUE | 0.67 |
| melanoma | NRAS_61 | ATRX | Any mutation | 120 | 76 | Signature 7 | -0.50 | -1.19 | 0.12 | 1427.14 | 1.00 | 287 | 106 | 62 | 14 | TRUE | 0.88 |
| melanoma | NRAS_61 | ATRX | Any mutation | 120 | 76 | Signature overall | -0.37 | -4.23 | 4.16 | 1371.66 | 1.00 | 287 | 106 | 62 | 14 | TRUE | 0.07 |
| melanoma | NRAS_61 | PTPRD | Any mutation | 129 | 247 | Signature 7 | -0.61 | -0.98 | -0.19 | 1275.25 | 1.00 | 206 | 84 | 202 | 45 | FALSE | 2.54 |
| melanoma | NRAS_61 | PTPRD | Any mutation | 129 | 247 | Signature overall | -0.49 | -4.78 | 3.81 | 1525.72 | 1.00 | 206 | 84 | 202 | 45 | FALSE | 0.10 |
| melanoma | NRAS_61 | PIK3C2G | Any mutation | 119 | 174 | Signature 7 | -0.53 | -0.99 | -0.07 | 985.59 | 1.00 | 217 | 86 | 141 | 33 | FALSE | 1.65 |
| melanoma | NRAS_61 | PIK3C2G | Any mutation | 119 | 174 | Signature overall | -0.38 | -4.22 | 4.23 | 1411.61 | 1.00 | 217 | 86 | 141 | 33 | FALSE | 0.07 |
| melanoma | NRAS_61 | PTPRT | Any mutation | 14 | 12 | Signature 11 | -0.15 | -1.42 | 1.07 | 1374.01 | 1.00 | 37 | 11 | 9 | 3 | FALSE | 0.09 |
| melanoma | NRAS_61 | PTPRT | Any mutation | 134 | 346 | Signature 7 | -0.37 | -0.74 | 0.00 | 1357.96 | 1.00 | 179 | 65 | 277 | 69 | FALSE | 1.25 |
| melanoma | NRAS_61 | PTPRT | Any mutation | 148 | 358 | Signature overall | -0.22 | -2.05 | 1.68 | 1471.51 | 1.00 | 216 | 76 | 286 | 72 | FALSE | 0.09 |
| melanoma | NRAS_61 | ALK | Any mutation | 121 | 117 | Signature 7 | -0.61 | -1.15 | -0.10 | 1546.43 | 1.00 | 255 | 100 | 96 | 21 | TRUE | 1.55 |
| melanoma | NRAS_61 | ALK | Any mutation | 121 | 117 | Signature overall | -0.50 | -4.49 | 3.96 | 1406.30 | 1.00 | 255 | 100 | 96 | 21 | TRUE | 0.10 |
| melanoma | NRAS_61 | IKZF1 | Any mutation | 120 | 93 | Signature 7 | -0.63 | -1.26 | -0.08 | 1406.57 | 1.00 | 270 | 104 | 77 | 16 | TRUE | 1.42 |
| melanoma | NRAS_61 | IKZF1 | Any mutation | 120 | 93 | Signature overall | -0.52 | -4.53 | 3.80 | 1546.16 | 1.00 | 270 | 104 | 77 | 16 | TRUE | 0.10 |
| melanoma | NRAS_61 | FAT1 | Any mutation | 119 | 128 | Signature 7 | -0.55 | -1.04 | -0.08 | 1227.08 | 1.01 | 253 | 96 | 105 | 23 | FALSE | 1.62 |
| melanoma | NRAS_61 | FAT1 | Any mutation | 119 | 128 | Signature overall | -0.54 | -4.38 | 3.54 | 1460.48 | 1.00 | 253 | 96 | 105 | 23 | FALSE | 0.12 |
| melanoma | NRAS_61 | KMT2A | Any mutation | 121 | 124 | Signature 7 | -0.72 | -1.30 | -0.22 | 1213.58 | 1.00 | 259 | 101 | 104 | 20 | FALSE | 2.08 |
| melanoma | NRAS_61 | KMT2A | Any mutation | 121 | 124 | Signature overall | -0.63 | -4.53 | 4.17 | 1336.02 | 1.00 | 259 | 101 | 104 | 20 | FALSE | 0.12 |
| melanoma | NRAS_61 | PAK7 | Any mutation | 120 | 205 | Signature 7 | -0.76 | -1.22 | -0.36 | 1372.51 | 1.00 | 186 | 84 | 169 | 36 | FALSE | 3.29 |
| melanoma | NRAS_61 | PAK7 | Any mutation | 120 | 205 | Signature overall | -0.70 | -4.77 | 3.46 | 1643.26 | 1.00 | 186 | 84 | 169 | 36 | FALSE | 0.14 |
| melanoma | NRAS_61 | TERT | Any mutation | 15 | 48 | Signature 11 | 1.57 | 0.18 | 3.08 | 1374.80 | 1.00 | 12 | 1 | 34 | 14 | TRUE | 1.50 |
| melanoma | NRAS_61 | TERT | Any mutation | 10 | 20 | Signature 19 | 2.25 | 0.66 | 4.26 | 1495.29 | 1.00 | 7 | 0 | 10 | 10 | TRUE | 1.85 |
| melanoma | NRAS_61 | TERT | Any mutation | 8 | 17 | Signature 1A | 1.54 | 0.27 | 2.92 | 1557.65 | 1.00 | 44 | 3 | 12 | 5 | TRUE | 1.61 |
| melanoma | NRAS_61 | TERT | Any mutation | 132 | 473 | Signature 7 | 0.73 | 0.09 | 1.43 | 1582.39 | 1.00 | 61 | 12 | 353 | 120 | TRUE | 1.46 |
| melanoma | NRAS_61 | TERT | Any mutation | 165 | 558 | Signature overall | 1.50 | 0.18 | 2.93 | 1639.97 | 1.00 | 124 | 16 | 409 | 149 | TRUE | 1.50 |
| melanoma | NRAS_61 | NOTCH3 | Any mutation | 119 | 116 | Signature 7 | -1.05 | -1.69 | -0.46 | 1132.46 | 1.00 | 254 | 104 | 101 | 15 | TRUE | 3.17 |
| melanoma | NRAS_61 | NOTCH3 | Any mutation | 119 | 116 | Signature overall | -0.88 | -4.76 | 3.53 | 1437.51 | 1.00 | 254 | 104 | 101 | 15 | TRUE | 0.19 |
| melanoma | NRAS_61 | NOTCH4 | Any mutation | 116 | 141 | Signature 7 | -0.41 | -0.90 | 0.07 | 1247.35 | 1.00 | 226 | 87 | 112 | 29 | TRUE | 0.96 |
| melanoma | NRAS_61 | NOTCH4 | Any mutation | 116 | 141 | Signature overall | -0.38 | -5.01 | 3.69 | 1462.66 | 1.00 | 226 | 87 | 112 | 29 | TRUE | 0.07 |
| melanoma | NRAS_61 | CDKN2A | Any mutation | 123 | 108 | Signature 7 | -0.20 | -0.69 | 0.30 | 1310.41 | 1.00 | 253 | 97 | 82 | 26 | TRUE | 0.36 |
| melanoma | NRAS_61 | CDKN2A | Any mutation | 123 | 108 | Signature overall | -0.11 | -4.33 | 4.32 | 1262.49 | 1.00 | 253 | 97 | 82 | 26 | TRUE | 0.02 |
| melanoma | NRAS_61 | KMT2D | Any mutation | 13 | 13 | Signature 11 | -0.38 | -1.35 | 0.58 | 1468.07 | 1.00 | 32 | 10 | 10 | 3 | FALSE | 0.37 |
| melanoma | NRAS_61 | KMT2D | Any mutation | 130 | 184 | Signature 7 | -0.40 | -0.80 | 0.01 | 1475.39 | 1.00 | 245 | 93 | 147 | 37 | FALSE | 1.23 |
| melanoma | NRAS_61 | KMT2D | Any mutation | 143 | 197 | Signature overall | -0.40 | -1.43 | 0.60 | 1651.13 | 1.00 | 277 | 103 | 157 | 40 | FALSE | 0.36 |
| melanoma | NRAS_61 | APC | Any mutation | 119 | 102 | Signature 7 | -0.87 | -1.43 | -0.28 | 378.71 | 1.01 | 263 | 104 | 87 | 15 | TRUE | 2.47 |
| melanoma | NRAS_61 | APC | Any mutation | 119 | 102 | Signature overall | -0.69 | -4.13 | 3.37 | 1490.19 | 1.00 | 263 | 104 | 87 | 15 | TRUE | 0.16 |
| melanoma | NRAS_61 | ARID2 | Any mutation | 126 | 109 | Signature 7 | 0.06 | -0.43 | 0.54 | 1550.69 | 1.00 | 274 | 96 | 79 | 30 | FALSE | 0.10 |
| melanoma | NRAS_61 | ARID2 | Any mutation | 126 | 128 | Signature overall | -0.65 | -5.24 | 3.52 | 1495.59 | 1.00 | 292 | 96 | 98 | 30 | FALSE | 0.12 |
| melanoma | NRAS_61 | EPHA3 | Any mutation | 120 | 97 | Signature 7 | -0.14 | -0.68 | 0.39 | 1442.65 | 1.00 | 274 | 97 | 74 | 23 | FALSE | 0.21 |
| melanoma | NRAS_61 | EPHA3 | Any mutation | 120 | 97 | Signature overall | -0.14 | -4.01 | 4.15 | 1272.34 | 1.00 | 274 | 97 | 74 | 23 | FALSE | 0.03 |
| melanoma | NRAS_61 | KDR | Any mutation | 119 | 121 | Signature 7 | -0.71 | -1.26 | -0.16 | 988.97 | 1.00 | 254 | 99 | 101 | 20 | TRUE | 1.99 |
| melanoma | NRAS_61 | KDR | Any mutation | 119 | 121 | Signature overall | -0.64 | -4.65 | 3.63 | 1317.01 | 1.00 | 254 | 99 | 101 | 20 | TRUE | 0.13 |
| melanoma | NRAS_61 | NTRK3 | Any mutation | 122 | 93 | Signature 7 | -0.75 | -1.37 | -0.20 | 849.13 | 1.00 | 266 | 107 | 78 | 15 | FALSE | 1.87 |
| melanoma | NRAS_61 | NTRK3 | Any mutation | 122 | 93 | Signature overall | -0.49 | -4.15 | 4.07 | 1300.52 | 1.00 | 266 | 107 | 78 | 15 | FALSE | 0.10 |
| melanoma | NRAS_61 | GRIN2A | Any mutation | 13 | 13 | Signature 11 | -0.87 | -2.25 | 0.42 | 1177.90 | 1.00 | 32 | 11 | 11 | 2 | FALSE | 0.72 |
| melanoma | NRAS_61 | GRIN2A | Any mutation | 130 | 278 | Signature 7 | -0.83 | -1.26 | -0.42 | 1440.29 | 1.00 | 197 | 86 | 234 | 44 | FALSE | 4.09 |
| melanoma | NRAS_61 | GRIN2A | Any mutation | 143 | 291 | Signature overall | -0.85 | -2.45 | 0.62 | 1314.35 | 1.00 | 229 | 97 | 245 | 46 | FALSE | 0.55 |
| melanoma | NRAS_61 | ERBB4 | Any mutation | 121 | 171 | Signature 7 | -1.24 | -1.80 | -0.71 | 1274.40 | 1.00 | 225 | 101 | 151 | 20 | TRUE | 5.18 |
| melanoma | NRAS_61 | ERBB4 | Any mutation | 121 | 171 | Signature overall | -1.01 | -4.84 | 3.28 | 1422.40 | 1.00 | 225 | 101 | 151 | 20 | TRUE | 0.22 |
| melanoma | NRAS_61 | NF1 | Any mutation | 13 | 17 | Signature 11 | -1.49 | -2.76 | -0.18 | 1445.93 | 1.00 | 33 | 11 | 15 | 2 | TRUE | 1.63 |
| melanoma | NRAS_61 | NF1 | Any mutation | 122 | 242 | Signature 7 | -1.76 | -2.25 | -1.30 | 727.27 | 1.01 | 189 | 102 | 222 | 20 | TRUE | 11.39 |
| melanoma | NRAS_61 | NF1 | Any mutation | 135 | 259 | Signature overall | -1.61 | -3.03 | -0.09 | 1353.33 | 1.00 | 222 | 113 | 237 | 22 | TRUE | 1.59 |
| melanoma | NRAS_61 | FLT1 | Any mutation | 121 | 110 | Signature 7 | -0.57 | -1.10 | -0.04 | 994.11 | 1.00 | 261 | 101 | 90 | 20 | FALSE | 1.38 |
| melanoma | NRAS_61 | FLT1 | Any mutation | 121 | 110 | Signature overall | -0.38 | -4.37 | 3.94 | 1421.67 | 1.00 | 261 | 101 | 90 | 20 | FALSE | 0.07 |
| melanoma | NRAS_61 | ROS1 | Any mutation | 13 | 11 | Signature 11 | 0.17 | -1.11 | 1.71 | 1285.89 | 1.00 | 35 | 9 | 7 | 4 | TRUE | 0.09 |
| melanoma | NRAS_61 | ROS1 | Any mutation | 124 | 231 | Signature 7 | -0.81 | -1.25 | -0.42 | 1394.15 | 1.00 | 213 | 89 | 196 | 35 | TRUE | 4.00 |
| melanoma | NRAS_61 | ROS1 | Any mutation | 137 | 242 | Signature overall | -0.28 | -1.88 | 1.81 | 1455.52 | 1.00 | 248 | 98 | 203 | 39 | TRUE | 0.12 |
| melanoma | NRAS_61 | PIK3CG | Any mutation | 119 | 92 | Signature 7 | -1.24 | -1.99 | -0.59 | 1411.44 | 1.00 | 272 | 109 | 82 | 10 | FALSE | 3.19 |
| melanoma | NRAS_61 | PIK3CG | Any mutation | 119 | 92 | Signature overall | -1.13 | -5.35 | 3.28 | 1398.88 | 1.00 | 272 | 109 | 82 | 10 | FALSE | 0.24 |
| melanoma | NRAS_61 | BRAF | Any mutation | 13 | 25 | Signature 11 | -2.08 | -3.53 | -0.79 | 1330.13 | 1.00 | 20 | 11 | 23 | 2 | TRUE | 2.43 |
| melanoma | NRAS_61 | BRAF | Any mutation | 8 | 11 | Signature 1A | -2.46 | -4.78 | -0.66 | 1546.28 | 1.00 | 44 | 8 | 11 | 0 | TRUE | 1.83 |
| melanoma | NRAS_61 | BRAF | Any mutation | 121 | 191 | Signature 7 | -2.18 | -2.79 | -1.61 | 1386.56 | 1.00 | 166 | 108 | 178 | 13 | TRUE | 12.35 |
| melanoma | NRAS_61 | BRAF | Any mutation | 142 | 227 | Signature overall | -2.21 | -3.76 | -0.81 | 1465.93 | 1.00 | 230 | 127 | 212 | 15 | TRUE | 2.59 |
| melanoma | NRAS_61 | CARD11 | Any mutation | 119 | 107 | Signature 7 | -0.95 | -1.52 | -0.34 | 407.65 | 1.01 | 256 | 104 | 92 | 15 | FALSE | 2.75 |
| melanoma | NRAS_61 | CARD11 | Any mutation | 119 | 107 | Signature overall | -0.87 | -4.72 | 3.14 | 1415.62 | 1.00 | 256 | 104 | 92 | 15 | FALSE | 0.20 |
| melanoma | NRAS_61 | TP63 | Any mutation | 115 | 152 | Signature 7 | -0.53 | -1.03 | -0.06 | 1096.77 | 1.00 | 215 | 86 | 123 | 29 | FALSE | 1.53 |
| melanoma | NRAS_61 | TP63 | Any mutation | 115 | 152 | Signature overall | -0.43 | -4.81 | 4.40 | 1429.46 | 1.00 | 215 | 86 | 123 | 29 | FALSE | 0.08 |
| melanoma | NRAS_61 | ZFHX3 | Any mutation | 114 | 90 | Signature 7 | -0.78 | -1.42 | -0.17 | 1431.37 | 1.00 | 258 | 100 | 76 | 14 | FALSE | 1.85 |
| melanoma | NRAS_61 | ZFHX3 | Any mutation | 114 | 129 | Signature overall | -1.31 | -6.00 | 3.24 | 1563.38 | 1.00 | 275 | 100 | 115 | 14 | FALSE | 0.25 |
| melanoma | NRAS_61 | PREX2 | Any mutation | 82 | 158 | Signature 7 | -0.46 | -0.99 | 0.02 | 1524.08 | 1.00 | 118 | 49 | 125 | 33 | FALSE | 1.13 |
| melanoma | NRAS_61 | PREX2 | Any mutation | 82 | 158 | Signature overall | -0.42 | -4.31 | 3.86 | 1393.32 | 1.00 | 118 | 49 | 125 | 33 | FALSE | 0.08 |
| melanoma | NRAS_61 | EPHA7 | Any mutation | 116 | 141 | Signature 7 | -0.66 | -1.21 | -0.16 | 960.52 | 1.00 | 233 | 92 | 117 | 24 | FALSE | 1.95 |
| melanoma | NRAS_61 | EPHA7 | Any mutation | 116 | 141 | Signature overall | -0.52 | -4.36 | 3.98 | 1516.08 | 1.00 | 233 | 92 | 117 | 24 | FALSE | 0.11 |
| cancer of unknown primary | RAS_12-61 | TP53 | Inactivating mutation | 30 | 15 | TMB quintile 2 | -0.32 | -1.20 | 0.53 | 1127.14 | 1.00 | 75 | 26 | 11 | 4 | TRUE | 0.33 |
| cancer of unknown primary | RAS_12-61 | TP53 | Inactivating mutation | 40 | 29 | TMB quintile 3 | -0.21 | -0.96 | 0.54 | 1439.24 | 1.00 | 84 | 32 | 21 | 8 | TRUE | 0.24 |
| cancer of unknown primary | RAS_12-61 | TP53 | Inactivating mutation | 39 | 29 | TMB quintile 4 | -0.68 | -1.56 | 0.09 | 1390.52 | 1.00 | 77 | 35 | 25 | 4 | TRUE | 1.00 |
| cancer of unknown primary | RAS_12-61 | TP53 | Inactivating mutation | 47 | 57 | TMB quintile 5 | -0.23 | -0.81 | 0.38 | 1505.64 | 1.00 | 99 | 34 | 44 | 13 | TRUE | 0.32 |
| colorectal cancer | RAS_12-61 | TP53 | Inactivating mutation | 28 | 39 | TMB quintile 2 | -0.67 | -1.38 | -0.01 | 1608.93 | 1.00 | 75 | 23 | 34 | 5 | TRUE | 1.22 |
| colorectal cancer | RAS_12-61 | TP53 | Inactivating mutation | 192 | 146 | TMB quintile 3 | -0.72 | -1.12 | -0.35 | 1248.60 | 1.00 | 188 | 153 | 107 | 39 | TRUE | 3.41 |
| colorectal cancer | RAS_12-61 | TP53 | Inactivating mutation | 376 | 208 | TMB quintile 4 | -0.35 | -0.65 | -0.05 | 1495.91 | 1.00 | 296 | 291 | 123 | 85 | TRUE | 1.64 |
| colorectal cancer | RAS_12-61 | TP53 | Inactivating mutation | 340 | 108 | TMB quintile 5 | -0.44 | -0.83 | -0.08 | 1507.58 | 1.00 | 230 | 291 | 59 | 49 | TRUE | 1.59 |
| colorectal cancer | RAS_12-61 | TP53 | Inactivating mutation | 39 | 31 | TMB quintile 6 | -0.15 | -0.82 | 0.58 | 1663.30 | 1.00 | 87 | 29 | 21 | 10 | TRUE | 0.17 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Inactivating mutation | 83 | 49 | TMB quintile 2 | -0.83 | -1.60 | -0.13 | 1408.61 | 1.00 | 315 | 77 | 43 | 6 | TRUE | 1.60 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Inactivating mutation | 159 | 116 | TMB quintile 3 | -0.98 | -1.53 | -0.48 | 1438.76 | 1.00 | 370 | 144 | 101 | 15 | TRUE | 3.69 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Inactivating mutation | 268 | 145 | TMB quintile 4 | -1.05 | -1.48 | -0.64 | 1573.27 | 1.00 | 379 | 242 | 119 | 26 | TRUE | 5.98 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Inactivating mutation | 474 | 346 | TMB quintile 5 | -0.97 | -1.24 | -0.69 | 1589.15 | 1.00 | 493 | 395 | 267 | 79 | TRUE | 11.69 |
| pancreatic cancer | RAS_12-61 | TP53 | Inactivating mutation | 277 | 72 | TMB quintile 2 | 1.49 | 0.86 | 2.12 | 1426.36 | 1.00 | 65 | 209 | 4 | 68 | TRUE | 5.11 |
| pancreatic cancer | RAS_12-61 | TP53 | Inactivating mutation | 458 | 131 | TMB quintile 3 | 1.59 | 1.01 | 2.27 | 1402.70 | 1.00 | 62 | 331 | 4 | 127 | TRUE | 6.04 |
| pancreatic cancer | RAS_12-61 | TP53 | Inactivating mutation | 241 | 74 | TMB quintile 4 | 1.48 | 0.86 | 2.15 | 1176.63 | 1.00 | 35 | 172 | 5 | 69 | TRUE | 5.02 |
| pancreatic cancer | RAS_12-61 | TP53 | Inactivating mutation | 38 | 14 | TMB quintile 5 | 1.50 | 0.80 | 2.27 | 1404.33 | 1.00 | 16 | 26 | 2 | 12 | TRUE | 4.19 |
| uterine cancer | RAS_12-61 | TP53 | Inactivating mutation | 14 | 21 | TMB quintile 2 | -0.61 | -1.78 | 0.55 | 1483.64 | 1.00 | 112 | 12 | 19 | 2 | TRUE | 0.52 |
| uterine cancer | RAS_12-61 | TP53 | Inactivating mutation | 26 | 38 | TMB quintile 3 | -0.86 | -1.92 | 0.11 | 1418.73 | 1.00 | 180 | 24 | 36 | 2 | TRUE | 1.02 |
| uterine cancer | RAS_12-61 | TP53 | Inactivating mutation | 48 | 33 | TMB quintile 4 | -1.06 | -2.13 | -0.18 | 1647.21 | 1.00 | 151 | 46 | 31 | 2 | TRUE | 1.44 |
| uterine cancer | RAS_12-61 | TP53 | Inactivating mutation | 71 | 19 | TMB quintile 5 | -0.49 | -1.47 | 0.44 | 1423.39 | 1.00 | 179 | 66 | 14 | 5 | TRUE | 0.51 |
| cancer of unknown primary | RAS_12-61 | TP53 | Inactivating mutation | 160 | 144 | TMB overall | -0.35 | -1.03 | 0.34 | 1390.90 | 1.00 | 340 | 129 | 113 | 31 | TRUE | 0.50 |
| colorectal cancer | RAS_12-61 | TP53 | Inactivating mutation | 975 | 532 | TMB overall | -0.47 | -0.98 | 0.03 | 1360.69 | 1.00 | 876 | 787 | 344 | 188 | TRUE | 1.17 |
| non-small cell lung cancer | RAS_12-61 | TP53 | Inactivating mutation | 984 | 656 | TMB overall | -0.95 | -1.56 | -0.35 | 1344.15 | 1.00 | 1557 | 858 | 530 | 126 | TRUE | 2.62 |
| pancreatic cancer | RAS_12-61 | TP53 | Inactivating mutation | 1014 | 291 | TMB overall | 1.51 | 0.91 | 2.14 | 1354.66 | 1.00 | 178 | 738 | 15 | 276 | TRUE | 5.42 |
| uterine cancer | RAS_12-61 | TP53 | Inactivating mutation | 159 | 111 | TMB overall | -0.74 | -1.66 | 0.12 | 1537.57 | 1.00 | 622 | 148 | 100 | 11 | TRUE | 1.03 |
| colorectal cancer | RAS_12-61 | FBXW7 | Inactivating mutation | 192 | 11 | TMB quintile 3 | -0.42 | -1.44 | 0.54 | 1298.30 | 1.00 | 287 | 189 | 8 | 3 | TRUE | 0.40 |
| colorectal cancer | RAS_12-61 | FBXW7 | Inactivating mutation | 375 | 27 | TMB quintile 4 | -0.37 | -1.13 | 0.34 | 1276.20 | 1.00 | 400 | 365 | 17 | 10 | TRUE | 0.49 |
| colorectal cancer | RAS_12-61 | FBXW7 | Inactivating mutation | 341 | 49 | TMB quintile 5 | 0.43 | -0.09 | 1.00 | 1491.92 | 1.00 | 271 | 309 | 17 | 32 | TRUE | 0.90 |
| colorectal cancer | RAS_12-61 | FBXW7 | Inactivating mutation | 37 | 24 | TMB quintile 6 | 0.32 | -0.54 | 1.13 | 1488.52 | 1.00 | 89 | 29 | 16 | 8 | TRUE | 0.35 |
| colorectal cancer | RAS_12-61 | FBXW7 | Inactivating mutation | 945 | 111 | TMB overall | -0.02 | -0.88 | 0.89 | 1387.72 | 1.00 | 1047 | 892 | 58 | 53 | TRUE | 0.02 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Inactivating mutation | 159 | 12 | TMB quintile 3 | 1.18 | 0.14 | 2.31 | 1504.31 | 1.00 | 463 | 151 | 4 | 8 | FALSE | 1.44 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Inactivating mutation | 267 | 28 | TMB quintile 4 | 0.46 | -0.26 | 1.12 | 1465.42 | 1.00 | 480 | 254 | 15 | 13 | FALSE | 0.68 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Inactivating mutation | 476 | 94 | TMB quintile 5 | -0.25 | -0.71 | 0.21 | 1394.63 | 1.00 | 686 | 446 | 64 | 30 | FALSE | 0.54 |
| non-small cell lung cancer | RAS_12-61 | SMARCA4 | Inactivating mutation | 902 | 134 | TMB overall | 0.45 | -0.73 | 1.75 | 1429.22 | 1.00 | 1629 | 851 | 83 | 51 | FALSE | 0.33 |
| colorectal cancer | RAS_12-61 | PTEN | Inactivating mutation | 375 | 17 | TMB quintile 4 | 0.24 | -0.70 | 1.19 | 1488.68 | 1.00 | 410 | 365 | 7 | 10 | TRUE | 0.22 |
| colorectal cancer | RAS_12-61 | PTEN | Inactivating mutation | 340 | 44 | TMB quintile 5 | -0.93 | -1.57 | -0.30 | 1383.49 | 1.00 | 266 | 326 | 30 | 14 | TRUE | 2.34 |
| colorectal cancer | RAS_12-61 | PTEN | Inactivating mutation | 43 | 57 | TMB quintile 6 | 0.20 | -0.51 | 0.92 | 1461.88 | 1.00 | 76 | 26 | 40 | 17 | TRUE | 0.23 |
| uterine cancer | RAS_12-61 | PTEN | Inactivating mutation | 27 | 35 | TMB quintile 3 | -0.05 | -1.04 | 0.80 | 1482.87 | 1.00 | 188 | 23 | 31 | 4 | TRUE | 0.04 |
| uterine cancer | RAS_12-61 | PTEN | Inactivating mutation | 51 | 72 | TMB quintile 4 | 0.10 | -0.54 | 0.71 | 1432.89 | 1.00 | 138 | 35 | 56 | 16 | TRUE | 0.12 |
| uterine cancer | RAS_12-61 | PTEN | Inactivating mutation | 87 | 190 | TMB quintile 5 | 0.38 | -0.11 | 0.89 | 1435.67 | 1.00 | 93 | 29 | 132 | 58 | TRUE | 0.89 |
| uterine cancer | RAS_12-61 | PTEN | Inactivating mutation | 10 | 41 | TMB quintile 6 | -0.20 | -1.24 | 0.87 | 1668.34 | 1.00 | 25 | 5 | 36 | 5 | TRUE | 0.14 |
| colorectal cancer | RAS_12-61 | PTEN | Inactivating mutation | 758 | 118 | TMB overall | -0.14 | -1.80 | 1.64 | 1448.03 | 1.00 | 752 | 717 | 77 | 41 | TRUE | 0.06 |
| uterine cancer | RAS_12-61 | PTEN | Inactivating mutation | 175 | 338 | TMB overall | 0.05 | -0.88 | 0.93 | 1458.54 | 1.00 | 444 | 92 | 255 | 83 | TRUE | 0.04 |
| colorectal cancer | RAS_12-61 | ARID1A | Inactivating mutation | 376 | 24 | TMB quintile 4 | -0.37 | -1.19 | 0.41 | 1342.39 | 1.00 | 402 | 366 | 14 | 10 | TRUE | 0.43 |
| colorectal cancer | RAS_12-61 | ARID1A | Inactivating mutation | 340 | 87 | TMB quintile 5 | -0.88 | -1.36 | -0.42 | 1521.36 | 1.00 | 243 | 310 | 57 | 30 | TRUE | 3.57 |
| colorectal cancer | RAS_12-61 | ARID1A | Inactivating mutation | 45 | 96 | TMB quintile 6 | -0.18 | -0.86 | 0.48 | 1542.58 | 1.00 | 54 | 21 | 72 | 24 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Inactivating mutation | 267 | 34 | TMB quintile 4 | -0.30 | -0.96 | 0.32 | 1472.60 | 1.00 | 472 | 257 | 24 | 10 | TRUE | 0.45 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Inactivating mutation | 478 | 103 | TMB quintile 5 | -0.17 | -0.57 | 0.22 | 1107.40 | 1.00 | 684 | 442 | 67 | 36 | TRUE | 0.41 |
| pancreatic cancer | RAS_12-61 | ARID1A | Inactivating mutation | 277 | 13 | TMB quintile 2 | -0.81 | -1.64 | 0.05 | 1666.36 | 1.00 | 64 | 269 | 5 | 8 | TRUE | 1.22 |
| pancreatic cancer | RAS_12-61 | ARID1A | Inactivating mutation | 458 | 42 | TMB quintile 3 | -0.15 | -0.84 | 0.62 | 1436.63 | 1.00 | 61 | 421 | 5 | 37 | TRUE | 0.16 |
| pancreatic cancer | RAS_12-61 | ARID1A | Inactivating mutation | 243 | 39 | TMB quintile 4 | -0.21 | -0.96 | 0.55 | 1523.11 | 1.00 | 33 | 211 | 7 | 32 | TRUE | 0.23 |
| pancreatic cancer | RAS_12-61 | ARID1A | Inactivating mutation | 39 | 14 | TMB quintile 5 | -0.08 | -1.05 | 0.89 | 1389.33 | 1.00 | 14 | 30 | 5 | 9 | TRUE | 0.06 |
| uterine cancer | RAS_12-61 | ARID1A | Inactivating mutation | 26 | 26 | TMB quintile 3 | 0.45 | -0.70 | 1.47 | 1575.85 | 1.00 | 194 | 22 | 22 | 4 | TRUE | 0.37 |
| uterine cancer | RAS_12-61 | ARID1A | Inactivating mutation | 51 | 69 | TMB quintile 4 | 1.00 | 0.35 | 1.63 | 1256.88 | 1.00 | 141 | 27 | 45 | 24 | TRUE | 2.70 |
| uterine cancer | RAS_12-61 | ARID1A | Inactivating mutation | 95 | 284 | TMB quintile 5 | 0.42 | -0.16 | 1.06 | 1562.78 | 1.00 | 57 | 16 | 205 | 79 | TRUE | 0.75 |
| uterine cancer | RAS_12-61 | ARID1A | Inactivating mutation | 17 | 75 | TMB quintile 6 | 1.62 | 0.13 | 3.66 | 1431.71 | 1.00 | 12 | 0 | 58 | 17 | TRUE | 1.11 |
| colorectal cancer | RAS_12-61 | ARID1A | Inactivating mutation | 761 | 207 | TMB overall | -0.48 | -2.06 | 1.13 | 1404.58 | 1.00 | 699 | 697 | 143 | 64 | TRUE | 0.26 |
| non-small cell lung cancer | RAS_12-61 | ARID1A | Inactivating mutation | 745 | 137 | TMB overall | -0.23 | -1.21 | 0.74 | 1357.30 | 1.00 | 1156 | 699 | 91 | 46 | TRUE | 0.19 |
| pancreatic cancer | RAS_12-61 | ARID1A | Inactivating mutation | 1017 | 108 | TMB overall | -0.30 | -1.12 | 0.57 | 1574.88 | 1.00 | 172 | 931 | 22 | 86 | TRUE | 0.32 |
| uterine cancer | RAS_12-61 | ARID1A | Inactivating mutation | 189 | 454 | TMB overall | 0.85 | -0.70 | 2.30 | 1269.51 | 1.00 | 404 | 65 | 330 | 124 | TRUE | 0.58 |
| uterine cancer | RAS_12-61 | PIK3R1 | Inactivating mutation | 26 | 13 | TMB quintile 3 | -1.20 | -3.73 | 0.33 | 1571.80 | 1.00 | 202 | 26 | 13 | 0 | TRUE | 0.63 |
| uterine cancer | RAS_12-61 | PIK3R1 | Inactivating mutation | 49 | 32 | TMB quintile 4 | -0.71 | -1.77 | 0.20 | 1397.74 | 1.00 | 156 | 45 | 28 | 4 | TRUE | 0.78 |
| uterine cancer | RAS_12-61 | PIK3R1 | Inactivating mutation | 77 | 57 | TMB quintile 5 | 0.49 | -0.10 | 1.05 | 1565.01 | 1.00 | 164 | 55 | 35 | 22 | TRUE | 0.97 |
| uterine cancer | RAS_12-61 | PIK3R1 | Inactivating mutation | 10 | 14 | TMB quintile 6 | -1.38 | -3.80 | 0.16 | 1341.01 | 1.00 | 39 | 10 | 14 | 0 | TRUE | 0.73 |
| uterine cancer | RAS_12-61 | PIK3R1 | Inactivating mutation | 162 | 116 | TMB overall | -0.68 | -2.24 | 0.43 | 1564.29 | 1.00 | 561 | 136 | 90 | 26 | TRUE | 0.50 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Inactivating mutation | 277 | 18 | TMB quintile 2 | 1.16 | 0.08 | 2.62 | 1355.77 | 1.00 | 69 | 259 | 0 | 18 | TRUE | 1.18 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Inactivating mutation | 459 | 78 | TMB quintile 3 | 0.88 | 0.11 | 1.72 | 1483.99 | 1.00 | 59 | 388 | 7 | 71 | TRUE | 1.51 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Inactivating mutation | 241 | 44 | TMB quintile 4 | 1.36 | 0.40 | 2.41 | 1528.64 | 1.00 | 38 | 199 | 2 | 42 | TRUE | 2.07 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Inactivating mutation | 39 | 13 | TMB quintile 5 | 1.64 | 0.56 | 2.92 | 1433.18 | 1.00 | 17 | 27 | 1 | 12 | TRUE | 2.13 |
| pancreatic cancer | RAS_12-61 | SMAD4 | Inactivating mutation | 1016 | 153 | TMB overall | 1.24 | 0.30 | 2.36 | 1245.02 | 1.00 | 183 | 873 | 10 | 143 | TRUE | 1.72 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Inactivating mutation | 159 | 28 | TMB quintile 3 | -1.46 | -2.50 | -0.66 | 1472.91 | 1.00 | 440 | 158 | 27 | 1 | TRUE | 2.82 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Inactivating mutation | 267 | 40 | TMB quintile 4 | -1.22 | -1.92 | -0.56 | 1410.95 | 1.00 | 461 | 261 | 34 | 6 | TRUE | 3.26 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Inactivating mutation | 474 | 86 | TMB quintile 5 | -1.08 | -1.59 | -0.61 | 1446.03 | 1.00 | 682 | 457 | 69 | 17 | TRUE | 4.54 |
| non-small cell lung cancer | RAS_12-61 | RB1 | Inactivating mutation | 900 | 154 | TMB overall | -1.24 | -2.01 | -0.61 | 1473.03 | 1.00 | 1583 | 876 | 130 | 24 | TRUE | 3.32 |
| uterine cancer | RAS_12-61 | JAK1 | Inactivating mutation | 74 | 76 | TMB quintile 5 | 0.17 | -0.39 | 0.70 | 1492.44 | 1.00 | 153 | 53 | 55 | 21 | TRUE | 0.26 |
| uterine cancer | RAS_12-61 | JAK1 | Inactivating mutation | 12 | 25 | TMB quintile 6 | 0.56 | -0.38 | 1.72 | 1354.50 | 1.00 | 37 | 5 | 18 | 7 | TRUE | 0.52 |
| uterine cancer | RAS_12-61 | JAK1 | Inactivating mutation | 86 | 101 | TMB overall | 0.37 | -0.80 | 1.76 | 1410.97 | 1.00 | 190 | 58 | 73 | 28 | TRUE | 0.25 |
| uterine cancer | RAS_12-61 | CTCF | Inactivating mutation | 72 | 83 | TMB quintile 5 | -0.01 | -0.58 | 0.53 | 1204.66 | 1.00 | 132 | 50 | 61 | 22 | FALSE | 0.01 |
| uterine cancer | RAS_12-61 | CTCF | Inactivating mutation | 11 | 26 | TMB quintile 6 | 0.23 | -0.64 | 1.35 | 1433.48 | 1.00 | 33 | 5 | 20 | 6 | FALSE | 0.18 |
| uterine cancer | RAS_12-61 | CTCF | Inactivating mutation | 83 | 109 | TMB overall | 0.10 | -1.05 | 1.35 | 1366.72 | 1.00 | 165 | 55 | 81 | 28 | FALSE | 0.07 |
| melanoma | RAS_12-61 | NF1 | Inactivating mutation | 17 | 11 | TMB quintile 3 | -0.81 | -2.68 | 0.84 | 1591.51 | 1.00 | 84 | 16 | 10 | 1 | TRUE | 0.43 |
| melanoma | RAS_12-61 | NF1 | Inactivating mutation | 163 | 117 | TMB quintile 5 | -1.13 | -1.66 | -0.62 | 1588.33 | 1.00 | 170 | 139 | 93 | 24 | TRUE | 4.77 |
| melanoma | RAS_12-61 | NF1 | Inactivating mutation | 14 | 68 | TMB quintile 6 | 0.45 | -0.74 | 1.78 | 1224.52 | 1.00 | 21 | 2 | 56 | 12 | TRUE | 0.31 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Inactivating mutation | 159 | 18 | TMB quintile 3 | -1.45 | -2.76 | -0.39 | 1509.88 | 1.00 | 450 | 158 | 17 | 1 | TRUE | 1.73 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Inactivating mutation | 267 | 48 | TMB quintile 4 | -1.44 | -2.26 | -0.67 | 1432.72 | 1.00 | 460 | 262 | 43 | 5 | TRUE | 3.45 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Inactivating mutation | 476 | 108 | TMB quintile 5 | -0.70 | -1.18 | -0.27 | 1343.94 | 1.00 | 679 | 448 | 80 | 28 | TRUE | 2.66 |
| melanoma | RAS_12-61 | NF1 | Inactivating mutation | 194 | 196 | TMB overall | -0.44 | -2.23 | 1.50 | 1545.92 | 1.00 | 275 | 157 | 159 | 37 | TRUE | 0.19 |
| non-small cell lung cancer | RAS_12-61 | NF1 | Inactivating mutation | 902 | 174 | TMB overall | -1.17 | -2.18 | -0.17 | 1542.43 | 1.00 | 1589 | 868 | 140 | 34 | TRUE | 1.74 |
| colorectal cancer | RAS_12-61 | APC | Inactivating mutation | 29 | 77 | TMB quintile 2 | -0.73 | -1.41 | -0.08 | 1243.85 | 1.00 | 49 | 19 | 67 | 10 | TRUE | 1.41 |
| colorectal cancer | RAS_12-61 | APC | Inactivating mutation | 226 | 422 | TMB quintile 3 | -0.39 | -0.76 | -0.05 | 1279.21 | 1.00 | 86 | 76 | 272 | 150 | TRUE | 1.46 |
| colorectal cancer | RAS_12-61 | APC | Inactivating mutation | 523 | 936 | TMB quintile 4 | 0.14 | -0.19 | 0.46 | 1256.67 | 1.00 | 85 | 72 | 485 | 451 | TRUE | 0.40 |
| colorectal cancer | RAS_12-61 | APC | Inactivating mutation | 545 | 781 | TMB quintile 5 | 0.95 | 0.61 | 1.29 | 1477.73 | 1.00 | 103 | 61 | 297 | 484 | TRUE | 7.66 |
| colorectal cancer | RAS_12-61 | APC | Inactivating mutation | 62 | 151 | TMB quintile 6 | 0.36 | -0.18 | 0.97 | 1502.13 | 1.00 | 54 | 14 | 103 | 48 | TRUE | 0.67 |
| colorectal cancer | RAS_12-61 | APC | Inactivating mutation | 1385 | 2367 | TMB overall | 0.07 | -0.56 | 0.66 | 1482.21 | 1.00 | 377 | 242 | 1224 | 1143 | TRUE | 0.09 |
| colorectal cancer | RAS_12-61 | KMT2D | Inactivating mutation | 340 | 46 | TMB quintile 5 | -1.27 | -1.96 | -0.65 | 1334.30 | 1.00 | 263 | 328 | 34 | 12 | FALSE | 3.85 |
| colorectal cancer | RAS_12-61 | KMT2D | Inactivating mutation | 46 | 111 | TMB quintile 6 | -0.38 | -1.01 | 0.26 | 1420.33 | 1.00 | 46 | 20 | 85 | 26 | FALSE | 0.60 |
| uterine cancer | RAS_12-61 | KMT2D | Inactivating mutation | 71 | 88 | TMB quintile 5 | -0.68 | -1.32 | -0.11 | 481.65 | 1.00 | 128 | 55 | 72 | 16 | FALSE | 1.57 |
| uterine cancer | RAS_12-61 | KMT2D | Inactivating mutation | 11 | 29 | TMB quintile 6 | -0.80 | -1.89 | 0.10 | 945.73 | 1.00 | 31 | 8 | 26 | 3 | FALSE | 0.95 |
| colorectal cancer | RAS_12-61 | KMT2D | Inactivating mutation | 386 | 157 | TMB overall | -0.74 | -3.28 | 1.92 | 1323.48 | 1.00 | 309 | 348 | 119 | 38 | FALSE | 0.26 |
| uterine cancer | RAS_12-61 | KMT2D | Inactivating mutation | 82 | 117 | TMB overall | -0.72 | -1.84 | 0.35 | 1050.30 | 1.00 | 159 | 63 | 98 | 19 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Inactivating mutation | 160 | 16 | TMB quintile 3 | -0.23 | -1.26 | 0.54 | 1566.60 | 1.00 | 456 | 158 | 14 | 2 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Inactivating mutation | 267 | 34 | TMB quintile 4 | 0.02 | -0.62 | 0.64 | 1419.44 | 1.00 | 476 | 256 | 23 | 11 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Inactivating mutation | 479 | 50 | TMB quintile 5 | 0.51 | 0.00 | 1.05 | 1499.48 | 1.00 | 730 | 451 | 22 | 28 | FALSE | 1.24 |
| non-small cell lung cancer | RAS_12-61 | SETD2 | Inactivating mutation | 906 | 100 | TMB overall | 0.09 | -0.70 | 0.76 | 1475.17 | 1.00 | 1662 | 865 | 59 | 41 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Inactivating mutation | 83 | 26 | TMB quintile 2 | 0.53 | -0.14 | 1.14 | 1436.43 | 1.00 | 338 | 77 | 20 | 6 | FALSE | 1.04 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Inactivating mutation | 159 | 40 | TMB quintile 3 | 0.60 | 0.07 | 1.09 | 1279.11 | 1.00 | 441 | 145 | 26 | 14 | FALSE | 1.63 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Inactivating mutation | 268 | 76 | TMB quintile 4 | 0.91 | 0.47 | 1.30 | 1398.48 | 1.00 | 461 | 226 | 34 | 42 | FALSE | 4.81 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Inactivating mutation | 477 | 133 | TMB quintile 5 | 1.06 | 0.73 | 1.41 | 1486.90 | 1.00 | 702 | 393 | 49 | 84 | FALSE | 9.11 |
| non-small cell lung cancer | RAS_12-61 | RBM10 | Inactivating mutation | 987 | 275 | TMB overall | 0.78 | 0.32 | 1.25 | 1500.91 | 1.00 | 1942 | 841 | 129 | 146 | FALSE | 2.81 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Inactivating mutation | 159 | 17 | TMB quintile 3 | 0.07 | -0.90 | 1.03 | 1401.67 | 1.00 | 456 | 153 | 11 | 6 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Inactivating mutation | 267 | 27 | TMB quintile 4 | -0.22 | -0.98 | 0.54 | 1347.91 | 1.00 | 477 | 258 | 18 | 9 | TRUE | 0.26 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Inactivating mutation | 475 | 96 | TMB quintile 5 | -0.90 | -1.41 | -0.44 | 1288.95 | 1.00 | 674 | 456 | 77 | 19 | TRUE | 3.40 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Inactivating mutation | 277 | 25 | TMB quintile 2 | 1.43 | 0.47 | 2.67 | 1386.27 | 1.00 | 68 | 253 | 1 | 24 | TRUE | 1.91 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Inactivating mutation | 460 | 102 | TMB quintile 3 | 2.07 | 1.12 | 3.31 | 1571.14 | 1.00 | 65 | 359 | 1 | 101 | TRUE | 3.55 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Inactivating mutation | 245 | 63 | TMB quintile 4 | 1.49 | 0.44 | 2.54 | 1279.69 | 1.00 | 35 | 187 | 5 | 58 | TRUE | 2.31 |
| non-small cell lung cancer | RAS_12-61 | CDKN2A | Inactivating mutation | 901 | 140 | TMB overall | -0.37 | -1.30 | 0.60 | 1449.19 | 1.00 | 1607 | 867 | 106 | 34 | TRUE | 0.34 |
| pancreatic cancer | RAS_12-61 | CDKN2A | Inactivating mutation | 982 | 190 | TMB overall | 1.64 | 0.50 | 2.88 | 1348.18 | 1.00 | 168 | 799 | 7 | 183 | TRUE | 2.16 |
| colorectal cancer | RAS_12-61 | SOX9 | Inactivating mutation | 192 | 14 | TMB quintile 3 | -0.47 | -1.42 | 0.40 | 1503.17 | 1.00 | 285 | 188 | 10 | 4 | FALSE | 0.49 |
| colorectal cancer | RAS_12-61 | SOX9 | Inactivating mutation | 376 | 73 | TMB quintile 4 | 0.28 | -0.19 | 0.73 | 1433.60 | 1.00 | 383 | 336 | 33 | 40 | FALSE | 0.63 |
| colorectal cancer | RAS_12-61 | SOX9 | Inactivating mutation | 342 | 88 | TMB quintile 5 | 0.09 | -0.35 | 0.51 | 1460.04 | 1.00 | 252 | 293 | 39 | 49 | FALSE | 0.15 |
| colorectal cancer | RAS_12-61 | SOX9 | Inactivating mutation | 38 | 43 | TMB quintile 6 | 0.27 | -0.50 | 0.99 | 1495.29 | 1.00 | 79 | 25 | 30 | 13 | FALSE | 0.34 |
| colorectal cancer | RAS_12-61 | SOX9 | Inactivating mutation | 948 | 218 | TMB overall | 0.04 | -0.91 | 0.92 | 1453.53 | 1.00 | 999 | 842 | 112 | 106 | FALSE | 0.03 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Inactivating mutation | 161 | 59 | TMB quintile 3 | 1.27 | 0.79 | 1.75 | 1365.48 | 1.00 | 441 | 128 | 26 | 33 | TRUE | 6.19 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Inactivating mutation | 267 | 106 | TMB quintile 4 | 1.21 | 0.81 | 1.63 | 1575.42 | 1.00 | 454 | 202 | 41 | 65 | TRUE | 8.45 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Inactivating mutation | 475 | 183 | TMB quintile 5 | 0.44 | 0.11 | 0.76 | 1136.01 | 1.00 | 651 | 391 | 99 | 84 | TRUE | 2.14 |
| non-small cell lung cancer | RAS_12-61 | STK11 | Inactivating mutation | 903 | 348 | TMB overall | 0.97 | 0.25 | 1.65 | 1551.74 | 1.00 | 1546 | 721 | 166 | 182 | TRUE | 2.19 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Inactivating mutation | 267 | 35 | TMB quintile 4 | 0.75 | 0.08 | 1.52 | 1075.22 | 1.00 | 481 | 246 | 14 | 21 | FALSE | 1.38 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Inactivating mutation | 474 | 69 | TMB quintile 5 | 0.10 | -0.42 | 0.61 | 1206.02 | 1.00 | 706 | 448 | 43 | 26 | FALSE | 0.16 |
| non-small cell lung cancer | RAS_12-61 | KEAP1 | Inactivating mutation | 741 | 104 | TMB overall | 0.42 | -0.61 | 1.69 | 1483.16 | 1.00 | 1187 | 694 | 57 | 47 | FALSE | 0.34 |
| colorectal cancer | RAS_12-61 | RNF43 | Inactivating mutation | 375 | 21 | TMB quintile 4 | -0.94 | -1.89 | -0.06 | 1613.22 | 1.00 | 402 | 369 | 15 | 6 | TRUE | 1.33 |
| colorectal cancer | RAS_12-61 | RNF43 | Inactivating mutation | 342 | 58 | TMB quintile 5 | -1.44 | -2.07 | -0.86 | 1542.02 | 1.00 | 249 | 328 | 44 | 14 | TRUE | 5.32 |
| colorectal cancer | RAS_12-61 | RNF43 | Inactivating mutation | 43 | 113 | TMB quintile 6 | -0.56 | -1.21 | 0.16 | 1537.21 | 1.00 | 41 | 19 | 89 | 24 | TRUE | 0.96 |
| colorectal cancer | RAS_12-61 | RNF43 | Inactivating mutation | 760 | 192 | TMB overall | -0.95 | -2.86 | 0.85 | 1543.91 | 1.00 | 692 | 716 | 148 | 44 | TRUE | 0.52 |
| colorectal cancer | RAS_12-61 | B2M | Inactivating mutation | 324 | 45 | TMB quintile 5 | -0.90 | -1.53 | -0.28 | 1616.86 | 1.00 | 250 | 309 | 30 | 15 | FALSE | 2.39 |
| colorectal cancer | RAS_12-61 | B2M | Inactivating mutation | 45 | 66 | TMB quintile 6 | 0.33 | -0.35 | 1.01 | 1412.93 | 1.00 | 69 | 23 | 44 | 22 | FALSE | 0.47 |
| colorectal cancer | RAS_12-61 | B2M | Inactivating mutation | 369 | 111 | TMB overall | -0.28 | -2.50 | 1.96 | 1638.86 | 1.00 | 319 | 332 | 74 | 37 | FALSE | 0.10 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Inactivating mutation | 177 | 13 | TMB quintile 3 | -0.22 | -1.16 | 0.69 | 1366.08 | 1.00 | 254 | 172 | 8 | 5 | FALSE | 0.19 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Inactivating mutation | 342 | 39 | TMB quintile 4 | 0.09 | -0.52 | 0.70 | 1407.60 | 1.00 | 359 | 322 | 19 | 20 | FALSE | 0.11 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Inactivating mutation | 314 | 57 | TMB quintile 5 | -0.34 | -0.90 | 0.18 | 1449.32 | 1.00 | 235 | 288 | 31 | 26 | FALSE | 0.68 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Inactivating mutation | 36 | 48 | TMB quintile 6 | 0.19 | -0.52 | 0.91 | 1401.26 | 1.00 | 66 | 22 | 34 | 14 | FALSE | 0.22 |
| colorectal cancer | RAS_12-61 | TCF7L2 | Inactivating mutation | 869 | 157 | TMB overall | -0.07 | -1.02 | 0.94 | 1358.49 | 1.00 | 914 | 804 | 92 | 65 | FALSE | 0.05 |
| non-small cell lung cancer | RAS_12-61 | MGA | Inactivating mutation | 249 | 16 | TMB quintile 4 | 0.55 | -0.28 | 1.50 | 1432.88 | 1.00 | 422 | 240 | 7 | 9 | FALSE | 0.65 |
| non-small cell lung cancer | RAS_12-61 | MGA | Inactivating mutation | 435 | 73 | TMB quintile 5 | 0.32 | -0.15 | 0.82 | 1527.40 | 1.00 | 631 | 402 | 40 | 33 | FALSE | 0.71 |
| non-small cell lung cancer | RAS_12-61 | MGA | Inactivating mutation | 684 | 89 | TMB overall | 0.45 | -0.92 | 2.02 | 1376.64 | 1.00 | 1053 | 642 | 47 | 42 | FALSE | 0.29 |
| uterine cancer | RAS_12-61 | ZFHX3 | Inactivating mutation | 44 | 12 | TMB quintile 4 | -0.37 | -1.65 | 0.74 | 1236.48 | 1.00 | 151 | 42 | 10 | 2 | FALSE | 0.25 |
| uterine cancer | RAS_12-61 | ZFHX3 | Inactivating mutation | 68 | 66 | TMB quintile 5 | 0.05 | -0.59 | 0.63 | 1277.62 | 1.00 | 142 | 50 | 48 | 18 | FALSE | 0.06 |
| uterine cancer | RAS_12-61 | ZFHX3 | Inactivating mutation | 12 | 26 | TMB quintile 6 | 0.07 | -1.07 | 1.11 | 1507.58 | 1.00 | 33 | 7 | 21 | 5 | FALSE | 0.05 |
| uterine cancer | RAS_12-61 | ZFHX3 | Inactivating mutation | 124 | 104 | TMB overall | -0.09 | -1.42 | 1.16 | 1342.08 | 1.00 | 326 | 99 | 79 | 25 | FALSE | 0.05 |
| colorectal cancer | RAS_12-61 | AMER1 | Inactivating mutation | 375 | 31 | TMB quintile 4 | 1.31 | 0.52 | 2.20 | 1473.20 | 1.00 | 410 | 350 | 6 | 25 | FALSE | 2.74 |
| colorectal cancer | RAS_12-61 | AMER1 | Inactivating mutation | 338 | 47 | TMB quintile 5 | 0.78 | 0.21 | 1.43 | 1495.59 | 1.00 | 274 | 305 | 14 | 33 | FALSE | 1.92 |
| colorectal cancer | RAS_12-61 | AMER1 | Inactivating mutation | 37 | 27 | TMB quintile 6 | 0.75 | -0.11 | 1.60 | 1486.72 | 1.00 | 87 | 27 | 17 | 10 | FALSE | 1.08 |
| colorectal cancer | RAS_12-61 | AMER1 | Inactivating mutation | 750 | 105 | TMB overall | 0.92 | -0.40 | 2.22 | 1587.41 | 1.00 | 771 | 682 | 37 | 68 | FALSE | 0.80 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Inactivating mutation | 29 | 15 | TMB quintile 2 | -0.25 | -1.14 | 0.61 | 1379.29 | 1.00 | 76 | 25 | 11 | 4 | TRUE | 0.24 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Inactivating mutation | 36 | 29 | TMB quintile 3 | -0.09 | -0.79 | 0.65 | 1444.17 | 1.00 | 88 | 28 | 21 | 8 | TRUE | 0.09 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Inactivating mutation | 36 | 29 | TMB quintile 4 | -0.59 | -1.47 | 0.16 | 1364.13 | 1.00 | 80 | 32 | 25 | 4 | TRUE | 0.78 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Inactivating mutation | 42 | 57 | TMB quintile 5 | -0.24 | -0.95 | 0.37 | 1385.74 | 1.00 | 102 | 31 | 46 | 11 | TRUE | 0.33 |
| colorectal cancer | KRAS_12-61 | TP53 | Inactivating mutation | 27 | 39 | TMB quintile 2 | -0.68 | -1.42 | 0.01 | 1558.82 | 1.00 | 76 | 22 | 34 | 5 | TRUE | 1.24 |
| colorectal cancer | KRAS_12-61 | TP53 | Inactivating mutation | 175 | 146 | TMB quintile 3 | -0.71 | -1.12 | -0.32 | 1453.04 | 1.00 | 201 | 140 | 111 | 35 | TRUE | 3.35 |
| colorectal cancer | KRAS_12-61 | TP53 | Inactivating mutation | 342 | 208 | TMB quintile 4 | -0.43 | -0.74 | -0.13 | 1497.60 | 1.00 | 319 | 268 | 134 | 74 | TRUE | 2.27 |
| colorectal cancer | KRAS_12-61 | TP53 | Inactivating mutation | 315 | 108 | TMB quintile 5 | -0.57 | -0.94 | -0.20 | 1525.89 | 1.00 | 248 | 273 | 66 | 42 | TRUE | 2.46 |
| colorectal cancer | KRAS_12-61 | TP53 | Inactivating mutation | 35 | 31 | TMB quintile 6 | -0.45 | -1.12 | 0.24 | 1300.92 | 1.00 | 88 | 28 | 24 | 7 | TRUE | 0.73 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Inactivating mutation | 83 | 49 | TMB quintile 2 | -0.80 | -1.56 | -0.09 | 1528.06 | 1.00 | 315 | 77 | 43 | 6 | TRUE | 1.55 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Inactivating mutation | 155 | 116 | TMB quintile 3 | -0.94 | -1.47 | -0.46 | 1446.26 | 1.00 | 374 | 140 | 101 | 15 | TRUE | 3.50 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Inactivating mutation | 263 | 145 | TMB quintile 4 | -1.06 | -1.49 | -0.67 | 1527.05 | 1.00 | 383 | 238 | 120 | 25 | TRUE | 6.16 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Inactivating mutation | 454 | 346 | TMB quintile 5 | -0.91 | -1.19 | -0.64 | 1473.05 | 1.00 | 512 | 376 | 268 | 78 | TRUE | 9.75 |
| pancreatic cancer | KRAS_12-61 | TP53 | Inactivating mutation | 277 | 72 | TMB quintile 2 | 1.43 | 0.83 | 2.06 | 1222.42 | 1.00 | 65 | 209 | 4 | 68 | TRUE | 5.39 |
| pancreatic cancer | KRAS_12-61 | TP53 | Inactivating mutation | 454 | 131 | TMB quintile 3 | 1.50 | 0.95 | 2.08 | 1119.97 | 1.00 | 65 | 328 | 5 | 126 | TRUE | 6.47 |
| pancreatic cancer | KRAS_12-61 | TP53 | Inactivating mutation | 239 | 74 | TMB quintile 4 | 1.46 | 0.83 | 2.09 | 1257.02 | 1.00 | 37 | 170 | 5 | 69 | TRUE | 5.16 |
| pancreatic cancer | KRAS_12-61 | TP53 | Inactivating mutation | 38 | 14 | TMB quintile 5 | 1.44 | 0.72 | 2.15 | 1515.08 | 1.00 | 16 | 26 | 2 | 12 | TRUE | 4.24 |
| uterine cancer | KRAS_12-61 | TP53 | Inactivating mutation | 13 | 21 | TMB quintile 2 | -0.74 | -1.89 | 0.31 | 1460.27 | 1.00 | 113 | 11 | 19 | 2 | TRUE | 0.73 |
| uterine cancer | KRAS_12-61 | TP53 | Inactivating mutation | 26 | 38 | TMB quintile 3 | -0.95 | -2.02 | 0.04 | 1563.87 | 1.00 | 180 | 24 | 36 | 2 | TRUE | 1.14 |
| uterine cancer | KRAS_12-61 | TP53 | Inactivating mutation | 44 | 33 | TMB quintile 4 | -1.09 | -2.11 | -0.19 | 1407.05 | 1.00 | 155 | 42 | 31 | 2 | TRUE | 1.52 |
| uterine cancer | KRAS_12-61 | TP53 | Inactivating mutation | 63 | 19 | TMB quintile 5 | -0.87 | -1.89 | 0.07 | 1421.50 | 1.00 | 185 | 60 | 16 | 3 | TRUE | 1.07 |
| cancer of unknown primary | KRAS_12-61 | TP53 | Inactivating mutation | 146 | 144 | TMB overall | -0.27 | -0.98 | 0.43 | 1509.43 | 1.00 | 352 | 117 | 115 | 29 | TRUE | 0.35 |
| colorectal cancer | KRAS_12-61 | TP53 | Inactivating mutation | 894 | 532 | TMB overall | -0.56 | -1.02 | -0.03 | 1599.98 | 1.00 | 932 | 731 | 369 | 163 | TRUE | 1.66 |
| non-small cell lung cancer | KRAS_12-61 | TP53 | Inactivating mutation | 955 | 656 | TMB overall | -0.93 | -1.55 | -0.35 | 1459.07 | 1.00 | 1584 | 831 | 532 | 124 | TRUE | 2.66 |
| pancreatic cancer | KRAS_12-61 | TP53 | Inactivating mutation | 1008 | 291 | TMB overall | 1.45 | 0.87 | 2.06 | 1306.03 | 1.00 | 183 | 733 | 16 | 275 | TRUE | 5.78 |
| uterine cancer | KRAS_12-61 | TP53 | Inactivating mutation | 146 | 111 | TMB overall | -0.91 | -1.88 | -0.05 | 1476.08 | 1.00 | 633 | 137 | 102 | 9 | TRUE | 1.31 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Inactivating mutation | 175 | 11 | TMB quintile 3 | -0.30 | -1.31 | 0.63 | 1473.32 | 1.00 | 304 | 172 | 8 | 3 | TRUE | 0.26 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Inactivating mutation | 341 | 27 | TMB quintile 4 | -0.22 | -0.90 | 0.48 | 1494.77 | 1.00 | 434 | 331 | 17 | 10 | TRUE | 0.28 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Inactivating mutation | 316 | 49 | TMB quintile 5 | 0.36 | -0.17 | 0.89 | 1671.67 | 1.00 | 293 | 287 | 20 | 29 | TRUE | 0.72 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Inactivating mutation | 34 | 24 | TMB quintile 6 | 0.45 | -0.45 | 1.29 | 1398.13 | 1.00 | 92 | 26 | 16 | 8 | TRUE | 0.51 |
| colorectal cancer | KRAS_12-61 | FBXW7 | Inactivating mutation | 866 | 111 | TMB overall | 0.07 | -0.83 | 1.01 | 1419.71 | 1.00 | 1123 | 816 | 61 | 50 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Inactivating mutation | 155 | 12 | TMB quintile 3 | 1.16 | 0.09 | 2.27 | 1508.31 | 1.00 | 467 | 147 | 4 | 8 | FALSE | 1.39 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Inactivating mutation | 262 | 28 | TMB quintile 4 | 0.37 | -0.36 | 1.04 | 1593.60 | 1.00 | 484 | 250 | 16 | 12 | FALSE | 0.53 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Inactivating mutation | 456 | 94 | TMB quintile 5 | -0.22 | -0.67 | 0.22 | 1395.82 | 1.00 | 705 | 427 | 65 | 29 | FALSE | 0.45 |
| non-small cell lung cancer | KRAS_12-61 | SMARCA4 | Inactivating mutation | 873 | 134 | TMB overall | 0.43 | -0.76 | 1.73 | 1498.13 | 1.00 | 1656 | 824 | 85 | 49 | FALSE | 0.32 |
| colorectal cancer | KRAS_12-61 | PTEN | Inactivating mutation | 341 | 17 | TMB quintile 4 | 0.18 | -0.78 | 1.09 | 1508.78 | 1.00 | 443 | 332 | 8 | 9 | TRUE | 0.15 |
| colorectal cancer | KRAS_12-61 | PTEN | Inactivating mutation | 314 | 44 | TMB quintile 5 | -0.99 | -1.67 | -0.35 | 1472.54 | 1.00 | 290 | 302 | 32 | 12 | TRUE | 2.39 |
| colorectal cancer | KRAS_12-61 | PTEN | Inactivating mutation | 38 | 57 | TMB quintile 6 | -0.14 | -0.89 | 0.57 | 1233.55 | 1.00 | 77 | 25 | 44 | 13 | TRUE | 0.15 |
| uterine cancer | KRAS_12-61 | PTEN | Inactivating mutation | 27 | 35 | TMB quintile 3 | -0.06 | -1.07 | 0.86 | 1556.17 | 1.00 | 188 | 23 | 31 | 4 | TRUE | 0.04 |
| uterine cancer | KRAS_12-61 | PTEN | Inactivating mutation | 47 | 72 | TMB quintile 4 | 0.12 | -0.59 | 0.76 | 1574.37 | 1.00 | 141 | 32 | 57 | 15 | TRUE | 0.15 |
| uterine cancer | KRAS_12-61 | PTEN | Inactivating mutation | 78 | 190 | TMB quintile 5 | 0.50 | -0.01 | 1.01 | 1655.57 | 1.00 | 98 | 24 | 136 | 54 | TRUE | 1.23 |
| uterine cancer | KRAS_12-61 | PTEN | Inactivating mutation | 7 | 41 | TMB quintile 6 | -0.36 | -1.57 | 0.78 | 1508.83 | 1.00 | 26 | 4 | 38 | 3 | TRUE | 0.26 |
| colorectal cancer | KRAS_12-61 | PTEN | Inactivating mutation | 693 | 118 | TMB overall | -0.31 | -1.93 | 1.36 | 1490.12 | 1.00 | 810 | 659 | 84 | 34 | TRUE | 0.15 |
| uterine cancer | KRAS_12-61 | PTEN | Inactivating mutation | 159 | 338 | TMB overall | 0.06 | -0.97 | 1.03 | 1418.01 | 1.00 | 453 | 83 | 262 | 76 | TRUE | 0.04 |
| colorectal cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 342 | 24 | TMB quintile 4 | -0.36 | -1.19 | 0.43 | 1588.48 | 1.00 | 435 | 333 | 15 | 9 | TRUE | 0.41 |
| colorectal cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 314 | 87 | TMB quintile 5 | -0.80 | -1.25 | -0.35 | 1225.42 | 1.00 | 267 | 286 | 59 | 28 | TRUE | 3.32 |
| colorectal cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 40 | 96 | TMB quintile 6 | -0.20 | -0.91 | 0.46 | 1621.69 | 1.00 | 56 | 19 | 75 | 21 | TRUE | 0.24 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 262 | 34 | TMB quintile 4 | -0.26 | -0.92 | 0.32 | 1581.95 | 1.00 | 477 | 252 | 24 | 10 | TRUE | 0.40 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 458 | 103 | TMB quintile 5 | -0.10 | -0.50 | 0.30 | 1431.69 | 1.00 | 704 | 422 | 67 | 36 | TRUE | 0.21 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 277 | 13 | TMB quintile 2 | -0.84 | -1.67 | 0.02 | 1591.72 | 1.00 | 64 | 269 | 5 | 8 | TRUE | 1.29 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 454 | 42 | TMB quintile 3 | -0.14 | -0.82 | 0.65 | 1535.17 | 1.00 | 65 | 417 | 5 | 37 | TRUE | 0.14 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 241 | 39 | TMB quintile 4 | -0.31 | -1.03 | 0.43 | 1446.96 | 1.00 | 34 | 210 | 8 | 31 | TRUE | 0.40 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 39 | 14 | TMB quintile 5 | -0.12 | -1.05 | 0.80 | 1530.53 | 1.00 | 14 | 30 | 5 | 9 | TRUE | 0.09 |
| uterine cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 26 | 26 | TMB quintile 3 | 0.44 | -0.67 | 1.47 | 1523.90 | 1.00 | 194 | 22 | 22 | 4 | TRUE | 0.37 |
| uterine cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 47 | 69 | TMB quintile 4 | 1.18 | 0.53 | 1.81 | 1494.13 | 1.00 | 145 | 23 | 45 | 24 | TRUE | 3.50 |
| uterine cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 86 | 284 | TMB quintile 5 | 0.67 | 0.02 | 1.31 | 1544.23 | 1.00 | 61 | 12 | 210 | 74 | TRUE | 1.32 |
| uterine cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 12 | 75 | TMB quintile 6 | 1.31 | -0.28 | 3.41 | 1506.23 | 1.00 | 12 | 0 | 63 | 12 | TRUE | 0.78 |
| colorectal cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 696 | 207 | TMB overall | -0.42 | -2.08 | 1.19 | 1555.51 | 1.00 | 758 | 638 | 149 | 58 | TRUE | 0.21 |
| non-small cell lung cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 720 | 137 | TMB overall | -0.18 | -1.12 | 0.67 | 1215.52 | 1.00 | 1181 | 674 | 91 | 46 | TRUE | 0.15 |
| pancreatic cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 1011 | 108 | TMB overall | -0.36 | -1.13 | 0.46 | 1493.96 | 1.00 | 177 | 926 | 23 | 85 | TRUE | 0.40 |
| uterine cancer | KRAS_12-61 | ARID1A | Inactivating mutation | 171 | 454 | TMB overall | 0.91 | -0.60 | 2.54 | 1532.50 | 1.00 | 412 | 57 | 340 | 114 | TRUE | 0.64 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Inactivating mutation | 26 | 13 | TMB quintile 3 | -1.02 | -3.27 | 0.47 | 1487.57 | 1.00 | 202 | 26 | 13 | 0 | TRUE | 0.55 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Inactivating mutation | 45 | 32 | TMB quintile 4 | -0.54 | -1.65 | 0.39 | 1449.22 | 1.00 | 160 | 41 | 28 | 4 | TRUE | 0.56 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Inactivating mutation | 69 | 57 | TMB quintile 5 | 0.47 | -0.17 | 1.12 | 1571.31 | 1.00 | 170 | 49 | 37 | 20 | TRUE | 0.84 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Inactivating mutation | 7 | 14 | TMB quintile 6 | -1.08 | -3.31 | 0.47 | 1608.19 | 1.00 | 42 | 7 | 14 | 0 | TRUE | 0.55 |
| uterine cancer | KRAS_12-61 | PIK3R1 | Inactivating mutation | 147 | 116 | TMB overall | -0.54 | -1.99 | 0.50 | 1393.98 | 1.00 | 574 | 123 | 92 | 24 | TRUE | 0.40 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Inactivating mutation | 277 | 18 | TMB quintile 2 | 1.17 | 0.17 | 2.62 | 1342.57 | 1.00 | 69 | 259 | 0 | 18 | TRUE | 1.26 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Inactivating mutation | 455 | 78 | TMB quintile 3 | 0.94 | 0.20 | 1.72 | 1478.13 | 1.00 | 63 | 384 | 7 | 71 | TRUE | 1.75 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Inactivating mutation | 239 | 44 | TMB quintile 4 | 1.41 | 0.47 | 2.43 | 1482.22 | 1.00 | 40 | 197 | 2 | 42 | TRUE | 2.28 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Inactivating mutation | 39 | 13 | TMB quintile 5 | 1.66 | 0.56 | 3.02 | 1424.33 | 1.00 | 17 | 27 | 1 | 12 | TRUE | 2.14 |
| pancreatic cancer | KRAS_12-61 | SMAD4 | Inactivating mutation | 1010 | 153 | TMB overall | 1.29 | 0.36 | 2.35 | 1526.86 | 1.00 | 189 | 867 | 10 | 143 | TRUE | 2.01 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Inactivating mutation | 155 | 28 | TMB quintile 3 | -1.54 | -2.55 | -0.72 | 1467.56 | 1.00 | 444 | 154 | 27 | 1 | TRUE | 3.10 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Inactivating mutation | 262 | 40 | TMB quintile 4 | -1.35 | -2.11 | -0.68 | 1478.06 | 1.00 | 465 | 257 | 35 | 5 | TRUE | 3.72 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Inactivating mutation | 454 | 86 | TMB quintile 5 | -1.19 | -1.73 | -0.67 | 1547.98 | 1.00 | 700 | 439 | 71 | 15 | TRUE | 4.95 |
| non-small cell lung cancer | KRAS_12-61 | RB1 | Inactivating mutation | 871 | 154 | TMB overall | -1.36 | -2.10 | -0.67 | 1534.15 | 1.00 | 1609 | 850 | 133 | 21 | TRUE | 3.63 |
| uterine cancer | KRAS_12-61 | JAK1 | Inactivating mutation | 66 | 76 | TMB quintile 5 | 0.28 | -0.33 | 0.86 | 1155.12 | 1.00 | 160 | 46 | 56 | 20 | TRUE | 0.47 |
| uterine cancer | KRAS_12-61 | JAK1 | Inactivating mutation | 9 | 25 | TMB quintile 6 | 0.79 | -0.28 | 2.11 | 1166.13 | 1.00 | 39 | 3 | 19 | 6 | TRUE | 0.71 |
| uterine cancer | KRAS_12-61 | JAK1 | Inactivating mutation | 75 | 101 | TMB overall | 0.54 | -0.88 | 2.08 | 1391.52 | 1.00 | 199 | 49 | 75 | 26 | TRUE | 0.35 |
| uterine cancer | KRAS_12-61 | CTCF | Inactivating mutation | 64 | 83 | TMB quintile 5 | 0.13 | -0.46 | 0.69 | 1280.79 | 1.00 | 139 | 43 | 62 | 21 | FALSE | 0.18 |
| uterine cancer | KRAS_12-61 | CTCF | Inactivating mutation | 7 | 26 | TMB quintile 6 | 0.30 | -0.82 | 1.57 | 1415.21 | 1.00 | 35 | 3 | 22 | 4 | FALSE | 0.22 |
| uterine cancer | KRAS_12-61 | CTCF | Inactivating mutation | 71 | 109 | TMB overall | 0.23 | -1.22 | 1.78 | 1525.95 | 1.00 | 174 | 46 | 84 | 25 | FALSE | 0.12 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Inactivating mutation | 155 | 18 | TMB quintile 3 | -1.45 | -2.80 | -0.44 | 1437.08 | 1.00 | 454 | 154 | 17 | 1 | TRUE | 1.86 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Inactivating mutation | 262 | 48 | TMB quintile 4 | -1.44 | -2.25 | -0.74 | 1433.44 | 1.00 | 465 | 257 | 43 | 5 | TRUE | 3.72 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Inactivating mutation | 456 | 108 | TMB quintile 5 | -0.90 | -1.40 | -0.45 | 1311.51 | 1.00 | 694 | 433 | 85 | 23 | TRUE | 3.80 |
| non-small cell lung cancer | KRAS_12-61 | NF1 | Inactivating mutation | 873 | 174 | TMB overall | -1.24 | -2.16 | -0.39 | 1324.30 | 1.00 | 1613 | 844 | 145 | 29 | TRUE | 2.14 |
| colorectal cancer | KRAS_12-61 | APC | Inactivating mutation | 28 | 77 | TMB quintile 2 | -0.70 | -1.43 | -0.04 | 1354.91 | 1.00 | 50 | 18 | 67 | 10 | TRUE | 1.32 |
| colorectal cancer | KRAS_12-61 | APC | Inactivating mutation | 207 | 422 | TMB quintile 3 | -0.42 | -0.78 | -0.07 | 1382.91 | 1.00 | 91 | 71 | 286 | 136 | TRUE | 1.76 |
| colorectal cancer | KRAS_12-61 | APC | Inactivating mutation | 473 | 936 | TMB quintile 4 | -0.02 | -0.34 | 0.28 | 1446.11 | 1.00 | 86 | 71 | 534 | 402 | TRUE | 0.05 |
| colorectal cancer | KRAS_12-61 | APC | Inactivating mutation | 504 | 781 | TMB quintile 5 | 0.83 | 0.49 | 1.15 | 1540.49 | 1.00 | 106 | 58 | 335 | 446 | TRUE | 5.95 |
| colorectal cancer | KRAS_12-61 | APC | Inactivating mutation | 55 | 151 | TMB quintile 6 | 0.16 | -0.41 | 0.73 | 1364.67 | 1.00 | 54 | 14 | 110 | 41 | TRUE | 0.22 |
| colorectal cancer | KRAS_12-61 | APC | Inactivating mutation | 1267 | 2367 | TMB overall | -0.04 | -0.64 | 0.59 | 1412.51 | 1.00 | 387 | 232 | 1332 | 1035 | TRUE | 0.05 |
| colorectal cancer | KRAS_12-61 | KMT2D | Inactivating mutation | 315 | 46 | TMB quintile 5 | -1.13 | -1.79 | -0.48 | 1540.06 | 1.00 | 288 | 303 | 34 | 12 | FALSE | 3.10 |
| colorectal cancer | KRAS_12-61 | KMT2D | Inactivating mutation | 40 | 111 | TMB quintile 6 | -0.55 | -1.26 | 0.14 | 1505.79 | 1.00 | 47 | 19 | 90 | 21 | FALSE | 0.92 |
| uterine cancer | KRAS_12-61 | KMT2D | Inactivating mutation | 63 | 88 | TMB quintile 5 | -0.64 | -1.29 | -0.05 | 1357.60 | 1.00 | 134 | 49 | 74 | 14 | FALSE | 1.35 |
| uterine cancer | KRAS_12-61 | KMT2D | Inactivating mutation | 8 | 29 | TMB quintile 6 | -0.58 | -1.65 | 0.64 | 1363.94 | 1.00 | 34 | 5 | 26 | 3 | FALSE | 0.51 |
| colorectal cancer | KRAS_12-61 | KMT2D | Inactivating mutation | 355 | 157 | TMB overall | -0.78 | -3.15 | 1.85 | 1598.98 | 1.00 | 335 | 322 | 124 | 33 | FALSE | 0.27 |
| uterine cancer | KRAS_12-61 | KMT2D | Inactivating mutation | 71 | 117 | TMB overall | -0.61 | -1.89 | 0.74 | 1427.20 | 1.00 | 168 | 54 | 100 | 17 | FALSE | 0.41 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Inactivating mutation | 156 | 16 | TMB quintile 3 | -0.20 | -1.30 | 0.56 | 1398.09 | 1.00 | 460 | 154 | 14 | 2 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Inactivating mutation | 262 | 34 | TMB quintile 4 | 0.05 | -0.63 | 0.65 | 1370.92 | 1.00 | 481 | 251 | 23 | 11 | FALSE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Inactivating mutation | 459 | 50 | TMB quintile 5 | 0.49 | 0.01 | 1.00 | 1505.23 | 1.00 | 749 | 432 | 23 | 27 | FALSE | 1.20 |
| non-small cell lung cancer | KRAS_12-61 | SETD2 | Inactivating mutation | 877 | 100 | TMB overall | 0.10 | -0.71 | 0.77 | 1309.87 | 1.00 | 1690 | 837 | 60 | 40 | FALSE | 0.11 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Inactivating mutation | 83 | 26 | TMB quintile 2 | 0.55 | -0.14 | 1.10 | 1424.55 | 1.00 | 338 | 77 | 20 | 6 | FALSE | 1.06 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Inactivating mutation | 155 | 40 | TMB quintile 3 | 0.63 | 0.06 | 1.16 | 1229.93 | 1.00 | 445 | 141 | 26 | 14 | FALSE | 1.67 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Inactivating mutation | 263 | 76 | TMB quintile 4 | 0.89 | 0.46 | 1.29 | 1454.21 | 1.00 | 465 | 222 | 35 | 41 | FALSE | 4.49 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Inactivating mutation | 457 | 133 | TMB quintile 5 | 1.10 | 0.78 | 1.43 | 1270.06 | 1.00 | 721 | 374 | 50 | 83 | FALSE | 10.54 |
| non-small cell lung cancer | KRAS_12-61 | RBM10 | Inactivating mutation | 958 | 275 | TMB overall | 0.80 | 0.28 | 1.23 | 1420.27 | 1.00 | 1969 | 814 | 131 | 144 | FALSE | 2.95 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Inactivating mutation | 155 | 17 | TMB quintile 3 | 0.08 | -0.79 | 1.05 | 1538.72 | 1.00 | 460 | 149 | 11 | 6 | TRUE | 0.06 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Inactivating mutation | 262 | 27 | TMB quintile 4 | -0.18 | -0.90 | 0.55 | 1542.12 | 1.00 | 482 | 253 | 18 | 9 | TRUE | 0.20 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Inactivating mutation | 455 | 96 | TMB quintile 5 | -0.82 | -1.34 | -0.34 | 1488.52 | 1.00 | 694 | 436 | 77 | 19 | TRUE | 2.83 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Inactivating mutation | 277 | 25 | TMB quintile 2 | 1.46 | 0.39 | 2.69 | 1520.98 | 1.00 | 68 | 253 | 1 | 24 | TRUE | 1.97 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Inactivating mutation | 456 | 102 | TMB quintile 3 | 2.10 | 1.16 | 3.30 | 1537.60 | 1.00 | 69 | 355 | 1 | 101 | TRUE | 4.02 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Inactivating mutation | 243 | 63 | TMB quintile 4 | 1.55 | 0.54 | 2.56 | 1517.21 | 1.00 | 37 | 185 | 5 | 58 | TRUE | 2.58 |
| non-small cell lung cancer | KRAS_12-61 | CDKN2A | Inactivating mutation | 872 | 140 | TMB overall | -0.29 | -1.28 | 0.79 | 1462.50 | 1.00 | 1636 | 838 | 106 | 34 | TRUE | 0.25 |
| pancreatic cancer | KRAS_12-61 | CDKN2A | Inactivating mutation | 976 | 190 | TMB overall | 1.69 | 0.68 | 2.80 | 1338.69 | 1.00 | 174 | 793 | 7 | 183 | TRUE | 2.65 |
| colorectal cancer | KRAS_12-61 | SOX9 | Inactivating mutation | 175 | 14 | TMB quintile 3 | -0.36 | -1.29 | 0.54 | 1402.71 | 1.00 | 302 | 171 | 10 | 4 | FALSE | 0.36 |
| colorectal cancer | KRAS_12-61 | SOX9 | Inactivating mutation | 342 | 73 | TMB quintile 4 | 0.24 | -0.22 | 0.71 | 1389.33 | 1.00 | 413 | 306 | 37 | 36 | FALSE | 0.51 |
| colorectal cancer | KRAS_12-61 | SOX9 | Inactivating mutation | 317 | 88 | TMB quintile 5 | 0.22 | -0.20 | 0.63 | 1481.19 | 1.00 | 276 | 269 | 40 | 48 | FALSE | 0.49 |
| colorectal cancer | KRAS_12-61 | SOX9 | Inactivating mutation | 35 | 43 | TMB quintile 6 | 0.11 | -0.60 | 0.84 | 1487.84 | 1.00 | 80 | 24 | 32 | 11 | FALSE | 0.11 |
| colorectal cancer | KRAS_12-61 | SOX9 | Inactivating mutation | 869 | 218 | TMB overall | 0.06 | -0.80 | 0.90 | 1308.39 | 1.00 | 1071 | 770 | 119 | 99 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Inactivating mutation | 157 | 59 | TMB quintile 3 | 1.18 | 0.69 | 1.71 | 1454.88 | 1.00 | 443 | 126 | 28 | 31 | TRUE | 5.31 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Inactivating mutation | 262 | 106 | TMB quintile 4 | 1.23 | 0.84 | 1.62 | 1232.29 | 1.00 | 459 | 197 | 41 | 65 | TRUE | 8.81 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Inactivating mutation | 455 | 183 | TMB quintile 5 | 0.50 | 0.21 | 0.83 | 1376.62 | 1.00 | 670 | 372 | 100 | 83 | TRUE | 2.64 |
| non-small cell lung cancer | KRAS_12-61 | STK11 | Inactivating mutation | 874 | 348 | TMB overall | 0.97 | 0.36 | 1.62 | 1343.63 | 1.00 | 1572 | 695 | 169 | 179 | TRUE | 2.52 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Inactivating mutation | 262 | 35 | TMB quintile 4 | 0.76 | 0.12 | 1.54 | 981.70 | 1.00 | 486 | 241 | 14 | 21 | FALSE | 1.47 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Inactivating mutation | 454 | 69 | TMB quintile 5 | 0.23 | -0.32 | 0.80 | 74.80 | 1.04 | 726 | 428 | 43 | 26 | FALSE | 0.37 |
| non-small cell lung cancer | KRAS_12-61 | KEAP1 | Inactivating mutation | 716 | 104 | TMB overall | 0.50 | -0.44 | 1.60 | 1299.71 | 1.00 | 1212 | 669 | 57 | 47 | FALSE | 0.48 |
| colorectal cancer | KRAS_12-61 | RNF43 | Inactivating mutation | 341 | 21 | TMB quintile 4 | -0.81 | -1.76 | 0.07 | 1473.46 | 1.00 | 436 | 335 | 15 | 6 | TRUE | 1.05 |
| colorectal cancer | KRAS_12-61 | RNF43 | Inactivating mutation | 317 | 58 | TMB quintile 5 | -1.24 | -1.87 | -0.66 | 1465.54 | 1.00 | 274 | 303 | 44 | 14 | TRUE | 4.32 |
| colorectal cancer | KRAS_12-61 | RNF43 | Inactivating mutation | 39 | 113 | TMB quintile 6 | -0.63 | -1.36 | 0.05 | 1408.00 | 1.00 | 42 | 18 | 92 | 21 | TRUE | 1.11 |
| colorectal cancer | KRAS_12-61 | RNF43 | Inactivating mutation | 697 | 192 | TMB overall | -0.85 | -2.71 | 0.97 | 1490.00 | 1.00 | 752 | 656 | 151 | 41 | TRUE | 0.44 |
| colorectal cancer | KRAS_12-61 | B2M | Inactivating mutation | 300 | 45 | TMB quintile 5 | -0.73 | -1.40 | -0.14 | 1538.81 | 1.00 | 274 | 285 | 30 | 15 | FALSE | 1.60 |
| colorectal cancer | KRAS_12-61 | B2M | Inactivating mutation | 42 | 66 | TMB quintile 6 | 0.38 | -0.35 | 1.09 | 1487.17 | 1.00 | 71 | 21 | 45 | 21 | FALSE | 0.52 |
| colorectal cancer | KRAS_12-61 | B2M | Inactivating mutation | 342 | 111 | TMB overall | -0.16 | -2.33 | 1.97 | 1569.20 | 1.00 | 345 | 306 | 75 | 36 | FALSE | 0.05 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Inactivating mutation | 161 | 13 | TMB quintile 3 | -0.10 | -1.12 | 0.84 | 1447.12 | 1.00 | 270 | 156 | 8 | 5 | FALSE | 0.08 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Inactivating mutation | 310 | 39 | TMB quintile 4 | 0.17 | -0.44 | 0.79 | 1479.19 | 1.00 | 390 | 291 | 20 | 19 | FALSE | 0.23 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Inactivating mutation | 290 | 57 | TMB quintile 5 | -0.38 | -0.93 | 0.16 | 1349.64 | 1.00 | 256 | 267 | 34 | 23 | FALSE | 0.77 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Inactivating mutation | 33 | 48 | TMB quintile 6 | 0.35 | -0.41 | 1.13 | 1441.96 | 1.00 | 69 | 19 | 34 | 14 | FALSE | 0.42 |
| colorectal cancer | KRAS_12-61 | TCF7L2 | Inactivating mutation | 794 | 157 | TMB overall | 0.01 | -0.98 | 1.07 | 1537.43 | 1.00 | 985 | 733 | 96 | 61 | FALSE | 0.01 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Inactivating mutation | 244 | 16 | TMB quintile 4 | 0.19 | -0.66 | 1.03 | 1662.80 | 1.00 | 425 | 237 | 9 | 7 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Inactivating mutation | 417 | 73 | TMB quintile 5 | 0.24 | -0.24 | 0.68 | 1339.05 | 1.00 | 647 | 386 | 42 | 31 | FALSE | 0.51 |
| non-small cell lung cancer | KRAS_12-61 | MGA | Inactivating mutation | 661 | 89 | TMB overall | 0.18 | -1.19 | 1.60 | 1409.46 | 1.00 | 1072 | 623 | 51 | 38 | FALSE | 0.10 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Inactivating mutation | 40 | 12 | TMB quintile 4 | -0.24 | -1.58 | 0.84 | 1487.25 | 1.00 | 155 | 38 | 10 | 2 | FALSE | 0.16 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Inactivating mutation | 60 | 66 | TMB quintile 5 | 0.16 | -0.44 | 0.75 | 1468.41 | 1.00 | 149 | 43 | 49 | 17 | FALSE | 0.21 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Inactivating mutation | 9 | 26 | TMB quintile 6 | 0.12 | -1.08 | 1.32 | 1577.74 | 1.00 | 35 | 5 | 22 | 4 | FALSE | 0.08 |
| uterine cancer | KRAS_12-61 | ZFHX3 | Inactivating mutation | 109 | 104 | TMB overall | 0.01 | -1.39 | 1.29 | 1563.24 | 1.00 | 339 | 86 | 81 | 23 | FALSE | 0.01 |
| colorectal cancer | KRAS_12-61 | AMER1 | Inactivating mutation | 341 | 31 | TMB quintile 4 | 0.88 | 0.26 | 1.64 | 1530.05 | 1.00 | 440 | 320 | 10 | 21 | FALSE | 1.90 |
| colorectal cancer | KRAS_12-61 | AMER1 | Inactivating mutation | 313 | 47 | TMB quintile 5 | 0.54 | -0.04 | 1.15 | 1599.94 | 1.00 | 295 | 284 | 18 | 29 | FALSE | 1.19 |
| colorectal cancer | KRAS_12-61 | AMER1 | Inactivating mutation | 34 | 27 | TMB quintile 6 | 0.63 | -0.29 | 1.45 | 1335.56 | 1.00 | 89 | 25 | 18 | 9 | FALSE | 0.82 |
| colorectal cancer | KRAS_12-61 | AMER1 | Inactivating mutation | 688 | 105 | TMB overall | 0.69 | -0.50 | 1.83 | 1568.31 | 1.00 | 824 | 629 | 46 | 59 | FALSE | 0.64 |
| cancer of unknown primary | RAS_12 | TP53 | Inactivating mutation | 23 | 15 | TMB quintile 2 | -0.26 | -1.15 | 0.58 | 1368.91 | 1.00 | 81 | 20 | 12 | 3 | TRUE | 0.25 |
| cancer of unknown primary | RAS_12 | TP53 | Inactivating mutation | 34 | 29 | TMB quintile 3 | -0.15 | -0.90 | 0.58 | 1182.94 | 1.00 | 89 | 27 | 22 | 7 | TRUE | 0.15 |
| cancer of unknown primary | RAS_12 | TP53 | Inactivating mutation | 35 | 29 | TMB quintile 4 | -0.56 | -1.44 | 0.26 | 1452.50 | 1.00 | 81 | 31 | 25 | 4 | TRUE | 0.70 |
| cancer of unknown primary | RAS_12 | TP53 | Inactivating mutation | 36 | 57 | TMB quintile 5 | -0.09 | -0.75 | 0.53 | 1552.02 | 1.00 | 108 | 25 | 46 | 11 | TRUE | 0.11 |
| colorectal cancer | RAS_12 | TP53 | Inactivating mutation | 17 | 39 | TMB quintile 2 | -0.40 | -1.21 | 0.37 | 1238.79 | 1.00 | 86 | 12 | 34 | 5 | TRUE | 0.49 |
| colorectal cancer | RAS_12 | TP53 | Inactivating mutation | 147 | 146 | TMB quintile 3 | -0.69 | -1.12 | -0.28 | 1224.57 | 1.00 | 223 | 118 | 117 | 29 | TRUE | 2.82 |
| colorectal cancer | RAS_12 | TP53 | Inactivating mutation | 283 | 208 | TMB quintile 4 | -0.44 | -0.77 | -0.10 | 1328.85 | 1.00 | 363 | 224 | 149 | 59 | TRUE | 2.06 |
| colorectal cancer | RAS_12 | TP53 | Inactivating mutation | 235 | 108 | TMB quintile 5 | -0.53 | -0.94 | -0.12 | 1539.04 | 1.00 | 316 | 205 | 78 | 30 | TRUE | 1.91 |
| colorectal cancer | RAS_12 | TP53 | Inactivating mutation | 22 | 31 | TMB quintile 6 | -0.49 | -1.29 | 0.31 | 1617.11 | 1.00 | 98 | 18 | 27 | 4 | TRUE | 0.65 |
| non-small cell lung cancer | RAS_12 | TP53 | Inactivating mutation | 75 | 49 | TMB quintile 2 | -0.90 | -1.63 | -0.16 | 1454.80 | 1.00 | 322 | 70 | 44 | 5 | TRUE | 1.75 |
| non-small cell lung cancer | RAS_12 | TP53 | Inactivating mutation | 130 | 116 | TMB quintile 3 | -0.85 | -1.41 | -0.32 | 1518.25 | 1.00 | 398 | 116 | 102 | 14 | TRUE | 2.72 |
| non-small cell lung cancer | RAS_12 | TP53 | Inactivating mutation | 231 | 145 | TMB quintile 4 | -1.22 | -1.70 | -0.75 | 1733.37 | 1.00 | 408 | 213 | 127 | 18 | TRUE | 6.49 |
| non-small cell lung cancer | RAS_12 | TP53 | Inactivating mutation | 396 | 346 | TMB quintile 5 | -0.94 | -1.22 | -0.65 | 1471.33 | 1.00 | 557 | 331 | 281 | 65 | TRUE | 9.61 |
| pancreatic cancer | RAS_12 | TP53 | Inactivating mutation | 252 | 72 | TMB quintile 2 | 0.68 | 0.24 | 1.19 | 1492.03 | 1.00 | 84 | 190 | 10 | 62 | TRUE | 2.34 |
| pancreatic cancer | RAS_12 | TP53 | Inactivating mutation | 420 | 131 | TMB quintile 3 | 0.74 | 0.35 | 1.19 | 1436.55 | 1.00 | 90 | 303 | 14 | 117 | TRUE | 3.17 |
| pancreatic cancer | RAS_12 | TP53 | Inactivating mutation | 216 | 74 | TMB quintile 4 | 0.51 | -0.03 | 0.98 | 1536.86 | 1.00 | 48 | 159 | 17 | 57 | TRUE | 1.32 |
| pancreatic cancer | RAS_12 | TP53 | Inactivating mutation | 34 | 14 | TMB quintile 5 | 0.60 | -0.04 | 1.20 | 1656.46 | 1.00 | 18 | 24 | 4 | 10 | TRUE | 1.35 |
| uterine cancer | RAS_12 | TP53 | Inactivating mutation | 13 | 21 | TMB quintile 2 | -1.06 | -2.24 | 0.02 | 1359.55 | 1.00 | 112 | 12 | 20 | 1 | TRUE | 1.20 |
| uterine cancer | RAS_12 | TP53 | Inactivating mutation | 24 | 38 | TMB quintile 3 | -1.05 | -2.14 | -0.09 | 1500.51 | 1.00 | 182 | 22 | 36 | 2 | TRUE | 1.37 |
| uterine cancer | RAS_12 | TP53 | Inactivating mutation | 40 | 33 | TMB quintile 4 | -1.12 | -2.16 | -0.21 | 1540.94 | 1.00 | 159 | 38 | 31 | 2 | TRUE | 1.64 |
| uterine cancer | RAS_12 | TP53 | Inactivating mutation | 52 | 19 | TMB quintile 5 | -1.03 | -2.17 | -0.06 | 1413.33 | 1.00 | 195 | 50 | 17 | 2 | TRUE | 1.32 |
| cancer of unknown primary | RAS_12 | TP53 | Inactivating mutation | 132 | 144 | TMB overall | -0.27 | -0.99 | 0.41 | 1275.45 | 1.00 | 364 | 105 | 117 | 27 | TRUE | 0.35 |
| colorectal cancer | RAS_12 | TP53 | Inactivating mutation | 704 | 532 | TMB overall | -0.51 | -1.02 | 0.01 | 1486.67 | 1.00 | 1086 | 577 | 405 | 127 | TRUE | 1.21 |
| non-small cell lung cancer | RAS_12 | TP53 | Inactivating mutation | 832 | 656 | TMB overall | -0.97 | -1.55 | -0.35 | 1407.72 | 1.00 | 1685 | 730 | 554 | 102 | TRUE | 2.76 |
| pancreatic cancer | RAS_12 | TP53 | Inactivating mutation | 922 | 291 | TMB overall | 0.64 | 0.20 | 1.10 | 1429.33 | 1.00 | 240 | 676 | 45 | 246 | TRUE | 2.20 |
| uterine cancer | RAS_12 | TP53 | Inactivating mutation | 129 | 111 | TMB overall | -1.06 | -2.06 | -0.21 | 1483.14 | 1.00 | 648 | 122 | 104 | 7 | TRUE | 1.61 |
| colorectal cancer | RAS_12 | FBXW7 | Inactivating mutation | 147 | 11 | TMB quintile 3 | -0.30 | -1.44 | 0.71 | 1429.58 | 1.00 | 332 | 144 | 8 | 3 | TRUE | 0.24 |
| colorectal cancer | RAS_12 | FBXW7 | Inactivating mutation | 282 | 27 | TMB quintile 4 | -0.58 | -1.41 | 0.20 | 1414.95 | 1.00 | 489 | 276 | 21 | 6 | TRUE | 0.80 |
| colorectal cancer | RAS_12 | FBXW7 | Inactivating mutation | 236 | 49 | TMB quintile 5 | 0.34 | -0.22 | 0.89 | 1623.86 | 1.00 | 367 | 213 | 26 | 23 | TRUE | 0.65 |
| colorectal cancer | RAS_12 | FBXW7 | Inactivating mutation | 20 | 24 | TMB quintile 6 | -0.21 | -1.40 | 0.85 | 1654.23 | 1.00 | 101 | 17 | 21 | 3 | TRUE | 0.15 |
| colorectal cancer | RAS_12 | FBXW7 | Inactivating mutation | 685 | 111 | TMB overall | -0.19 | -1.10 | 0.77 | 1425.59 | 1.00 | 1289 | 650 | 76 | 35 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Inactivating mutation | 130 | 12 | TMB quintile 3 | 1.42 | 0.36 | 2.54 | 1449.35 | 1.00 | 492 | 122 | 4 | 8 | FALSE | 1.89 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Inactivating mutation | 231 | 28 | TMB quintile 4 | 0.54 | -0.20 | 1.28 | 1485.46 | 1.00 | 515 | 219 | 16 | 12 | FALSE | 0.83 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Inactivating mutation | 398 | 94 | TMB quintile 5 | -0.16 | -0.65 | 0.30 | 1391.51 | 1.00 | 760 | 372 | 68 | 26 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12 | SMARCA4 | Inactivating mutation | 759 | 134 | TMB overall | 0.59 | -0.64 | 1.88 | 1498.14 | 1.00 | 1767 | 713 | 88 | 46 | FALSE | 0.46 |
| colorectal cancer | RAS_12 | PTEN | Inactivating mutation | 282 | 17 | TMB quintile 4 | 0.25 | -0.66 | 1.16 | 1557.57 | 1.00 | 501 | 274 | 9 | 8 | TRUE | 0.24 |
| colorectal cancer | RAS_12 | PTEN | Inactivating mutation | 233 | 44 | TMB quintile 5 | -1.15 | -1.95 | -0.39 | 1455.08 | 1.00 | 366 | 226 | 37 | 7 | TRUE | 2.28 |
| colorectal cancer | RAS_12 | PTEN | Inactivating mutation | 24 | 57 | TMB quintile 6 | -0.20 | -1.13 | 0.62 | 1591.88 | 1.00 | 86 | 16 | 49 | 8 | TRUE | 0.18 |
| uterine cancer | RAS_12 | PTEN | Inactivating mutation | 25 | 35 | TMB quintile 3 | 0.09 | -0.90 | 0.98 | 1340.33 | 1.00 | 190 | 21 | 31 | 4 | TRUE | 0.07 |
| uterine cancer | RAS_12 | PTEN | Inactivating mutation | 42 | 72 | TMB quintile 4 | 0.23 | -0.50 | 0.90 | 1473.10 | 1.00 | 145 | 28 | 58 | 14 | TRUE | 0.28 |
| uterine cancer | RAS_12 | PTEN | Inactivating mutation | 65 | 190 | TMB quintile 5 | 0.41 | -0.13 | 0.96 | 1464.51 | 1.00 | 101 | 21 | 146 | 44 | TRUE | 0.83 |
| colorectal cancer | RAS_12 | PTEN | Inactivating mutation | 539 | 118 | TMB overall | -0.41 | -2.25 | 1.30 | 1391.06 | 1.01 | 953 | 516 | 95 | 23 | TRUE | 0.20 |
| uterine cancer | RAS_12 | PTEN | Inactivating mutation | 134 | 338 | TMB overall | 0.25 | -0.82 | 1.32 | 1286.22 | 1.00 | 466 | 70 | 274 | 64 | TRUE | 0.18 |
| colorectal cancer | RAS_12 | ARID1A | Inactivating mutation | 283 | 24 | TMB quintile 4 | -0.06 | -0.92 | 0.74 | 1646.33 | 1.00 | 494 | 274 | 15 | 9 | TRUE | 0.05 |
| colorectal cancer | RAS_12 | ARID1A | Inactivating mutation | 234 | 87 | TMB quintile 5 | -0.74 | -1.27 | -0.24 | 1444.13 | 1.00 | 339 | 214 | 67 | 20 | TRUE | 2.40 |
| colorectal cancer | RAS_12 | ARID1A | Inactivating mutation | 25 | 96 | TMB quintile 6 | -0.40 | -1.23 | 0.40 | 1308.47 | 1.00 | 62 | 13 | 84 | 12 | TRUE | 0.46 |
| non-small cell lung cancer | RAS_12 | ARID1A | Inactivating mutation | 231 | 34 | TMB quintile 4 | -0.45 | -1.19 | 0.18 | 1529.85 | 1.00 | 505 | 224 | 27 | 7 | TRUE | 0.68 |
| non-small cell lung cancer | RAS_12 | ARID1A | Inactivating mutation | 400 | 103 | TMB quintile 5 | -0.11 | -0.53 | 0.26 | 1454.66 | 1.00 | 758 | 368 | 71 | 32 | TRUE | 0.22 |
| pancreatic cancer | RAS_12 | ARID1A | Inactivating mutation | 252 | 13 | TMB quintile 2 | -0.88 | -1.79 | -0.08 | 1438.50 | 1.00 | 87 | 246 | 7 | 6 | TRUE | 1.31 |
| pancreatic cancer | RAS_12 | ARID1A | Inactivating mutation | 420 | 42 | TMB quintile 3 | 0.10 | -0.56 | 0.88 | 1371.83 | 1.00 | 98 | 384 | 6 | 36 | TRUE | 0.11 |
| pancreatic cancer | RAS_12 | ARID1A | Inactivating mutation | 217 | 39 | TMB quintile 4 | -0.20 | -0.84 | 0.48 | 1399.20 | 1.00 | 55 | 189 | 11 | 28 | TRUE | 0.27 |
| pancreatic cancer | RAS_12 | ARID1A | Inactivating mutation | 35 | 14 | TMB quintile 5 | -0.07 | -0.99 | 0.83 | 1383.06 | 1.00 | 17 | 27 | 6 | 8 | TRUE | 0.06 |
| uterine cancer | RAS_12 | ARID1A | Inactivating mutation | 24 | 26 | TMB quintile 3 | 0.51 | -0.67 | 1.54 | 1467.40 | 1.00 | 196 | 20 | 22 | 4 | TRUE | 0.44 |
| uterine cancer | RAS_12 | ARID1A | Inactivating mutation | 43 | 69 | TMB quintile 4 | 1.28 | 0.62 | 2.00 | 1501.17 | 1.00 | 148 | 20 | 46 | 23 | TRUE | 3.57 |
| uterine cancer | RAS_12 | ARID1A | Inactivating mutation | 73 | 284 | TMB quintile 5 | 0.67 | -0.05 | 1.45 | 1530.48 | 1.00 | 63 | 10 | 221 | 63 | TRUE | 1.16 |
| colorectal cancer | RAS_12 | ARID1A | Inactivating mutation | 542 | 207 | TMB overall | -0.42 | -2.00 | 1.37 | 1357.88 | 1.00 | 895 | 501 | 166 | 41 | TRUE | 0.21 |
| non-small cell lung cancer | RAS_12 | ARID1A | Inactivating mutation | 631 | 137 | TMB overall | -0.28 | -1.41 | 0.72 | 1493.09 | 1.00 | 1263 | 592 | 98 | 39 | TRUE | 0.21 |
| pancreatic cancer | RAS_12 | ARID1A | Inactivating mutation | 924 | 108 | TMB overall | -0.26 | -1.08 | 0.52 | 1430.14 | 1.00 | 257 | 846 | 30 | 78 | TRUE | 0.28 |
| uterine cancer | RAS_12 | ARID1A | Inactivating mutation | 143 | 454 | TMB overall | 0.74 | -0.85 | 2.47 | 1497.39 | 1.00 | 419 | 50 | 361 | 93 | TRUE | 0.44 |
| uterine cancer | RAS_12 | PIK3R1 | Inactivating mutation | 24 | 13 | TMB quintile 3 | -1.07 | -3.13 | 0.38 | 1534.87 | 1.00 | 204 | 24 | 13 | 0 | TRUE | 0.62 |
| uterine cancer | RAS_12 | PIK3R1 | Inactivating mutation | 41 | 32 | TMB quintile 4 | -0.52 | -1.65 | 0.41 | 1277.70 | 1.00 | 164 | 37 | 28 | 4 | TRUE | 0.52 |
| uterine cancer | RAS_12 | PIK3R1 | Inactivating mutation | 56 | 57 | TMB quintile 5 | 0.07 | -0.65 | 0.76 | 1610.69 | 1.00 | 176 | 43 | 44 | 13 | TRUE | 0.07 |
| uterine cancer | RAS_12 | PIK3R1 | Inactivating mutation | 123 | 116 | TMB overall | -0.62 | -2.05 | 0.56 | 1580.34 | 1.00 | 591 | 106 | 99 | 17 | TRUE | 0.47 |
| pancreatic cancer | RAS_12 | SMAD4 | Inactivating mutation | 252 | 18 | TMB quintile 2 | 0.66 | -0.15 | 1.83 | 1559.53 | 1.00 | 93 | 235 | 1 | 17 | TRUE | 0.77 |
| pancreatic cancer | RAS_12 | SMAD4 | Inactivating mutation | 421 | 78 | TMB quintile 3 | 0.47 | -0.12 | 1.07 | 1373.52 | 1.00 | 91 | 356 | 13 | 65 | TRUE | 0.93 |
| pancreatic cancer | RAS_12 | SMAD4 | Inactivating mutation | 216 | 44 | TMB quintile 4 | 0.58 | -0.10 | 1.30 | 1405.37 | 1.00 | 57 | 180 | 8 | 36 | TRUE | 1.00 |
| pancreatic cancer | RAS_12 | SMAD4 | Inactivating mutation | 35 | 13 | TMB quintile 5 | 1.07 | 0.16 | 2.10 | 1574.71 | 1.00 | 20 | 24 | 2 | 11 | TRUE | 1.47 |
| pancreatic cancer | RAS_12 | SMAD4 | Inactivating mutation | 924 | 153 | TMB overall | 0.69 | -0.03 | 1.56 | 1521.86 | 1.00 | 261 | 795 | 24 | 129 | TRUE | 1.11 |
| non-small cell lung cancer | RAS_12 | RB1 | Inactivating mutation | 130 | 28 | TMB quintile 3 | -1.48 | -2.58 | -0.59 | 1444.36 | 1.00 | 469 | 129 | 27 | 1 | TRUE | 2.54 |
| non-small cell lung cancer | RAS_12 | RB1 | Inactivating mutation | 231 | 40 | TMB quintile 4 | -1.37 | -2.23 | -0.65 | 1455.46 | 1.00 | 495 | 227 | 36 | 4 | TRUE | 3.26 |
| non-small cell lung cancer | RAS_12 | RB1 | Inactivating mutation | 396 | 86 | TMB quintile 5 | -1.15 | -1.73 | -0.61 | 1536.15 | 1.00 | 756 | 383 | 73 | 13 | TRUE | 4.15 |
| non-small cell lung cancer | RAS_12 | RB1 | Inactivating mutation | 757 | 154 | TMB overall | -1.33 | -2.12 | -0.64 | 1452.70 | 1.00 | 1720 | 739 | 136 | 18 | TRUE | 3.31 |
| uterine cancer | RAS_12 | JAK1 | Inactivating mutation | 55 | 76 | TMB quintile 5 | -0.09 | -0.74 | 0.56 | 1494.21 | 1.00 | 165 | 41 | 62 | 14 | TRUE | 0.11 |
| uterine cancer | RAS_12 | JAK1 | Inactivating mutation | 57 | 101 | TMB overall | -0.09 | -2.23 | 2.13 | 1610.18 | 1.00 | 206 | 42 | 86 | 15 | TRUE | 0.03 |
| uterine cancer | RAS_12 | CTCF | Inactivating mutation | 54 | 83 | TMB quintile 5 | -0.16 | -0.80 | 0.44 | 1390.84 | 1.00 | 144 | 38 | 67 | 16 | FALSE | 0.21 |
| uterine cancer | RAS_12 | CTCF | Inactivating mutation | 56 | 109 | TMB overall | -0.91 | -3.94 | 1.43 | 1521.03 | 1.00 | 180 | 40 | 93 | 16 | FALSE | 0.29 |
| non-small cell lung cancer | RAS_12 | NF1 | Inactivating mutation | 130 | 18 | TMB quintile 3 | -2.21 | -4.28 | -0.78 | 1580.63 | 1.00 | 478 | 130 | 18 | 0 | TRUE | 1.80 |
| non-small cell lung cancer | RAS_12 | NF1 | Inactivating mutation | 231 | 48 | TMB quintile 4 | -2.11 | -3.40 | -1.18 | 1478.12 | 1.00 | 493 | 229 | 46 | 2 | TRUE | 3.52 |
| non-small cell lung cancer | RAS_12 | NF1 | Inactivating mutation | 397 | 108 | TMB quintile 5 | -1.12 | -1.68 | -0.60 | 1464.46 | 1.01 | 747 | 380 | 91 | 17 | TRUE | 4.20 |
| non-small cell lung cancer | RAS_12 | NF1 | Inactivating mutation | 758 | 174 | TMB overall | -1.79 | -3.17 | -0.73 | 1423.53 | 1.00 | 1718 | 739 | 155 | 19 | TRUE | 2.43 |
| colorectal cancer | RAS_12 | APC | Inactivating mutation | 18 | 77 | TMB quintile 2 | -0.85 | -1.72 | -0.05 | 1491.46 | 1.00 | 55 | 13 | 72 | 5 | TRUE | 1.32 |
| colorectal cancer | RAS_12 | APC | Inactivating mutation | 176 | 422 | TMB quintile 3 | -0.17 | -0.52 | 0.19 | 1583.78 | 1.00 | 108 | 54 | 300 | 122 | TRUE | 0.45 |
| colorectal cancer | RAS_12 | APC | Inactivating mutation | 387 | 936 | TMB quintile 4 | -0.07 | -0.39 | 0.26 | 1529.47 | 1.00 | 97 | 60 | 609 | 327 | TRUE | 0.17 |
| colorectal cancer | RAS_12 | APC | Inactivating mutation | 370 | 781 | TMB quintile 5 | 0.48 | 0.15 | 0.80 | 1543.45 | 1.00 | 115 | 49 | 460 | 321 | TRUE | 2.30 |
| colorectal cancer | RAS_12 | APC | Inactivating mutation | 36 | 151 | TMB quintile 6 | 0.31 | -0.36 | 1.04 | 1488.15 | 1.00 | 61 | 7 | 122 | 29 | TRUE | 0.41 |
| colorectal cancer | RAS_12 | APC | Inactivating mutation | 987 | 2367 | TMB overall | -0.06 | -0.71 | 0.60 | 1627.05 | 1.00 | 436 | 183 | 1563 | 804 | TRUE | 0.07 |
| colorectal cancer | RAS_12 | KMT2D | Inactivating mutation | 235 | 46 | TMB quintile 5 | -0.98 | -1.78 | -0.25 | 1548.31 | 1.00 | 365 | 226 | 37 | 9 | FALSE | 1.96 |
| colorectal cancer | RAS_12 | KMT2D | Inactivating mutation | 26 | 111 | TMB quintile 6 | -0.29 | -1.11 | 0.56 | 1349.45 | 1.00 | 55 | 11 | 96 | 15 | FALSE | 0.30 |
| uterine cancer | RAS_12 | KMT2D | Inactivating mutation | 52 | 88 | TMB quintile 5 | -1.24 | -2.09 | -0.46 | 1459.09 | 1.00 | 139 | 44 | 80 | 8 | FALSE | 2.58 |
| colorectal cancer | RAS_12 | KMT2D | Inactivating mutation | 261 | 157 | TMB overall | -0.58 | -3.08 | 2.06 | 1187.30 | 1.00 | 420 | 237 | 133 | 24 | FALSE | 0.19 |
| uterine cancer | RAS_12 | KMT2D | Inactivating mutation | 54 | 117 | TMB overall | -1.70 | -4.87 | 0.74 | 1485.31 | 1.00 | 176 | 46 | 109 | 8 | FALSE | 0.69 |
| non-small cell lung cancer | RAS_12 | SETD2 | Inactivating mutation | 131 | 16 | TMB quintile 3 | -0.22 | -1.24 | 0.54 | 1409.80 | 1.00 | 485 | 129 | 14 | 2 | FALSE | 0.20 |
| non-small cell lung cancer | RAS_12 | SETD2 | Inactivating mutation | 231 | 34 | TMB quintile 4 | -0.16 | -0.94 | 0.48 | 1297.99 | 1.00 | 509 | 223 | 26 | 8 | FALSE | 0.17 |
| non-small cell lung cancer | RAS_12 | SETD2 | Inactivating mutation | 400 | 50 | TMB quintile 5 | 0.33 | -0.19 | 0.84 | 1283.67 | 1.00 | 803 | 378 | 28 | 22 | FALSE | 0.66 |
| non-small cell lung cancer | RAS_12 | SETD2 | Inactivating mutation | 762 | 100 | TMB overall | -0.01 | -0.79 | 0.64 | 1460.09 | 1.00 | 1797 | 730 | 68 | 32 | FALSE | 0.01 |
| non-small cell lung cancer | RAS_12 | RBM10 | Inactivating mutation | 75 | 26 | TMB quintile 2 | 0.47 | -0.25 | 1.07 | 1500.93 | 1.00 | 345 | 70 | 21 | 5 | FALSE | 0.81 |
| non-small cell lung cancer | RAS_12 | RBM10 | Inactivating mutation | 130 | 40 | TMB quintile 3 | 0.58 | 0.04 | 1.08 | 1521.61 | 1.00 | 468 | 118 | 28 | 12 | FALSE | 1.52 |
| non-small cell lung cancer | RAS_12 | RBM10 | Inactivating mutation | 232 | 76 | TMB quintile 4 | 0.79 | 0.39 | 1.19 | 1561.86 | 1.00 | 491 | 196 | 40 | 36 | FALSE | 3.89 |
| non-small cell lung cancer | RAS_12 | RBM10 | Inactivating mutation | 399 | 133 | TMB quintile 5 | 0.91 | 0.58 | 1.23 | 1378.90 | 1.00 | 766 | 329 | 63 | 70 | FALSE | 7.64 |
| non-small cell lung cancer | RAS_12 | RBM10 | Inactivating mutation | 836 | 275 | TMB overall | 0.70 | 0.21 | 1.15 | 1575.02 | 1.00 | 2070 | 713 | 152 | 123 | FALSE | 2.50 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Inactivating mutation | 130 | 17 | TMB quintile 3 | 0.27 | -0.64 | 1.27 | 1543.35 | 1.00 | 485 | 124 | 11 | 6 | TRUE | 0.23 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Inactivating mutation | 231 | 27 | TMB quintile 4 | -0.15 | -0.91 | 0.61 | 1415.80 | 1.00 | 512 | 223 | 19 | 8 | TRUE | 0.16 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Inactivating mutation | 397 | 96 | TMB quintile 5 | -0.74 | -1.26 | -0.22 | 1446.02 | 1.00 | 750 | 380 | 79 | 17 | TRUE | 2.20 |
| pancreatic cancer | RAS_12 | CDKN2A | Inactivating mutation | 252 | 25 | TMB quintile 2 | 0.79 | 0.11 | 1.58 | 1484.45 | 1.00 | 91 | 230 | 3 | 22 | TRUE | 1.36 |
| pancreatic cancer | RAS_12 | CDKN2A | Inactivating mutation | 422 | 102 | TMB quintile 3 | 1.26 | 0.65 | 1.94 | 1479.13 | 1.00 | 97 | 327 | 7 | 95 | TRUE | 3.97 |
| pancreatic cancer | RAS_12 | CDKN2A | Inactivating mutation | 220 | 63 | TMB quintile 4 | 0.91 | 0.21 | 1.60 | 1396.86 | 1.00 | 55 | 167 | 10 | 53 | TRUE | 1.98 |
| non-small cell lung cancer | RAS_12 | CDKN2A | Inactivating mutation | 758 | 140 | TMB overall | -0.20 | -1.19 | 0.88 | 1498.27 | 1.00 | 1747 | 727 | 109 | 31 | TRUE | 0.16 |
| pancreatic cancer | RAS_12 | CDKN2A | Inactivating mutation | 894 | 190 | TMB overall | 0.99 | 0.20 | 1.81 | 1318.83 | 1.00 | 243 | 724 | 20 | 170 | TRUE | 1.80 |
| colorectal cancer | RAS_12 | SOX9 | Inactivating mutation | 147 | 14 | TMB quintile 3 | -0.42 | -1.48 | 0.54 | 1471.00 | 1.00 | 329 | 144 | 11 | 3 | FALSE | 0.37 |
| colorectal cancer | RAS_12 | SOX9 | Inactivating mutation | 283 | 73 | TMB quintile 4 | 0.24 | -0.25 | 0.69 | 1373.79 | 1.00 | 466 | 253 | 43 | 30 | FALSE | 0.47 |
| colorectal cancer | RAS_12 | SOX9 | Inactivating mutation | 237 | 88 | TMB quintile 5 | 0.22 | -0.23 | 0.65 | 1213.85 | 1.00 | 345 | 200 | 51 | 37 | FALSE | 0.48 |
| colorectal cancer | RAS_12 | SOX9 | Inactivating mutation | 20 | 43 | TMB quintile 6 | 0.38 | -0.54 | 1.22 | 1474.09 | 1.00 | 92 | 12 | 35 | 8 | FALSE | 0.40 |
| colorectal cancer | RAS_12 | SOX9 | Inactivating mutation | 687 | 218 | TMB overall | 0.12 | -0.86 | 1.10 | 1415.48 | 1.00 | 1232 | 609 | 140 | 78 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12 | STK11 | Inactivating mutation | 132 | 59 | TMB quintile 3 | 0.96 | 0.46 | 1.46 | 1574.91 | 1.00 | 461 | 108 | 35 | 24 | TRUE | 3.71 |
| non-small cell lung cancer | RAS_12 | STK11 | Inactivating mutation | 231 | 106 | TMB quintile 4 | 1.20 | 0.80 | 1.61 | 1262.54 | 1.00 | 485 | 171 | 46 | 60 | TRUE | 8.18 |
| non-small cell lung cancer | RAS_12 | STK11 | Inactivating mutation | 397 | 183 | TMB quintile 5 | 0.41 | 0.09 | 0.74 | 1476.92 | 1.00 | 715 | 327 | 113 | 70 | TRUE | 1.85 |
| non-small cell lung cancer | RAS_12 | STK11 | Inactivating mutation | 760 | 348 | TMB overall | 0.85 | 0.19 | 1.52 | 1420.29 | 1.00 | 1661 | 606 | 194 | 154 | TRUE | 2.03 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Inactivating mutation | 231 | 35 | TMB quintile 4 | 0.69 | -0.04 | 1.50 | 669.17 | 1.01 | 515 | 212 | 16 | 19 | FALSE | 1.17 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Inactivating mutation | 396 | 69 | TMB quintile 5 | 0.14 | -0.40 | 0.62 | 573.17 | 1.01 | 780 | 374 | 47 | 22 | FALSE | 0.23 |
| non-small cell lung cancer | RAS_12 | KEAP1 | Inactivating mutation | 627 | 104 | TMB overall | 0.42 | -0.66 | 1.50 | 1548.60 | 1.00 | 1295 | 586 | 63 | 41 | FALSE | 0.34 |
| colorectal cancer | RAS_12 | RNF43 | Inactivating mutation | 282 | 21 | TMB quintile 4 | -0.68 | -1.68 | 0.22 | 1591.89 | 1.00 | 494 | 277 | 16 | 5 | TRUE | 0.78 |
| colorectal cancer | RAS_12 | RNF43 | Inactivating mutation | 237 | 58 | TMB quintile 5 | -0.93 | -1.63 | -0.30 | 1355.23 | 1.00 | 352 | 225 | 46 | 12 | TRUE | 2.33 |
| colorectal cancer | RAS_12 | RNF43 | Inactivating mutation | 24 | 113 | TMB quintile 6 | -0.40 | -1.25 | 0.43 | 1042.34 | 1.00 | 50 | 10 | 99 | 14 | TRUE | 0.45 |
| colorectal cancer | RAS_12 | RNF43 | Inactivating mutation | 543 | 192 | TMB overall | -0.69 | -2.52 | 1.25 | 1547.03 | 1.00 | 896 | 512 | 161 | 31 | TRUE | 0.33 |
| colorectal cancer | RAS_12 | B2M | Inactivating mutation | 221 | 45 | TMB quintile 5 | -0.52 | -1.23 | 0.12 | 1444.08 | 1.00 | 350 | 209 | 33 | 12 | FALSE | 0.86 |
| colorectal cancer | RAS_12 | B2M | Inactivating mutation | 25 | 66 | TMB quintile 6 | 0.04 | -0.78 | 0.82 | 1398.91 | 1.00 | 78 | 14 | 55 | 11 | FALSE | 0.03 |
| colorectal cancer | RAS_12 | B2M | Inactivating mutation | 246 | 111 | TMB overall | -0.23 | -2.38 | 1.94 | 1422.79 | 1.00 | 428 | 223 | 88 | 23 | FALSE | 0.08 |
| colorectal cancer | RAS_12 | TCF7L2 | Inactivating mutation | 133 | 13 | TMB quintile 3 | 0.14 | -0.90 | 1.10 | 1485.17 | 1.00 | 298 | 128 | 8 | 5 | FALSE | 0.10 |
| colorectal cancer | RAS_12 | TCF7L2 | Inactivating mutation | 259 | 39 | TMB quintile 4 | 0.38 | -0.25 | 1.01 | 1620.36 | 1.00 | 440 | 241 | 21 | 18 | FALSE | 0.62 |
| colorectal cancer | RAS_12 | TCF7L2 | Inactivating mutation | 218 | 57 | TMB quintile 5 | -0.61 | -1.22 | -0.03 | 1670.38 | 1.00 | 319 | 204 | 43 | 14 | FALSE | 1.31 |
| colorectal cancer | RAS_12 | TCF7L2 | Inactivating mutation | 19 | 48 | TMB quintile 6 | 0.43 | -0.48 | 1.31 | 1581.69 | 1.00 | 78 | 10 | 39 | 9 | FALSE | 0.45 |
| colorectal cancer | RAS_12 | TCF7L2 | Inactivating mutation | 629 | 157 | TMB overall | 0.07 | -1.06 | 1.19 | 1430.11 | 1.00 | 1135 | 583 | 111 | 46 | FALSE | 0.04 |
| non-small cell lung cancer | RAS_12 | MGA | Inactivating mutation | 217 | 16 | TMB quintile 4 | 0.50 | -0.31 | 1.46 | 1473.40 | 1.00 | 453 | 209 | 8 | 8 | FALSE | 0.61 |
| non-small cell lung cancer | RAS_12 | MGA | Inactivating mutation | 365 | 73 | TMB quintile 5 | 0.30 | -0.17 | 0.78 | 1517.81 | 1.00 | 696 | 337 | 45 | 28 | FALSE | 0.68 |
| non-small cell lung cancer | RAS_12 | MGA | Inactivating mutation | 582 | 89 | TMB overall | 0.42 | -1.07 | 1.87 | 1406.65 | 1.00 | 1149 | 546 | 53 | 36 | FALSE | 0.27 |
| uterine cancer | RAS_12 | ZFHX3 | Inactivating mutation | 37 | 12 | TMB quintile 4 | -0.29 | -1.82 | 0.97 | 1505.23 | 1.00 | 158 | 35 | 10 | 2 | FALSE | 0.16 |
| uterine cancer | RAS_12 | ZFHX3 | Inactivating mutation | 49 | 66 | TMB quintile 5 | 0.05 | -0.64 | 0.71 | 1356.68 | 1.00 | 156 | 36 | 53 | 13 | FALSE | 0.05 |
| uterine cancer | RAS_12 | ZFHX3 | Inactivating mutation | 88 | 104 | TMB overall | -0.16 | -1.91 | 1.49 | 1456.37 | 1.00 | 353 | 72 | 88 | 16 | FALSE | 0.07 |
| colorectal cancer | RAS_12 | AMER1 | Inactivating mutation | 282 | 31 | TMB quintile 4 | 1.07 | 0.35 | 1.75 | 1696.64 | 1.00 | 498 | 262 | 11 | 20 | FALSE | 2.45 |
| colorectal cancer | RAS_12 | AMER1 | Inactivating mutation | 233 | 47 | TMB quintile 5 | 0.45 | -0.15 | 1.02 | 1394.85 | 1.00 | 368 | 211 | 25 | 22 | FALSE | 0.87 |
| colorectal cancer | RAS_12 | AMER1 | Inactivating mutation | 20 | 27 | TMB quintile 6 | 0.18 | -0.88 | 1.13 | 1390.03 | 1.00 | 98 | 16 | 23 | 4 | FALSE | 0.13 |
| colorectal cancer | RAS_12 | AMER1 | Inactivating mutation | 535 | 105 | TMB overall | 0.57 | -0.75 | 1.86 | 1451.45 | 1.00 | 964 | 489 | 59 | 46 | FALSE | 0.40 |
| cancer of unknown primary | KRAS_12 | TP53 | Inactivating mutation | 23 | 15 | TMB quintile 2 | -0.20 | -1.14 | 0.61 | 1436.32 | 1.00 | 81 | 20 | 12 | 3 | TRUE | 0.18 |
| cancer of unknown primary | KRAS_12 | TP53 | Inactivating mutation | 32 | 29 | TMB quintile 3 | -0.04 | -0.79 | 0.74 | 1686.51 | 1.00 | 91 | 25 | 22 | 7 | TRUE | 0.04 |
| cancer of unknown primary | KRAS_12 | TP53 | Inactivating mutation | 33 | 29 | TMB quintile 4 | -0.48 | -1.33 | 0.28 | 1595.19 | 1.00 | 83 | 29 | 25 | 4 | TRUE | 0.58 |
| cancer of unknown primary | KRAS_12 | TP53 | Inactivating mutation | 35 | 57 | TMB quintile 5 | -0.06 | -0.72 | 0.59 | 1448.81 | 1.00 | 109 | 24 | 46 | 11 | TRUE | 0.07 |
| colorectal cancer | KRAS_12 | TP53 | Inactivating mutation | 17 | 39 | TMB quintile 2 | -0.45 | -1.24 | 0.33 | 1358.78 | 1.00 | 86 | 12 | 34 | 5 | TRUE | 0.58 |
| colorectal cancer | KRAS_12 | TP53 | Inactivating mutation | 144 | 146 | TMB quintile 3 | -0.66 | -1.11 | -0.26 | 1056.92 | 1.00 | 226 | 115 | 117 | 29 | TRUE | 2.66 |
| colorectal cancer | KRAS_12 | TP53 | Inactivating mutation | 272 | 208 | TMB quintile 4 | -0.46 | -0.83 | -0.12 | 1415.75 | 1.00 | 371 | 216 | 152 | 56 | TRUE | 2.17 |
| colorectal cancer | KRAS_12 | TP53 | Inactivating mutation | 229 | 108 | TMB quintile 5 | -0.60 | -1.03 | -0.19 | 1563.58 | 1.00 | 320 | 201 | 80 | 28 | TRUE | 2.23 |
| colorectal cancer | KRAS_12 | TP53 | Inactivating mutation | 19 | 31 | TMB quintile 6 | -0.76 | -1.62 | 0.04 | 1470.96 | 1.00 | 99 | 17 | 29 | 2 | TRUE | 1.11 |
| non-small cell lung cancer | KRAS_12 | TP53 | Inactivating mutation | 75 | 49 | TMB quintile 2 | -0.89 | -1.61 | -0.13 | 1358.58 | 1.00 | 322 | 70 | 44 | 5 | TRUE | 1.70 |
| non-small cell lung cancer | KRAS_12 | TP53 | Inactivating mutation | 130 | 116 | TMB quintile 3 | -0.86 | -1.43 | -0.34 | 1541.63 | 1.00 | 398 | 116 | 102 | 14 | TRUE | 2.73 |
| non-small cell lung cancer | KRAS_12 | TP53 | Inactivating mutation | 230 | 145 | TMB quintile 4 | -1.27 | -1.78 | -0.81 | 1346.31 | 1.00 | 408 | 213 | 128 | 17 | TRUE | 6.76 |
| non-small cell lung cancer | KRAS_12 | TP53 | Inactivating mutation | 395 | 346 | TMB quintile 5 | -0.92 | -1.21 | -0.64 | 1219.23 | 1.00 | 558 | 330 | 281 | 65 | TRUE | 8.89 |
| pancreatic cancer | KRAS_12 | TP53 | Inactivating mutation | 252 | 72 | TMB quintile 2 | 0.69 | 0.25 | 1.18 | 1344.20 | 1.00 | 84 | 190 | 10 | 62 | TRUE | 2.39 |
| pancreatic cancer | KRAS_12 | TP53 | Inactivating mutation | 419 | 131 | TMB quintile 3 | 0.76 | 0.35 | 1.19 | 1395.65 | 1.00 | 91 | 302 | 14 | 117 | TRUE | 3.28 |
| pancreatic cancer | KRAS_12 | TP53 | Inactivating mutation | 216 | 74 | TMB quintile 4 | 0.52 | -0.02 | 0.99 | 1367.16 | 1.00 | 48 | 159 | 17 | 57 | TRUE | 1.33 |
| pancreatic cancer | KRAS_12 | TP53 | Inactivating mutation | 34 | 14 | TMB quintile 5 | 0.62 | 0.00 | 1.18 | 1513.08 | 1.00 | 18 | 24 | 4 | 10 | TRUE | 1.42 |
| uterine cancer | KRAS_12 | TP53 | Inactivating mutation | 12 | 21 | TMB quintile 2 | -1.37 | -2.69 | -0.26 | 1182.48 | 1.00 | 113 | 11 | 20 | 1 | TRUE | 1.58 |
| uterine cancer | KRAS_12 | TP53 | Inactivating mutation | 24 | 38 | TMB quintile 3 | -1.33 | -2.52 | -0.27 | 1400.23 | 1.00 | 182 | 22 | 36 | 2 | TRUE | 1.68 |
| uterine cancer | KRAS_12 | TP53 | Inactivating mutation | 39 | 33 | TMB quintile 4 | -1.45 | -2.61 | -0.45 | 1319.38 | 1.00 | 160 | 37 | 31 | 2 | TRUE | 1.97 |
| uterine cancer | KRAS_12 | TP53 | Inactivating mutation | 49 | 19 | TMB quintile 5 | -1.64 | -3.00 | -0.53 | 1144.08 | 1.00 | 196 | 49 | 19 | 0 | TRUE | 2.00 |
| cancer of unknown primary | KRAS_12 | TP53 | Inactivating mutation | 126 | 144 | TMB overall | -0.18 | -0.89 | 0.50 | 1615.30 | 1.00 | 370 | 99 | 117 | 27 | TRUE | 0.22 |
| colorectal cancer | KRAS_12 | TP53 | Inactivating mutation | 681 | 532 | TMB overall | -0.60 | -1.17 | -0.07 | 1560.96 | 1.00 | 1102 | 561 | 412 | 120 | TRUE | 1.56 |
| non-small cell lung cancer | KRAS_12 | TP53 | Inactivating mutation | 830 | 656 | TMB overall | -0.98 | -1.56 | -0.38 | 1390.65 | 1.00 | 1686 | 729 | 555 | 101 | TRUE | 2.94 |
| pancreatic cancer | KRAS_12 | TP53 | Inactivating mutation | 921 | 291 | TMB overall | 0.65 | 0.19 | 1.14 | 1290.54 | 1.00 | 241 | 675 | 45 | 246 | TRUE | 2.11 |
| uterine cancer | KRAS_12 | TP53 | Inactivating mutation | 124 | 111 | TMB overall | -1.45 | -2.53 | -0.44 | 1301.88 | 1.00 | 651 | 119 | 106 | 5 | TRUE | 2.24 |
| colorectal cancer | KRAS_12 | FBXW7 | Inactivating mutation | 144 | 11 | TMB quintile 3 | -0.28 | -1.39 | 0.73 | 1503.26 | 1.00 | 335 | 141 | 8 | 3 | TRUE | 0.22 |
| colorectal cancer | KRAS_12 | FBXW7 | Inactivating mutation | 271 | 27 | TMB quintile 4 | -0.53 | -1.38 | 0.26 | 1301.45 | 1.00 | 500 | 265 | 21 | 6 | TRUE | 0.73 |
| colorectal cancer | KRAS_12 | FBXW7 | Inactivating mutation | 230 | 49 | TMB quintile 5 | 0.31 | -0.28 | 0.86 | 1414.78 | 1.00 | 372 | 208 | 27 | 22 | TRUE | 0.55 |
| colorectal cancer | KRAS_12 | FBXW7 | Inactivating mutation | 18 | 24 | TMB quintile 6 | -0.12 | -1.26 | 0.89 | 1468.79 | 1.00 | 103 | 15 | 21 | 3 | TRUE | 0.08 |
| colorectal cancer | KRAS_12 | FBXW7 | Inactivating mutation | 663 | 111 | TMB overall | -0.16 | -1.11 | 0.72 | 1538.11 | 1.00 | 1310 | 629 | 77 | 34 | TRUE | 0.14 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Inactivating mutation | 130 | 12 | TMB quintile 3 | 1.43 | 0.35 | 2.64 | 1267.83 | 1.00 | 492 | 122 | 4 | 8 | FALSE | 1.90 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Inactivating mutation | 230 | 28 | TMB quintile 4 | 0.55 | -0.16 | 1.24 | 1242.84 | 1.00 | 516 | 218 | 16 | 12 | FALSE | 0.91 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Inactivating mutation | 397 | 94 | TMB quintile 5 | -0.22 | -0.69 | 0.26 | 1395.46 | 1.00 | 760 | 372 | 69 | 25 | FALSE | 0.43 |
| non-small cell lung cancer | KRAS_12 | SMARCA4 | Inactivating mutation | 757 | 134 | TMB overall | 0.57 | -0.63 | 1.93 | 1528.34 | 1.00 | 1768 | 712 | 89 | 45 | FALSE | 0.43 |
| colorectal cancer | KRAS_12 | PTEN | Inactivating mutation | 271 | 17 | TMB quintile 4 | 0.28 | -0.65 | 1.20 | 1473.42 | 1.00 | 512 | 263 | 9 | 8 | TRUE | 0.25 |
| colorectal cancer | KRAS_12 | PTEN | Inactivating mutation | 227 | 44 | TMB quintile 5 | -1.13 | -2.02 | -0.40 | 1359.38 | 1.00 | 372 | 220 | 37 | 7 | TRUE | 2.29 |
| colorectal cancer | KRAS_12 | PTEN | Inactivating mutation | 20 | 57 | TMB quintile 6 | -0.92 | -2.08 | 0.10 | 1303.20 | 1.00 | 86 | 16 | 53 | 4 | TRUE | 1.03 |
| uterine cancer | KRAS_12 | PTEN | Inactivating mutation | 25 | 35 | TMB quintile 3 | 0.09 | -0.99 | 1.08 | 1608.21 | 1.00 | 190 | 21 | 31 | 4 | TRUE | 0.06 |
| uterine cancer | KRAS_12 | PTEN | Inactivating mutation | 41 | 72 | TMB quintile 4 | 0.15 | -0.52 | 0.81 | 1549.65 | 1.00 | 145 | 28 | 59 | 13 | TRUE | 0.19 |
| uterine cancer | KRAS_12 | PTEN | Inactivating mutation | 62 | 190 | TMB quintile 5 | 0.49 | -0.06 | 1.05 | 1501.09 | 1.00 | 103 | 19 | 147 | 43 | TRUE | 1.03 |
| colorectal cancer | KRAS_12 | PTEN | Inactivating mutation | 518 | 118 | TMB overall | -0.54 | -2.17 | 1.33 | 1487.31 | 1.00 | 970 | 499 | 99 | 19 | TRUE | 0.27 |
| uterine cancer | KRAS_12 | PTEN | Inactivating mutation | 130 | 338 | TMB overall | 0.23 | -0.91 | 1.30 | 1491.58 | 1.00 | 468 | 68 | 276 | 62 | TRUE | 0.16 |
| colorectal cancer | KRAS_12 | ARID1A | Inactivating mutation | 272 | 24 | TMB quintile 4 | 0.00 | -0.89 | 0.79 | 1387.19 | 1.00 | 505 | 263 | 15 | 9 | TRUE | 0.00 |
| colorectal cancer | KRAS_12 | ARID1A | Inactivating mutation | 228 | 87 | TMB quintile 5 | -0.70 | -1.23 | -0.19 | 1226.49 | 1.00 | 345 | 208 | 67 | 20 | TRUE | 2.02 |
| colorectal cancer | KRAS_12 | ARID1A | Inactivating mutation | 21 | 96 | TMB quintile 6 | -0.62 | -1.60 | 0.23 | 1486.95 | 1.00 | 63 | 12 | 87 | 9 | TRUE | 0.75 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Inactivating mutation | 230 | 34 | TMB quintile 4 | -0.43 | -1.18 | 0.21 | 1542.93 | 1.00 | 506 | 223 | 27 | 7 | TRUE | 0.67 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Inactivating mutation | 399 | 103 | TMB quintile 5 | -0.10 | -0.52 | 0.32 | 1629.49 | 1.00 | 759 | 367 | 71 | 32 | TRUE | 0.19 |
| pancreatic cancer | KRAS_12 | ARID1A | Inactivating mutation | 252 | 13 | TMB quintile 2 | -0.89 | -1.80 | -0.07 | 1509.25 | 1.00 | 87 | 246 | 7 | 6 | TRUE | 1.36 |
| pancreatic cancer | KRAS_12 | ARID1A | Inactivating mutation | 419 | 42 | TMB quintile 3 | 0.10 | -0.60 | 0.81 | 1511.20 | 1.00 | 99 | 383 | 6 | 36 | TRUE | 0.10 |
| pancreatic cancer | KRAS_12 | ARID1A | Inactivating mutation | 217 | 39 | TMB quintile 4 | -0.21 | -0.86 | 0.44 | 1433.78 | 1.00 | 55 | 189 | 11 | 28 | TRUE | 0.27 |
| pancreatic cancer | KRAS_12 | ARID1A | Inactivating mutation | 35 | 14 | TMB quintile 5 | -0.06 | -0.93 | 0.89 | 1675.92 | 1.00 | 17 | 27 | 6 | 8 | TRUE | 0.05 |
| uterine cancer | KRAS_12 | ARID1A | Inactivating mutation | 24 | 26 | TMB quintile 3 | 0.52 | -0.57 | 1.54 | 1509.79 | 1.00 | 196 | 20 | 22 | 4 | TRUE | 0.47 |
| uterine cancer | KRAS_12 | ARID1A | Inactivating mutation | 42 | 69 | TMB quintile 4 | 1.33 | 0.67 | 2.05 | 1537.47 | 1.00 | 149 | 19 | 46 | 23 | TRUE | 3.80 |
| uterine cancer | KRAS_12 | ARID1A | Inactivating mutation | 70 | 284 | TMB quintile 5 | 0.90 | 0.20 | 1.70 | 1419.97 | 1.00 | 65 | 8 | 222 | 62 | TRUE | 1.73 |
| colorectal cancer | KRAS_12 | ARID1A | Inactivating mutation | 521 | 207 | TMB overall | -0.44 | -2.20 | 1.22 | 1639.51 | 1.00 | 913 | 483 | 169 | 38 | TRUE | 0.21 |
| non-small cell lung cancer | KRAS_12 | ARID1A | Inactivating mutation | 629 | 137 | TMB overall | -0.26 | -1.31 | 0.68 | 1417.29 | 1.00 | 1265 | 590 | 98 | 39 | TRUE | 0.23 |
| pancreatic cancer | KRAS_12 | ARID1A | Inactivating mutation | 923 | 108 | TMB overall | -0.27 | -1.04 | 0.58 | 1472.95 | 1.00 | 258 | 845 | 30 | 78 | TRUE | 0.30 |
| uterine cancer | KRAS_12 | ARID1A | Inactivating mutation | 139 | 454 | TMB overall | 0.77 | -0.87 | 2.50 | 1469.76 | 1.00 | 422 | 47 | 362 | 92 | TRUE | 0.45 |
| uterine cancer | KRAS_12 | PIK3R1 | Inactivating mutation | 24 | 13 | TMB quintile 3 | -1.10 | -3.46 | 0.43 | 1656.60 | 1.00 | 204 | 24 | 13 | 0 | TRUE | 0.54 |
| uterine cancer | KRAS_12 | PIK3R1 | Inactivating mutation | 40 | 32 | TMB quintile 4 | -0.50 | -1.58 | 0.43 | 1656.77 | 1.00 | 165 | 36 | 28 | 4 | TRUE | 0.49 |
| uterine cancer | KRAS_12 | PIK3R1 | Inactivating mutation | 53 | 57 | TMB quintile 5 | 0.02 | -0.74 | 0.74 | 1327.58 | 1.00 | 178 | 41 | 45 | 12 | TRUE | 0.02 |
| uterine cancer | KRAS_12 | PIK3R1 | Inactivating mutation | 119 | 116 | TMB overall | -0.64 | -2.10 | 0.49 | 1408.70 | 1.00 | 594 | 103 | 100 | 16 | TRUE | 0.47 |
| pancreatic cancer | KRAS_12 | SMAD4 | Inactivating mutation | 252 | 18 | TMB quintile 2 | 0.67 | -0.16 | 1.79 | 1414.79 | 1.00 | 93 | 235 | 1 | 17 | TRUE | 0.76 |
| pancreatic cancer | KRAS_12 | SMAD4 | Inactivating mutation | 420 | 78 | TMB quintile 3 | 0.47 | -0.12 | 1.05 | 1213.52 | 1.00 | 92 | 355 | 13 | 65 | TRUE | 0.92 |
| pancreatic cancer | KRAS_12 | SMAD4 | Inactivating mutation | 216 | 44 | TMB quintile 4 | 0.59 | -0.15 | 1.29 | 1365.30 | 1.00 | 57 | 180 | 8 | 36 | TRUE | 1.01 |
| pancreatic cancer | KRAS_12 | SMAD4 | Inactivating mutation | 35 | 13 | TMB quintile 5 | 1.07 | 0.14 | 2.15 | 1469.60 | 1.00 | 20 | 24 | 2 | 11 | TRUE | 1.48 |
| pancreatic cancer | KRAS_12 | SMAD4 | Inactivating mutation | 923 | 153 | TMB overall | 0.68 | -0.07 | 1.50 | 1422.78 | 1.00 | 262 | 794 | 24 | 129 | TRUE | 1.03 |
| non-small cell lung cancer | KRAS_12 | RB1 | Inactivating mutation | 130 | 28 | TMB quintile 3 | -1.47 | -2.51 | -0.61 | 1474.09 | 1.00 | 469 | 129 | 27 | 1 | TRUE | 2.78 |
| non-small cell lung cancer | KRAS_12 | RB1 | Inactivating mutation | 230 | 40 | TMB quintile 4 | -1.38 | -2.17 | -0.66 | 1351.66 | 1.00 | 496 | 226 | 36 | 4 | TRUE | 3.52 |
| non-small cell lung cancer | KRAS_12 | RB1 | Inactivating mutation | 395 | 86 | TMB quintile 5 | -1.16 | -1.77 | -0.60 | 1384.09 | 1.00 | 757 | 382 | 73 | 13 | TRUE | 4.05 |
| non-small cell lung cancer | KRAS_12 | RB1 | Inactivating mutation | 755 | 154 | TMB overall | -1.33 | -2.10 | -0.60 | 1511.20 | 1.00 | 1722 | 737 | 136 | 18 | TRUE | 3.39 |
| uterine cancer | KRAS_12 | JAK1 | Inactivating mutation | 52 | 76 | TMB quintile 5 | -0.02 | -0.66 | 0.61 | 1488.69 | 1.00 | 168 | 38 | 62 | 14 | TRUE | 0.02 |
| uterine cancer | KRAS_12 | JAK1 | Inactivating mutation | 54 | 101 | TMB overall | -0.08 | -2.33 | 2.06 | 1328.43 | 1.00 | 209 | 39 | 86 | 15 | TRUE | 0.03 |
| uterine cancer | KRAS_12 | CTCF | Inactivating mutation | 51 | 83 | TMB quintile 5 | -0.05 | -0.69 | 0.56 | 1434.70 | 1.00 | 147 | 35 | 67 | 16 | FALSE | 0.05 |
| uterine cancer | KRAS_12 | CTCF | Inactivating mutation | 53 | 109 | TMB overall | -0.82 | -3.96 | 1.40 | 1338.46 | 1.00 | 183 | 37 | 93 | 16 | FALSE | 0.26 |
| non-small cell lung cancer | KRAS_12 | NF1 | Inactivating mutation | 130 | 18 | TMB quintile 3 | -2.21 | -4.45 | -0.86 | 1485.60 | 1.00 | 478 | 130 | 18 | 0 | TRUE | 1.85 |
| non-small cell lung cancer | KRAS_12 | NF1 | Inactivating mutation | 230 | 48 | TMB quintile 4 | -2.12 | -3.35 | -1.12 | 1504.54 | 1.00 | 494 | 228 | 46 | 2 | TRUE | 3.59 |
| non-small cell lung cancer | KRAS_12 | NF1 | Inactivating mutation | 396 | 108 | TMB quintile 5 | -1.12 | -1.69 | -0.62 | 1468.01 | 1.00 | 748 | 379 | 91 | 17 | TRUE | 4.34 |
| non-small cell lung cancer | KRAS_12 | NF1 | Inactivating mutation | 756 | 174 | TMB overall | -1.80 | -3.20 | -0.76 | 1586.82 | 1.00 | 1720 | 737 | 155 | 19 | TRUE | 2.31 |
| colorectal cancer | KRAS_12 | APC | Inactivating mutation | 18 | 77 | TMB quintile 2 | -0.87 | -1.74 | -0.07 | 1541.18 | 1.00 | 55 | 13 | 72 | 5 | TRUE | 1.40 |
| colorectal cancer | KRAS_12 | APC | Inactivating mutation | 173 | 422 | TMB quintile 3 | -0.20 | -0.57 | 0.18 | 1416.45 | 1.00 | 108 | 54 | 303 | 119 | TRUE | 0.54 |
| colorectal cancer | KRAS_12 | APC | Inactivating mutation | 374 | 936 | TMB quintile 4 | -0.13 | -0.46 | 0.21 | 1484.69 | 1.00 | 97 | 60 | 622 | 314 | TRUE | 0.36 |
| colorectal cancer | KRAS_12 | APC | Inactivating mutation | 360 | 781 | TMB quintile 5 | 0.45 | 0.12 | 0.78 | 1271.10 | 1.00 | 116 | 48 | 469 | 312 | TRUE | 2.12 |
| colorectal cancer | KRAS_12 | APC | Inactivating mutation | 31 | 151 | TMB quintile 6 | 0.11 | -0.53 | 0.87 | 1379.09 | 1.00 | 61 | 7 | 127 | 24 | TRUE | 0.12 |
| colorectal cancer | KRAS_12 | APC | Inactivating mutation | 956 | 2367 | TMB overall | -0.14 | -0.80 | 0.50 | 1320.12 | 1.00 | 437 | 182 | 1593 | 774 | TRUE | 0.16 |
| colorectal cancer | KRAS_12 | KMT2D | Inactivating mutation | 229 | 46 | TMB quintile 5 | -0.93 | -1.67 | -0.20 | 1295.73 | 1.00 | 371 | 220 | 37 | 9 | FALSE | 1.93 |
| colorectal cancer | KRAS_12 | KMT2D | Inactivating mutation | 21 | 111 | TMB quintile 6 | -0.56 | -1.45 | 0.35 | 1488.80 | 1.00 | 56 | 10 | 100 | 11 | FALSE | 0.65 |
| uterine cancer | KRAS_12 | KMT2D | Inactivating mutation | 49 | 88 | TMB quintile 5 | -1.16 | -2.05 | -0.34 | 1563.34 | 1.00 | 142 | 41 | 80 | 8 | FALSE | 2.14 |
| colorectal cancer | KRAS_12 | KMT2D | Inactivating mutation | 250 | 157 | TMB overall | -0.68 | -3.14 | 1.96 | 1380.69 | 1.00 | 427 | 230 | 137 | 20 | FALSE | 0.23 |
| uterine cancer | KRAS_12 | KMT2D | Inactivating mutation | 51 | 117 | TMB overall | -1.56 | -4.57 | 0.80 | 1456.07 | 1.00 | 179 | 43 | 109 | 8 | FALSE | 0.64 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Inactivating mutation | 131 | 16 | TMB quintile 3 | -0.22 | -1.26 | 0.57 | 1436.56 | 1.00 | 485 | 129 | 14 | 2 | FALSE | 0.20 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Inactivating mutation | 230 | 34 | TMB quintile 4 | -0.15 | -0.87 | 0.49 | 1564.90 | 1.00 | 510 | 222 | 26 | 8 | FALSE | 0.18 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Inactivating mutation | 399 | 50 | TMB quintile 5 | 0.32 | -0.22 | 0.86 | 1599.57 | 1.00 | 804 | 377 | 28 | 22 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12 | SETD2 | Inactivating mutation | 760 | 100 | TMB overall | -0.03 | -0.82 | 0.65 | 1536.34 | 1.00 | 1799 | 728 | 68 | 32 | FALSE | 0.02 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Inactivating mutation | 75 | 26 | TMB quintile 2 | 0.47 | -0.20 | 1.05 | 1413.25 | 1.00 | 345 | 70 | 21 | 5 | FALSE | 0.89 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Inactivating mutation | 130 | 40 | TMB quintile 3 | 0.59 | 0.02 | 1.10 | 1436.88 | 1.00 | 468 | 118 | 28 | 12 | FALSE | 1.55 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Inactivating mutation | 231 | 76 | TMB quintile 4 | 0.81 | 0.41 | 1.23 | 1377.33 | 1.00 | 492 | 195 | 40 | 36 | FALSE | 4.17 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Inactivating mutation | 398 | 133 | TMB quintile 5 | 0.92 | 0.58 | 1.23 | 1342.42 | 1.00 | 767 | 328 | 63 | 70 | FALSE | 7.47 |
| non-small cell lung cancer | KRAS_12 | RBM10 | Inactivating mutation | 834 | 275 | TMB overall | 0.70 | 0.20 | 1.18 | 1522.87 | 1.00 | 2072 | 711 | 152 | 123 | FALSE | 2.41 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Inactivating mutation | 130 | 17 | TMB quintile 3 | 0.28 | -0.63 | 1.27 | 1435.46 | 1.00 | 485 | 124 | 11 | 6 | TRUE | 0.24 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Inactivating mutation | 230 | 27 | TMB quintile 4 | -0.13 | -0.92 | 0.61 | 1406.93 | 1.00 | 513 | 222 | 19 | 8 | TRUE | 0.13 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Inactivating mutation | 396 | 96 | TMB quintile 5 | -0.74 | -1.29 | -0.26 | 1187.65 | 1.01 | 751 | 379 | 79 | 17 | TRUE | 2.25 |
| pancreatic cancer | KRAS_12 | CDKN2A | Inactivating mutation | 252 | 25 | TMB quintile 2 | 0.77 | 0.01 | 1.63 | 1465.13 | 1.00 | 91 | 230 | 3 | 22 | TRUE | 1.24 |
| pancreatic cancer | KRAS_12 | CDKN2A | Inactivating mutation | 421 | 102 | TMB quintile 3 | 1.26 | 0.67 | 1.92 | 1440.96 | 1.00 | 98 | 326 | 7 | 95 | TRUE | 4.05 |
| pancreatic cancer | KRAS_12 | CDKN2A | Inactivating mutation | 220 | 63 | TMB quintile 4 | 0.91 | 0.21 | 1.61 | 1604.04 | 1.00 | 55 | 167 | 10 | 53 | TRUE | 2.02 |
| non-small cell lung cancer | KRAS_12 | CDKN2A | Inactivating mutation | 756 | 140 | TMB overall | -0.21 | -1.22 | 0.81 | 1412.08 | 1.00 | 1749 | 725 | 109 | 31 | TRUE | 0.16 |
| pancreatic cancer | KRAS_12 | CDKN2A | Inactivating mutation | 893 | 190 | TMB overall | 0.98 | 0.15 | 1.83 | 1337.87 | 1.00 | 244 | 723 | 20 | 170 | TRUE | 1.65 |
| colorectal cancer | KRAS_12 | SOX9 | Inactivating mutation | 144 | 14 | TMB quintile 3 | -0.38 | -1.49 | 0.58 | 1477.02 | 1.00 | 332 | 141 | 11 | 3 | FALSE | 0.34 |
| colorectal cancer | KRAS_12 | SOX9 | Inactivating mutation | 272 | 73 | TMB quintile 4 | 0.23 | -0.25 | 0.67 | 1571.61 | 1.00 | 476 | 243 | 44 | 29 | FALSE | 0.48 |
| colorectal cancer | KRAS_12 | SOX9 | Inactivating mutation | 231 | 88 | TMB quintile 5 | 0.27 | -0.18 | 0.73 | 1517.44 | 1.00 | 351 | 194 | 51 | 37 | FALSE | 0.64 |
| colorectal cancer | KRAS_12 | SOX9 | Inactivating mutation | 18 | 43 | TMB quintile 6 | 0.33 | -0.53 | 1.20 | 1242.42 | 1.00 | 93 | 11 | 36 | 7 | FALSE | 0.34 |
| colorectal cancer | KRAS_12 | SOX9 | Inactivating mutation | 665 | 218 | TMB overall | 0.12 | -0.81 | 1.07 | 1575.28 | 1.00 | 1252 | 589 | 142 | 76 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12 | STK11 | Inactivating mutation | 132 | 59 | TMB quintile 3 | 0.95 | 0.45 | 1.45 | 1229.75 | 1.00 | 461 | 108 | 35 | 24 | TRUE | 3.85 |
| non-small cell lung cancer | KRAS_12 | STK11 | Inactivating mutation | 230 | 106 | TMB quintile 4 | 1.20 | 0.81 | 1.60 | 1558.31 | 1.00 | 486 | 170 | 46 | 60 | TRUE | 8.17 |
| non-small cell lung cancer | KRAS_12 | STK11 | Inactivating mutation | 396 | 183 | TMB quintile 5 | 0.41 | 0.07 | 0.74 | 1572.03 | 1.00 | 716 | 326 | 113 | 70 | TRUE | 1.83 |
| non-small cell lung cancer | KRAS_12 | STK11 | Inactivating mutation | 758 | 348 | TMB overall | 0.85 | 0.25 | 1.46 | 1422.00 | 1.00 | 1663 | 604 | 194 | 154 | TRUE | 2.25 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Inactivating mutation | 230 | 35 | TMB quintile 4 | 0.72 | 0.06 | 1.47 | 1058.37 | 1.00 | 516 | 211 | 16 | 19 | FALSE | 1.34 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Inactivating mutation | 395 | 69 | TMB quintile 5 | 0.17 | -0.34 | 0.68 | 564.08 | 1.00 | 781 | 373 | 47 | 22 | FALSE | 0.27 |
| non-small cell lung cancer | KRAS_12 | KEAP1 | Inactivating mutation | 625 | 104 | TMB overall | 0.45 | -0.46 | 1.51 | 1290.78 | 1.00 | 1297 | 584 | 63 | 41 | FALSE | 0.45 |
| colorectal cancer | KRAS_12 | RNF43 | Inactivating mutation | 271 | 21 | TMB quintile 4 | -0.63 | -1.66 | 0.31 | 1362.12 | 1.00 | 505 | 266 | 16 | 5 | TRUE | 0.66 |
| colorectal cancer | KRAS_12 | RNF43 | Inactivating mutation | 231 | 58 | TMB quintile 5 | -0.87 | -1.57 | -0.28 | 1203.71 | 1.00 | 358 | 219 | 46 | 12 | TRUE | 2.12 |
| colorectal cancer | KRAS_12 | RNF43 | Inactivating mutation | 21 | 113 | TMB quintile 6 | -0.44 | -1.36 | 0.43 | 1538.86 | 1.00 | 51 | 9 | 101 | 12 | TRUE | 0.48 |
| colorectal cancer | KRAS_12 | RNF43 | Inactivating mutation | 523 | 192 | TMB overall | -0.64 | -2.58 | 1.34 | 1469.90 | 1.00 | 914 | 494 | 163 | 29 | TRUE | 0.30 |
| colorectal cancer | KRAS_12 | B2M | Inactivating mutation | 215 | 45 | TMB quintile 5 | -0.48 | -1.17 | 0.15 | 1590.04 | 1.00 | 356 | 203 | 33 | 12 | FALSE | 0.81 |
| colorectal cancer | KRAS_12 | B2M | Inactivating mutation | 23 | 66 | TMB quintile 6 | -0.01 | -0.90 | 0.87 | 1475.31 | 1.00 | 79 | 13 | 56 | 10 | FALSE | 0.01 |
| colorectal cancer | KRAS_12 | B2M | Inactivating mutation | 238 | 111 | TMB overall | -0.25 | -2.57 | 2.17 | 1394.08 | 1.00 | 435 | 216 | 89 | 22 | FALSE | 0.08 |
| colorectal cancer | KRAS_12 | TCF7L2 | Inactivating mutation | 130 | 13 | TMB quintile 3 | 0.17 | -0.90 | 1.15 | 1392.98 | 1.00 | 301 | 125 | 8 | 5 | FALSE | 0.13 |
| colorectal cancer | KRAS_12 | TCF7L2 | Inactivating mutation | 248 | 39 | TMB quintile 4 | 0.34 | -0.32 | 0.95 | 1529.11 | 1.00 | 450 | 231 | 22 | 17 | FALSE | 0.53 |
| colorectal cancer | KRAS_12 | TCF7L2 | Inactivating mutation | 213 | 57 | TMB quintile 5 | -0.66 | -1.27 | -0.08 | 1656.43 | 1.00 | 323 | 200 | 44 | 13 | FALSE | 1.47 |
| colorectal cancer | KRAS_12 | TCF7L2 | Inactivating mutation | 17 | 48 | TMB quintile 6 | 0.61 | -0.31 | 1.52 | 1630.06 | 1.00 | 80 | 8 | 39 | 9 | FALSE | 0.70 |
| colorectal cancer | KRAS_12 | TCF7L2 | Inactivating mutation | 608 | 157 | TMB overall | 0.14 | -1.01 | 1.31 | 1680.12 | 1.00 | 1154 | 564 | 113 | 44 | FALSE | 0.09 |
| non-small cell lung cancer | KRAS_12 | MGA | Inactivating mutation | 216 | 16 | TMB quintile 4 | 0.34 | -0.53 | 1.17 | 1382.83 | 1.00 | 453 | 209 | 9 | 7 | FALSE | 0.35 |
| non-small cell lung cancer | KRAS_12 | MGA | Inactivating mutation | 364 | 73 | TMB quintile 5 | 0.29 | -0.18 | 0.79 | 1468.48 | 1.00 | 697 | 336 | 45 | 28 | FALSE | 0.62 |
| non-small cell lung cancer | KRAS_12 | MGA | Inactivating mutation | 580 | 89 | TMB overall | 0.28 | -1.05 | 1.63 | 1383.22 | 1.00 | 1150 | 545 | 54 | 35 | FALSE | 0.18 |
| uterine cancer | KRAS_12 | ZFHX3 | Inactivating mutation | 36 | 12 | TMB quintile 4 | -0.26 | -1.70 | 0.98 | 1524.56 | 1.00 | 159 | 34 | 10 | 2 | FALSE | 0.15 |
| uterine cancer | KRAS_12 | ZFHX3 | Inactivating mutation | 46 | 66 | TMB quintile 5 | 0.16 | -0.56 | 0.84 | 1490.06 | 1.00 | 159 | 33 | 53 | 13 | FALSE | 0.18 |
| uterine cancer | KRAS_12 | ZFHX3 | Inactivating mutation | 84 | 104 | TMB overall | -0.11 | -1.80 | 1.47 | 1418.03 | 1.00 | 357 | 68 | 88 | 16 | FALSE | 0.05 |
| colorectal cancer | KRAS_12 | AMER1 | Inactivating mutation | 271 | 31 | TMB quintile 4 | 0.98 | 0.30 | 1.67 | 1463.85 | 1.00 | 508 | 252 | 12 | 19 | FALSE | 2.30 |
| colorectal cancer | KRAS_12 | AMER1 | Inactivating mutation | 227 | 47 | TMB quintile 5 | 0.38 | -0.20 | 0.95 | 1673.61 | 1.00 | 373 | 206 | 26 | 21 | FALSE | 0.72 |
| colorectal cancer | KRAS_12 | AMER1 | Inactivating mutation | 18 | 27 | TMB quintile 6 | -0.03 | -1.25 | 1.09 | 1517.07 | 1.00 | 99 | 15 | 24 | 3 | FALSE | 0.02 |
| colorectal cancer | KRAS_12 | AMER1 | Inactivating mutation | 516 | 105 | TMB overall | 0.46 | -1.06 | 1.80 | 1420.86 | 1.00 | 980 | 473 | 62 | 43 | FALSE | 0.30 |
| non-small cell lung cancer | RAS_12C | TP53 | Inactivating mutation | 13 | 49 | TMB quintile 2 | -0.11 | -1.22 | 1.11 | 1320.79 | 1.00 | 382 | 10 | 46 | 3 | TRUE | 0.07 |
| non-small cell lung cancer | RAS_12C | TP53 | Inactivating mutation | 18 | 116 | TMB quintile 3 | -0.92 | -2.30 | 0.10 | 1363.93 | 1.00 | 497 | 17 | 115 | 1 | TRUE | 0.95 |
| non-small cell lung cancer | RAS_12C | TP53 | Inactivating mutation | 42 | 145 | TMB quintile 4 | -1.07 | -2.17 | -0.25 | 1411.80 | 1.00 | 581 | 40 | 143 | 2 | TRUE | 1.49 |
| non-small cell lung cancer | RAS_12C | TP53 | Inactivating mutation | 93 | 346 | TMB quintile 5 | -0.35 | -0.85 | 0.12 | 1287.59 | 1.00 | 816 | 72 | 325 | 21 | TRUE | 0.79 |
| non-small cell lung cancer | RAS_12C | TP53 | Inactivating mutation | 166 | 656 | TMB overall | -0.62 | -1.52 | 0.20 | 1195.04 | 1.00 | 2276 | 139 | 629 | 27 | TRUE | 0.82 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Inactivating mutation | 18 | 12 | TMB quintile 3 | 1.39 | -0.06 | 2.78 | 1241.41 | 1.00 | 598 | 16 | 10 | 2 | FALSE | 1.26 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Inactivating mutation | 42 | 28 | TMB quintile 4 | 1.60 | 0.67 | 2.55 | 1417.67 | 1.00 | 699 | 35 | 21 | 7 | FALSE | 3.05 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Inactivating mutation | 94 | 94 | TMB quintile 5 | 0.00 | -0.89 | 0.78 | 1424.92 | 1.00 | 1044 | 88 | 88 | 6 | FALSE | 0.00 |
| non-small cell lung cancer | RAS_12C | SMARCA4 | Inactivating mutation | 154 | 134 | TMB overall | 0.98 | -0.41 | 2.45 | 1251.31 | 1.00 | 2341 | 139 | 119 | 15 | FALSE | 0.76 |
| non-small cell lung cancer | RAS_12C | ARID1A | Inactivating mutation | 42 | 34 | TMB quintile 4 | -0.38 | -1.97 | 0.73 | 1303.52 | 1.00 | 688 | 41 | 33 | 1 | TRUE | 0.24 |
| non-small cell lung cancer | RAS_12C | ARID1A | Inactivating mutation | 94 | 103 | TMB quintile 5 | 0.05 | -0.69 | 0.72 | 1363.23 | 1.00 | 1041 | 85 | 94 | 9 | TRUE | 0.05 |
| non-small cell lung cancer | RAS_12C | ARID1A | Inactivating mutation | 136 | 137 | TMB overall | -0.16 | -1.58 | 1.05 | 1486.99 | 1.00 | 1729 | 126 | 127 | 10 | TRUE | 0.09 |
| non-small cell lung cancer | RAS_12C | RB1 | Inactivating mutation | 18 | 28 | TMB quintile 3 | -1.63 | -3.66 | 0.27 | 1498.46 | 1.00 | 581 | 17 | 27 | 1 | TRUE | 1.03 |
| non-small cell lung cancer | RAS_12C | RB1 | Inactivating mutation | 42 | 40 | TMB quintile 4 | -2.07 | -4.23 | -0.51 | 1431.27 | 1.00 | 680 | 42 | 40 | 0 | TRUE | 1.52 |
| non-small cell lung cancer | RAS_12C | RB1 | Inactivating mutation | 93 | 86 | TMB quintile 5 | -1.96 | -3.72 | -0.63 | 1565.35 | 1.00 | 1047 | 92 | 85 | 1 | TRUE | 1.78 |
| non-small cell lung cancer | RAS_12C | RB1 | Inactivating mutation | 153 | 154 | TMB overall | -1.87 | -3.74 | -0.36 | 1561.28 | 1.00 | 2308 | 151 | 152 | 2 | TRUE | 1.48 |
| non-small cell lung cancer | RAS_12C | NF1 | Inactivating mutation | 18 | 18 | TMB quintile 3 | -3.22 | -6.43 | -0.77 | 1300.89 | 1.00 | 590 | 18 | 18 | 0 | TRUE | 1.53 |
| non-small cell lung cancer | RAS_12C | NF1 | Inactivating mutation | 42 | 48 | TMB quintile 4 | -3.28 | -6.58 | -1.08 | 1431.93 | 1.00 | 680 | 42 | 48 | 0 | TRUE | 1.72 |
| non-small cell lung cancer | RAS_12C | NF1 | Inactivating mutation | 93 | 108 | TMB quintile 5 | -2.98 | -5.70 | -1.18 | 1305.17 | 1.00 | 1035 | 92 | 107 | 1 | TRUE | 1.97 |
| non-small cell lung cancer | RAS_12C | NF1 | Inactivating mutation | 153 | 174 | TMB overall | -3.13 | -5.78 | -1.02 | 1297.52 | 1.00 | 2305 | 152 | 173 | 1 | TRUE | 1.91 |
| non-small cell lung cancer | RAS_12C | SETD2 | Inactivating mutation | 18 | 16 | TMB quintile 3 | -0.27 | -2.02 | 1.02 | 1535.13 | 1.00 | 596 | 18 | 16 | 0 | FALSE | 0.13 |
| non-small cell lung cancer | RAS_12C | SETD2 | Inactivating mutation | 42 | 34 | TMB quintile 4 | -0.26 | -1.79 | 0.82 | 1424.62 | 1.00 | 691 | 41 | 33 | 1 | FALSE | 0.16 |
| non-small cell lung cancer | RAS_12C | SETD2 | Inactivating mutation | 95 | 50 | TMB quintile 5 | 0.21 | -0.79 | 1.05 | 1472.30 | 1.00 | 1092 | 89 | 44 | 6 | FALSE | 0.19 |
| non-small cell lung cancer | RAS_12C | SETD2 | Inactivating mutation | 155 | 100 | TMB overall | -0.12 | -1.51 | 0.98 | 1625.43 | 1.00 | 2379 | 148 | 93 | 7 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | RBM10 | Inactivating mutation | 13 | 26 | TMB quintile 2 | -0.13 | -1.69 | 0.94 | 1600.08 | 1.00 | 402 | 13 | 26 | 0 | FALSE | 0.07 |
| non-small cell lung cancer | RAS_12C | RBM10 | Inactivating mutation | 18 | 40 | TMB quintile 3 | -0.19 | -1.66 | 0.85 | 1526.46 | 1.00 | 568 | 18 | 40 | 0 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | RBM10 | Inactivating mutation | 43 | 76 | TMB quintile 4 | 0.59 | -0.10 | 1.34 | 1587.84 | 1.00 | 653 | 34 | 67 | 9 | FALSE | 0.97 |
| non-small cell lung cancer | RAS_12C | RBM10 | Inactivating mutation | 94 | 133 | TMB quintile 5 | 0.20 | -0.41 | 0.77 | 1628.65 | 1.00 | 1013 | 82 | 121 | 12 | FALSE | 0.29 |
| non-small cell lung cancer | RAS_12C | RBM10 | Inactivating mutation | 168 | 275 | TMB overall | 0.12 | -0.78 | 0.87 | 1500.61 | 1.00 | 2636 | 147 | 254 | 21 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Inactivating mutation | 18 | 17 | TMB quintile 3 | -1.52 | -4.14 | 0.33 | 1537.03 | 1.00 | 591 | 18 | 17 | 0 | TRUE | 0.72 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Inactivating mutation | 42 | 27 | TMB quintile 4 | -1.66 | -4.05 | 0.09 | 1385.31 | 1.00 | 693 | 42 | 27 | 0 | TRUE | 0.85 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Inactivating mutation | 94 | 96 | TMB quintile 5 | -0.97 | -2.27 | 0.01 | 1496.01 | 1.00 | 1040 | 90 | 92 | 4 | TRUE | 1.05 |
| non-small cell lung cancer | RAS_12C | CDKN2A | Inactivating mutation | 154 | 140 | TMB overall | -1.36 | -3.22 | 0.15 | 1487.89 | 1.00 | 2324 | 150 | 136 | 4 | TRUE | 0.90 |
| non-small cell lung cancer | RAS_12C | STK11 | Inactivating mutation | 19 | 59 | TMB quintile 3 | 0.92 | 0.06 | 1.89 | 1404.60 | 1.00 | 556 | 13 | 53 | 6 | TRUE | 1.28 |
| non-small cell lung cancer | RAS_12C | STK11 | Inactivating mutation | 42 | 106 | TMB quintile 4 | 0.52 | -0.16 | 1.17 | 1532.40 | 1.00 | 623 | 33 | 97 | 9 | TRUE | 0.89 |
| non-small cell lung cancer | RAS_12C | STK11 | Inactivating mutation | 93 | 183 | TMB quintile 5 | 0.25 | -0.33 | 0.74 | 1447.59 | 1.00 | 964 | 78 | 168 | 15 | TRUE | 0.44 |
| non-small cell lung cancer | RAS_12C | STK11 | Inactivating mutation | 154 | 348 | TMB overall | 0.56 | -0.23 | 1.43 | 1430.51 | 1.00 | 2143 | 124 | 318 | 30 | TRUE | 0.72 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Inactivating mutation | 42 | 35 | TMB quintile 4 | -0.13 | -1.27 | 0.83 | 1171.73 | 1.00 | 687 | 40 | 33 | 2 | FALSE | 0.09 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Inactivating mutation | 93 | 69 | TMB quintile 5 | -0.14 | -1.04 | 0.69 | 1163.91 | 1.00 | 1066 | 88 | 64 | 5 | FALSE | 0.12 |
| non-small cell lung cancer | RAS_12C | KEAP1 | Inactivating mutation | 135 | 104 | TMB overall | -0.14 | -1.23 | 0.84 | 1159.56 | 1.00 | 1753 | 128 | 97 | 7 | FALSE | 0.10 |
| non-small cell lung cancer | RAS_12C | MGA | Inactivating mutation | 40 | 16 | TMB quintile 4 | -0.86 | -4.63 | 1.03 | 1368.44 | 1.00 | 622 | 40 | 16 | 0 | FALSE | 0.25 |
| non-small cell lung cancer | RAS_12C | MGA | Inactivating mutation | 85 | 73 | TMB quintile 5 | 0.56 | -0.18 | 1.25 | 1534.67 | 1.00 | 958 | 75 | 63 | 10 | FALSE | 0.87 |
| non-small cell lung cancer | RAS_12C | MGA | Inactivating mutation | 125 | 89 | TMB overall | -0.16 | -3.15 | 1.95 | 1650.70 | 1.00 | 1580 | 115 | 79 | 10 | FALSE | 0.05 |
| non-small cell lung cancer | KRAS_12C | TP53 | Inactivating mutation | 27 | 49 | TMB quintile 2 | -0.46 | -1.47 | 0.50 | 1256.57 | 1.00 | 368 | 24 | 46 | 3 | TRUE | 0.43 |
| non-small cell lung cancer | KRAS_12C | TP53 | Inactivating mutation | 46 | 116 | TMB quintile 3 | -0.67 | -1.44 | 0.08 | 1607.80 | 1.00 | 473 | 41 | 111 | 5 | TRUE | 1.09 |
| non-small cell lung cancer | KRAS_12C | TP53 | Inactivating mutation | 127 | 145 | TMB quintile 4 | -0.72 | -1.28 | -0.22 | 1353.48 | 1.00 | 508 | 113 | 131 | 14 | TRUE | 2.03 |
| non-small cell lung cancer | KRAS_12C | TP53 | Inactivating mutation | 222 | 346 | TMB quintile 5 | -0.63 | -0.96 | -0.29 | 1508.21 | 1.00 | 707 | 181 | 305 | 41 | TRUE | 3.46 |
| non-small cell lung cancer | KRAS_12C | TP53 | Inactivating mutation | 422 | 656 | TMB overall | -0.62 | -1.35 | 0.12 | 1666.80 | 1.00 | 2056 | 359 | 593 | 63 | TRUE | 1.03 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Inactivating mutation | 46 | 12 | TMB quintile 3 | 1.29 | 0.02 | 2.48 | 1441.52 | 1.00 | 572 | 42 | 8 | 4 | FALSE | 1.41 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Inactivating mutation | 127 | 28 | TMB quintile 4 | 0.81 | 0.02 | 1.57 | 1426.62 | 1.00 | 616 | 118 | 19 | 9 | FALSE | 1.41 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Inactivating mutation | 223 | 94 | TMB quintile 5 | -0.15 | -0.76 | 0.40 | 1398.43 | 1.00 | 923 | 209 | 80 | 14 | FALSE | 0.21 |
| non-small cell lung cancer | KRAS_12C | SMARCA4 | Inactivating mutation | 396 | 134 | TMB overall | 0.66 | -0.58 | 1.95 | 1281.87 | 1.00 | 2111 | 369 | 107 | 27 | FALSE | 0.51 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Inactivating mutation | 127 | 34 | TMB quintile 4 | -0.57 | -1.66 | 0.22 | 1401.95 | 1.00 | 605 | 124 | 31 | 3 | TRUE | 0.65 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Inactivating mutation | 224 | 103 | TMB quintile 5 | -0.13 | -0.68 | 0.38 | 1515.71 | 1.00 | 920 | 206 | 85 | 18 | TRUE | 0.20 |
| non-small cell lung cancer | KRAS_12C | ARID1A | Inactivating mutation | 351 | 137 | TMB overall | -0.34 | -1.59 | 0.76 | 1328.68 | 1.00 | 1525 | 330 | 116 | 21 | TRUE | 0.26 |
| non-small cell lung cancer | KRAS_12C | RB1 | Inactivating mutation | 46 | 28 | TMB quintile 3 | -1.20 | -2.49 | 0.00 | 1482.76 | 1.00 | 553 | 45 | 27 | 1 | TRUE | 1.22 |
| non-small cell lung cancer | KRAS_12C | RB1 | Inactivating mutation | 127 | 40 | TMB quintile 4 | -1.35 | -2.50 | -0.38 | 1514.85 | 1.00 | 597 | 125 | 38 | 2 | TRUE | 1.85 |
| non-small cell lung cancer | KRAS_12C | RB1 | Inactivating mutation | 222 | 86 | TMB quintile 5 | -1.21 | -2.02 | -0.49 | 1549.89 | 1.00 | 923 | 216 | 80 | 6 | TRUE | 2.65 |
| non-small cell lung cancer | KRAS_12C | RB1 | Inactivating mutation | 395 | 154 | TMB overall | -1.24 | -2.26 | -0.15 | 1365.07 | 1.00 | 2073 | 386 | 145 | 9 | TRUE | 1.73 |
| non-small cell lung cancer | KRAS_12C | NF1 | Inactivating mutation | 46 | 18 | TMB quintile 3 | -1.65 | -3.99 | -0.06 | 1602.29 | 1.00 | 562 | 46 | 18 | 0 | TRUE | 1.05 |
| non-small cell lung cancer | KRAS_12C | NF1 | Inactivating mutation | 127 | 48 | TMB quintile 4 | -1.56 | -2.92 | -0.51 | 1499.16 | 1.00 | 597 | 125 | 46 | 2 | TRUE | 2.00 |
| non-small cell lung cancer | KRAS_12C | NF1 | Inactivating mutation | 223 | 108 | TMB quintile 5 | -1.07 | -1.75 | -0.42 | 1449.19 | 1.00 | 913 | 214 | 99 | 9 | TRUE | 2.71 |
| non-small cell lung cancer | KRAS_12C | NF1 | Inactivating mutation | 396 | 174 | TMB overall | -1.42 | -2.80 | -0.28 | 1439.21 | 1.00 | 2072 | 385 | 163 | 11 | TRUE | 1.54 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Inactivating mutation | 46 | 16 | TMB quintile 3 | -0.53 | -2.37 | 0.69 | 1068.13 | 1.00 | 568 | 46 | 16 | 0 | FALSE | 0.29 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Inactivating mutation | 127 | 34 | TMB quintile 4 | -0.29 | -1.30 | 0.55 | 1414.24 | 1.00 | 609 | 123 | 30 | 4 | FALSE | 0.27 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Inactivating mutation | 225 | 50 | TMB quintile 5 | 0.39 | -0.26 | 1.00 | 1560.23 | 1.00 | 970 | 211 | 36 | 14 | FALSE | 0.65 |
| non-small cell lung cancer | KRAS_12C | SETD2 | Inactivating mutation | 398 | 100 | TMB overall | -0.14 | -1.36 | 0.85 | 1336.33 | 1.00 | 2147 | 380 | 82 | 18 | FALSE | 0.10 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Inactivating mutation | 27 | 26 | TMB quintile 2 | 0.05 | -1.10 | 0.93 | 1357.92 | 1.00 | 389 | 26 | 25 | 1 | FALSE | 0.04 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Inactivating mutation | 46 | 40 | TMB quintile 3 | 0.16 | -0.82 | 0.93 | 1497.03 | 1.00 | 543 | 43 | 37 | 3 | FALSE | 0.14 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Inactivating mutation | 128 | 76 | TMB quintile 4 | 0.70 | 0.21 | 1.20 | 1554.44 | 1.00 | 581 | 106 | 54 | 22 | FALSE | 2.26 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Inactivating mutation | 223 | 133 | TMB quintile 5 | 0.42 | 0.01 | 0.81 | 1353.42 | 1.00 | 904 | 191 | 101 | 32 | FALSE | 1.40 |
| non-small cell lung cancer | KRAS_12C | RBM10 | Inactivating mutation | 424 | 275 | TMB overall | 0.33 | -0.41 | 1.00 | 1480.32 | 1.00 | 2417 | 366 | 217 | 58 | FALSE | 0.45 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Inactivating mutation | 46 | 17 | TMB quintile 3 | 0.21 | -1.13 | 1.45 | 1423.92 | 1.00 | 566 | 43 | 14 | 3 | TRUE | 0.12 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Inactivating mutation | 127 | 27 | TMB quintile 4 | -0.76 | -2.02 | 0.22 | 1552.91 | 1.00 | 610 | 125 | 25 | 2 | TRUE | 0.73 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Inactivating mutation | 223 | 96 | TMB quintile 5 | -0.64 | -1.31 | -0.05 | 1408.15 | 1.00 | 917 | 213 | 86 | 10 | TRUE | 1.30 |
| non-small cell lung cancer | KRAS_12C | CDKN2A | Inactivating mutation | 396 | 140 | TMB overall | -0.39 | -1.53 | 0.88 | 1455.49 | 1.00 | 2093 | 381 | 125 | 15 | TRUE | 0.29 |
| non-small cell lung cancer | KRAS_12C | STK11 | Inactivating mutation | 47 | 59 | TMB quintile 3 | 0.88 | 0.23 | 1.56 | 1283.96 | 1.00 | 532 | 37 | 49 | 10 | TRUE | 1.96 |
| non-small cell lung cancer | KRAS_12C | STK11 | Inactivating mutation | 127 | 106 | TMB quintile 4 | 1.13 | 0.70 | 1.58 | 1463.84 | 1.00 | 566 | 90 | 69 | 37 | TRUE | 6.11 |
| non-small cell lung cancer | KRAS_12C | STK11 | Inactivating mutation | 223 | 183 | TMB quintile 5 | 0.13 | -0.28 | 0.54 | 1525.38 | 1.00 | 853 | 189 | 149 | 34 | TRUE | 0.27 |
| non-small cell lung cancer | KRAS_12C | STK11 | Inactivating mutation | 397 | 348 | TMB overall | 0.70 | -0.13 | 1.50 | 1533.29 | 1.00 | 1951 | 316 | 267 | 81 | TRUE | 1.09 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Inactivating mutation | 127 | 35 | TMB quintile 4 | 0.35 | -0.24 | 1.03 | 737.73 | 1.00 | 610 | 117 | 25 | 10 | FALSE | 0.53 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Inactivating mutation | 222 | 69 | TMB quintile 5 | 0.13 | -0.45 | 0.63 | 1101.97 | 1.00 | 944 | 210 | 57 | 12 | FALSE | 0.19 |
| non-small cell lung cancer | KRAS_12C | KEAP1 | Inactivating mutation | 349 | 104 | TMB overall | 0.22 | -0.51 | 0.96 | 957.36 | 1.00 | 1554 | 327 | 82 | 22 | FALSE | 0.25 |
| non-small cell lung cancer | KRAS_12C | MGA | Inactivating mutation | 121 | 16 | TMB quintile 4 | 0.55 | -0.36 | 1.46 | 1580.56 | 1.00 | 546 | 116 | 11 | 5 | FALSE | 0.64 |
| non-small cell lung cancer | KRAS_12C | MGA | Inactivating mutation | 204 | 73 | TMB quintile 5 | 0.50 | -0.06 | 1.03 | 1539.07 | 1.00 | 848 | 185 | 54 | 19 | FALSE | 1.15 |
| non-small cell lung cancer | KRAS_12C | MGA | Inactivating mutation | 325 | 89 | TMB overall | 0.52 | -0.75 | 1.81 | 1546.97 | 1.00 | 1394 | 301 | 65 | 24 | FALSE | 0.38 |
| colorectal cancer | RAS_13 | TP53 | Inactivating mutation | 10 | 39 | TMB quintile 2 | -0.56 | -1.62 | 0.22 | 1446.87 | 1.00 | 88 | 10 | 39 | 0 | TRUE | 0.61 |
| colorectal cancer | RAS_13 | TP53 | Inactivating mutation | 25 | 146 | TMB quintile 3 | -0.48 | -1.22 | 0.17 | 1580.94 | 1.00 | 320 | 21 | 142 | 4 | TRUE | 0.76 |
| colorectal cancer | RAS_13 | TP53 | Inactivating mutation | 62 | 208 | TMB quintile 4 | -0.06 | -0.58 | 0.47 | 1467.20 | 1.00 | 542 | 45 | 191 | 17 | TRUE | 0.09 |
| colorectal cancer | RAS_13 | TP53 | Inactivating mutation | 80 | 108 | TMB quintile 5 | -0.15 | -0.67 | 0.37 | 1466.38 | 1.00 | 454 | 67 | 95 | 13 | TRUE | 0.25 |
| colorectal cancer | RAS_13 | TP53 | Inactivating mutation | 16 | 31 | TMB quintile 6 | 0.12 | -0.62 | 0.93 | 1273.35 | 1.00 | 106 | 10 | 25 | 6 | TRUE | 0.11 |
| colorectal cancer | RAS_13 | TP53 | Inactivating mutation | 193 | 532 | TMB overall | -0.23 | -0.84 | 0.30 | 1425.41 | 1.00 | 1510 | 153 | 492 | 40 | TRUE | 0.36 |
| colorectal cancer | RAS_13 | FBXW7 | Inactivating mutation | 25 | 11 | TMB quintile 3 | -0.16 | -1.91 | 1.27 | 1397.27 | 1.00 | 451 | 25 | 11 | 0 | TRUE | 0.07 |
| colorectal cancer | RAS_13 | FBXW7 | Inactivating mutation | 62 | 27 | TMB quintile 4 | 0.28 | -0.87 | 1.25 | 1502.62 | 1.00 | 706 | 59 | 24 | 3 | TRUE | 0.21 |
| colorectal cancer | RAS_13 | FBXW7 | Inactivating mutation | 80 | 49 | TMB quintile 5 | 0.15 | -0.62 | 0.90 | 1436.67 | 1.00 | 507 | 73 | 42 | 7 | TRUE | 0.15 |
| colorectal cancer | RAS_13 | FBXW7 | Inactivating mutation | 16 | 24 | TMB quintile 6 | 0.70 | -0.37 | 1.71 | 1061.50 | 1.00 | 107 | 11 | 19 | 5 | TRUE | 0.75 |
| colorectal cancer | RAS_13 | FBXW7 | Inactivating mutation | 183 | 111 | TMB overall | 0.26 | -0.84 | 1.25 | 1361.44 | 1.00 | 1771 | 168 | 96 | 15 | TRUE | 0.21 |
| colorectal cancer | RAS_13 | PTEN | Inactivating mutation | 62 | 17 | TMB quintile 4 | -0.44 | -2.39 | 0.99 | 1519.51 | 1.00 | 714 | 61 | 16 | 1 | TRUE | 0.22 |
| colorectal cancer | RAS_13 | PTEN | Inactivating mutation | 81 | 44 | TMB quintile 5 | -0.42 | -1.45 | 0.47 | 1559.58 | 1.00 | 515 | 77 | 40 | 4 | TRUE | 0.40 |
| colorectal cancer | RAS_13 | PTEN | Inactivating mutation | 18 | 57 | TMB quintile 6 | 0.32 | -0.65 | 1.24 | 1299.12 | 1.00 | 92 | 10 | 49 | 8 | TRUE | 0.29 |
| colorectal cancer | RAS_13 | PTEN | Inactivating mutation | 161 | 118 | TMB overall | -0.16 | -1.82 | 1.44 | 1400.04 | 1.00 | 1321 | 148 | 105 | 13 | TRUE | 0.07 |
| colorectal cancer | RAS_13 | ARID1A | Inactivating mutation | 62 | 24 | TMB quintile 4 | -2.07 | -5.68 | 0.04 | 1458.25 | 1.00 | 706 | 62 | 24 | 0 | TRUE | 0.80 |
| colorectal cancer | RAS_13 | ARID1A | Inactivating mutation | 80 | 87 | TMB quintile 5 | -0.64 | -1.46 | 0.12 | 1523.42 | 1.00 | 480 | 73 | 80 | 7 | TRUE | 0.95 |
| colorectal cancer | RAS_13 | ARID1A | Inactivating mutation | 19 | 96 | TMB quintile 6 | 0.00 | -0.91 | 0.91 | 1581.82 | 1.00 | 67 | 8 | 85 | 11 | TRUE | 0.00 |
| colorectal cancer | RAS_13 | ARID1A | Inactivating mutation | 161 | 207 | TMB overall | -0.88 | -3.17 | 1.13 | 1481.02 | 1.00 | 1253 | 143 | 189 | 18 | TRUE | 0.40 |
| colorectal cancer | RAS_13 | APC | Inactivating mutation | 10 | 77 | TMB quintile 2 | 0.05 | -0.85 | 0.95 | 1522.05 | 1.00 | 63 | 5 | 72 | 5 | TRUE | 0.04 |
| colorectal cancer | RAS_13 | APC | Inactivating mutation | 26 | 422 | TMB quintile 3 | -0.48 | -1.21 | 0.20 | 1374.21 | 1.00 | 150 | 12 | 408 | 14 | TRUE | 0.74 |
| colorectal cancer | RAS_13 | APC | Inactivating mutation | 89 | 936 | TMB quintile 4 | 0.30 | -0.26 | 0.92 | 1417.36 | 1.00 | 147 | 10 | 857 | 79 | TRUE | 0.50 |
| colorectal cancer | RAS_13 | APC | Inactivating mutation | 133 | 781 | TMB quintile 5 | 0.90 | 0.38 | 1.45 | 1535.64 | 1.00 | 154 | 10 | 658 | 123 | TRUE | 2.93 |
| colorectal cancer | RAS_13 | APC | Inactivating mutation | 25 | 151 | TMB quintile 6 | 0.55 | -0.19 | 1.33 | 1502.36 | 1.00 | 63 | 5 | 131 | 20 | TRUE | 0.83 |
| colorectal cancer | RAS_13 | APC | Inactivating mutation | 283 | 2367 | TMB overall | 0.25 | -0.37 | 0.93 | 1482.52 | 1.00 | 577 | 42 | 2126 | 241 | TRUE | 0.34 |
| colorectal cancer | RAS_13 | KMT2D | Inactivating mutation | 80 | 46 | TMB quintile 5 | -0.82 | -2.07 | 0.23 | 1387.30 | 1.00 | 514 | 77 | 43 | 3 | FALSE | 0.78 |
| colorectal cancer | RAS_13 | KMT2D | Inactivating mutation | 19 | 111 | TMB quintile 6 | 0.00 | -0.92 | 0.96 | 1543.62 | 1.00 | 59 | 7 | 99 | 12 | FALSE | 0.00 |
| colorectal cancer | RAS_13 | KMT2D | Inactivating mutation | 99 | 157 | TMB overall | -0.38 | -2.90 | 2.13 | 1355.22 | 1.00 | 573 | 84 | 142 | 15 | FALSE | 0.12 |
| colorectal cancer | RAS_13 | SOX9 | Inactivating mutation | 25 | 14 | TMB quintile 3 | 0.07 | -1.35 | 1.35 | 1416.12 | 1.00 | 449 | 24 | 13 | 1 | FALSE | 0.04 |
| colorectal cancer | RAS_13 | SOX9 | Inactivating mutation | 62 | 73 | TMB quintile 4 | 0.17 | -0.60 | 0.90 | 1519.23 | 1.00 | 664 | 55 | 66 | 7 | FALSE | 0.19 |
| colorectal cancer | RAS_13 | SOX9 | Inactivating mutation | 80 | 88 | TMB quintile 5 | -0.01 | -0.65 | 0.60 | 1370.39 | 1.00 | 476 | 69 | 77 | 11 | FALSE | 0.01 |
| colorectal cancer | RAS_13 | SOX9 | Inactivating mutation | 17 | 43 | TMB quintile 6 | 0.30 | -0.59 | 1.23 | 1605.28 | 1.00 | 93 | 11 | 37 | 6 | FALSE | 0.28 |
| colorectal cancer | RAS_13 | SOX9 | Inactivating mutation | 184 | 218 | TMB overall | 0.14 | -0.84 | 1.13 | 1504.41 | 1.00 | 1682 | 159 | 193 | 25 | FALSE | 0.11 |
| colorectal cancer | RAS_13 | RNF43 | Inactivating mutation | 62 | 21 | TMB quintile 4 | -1.00 | -3.28 | 0.72 | 1559.34 | 1.00 | 710 | 61 | 20 | 1 | TRUE | 0.49 |
| colorectal cancer | RAS_13 | RNF43 | Inactivating mutation | 80 | 58 | TMB quintile 5 | -1.56 | -3.17 | -0.40 | 1342.40 | 1.00 | 499 | 78 | 56 | 2 | TRUE | 1.52 |
| colorectal cancer | RAS_13 | RNF43 | Inactivating mutation | 18 | 113 | TMB quintile 6 | -0.67 | -1.61 | 0.25 | 1380.41 | 1.00 | 51 | 9 | 104 | 9 | TRUE | 0.79 |
| colorectal cancer | RAS_13 | RNF43 | Inactivating mutation | 160 | 192 | TMB overall | -1.02 | -3.39 | 1.05 | 1460.21 | 1.00 | 1260 | 148 | 180 | 12 | TRUE | 0.45 |
| colorectal cancer | RAS_13 | B2M | Inactivating mutation | 78 | 45 | TMB quintile 5 | -0.72 | -1.93 | 0.32 | 1578.50 | 1.00 | 484 | 75 | 42 | 3 | FALSE | 0.67 |
| colorectal cancer | RAS_13 | B2M | Inactivating mutation | 19 | 66 | TMB quintile 6 | 0.64 | -0.29 | 1.60 | 1462.14 | 1.00 | 84 | 8 | 55 | 11 | FALSE | 0.73 |
| colorectal cancer | RAS_13 | B2M | Inactivating mutation | 97 | 111 | TMB overall | -0.05 | -2.51 | 2.23 | 1530.87 | 1.00 | 568 | 83 | 97 | 14 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | TCF7L2 | Inactivating mutation | 25 | 13 | TMB quintile 3 | -0.80 | -3.06 | 0.94 | 1366.89 | 1.00 | 401 | 25 | 13 | 0 | FALSE | 0.37 |
| colorectal cancer | RAS_13 | TCF7L2 | Inactivating mutation | 56 | 39 | TMB quintile 4 | -0.48 | -1.78 | 0.61 | 1497.71 | 1.00 | 627 | 54 | 37 | 2 | FALSE | 0.37 |
| colorectal cancer | RAS_13 | TCF7L2 | Inactivating mutation | 70 | 57 | TMB quintile 5 | 0.36 | -0.35 | 1.03 | 1477.99 | 1.00 | 463 | 60 | 47 | 10 | FALSE | 0.51 |
| colorectal cancer | RAS_13 | TCF7L2 | Inactivating mutation | 16 | 48 | TMB quintile 6 | -0.18 | -1.29 | 0.82 | 1543.04 | 1.00 | 77 | 11 | 43 | 5 | FALSE | 0.13 |
| colorectal cancer | RAS_13 | TCF7L2 | Inactivating mutation | 167 | 157 | TMB overall | -0.28 | -1.63 | 0.96 | 1501.94 | 1.00 | 1568 | 150 | 140 | 17 | FALSE | 0.17 |
| colorectal cancer | RAS_13 | AMER1 | Inactivating mutation | 62 | 31 | TMB quintile 4 | 0.03 | -1.17 | 1.01 | 1394.67 | 1.00 | 700 | 60 | 29 | 2 | FALSE | 0.02 |
| colorectal cancer | RAS_13 | AMER1 | Inactivating mutation | 80 | 47 | TMB quintile 5 | 0.48 | -0.27 | 1.16 | 1460.38 | 1.00 | 508 | 71 | 38 | 9 | FALSE | 0.72 |
| colorectal cancer | RAS_13 | AMER1 | Inactivating mutation | 16 | 27 | TMB quintile 6 | 0.84 | -0.10 | 1.76 | 1255.51 | 1.00 | 104 | 10 | 21 | 6 | FALSE | 1.07 |
| colorectal cancer | RAS_13 | AMER1 | Inactivating mutation | 158 | 105 | TMB overall | 0.45 | -0.66 | 1.47 | 1451.25 | 1.00 | 1312 | 141 | 88 | 17 | FALSE | 0.40 |
| colorectal cancer | KRAS_13 | TP53 | Inactivating mutation | 10 | 39 | TMB quintile 2 | -0.56 | -1.62 | 0.21 | 1600.20 | 1.00 | 88 | 10 | 39 | 0 | TRUE | 0.64 |
| colorectal cancer | KRAS_13 | TP53 | Inactivating mutation | 23 | 146 | TMB quintile 3 | -0.48 | -1.22 | 0.19 | 1486.64 | 1.00 | 322 | 19 | 142 | 4 | TRUE | 0.77 |
| colorectal cancer | KRAS_13 | TP53 | Inactivating mutation | 59 | 208 | TMB quintile 4 | -0.10 | -0.62 | 0.40 | 1504.18 | 1.00 | 544 | 43 | 192 | 16 | TRUE | 0.16 |
| colorectal cancer | KRAS_13 | TP53 | Inactivating mutation | 76 | 108 | TMB quintile 5 | -0.18 | -0.73 | 0.35 | 1406.38 | 1.00 | 457 | 64 | 96 | 12 | TRUE | 0.30 |
| colorectal cancer | KRAS_13 | TP53 | Inactivating mutation | 15 | 31 | TMB quintile 6 | -0.01 | -0.78 | 0.80 | 1186.07 | 1.00 | 106 | 10 | 26 | 5 | TRUE | 0.01 |
| colorectal cancer | KRAS_13 | TP53 | Inactivating mutation | 183 | 532 | TMB overall | -0.26 | -0.84 | 0.34 | 1180.72 | 1.00 | 1517 | 146 | 495 | 37 | TRUE | 0.43 |
| colorectal cancer | KRAS_13 | FBXW7 | Inactivating mutation | 23 | 11 | TMB quintile 3 | -0.12 | -1.97 | 1.25 | 1262.73 | 1.00 | 453 | 23 | 11 | 0 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | FBXW7 | Inactivating mutation | 59 | 27 | TMB quintile 4 | 0.29 | -0.79 | 1.25 | 1433.51 | 1.00 | 709 | 56 | 24 | 3 | TRUE | 0.23 |
| colorectal cancer | KRAS_13 | FBXW7 | Inactivating mutation | 76 | 49 | TMB quintile 5 | 0.25 | -0.56 | 0.97 | 1530.52 | 1.00 | 511 | 69 | 42 | 7 | TRUE | 0.28 |
| colorectal cancer | KRAS_13 | FBXW7 | Inactivating mutation | 15 | 24 | TMB quintile 6 | 0.80 | -0.26 | 1.79 | 1484.83 | 1.00 | 108 | 10 | 19 | 5 | TRUE | 0.91 |
| colorectal cancer | KRAS_13 | FBXW7 | Inactivating mutation | 173 | 111 | TMB overall | 0.30 | -0.76 | 1.33 | 1492.58 | 1.00 | 1781 | 158 | 96 | 15 | TRUE | 0.24 |
| colorectal cancer | KRAS_13 | PTEN | Inactivating mutation | 59 | 17 | TMB quintile 4 | -0.42 | -2.56 | 1.08 | 1406.64 | 1.00 | 717 | 58 | 16 | 1 | TRUE | 0.19 |
| colorectal cancer | KRAS_13 | PTEN | Inactivating mutation | 77 | 44 | TMB quintile 5 | -0.37 | -1.41 | 0.57 | 1332.22 | 1.00 | 519 | 73 | 40 | 4 | TRUE | 0.32 |
| colorectal cancer | KRAS_13 | PTEN | Inactivating mutation | 17 | 57 | TMB quintile 6 | 0.41 | -0.55 | 1.36 | 1423.60 | 1.00 | 93 | 9 | 49 | 8 | TRUE | 0.40 |
| colorectal cancer | KRAS_13 | PTEN | Inactivating mutation | 153 | 118 | TMB overall | -0.12 | -1.84 | 1.50 | 1398.28 | 1.00 | 1329 | 140 | 105 | 13 | TRUE | 0.05 |
| colorectal cancer | KRAS_13 | ARID1A | Inactivating mutation | 59 | 24 | TMB quintile 4 | -1.94 | -5.74 | 0.11 | 1548.53 | 1.00 | 709 | 59 | 24 | 0 | TRUE | 0.73 |
| colorectal cancer | KRAS_13 | ARID1A | Inactivating mutation | 76 | 87 | TMB quintile 5 | -0.57 | -1.46 | 0.21 | 1358.37 | 1.00 | 484 | 69 | 80 | 7 | TRUE | 0.73 |
| colorectal cancer | KRAS_13 | ARID1A | Inactivating mutation | 18 | 96 | TMB quintile 6 | 0.15 | -0.85 | 1.08 | 1499.44 | 1.00 | 68 | 7 | 85 | 11 | TRUE | 0.12 |
| colorectal cancer | KRAS_13 | ARID1A | Inactivating mutation | 153 | 207 | TMB overall | -0.73 | -3.06 | 1.38 | 1476.52 | 1.00 | 1261 | 135 | 189 | 18 | TRUE | 0.31 |
| colorectal cancer | KRAS_13 | APC | Inactivating mutation | 10 | 77 | TMB quintile 2 | 0.01 | -0.90 | 0.89 | 1454.30 | 1.00 | 63 | 5 | 72 | 5 | TRUE | 0.01 |
| colorectal cancer | KRAS_13 | APC | Inactivating mutation | 24 | 422 | TMB quintile 3 | -0.62 | -1.33 | 0.09 | 1594.63 | 1.00 | 150 | 12 | 410 | 12 | TRUE | 1.04 |
| colorectal cancer | KRAS_13 | APC | Inactivating mutation | 83 | 936 | TMB quintile 4 | 0.21 | -0.33 | 0.78 | 1472.99 | 1.00 | 147 | 10 | 863 | 73 | TRUE | 0.35 |
| colorectal cancer | KRAS_13 | APC | Inactivating mutation | 126 | 781 | TMB quintile 5 | 0.83 | 0.25 | 1.39 | 1558.20 | 1.00 | 154 | 10 | 665 | 116 | TRUE | 2.39 |
| colorectal cancer | KRAS_13 | APC | Inactivating mutation | 23 | 151 | TMB quintile 6 | 0.41 | -0.32 | 1.20 | 1395.31 | 1.00 | 63 | 5 | 133 | 18 | TRUE | 0.54 |
| colorectal cancer | KRAS_13 | APC | Inactivating mutation | 266 | 2367 | TMB overall | 0.17 | -0.50 | 0.86 | 1564.31 | 1.00 | 577 | 42 | 2143 | 224 | TRUE | 0.20 |
| colorectal cancer | KRAS_13 | KMT2D | Inactivating mutation | 76 | 46 | TMB quintile 5 | -0.78 | -2.03 | 0.22 | 1615.39 | 1.00 | 518 | 73 | 43 | 3 | FALSE | 0.73 |
| colorectal cancer | KRAS_13 | KMT2D | Inactivating mutation | 18 | 111 | TMB quintile 6 | -0.10 | -1.12 | 0.85 | 1458.44 | 1.00 | 59 | 7 | 100 | 11 | FALSE | 0.07 |
| colorectal cancer | KRAS_13 | KMT2D | Inactivating mutation | 94 | 157 | TMB overall | -0.42 | -3.05 | 2.23 | 1391.82 | 1.00 | 577 | 80 | 143 | 14 | FALSE | 0.13 |
| colorectal cancer | KRAS_13 | SOX9 | Inactivating mutation | 23 | 14 | TMB quintile 3 | 0.14 | -1.39 | 1.41 | 1442.09 | 1.00 | 451 | 22 | 13 | 1 | FALSE | 0.08 |
| colorectal cancer | KRAS_13 | SOX9 | Inactivating mutation | 59 | 73 | TMB quintile 4 | 0.23 | -0.53 | 0.93 | 1525.35 | 1.00 | 667 | 52 | 66 | 7 | FALSE | 0.26 |
| colorectal cancer | KRAS_13 | SOX9 | Inactivating mutation | 76 | 88 | TMB quintile 5 | 0.06 | -0.62 | 0.67 | 1309.96 | 1.00 | 480 | 65 | 77 | 11 | FALSE | 0.07 |
| colorectal cancer | KRAS_13 | SOX9 | Inactivating mutation | 16 | 43 | TMB quintile 6 | 0.17 | -0.88 | 1.15 | 1305.22 | 1.00 | 93 | 11 | 38 | 5 | FALSE | 0.13 |
| colorectal cancer | KRAS_13 | SOX9 | Inactivating mutation | 174 | 218 | TMB overall | 0.14 | -0.89 | 1.16 | 1540.42 | 1.00 | 1691 | 150 | 194 | 24 | FALSE | 0.10 |
| colorectal cancer | KRAS_13 | RNF43 | Inactivating mutation | 59 | 21 | TMB quintile 4 | -0.97 | -3.20 | 0.66 | 1499.73 | 1.00 | 713 | 58 | 20 | 1 | TRUE | 0.48 |
| colorectal cancer | KRAS_13 | RNF43 | Inactivating mutation | 76 | 58 | TMB quintile 5 | -1.52 | -2.97 | -0.31 | 1273.01 | 1.00 | 503 | 74 | 56 | 2 | TRUE | 1.56 |
| colorectal cancer | KRAS_13 | RNF43 | Inactivating mutation | 17 | 113 | TMB quintile 6 | -0.85 | -1.85 | 0.11 | 1505.99 | 1.00 | 51 | 9 | 105 | 8 | TRUE | 1.08 |
| colorectal cancer | KRAS_13 | RNF43 | Inactivating mutation | 152 | 192 | TMB overall | -1.09 | -3.28 | 0.90 | 1434.16 | 1.00 | 1267 | 141 | 181 | 11 | TRUE | 0.54 |
| colorectal cancer | KRAS_13 | B2M | Inactivating mutation | 74 | 45 | TMB quintile 5 | -0.68 | -1.90 | 0.33 | 1524.01 | 1.00 | 488 | 71 | 42 | 3 | FALSE | 0.62 |
| colorectal cancer | KRAS_13 | B2M | Inactivating mutation | 18 | 66 | TMB quintile 6 | 0.78 | -0.13 | 1.73 | 1439.79 | 1.00 | 85 | 7 | 55 | 11 | FALSE | 0.96 |
| colorectal cancer | KRAS_13 | B2M | Inactivating mutation | 92 | 111 | TMB overall | 0.06 | -2.53 | 2.50 | 1349.39 | 1.00 | 573 | 78 | 97 | 14 | FALSE | 0.02 |
| colorectal cancer | KRAS_13 | TCF7L2 | Inactivating mutation | 23 | 13 | TMB quintile 3 | -0.71 | -2.98 | 0.94 | 1462.56 | 1.00 | 403 | 23 | 13 | 0 | FALSE | 0.31 |
| colorectal cancer | KRAS_13 | TCF7L2 | Inactivating mutation | 53 | 39 | TMB quintile 4 | -0.42 | -1.77 | 0.67 | 1442.16 | 1.00 | 630 | 51 | 37 | 2 | FALSE | 0.30 |
| colorectal cancer | KRAS_13 | TCF7L2 | Inactivating mutation | 66 | 57 | TMB quintile 5 | 0.43 | -0.34 | 1.14 | 1566.13 | 1.00 | 467 | 56 | 47 | 10 | FALSE | 0.60 |
| colorectal cancer | KRAS_13 | TCF7L2 | Inactivating mutation | 15 | 48 | TMB quintile 6 | -0.07 | -1.17 | 0.96 | 1441.52 | 1.00 | 78 | 10 | 43 | 5 | FALSE | 0.05 |
| colorectal cancer | KRAS_13 | TCF7L2 | Inactivating mutation | 157 | 157 | TMB overall | -0.18 | -1.46 | 1.00 | 1507.65 | 1.00 | 1578 | 140 | 140 | 17 | FALSE | 0.12 |
| colorectal cancer | KRAS_13 | AMER1 | Inactivating mutation | 59 | 31 | TMB quintile 4 | -0.40 | -1.93 | 0.75 | 1416.87 | 1.00 | 702 | 58 | 30 | 1 | FALSE | 0.24 |
| colorectal cancer | KRAS_13 | AMER1 | Inactivating mutation | 76 | 47 | TMB quintile 5 | 0.07 | -0.74 | 0.83 | 1356.20 | 1.00 | 509 | 70 | 41 | 6 | FALSE | 0.07 |
| colorectal cancer | KRAS_13 | AMER1 | Inactivating mutation | 15 | 27 | TMB quintile 6 | 0.83 | -0.27 | 1.87 | 1511.24 | 1.00 | 105 | 9 | 21 | 6 | FALSE | 0.90 |
| colorectal cancer | KRAS_13 | AMER1 | Inactivating mutation | 150 | 105 | TMB overall | 0.16 | -1.22 | 1.40 | 1482.77 | 1.00 | 1316 | 137 | 92 | 13 | FALSE | 0.09 |
| melanoma | NRAS_12-61 | NF1 | Inactivating mutation | 14 | 11 | TMB quintile 3 | -0.67 | -3.07 | 1.01 | 1484.49 | 1.00 | 87 | 13 | 10 | 1 | TRUE | 0.29 |
| melanoma | NRAS_12-61 | NF1 | Inactivating mutation | 147 | 117 | TMB quintile 5 | -1.58 | -2.20 | -1.02 | 1345.08 | 1.00 | 177 | 132 | 102 | 15 | TRUE | 6.67 |
| melanoma | NRAS_12-61 | NF1 | Inactivating mutation | 11 | 68 | TMB quintile 6 | 0.72 | -0.68 | 2.44 | 1379.17 | 1.00 | 22 | 1 | 58 | 10 | TRUE | 0.44 |
| melanoma | NRAS_12-61 | NF1 | Inactivating mutation | 172 | 196 | TMB overall | -0.51 | -2.62 | 1.69 | 1536.97 | 1.00 | 286 | 146 | 170 | 26 | TRUE | 0.20 |
| colorectal cancer | NRAS_12-61 | APC | Inactivating mutation | 19 | 422 | TMB quintile 3 | 0.38 | -0.57 | 1.38 | 1529.20 | 1.00 | 157 | 5 | 408 | 14 | TRUE | 0.35 |
| colorectal cancer | NRAS_12-61 | APC | Inactivating mutation | 50 | 936 | TMB quintile 4 | 1.45 | 0.42 | 2.69 | 1556.99 | 1.00 | 156 | 1 | 887 | 49 | TRUE | 1.89 |
| colorectal cancer | NRAS_12-61 | APC | Inactivating mutation | 46 | 781 | TMB quintile 5 | 0.94 | 0.09 | 1.85 | 1475.24 | 1.00 | 160 | 4 | 739 | 42 | TRUE | 1.39 |
| colorectal cancer | NRAS_12-61 | APC | Inactivating mutation | 116 | 2367 | TMB overall | 0.49 | -0.76 | 1.54 | 1536.94 | 1.00 | 608 | 11 | 2262 | 105 | TRUE | 0.40 |
| melanoma | RAS_61 | NF1 | Inactivating mutation | 11 | 11 | TMB quintile 3 | -2.39 | -6.33 | 0.09 | 1549.11 | 1.00 | 89 | 11 | 11 | 0 | TRUE | 0.84 |
| melanoma | RAS_61 | NF1 | Inactivating mutation | 135 | 117 | TMB quintile 5 | -1.88 | -2.54 | -1.25 | 1449.36 | 1.00 | 185 | 124 | 106 | 11 | TRUE | 7.77 |
| melanoma | RAS_61 | NF1 | Inactivating mutation | 151 | 196 | TMB overall | -1.50 | -3.95 | 0.80 | 1597.14 | 1.00 | 296 | 136 | 181 | 15 | TRUE | 0.70 |
| colorectal cancer | RAS_61 | APC | Inactivating mutation | 24 | 422 | TMB quintile 3 | -0.40 | -1.16 | 0.36 | 1258.06 | 1.00 | 152 | 10 | 408 | 14 | TRUE | 0.50 |
| colorectal cancer | RAS_61 | APC | Inactivating mutation | 48 | 936 | TMB quintile 4 | 0.66 | -0.13 | 1.63 | 1504.09 | 1.00 | 154 | 3 | 891 | 45 | TRUE | 0.84 |
| colorectal cancer | RAS_61 | APC | Inactivating mutation | 48 | 781 | TMB quintile 5 | 0.85 | 0.02 | 1.80 | 1433.52 | 1.00 | 161 | 3 | 736 | 45 | TRUE | 1.23 |
| colorectal cancer | RAS_61 | APC | Inactivating mutation | 123 | 2367 | TMB overall | -0.08 | -1.22 | 0.99 | 1273.41 | 1.00 | 600 | 19 | 2263 | 104 | TRUE | 0.06 |
| melanoma | NRAS_61 | NF1 | Inactivating mutation | 10 | 11 | TMB quintile 3 | -2.21 | -5.96 | 0.48 | 1457.61 | 1.00 | 90 | 10 | 11 | 0 | TRUE | 0.77 |
| melanoma | NRAS_61 | NF1 | Inactivating mutation | 131 | 117 | TMB quintile 5 | -1.94 | -2.70 | -1.29 | 1517.47 | 1.00 | 188 | 121 | 107 | 10 | TRUE | 7.26 |
| melanoma | NRAS_61 | NF1 | Inactivating mutation | 146 | 196 | TMB overall | -1.45 | -3.89 | 0.85 | 1646.83 | 1.00 | 300 | 132 | 182 | 14 | TRUE | 0.67 |
R version 4.2.1 (2022-06-23)
Platform: x86_64-apple-darwin21.5.0 (64-bit)
Running under: macOS Monterey 12.5.1
Matrix products: default
BLAS: /usr/local/Cellar/openblas/0.3.20/lib/libopenblasp-r0.3.20.dylib
LAPACK: /usr/local/Cellar/r/4.2.1/lib/R/lib/libRlapack.dylib
locale:
[1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8
attached base packages:
[1] stats graphics grDevices utils datasets methods base
other attached packages:
[1] here_1.0.1 gt_0.6.0 forcats_0.5.1 stringr_1.4.0
[5] dplyr_1.0.9 purrr_0.3.4 readr_2.1.2 tidyr_1.2.0
[9] tibble_3.1.8 ggplot2_3.3.6 tidyverse_1.3.2 magrittr_2.0.3
[13] workflowr_1.7.0
loaded via a namespace (and not attached):
[1] httr_1.4.3 sass_0.4.2 bit64_4.0.5
[4] vroom_1.5.7 jsonlite_1.8.0 modelr_0.1.8
[7] bslib_0.4.0 assertthat_0.2.1 getPass_0.2-2
[10] highr_0.9 googlesheets4_1.0.1 cellranger_1.1.0
[13] yaml_2.3.5 pillar_1.8.0 backports_1.4.1
[16] glue_1.6.2 digest_0.6.29 checkmate_2.1.0
[19] promises_1.2.0.1 rvest_1.0.2 colorspace_2.0-3
[22] htmltools_0.5.3 httpuv_1.6.5 pkgconfig_2.0.3
[25] broom_1.0.0 haven_2.5.0 scales_1.2.0
[28] processx_3.7.0 whisker_0.4 later_1.3.0
[31] tzdb_0.3.0 git2r_0.30.1 googledrive_2.0.0
[34] generics_0.1.3 ellipsis_0.3.2 cachem_1.0.6
[37] withr_2.5.0 cli_3.3.0 crayon_1.5.1
[40] readxl_1.4.0 evaluate_0.16 ps_1.7.1
[43] fs_1.5.2 fansi_1.0.3 xml2_1.3.3
[46] tools_4.2.1 hms_1.1.1 gargle_1.2.0
[49] lifecycle_1.0.1 munsell_0.5.0 reprex_2.0.1
[52] callr_3.7.1 compiler_4.2.1 jquerylib_0.1.4
[55] rlang_1.0.4 grid_4.2.1 rstudioapi_0.13
[58] rmarkdown_2.14 gtable_0.3.0 DBI_1.1.3
[61] R6_2.5.1 lubridate_1.8.0 knitr_1.39
[64] bit_4.0.4 fastmap_1.1.0 utf8_1.2.2
[67] rprojroot_2.0.3 stringi_1.7.8 parallel_4.2.1
[70] Rcpp_1.0.9 vctrs_0.4.1 dbplyr_2.2.1
[73] tidyselect_1.1.2 xfun_0.32